PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Greene, E; Pack, A; Stanton, J; Shelus, V; Tolley, EE; Taylor, J; El Sadr, WM; Branson, BM; Leider, J; Rakhmanina, N; Gamble, T				Greene, Elizabeth; Pack, Allison; Stanton, Jill; Shelus, Victoria; Tolley, Elizabeth E.; Taylor, Jamilah; El Sadr, Wafaa M.; Branson, Bernard M.; Leider, Jason; Rakhmanina, Natella; Gamble, Theresa			"It Makes You Feel Like Someone Cares" acceptability of a financial incentive intervention for HIV viral suppression in the HPTN 065 (TLC-Plus) study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ENCOURAGING UPTAKE; HEALTHY BEHAVIORS; ADHERENCE; MORTALITY	Background HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $70 gift card financial incentives to HIV-infected patients on antiretroviral therapy (ART) to encourage ART adherence and viral suppression, and represents the largest study to-date of a financial incentive intervention for HIV viral suppression. A post-trial qualitative sub-study was undertaken to examine acceptability of the financial incentives among those receiving and implementing the intervention. Methods Between July and October 2013, semi-structured interviews were conducted with 72 patients and 12 investigators from 14 sites; three focus groups were conducted with 12 staff from 10 sites. Qualitative data collection elicited experiences with and attitudes about the intervention, including philosophical viewpoints and implementation experiences. Transcripts were analyzed in NVivo 10. Memos and matrices were developed to explore themes from different participant group perspectives. Results Patients, investigators, and staff found the intervention highly acceptable, primarily due to the emotional benefits gained through giving or receiving the incentive. Feeling rewarded or cared for was a main value perceived by patients; this was closely tied to the financial benefit for some. Other factors influencing acceptability for all included perceived effectiveness and health-related benefits, philosophical concerns about the use of incentives for health behavior change, and implementation issues. The termination of the incentive at the end of the study was disappointing to participants and unexpected by some, but generally accepted. Conclusion Positive experiences with the financial incentive intervention and strategies used to facilitate implementation led to high acceptability of the intervention, despite some reluctance in principle to the use of incentives. The findings of this analysis provide encouraging evidence in support of the acceptability of a large-scale financial incentive intervention for HIV viral suppression in a clinical setting, and offer valuable lessons for future applications of similar interventions.	[Greene, Elizabeth; Stanton, Jill; Gamble, Theresa] FHI 360, Sci Facilitat Dept, Durham, NC 27701 USA; [Pack, Allison] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Shelus, Victoria] Georgetown Univ, Inst Reprod Hlth, Washington, DC USA; [Tolley, Elizabeth E.; Taylor, Jamilah] FHI 360, Social & Behav Hlth Sci, Durham, NC USA; [El Sadr, Wafaa M.] Columbia Univ, ICAP, Mailman Sch Publ Hlth, New York, NY USA; [Branson, Bernard M.] Sci Affairs LLC, Atlanta, GA USA; [Leider, Jason] Jacobi Med Ctr, New York, NY USA; [Rakhmanina, Natella] Childrens Natl Hlth Syst, Washington, DC USA; [Rakhmanina, Natella] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA	FHI 360; University of North Carolina; University of North Carolina Chapel Hill; Georgetown University; FHI 360; Columbia University; Jacobi Medical Center; Children's National Health System	Greene, E (corresponding author), FHI 360, Sci Facilitat Dept, Durham, NC 27701 USA.	egreene@fhi360.org		Shelus, Victoria/0000-0001-7418-6002				[Anonymous], 2015, GUIDELINES USE ANTIR, pC; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooke CE, 2014, J MANAGE CARE PHARM, V20, P86, DOI 10.18553/jmcp.2014.20.1.86; Donnell Deborah J, 2012, Open AIDS J, V6, P122, DOI 10.2174/1874613601206010122; Farber S, 2013, AIDS BEHAV, V17, P2293, DOI 10.1007/s10461-013-0416-1; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Javanbakht Marjan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P143, DOI 10.1177/1545109706291706; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Marteau TM, 2009, BMJ, V338; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega Jean B, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P128, DOI 10.1177/1545109712437244; Oliver A, 2012, J HEALTH POLIT POLIC, V37, P201, DOI 10.1215/03616878-1538602; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petry NM, 2010, ADDICTION, V105, P1507, DOI 10.1111/j.1360-0443.2009.02879.x; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rosen MI, 2007, AIDS PATIENT CARE ST, V21, P30, DOI 10.1089/apc.2006.0028; Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020; Solomon SS, 2014, CLIN INFECT DIS; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tolley E, 2016, QUALITATIVE METHODS, P85	28	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170686	10.1371/journal.pone.0170686	http://dx.doi.org/10.1371/journal.pone.0170686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182706	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800016
J	Hung, SY; Loh, CYY; Kwon, SH; Tsai, CH; Chang, KP; Kao, HK				Hung, Shao-Yu; Loh, Charles Yuen Yung; Kwon, Soo-Ha; Tsai, Chia-Hsuan; Chang, Kai-Ping; Kao, Huang-Kai			Assessing the suitability of medial sural artery perforator flaps in tongue reconstruction - An outcome study	PLOS ONE			English	Article							ANTEROLATERAL THIGH FLAP; FREE TISSUE TRANSFER; RADIAL FOREARM FLAP; TERM-FOLLOW-UP; FUNCTIONAL ASSESSMENT; HEMIGLOSSECTOMY; NECK; HEAD; SURGERY	Introduction Oncological resection of the tongue can be reconstructed using a multitude of free flaps. The medial sural artery perforator (MSAP) flap has been well described in the literature in terms of its anatomy and harvest. However, functional outcome studies of post-reconstruction tongue defects using the MSAP flap have not been reported. This study represents the largest outcome study of patients with tongue reconstructions using MSAP flaps and a comprehensive review of its use. Materials and methods From December of 2010 to October of 2015, 579 patients with subtotal glossectomy and free flap reconstructions in Chang Gung Memorial Hospital were retrospectively reviewed. 27 patients were reconstructed with MSAP flap. The pre- and intra-operative factors, as well as flap-related factors were analyzed. Post-operative complications and functional outcomes were evaluated. Donor site assessment were also conducted. Results A 96.3% flap survival rate was found with an average total operating time of 6 hours and 18 minutes. 84.6% of patients had primary closure of the donor site with and the remaining either had skin grafts or delayed closure. Donor site closure can be achieved primarily with no functional deficit. Speech intelligibility remained for most patients. 100% of patients resumed normal oral feeding. Conclusion The MSAP flap is a small to medium sized flap most suited for subtotal glossectomy defects where optimal outcomes can be achieved in terms of speech clarity and restoration of oral intake.	[Hung, Shao-Yu; Loh, Charles Yuen Yung; Kwon, Soo-Ha; Tsai, Chia-Hsuan; Kao, Huang-Kai] Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Hung, Shao-Yu; Loh, Charles Yuen Yung; Kwon, Soo-Ha; Tsai, Chia-Hsuan; Kao, Huang-Kai] Chang Gung Mem Hosp, Taoyuan, Taiwan; [Hung, Shao-Yu; Loh, Charles Yuen Yung; Kwon, Soo-Ha; Tsai, Chia-Hsuan; Kao, Huang-Kai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Loh, Charles Yuen Yung] Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Taoyuan, Taiwan; [Loh, Charles Yuen Yung] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Kai-Ping] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Kao, HK (corresponding author), Dept Plast & Reconstruct Surg, Taoyuan, Taiwan.; Kao, HK (corresponding author), Chang Gung Mem Hosp, Taoyuan, Taiwan.; Kao, HK (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	kai3488@gmail.com	Loh, Charles Yuen Yung/AAA-3762-2020; Loh, Charles Yuen Yung/AAZ-1783-2021	Loh, Charles Yuen Yung/0000-0003-2646-0358; 				Adel M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002950; Akashi M, 2015, J CRANIOFAC SURG, V26, P48, DOI 10.1097/SCS.0000000000001176; Baas M, 2015, J PLAST RECONSTR AES, V68, P1025, DOI 10.1016/j.bjps.2015.04.020; Cavadas PC, 2001, PLAST RECONSTR SURG, V108, P1609, DOI 10.1097/00006534-200111000-00027; Chang YM, 2016, CLIN PLAST SURG, V43, P747, DOI 10.1016/j.cps.2016.06.002; de Vicente JC, 2008, J ORAL MAXIL SURG, V66, P2270, DOI 10.1016/j.joms.2008.01.018; Deek NFAL, 2016, CLIN PLAST SURG, V43, P621, DOI 10.1016/j.cps.2016.06.003; Engel H, 2010, PLAST RECONSTR SURG, V126, P1967, DOI 10.1097/PRS.0b013e3181f44742; Fujimoto Y, 1997, Nihon Jibiinkoka Gakkai Kaiho, V100, P1401; Gupta B, 2016, ONCOLOGY; Kao HK, 2010, PLAST RECONSTR SURG, V125, P1135, DOI 10.1097/PRS.0b013e3181d180ac; Kao HK, 2009, PLAST RECONSTR SURG, V124, P1125, DOI 10.1097/PRS.0b013e3181b457cf; Li XR, 2016, J CRANIOFAC SURG, V27, pE172, DOI 10.1097/SCS.0000000000002261; Lu MX, 2015, MED ORAL PATOL ORAL, V20, pE757, DOI 10.4317/medoral.20727; Offodile AC, 2016, ANN SURG ONCOL; Saba L, 2013, ACTA RADIOL, V54, P89, DOI 10.1258/ar.2012.120245; Taguchi T., 1966, TREATMENT SPEECH DIS, P37; Tsao CK, 2016, HEAD NECK-J SCI SPEC, V38, pE2515, DOI 10.1002/hed.24539	18	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171570	10.1371/journal.pone.0171570	http://dx.doi.org/10.1371/journal.pone.0171570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182639	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800074
J	Wu, B; Xiao, F; Li, PW; Du, Y; Lin, JQ; Ming, KH; Chen, B; Lei, XX; Xu, BL; Liu, DY				Wu, Bin; Xiao, Feng; Li, Peiwen; Du, Yan; Lin, Jinqiong; Ming, Kaihua; Chen, Bin; Lei, Xiuxia; Xu, Banglao; Liu, Dayu			Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR	PLOS ONE			English	Article							VERSANT HBV DNA-3.0; PLASMID DNA; VIRAL LOAD; TAQMAN HBV; ASSAY; MEMBRANES; QUANTIFICATION; TRANSMISSION; QUANTITATION; SYSTEM	Background A simple and reliable DNA extraction of hepatitis B virus (HBV) is critical in developing an ultrasensitive detection method for HBV infection. Current commercially available serum Hepatitis B Virus (HBV) DNA extraction methods are time-consuming, expensive and/or require specialized equipment, which hinders wide adoption of clinical laboratories. This study offers a report on an ultrasensitive HBV DNA detection method by coupling serum HBV DNA extraction by ultrafiltration (UF) with real-time PCR (qPCR) detection. Methods Serum proteins were precipitated by phenol to release HBV DNA in the supernatant which was then transferred to the UF devices. The resultant DNA concentrate was eluted and released into qPCR pre-mixture. The UF-qPCR assay performance, including recovery rate, linearity, detection sensitivity, precision and diagnostic accuracy that compared to the CAP-CTM V2.0 assay by analyzing batched low viral load clinical samples was evaluated. Results The recovery rate of the UF-based HBV DNA extraction method was above 80%. The assay linearity was demonstrated with a slope of 0.95 and R-2 values of 0.99. Limit-of-detection (LOD) of the UF-qPCR assay was determined to be 12.1IU/ml. The coefficient of variation (CV) of HBV quantitation for high, low and limit titer samples was 2.28%, 5.77% and 25.59%, respectively. Accuracy of the UF-qPCR assay was confirmed with the reference panel, and there was a strong correlation between these two methods (R-2 = 0.55, p < 0.01). Conclusions The UF-qPCR assay is reliable, highly sensitive, affordable and time-saving, and the method can be used for ultrasensitive detection of serum HBV.	[Wu, Bin; Xiao, Feng; Li, Peiwen; Du, Yan; Lin, Jinqiong; Ming, Kaihua; Chen, Bin; Lei, Xiuxia; Xu, Banglao; Liu, Dayu] Affiliated Hosp Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Ming, Kaihua; Chen, Bin; Lei, Xiuxia; Xu, Banglao; Liu, Dayu] Clin Mol Med & Mol Diag Key Lab Guangdong Prov, Guangzhou, Guangdong, Peoples R China		Lei, XX; Liu, DY (corresponding author), Affiliated Hosp Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.; Lei, XX; Liu, DY (corresponding author), Clin Mol Med & Mol Diag Key Lab Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	leixx999@163.com; ruark@126.com						Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Arkhangelsky E, 2008, DESALINATION, V227, P111, DOI 10.1016/j.desal.2007.07.017; ARRIBAS JR, 1995, J CLIN MICROBIOL, V33, P1580, DOI 10.1128/JCM.33.6.1580-1583.1995; Bilad MR, 2014, BIOTECHNOL ADV, V32, P1283, DOI 10.1016/j.biotechadv.2014.07.008; Cha BH, 2009, BIOSENS BIOELECTRON, V25, P130, DOI 10.1016/j.bios.2009.06.015; Ciotti M, 2008, J CLIN MICROBIOL, V46, P1517, DOI 10.1128/JCM.02046-07; FAGAN EA, 1985, J VIROL METHODS, V12, P251, DOI 10.1016/0166-0934(85)90136-3; Garbuglia AR, 2007, J VIROL METHODS, V146, P274, DOI 10.1016/j.jviromet.2007.07.005; Goldar A, 2004, EUR PHYS J E, V14, P211, DOI 10.1140/epje/i2004-10011-7; Goosen MFA, 2004, SEP SCI TECHNOL, V39, P2261, DOI 10.1081/SS-120039343; HANCHER CW, 1973, BIOTECHNOL BIOENG, V15, P677, DOI 10.1002/bit.260150404; HIRASAKI T, 1995, J MEMBRANE SCI, V106, P123, DOI 10.1016/0376-7388(95)00082-N; Hochberger S, 2006, J CLIN VIROL, V35, P373, DOI 10.1016/j.jcv.2006.01.003; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kramvis A, 1996, J CLIN MICROBIOL, V34, P2731, DOI 10.1128/JCM.34.11.2731-2733.1996; Lai MW, 2012, GASTROENTEROLOGY, V143, P400, DOI 10.1053/j.gastro.2012.05.002; Latulippe DR, 2008, BIOTECHNOL BIOENG, V99, P390, DOI 10.1002/bit.21575; Latulippe DR, 2007, J MEMBRANE SCI, V294, P169, DOI 10.1016/j.memsci.2007.02.033; Lee KB, 2012, FOOD ENVIRON VIROL, V4, P68, DOI 10.1007/s12560-012-9077-x; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liang Y, 2011, ALIMENT PHARM THER, V34, P344, DOI 10.1111/j.1365-2036.2011.04738.x; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lindh M, 2005, J CLIN MICROBIOL, V43, P4251, DOI 10.1128/JCM.43.8.4251-4254.2005; Liu PB, 2012, J MICROBIOL METH, V88, P155, DOI 10.1016/j.mimet.2011.11.007; Liu YP, 2015, WORLD J GASTROENTERO, V21, P11954, DOI 10.3748/wjg.v21.i42.11954; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lu YQ, 2006, WORLD J GASTROENTERO, V12, P7365, DOI 10.3748/wjg.v12.i45.7365; Nyan DC, 2014, CLIN INFECT DIS, V59, P16, DOI 10.1093/cid/ciu210; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pas SD, 2000, J CLIN MICROBIOL, V38, P2897, DOI 10.1128/JCM.38.8.2897-2901.2000; Portilho MM, 2015, J VIROL METHODS, V223, P40, DOI 10.1016/j.jviromet.2015.07.010; Pyne MT, 2012, J CLIN MICROBIOL, V50, P2337, DOI 10.1128/JCM.00746-12; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Ronsin C, 2006, J CLIN MICROBIOL, V44, P1390, DOI 10.1128/JCM.44.4.1390-1399.2006; Thibault V, 2007, J CLIN MICROBIOL, V45, P3948, DOI 10.1128/JCM.01180-07; *WHO GUID APPR GUI, 2015, GUID PREV CAR TREATM; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Yao CY, 2013, SENSOR ACTUAT B-CHEM, V181, P382, DOI 10.1016/j.snb.2013.01.063; Yeh ML, 2014, J CLIN VIROL, V60, P206, DOI 10.1016/j.jcv.2014.04.008	39	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170290	10.1371/journal.pone.0170290	http://dx.doi.org/10.1371/journal.pone.0170290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182626	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800010
J	Blanco, AM; Gomez-Boronat, M; Alonso-Gomez, AL; Yufa, R; Unniappan, S; Delgado, MJ; Valenciano, AI				Melisa Blanco, Ayelen; Gomez-Boronat, Miguel; Luis Alonso-Gomez, Angel; Yufa, Roman; Unniappan, Suraj; Jesus Delgado, Maria; Isabel Valenciano, Ana			Characterization of Ghrelin O-Acyltransferase (GOAT) in goldfish (Carassius auratus)	PLOS ONE			English	Article							DES-ACYL GHRELIN; CIRCADIAN SYSTEM; EXPRESSION; IDENTIFICATION; MODULATION; ACCURACY; PEPTIDE; ENZYME	Ghrelin is the only known hormone posttranslationally modified with an acylation. This modification is crucial for most of ghrelin's physiological effects and is catalyzed by the polytopic enzyme ghrelin O-acyltransferase (GOAT). The aim of this study was to characterize GOAT in a teleost model, goldfish (Carassius auratus). First, the full-length cDNA sequence was obtained by RT-PCR and rapid amplification of cDNA ends methods. Two highly homologous cDNAs of 1491 and 1413 bp, respectively, named goat-V1 and goat-V2 were identified. Deduced protein sequences (393 and 367 amino acids, respectively) are predicted to present 11 and 9 transmembrane regions, respectively, and both contain two conserved key residues proposed to be involved in catalysis: asparagine 273 and histidine 304. RTqPCR revealed that both forms of goat mRNAs show a similar widespread tissue distribution, with the highest expression in the gastrointestinal tract and gonads and less but considerable expression in brain, pituitary, liver and adipose tissue. Immunostaining of intestinal sections showed the presence of GOAT immunoreactive cells in the intestinal mucosa, some of which colocalize with ghrelin. Using an in vitro approach, we observed that acylated ghrelin downregulates GOAT gene and protein levels in cultured intestine in a time-dependent manner. Finally, we found a rhythmic oscillation of goat mRNA expression in the hypothalamus, pituitary and intestinal bulb of goldfish fed at midday, but not at midnight. Together, these findings report novel data characterizing GOAT, and offer new information about the ghrelinergic system in fish.	[Melisa Blanco, Ayelen; Gomez-Boronat, Miguel; Luis Alonso-Gomez, Angel; Jesus Delgado, Maria; Isabel Valenciano, Ana] Univ Complutense Madrid, Fac Biol, Dept Fisiol Fisiol Anim 2, Madrid, Spain; [Yufa, Roman] York Univ, Dept Biol, Toronto, ON, Canada; [Unniappan, Suraj] Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Saskatoon, SK, Canada	Complutense University of Madrid; York University - Canada; University of Saskatchewan	Valenciano, AI (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Fisiol Fisiol Anim 2, Madrid, Spain.	aivalenciano@bio.ucm.es	Delgado, María J/I-3856-2017; Delgado, María J./I-3535-2017; Alonso-Gómez, Ángel L/F-4033-2016; BORONAT, MIGUEL GOMEZ/R-7225-2019; Valenciano, Ana Isabel/F-4119-2016	Delgado, María J/0000-0002-1185-9377; Delgado, María J./0000-0002-1185-9377; Alonso-Gómez, Ángel L/0000-0003-3219-2265; BORONAT, MIGUEL GOMEZ/0000-0003-4902-5252; Valenciano, Ana Isabel/0000-0002-0416-2192; Blanco, Ayelen Melisa/0000-0002-7683-4154	Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2016-74857 C3-2-R]; Natural Sciences and Engineering Research Council (NSERC) of Canada [341292-2012-RGPIN, 429436-2012-RGPAS]; Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was supported by the Spanish Ministerio de Economia y Competitividad (MINECO; AGL2016-74857 C3-2-R) to MJD, and partly by a Discovery Grant (341292-2012-RGPIN), and Discovery Accelerator Supplement (429436-2012-RGPAS) award from the Natural Sciences and Engineering Research Council (NSERC) of Canada, an Establishment grant from Saskatchewan Health Research Foundation (SHRF) and John R. Evans Leaders Fund from the Canada Foundation for Innovation to SU. AMB and MGB are predoctoral fellows from the Spanish Ministerio de Educacion, Cultura y Deporte and MINECO, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WJ, 2010, CELL PHYSIOL BIOCHEM, V26, P707, DOI 10.1159/000322338; Blanco AM, 2016, J COMP PHYSIOL B, V186, P727, DOI 10.1007/s00360-016-0986-0; Blanco AM, 2017, J EXP BIOL; Blanco AM, 2016, ANAT REC, V299, P748, DOI 10.1002/ar.23346; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; DELGADO MJ, 1993, GEN COMP ENDOCR, V92, P143, DOI 10.1006/gcen.1993.1151; Delhanty PJ, 2013, ENDOCR DEV, V25, P112, DOI 10.1159/000346059; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Gahete MD, 2014, J ENDOCRINOL, V220, pR1, DOI 10.1530/JOE-13-0391; Gomez R, 2009, ARTHRITIS RHEUM-US, V60, P1704, DOI 10.1002/art.24522; Gonzalez CR, 2008, J MOL ENDOCRINOL, V41, P415, DOI 10.1677/JME-08-0102; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hatef A, 2015, GHRELIN O ACYL TRANS; Heppner KM, 2011, CURR OPIN ENDOCRINOL, V18, P50, DOI 10.1097/MED.0b013e328341e1d3; Isorna E, 2017, J ENDOCRINOL, V232, pR141, DOI 10.1530/JOE-16-0330; Jonsson E, 2013, GEN COMP ENDOCR, V187, P79, DOI 10.1016/j.ygcen.2013.03.013; Kaiya H, 2013, GEN COMP ENDOCR, V181, P187, DOI 10.1016/j.ygcen.2012.10.015; Khatib MN, 2015, J CLIN DIAGN RES; Kitazawa T, 2012, GEN COMP ENDOCR, V178, P539, DOI 10.1016/j.ygcen.2012.06.025; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Koukkari WL, 2006, CHRONOBIOMETRY ANAL, P577; LARHAMMAR D, 1994, MOL PHYLOGENET EVOL, V3, P59, DOI 10.1006/mpev.1994.1007; Lear PV, 2010, ENDOCRINOLOGY, V151, P3286, DOI 10.1210/en.2009-1205; Lim CT, 2011, ENDOCR J, V58, P707, DOI 10.1507/endocrj.K11E-117; Lim CT, 2011, REV ENDOCR METAB DIS, V12, P173, DOI 10.1007/s11154-011-9169-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda K, 2006, PEPTIDES, V27, P2321, DOI 10.1016/j.peptides.2006.03.028; Mohan H, 2013, ENDOCR DEV, V25, P16, DOI 10.1159/000346039; Nisembaum LG, 2014, GEN COMP ENDOCR, V205, P287, DOI 10.1016/j.ygcen.2014.03.016; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Ohgusu H, 2009, BIOCHEM BIOPH RES CO, V386, P153, DOI 10.1016/j.bbrc.2009.06.001; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Romero A, 2010, EUR J ENDOCRINOL, V163, P1, DOI 10.1530/EJE-10-0099; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Sanchez-Bretano A, 2016, J COMP PHYSIOL B, V186, P73, DOI 10.1007/s00360-015-0936-2; Sanchez-Bretano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141043; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Satou M, 2010, ENDOCRINOLOGY, V151, P4765, DOI 10.1210/en.2010-0412; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Shlimun A, 2011, INT J PEPT, V2011, P1; Stengel A, 2010, BIOCHEM BIOPH RES CO, V392, P67, DOI 10.1016/j.bbrc.2009.12.169; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MS, 2015, BIOORG CHEM, V62, P64, DOI 10.1016/j.bioorg.2015.07.003; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Unniappan S, 2004, AM J PHYSIOL-REG I, V286, pR1093, DOI 10.1152/ajpregu.00669.2003; Unniappan S, 2010, GEN COMP ENDOCR, V167, P340, DOI 10.1016/j.ygcen.2009.12.003; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang J, 2013, BIOINFORMATICS, V29, P2579, DOI 10.1093/bioinformatics/btt440; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171874	10.1371/journal.pone.0171874	http://dx.doi.org/10.1371/journal.pone.0171874			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178327	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000393712500076
J	Ozer, B; Sezerman, U				Ozer, Bugra; Sezerman, Ugur			An integrative study on the impact of highly differentially methylated genes on expression and cancer etiology	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; DNA METHYLATION; LUNG-CANCER; COLORECTAL-CANCER; FUNDAMENTAL ROLE; CPG-METHYLATION; THYROID-CANCER; COLON-CANCER; CELL-GROWTH; HYPOMETHYLATION	DNA methylation is an important epigenetic phenomenon that plays a key role in the regulation of expression. Most of the studies on the topic of methylation's role in cancer mechanisms include analyses based on differential methylation, with the integration of expression information as supporting evidence. In the present study, we sought to identify methylationdriven patterns by also integrating protein-protein interaction information. We performed integrative analyses of DNA methylation, expression, SNP and copy number data on paired samples from six different cancer types. As a result, we found that genes that show a methylation change larger than 32.2% may influence cancer-related genes via fewer interaction steps and with much higher percentages compared with genes showing a methylation change less than 32.2%. Additionally, we investigated whether there were shared cancer mechanisms among different cancer types. Specifically, five cancer types shared a change in AGTR1 and IGF1 genes, which implies that there may be similar underlying disease mechanisms among these cancers. Additionally, when the focus was placed on distinctly altered genes within each cancer type, we identified various cancer-specific genes that are also supported in the literature and may play crucial roles as therapeutic targets. Overall, our novel graph-based approach for identifying methylation-driven patterns will improve our understanding of the effects of methylation on cancer progression and lead to improved knowledge of cancer etiology.	[Ozer, Bugra] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey; [Sezerman, Ugur] Acibadem Univ, Dept Biostat & Med Informat, Istanbul, Turkey	Sabanci University; Acibadem University	Ozer, B (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, Istanbul, Turkey.	bugraozer@sabanciuniv.edu	SEZERMAN, OSMAN U/X-6441-2018	Sezerman, Osman Ugur/0000-0003-0905-6783				Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Akiyama Y, 2003, AM J PATHOL, V163, P1911, DOI 10.1016/S0002-9440(10)63549-3; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Alvaro D, 2006, AM J PATHOL, V169, P877, DOI 10.2353/ajpath.2006.050464; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Bartlett TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143178; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLOCH D, 1966, J AM STAT ASSOC, V61, P852, DOI 10.2307/2282794; Butcher LM, 2015, METHODS, V72, P21, DOI 10.1016/j.ymeth.2014.10.036; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Cheung HH, 2009, BIRTH DEFECTS RES C, V87, P335, DOI 10.1002/bdrc.20163; Cui HM, 2002, CANCER RES, V62, P6442; Dai YN, 2015, CANCER CAUSE CONTROL, V26, P1245, DOI 10.1007/s10552-015-0617-1; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Fang WT, 2014, INT J CANCER, V135, P809, DOI 10.1002/ijc.28734; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feinberg AP, 2002, CANCER RES, V62, P6784; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Gehlenborg N., R PACKAGE VERSION 1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gevaert O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0579-8; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Goh L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017810; Gunes EG, 2009, MOL MED REP, V2, P1029, DOI 10.3892/mmr_00000210; Guo SC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-014-0035-3; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Jhala NC, 2005, ARCH PATHOL LAB MED, V129, P481; Jiao YM, 2014, BIOINFORMATICS, V30, P2360, DOI 10.1093/bioinformatics/btu316; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kanemoto M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-641; Kim JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-526; Kimura ET, 2003, CANCER RES, V63, P1454; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kramer HB, 2016, NUCLEIC ACIDS RES, V44, P582, DOI 10.1093/nar/gkv948; Lee ST, 2016, NUCLEIC ACIDS RES, V44, P1105, DOI 10.1093/nar/gkv1038; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073436; Major JM, 2010, BRIT J CANCER, V103, P132, DOI 10.1038/sj.bjc.6605722; Mansuroglu T, 2009, EUR J GASTROEN HEPAT, V21, P1206, DOI 10.1097/MEG.0b013e328317f4ef; Marcucci G, 2014, J CLIN ONCOL, V32, P548, DOI 10.1200/JCO.2013.50.6337; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Okamoto K, 2010, INT J ONCOL, V37, P1251, DOI 10.3892/ijo_00000776; Ozer B, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; QIAGEN, 2016, QIAGEN ONC TUM SUPPR; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090400; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Stuver SO, 2000, INT J CANCER, V87, P118, DOI 10.1002/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taccaliti A, 2011, CURR GENOMICS, V12, P618, DOI 10.2174/138920211798120835; TADA M, 1992, CANCER, V69, P1115; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1271-4; Wang Yun, 2005, Sheng Li Ke Xue Jin Zhan, V36, P71; Wei JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9699; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yoo S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004898; Yoshiji H, 2011, CURR CANCER DRUG TAR, V11, P431, DOI 10.2174/156800911795538084; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268	81	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171694	10.1371/journal.pone.0171694	http://dx.doi.org/10.1371/journal.pone.0171694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178311	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500060
J	Roesch, LFW; Silveira, RC; Corso, AL; Dobbler, PT; Mai, V; Rojas, BS; Laureano, AM; Procianoy, RS				Wurdig Roesch, Luiz Fernando; Silveira, Rita C.; Corso, Andrea L.; Dobbler, Priscila Thiago; Mai, Volker; Rojas, Bruna S.; Laureano, Alvaro M.; Procianoy, Renato S.			Diversity and composition of vaginal microbiota of pregnant women at risk for transmitting Group B Streptococcus treated with intrapartum penicillin	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIA; STABILITY	Background Administering intravenous antibiotics during labor to women at risk for transmitting Group B Streptococcus (GBS) can prevent infections in newborns. However, the impact of intrapartum antibiotic prophylaxis on mothers' microbial community composition is largely unknown. We compared vaginal microbial composition in pregnant women experiencing preterm birth at <= 32 weeks gestation that received intrapartum antibiotic prophylaxis with that in controls. Methods Microbiota in vaginal swabs collected shortly before delivery from GBS positive women that received penicillin intravenously during labor or after premature rupture of membranes was compared to controls. Microbiota was analyzed by 16S rRNA sequencing using the PGM Ion Torrent to determine the effects of penicillin use during hospitalization and GBS status on its composition. Results Penicillin administration was associated with an altered vaginal microbial community composition characterized by increased microbial diversity. Lactobacillus sp. contributed only 13.1% of the total community in the women that received penicillin compared to 88.1% in the controls. Streptococcus sp. were present in higher abundance in GBS positive woman compared to controls, with 60% of the total vaginal microbiota in severe cases identified as Streptococcus sp. Conclusions Vaginal communities of healthy pregnant women were dominated by Lactobacillus sp. and contained low diversity, while Group B Streptococcus positive women receiving intrapartum antibiotic prophylaxis had a modified vaginal microbiota composition with low abundance of Lactobacillus but higher microbial diversity.	[Wurdig Roesch, Luiz Fernando; Dobbler, Priscila Thiago; Laureano, Alvaro M.] Univ Fed Pampa, Ctr Interdisciplinar Pesquisas Biotecnol CIP Biot, Campus Sao Gabriel, Sao Gabriel, RS, Brazil; [Silveira, Rita C.; Corso, Andrea L.; Rojas, Bruna S.; Procianoy, Renato S.] Univ Fed Rio Grande do Sul, Unidade Neonatol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Mai, Volker] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Mai, Volker] Univ Florida, Coll Med, Emerging Pathogens Inst, Gainesville, FL USA	Universidade Federal do Pampa; Universidade Federal do Rio Grande do Sul; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Procianoy, RS (corresponding author), Univ Fed Rio Grande do Sul, Unidade Neonatol, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.	rprocianoy@gmail.com	Dobbler, Priscila Caroline Thiago/E-4387-2018; Roesch, Luiz/GRS-4638-2022; Roesch, Luiz F W/D-2838-2009; Procianoy, Renato/I-5133-2014	Dobbler, Priscila Caroline Thiago/0000-0002-7681-5463; Roesch, Luiz F W/0000-0003-1450-8828; Procianoy, Renato/0000-0001-8297-4164; Laureano, Alvaro/0000-0001-5455-3709; Corso, Andrea Lucia/0000-0003-1118-1145; SILVEIRA, RITA DE CASSIA/0000-0002-2982-2652	Bill and Melinda Gates Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologio (CNPQ); DECIT/Ministerio da Saude do Brasil [401596/2013-3]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologio (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DECIT/Ministerio da Saude do Brasil	This work was supported by a grant from Bill and Melinda Gates Foundation, Conselho Nacional de Desenvolvimento Cientifico e Tecnologio (CNPQ) and DECIT/Ministerio da Saude do Brasil, Grant number 401596/2013-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; GARDNER SE, 1979, AM J OBSTET GYNECOL, V135, P1062, DOI 10.1016/0002-9378(79)90737-3; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; HernuYndez-Rodruiguez C., 2011, INFECT DIS OBSTET GY, V2011, P1, DOI 10.1155/2011/851485; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Li LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31448; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Mayer BT, 2015, J INFECT DIS, V212, P793, DOI 10.1093/infdis/jiv079; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, P7; Oksanen J., 2016, R PACKAG; Pybus V, 1999, MICROBES INFECT, V1, P285, DOI 10.1016/S1286-4579(99)80024-0; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sleator RD, 2010, MED HYPOTHESES, V74, P214, DOI 10.1016/j.mehy.2009.08.047; Sobel, 1999, CURR INFECT DIS REP, V1, P379, DOI DOI 10.1007/S11908-999-0045-Z; Stokholm J, 2014, CLIN MICROBIOL INFEC, V20, P629, DOI 10.1111/1469-0691.12411; Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116	36	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0169916	10.1371/journal.pone.0169916	http://dx.doi.org/10.1371/journal.pone.0169916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178310	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500004
J	Polanski, A; Szczesna, A; Garbulowski, M; Kimmel, M				Polanski, Andrzej; Szczesna, Agnieszka; Garbulowski, Mateusz; Kimmel, Marek			Coalescence computations for large samples drawn from populations of time-varying sizes	PLOS ONE			English	Article							FREQUENCY-SPECTRUM; DNA-SEQUENCES; INFERENCE; MODELS; DISTRIBUTIONS; GENETICS; GROWTH	We present new results concerning probability distributions of times in the coalescence tree and expected allele frequencies for coalescent with large sample size. The obtained results are based on computational methodologies, which involve combining coalescence time scale changes with techniques of integral transformations and using analytical formulae for infinite products. We show applications of the proposed methodologies for computing probability distributions of times in the coalescence tree and their limits, for evaluation of accuracy of approximate expressions for times in the coalescence tree and expected allele frequencies, and for analysis of large human mitochondrial DNA dataset.	[Polanski, Andrzej; Szczesna, Agnieszka; Garbulowski, Mateusz] Silesian Tech Univ, Inst Informat, Ul Akad 16, PL-44100 Gliwice, Poland; [Garbulowski, Mateusz] Uppsala Univ, BMC, Linnaeus Ctr Bioinformat, Uppsala, Sweden; [Kimmel, Marek] Silesian Tech Univ, Syst Engn Grp, Ul Akad 16, PL-44100 Gliwice, Poland; [Kimmel, Marek] Rice Univ, Dept Stat, MS 138,6100 Main St, Houston, TX 77005 USA	Silesian University of Technology; Uppsala University; Silesian University of Technology; Rice University	Polanski, A (corresponding author), Silesian Tech Univ, Inst Informat, Ul Akad 16, PL-44100 Gliwice, Poland.	Andrzej.Polanski@polsl.pl	Polański, Andrzej/H-5323-2016; Szczęsna, Agnieszka/AAS-9937-2020	Polański, Andrzej/0000-0002-1793-9546; Szczesna, Agnieszka/0000-0002-4354-8258	Polish National Science Centre, OPUS grant [2016/21/B/ST6/02153]; Polish National Science Centre, Maestro grant [DEC-012/04/A/ST7/00353]; Silesian University of Technology, Institute of Informatics, Statute project [BK/RAU-2/2016]; Polish National Science Centre, SYMFONIA 3 grant [UMO 2015/16/W/NZ2/00314]	Polish National Science Centre, OPUS grant; Polish National Science Centre, Maestro grant; Silesian University of Technology, Institute of Informatics, Statute project; Polish National Science Centre, SYMFONIA 3 grant	This work was supported by Polish National Science Centre, OPUS grant (2016/21/B/ST6/02153) (Prof. Andrzej Polanski [AP]); Polish National Science Centre, Maestro grant (DEC-012/04/A/ST7/00353) (Prof. Marek Kimmel [MK]); Silesian University of Technology, Institute of Informatics, Statute project, (BK/RAU-2/2016) (PhD Agnieszka Szczesna [AS]), and Polish National Science Centre, SYMFONIA 3 grant (UMO 2015/16/W/NZ2/00314) (MSc Mateusz Garbulowski [MG]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Bhaskar A, 2015, GENOME RES, V25, P268, DOI 10.1101/gr.178756.114; Campbell RB, 2007, B MATH BIOL, V69, P2249, DOI 10.1007/s11538-007-9218-9; Chamberland M, 2013, ADV APPL MATH, V51, P546, DOI 10.1016/j.aam.2013.07.003; Chen H, 2015, MOL BIOL EVOL, V32, P2996, DOI 10.1093/molbev/msv158; Chen H, 2013, GENETICS, V194, P721, DOI 10.1534/genetics.113.151522; Chen H, 2012, THEOR POPUL BIOL, V81, P179, DOI 10.1016/j.tpb.2011.11.004; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Davies B., 2002, INTEGRAL TRANSFORMS, DOI [10.1007/978-1-4684-9283-5, DOI 10.1007/978-1-4684-9283-5]; DIECKMANN A, COLLECTION INFINITE; Durrett R, 2013, ANN APPL PROBAB, V23, P230, DOI 10.1214/11-AAP824; Eldon B, 2015, GENETICS, V199, P841, DOI 10.1534/genetics.114.173807; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Gradshteyn I. S., 1980, TABLE OF INTEGRALS S; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; GRIFFITHS RC, 1984, J MATH BIOL, V21, P67, DOI 10.1007/BF00275223; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Griffiths RC, 1999, THEOR POPUL BIOL, V55, P137, DOI 10.1006/tpbi.1998.1390; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jenkins PA, 2014, GENETICS, V196, P295, DOI 10.1534/genetics.113.158584; Kimura M., 1983, NEUTRAL THEORY MOL E; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Krone SM, 1997, THEOR POPUL BIOL, V51, P210, DOI 10.1006/tpbi.1997.1299; Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254; Maruvka YE, 2011, MOL BIOL EVOL, V28, P1617, DOI 10.1093/molbev/msq331; Neuhauser C, 1997, GENETICS, V145, P519; Polanski A, 2003, GENETICS, V165, P427; Polanski A, 2003, THEOR POPUL BIOL, V63, P33, DOI 10.1016/S0040-5809(02)00010-2; Shampine LF, 2008, J COMPUT APPL MATH, V211, P131, DOI 10.1016/j.cam.2006.11.021; Sidow A, 2015, TRENDS GENET, V31, P208, DOI 10.1016/j.tig.2015.02.001; SLATKIN M, 1991, GENETICS, V129, P555; Stephens M, 2000, THEOR POPUL BIOL, V57, P109, DOI 10.1006/tpbi.1999.1442; Wakeley J, 2001, THEOR POPUL BIOL, V59, P133, DOI 10.1006/tpbi.2000.1495; Wooding S, 2002, GENETICS, V161, P1641; Zivkovic D, 2008, GENETICS, V180, P341, DOI 10.1534/genetics.108.091231	40	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170701	10.1371/journal.pone.0170701	http://dx.doi.org/10.1371/journal.pone.0170701			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170404	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500009
J	Smith, D; Lovell, J; Weller, C; Kennedy, B; Winbolt, M; Young, C; Ibrahim, J				Smith, Daisy; Lovell, Janaka; Weller, Carolina; Kennedy, Briohny; Winbolt, Margaret; Young, Carmel; Ibrahim, Joseph			A systematic review of medication non-adherence in persons with dementia or cognitive impairment	PLOS ONE			English	Review							OLDER-ADULTS; TREATMENT ADHERENCE; MANAGEMENT; CARE; PREDICTORS; CAREGIVERS; REGIMENS; THERAPY; PROGRAM; DEVICE	Background Adherence to medication is vital for disease management while simultaneously reducing healthcare expenditure. Older persons with cognitive impairment (CI) are at risk for nonadherence as cognitive processes are needed to manage medications. This systematic review focuses on the relationship between medication non-adherence and specific cognitive domains in persons with CI, and explores determinants of medication non-adherence. When available, relationships and factors are compared with cognitively intact populations. Methods A seven database systematic search of studies published between 1 January 1949-31 December 2015 examining medication non-adherence in community dwelling persons with CI or dementia was conducted. Articles reporting medication non-adherence in people with CI or dementia in the community, with or without caregiver supports were eligible for inclusion. Papers reporting adherence to treatments in cognitively intact populations, populations from hospital or institutional settings, for non-prescribed medication or those describing dementia as a factor predicting medication non-adherence were excluded. Data on study and population characteristics, research design, data sources and analysis, specific cognitive domains, non-adherence prevalence, measurement of adherence, salient findings, factors associated with adherence and strategies to improve medication adherence were extracted. Study limitations included inconsistencies between data sources and definitions, resulting in a loss of fidelity in the value and comprehensiveness of data, as well as exclusion of non -pharmacological treatments and regimens. Findings Fifteen studies met inclusion criteria. Adherence among CI subjects ranged from 10.7%38% with better rates of adherence in non-CI individuals. Medication non-adherence definitions varied considerably. New-learning, memory and executive functioning were associated with improved adherence and formed the focus of most studies. Multiple factors were identified as modulators of non-adherence. Conclusion This review highlights a gap in knowledge on how specific cognitive domains contribute to medication non-adherence amongst CI populations, and demonstrates the current focus is limited to two domains: memory and executive functioning.	[Smith, Daisy; Kennedy, Briohny; Young, Carmel; Ibrahim, Joseph] Monash Univ, Dept Forens Med, Southbank, Vic, Australia; [Lovell, Janaka] Ballarat Hlth Serv, Ballarat, Vic, Australia; [Weller, Carolina] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [Winbolt, Margaret] La Trobe Univ, Coll Sci Hlth & Engn, Australian Ctr Evidence Based Aged Care, Bundoora, Vic 3086, Australia	Monash University; Monash University; La Trobe University	Smith, D (corresponding author), Monash Univ, Dept Forens Med, Southbank, Vic, Australia.	daisy.smith@monash.edu	Ibrahim, Joseph Elias/AGK-9867-2022; Weller, Carolina/I-2268-2014	Ibrahim, Joseph Elias/0000-0003-2828-9160; Weller, Carolina/0000-0002-8016-1060; Smith, Daisy/0000-0001-5829-9090	Australian Government Dementia Training Study Centers	Australian Government Dementia Training Study Centers(Australian Government)	This work was partially supported by the Australian Government Dementia Training Study Centers. There were no other funding or sources of support received during this specific study, neither internal nor external. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, NEUR DIS DIAGN STAT, DOI 10.1176/appi.books.9780890425596.dsm17; Andrade ASA, 2005, CLIN INFECT DIS, V41, P875, DOI 10.1086/432877; [Anonymous], 2011, DESCR GLOB BURD NCDS; Arlt S, 2008, DRUG AGING, V25, P1033, DOI 10.2165/0002512-200825120-00005; Becker BW, 2011, AIDS BEHAV, V15, P1888, DOI 10.1007/s10461-011-9924-z; Boucher L, 1996, J AM GERIATR SOC, V44, P828, DOI 10.1111/j.1532-5415.1996.tb03742.x; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Bunn F, 2013, COMORBIDITY DEMENTIA; Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4; Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Cameron J, 2010, EUR J HEART FAIL, V12, P508, DOI 10.1093/eurjhf/hfq042; Campbell NL, 2012, AM J GERIATR PHARMAC, V10, P165, DOI 10.1016/j.amjopharm.2012.04.004; Chronic Disease Prevention and Health Promotion, 2013, CHRON DIS LEAD CAUS; Conn V, 1994, J Gerontol Nurs, V20, P41; Corsonello A, 2010, BMC GERIATR, P5; Cotrell V, 2006, J GERONTOL SOC WORK, V47, P31, DOI 10.1300/J083v47n03_03; Depont F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145076; Dunbar-Jacob J, 2001, J CLIN EPIDEMIOL, V54, pS57, DOI 10.1016/S0895-4356(01)00457-7; Elliott RA, 2015, CURR CLIN PHARMACOL, V10, P213, DOI 10.2174/1574884710666150812141525; Foebel AD, 2012, AGING CLIN EXP RES, V24, P718, DOI 10.3275/8475; Fulmer T, 1997, INT J GERIATR PSYCH, V12, P920, DOI 10.1002/(SICI)1099-1166(199709)12:9<920::AID-GPS664>3.0.CO;2-I; Hamilton Glenys A, 2003, Eur J Cardiovasc Nurs, V2, P219, DOI 10.1016/S1474-5151(03)00058-6; Hawkins LA, 2012, HEART LUNG, V41, P572, DOI 10.1016/j.hrtlng.2012.06.001; Hayes TL, 2009, TELEMED J E-HEALTH, V15, P770, DOI 10.1089/tmj.2009.0033; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hughes CM, 2004, DRUG AGING, V21, P793, DOI 10.2165/00002512-200421120-00004; Insel K, 2006, J GERONTOL B-PSYCHOL, V61, pP102, DOI 10.1093/geronb/61.2.P102; Julius RJ, 2009, J PSYCHIATR PRACT, V15, P34, DOI 10.1097/01.pra.0000344917.43780.77; Kamimura T, 2012, AM J ALZHEIMERS DIS, V27, P238, DOI 10.1177/1533317512450066; Klepin HD, 2014, CANCER PREV RES, V7, P161, DOI 10.1158/1940-6207.CAPR-13-0165; Lassen L C, 1989, Scand J Prim Health Care, V7, P179, DOI 10.3109/02813438909087237; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Mackin RS, 2007, INT J GERIATR PSYCH, V22, P55, DOI 10.1002/gps.1653; National Institute of Health, 2014, QUAL ASS TOOL OBS CR; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Okuno J, 2001, EUR J CLIN PHARMACOL, V57, P589, DOI 10.1007/s002280100347; PARK DC, 1992, PSYCHOL AGING, V7, P252, DOI 10.1037/0882-7974.7.2.252; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Poon I, 2009, ANN PHARMACOTHER, V43, P185, DOI 10.1345/aph.1L368; Schwartz SM, 2010, AM J HEALTH PROMOT, V25, P126, DOI 10.4278/ajhp.091201-QUAL-377; Smith Glenn E, 2007, Am J Alzheimers Dis Other Demen, V22, P20, DOI 10.1177/1533317506295888; Stilley CS, 2010, HEALTH PSYCHOL, V29, P50, DOI 10.1037/a0016940; Stoehr GP, 2008, AM J GERIATR PHARMAC, V6, P255, DOI 10.1016/j.amjopharm.2008.11.001; Sturgess IK, 1998, BRITISH PHARMACEUTIC, P348; Thaler NS, 2015, NEUROPSYCHOLOGY, V29, P919, DOI 10.1037/neu0000191; Thiruchselvam T, 2012, INT J GERIATR PSYCH, V27, P1275, DOI 10.1002/gps.3778; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; World Health Organization, 2003, CHRON DIS HLTH PROM	50	104	108	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170651	10.1371/journal.pone.0170651	http://dx.doi.org/10.1371/journal.pone.0170651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166234	Green Published, gold			2022-12-27	WOS:000393700100012
J	Elschot, K; Vermeulen, A; Vandenbruwaene, W; Bakker, JP; Bouma, TJ; Stahl, J; Castelijns, H; Temmerman, S				Elschot, Kelly; Vermeulen, Anke; Vandenbruwaene, Wouter; Bakker, Jan P.; Bouma, Tjeerd J.; Stahl, Julia; Castelijns, Henk; Temmerman, Stijn			Top-down vs. bottom-up control on vegetation composition in a tidal marsh depends on scale	PLOS ONE			English	Article							GEESE ANSER ANSER; LONG-TERM CHANGES; SEA-LEVEL RISE; SALT-MARSH; DIVERSITY DEPENDS; SPECIES RICHNESS; RESOURCE CONTROL; COASTAL MARSHES; PLANT-GROWTH; SNOW GEESE	The relative impact of top-down control by herbivores and bottom-up control by environmental conditions on vegetation is a subject of debate in ecology. In this study, we hypothesize that top-down control by goose foraging and bottom-up control by sediment accretion on vegetation composition within an ecosystem can co-occur but operate at different spatial and temporal scales. We used a highly dynamic marsh system with a large population of the Greylag goose (Anser anser) to investigate the potential importance of spatial and temporal scales on these processes. At the local scale, Greylag geese grub for below-ground storage organs of the vegetation, thereby creating bare patches of a few square metres within the marsh vegetation. In our study, such activities by Greylag geese allowed them to exert top-down control by setting back vegetation succession. However, we found that the patches reverted back to the initial vegetation type within 12 years. At large spatial (i.e. several square kilometres) and temporal scales (i.e. decades), high rates of sediment accretion surpassing the rate of local sea-level rise were found to drive long-term vegetation succession and increased cover of several climax vegetation types. In summary, we conclude that the vegetation composition within this tidal marsh was primarily controlled by the bottom-up factor of sediment accretion, which operates at large spatial as well as temporal scales. Top-down control exerted by herbivores was found to be a secondary process and operated at much smaller spatial and temporal scales.	[Elschot, Kelly; Bakker, Jan P.] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Cc Groningen, Netherlands; [Vermeulen, Anke; Temmerman, Stijn] Univ Antwerp, Ecosyst Management Res Grp, Univ Pl, Antwerp, Belgium; [Vandenbruwaene, Wouter] Flemish Govt, Flanders Hydraul Res, Antwerp, Belgium; [Bouma, Tjeerd J.] NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Ac Yerseke, Netherlands; [Bouma, Tjeerd J.] Univ Utrecht, Ac Yerseke, Netherlands; [Stahl, Julia] Sovon, Dutch Ctr Field Ornithol, Ga Nijmegen, Netherlands; [Castelijns, Henk] Nat Beschermingsvereniging Steltkluut, Ah Terneuzen, Netherlands; [Elschot, Kelly] Wageningen Univ & Res, Wageningen Marine Res, Ab Den Helder, Netherlands; [Vermeulen, Anke] Univ Antwerp, Ethol Res Grp, Univ Pl, Antwerp, Belgium	University of Groningen; University of Antwerp; Flanders Hydraulics Research (FHR); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Wageningen University & Research; University of Antwerp	Bakker, JP (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Cc Groningen, Netherlands.	j.p.bakker@rug.nl	Temmerman, Stijn/C-5521-2009	Temmerman, Stijn/0000-0003-3346-9115; Bouma, Tjeerd/0000-0001-7824-7546; Vandenbruwaene, Wouter/0000-0003-3779-6076	Netherlands Organization for Scientific Research (NWOZKO) [83908320]; Netherlands Organisation for Scientific Research (NWO) [850.13.011]; Deltares; Boskalis; Van Oord; Rijkswaterstaat; World Wildlife Fund; HZ University of Applied Science	Netherlands Organization for Scientific Research (NWOZKO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deltares; Boskalis; Van Oord; Rijkswaterstaat; World Wildlife Fund; HZ University of Applied Science	This work was funded by the Netherlands Organization for Scientific Research (NWOZKO, project 83908320). It forms part of the research programme BE SAFE, which is financed by the Netherlands Organisation for Scientific Research (NWO; grant #850.13.011), Deltares, Boskalis, Van Oord, Rijkswaterstaat, World Wildlife Fund and HZ University of Applied Science, of which T.J. Bouma is a principal investigator. This work is part of the UA-BOF DOCPRO awarded to S. Temmerman. There was no additional external funding received for this study. The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Alberti J, 2010, OECOLOGIA, V163, P181, DOI 10.1007/s00442-009-1504-9; AMAT JA, 1986, BIRD STUDY, V33, P74, DOI 10.1080/00063658609476899; AMAT JA, 1995, ECOGRAPHY, V18, P155, DOI 10.1111/j.1600-0587.1995.tb00336.x; Amat JA, 2008, WATERBIRDS, V31, P133, DOI 10.1675/1524-4695(2008)31[133:GIASCO]2.0.CO;2; ANDRESEN H, 1990, VEGETATIO, V89, P137, DOI 10.1007/BF00032166; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; Bockelmann AC, 1999, J ECOL, V87, P503, DOI 10.1046/j.1365-2745.1999.00368.x; Bockelmann AC, 2002, AQUAT BOT, V73, P211, DOI 10.1016/S0304-3770(02)00022-0; Bos D, 2002, APPL VEG SCI, V5, P45, DOI 10.1658/1402-2001(2002)005[0045:LTVCIE]2.0.CO;2; Calle P, 2015, LEVENDE NATUUR, V116, P215; Castelijns H, 2010, LEVENDE NATUUR, P45; Castelijns Henk, 1998, Oriolus, V64, P90; Daleo P, 2015, ECOLOGY, V96, P2147, DOI 10.1890/14-1776.1; Davy AJ, 2011, J ECOL, V99, P1350, DOI 10.1111/j.1365-2745.2011.01870.x; de Groot AV, 2011, GEOMORPHOLOGY, V134, P280, DOI 10.1016/j.geomorph.2011.07.005; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; DIJKEMA KS, 1990, BIOL CONSERV, V51, P191, DOI 10.1016/0006-3207(90)90151-E; Elschot K, 2015, MAR ECOL PROG SER, V537, P9, DOI 10.3354/meps11447; Elschot K, 2013, ESTUAR COAST SHELF S, V133, P109, DOI 10.1016/j.ecss.2013.08.021; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Esselink P, 1997, AQUAT BOT, V55, P261, DOI 10.1016/S0304-3770(96)01076-5; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Gauthier G, 2005, GLOBAL CHANGE BIOL, V11, P856, DOI 10.1111/j.1365-2486.2005.00944.x; Gough L, 2012, ECOLOGY, V93, P1683, DOI 10.1890/11-1631.1; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hansen BB, 2007, POLAR BIOL, V30, P549, DOI 10.1007/s00300-006-0212-8; He YL, 2011, WETL ECOL MANAG, V19, P341, DOI 10.1007/s11273-011-9220-8; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; HUNTER MD, 1992, ECOLOGY, V73, P724; IACOBELLI A, 1991, J ECOL, V79, P61, DOI 10.2307/2260784; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; KERBES RH, 1990, J APPL ECOL, V27, P242, DOI 10.2307/2403582; Kerimoglu O, 2013, OIKOS, V122, P223, DOI 10.1111/j.1600-0706.2012.20603.x; Kirwan ML, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001400; Klok C, 2010, ANIM BIOL, V60, P373, DOI 10.1163/157075610X523260; Knochel DG, 2010, ECOL APPL, V20, P1903, DOI 10.1890/09-1944.1; Kuijper DPJ, 2005, ECOLOGY, V86, P914, DOI 10.1890/04-0693; Leemans J, 1980, SAEFTINGHE VEGETATIE; Leendertse PC, 1997, PLANT ECOL, V132, P49, DOI 10.1023/A:1009795002076; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Lovelock CE, 2011, ECOSYSTEMS, V14, P745, DOI 10.1007/s10021-011-9443-9; MADSEN J, 1991, ARDEA, V79, P113; Madsen J., 1999, GOOSE POPULATIONS W; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; McLaren JR, 2004, J ECOL, V92, P648, DOI 10.1111/j.0022-0477.2004.00897.x; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001591; Nilsson Leif, 2006, P514; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olff H, 1997, J ECOL, V85, P799, DOI 10.2307/2960603; Peterson SL, 2013, ARCT ANTARCT ALP RES, V45, P575, DOI 10.1657/1938-4246.45.4.575; Petraitis PS, 1999, ECOLOGY, V80, P429, DOI 10.1890/0012-9658(1999)080[0429:TIOSIT]2.0.CO;2; Piernik A, 2005, PHYTOCOENOLOGIA, V35, P19, DOI 10.1127/0340-269X/2005/0035-0019; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140181; Reitsma JM, 2006, TOELICHTING BIJ VEGE; Russell BD, 2005, MAR ECOL PROG SER, V289, P5, DOI 10.3354/meps289005; Schepers L, 2017, LIMNOL OCEANOGR, V62, P137, DOI 10.1002/lno.10381; Schrama M, 2015, ECOSCIENCE, V22, P71, DOI 10.1080/11956860.2015.1079409; SHUMWAY SW, 1992, OECOLOGIA, V92, P490, DOI 10.1007/BF00317840; SHUMWAY SW, 1994, ECOLOGY, V75, P564, DOI 10.2307/1939559; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Souza L, 2016, OIKOS, V125, P566, DOI 10.1111/oik.02579; Srivastava DS, 1996, J ECOL, V84, P31, DOI 10.2307/2261697; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tessier M, 2003, ACTA OECOL, V24, P103, DOI 10.1016/S1146-609X(03)00049-3; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; van der Wal R, 2000, ECOGRAPHY, V23, P60, DOI 10.1034/j.1600-0587.2000.230107.x; Van Eerden MR, 2005, GLOBAL CHANGE BIOL, V11, P894, DOI 10.1111/j.1365-2486.2005.00940.x; van Oene H, 1999, ECOSYSTEMS, V2, P122, DOI 10.1007/s100219900064; Vandenbruwaene W, 2015, GEOMORPHOLOGY, V231, P40, DOI 10.1016/j.geomorph.2014.11.020; Vandenbruwaene W, 2013, EARTH SURF PROC LAND, V38, P122, DOI 10.1002/esp.3265; Veeneklaas RM, 2013, APPL VEG SCI, V16, P205, DOI 10.1111/j.1654-109X.2012.01228.x; Wang C, 2013, J GEOPHYS RES-EARTH, V118, P229, DOI 10.1029/2012JF002474; Wanner A, 2014, AGR ECOSYST ENVIRON, V182, P69, DOI 10.1016/j.agee.2013.08.014; Zimmerman RC, 1996, OECOLOGIA, V107, P560, DOI 10.1007/BF00333949	80	7	7	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169960	10.1371/journal.pone.0169960	http://dx.doi.org/10.1371/journal.pone.0169960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158218	Green Published, gold			2022-12-27	WOS:000396161700007
J	Kawazoe, H; Yano, A; Ishida, Y; Takechi, K; Katayama, H; Ito, R; Yakushijin, Y; Moriguchi, T; Tanaka, M; Tanaka, A; Araki, H				Kawazoe, Hitoshi; Yano, Akiko; Ishida, Yuri; Takechi, Kenshi; Katayama, Hitoshi; Ito, Ryoji; Yakushijin, Yoshihiro; Moriguchi, Toshihide; Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki			Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; RANDOMIZED PHASE-III; RENAL-FUNCTION; MAINTENANCE BEVACIZUMAB; JAPANESE PATIENTS; RISK-FACTORS; CISPLATIN; CHEMOTHERAPY; NEPHROPATHY; METHOTREXATE	Purpose As the major toxicity induced by pemetrexed plus carboplatin is severe hematologic toxicities, the aim of this study was to determine the risk factors for severe hematologic toxicities in lung cancer patients. Methods We retrospectively investigated data from lung cancer patients who had received pemetrexed plus carboplatin, with or without bevacizumab. This observational study was carried out at Ehime University Hospital using electronic medical records dating from July 2009 to March 2015. Severe hematologic toxicities were defined as grade 3 or 4, according to the Common Terminology Criteria for Adverse Events, version 4.0. Results Forty-two patients were included in the study. The incidence of grade 3 or 4 hematologic toxicities during the first cycle of chemotherapy and during all cycles was 19.0% and 16.1%, respectively. Multivariate time-depend generalized estimating equations logistic regression analysis revealed that regular use of non- steroidal anti-inflammatory drugs (NSAIDs) was significantly associated with an increased risk of severe hematologic toxicities during all cycles (adjusted odds ratio (OR): 8.32, 95% confidence interval (CI): 1.27-54.38; p = 0.03), whereas creatinine clearance of <45 mL/min was not significantly associated with an increased risk of severe hematologic toxicities during all cycles (adjusted OR: 0.91, 95% CI: 0.25-3.34; p = 0.88). Conclusions The results suggest that severe hematologic toxicities in patients receiving carboplatin-based pemetrexed may be significantly induced by the inhibition of renal tubular pemetrexed secretion through drug-drug interactions between NSAIDs and pemetrexed rather than through glomerular filtration of pemetrexed, even with moderate to sufficient renal function.	[Kawazoe, Hitoshi; Yano, Akiko; Takechi, Kenshi; Moriguchi, Toshihide; Tanaka, Mamoru; Tanaka, Akihiro; Araki, Hiroaki] Ehime Univ Hosp, Div Pharm, Toon, Ehime, Japan; [Ishida, Yuri] Komazawa Hosp, Div Pharm, Setagaya Ku, Tokyo, Japan; [Katayama, Hitoshi] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan; [Ito, Ryoji] Natl Hosp Org, Ehime Med Ctr, Dept Resp Med, Toon, Ehime, Japan; [Yakushijin, Yoshihiro] Ehime Univ Hosp, Ctr Canc, Toon, Ehime, Japan; [Takechi, Kenshi] Tokushima Univ Hosp, Clin Trial Ctr Dev Therapeut, Tokushima, Japan; [Moriguchi, Toshihide] Saiseikai Imabari Hosp, Div Pharm, Imabari, Ehime, Japan	Ehime University; Ehime University; Ehime University; Tokushima University	Tanaka, A (corresponding author), Ehime Univ Hosp, Div Pharm, Toon, Ehime, Japan.	akiki@m.ehime-u.ac.jp		Kawazoe, Hitoshi/0000-0002-0626-7908				Barlesi F, 2013, J CLIN ONCOL, V31, P3004, DOI 10.1200/JCO.2012.42.3749; Bezabeh S, 2012, ONCOLOGIST, V17, P550, DOI 10.1634/theoncologist.2011-0431; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Hesketh PJ, 2016, J CLIN ONCOL, V34, P381, DOI 10.1200/JCO.2015.64.3635; Ikesue H, 2015, BIOL PHARM BULL, V38, P1192, DOI 10.1248/bpb.b15-00162; Kurata T, 2014, DRUG METAB PHARMACOK, V29, P148, DOI 10.2133/dmpk.DMPK-13-RG-042; Latz JE, 2006, CANCER CHEMOTH PHARM, V57, P401, DOI 10.1007/s00280-005-0036-1; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; MAICHE AG, 1986, LANCET, V1, P1390; Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998; Mita AC, 2006, J CLIN ONCOL, V24, P552, DOI 10.1200/JCO.2004.00.9720; Nakagawa K, 2008, JPN J CLIN ONCOL, V38, P339, DOI 10.1093/jjco/hyn024; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Posada MM, 2015, DRUG METAB DISPOS, V43, P325, DOI 10.1124/dmd.114.059618; Reeves DJ, 2014, BRIT J CLIN PHARMACO, V78, P565, DOI 10.1111/bcp.12384; Sakata Y, 2013, YAKUGAKU ZASSHI, V133, P1209, DOI 10.1248/yakushi.13-00180; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shimokata T, 2010, CANCER SCI, V101, P2601, DOI 10.1111/j.1349-7006.2010.01729.x; Suzuki K, 2009, BRIT J CLIN PHARMACO, V67, P44, DOI 10.1111/j.1365-2125.2008.03303.x; Sweeney CJ, 2006, CLIN CANCER RES, V12, P536, DOI 10.1158/1078-0432.CCR-05-1834; THYSS A, 1986, LANCET, V1, P256; Tiseo M, 2007, TUMORI, V93, P138; Tomita K, 2007, DIABETES CARE, V30, P1581, DOI 10.2337/dc06-2493; Uwai Yuichi, 2004, Drug Metab Pharmacokinet, V19, P369, DOI 10.2133/dmpk.19.369	28	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171066	10.1371/journal.pone.0171066	http://dx.doi.org/10.1371/journal.pone.0171066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158216	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700027
J	Lee, LW; Liao, YS; Lu, HK; Hsiao, PL; Chen, YY; Chi, CC; Hsieh, KC				Lee, Li-Wen; Liao, Yu-San; Lu, Hsueh-Kuan; Hsiao, Pei-Lin; Chen, Yu-Yawn; Chi, Ching-Chi; Hsieh, Kuen-Chang			Validation of two portable bioelectrical impedance analyses for the assessment of body composition in school age children	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; SKELETAL-MUSCLE MASS; CORRELATION-COEFFICIENT; BIOIMPEDANCE ANALYSIS; ASSESSING AGREEMENT; RELIABILITY; ADOLESCENTS; PREDICTION; VALIDITY; BIA	Background Bioelectrical impedance analysis (BIA) is a convenient and child-friendly method for longitudinal analysis of changes in body composition. However, most validation studies of BIA have been performed on adult Caucasians. The present cross-sectional study investigated the validity of two portable BIA devices, the Inbody 230 (BIA(8MF)) and the Tanita BC-418 (BIA(8SF)), in healthy Taiwanese children. Methods Children aged 7-12 years (72 boys and 78 girls) were recruited. Body composition was measured by the BIA(8SF) and the BIA(8MF). Dual X-ray absorptiometry (DXA) was used as the reference method. Results There were strong linear correlations in body composition measurements between the BIA(8SF) and DXA and between the BIA(8MF) and DXA. Both BIAs underestimated fat mass (FM) and percentage body fat (%BF) relative to DXA in both genders The degree of agreement in lean body mass (LBM), FM, and %BF estimates was higher between BIA(8MF) and DXA than between BIA(8SF) and DXA. The Lin's concordance correlation coefficient (rho(c)) for LBM8MF met the criteria of substantial to perfect agreement whereas the rho(c) for FM8MF met the criteria of fair to substantial agreement. Bland-Altman analysis showed a clinically acceptable agreement between LBM measures by BIA(8MF) and DXA. The limit of agreement in %BF estimation by BIA and DXA were wide and the errors were clinically important. For the estimation of ALM, BIA(8SF) and BIA(8MF) both provided poor accuracy. Conclusions For all children, LBM measures were precise and accurate using the BIA(8MF) whereas clinically significant errors occurred in FM and %BF estimates. Both BIAs underestimated FM and %BF in children. Thus, the body composition results obtained using the inbuilt equations of the BIA(8SF) and BIA(8MF) should be interpreted with caution, and high quality validation studies for specific subgroups of children are required prior to field research.	[Lee, Li-Wen; Liao, Yu-San; Hsiao, Pei-Lin] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Lee, Li-Wen; Liao, Yu-San] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan; [Lu, Hsueh-Kuan] Natl Taiwan Univ Sport, Sport Sci Res Ctr, Taichung, Taiwan; [Chen, Yu-Yawn] Natl Taiwan Univ Sport, Dept Phys Educ, Taichung, Taiwan; [Chen, Yu-Yawn] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Yilan, Taiwan; [Chi, Ching-Chi] Chang Gung Mem Hosp, Dept Dermatol, Linkou, Taiwan; [Chi, Ching-Chi] Chang Gung Mem Hosp, Dept Dermatol, Chiayi, Taiwan; [Chi, Ching-Chi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsieh, Kuen-Chang] Natl Chung Hsing Univ, Off Phys Educ & Sport, Taichung, Taiwan; [Hsieh, Kuen-Chang] Charder Elect Co Ltd, Res Ctr, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; National Taiwan University of Sport; National Taiwan University of Sport; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Chung Hsing University	Chi, CC (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, Linkou, Taiwan.; Chi, CC (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, Chiayi, Taiwan.; Chi, CC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Hsieh, KC (corresponding author), Natl Chung Hsing Univ, Off Phys Educ & Sport, Taichung, Taiwan.; Hsieh, KC (corresponding author), Charder Elect Co Ltd, Res Ctr, Taichung, Taiwan.	chingchi@cgmh.org.tw; abaqus0927@yahoo.com.tw	Chi, Ching-Chi/A-6415-2009; Lee, Li-Wen/AAY-3542-2021; Hsieh, Kuen-Chang/AAA-3324-2019	Chi, Ching-Chi/0000-0001-5699-0283; Lee, Li-Wen/0000-0001-8019-1772	Chang Gung Memorial Hospital [CMRPG6D0353, CMRPG6C0052]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was funded by a single institution, the Chang Gung Memorial Hospital (grant number CMRPG6D0353, CCC and CMRPG6C0052, LWL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (KCH) is an employee of Charder Electronic Co, Ltd. This company did not provide KCH financial support in executing this study. Nor did the company have any additional role in the research funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the Author Contributions section.	[Anonymous], 1996, INBODY US MAN; Barnhart HX, 2007, J BIOPHARM STAT, V17, P529, DOI 10.1080/10543400701376480; BLAND JM, 1990, COMPUT BIOL MED, V20, P337, DOI 10.1016/0010-4825(90)90013-F; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clasey JL, 2011, OBESITY, V19, P1813, DOI 10.1038/oby.2011.158; Dittmar M, 2001, AM J PHYSIOL-ENDOC M, V281, pE1005, DOI 10.1152/ajpendo.2001.281.5.E1005; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gudivaka R, 1985, J APPL PHYSIOL, V1999, P1087; Haroun D, 2009, OBESITY, V17, P2245, DOI 10.1038/oby.2009.98; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460; Khalil SF, 2014, SENSORS-BASEL, V14, P10895, DOI 10.3390/s140610895; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kim J, 2006, AM J CLIN NUTR, V84, P1014, DOI 10.1093/ajcn/84.5.1014; Kriemler S, 2009, EUR J CLIN NUTR, V63, P619, DOI 10.1038/ejcn.2008.19; KUSHNER RF, 1992, J AM COLL NUTR, V11, P199; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lewy VD, 1999, J PEDIATR ENDOCR MET, V12, P443; Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x; McBride GB, 2005, HAM2005062 NIWA; ORGAN LW, 1994, J APPL PHYSIOL, V77, P98, DOI 10.1152/jappl.1994.77.1.98; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Pietrobelli A, 1998, EUR J CLIN NUTR, V52, P507, DOI 10.1038/sj.ejcn.1600592; Prins M, 2008, EUR J CLIN NUTR, V62, P1065, DOI 10.1038/sj.ejcn.1602830; Shaikh MG, 2007, HORM RES, V68, P8, DOI 10.1159/000098481; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Silva AM, 2013, J OBES, V2013, DOI 10.1155/2013/148696; Talma H, 2013, OBES REV, V14, P895, DOI 10.1111/obr.12061; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2005, ARCH DIS CHILD, V90, P965, DOI 10.1136/adc.2004.067538; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908	32	42	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171568	10.1371/journal.pone.0171568	http://dx.doi.org/10.1371/journal.pone.0171568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158304	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700101
J	Gao, ZM; Gao, S; Qu, HC; Li, K; Li, N; Liu, CL; Zhu, XW; Liu, YL; Wang, P; Zheng, XH				Gao, Zi-Ming; Gao, Shan; Qu, Hong-Chen; Li, Kai; Li, Ning; Liu, Chun-Lai; Zhu, Xing-Wang; Liu, Yi-Li; Wang, Ping; Zheng, Xiao-Hua			Minimally invasive percutaneous nephrolithotomy improves stone-free rates for impacted proximal ureteral stones: A systematic review and meta-analysis	PLOS ONE			English	Article							RETROGRADE URETEROLITHOTRIPSY; ANTEGRADE URETEROLITHOTRIPSY; URETEROSCOPIC LITHOTRIPSY; FLEXIBLE URETEROSCOPY; CALCULI; EXPERIENCE; MANAGEMENT; PCNL	Background Urinary stones are common medical disorders and the treatment of impacted proximal ureteral stones (IPUS) is still a challenge for urologists. The aim of this study was to compare the efficacy and safety of minimally invasive percutaneous nephrolithotomy (MI-PCNL) and ureteroscopic lithotripsy (URL) in the treatment of IPUS via a meta-analysis. Methods We collected studies using PubMed, Embase, and Cochrane Library from 1978 to November 2016 and analyzed them using Stata 12.0 and RevMan 5.3. Odds ratios (ORs) and standard mean difference (SMD) were calculated for binary and continuous variables respectively, accompanied with 95% confidence intervals (Cis). All study procedures followed the PRISMA guidelines. Results Five prospective studies were included in our meta-analysis, with 242 MI-PCNL and 256 URL cases. MI-PCNL was associated with a longer postoperative hospital stay than URL (SMD, 3.14; 95% CI, 1.27 to 5.55). However, no significant difference was observed in operative time (SMD,-0.38; 95% CI,-3.15 to 2.38). In addition, MI-PCNL had higher initial (OR, 11.12; 95% CI, 5.56 to 22.24) and overall stone-free rates (OR, 8.70; 95% CI, 3.23 to 23.45) than URL, along with lower possibilities of surgical conversion (OR, 0.11; 95% CI, 0.03 to 0.49) and postoperative shock wave lithotripsy (OR, 0.06; 95% CI, 0.02 to 0.18). Regarding complications, no significant differences were observed between MI-PCNL and URL (OR, 1.39; 95% CI, 0.93 to 2.10), except for hematuria (OR, 4.80; 95% CI, 1.45 to 15.94). Conclusions MI-PCNL is optimal and should be considered as the preferred treatment method for IPUS, as it has better efficacy and a safety profile similar to that of URL. However, further high quality studies with larger sample size are required in future.	[Gao, Zi-Ming; Li, Ning; Liu, Chun-Lai; Zhu, Xing-Wang; Liu, Yi-Li; Wang, Ping] China Med Univ, Affiliated Hosp 4, Dept Urol Surg, Shenyang, Liaoning, Peoples R China; [Gao, Shan] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Liaoning, Peoples R China; [Qu, Hong-Chen] China Med Univ, Canc Hosp, Liaoning Canc Hosp, Dept Urol Surg, Shenyang, Liaoning, Peoples R China; [Li, Kai] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning, Peoples R China; [Zheng, Xiao-Hua] Peoples Liberat Army, Hosp 202, Dept Cardre Ward, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Zheng, XH (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Urol Surg, Shenyang, Liaoning, Peoples R China.	cmu4h-wp@126.com; zhengxiaohua202@126.com			National Natural Science Foundation of China [31271238]; Science and Technology Planning Project of Liaoning Province [2013225089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Liaoning Province	This project was supported by grants from the National Natural Science Foundation of China (31271238) and the Science and Technology Planning Project of Liaoning Province (2013225089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravantinos E, 2012, J ENDOUROL, V26, pA194; Desai MR, 2011, BJU INT, V108, P462, DOI 10.1111/j.1464-410X.2011.10418.x; Gu XJ, 2013, WORLD J UROL, V31, P1605, DOI 10.1007/s00345-013-1026-2; Hamamoto S, 2014, J ENDOUROL, V28, P28, DOI 10.1089/end.2013.0361; Jackman SV, 1998, WORLD J UROL, V16, P371, DOI 10.1007/s003450050083; Lahme S, 2001, EUR UROL, V40, P619, DOI 10.1159/000049847; Lee YH, 2006, UROLOGY, V67, P480, DOI 10.1016/j.urology.2005.09.067; Liu M, 2016, MINERVA UROLOGICA E; Liu YH, 2013, PAK J MED SCI, V29, P1358; Long QL, 2013, UROL INT, V90, P384, DOI 10.1159/000343668; Mercimek Mehmet Necmettin, 2015, World J Nephrol, V4, P271, DOI 10.5527/wjn.v4.i2.271; Park H, 1998, J ENDOUROL, V12, P501, DOI 10.1089/end.1998.12.501; Perera M, 2016, J ENDOUROL, V30, P1194, DOI 10.1089/end.2016.0513; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Srisubat A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007044.pub3; Sun XW, 2008, J ENDOUROL, V22, P913, DOI 10.1089/end.2007.0230; Torricelli FCM, 2016, INT BRAZ J UROL, V42, P645, DOI 10.1590/S1677-5538.IBJU.2015.0696; Yang ZS, 2012, UROLOGY, V80, P1192, DOI 10.1016/j.urology.2012.08.045; Zhang Y, 2014, UROLOGY, V83, P999, DOI 10.1016/j.urology.2013.11.034	19	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171230	10.1371/journal.pone.0171230	http://dx.doi.org/10.1371/journal.pone.0171230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152097	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200111
J	Ullah, R; Rehman, A; Zafeer, MF; Rehman, L; Khan, YA; Khan, MAH; Khan, SN; Khan, AU; Abidi, SMA				Ullah, Rizwan; Rehman, Abdur; Zafeer, Mohd Faraz; Rehman, Lubna; Khan, Yasir A.; Khan, M. A. Hannan; Khan, Shahper N.; Khan, Asad U.; Abidi, S. M. A.			Anthelmintic Potential of Thymoquinone and Curcumin on Fasciola gigantica	PLOS ONE			English	Article							NIGELLA-SATIVA OIL; TEGUMENTAL SURFACE CHANGES; IN-VITRO EFFICACY; SCHISTOSOMA-MANSONI; HEPATICA; TRICLABENDAZOLE; GLUTATHIONE; LIVER; RESISTANCE; PROTEINS	Fasciolosis an economically important global disease of ruminants in the temperate and tropical regions, caused by Fasciola hepatica and F. gigantica, respectively, also poses a potential zoonotic threat. In India alone it causes huge losses to stakeholders. Anthelmintics including triclabendazole have been used to control this menace but the emerging resistance against the available compounds necessitates identification of novel and alternative therapeutic measures involving plant derived natural compounds for their anthelmintic potential. Thymoquinone (T) and curcumin (C), the active ingredients of Nigella sativa and Curcuma longa respectively have been used as antiparasitic agents but the information on their flukicidal effect is very limited. Adult flukes of F. gigantica were in vitro exposed to different concentrations of thymoquinone and curcumin separately for 3h at 37 +/- 1 degrees C. A significant (p<0.05) reduction in the worm motility at 60 mu M concentration of both T and C was observed though all the worms remained alive after 3h exposure, whereas the effect on egg shedding was statistically insignificant. Pronounced tegumental disruptions and erosion of spines in the posterior region and around the acetabulum was evident. A significant (p<0.05) decrease in glutathione-S-transferase and superoxide dismutase activity and reduced glutathione (GSH) level was observed, while protein carbonylation increased differentially. A significant inhibition of CathepsinL (CatL) gene expression in thymoquinone treated worms was also evident. Further, in silico molecular docking of T and C with CatL revealed a stronger interaction of curcumin with the involvement of higher number of amino acids as compared to thymoquinone that could be more effective in inhibiting the antioxidant enzymes of F. gigantica. It is concluded that both the compounds understudy will decrease the detoxification ability of F. gigantica, while inhibition of CatL will significantly affect their virulence potential. Thus, both thymoquinone and curcumin appeared to be promising anthelmintic compounds for further investigations.	[Ullah, Rizwan; Rehman, Abdur; Rehman, Lubna; Khan, Yasir A.; Khan, M. A. Hannan; Abidi, S. M. A.] Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India; [Zafeer, Mohd Faraz] Aligarh Muslim Univ, JN Med Coll, IBRC, Aligarh, Uttar Pradesh, India; [Khan, Shahper N.; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Khan, Yasir A.] Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ullah, R (corresponding author), Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India.	rizwanullah1987@gmail.com	Khan, Asad U/K-8157-2013; Khan, M. A. Hannan/AAE-7567-2019	Khan, Asad U/0000-0001-9191-9423; Khan, M. A. Hannan/0000-0002-0742-1372; Khan, Shahper N./0000-0002-3931-6702; Zafeer, Mohd faraz/0000-0001-9595-0452	Department of Biotechnology, Government of India, New Delhi, under the DBT-BUILDER programme [BT/PR4872/INF/22/150/2012]	Department of Biotechnology, Government of India, New Delhi, under the DBT-BUILDER programme	The financial assistance in the form of fellowships by the Department of Biotechnology, Government of India, New Delhi, under the DBT-BUILDER programme (Grant No. BT/PR4872/INF/22/150/2012) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Ela EI, 2002, MUTAT RES-GEN TOX EN, V516, P11, DOI 10.1016/S1383-5718(01)00333-3; AGARWAL R, 1979, INDIAN J EXP BIOL, V17, P1264; AHMAD M, 1983, ANN NY ACAD SCI, V411, P347, DOI 10.1111/j.1749-6632.1983.tb47322.x; AHMAD M, 1988, ZOOL ANZ, V220, P59; Aljabre SHM, 2015, J DERMATOL DERMATOL, V19, P92, DOI 10.1016/j.jdds.2015.04.002; Allam G, 2009, IMMUNOBIOLOGY, V214, P712, DOI 10.1016/j.imbio.2008.11.017; [Anonymous], 2004, WATERBORNE ZOONOSES; Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004; Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Ayaz E, 2007, SAUDI MED J, V28, P1654; Bero J, 2014, NOVEL PLANT BIORESOURCES: APPLICATIONS IN FOOD, MEDICINE AND COSMETICS, P455; Bhambal S S, 1980, Indian Pediatr, V17, P469; Brennan GP, 2007, EXP MOL PATHOL, V82, P104, DOI 10.1016/j.yexmp.2007.01.009; CHENSUE SW, 1984, BIOCHEM BIOPH RES CO, V122, P184, DOI 10.1016/0006-291X(84)90457-1; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Das K, 2007, Indian J Gastroenterol, V26, P92; El-Baba C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-201; Elhence V, 2001, Indian J Gastroenterol, V20, P164; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; FELDMAN GM, 1990, J LEUKOCYTE BIOL, V47, P344, DOI 10.1002/jlb.47.4.344; Gandhi V, 2010, BMJ CASE REP, V29, P2010, DOI DOI 10.1007/S12664-010-0029-9; Gharib B, 1999, J HEPATOL, V30, P594, DOI 10.1016/S0168-8278(99)80189-5; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halton DW, 2004, MICRON, V35, P361, DOI 10.1016/j.micron.2003.12.001; Hanna REB, 2015, VET PARASITOL, V207, P34, DOI 10.1016/j.vetpar.2014.11.016; Haq A, 1999, INT J IMMUNOPHARMACO, V21, P283, DOI 10.1016/S0192-0561(99)00010-7; Jefferies JR, 2001, PROTEOMICS, V1, P1128, DOI 10.1002/1615-9861(200109)1:9<1128::AID-PROT1128>3.0.CO;2-0; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Keiser J, 2008, EXP PARASITOL, V119, P87, DOI 10.1016/j.exppara.2007.12.015; Keiser J, 2006, J ANTIMICROB CHEMOTH, V57, P1139, DOI 10.1093/jac/dkl125; Kelley JM, 2016, TRENDS PARASITOL, V32, P458, DOI 10.1016/j.pt.2016.03.002; Khan SN, 2008, EUR J PHARM SCI, V35, P371, DOI 10.1016/j.ejps.2008.07.010; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; LaCourse EJ, 2012, PLOS NEGLECT TROP D, V6, P5; Laouer H, 2009, NAT PROD COM, V4, P1; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Rondon FCM, 2012, REV BRAS PARASITOL V, V21, P185, DOI 10.1590/S1984-29612012000300002; Mahmoud MR, 2002, J ETHNOPHARMACOL, V79, P1, DOI 10.1016/S0378-8741(01)00310-5; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; McCormick ML, 1996, J IMMUNOL, V157, P5009; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; McKinstry B, 2003, PARASITOL RES, V91, P251, DOI 10.1007/s00436-003-0930-6; McVeigh P, 2014, PLOS NEGLECT TROP D, V8, P9; Mehlhorn H, 2008, ENCY PARASITOLOGY; Mohamed AM, 2005, MEM I OSWALDO CRUZ, V100, P205, DOI 10.1590/S0074-02762005000200016; Morphew RM, 2007, MOL CELL PROTEOMICS, V6, P963, DOI 10.1074/mcp.M600375-MCP200; Morphew RM, 2012, J PROTEOME RES, V11, P5876, DOI 10.1021/pr300654w; Narain Kanwar, 1997, Journal of Communicable Diseases, V29, P161; Nayak A, 2012, PARASITOL RES, V111, P1173, DOI 10.1007/s00436-012-2948-0; Novobilsky A, 2016, INT J PARASITOL-DRUG, V6, P141, DOI 10.1016/j.ijpddr.2016.06.004; Ramachandran J, 2012, J POSTGRAD MED, V58, P150, DOI 10.4103/0022-3859.97180; Sanmartin-Suarez C, 2011, J PHARMACOL TOX MET, V63, P209, DOI 10.1016/j.vascn.2010.10.004; Saowakon N, 2009, EXP PARASITOL, V122, P289, DOI 10.1016/j.exppara.2009.04.011; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Shalaby H. A., 2012, Global Veterinaria, V9, P465; Shalaby HA, 2009, VET PARASITOL, V160, P76, DOI 10.1016/j.vetpar.2008.10.027; Shareef PAA, 2014, ACTA TROP, V136, P108, DOI 10.1016/j.actatropica.2014.04.011; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Spithill TW, 1999, FASCIOLOSIS, P465; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stepek G, 2005, PARASITOLOGY, V130, P203, DOI 10.1017/S0031182004006225; STITT AW, 1993, PARASITOL RES, V79, P529, DOI 10.1007/BF00932235; Tu X, 2013, PARASITOL RES, V112, P2839, DOI 10.1007/s00436-013-3455-7; Umar S, 2016, POULTRY SCI, V95, P1513, DOI 10.3382/ps/pew069; van Bladeren PJ, 2000, CHEM-BIOL INTERACT, V129, P61, DOI 10.1016/S0009-2797(00)00214-3; van Vuuren SF, 2006, S AFR J BOT, V72, P287, DOI 10.1016/j.sajb.2005.07.007; Vibanco-Perez N, 2002, PARASITOL RES, V88, P398, DOI 10.1007/s00436-001-0580-5; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Winkelhagen AJS, 2012, EMERG INFECT DIS, V18, P1028, DOI 10.3201/eid1806.120302	74	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171267	10.1371/journal.pone.0171267	http://dx.doi.org/10.1371/journal.pone.0171267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152102	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200121
J	Lyon, A; Powers, AK; Gross, JB; O'Quin, KE				Lyon, Anastasia; Powers, Amanda K.; Gross, Joshua B.; O'Quin, Kelly E.			Two - three loci control scleral ossicle formation via epistasis in the cavefish Astyanax mexicanus	PLOS ONE			English	Article							BLIND CAVEFISH; REGRESSIVE EVOLUTION; SKELETAL ELEMENTS; EYE; FGF8; DEGENERATION; FOREBRAIN; SHH	The sclera is the protective outer layer of the eye. In fishes, birds, and reptiles, the sclera may be reinforced with additional bony elements called scleral ossicles. Teleost fish vary in the number and size of scleral ossicles; however, the genetic mechanisms responsible for this variation remain poorly understood. In this study, we examine the inheritance of scleral ossicles in the Mexican tetra, Astyanax mexicanus, which exhibits both a cave morph and a surface fish morph. As these morphs and their hybrids collectively exhibit zero, one, and two scleral ossicles, they represent a microcosm of teleost scleral ossicle diversity. Our previous research in F2 hybrids of cavefish from Pachon cave and surface fish from Texas suggested that three genes likely influence the formation of scleral ossicles in this group through an epistatic threshold model of inheritance, though our sample size was small. In this study, we expand our sample size using additional hybrids of Pachon cavefish and Mexican surface fish to (1) confirm the threshold model of inheritance, (2) refine the number of genes responsible for scleral ossicle formation, and (3) increase our power to detect quantitative trait loci (QTL) for this trait. To answer these three questions, we scored surface fish and cavefish F2 hybrids for the presence of zero, one, or two scleral ossicles. We then analyzed their distribution among the F2 hybrids using a chi-square (chi(2)) test, and used a genetic linkage map of over 100 microsatellite markers to identify QTL responsible for scleral ossicle number. We found that inheritance of scleral ossicles follows an epistatic threshold model of inheritance controlled by two genes, which contrasts the three-locus model estimated from our previous study. Finally, the combined analysis of hybrids from both crosses identified two strong QTL for scleral ossicle number on linkage groups 4.2 and 21, and a weaker QTL on linkage group 4.1. Scleral ossification remains a complex trait with limited knowledge of its genetic basis. This study provides new insight into the number and location of genes controlling the formation of scleral ossicles in a teleost fish species.	[Lyon, Anastasia; O'Quin, Kelly E.] Ctr Coll Danville, Biol Program, Danville, KY 40422 USA; [Powers, Amanda K.; Gross, Joshua B.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	O'Quin, KE (corresponding author), Ctr Coll Danville, Biol Program, Danville, KY 40422 USA.	koquin@umd.edu		Lyon, Anastasia/0000-0002-7365-4035	NIDCR NIH HHS [R01 DE025033] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025033] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABBOTT U. K., 1957, JOUR HEREDITY, V48, P63; Albertson RC, 2007, DEV BIOL, V306, P505, DOI 10.1016/j.ydbio.2007.03.025; Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Coghill LM, 2014, MOL PHYLOGENET EVOL, V79, P368, DOI 10.1016/j.ympev.2014.06.029; Duench K, 2012, DEV BIOL, V365, P251, DOI 10.1016/j.ydbio.2012.02.016; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; Franklin T., 2007, JISC, P1; Franz-Odendaal TA, 2008, ANAT REC, V291, P161, DOI 10.1002/ar.20639; Franz-Odendaal TA, 2006, J MORPHOL, V267, P1326, DOI 10.1002/jmor.10479; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P1244, DOI 10.1002/dvdy.20718; Gross JB, 2014, GENETICS, V196, P1303, DOI 10.1534/genetics.114.161661; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Hall B.K., 2015, BONES CARTILAGE DEV; Hanken J., 1981, Functional Photography, V16, P22; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Mok HK, 2012, ZOOL STUD, V51, P1490; O'Quin K, 2016, BIOLOGY AND EVOLUTION OF THE MEXICAN CAVEFISH, P111, DOI 10.1016/B978-0-12-802148-4.00006-2; O'Quin KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142208; O'Quin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057281; PALMOSKI MJ, 1970, J EXP ZOOL, V174, P157, DOI 10.1002/jez.1401740205; Pottin K, 2011, DEVELOPMENT, V138, P2467, DOI 10.1242/dev.054106; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Smoak K. D, 1983, T AM MICROSCOPICAL S, P135; Wells KL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-257; Wilkens H, 1988, EVOL BIOL, V23, P367; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	33	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171061	10.1371/journal.pone.0171061	http://dx.doi.org/10.1371/journal.pone.0171061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182695	Green Published, gold			2022-12-27	WOS:000394231800029
J	Mooney, R; Quinlan, LR; Corley, G; Godfrey, A; Osborough, C; Laighin, GO				Mooney, Robert; Quinlan, Leo R.; Corley, Gavin; Godfrey, Alan; Osborough, Conor; Laighin, Gearoid O.			Evaluation of the Finis Swimsense (R) and the Garmin Swim (TM) activity monitors for swimming performance and stroke kinematics analysis	PLOS ONE			English	Article							INTER-ARM COORDINATION; FRONT-CRAWL; ENERGY-COST; VELOCITY	Aims The study aims were to evaluate the validity of two commercially available swimming activity monitors for quantifying temporal and kinematic swimming variables. Methods Ten national level swimmers (5 male, 5 female; 15.3 +/- 1.3years; 164.8 +/- 12.9cm; 62.4 +/- 11.1kg; 425 +/- 66 FINA points) completed a set protocol comprising 1,500m of swimming involving all four competitive swimming strokes. Swimmers wore the Finis Swimsense and the Garmin Swim activity monitors throughout. The devices automatically identified stroke type, swim distance, lap time, stroke count, stroke rate, stroke length and average speed. Video recordings were also obtained and used as a criterion measure to evaluate performance. Results A significant positive correlation was found between the monitors and video for the identification of each of the four swim strokes (Garmin: X-2 (3) = 31.292, p<0.05; Finis:X-2 (3) = 33.004, p<0.05). No significant differences were found for swim distance measurements. Swimming laps performed in the middle of a swimming interval showed no significant difference from the criterion (Garmin: bias -0.065, 95% confidence intervals -3.828-6.920; Finis bias -0.02, 95% confidence intervals -3.095-3.142). However laps performed at the beginning and end of an interval were not as accurately timed. Additionally, a statistical difference was found for stroke count measurements in all but two occasions (p<0.05). These differences affect the accuracy of stroke rate, stroke length and average speed scores reported by the monitors, as all of these are derived from lap times and stroke counts. Conclusions Both monitors were found to operate with a relatively similar performance level and appear suited for recreational use. However, issues with feature detection accuracy may be related to individual variances in stroke technique. It is reasonable to expect that this level of error would increase when the devices are used by recreational swimmers rather than elite swimmers. Further development to improve accuracy of feature detection algorithms, specifically for lap time and stroke count, would also increase their suitability within competitive settings.	[Mooney, Robert; Corley, Gavin; Laighin, Gearoid O.] NUI Galway, Sch Engn & Informat, Elect & Elect Engn, Galway, Ireland; [Mooney, Robert; Corley, Gavin; Laighin, Gearoid O.] NUI Galway, Natl Ctr Biomed Engn Sci, Bioelect Res Cluster, Galway, Ireland; [Quinlan, Leo R.] NUI Galway, Sch Med, Physiol, Galway, Ireland; [Quinlan, Leo R.; Laighin, Gearoid O.] NUI Galway, CURAM, SFI Ctr Res Med Devices, Galway, Ireland; [Godfrey, Alan] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Osborough, Conor] Manchester Metropolitan Univ, Dept Exercise & Sports Sci, Crewe, England	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Newcastle University - UK; Manchester Metropolitan University	Quinlan, LR (corresponding author), NUI Galway, Sch Med, Physiol, Galway, Ireland.; Quinlan, LR (corresponding author), NUI Galway, CURAM, SFI Ctr Res Med Devices, Galway, Ireland.	leo.quinlan@nuigalway.ie	ÓLaighin, Gearóid/A-5239-2009; Quinlan, Leo R/N-4117-2014	ÓLaighin, Gearóid/0000-0002-1885-814X; Quinlan, Leo R/0000-0002-4011-6732; Godfrey, Alan/0000-0003-4049-9291	Irish Research Council Enterprise Partnership Scheme; Swim Ireland [EPSPG\2012\361]	Irish Research Council Enterprise Partnership Scheme; Swim Ireland	This research is funded by the Irish Research Council Enterprise Partnership Scheme in conjunction with Swim Ireland (Grant award reference EPSPG\2012\361).	Anthony JJ, 2010, US Patent, Patent No. [US 20100210975A1, 20100210975]; Bachlin M, 2012, PERVASIVE MOB COMPUT, V8, P68, DOI 10.1016/j.pmcj.2011.05.003; Barden JM, 2011, J SPORT SCI, V29, P517, DOI 10.1080/02640414.2010.543912; Beanland E, 2014, J SCI MED SPORT, V17, P234, DOI 10.1016/j.jsams.2013.04.007; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Carstensen B., 2008, INT J BIOSTATISTICS, V4; Chollet D, 2004, INT J SPORTS MED, V25, P486, DOI 10.1055/s-2004-820943; CRAIG AB, 1985, MED SCI SPORT EXER, V17, P625, DOI 10.1249/00005768-198512000-00001; Crawford D, 2009, INDEPENDENT SPORT PA; Dadashi F, 2012, SENSORS-BASEL, V12, P12927, DOI 10.3390/s121012927; Davey N., 2008, SPORT TECHNOL, V1, P202, DOI [10.1080/19346182.2008.9648474, DOI 10.1002/JST.59]; East D. J., 1970, NZ J HLTH PHYS ED RE, V3, P16; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Figueiredo P, 2012, HUM MOVEMENT SCI, V31, P1200, DOI 10.1016/j.humov.2012.01.006; Finis, 2010, SWIMS PERF MON QUICK, P13; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Garmin, 2013, GARM SWIM OWN MAN, P6; Hellard P, 2008, J SPORT SCI, V26, P35, DOI 10.1080/02640410701332515; Kelly E, 2012, SWIMMING IRELAND STA; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Komar J, 2012, HUM MOVEMENT SCI, V31, P620, DOI 10.1016/j.humov.2011.07.011; Maglischo E.W., 2003, SWIMMING FASTEST; Mooney R, 2015, J SPORTS SCI, V34, P1; Mooney R., 2015, SPORT EXERC MED OPEN, V1, P133, DOI [10.17140/SEMOJ-1-121, DOI 10.17140/SEMOJ-1-121]; Mooney R, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010018; Nikodelis T, 2005, J SPORT SCI, V23, P737, DOI 10.1080/02640410400021955; Oh DJ, 2015, J EXERC REHABIL, V11, P48, DOI 10.12965/jer.150185; Ohgi Y., 2003, SPORTS ENG, V6, P113, DOI [10.1007/BF02903532, DOI 10.1007/BF02903532]; Ohgi Y, 2014, PROCEDIA ENGINEER, V72, P829, DOI 10.1016/j.proeng.2014.06.036; Osborough CD, 2010, HUM MOVEMENT SCI, V29, P921, DOI 10.1016/j.humov.2010.05.009; Roy A, 2009, J BIOPHARM STAT, V19, P150, DOI 10.1080/10543400802535141; Schnitzler C, 2010, INT J SPORTS MED, V31, P875, DOI 10.1055/s-0030-1265149; Seifert L, 2004, J SPORT SCI, V22, P651, DOI 10.1080/02640410310001655787; Seifert L, 2010, HUM MOVEMENT SCI, V29, P103, DOI 10.1016/j.humov.2009.05.003; Seifert L, 2008, J STRENGTH COND RES, V22, P1670, DOI 10.1519/JSC.0b013e318182029d; Siirtola P., 2011, Proceedings 2011 IEEE Symposium on Computational Intelligence and Data Mining (CIDM 2011), P156, DOI 10.1109/CIDM.2011.5949430; Stamm A, 2013, SPORTS ENG, V16, P1, DOI 10.1007/s12283-012-0107-6; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wilkerson DP, 2012, EUR J APPL PHYSIOL, V112, P4127, DOI 10.1007/s00421-012-2397-6; Zhao Q, 2009, J ELECTRON IMAGING, V18, DOI 10.1117/1.3247860	41	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170902	10.1371/journal.pone.0170902	http://dx.doi.org/10.1371/journal.pone.0170902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178301	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000393712500017
J	Onywera, H; Maman, D; Inzaule, S; Auma, E; Were, K; Fredrick, H; Owiti, P; Opollo, V; Etard, JF; Mukui, I; Kim, AA; Zeh, C				Onywera, Harris; Maman, David; Inzaule, Seth; Auma, Erick; Were, Kennedy; Fredrick, Harrison; Owiti, Prestone; Opollo, Valarie; Etard, Jean-Francois; Mukui, Irene; Kim, Andrea A.; Zeh, Clement			Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naIve persons in rural western Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; GENETIC DIVERSITY; INDIVIDUALS; PREVALENCE; THERAPY; TRANSMISSION; MUTATIONS; TYPE-1; IMPACT; WOMEN	HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa with the rollout of antiretroviral (ARV) therapy. Such data are, however, limited in Kenya, where HIV-1 drug resistance testing is not routinely performed. From a population-based household survey conducted between September and November 2012 in rural western Kenya, we retrospectively assessed HIV-1 TDR baseline rates, its determinants, and genetic diversity among drug-na ve persons aged 15-59 years with acute HIV-1 infections (AHI) and recent HIV-1 infections (RHI) as determined by nucleic acid amplification test and both Limiting Antigen and BioRad avidity immunoassays, respectively. HIV-1 po/sequences were scored for drug resistance mutations using Stanford HIVdb and WHO 2009 mutation guidelines. HIV-1 subtyping was computed in MEGA6. Eighty seven (93.5%) of the eligible samples were successfully sequenced. Of these, 8 had at least one TDR mutation, resulting in a TDR prevalence of 9.2% (95% CI 4.7-17.1). No TDR was observed among persons with AHI (n = 7). TDR prevalence was 4.6% (95% CI 1.8-11.2) for nucleoside reverse transcriptase inhibitors (NRTIs), 6.9% (95% CI 3.2-14.2) for non- nucleoside reverse transcriptase inhibitors (NNRTIs), and 1.2% (95% CI 0.2-6.2) for protease inhibitors. Three (3.4% 95% CI 0.8-10.1) persons had dual-class NRTI/NNRTI resistance. Predominant TDR mutations in the reverse transcriptase included K103N/S (4.6%) and M184V (2.3%); only M461/L (1.1%) occurred in the protease. All the eight persons were predicted to have different grades of resistance to the ARV regimens, ranging from potential low-level to high-level resistance. HIV-1 subtype distribution was heterogeneous: A (57.5%), C (6.9%), D (21.8%), G (2.3%), and circulating recombinant forms (11.5%). Only low CD4 count was associated with TDR (p = 0.0145). Our findings warrant the need for enhanced HIV-1 TDR monitoring in order to inform on population-based therapeutic guidelines and public health interventions.	[Onywera, Harris; Inzaule, Seth; Auma, Erick; Were, Kennedy; Fredrick, Harrison; Owiti, Prestone; Opollo, Valarie] Kenya Med Res Inst KEMRI, CGHR, Kisumu, Kenya; [Maman, David] MSF, Epictr, Paris, France; [Etard, Jean-Francois] Univ Montpellier, TransVIHMI, IRD, UMI 233,INSERM,U 1175, Montpellier, France; [Mukui, Irene] Minist Hlth, Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Kim, Andrea A.] US Ctr Dis Control & Prevent CDC, Nairobi, Kenya; [Zeh, Clement] US Ctr Dis Control & Prevent CDC, Kisumu, Kenya	Kenya Medical Research Institute; Doctors Without Borders; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Onywera, H (corresponding author), Kenya Med Res Inst KEMRI, CGHR, Kisumu, Kenya.; Zeh, C (corresponding author), US Ctr Dis Control & Prevent CDC, Kisumu, Kenya.	do79harris@gmail.com; cbz2@cdc.gov	Onywera, Harris/AAM-6198-2021; Etard, Jean-Francois/V-4865-2019; Mukui, Irene/GYE-0151-2022; Etard, Jean François/A-9630-2008	Onywera, Harris/0000-0002-7298-4921; Etard, Jean-Francois/0000-0002-4873-0788; Etard, Jean François/0000-0002-4873-0788; Maman, David/0000-0002-9839-3011; Mukui, Irene/0000-0002-3699-1841	Medecins Sans Frontieres (MSF)	Medecins Sans Frontieres (MSF)	This work was funded by the Medecins Sans Frontieres (MSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chan Philip A., 2009, HIV Therapy, V3, P447, DOI [10.2217/hiv.09.30, 10.2217/HIV.09.30]; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Guha SK, 2012, MED UPDATE 2012, P84; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2008, ANTIVIR THER, V13, P625; Hamers RL, 2013, CURR OPIN HIV AIDS, V8, P19, DOI 10.1097/COH.0b013e32835b7f94; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hassan AS, 2013, AIDS RES HUM RETROV, V29, P129, DOI [10.1089/aid.2012.0167, 10.1089/AID.2012.0167]; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Hosseinipour MC, 2013, J INFECT DIS, V207, pS49, DOI 10.1093/infdis/jit107; Hurt CB, 2009, ANTIVIR THER, V14, P673; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Lal RB, 2005, INDIAN J MED RES, V121, P287; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Lee GQ, 2014, AIDS RES HUM RETROV, V30, P896, DOI [10.1089/aid.2014.0043, 10.1089/AID.2014.0043]; Lihana RW, 2009, AIDS RES HUM RETROV, V25, P1211, DOI 10.1089/aid.2009.0007; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Maman D, 2014, NDHIWA HIV IMPACT PO; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health, 2014, KEN HIV PREV REV ROA; NASCOP, 2013, KEN AIDS IND SURV 20; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Ndembi N, 2013, AIDS RES HUM RETROV, V29, P788, DOI [10.1089/AID.2012.0123, DOI 10.1089/AID.2012.0123]; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Nieburg P, 2011, HIV PREVENTION INJEC; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Readhead AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040533; Ruelle J, 2013, AIDS RES HUM RETROV, V29, P1306, DOI [10.1089/aid.2013.0108, 10.1089/AID.2013.0108]; Sigallof KCE, 2012, AIDS RES HUM RETROV, V27, P1; Skoura L, 2013, CLIN MICROBIOL INFEC, V19, pE169, DOI 10.1111/1469-0691.12124; Somi GR, 2008, ANTIVIR THER, V13, P77; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P1784, DOI [10.1089/aid.2012.0090, 10.1089/AID.2012.0090]; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang MW, 2012, INTERVIROLOGY, V55, P98, DOI 10.1159/000331998; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; UNAIDS, 2020, UNAIDS 2020 GLOB REP; UNAIDS/WHO, 2011, 1S ASS REC 2NF EST H; Wainberg MA, 2011, RETROVIROLOGY S2, V8, pO14; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; Westreich D, 2007, J INFECT DIS, V195, P837, DOI 10.1086/511276; WHO, 2012, M REP FRAM METR SUPP; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; Yang CF, 2004, AIDS RES HUM RETROV, V20, P565, DOI 10.1089/088922204323087822; Yanik EL, 2012, JAIDS-J ACQ IMM DEF, V61, P258, DOI 10.1097/QAI.0b013e3182618f05; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757; Zeh C, 2015, CROI, P625; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	64	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171124	10.1371/journal.pone.0171124	http://dx.doi.org/10.1371/journal.pone.0171124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178281	Green Submitted, gold, Green Published			2022-12-27	WOS:000393712500025
J	Schoberl, I; Wedl, M; Beetz, A; Kotrschal, K				Schoeberl, Iris; Wedl, Manuela; Beetz, Andrea; Kotrschal, Kurt			Psychobiological Factors Affecting Cortisol Variability in Human-Dog Dyads	PLOS ONE			English	Article							GENDER-DIFFERENCES; STRANGE SITUATION; EMOTIONAL CONTAGION; SALIVARY CORTISOL; MAJOR DEPRESSION; CIRCADIAN-RHYTHM; SEX-DIFFERENCES; STRESS; RESPONSES; BEHAVIOR	Stress responses within dyads are modulated by interactions such as mutual emotional support and conflict. We investigated dyadic psychobiological factors influencing intra-individual cortisol variability in response to different challenging situations by testing 132 owners and their dogs in a laboratory setting. Salivary cortisol was measured and questionnaires were used to assess owner and dog personality as well as owners' social attitudes towards the dog and towards other humans. We calculated the individual coefficient of variance of cortisol (iCV = sd/mean*100) over the different test situations as a parameter representing individual variability of cortisol concentration. We hypothesized that high cortisol variability indicates efficient and adaptive coping and a balanced individual and dyadic social performance. Female owners of male dogs had lower iCV than all other owner gender-dog sex combinations (F = 14.194, p<0.001), whereas owner Agreeableness (NEO-FFI) scaled positively with owner iCV (F=4.981, p = 0.028). Dogs of owners high in Neuroticism (NEO-FFI) and of owners who were insecure -ambivalently attached to their dogs (FERT), had low iCV (F= 4.290, p = 0.041 and F= 5.948, p = 0.016), as had dogs of owners with human -directed separation anxiety (RSQ) or dogs of owners with a strong desire of independence (RSQ) (F= 7.661, p= 0.007 and F= 9.192, p = 0.003). We suggest that both owner and dog social characteristics influence dyadic cortisol variability, with the human partner being more influential than the dog. Our results support systemic approaches (i.e. considering the social context) in science and in counselling.	[Schoeberl, Iris; Wedl, Manuela; Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Schoeberl, Iris; Wedl, Manuela; Kotrschal, Kurt] Univ Vienna, Core Facil Konrad Lorenz Res Stn, Grunau Im Almtal, Austria; [Beetz, Andrea] Univ Rostock, Inst Sonderpadagog Entwicklungsforderung & Rehabi, Dept Special Educ, Rostock, Germany	University of Vienna; University of Vienna; University of Rostock	Schoberl, I (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.; Schoberl, I (corresponding author), Univ Vienna, Core Facil Konrad Lorenz Res Stn, Grunau Im Almtal, Austria.	iris.schoeberl@univie.ac.at			Austrian Science Fund (FWF) [P23345]; PhD program Cognition and Communication from the Austrian Science Fund (FWF) [W1234-G17]; Austrian Science Fund (FWF) [P 23345] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); PhD program Cognition and Communication from the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was funded by the Austrian Science Fund (FWF; https://WWW.fwf.ac.at/en/): Project P23345 to KK and MW, and the PhD program Cognition and Communication from the Austrian Science Fund (FWF): Project W1234-G17 to KK. The funding agencies were not involved in the collection, analysis and interpretation of data.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Ainsworth M.D.S., 1978, PATTERNS ATTACHMENT, DOI DOI 10.4324/9780203758045; Albuquerque N, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0883; Aureli F., 2000, NATURAL CONFLICT RES; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beetz AM, 2004, INT C HUM AN INT IAH; Beetz A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00234, 10.3389/fpsyg.2012.00352]; Ben-Ner A, 2004, J ECON PSYCHOL, V25, P581, DOI 10.1016/S0167-4870(03)00065-5; Berns GS, 2015, BEHAV PROCESS, V110, P37, DOI 10.1016/j.beproc.2014.02.011; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Bonein A., 2009, J SOCIO-ECON, V38, P779; Borkenau P., 1993, NEO FUNF FAKTOREN IN; BOWLBY J, 1969, ATTACHMENT LOSS, DOI DOI 10.1177/000306518403200125; Cobb ML, 2016, DOMEST ANIM ENDOCRIN, V57, P31, DOI 10.1016/j.domaniend.2016.04.003; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Costa PT, 2007, REVISED NEO PERSONAL; DeVries AC, 2003, PHYSIOL BEHAV, V79, P399, DOI 10.1016/S0031-9384(03)00152-5; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duranton C, 2015, J VET BEHAV, V10, P513, DOI 10.1016/j.jveb.2015.08.008; Ellis BJ, 2006, DEV REV, V26, P175, DOI 10.1016/j.dr.2006.02.004; Fanous A, 2002, PSYCHOL MED, V32, P719, DOI 10.1017/S003329170200541X; Frantz LAF, 2016, SCIENCE, V352, P1228, DOI 10.1126/science.aaf3161; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Friedmann E, 2000, COMPANION ANIMALS AND US, P125; George C., 2008, HDB ATTACHMENT THEOR, V2, P833; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Griffin DW, 1994, ATTACHMENT PROCESSES, P17, DOI DOI 10.1037//0022-3514.67.3.430; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Johansson AC, 2008, EUR J PAIN, V12, P633, DOI 10.1016/j.ejpain.2007.10.009; Julius H, 2012, ATTACHMENT TO PETS; Karlson B, 2011, STRESS HEALTH, V27, pE11, DOI 10.1002/smi.1330; Kelly MM, 2008, J BEHAV THER EXP PSY, V39, P87, DOI 10.1016/j.jbtep.2007.02.003; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kirschbaum Clemens, 1999, Noise Health, V1, P57; Kolevska J, 2003, ACTA VET BRNO, V72, P599, DOI 10.2754/avb200372040599; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ligout S, 2009, P 7 INT VET BEH M, P143; Lynn R, 1997, J SOC PSYCHOL, V137, P369, DOI 10.1080/00224549709595447; Main M., 1990, ATTACHMENT PRESCHOOL, P161, DOI DOI 10.1016/J.NCL.2015.11.007; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Merola I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047653; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Muller CA, 2015, CURR BIOL, V25, P601, DOI 10.1016/j.cub.2014.12.055; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nicolson N, 2007, HDB PHYSL RES METHOD, P37, DOI DOI 10.4135/9781412976244.N3; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; OFarrell V, 1997, APPL ANIM BEHAV SCI, V52, P205, DOI 10.1016/S0168-1591(96)01123-9; Osborne JW., 2004, PRACTICAL ASSESSMENT, V9, P1, DOI [10.7275/QF69-7K43, DOI 10.7275/QF69-7K43, 10.7275/qf69-7k43]; PALAZZOLO DL, 1987, EXP GERONTOL, V22, P379, DOI 10.1016/0531-5565(87)90019-2; Palme R, 1997, Z SAUGETIERKD, V62, P192; Poesel A, 2006, ANIM BEHAV, V72, P531, DOI 10.1016/j.anbehav.2005.10.022; Prato-Previde E, 2006, ETHOLOGY, V112, P64, DOI 10.1111/j.1439-0310.2006.01123.x; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Roberts SB, 1999, PSYCHOL MED, V29, P1101, DOI 10.1017/S0033291799008739; Romero T, 2014, P NATL ACAD SCI USA, V111, P9085, DOI 10.1073/pnas.1322868111; Scheiber IBR, 2005, BEHAVIOUR, V142, P1535, DOI 10.1163/156853905774831873; Schleidt WM, 2003, EVOLUTION COGNITION, V9; Schoberl I, 2016, J VET BEHAV, V11, P77, DOI 10.1016/j.jveb.2015.09.007; Schoberl I, 2015, BEHAV RES METHODS, V47, P1356, DOI 10.3758/s13428-014-0546-z; Schoberl I, 2012, ANTHROZOOS, V25, P199, DOI 10.2752/175303712X13316289505422; Solomon J, 2014, INT SOC ANTR ISAZ AN; Somppi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143047; Spangler G, 1998, INT J BEHAV DEV, V22, P681, DOI 10.1080/016502598384126; Steffanowski A, 2001, STORUNGSSPEZIFISCHE; Sumegi Z, 2014, APPL ANIM BEHAV SCI, V160, P106, DOI 10.1016/j.applanim.2014.09.001; Sutter M, 2009, EXP ECON, V12, P318, DOI 10.1007/s10683-009-9217-9; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turcsan B, 2015, ANIM COGN, V18, P83, DOI 10.1007/s10071-014-0779-3; Underwood J, 2000, LEARN INSTR, V10, P447, DOI 10.1016/S0959-4752(00)00008-6; Urquiza-Haas EG, 2015, ANIM BEHAV, V109, P167, DOI 10.1016/j.anbehav.2015.08.011; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Veen G, 2009, METABOLISM, V58, P821, DOI 10.1016/j.metabol.2009.02.009; Vollrath M, 2001, SCAND J PSYCHOL, V42, P335, DOI 10.1111/1467-9450.00245; von Holst D, 1998, ADV STUD BEHAV, V27, P1; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147; Wascher CAF, 2008, J COMP PSYCHOL, V122, P100, DOI 10.1037/0735-7036.122.1.100; Waugh CE, 2008, J RES PERS, V42, P1031, DOI 10.1016/j.jrp.2008.02.005; Wedl M, 2015, ANTHROZOOS, V28, P601, DOI 10.1080/08927936.2015.1070002; Wedl M, 2010, INTERACT STUD, V11, P482, DOI 10.1075/is.11.3.09wed; Wedl M, 2009, ANTHROZOOS, V22, P383, DOI 10.2752/089279309X12538695316220; Yong MH, 2014, BEHAV PROCESS, V108, P155, DOI 10.1016/j.beproc.2014.10.006; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zilcha-Mano S, 2011, J RES PERS, V45, P345, DOI 10.1016/j.jrp.2011.04.001	96	25	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170707	10.1371/journal.pone.0170707	http://dx.doi.org/10.1371/journal.pone.0170707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178272	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500012
J	Hagos, S; Hailemariam, D; WoldeHanna, T; Lindtjorn, B				Hagos, Seifu; Hailemariam, Damen; WoldeHanna, Tasew; Lindtjorn, Bernt			Spatial heterogeneity and risk factors for stunting among children under age five in Ethiopia: A Bayesian geo-statistical model	PLOS ONE			English	Article							NUTRITIONAL-STATUS; MALNUTRITION; GROWTH	Background Understanding the spatial distribution of stunting and underlying factors operating at mesoscale is of paramount importance for intervention designing and implementations. Yet, little is known about the spatial distribution of stunting and some discrepancies are documented on the relative importance of reported risk factors. Therefore, the present study aims at exploring the spatial distribution of stunting at meso-(district) scale, and evaluates the effect of spatial dependency on the identification of risk factors and their relative contribution to the occurrence of stunting and severe stunting in a rural area of Ethiopia. Methods A community based cross sectional study was conducted to measure the occurrence of stunting and severe stunting among children aged 0-59 months. Additionally, we collected relevant information on anthropometric measures, dietary habits, parent and child-related demographic and socio-economic status. Latitude and longitude of surveyed households were also recorded. Local Anselin Moran's I was calculated to investigate the spatial variation of stunting prevalence and identify potential local pockets (hotspots) of high prevalence. Finally, we employed a Bayesian geo-statistical model, which accounted for spatial dependency structure in the data, to identify potential risk factors for stunting in the study area. Results Overall, the prevalence of stunting and severe stunting in the district was 43.7% [95% CI: 40.9, 46.4] and 21.3% [95% CI: 19.5, 23.3] respectively. We identified statistically significant clusters of high prevalence of stunting (hotspots) in the eastern part of the district and clusters of low prevalence (cold spots) in the western. We found out that the inclusion of spatial structure of the data into the Bayesian model has shown to improve the fit for stunting model. The Bayesian geo-statistical model indicated that the risk of stunting increased as the child's age increased (OR 4.74; 95% Bayesian credible interval [BCI]: 3.35-6.58) and among boys (OR 1.28; 95% BCI; 1.12-1.45). However, maternal education and household food security were found to be protective against stunting and severe stunting. Conclusion Stunting prevalence may vary across space at different scale. For this, it's important that nutrition studies and, more importantly, control interventions take into account this spatial heterogeneity in the distribution of nutritional deficits and their underlying associated factors. The findings of this study also indicated that interventions integrating household food insecurity in nutrition programs in the district might help to avert the burden of stunting.	[Hagos, Seifu; Hailemariam, Damen] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Hagos, Seifu; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [WoldeHanna, Tasew] Univ Addis Ababa, Coll Business & Econ, Dept Econ, Addis Ababa, Ethiopia	Addis Ababa University; University of Bergen; Addis Ababa University	Hagos, S (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia.; Hagos, S (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	seif_h23@yahoo.com	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984	Center for International Health at the University of Bergen	Center for International Health at the University of Bergen	We would like to acknowledge the Center for International Health at the University of Bergen for funding the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2015, NUTRITION, V31, P964, DOI 10.1016/j.nut.2015.01.013; Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; [Anonymous], 2001, ETH DEM HLTH SURV 20; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, P382; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia], 2014, ETH MIN DEM HLTH SUR; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; de Onis M, 2013, MATERNAL CHILD NU S2, V9; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dewey KG, 2011, MATERNAL CHILD NU S3, V7; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Gebreyesus S.H., 2015, BMC NUTR, V1, P2, DOI [DOI 10.1186/2055-0928-1-1, 10.1186/2055-0928-1-2]; Herrador Z, 2014, PLOS ONE, V9; Humphries DL, 2015, J NUTR; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Khatab K, 2010, AM J TROP MED HYG, V82, P653, DOI 10.4269/ajtmh.2010.09-0501; Lemma F, 2013, LANCET, V382, P488, DOI 10.1016/S0140-6736(13)61054-5; Lindtjorn B, 2002, J HLTH POPULATION NU, V20; Medhin G, 2010, BMC PUBLIC HLTH, P10; Mulugeta A, 2010, E AFRICAN MED J, V87; Outes I, 2013, EC HUMAN BIOL, V11; Petrou S, 1982, SOCIAL SCI MED, V71; Pfeiffer D, 2010, SPATIAL ANAL EPIDEMI; Psaki S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-24; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; ROWLAND MGM, 1977, BRIT J NUTR, V37, P441, DOI 10.1079/BJN19770047; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; Singh A, 2014, LANCET GLOBAL HLTH, V2; Smith L.C., 2000, EXPLAINING CHILD MAL; Stein AD, 2005, MATERNAL CHILD NUTR, V1; Stewart CP, 2013, MATERNAL CHILD NU S2, V9; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; Umeta M, 2003, J NUTR, V133, P1064, DOI 10.1093/jn/133.4.1064; UNICEF, 1990, STRATEGY FOR IMPROVI; Victora CG, 2008, LANCET, V371; Vollmer S., 2014, LANCET GLOBAL HLTH, V2	43	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170785	10.1371/journal.pone.0170785	http://dx.doi.org/10.1371/journal.pone.0170785			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170407	gold, Green Published, Green Submitted			2022-12-27	WOS:000393705500011
J	Kim, SE; Choo, J; Yoon, J; Chu, JR; Bae, YJ; Lee, S; Park, T; Sung, MK				Kim, Sung-Eun; Choo, Jinsil; Yoon, Joon; Chu, Jae Ryang; Bae, Yun Jung; Lee, Seungyeoun; Park, Taesung; Sung, Mi-Kyung			Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INDUCED OBESITY; ULCERATIVE-COLITIS; NHE3-DEFICIENT MICE; COLORECTAL-CANCER; ADIPOSE-TISSUE; EXPRESSION; RESISTANCE; AUTOTAXIN; RISK	Obesity-induced chronic inflammation is known to increase the risk of ulcerative colitis, Crohn's disease, and colorectal cancer. Accumulating evidence suggests that leptin and insulin are key molecules linking obesity with diseases of the lower intestine. Here, we identified serum phenotype-associated genes in the colon of diet-induced obese mice as early biomarkers of obesity-associated colonic diseases. C57BL/6J mice were fed with either normal diet (ND, 15% of fat calories) or high-fat diet (HFD, 45% of fat calories) for 8 weeks. Serum concentrations of insulin, insulin-like growth factor-1 (IGF-1), leptin, and adiponectin were measured as obesity-related phenotypic markers. Genome-wide gene expression profiles of colon tissue were determined, followed by statistical analyses to detect differentially expressed and serum phenotype-associated genes. HFD-fed mice showed higher serum concentrations of leptin (P < 0.001) and insulin (P < 0.01) than those in the ND group, whereas serum IGF-1 and adiponectin concentrations did not differ between the two dietary groups. Among differentially expressed genes affected by HFD, 135, 128, 110, and 341 genes were associated with serum levels of leptin, insulin, IGF-1, and adiponectin, respectively. We identified 17 leptin-associated genes and 4 insulin-associated genes that inversely responded to HFD and ND. Among these, leptin-associated Peli3 (Pellino E3 ubiquitin protein ligase family member 3), Creb1 (cAMP responsive element binding protein 1), and Enpp2 (ectonucleotide pyrophosphatase/phosphodiesterase 2, autotaxin) and insulinassociated Centg1 (AGAP2, ArfGAP with GTPase domain) are reported to play a role either in obesity or colonic diseases. mRNA expression of these genes was validated by RTqPCR. Our data suggest Peli3, Creb1, Enpp2, and Centg1 as potential early biomarker candidates for obesity-induced pathophysiological changes in the colon. Future studies verifying the function of these candidates are needed for the prevention, early detection, and treatment of colon diseases.	[Kim, Sung-Eun; Sung, Mi-Kyung] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Choo, Jinsil; Chu, Jae Ryang] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea; [Yoon, Joon; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Bae, Yun Jung] Shinhan Univ, Div Food Sci & Culinary Arts, Gyeonggi Do, South Korea; [Lee, Seungyeoun] Sejong Univ, Dept Math & Stat, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Sookmyung Women's University; Sookmyung Women's University; Seoul National University (SNU); Sejong University; Seoul National University (SNU)	Sung, MK (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	mksung@sm.ac.kr		BAE, YUN JUNG/0000-0003-1185-3095; Yoon, Joon/0000-0002-9509-119X	SRC program (Center for Food & Nutritional Genomics) [2015R1A5A6001906]; Mid-Career Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A2A2A01004607]	SRC program (Center for Food & Nutritional Genomics); Mid-Career Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the SRC program (Center for Food & Nutritional Genomics: No.2015R1A5A6001906) and the Mid-Career Research Program (No.2015R1A2A2A01004607) of the National Research Foundation of Korea (NRF, www.nrt.re.kr/nrf_eng_cms/) funded by the Ministry of Education, Science and Technology to M-KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awada R, 2014, J CELL BIOCHEM, V115, P2123, DOI 10.1002/jcb.24889; Ben QW, 2012, GASTROENTEROLOGY, V142, P762, DOI 10.1053/j.gastro.2011.12.050; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Buffart TE, 2008, BRIT J CANCER, V99, P1802, DOI 10.1038/sj.bjc.6604777; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chan CB, 2010, DIABETES, V59, P883, DOI 10.2337/db09-1404; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Fan H, 2008, MOL MED, V14, P422, DOI 10.2119/2007-00106.Fan; Fonseca-Camarillo G, 2012, INFLAMM BOWEL DIS, V18, P1197, DOI 10.1002/ibd.22968; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Giegerich AK, 2014, AUTOPHAGY, V10, P1937, DOI 10.4161/auto.32178; Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Khalili H, 2015, INFLAMM BOWEL DIS, V21, P361, DOI 10.1097/MIB.0000000000000283; Kim YJ, 2008, NUTR RES, V28, P414, DOI 10.1016/j.nutres.2008.03.015; Korkmaz H, 2014, EUR J GASTROEN HEPAT, V26, P725, DOI 10.1097/MEG.0000000000000104; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008; Leclerc D, 2013, CANCER PREV RES, V6, P1171, DOI 10.1158/1940-6207.CAPR-13-0198; Lind GE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-13; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Ma RQ, 2015, ONCOL LETT, V10, P957, DOI 10.3892/ol.2015.3355; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Miller RS, 2008, J NUTR, V138, P1033, DOI 10.1093/jn/138.6.1033; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Moon HS, 2013, GUT, V62, P561, DOI 10.1136/gutjnl-2012-302092; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Oh HY, 2013, GENES NUTR, V8, P301, DOI 10.1007/s12263-012-0322-6; Park SY, 2012, INT J OBESITY, V36, P273, DOI 10.1038/ijo.2011.83; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Priyamvada S, 2015, INFLAMM BOWEL DIS, V21, P2926, DOI 10.1097/MIB.0000000000000504; Qi Q, 2013, ACTA PHARMACOL SIN, V34, P991, DOI 10.1038/aps.2013.71; REIFENBERGER G, 1994, CANCER RES, V54, P4299; Roberts DL, 2015, ONCOTARGET, V6, P10786, DOI 10.18632/oncotarget.3198; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Schmidt DR, 2011, J BIOL CHEM, V286, P2425, DOI 10.1074/jbc.M110.181230; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Sitaraman S, 2004, FASEB J, V18, P696, DOI 10.1096/fj.03-0422fje; Spielbauer B, 2005, MOL NUTR FOOD RES, V49, P908, DOI 10.1002/mnfr.200500033; Sung MK, 2010, BIOTECHNOL J, V5, P930, DOI 10.1002/biot.201000165; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tuzun A, 2004, J GASTROEN HEPATOL, V19, P429, DOI 10.1111/j.1440-1746.2003.03300.x; Valentini L, 2009, NUTRITION, V25, P172, DOI 10.1016/j.nut.2008.07.020; Volat FE, 2012, DIABETES, V61, P2796, DOI 10.2337/db11-1297; Wang R, 2014, CELL DEATH DIFFER, V21, P427, DOI 10.1038/cdd.2013.163; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011; Wu XY, 2014, WORLD J GASTROENTERO, V20, P16268, DOI 10.3748/wjg.v20.i43.16268; Zimmet PZ, 1998, INT J OBESITY, V22, P171, DOI 10.1038/sj.ijo.0800559	57	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171664	10.1371/journal.pone.0171664	http://dx.doi.org/10.1371/journal.pone.0171664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170448	Green Submitted, Green Published, gold			2022-12-27	WOS:000393705500050
J	Derogis, PBM; Sanches, LR; de Aranda, VF; Colombini, MP; Mangueira, CLP; Katz, M; Faulhaber, ACL; Mendes, CEA; Ferreira, CED; Franca, CN; Guerra, JCD				Matos Derogis, Priscilla Bento; Sanches, Livia Rentas; de Aranda, Valdir Fernandes; Colombini, Marjorie Paris; Pitangueira Mangueira, Cristovao Luis; Katz, Marcelo; Leme Faulhaber, Adriana Caschera; Albers Mendes, Claudio Ernesto; dos Santos Ferreira, Carlos Eduardo; Franca, Carolina Nunes; de Campos Guerra, Joao Carlos			Determination of rivaroxaban in patient's plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)	PLOS ONE			English	Article							DIRECT ORAL ANTICOAGULANTS; VENOUS THROMBOEMBOLISM; ACCURATE DETERMINATION; INHIBITOR RIVAROXABAN; TOTAL HIP; DABIGATRAN; ASSAYS; APIXABAN; REPLACEMENT; PREVENTION	Rivaroxaban is an oral direct factor Xa inhibitor, therapeutically indicated in the treatment of thromboembolic diseases. As other new oral anticoagulants, routine monitoring of rivaroxaban is not necessary, but important in some clinical circumstances. In our study a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method was validated to measure rivaroxaban plasmatic concentration. Our method used a simple sample preparation, protein precipitation, and a fast chromatographic run. It was developed a precise and accurate method, with a linear range from 2 to 500 ng/mL, and a lower limit of quantification of 4 pg on column. The new method was compared to a reference method (anti-factor Xa activity) and both presented a good correlation (r = 0.98, p < 0.001). In addition, we validated hemolytic, icteric or lipemic plasma samples for rivaroxaban measurement by HPLC-MS/MS without interferences. The chromogenic and HPLC-MS/MS methods were highly correlated and should be used as clinical tools for drug monitoring. The method was applied successfully in a group of 49 real-life patients, which allowed an accurate determination of rivaroxaban in peak and trough levels.	[Matos Derogis, Priscilla Bento; Sanches, Livia Rentas; de Aranda, Valdir Fernandes; Colombini, Marjorie Paris; Pitangueira Mangueira, Cristovao Luis; Katz, Marcelo; Leme Faulhaber, Adriana Caschera; Albers Mendes, Claudio Ernesto; dos Santos Ferreira, Carlos Eduardo; de Campos Guerra, Joao Carlos] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Franca, Carolina Nunes] Santo Amaro Univ UNISA, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Santo Amaro (UNISA)	Guerra, JCD (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	joao.guerra@einstein.br	França, Carolina Nunes/J-2429-2015	França, Carolina Nunes/0000-0002-4167-4293; Mangueira, Cristovao/0000-0002-4227-3723; Bento Matos Cruz Derogis, Priscilla/0000-0003-2345-3996				[Anonymous], 1989, 11184487EN, DOI [10.1208/aapsj0903042, DOI 10.1208/AAPSJ0903042]; Baglin T, 2013, J THROMB HAEMOST, V11, P122, DOI 10.1111/jth.12227; Baglin T, 2013, J Thromb Haemost, DOI 10.1111/jth.12149; Baglin T, 2012, BRIT J HAEMATOL, V159, P427, DOI 10.1111/bjh.12052; Bardy G, 2015, THROMB RES, V136, P396, DOI 10.1016/j.thromres.2015.05.015; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Burness CB, 2014, DRUGS, V74, P243, DOI 10.1007/s40265-013-0174-4; Douxfils J, 2013, THROMB HAEMOSTASIS, V110, P723, DOI 10.1160/TH13-04-0274; Duggan ST, 2009, DRUGS, V69, P1829, DOI 10.2165/11200890-000000000-00000; Gosselin RC, 2014, ARCH PATHOL LAB MED, V138, P1680, DOI 10.5858/arpa.2013-0750-OA; Gous T, 2014, THER DRUG MONIT, V36, P597, DOI 10.1097/FTD.0000000000000059; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Haas S, 2009, EUR J HAEMATOL, V82, P339, DOI 10.1111/j.1600-0609.2009.01230.x; Harenberg J, 2016, CLIN CHEM LAB MED, V54, P275, DOI 10.1515/cclm-2015-0389; Hughes NC, 2007, AAPS J, V9, pE353, DOI 10.1208/aapsj0903042; Iqbal M, 2015, J THROMB THROMBOLYS, V39, P79, DOI 10.1007/s11239-014-1121-2; Korostelev M, 2014, J PHARMACEUT BIOMED, V100, P230, DOI 10.1016/j.jpba.2014.08.011; Kreutz R, 2012, FUND CLIN PHARMACOL, V26, P27, DOI 10.1111/j.1472-8206.2011.00981.x; Kuhn J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145478; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lindhoff-Last E, 2010, THER DRUG MONIT, V32, P673, DOI 10.1097/FTD.0b013e3181f2f264; Mani H, 2012, THROMB HAEMOSTASIS, V108, P191, DOI 10.1160/TH11-12-0832; Mueck W, 2008, THROMB HAEMOSTASIS, V100, P453, DOI 10.1160/07-12-0714; Mueck W, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-10; Rathbun S, 2015, THROMB RES, V135, P394, DOI 10.1016/j.thromres.2014.11.017; Rohde G, 2008, J CHROMATOGR B, V872, P43, DOI 10.1016/j.jchromb.2008.07.015; Samama MM, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-11; Samama MM, 2011, THROMB RES, V127, P497, DOI 10.1016/j.thromres.2010.09.008; Schmitz EMH, 2014, J THROMB HAEMOST, V12, P1636, DOI 10.1111/jth.12702; Thomas TF, 2013, CLIN THER, V35, P4, DOI 10.1016/j.clinthera.2012.12.005; Tripodi A, 2013, J THROMB HAEMOST, V11, P576, DOI 10.1111/jth.12166; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Vera-Aguilera Jesus, 2016, Adv Hematol, V2016, P4054806, DOI 10.1155/2016/4054806; Vogeser M, 2008, CLIN BIOCHEM, V41, P649, DOI 10.1016/j.clinbiochem.2008.02.017; Wiesen MHJ, 2016, CHEST, V150, pE1, DOI 10.1016/j.chest.2016.01.021	35	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171272	10.1371/journal.pone.0171272	http://dx.doi.org/10.1371/journal.pone.0171272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170419	Green Submitted, gold, Green Published			2022-12-27	WOS:000393705500027
J	von Saltzwedel, H; Scheu, S; Schaefer, I				von Saltzwedel, Helge; Scheu, Stefan; Schaefer, Ina			Genetic structure and distribution of Parisotoma notabilis (Collembola) in Europe: Cryptic diversity, split of lineages and colonization patterns	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; HYBRID ZONE; HEXAPODA; PHYLOGEOGRAPHY; BIODIVERSITY; SUCCESSION; SPECIATION; RESPONSES	Climatic and biome changes of the past million years influenced the population structure and genetic diversity of soil-living arthropods in Europe. However, their effects on the genetic structure of widespread and abundant soil animal species such as the Collembola Parisotoma notabilis remain virtually unknown. This generalist and parthenogenetic species is an early colonizer of disturbed habitats and often occurs in human modified environments. To investigate ancient climatic influence and recent distributions on the genetic structure of P. notabilis we analyzed populations on a pan-European scale using three genetic markers differing in substitution rates. The results showed that P. notabilis comprises several genetic lineages with distinct distribution ranges that diverged in the Miocene. Genetic distances of COI between lineages ranged between 15% and 18% and molecular clock estimates suggest Late Miocene divergences considering the standard arthropod rate of 2.3% per my. Compared to other soil-living arthropods like oribatid mites, European lineages of P. notabilis are rather young and genetically uniform. The close association with anthropogenic habitats presumably contributed to rapid spread in Europe.	[von Saltzwedel, Helge; Scheu, Stefan; Schaefer, Ina] Georg August Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany	University of Gottingen	von Saltzwedel, H (corresponding author), Georg August Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	hsaltzw1@gwdg.de	Scheu, Stefan/H-7049-2015		Deutsche Forschungsgemeinschaft [SCHE 376/13-1 u. 13-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (SCHE 376/13-1 u. 13-2).	[Anonymous], 2010, ARCTIC ANTARCIT ALP, V42, P422; Avise John C., 1994, pi; Bell G, 1982, MASTERPIECE NATURE E; Birky CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052544; Birky CW, 2005, HYDROBIOLOGIA, V546, P29, DOI 10.1007/s10750-005-4097-2; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bruch AA, 2007, PALAEOGEOGR PALAEOCL, V253, P1, DOI 10.1016/j.palaeo.2007.03.030; Chahartaghi M, 2005, SOIL BIOL BIOCHEM, V37, P1718, DOI 10.1016/j.soilbio.2005.02.006; Chahartaghi M, 2006, PEDOBIOLOGIA, V50, P331, DOI 10.1016/j.pedobi.2006.06.001; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Collins MM, 2013, ANN CARNEGIE MUS, V82, P193, DOI 10.2992/007.082.0204; DAVIS MB, 1983, ANN MO BOT GARD, V70, P550, DOI 10.2307/2992086; Deharveng L., 2012, CNFRA BIOL SOLS, V48, P33; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezard T, 2009, SPECIES LIMITS THRES; Fiera C, 2012, BIOL J LINN SOC, V105, P498, DOI 10.1111/j.1095-8312.2011.01816.x; FJELLBERG A, 1977, ENTOMOL SCAND, V8, P9, DOI 10.1163/187631277X00026; Fjellberg A, 1980, IDENTIFICATION KEYS; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fountain MT, 2004, ECOTOXICOLOGY, V13, P555, DOI 10.1023/B:ECTX.0000037192.70167.00; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garcia-Gomez A, 2009, PESQUI AGROPECU BRAS, V44, P911, DOI 10.1590/S0100-204X2009000800016; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Hewitt G.M., 2001, INTEGRATING ECOLOGY, P271; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hopkin S.P., 2007, KEY COLLEMBOLA SPRIN; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Kempson D., 1963, Pedobiologia, V3, P1; Kovac L, 2005, PEDOBIOLOGIA, V49, P29, DOI 10.1016/j.pedobi.2004.07.009; Kutnik M, 2004, MOL ECOL, V13, P3099, DOI 10.1111/j.1365-294X.2004.02294.x; Kuznetsova NA, 2006, PEDOBIOLOGIA, V50, P157, DOI 10.1016/j.pedobi.2005.12.004; Lindberg N, 2005, APPL SOIL ECOL, V28, P163, DOI 10.1016/j.apsoil.2004.07.003; Mila B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-192; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Patel S, 2015, MOL ECOL, V24, P643, DOI 10.1111/mec.13049; Ponge JF, 2008, PEDOBIOLOGIA, V52, P19, DOI 10.1016/j.pedobi.2008.01.005; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046056; POTAPOV M B, 1991, Acta Zoologica Cracoviensia, V34, P267; Pound MJ, 2012, EARTH-SCI REV, V112, P1, DOI 10.1016/j.earscirev.2012.02.005; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Rosenberger M, 2013, PEDOBIOLOGIA, V56, P79, DOI 10.1016/j.pedobi.2012.11.003; RUSEK J, 1984, ACTA ENTOMOL BOHEMOS, V81, P343; Salamon JA, 2009, EUR J SOIL BIOL, V45, P199, DOI 10.1016/j.ejsobi.2008.12.005; Salicini I, 2013, J BIOGEOGR, V40, P1182, DOI 10.1111/jbi.12062; Scheu S, 1996, BIODIVERS CONSERV, V5, P235, DOI 10.1007/BF00055833; Shaw Peter, 2013, Soil Organisms, V85, P161; Sommer RS, 2005, MAMMAL REV, V35, P156, DOI 10.1111/j.1365-2907.2005.00063.x; Soto-Adames FN, 2002, MOL PHYLOGENET EVOL, V25, P27, DOI 10.1016/S1055-7903(02)00250-6; Stamatakis A, 2009, PARALLEL COMPUTING T, P288; Tastard E, 2012, J EVOLUTION BIOL, V25, P388, DOI 10.1111/j.1420-9101.2011.02433.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; Tully T, 2006, PEDOBIOLOGIA, V50, P95, DOI 10.1016/j.pedobi.2005.11.003; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; von Saltzwedel H, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0719-8; Wanner M, 2002, EUR J SOIL BIOL, V38, P137, DOI 10.1016/S1164-5563(02)01135-4; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	70	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170909	10.1371/journal.pone.0170909	http://dx.doi.org/10.1371/journal.pone.0170909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170395	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500013
J	Kashiwagi, S; Asano, Y; Goto, W; Takada, K; Takahashi, K; Noda, S; Takashima, T; Onoda, N; Tomita, S; Ohsawa, M; Hirakawa, K; Ohira, M				Kashiwagi, Shinichiro; Asano, Yuka; Goto, Wataru; Takada, Koji; Takahashi, Katsuyuki; Noda, Satoru; Takashima, Tsutomu; Onoda, Naoyoshi; Tomita, Shuhei; Ohsawa, Masahiko; Hirakawa, Kosei; Ohira, Masaichi			Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HALICHONDRIN-B; METASTASIS; CELLS; MECHANISM; DISCOVERY; SUBTYPES; IMPACT; SOIL; EMT	Background Eribulin mesylate (eribulin) is currently indicated for treatment of locally advanced or metastatic breast cancer (MBC). It is a cytotoxic agent with unique mechanisms that suppress epithelial-mesenchymal transition (EMT) of cancer cells. On the other hand, Tumor-infiltrating lymphocytes (TILs), which are considered indicators of immune response monitoring, have been reported as prognostic factors and predictors of therapeutic efficacy. We thought that eribulin, which has an EMT-inhibiting mechanism, may produce an antitumor effect by improving the immune microenvironment, and in this study investigated the effects of breast cancer eribulin chemotherapy on the immune microenvironment with TILs as a marker. Methods TILs was evaluated in 52 patients with MBC who underwent chemotherapy with eribulin. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of eribulin chemotherapy, was investigated retrospectively. Results Of the 52 MBC patients, 29 (55.8%) were in the high TILs group and 23 (44.2%) were in the low TILs group. The high TILs group included significantly more triple-negative breast cancer (TNBC) (p = 0.008) than the low TILs group. In an analysis of outcomes, TNBC patients in the high TILs group had significantly longer disease-free survival than TNBC patients in the low TILs group (p = 0.033, log-rank), but no significant differences were seen in all breast cancer patients (p = 0.489, log-rank) or in non-TNBC patients (p = 0.878, log-rank). In a multivariate analysis of recurrence in TNBC patients, being in the high TILs group was again an independent factor for a good outcome (p = 0.031, HR = 0.063). Conclusion The results of this study suggest that TILs may be useful as a predictive marker of the therapeutic effect of eribulin chemotherapy in TNBC.	[Kashiwagi, Shinichiro; Asano, Yuka; Goto, Wataru; Takada, Koji; Noda, Satoru; Takashima, Tsutomu; Onoda, Naoyoshi; Hirakawa, Kosei; Ohira, Masaichi] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan; [Takahashi, Katsuyuki; Tomita, Shuhei] Osaka City Univ, Grad Sch Med, Dept Pharmacol, Osaka, Japan; [Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Kashiwagi, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan.	spqv9ke9@view.ocn.ne.jp	Kashiwagi, Shinichiro/AAC-7070-2019; Kashiwagi, Shinichiro/AAE-5243-2020	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599; TAKAHASHI, KATSUYUKI/0000-0001-9183-0760	Grants-in-Aid for Scientific Research [17K08602] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BAI R, 1991, J BIOL CHEM, V266, P15882; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; HIRATA J, 1986, LEUKEMIA RES, V10, P1441, DOI 10.1016/0145-2126(86)90011-1; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaufman PA, 2015, J CLIN ONCOL, V33, P594, DOI 10.1200/JCO.2013.52.4892; Kocian P, 2011, HUM IMMUNOL, V72, P1022, DOI 10.1016/j.humimm.2011.07.312; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kuznetsov G, 2004, CANCER RES, V64, P5760, DOI 10.1158/0008-5472.CAN-04-1169; Ledford H, 2010, NATURE, V468, P608, DOI 10.1038/468608a; Lee WS, 2013, ANN SURG ONCOL, V20, P697, DOI 10.1245/s10434-012-2752-1; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu H, 2012, CANCER IMMUNOL IMMUN, V61, P1849, DOI 10.1007/s00262-012-1231-7; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Mao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115103; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; Mathot L, 2012, CANCER SCI, V103, P626, DOI 10.1111/j.1349-7006.2011.02195.x; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Ono M, 2012, BREAST CANCER RES TR, V132, P793, DOI 10.1007/s10549-011-1554-7; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Terashima M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-417; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Twelves C, 2015, BREAST CANCER RES TR, V149, P313, DOI 10.1007/s10549-014-3245-7; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	30	66	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170634	10.1371/journal.pone.0170634	http://dx.doi.org/10.1371/journal.pone.0170634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166544	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100011
J	Bondarenko, SM; Artemov, GN; Sharakhov, IV; Stegniy, VN				Bondarenko, Semen M.; Artemov, Gleb N.; Sharakhov, Igor V.; Stegniy, Vladimir N.			Tissue-specific features of the X chromosome and nucleolus spatial dynamics in a malaria mosquito, Anopheles atroparvus	PLOS ONE			English	Article							MELANOGASTER INTERPHASE NUCLEI; DROSOPHILA-MELANOGASTER; 3-DIMENSIONAL ORGANIZATION; SYSTEMIC REORGANIZATION; PHYLOGENETIC LEVELS; ARCHITECTURE; ENVELOPE; CELLS	Spatial organization of chromosome territories is important for maintenance of genomic stability and regulation of gene expression. Recent studies have shown tissue-specific features of chromosome attachments to the nuclear envelope in various organisms including malaria mosquitoes. However, other spatial characteristics of nucleus organization, like volume and shape of chromosome territories, have not been studied in Anopheles. We conducted a thorough analysis of tissue-specific features of the X chromosome and nucleolus volume and shape in follicular epithelium and nurse cells of the Anopheles atroparvus ovaries using a modern open-source software. DNA of the polytene X chromosome from ovarian nurse cells was obtained by microdissection and was used as a template for amplification with degenerate oligo primers. A fluorescently labeled X chromosome painting probe was hybridized with formaldehyde-fixed ovaries of mosquitoes using a 3D-FISH method. The nucleolus was stained by immunostaining with an anti-fibrillarin antibody. The analysis was conducted with TANGO a software for a chromosome spatial organization analysis. We show that the volume and position of the X chromosome have tissue-specific characteristics. Unlike nurse cell nuclei, the growth of follicular epithelium nuclei is not accompanied with the proportional growth of the X chromosome. However, the shape of the X chromosome does not differ between the tissues. The dynamics of the X chromosome attachment regions location is tissue -specific and it is correlated with the process of nucleus growth in follicular epithelium and nurse cells.	[Bondarenko, Semen M.; Artemov, Gleb N.; Sharakhov, Igor V.; Stegniy, Vladimir N.] Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk, Russia; [Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA	Tomsk State University; Virginia Polytechnic Institute & State University	Sharakhov, IV; Stegniy, VN (corresponding author), Tomsk State Univ, Lab Ecol Genet & Environm Protect, Tomsk, Russia.; Sharakhov, IV (corresponding author), Virginia Polytech Inst & State Univ, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	igor@vt.edu; stegniy@res.tsu.ru	Bondarenko, Semen/ABD-5283-2020; Stegniy, Vladimir/N-7656-2014; Artemov, Gleb/E-7935-2019; Stegniy, Vladimir/ABC-6763-2020; Artemov, Gleb N./N-7651-2014; Sharakhov, Igor/B-1972-2008	Bondarenko, Semen/0000-0003-0753-581X; Stegniy, Vladimir/0000-0001-8947-041X; Sharakhov, Igor/0000-0003-0752-3747	Russian Science Foundation [15-14-20011]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was performed using the grant from the Russian Science Foundation 15-14-20011 (to IVS). The funding agencies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Artemov GN, 2011, RUSS J GENET+, V47, P1161, DOI 10.1134/S1022795411100024; Artemov G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115281; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer T, 2010, COLD SPRING HARBOR P, V2; Fritz AJ, 2016, J CELL BIOCHEM, V117, P9, DOI 10.1002/jcb.25280; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1455, DOI 10.1083/jcb.104.6.1455; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Kinney NA, 2015, NUCLEUS-PHILA, V6, P212, DOI 10.1080/19491034.2015.1056441; Kinney NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091943; Kokhanenko AA, 2013, PROTOPLASMA, V250, P141, DOI 10.1007/s00709-012-0385-7; MARCHI A, 1994, HEREDITY, V72, P599, DOI 10.1038/hdy.1994.83; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Paz N, 2015, CHROMOSOME RES, V23, P285, DOI 10.1007/s10577-015-9467-7; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Sharakhov IV, 2015, CURR OPIN INSECT SCI, V10, P110, DOI 10.1016/j.cois.2015.05.003; STEGNIY VN, 1987, GENETIKA+, V23, P821; STEGNY VN, 1991, GENETIKA+, V27, P828; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867	24	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171290	10.1371/journal.pone.0171290	http://dx.doi.org/10.1371/journal.pone.0171290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158219	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161700053
J	Fernandez-Garcia, JC; Alcaide, J; Santiago-Fernandez, C; Roca-Rodriguez, MM; Aguera, Z; Banos, R; Botella, C; de la Torre, R; Fernandez-Real, JM; Fruhbeck, G; Gomez-Ambrosi, J; Jimenez-Murcia, S; Menchon, JM; Casanueva, FF; Fernandez-Aranda, F; Tinahones, FJ; Garrido-Sanchez, L				Carlos Fernandez-Garcia, Jose; Alcaide, Juan; Santiago-Fernandez, Concepcion; Roca-Rodriguez, M. M.; Aguera, Zaida; Banos, Rosa; Botella, Cristina; de la Torre, Rafael; Fernandez-Real, Jose M.; Fruhbeck, Gema; Gomez-Ambrosi, Javier; Jimenez-Murcia, Susana; Menchon, Jose M.; Casanueva, Felipe F.; Fernandez-Aranda, Fernando; Tinahones, Francisco J.; Garrido-Sanchez, Lourdes			An increase in visceral fat is associated with a decrease in the taste and olfactory capacity	PLOS ONE			English	Article							SWEET TASTE; INSULIN-RESISTANCE; MORBIDLY OBESE; BODY-WEIGHT; SENSITIVITY; LEPTIN; ODOR; DISCRIMINATION; PERCEPTION; CHILDREN	Introduction Sensory factors may play an important role in the determination of appetite and food choices. Also, some adipokines may alter or predict the perception and pleasantness of specific odors. We aimed to analyze differences in smell-taste capacity between females with different weights and relate them with fat and fat-free mass, visceral fat, and several adipokines. Materials and methods 179 females with different weights (from low weight to morbid obesity) were studied. We analyzed the relation between fat, fat-free mass, visceral fat (indirectly estimated by bioelectrical impedance analysis with visceral fat rating (VFR)), leptin, adiponectin and visfatin. The smell and taste assessments were performed through the "Sniffin' Sticks" and "Taste Strips" respectively. Results We found a lower score in the measurement of smell (TDI-score (Threshold, Discrimination and Identification)) in obese subjects. All the olfactory functions measured, such as threshold, discrimination, identification and the TDI-score, correlated negatively with age, body mass index (BMI), leptin, fat mass, fat-free mass and VFR. In a multiple linear regression model, VFR mainly predicted the TDI-score. With regard to the taste function measurements, the normal weight subjects showed a higher score of taste functions. However a tendency to decrease was observed in the groups with greater or lesser BMI. In a multiple linear regression model VFR and age mainly predicted the total taste scores. Discussion We show for the first time that a reverse relationship exists between visceral fat and sensory signals, such as smell and taste, across a population with different body weight conditions.	[Carlos Fernandez-Garcia, Jose; Aguera, Zaida; Banos, Rosa; Botella, Cristina; de la Torre, Rafael; Fernandez-Real, Jose M.; Fruhbeck, Gema; Gomez-Ambrosi, Javier; Jimenez-Murcia, Susana; Casanueva, Felipe F.; Fernandez-Aranda, Fernando; Tinahones, Francisco J.; Garrido-Sanchez, Lourdes] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain; [Carlos Fernandez-Garcia, Jose; Alcaide, Juan; Santiago-Fernandez, Concepcion; Roca-Rodriguez, M. M.; Tinahones, Francisco J.; Garrido-Sanchez, Lourdes] Hosp Clin Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Malaga, Spain; [Aguera, Zaida; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Banos, Rosa] Univ Valencia, Dept Psychol Personal Evaluat & Treatment, Valencia, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol, Clin & Psychobiol, Castellon de La Plana, Spain; [de la Torre, Rafael] Hosp del Mar Med Res Inst IMIM, Human Pharmacol & Clin Neurosci Res Grp, Neurosci Res Program, Barcelona, Spain; [de la Torre, Rafael] Univ Pompeu Fabra Barcelona, Dept Expt & Hlth Sci, Barcelona, Spain; [Fernandez-Real, Jose M.] Hosp Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Fruhbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, IdiSNA, Clin Univ Navarra, Metab Res Lab, Pamplona, Spain; [Jimenez-Murcia, Susana; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Menchon, Jose M.] Inst Salud Carlos III, CIBER Salud Mental CIBERSAM, Barcelona, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Div Endocrine, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Malaga; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Valencia; Universitat Jaume I; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Navarra; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Tinahones, FJ (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain.; Tinahones, FJ (corresponding author), Hosp Clin Virgen de la Victoria, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Endocrinol & Nutr, Malaga, Spain.	fjtinahones@hotmail.com	Gómez-Ambrosi, Javier/D-2984-2017; de la Torre, Rafael/D-3561-2018; Fernandez-Garcia, Jose Carlos/B-5312-2013; Fernandez-Aranda, Fernando/L-9762-2014; Botella, Cristina/F-9230-2010; JIMENEZ-MURCIA, SUSANA/L-9786-2014; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; AGÜERA, ZAIDA/K-9771-2014; Fernández-Real, Jose Manuel/AGH-3599-2022; BAÑOS, ROSA MARIA/C-6077-2011; Tinahones, Francisco José/AAB-2882-2020; Menchon, Jose/A-5242-2009	Gómez-Ambrosi, Javier/0000-0001-5601-1604; de la Torre, Rafael/0000-0002-6765-1866; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Botella, Cristina/0000-0001-8783-6959; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; AGÜERA, ZAIDA/0000-0003-4453-4939; Fernández-Real, Jose Manuel/0000-0002-7442-9323; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Menchon, Jose/0000-0002-6231-6524; Santiago Fernandez, Conchi/0000-0003-4439-6863	Institute Salud Carlos III [FIS PI14/00290]; CIBERObn of ISCIII, Spain; CIBERSAM of ISCIII, Spain; Fondos Europeos de Desarrollo Regional (FEDER) Ministerio de Economia y Competitividad [PSI2015-68701-R]; Servicio Andaluz de Salud (SAS) [B-0033-2014]; Fondo de Investigacion Sanitaria (FIS) [MS13/00188-CP13/00188]	Institute Salud Carlos III(Instituto de Salud Carlos III); CIBERObn of ISCIII, Spain; CIBERSAM of ISCIII, Spain; Fondos Europeos de Desarrollo Regional (FEDER) Ministerio de Economia y Competitividad; Servicio Andaluz de Salud (SAS); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III)	Institute Salud Carlos III (FIS PI14/00290) CIBERObn and CIBERSAM are both initiatives of ISCIII, Spain. Fondos Europeos de Desarrollo Regional (FEDER) Ministerio de Economia y Competitividad (PSI2015-68701-R) Jose C. Fernandez-Garcia is recipient of a research contract from Servicio Andaluz de Salud (SAS) (B-0033-2014). L. Garrido-Sanchez is supported by a fellowship from the Fondo de Investigacion Sanitaria (FIS) "Miguel Servet I" MS13/00188-CP13/00188. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	Astrup A, 2001, Public Health Nutr, V4, P499; Ayeser T, 2016, DIABETES METAB SYND, V10, pS165, DOI 10.1016/j.dsx.2016.03.010; Bertoli S, 2014, WORLD J DIABETES, V5, P717, DOI 10.4239/wjd.v5.i5.717; BURDACH KJ, 1987, PHYSIOL BEHAV, V41, P353, DOI 10.1016/0031-9384(87)90400-8; Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2; Cox DN, 2016, FOOD QUAL PREFER, V48, P359, DOI 10.1016/j.foodqual.2015.01.006; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; DREWNOWSKI A, 1985, PHYSIOL BEHAV, V35, P617, DOI 10.1016/0031-9384(85)90150-7; Fernandez-Garcia JC, 2013, CURR VASC PHARMACOL, V11, P906, DOI 10.2174/15701611113116660175; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FRIJTERS JER, 1982, J GEN PSYCHOL, V107, P233, DOI 10.1080/00221309.1982.9709931; Garrido-Sanchez L, 2012, SURG OBES RELAT DIS, V8, P145, DOI 10.1016/j.soard.2011.03.010; Gasteyger C, 2002, J ENDOCRINOL INVEST, V25, P876, DOI 10.1007/BF03344051; Getchell TV, 2006, PHYSIOL BEHAV, V87, P848, DOI 10.1016/j.physbeh.2005.11.016; Goldschmidt AB, 2008, OBESITY, V16, P257, DOI 10.1038/oby.2007.48; Griep MI, 1996, EUR J CLIN NUTR, V50, P816; Haehner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061680; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; JACOBS HL, 1969, ANN NY ACAD SCI, V157, P1084, DOI 10.1111/j.1749-6632.1969.tb12939.x; Karatzi K, 2016, NUTRITION, V32, P1063, DOI 10.1016/j.nut.2016.02.022; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Korsic Mirko, 2011, Lijec Vjesn, V133, P284; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; MALCOLM R, 1980, INT J OBESITY, V4, P203; Miras AD, 2010, CURR OPIN GASTROEN, V26, P140, DOI 10.1097/MOG.0b013e328333e94a; Mojet J, 2003, CHEM SENSES, V28, P397, DOI 10.1093/chemse/28.5.397; Mueller C, 2003, RHINOLOGY, V41, P2; Ng K, 2004, J PAIN SYMPTOM MANAG, V28, P28, DOI 10.1016/j.jpainsymman.2003.11.007; Obrebowski A, 2000, INT J PEDIATR OTORHI, V55, P191, DOI 10.1016/S0165-5876(00)00397-9; Palouzier-Paulignan B, 2012, CHEM SENSES, V37, P769, DOI 10.1093/chemse/bjs059; Pasquet P, 2007, INT J PEDIATR OBES, V2, P242, DOI 10.1080/17477160701440521; Pepino MY, 2010, OBESITY, V18, P959, DOI 10.1038/oby.2009.493; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Richardson BE, 2004, OBES SURG, V14, P967, DOI 10.1381/0960892041719617; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; SCRUGGS DM, 1994, OBES SURG, V4, P24, DOI 10.1381/096089294765558854; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Simchen U, 2006, EUR J CLIN NUTR, V60, P698, DOI 10.1038/sj.ejcn.1602371; Stafford LD, 2015, CHEM SENSES, V40, P279, DOI 10.1093/chemse/bjv007; Stafford LD, 2011, CHEM SENSES, V36, P189, DOI 10.1093/chemse/bjq114; Strain GW, 2008, OBESITY, V16, P1953, DOI 10.1038/oby.2008.321; Thanos PK, 2013, SYNAPSE, V67, P171, DOI 10.1002/syn.21627; Thiebaud N, 2014, J NEUROSCI, V34, P6970, DOI 10.1523/JNEUROSCI.3366-13.2014; Tichansky DS, 2011, SURG ENDOSC, V25, P1176, DOI 10.1007/s00464-010-1335-0; Tinahones FJ, 2010, OBES SURG, V20, P1559, DOI 10.1007/s11695-010-0194-z; Trellakis S, 2011, REGUL PEPTIDES, V167, P112, DOI 10.1016/j.regpep.2010.12.005; Tucker KR, 2012, PHYSIOL BEHAV, V107, P424, DOI 10.1016/j.physbeh.2012.09.007; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Wolfensberger M, 1999, HNO, V47, P629, DOI 10.1007/s001060050436	51	37	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171204	10.1371/journal.pone.0171204	http://dx.doi.org/10.1371/journal.pone.0171204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158237	Green Published, gold			2022-12-27	WOS:000396161700042
J	Dahl, KA; Fitzpatrick, MF; Spanger-Siegfried, E				Dahl, Kristina A.; Fitzpatrick, Melanie F.; Spanger-Siegfried, Erika			Sea level rise drives increased tidal flooding frequency at tide gauges along the US East and Gulf Coasts: Projections for 2030 and 2045	PLOS ONE			English	Article							CLIMATE-CHANGE; UNITED-STATES; EXTREME	Tidal flooding is among the most tangible present-day effects of global sea level rise. Here, we utilize a set of NOAA tide gauges along the U.S. East and Gulf Coasts to evaluate the potential impact of future sea level rise on the frequency and severity of tidal flooding. Using the 2001-2015 time period as a baseline, we first determine how often tidal flooding currently occurs. Using localized sea level rise projections based on the Intermediate-Low, Intermediate-High, and Highest projections from the U.S. National Climate Assessment, we then determine the frequency and extent of such flooding at these locations for two near-term time horizons: 2030 and 2045. We show that increases in tidal flooding will be substantial and nearly universal at the 52 locations included in our analysis. Long before areas are permanently inundated, the steady creep of sea level rise will force many communities to grapple with chronic high tide flooding in the next 15 to 30 years.	[Dahl, Kristina A.] Dahl Sci, San Francisco, CA USA; [Spanger-Siegfried, Erika] Union Concerned Scientists, Climate & Energy Program, Cambridge, MA USA		Dahl, KA (corresponding author), Dahl Sci, San Francisco, CA USA.	kdahl@alum.mit.edu	Dahl, Kristina/AAC-4813-2021	Dahl, Kristina/0000-0001-6471-8845	Grantham Foundation; Barr Foundation; Energy Foundation	Grantham Foundation; Barr Foundation; Energy Foundation	The Union of Concerned Scientists received funding for this study from The Grantham Foundation, The Barr Foundation, The Energy Foundation, Mr. and Mrs. Jerry Babicka, Dr. Randall D. and Sally Knight. From these funds, the Union of Concerned Scientists provided Dahl Scientific support in the form of salaries for the first author (KAD), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain M, 2009, OCEAN SCI, V5, P193, DOI 10.5194/os-5-193-2009; [Anonymous], 2014, SEA LEVEL RISE NUISA; Applegate A., 2014, PILOTONLINE; Atkinson L.P., 2013, SEA GRANT LAW POLICY, DOI DOI 10.1038/S41598-017-15309-5.AVAILABLE; Baart F, 2012, J COASTAL RES, V28, P511, DOI 10.2112/JCOASTRES-D-11-00169.1; Boon JD., 2011, J COASTAL RES, V2012; Cherniawsky JY, 2010, CONT SHELF RES, V30, P575, DOI 10.1016/j.csr.2009.10.002; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Climate Central, 2014, SURG SEAS SEA LEV RI; Davenport C, 2014, NY TIMES; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Eggington, 2013, RECURRENT FLOODING S; Eliot M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006306; Ezer T, 2014, EARTHS FUTURE, V2, P362, DOI 10.1002/2014EF000252; Ezer T, 2013, J GEOPHYS RES-OCEANS, V118, P685, DOI 10.1002/jgrc.20091; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; Flick RE, 2003, J WATERW PORT C-ASCE, V129, P155, DOI 10.1061/(ASCE)0733-950X(2003)129:4(155); Galloway J., 2015, AJC; Goddard PB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7346; Gregory K., 2013, NY TIMES; Haigh ID, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006645; Hay CC, 2015, NATURE, V517, P481, DOI 10.1038/nature14093; Horton BP, 2014, QUATERNARY SCI REV, V84, P1, DOI 10.1016/j.quascirev.2013.11.002; Horton R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032486; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Iowa Environmental Mesonet, 2015, IOW ENV MES VAL TIM; Jevrejeva S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042947; Kirkman R., MERLEAU PONTY ENV PH, P19; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Lake County Department of Economic Growth, 2016, COMPR PLAN PLANN HOR; Leuliette EW, 2011, OCEANOGRAPHY, V24, P122, DOI 10.5670/oceanog.2011.32; Milliken KT, 2008, GEOL SOC AM SPEC PAP, V443, P1, DOI 10.1130/2008.2443(01); Mitrovica JX, 2009, SCIENCE, V323, P753, DOI 10.1126/science.1166510; Moftakhari HR, 2015, GEOPHYS RES LETT, V42, P9846, DOI 10.1002/2015GL066072; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; Muller M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006387; National Oceanic and Atmospheric Administration, 2013, IN AN NOAA TID CURR; National Oceanic and Atmospheric Administration, 2013, SEA LEV TRENDS NOAA; National Weather Service, 2015, ADV HYDR PRED SERV; Parris A., GLOBAL SEA LEVEL RIS, P1; Passeri DL, 2016, EARTHS FUTURE, V4, P159, DOI 10.1002/2015EF000332; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Prothero A., 2013, WLRN TV; Ray RD, 2006, CONT SHELF RES, V26, P422, DOI 10.1016/j.csr.2005.12.005; Ray RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040217; Ryan McNeill, 2014, REUTERS; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Spanger-Siegfried E, 2014, UNION SCI, V76; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sweet WV, 2014, EARTHS FUTURE, V2, P579, DOI 10.1002/2014EF000272; Tebaldi C, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014032; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wadey MP, 2014, OCEAN SCI, V10, P1031, DOI 10.5194/os-10-1031-2014; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [10.7930/J0KW5CXT, DOI 10.7930/J0KW5CXT]; Whitney Bailey C, 2011, FLOOD MITIGATION STR; Witze A, 2008, NATURE, V452, P798, DOI 10.1038/452798a; Woodworth PL, 2010, CONT SHELF RES, V30, P1680, DOI 10.1016/j.csr.2010.07.002	60	47	47	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170949	10.1371/journal.pone.0170949	http://dx.doi.org/10.1371/journal.pone.0170949			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158209	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700021
J	Dasgupta, A; Sarkar, J; Ghosh, M; Bhattacharya, A; Mukherjee, A; Chattopadhyay, D; Acharya, K				Dasgupta, Adhiraj; Sarkar, Joy; Ghosh, Manosij; Bhattacharya, Amartya; Mukherjee, Anita; Chattopadhyay, Dipankar; Acharya, Krishnendu			Green conversion of graphene oxide to graphene nanosheets and its biosafety study	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; ECTOMYCORRHIZAL EDIBLE MUSHROOM; DIOXIDE TIO2 NANOPARTICLES; EXFOLIATED GRAPHITE OXIDE; MS/MS PROTEOME ANALYSIS; HEPATOMA HEPG2 CELLS; ALBONIGRA KROMBH. FR; IN-VITRO; SILVER NANOPARTICLES; DNA-DAMAGE	Chemical reduction of graphene oxide (GO) to graphene employs the use of toxic and environmentally harmful reducing agents, hindering mass production of graphene which is of tremendous technological importance. In this study we report a green approach to the synthesis of graphene, bio-reduced by crude polysaccharide. The polysaccharide reduces exfoliated GO to graphene at room temperature in an aqueous medium. Transmission electron microscopy image provides clear evidence for the formation of few layer graphene. Characterization of the resulting polysaccharide reduced GO by Raman spectroscopy, Fourier transform infrared spectroscopy and Energy dispersive X-ray analysis confirms reduction of GO to graphene. We also investigated the degree of biosafety of the reduced GO and found it to be safe under 100 mu g/ml.	[Dasgupta, Adhiraj; Sarkar, Joy; Acharya, Krishnendu] Univ Calcutta, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India; [Sarkar, Joy] Dinabandhu Andrews Coll, Dept Bot, Kolkata, W Bengal, India; [Ghosh, Manosij; Mukherjee, Anita] Univ Calcutta, Cell Biol & Genet Toxicol Lab, Ctr Adv Study Cell & Chromosome Res, Dept Bot, Kolkata, W Bengal, India; [Bhattacharya, Amartya; Chattopadhyay, Dipankar] Univ Calcutta, Dept Polymer Sci & Technol, Univ Coll Sci & Technol, Kolkata, W Bengal, India; [Acharya, Krishnendu] Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Technol Campus, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; University of Calcutta; University of Calcutta	Acharya, K (corresponding author), Univ Calcutta, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India.; Acharya, K (corresponding author), Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Technol Campus, Kolkata, W Bengal, India.	krish_paper@yahoo.com	SARKAR, JOY/AAR-2992-2021; Acharya, Krishnendu/G-2317-2012; Ghosh, Manosij/G-3374-2013; Ghosh, Manosij/AAU-2853-2021	SARKAR, JOY/0000-0002-6404-7428; Acharya, Krishnendu/0000-0003-1193-1823; Ghosh, Manosij/0000-0001-5034-001X; Ghosh, Manosij/0000-0001-5034-001X; Chattopadhyay, Dipankar/0000-0002-0863-5882; Dasgupta, Adhiraj/0000-0002-3544-8257				AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akhavan O, 2013, CARBON, V54, P419, DOI 10.1016/j.carbon.2012.11.058; Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Cai SW, 2004, BIOCHEMISTRY-US, V43, P2541, DOI 10.1021/bi030149y; Cao AN, 2010, ADV MATER, V22, P103, DOI 10.1002/adma.200901920; Chen DZ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/32/325601; Das SK, 2009, LANGMUIR, V25, P8192, DOI 10.1021/la900585p; Devi T.R., 2010, INT J PHARM SCI REV, V2, P106, DOI DOI 10.HTTPS://D0I.0RG/10.1155/2012/741561; Dhawan A, 2010, ANAL BIOANAL CHEM, V398, P589, DOI 10.1007/s00216-010-3996-x; Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI [10.2217/nnm.10.158, 10.2217/NNM.10.158]; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Ghosh M, 2013, J APPL TOXICOL, V33, P1097, DOI 10.1002/jat.2863; Ghosh M, 2012, MUTAT RES-GEN TOX EN, V749, P60, DOI 10.1016/j.mrgentox.2012.08.007; Ghosh M, 2011, J HAZARD MATER, V197, P327, DOI 10.1016/j.jhazmat.2011.09.090; Ghosh M, 2010, CHEMOSPHERE, V81, P1253, DOI 10.1016/j.chemosphere.2010.09.022; GOEGAN P, 1995, TOXICOL IN VITRO, V9, P257, DOI 10.1016/0887-2333(95)00004-R; Guo HL, 2009, ACS NANO, V3, P2653, DOI 10.1021/nn900227d; Khanra P, 2012, CHEM ENG J, V183, P526, DOI 10.1016/j.cej.2011.12.075; Kuila T, 2012, CARBON, V50, P914, DOI 10.1016/j.carbon.2011.09.053; Kuila T, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305710; Leung MYK, 2004, GLYCOBIOLOGY, V14, P501, DOI 10.1093/glycob/cwh050; Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v; Lim JM, 2005, CARBOHYD POLYM, V61, P296, DOI 10.1016/j.carbpol.2005.04.004; Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x; Matesanz MC, 2013, BIOMATERIALS, V34, P1562, DOI 10.1016/j.biomaterials.2012.11.001; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nandi AK, 2014, CARBOHYD POLYM, V99, P774, DOI 10.1016/j.carbpol.2013.09.016; Nandi AK, 2013, CARBOHYD POLYM, V94, P918, DOI 10.1016/j.carbpol.2013.02.019; Nandi AK, 2012, CARBOHYD RES, V363, P43, DOI 10.1016/j.carres.2012.10.002; Nitschke J, 2011, FOOD CHEM, V127, P791, DOI 10.1016/j.foodchem.2010.12.149; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Parlak O, 2014, ADV MAT; Parlak O, 2013, BIOSENS BIOELECTRON, V49, P53, DOI 10.1016/j.bios.2013.04.004; Patra P, 2012, CARBOHYD RES, V362, P1, DOI 10.1016/j.carres.2012.09.009; Qiao Y, 2013, ANAL CHEM, V85, P4107, DOI 10.1021/ac400242w; Qiu T, 2013, CARBOHYD POLYM, V98, P922, DOI 10.1016/j.carbpol.2013.07.014; Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175; Samanta S, 2013, CARBOHYD RES, V367, P33, DOI 10.1016/j.carres.2012.12.002; Sarkar J, 2014, BIOPROC BIOSYST ENG, V37, P165, DOI 10.1007/s00449-013-0982-7; Sarkar J, 2011, DIG J NANOMATER BIOS, V6, P563; Sasidharan A, 2012, SMALL, V8, P1251, DOI 10.1002/smll.201102393; Sathyavathi R, ADV SCI LETT, P138; Schuchardt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08839; Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x; Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c; Singh AK, 2010, J NANOPART RES, V12, P1667, DOI 10.1007/s11051-009-9835-3; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Subarna Saha, 2013, International Journal of Green Pharmacy, V7, P182; Subbaiah YPV, 2016, ADV FUNCT MATER, V26, P2046, DOI 10.1002/adfm.201504202; Sui Y, 2009, NANO LETT, V9, P2973, DOI 10.1021/nl901396g; Sun ZP, 2010, ACS NANO, V4, P803, DOI 10.1021/nn901703e; Synytsya A, 2009, CARBOHYD POLYM, V76, P548, DOI 10.1016/j.carbpol.2008.11.021; Thakur S, 2012, CARBON, V50, P5331, DOI 10.1016/j.carbon.2012.07.023; Tiginyanu I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32913; Vallabani NVS, 2011, J BIOMED NANOTECHNOL, V7, P106, DOI 10.1166/jbn.2011.1224; Wang GM, 2011, NANO RES, V4, P563, DOI 10.1007/s12274-011-0112-2; Wang HL, 2009, J AM CHEM SOC, V131, P9910, DOI 10.1021/ja904251p; William S., 1958, J AM CHEM SOC, V80, P1339, DOI DOI 10.1021/JA01539A017; Wu T, 2011, CHEM ENG J, V173, P144, DOI 10.1016/j.cej.2011.07.050; Xu LQ, 2010, MACROMOLECULES, V43, P8336, DOI 10.1021/ma101526k; Yang C, 2010, JPC-J PLANAR CHROMAT, V23, P46, DOI 10.1556/JPC.23.2010.1.8; Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332; Yuan JF, 2011, TOXICOL LETT, V207, P213, DOI 10.1016/j.toxlet.2011.09.014; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031; Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176; Zhou M, 2009, ANAL CHEM, V81, P5603, DOI 10.1021/ac900136z; Zhu CZ, 2010, ACS NANO, V4, P2429, DOI 10.1021/nn1002387	78	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171607	10.1371/journal.pone.0171607	http://dx.doi.org/10.1371/journal.pone.0171607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158272	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700109
J	Gavett, BE; Zhao, R; John, SE; Bussell, CA; Roberts, JR; Yue, C				Gavett, Brandon E.; Zhao, Rui; John, Samantha E.; Bussell, Cara A.; Roberts, Jennifer R.; Yue, Chuan			Phishing suspiciousness in older and younger adults: The role of executive functioning	PLOS ONE			English	Article							ECOLOGICAL VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; FINANCIAL CAPACITY; INSTRUMENTAL ACTIVITIES; ALZHEIMERS-DISEASE; DECISION-MAKING; WORKING-MEMORY; EXPLOITATION; PERFORMANCE; SUSCEPTIBILITY	Phishing is the spoofing of Internet websites or emails aimed at tricking users into entering sensitive information, with such goals as financial or identity theft. The current study sought to determine whether age is associated with increased susceptibility to phishing and whether tests of executive functioning can predict phishing susceptibility. A total of 193 cognitively intact participants, 91 younger adults and 102 older adults, were primarily recruited through a Psychology department undergraduate subject pool and a gerontology research registry, respectively. The Executive Functions Module from the Neuropsychological Assessment Battery and the Iowa Gambling Task were the primary cognitive predictors of reported phishing suspiciousness. Other predictors included age group (older vs. younger), sex, education, race, ethnicity, prior knowledge of phishing, prior susceptibility to phishing, and whether or not browsing behaviors were reportedly different in the laboratory setting versus at home. A logistic regression, which accounted for a 22.7% reduction in error variance compared to the null model and predicted phishing suspiciousness with 73.1% (95% CI [66.0, 80.3]) accuracy, revealed three statistically significant predictors: the main effect of education (b = 0.58, SE = 0.27) and the interactions of age group with prior awareness of phishing (b = 2.31, SE = 1.12) and performance on the Neuropsychological Assessment Battery Mazes test (b = 0.16, SE = 0.07). Whether or not older adults reported being suspicious of the phishing attacks used in this study was partially explained by educational history and prior phishing knowledge. This suggests that simple educational interventions may be effective in reducing phishing vulnerability. Although one test of executive functioning was found useful for identifying those at risk of phishing susceptibility, four tests were not found to be useful; these results speak to the need for more ecologically valid tools in clinical neuropsychology.	[Gavett, Brandon E.; Bussell, Cara A.; Roberts, Jennifer R.] Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA; [Zhao, Rui; Yue, Chuan] Colorado Sch Mines, Div Comp Sci, Golden, CO 80401 USA; [John, Samantha E.] Emory Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr, Atlanta, GA 30322 USA	University of Colorado System; University of Colorado at Colorado Springs; Colorado School of Mines; Emory University	Gavett, BE (corresponding author), Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA.	bgavett@uccs.edu		John, Samantha/0000-0003-1347-4865; Gavett, Brandon/0000-0003-1938-1854; Roberts, Jennifer R./0000-0003-2264-7430	National Science Foundation [CNS-1624149, CNS-1359542]; Direct For Computer & Info Scie & Enginr [1624149] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This material is based upon work supported by the National Science Foundation under Grant Nos. CNS-1624149 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1624149) and CNS-1359542 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1359542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alseadoon I, 2015, LECT NOTES ELECTR EN, V315, DOI 10.1007/978-3-319-07674-4_89; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A., 2007, IOWA GAMBLING TASK P; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Boyle PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043647; Brand M, 2010, GERONTOLOGY, V56, P319, DOI 10.1159/000248829; Carpenter S, 2014, APPL ERGON, V45, P1337, DOI 10.1016/j.apergo.2013.10.005; Carr DB, 2011, J AM GERIATR SOC, V59, P2112, DOI 10.1111/j.1532-5415.2011.03657.x; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Czaja SJ, 2006, PSYCHOL AGING, V21, P333, DOI 10.1037/0882-7974.21.2.333; Dhamija R, 2006, P SIGCHI C HUM FACT, P581, DOI DOI 10.1145/1124772.1124861; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Goel V, 2004, J COGNITIVE NEUROSCI, V16, P654, DOI 10.1162/089892904323057362; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrison B, 2016, ONLINE INFORM REV, V40, P265, DOI 10.1108/OIR-04-2015-0106; Harrison B, 2016, P ANN HICSS, P5628, DOI 10.1109/HICSS.2016.696; Hart RP, 2010, AGING NEUROPSYCHOL C, V18, P64, DOI 10.1080/13825585.2010.510637; Hong K.W., 2013, P HUMAN FACTORS ERGO, P1012, DOI DOI 10.1177/1541931213571226; Huang YMH, 2015, PSYCHOL AGING, V30, P675, DOI 10.1037/pag0000038; Iuga C, 2016, HUM-CENT COMPUT INFO, V6, DOI 10.1186/s13673-016-0065-2; Kelley C.M., 2012, P HUMAN FACTORS ERGO, V56, P2108, DOI [DOI 10.1177/1071181312561447, https://doi.org/10.1177/1071181312561447]; Kumaraguru P, 2010, ACM T INTERNET TECHN, V10, DOI 10.1145/1754393.1754396; Lamar M, 2004, NEUROBIOL AGING, V25, P553, DOI 10.1016/j.neurobiolaging.2003.06.005; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lichtenberg PA, 2016, AM PSYCHOL, V71, P312, DOI 10.1037/a0040192; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; Lorence Daniel P, 2006, Technol Health Care, V14, P91; MacDougall EE, 2013, CLIN NEUROPSYCHOL, V27, P827, DOI 10.1080/13854046.2013.786759; Mackin RS, 2009, J INT NEUROPSYCH SOC, V15, P793, DOI 10.1017/S1355617709990300; Marquie JC, 2002, BEHAV INFORM TECHNOL, V21, P273, DOI 10.1080/0144929021000020998; Marson DC, 2013, AM J GERIAT PSYCHIAT, V21, P382, DOI [10.1016/j.jagp.2013.01.033, 10.1097/JGP.0b013e31826682f4]; Martyr A, 2012, DEMENT GERIATR COGN, V33, P189, DOI 10.1159/000338233; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; Metzger MJ, 2003, COMPUT EDUC, V41, P271, DOI 10.1016/S0360-1315(03)00049-6; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; Moye J, 2013, AM PSYCHOL, V68, P158, DOI 10.1037/a0032159; Pinsker DM, 2010, AGING NEUROPSYCHOL C, V17, P673, DOI 10.1080/13825585.2010.501403; Poynton TA, 2005, COMPUT HUM BEHAV, V21, P861, DOI 10.1016/j.chb.2004.03.004; Purkait Swapan, 2014, Information Management & Computer Security, V22, P194, DOI 10.1108/IMCS-05-2013-0032; R Core Team, 2016, R LANG ENV STAT COMP, V2016; Rabiner Donna J, 2006, J Aging Soc Policy, V18, P47, DOI 10.1300/J031v18n02_04; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Rogers WA, 1998, HUM FACTORS, V40, P111, DOI 10.1518/001872098779480613; Sheng S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P373; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; Vaughan L, 2010, PSYCHOL AGING, V25, P343, DOI 10.1037/a0017729; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Vishwanath A, 2011, DECIS SUPPORT SYST, V51, P576, DOI 10.1016/j.dss.2011.03.002; Wang JG, 2012, IEEE T PROF COMMUN, V55, P345, DOI 10.1109/TPC.2012.2208392; Welk Allaire K., 2015, International Journal of Cyber Behavior, Psychology and Learning, V5, P1, DOI 10.4018/IJCBPL.2015100101; Wood S, 2014, J ELDER ABUSE NEGL, V26, P414, DOI 10.1080/08946566.2014.881270; Yue Chuan., 2013, USENIX WORKSH LARG S; Zgaljardic DJ, 2011, REHABIL PSYCHOL, V56, P359, DOI 10.1037/a0025466; Zhao R, 2016, IEEE IC COMP COM NET; Zielinska O.A., 2014, P HUM FACTORS ERGON, V58, P1466, DOI [10.1177/1541931214581306, DOI 10.1177/1541931214581306]	57	24	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171620	10.1371/journal.pone.0171620	http://dx.doi.org/10.1371/journal.pone.0171620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158316	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700113
J	Bassetti, M; Peghin, M; Trecarichi, EM; Carnelutti, A; Righi, E; Del Giacomo, P; Ansaldi, F; Trucchi, C; Alicino, C; Cauda, R; Sartor, A; Spanu, T; Scarparo, C; Tumbarello, M				Bassetti, Matteo; Peghin, Maddalena; Trecarichi, Enrico Maria; Carnelutti, Alessia; Righi, Elda; Del Giacomo, Paola; Ansaldi, Filippo; Trucchi, Cecilia; Alicino, Cristiano; Cauda, Roberto; Sartor, Assunta; Spanu, Teresa; Scarparo, Claudio; Tumbarello, Mario			Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality	PLOS ONE			English	Article							INFECTIOUS-DISEASE CONSULTATION; BLOOD-STREAM INFECTION; QUALITY-OF-CARE; METHICILLIN-RESISTANT; EPIDEMIOLOGY; THERAPY; IMPACT	We aimed to describe the characteristics of patients with Staphylococcus aureus bacteremia and to evaluate the risk factors associated with early (7-day) and late (30-day) mortality. We performed an observational study including all consecutive episodes of Staphylococcus aureus bacteremia diagnosed at two Italian university hospitals during 2010(_)2014. A total of 337 patients were included. Mean age was 69 years (range, 57(_)78) and 65% were males. Methicillin-resistant S. aureus (MRSA) was identified in 132/337 (39%) cases. Overall 7-and 30-day mortality were 13% and 26%, respectively. Early mortality was associated with increased Charlson scores (OR 1.3, 95% CI 1.1(_)1.5), MRSA bacteremia (OR 3.2, 95% CI 1.4-8.1), presentation with septic shock (OR 13.5, 95% CI 5.4(_)36.4), and occurrence of endocarditis (OR 4.5, 95% CI 1.4-14.6). Similar risk factors were identified for late mortality, including increased Charlson scores (OR 1.2, 95% CI 1.1(_)1.4), MRSA bacteremia (OR 2.1, 95% CI 1.2-3.9), presentation with septic shock (OR 4, 95% CI 1.7(_)9.7), occurrence of endocarditis (OR 3.8, 95% CI 1.4-10.2) as well as Child C cirrhosis (OR 3.9, 95% CI 1.1-14.4) and primary bacteremia (OR 2.5, 95% CI 1.3-5). Infectious disease consultation resulted in better outcomes both at 7 (OR 0.1, 95% CI 0.05-0.4) and at 30 days (OR 0.4, 95% CI 0.2-0.7). In conclusion, our study highlighted high rates of MRSA infection in nosocomial Staphylococcus aureus bacteremia. Multiple comorbidities, disease severity and methicillin-resistance are key factors for early and late mortality in this group. In patients with Staphylococcus aureus bacteremia, infectious disease consultation remains a valuable tool to improve clinical outcome.	[Bassetti, Matteo; Peghin, Maddalena; Carnelutti, Alessia; Righi, Elda] Santa Maria Misericordia Univ Hosp, Div Infect Dis, Udine, Italy; [Trecarichi, Enrico Maria; Del Giacomo, Paola; Cauda, Roberto; Tumbarello, Mario] Univ Cattolica Sacro Cuore, Inst Infect Dis, Rome, Italy; [Ansaldi, Filippo; Trucchi, Cecilia; Alicino, Cristiano] Univ Genoa, Dept Hlth Sci, IRCCS AOU San Martino IST, Genoa, Italy; [Sartor, Assunta; Scarparo, Claudio] Santa Maria Misericordia Univ Hosp, Microbiol Unit, Udine, Italy; [Spanu, Teresa] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy	Hospital Santa Maria della Misericordia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Genoa; IRCCS AOU San Martino IST; Hospital Santa Maria della Misericordia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bassetti, M (corresponding author), Santa Maria Misericordia Univ Hosp, Div Infect Dis, Udine, Italy.	mattba@tin.it	Righi, Elda/Y-3558-2019; Bassetti, Matteo/L-3081-2019; Trecarichi, Enrico/AAQ-5600-2020; Sartor, Assunta/ADI-1177-2022; Tumbarello, Mario/A-8549-2019	Righi, Elda/0000-0001-8718-1200; Tumbarello, Mario/0000-0002-9519-8552; Bassetti, Matteo/0000-0002-0145-9740				Bai AD, 2015, CLIN INFECT DIS, V60, P1451, DOI 10.1093/cid/civ120; Bassetti M, 2012, CLIN MICROBIOL INFEC, V18, P862, DOI 10.1111/j.1469-0691.2011.03679.x; Center for Disease Dynamics EP, 2015, STAT WORLDS ANT CW; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Davis JS, 2016, CLIN INFECT DIS, V62, P173, DOI 10.1093/cid/civ808; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Epstein L, 2016, CLIN INFECT DIS, V62, P45, DOI 10.1093/cid/civ777; EUCAST, 2016, TECOAST BREAKP TABL; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gasch O, 2013, J ANTIMICROB CHEMOTH, V68, P1423, DOI 10.1093/jac/dkt016; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kang CI, 2011, INT J INFECT DIS, V15, pE58, DOI 10.1016/j.ijid.2010.09.012; Kullar R, 2014, CLIN INFECT DIS, V59, P1455, DOI 10.1093/cid/ciu583; Lamagni TL, 2011, J HOSP INFECT, V77, P16, DOI 10.1016/j.jhin.2010.07.015; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Lopez-Cortes LE, 2013, CLIN INFECT DIS, V57, P1225, DOI 10.1093/cid/cit499; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Rhee Y, 2015, INFECT CONT HOSP EP, V36, P1417, DOI 10.1017/ice.2015.213; Singal AK, 2013, J CLIN EXP HEPATOL, V3, P50, DOI 10.1016/j.jceh.2012.11.002; Soriano A, 2000, CLIN INFECT DIS, V30, P368, DOI 10.1086/313650; Tabah A, 2016, CLIN INFECT DIS, V62, P1009, DOI 10.1093/cid/civ1199; Tacconelli E, 2006, J HOSP INFECT, V64, P251, DOI 10.1016/j.jhin.2006.07.001; Tissot F, 2014, J INFECTION, V69, P226, DOI 10.1016/j.jinf.2014.05.004; Tom S, 2014, CLIN MICROBIOL INFEC, V20, pO630, DOI 10.1111/1469-0691.12564; Vogel M, 2016, J INFECTION, V72, P19, DOI 10.1016/j.jinf.2015.09.037; Vos FJ, 2012, MEDICINE, V91, P86, DOI 10.1097/MD.0b013e31824d7ed2; Wolkewitz M, 2011, J ANTIMICROB CHEMOTH, V66, P381, DOI 10.1093/jac/dkq424; Yilmaz M, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0122-8	31	45	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170236	10.1371/journal.pone.0170236	http://dx.doi.org/10.1371/journal.pone.0170236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152067	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200018
J	Lindberg, P; Netter, P; Koller, M; Steinger, B; Klinkhammer-Schalke, M				Lindberg, Patricia; Netter, Petra; Koller, Michael; Steinger, Brunhilde; Klinkhammer-Schalke, Monika			Breast cancer survivors' recollection of their quality of life: Identifying determinants of recall bias in a longitudinal population-based trial	PLOS ONE			English	Article							EUROPEAN-ORGANIZATION; NEGATIVE AFFECT; RESPONSE SHIFT; MEMORY BIAS; HEALTH; PERSONALITY; DIAGNOSIS; ACCURACY; SYMPTOMS; IMPLICIT	Background The recollections of survivors of breast cancer are an important source of information about the disease for their family, friends, and newly diagnosed patients. So far, little is known about these memories. This study investigated how accurately survivors of breast cancer remember their past quality of life (QoL) during the disease and if this memory is modified by women's present QoL and negative affect. Material and methods The longitudinal population-based study included 133 survivors of breast cancer (response rate 80%). Participants were asked for their present QoL and to recall their baseline QoL (EORTC QLQ-C30, QLQ-BR23) that had been assessed about seven years ago before discharge from hospital. The dependent variable was recall bias in ten QoL dimensions. Present QoL and negative affect (PANAS) were investigated as predictor variables. Results Overall, baseline QoL was retrospectively underrated on seven out of ten scales whereas no significant overestimation was found. In multiple linear regression analyses, controlling for confounders, a stronger underrating of QoL was significantly predicted by a lower present QoL on nine out of ten scales and by higher negative affect on six scales. Conclusions Survivors of breast cancer tend to underestimate their past QoL during the disease when asked about seven years later. Lower present QoL and higher negative affect contribute to this recall bias. This needs to be considered when interpreting retrospectively reported QoL data. Results are discussed in relation to theory of change or stability and mood congruency theory.	[Lindberg, Patricia; Steinger, Brunhilde; Klinkhammer-Schalke, Monika] Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr Regensburg, Regensburg, Germany; [Netter, Petra] Univ Giessen, Dept Psychol, Giessen, Germany; [Koller, Michael] Univ Hosp Regensburg, Ctr Clin Trials, Regensburg, Germany	University of Regensburg; Justus Liebig University Giessen; University of Regensburg	Lindberg, P (corresponding author), Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr Regensburg, Regensburg, Germany.	patricia.lindberg@ur.de			German Cancer Aid [109216]	German Cancer Aid(Deutsche Krebshilfe)	This work was funded by the German Cancer Aid, 109216. The funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Adang EMM, 1998, TRANSPL INT, V11, P11, DOI 10.1007/s001470050095; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Baddeley A, 2010, MEMORY, P137; Bitzer EM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-23; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Broderick JE, 2008, PAIN, V139, P146, DOI 10.1016/j.pain.2008.03.024; CONWAY M, 1984, J PERS SOC PSYCHOL, V47, P738, DOI 10.1037/0022-3514.47.4.738; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Dabakuyo TS, 2013, QUAL LIFE RES, V22, P1, DOI 10.1007/s11136-012-0135-5; Edwards PJ, 2009, COCHRANE DATABASE SY, P3; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fransson P, 2005, ACTA ONCOL, V44, P355, DOI 10.1080/02841860510029806; Gilbert DT, 2009, SCIENCE, V323, P1617, DOI 10.1126/science.1166632; Hartl K, 2010, PSYCHO-ONCOLOGY, V19, P160, DOI 10.1002/pon.1536; Hinz A, 2014, ACTA ONCOL, V53, P958, DOI 10.3109/0284186X.2013.879998; Hirsch JK, 2012, QUAL LIFE RES, V21, P187, DOI 10.1007/s11136-011-9933-4; HJERMSTAD MJ, 1995, J CLIN ONCOL, V13, P1249, DOI 10.1200/JCO.1995.13.5.1249; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Howlader N, 2014, SEER CANC STAT REV; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Klinkhammer-Schalke M, 2012, BRIT J CANCER, V106, P826, DOI 10.1038/bjc.2012.4; Koller M, 1996, CANCER, V77, P983, DOI 10.1002/(SICI)1097-0142(19960301)77:5<983::AID-CNCR27>3.0.CO;2-Z; Koller M, 1999, CANCER-AM CANCER SOC, V86, P1609, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1609::AID-CNCR32>3.0.CO;2-3; KOPEC JA, 1990, J EPIDEMIOL COMMUN H, V44, P179, DOI 10.1136/jech.44.3.179; Krohne HW, 1996, DIAGNOSTICA, V42, P139; LARSEN RJ, 1992, J PERS SOC PSYCHOL, V62, P480, DOI 10.1037/0022-3514.62.3.480; Lindberg P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1573-6; Litwin MS, 1999, J CLIN ONCOL, V17, P2882, DOI 10.1200/JCO.1999.17.9.2882; MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P; McPhail S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-65; Nieuwkerk PT, 2007, MED CARE, V45, P199, DOI 10.1097/01.mlr.0000246613.49214.46; Rees J, 2003, BJU INT, V92, P703, DOI 10.1046/j.1464-410X.2003.04462.x; Robert Koch Institut und Gesellschaft der epide-miologischen Krebsregister in Deutschland e.V, 2013, KREBS DEUTSCHL 2009; ROSS M, 1981, J PERS SOC PSYCHOL, V40, P627, DOI 10.1037/0022-3514.40.4.627; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; RUIZCABALLERO JA, 1994, COGNITION EMOTION, V8, P555, DOI 10.1080/02699939408408959; Safer MA, 2002, EMOTION, V2, P162, DOI 10.1037//1528-3542.2.2.162; Snyder CF, 2015, QUAL LIFE RES, V24, P1207, DOI 10.1007/s11136-014-0853-y; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Walentynowicz M, 2015, HEALTH PSYCHOL, V34, P1166, DOI 10.1037/hea0000222; Watkins PC, 1996, J ABNORM PSYCHOL, V105, P34, DOI 10.1037/0021-843X.105.1.34; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x	49	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171519	10.1371/journal.pone.0171519	http://dx.doi.org/10.1371/journal.pone.0171519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152108	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200153
J	Melchior, J; Wang, N; Wiskott, L				Melchior, Jan; Wang, Nan; Wiskott, Laurenz			Gaussian-binary restricted Boltzmann machines for modeling natural image statistics	PLOS ONE			English	Article								We present a theoretical analysis of Gaussian-binary restricted Boltzmann machines (GRBMs) from the perspective of density models. The key aspect of this analysis is to show that GRBMs can be formulated as a constrained mixture of Gaussians, which gives a much better insight into the model's capabilities and limitations. We further show that GRBMs are capable of learning meaningful features without using a regularization term and that the results are comparable to those of independent component analysis. This is illustrated for both a two-dimensional blind source separation task and for modeling natural image patches. Our findings exemplify that reported difficulties in training GRBMs are due to the failure of the training algorithm rather than the model itself. Based on our analysis we derive a better training setup and show empirically that it leads to faster and more robust training of GRBMs. Finally, we compare different sampling algorithms for training GRBMs and show that Contrastive Divergence performs better than training methods that use a persistent Markov chain.	[Melchior, Jan; Wang, Nan; Wiskott, Laurenz] Ruhr Univ Bochum, Inst Neuroinformat, D-44801 Bochum, Germany	Ruhr University Bochum	Melchior, J (corresponding author), Ruhr Univ Bochum, Inst Neuroinformat, D-44801 Bochum, Germany.	jan.melchior@ini.rub.de	Wiskott, Laurenz/P-7715-2017	Wiskott, Laurenz/0000-0001-6237-740X	International Graduate School of Neuroscience at the Ruhr-Universitat Bochum	International Graduate School of Neuroscience at the Ruhr-Universitat Bochum	Author Nan Wang was employed by Institut fur Neuroinformatik, Ruhr-Universitat at Bochum at the time of the study and is now employed by Zalando SE. Zalando SE provided no financial support for the study. Nan Wang was supported by a scholarship of the International Graduate School of Neuroscience at the Ruhr-Universitat Bochum. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach FR, 2003, J MACH LEARN RES, V3, P1, DOI 10.1162/153244303768966085; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bengio Y., 2011, P 14 INT C ART INT S, P233; Bengio Y, 2006, P 19 INT C NEUR INF, P153; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Bishop C. M., 2006, PATTERN RECOGN, P359; Cho K.H., 2013, P INT JOINT C NEUR N, P1; Cho K, 2011, LECT NOTES COMPUT SC, V6791, P10, DOI 10.1007/978-3-642-21735-7_2; Desjardins G., 2010, P INT C ART INT STAT; Erhan D, 2010, J MACH LEARN RES, V11, P625; Fischer Asja, 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P14, DOI 10.1007/978-3-642-33275-3_2; Fischer A, 2011, NEURAL COMPUT, V23, P664, DOI 10.1162/NECO_a_00085; Fischer A, 2010, LECT NOTES COMPUT SC, V6354, P208, DOI 10.1007/978-3-642-15825-4_26; Freund Y, 1992, ADV NEURAL INFORM PR, V4, P912; Glorot X., 2010, P 13 INT C ART INT S, VVolume 9, P249; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Koster U, 2010, NEURAL COMPUT, V22, P2308, DOI 10.1162/NECO_a_00010; Krizhevsky A., 2009, LEARNING MULTIPLE LA; Laparra V, 2011, IEEE T NEURAL NETWOR, V22, P537, DOI 10.1109/TNN.2011.2106511; Le Roux N, 2011, NEURAL COMPUT, V23, P593, DOI 10.1162/NECO_a_00086; Lee H., 2009, P ANN INT C MACH LEA, P609; Lee H., 2007, P C NEUR INF PROC SY; Lewicki MS, 1999, J OPT SOC AM A, V16, P1587, DOI 10.1364/JOSAA.16.001587; Melchior J., 2012, THESIS; Melchior J., 2016, J MACHINE L IN PRESS, V17; Nair Vinod, 2010, P 27 INT C INT C MAC, P807; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Ranzato M., 2010, P 13 INT C ART INT S, P621; Ranzato M, 2010, PROC CVPR IEEE, P2551, DOI 10.1109/CVPR.2010.5539962; Salakhutdinov R., 2009, ARTIF INTELL, P1; Schulz H., 2010, NIPS 2010 WORKSHOP D, V1, P6; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1, P194; Theis L, 2011, J MACH LEARN RES, V12, P3071; Tieleman T., 2008, P 25 INT C MACHINE L, P1064, DOI DOI 10.1145/1390156.1390290; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Wang N, 2012, EUR S ART NEUR NETW, P287; Wang N, 2016, THESIS; Wang N., 2014, CORR; Welling M., 2004, ADV NEURAL INFORM PR, V17, P1481; Zetzsche C, 2001, NETWORK-COMP NEURAL, V12, P331, DOI 10.1088/0954-898X/12/3/306	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171015	10.1371/journal.pone.0171015	http://dx.doi.org/10.1371/journal.pone.0171015			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152552	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200072
J	Vemer, P; Al, MJ; Oppe, M; Rutten-van Molken, MPMH				Vemer, Pepijn; Al, Maiwenn J.; Oppe, Mark; Rutten-van Molken, Maureen P. M. H.			Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes	PLOS ONE			English	Article							NETWORK METAANALYSIS; INCONSISTENCY; INTERVENTIONS	Background Decision-analytic cost-effectiveness (CE) models combine many parameters, often obtained after meta-analysis. Aim We compared different methods of mixed-treatment comparison (MTC) to combine transition and event probabilities derived from several trials, especially with respect to health-economic (HE) outcomes like (quality adjusted) life years and costs. Methods Trials were drawn from a simulated reference population, comparing two of four fictitious interventions. The goal was to estimate the CE between two of these. The amount of heterogeneity between trials was varied in scenarios. Parameter estimates were combined using direct comparison, MTC methods proposed by Song and Puhan, and Bayesian generalized linear fixed effects (GLMFE) and random effects models (GLMRE). Parameters were entered into a Markov model. Parameters and HE outcomes were compared with the reference population using coverage, statistical power, bias and mean absolute deviation (MAD) as performance indicators. Each analytical step was repeated 1,000 times. Results The direct comparison was outperformed by the MTC methods on all indicators, Song's method yielded low bias and MAD, but uncertainty was overestimated. Puhan's method had low bias and MAD and did not overestimate uncertainty. GLMFE generally had the lowest bias and MAD, regardless of the amount of heterogeneity, but uncertainty was overestimated. GLMRE showed large bias and MAD and overestimated uncertainty. Song's and Puhan's methods lead to the least amount of uncertainty, reflected in the shape of the CE acceptability curve. GLMFE showed slightly more uncertainty. Conclusions Combining direct and indirect evidence is superior to using only direct evidence. Puhan's method and GLMFE are preferred.	[Vemer, Pepijn; Al, Maiwenn J.; Oppe, Mark; Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, iMTA, Rotterdam, Netherlands	Erasmus University Rotterdam	Vemer, P (corresponding author), Erasmus Univ, iMTA, Rotterdam, Netherlands.	Healthecon@PepijnVemer.nl	Molken, Maureen Rutten-van/X-8712-2019; Molken, Maureen PMH Rutten-van/G-8481-2014	Molken, Maureen Rutten-van/0000-0001-8706-3159; Molken, Maureen PMH Rutten-van/0000-0001-8706-3159	Netherlands Organization for Health Research and Development (ZonMW) [152002002]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMW, http://www.zonmw.nl/nl/projecten/project-detail/updating-parameters-of-decision-analytic-cost-effectiveness-models-a-systematic-comparison-of-metho/voortgang/), project number 152002002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry DA, 2012, CLIN TRIALS, V9, P37, DOI 10.1177/1740774511417470; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Cooper NJ, 2011, VALUE HEALTH, V14, P371, DOI 10.1016/j.jval.2010.09.001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2012, NICE DSU TECHNICAL S; Dias S., 2011, NICE DSU TECHNICAL S; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Hasselblad V, 1998, MED DECIS MAKING, V18, P37, DOI 10.1177/0272989X9801800110; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jaynes E.T., 1976, FDN PROBABILITY THEO, VII, P175, DOI DOI 10.1007/978-94-010-1436-6_6; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; NZa, 2011, BEL DUR GEN; O'Hagan A, 2003, PRIMER BAYESIAN STAT; Oppe M, 2011, PHARMACOECONOMICS, V29, P239, DOI 10.2165/11539870-000000000-00000; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Puhan MA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-2; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Strassmann R, 2009, EUR RESPIR J, V34, P634, DOI 10.1183/09031936.00167708; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; van Valkenhoef G, 2013, VALUE HEALTH, V16, P449, DOI 10.1016/j.jval.2012.11.012; Vemer P, 2013, PHARMACOECONOMICS, V31, P719, DOI 10.1007/s40273-013-0067-0	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171292	10.1371/journal.pone.0171292	http://dx.doi.org/10.1371/journal.pone.0171292			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152099	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200122
J	Pan, H; Gu, LQ; Liu, BJ; Li, YP; Wang, YH; Bai, XN; Li, L; Wang, BS; Peng, Q; Yao, ZGG; Tang, ZG				Pan, Hao; Gu, Liqun; Liu, Binjie; Li, Yiping; Wang, Yuehong; Bai, Xinna; Li, Long; Wang, Baisheng; Peng, Qian; Yao, Zhigang; Tang, Zhangui			Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma	PLOS ONE			English	Article							MICRORNA-21 TARGETS; PROTEOMIC ANALYSIS; COLORECTAL-CANCER; IDENTIFICATION; TRANSFORMATION; EXPRESSION; MIR-21; GENES; METHYLATION; METASTASIS	It is widely accepted that oral squamous cell carcinoma (OSCC) is a major contributor to the incidence and mortality of neck and head cancer. Tropomyosin-1 (TPM1), which is expressed at a low level, has been considered a prominent tumor-suppressing gene in a variety of solid tumors, although the precise mechanism of the TPM1 gene in OSCC progression remains unknown. We found that TPM1 expression levels decreased in OSCC patients and OSCC cell lines. The overall and cancer-specific survival of patients who exhibited low TPM1 levels were inferior to those of patients who had high TPM1 levels. It was also found that OSCC patients who suffered from disease stageI-II were more likely to have an up-regulated TPM1 expression level, and OSCC patients with lymph node metastasis had a higher probability of exhibiting reduced TPM1 expression. We show that overexpression of TPM1 can promote cell apoptosis and inhibit migration. Our results suggest that TPM1 can suppress tumors in OSCC, and the TPM1 expression level is related to OSCC patient prognosis.	[Pan, Hao; Gu, Liqun; Wang, Baisheng; Peng, Qian; Tang, Zhangui] Cent S Univ, Xiangya Stomatol Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China; [Pan, Hao; Gu, Liqun; Liu, Binjie; Li, Yiping; Wang, Yuehong; Bai, Xinna; Li, Long; Wang, Baisheng; Peng, Qian; Yao, Zhigang; Tang, Zhangui] Cent S Univ, Sch Stomatol, Changsha, Hunan, Peoples R China; [Liu, Binjie] Cent S Univ, Xiangya Stomatol Hosp, Dept Periodont, Changsha, Hunan, Peoples R China; [Li, Yiping; Wang, Yuehong] Cent S Univ, Xiangya Stomatol Hosp, Dept Prosthodont, Changsha, Hunan, Peoples R China; [Bai, Xinna] Cent S Univ, Xiangya Stomatol Hosp, Dept Conservat Dent & Endodont, Changsha, Hunan, Peoples R China; [Li, Long; Yao, Zhigang] Cent S Univ, Xiangya Stomatol Hosp, Dept Oral Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Tang, ZG (corresponding author), Cent S Univ, Xiangya Stomatol Hosp, Dept Oral & Maxillofacial Surg, Changsha, Hunan, Peoples R China.; Tang, ZG (corresponding author), Cent S Univ, Sch Stomatol, Changsha, Hunan, Peoples R China.	tangzhangui@aliyun.com						Ali S, 2011, AM J TRANSL RES, V3, P28; Bailey Mark J, 2013, J Carcinog, V12, P10, DOI 10.4103/1477-3163.114216; Campa MJ, 2016, CANCER IMMUNOL IMMUN, V65, P171, DOI 10.1007/s00262-015-1787-0; Chen C, 2016, ONCOTARGETS THER, V9, P1545, DOI 10.2147/OTT.S98807; Chinn SB, 2015, J CLIN ONCOL, V33, P3269, DOI 10.1200/JCO.2015.61.2929; Dube S, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/859427; Dube S, 2016, ONCOL REP, V35, P3143, DOI 10.3892/or.2016.4732; He QY, 2004, PROTEOMICS, V4, P271, DOI 10.1002/pmic.200300550; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; Hu J, 2013, P NATL ACAD SCI USA, V110, P14520, DOI 10.1073/pnas.1308610110; Johnson N W, 2011, Adv Dent Res, V23, P237, DOI 10.1177/0022034511402082; Khori V, 2015, EUR J PHARMACOL, V765, P179, DOI 10.1016/j.ejphar.2015.08.031; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Lodi G, 2016, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858.CD001829.pub4, DOI 10.1002/14651858.CD001829]; Ma YM, 2016, FRONT MED-PRC, V10, P278, DOI 10.1007/s11684-016-0453-z; Masthan KMK, 2012, ASIAN PAC J CANCER P, V13, P3573, DOI 10.7314/APJCP.2012.13.8.3573; Mlakar V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-282; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Qi YJ, 2005, PROTEOMICS, V5, P2960, DOI 10.1002/pmic.200401175; Redwood C, 2013, J MUSCLE RES CELL M, V34, P285, DOI 10.1007/s10974-013-9358-5; Rosko AJ, 2016, OFFICIAL J AM ACAD O; Tang HY, 2013, J PROTEOMICS, V89, P165, DOI 10.1016/j.jprot.2013.06.016; Thiel UJE, 2011, J ORAL PATHOL MED, V40, P369, DOI 10.1111/j.1600-0714.2010.00982.x; Varga AE, 2005, ONCOGENE, V24, P5043, DOI 10.1038/sj.onc.1208688; Wang J, 2015, ONCOL REP, V33, P1326, DOI 10.3892/or.2015.3733; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Xie S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116517; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhang SK, 2015, CHINESE J CANCER RES, V27, P44, DOI 10.3978/j.issn.1000-9604.2015.01.03; Zheng G, 2016, J MOL MED; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	39	22	24	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0168900	10.1371/journal.pone.0168900	http://dx.doi.org/10.1371/journal.pone.0168900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182650	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800004
J	Aguayo, J; Mostert, D; Fourrier-Jeandel, C; Cerf-Wendling, I; Hostachy, B; Viljoen, A; Ioos, R				Aguayo, Jaime; Mostert, Diane; Fourrier-Jeandel, Celine; Cerf-Wendling, Isabelle; Hostachy, Bruno; Viljoen, Altus; Ioos, Renaud			Development of a hydrolysis probe-based real-time assay for the detection of tropical strains of Fusarium oxysporum f. sp cubense race 4	PLOS ONE			English	Article							VEGETATIVE COMPATIBILITY GROUPS; MEDIATED ISOTHERMAL AMPLIFICATION; SENSITIVE DETECTION; RAPID DETECTION; HIGH-THROUGHPUT; PCR; BANANA; PLANT; WILT; SOIL	Fusarium oxysporum f. sp. cubense (Foc) is one of the most important threats to global banana production. Strategies to control the pathogen are lacking, with plant resistance offering the only long-term solution, if sources of resistance are available. Prevention of introduction of Foc into disease-free areas thus remains a key strategy to continue sustainable banana production. In recent years, strains of Foc affecting Cavendish bananas have destroyed plantations in a number of countries in Asia and in the Middle East, and one African country. One vegetative compatibility group (VCG), 01213/16, is considered the major threat to bananas in tropical and subtropical climatic conditions. However, other genetically related VCGs, such as 0121, may potentially jeopardize banana cultures if they were introduced into disease-free areas. To prevent the introduction of these VCGs into disease-free Cavendish banana-growing countries, a real-time PCR test was developed to accurately detect both VCGs. A previously described putative virulence gene was used to develop a specific combination of hydrolysis probe/primers for the detection of tropical Foc race 4 strains. The real-time PCR parameters were optimized by following a statistical approach relying on orthogonal arrays and the Taguchi method in an attempt to enhance sensitivity and ensure high specificity of the assay. This study also assessed critical performance criteria, such as repeatability, reproducibility, robustness, and specificity, with a large including set of 136 F. oxysporum isolates, including 73 Foc pathogenic strains representing 24 VCGs. The validation data demonstrated that the new assay could be used for regulatory testing applications on banana plant material and can contribute to preventing the introduction and spread of Foc strains affecting Cavendish bananas in the tropics.	[Aguayo, Jaime; Fourrier-Jeandel, Celine; Cerf-Wendling, Isabelle; Ioos, Renaud] ANSES, LSV, Unite Mycol, Domaine De Pixerecourt, Malzeville, France; [Mostert, Diane; Viljoen, Altus] Univ Stellenbosch, Fac AgriSci, Dept Plant Pathol, Matieland, South Africa; [Hostachy, Bruno] ANSES, LSV, Unite Ravageurs & Agents Pathogenes Tropicaux, St Pierre, Reunion, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Stellenbosch University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Aguayo, J (corresponding author), ANSES, LSV, Unite Mycol, Domaine De Pixerecourt, Malzeville, France.	jaime.aguayo@anses.fr		Aguayo, Jaime/0000-0002-7552-0655; Viljoen, Altus/0000-0001-7146-0491; Mostert, Diane/0000-0002-3382-8555; Ioos, Renaud/0000-0001-9359-5098	Agence Nationale de Securite Sanitaire de ('Alimentation, de l'Environnement et du Travail (ANSES)-Laboratoire de la Sante des Vegetaux; Plant Pathology laboratory of the University of Stellenbosch	Agence Nationale de Securite Sanitaire de ('Alimentation, de l'Environnement et du Travail (ANSES)-Laboratoire de la Sante des Vegetaux; Plant Pathology laboratory of the University of Stellenbosch	This research was funded by the Agence Nationale de Securite Sanitaire de ('Alimentation, de l'Environnement et du Travail (ANSES)-Laboratoire de la Sante des Vegetaux and the Plant Pathology laboratory of the University of Stellenbosch.	[Anonymous], 2014, TECHNICAL MANUAL PRE, DOI DOI 10.1093/nar/gkm306; [Anonymous], 2010, EPPO B, V40, P5, DOI DOI 10.1111/J.1365-2338.2009.02347.X; Arzanlou M, 2007, PHYTOPATHOLOGY, V97, P1112, DOI 10.1094/PHYTO-97-9-1112; Ballantyne KN, 2008, FORENS SCI INT-GEN S, V1, P7, DOI 10.1016/j.fsigss.2007.10.050; Bentley S, 1998, PHYTOPATHOLOGY, V88, P1283, DOI 10.1094/PHYTO.1998.88.12.1283; Besseris GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108973; BOEHM EWA, 1994, MOL PLANT MICROBE IN, V7, P196, DOI 10.1094/MPMI-7-0196; Boonham N, 2008, EUR J PLANT PATHOL, V121, P355, DOI 10.1007/s10658-008-9284-3; Bustin Stephen A, 2014, Biomol Detect Quantif, V2, P35; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butler D, 2013, NATURE, V504, P195, DOI 10.1038/504195a; Cai L, 2011, FUNGAL DIVERS, V50, P121, DOI 10.1007/s13225-011-0127-8; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091824; Chen QH, 2013, EUR J PLANT PATHOL, V137, P597, DOI 10.1007/s10658-013-0273-9; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Dabrowski W, 2003, FEMS MICROBIOL LETT, V218, P51, DOI 10.1016/S0378-1097(02)01183-7; Daniells JW, 2011, ACTA HORTIC, V897, P475; de Sousa MV, 2014, PLANT PATHOLOGY; Dita MA, 2013, ACTA HORTIC, V986, P127, DOI 10.17660/ActaHortic.2013.986.11; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fourie G, 2009, APPL ENVIRON MICROB, V75, P4770, DOI 10.1128/AEM.00370-09; Fox J, 2015, PACKAGE CAR; Fraser-Smith S, 2014, PLANT PATHOL, V63, P1044, DOI 10.1111/ppa.12184; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Garcia-Bastidas F, 2014, PLANT DIS, V98, P694, DOI 10.1094/PDIS-09-13-0954-PDN; Ghag SB, 2015, INT J PEST MANAGE, V61, P250, DOI 10.1080/09670874.2015.1043972; Groenewald S, 2006, MYCOL RES, V110, P297, DOI 10.1016/j.mycres.2005.10.004; Grosdidier M, 2016, PLANT PATHOLOGY; Harper SJ, 2010, PHYTOPATHOLOGY, V100, P1282, DOI 10.1094/PHYTO-06-10-0168; Ioos R, 2009, PHYTOPATHOLOGY, V99, P582, DOI 10.1094/PHYTO-99-5-0582; Kema GHJ, 2013, NATURE, V504, P218, DOI 10.1038/504218b; Koenig RL, 1997, PHYTOPATHOLOGY, V87, P915, DOI 10.1094/PHYTO.1997.87.9.915; Li BJ, 2013, EUR J PLANT PATHOL, V135, P903, DOI 10.1007/s10658-012-0136-9; Li C, 2013, FUNGAL GENOMICS BIOL; Li MH, 2013, CAN J PLANT PATHOL, V35, P482, DOI 10.1080/07060661.2013.828321; Lievens B, 2008, PEST MANAG SCI, V64, P781, DOI 10.1002/ps.1564; Lievens B, 2006, PLANT SCI, V171, P155, DOI 10.1016/j.plantsci.2006.03.009; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Lin YH, 2013, EUR J PLANT PATHOL, V135, P395, DOI 10.1007/s10658-012-0096-0; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; McTaggart AR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005475; Molina A, 2010, MITIGATING THREAT BA, V1571, P2010; Nel B, 2006, PLANT PATHOL, V55, P207, DOI 10.1111/j.1365-3059.2006.01343.x; Ordonez N., 2015, PLANT DIS; Ordonez N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005197; Peng J, 2014, J APPL MICROBIOL, V117, P1740, DOI 10.1111/jam.12645; Peng Y, 2007, J APPL MICROBIOL, V103, P2095, DOI 10.1111/j.1365-2672.2007.03440.x; PLOETZ RC, 1988, PLANT DIS, V72, P325, DOI 10.1094/PD-72-0325; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Ploetz RC, 2015, ANN REV PHYTOPATHOLO, V53; Ploetz RC, 2015, CROP PROTECTION; Ploetz RC, 2006, PLANT HLTH PROGR; PO EP, 2010, EPPO B, V40, P350; Pocasangre LE, 2011, RAISING AWARENESS TH, P331; Rao Ravella Sreenivas, 2008, Biotechnology Journal, V3, P510, DOI 10.1002/biot.200700201; Riska J., 2012, Journal of Agricultural and Biological Science, V7, P244; Schaad NW, 2002, CAN J PLANT PATHOL, V24, P250; Sutherland R., 2013, South African Journal of Science, V109, P61; Thanakiatkrai P, 2012, INT J LEGAL MED, V126, P161, DOI 10.1007/s00414-011-0558-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Dam P, 2016, ENV MICROBIOLOGY; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yang L, 2015, CHINA FOOD SECUR, V2015, P1, DOI DOI 10.1177/0954405414523752; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	68	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171767	10.1371/journal.pone.0171767	http://dx.doi.org/10.1371/journal.pone.0171767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178348	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500069
J	Asamitsu, K; Hirokawa, T; Okamoto, T				Asamitsu, Kaori; Hirokawa, Takatsugu; Okamoto, Takashi			MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; PROTEINS SPECIFICALLY ASSOCIATE; INHIBIT HIV TRANSCRIPTION; CYCLIN T1 PROTEINS; FACTOR P-TEFB; ELONGATION COMPLEX; 7SK SNRNA; IN-VIVO; KINASE	In this study, we applied molecular dynamics (MD) simulation to analyze the dynamic behavior of the Tat/CycT1/CDK9 tri-molecular complex and revealed the structural changes of P-TEFb upon Tat binding. We found that Tat could deliberately change the local flexibility of CycT1. Although the structural coordinates of the H1 and H2 helices did not substantially change, H1', H2', and H3' exhibited significant changes en masse. Consequently, the CycT1 residues involved in Tat binding, namely Tat-recognition residues (TRRs), lost their flexibility with the addition of Tat to P-TEFb. In addition, we clarified the structural variation of CDK9 in complex with CycT1 in the presence or absence of Tat. Interestingly, Tat addition significantly reduced the structural variability of the T-loop, thus consolidating the structural integrity of P-TEFb. Finally, we deciphered the formation of the hidden catalytic cavity of CDK9 upon Tat binding. MD simulation revealed that the PITALRE signature sequence of CDK9 flips the inactive kinase cavity of CDK9 into the active form by connecting with Thr186, which is crucial for its activity, thus presumably recruiting the substrate peptide such as the C-terminal domain of RNA pol II. These findings provide vital information for the development of effective novel anti-HIV drugs with CDK9 catalytic activity as the target.	[Asamitsu, Kaori; Okamoto, Takashi] Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki, Japan	Nagoya City University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Okamoto, T (corresponding author), Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Nagoya, Aichi, Japan.; Hirokawa, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan.; Hirokawa, T (corresponding author), Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki, Japan.	t-hirokawa@aist.go.jp; tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011	Asahi Grass Foundation; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and technology (MEXT); Japen Agency for Medical Research and Development (AMED); Junwakai Foundtion, Aujo, Japan	Asahi Grass Foundation; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and technology (MEXT); Japen Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Junwakai Foundtion, Aujo, Japan	This research was partially supported by the Asahi Grass Foundation, the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science, and technology (MEXT), the Japen Agency for Medical Research and Development (AMED) and Junwakai Foundtion, Aujo, Japan.	Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Asamitsu K, 2016, GENES CELLS, V21, P706, DOI 10.1111/gtc.12375; Asamitsu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119451; Asamitsu K, 2011, J MOL BIOL, V410, P887, DOI 10.1016/j.jmb.2011.04.061; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; De Luca A, 2003, J CELL PHYSIOL, V194, P101, DOI 10.1002/jcp.10196; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Filomia F, 2010, BIOORGAN MED CHEM, V18, P6805, DOI 10.1016/j.bmc.2010.07.047; Fujinaga K, 1999, P NATL ACAD SCI USA, V96, P1285, DOI 10.1073/pnas.96.4.1285; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hornak V, 2006, J AM CHEM SOC, V128, P2812, DOI 10.1021/ja058211x; Jadlowsky JK, 2008, J GEN VIROL, V89, P2783, DOI 10.1099/vir.0.2008/002857-0; Jadlowsky JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-63; Jin HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124673; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOBAL REPORT UNAIDS; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Ramakrishnan R, 2012, J CELL PHYSIOL, V227, P609, DOI 10.1002/jcp.22760; Ramakrishnan Rajesh, 2011, BMC Res Notes, V4, P260, DOI 10.1186/1756-0500-4-260; Ramakrishnan R, 2009, J LEUKOCYTE BIOL, V86, P1345, DOI 10.1189/jlb.0509309; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulze-Gahmen U, 2014, ELIFE, V3, DOI 10.7554/eLife.02375; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Toth G, 2006, BIOCHEMISTRY-US, V45, P6606, DOI 10.1021/bi060188k; Verstraete N, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-50; Victoriano AFB, 2012, AIDS RES HUM RETROV, V28, P125, DOI [10.1089/aid.2011.0263, 10.1089/AID.2011.0263]; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XZ, 1996, J VIROL, V70, P4576, DOI 10.1128/JVI.70.7.4576-4584.1996; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	56	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171727	10.1371/journal.pone.0171727	http://dx.doi.org/10.1371/journal.pone.0171727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178316	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500063
J	Barman, S; Kwon, YK				Barman, Shohag; Kwon, Yung-Keun			A novel mutual information-based Boolean network inference method from time-series gene expression data	PLOS ONE			English	Article							REGULATORY NETWORKS	Background Inferring a gene regulatory network from time-series gene expression data in systems biology is a challenging problem. Many methods have been suggested, most of which have a scalability limitation due to the combinatorial cost of searching a regulatory set of genes. In addition, they have focused on the accurate inference of a network structure only. Therefore, there is a pressing need to develop a network inference method to search regulatory genes efficiently and to predict the network dynamics accurately. Results In this study, we employed a Boolean network model with a restricted update rule scheme to capture coarse-grained dynamics, and propose a novel mutual information-based Boolean network inference (MIBNI) method. Given time-series gene expression data as an input, the method first identifies a set of initial regulatory genes using mutual information-based feature selection, and then improves the dynamics prediction accuracy by iteratively swapping a pair of genes between sets of the selected regulatory genes and the other genes. Through extensive simulations with artificial datasets, MIBNI showed consistently better performance than six well-known existing methods, REVEAL, Best-Fit, RelNet, CST, CLR, and BIBN in terms of both structural and dynamics prediction accuracy. We further tested the proposed method with two real gene expression datasets for an Escherichia coli gene regulatory network and a fission yeast cell cycle network, and also observed better results using MIBNI compared to the six other methods. Conclusions Taken together, MIBNI is a promising tool for predicting both the structure and the dynamics of a gene regulatory network.	[Barman, Shohag; Kwon, Yung-Keun] Univ Ulsan, Sch Elect Engn, Ulsan, South Korea	University of Ulsan	Kwon, YK (corresponding author), Univ Ulsan, Sch Elect Engn, Ulsan, South Korea.	kwonyk@ulsan.ac.kr	Barman, Shohag/AHA-5980-2022		Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2015R1D1A1A09060910]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2015R1D1A1A09060910) [http://www.nrf.re.kr/nrf.eng_crns/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ANAL GENE EXPRESSION; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Berestovsky N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066031; Butte AJ, PAC S BIOCOMPUTING20; Chen T, PAC S BIOC, P29; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Han ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115806; Imoto S, PAC S BIOCOMPUTING20, P175; Karlebach G, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-11; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kim H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-37; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li P, 2014, EURASIP J BIOINFORM, DOI 10.1186/s13637-014-0012; Liang S, PAC S BIOC; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Ouyang HJ, 2014, EURASIP J BIOINFORM, DOI 10.1186/s13637-014-0010-5; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Zhang Xiao, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P104; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	26	32	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171097	10.1371/journal.pone.0171097	http://dx.doi.org/10.1371/journal.pone.0171097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178334	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500024
J	Bauer, J; Muller, P; Maier, W; Groneberg, DA				Bauer, Jan; Mueller, Peter; Maier, Werner; Groneberg, David A.			Orthopedic workforce planning in Germany - an analysis of orthopedic accessibility	PLOS ONE			English	Article							MEASURING SPATIAL ACCESSIBILITY; PRIMARY-HEALTH-CARE; CATCHMENT-AREA METHOD; INSURANCE TYPE; ACCESS; NEIGHBORHOODS; ARTHROPLASTY; DISPARITIES; SERVICES; IMPACT	In Germany, orthopedic workforce planning relies on population-to-provider-ratios represented by the 'official degree of care provision'. However, with geographic information systems (GIS), more sophisticated measurements are available. By utilizing GIS-based technologies we analyzed the current state of demand and supply of the orthopedic workforce in Germany (orthopedic accessibility) with the integrated Floating Catchment Area method. The analysis of n = 153,352,220 distances revealed significant geographical variations on national scale: 5,617,595 people (6.9% of total population) lived in an area with significant low orthopedic accessibility (average z-score = -4.0), whereas 31,748,161 people (39.0% of total population) lived in an area with significant high orthopedic accessibility (average z-score = 8.0). Accessibility was positively correlated with the degree of urbanization (r = 0.49; p<0.001) and the official degree of care provision (r = 0.33; p< 0.001) and negatively correlated with regional social deprivation (r = -0.47; p< 0.001). Despite advantages of simpler measures regarding implementation and acceptance in health policy, more sophisticated measures of accessibility have the potential to reduce costs as well as improve health care. With this study, significant geographical variations were revealed that show the need to reduce oversupply in less deprived urban areas in order to enable adequate care in more deprived rural areas.	[Bauer, Jan; Groneberg, David A.] Goethe Univ, Inst Occupat Social & Environm Med, Frankfurt, Germany; [Mueller, Peter] Publ Hlth Fdn Stiftung Gesundheit, Hamburg, Germany; [Maier, Werner] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Ingolstadter Landstr 1, Neuherberg, Germany	Goethe University Frankfurt; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bauer, J (corresponding author), Goethe Univ, Inst Occupat Social & Environm Med, Frankfurt, Germany.	j.bauer@med.uni-frankfurt.de	Bauer, Jan/Q-2197-2015; Groneberg, David/A-5132-2018	Bauer, Jan/0000-0001-6267-9731; Groneberg, David/0000-0001-8551-6556; Maier, Werner/0000-0003-4356-7296				[Anonymous], 2016, OP DAT FREIE DAT DIE; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Badley EM, 2012, BEST PRACT RES CL RH, V26, P599, DOI 10.1016/j.berh.2012.09.002; Bauer J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159148; Bell S, 2013, ANN ASSOC AM GEOGR, V103, P85, DOI 10.1080/00045608.2012.685050; Bissonnette L, 2012, HEALTH PLACE, V18, P841, DOI 10.1016/j.healthplace.2012.03.007; Braggion M, 2015, HEALTH PROMOT INT, V30, P706, DOI 10.1093/heapro/dat053; Canizares M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004472; Comber AJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-44; Delamater PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054900; Dijkstra L, 2014, 012014 WP; Draeger RW, 2014, J HAND SURG-AM, V39, P527, DOI 10.1016/j.jhsa.2013.10.031; Engler-Stringer R, 2014, SPAT SPATIO-TEMPORAL, V11, P23, DOI 10.1016/j.sste.2014.07.001; Federal Joint Committee, 2016, REQ PLAN DIR; Federal Office for Building and Regional Planning, 2016, MAJ URB AR; Federal Statistical Office, 2016, MUN DIR INF SYST; Fransen K, 2015, HEALTH PLACE, V32, P65, DOI 10.1016/j.healthplace.2015.01.002; Freiberg A, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0113-x; Froelich JM, 2013, ORTHOPEDICS, V36, pE1272, DOI 10.3928/01477447-20130920-19; Fu MC, 2013, CLIN ORTHOP RELAT R, V471, P3074, DOI 10.1007/s11999-013-3131-3; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Guagliardo MF, 2004, HEALTH PLACE, V10, P273, DOI 10.1016/j.healthplace.2003.01.001; IGES Institute, 2012, PATIENT ORIENTED REQ; Jones M, 2016, CAN GEOGR-GEOGR CAN, V60, P346, DOI 10.1111/cag.12286; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Kim CY, 2015, J ARTHROPLASTY, V30, P1498, DOI 10.1016/j.arth.2015.03.015; Kringos D.S., 2015, EUROPEAN OBSERVATORY, P27; Lagu T, 2014, NEW ENGL J MED, V370, P1847, DOI 10.1056/NEJMsb1315940; Lavernia CJ, 2012, J ARTHROPLASTY, V27, P1585, DOI 10.1016/j.arth.2012.03.014; Luo J, 2014, T GIS, V18, P436, DOI 10.1111/tgis.12096; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Mauss D, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0103-z; McGrail MR, 2014, APPL GEOGR, V54, P182, DOI 10.1016/j.apgeog.2014.08.005; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; Mennicken R, 2014, HEALTH POLICY, V118, P396, DOI 10.1016/j.healthpol.2014.07.017; Mullen MT, 2014, STROKE, V45, P3381, DOI 10.1161/STROKEAHA.114.006021; National Association of Statutory Health Insurance Physicians, 2016, HLTH DAT; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Phongamwong C, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0063-8; Sauer MW, 2012, PEDIATR EMERG CARE, V28, P680, DOI 10.1097/PEC.0b013e31825d2121; Sawyer J, 2015, J PEDIATR ORTHOPED, P1; Schafer T, 2013, OSTEOARTHR CARTILAGE, V21, P279, DOI 10.1016/j.joca.2012.11.006; Shahid R, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-200; Sielatycki JA, 2016, J ORTHOP TRAUMA, V30, P278, DOI 10.1097/BOT.0000000000000540; Steinhaeuser J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-147; Stiftung Gesundheit, ARZT AUSK PROF; Sundling C, 2014, INT J ENV RES PUB HE, V11, P12938, DOI 10.3390/ijerph111212938; Trosken T, 2005, GESUNDHEITSWESEN, V67, P613, DOI 10.1055/s-2005-858600; Wan N, 2012, INT J GEOGR INF SCI, V26, P1073, DOI 10.1080/13658816.2011.624987; Wang FH, 2012, ANN ASSOC AM GEOGR, V102, P1104, DOI 10.1080/00045608.2012.657146	54	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171747	10.1371/journal.pone.0171747	http://dx.doi.org/10.1371/journal.pone.0171747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178335	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500066
J	Leegwater, NC; Bakker, AD; Hogervorst, JMA; Nolte, PA; Klein-Nulend, J				Leegwater, Nick C.; Bakker, Astrid D.; Hogervorst, Jolanda M. A.; Nolte, Peter A.; Klein-Nulend, Jenneke			Hypothermia reduces VEGF-165 expression, but not osteogenic differentiation of human adipose stem cells under hypoxia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STROMAL-VASCULAR FRACTION; NITRIC-OXIDE SYNTHASE; BONE-MARROW; REPERFUSION INJURY; IN-VIVO; ISCHEMIA/REPERFUSION INJURY; SKELETAL-MUSCLE; TISSUE; CRYOTHERAPY	Cryotherapy is successfully used in the clinic to reduce pain and inflammation after musculoskeletal damage, and might prevent secondary tissue damage under the prevalent hypoxic conditions. Whether cryotherapy reduces mesenchymal stem cell (MSC) number and differentiation under hypoxic conditions, causing impaired callus formation is unknown. We aimed to determine whether hypothermia modulates proliferation, apoptosis, nitric oxide production, VEGF gene and protein expression, and osteogenic/chondrogenic differentiation of human MSCs under hypoxia. Human adipose MSCs were cultured under hypoxia (37 degrees C, 1% O-2), hypothermia and hypoxia (30 degrees C, 1% O-2), or control conditions (37 degrees C, 20% O-2). Total DNA, protein, nitric oxide production, alkaline phosphatase activity, gene expression, and VEGF protein concentration were measured up to day 8. Hypoxia enhanced K167 expression at day 4. The combination of hypothermia and hypoxia further enhanced K167 gene expression compared to hypoxia alone, but was unable to prevent the 1.2-fold reduction in DNA amount caused by hypoxia at day 4. Addition of hypothermia to hypoxic cells did not alter the effect of hypoxia alone on BAX-to-BCL-2 ratio, alkaline phosphatase activity, gene expression of SOX9, COL1, or osteocalcin, or nitric oxide production. Hypothermia decreased the stimulating effect of hypoxia on VEGF-165 gene expression by 6-fold at day 4 and by 2-fold at day 8. Hypothermia also decreased VEGF protein expression under hypoxia by 2.9-fold at day 8. In conclusion, hypothermia decreased VEGF-165 gene and protein expression, but did not affect differentiation, or apoptosis of MSCs cultured under hypoxia. These in vitro results implicate that hypothermia treatment in vivo, applied to alleviate pain and inflammation, is not likely to harm early stages of callus formation.	[Leegwater, Nick C.; Nolte, Peter A.] Spaarne Hosp, Dept Orthopaed, Hoofddorp, Netherlands; [Bakker, Astrid D.; Hogervorst, Jolanda M. A.; Klein-Nulend, Jenneke] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Bakker, Astrid D.; Hogervorst, Jolanda M. A.; Klein-Nulend, Jenneke] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Klein-Nulend, Jenneke] ACTA VU Univ Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands	Spaarne Hospital; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Klein-Nulend, J (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.; Klein-Nulend, J (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.; Klein-Nulend, J (corresponding author), ACTA VU Univ Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands.	j.kleinnulend@acta.nl	Nolte, Peter albertus/F-3657-2012; Bakker, Astrid Diana/AAD-1286-2019	Nolte, Peter albertus/0000-0002-7474-2715; 				Adie S, 2010, J ARTHROPLASTY, V25, P709, DOI 10.1016/j.arth.2009.07.010; Agata H, 2010, TISSUE ENG PT A, V16, P663, DOI [10.1089/ten.tea.2009.0500, 10.1089/ten.TEA.2009.0500]; Bastidas-Coral AP, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1318256; Bornes TD, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0075-4; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Choi EK, 2015, INT J SURG, V22, P74, DOI 10.1016/j.ijsu.2015.08.016; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Coassin M, 2010, BRIT J OPHTHALMOL, V94, P1678, DOI 10.1136/bjo.2009.168864; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Faustini M, 2010, TISSUE ENG PART C-ME, V16, P1515, DOI [10.1089/ten.tec.2010.0214, 10.1089/ten.TEC.2010.0214]; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735; Holwerda SW, 2013, SPORTS HEALTH, V5, P27, DOI 10.1177/1941738112450863; Horst K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154788; Janda J, 2016, ARCH DERMATOL RES, V308, P239, DOI 10.1007/s00403-016-1628-9; Juhl M, 2016, SCAND J CLIN LAB INV, V76, P93, DOI 10.3109/00365513.2015.1099723; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kim JH, 2012, STEM CELLS DEV, V21, P2212, DOI 10.1089/scd.2011.0561; Knippenberg M, 2007, TISSUE ENG, V13, P2495, DOI 10.1089/ten.2006.0420; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Lee JS, 2015, BONE, V78, P34, DOI 10.1016/j.bone.2015.04.044; Leegwater NC, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1000-4; LOWRY OH, 1955, METHOD ENZYMOL, V4, P371; Lu J, 2014, WORLD J EMERG MED, V5, P298, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.010; Luo C, 2015, NEURAL REGEN RES, V10, P153, DOI 10.4103/1673-5374.150725; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Merrick Mark A., 1993, Journal of Athletic Training, V28, P241; Messina A, 2000, LAB INVEST, V80, P423, DOI 10.1038/labinvest.3780047; Naaijkens BA, 2012, CELL TISSUE RES, V348, P119, DOI 10.1007/s00441-012-1360-5; Park JW, 2005, MICROSURG, V25, P606, DOI 10.1002/micr.20175; Patel JJ, 2012, EXP CELL RES, V318, P2237, DOI 10.1016/j.yexcr.2012.06.021; Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120; Prins HJ, 2016, STEM CELL TRANSL MED, V5, P1362, DOI 10.5966/sctm.2015-0369; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schaser KD, 2007, AM J SPORT MED, V35, P93, DOI 10.1177/0363546506294569; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Stalman A, 2011, J BONE JOINT SURG AM, V93A, P1961, DOI 10.2106/JBJS.J.01790; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tjabringa GS, 2006, STEM CELLS, V24, P2262, DOI 10.1634/stemcells.2005-0625; van Esterik FAS, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1934270; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Xian LL, 2012, NAT MED, V18, P1095, DOI 10.1038/nm.2793; Yodmuang S, 2015, STEM CELL REV REP, V11, P228, DOI 10.1007/s12015-015-9584-x; Yoo HI, 2016, KOREAN J PHYSIOL PHA, V20, P53, DOI 10.4196/kjpp.2016.20.1.53; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhou NA, 2015, CELL PHYSIOL BIOCHEM, V36, P44, DOI 10.1159/000374052; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171492	10.1371/journal.pone.0171492	http://dx.doi.org/10.1371/journal.pone.0171492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166273	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100048
J	Grosen, K; Olesen, AE; Gram, M; Jonsson, T; Kamp-Jensen, M; Andresen, T; Nielsen, C; Pozlep, G; Pfeiffer-Jensen, M; Morlion, B; Drewes, AM				Grosen, Kasper; Olesen, Anne E.; Gram, Mikkel; Jonsson, Torsten; Kamp-Jensen, Michael; Andresen, Trine; Nielsen, Christian; Pozlep, Gorazd; Pfeiffer-Jensen, Mogens; Morlion, Bart; Drewes, Asbjorn M.			Predictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study	PLOS ONE			English	Article							CLINICAL-TRIALS; NEUROPATHIC PAIN; ASSOCIATIONS; ANALGESICS; RESPONSES	Opioids are increasingly used for treatment of chronic pain. However, they are only effective in a subset of patients and have multiple side effects. Thus, studies using biomarkers for response are highly warranted. The current study prospectively examined 63 opioid-naive patients initiating opioid use for diverse types of chronic pain at five European centers. Quantitative sensory testing, electroencephalography (EEG) recordings, and assessment of pain catastrophizing were performed prior to treatment. The co-primary outcomes were change from baseline in ratings of chronic pain and quality of life after 14 days of opioid treatment. Secondary outcomes included patient's global impression of clinical change and side effects. Logistic regression models adjusted for age and sex were used to identify biomarkers predictive for successful treatment, defined as at least a 30% reduction in average pain intensity or an improvement in quality of life of at least 10 scale points. Fifty-nine patients (94%) completed the study. The mean age was 55 +/- 16 years and 69% were females. Pain reduction was predicted by cold pain intensity (OR: 0.69; P = 0.01), pain catastrophizing (OR: 0.82; P = 0.03), relative delta (OR: 0.76; P = 0.03) and beta EEG activity (OR: 1.18; P = 0.04) induced by experimental cold pain. None of the study variables were related to improvement in quality of life. For the first time, individual pain processing characteristics have been linked to opioid response in a mixed chronic pain population. This has the potential to personalize treatment of chronic pain and restrict opioid use to patients with high likelihood for response.	[Grosen, Kasper; Olesen, Anne E.; Gram, Mikkel; Drewes, Asbjorn M.] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Mech Sense, Aalborg, Denmark; [Grosen, Kasper] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Olesen, Anne E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Olesen, Anne E.; Drewes, Asbjorn M.] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Jonsson, Torsten; Kamp-Jensen, Michael] Valdemar Hosp, Ringsted, Denmark; [Andresen, Trine; Nielsen, Christian] Friklinikken, Reg Southern Denmark, Give, Denmark; [Pozlep, Gorazd] Univ Ljubljana, Med Ctr, Dept Anaesthet & Surg Intens Care, Ljubljana, Slovenia; [Pfeiffer-Jensen, Mogens] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark; [Morlion, Bart] Univ Hosp Leuven, Leuven Ctr Algol & Pain Management, Pellenberg, Belgium	Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen; Aalborg University; University of Ljubljana; Aarhus University; KU Leuven; University Hospital Leuven	Drewes, AM (corresponding author), Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Mech Sense, Aalborg, Denmark.; Drewes, AM (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	amd@rn.dk	Olesen, Anne Estrup/B-3127-2016; Drewes, Asbjørn/AAR-7479-2021	Olesen, Anne Estrup/0000-0001-9365-1918; Drewes, Asbjørn/0000-0001-7465-964X; Morlion, Bart/0000-0002-6156-880X; Grosen, Kasper/0000-0002-2147-899X	Innovation Fund Denmark [0603-00411b]; Karen Elise Jensen's Foundation; Obel Family Foundation	Innovation Fund Denmark; Karen Elise Jensen's Foundation; Obel Family Foundation	This work was supported by Innovation Fund Denmark (Grant number 0603-00411b), Karen Elise Jensen's Foundation, and the Obel Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the funders.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006; BACKONJA M, 1991, ELECTROEN CLIN NEURO, V79, P192, DOI 10.1016/0013-4694(91)90137-S; Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; Baron R, 2014, PAIN, V155, P2215, DOI 10.1016/j.pain.2014.08.021; Baron R, 2012, LANCET NEUROL, V11, P999, DOI 10.1016/S1474-4422(12)70189-8; Borsook D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008320; Califf RM, 2016, NEW ENGL J MED, V374, P1480, DOI 10.1056/NEJMsr1601307; Campbell CM, 2010, J PAIN, V11, P443, DOI 10.1016/j.jpain.2009.08.009; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Derry S, 2012, COCHRANE DB SYST REV, V3, DOI DOI 10.1111/BCP.12137; Drewes AM, 2013, BRIT J CLIN PHARMACO, V75, P60, DOI 10.1111/j.1365-2125.2012.04317.x; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; Edwards RR, 2016, PAIN, V157, P1851, DOI 10.1097/j.pain.0000000000000602; Goodin BR, 2009, J PAIN, V10, P180, DOI 10.1016/j.jpain.2008.08.012; Gram M, 2015, EUR J PAIN, V19, P1552, DOI 10.1002/ejp.734; Gram M, 2013, BRIT J CLIN PHARMACO, V76, P951, DOI 10.1111/bcp.12120; Grosen K, 2013, EUR J PAIN, V17, P1267, DOI 10.1002/j.1532-2149.2013.00330.x; Malver LP, 2014, BRIT J CLIN PHARMACO, V77, P72, DOI 10.1111/bcp.12137; Mankovsky T, 2012, PAIN RES MANAG, V17, P10, DOI 10.1155/2012/970423; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Olesen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057963; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Schiff S, 2016, HEPATOLOGY, V63, P1651, DOI 10.1002/hep.28477; Shy ME, 2003, NEUROLOGY, V60, P898, DOI 10.1212/01.WNL.0000058546.16985.11; Staahl C, 2009, BRIT J CLIN PHARMACO, V68, P149, DOI 10.1111/j.1365-2125.2009.03456.x; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Yarnitsky D, 2015, EUR J PAIN, V19, P805, DOI 10.1002/ejp.605; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171723	10.1371/journal.pone.0171723	http://dx.doi.org/10.1371/journal.pone.0171723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158269	Green Published, gold			2022-12-27	WOS:000396161700120
J	Kandemir, B; Dag, U; Gungor, BB; Durasi, IM; Erdogan, B; Sahin, E; Sezerman, U; Kurnaz, IA				Kandemir, Basak; Dag, Ugur; Gungor, Burcu Bakir; Durasi, Ilknur Melis; Erdogan, Burcu; Sahin, Eray; Sezerman, Ugur; Kurnaz, Isil Aksan			In silico analyses and global transcriptional profiling reveal novel putative targets for Pea3 transcription factor related to its function in neurons	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; KINASE ACTIVATION; PRECURSOR CELLS; MOTOR-NEURONS; EPH RECEPTORS; C-JUN; ETS; EXPRESSION; PROTEIN	Pea3 transcription factor belongs to the PEA3 subfamily within the ETS domain transcription factor superfamily, and has been largely studied in relation to its role in breast cancer metastasis. Nonetheless, Pea3 plays a role not only in breast tumor, but also in other tissues with branching morphogenesis, including kidneys, blood vasculature, bronchi and the developing nervous system. Identification of Pea3 target promoters in these systems are important for a thorough understanding of how Pea3 functions. Present study particularly focuses on the identification of novel neuronal targets of Pea3 in a combinatorial approach, through curation, computational analysis and microarray studies in a neuronal model system, SH-SY5Y neuroblastoma cells. We not only show that quite a number of genes in cancer, immune system and cell cycle pathways, among many others, are either up- or down-regulated by Pea3, but also identify novel targets including ephrins and ephrin receptors, semaphorins, cell adhesion molecules, as well as metalloproteases such as kallikreins, to be among potential target promoters in neuronal systems. Our overall results indicate that rather than early stages of neurite extension and axonal guidance, Pea3 is more involved in target identification and synaptic maturation.	[Kandemir, Basak; Durasi, Ilknur Melis; Sahin, Eray; Kurnaz, Isil Aksan] Gebze Tech Univ, Dept Mol Biol & Genet, Kocaeli, Turkey; [Kandemir, Basak; Dag, Ugur; Erdogan, Burcu; Sahin, Eray] Yeditepe Univ, Biotechnol Grad Program, Istanbul, Turkey; [Gungor, Burcu Bakir; Durasi, Ilknur Melis; Sezerman, Ugur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey; [Kurnaz, Isil Aksan] Gebze Tech Univ, Inst Biotechnol, Kocaeli, Turkey; [Dag, Ugur] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Erdogan, Burcu] Boston Coll, Dept Biol, Chestnut Hill, MA USA; [Gungor, Burcu Bakir] Abdullah Gul Univ, Dept Comp Engn, Fac Engn, Kayseri, Turkey; [Sezerman, Ugur] Acibadem Univ, Fac Med, Istanbul, Turkey	Gebze Technical University; Yeditepe University; Sabanci University; Gebze Technical University; Howard Hughes Medical Institute; Boston College; Abdullah Gul University; Erciyes University; Acibadem University	Kurnaz, IA (corresponding author), Gebze Tech Univ, Dept Mol Biol & Genet, Kocaeli, Turkey.; Kurnaz, IA (corresponding author), Gebze Tech Univ, Inst Biotechnol, Kocaeli, Turkey.	ikurnaz@gtu.edu.tr	Kandemir, Başak/ABC-7240-2020; DURASI, ILKNUR MELIS/AAE-8729-2021; Sahin, Eray/GZB-9354-2022; KURNAZ, ISIL/GXG-5616-2022; SEZERMAN, OSMAN U/X-6441-2018	Sahin, Eray/0000-0002-0873-2439; Bakir-Gungor, Burcu/0000-0002-2272-6270; Sezerman, Osman Ugur/0000-0003-0905-6783; kandemir, basak/0000-0003-1909-5778	TUBITAK BIDEB; TUBITAK [107S064, 214Z278]	TUBITAK BIDEB(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	Support was provided by TUBITAK BIDEB project grants to UD and BE; TUBITAK grants no 107S064 and 214Z278 to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz NM, 2009, INT J DEV BIOL, V53, P559, DOI 10.1387/ijdb.082777na; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Caglayan B, 2010, J NEUROCHEM, V115, P16; Chaturvedi S, 2015, PEDIATR NEPHROL, V30, P561, DOI 10.1007/s00467-014-2825-4; Chedotal A, 2007, ADV EXP MED BIOL, V621, P65, DOI 10.1007/978-0-387-76715-4_5; Chen JH, 1996, ONCOGENE, V13, P1667; Chotteau-Lelievre A, 2001, MECH DEVELOP, V108, P191, DOI 10.1016/S0925-4773(01)00480-4; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Custer AW, 2003, J NEUROSCI, V23, P10032; Day BW, 2014, BRIT J CANCER, V111, P1255, DOI 10.1038/bjc.2014.73; de Launoit Y, 2000, ADV EXP MED BIOL, V480, P107; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; Demir O, 2008, NEUROSCI LETT, V437, P20, DOI 10.1016/j.neulet.2008.03.064; Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; Diaz-Balzac CA, 2015, CELL REP, V11, P1377, DOI 10.1016/j.celrep.2015.04.057; Diolaiti D, 2007, EXP CELL RES, V313, P2980, DOI 10.1016/j.yexcr.2007.06.002; Dong Y, 2014, BIOL CHEM, V395, P977, DOI 10.1515/hsz-2014-0147; Doty KR, 2015, BRAIN RES, V1617, P155, DOI 10.1016/j.brainres.2014.09.008; Duffy SL, 2006, GENE EXPR PATTERNS, V6, P719, DOI 10.1016/j.modgep.2005.12.007; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; Endo R, 2009, J BIOL CHEM, V284, P26029, DOI 10.1074/jbc.M109.026443; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Garcia-Garcia E, 2012, MOL BIOL CELL, V23, P1167, DOI 10.1091/mbc.E11-06-0524; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Giniger E, 2012, CURR OPIN GENET DEV, V22, P339, DOI 10.1016/j.gde.2012.04.003; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Gu CK, 2005, ONCOGENE, V24, P4243, DOI 10.1038/sj.onc.1208584; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hauser S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018989; Hayano Y, 2014, P NATL ACAD SCI USA, V111, P15226, DOI 10.1073/pnas.1402095111; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; HIGASHINO F, 1995, ONCOGENE, V10, P1461; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hua D, 2009, ACTA BIOCH BIOPH SIN, V41, P63, DOI 10.1093/abbs/gmn007; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Ishikawa Y, 2008, J NEUROSCI, V28, P843, DOI 10.1523/JNEUROSCI.4397-07.2008; Ishikawa Y, 2011, J PHYSIOL-LONDON, V589, P3559, DOI 10.1113/jphysiol.2011.206169; Janknecht R, 1996, MOL CELL BIOL, V16, P1550; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; Jukam D, 2013, SCIENCE, V342, P211, DOI 10.1126/science.1238016; Kandemir B, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00059; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim M, 2014, BMB REP, V47, P540, DOI 10.5483/BMBRep.2014.47.10.177; Konar A, 2015, THER TARGETS NEUROL, V2, pe503; Koo SJ, 2002, NEURON, V35, P823, DOI 10.1016/S0896-6273(02)00870-X; Korja M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-57; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Leight ER, 2015, GENETICS, V199, P761, DOI 10.1534/genetics.114.172668; Li HX, 2008, PROTEIN SCI, V17, P664, DOI 10.1110/ps.073333208; Liao WX, 2010, HISTOL HISTOPATHOL, V25, P1181, DOI 10.14670/HH-25.1181; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lisle JE, 2015, EXP CELL RES, V333, P136, DOI 10.1016/j.yexcr.2015.02.014; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; McCabe KL, 2006, DEV DYNAM, V235, P327, DOI 10.1002/dvdy.20631; Meydan C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S13; Moleirinho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060028; MOSCOSO LM, 1995, J COMP NEUROL, V352, P321, DOI 10.1002/cne.903520302; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; North HA, 2013, CEREB CORTEX, V23, P1765, DOI 10.1093/cercor/bhs183; Oka T, 2002, NEUROSCI LETT, V321, P141, DOI 10.1016/S0304-3940(01)02470-3; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Park I, 2015, MOL CELLS, V38, P14, DOI 10.14348/molcells.2015.2116; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Qin J, 2000, ACTA NEUROPATHOL, V100, P168, DOI 10.1007/s004019900154; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Rugarli EI, 1996, HUM MOL GENET, V5, P1109, DOI 10.1093/hmg/5.8.1109; Ryu H, 2000, J IMMUNOL, V165, P2116, DOI 10.4049/jimmunol.165.4.2116; Saito A, 2013, GENES CELLS, V18, P533, DOI 10.1111/gtc.12054; Shannon P., 2014, MOTIFDB ANNOTATED CO; Shi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014570; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; TRIMBLE MS, 1993, ONCOGENE, V8, P3037; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Weisinger K, 2010, DEV BIOL, V344, P881, DOI 10.1016/j.ydbio.2010.06.001; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; YANG SH, 2006, BIOCHEM SOC SYMP, P121; Yukawa K, 2005, INT J MOL MED, V16, P115; Zhang XS, 2013, J BIOL CHEM, V288, P32742, DOI 10.1074/jbc.M113.478016; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015; Zou YM, 2004, NEURON, V43, P159, DOI 10.1016/j.neuron.2004.07.004	103	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170585	10.1371/journal.pone.0170585	http://dx.doi.org/10.1371/journal.pone.0170585			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158215	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161700015
J	Krezanoski, PJ; Campbell, JI; Santorino, D; Bangsberg, DR				Krezanoski, Paul J.; Campbell, Jeffrey I.; Santorino, Data; Bangsberg, David R.			Objective monitoring of Insecticide-treated bednet use to improve malaria prevention: SmartNet development and validation	PLOS ONE			English	Article							NETS; CAMPAIGN; COVERAGE	Malaria is a serious health concern for three billion people worldwide, killing nearly 600,000 people a year. Insecticide-treated bednets (ITNs) are an effective and valuable tool for preventing malaria and hundreds of millions of ITNs have been distributed throughout sub-Saharan Africa. Nevertheless, our current methods for measuring ITN use are inadequate to inform malaria prevention programs. The most common method, self-reported ITN use, is limited by 1) social desirability, 2) recall and 3) sampling bias. An acceptable objective and longitudinal method of assessing adherence to ITN use would improve our ability to better understand the determinants of ITN use and design more effective malaria prevention interventions. We describe the development and initial proof-of-concept validity testing of an ITN adherence monitoring tool called SmartNet. SmartNet uses conductive thread interwoven into an ITN and a microcontroller to detect the state of the ITN. We tested SmartNet among five volunteers using the device over their beds in Boston, USA for two weeks with the goal of evaluating device reliability, accuracy and acceptability to inform future device improvements. The device recorded data for 63.1% (35172/55711) of installed two-minute time intervals, with 97.3% (19990/20539) of the recording errors relating to battery failures. Overall, the device was 71.7% (25204/35172) accurate in determining the state of the ITN (whether it was folded up or unfurled) and performed significantly better at detecting an unfurled ITN than a folded ITN, 77.3% versus 68.4% (p<0.001). Participants noted no significant acceptability concerns and all participants felt SmartNet was easy or very easy to use. SmartNet is a novel approach to objectively measure ITN adherence over time. Our results suggest a variety of device improvements to both extend reliability and improve performance of SmartNet prior to deployment in a malaria-endemic setting.	[Krezanoski, Paul J.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; [Krezanoski, Paul J.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Pediat, San Francisco, CA 94143 USA; [Campbell, Jeffrey I.] Harvard Med Sch, Boston, MA USA; [Santorino, Data] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Bangsberg, David R.] Portland State Univ, Oregon Hlth Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Oregon Health & Science University; Portland State University	Krezanoski, PJ (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA.; Krezanoski, PJ (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Pediat, San Francisco, CA 94143 USA.	Paul.Krezanoski@ucsf.edu			American Academy of Pediatrics Resident Research Grant; Child Health Foundation Innovative Small Grants Program; Thrasher Research Foundation Early Career Award [11892]	American Academy of Pediatrics Resident Research Grant; Child Health Foundation Innovative Small Grants Program; Thrasher Research Foundation Early Career Award	Generous funding for this study was provided by an American Academy of Pediatrics Resident Research Grant (PJK), the Child Health Foundation Innovative Small Grants Program (PJK) and a Thrasher Research Foundation Early Career Award (PJK; #11892). The sponsors of this study had no role in the design, collection, analysis or interpretation of data, in the writing of the report, nor in the decision to submit the article for publication.	Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Becker-Dreps SI, 2009, AM J TROP MED HYG, V81, P496, DOI 10.4269/ajtmh.2009.81.496; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Cohee L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-76; Fernando SD, 2009, T ROY SOC TROP MED H, V103, P1204, DOI 10.1016/j.trstmh.2008.10.018; Frey C, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-70; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Haberer JE, 2012, AIDS BEHAV, V16, P375, DOI 10.1007/s10461-011-9933-y; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Koudou B, PARASITES VECTORS, V7; Krezanoski PJ, 2016, MALARIA RES TREATMEN; Kulkarni MA, 2010, AM J TROP MED HYG, V82, P420, DOI 10.4269/ajtmh.2010.09-0597; Kuphaldt T.R., LESSONS ELECT CIRCUI, VI; Leake D W Jr, 1994, Asia Pac J Public Health, V7, P92; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; WHO, 2013, WORLD MALARIA REPORT 2013, P1	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0168116	10.1371/journal.pone.0168116	http://dx.doi.org/10.1371/journal.pone.0168116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158233	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700002
J	Lv, XH; Qiao, WH; Leng, YF; Wu, LP; Zhou, YM				Lv, Xinghua; Qiao, Wenhui; Leng, Yufang; Wu, Lupeng; Zhou, Yanming			Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis	PLOS ONE			English	Article							LONG-TERM SURVIVAL; DUCTAL ADENOCARCINOMA; RISK-FACTORS; MORTALITY; SURGERY; ASSOCIATION; PREDICTION; FISTULA; OBESITY	Background and objective Diabetes mellitus (DM) is a risk factor for pancreatic cancer but its impact on postoperative outcomes and long-term survival after cancer resection remains controversial. A meta-analysis of published studies was conducted to address this issue. Methods An extensive electronic search of four databases was performed for relevant articles. Data were processed for meta-analysis using Review Manager version 5.1. Results Seventeen observational studies involving 5407 patients were subjected to the analysis. Overall morbidity or any type of complications and mortality were comparable between diabetic and non-diabetic subjects. Overall DM has a significant negative impact on survival (risk ratio [RR], 1.24, 95% confidence interval [CI], 1.05-1.45; P = 0.01). Stratification by the type of DM revealed that new-onset DM (< 2 years duration, RR, 1.54, 95% CI, 1.24-1.91; P<0.001) but not long-standing DM (>= 2 years duration, RR, 1.74, 95% CI, 0.86-3.52; P = 0.12) was associated with reduced survival. Conclusions fDiabetes mellitus does not affect perioperative outcomes in patients undergoing surgery for pancreatic cancer. However, new-onset DM confers a negative impact on survival of pancreatic cancer in patients undergoing surgical resection.	[Lv, Xinghua; Qiao, Wenhui; Leng, Yufang] Lanzhou Univ, Hosp 1, Dept Anaesthesiol, Lanzhou, Peoples R China; [Wu, Lupeng; Zhou, Yanming] Xiamen Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreatovasc Surg, Xiamen, Peoples R China	Lanzhou University; Xiamen University	Zhou, YM (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreatovasc Surg, Xiamen, Peoples R China.	zhouymsxy@sina.cn	Leng, Yufang/AAL-2786-2021					Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Barbas AS, 2012, J AM GERIATR SOC, V60, P344, DOI 10.1111/j.1532-5415.2011.03785.x; Batabyal P, 2014, ANN SURG ONCOL, V21, P2453, DOI 10.1245/s10434-014-3625-6; Ben QW, 2012, DIABETES-METAB RES, V28, P169, DOI 10.1002/dmrr.1284; Calle EE, 1998, CANCER CAUSE CONTROL, V9, P403, DOI 10.1023/A:1008819701485; Chu CK, 2010, J AM COLL SURGEONS, V210, P463, DOI 10.1016/j.jamcollsurg.2009.12.029; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; Dandona M, 2011, PANCREAS, V40, P931, DOI 10.1097/MPA.0b013e318215a9b1; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Duan CY, 2016, CLIN MED CHINA, V32, P160; Hart PA, 2014, AM J GASTROENTEROL, V109, P1484, DOI 10.1038/ajg.2014.193; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; He XY, 2013, ANN SURG ONCOL, V20, P3809, DOI 10.1245/s10434-013-3095-2; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kozak MM, 2016, PANCREAS, V45, P64, DOI 10.1097/MPA.0000000000000470; Lee W, 2016, J SURG ONCOL, V113, P203, DOI 10.1002/jso.24133; Little SA, 2002, J GASTROINTEST SURG, V6, P88, DOI 10.1016/S1091-255X(01)00019-1; Maisonneuve P, 2010, DIGEST DIS, V28, P645, DOI 10.1159/000320068; Malleo G, 2013, SURGERY, V153, P641, DOI 10.1016/j.surg.2012.10.015; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Neumayer L, 2007, J AM COLL SURGEONS, V204, P1178, DOI 10.1016/j.jamcollsurg.2007.03.022; Olson SH, 2010, INT J CANCER, V127, P2412, DOI 10.1002/ijc.25240; Pannala R, 2008, GASTROENTEROLOGY, V134, P981, DOI 10.1053/j.gastro.2008.01.039; Pessaux P, 2011, ANN SURG, V253, P879, DOI 10.1097/SLA.0b013e31821219af; Pratt WB, 2008, WORLD J SURG, V32, P419, DOI 10.1007/s00268-007-9388-5; Sahin IH, 2012, CANCER MED-US, V1, P357, DOI 10.1002/cam4.43; Sperti C, 1996, BRIT J SURG, V83, P625, DOI 10.1002/bjs.1800830512; Srivastava S, 2001, ANZ J SURG, V71, P511, DOI 10.1046/j.1440-1622.2001.02184.x; Talar-Wojnarowska R, 2003, NEOPLASMA, V50, P383; Tsai MS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001467; Wakasugi Hideyuki, 2001, International Journal of Clinical Oncology, V6, P50, DOI 10.1007/PL00012080; Walter U, 2014, ANN SURG ONCOL, V21, P1082, DOI 10.1245/s10434-013-3415-6; [许崇祥 Xu Chongxiang], 2015, [中华肝胆外科杂志, Chinese Journal of Hepatobiliary Surgery], V21, P761; [郑四鸣 Zheng Siming], 2013, [中华普通外科杂志, Chinese Journal of General Surgery], V28, P649; Zhu XG, 2016, ANTITUMOR PHARM, V6, P217	35	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171370	10.1371/journal.pone.0171370	http://dx.doi.org/10.1371/journal.pone.0171370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158300	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700069
J	Min, LJ; Kobayashi, Y; Mogi, M; Tsukuda, K; Yamada, A; Yamauchi, K; Abe, F; Iwanami, J; Xiao, JZ; Horiuchi, M				Min, Li-Juan; Kobayashi, Yodai; Mogi, Masaki; Tsukuda, Kana; Yamada, Akio; Yamauchi, Koji; Abe, Fumiaki; Iwanami, Jun; Xiao, Jin-Zhong; Horiuchi, Masatsugu			Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; ANIMAL-MODEL; DEMENTIA; IMPAIRMENT; INFLAMMATION; PERINDOPRIL; HYPERTENSION; ASSOCIATION	There is a growing interest in identifying natural food ingredients that may serve to prevent dementia such as that due to Alzheimer disease (AD). Peptides derived from food proteins have been demonstrated to have various physiological activities such as a hypotensive action. Recent findings have indicated possible associations of hypertension with AD progression, and suggest that angiotensin converting enzyme (ACE) inhibitors with potential to pass through the blood brain barrier (BBB) may reduce the risk of AD. In this study, we investigated the effect of milk peptide (CH-3) on cognitive function in AD model mice. CH-3 contains a tripeptide (methionine-lysine-proline, MKP) that has been found to have a strong ACE inhibitory effect and the potential to pass through the BBB. Adult male ddY mice were used in this study, and an animal model of AD was induced by intracerebroventricular (ICV) injection of A beta 1-42. CH-3 (250 mg/kg/day) or MKP (0.5 mg/kg/day) was orally administered every day starting 2 days before ICV injection. At 3 weeks after ICV injection, cognitive function was evaluated by the Morris water maze test. Brain samples were obtained after behavioral testing, and expression of inflammatory cytokines and NADPH oxidase subunits was measured by real-time quantitative RT-PCR. ICV injection of A beta 1-42 significantly impaired cognitive function compared with that in PBS-injected mice. Daily administration of CH-3 markedly attenuated this A beta 1-42-induced cognitive decline. A beta 1-42 injection significantly enhanced the expression of tumor necrosis factor-alpha (TNF-alpha), inducible nitric oxide synthase (iNOS) and p22(phox) in the mouse hippocampus compared with PBS injection, and showed a tendency to increase the expression of monocyte chemoattractant protein-1 (MCP-1), p47(phox) and gp91(phox), whereas CH-3 treatment markedly reduced A beta 1-42-induced TNF-alpha, MCP-1, iNOS, p47(phox) and gp91(phox) expression. Finally, administration of MKP also attenuated A beta 1-42-induced cognitive impairment with an increase in cerebral blood flow. The present study demonstrated that repeated oral administration of CH-3 to AD model mice not only improved cognitive function but also suppressed the expression of inflammatory cytokines and production of oxidative stress, and suggests its therapeutic potential for preventing cognitive impairment in AD.	[Min, Li-Juan; Mogi, Masaki; Tsukuda, Kana; Iwanami, Jun; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Kobayashi, Yodai; Yamada, Akio; Yamauchi, Koji; Abe, Fumiaki; Xiao, Jin-Zhong] Morinaga Milk Ind Co Ltd, Zama, Kanagawa, Japan	Ehime University; Morinaga Milk Industry Company, Ltd	Mogi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	mmogi@m.ehime-u.ac.jp	Mogi, Masaki/ABH-2011-2020	Mogi, Masaki/0000-0002-0275-9198	Morinaga Milk Industry Co., Ltd.; JSPS [25293310, 25462220, 15K19974, 26860567]	Morinaga Milk Industry Co., Ltd.; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors received no specific funding for this work. Morinaga Milk Industry Co., Ltd., provided support in the form of salaries for authors Y.K., A.Y., K.Y., F.A. and J.X., but did not have any role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'author contributions' section. Moreover, this study was supported by JSPS KAKENHI [Grant Number 25293310 to M.H., 25462220 to M.M., 15K19974 to J.I., and 26860567 to L.-J.M.] and research grants from Morinaga Milk Industry Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BARNES JM, 1989, BRAIN RES, V491, P136, DOI 10.1016/0006-8993(89)90095-4; BARNES JM, 1990, BRAIN RES, V507, P341, DOI 10.1016/0006-8993(90)90294-L; Chalmers J, 2003, J HYPERTENS, V21, pS9, DOI 10.1097/00004872-200306005-00003; Ciobica A, 2009, ACTA NEUROL BELG, V109, P171; Dong YF, 2011, FASEB J, V25, P2911, DOI 10.1096/fj.11-182873; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Kawasaki T, 2000, J HUM HYPERTENS, V14, P519, DOI 10.1038/sj.jhh.1001065; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Miners S, 2009, AM J TRANSL RES, V1, P163; Mogi M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/169649; Murray BA, 2007, CURR PHARM DESIGN, V13, P773, DOI 10.2174/138161207780363068; Nagai M, 2010, AM J HYPERTENS, V23, P116, DOI 10.1038/ajh.2009.212; NGUYEN DCA, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI DOI 10.1089/ARS.2012.4641; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Ohrui T, 2004, J AM GERIATR SOC, V52, P649, DOI 10.1111/j.1532-5415.2004.52178_7.x; Ongali B, 2014, NEUROBIOL DIS, V68, P126, DOI 10.1016/j.nbd.2014.04.018; Paganelli R, 2002, EXP GERONTOL, V37, P257, DOI 10.1016/S0531-5565(01)00191-7; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; Tsukuda K, 2008, HYPERTENSION, V51, P528, DOI 10.1161/HYPERTENSIONAHA.107.101634; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Watabe T, 2013, J NUCL MED, V54, P283, DOI 10.2967/jnumed.112.109751; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yamada A, 2013, FOOD CHEM, V141, P3781, DOI 10.1016/j.foodchem.2013.06.089; Yamada K, 2010, BRAIN RES, V1352, P176, DOI 10.1016/j.brainres.2010.07.006	38	36	38	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171515	10.1371/journal.pone.0171515	http://dx.doi.org/10.1371/journal.pone.0171515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158298	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700090
J	Prati, G; De Angelis, M; Puchades, VM; Fraboni, F; Pietrantoni, L				Prati, Gabriele; De Angelis, Marco; Puchades, Victor Marin; Fraboni, Federico; Pietrantoni, Luca			Characteristics of cyclist crashes in Italy using latent class analysis and association rule mining	PLOS ONE			English	Article							VEHICLE-BICYCLE INTERACTIONS; ROAD USER CRASHES; INJURY SEVERITY; STATISTICAL-ANALYSIS; SAFETY; RISK; ACCIDENTS; TRAVEL; DETERMINANTS; INVOLVEMENT	The factors associated with severity of the bicycle crashes may differ across different bicycle crash patterns. Therefore, it is important to identify distinct bicycle crash patterns with homogeneous attributes. The current study aimed at identifying subgroups of bicycle crashes in Italy and analyzing separately the different bicycle crash types. The present study focused on bicycle crashes that occurred in Italy during the period between 2011 and 2013. We analyzed categorical indicators corresponding to the characteristics of infrastructure (road type, road signage, and location type), road user (i.e., opponent vehicle and cyclist's maneuver, type of collision, age and gender of the cyclist), vehicle (type of opponent vehicle), and the environmental and time period variables (time of the day, day of the week, season, pavement condition, and weather). To identify homogenous subgroups of bicycle crashes, we used latent class analysis. Using latent class analysis, the bicycle crash data set was segmented into 19 classes, which represents 19 different bicycle crash types. Logistic regression analysis was used to identify the association between class membership and severity of the bicycle crashes. Finally, association rules were conducted for each of the latent classes to uncover the factors associated with an increased likelihood of severity. Association rules highlighted different crash characteristics associated with an increased likelihood of severity for each of the 19 bicycle crash types.	[Prati, Gabriele; De Angelis, Marco; Puchades, Victor Marin; Fraboni, Federico; Pietrantoni, Luca] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna	Prati, G (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	gabriele.prati@unibo.it	PIETRANTONI, LUCA/AAX-2518-2020; De Angelis, Marco/V-8434-2019; Fraboni, Federico/K-8171-2019; Prati, Gabriele/K-8426-2014	PIETRANTONI, LUCA/0000-0002-3966-3800; De Angelis, Marco/0000-0001-9351-5940; Fraboni, Federico/0000-0002-4777-1617; Prati, Gabriele/0000-0002-0749-183X; Marin Puchades, Victor/0000-0001-8983-4519	European Commission of the European Union [635975]	European Commission of the European Union	This work was supported by the European Commission under the Horizon 2020 Framework Programme of the European Union (2014-2020). Project XCYCLE contract number: 635975.	Ackery AD, 2012, INJURY PREV, V18, P22, DOI 10.1136/injuryprev-2011-040066; Amoros Emmanuelle, 2011, BMC Public Health, V11, P653, DOI 10.1186/1471-2458-11-653; Amsden M, 2006, BICYCLE CRASH ANAL W; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; ASHBAUGH SJ, 1995, CLIN PEDIATR, V34, P256, DOI 10.1177/000992289503400505; Bil M, 2010, ACCIDENT ANAL PREV, V42, P1632, DOI 10.1016/j.aap.2010.04.001; Boufous S, 2012, ACCIDENT ANAL PREV, V49, P404, DOI 10.1016/j.aap.2012.03.011; Brand S, 2013, TRAFFIC INJ PREV, V14, P56, DOI 10.1080/15389588.2012.688152; Charlton SG, 2006, ACCIDENT ANAL PREV, V38, P496, DOI 10.1016/j.aap.2005.11.007; Chen L, 2012, AM J PUBLIC HEALTH, V102, P1120, DOI 10.2105/AJPH.2011.300319; de Geus B, 2012, ACCIDENT ANAL PREV, V45, P683, DOI 10.1016/j.aap.2011.09.045; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; de Ona J, 2013, ACCIDENT ANAL PREV, V51, P1, DOI 10.1016/j.aap.2012.10.016; Depaire B, 2008, ACCIDENT ANAL PREV, V40, P1257, DOI 10.1016/j.aap.2008.01.007; Dumbaugh E, 2011, J AM PLANN ASSOC, V77, P69, DOI 10.1080/01944363.2011.536101; EilertPetersson E, 1997, ACCIDENT ANAL PREV, V29, P363, DOI 10.1016/S0001-4575(97)00002-X; Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1016/S0033-3506(01)00411-5; Eluru N, 2008, ACCIDENT ANAL PREV, V40, P1033, DOI 10.1016/j.aap.2007.11.010; Eluru N, 2012, ACCIDENT ANAL PREV, V47, P119, DOI 10.1016/j.aap.2012.01.027; European Commission, 2014, QUAL TRANSP SPEC EUR; Fyhri A, 2012, TRANSPORT RES F-TRAF, V15, P612, DOI 10.1016/j.trf.2012.06.003; Garder P., 1994, TRANSPORT RES REC, V1438, P34; Gerberich S G, 1994, Minn Med, V77, P27; Geurts K, 2005, ACCIDENT ANAL PREV, V37, P787, DOI 10.1016/j.aap.2005.03.023; Gotschi T, 2016, TRANSPORT REV, V36, P45, DOI 10.1080/01441647.2015.1057877; Habibovic A, 2012, ACCIDENT ANAL PREV, V49, P493, DOI 10.1016/j.aap.2012.03.022; Habibovic A, 2011, ACCIDENT ANAL PREV, V43, P1570, DOI 10.1016/j.aap.2011.03.019; Haileyesus T, 2007, INJURY PREV, V13, P202, DOI 10.1136/ip.2006.014019; Hamann CJ, 2015, J TRANSP HEALTH, V2, P178, DOI 10.1016/j.jth.2014.08.006; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Hess G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136973; Hoffman MR, 2010, J TRAUMA, V69, P1112, DOI 10.1097/TA.0b013e3181f990a1; Hunter W. W., 1995, TRANSPORT RES REC, V1502, P65; Kaplan S, 2015, TRAFFIC INJ PREV, V16, P724, DOI 10.1080/15389588.2014.1003818; Kaplan S, 2013, TRAFFIC INJ PREV, V14, P725, DOI 10.1080/15389588.2012.759654; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Kim JK, 2007, ACCIDENT ANAL PREV, V39, P238, DOI 10.1016/j.aap.2006.07.002; Klassen J, 2014, SAFETY SCI, V62, P295, DOI 10.1016/j.ssci.2013.09.007; Klop J. R, 1999, TRANSPORT RES REC, V1674, P78; Konstantopoulos P, 2010, ACCIDENT ANAL PREV, V42, P827, DOI 10.1016/j.aap.2009.09.022; Koustanai A, 2008, ACCIDENT ANAL PREV, V40, P461, DOI 10.1016/j.aap.2007.08.001; Kumagai S, 2015, J ENERGY STORAGE, V2, P1, DOI 10.1016/j.est.2015.05.005; Kwan I, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003438.pub2; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Liu X, 1995, TRANSPORT RES REC, V1487, P75; Macmillan A, 2014, ENVIRON HEALTH PERSP, V122, P335, DOI 10.1289/ehp.1307250; Macpherson AK, 2004, ACCIDENT ANAL PREV, V36, P649, DOI 10.1016/S0001-4575(03)00086-1; Martensen H, 2016, TRANSP RES PROC, V14, P96, DOI 10.1016/j.trpro.2016.05.045; McCarthy M., 1996, ACCID ANAL PREV V, V28, P275, DOI DOI 10.1016/0001-4575(95)00061-5; Meng M, 2016, INT J SUSTAIN TRANSP, V10, P773, DOI 10.1080/15568318.2016.1149646; Minikel E, 2012, ACCIDENT ANAL PREV, V45, P241, DOI 10.1016/j.aap.2011.07.009; Miranda-Moreno L, 2011, US TRANSP RES BOARD; Moore DN, 2011, ACCIDENT ANAL PREV, V43, P621, DOI 10.1016/j.aap.2010.09.015; Nathanail E, 2013, TRANSPORT RES F-TRAF, V18, P107, DOI 10.1016/j.trf.2012.12.003; Nicaj L, 2009, TRAFFIC INJ PREV, V10, P157, DOI 10.1080/15389580802641761; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; R Core Team, 2021, R LANGUAGE ENV STAT; Rasanen M, 1998, ACCIDENT ANAL PREV, V30, P657, DOI 10.1016/S0001-4575(98)00007-4; Rissel C., 2002, AUST J PRIM HEALTH, V8, P66, DOI [DOI 10.1071/PY02029, 10.1071/PY02029]; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Rodgers GB, 1997, J SAFETY RES, V28, P233, DOI 10.1016/S0022-4375(97)00009-1; Rojas-Rueda D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149990; Romanow NTR, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/487681; Rose G, 2011, TRANSP RES BOARD ANN; Sayed T, 2013, SAFETY SCI, V59, P163, DOI 10.1016/j.ssci.2013.05.009; Schepers P, 2014, ACCIDENT ANAL PREV, V62, P331, DOI 10.1016/j.aap.2013.03.032; Schepers P, 2012, INJURY PREV, V18, P240, DOI 10.1136/injuryprev-2011-040097; Shaheed MS, 2014, ANAL METHODS ACCID R, V2, P30, DOI 10.1016/j.amar.2014.03.002; Silvano AP, 2016, ACCIDENT ANAL PREV, V97, P38, DOI 10.1016/j.aap.2016.08.016; Stimpson J. P., 2013, PUBLIC HLTH REPORT, V128, P436; STONE M, 1999, ACCIDENT ANAL PREV, V35, P549, DOI DOI 10.1016/S0001-4575(02)00032-5; Summala H, 1996, ACCIDENT ANAL PREV, V28, P147, DOI 10.1016/0001-4575(95)00041-0; Taddei C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125491; Thomas B, 2013, ACCIDENT ANAL PREV, V52, P219, DOI 10.1016/j.aap.2012.12.017; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655; Twisk DAM, 2007, J SAFETY RES, V38, P245, DOI 10.1016/j.jsr.2007.03.006; Twisk DAM, 2014, ACCIDENT ANAL PREV, V66, P55, DOI 10.1016/j.aap.2014.01.002; van den Dool D, 2014, J AUSTRALAS COLL ROA, V25, P58; Van der Meel EM., 2013, RED LIGHT RUNNING CY; Vandenbulcke G, 2014, ACCIDENT ANAL PREV, V62, P341, DOI 10.1016/j.aap.2013.07.001; Vandenbulcke G, 2009, TRANSPORT POLICY, V16, P77, DOI 10.1016/j.tranpol.2009.03.004; Vansteenkiste P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102792; Wang C, 2015, TRAFFIC INJ PREV, V16, P507, DOI 10.1080/15389588.2014.969802; Wang YH, 2004, ACCIDENT ANAL PREV, V36, P313, DOI 10.1016/S0001-4575(03)00009-5; Wegman F, 2012, ACCIDENT ANAL PREV, V44, P19, DOI 10.1016/j.aap.2010.11.010; Wei F, 2013, ACCIDENT ANAL PREV, V61, P129, DOI 10.1016/j.aap.2012.05.018; Wessels R, 1996, TRANSPORT RES REC, V1538, P81, DOI DOI 10.1177/0361198196153800111; Wojan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130903; Xia T, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/797312; Yan XP, 2011, ACCIDENT ANAL PREV, V43, P1751, DOI 10.1016/j.aap.2011.04.006; Yang Y, 2013, TRANSPORT RES REC, P117, DOI 10.3141/2393-13	93	24	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171484	10.1371/journal.pone.0171484	http://dx.doi.org/10.1371/journal.pone.0171484			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158296	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700084
J	Sun, TH; Li, CT; Xiong, LF; Ning, ZY; Leung, F; Peng, SL; Lu, WW				Sun, Tianhao; Li, Chen-Tian; Xiong, Lifeng; Ning, Ziyu; Leung, Frankie; Peng, Songlin; Lu, William W.			miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and beta-catenin	PLOS ONE			English	Article							BONE-FORMATION; DIFFERENTIATION; PROLIFERATION; OSTEOPOROSIS; APOPTOSIS; CELLS; MASS	Wnt signaling pathways are essential for bone formation. Previous studies showed that Wnt signaling pathways were regulated by miR-375. Thus, we aim to explore whether miR-375 could affect osteogenesis. In the present study, we investigated the roles of miR-375 and its downstream targets. Firstly, we revealed that miR-375-3p negatively modulated osteogenesis by suppressing positive regulators of osteogenesis and promoting negative regulators of osteogenesis. In addition, the results of TUNEL cell apoptosis assay showed that miR-3753p induced MC3T3-E1 cell apoptosis. Secondly, miR-375-3p targeted low -density lipoprotein receptor -related protein 5 (LRP5), a co -receptor of the Wnt signaling pathways, and 13catenin as determined by luciferase activity assay, and it decreased the expression levels of LRP5 and p-catenin. Thirdly, the decline of protein levels of p-catenin was determined by immunocytochemistry and immunofluorescence. Finally, silence of LRP5 in osteoblast precursor cells resulted in diminished cell viability and cell proliferation as detected by WST-1based colorimetric assay. Additionally, all the parameters including the relative bone volume from pCT measurement suggested that LRP5 knockout in mice resulted in a looser and worse -connected trabeculae. The mRNA levels of important negative modulators relating to osteogenesis increased after the functions of LRP5 were blocked in mice. Last but not least, the expression levels of LRP5 increased during the osteogenesis of MC3T3-E1, while the levels of P-catenin decreased in bone tissues from osteoporotic patients with vertebral compression fractures. In conclusion, we revealed miR-375-3p negatively regulated osteogenesis by targeting LRP5 and p-catenin. In addition, loss of functions of LRP5 damaged bone formation in vivo. Clinically, miR-375-3p and its targets might be used as diagnostic biomarkers for osteoporosis and might be also as novel therapeutic agents in osteoporosis treatment. The relevant products of miR-375-3p might be developed into molecular drugs in the future. These molecules could be used in translational medicine.	[Sun, Tianhao; Li, Chen-Tian; Leung, Frankie; Lu, William W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Sun, Tianhao; Peng, Songlin] Jinan Univ, Coll Med 2, Shenzhen Peoples Hosp, Dept Spine Surg, Shenzhen, Peoples R China; [Xiong, Lifeng] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ning, Ziyu] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Jinan University; University of Hong Kong; University of Hong Kong	Leung, F; Lu, WW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China.; Peng, SL (corresponding author), Jinan Univ, Coll Med 2, Shenzhen Peoples Hosp, Dept Spine Surg, Shenzhen, Peoples R China.	klleunga@hku.hk; songlin824@gmail.com; wwlu@hku.hk	Li, Chentian/GZN-1242-2022; Li, Chentian/GZN-1189-2022	Li, Chentian/0000-0002-9362-5952; Li, Chentian/0000-0002-9362-5952; Peng, Songlin/0000-0002-4042-7071	National Natural Science Foundation of China [NSFC81371989, NSFC81270967]; Guangdong Science and Technology Department Project [2015A030313776, 2016A050503008]; Shenzhen Municipal Science and Technology Innovation Committee Project [CXZZ20151015151249563, CXZZ20150401152251209, JCYJ20140416122812013]; General Research Fund of Research Grant Council of Hong Kong [RGC 715213, RGC 17205714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department Project; Shenzhen Municipal Science and Technology Innovation Committee Project; General Research Fund of Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by grants from the National Natural Science Foundation of China (NSFC81371989 and NSFC81270967), Guangdong Science and Technology Department Project (2015A030313776, 2016A050503008), Shenzhen Municipal Science and Technology Innovation Committee Project (CXZZ20151015151249563, CXZZ20150401152251209 and JCYJ20140416122812013), and General Research Fund of Research Grant Council of Hong Kong (RGC 715213 and RGC 17205714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgers TA, 2013, BONE, V54, P244, DOI 10.1016/j.bone.2013.02.022; Cantafio MEG, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.59; Chen Jia-Shing, 2014, BMC Res Notes, V7, P15, DOI 10.1186/1756-0500-7-15; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Delgado-Calle J, 2016, BONE; Guo Y, 2016, ONCOL REP, V36, P952, DOI 10.3892/or.2016.4852; Jacobsen CM, 2016, BONE, V90, P127, DOI 10.1016/j.bone.2016.06.005; Javaheri B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035726; Jin HT, 2015, BONE, V71, P63, DOI 10.1016/j.bone.2014.07.039; Joiner DM, 2013, TRENDS ENDOCRIN MET, V24, P31, DOI 10.1016/j.tem.2012.10.003; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Lian L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101633; Maupin KA, 2013, BONE RES, V1, DOI 10.4248/BR201301004; Miao CG, 2015, IMMUNOL LETT, V164, P1, DOI 10.1016/j.imlet.2015.01.003; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Riddle RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063323; Rivadeneira F, 2016, TRENDS ENDOCRIN MET, V27, P262, DOI 10.1016/j.tem.2016.03.006; Selth LA, 2016, ONCOGENE; Sun TH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020236; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Xu L., 2016, ONCOTARGET; Xu LL, 2016, ONCOTARGET, V7, P40644, DOI 10.18632/oncotarget.9811; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yano M, 2012, ENDOCR J, V59, P653, DOI 10.1507/endocrj.EJ12-0022; Yu X, 2016, INT J GYNECOL CANCER, V26, P851, DOI 10.1097/IGC.0000000000000711; Zhong ZDA, 2015, DEV DYNAM, V244, P1347, DOI 10.1002/dvdy.24316; Zhong ZDA, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.13	30	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171281	10.1371/journal.pone.0171281	http://dx.doi.org/10.1371/journal.pone.0171281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158288	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700052
J	Agwu, AL; Fleishman, JA; Mahiane, G; Nonyane, BAS; Althoff, KN; Yehia, BR; Berry, SA; Rutstein, R; Nijhawan, A; Mathews, C; Aberg, JA; Keruly, JC; Moore, RD; Gebo, KA				Agwu, Allison L.; Fleishman, John A.; Mahiane, Guy; Nonyane, Bareng Aletta Sanny; Althoff, Keri N.; Yehia, Baligh R.; Berry, Stephen A.; Rutstein, Richard; Nijhawan, Ank; Mathews, Christopher; Aberg, Judith A.; Keruly, Jeanne C.; Moore, Richard D.; Gebo, Kelly A.		HIV Res Network	Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; YOUNG-ADULTS; CELL COUNT; FOLLOW-UP; VIROLOGICAL SUPPRESSION; IMMUNOLOGICAL OUTCOMES; IMMUNE RECONSTITUTION; INITIATING HAART; UNITED-STATES	Background Youth have residual thymic tissue and potentially greater capacity for immune reconstitution than adults after initiation of combination antiretroviral therapy (cART). However, youth face behavioral and psychosocial challenges that may make them more likely than adults to delay ART initiation and less likely to attain similar CD4 outcomes after initiating cART. This study compared CD4 outcomes over time following cART initiation between ART-naive non-perinatally HIV-infected (nPHIV) youth (13-24 years-old) and adults (>= 25-44 years-old). Methods Retrospective analysis of ART-naive nPHIV individuals 13-44 years-old, who initiated their first cART between 2008 and 2011 at clinical sites in the HIV Research Network. A linear mixed model was used to assess the association between CD4 levels after cART initiation and age (13-24, 25-34, 35-44 years), accounting for random variation within participants and between sites, and adjusting for key variables including gender, race/ethnicity, viral load, gaps in care (defined as >365 days between CD4 tests), and CD4 levels prior to cART initiation (baseline CD4). Results Among 2,595 individuals (435 youth; 2,160 adults), the median follow-up after cART initiation was 179 weeks (IQR 92-249). Baseline CD4 was higher for youth (320 cells/mm(3)) than for ages 25-34 (293) or 35-44 (258). At 239 weeks after cART initiation, median unadjusted CD4 was higher for youth than adults (576 vs. 539 and 476 cells/mm(3), respectively), but this difference was not significant when baseline CD4 was controlled. Compared to those with baseline CD4 <= 200 cells/mm(3), individuals with baseline CD4 of 201-500 and >500 cells/mm(3) had greater predicted CD4 levels: 390, 607, and 831, respectively. Additionally, having no gaps in care and higher viral load were associated with better CD4 outcomes. Conclusions Despite having residual thymic tissue, youth attain similar, not superior, CD4 gains as adults. Early ART initiation with minimal delay is as essential to optimizing outcomes for youth as it is for their adult counterparts.	[Agwu, Allison L.] Johns Hopkins Sch Med, Dept Pediat, Div Pediat Infect Dis, Baltimore, MD 21205 USA; [Agwu, Allison L.; Berry, Stephen A.; Keruly, Jeanne C.; Gebo, Kelly A.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA; [Fleishman, John A.] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA; [Mahiane, Guy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Nonyane, Bareng Aletta Sanny] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Althoff, Keri N.] Johns Hopkins Med Inst, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Yehia, Baligh R.] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Rutstein, Richard] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Nijhawan, Ank] UT Southwestern Med Ctr, Dept Internal Med, Parkland Hlth & Hosp Syst, Dallas, TX USA; [Mathews, Christopher] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Aberg, Judith A.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Moore, Richard D.] Johns Hopkins Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Agency for Healthcare Research & Quality; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine	Agwu, AL (corresponding author), Johns Hopkins Sch Med, Dept Pediat, Div Pediat Infect Dis, Baltimore, MD 21205 USA.	ageorg10@jhmi.edu	Gebo, Kelly/AHA-7533-2022; Nonyane, Bareng A.S./AAC-8118-2020; Althoff, Keri N/HGC-5595-2022	Gebo, Kelly/0000-0003-4010-398X; Nonyane, Bareng A.S./0000-0001-5633-7487; Althoff, Keri/0000-0002-5068-6595; Korthuis, Philip/0000-0001-5556-3597	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI112477] Funding Source: NIH RePORTER; NIAID NIH HHS [K23 AI112477] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agwu AL, 2014, JAMA PEDIATR, V168, P381, DOI 10.1001/jamapediatrics.2013.4531; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Agwu AL, 2011, JAIDS-J ACQ IMM DEF, V58, P100, DOI 10.1097/QAI.0b013e31822327df; Althoff KN, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-45; Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], GUID US ANT AG HIV 1; [Anonymous], 2008, AIDS, V22, P1463, DOI [10.1097/QAD.0b013e3282f88d02, DOI 10.1097/QAD.0B013E3282F88D02]; Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Blum RW, 2002, J ADOLESCENT HEALTH, V31, P28, DOI 10.1016/S1054-139X(02)00411-1; Centers for Disease CNCfHA Viral Hepatitis STD and TB Prevention, 2012, MOR HALF YOUNG HIV I; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; Farmer C, 2016, J PEDIAT INF DIS SOC, V5, P39, DOI 10.1093/jpids/piu102; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Flynn PM, 2004, J INFECT DIS, V190, P271, DOI 10.1086/421521; Gagliardo C, 2014, CLIN INFECT DIS, V58, P865, DOI 10.1093/cid/ciu003; Gebo Kelly A, 2003, Hopkins HIV Rep, V15, P5; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luz PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093039; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Moore RD, 2012, CLIN INFECT DIS, V55, P1242, DOI 10.1093/cid/cis654; Mpondo BC, 2016, J SEXUALLY TRANSMITT, V2016; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Naar-King S, 2010, AIDS CARE, V22, P475, DOI 10.1080/09540120903220279; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Rudy BJ, 2006, AIDS RES HUM RETROV, V22, P213, DOI 10.1089/aid.2006.22.213; Rudy BJ, 2015, JAIDS-J ACQ IMM DEF, V69, P52, DOI 10.1097/QAI.0000000000000549; Rudy BJ, 2009, AIDS PATIENT CARE ST, V23, P185, DOI 10.1089/apc.2008.0162; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Sabin CA, 2008, AIDS, V22, P1463; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Siberry GK, 2011, JAIDS-J ACQ IMM DEF, V57, P223, DOI 10.1097/QAI.0b013e318218e068; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; World Health Organization, 2015, GUID START ANT THER	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171125	10.1371/journal.pone.0171125	http://dx.doi.org/10.1371/journal.pone.0171125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182675	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800035
J	Clouse, K; Blevins, M; Lindegren, ML; Yotebieng, M; Nguyen, DT; Omondi, A; Michael, D; Zannou, DM; Carriquiry, G; Pettit, A				Clouse, Kate; Blevins, Meridith; Lindegren, Mary Lou; Yotebieng, Marcel; Dung Thi Nguyen; Omondi, Alfred; Michael, Denna; Zannou, Djimon Marcel; Carriquiry, Gabriela; Pettit, April		IeDEA Collaboration	Low implementation of Xpert MTB/RIF among HIV/TBco-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program	PLOS ONE			English	Article							OF-CARE DIAGNOSIS; TUBERCULOSIS; TB; BURDEN; FEASIBILITY; MULTICENTER; ACCURACY; IMPACT	Objective Xpert MTB/RIF is recommended by the World Health Organization (WHO) as the initial tuberculosis (TB) diagnostic test in individuals suspected of HIV-associated TB. We sought to evaluate field implementation of Xpert among a cohort of HIV/TBco-infected individuals, including availability, utilization and outcomes. Design Observational cohort study (patient-level data) and cross-sectional study (site-level Xpert availability data). Methods Data were collected at 30 participating International epidemiologic Databases to Evaluate AIDS (IeDEA) sites in 18 countries from January 2012-January 2016. All patients were HIVinfected and diagnosed with TB, either bacteriologically or clinically, and followed until a determination of TB treatment outcome. We used multivariable modified Poisson regression to estimate adjusted relative risk (RR) and 95% confidence intervals for unfavorable TB treatment outcomes. Results Most sites (63%) had access to Xpert, either in the clinic (13%), in the same facility (20%) or offsite (30%). Among 2722 HIV/TB patients included, median age was 35.4 years and 41% were female; BMI and CD4 count were low. Overall, most patients (76%) received at least one TB test; 45% were positive. Only 4% of all patients were tested using Xpert: 64% were Xpert-positive, 13% showed rifampicin (RIF) resistance and 30% were extrapulmonary (EPTB) or both pulmonary-EPTB. Treatment outcomes were mostly favorable (77%) and we found little association between Xpert use and an unfavorable TB treatment outcome (RR 1.25, 95% CI: 0.83, 1.90). Conclusions In this cohort, Xpert utilization was low even though the majority of sites had access to the test. Our findings show the need for expanded implementation and further research exploring barriers to use in low-resource settings.	[Clouse, Kate; Blevins, Meridith; Lindegren, Mary Lou] Vanderbilt Inst Global Hlth, Nashville, TN USA; [Clouse, Kate; Lindegren, Mary Lou; Pettit, April] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Clouse, Kate; Pettit, April] Vanderbilt TB Ctr, Nashville, TN 37232 USA; [Blevins, Meridith] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Yotebieng, Marcel] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Dung Thi Nguyen] Natl Hosp Trop Dis, Hanoi, Vietnam; [Omondi, Alfred] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Michael, Denna] NIMR, Mwanza, Tanzania; [Zannou, Djimon Marcel] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Carriquiry, Gabriela] Inst Med Trop Alexander Von Humboldt, Lima, Peru	Vanderbilt University; Vanderbilt University; Vanderbilt University; University System of Ohio; Ohio State University; National Hospital of Tropical Diseases; National Institute of Medical Research; University of Abomey Calavi; Universidad Peruana Cayetano Heredia	Pettit, A (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.; Pettit, A (corresponding author), Vanderbilt TB Ctr, Nashville, TN 37232 USA.	april.pettit@vanderbilt.edu	Mkwashapi, Denna/ABE-8894-2021; Yotebieng, Marcel/L-2083-2013	Yotebieng, Marcel/0000-0003-2110-2631; Clouse, Kate/0000-0002-0190-7398; Mkwashapi, Denna/0000-0001-6883-1431	National Institutes of Health; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse [K08 AI104352, K01 MH107256, UL1 TR000445, U01 AI096299, U01 AI069919, U01 AI069911, U01 AI069907, U01 AI069923, U01 AI096186]; United States Agency for International Development (USAID) under the terms of Cooperative [AID-623-A-12-0001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI096299, U01AI069907, K08AI104352, U01AI069911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH107256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); United States Agency for International Development (USAID) under the terms of Cooperative(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the the National Institutes of Health, the U.S. National Institutes of Healths National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Cancer Institute, the National Institute of Mental Health, and the National Institute on Drug Abuse under award numbers: K08 AI104352 (April Pettit, PI), K01 MH107256 (Clouse), UL1 TR000445 (Vanderbilt Clinical and Translational Science Award), U01 AI096299 (Central Africa IeDEA), U01 AI069919 (Western Africa IeDEA), U01 AI069911 (Eastern Africa IeDEA), U01 AI069907 (IeDEA Asia-Pacific), U01 AI069923 (CCASAnet IeDEA), and U01 AI096186 (IeDEA Network Coordinating Center). It has also been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement number AID-623-A-12-0001. The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the NIH, PEPFAR, or USAID.	Ardizzoni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144656; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cepheid, 2009, CGXMTBRF10 CEPH; Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Hanrahan CF, 2015, INT J TUBERC LUNG D, V19, P811, DOI 10.5588/ijtld.15.0013; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Mbonze NB, 2016, INT J TUBERC LUNG D, V20, P240, DOI 10.5588/ijtld.15.0177; Nakiyingi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074023; Ormerod LP, 2005, BRIT MED BULL, V73-74, P17, DOI 10.1093/bmb/ldh047; Qin ZZ, 2015, EUR RESPIR J, V45, P549, DOI 10.1183/09031936.00147714; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; United Nation, 2001, ROAD MAP IMPL UN MIL; Van Gemert W, 2015, 2010 2015 UPTAKE IMP; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, THE END TB STRAT; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2010, ROADM ROLL XPERT MTB; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171384	10.1371/journal.pone.0171384	http://dx.doi.org/10.1371/journal.pone.0171384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182705	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800058
J	Liu, DT; Liu, JY; Wen, ZY; Li, Y; Sun, ZH; Xu, Q; Fan, ZM				Liu, Dongting; Liu, Jiayi; Wen, Zhaoying; Li, Yu; Sun, Zhonghua; Xu, Qin; Fan, Zhanming			320-row CT renal perfusion imaging in patients with aortic dissection: A preliminary study	PLOS ONE			English	Article							DYNAMIC COMPUTED-TOMOGRAPHY; GLOMERULAR-FILTRATION-RATE; A DISSECTION; HEPATOCELLULAR-CARCINOMA; FUNCTIONAL ASSESSMENT; DOSE ESTIMATION; SINGLE-SESSION; TUMORS; HEMODYNAMICS; MALPERFUSION	Objective To investigate the clinical value of renal perfusion imaging in patients with aortic dissection (AD) using 320-row computed tomography (CT), and to determine the relationship between renal CT perfusion imaging and various factors of aortic dissection. Methods Forty-three patients with AD who underwent 320-row CT renal perfusion before operation were prospectively enrolled in this study. Diagnosis of AD was confirmed by transthoracic echocardiography. Blood flow (BF) of bilateral renal perfusion was measured and analyzed. CT perfusion imaging signs of AD in relation to the type of AD, number of entry tears and the false lumen thrombus were observed and compared. Results The BF values of patients with type A AD were significantly lower than those of patients with type B AD (P = 0.004). No significant difference was found in the BF between different numbers of intimal tears (P = 0.288), but BF values were significantly higher in cases with a false lumen without thrombus and renal arteries arising from the true lumen than in those with thrombus (P = 0.036). The BF values measured between the true lumen, false lumen and overriding groups were different (P = 0.02), with the true lumen group having the highest. Also, the difference in BF values between true lumen and false lumen groups was statistically significant (P = 0.016), while no statistical significance was found in the other two groups (P > 0.05). The larger the size of intimal entry tears, the greater the BF values (P = 0.044). Conclusions This study shows a direct correlation between renal CT perfusion changes and AD, with the size, number of intimal tears, different types of AD, different renal artery origins and false lumen thrombosis, significantly affecting the perfusion values.	[Liu, Dongting; Liu, Jiayi; Wen, Zhaoying; Li, Yu; Fan, Zhanming] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Sun, Zhonghua] Curtin Univ, Dept Med Radiat Sci, Perth, WA, Australia; [Xu, Qin] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China	Capital Medical University; Curtin University; Capital Medical University	Fan, ZM (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.	fanzm120@126.com	Sun, Zhonghua/B-3125-2010; Sun, Zhonghua/N-1648-2019	Sun, Zhonghua/0000-0002-7538-4761; Sun, Zhonghua/0000-0002-7538-4761				Beckman JA, 2004, VASC MED, V9, P267, DOI 10.1191/1358863x04vm561oa; Blomley MJK, 1999, EUR J RADIOL, V30, P214, DOI 10.1016/S0720-048X(99)00014-5; Braverman AC, 2010, CIRCULATION, V122, P184, DOI 10.1161/CIRCULATIONAHA.110.958975; Brix G, 2004, EUR RADIOL, V14, P1275, DOI 10.1007/s00330-004-2267-7; Cenic A, 2000, AM J NEURORADIOL, V21, P462; Chaichana T, 2014, COMPUT METHOD BIOMEC, V17, P108, DOI 10.1080/10255842.2012.671308; Chang J, 2011, J VET SCI, V12, P393, DOI 10.4142/jvs.2011.12.4.393; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085522; Chen Y, 2010, ABDOM IMAGING, V35, P622, DOI 10.1007/s00261-009-9565-0; Cros M, 2016, AM J ROENTGENOL, V206, P129, DOI 10.2214/AJR.15.14913; Daghini E, 2007, RADIOLOGY, V243, P405, DOI 10.1148/radiol.2432060655; Deeb GM, 1997, ANN THORAC SURG, V64, P1669, DOI 10.1016/S0003-4975(97)01100-4; Dillon-Murphy D, 2016, BIOMECH MODEL MECHAN, V15, P857, DOI 10.1007/s10237-015-0729-2; Djuric-Stefanovic A, 2013, EUR J RADIOL, V82, P1716, DOI 10.1016/j.ejrad.2013.05.038; El-Diasty TA, 2004, J UROLOGY, V171, P31, DOI 10.1097/01.ju.0000099784.52825.8e; Fiorella D, 2004, AM J NEURORADIOL, V25, P97; Girardi LN, 2004, ANN THORAC SURG, V77, P1309, DOI 10.1016/j.athoracsur.2003.09.056; Goh V, 2012, INVEST RADIOL, V47, P2, DOI 10.1097/RLI.0b013e318229ff3e; Helck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091774; Helck A, 2010, INVEST RADIOL, V45, P387, DOI 10.1097/RLI.0b013e3181e332d0; Jiang T, 2012, INVEST RADIOL, V47, P11, DOI 10.1097/RLI.0b013e3182199bb5; Kandel S, 2009, EUR RADIOL, V19, P2641, DOI 10.1007/s00330-009-1453-z; Khoynezhad A, 2010, J VASC SURG, V52, P562, DOI 10.1016/j.jvs.2010.04.036; Kuang Yi, 2015, Zhonghua Yi Xue Za Zhi, V95, P3514; Lerman LO, 2001, HYPERTENSION, V38, P625, DOI 10.1161/hy09t1.095205; MILES KA, 1991, BRIT J RADIOL, V64, P409, DOI 10.1259/0007-1285-64-761-409; MILES KA, 1993, RADIOLOGY, V188, P405, DOI 10.1148/radiology.188.2.8327686; Miles KA, 2003, BRIT J RADIOL, V76, P220, DOI 10.1259/bjr/13564625; MILES KA, 1995, BRIT J RADIOL, V68, P471, DOI 10.1259/0007-1285-68-809-471; MILES KA, 1991, LANCET, V337, P643, DOI 10.1016/0140-6736(91)92455-B; Paul JF, 2001, RADIOLOGY, V221, P261, DOI 10.1148/radiol.2211001558; Radtke JP, 2016, RADIOLOGE, V56, P285, DOI 10.1007/s00117-016-0087-9; Shamalov NA, 2012, ZH NEVROL PSIKHIATR, V112, P3; Squillaci E, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-138; Suliman A, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-4; Sun ZH, 2016, INT J CARDIOL, V210, P28, DOI 10.1016/j.ijcard.2016.02.099; Suzuki G, 2003, CIRCULATION, V108, P100; Theisen D, 2007, RADIOLOGE, V47, P982, DOI 10.1007/s00117-007-1580-y; Wu D, 2015, INVEST RADIOL, V50, P188, DOI 10.1097/RLI.0000000000000098; Yilmaz O, 2009, J PEDIATR SURG, V44, P1977, DOI 10.1016/j.jpedsurg.2009.01.072; Yuan XD, 2016, RADIOLOGY, V279, P254, DOI 10.1148/radiol.2015142757; Zhong JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074365	42	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171235	10.1371/journal.pone.0171235	http://dx.doi.org/10.1371/journal.pone.0171235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182709	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800049
J	Burnet, JB; Faraj, T; Cauchie, HM; Joaquim-Justo, C; Servais, P; Prevost, M; Dorner, SM				Burnet, Jean-Baptiste; Faraj, Tarek; Cauchie, Henry-Michel; Joaquim-Justo, Celia; Servais, Pierre; Prevost, Michele; Dorner, Sarah M.			How does the cladoceran Daphnia pulex affect the fate of Escherichia coli in water?	PLOS ONE			English	Article							FRESH-WATER; COMMUNITY STRUCTURE; FILTERING RATES; DRINKING-WATER; FECAL BACTERIA; BODY-SIZE; SURVIVAL; ZOOPLANKTON; PREDATION; MAGNA	The faecal indicator Escherichia coli plays a central role in water quality assessment and monitoring. It is therefore essential to understand its fate under various environmental constraints such as predation by bacterivorous zooplankton. Whereas most studies have examined how protozooplankton communities (heterotrophic nanoflagellates and ciliates) affect the fate of E. coli in water, the capacity of metazooplankton to control the faecal indicator remains poorly understood. In this study, we investigated how the common filter-feeding cladoceran, Daphnia pulex, affects the fate of E. coli under different experimental conditions. Daphnia ingested E. coli and increased its loss rates in water, but the latter rates decreased from 1.65 d(-1) to 0.62 d(-1) after a 1,000-fold reduction in E. coli initial concentrations, due to lower probability of encounter between Daphnia and E. coli. The combined use of culture and PMA qPCR (viability-qPCR) demonstrated that exposure to Daphnia did not result into the formation of viable but non-culturable E. coli cells. In lake water, a significant part of E. coli population loss was associated with matrix-related factors, most likely due to predation by other bacterivorous biota and/or bacterial competition. However, when exposing E. coli to a D. pulex gradient (from 0 to 65 ind. L-1), we observed an increasing impact of Daphnia on E. coli loss rates, which reached 0.47 d(-1) in presence of 65 ind. L-1. Our results suggest that the filter-feeder can exert a non-negligible predation pressure on E. coli, especially during seasonal Daphnia population peaks. Similar trials using other Daphnia species as well as stressed E. coli cells will increase our knowledge on the capacity of this widespread zooplankter to control E. coli in freshwater resources. Based on our results, we strongly advocate the use of natural matrices to study these biotic interactions in order to avoid overestimation of Daphnia impact.	[Burnet, Jean-Baptiste; Faraj, Tarek; Dorner, Sarah M.] Polytech Montreal, Dept Civil Geol & Min Engn, Canada Res Chair Source Water Protect, Montreal, PQ, Canada; [Cauchie, Henry-Michel] Luxembourg Inst Sci & Technol, Environm Res & Innovat, Esch Sur Alzette, Luxembourg; [Joaquim-Justo, Celia] Univ Liege, Inst Chim, Lab Ecol Anim & Ecotoxicol, Liege, Belgium; [Servais, Pierre] Univ Libre Bruxelles, Ecol Syst Aquat, Campus Plaine,CP 221,Blvd Triomphe, Brussels, Belgium; [Prevost, Michele] Polytech Montreal, Dept Civil Geol & Min Engn, NSERC Ind Chair Drinking Water, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Luxembourg Institute of Science & Technology; University of Liege; Universite Libre de Bruxelles; Universite de Montreal; Polytechnique Montreal	Burnet, JB (corresponding author), Polytech Montreal, Dept Civil Geol & Min Engn, Canada Res Chair Source Water Protect, Montreal, PQ, Canada.	jean-baptiste.burnet@polymtl.ca	Cauchie, Henry-Michel FV/K-8123-2014	Cauchie, Henry-Michel FV/0000-0003-4780-6100; Burnet, Jean-Baptiste/0000-0002-6126-0338	National Research Fund, Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND); NSERC; Canada Research Chair (CRC) in Source Water Protection	National Research Fund, Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair (CRC) in Source Water Protection	The present study has been financially supported by the National Research Fund, Luxembourg, and co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), NSERC, as well as by the Canada Research Chair (CRC) in Source Water Protection.; The authors would like to thank Dr Marc Schallenberg for providing insightful comments on the manuscript. The authors also thank Yves Fontaine, Audrey Lafrenaye, Rose-Mery Yagh-mour and Jacinthe Mailly for their excellent technical support as well as Prof. Remy Tadonleke and Prof. Bernadette Pinel-Alloul for their help with zooplankton. The present study has been financially supported by the National Research Fund, Luxembourg and co-funded under the Marie Curie Actions of the European Commission (FP7-COFUND), NSERC, as well as by the Canada Research Chair (CRC) in Source Water Protection.	Barcina I, 1997, FEMS MICROBIOL ECOL, V23, P1, DOI 10.1111/j.1574-6941.1997.tb00385.x; Bichai F, 2008, CAN J MICROBIOL, V54, P509, DOI [10.1139/W08-039, 10.1139/w08-039]; Bichai F, 2010, WATER RES, V44, P1072, DOI 10.1016/j.watres.2009.09.001; Blaustein RA, 2013, WATER RES, V47, P569, DOI 10.1016/j.watres.2012.10.027; Boehm AB, 2005, WATER RES, V39, P3565, DOI 10.1016/j.watres.2005.06.026; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; BRENDELBERGER H, 1991, LIMNOL OCEANOGR, V36, P884, DOI 10.4319/lo.1991.36.5.0884; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; Cauchie HM, 2000, J PLANKTON RES, V22, P2263, DOI 10.1093/plankt/22.12.2263; Chern EC, 2011, LETT APPL MICROBIOL, V52, P298, DOI 10.1111/j.1472-765X.2010.03001.x; Connelly SJ, 2007, APPL ENVIRON MICROB, V73, P7277, DOI 10.1128/AEM.01206-07; DABORN GR, 1978, CAN J ZOOL, V56, P1392, DOI 10.1139/z78-192; DAVIES J, 1985, HYDROBIOLOGIA, V120, P103, DOI 10.1007/BF00032130; Degans H, 2002, FEMS MICROBIOL ECOL, V42, P137, DOI 10.1111/j.1574-6941.2002.tb01003.x; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; FOX HM, 1952, NATURE, V169, P1051, DOI 10.1038/1691051b0; Freese HM, 2013, HYDROBIOLOGIA, V715, P63, DOI 10.1007/s10750-012-1375-7; GOPHEN M, 1974, NATURE, V247, P393, DOI 10.1038/247393a0; GUDE H, 1988, HYDROBIOLOGIA, V159, P63, DOI 10.1007/BF00007368; HADAS O, 1983, HYDROBIOLOGIA, V102, P163, DOI 10.1007/BF00006343; HANEY JF, 1985, LIMNOL OCEANOGR, V30, P397, DOI 10.4319/lo.1985.30.2.0397; HELGEN JC, 1987, HYDROBIOLOGIA, V154, P113, DOI 10.1007/BF00026835; Jackson BP, 2009, ANAL BIOANAL CHEM, V394, P911, DOI 10.1007/s00216-009-2768-y; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; JURGENS K, 1994, ARCH HYDROBIOL, V131, P55; JURGENS K, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P295; Kamjunke N, 1999, J PLANKTON RES, V21, P1175, DOI 10.1093/plankt/21.6.1175; KING CH, 1991, LIMNOL OCEANOGR, V36, P829, DOI 10.4319/lo.1991.36.5.0829; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; KVAM OV, 1995, HYDROBIOLOGIA, V307, P177, DOI 10.1007/BF00032010; Lin T, 2016, WATER RES, V89, P20, DOI 10.1016/j.watres.2015.11.015; Lurling M, 2003, J PLANKTON RES, V25, P967, DOI 10.1093/plankt/25.8.967; MCCAMBRIDGE J, 1980, APPL ENVIRON MICROB, V40, P907, DOI 10.1128/AEM.40.5.907-911.1980; McMAHON J. W., 1965, LIMNOL OCEANOGR, V10, P105; Menon P, 2003, WATER RES, V37, P4151, DOI 10.1016/S0043-1354(03)00349-X; Ndong M, 2014, WATER RES, V56, P98, DOI 10.1016/j.watres.2014.02.023; Pau C, 2013, WATER RES, V47, P181, DOI 10.1016/j.watres.2012.09.047; PETERSON BJ, 1978, LIMNOL OCEANOGR, V23, P1039, DOI 10.4319/lo.1978.23.5.1039; Pilati A, 2004, FRESHWATER BIOL, V49, P913, DOI 10.1111/j.1365-2427.2004.01234.x; RHODES MW, 1988, APPL ENVIRON MICROB, V54, P2902, DOI 10.1128/AEM.54.12.2902-2907.1988; RIEMANN B, 1985, APPL ENVIRON MICROB, V50, P187, DOI 10.1128/AEM.50.2.187-193.1985; SANDERS RW, 1989, LIMNOL OCEANOGR, V34, P673, DOI 10.4319/lo.1989.34.4.0673; Schallenberg M, 2005, APPL ENVIRON MICROB, V71, P5085, DOI 10.1128/AEM.71.9.5085-5088.2005; Servais P, 2009, CAN J MICROBIOL, V55, P905, DOI [10.1139/W09-043, 10.1139/w09-043]; SHERR BF, 1987, APPL ENVIRON MICROB, V53, P958, DOI 10.1128/AEM.53.5.958-965.1987; Simek K, 1997, AQUAT MICROB ECOL, V12, P49, DOI 10.3354/ame012049; Stott R, 2003, WATER SCI TECHNOL, V47, P77, DOI 10.2166/wst.2003.0166; TEZUKA Y, 1971, Japanese Journal of Ecology, V21, P127; Thouvenot A, 1999, J PLANKTON RES, V21, P1659, DOI 10.1093/plankt/21.9.1659; US EPA Environmental Protection Agency, 2002, PUBLICATION USEPA, p4303T; USEPA, 2006, LT2ESWTR LONG TERM 2; VAQUE D, 1992, J PLANKTON RES, V14, P307, DOI 10.1093/plankt/14.2.307; Walters SP, 2009, WATER RES, V43, P4929, DOI 10.1016/j.watres.2009.05.047; Wanjugi P, 2013, ENVIRON MICROBIOL, V15, P517, DOI 10.1111/j.1462-2920.2012.02877.x; Wcislo R, 2000, POL J ENVIRON STUD, V9, P215; Whitman RL, 2008, SCI TOTAL ENVIRON, V390, P448, DOI 10.1016/j.scitotenv.2007.10.014; WIEDNER C, 1995, HYDROBIOLOGIA, V302, P89, DOI 10.1007/BF00027033	59	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171705	10.1371/journal.pone.0171705	http://dx.doi.org/10.1371/journal.pone.0171705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178322	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000393712500061
J	Cerutti, R; Spensieri, V; Valastro, C; Presaghi, F; Canitano, R; Guidetti, V				Cerutti, Rita; Spensieri, Valentina; Valastro, Carmela; Presaghi, Fabio; Canitano, Roberto; Guidetti, Vincenzo			A comprehensive approach to understand somatic symptoms and their impact on emotional and psychosocial functioning in children	PLOS ONE			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; RECURRENT ABDOMINAL-PAIN; PSYCHOMETRIC PROPERTIES; SOMATIZATION INVENTORY; SOMATOFORM DISORDERS; PHYSICAL SYMPTOMS; ALEXITHYMIA; DEPRESSION; ANXIETY; SAMPLE	Introduction Somatic symptoms are frequently reported by children with significant impairment in functioning. Despite studies on adult populations that suggest somatic symptoms often co-occur with difficulties in identifying and describing feelings, little research has been done in childhood. This study aimed to investigate the prevalence and frequency of somatic symptoms as well as to investigate the functional impairment in children with high number of self reported somatic symptoms versus those with fewer somatic symptoms. Additionally the parental perception of their children's somatic symptoms and functioning was explored. Finally, we explored the direct and indirect effects of difficulties in identifying feelings in predicting somatic symptoms and functional disability among school-aged children. Methods 356 Italian school-aged children and their mothers participated in this study. Children (mean age = 11.43; SD = 2.41) completed the Children's Somatization Inventory (CSI-24) to assess somatic symptoms, the Functional Disability Inventory (FDI) to assess physical and psychosocial functioning and the Alexithymia Questionnaire for Children (AQC) to evaluate alexithymic features. Mothers completed the parental forms of the CSI and the FDI. Results Among children, 66.3% did not declare somatic symptoms and 33.7% reported one or more somatic symptoms in the last two weeks. A significant positive correlation emerged between children's and mothers' CSI total scores. Both children's and mothers' FDI total scores were significantly correlated with CSI scores. A significant correlation was observed between somatic symptoms and alexithymic features. Furthermore, the data showed that somatic symptoms mediated the relationship between difficulties in identifying feelings and functional impairment. Finally, it was showed that alexithymia facet of difficulty in identifying feelings contributed in large part to the prediction of the somatic symptomatology (b = 0.978, p < 0.001; R-2 = 0.164, F(5, 350) = 10.32, p < 0.001). Conclusions Findings from this study provide evidence that a higher frequency of somatic symptoms is associated with functional disabilities and alexithymic facets in school-aged children.	[Cerutti, Rita; Spensieri, Valentina; Valastro, Carmela] Sapienza Univ, Dept Dynam & Clin Psychol, Rome, Italy; [Presaghi, Fabio] Sapienza Univ, Dept Psychol Dev & Social Proc, Rome, Italy; [Canitano, Roberto] Univ Hosp Siena, Div Child & Adolescent Neuropsychiat, Siena, Italy; [Guidetti, Vincenzo] Sapienza Univ, Dept Paediat & Child & Adolescent Neuropsychiat, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University of Siena; University Hospital of Siena; Sapienza University Rome	Cerutti, R (corresponding author), Sapienza Univ, Dept Dynam & Clin Psychol, Rome, Italy.	rita.cerutti@uniroma1.it	Presaghi, Fabio/N-1590-2019	Presaghi, Fabio/0000-0001-7880-6715; SPENSIERI, VALENTINA/0000-0001-5413-3528; Guidetti, Vincenzo/0000-0003-1643-8392				Allen LB, 2011, J HEALTH PSYCHOL, V16, P1177, DOI 10.1177/1359105311402407; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andresen JM, 2011, CLIN PEDIATR, V50, P904, DOI 10.1177/0009922811406717; Arruda MA, 2010, CEPHALALGIA, V30, P1056, DOI 10.1177/0333102409361214; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; Bellini B, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-79; Bisht J, 2008, INDIAN PEDIATR, V45, P111; Campo JV, 2012, J CHILD PSYCHOL PSYC, V53, P575, DOI 10.1111/j.1469-7610.2012.02535.x; Cerutti R, 2016, HEADACHE, V56, P1161, DOI 10.1111/head.12840; Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002; Conrad R, 2009, PSYCHIAT RES, V165, P137, DOI 10.1016/j.psychres.2007.10.013; Di Trani M, 2009, PSICOLOGIA SALUTE, V2, P131, DOI DOI 10.3280/PDS2009-002009; Eisenberg N, 2003, DEV PSYCHOL, V39, P3, DOI 10.1037//0012-1649.39.1.3; Escobar JI, 2002, ENVIRON HEALTH PERSP, V110, P631, DOI 10.1289/ehp.02110s4631; Garber J, 1998, J ABNORM CHILD PSYCH, V26, P381, DOI 10.1023/A:1021955907190; Garber J., 1991, PSYCHOL ASSESSMENT, V3, P588, DOI DOI 10.1037/1040-3590.3.4.588; Geist R, 2008, PAED CHILD HEALT-CAN, V13, P487, DOI 10.1093/pch/13.6.487; Grabe HJ, 2004, AM J PSYCHIAT, V161, P1299, DOI 10.1176/appi.ajp.161.7.1299; Helmers KF, 1999, J PSYCHOSOM RES, V47, P635, DOI 10.1016/S0022-3999(99)00067-7; Imran N, 2014, J PSYCHOSOM RES, V76, P105, DOI 10.1016/j.jpsychores.2013.11.016; Jellesma FC, 2009, PSYCHOL HEALTH, V24, P881, DOI 10.1080/08870440801998970; Kashikar-Zuck S, 2011, PAIN, V152, P1600, DOI 10.1016/j.pain.2011.02.050; Klineberg E, 2014, J PAEDIATR CHILD H, V50, P775, DOI 10.1111/jpc.12653; Konijnenberg AY, 2005, ARCH DIS CHILD, V90, P680, DOI 10.1136/adc.2004.056820; Kooiman CG, 2000, PSYCHOSOM MED, V62, P768, DOI 10.1097/00006842-200011000-00005; Litcher L, 2001, J ABNORM CHILD PSYCH, V29, P165, DOI 10.1023/A:1005240214564; Meesters C, 2003, J PEDIATR PSYCHOL, V28, P413, DOI 10.1093/jpepsy/jsg031; Modestin J, 2004, J PSYCHOSOM RES, V56, P707, DOI 10.1016/S0022-3999(03)00125-9; Moreno MA, 2013, JAMA PEDIATR, V167, P204, DOI 10.1001/jamapediatrics.2013.1665; Nemzer E., 1996, SOMATOFORM DISORDERS; Picardi A, 2007, J PSYCHOSOM RES, V62, P223, DOI 10.1016/j.jpsychores.2006.09.002; Pirinen T, 2012, ACTA PAEDIATR, V101, P433, DOI 10.1111/j.1651-2227.2011.02541.x; Rieffe C, 2006, PERS INDIV DIFFER, V40, P123, DOI 10.1016/j.paid.2005.05.013; Schulte IE, 2011, J PSYCHOSOM RES, V70, P218, DOI 10.1016/j.jpsychores.2010.08.005; Shibata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090984; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; van de Putte EM, 2006, ARCH DIS CHILD, V91, P824, DOI 10.1136/adc.2006.094623; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39; WALKER LS, 1989, J PEDIATR PSYCHOL, V14, P231, DOI 10.1093/jpepsy/14.2.231; WALKER LS, 1991, J ABNORM CHILD PSYCH, V19, P379, DOI 10.1007/BF00919084; Walker LS, 1992, CHILDRENS SOMATIZATI; Walker LS, 2009, J PEDIATR PSYCHOL, V34, P430, DOI 10.1093/jpepsy/jsn093; Waller E, 2004, J PSYCHOSOM RES, V57, P239, DOI 10.1016/S0022-3999(03)00613-5; Zolog TC, 2011, J COGN BEHAV PSYCHOT, V11, P191	44	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171867	10.1371/journal.pone.0171867	http://dx.doi.org/10.1371/journal.pone.0171867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178333	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500075
J	Dullin, C; Ufartes, R; Larsson, E; Martin, S; Lazzarini, M; Tromba, G; Missbach-Guentner, J; Pinkert-Leetsch, D; Katschinski, DM; Alves, F				Dullin, Christian; Ufartes, Roser; Larsson, Emanuel; Martin, Sabine; Lazzarini, Marcio; Tromba, Giuliana; Missbach-Guentner, Jeannine; Pinkert-Leetsch, Diana; Katschinski, Doerthe M.; Alves, Frauke			mu CT of ex-vivo stained mouse hearts and embryos enables a precise match between 3D virtual histology, classical histology and immunochemistry	PLOS ONE			English	Article							TISSUE	The small size of the adult and developing mouse heart poses a great challenge for imaging in preclinical research. The aim of the study was to establish a phosphotungstic acid (PTA) ex-vivo staining approach that efficiently enhances the x-ray attenuation of soft-tissue to allow high resolution 3D visualization of mouse hearts by synchrotron radiation based pCT (SRpCT) and classical pCT. We demonstrate that SRpCT of PTA stained mouse hearts ex vivo allows imaging of the cardiac atrium, ventricles, myocardium especially its fibre structure and vessel walls in great detail and furthermore enables the depiction of growth and anatomical changes during distinct developmental stages of hearts in mouse embryos. Our x-ray based virtual histology approach is not limited to SRpCT as it does not require monochromatic and/or coherent x-ray sources and even more importantly can be combined with conventional histological procedures. Furthermore, it permits volumetric measurements as we show for the assessment of the plaque volumes in the aortic valve region of mice from an ApoE-/- mouse model. Subsequent, Masson-Goldner trichrome staining of paraffin sections of PTA stained samples revealed intact collagen and muscle fibres and positive staining of CD31 on endothelial cells by immunohistochemistry illustrates that our approach does not prevent immunochemistry analysis. The feasibility to scan hearts already embedded in paraffin ensured a 100% correlation between virtual cut sections of the CT data sets and histological heart sections of the same sample and may allow in future guiding the cutting process to specific regions of interest. In summary, since our CT based virtual histology approach is a powerful tool for the 3D depiction of morphological alterations in hearts and embryos in high resolution and can be combined with classical histological analysis it may be used in preclinical research to unravel structural alterations of various heart diseases.	[Dullin, Christian; Missbach-Guentner, Jeannine; Alves, Frauke] Univ Med Ctr, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Dullin, Christian; Larsson, Emanuel; Tromba, Giuliana] Synchrotron Light Source Elettra, Trieste, Italy; [Ufartes, Roser; Martin, Sabine; Lazzarini, Marcio; Alves, Frauke] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Gottingen, Germany; [Martin, Sabine] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany; [Missbach-Guentner, Jeannine; Pinkert-Leetsch, Diana; Alves, Frauke] Univ Med Ctr, Clin Haematol & Med Oncol, Gottingen, Germany; [Katschinski, Doerthe M.] Univ Med Ctr, Inst Cardiovasc Physiol, Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen; University of Gottingen	Dullin, C (corresponding author), Univ Med Ctr, Inst Diagnost & Intervent Radiol, Gottingen, Germany.; Dullin, C (corresponding author), Synchrotron Light Source Elettra, Trieste, Italy.	Christian.dullin@med.uni-goettingen.de	Larsson, Emanuel/A-5807-2019	Larsson, Emanuel/0000-0002-3586-5763; Dullin, Christian/0000-0003-4297-8077	Cluster of Excellence; German Research Foundation (DFG) [DU 1403/1-1]; 'EXTREMA' COST action [MP1207]; COST action [MP1203]; 'Talents3' mobility fellowship of the Italian region 'Friuli Venezia Giulia'; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	Cluster of Excellence; German Research Foundation (DFG)(German Research Foundation (DFG)); 'EXTREMA' COST action; COST action(European Cooperation in Science and Technology (COST)); 'Talents3' mobility fellowship of the Italian region 'Friuli Venezia Giulia'; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	Sabine Martin was funded through the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain. Christian Dullin was supported by the German Research Foundation (DFG, DU 1403/1-1) and by the 'EXTREMA' COST action MP1207 action, the COST action MP1203 and by the 'Talents3' mobility fellowship of the Italian region 'Friuli Venezia Giulia'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.048103; Beltran MA, 2010, 2D 3D XRAY PHASE RET, V6423; Cardiff RD, 2014, COLD SPRING HARB PRO, V2014; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Dunmore-Buyze PJ, 2014, CONTRAST MEDIA MOL I; Dweck MR, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004805; HELANDER KG, 1994, BIOTECH HISTOCHEM, V69, P177, DOI 10.3109/10520299409106282; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Keggin JF, 1933, NATURE, V131, P908, DOI 10.1038/131908b0; Lang S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897225; Martin S, 2016, MOL NEUROBIOL; Masson P., 1929, J TECH METHODS, V12, P75; McAteer MA, 2004, ARTERIOSCL THROM VAS, V24, P2384, DOI 10.1161/01.ATV.0000146811.19029.fb; Metscher BD, 2009, MICROCT DEV BIOL VER, P632; Metscher BD, 2011, MICROCT MOL IMAGING, P2301; Metscher BD, 2009, MICROCT COMP MORPHOL, V11; Montanari F., 2003, SYRMEP TOMO PROJECT; Nakashima Y, 1994, ARTERIOSCLER THROMB, P133; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; QUINTARELLI G, 1971, J HISTOCHEM CYTOCHEM, V19, P641, DOI 10.1177/19.11.641; Rastogi V., 2013, J CLIN DIAGN RES; Robinson PS, 2007, DEV FUNCTIONAL TISSU; Rouillard AD, 2014, PROG BIOPHYS MOL BIO; Schulz G, 2011, J NEUROSCI METH, V202, P17, DOI 10.1016/j.jneumeth.2011.08.031; Shinohara M, 2007, AM J PHYSIOL-HEART C, V294, pH1094; Tromba G, 2010, SYRMEP BEAMLINE ELET, P18; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; Zanette I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4848595	28	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170597	10.1371/journal.pone.0170597	http://dx.doi.org/10.1371/journal.pone.0170597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178293	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500011
J	Ni, YW; Teng, T; Li, RT; Simonyi, A; Sun, GY; Lee, JC				Ni, Yawen; Teng, Tao; Li, Runting; Simonyi, Agnes; Sun, Grace Y.; Lee, James C.			TNF alpha alters occludin and cerebral endothelial permeability: Role of p38MAPK	PLOS ONE			English	Article							PHOSPHORYLATION; MECHANISM; DISRUPTION	Occludin is a key tight junction (TJ) protein in cerebral endothelial cells (CECs) playing an important role in modulating blood-brain barrier (BBB) functions. This protein (65kDa) has been shown to engage in many signaling pathways and phosphorylation by both tyrosine and threonine kinases. Despite yet unknown mechanisms, pro-inflammatory cytokines and endotoxin (lipopolysaccharides, LPS) may alter TJ proteins in CECs and BBB functions. Here we demonstrate the responses of occludin in an immortalized human cerebral endothelial cell line (hCMEC/D3) to stimulation by TNFa (10 ng/mL), IL-1 beta (10 ng/mL) and LPS (100 ng/mL). Exposing cells to TNFa resulted in a rapid and transient upward band-shift of occludin, suggesting of an increase in phosphorylation. Exposure to IL-1 beta produced significantly smaller effects and LPS produced almost no effects on occludin band-shift. TNFa also caused transient stimulation of p38MAPK and ERK1/2 in hCMEC/D3 cells, and the occludin band-shift induced by TNFa was suppressed by SB202190, an inhibitor for p38MAPK, and partly by U0126, the MEK1/2-ERK1/2 inhibitor. Cells treated with TNFa and IL-1 beta but not LPS for 24 h resulted in a significant (p < 0.001) decrease in the expression of occludin, and the decrease could be partially blocked by SB202190, the inhibitor for p38MAPK. Treatment with TNF alpha also altered cell morphology and enhanced permeability of the CEC layer as measured by the FITC-dextran assay and the trans-endothelial electrical resistances (TEER). However, treatment with SB202190 alone could not effectively reverse the TNF alpha-induced morphology changes or the enhanced permeability changes. These results suggest that despite effects of TNF alpha on p38MAPK-mediated occludin phosphorylation and expression, these changes are not sufficient to avert the TNF alpha-induced alterations on cell morphology and permeability.	[Ni, Yawen] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA; [Teng, Tao; Lee, James C.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Li, Runting; Simonyi, Agnes; Sun, Grace Y.] Univ Missouri, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Missouri System; University of Missouri Columbia	Lee, JC (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	leejam@uic.edu	Teng, Tao/T-1557-2017	Teng, Tao/0000-0003-4078-1545	National Institute on Aging [R01 AG044404-04]; NATIONAL INSTITUTE ON AGING [R01AG044404] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by R01 AG044404-04 from the National Institute on Aging to JCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bolinger MT, 2016, MOL CELL BIOL, V36, P2051, DOI 10.1128/MCB.00053-16; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cui Wei, 2007, Zhonghua Nei Ke Za Zhi, V46, P478; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Kant S, 2011, GENE DEV, V25, P2069, DOI 10.1101/gad.17224711; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ozaki H, 1999, J IMMUNOL, V163, P553; Qin LH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/120641; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Sun GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141509; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Xu C, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12636	23	61	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170346	10.1371/journal.pone.0170346	http://dx.doi.org/10.1371/journal.pone.0170346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170408	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500004
J	Yang, MQ; Li, DZ; Wen, J; Yi, TS				Yang, Mei-Qing; Li, De-Zhu; Wen, Jun; Yi, Ting-Shuang			Phylogeny and biogeography of the amphi-Pacific genus Aphananthe	PLOS ONE			English	Article							DNA-SEQUENCE DATA; NORTHERN-HEMISPHERE; ULMACEAE URTICALES; SOUTHEAST-ASIA; INDIAN-OCEAN; EASTERN ASIA; INTERCONTINENTAL DISJUNCTIONS; GEOGRAPHIC RANGE; CHLOROPLAST DNA; PLATE-TECTONICS	Aphananthe is a small genus of five species showing an intriguing amphi-Pacific distribution in eastern, southern and southeastern Asia, Australia, and Mexico, also with one species in Madagascar. The phylogenetic relationships of Aphananthe were reconstructed with two nuclear (ITS & ETS) and two plastid (psbA-trnH & trnL-trnF) regions. Clade divergence times were estimated with a Bayesian approach, and the ancestral areas were inferred using the dispersal-extinction-cladogenesis and Bayesian Binary MCMC analyses. Aphananthe was supported to be monophyletic, with the eastern Asian A. aspera resolved as sister to a clade of the remaining four species. Aphananthe was inferred to have originated in the Late Cretaceous (71.5 mya, with 95% HPD: 66.6-81.3 mya), and the crown age of the genus was dated to be in the early Miocene (19.1 mya, with 95% HPD: 12.4-28.9 mya). The fossil record indicates that Aphananthe was present in the high latitude thermophilic forests in the early Tertiary, and experienced extinctions from the middle Tertiary onwards. Aphananthe originated in Europe based on the inference that included fossil and extant species, but eastern Asia was estimated to be the ancestral area of the clade of the extant species of Aphananthe. Both the West Gondwanan vicariance hypothesis and the boreotropics hypothesis could be excluded as explanation for its amphi-Pacific distribution. Long-distance dispersals out of eastern Asia into North America, southern and southeastern Asia and Australia, and Madagascar during the Miocene account for its wide intercontinental disjunct distribution.	[Yang, Mei-Qing; Li, De-Zhu; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Yang, Mei-Qing] Baotou Med Coll, Baotou, Inner Mongolia, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Baotou Medical College; Smithsonian Institution; Smithsonian National Museum of Natural History	Yi, TS (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.; Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; tingshuangyi@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Key Basic Research Program of China [2014CB954100-01]; National Natural Science Foundation [31129001, 31500181]; Talent Project of Yunnan Province [2011CI042]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Talent Project of Yunnan Province	This study was supported by grants from the National Key Basic Research Program of China (Grant No. 2014CB954100-01), the National Natural Science Foundation (Project No. 31129001), the Talent Project of Yunnan Province (Project No. 2011CI042), and National Natural Science Foundation (Project No. 31500181).	Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Baldwin BG, 1998, MOL PHYLOGENET EVOL, V10, P449, DOI 10.1006/mpev.1998.0545; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Chandler M. E. J., 1964, LOWER TERTIARY FLORA; Choi SK, 2010, IAWA J, V31, P95, DOI 10.1163/22941932-90000009; Christenhusz MJM, 2013, BOT J LINN SOC, V171, P277, DOI 10.1111/j.1095-8339.2012.01301.x; Conti E, 2002, EVOLUTION, V56, P1931; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Davis CC, 2002, EVOLUTION, V56, P2395; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Dorofeev P., 1982, FOSSIL FLOWERING PLA, V2; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2009, GENEIOUS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Floyd A.G., 1989, RAINFOREST TREES MAI; Fritsch PW, 2015, J BIOGEOGR, V42, P891, DOI 10.1111/jbi.12442; Fu LG., 2003, FLORA CHINA, P1; Fuchs J, 2006, MOL PHYLOGENET EVOL, V39, P186, DOI 10.1016/j.ympev.2005.07.020; GIANNASI DE, 1978, TAXON, V27, P331, DOI 10.2307/1220369; Goswami BN, 2003, P INDIAN AS-EARTH, V112, P61; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hamilton MB, 1999, MOL ECOL, V8, P521; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harvey PH, 1998, P ROY SOC B-BIOL SCI, V265, P1691, DOI 10.1098/rspb.1998.0490; Ickert-Bond SM, 2006, MOL PHYLOGENET EVOL, V39, P512, DOI 10.1016/j.ympev.2005.12.003; Jonsson KA, 2006, J BIOGEOGR, V33, P1155, DOI 10.1111/j.1365-2699.2006.01507.x; Knobloch E, 1986, ROZPRAVY STRED HO ST, V47, P1; Kubitzki K., 1996, FLORISTIC CHARACTERI, P65; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LAVIN M, 1993, AM J BOT, V80, P1, DOI 10.2307/2445114; Leroy J. F., 1961, Journal d'Agriculture tropicale, V8, P72; Leroy Jean-F., 1946, BULL MUS NATION HIST NAT [PARIS], V18, P118; Li R, 2016, J SYST EVOL, V54, P453, DOI 10.1111/jse.12196; Li R, 2014, J SYST EVOL, V52, P431, DOI 10.1111/jse.12052; Li R, 2013, SYST BOT, V38, P536, DOI 10.1600/036364413X666606; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Manchester S.R., 1994, PALEONTOGRAPHICA AM, V58, P1; Manchester S.R., 1981, OREGON GEOLOGY, V43, P75; Manchester SR, 2002, INT J PLANT SCI, V163, P725, DOI 10.1086/341513; McKenna MC, 1973, IMPLICATIONCONTINE, V1, P291; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Morley RJ., 1998, BIOGEOGRAPHY GEOLOGI, V22, P211; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Nauheimer L, 2012, NEW PHYTOL, V195, P938, DOI 10.1111/j.1469-8137.2012.04220.x; Nauheimer L, 2012, MOL PHYLOGENET EVOL, V63, P43, DOI 10.1016/j.ympev.2011.12.011; New AL, 2005, PHILOS T ROY SOC A, V363, P151, DOI 10.1098/rsta.2004.1484; OGINUMA K, 1990, BOT MAG TOKYO, V103, P113, DOI 10.1007/BF02489620; Prive-Gill C, 1999, REV PALAEOBOT PALYNO, V107, P191, DOI 10.1016/S0034-6667(99)00017-2; RAMBAUT A, 2004, TRACER VERSION 1 3; Reddy S, 2012, P ROY SOC B-BIOL SCI, V279, P2062, DOI 10.1098/rspb.2011.2380; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reid EM., 1933, LONDON CLAY FLORA; Renner SS, 2004, PHILOS T R SOC B, V359, P1485, DOI 10.1098/rstb.2004.1530; Richardson J.E., 2012, BIOTIC EVOLUTION ENV, P138, DOI DOI 10.1017/CBO9780511735882.008; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rogl VF., 1999, MIOCENE LAND MAMMALS, P39; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutschmann F, 2004, INT J PLANT SCI, V165, pS69, DOI 10.1086/383335; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Silvertown J, 2005, J ECOL, V93, P653, DOI 10.1111/j.1365-2745.2005.01038.x; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; Sirichamorn Y, 2014, J BIOGEOGR, V41, P882, DOI 10.1111/jbi.12262; [宋葆华 Song Baohua], 2002, [植物分类学报, Acta Phytotaxonomica Sinica], V40, P125; Song BH, 2001, PLANT SYST EVOL, V228, P107, DOI 10.1007/s006060170041; Su YCF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-153; Sytsma KJ, 2002, AM J BOT, V89, P1531, DOI 10.3732/ajb.89.9.1531; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAKASO T, 1990, BOT MAG TOKYO, V103, P25, DOI 10.1007/BF02488408; Thomas DC, 2012, J BIOGEOGR, V39, P98, DOI 10.1111/j.1365-2699.2011.02596.x; THORNE RF, 1972, Q REV BIOL, V47, P365, DOI 10.1086/407399; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Ueda K, 1997, J PLANT RES, V110, P171, DOI 10.1007/BF02509305; van Hinsbergen DJJ, 2012, P NATL ACAD SCI USA, V109, P7659, DOI 10.1073/pnas.1117262109; van Steenis CGGJ, 1962, BLUMEA, V11, P266; Voelker G, 2008, J EVOLUTION BIOL, V21, P1779, DOI 10.1111/j.1420-9101.2008.01588.x; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; Wen J., 2011, Contributions from the United States National Herbarium, V57, P5; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Wen J., 2010, DARWINS HERITAGE TOD, P252; Wen J, 2016, J SYST EVOL, V54, P469, DOI 10.1111/jse.12222; Wiegrefe SJ, 1998, PLANT SYST EVOL, V210, P249, DOI 10.1007/BF00985671; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Xie L, 2010, MOL PHYLOGENET EVOL, V56, P675, DOI 10.1016/j.ympev.2010.02.018; Yang MQ, 2013, TAXON, V62, P473, DOI 10.12705/623.9; Yi TS, 2004, MOL PHYLOGENET EVOL, V33, P861, DOI 10.1016/j.ympev.2004.07.006; Yoshikawa Tetsuro, 2009, Journal of Ecology and Field Biology, V32, P137; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou LL, 2012, J BIOGEOGR, V39, P322, DOI 10.1111/j.1365-2699.2011.02598.x	106	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171405	10.1371/journal.pone.0171405	http://dx.doi.org/10.1371/journal.pone.0171405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170425	gold, Green Submitted, Green Published			2022-12-27	WOS:000393705500036
J	Alexander, L; Woeste, K				Alexander, Lisa; Woeste, Keith			Pollen gene flow, male reproductive success, and genetic correlations among offspring in a northern red oak (Quercus rubra L.) seed orchard	PLOS ONE			English	Article							MATING PATTERNS; PATERNITY ANALYSIS; WIND-POLLINATION; MICROSATELLITE MARKERS; MOLECULAR MARKERS; BUR OAK; PINE; CONTAMINATION; EUCALYPTUS; PHENOLOGY	Northern red oak is a high-value hardwood used for lumber, furniture and veneer. Intensively managed northern red oak seed orchards are required to obtain genetic gain for trait improvement. Data from conifer seed orchards and natural and managed stands of hardwood trees have shed light on the distance over which pollen can move, and underscore the need for managerial attention to seed orchard design, placement, and maintenance. We used eleven microsatellite markers to investigate pollen gene flow, female mate choice, and male reproductive success in a clonal seed orchard of northern red oak based on paternity analysis of seed orchard offspring in progeny tests. Nearly all (93%) offspring were sired by a male parent within the seed orchard. The mean number of male parents per year was 69.5, or 47.6% of all clones in the seed orchard. Female clones in the early phenology group had more offspring sired from extra-orchard pollen (13%) than clones in the intermediate (5%) and late (1%) phenology groups. Distance was the largest influence on pollination success, and pollination occurred most often by male trees in the same subline as the maternal tree. Males in the early phenology group sired more offspring overall in the progeny pool and more offspring per mother tree than males in the intermediate or late phenology groups. Average genetic correlations among all OP progeny ranged between 0.2557 and 0.3529 with a mean of 0.28 +/- 0.01. The importance of progeny test genotyping for northern red oak improvement likely is increasing with the demand for improved varieties. The current study demonstrated the feasibility of post hoc assembly of full-sib families for genetic analysis.	[Alexander, Lisa; Woeste, Keith] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Woeste, Keith] Purdue Univ, USDA, US Forest Serv, Northern Res Stn,Hardwood Tree Improvement & Rege, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service	Alexander, L (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	Lisa.Alexander@ars.usda.gov			Fred M. van Eck Foundation	Fred M. van Eck Foundation	LA received partial funding from the Fred M. van Eck Foundation for Purdue University. KW received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W. T., 1992, New Forests, V6, P217, DOI 10.1007/BF00120646; Aldrich PR, 2003, SILVAE GENET, V52, P176; Aldrich PR, 2002, MOL ECOL NOTES, V2, P472, DOI 10.1046/j.1471-8286.2002.00282.x; Alexander LW, 2016, CAN J FOREST RES, V46, P629, DOI 10.1139/cjfr-2015-0312; ASKEW GR, 1994, THEOR APPL GENET, V88, P267, DOI 10.1007/BF00225908; Bai WN, 2006, ANN BOT-LONDON, V98, P397, DOI 10.1093/aob/mcl111; Buiteveld J., 2001, Forest Genetics, V8, P331; Burczyk J, 2002, MOL ECOL, V11, P2379, DOI 10.1046/j.1365-294X.2002.01603.x; Burczyk J, 1996, HEREDITY, V77, P251, DOI 10.1038/hdy.1996.139; Burczyk JL, 1997, HEREDITY, V79, P638, DOI 10.1038/hdy.1997.210; Chaix G, 2003, THEOR APPL GENET, V107, P705, DOI 10.1007/s00122-003-1294-0; Doerksen TK, 2008, CAN J FOREST RES, V38, P1742, DOI 10.1139/X08-025; Dow BD, 1998, J HERED, V89, P62, DOI 10.1093/jhered/89.1.62; Dow BD, 1998, NEW FOREST, V15, P161, DOI 10.1023/A:1006557904751; ELKASSABY YA, 1986, SILVAE GENET, V35, P240; ERICKSON VJ, 1990, CAN J FOREST RES, V20, P1672, DOI 10.1139/x90-220; FRIEDMAN ST, 1985, THEOR APPL GENET, V69, P609, DOI 10.1007/BF00251112; Friedman ST, 1981, P 16 SO FOR TREE IMP; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; Hansen OK, 2008, FOREST ECOL MANAG, V256, P1167, DOI 10.1016/j.foreco.2008.06.032; Hansen OK, 2006, CAN J FOREST RES, V36, P1054, DOI 10.1139/X05-299; Hansen OK, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010028; Gaspar MJ, 2009, TREE GENET GENOMES, V5, P609, DOI 10.1007/s11295-009-0213-1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kimura MK, 2012, PLANT ECOL, V213, P1477, DOI 10.1007/s11258-012-0105-6; Knapp EE, 2001, OECOLOGIA, V128, P48, DOI 10.1007/s004420000623; Kumar S, 2005, MOL BREEDING, V15, P55, DOI 10.1007/s11032-004-2059-4; Lambeth C, 2001, THEOR APPL GENET, V103, P930, DOI 10.1007/s001220100627; Lexer C, 1999, THEOR APPL GENET, V99, P185, DOI 10.1007/s001220051223; Lindgren D, 1998, CAN J FOREST RES, V28, P276, DOI 10.1139/cjfr-28-2-276; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Nielsen UB, 2007, SCAND J FOREST RES, V22, P99, DOI 10.1080/02827580701231597; OWENS JN, 1995, TREE PHYSIOL, V15, P477, DOI 10.1093/treephys/15.7-8.477; Pakkanen A, 2000, SCAND J FOREST RES, V15, P399, DOI 10.1080/028275800750172574; Plomion C, 2001, CAN J FOREST RES, V31, P1816, DOI 10.1139/cjfr-31-10-1816; Robichaud RL, 2007, THESIS; SCHOEN DJ, 1987, GENETICS, V116, P141; Skroppa T., 1994, Forest Genetics, V1, P13; Slavov GT, 2005, CAN J FOREST RES, V35, P1592, DOI 10.1139/X05-082; SORENSEN FC, 1988, FOREST SCI, V34, P102; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Squillace A. E., 1974, Silvae Genetica, V23, P149; Stoehr MU, 2002, CAN J FOREST RES, V32, P469, DOI 10.1139/X01-222; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Victory ER, 2006, AM J BOT, V93, P118, DOI 10.3732/ajb.93.1.118; White T. L., 2007, FOREST GENETICS	46	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171598	10.1371/journal.pone.0171598	http://dx.doi.org/10.1371/journal.pone.0171598			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166543	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100057
J	Piantadosi, S				Piantadosi, Steven			Three dimensional mathematical modeling of violin plate surfaces: An approach based on an ensemble of contour lines	PLOS ONE			English	Article								This paper presents an approach to describing the three dimensional shape of a violin plate in mathematical form. The shape description begins with standard contour lines and ends with an equation for a surface in three dimensional space. The traditional specification of cross sectional arching is unnecessary. Advantages of this approach are that it employs simple and universal description of plate geometry and yields a complete, smoothed, precise mathematical equation of the plate that is suitable for modern three dimensional production. It is quite general and suitable for both exterior and interior plate surfaces, yielding the ability to control thicknesses along with shape. This method can produce mathematical descriptions with tolerances easily less than 0.001 millimeters suitable for modern computerized numerical control carving and hand finishing.	[Piantadosi, Steven] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Piantadosi, S (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.	steven.piantadosi@csmc.edu						Conti CA, 2011, INTERFACE FOCUS, V1, P384, DOI 10.1098/rsfs.2010.0029; De Boor C., 2001, PRACTICAL GUIDE SPLI; de Boor C., 2001, APPL MATH SCI, V27; Dierkes U., 2003, SINGULAR MINIMAL SUR; Heron-Allen E., 1907, VIOLIN MAKING IT WAS; Lagrange J.L, 1853, MECANIQUE ANAL; McNeel R, 2015, RHINO VERSION 5; Mottola R., 2011, SAVART J N AM, P1; Mottola R., 2012, SAVART J N AM, P1; Muratov S., 2015, ART VIOLIN DESIGN FI; Piker D, 2015, KANGAROO3D; Pinsky MA, 2002, INTRO FOURIER ANAL W, V102; Poisson SD, 1816, MEMOIRE SURFACES ELA; Proctor R.A., 1878, TREATISE CYCLOID ALL; Roy K., 2006, VIOLIN ITS HIST MAKI; Sacconi SF, 1972, SEGRETI STRADIVARI C; SoftSoft, 2016, WINTOPO RAST VECT CO; Wan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145570; Weisstein EW, 2015, CURTATE CYCLOID; Weisstein EW, 2015, FOURIER SERIES; Weisstein EW, 2015, BRACHISTOCHRONE PROB; Weisstein EW, 2015, CASSINI OVALS; Wolfram Research I, 2016, MATH VERS 11	23	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171167	10.1371/journal.pone.0171167	http://dx.doi.org/10.1371/journal.pone.0171167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166230	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100026
J	Zhang, YH; Zang, WC; Qin, LM; Zheng, L; Cao, Y; Yan, ZG; Yi, XL; Zeng, HH; Liu, ZT				Zhang, Yahui; Zang, Wenchao; Qin, Lumei; Zheng, Lei; Cao, Ying; Yan, Zhenguang; Yi, Xianliang; Zeng, Honghu; Liu, Zhengtao			Water Quality Criteria for Copper Based on the BLM Approach in the Freshwater in China	PLOS ONE			English	Article							BIOTIC LIGAND MODEL; DISSOLVED ORGANIC-CARBON; TROUT ONCORHYNCHUS-MYKISS; SPECIES SENSITIVITY DISTRIBUTIONS; AQUATIC LIFE CRITERIA; ACUTE TOXICITY; DAPHNIA-MAGNA; FIELD VALIDATION; FATHEAD MINNOWS; MATTER SOURCE	The bioavailability and toxicity of metals to aquatic organisms are highly dependent on water quality parameters in freshwaters. The biotic ligand model (BLM) for copper is an approach to generate the water quality criteria (WQC) with water chemistry in the ambient environment. However, few studies were carried out on the WQCs for copper based on the BLM approach in China. In the present study, the toxicity for copper to native Chinese aquatic organisms was conducted and the published toxicity data with water quality parameters to Chinese aquatic species were collected to derive the WQCs for copper by the BLM approach. The BLM-based WQCs (the criterion maximum criteria (CMC) and the criterion continuous concentration (CCC)) for copper in the freshwater for the nation and in the Taihu Lake were obtained. The CMC and CCC values for copper in China were derived to be 1.391 mu g/L and 0.495 mu g/L, respectively, and the CMC and CCC in the Taihu Lake were 32.194 mu g/L and 9.697 mu g/L. The high concentration of dissolved organic carbon might be a main reason which resulted in the higher WQC values in the Taihu Lake. The WQC of copper in the freshwater would provide a scientific foundation for water quality standards and the environment risk assessment in China.	[Zhang, Yahui; Zheng, Lei; Cao, Ying; Yan, Zhenguang; Liu, Zhengtao] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Ecol Effects & Ris, Beijing, Peoples R China; [Zang, Wenchao] MEP, Solid Waste & Chem Management Ctr, Beijing, Peoples R China; [Qin, Lumei] Guangxi Polytech Construct, Nanning, Guangxi Provinc, Peoples R China; [Qin, Lumei; Zeng, Honghu] Guilin Univ Technol, Coll Environm Sci & Engn, Guilin, Guangxi Provinc, Peoples R China; [Yi, Xianliang] Dalian Univ Technol, Dalian, Liaoning Provin, Peoples R China	Chinese Research Academy of Environmental Sciences; Guilin University of Technology; Dalian University of Technology	Yan, ZG; Liu, ZT (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Ecol Effects & Ris, Beijing, Peoples R China.	zgyan@craes.org.cn; liuzt@craes.org.cn			National Science and Technology Project of Water Pollution Control and Abatement of China [2012ZX07501-003]; National Natural Science Foundation of the People's Republic of China [21407139]; Science and Technology Basic Work of Science and Technology [2014FY120600]	National Science and Technology Project of Water Pollution Control and Abatement of China; National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Science and Technology Basic Work of Science and Technology	This work was financially supported by the National Science and Technology Project of Water Pollution Control and Abatement of China (2012ZX07501-003) (http://nwpcp.mep.gov.cn/), the National Natural Science Foundation of the Peoples Republic of China (21407139) (http://www.nsfc.gov.cn/) and the Science and Technology Basic Work of Science and Technology (2014FY120600) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTM, 1993, STAND GUID COND AC T, P88; Bianchini A, 2004, INT CONGR SER, V1275, P189, DOI 10.1016/j.ics.2004.08.074; CCME. Council of Ministers of the Environment, 2007, PROT DER WAT QUAL GU; Chen ZZ, 2010, ENVIRON SCI TECHNOL, V44, P3580, DOI 10.1021/es1003457; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P192, DOI 10.1065/espr2002.11.141.1; [丛宁 Cong Ning], 2005, [扬州大学学报. 农业与生命科学版, Journal of Yangzhou University], V26, P89; Craven AM, 2012, ENVIRON SCI TECHNOL, V46, P9948, DOI 10.1021/es301015p; De Schamphelaere KAC, 2003, ENVIRON TOXICOL CHEM, V22, P2454, DOI 10.1897/02-499; De Schamphelaere KAC, 2002, COMP BIOCHEM PHYS C, V133, P243, DOI 10.1016/S1532-0456(02)00087-X; De Schamphelaere KAC, 2002, ENVIRON SCI TECHNOL, V36, P48, DOI 10.1021/es000253s; de Schamphelaere KAC, 2007, ENVIRON TOXICOL CHEM, V26, P535, DOI 10.1897/06-247R.1; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1002/etc.5620201034; Erickson RJ, 1996, ENVIRON TOXICOL CHEM, V15, P181, DOI 10.1002/etc.5620150217; Feng CL, 2012, ENVIRON SCI TECHNOL, V46, P10877, DOI 10.1021/es303500n; Ignacio RD, 2005, ENVIRON SCI TECHNOL, V39, P1542, DOI 10.1021/es040545j; Janssen CR, 2003, ENVIRON INT, V28, P793, DOI 10.1016/S0160-4120(02)00126-5; Jia XY, 2005, RES ENV SCI, V5, P26; Jin XW, 2012, ENVIRON SCI POLLUT R, V19, P609, DOI 10.1007/s11356-011-0594-1; Kennedy CJ, 2012, ENVIRON TOXICOL CHEM, V31, P2281, DOI 10.1002/etc.1948; Kong ZM, 1998, ENVIRON POLLUT, V99, P279, DOI 10.1016/S0269-7491(97)00111-5; Liu CQ, J ANHUI AGR SCI; MacRae RK, 1999, ENVIRON TOXICOL CHEM, V18, P1180, DOI 10.1002/etc.5620180616; Marr JCA, 1999, CAN J FISH AQUAT SCI, V56, P1471, DOI 10.1139/cjfas-56-8-1471; MEADOR JP, 1991, AQUAT TOXICOL, V19, P13, DOI 10.1016/0166-445X(91)90025-5; MOUNT DI, 1968, WATER RES, V2, P215, DOI 10.1016/0043-1354(68)90027-4; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; OECD (Organization for Economic Cooperation and Development), OECD GUID TEST CHEM; PLAYLE RC, 1993, CAN J FISH AQUAT SCI, V50, P2678, DOI 10.1139/f93-291; Ryan AC, 2009, ENVIRON TOXICOL CHEM, V28, P1663, DOI 10.1897/08-361.1; Santore RC, 2001, ENVIRON TOXICOL CHEM, V20, P2397, DOI [10.1002/etc.5620201035, 10.1897/1551-5028(2001)020&lt;2397:BLMOTA&gt;2.0.CO;2]; Schwartz ML, 2004, ENVIRON TOXICOL CHEM, V23, P2889, DOI 10.1897/03-561.1; Tsushima K, 2010, CHEMOSPHERE, V80, P563, DOI 10.1016/j.chemosphere.2010.04.031; USEPA, 2007, AQ LIF AMB FRESHW QU; USEPA, 1985, PB85227049 USEPA; Wang Chunyan, 2013, Asian Journal of Ecotoxicology, V8, P998, DOI 10.7524/AJE.1673-5897.20110916001; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076624; Wang J, 1992, ACTA ECOL SINICA, V12, P201; Wang N, 2011, ENVIRON TOXICOL CHEM, V30, P2115, DOI 10.1002/etc.596; Wang Wan-bin, 2014, Huanjing Kexue, V35, P3947; Wang XN, 2013, J HAZARD MATER, V260, P1017, DOI 10.1016/j.jhazmat.2013.07.007; Wang XN, 2014, ENVIRON SCI POLLUT R, V21, P168, DOI 10.1007/s11356-013-2110-2; Wang Zhen, 2014, Asian Journal of Ecotoxicology, V9, P640, DOI 10.7524/AJE.1673-589720140531001; Warne Michael St J., 2008, Australasian Journal of Ecotoxicology, V14, P1; Wu FC, 2010, ENVIRON SCI TECHNOL, V44, P7992, DOI 10.1021/es1029365; Wu JY, 2015, ENVIRON POLLUT, V196, P141, DOI 10.1016/j.envpol.2014.09.024; Yan H, 2001, ENV SCI, V22, P23; Yan ZG, 2012, ENVIRON POLLUT, V162, P86, DOI 10.1016/j.envpol.2011.11.007; Yang L., 2003, J S CHINA NORMAL U, V2, P101, DOI [10.6054/j.jscnun.2003.05.021, DOI 10.6054/J.JSCNUN.2003.05.021]; Yang SW, 2014, SCI TOTAL ENVIRON, V470, P677, DOI 10.1016/j.scitotenv.2013.09.094; Yu T, 2012, ENVIRON MONIT ASSESS, V184, P4367, DOI 10.1007/s10661-011-2270-9; Zhou LH, 1994, J XIAMEN FISHERIES C, V16, P11; Zhou T, 2014, ENV SCI, V35, P332; Zhou W.M., 1991, RES ENV SCI, P9, DOI DOI 10.13198/j.res.1991.06.11.zhouwm.002.; ZITKO P, 1973, B ENVIRON CONTAM TOX, V10, P265, DOI 10.1007/BF01684814	54	16	17	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170105	10.1371/journal.pone.0170105	http://dx.doi.org/10.1371/journal.pone.0170105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166229	gold, Green Submitted, Green Published			2022-12-27	WOS:000393700100005
J	Eickmeier, O; Fussbroich, D; Mueller, K; Serve, F; Smaczny, C; Zielen, S; Schubert, R				Eickmeier, Olaf; Fussbroich, Daniela; Mueller, Klaus; Serve, Friederike; Smaczny, Christina; Zielen, Stefan; Schubert, Ralf			Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY INFLAMMATION; CFTR EXPRESSION; RESOLUTION; ASSOCIATION; NEUTROPHILS; MECHANISMS; STRATEGIES; PROFILES; CHILDREN	Background Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects multiple organs, including the lungs, pancreas, liver and intestine. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) locus lead to defective proteins and reduced Cl-secretion and Na+ hyperabsorption in the affected organs. In addition, patients suffering from CF display chronic inflammation that contributes to the pathogenesis of CF. Recent work suggests that CF patients have a reduced capacity to biosynthesize specialized pro-resolving lipid mediators (SPMs), which contributes to the development and duration of the unwanted inflammation. Alterations in the metabolism of arachidonic acid (AA) and docosahexaenoic acid (DHA) to specialized pro-resolving mediators (SPMs), like lipoxins (LXs), maresins (MaRs), protectins (PDs) and resolvins (Rvs), may play a major role on clinical impact of airway inflammation in CF. Methods In this study, our aims were to detect and quantitate Resolvin D1 (RvD1) in sputum and plasma from patients with CF and compare levels of RvD1 with biomarkers of inflammation and lung function. We studied 27 CF patients aged 6 to 55 years (median 16 years) in a prospective approach. Results DHA can be found in the plasma of our CF patients in the milligram range and is decreased in comparison to a healthy control group. The DHA-derived pro-resolving mediator Resolvin D1 (RvD1) was also present in the plasma (286.4 +/- 50 pg/ mL, mean +/- SEM) and sputum (30.0 +/- 2.6 pg/ mL, mean +/- SEM) samples from our patients with CF and showed a positive correlation with sputum inflammatory markers. The plasma concentrations of RvD1 were ten times higher than sputum concentrations. Interestingly, sputum RvD1/IL-8 levels showed a positive correlation with FEV1 (r(s) = 0.3962, p< 0.05). Conclusions SPMs, like RvD1, are well known to down-regulate inflammatory pathways. Our study shows that the bioactive lipid mediator RvD1, derived from DHA, was present in sputum and plasma of CF patients and may serve as a representative peripheral biomarker of the lung resolution program for CF patients.	[Eickmeier, Olaf; Fussbroich, Daniela; Mueller, Klaus; Serve, Friederike; Zielen, Stefan; Schubert, Ralf] Goethe Univ, Div Allergol Pulmonol & Cyst Fibrosis, Dept Children & Adolescents, Frankfurt, Germany; [Fussbroich, Daniela] Univ Appl Sci, Dept Food Technol, Fulda, Germany; [Smaczny, Christina] Goethe Univ, Dept Internal Med 3, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Eickmeier, O (corresponding author), Goethe Univ, Div Allergol Pulmonol & Cyst Fibrosis, Dept Children & Adolescents, Frankfurt, Germany.	olaf.eickmeier@kgu.de	Zielen, Stefan/AAD-7243-2020	Eickmeier, Olaf/0000-0003-2835-9886				Al-Turkmani MR, 2007, PROSTAG LEUKOTR ESS, V77, P309, DOI 10.1016/j.plefa.2007.10.009; BLANCHARD J, 1992, THER DRUG MONIT, V14, P48, DOI 10.1097/00007691-199202000-00008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bruscia EM, 2016, CLIN CHEST MED, V37, P17, DOI 10.1016/j.ccm.2015.11.010; Burgel PR, 2007, THORAX, V62, P153, DOI 10.1136/thx.2006.062190; Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Carevic M, 2015, EUR RESPIR J, V46, P395, DOI 10.1183/09031936.00173514; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Doring G, 2000, Paediatr Respir Rev, V1, P101, DOI 10.1053/prrv.2000.0030; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Eckrich J, 2016, J CYSTIC FIBROSIS OF; Efthimiadis A, 2002, EUR RESPIR J, V20, p19S, DOI 10.1183/09031936.02.00001902; Eickmeier O., 2013, Mediators of Inflammation, V2013, P913135, DOI 10.1155/2013/913135; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Elborn JS., 2016, LANCET LONDON ENGLAN; Ettorre M, 2014, BBA-GEN SUBJECTS, V1840, P3088, DOI 10.1016/j.bbagen.2014.07.010; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fantino E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-28; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Freedman SD, 1999, P NATL ACAD SCI USA, V96, P13995, DOI 10.1073/pnas.96.24.13995; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Haworth O, 2007, EUR RESPIR J, V30, P980, DOI 10.1183/09031936.00005807; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024399; Karp CL, 2005, PROSTAG LEUKOTR ESS, V73, P263, DOI 10.1016/j.plefa.2005.05.015; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072981; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Kohn G, 1996, Z ERNAHRUNGSWISS, V35, P226, DOI 10.1007/BF01625685; Kormann MSD, 2012, EUR RESPIR J, V39, P1385, DOI 10.1183/09031936.00130011; Laval J, 2016, BIOL CHEM, V397, P485, DOI 10.1515/hsz-2015-0271; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; Mattoscio D, 2010, FASEB J, V24, P3970, DOI 10.1096/fj.10-159921; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Muller U, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/626530; Oliver C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002201.pub5; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Plant BJ, 2013, LANCET RESP MED, V1, P164, DOI 10.1016/S2213-2600(13)70025-0; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Ringholz FC, 2014, EUR RESPIR J, V44, P394, DOI 10.1183/09031936.00106013; Rosewich M, 2015, CYTOKINE, V73, P156, DOI 10.1016/j.cyto.2014.10.026; Rothman S, 1996, GASTROENTEROLOGY, V111, P833, DOI 10.1053/gast.1996.v111.agast961110833; Sagel SD, 2003, CURR OPIN PULM MED, V9, P516, DOI 10.1097/00063198-200311000-00012; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Shanshiashvili LV, 2012, MOL IMMUNOL, V51, P310, DOI 10.1016/j.molimm.2012.03.029; Starosta V, 2006, EUR RESPIR J, V28, P581, DOI 10.1183/09031936.06.00071405; Takashi M, 1990, JAPANESE J UROLOGY, V81, P116; Tu ML, 2013, SCI WORLD J, DOI 10.1155/2013/402140; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Wojewodka G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088567	56	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171249	10.1371/journal.pone.0171249	http://dx.doi.org/10.1371/journal.pone.0171249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158236	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700046
J	Gracia, MJ; Moreno, C; Ferrer, M; Sanz, A; Peribanez, MA; Estrada, R				Jesus Gracia, Maria; Moreno, Carlos; Ferrer, Montserrat; Sanz, Alfredo; Angel Peribanez, Miguel; Estrada, Rosa			Field efficacy of acaricides against Varroa destructor	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; JACOBSONI ACARI; PARASITIC MITES; PLANT-EXTRACTS; ESSENTIAL OILS; COLONIES; THYMOL; PERSISTENCE; APIGUARD; RESIDUE	Field trials were conducted in Northeast Spain (Aragon) to evaluate the effectiveness of two acaricides against Varroa destructor. These experiments took into account the season of the year, apiary, colony, and developmental state and strength of the colony. The acaricides used were a synthetic (amitraz, Apivar (R)) and a natural (formulated from Api Life Var (R), thymol oil and thymol alcohol) product. The treatments used in the present study reduce high infestations of V. destructor, although they do not eliminate the infestation. Similar efficacies between treatments were found. Nevertheless, the efficacy of a treatment depends on the apiary where applied. Moreover, the detected variability in the apiary and hive poses a challenge to the identification of the significant factors. Therefore, more field studies to assess efficacies in several apiaries are needed to obtain a better understanding of the effects of the applied treatments.	[Jesus Gracia, Maria; Angel Peribanez, Miguel; Estrada, Rosa] Univ Zaragoza CITA, Fac Vet, Dept Patol Anim, Parasitol & Enfermedades Parasitarias, Zaragoza, Spain; [Moreno, Carlos] Univ Zaragoza CITA, Fac Vet, Dept Anat Embriol & Genet Anim, Genet Anim, Zaragoza, Spain; [Ferrer, Montserrat] Diputacio Gen Aragon, Dept Agr & Alimentac, Serv Ordenac & Sanidad Anim, Zaragoza, Spain; [Sanz, Alfredo] Asociacio Apicola, ARNA, Zaragoza, Spain		Gracia, MJ (corresponding author), Univ Zaragoza CITA, Fac Vet, Dept Patol Anim, Parasitol & Enfermedades Parasitarias, Zaragoza, Spain.	mjgracia@unizar.es	, Miguel/ABF-5399-2020	Peribanez, Miguel A/0000-0003-3436-776X	Spanish Government, INIA [API 98-008]	Spanish Government, INIA	This study was carried out with the financial contribution of the Spanish Government, INIA project (API 98-008).	Accorti M, 1986, APICOLTURA, V2, P165; [Anonymous], ESTRATEGIA CONTROL V; Arculeo P., 2002, ATT CONV AMA 2 RUOL; Bulacio Cagnolo N., 2010, InVet, V12, P85; Calderone NW, 1999, J ECON ENTOMOL, V92, P253, DOI 10.1093/jee/92.2.253; CALDERONE NW, 1995, J ECON ENTOMOL, V88, P1211, DOI 10.1093/jee/88.5.1211; Calderone NW, 1997, J ECON ENTOMOL, V90, P1080, DOI 10.1093/jee/90.5.1080; Carmona M, 2002, VIDA APIC, V113, P35; CHIESA F, 1991, APIDOLOGIE, V22, P135, DOI 10.1051/apido:19910206; Chuda-Mickiewicz Bozena, 2007, Journal of Apicultural Science, V51, P47; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Emsen B, 2009, J ANIM VET ADV, V8, P1004; EVANS PD, 1980, NATURE, V287, P60, DOI 10.1038/287060a0; Faucon JP, 2007, REV MED VET-TOULOUSE, V158, P283; Ferrer-Dufol M, 1995, J APICULT RES, V34, P147, DOI 10.1080/00218839.1995.11100899; Flores J. M., 2000, VIDA APICOLA, V104, P26; Floris I, 2004, J ECON ENTOMOL, V97, P187, DOI 10.1603/0022-0493-97.2.187; Floris I, 2001, APIDOLOGIE, V32, P577, DOI 10.1051/apido:2001145; Giovenazzo P, 2011, EXP APPL ACAROL, V55, P65, DOI 10.1007/s10493-011-9447-3; Imdorf A, 1999, APIDOLOGIE, V30, P209, DOI 10.1051/apido:19990210; IMDORF A, 1995, BEE WORLD, V76, P77, DOI 10.1080/0005772X.1995.11099245; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Mattila HR, 1999, AM BEE J, V139, P947; Mattila HR, 2000, AM BEE J, V140, P969; Molins-Marin JL, 1987, VIDA APICOLA, V21, P32; OIE (World Organisation for Animal Health), 2008, MAN DIAGN TESTS VACC, V6, P424; Pohorecka K, 2008, P 25 SCI C AP PUL PO, P83; Rademacher E, 2006, APIDOLOGIE, V37, P98, DOI 10.1051/apido:2005063; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Schmidt S. V., 2008, Agro Sur, V36, P8; Semkiw P, 2013, J APIC SCI, V57, P107, DOI 10.2478/jas-2013-0012; Vallon J., 2007, B TECH APIC, V34, P49; Vanengelsdorp D, 2008, J ECON ENTOMOL, V101, P256, DOI 10.1603/0022-0493(2008)101[256:SFOHBH]2.0.CO;2	33	18	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171633	10.1371/journal.pone.0171633	http://dx.doi.org/10.1371/journal.pone.0171633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158303	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700116
J	Jiang, YF; Dong, H; Eckmann, L; Hanson, EM; Ihn, KC; Mittal, RK				Jiang, Yanfen; Dong, Hui; Eckmann, Lars; Hanson, Elaine M.; Ihn, Katherine C.; Mittal, Ravinder K.			Visualizing the enteric nervous system using genetically engineered double reporter mice: Comparison with immunofluorescence	PLOS ONE			English	Article							MYENTERIC NEURONS; CHOLINE-ACETYLTRANSFERASE; IMMUNOREACTIVITY; INNERVATION; PROJECTIONS; EXPRESSION; PLEXUS	Background and aims The enteric nervous system (ENS) plays a crucial role in the control of gastrointestinal motility, secretion and absorption functions. Immunohistochemistry has been widely used to visualize neurons of the ENS for more than two decades. Genetically engineered mice that report specific proteins can also be used to visualize neurons of the ENS. The goal of our study was to develop a mouse that expresses fluorescent neuronal nitric oxide synthase (nNOS) and choline acetyltransferase (ChAT), the two proteins expressed in 95% of the ENS neurons. We compared ENS neurons visualized in the reporter mouse with the wild type mouse stained using classical immunostaining techniques. Methods Mice hemizygous for ChAT-ChR2-YFP BAC transgene with expression of the mhChR2: YFP fusion protein directed by ChAT promoter/enhancer regions on the BAC transgene were purchased commercially. The Cre/LoxP technique of somatic recombination was used to construct mice with nNOS positive neurons. The two mice were crossbred and tissues were harvested and examined using fluorescent microscopy. Immunostaining was performed in the wild type mice, using antibodies to nNOS, ChAT, Hu and PGP 9.5. Results Greater than 95% of the ENS neurons were positive for either nNOS or ChAT or both. The nNOS and ChAT neurons and their processes in the ENS were well visualized in all the regions of the GI tract, i.e., esophagus, small intestine and colon. The number of nNOS and ChAT neurons was approximately same in the reporter mouse and immunostaining method in the wild type mouse. The nNOS fluorescence in the reporter mouse was seen in both cytoplasm as well as nucleus but in the immunostained specimens it was seen only in the cytoplasm. Conclusion We propose that the genetically engineered double reporter mouse for ChAT and nNOS proteins is a powerful tool to study of the effects of various diseases on the ENS without the need for immunostaining.	[Jiang, Yanfen; Dong, Hui; Eckmann, Lars; Hanson, Elaine M.; Ihn, Katherine C.; Mittal, Ravinder K.] Univ Calif San Diego, Dept Med, Sch Med, Div Gastroenterol, San Diego, CA 92103 USA; [Mittal, Ravinder K.] San Diego VA Hlth Care Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego	Mittal, RK (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, Div Gastroenterol, San Diego, CA 92103 USA.; Mittal, RK (corresponding author), San Diego VA Hlth Care Syst, San Diego, CA 92161 USA.	rmittal@ucsd.edu	Mittal, Ravinder/ABH-2171-2021		VA MERIT Grant;  [P30 NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	VA MERIT Grant; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by VA MERIT Grant to RKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by VA MERIT Grant to RKM. All images were taken at the UCSD School of Medicine Microscopy Core Laboratory, which is supported by the Grant P30 NS047101. We thank Jennifer Santini of the UCSD microscopy core for help with the image acquisition.	Brookes SJH, 1996, GASTROENTEROLOGY, V111, P108, DOI 10.1053/gast.1996.v111.pm8698189; Carbone SE, 2014, NEUROGASTROENT MOTIL, V26, P1812, DOI 10.1111/nmo.12453; Costa M., 2000, Gut, V47, piv15, DOI 10.1136/gut.47.suppl_4.iv15; COSTA M, 1992, NEUROSCI LETT, V148, P121, DOI 10.1016/0304-3940(92)90819-S; Erickson CS, 2014, NEUROGASTROENT MOTIL, V26, P874, DOI 10.1111/nmo.12343; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hao MM, 2013, J COMP NEUROL, V521, P3358, DOI 10.1002/cne.23354; Mawe GM, 1997, MICROSC RES TECHNIQ, V39, P1, DOI 10.1002/(SICI)1097-0029(19971001)39:1<1::AID-JEMT1>3.0.CO;2-R; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Murphy EMA, 2007, NEUROGASTROENT MOTIL, V19, P126, DOI 10.1111/j.1365-2982.2006.00843.x; NEUHUBER WL, 1994, CELL TISSUE RES, V276, P23, DOI 10.1007/BF00354780; Porter AJ, 1996, GASTROENTEROLOGY, V111, P401, DOI 10.1053/gast.1996.v111.pm8690205; Porter AJ, 2002, GUT, V51, P70, DOI 10.1136/gut.51.1.70; Sang Q, 1997, J ANAT, V190, P209, DOI 10.1046/j.1469-7580.1997.19020209.x; Udit S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00134; Wattchow D, 2008, NEUROGASTROENT MOTIL, V20, P1298, DOI 10.1111/j.1365-2982.2008.01165.x	17	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171239	10.1371/journal.pone.0171239	http://dx.doi.org/10.1371/journal.pone.0171239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158225	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700045
J	O'Connor, EM; Koufaki, P; Mercer, TH; Lindup, H; Nugent, E; Goldsmith, D; Macdougall, IC; Greenwood, SA				O'Connor, Ellen M.; Koufaki, Pelagia; Mercer, Thomas H.; Lindup, Herolin; Nugent, Eilish; Goldsmith, David; Macdougall, Iain C.; Greenwood, Sharlene A.			Long-term pulse wave velocity outcomes with aerobic and resistance training in kidney transplant recipients - A pilot randomised controlled trial	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; STAGE RENAL-DISEASE; AORTIC STIFFNESS; HEMODIALYSIS-PATIENTS; ARTERIAL STIFFNESS; PHYSICAL-ACTIVITY; EXERCISE PROGRAM; RISK; SURVIVAL; IMPACT	Background This pilot study examined long-term pulse wave velocity (PWV) and peak oxygen uptake (VO(2)peak) outcomes following a 12-week moderate-intensity aerobic or resistance training programme in kidney transplant recipients. Method Single-blind, bi-centre randomised controlled parallel trial. 42 out of 60 participants completed a 9-month follow-up assessment (Aerobic training = 12, Resistance training = 10 and usual care = 20). Participants completed 12 weeks of twice-weekly supervised aerobic or resistance training. Following the 12-week exercise intervention, participants were transitioned to self-managed community exercise activity using motivational interviewing techniques. Usual care participants received usual encouragement for physical activity during routine clinical appointments in the transplant clinic. PWV, VO2peak, blood pressure and body weight were assessed at 12 weeks and 12 months, and compared to baseline. Results ANCOVA analysis, covarying for baseline values, age, and length of time on dialysis pretransplantation, revealed a significant mean between-group difference in PWV of -1.30 m/sec (95% CI-2.44 to -0.17, p = 0.03) between resistance training and usual care groups. When comparing the aerobic training and usual care groups at 9-month follow-up, there was a mean difference of -1.05 m/sec (95%CI -2.11 to 0.017, p = 0.05). A significant mean between-group difference in relative VO2peak values of 2.2 ml/kg/min (95% CI 0.37 to 4.03, p = 0.02) when comparing aerobic training with usual care was revealed. There was no significant between group differences in body weight or blood pressure. There were no significant adverse effects associated with the interventions. Conclusions Significant between-group differences in 9-month follow-up PWV existed when comparing resistance exercise intervention with usual care. A long-term between-group difference in VO(2)peak was only evident when comparing aerobic intervention with usual care. This pilot study, with a small sample size, did not aim to elucidate mechanistic mediators related to the exercise interventions. It is however suggested that a motivational interviewing approach, combined with appropriate transition to community training programmes, could maintain the improvements gained from the 12-week exercise interventions and further research in this area is therefore warranted.	[O'Connor, Ellen M.; Lindup, Herolin; Greenwood, Sharlene A.] Kings Coll Hosp London, Physiotherapy Dept, London, England; [O'Connor, Ellen M.; Macdougall, Iain C.; Greenwood, Sharlene A.] Kings Coll Hosp London, Dept Renal Med, London, England; [O'Connor, Ellen M.; Macdougall, Iain C.; Greenwood, Sharlene A.] Kings Coll London, Renal Sci, London, England; [Koufaki, Pelagia; Mercer, Thomas H.] Queen Margaret Univ, Sch Hlth Sci, Edinburgh, Midlothian, Scotland; [Nugent, Eilish; Goldsmith, David] Guys & St Thomas Hosp, Dept Renal Med, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Queen Margaret University; Guy's & St Thomas' NHS Foundation Trust	O'Connor, EM (corresponding author), Kings Coll Hosp London, Physiotherapy Dept, London, England.; O'Connor, EM (corresponding author), Kings Coll Hosp London, Dept Renal Med, London, England.; O'Connor, EM (corresponding author), Kings Coll London, Renal Sci, London, England.	ellen.o'connor@nhs.net	Goldsmith, David J A/H-6965-2018	Goldsmith, David J A/0000-0002-4349-9193; Castle, Ellen/0000-0002-6961-6108; greenwood, sharlene/0000-0001-9485-4645	National Institute for Health Research (NIHR); NIHR; National Institute for Health Research [DRF-2012-05-874] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Ellen O'Connor and Sharlene Greenwood were funded by the National Institute for Health Research (NIHR). The study was hosted in the KCH NIHR Clinical Research Facility. This paper presents independent research funded by the NIHR. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders did not have any role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.	Barnett N., 2011, SURG OXF, V29, P330; Bennett PN, 2010, SEMIN DIALYSIS, V23, P62, DOI 10.1111/j.1525-139X.2009.00652.x; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Cook SA, 2008, NEPHROL DIAL TRANSPL, V23, P263, DOI 10.1093/ndt/gfm511; Dahle DO, 2015, TRANSPLANTATION, V99, P1730, DOI 10.1097/TP.0000000000000660; Garcia GG, 2012, NEPHRON CLIN PRACT, V120, pC101, DOI 10.1159/000337043; Greenwood SA, 2015, AM J KIDNEY DIS; Greenwood SA, 2015, AM J KIDNEY DIS, V65, P425, DOI 10.1053/j.ajkd.2014.07.015; Greenwood SA, 2014, J RENAL CARE, V40, P219, DOI 10.1111/jorc.12080; Heiwe S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003236.pub2; Hickson SS, 2009, HYPERTENS RES, V32, P1079, DOI 10.1038/hr.2009.154; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1735, DOI 10.1681/ASN.V1191735; Koufaki P, 2015, J SPORTS SCI; Kouidi E, 2013, NEPHROL DIAL TRANSPL, V28, P1294, DOI 10.1093/ndt/gfs455; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mihaescu A, 2013, NEPHRON CLIN PRACT, V124, P72, DOI 10.1159/000355856; Mustata S, 2004, J AM SOC NEPHROL, V15, P2713, DOI 10.1097/01.ASN.0000140256.21892.89; O'Halloran PD, 2014, CLIN REHABIL, V28, P1159, DOI 10.1177/0269215514536210; Orazio L, 2009, J RENAL NUTR, V19, P304, DOI 10.1053/j.jrn.2008.11.006; Painter PL, 2003, AM J KIDNEY DIS, V42, P362, DOI 10.1016/S0272-6386(03)00673-5; Painter PL, 2002, TRANSPLANTATION, V74, P42, DOI 10.1097/00007890-200207150-00008; Riess KJ, 2014, APPL PHYSIOL NUTR ME, V39, P566, DOI 10.1139/apnm-2013-0449; Rollnick S., 2008, MOTIVATIONAL INTERVI; Rosas SE, 2012, AM J NEPHROL, V35, P17, DOI 10.1159/000334732; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x; Ten Have T. R., 2008, PSYCHIAT ANN, V38; Ting SMS, 2014, J AM SOC NEPHROL, V25, P187, DOI 10.1681/ASN.2013040348; Toussaint ND, 2008, HEMODIAL INT, V12, P254, DOI 10.1111/j.1542-4758.2008.00262.x; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; WELTMAN A, 1994, J CLIN ENDOCR METAB, V78, P543, DOI 10.1210/jc.78.3.543; Zelle DM, 2013, CLIN TRANSPLANT, V27, pE484, DOI 10.1111/ctr.12149	34	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171063	10.1371/journal.pone.0171063	http://dx.doi.org/10.1371/journal.pone.0171063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158243	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700026
J	Walker, XJ; Frey, MD; Conway, AJ; Jean, M; Johnstone, JF				Walker, Xanthe J.; Frey, Matthew D.; Conway, Alexandra J.; Jean, Melanie; Johnstone, Jill F.			Impacts of fire on non-native plant recruitment in black spruce forests of interior Alaska	PLOS ONE			English	Article							CANADIAN WEEDS; TREE RECRUITMENT; BOREAL FOREST; COMMUNITIES; INVASIONS; BIOLOGY; SUSCEPTIBILITY; ECOSYSTEMS	Climate change is expected to increase the extent and severity of wildfires throughout the boreal forest. Historically, black spruce (Picea mariana (Mill.) B.S.P.) forests in interior Alaska have been relatively free of non-native species, but the compounding effects of climate change and an altered fire regime could facilitate the expansion of non-native plants. We tested the effects of wildfire on non-native plant colonization by conducting a seeding experiment of non-native plants on different substrate types in a burned black spruce forest, and surveying for non-native plants in recently burned and mature black spruce forests. We found few non-native plants in burned or mature forests, despite their high roadside presence, although invasion of some burned sites by dandelion (Taraxacum officinale) indicated the potential for non-native plants to move into burned forest. Experimental germination rates were significantly higher on mineral soil compared to organic soil, indicating that severe fires that combust much of the organic layer could increase the potential for non-native plant colonization. We conclude that fire disturbances that remove the organic layer could facilitate the invasion of non-native plants providing there is a viable seed source and dispersal vector.	[Walker, Xanthe J.] No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA; [Frey, Matthew D.; Conway, Alexandra J.; Jean, Melanie; Johnstone, Jill F.] Univ Saskatchewan, Dept Biol, Saskatoon, SK, Canada	Northern Arizona University; University of Saskatchewan	Walker, XJ (corresponding author), No Arizona Univ, Ctr Ecosyst Sci & Soc, Flagstaff, AZ 86011 USA.	xanthe.walker@gmail.com	Johnstone, Jill F./C-9204-2009; Walker, Xanthe/K-1649-2019; Jean, Mélanie/AAG-2814-2019	Johnstone, Jill F./0000-0001-6131-9339; Walker, Xanthe/0000-0002-2448-691X; Jean, Mélanie/0000-0002-7393-5566	U. S. Department of Defense's Strategic Environmental Research and Development Program (SERDP) [RC-2109]	U. S. Department of Defense's Strategic Environmental Research and Development Program (SERDP)	Funding for this research was provided by the U. S. Department of Defenses Strategic Environmental Research and Development Program (SERDP) under project RC-2109.	AARSSEN LW, 1986, CAN J PLANT SCI, V66, P711, DOI 10.4141/cjps86-092; [Anonymous], 2002, PLANTS DAT VERS 3 5; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Carlson M.L., 2008, INVASIVENESS RANKING; Conn JS, 2008, ARCT ANTARCT ALP RES, V40, P298, DOI 10.1657/1523-0430(06-007)[CONN]2.0.CO;2; Conn JS, 2011, ARCT ANTARCT ALP RES, V43, P343, DOI 10.1657/1938-4246-43.3.343; DENSMORE RV, 2001, EXOTIC PLANTS ALASKA; DYRNESS CT, 1983, CAN J FOREST RES, V13, P879, DOI 10.1139/x83-118; Fife D, 2014, FIFER COLLECTION MIS; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Frey M, 2013, THESIS; Greene DF, 2007, CAN J FOREST RES, V37, P1012, DOI 10.1139/X06-245; Hollingsworth TN, 2006, CAN J FOREST RES, V36, P1781, DOI 10.1139/X06-061; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Kutner M., 2005, APPL LINEAR STAT MOD; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Nolen A., 2002, VETCH INFESTATIONS A, P39; Osterkamp TE, 1999, PERMAFROST PERIGLAC, V10, P17, DOI 10.1002/(SICI)1099-1530(199901/03)10:1&lt;17::AID-PPP303&gt;3.0.CO;2-4; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rose M, 2004, OECOLOGIA, V139, P467, DOI 10.1007/s00442-004-1527-1; Royer F, 1999, WEEDS NO US CANADA G; Sanderson LA, 2012, FORESTRY, P1; Spellman KV, 2014, BIOL INVASIONS, V16, P1879, DOI 10.1007/s10530-013-0633-6; Stewart-Wade SM, 2002, CAN J PLANT SCI, V82, P825, DOI 10.4141/P01-010; TURKINGTON RA, 1978, CAN J PLANT SCI, V58, P523, DOI 10.4141/cjps78-078; VANCLEVE K, 1983, CAN J FOREST RES, V13, P894; Villano K. L., 2008, INVASIVE PLANT SPREA; WHITSON TD, 1991, WEEDS W	32	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171599	10.1371/journal.pone.0171599	http://dx.doi.org/10.1371/journal.pone.0171599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158284	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700106
J	Chu, C; Liu, JZ; Shen, C; Jin, JH; Shi, L				Chu, Chen; Liu, Jinzhuo; Shen, Chen; Jin, Jiahua; Shi, Lei			Win-stay-lose-learn promotes cooperation in the prisoner's dilemma game with voluntary participation	PLOS ONE			English	Article							SCALE-FREE NETWORKS; EVOLUTIONARY GAMES; RESONANCE; NOISE	Voluntary participation, demonstrated to be a simple yet effective mechanism to promote persistent cooperative behavior, has been extensively studied. It has also been verified that the aspiration-based win-stay-lose-learn strategy updating rule promotes the evolution of cooperation. Inspired by this well-known fact, we combine the Win-Stay-Lose-Learn updating rule with voluntary participation: Players maintain their strategies when they are satisfied, or players attempt to imitate the strategy of one randomly chosen neighbor. We find that this mechanism maintains persistent cooperative behavior, even further promotes the evolution of cooperation under certain conditions.	[Chu, Chen; Shen, Chen; Jin, Jiahua; Shi, Lei] Yunnan Univ Finance & Econ, Sch Math & Stat, Kunming, Yunnan, Peoples R China; [Liu, Jinzhuo] Yunnan Univ, Sch Software, Kunming, Yunnan, Peoples R China; [Jin, Jiahua] Lib Yunnan Normal Univ, Kunming, Yunnan, Peoples R China	Yunnan University of Finance & Economics; Yunnan University	Shi, L (corresponding author), Yunnan Univ Finance & Econ, Sch Math & Stat, Kunming, Yunnan, Peoples R China.	shi_lei65@hotmail.com	Jin, Jiahua/I-8864-2012	Jin, Jiahua/0000-0002-7592-2160	National Natural Science Foundation of China (Yunnan United Fund (Key Project) [U1302267]; National Natural Science Foundation of China [11671348, 11161053, 61462092, 61662085]; Key Project of Natural Science Foundation of Yunnan Province [2014FD006, 2015FA014]; Science Foundation of Yunnan Province Education Department [2015Y013]	National Natural Science Foundation of China (Yunnan United Fund (Key Project)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Yunnan Province; Science Foundation of Yunnan Province Education Department	We appreciate the support from (I) National Natural Science Foundation of China (Yunnan United Fund (Key Project) grants no. U1302267), (II) National Natural Science Foundation of China (grants no. 11671348, 11161053, 61462092, 61662085), (III) Key Project of Natural Science Foundation of Yunnan Province (grants no.2014FD006, 2015FA014); (IV) Science Foundation of Yunnan Province Education Department (No. 2015Y013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MA, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032317; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Chen X, 2008, PHYS LETT A, V372, P1161, DOI 10.1016/j.physleta.2007.09.044; Cho IK, 2005, J ECON THEORY, V124, P171, DOI 10.1016/j.jet.2004.12.001; Du WB, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/60004; Du WB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/1/010204; Du WB, 2009, PHYSICA A, V388, P5005, DOI 10.1016/j.physa.2009.08.026; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Maynard S.J., 1982, EVOLUTION THEORY GAM; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/9/183; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Platkowski T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036103; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang GQ, 2013, CHAOS SOLITON FRACT, V51, P31, DOI 10.1016/j.chaos.2013.03.003	45	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171680	10.1371/journal.pone.0171680	http://dx.doi.org/10.1371/journal.pone.0171680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182707	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800088
J	De Smet, L; Hatjina, F; Ioannidis, P; Hamamtzoglou, A; Schoonvaere, K; Francis, F; Meeus, I; Smagghe, G; de Graaf, DC				De Smet, Lina; Hatjina, Fani; Ioannidis, Pavlos; Hamamtzoglou, Anna; Schoonvaere, Karel; Francis, Frederic; Meeus, Ivan; Smagghe, Guy; de Graaf, Dirk C.			Stress indicator gene expression profiles, colony dynamics and tissue development of honey bees exposed to sub-lethal doses of imidacloprid in laboratory and field experiments	PLOS ONE			English	Article							HYPOPHARYNGEAL GLANDS; NEONICOTINOIDS; PESTICIDES; AGE; QUANTIFICATION; MANAGEMENT; ACARICIDES; PROTEIN; WORKERS; BROOD	In this study, different context-dependent effects of imidacloprid exposure on the honey bee response were studied. Honey bees were exposed to different concentrations of imidacloprid during a time period of 40 days. Next to these variables, a laboratory-field comparison was conducted. The influence of the chronic exposure on gene expression levels was determined using an in-house developed microarray targeting different immunity-related and detoxification genes to determine stress-related gene expression changes. Increased levels of the detoxification genes encoding, CYP9Q3 and CYT P450, were detected in imidacloprid- exposed honey bees. The different context-dependent effects of imidacloprid exposure on honey bees were confirmed physiologically by decreased hypopharyngeal gland sizes. Honey bees exposed to imidacloprid in laboratory cages showed a general immunosuppression and no detoxification mechanisms were triggered significantly, while honey bees infield showed a resilient response with an immune stimulation at later time points. However, the treated colonies had a brood and population decline tendency after the first brood cycle in the field. In conclusion, this study highlighted the different context-dependent effects of imidacloprid exposure on the honey bee response. These findings warn for possible pitfalls concerning the generalization of results based on specific experiments with short exposure times. The increased levels of CYT P450 and CYP9Q3 combined with an immune response reaction can be used as markers for bees which are exposed to pesticides in the field.	[De Smet, Lina; Schoonvaere, Karel; de Graaf, Dirk C.] Univ Ghent, Fac Sci, Lab Mol Entomol & Bee Pathol, Ghent, Belgium; [Hatjina, Fani; Ioannidis, Pavlos; Hamamtzoglou, Anna] Hellen Agr Org DEMETER, Inst Anim Sci, Div Apiculture, Nea Moudania, Greece; [Francis, Frederic] Univ Liege, Gembloux AgrobioTech, Dept Funct & Evolut Entomol, Liege, Belgium; [Meeus, Ivan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Ghent, Belgium	Ghent University; University of Liege; Ghent University	De Smet, L (corresponding author), Univ Ghent, Fac Sci, Lab Mol Entomol & Bee Pathol, Ghent, Belgium.	lina.desmet@ugent.be	de Graaf, Dirk C./HGD-4017-2022; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; De Smet, Lina/0000-0002-8005-2059	Belgian Science Policy (BELSPO) [BR/132/A1/BELBEES]; EC-Greek Government project (EC) [797/07]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office); EC-Greek Government project (EC)	This work was supported by Belgian Science Policy (BELSPO; BR/132/A1/BELBEES; Multi-disciplinary assessment of BELgian wild BEE decline to adapt mitigation management policy), EC-Greek Government project (EC Dir. 797/07; Effect of neonicotinoids and air pollution on honey bees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger Bruno, 2005, Brazilian Journal of Morphological Sciences, V22, P1; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bloch G, 2010, P NATL ACAD SCI USA, V107, P11240, DOI 10.1073/pnas.1003265107; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Costa C, 2012, J APIC SCI, V56, P147, DOI 10.2478/v10289-012-0015-9; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; Cresswell JE, 2014, PEST MANAG SCI, V70, P332, DOI 10.1002/ps.3569; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P393, DOI 10.1016/S0022-1910(98)00022-5; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Lass A, 1996, INSECT SOC, V43, P347, DOI 10.1007/BF01258408; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Malone LA, 2004, APIDOLOGIE, V35, P655, DOI 10.1051/apido:2004063; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Garrido PM, 2013, J INSECT PHYSIOL, V59, P113, DOI 10.1016/j.jinsphys.2012.10.019; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Ravoet J, 2016, ENTOMOLOGICAL SCI; Rhodes J, 2003, 03049 NSW AGR RUR IN; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Skerl MIS, 2010, APIDOLOGIE, V41, P73, DOI 10.1051/apido/2009051; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stork A., 1999, MR55099; Suryanarayanan Sainath, 2013, Insects, V4, P153, DOI 10.3390/insects4010153; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilde J, 2016, J APICULTURAL RES; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winston M., 1987, The biology of the honey bee.; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108	58	51	52	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171529	10.1371/journal.pone.0171529	http://dx.doi.org/10.1371/journal.pone.0171529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182641	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800070
J	Miao, X; Huang, HS; Hu, XQ; Li, D; Yu, YY; Ao, YF				Miao, Xin; Huang, Hongshi; Hu, Xiaoqing; Li, Dai; Yu, Yuanyuan; Ao, Yingfang			The characteristics of EEG power spectra changes after ACL rupture	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; JOINT POSITION; CURRENT TRENDS; RECONSTRUCTION; KNEE; MECHANORECEPTORS; PROPRIOCEPTION; SYNCHRONIZATION; BIOMECHANICS; ACCESS	Background Reestablishing knee stability is the core of the treatment of ACL (Anterior Cruciate Ligament) injury. Some patients still have a feeling of instability of the knee after ACL injury treatment. This unstable feeling may be caused by central nervous system changes after ACL rupture. Methods To identify the central changes after ACL rupture, EEG spectra were recorded to compare ACL patients and healthy controls when they were walking, jogging, and landing. Results There was a significant increase in delta, theta, alpha and beta band power during walking, jogging and landing in ACL patients. We also found an asymmetry phenomenon of EEG only in the ACL patients, mainly in the frontal area and central-parietal area. The asymmetry of beta band power extended to the frontal and the central area during jogging and landing task. Conclusions There were significant differences in EEG power spectra between the ACL patients and healthy people. ACL patients showed high EEG band power activities and an asymmetry phenomenon. EEG power changes were affected by movements, the asymmetry extended when performing more complicated movements.	[Miao, Xin; Huang, Hongshi; Hu, Xiaoqing; Li, Dai; Yu, Yuanyuan; Ao, Yingfang] Peking Univ, Hosp 3, Inst Sports Med, Beijing, Peoples R China	Peking University	Ao, YF (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, Beijing, Peoples R China.	aoyingfang@163.com						Allen JJB, 2004, BIOL PSYCHOL, V67, P183, DOI 10.1016/j.biopsycho.2004.03.007; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; BARRETT DS, 1991, J BONE JOINT SURG BR, V73, P833, DOI 10.1302/0301-620X.73B5.1894677; Baumeister J, 2008, SCAND J MED SCI SPOR, V18, P473, DOI 10.1111/j.1600-0838.2007.00702.x; Baumeister J, 2011, J ORTHOP RES, V29, P1383, DOI 10.1002/jor.21380; Bonci CM, 1999, J ATHL TRAINING, V34, P155; Borsa PA, 1997, AM J SPORT MED, V25, P336, DOI 10.1177/036354659702500311; Del Percio C, 2011, NEUROSCIENCE, V175, P198, DOI 10.1016/j.neuroscience.2010.11.031; Fremerey RW, 2000, J BONE JOINT SURG BR, V82B, P801, DOI 10.1302/0301-620X.82B6.10306; Friden T, 2001, J ORTHOP SPORT PHYS, V31, P567, DOI 10.2519/jospt.2001.31.10.567; Fu FH, 2000, AM J SPORT MED, V28, P124, DOI 10.1177/03635465000280010801; Fu FH, 1999, AM J SPORT MED, V27, P821, DOI 10.1177/03635465990270062501; Georgoulis AD, 2001, KNEE SURG SPORT TR A, V9, P364, DOI 10.1007/s001670100240; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Hogervorst T, 1998, J BONE JOINT SURG AM, V80A, P1365, DOI 10.2106/00004623-199809000-00018; JOHANSSON H, 1991, CRIT REV BIOMED ENG, V18, P341; Kerick SE, 2004, MED SCI SPORT EXER, V36, P118, DOI 10.1249/01.MSS.0000106176.31784.D4; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Klimesch W, 2011, BRAIN RES, V1408, P52, DOI 10.1016/j.brainres.2011.06.003; Kristina P, 2014, PHYSIOL BEHAV, V123, P1; Papannagari R, 2006, AM J SPORT MED, V34, P2006, DOI 10.1177/0363546506290403; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Valeriani M, 1999, ACTA NEUROL SCAND, V99, P303, DOI 10.1111/j.1600-0404.1999.tb00680.x; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; ZIMNY ML, 1986, ANAT RECORD, V214, P204, DOI 10.1002/ar.1092140216	26	12	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170455	10.1371/journal.pone.0170455	http://dx.doi.org/10.1371/journal.pone.0170455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182627	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800011
J	Brown, PM; Harford, TJ; Agrawal, V; Yen-Lieberman, B; Rezaee, F; Piedimonte, G				Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni			Prenatal Exposure to Respiratory Syncytial Virus Alters Postnatal Immunity and Airway Smooth Muscle Contractility during Early-Life Reinfections	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DISEASE SEVERITY; INTERFERON-GAMMA; YOUNG-CHILDREN; INFECTION; BRONCHIOLITIS; INFANTS; ALLERGY; CELLS; ASTHMA	Maternal viral infections can have pathological effects on the developing fetus which last long after birth. Recently, maternal-fetal transmission of respiratory syncytial virus (RSV) was shown to cause postnatal airway hyperreactivity (AHR) during primary early-life reinfection; however, the influence of prenatal exposure to RSV on offspring airway immunity and smooth muscle contractility during recurrent postnatal reinfections remains unknown. Therefore, we sought to determine whether maternal RSV infection impairs specific aspects of cell-mediated offspring immunity during early-life reinfections and the mechanisms leading to AHR. Red fluorescent protein-expressing recombinant RSV (rrRSV) was inoculated into pregnant rat dams at midterm, followed by primary and secondary postnatal rrRSV inoculations of their offspring at early-life time points. Pups and weanlings were tested for specific lower airway leukocyte populations by flow cytometry; serum cytokine/chemokine concentrations by multiplex ELISA and neurotrophins concentrations by standard ELISA; and ex vivo lower airway smooth muscle (ASM) contraction by physiological tissue bath. Pups born to RSV-infected mothers displayed elevated total CD3(+) T cells largely lacking CD4(+) and CD8(+) surface expression after both primary and secondary postnatal rrRSV infection. Cytokine/chemokine analyses revealed reduced IFN-gamma, IL-2, IL-12, IL-17A, IL-18, and TNF-alpha, as well as elevated nerve growth factor (NGF) expression. Prenatal exposure to RSV also increased ASM reactivity and contractility during early-life rrRSV infection compared to non-exposed controls. We conclude that maternal RSV infection can predispose offspring to postnatal lower airways dysfunction by altering immunity development, NGF signaling, and ASM contraction during early-life RSV reinfections.	[Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni] Cleveland Clin Fdn, Lerner Res Inst, Ctr Pediat Res, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni] Cleveland Clin Fdn, Inst Pediat, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Brown, Paul M.; Harford, Terri J.; Agrawal, Vandana; Yen-Lieberman, Belinda; Rezaee, Fariba; Piedimonte, Giovanni] Childrens Hosp, Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Piedimonte, G (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Ctr Pediat Res, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Piedimonte, G (corresponding author), Cleveland Clin Fdn, Inst Pediat, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Piedimonte, G (corresponding author), Childrens Hosp, Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.	piedimg@ccf.org	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Harford, Terri/0000-0001-6590-0673	NIH [R01 HL061007, K08 Al112781]; Lerner Research Institute; Cleveland Clinic Children's Hospital of the Cleveland Clinic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI112781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lerner Research Institute; Cleveland Clinic Children's Hospital of the Cleveland Clinic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R01 HL061007 (GP), by NIH K08 Al112781 (FR), and by the Lerner Research Institute and Cleveland Clinic Children's Hospital of the Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CAR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5547; Bonini S, 1996, P NATL ACAD SCI USA, V93, P10955, DOI 10.1073/pnas.93.20.10955; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; Brown PM, 2015, PAEDIATR RESPIR REV, V16, P232, DOI 10.1016/j.prrv.2015.05.005; Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Gonzalez PA, 2013, CURR MOL MED, V13, P1122; Gonzalez PA, 2009, CURR MED CHEM, V16, P4609, DOI 10.2174/092986709789760724; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall CB, 2001, CLIN INFECT DIS, V33, P792, DOI 10.1086/322657; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim L., RESP SYNCYTIAL VIRUS; Kirin BK, 2013, BIOCHEM MEDICA, V23, P112, DOI 10.11613/BM.2013.014; Li XQ, 2006, J VIROL, V80, P537, DOI 10.1128/JVI.80.1.537-540.2006; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Manti S, 2016, NEUROTROPHINS VITAMI, V104; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Mella C, 2013, J INFECT DIS, V207, P564, DOI 10.1093/infdis/jis721; Menchise A, 2011, FETAL PEDIATR PATHOL, V30, P64, DOI 10.3109/15513815.2010.505632; MOK JYQ, 1984, ARCH DIS CHILD, V59, P306, DOI 10.1136/adc.59.4.306; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; MURRAY M, 1992, ARCH DIS CHILD, V67, P482, DOI 10.1136/adc.67.4.482; Noble V, 1997, ARCH DIS CHILD, V76, P315, DOI 10.1136/adc.76.4.315; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Piedimonte G, 2004, PEDIATR RES, V55, P657, DOI 10.1203/01.PDR.0000112244.72924.26; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Piedimonte G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061309; Rohwedder A, 1998, J MED VIROL, V54, P320, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;320::AID-JMV13&gt;3.0.CO;2-J; Sasser JM, 2008, AM J PHYSIOL-RENAL, V294, pF1342, DOI 10.1152/ajprenal.00067.2008; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; SIMS DG, 1978, BRIT MED J, V1, P11, DOI 10.1136/bmj.1.6104.11; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Sweetman LL, 2005, PEDIATR NEUROL, V32, P307, DOI 10.1016/j.pediatrneurol.2005.01.010; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Torres JP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-125; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Wu J, 2014, BURNS TRAUMA, V2, DOI [10.4103/2321-3868.124771, 10.4103/2321-3868.113326]; Yui I, 2003, J MED VIROL, V70, P481, DOI 10.1002/jmv.10421	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0168786	10.1371/journal.pone.0168786	http://dx.doi.org/10.1371/journal.pone.0168786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178290	gold, Green Submitted, Green Published			2022-12-27	WOS:000393712500001
J	Drake, MJ; Oelke, M; Snijder, R; Klaver, M; Traudtner, K; van Charldorp, K; Bongaerts, D; Van Kerrebroeck, P				Drake, Marcus J.; Oelke, Matthias; Snijder, Robert; Klaver, Monique; Traudtner, Klaudia; van Charldorp, Karin; Bongaerts, Dominique; Van Kerrebroeck, Philip			Incidence of urinary retention during treatment with single tablet combinations of solifenacin plus tamsulosin OCAS (TM) for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies	PLOS ONE			English	Article							BLADDER OUTLET OBSTRUCTION; TRACT SYMPTOMS; OVERACTIVE BLADDER; GUIDELINES; EFFICACY; THERAPY; SAFETY; TRIAL	Introduction The emergence of urinary retention (UR), specifically acute urinary retention (AUR), has been a concern when treating men with lower urinary tract symptoms (LUTS) with antimuscarinic drugs. Materials and methods In NEPTUNE (12-week, double-blind), men (>= 45 years) with LUTS were randomized to receive tamsulosin oral-controlled absorption system (TOCAS) 0.4 mg, fixed-dose combination (FDC) of solifenacin (Soli) 6 mg + TOCAS 0.4 mg, FDC Soli 9 mg + TOCAS 0.4 mg, or placebo. In NEPTUNE II (40-week, open-label extension of NEPTUNE), continuing patients received 4 -week FDC Soli 6 mg + TOCAS, then FDC Soli 6 mg or 9 mg + TOCAS for the remainder of the study, switchable every 3 months. Results Across both studies, 1208 men received >= 1 dose of FDC Soli 6 mg or 9 mg + TOCAS for up to 52 weeks; 1199 men completed NEPTUNE and 1066 received >= 1 dose in NEPTUNE II. In total, 13 men (1.1%; 95% CI, 0.6%-1.8%) reported a UR event while receiving FDC, eight of which were AUR (0.7%; 95% CI, 0.3%-1.3%, incidence 7/1000 man-years). Six men reported UR events while taking Soli 6 mg + TOCAS (three AUR), and seven men reported a UR event while taking Soli 9 mg + TOCAS (five AUR). One man developed AUR while taking TOCAS alone and four reported UR (three AUR) during placebo run-in. Most AUR/UR events occurred within 4 months of treatment initiation. Conclusions FDC Soli and TOCAS was associated with a low rate of UR and AUR in men with LUTS.	[Drake, Marcus J.] Univ Bristol, Bristol, Avon, England; [Drake, Marcus J.] Bristol Urol Inst, Bristol, Avon, England; [Oelke, Matthias] Hannover Med Sch, Hannover, Germany; [Snijder, Robert; Klaver, Monique; Traudtner, Klaudia; van Charldorp, Karin; Bongaerts, Dominique] Astellas Pharma Europe BV, Leiden, Netherlands; [Van Kerrebroeck, Philip] Maastricht Univ, Med Ctr, Maastricht, Netherlands	University of Bristol; Hannover Medical School; Astellas Pharmaceuticals; Maastricht University	Drake, MJ (corresponding author), Univ Bristol, Bristol, Avon, England.; Drake, MJ (corresponding author), Bristol Urol Inst, Bristol, Avon, England.	marcus.drake@nbt.nhs.uk	Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552	Astellas Pharma Europe; Astellas	Astellas Pharma Europe(Astellas Pharmaceuticals); Astellas(Astellas Pharmaceuticals)	This study was supported by Astellas Pharma Europe. Dominique Bongaerts, Monique Klaver, Robert Snijder, Klaudia Traudtner, and Karin van Charldorp are employees of Astellas Pharma Europe B.V. Astellas provided support in the form of salaries for authors DB, MK, RS, KT and KvC, and was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Athanasopoulos A, 2003, J UROLOGY, V169, P2253, DOI 10.1097/01.ju.0000067541.73285.eb; Bright E, 2014, EUR UROL, V66, P294, DOI 10.1016/j.eururo.2014.02.057; Chapple C, 2009, EUR UROL, V56, P534, DOI 10.1016/j.eururo.2008.11.026; Drake Marcus J, 2012, Can Urol Assoc J, V6, pS136, DOI 10.5489/cuaj.12202; Helfand BT, 2010, EUR UROL, V57, P586, DOI 10.1016/j.eururo.2009.12.025; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; Kaplan SA, 2011, INT J CLIN PRACT, V65, P487, DOI 10.1111/j.1742-1241.2010.02611.x; Kaplan SA, 2013, EUR UROL, V63, P158, DOI 10.1016/j.eururo.2012.07.003; Kaplan SA, 2009, J UROLOGY, V182, P2825, DOI 10.1016/j.juro.2009.08.023; Martin-Merino E, 2009, J UROLOGY, V182, P1442, DOI 10.1016/j.juro.2009.06.051; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Oelke M, 2015, UROLOGY, V86, P654, DOI 10.1016/j.urology.2015.06.025; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Oelke M, 2012, BJU INT, V110, P710, DOI 10.1111/j.1464-410X.2011.10808.x; Roehrborn CG, 2009, EUR UROL, V55, P472, DOI 10.1016/j.eururo.2008.06.032; van Kerrebroeck P, 2013, EUR UROL, V64, P1003, DOI 10.1016/j.eururo.2013.07.034; Van Kerrebroeck P, 2013, EUR UROL, V64, P398, DOI 10.1016/j.eururo.2013.03.031	18	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170726	10.1371/journal.pone.0170726	http://dx.doi.org/10.1371/journal.pone.0170726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166296	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100014
J	Farago, B; Kollar, T; Szabo, K; Budai, C; Losonczi, E; Bernath, G; Csenki-Bakos, Z; Urbanyi, B; Pribenszky, C; Horvath, A; Cserepes, J				Farago, Bernadett; Kollar, Timea; Szabo, Katalin; Budai, Csilla; Losonczi, Eszter; Bernath, Gergely; Csenki-Bakos, Zsolt; Urbanyi, Bela; Pribenszky, Csaba; Horvath, Akos; Cserepes, Judit			Stimulus-triggered enhancement of chilling tolerance in zebrafish embryos	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; DANIO-RERIO EMBRYOS; CARPIO L. EMBRYOS; LABEO-ROHITA; CRYOPROTECTANT; VITRIFICATION; SENSITIVITY; PERMEABILITY; STRESS; PRESERVATION	Background Cryopreservation of zebrafish embryos is still an unsolved problem despite market demand and massive efforts to preserve genetic variation among numerous existing lines. Chilled storage of embryos might be a step towards developing successful cryopreservation, but no methods to date have worked. Methods In the present study, we applied a novel strategy to improve the chilling tolerance of zebra fish embryos by introducing a preconditioning hydrostatic pressure treatment to the embryos. In our experiments, 26-somites and Prim-5 stage zebrafish embryos were chilled at 0 degrees C for 24 hours after preconditioning. Embryo survival rate, ability to reach maturation and fertilizing capacity were tested. Results Our results indicate that applied preconditioning technology made it possible for the chilled embryos to develop normally until maturity, and to produce healthy offspring as normal, thus passing on their genetic material successfully. Treated embryos had a significantly higher survival and better developmental rate, moreover the treated group had a higher ratio of normal morphology during continued development. While all controls from chilled embryos died by 30 day-post-fertilization, the treated group reached maturity (similar to 90-120 days) and were able to reproduce, resulting in offspring in expected quantity and quality. Conclusions Based on our results, we conclude that the preconditioning technology represents a significant improvement in zebrafish embryo chilling tolerance, thus enabling a long-time survival.Furthermore, as embryonic development is arrested during chilled storage this technology also provides a solution to synchronize or delay the development.	[Farago, Bernadett; Szabo, Katalin; Budai, Csilla; Losonczi, Eszter; Cserepes, Judit] Appl Cell Technol Ltd, Budapest, Hungary; [Kollar, Timea; Bernath, Gergely; Csenki-Bakos, Zsolt; Urbanyi, Bela; Horvath, Akos] Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary; [Pribenszky, Csaba] Univ Vet Sci, Fac Anim Hyg & Herdhlth & Vet Ethol, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; University of Veterinary Medicine Budapest	Cserepes, J (corresponding author), Appl Cell Technol Ltd, Budapest, Hungary.; Horvath, A (corresponding author), Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary.	horvath.akos@mkk.szie.hu; judit.cserepes@appcelltech.com	Horvath, Akos/F-8248-2013; Kollár, Tímea/K-6193-2019	Horvath, Akos/0000-0001-9760-2478; Kollár, Tímea/0000-0002-9689-287X; Csenki-Bakos, Zsolt/0000-0003-1750-2296; Bernath, Gergely/0000-0001-5055-3349	National Research, Development and Innovation Office [KMR_12-1-2012-0436]; European Cooperation in Science and Technology [9878-3/2016/FEKUT]; Hungarian Government (Research Centre of Excellence) [11476-3/2016/FEKUT]; Applied Cell Technology ltd	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Hungarian Government (Research Centre of Excellence); Applied Cell Technology ltd	This research was funded by National Research, Development and Innovation Office (KMR_12-1-2012-0436, nkfih.gov.hu), European Cooperation in Science and Technology (9878-3/2016/FEKUT, www.cost.eu) and Hungarian Government (Research Centre of Excellence - 11476-3/2016/FEKUT, www.nemzetikivalosag.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors who received the funding: BF TK KS CB EL ZC GB BU AH JC. The research was also funded by the owners of Applied Cell Technology ltd. These funders provided support in the form of salaries for authors (BF, KS, CB, EL, JC), but did not have any role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the authors contribution section.	Ahammad MM, 2003, THERIOGENOLOGY, V60, P1409, DOI 10.1016/S0093-691X(03)00118-3; Ahammad MM, 2003, CRYOBIOLOGY, V46, P2, DOI 10.1016/S0011-2240(02)00138-4; Ahammad MM, 2002, CRYOBIOLOGY, V44, P114, DOI 10.1016/S0011-2240(02)00012-3; Ahammad MM, 1998, CRYOBIOLOGY, V37, P318, DOI 10.1006/cryo.1998.2127; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Beirao J, 2006, AQUACULTURE, V261, P897, DOI 10.1016/j.aquaculture.2006.07.039; Cabrita E, 2003, CRYOBIOLOGY, V47, P204, DOI 10.1016/j.cryobiol.2003.10.001; Callesen H, 2010, REPROD FERT DEVELOP, V22, P40, DOI 10.1071/RD09213; Cardona-Costa J, 2007, CRYOLETTERS, V28, P303; Desai K, 2015, CRYOBIOLOGY, V71, P1, DOI 10.1016/j.cryobiol.2015.06.009; Desai K, 2015, ZEBRAFISH, V12, P111, DOI 10.1089/zeb.2013.0961; Du Y, 2008, REPRODUCTION, V135, P13, DOI 10.1530/REP-07-0362; Hagedorn M, 1997, CRYOBIOLOGY, V34, P251, DOI 10.1006/cryo.1997.2002; Hagedorn M, 1997, J EXP ZOOL, V278, P356, DOI 10.1002/(SICI)1097-010X(19970815)278:6&lt;356::AID-JEZ3&gt;3.0.CO;2-N; Hagedorn M, 2004, CRYOBIOLOGY, V49, P181, DOI 10.1016/j.cryobiol.2004.07.001; HAGEDORN M, 2011, CRYOPRESERVATION AQU, P483; HARVEY B, 1983, CRYOBIOLOGY, V20, P432, DOI 10.1016/0011-2240(83)90033-0; Horvath A, 2016, REPROD FERT DEVELOP, V28, P475, DOI 10.1071/RD14118; Jiang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21215; Kikuchi K, 2016, THERIOGENOLOGY, V86, P170, DOI 10.1016/j.theriogenology.2016.04.029; Lahnsteiner F, 2009, THERIOGENOLOGY, V72, P333, DOI 10.1016/j.theriogenology.2009.03.003; Lambertini M, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0545-7; Liu XH, 1999, CRYOBIOLOGY, V39, P236, DOI 10.1006/cryo.1999.2206; Liu XH, 1998, CRYO-LETT, V19, P309; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Magli MC, 2008, HUM REPROD, V23, P1253, DOI 10.1093/humrep/den068; Mara L, 2013, ANIM REPROD SCI, V138, P25, DOI 10.1016/j.anireprosci.2013.02.006; Parnpai R, 2016, THERIOGENOLOGY, V86, P214, DOI 10.1016/j.theriogenology.2016.04.034; Popovic L., 2013, Proceedings of the New Zealand Society of Animal Production, V73, P83; Pribenszky C, 2005, ANIM REPROD SCI, V87, P143, DOI 10.1016/j.anireprosci.2004.09.007; Pribenszky C, 2012, REPROD DOMEST ANIM, V47, P197, DOI 10.1111/j.1439-0531.2012.02076.x; Pribenszky C, 2011, REPROD FERT DEVELOP, V23, P48, DOI 10.1071/RD10231; Pribenszky C, 2010, BIOL REPROD, V83, P690, DOI 10.1095/biolreprod.110.083386; Robles V, 2005, THERIOGENOLOGY, V64, P1633, DOI 10.1016/j.theriogenology.2005.04.014; Robles V, 2004, THERIOGENOLOGY, V61, P1367, DOI 10.1016/j.theriogenology.2003.08.010; Schattman GL, 2015, NEW ENGL J MED, V373, P1755, DOI 10.1056/NEJMcp1307341; Siqueira E, 2011, REPROD FERT DEVELOP, V23, P585, DOI 10.1071/RD10203; Szaraz L, 2014, CRYOBIOLOGY, V69, P266, DOI 10.1016/j.cryobiol.2014.07.016; Valdez DM, 2005, THERIOGENOLOGY, V64, P112, DOI 10.1016/j.theriogenology.2004.11.006	39	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171520	10.1371/journal.pone.0171520	http://dx.doi.org/10.1371/journal.pone.0171520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166301	gold, Green Submitted, Green Published			2022-12-27	WOS:000393700100049
J	Hur, H; Andalib, MA; Maurer, JA; Hawley, JD; Ghaffarzadegan, N				Hur, Hyungjo; Andalib, Maryam A.; Maurer, Julie A.; Hawley, Joshua D.; Ghaffarzadegan, Navid			Recent trends in the US Behavioral and Social Sciences Research (BSSR) workforce	PLOS ONE			English	Article							DIVERSITY; GENDER; HEALTH; WOMEN; NIH; SUCCESS; RISK; RACE; STEM	While behavioral and social sciences occupations comprise one of the largest portions of the "STEM" workforce, most studies of diversity in STEM overlook this population, focusing instead on fields such as biomedical or physical sciences. This study evaluates major demographic trends and productivity in the behavioral and social sciences research (BSSR) workforce in the United States during the past decade. Our analysis shows that the demographic trends for different BSSR fields vary. In terms of gender balance, there is no single trend across all BSSR fields; rather, the problems are field-specific, and disciplines such as economics and political science continue to have more men than women. We also show that all BSSR fields suffer from a lack of racial and ethnic diversity. The BSSR workforce is, in fact, less representative of racial and ethnic minorities than are biomedical sciences or engineering. Moreover, in many BSSR subfields, minorities are less likely to receive funding. We point to various funding distribution patterns across different demographic groups of BSSR scientists, and discuss several policy implications.	[Hur, Hyungjo; Maurer, Julie A.; Hawley, Joshua D.] Ohio State Univ, John Glenn Coll Publ Affairs, Columbus, OH 43210 USA; [Andalib, Maryam A.; Ghaffarzadegan, Navid] Virginia Tech, Grado Dept Ind & Syst Engn, Blacksburg, VA 24061 USA	University System of Ohio; Ohio State University; Virginia Polytechnic Institute & State University	Ghaffarzadegan, N (corresponding author), Virginia Tech, Grado Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	navidg@vt.edu	Hur, Hyungjo/V-2803-2019	Hur, Hyungjo/0000-0002-9481-9433; Ghaffarzadegan, Navid/0000-0003-3632-8588	US National Institutes of Health [2U01GM094141-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094141] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was supported by a grant from the US National Institutes of Health (2U01GM094141-05), funding recipient: JH (http://grantome.com/grant/NIH/U01-GM094141-05S1), titled 'A Model-Based Examination of Behavioral & Social Science Workforce: Improving Health Outcomes'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Blume-Kohout ME, 2016, RES POLICY, V45, P1291, DOI 10.1016/j.respol.2016.03.011; Boyle P, 2015, NATURE, V525, P181, DOI 10.1038/525181a; Ceci SJ, 2010, CURRENT DIRECTIONS P; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Charleston LJ, 2014, J DIVERS HIGH EDUC, V7, P166, DOI 10.1037/a0036632; Davis G., 2009, SCI ENG CAREERS US A; Florida, 2003, CITY ENTERTAINMENT M, V9, P199, DOI [DOI 10.2307/20081019, 10.1016/S1479-3520(03)09007-X]; Ghaffarzadegan N, 2016, SYSTEM RES IN PRESS; Ghaffarzadegan N, 2015, US ARMY MED DEP J, P8; Ghaffarzadegan N, 2015, SYST RES BEHAV SCI, V32, P402, DOI 10.1002/sres.2324; Ghaffarzadegan N, 2014, SYST RES BEHAV SCI, V31, P301, DOI 10.1002/sres.2190; Gibbs KD, 2016, ELIFE, V5, DOI 10.7554/eLife.21393; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Glass JL, 2013, SOC FORCES, V92, P723, DOI 10.1093/sf/sot092; Hage J., 2007, SCI PUBL POLICY, V34, P731, DOI DOI 10.3152/030234207X265385; Harmon SHE, 2013, SCI PUBL POLICY, V40, P25, DOI 10.1093/scipol/scs117; Harris F, 2013, J DIVERS HIGH EDUC, V6, P174, DOI 10.1037/a0034224; Herring C, 2009, AM SOCIOL REV, V74, P208, DOI 10.1177/000312240907400203; Hosseinichimeh N, 2016, WORLD MED HEALTH POL, V8, P58, DOI 10.1002/wmh3.175; Hosseinichimeh N, 2014, WORLD MED HEALTH POL, V6, P9, DOI 10.1002/wmh3.77; Hur H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124928; Larson RC, 2014, SYST RES BEHAV SCI, V31, P745, DOI 10.1002/sres.2210; Larson Richard C, 2012, Serv Sci, V4, P69; Larson Richard C, 2012, Serv Sci, V4, P382; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Lomnitz H., 2006, SCI PUBLIC POLICY; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Martin EG, 2015, J POLICY ANAL MANAG, V34, P403, DOI 10.1002/pam.21797; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Reardon S, 2014, NATURE, V512, P243, DOI 10.1038/512243a; Richardson GP, 2015, SYST DYNAM REV, V31, P173, DOI 10.1002/sdr.1542; Smith DG, 2004, J HIGH EDUC-UK, V75, P133, DOI 10.1353/jhe.2004.0006; Stephan P, 2013, BIOSCIENCE, V63, P245, DOI 10.1525/bio.2013.63.4.2; Sterman JD, 2008, SCIENCE, V322, P532, DOI 10.1126/science.1162574; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; Turner CS, 2013, J DIVERS HIGH EDUC, V6, P155, DOI 10.1037/a0034356; United States Census Bureau, 2014, ANN EST RES POP SEX; Vakili K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120052; Winston MD, 2001, COLL RES LIBR, V62, P517, DOI 10.5860/crl.62.6.517; Wittenborn AK, 2016, PSYCHOL MED, V46, P551, DOI 10.1017/S0033291715002044; Xue YM, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/718924	43	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170887	10.1371/journal.pone.0170887	http://dx.doi.org/10.1371/journal.pone.0170887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166252	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100015
J	Clerici, I; Ferrazzoli, D; Maestri, R; Bossio, F; Zivi, I; Canesi, M; Pezzoli, G; Frazzitta, G				Clerici, Ilaria; Ferrazzoli, Davide; Maestri, Roberto; Bossio, Fabiola; Zivi, Ilaria; Canesi, Margherita; Pezzoli, Gianni; Frazzitta, Giuseppe			Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments	PLOS ONE			English	Article							PARKINSONS-DISEASE; INTENSIVE EXERCISE; BASAL GANGLIA; RATING-SCALE; BALANCE; GAIT; THERAPY; STROKE; TRUNK; NEUROPLASTICITY	Background to date, there are no medical or surgical treatments for progressive supranuclear palsy (PSP). It is possible to speculate that patients with PSP could benefit from rehabilitative treatments designed for Parkinson's disease, including the use of robot-assisted walking training. Objective to evaluate whether the use of the robotic device Lokomat(R) is superior in PSP patients to the use of treadmill with visual cues and auditory feedbacks (treadmill-plus) in the context of an aerobic, multidisciplinary, intensive, motor-cognitive and goal-based rehabilitation treatment (MIRT) conceived for Parkinsonian patients. Methods we enrolled twenty-four PSP patients. Twelve subjects underwent a 4-week MIRT exploiting the use of the treadmill-plus (MIRT group). Twelve subjects underwent the same treatment, but replacing the treadmill-plus with Lokomat r (MIRT-Lokomat group). Subjects were evaluated with clinical and functional scales at admission and discharge. The primary outcomes were the total PSP Rating Scale (PSPRS) score and its "limb" and "gait" sub-scores. Secondary outcomes were Berg Balance Scale (BBS), Six Minutes Walking test (6MWT) and the number of falls. Results total PSPRS, PSPRS-gait sub-score, BBS, 6MWT and number of falls improved significantly in both groups (p <= 0.003 all, except 6MWT, p = 0.032 and p = 0.018 in MIRT-Lokomat and MIRT group respectively). The PSPRS-limb sub-score improved significantly only in the MIRT group (p = 0.002). A significant difference between groups was observed only for total PSPRS, indicating a slightly better improvement for patients in the MIRT group (p = 0.047). No differences between groups were revealed for the other outcomes, indicating that the effect of rehabilitation was similar in both groups. Conclusions Lokomat(R) training, in comparison with treadmill-plus training, does not provide further benefits in PSP patients undergoing MIRT. Our findings suggest the usefulness of an aerobic, multidisciplinary, intensive, motor-cognitive and goal-based approach for the rehabilitation of patients suffering from such a complex disease as PSP.	[Clerici, Ilaria; Ferrazzoli, Davide; Bossio, Fabiola; Zivi, Ilaria; Frazzitta, Giuseppe] Moriggia Pelascini Hosp, Dept Parkinsons Dis Movement Disorders & Brain In, Gravedona Ed Uniti, Italy; [Maestri, Roberto] Sci Inst Montescano, Ist Clin Sci Maugeri, Dept Biomed Engn, Montescano, Italy; [Canesi, Margherita; Pezzoli, Gianni] Ist Clin Perfezionamento, Parkinson Inst, Milan, Italy	Istituti Clinici Scientifici Maugeri IRCCS	Clerici, I (corresponding author), Moriggia Pelascini Hosp, Dept Parkinsons Dis Movement Disorders & Brain In, Gravedona Ed Uniti, Italy.	ilaria.clerici86@gmail.com	Maestri, Roberto/AAA-7585-2019; Maestri, Roberto/J-8168-2016	Maestri, Roberto/0000-0002-2873-0430; Maestri, Roberto/0000-0002-2873-0430; Ferrazzoli, Davide/0000-0002-4005-0235; Frazzitta, Giuseppe/0000-0002-5555-4145; Pezzoli, Gianni/0000-0003-4665-6710				Araki K, 2016, NEUROPATHOLOGY, V36, P187, DOI 10.1111/neup.12259; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bloem BR, 2015, MOVEMENT DISORD, V30, P1504, DOI 10.1002/mds.26363; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; Cabanas-Valdes R, 2015, CLIN REHABIL; Cakit BD, 2007, CLIN REHABIL, V21, P698, DOI 10.1177/0269215507077269; Egerton T, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-116; Frazzitta G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/878472; Frazzitta G, 2015, NEUROREHAB NEURAL RE, V29, P123, DOI 10.1177/1545968314542981; Frazzitta G, 2013, AM J PHYS MED REHAB, V92, P523, DOI 10.1097/PHM.0b013e31828cd254; Frazzitta G, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/583278; Frazzitta G, 2010, MOVEMENT DISORD, V25, P609, DOI 10.1002/mds.22871; Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; GRAFMAN J, 1995, BRAIN COGNITION, V28, P311, DOI 10.1006/brcg.1995.1260; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hesse S, 2001, Curr Atheroscler Rep, V3, P287, DOI 10.1007/s11883-001-0021-z; Hohler AD, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/871974; Keus SHJ, 2009, MOVEMENT DISORD, V24, P1, DOI 10.1002/mds.22141; Kim JH, 2015, J PHYS THER SCI, V27, P2955, DOI 10.1589/jpts.27.2955; LACH HW, 1991, J AM GERIATR SOC, V39, P197, DOI 10.1111/j.1532-5415.1991.tb01626.x; Likhi M, 2013, TOP STROKE REHABIL, V20, P62, DOI 10.1310/tsr2001-62; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub4; Nicolai S, 2010, Z GERONTOL GERIATR, V43, P224, DOI 10.1007/s00391-010-0125-6; Nonnekes J, 2014, J PARKINSON DIS, V4, P567, DOI 10.3233/JPD-140436; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Petzinger GM, 2010, MOVEMENT DISORD, V25, pS141, DOI 10.1002/mds.22782; Sale P, 2012, EUR J PHYS REHAB MED, V48, P111; Sale P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00207; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; SOSNER J, 1993, ARCH PHYS MED REHAB, V74, P537, DOI 10.1016/0003-9993(93)90120-Y; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Steffen TM, 2007, PHYS THER, V87, P1078, DOI 10.2522/ptj.20060166; Steffen TM, 2014, PHYS THER, V94, P289, DOI 10.2522/ptj.20130052; Suteerawattananon M, 2002, PHYS THER, V82, P485, DOI 10.1093/ptj/82.5.485; Tang A, 2012, J NEUROL PHYS THER, V36, P115, DOI 10.1097/NPT.0b013e318262dbd0; Taylor ME, 2013, GAIT POSTURE, V37, P126, DOI 10.1016/j.gaitpost.2012.06.024; Toole T, 2005, NEUROREHABILITATION, V20, P307; Uhrbrand A, 2015, J NEUROL SCI, V353, P9, DOI 10.1016/j.jns.2015.04.004; Wu CY, 2014, PHYS THER, V94, P845, DOI 10.2522/ptj.20130101; Zampieri C, 2006, PHYS THER, V86, P870, DOI 10.1093/ptj/86.6.870	43	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170927	10.1371/journal.pone.0170927	http://dx.doi.org/10.1371/journal.pone.0170927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158197	Green Published, gold			2022-12-27	WOS:000396161700019
J	Pool, AC; Kraschnewski, JL; Poger, JM; Smyth, J; Stuckey, HL; Craig, TJ; Lehman, EB; Yang, CW; Sciamanna, CN				Pool, Andrew C.; Kraschnewski, Jennifer L.; Poger, Jennifer M.; Smyth, Joshua; Stuckey, Heather L.; Craig, Timothy J.; Lehman, Erik B.; Yang, Chengwu; Sciamanna, Christopher N.			Impact of online patient reminders to improve asthma care: A randomized controlled trial	PLOS ONE			English	Article							UNITED-STATES; DIABETES-MELLITUS; ADHERENCE; DISEASE; QUALITY; ADULTS; RISK; POPULATION; PREVENTION; MANAGEMENT	Importance Asthma is one of the most burdensome chronic illnesses in the US. Despite widespread dissemination of evidence-based guidelines, more than half of the adults with asthma have uncontrolled symptoms. Objective To examine the efficacy of an online tool designed to improve asthma control. Design 12-month single blind randomized controlled trial of the online tool (Intervention condition, IC) versus an active control tool (CC). Setting Patients enrolled in an insurance plan. Participants Participants were 408 adults (21-60 years of age) with persistent asthma. Intervention At least once each month and before provider visits, participants in the IC answered questions online about their asthma symptoms, asthma medications and asthma care received from providers, such as an asthma management plan. The tool then provided tailored feedback to remind patients 1) to ask health care providers specific questions that may improve asthma control (e.g., additional controller medications) and 2) to consistently perform specific self-care behaviors (e.g., proper inhaler technique). Participants in the CC received similar questions and feedback, yet focused instead on preventive services unrelated to asthma control (e.g., cancer screening). Main outcome measures The main outcome measure was asthma control, as assessed by the 5-question Asthma Control Test (ACT). Secondary outcomes included quality of life, medication use and healthcare utilization (e.g., emergency department visits). Results After 12 months, 323 participants completed follow-up measures (79.2%). Participants in the IC reported a greater mean improvement in the ACT score than participants in the CC (2.3 vs. 1.2; p = 0.02) and 9 of 11 individual asthma control survey items showed non-significant improvements favoring the IC. No differences were observed in medication adherence, number of asthma controller medications or health care utilization. Conclusion and relevance Simple and brief online patient reminders improved asthma control among insured patients. Although future studies are needed to understand the mechanism of the improvement, the magnitude of the effect on asthma control was similar to the addition of an additional controller medication. Given the widespread use of the Internet, simple tools such as this may be useful for improving the control of other chronic diseases as well.	[Pool, Andrew C.] Temple Univ, Coll Hlth Profess & Social Work, Dept Publ Hlth, Philadelphia, PA 19122 USA; [Pool, Andrew C.] Temple Univ, Sch Med, CORE, Philadelphia, PA 19122 USA; [Kraschnewski, Jennifer L.; Poger, Jennifer M.; Stuckey, Heather L.; Craig, Timothy J.; Sciamanna, Christopher N.] Penn State Coll Med, Dept Med, Hershey, PA 17033 USA; [Kraschnewski, Jennifer L.; Craig, Timothy J.] Penn State Coll Med, Dept Pediat, Hershey, PA USA; [Kraschnewski, Jennifer L.; Stuckey, Heather L.; Lehman, Erik B.; Yang, Chengwu; Sciamanna, Christopher N.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Smyth, Joshua] Penn State Univ, Dept Biobehav Hlth, State Coll, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Sciamanna, CN (corresponding author), Penn State Coll Med, Dept Med, Hershey, PA 17033 USA.; Sciamanna, CN (corresponding author), Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA.	csciamanna@hmc.psu.edu	Yang, Chengwu/X-6178-2018	Yang, Chengwu/0000-0003-0561-2340; Poger, Jennifer/0000-0003-3276-805X; Pool, Andrew/0000-0001-7249-6090; Smyth, Joshua/0000-0002-0904-5390	National Heart, Lung, And Blood Institute [R01HL088590]; National Institutes of Health; National Center for Advancing Translational Sciences, NIH [UL1RR033184, KL2RR033180]	National Heart, Lung, And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, NIH	The design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication was funded, in part, by grant R01HL088590 from the National Heart, Lung, And Blood Institute (PI, Sciamanna). The preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication was funded, in part, from the National Institutes of Health and by National Center for Advancing Translational Sciences, NIH through Grant UL1RR033184 and KL2RR033180 (PI, Kraschnewski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2002, J ALLERGY CLIN IMMUN, V110, P58, DOI 10.1067/mai.2002.125489; Akinbami Lara J, 2012, NCHS Data Brief, P1; Apter AJ, 2003, J ALLERGY CLIN IMMUN, V111, P1219, DOI 10.1067/mai.2003.1479; Balkrishnan R, 2003, CLIN THER, V25, P2958, DOI 10.1016/S0149-2918(03)80347-8; Beckman TJ, 2001, DIABETES CARE, V24, P2049, DOI 10.2337/diacare.24.12.2049; Bell RA, 2001, PREV MED, V32, P163, DOI 10.1006/pmed.2000.0785; Broderick JE, 2004, ANN BEHAV MED, V27, P50, DOI 10.1207/s15324796abm2701_7; Carlton BG, 2005, J ASTHMA, V42, P529, DOI 10.1081/JAS-200067000; Centers for Disease Control and Prevention, 2012, ASTHM IMP NAT DAT CD; Chan DS, 2007, PEDIATRICS, V119, P569, DOI 10.1542/peds.2006-1884; Elliott WJ, 2007, J AM BOARD FAM MED, V20, P72, DOI 10.3122/jabfm.2007.01.060094; Flay BR, 2004, ARCH PEDIAT ADOL MED, V158, P377, DOI 10.1001/archpedi.158.4.377; Fontana SA, 1997, AM J PUBLIC HEALTH, V87, P1190, DOI 10.2105/AJPH.87.7.1190; Fox S, 2005, DIGITAL DIVISIONS; Fox S, HLTH ONLINE 2013; GIBSON JT, 1988, AM J HOSP PHARM, V45, P337, DOI 10.1093/ajhp/45.2.337; Greenlund KJ, 2005, AM J PREV MED, V29, P81, DOI 10.1016/j.amepre.2005.07.007; Halm EA, 2005, CHEST, V128, P1943, DOI 10.1378/chest.128.4.1943; Halterman JS, 2007, AMBUL PEDIATR, V7, P153, DOI 10.1016/j.ambp.2006.11.007; Hartmann CW, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.1.e3; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Kim C, 2004, AM J PREV MED, V27, P1, DOI 10.1016/j.amepre.2004.03.008; Kravitz RL, 2003, ARCH INTERN MED, V163, P1673, DOI 10.1001/archinte.163.14.1673; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Krishna S, 2003, PEDIATRICS, V111, P503, DOI 10.1542/peds.111.3.503; Lion A, 2003, CHEST, V124, P1781, DOI 10.1378/chest.124.5.1781; Little R, 1996, BIOMETRICS, V52, P1324, DOI 10.2307/2532847; Mularski RA, 2006, CHEST, V130, P1844, DOI 10.1378/chest.130.6.1844; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Heart Lung and Blood Institute National Asthma Educa- tion and Prevention Program, 2007, 3 NAT HEART LUNG BLO; ORNSTEIN SM, 1991, J FAM PRACTICE, V32, P82; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rasmussen LM, 2005, J ALLERGY CLIN IMMUN, V115, P1137, DOI 10.1016/j.jaci.2005.03.030; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schatz M, 2007, J ASTHMA, V44, P341, DOI 10.1080/02770900701344421; Schatz M, 2010, AM J MANAG CARE, V16, pE281; Schonlau M, 2005, ANN FAM MED, V3, P200, DOI 10.1370/afm.269; Sciamanna CN, 2006, HEADACHE, V46, P92, DOI 10.1111/j.1526-4610.2006.00312.x; Sciamanna CN, 2005, AM J MED QUAL, V20, P127, DOI 10.1177/1062860605274518; Slejko JF, 2014, J ALLERGY CLIN IMMUN, V133, P1579, DOI 10.1016/j.jaci.2013.10.028; Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Sullivan PW, 2011, J ALLERGY CLIN IMMUN, V127, P363, DOI 10.1016/j.jaci.2010.10.042; Talreja N, 2011, ANN ALLERG ASTHMA IM, V106, P24, DOI 10.1016/j.anai.2010.10.017; Thiboutot J, 2013, J MED INTERNET RES, V15, P20, DOI 10.2196/jmir.2298; Thiboutot J, 2010, CONTEMP CLIN TRIALS, V31, P634, DOI 10.1016/j.cct.2010.08.012; van der Meer V, 2009, ANN INTERN MED, V151, P110, DOI 10.7326/0003-4819-151-2-200907210-00008; Van Sickle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055335; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; Yasui H, 2012, RESP MED, V106, P508, DOI 10.1016/j.rmed.2011.12.014; Yong PL, 2009, J ALLERGY CLIN IMMUN, V124, P961, DOI 10.1016/j.jaci.2009.07.027; [No title captured], DOI DOI 10.5888/PCD11.130389	52	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170447	10.1371/journal.pone.0170447	http://dx.doi.org/10.1371/journal.pone.0170447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158200	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700012
J	Victoriano-Romero, E; Valencia-Diaz, S; Toledo-Hernandez, VH; Flores-Palacios, A				Victoriano-Romero, Elizabeth; Valencia-Diaz, Susana; Hugo Toledo-Hernandez, Victor; Flores-Palacios, Alejandro			Dispersal limitation of Tillandsia species correlates with rain and host structure in a central Mexican tropical dry forest	PLOS ONE			English	Article							VASCULAR EPIPHYTES; GERMINATION; BROMELIACEAE; PREFERENCE; ABUNDANCE; RECURVATA; CATOPSIS	Seed dispersal permits the colonization of favorable habitats and generation of new populations, facilitating escape from habitats that are in decline. There is little experimental evidence of the factors that limit epiphyte dispersion towards their hosts. In a tropical dry forest in central Mexico, we monitored the phenology of dispersion of epiphyte species of the genus Tillandsia; we tested experimentally whether precipitation could cause failures in seed dispersal and whether seed capture differs among vertical strata and between host species with high (Bursera copallifera) and low (Conzattia multiflora) epiphyte loads. With the exception of one species that presents late dispersion and low abundance, all of the species disperse prior to the onset of the rainy season. However, early rains immobilize the seeds, affecting up to 24% of the fruits in species with late dispersion. We observed that Tillandsia seeds reach both Bursera and Conzattia hosts, but found that adherence to the host is 4-5 times higher in Bursera. Furthermore, seeds liberated from Bursera travel shorter distances and up to half may remain within the same crown, while the highest seed capture takes place in the upper strata of the trees. We conclude that dispersion of Tillandsia seeds is limited by early rains and by the capture of seeds within the trees where populations concentrate. This pattern of capture also helps to explain the high concentrations of epiphytes in certain hosts, while trees with few epiphytes can be simultaneously considered deficient receivers and efficient exporters of seeds.	[Victoriano-Romero, Elizabeth; Hugo Toledo-Hernandez, Victor; Flores-Palacios, Alejandro] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac CIByC, Av Univ, Cuernavaca, Morelos, Mexico; [Valencia-Diaz, Susana] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol CEIB, Av Univ, Cuernavaca, Morelos, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Flores-Palacios, A (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac CIByC, Av Univ, Cuernavaca, Morelos, Mexico.	alejandro.florez@uaem.mx	Valencia-díaz, Susana/ABB-4670-2020; Flores-Palacios, Alejandro/T-7074-2017	Flores-Palacios, Alejandro/0000-0002-2000-9964; Valencia Diaz, Susana/0000-0002-0089-226X; Toledo-Hernandez, Victor H./0000-0002-1119-2189; Victoriano Romero, Elizabeth/0000-0001-9665-7012	CONACyT-Ciencia Basica [80027];  [PROMEP/103.5/05/1901]	CONACyT-Ciencia Basica; 	This research was supported by grants to AFP (75%, PROMEP/103.5/05/1901), to the Red "Sistematica y Ecologia en Comunidades Forestales y Cultivos (18%, PROMEP 2009-2010) and CONACyT-Ciencia Basica 80027 (7%). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vergara-Torres CA, 2010, J TROP ECOL, V26, P563, DOI 10.1017/S0266467410000349; BENNETT BC, 1987, B TORREY BOT CLUB, V114, P265, DOI 10.2307/2996464; Benzing D.H., 1990, VASCULAR EPIPHYTES; Bernal R, 2005, CAN J BOT, V83, P1238, DOI 10.1139/b05-076; Cascante-Marin A, 2009, J TROP ECOL, V25, P63, DOI 10.1017/S0266467408005622; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Crawley M. J., 2013, R BOOK; Flores-Palacios A, 2015, SCI HORTIC-AMSTERDAM, V187, P72, DOI 10.1016/j.scienta.2015.03.003; GARCIA-FRANCO J G, 1988, Phytologia, V65, P73; GENTRY AH, 1987, ANN MO BOT GARD, V74, P205, DOI 10.2307/2399395; Harper J. L., 1977, Population biology of plants.; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; Lopez-Villalobos A, 2008, PLANT ECOL, V198, P265, DOI 10.1007/s11258-008-9402-5; MADISON M, 1977, Selbyana, V2, P1; Mondragon D, 2006, SOUTHWEST NAT, V51, P462, DOI 10.1894/0038-4909(2006)51[462:SDAGOT]2.0.CO;2; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Orozco-Ibarrola OA, 2015, BOT J LINN SOC, V177, P50, DOI 10.1111/boj.12225; Ruiz-Cordova JP, 2014, FLORA, V209, P375, DOI 10.1016/j.flora.2014.06.003; Palaci CA, 2004, SYST BOT, V29, P518, DOI 10.1600/0363644041744473; Pounden E, 2008, J ECOL, V96, P591, DOI 10.1111/j.1365-2745.2008.01380.x; Ruiz-Rivera C.A., 2001, SAN ANDRES CAL CULTO; Siegel S, 2014, ESTADISTICA PARAMETR; Sotelo-Caro O, 2016, THESIS; Valencia-Diaz S, 2010, J TROP ECOL, V26, P571, DOI 10.1017/S0266467410000374; Wagner K, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu092; Wester S, 2011, J TROP ECOL, V27, P115, DOI 10.1017/S0266467410000593; Winkler M, 2005, ANN BOT-LONDON, V95, P1039, DOI 10.1093/aob/mci115; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zotz G, 1997, ECOGRAPHY, V20, P264, DOI 10.1111/j.1600-0587.1997.tb00370.x; Zotz G, 2013, BOT J LINN SOC, V171, P453, DOI 10.1111/boj.12010	35	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171614	10.1371/journal.pone.0171614	http://dx.doi.org/10.1371/journal.pone.0171614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158320	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161700112
J	Datson, NA; Gonzalez-Barriga, A; Kourkouta, E; Weij, R; van de Giessen, J; Mulders, S; Kontkanen, O; Heikkinen, T; Lehtimaki, K; van Deutekom, JCT				Datson, Nicole A.; Gonzalez-Barriga, Anchel; Kourkouta, Eleni; Weij, Rudie; van de Giessen, Jeroen; Mulders, Susan; Kontkanen, Outi; Heikkinen, Taneli; Lehtimaki, Kimmo; van Deutekom, Judith C. T.			The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain	PLOS ONE			English	Article							MUTANT HUNTINGTIN; SEX-DIFFERENCES; DISEASE; PHENOTYPE; MODELS; PROGRESSION; INHIBITION; MECHANISMS; STRIATUM; DARPP-32	The aim of these studies was to demonstrate the therapeutic capacity of an antisense oligonucleotide with the sequence (CUG) 7 targeting the expanded CAG repeat in huntingtin (HTT) mRNA in vivo in the R6/2 N-terminal fragment and Q175 knock-in Huntington's disease (HD) mouse models. In a first study, R6/2 mice received six weekly intracerebroventricular infusions with a low and high dose of (CUG) 7 and were sacrificed 2 weeks later. A 15-60% reduction of both soluble and aggregated mutant HTT protein was observed in striatum, hippocampus and cortex of (CUG) 7-treated mice. This correction at the molecular level resulted in an improvement of performance in multiple motor tasks, increased whole brain and cortical volume, reduced levels of the gliosis marker myo-inositol, increased levels of the neuronal integrity marker N-aceyl aspartate and increased mRNA levels of the striatal marker Darpp-32. These neuroanatomical and neurochemical changes, together with the improved motor performance, suggest that treatment with (CUG) 7 ameliorates basal ganglia dysfunction. The HTT-lowering was confirmed by an independent study in Q175 mice using a similar (CUG) 7 AON dosing regimen, further demonstrating a lasting reduction of mutant HTT protein in striatum, hippocampus and cortex for up to 18 weeks post last infusion along with an increase in motor activity. Based on these encouraging results, (CUG) 7 may thus offer an interesting alternative HTT-lowering strategy for HD.	[Datson, Nicole A.; Gonzalez-Barriga, Anchel; Kourkouta, Eleni; Weij, Rudie; van de Giessen, Jeroen; Mulders, Susan; van Deutekom, Judith C. T.] BioMarin Nederland BV, Leiden, Netherlands; [Kontkanen, Outi; Heikkinen, Taneli; Lehtimaki, Kimmo] Charles River Discovery Res Serv, Kuopio, Finland		Datson, NA (corresponding author), BioMarin Nederland BV, Leiden, Netherlands.	nicole.datson@bmm.com	Lehtimäki, Kimmo K/A-6018-2009; Datson, Nicole A./O-8797-2014; González-Barriga, Anchel/G-5765-2016	Lehtimäki, Kimmo K/0000-0003-2750-8229; González-Barriga, Anchel/0000-0001-7072-5494; Datson, Nicole/0000-0003-2887-0238; Kourkouta, Eleni/0000-0002-6178-0712				Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bettencourt C, 2010, NEUROGENETICS, V11, P193, DOI 10.1007/s10048-009-0216-y; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Busan S, 2013, BIOCHEMISTRY-US, V52, P8219, DOI 10.1021/bi401129r; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cepeda-Prado E, 2012, J NEUROSCI, V32, P6456, DOI 10.1523/JNEUROSCI.0388-12.2012; Cummings DM, 2009, J NEUROSCI, V29, P10371, DOI 10.1523/JNEUROSCI.1592-09.2009; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Evers MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024308; Frank S, 2014, NEUROTHERAPEUTICS, V11, P153, DOI 10.1007/s13311-013-0244-z; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Jenkins BG, 2000, J NEUROCHEM, V74, P2108, DOI 10.1046/j.1471-4159.2000.0742108.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Menalled L, 2014, MOVEMENT DISORD, V29, P1375, DOI 10.1002/mds.26006; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; MYERS RH, 1991, ARCH NEUROL-CHICAGO, V48, P800, DOI 10.1001/archneur.1991.00530200036015; Nalavade R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.276; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Renoir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022133; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Rue L, 2016, J CLIN INVEST, V126, P4319, DOI 10.1172/JCI83185; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Southwell AL, 2014, MOL THER, V22, P2093, DOI 10.1038/mt.2014.153; Sturrock A, 2015, MOVEMENT DISORD, V30, P393, DOI 10.1002/mds.26118; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; van den Bogaard SJA, 2014, J HUNTINGTONS DIS, V3, P377, DOI 10.3233/JHD-140117; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zacharoff L, 2012, J CEREBR BLOOD F MET, V32, P502, DOI 10.1038/jcbfm.2011.157; Zarringhalam K, 2012, BEHAV BRAIN RES, V229, P216, DOI 10.1016/j.bbr.2012.01.015; Zielonka D, 2013, PARKINSONISM RELAT D, V19, P192, DOI 10.1016/j.parkreldis.2012.09.012; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	42	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171127	10.1371/journal.pone.0171127	http://dx.doi.org/10.1371/journal.pone.0171127			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182673	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800036
J	Hou, L; Hellerstein, S; Vitonis, A; Zou, LY; Ruan, Y; Wang, X; Zhang, WY				Hou, Lei; Hellerstein, Susan; Vitonis, Allison; Zou, Liying; Ruan, Yan; Wang, Xin; Zhang, Weiyuan			Cross sectional study of mode of delivery and maternal and perinatal outcomes in mainland China	PLOS ONE			English	Article							CESAREAN DELIVERY; CARE; SHANGHAI; HEALTH	Background Cesarean delivery (CD) rates have risen globally with nearly 50% of the non-indicated CDs worldwide in China and Brazil. In China's One Child Policy era (1979-015) most deliveries were women having their only child. Family size is a major determinant of the safety of medically non-indicated CD or CD on maternal request. The goal of this study is to document CD rates, indications, and analyze the relative safety of non-indicated CD compared to SVD and intrapartum CD. Methods Univariate and multivariate logistic regression analyses of the association between mode of delivery and short-term maternal and perinatal outcomes were performed on a cross-section of all deliveries at 39 hospitals in 14 provinces of China in 2011, presented as adjusted odds ratio (aOR), 99% confidence intervals (CI). Findings Among 108,847 deliveries, 59,415 were CD (54.6%) with 20.8% of deliveries or 38.2% of all cesareans were non-indicated CD. Compared to SVD, antepartum non-indicated CD was associated with a decreased likelihood of post-partum hemorrhage (PPH) (aOR = 0.80, CI = 0.69-0.92) and was not associated with maternal death or combined severe outcomes (maternal death, transfusion, or hysterectomy). Intrapartum indicated CD was associated with an increased risk of PPH (aOR = 1.68, CI = 1.50-.89) compared to SVD. Compared to SVD, antepartum non-indicated CD was associated with lower likelihood of neonatal death (aOR = 0.14, CI = 0.06-.34), neonatal ICU admission (aOR = 0.50, CI = 0.36-.69), 5-minute Apgar<4 (aOR = 0.06, CI = 0.10-0.36), and respiratory distress syndrome (RDS) (aOR = 0.31, CI = 0.16-.58), but not significantly associated with changes in rates of infection, hypoxic ischemic encephalopathy (HIEE), birth trauma or meconium aspiration rates. Conclusions In 2011 when 81% of deliveries were women having their first child antepartum non-indicated CD had short-term maternal and perinatal outcomes as safe as SVD. Now that all Chinese women can have a second child the safety profile may change.	[Hou, Lei; Zou, Liying; Ruan, Yan; Wang, Xin; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet, Beijing, Peoples R China; [Hellerstein, Susan; Vitonis, Allison] Brigham & Womens Hosp, Harvard Med Sch, Dept Obstet & Gynecol, Boston, MA 02115 USA	Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhang, WY (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet, Beijing, Peoples R China.	zhangwy9921@hotmail.com			Health industry special funds for Public Benefit Research Foundation; Ministry of Health, People's Republic of China [201002013]	Health industry special funds for Public Benefit Research Foundation; Ministry of Health, People's Republic of China	SH, AV - unfunded. WZ - This project was supported by "Health industry special funds for Public Benefit Research Foundation" from the Ministry of Health, People's Republic of China (Grant number 201002013).	[Anonymous], 2013, Obstet Gynecol, V121, P904, DOI 10.1097/01.AOG.0000428647.67925.d3; [Anonymous], 2006, NIH Consens State Sci Statements, V23, P1; [Anonymous], 1985, THEORETICAL EPIDEMIO; Blustein J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2410; Cheng PJ, 2016, BJOG-INT J OBSTET GY, V123, P7, DOI 10.1111/1471-0528.14290; Cui Hao-sheng, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P422; Deng W, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-285; Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f; Hellerstein S, 2015, BJOG-INT J OBSTET GY, V122, P160, DOI 10.1111/1471-0528.12971; Hellerstein S, 2016, BIRTH-ISS PERINAT C, V43, P193, DOI 10.1111/birt.12231; Lee Y. M., 2008, CURRENT OPINION OBST, V20, P1; Liu XH, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.043; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; National Institute for Health and Clinical Excellence, 2011, CAES SECT CLIN GUID; Ogden CL, PREVALENCE OBESITY A; Qian J., 2012, J POPUL DEV, V5, P39; Shen Y., 2011, J PRACTICAL OBSTET G, P183; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhu Yi-bo, 2012, Zhonghua Yi Xue Za Zhi, V92, P1734	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171779	10.1371/journal.pone.0171779	http://dx.doi.org/10.1371/journal.pone.0171779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182668	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800108
J	Huang, CC; Kuo, SC; Yeh, YW; Chen, CY; Yen, CH; Liang, CS; Ho, PS; Lu, RB; Huang, SY				Huang, Chang-Chih; Kuo, Shin-Chang; Yeh, Yi-Wei; Chen, Chun-Yen; Yen, Che-Hung; Liang, Chih-Sung; Ho, Pei-Shen; Lu, Ru-Band; Huang, San-Yuan			The SLC6A3 gene possibly affects susceptibility to late-onset alcohol dependence but not specific personality traits in a Han Chinese population	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; NOVELTY SEEKING; DAT1 GENE; SIGNIFICANT ASSOCIATION; NUCLEUS-ACCUMBENS; POLYMORPHISMS; SEROTONIN; DISORDERS; RELEASE; QUESTIONNAIRE	Dopaminergic dysfunction has an important role in the pathoetiology of alcohol dependence (AD). The purpose of this study was to determine whether the solute carrier family 6 member 3 (SLC6A3) gene (also known as the dopamine transporter DAT gene) was associated with AD, and whether variants in the SLC6A3 locus were associated with specific personality traits in patients with AD. Sixteen polymorphisms in SLC6A3 were analyzed using 637 patients with AD and 523 healthy controls. To reduce clinical heterogeneity, patients were classified into two subgroups: early-onset AD (EOAD) and late-onset AD (LOAD). The Tridimensional Personality Questionnaire was used to assess the personality traits novelty seeking (NS) and harm avoidance (HA) in the patients with AD. Using allele frequency and genotype distribution comparisons and logistic regression analysis, we found evidence of association between rs6350 and AD (P < 0.05). Following subgroup analysis, we confirmed evidence of an association in patients with LOAD (P = 0.003), but not in patients with EOAD. Heterozygous carriers of the A allele have a nearly 3 times greater risk to develop LOAD compared to individuals who do not have an A allele. Although we found that patients with AD had higher NS and HA scores compared to controls (P < 0.001), we did not find evidence of association between SLC6A3 polymorphisms and either NS or HA in patients with AD using linear regression analysis. The findings from our study indicate that the SLC6A3 gene may have a role in susceptibility to late-onset AD in the Han Chinese population.	[Huang, Chang-Chih; Kuo, Shin-Chang; Yeh, Yi-Wei; Chen, Chun-Yen; Yen, Che-Hung; Huang, San-Yuan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Chang-Chih] Taipei Buddhist Tzu Chi Gen Hosp, Dept Psychiat, New Taipei, Taiwan; [Kuo, Shin-Chang; Yeh, Yi-Wei; Chen, Chun-Yen; Huang, San-Yuan] Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yen, Che-Hung] Chiayi Yang Ming Hosp, Dept Internal Med, Dept Div Neurol, Chiayi, Taiwan; [Liang, Chih-Sung; Ho, Pei-Shen] Triserv Gen Hosp, Beitou Branch, Dept Psychiat, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ, Dept Psychiat, Inst Behav Med, Coll Med, Tainan, Taiwan	National Defense Medical Center; Buddhist Tzu Chi General Hospital; Tri-Service General Hospital; Tri-Service General Hospital; National Cheng Kung University	Huang, SY (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	hsy@mail.ndmctsgh.edu.tw	Liang, Chih-Sung/V-6720-2019	Liang, Chih-Sung/0000-0003-1138-5586; Yeh, Yi-Wei/0000-0001-8690-6206; Chen, Chun-Yen/0000-0002-8330-9569				Almasy L, 2003, ANN MED, V35, P337, DOI 10.1080/07853890310004903; Ando B, 2014, SUBST USE MISUSE, V49, P418, DOI 10.3109/10826084.2013.841250; Anghelescu I, 2010, WORLD J BIOL PSYCHIA, V11, P382, DOI [10.1080/15622970701775058, 10.3109/15622970701775058]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; Chen YC, 2011, J STUD ALCOHOL DRUGS, V72, P752, DOI 10.15288/jsad.2011.72.752; Cloninger CR, 1996, ALCOHOL HEALTH RES W, V20, P18; CLONINGER CR, 1995, NAT MED, V1, P623, DOI 10.1038/nm0795-623; Crum RM, 2005, DRUG ALCOHOL DEPEN, V79, P71, DOI 10.1016/j.drugalcdep.2005.01.001; Dobashi I, 1997, PSYCHIATR GENET, V7, P87, DOI 10.1097/00041444-199722000-00006; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Erjavec GN, 2014, PROG NEURO-PSYCHOPH, V54, P321, DOI 10.1016/j.pnpbp.2014.07.002; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; Evren C, 2012, DRUG ALCOHOL REV, V31, P81, DOI 10.1111/j.1465-3362.2011.00303.x; Fairbanks LA, 2011, GENES BRAIN BEHAV, V10, P683, DOI 10.1111/j.1601-183X.2011.00707.x; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hong CJ, 2003, J NEURAL TRANSM, V110, P345, DOI 10.1007/s00702-002-0790-8; Huang CC, 2015, EUR ARCH PSY CLIN N, V265, P281, DOI 10.1007/s00406-014-0570-0; Huang CC, 2011, PHARMACOGENET GENOM, V21, P94, DOI 10.1097/FPC.0b013e3283424d94; Huang SY, 2010, SCHIZOPHR RES, V116, P68, DOI 10.1016/j.schres.2009.10.004; Jiao X, 2006, BRAIN RES, V1073, P175, DOI 10.1016/j.brainres.2005.12.009; Kazantseva A, 2011, PROG NEURO-PSYCHOPH, V35, P1033, DOI 10.1016/j.pnpbp.2011.02.013; Kelada SN, 2005, PHARMACOGENET GENOM, V15, P659, DOI 10.1097/01.fpc.0000170917.04275.d6; Kranzler HR, 2011, J CLIN PSYCHOPHARM, V31, P22, DOI 10.1097/JCP.0b013e31820465fa; Krebs RM, 2011, NEUROIMAGE, V58, P647, DOI 10.1016/j.neuroimage.2011.06.038; Le Strat Y, 2008, ALCOHOL CLIN EXP RES, V32, P27, DOI 10.1111/j.1530-0277.2007.00552.x; Leggio L, 2009, NEUROPSYCHOL REV, V19, P115, DOI 10.1007/s11065-008-9080-z; Lind PA, 2009, PSYCHIAT GENET, V19, P117, DOI 10.1097/YPG.0b013e32832a4f7b; Littlefield AK, 2010, SOC PERSONAL PSYCHOL, V4, P767, DOI 10.1111/j.1751-9004.2010.00296.x; Ma YL, 2016, ALCOHOL CLIN EXP RES, V40, P1443, DOI 10.1111/acer.13104; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Meszaros K, 1999, ALCOHOL CLIN EXP RES, V23, P483, DOI 10.1097/00000374-199903000-00015; Mittleman G, 2011, ALCOHOL, V45, P325, DOI 10.1016/j.alcohol.2010.12.006; Muller SE, 2008, NEUROPSYCHOBIOLOGY, V57, P159, DOI 10.1159/000147469; Pascale E, 2015, ALCOHOL ALCOHOLISM, V50, P259, DOI 10.1093/alcalc/agv014; Pettinati HM, 2000, ALCOHOL CLIN EXP RES, V24, P1041, DOI 10.1111/j.1530-0277.2000.tb04648.x; Prescott CA, 2006, BEHAV GENET, V36, P473, DOI 10.1007/s10519-006-9072-9; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Schmid B, 2009, ADDICT BIOL, V14, P489, DOI 10.1111/j.1369-1600.2009.00171.x; Schosser A, 2010, WORLD J BIOL PSYCHIA, V11, P417, DOI 10.3109/15622970801935586; Shibuya N, 2009, BEHAV BRAIN RES, V203, P23, DOI 10.1016/j.bbr.2009.04.008; Tan A T, 1981, Prog Biochem Pharmacol, V18, P224; Tzeng NS, 2015, DRUG ALCOHOL DEPEN, V149, P100, DOI 10.1016/j.drugalcdep.2015.01.030; Ueno S, 1999, MOL PSYCHIATR, V4, P552, DOI 10.1038/sj.mp.4000562; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van der Zwaluw CS, 2009, PHARMACOGENOMICS, V10, P853, DOI 10.2217/PGS.09.24; Wingo T, 2015, J NEUROIMMUNE PHARM; Wu X, 2009, PROG MOD BIOMED, V9, P1440; Xu MQ, 2011, PROG NEURO-PSYCHOPH, V35, P1255, DOI 10.1016/j.pnpbp.2010.11.001; Yeh YW, 2010, GENES BRAIN BEHAV, V9, P638, DOI 10.1111/j.1601-183X.2010.00597.x; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171170	10.1371/journal.pone.0171170	http://dx.doi.org/10.1371/journal.pone.0171170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182634	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800039
J	Li, WZ; Teng, XH; Zhang, HF; Liu, T; Wang, Q; Yuan, GH; Guo, XR				Li, Wei-zheng; Teng, Xiao-hui; Zhang, Hong-fei; Liu, Ting; Wang, Qiong; Yuan, Guohui; Guo, Xian-ru			Comparative host selection responses of specialist (Helicoverpa assulta) and generalist (Helicoverpa armigera) moths in complex plant environments	PLOS ONE			English	Article							VOLATILE EMISSIONS; OVIPOSITION PREFERENCE; HUBNER LEPIDOPTERA; LARVAL PERFORMANCE; RECEPTOR NEURONS; CAPSICUM-ANNUUM; BEHAVIOR; COTTON; NOCTUIDAE; HERBIVORE	We tested the behavioral responses of ovipositing females and natal larvae of two sibling species, a generalist Helicoverpa armigera (Hubner) and a specialist Helicoverpa assulta (Guenee), to odor sources emitted from different combinations of six plant species (tobacco, Nicotiana tabacum; hot pepper, Capsicum annuum; tomato, Solanum esculentum; cotton, Gossypium hirsutum; peanut, Arachis hypogaea; maize, Zea mays). Under the conditions of plant materials versus corresponding controls, both stages of both species could find their corresponding host plants. However, H. assulta females and larvae exhibited a supersensitive and an insensitive response, respectively. Under the conditions of tobacco paired with each plant species, H. assulta females exhibited more specialized ovipositional response to tobacco than its sibling. When each plant species were combined with tobacco and tested against tobacco reference, peanut played an opposite role in the two species in their ovipositional responses to tobacco, and cotton can enhance the approaching response of H. armigera larvae when combined with tobacco. It seems that two attractive host plants also can act antagonistically with respect to host selection of the generalist via volatile exchange. Tomato should better be excluded from host list of H. assulta.	[Li, Wei-zheng; Teng, Xiao-hui; Zhang, Hong-fei; Liu, Ting; Wang, Qiong; Yuan, Guohui; Guo, Xian-ru] Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Henan Province, Peoples R China	Henan Agricultural University	Yuan, GH; Guo, XR (corresponding author), Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Henan Province, Peoples R China.	hnndygh@126.com; guoxianru@126.com		Yuan, Guohui/0000-0003-0173-4383	National Natural Science Foundation of China [31572331, 31471772]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (31572331) and The National Natural Science Foundation of China (31471772).	Ahn SJ, 2011, J INSECT PHYSIOL, V57, P1212, DOI 10.1016/j.jinsphys.2011.05.015; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Lopez YIA, 2012, J CHEM ECOL, V38, P1376, DOI 10.1007/s10886-012-0201-z; Benda ND, 2011, ENVIRON ENTOMOL, V40, P1478, DOI 10.1603/EN09335; Cardoza YJ, 2002, J CHEM ECOL, V28, P161, DOI 10.1023/A:1013523104853; Cianfrogna JA, 2002, J CHEM ECOL, V28, P1365, DOI 10.1023/A:1016244402019; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Finch S, 2000, ENTOMOL EXP APPL, V96, P91, DOI 10.1023/A:1004058518179; Glendinning JI, 2009, J COMP PHYSIOL A, V195, P591, DOI 10.1007/s00359-009-0434-7; Hegde M, 2011, J CHEM ECOL, V37, P741, DOI 10.1007/s10886-011-9980-x; Hull CD, 2004, J CHEM ECOL, V30, P2071, DOI 10.1023/B:JOEC.0000045596.13384.7e; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Jallow MFA, 1999, AUST J ENTOMOL, V38, P359, DOI 10.1046/j.1440-6055.1999.00131.x; JALLOW MFA, 1995, J AUST ENTOMOL SOC, V34, P281; Lee HS, 2006, CHEMOECOLOGY, V16, P153, DOI 10.1007/s00049-006-0341-0; Liu ZD, 2010, ENVIRON ENTOMOL, V39, P552, DOI 10.1603/EN09129; Malezieux E, 2012, AGRON SUSTAIN DEV, V32, P15, DOI 10.1007/s13593-011-0027-z; MCCALL PJ, 1994, J CHEM ECOL, V20, P3039, DOI 10.1007/BF02033709; Megido RC, 2014, ARTHROPOD-PLANT INTE, V8, P293, DOI 10.1007/s11829-014-9315-2; MITCHELL ER, 1990, J CHEM ECOL, V16, P1817, DOI 10.1007/BF01020496; Ngumbi E, 2009, J CHEM ECOL, V35, P1009, DOI 10.1007/s10886-009-9700-y; Ninkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069431; Proffit M, 2011, J CHEM ECOL, V37, P565, DOI 10.1007/s10886-011-9961-0; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; Rajapakse CNK, 2006, PHYSIOL ENTOMOL, V31, P270, DOI 10.1111/j.1365-3032.2006.00517.x; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; Reudler Talsma JH, 2008, ARTHROPOD-PLANT INTE, V2, P63, DOI 10.1007/s11829-008-9039-2; Rodriguez-Saona C, 2001, J CHEM ECOL, V27, P679, DOI 10.1023/A:1010393700918; Rostelien T, 2005, CHEM SENSES, V30, P443, DOI 10.1093/chemse/bji039; Shikano I, 2010, ARTHROPOD-PLANT INTE, V4, P197, DOI 10.1007/s11829-010-9100-9; Srinivasan R, 2006, CURR SCI INDIA, V90, P846; Stranden M, 2003, CHEMOECOLOGY, V13, P143, DOI 10.1007/s00049-003-0242-4; Sun JG, 2012, ARTHROPOD-PLANT INTE, V6, P375, DOI 10.1007/s11829-012-9190-7; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Wu Kun-Jun, 2006, Acta Entomologica Sinica, V49, P421; Xue HJ, 2008, NATURWISSENSCHAFTEN, V95, P639, DOI 10.1007/s00114-008-0367-y	38	5	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171948	10.1371/journal.pone.0171948	http://dx.doi.org/10.1371/journal.pone.0171948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182679	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800137
J	Shen, LQ; An, P; Liu, Z				Shen, Liquan; An, Ping; Liu, Zhi			Context-adaptive based CU processing for 3D-HEVC	PLOS ONE			English	Article							INTER-MODE DECISION; MULTIVIEW VIDEO; DEPTH; MOTION; OPTIMIZATION; DISPARITY	The 3D High Efficiency Video Coding (3D-HEVC) standard aims to code 3D videos that usually contain multi-view texture videos and its corresponding depth information. It inherits the same quadtree prediction structure of HEVC to code both texture videos and depth maps. Each coding unit (CU) allows recursively splitting into four equal sub-CUs. At each CU depth level, it enables 10 types of inter modes and 35 types of intra modes in inter frames. Furthermore, the inter-view prediction tools are applied to each view in the test model of 3D-HEVC (HTM), which uses variable size disparity-compensated prediction to exploit inter-view correlation within neighbor views. It also exploits redundancies between a texture video and its associated depth using inter-component coding tools. These achieve the highest coding efficiency to code 3D videos but require a very high computational complexity. In this paper, we propose a context-adaptive based fast CU processing algorithm to jointly optimize the most complex components of HTM including CU depth level decision, mode decision, motion estimation (ME) and disparity estimation (DE) processes. It is based on the hypothesis that the optimal CU depth level, prediction mode and motion vector of a CU are correlated with those from spatiotemporal, inter-view and inter-component neighboring CUs. We analyze the video content based on coding information from neighboring CUs and early predict each CU into one of five categories i.e., DE-omitted CU, ME-DE-omitted CU, SPLIT CU, Non-SPLIT CU and normal CU, and then each type of CU adaptively adopts different processing strategies. Experimental results show that the proposed algorithm saves 70% encoder runtime on average with only a 0.1% BD-rate increase on coded views and 0.8% BD-rate increase on synthesized views. Our algorithm outperforms the state-of-the-art algorithms in terms of coding time saving or with better RD performance.	[Shen, Liquan; An, Ping; Liu, Zhi] Shanghai Univ, Key Lab Adv Display & Syst Applicat, Minist Educ, Shanghai, Peoples R China	Shanghai University	Shen, LQ (corresponding author), Shanghai Univ, Key Lab Adv Display & Syst Applicat, Minist Educ, Shanghai, Peoples R China.	jsslq@shu.edu.cn	LIU, Zhi/D-4518-2012; Shen, Liquan/D-4832-2012	LIU, Zhi/0000-0002-8428-1131; Shen, Liquan/0000-0002-2148-6279				[Anonymous], 2011, ISOIECJTC1SC29WG11; [Anonymous], JCT3VA1100; [Anonymous], 2015, JCT3VK1001; Bjontegaard G., 2001, P 13 VCEG M AUST TX; Chiang P., 2013, IEEE INT S CIRC SYST, P19; Choi K, 2011, JCTVCF092; Gao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151689; Gu ZY, 2013, IEEE INT CONF MULTI; Gweon R., 2011, JCTVCF045; Heming Sun, 2012, 2012 IEEE International Conference on Multimedia and Expo (ICME), P1085, DOI 10.1109/ICME.2012.4; Jiang C., 2016, IEEE T CIRCUITS SYST, V26, P246; Kim M, 2016, IEEE T CIRC SYST VID, V26, P736, DOI 10.1109/TCSVT.2015.2416556; Kim Y, 2007, IEEE T CONSUM ELECTR, V53, P712, DOI 10.1109/TCE.2007.381750; Lei J., IEEE T CIRCUITS SYST; Lei JJ, 2015, IEEE T CIRC SYST VID, V25, P275, DOI 10.1109/TCSVT.2014.2335471; Ma SW, 2014, IEEE T MULTIMEDIA, V16, P266, DOI 10.1109/TMM.2013.2284751; Merkle P, 2007, IEEE T CIRC SYST VID, V17, P1461, DOI 10.1109/TCSVT.2007.903665; Merkle P, 2016, IEEE T CIRC SYST VID, V26, P570, DOI 10.1109/TCSVT.2015.2407791; Mora EG, 2014, IEEE T CIRC SYST VID, V24, P1554, DOI 10.1109/TCSVT.2013.2283110; Muller K, 2013, IEEE T IMAGE PROCESS, V22, P3366, DOI 10.1109/TIP.2013.2264820; Pan ZQ, 2015, IEEE T BROADCAST, V61, P166, DOI 10.1109/TBC.2015.2419824; Podder PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150673; Shen LQ, 2015, ACM T MULTIM COMPUT, V11, DOI 10.1145/2700298; Shen LQ, 2014, IEEE T CIRC SYST VID, V24, P1709, DOI 10.1109/TCSVT.2014.2313892; Shen LQ, 2014, IEEE T BROADCAST, V60, P128, DOI 10.1109/TBC.2013.2289635; Shen LQ, 2013, IEEE T MULTIMEDIA, V15, P465, DOI 10.1109/TMM.2012.2231060; Shen LQ, 2011, IEEE T CIRC SYST VID, V21, P837, DOI 10.1109/TCSVT.2011.2130310; Sullivan G. J., 2010, RECENT DEV STANDARDI; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Swati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105613; Tohidypour HR, 2016, IEEE T CIRC SYST VID, V26, P1870, DOI 10.1109/TCSVT.2015.2477955; Xiong J, 2014, IEEE T MULTIMEDIA, V16, P2141, DOI 10.1109/TMM.2014.2356795; Zeng HQ, 2014, IEEE T CIRC SYST VID, V24, P1566, DOI 10.1109/TCSVT.2014.2310143; Zhang N, 2013, P IEEE 6 INT C BIOM, P1; Zhang N, 2014, SIGNAL PROCESS-IMAGE, V29, P951, DOI 10.1016/j.image.2014.06.003; Zhao JC, 2016, OPTIK, V127, P12048, DOI 10.1016/j.ijleo.2016.10.008; Zhu W, 2010, IEEE T CONSUM ELECTR, V56, P1696, DOI 10.1109/TCE.2010.5606315	37	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171018	10.1371/journal.pone.0171018	http://dx.doi.org/10.1371/journal.pone.0171018			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182719	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800027
J	Omidvar, V; Mohorianu, I; Dalmay, T; Zheng, Y; Fei, ZJ; Pucci, A; Mazzucato, A; Vecerova, V; Sedlarova, M; Fellner, M				Omidvar, Vahid; Mohorianu, Irina; Dalmay, Tamas; Zheng, Yi; Fei, Zhangjun; Pucci, Anna; Mazzucato, Andrea; Vecerova, Vendula; Sedlarova, Michaela; Fellner, Martin			Transcriptional regulation of male-sterility in 7B-1 male-sterile tomato mutant	PLOS ONE			English	Article							TAPETUM-DEGENERATION-RETARDATION; MALE REPRODUCTIVE DEVELOPMENT; ANTHER DEVELOPMENT; DIFFERENTIAL EXPRESSION; STAMENLESS-2 MUTANT; RNA-SEQ; GENE; RICE; POLLEN; LYCOPERSICON	The 78-1 tomato (Solanum lycopersicum L. cv Rutgers) is a male-sterile mutant with enhanced tolerance to abiotic stress, which makes it a potential candidate for hybrid seed breeding and stress engineering. To underline the molecular mechanism regulating the male-sterility in 78-1, transcriptomic profiles of the 78-1 male -sterile and wild type (WT) anthers were studied using mRNA sequencing (RNA-Seq). In total, 768 differentially expressed genes (DEGs) were identified, including 132 up -regulated and 636 down -regulated transcripts. Gene ontology (GO) enrichment analysis of DEGs suggested a general impact of the 78-1 mutation on metabolic processes, such as proteolysis and carbohydrate catabolic process. Sixteen candidates with key roles in regulation of anther development were subjected to further analysis using qRT-PCR and in situ hybridization. Cytological studies showed several defects associated with anther development in the 78-1 mutant, including unsynchronized anther maturation, dysfunctional meiosis, arrested microspores, defect in callose degradation and abnormal tapetum development. TUNEL assay showed a defect in programmed cell death (PCD) of tapetal cells in 78-1 anthers. The present study provides insights into the transcriptome of the 78-1 mutant. We identified several genes with altered expression level in 78-1 (including beta-1,3 glucanase, GA2oxs, cystatin, cysteine protease, pectinesterase, TA29, and actin) that could potentially regulate anther developmental processes, such as meiosis, tapetum development, and cell-wall formation/degradation.	[Omidvar, Vahid; Fellner, Martin] Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Stechtitelu 27, Olomouc, Czech Republic; [Omidvar, Vahid; Fellner, Martin] Inst Expt Bot AS CR, Stechtitelu 27, Olomouc, Czech Republic; [Mohorianu, Irina] Univ East Anglia, Sch Comp Sci, Norwich, Norfolk, England; [Mohorianu, Irina; Dalmay, Tamas] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Zheng, Yi; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Pucci, Anna; Mazzucato, Andrea] Univ Tuscia, Dept Agr & Forestry Sci, Viterbo, Italy; [Vecerova, Vendula; Sedlarova, Michaela] Palacky Univ, Fac Sci, Dept Bot, Slechtitelu 27, Olomouc, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of East Anglia; University of East Anglia; Cornell University; Boyce Thompson Institute for Plant Research; Tuscia University; Palacky University Olomouc	Omidvar, V; Fellner, M (corresponding author), Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Stechtitelu 27, Olomouc, Czech Republic.; Omidvar, V; Fellner, M (corresponding author), Inst Expt Bot AS CR, Stechtitelu 27, Olomouc, Czech Republic.	vahid.omidvar@gmail.com; martin.fellner@upol.cz	Mazzucato, Andrea/AEA-1650-2022; Fellner, Martin/B-2068-2010; Fei, Zhangjun/H-5152-2012; SEDLÁŘOVÁ, Michaela/L-2055-2018; Mohorianu, Irina/J-2549-2019; Dalmay, Tamas/E-1377-2011	SEDLÁŘOVÁ, Michaela/0000-0003-2319-1033; Mohorianu, Irina/0000-0003-4863-761X; Dalmay, Tamas/0000-0003-1492-5429	Operational Programs Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/30.0004]; Ministry of Education, Youth and Sports [L01204]; Biotechnology and Biological Sciences Research Council [BB/G008078/1] Funding Source: researchfish; BBSRC [BB/G008078/1] Funding Source: UKRI	Operational Programs Education for Competitiveness-European Social Fund; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Operational Programs Education for Competitiveness-European Social Fund, project no. CZ.1.07/2.3.00/30.0004 to MF, and by Ministry of Education, Youth and Sports, project no. L01204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bergougnoux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045255; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Distelfeld A, 2012, PLANT MOL BIOL, V78, P515, DOI 10.1007/s11103-012-9881-6; Dong X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072178; Emmanuel E, 2002, CURR OPIN PLANT BIOL, V5, P112, DOI 10.1016/S1369-5266(02)00237-6; Fellner M, 2002, PLANTA, V214, P675, DOI 10.1007/s004250100671; Fellner M, 2001, J EXP BOT, V52, P725, DOI 10.1093/jexbot/52.357.725; Fu ZZ, 2014, PLANT CELL, V26, P1512, DOI 10.1105/tpc.114.123745; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gorguet B, 2009, THEOR APPL GENET, V118, P1199, DOI 10.1007/s00122-009-0974-9; Gorman SW, 1997, CRIT REV PLANT SCI, V16, P31, DOI 10.1080/713608142; Gu JN, 2014, PLANT J, V80, P1005, DOI 10.1111/tpj.12694; Guo RX, 2006, THEOR APPL GENET, V112, P1271, DOI 10.1007/s00122-006-0228-z; Huang F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-89; Ito T, 2007, PLANT CELL, V19, P3549, DOI 10.1105/tpc.107.054536; JACOBSEN SE, 1991, PLANT PHYSIOL, V97, P409, DOI 10.1104/pp.97.1.409; Jeong HJ, 2014, J EXP BOT; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim OK, 2010, PLANTA, V232, P353, DOI 10.1007/s00425-010-1178-x; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazan H, 2004, PLANT PHYSIOL BIOCH, V42, P847, DOI 10.1016/j.plaphy.2004.10.007; Li Han, 2011, J Biomed Biotechnol, V2011, P281651, DOI 10.1155/2011/281651; Li L, 2015, PLANTA, V241, P157, DOI 10.1007/s00425-014-2160-9; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Liu ZH, 2010, J INTEGR PLANT BIOL, V52, P670, DOI 10.1111/j.1744-7909.2010.00959.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2014, PLANT PHYSIOL, V164, P1893, DOI 10.1104/pp.113.233387; Lu Q, 2005, MOL GENET GENOMICS, V273, P507, DOI 10.1007/s00438-005-1155-4; Mamun ANK, 2007, INDIAN J EXP BIOL, V45, P1022; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Nakamura A, 2003, BIOSCI BIOTECH BIOCH, V67, P68, DOI 10.1271/bbb.67.68; Nawaz-ul-Rehman MS, 2007, MOL BIOTECHNOL, V36, P159, DOI 10.1007/s12033-007-0025-1; Niu NN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2396; Omidvar V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2077-0; Omidvar V, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.02.0008; Omidvar V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121864; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RASTOGI R, 1988, AM J BOT, V75, P513, DOI 10.2307/2444216; Rhee SY, 1998, PLANT J, V15, P79, DOI 10.1046/j.1365-313X.1998.00183.x; RICK. CHARLES M., 1948, HILGARDIA, V18, P599; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rong Z, 1996, ACTA BOT SIN, V38, P582; ROSS JJ, 1995, PLANT J, V7, P513, DOI 10.1046/j.1365-313X.1995.7030513.x; Sawhney V. K., 1997, Pollen biotechnology for crop production and improvement., P183, DOI 10.1017/CBO9780511525469.010; SAWHNEY VK, 1988, CAN J BOT, V66, P2013, DOI 10.1139/b88-275; Sawhney VK, 2004, J HORTIC SCI BIOTECH, V79, P138, DOI 10.1080/14620316.2004.11511726; Schreiber DN, 2004, PLANT PHYSIOL, V134, P1069, DOI 10.1104/pp.103.030577; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; SHUKLA A, 1994, PHYSIOL PLANTARUM, V91, P522, DOI 10.1111/j.1399-3054.1994.tb02983.x; SINGH S, 1992, PLANT SCI, V86, P147, DOI 10.1016/0168-9452(92)90160-N; SINGH S, 1992, PLANT CELL ENVIRON, V15, P373, DOI 10.1111/j.1365-3040.1992.tb00986.x; Smith MB, 2001, CROP SCI, V41, P702, DOI 10.2135/cropsci2001.413702x; Sun YJ, 2007, J INTEGR PLANT BIOL, V49, P60, DOI 10.1111/j.1744-7909.2006.00408.x; Tabuchi M, 2005, PLANT J, V42, P641, DOI 10.1111/j.1365-313X.2005.02406.x; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Wilson ZA, 2001, PLANT J, V28, P27, DOI 10.1046/j.1365-313X.2001.01125.x; Xu CG, 2013, PROTOPLASMA, V250, P415, DOI 10.1007/s00709-012-0386-6; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang C, 2007, PLANT CELL, V19, P3530, DOI 10.1105/tpc.107.054981; Yang X, 2014, J INTEGR PLANT BIOL; Yui R, 2003, PLANT J, V34, P57, DOI 10.1046/j.1365-313X.2003.01704.x; Zhang DS, 2008, MOL PLANT, V1, P599, DOI 10.1093/mp/ssn028; Zhang JY, 2012, J SCI FOOD AGR, V92, P3046, DOI 10.1002/jsfa.5722; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhu J, 2008, PLANT J, V55, P266, DOI 10.1111/j.1365-313X.2008.03500.x; Zhu J, 2011, J INTEGR PLANT BIOL, V53, P892, DOI 10.1111/j.1744-7909.2011.01078.x; Zhu Y, 2010, PLANT MOL BIOL, V72, P111, DOI 10.1007/s11103-009-9556-0	82	14	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170715	10.1371/journal.pone.0170715	http://dx.doi.org/10.1371/journal.pone.0170715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178307	Green Published, gold, Green Accepted			2022-12-27	WOS:000393712500013
J	Cortez-Toledo, O; Schnair, C; Sangngern, P; Metzger, D; Chao, LC				Cortez-Toledo, Omar; Schnair, Caitlin; Sangngern, Peer; Metzger, Daniel; Chao, Lily C.			Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IMPROVES METABOLIC PARAMETERS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; STRIATED-MUSCLE; FIBER GROWTH; STEM-CELLS; IN-VIVO; ATROPHY	Muscle atrophy is a prevalent condition in illness and aging. Identifying novel pathways that control muscle mass may lead to therapeutic advancement. We previously identified Nur77 as a transcriptional regulator of glycolysis in skeletal muscle. More recently, we showed that Nur77 expression also controls myofiber size in mice. It was unknown, however, whether Nur77's regulation of muscle size begins during developmental myogenesis or only in adulthood. To determine the importance of Nur77 throughout muscle growth, we examined myofiber size at E18.5, 3 weeks postnatal age, and in young adult mice. Using the global Nur77(-/-) mice, we showed that Nur77 deficiency reduced myofiber size as early as E18.5. The reduction in myofiber size became more pronounced by 3 weeks of age. We observed comparable reduction in myofiber size in young myofiber-specific Nur77-knockout mice. These findings suggest that Nur77's effect on muscle growth is intrinsic to its expression in differentiating myofibers, and not dependent on its expression in myogenic stem cells. To determine the importance of Nur77 expression in muscle accretion in mature mice, we generated an inducible-, muscle-specific, Nur77-deficient mouse model. We demonstrated that tamoxifen-induced deletion of Nur77 in 3-month-old mice reduced myofiber size. This change was accompanied by increased activity of Smad2 and FoxO3, two negative regulators of muscle mass. The role of Nur77 in muscle growth was further elaborated in the cardiotoxin-induced muscle regeneration model. Compared to wildtype mice, regenerated myofibers were smaller in Nur77(-/-) mice. However, when normalized to saline-injected muscle, the recovery of sarcoplasmic area was comparable between Nur77(-/-) and wildtype mice. These findings suggest that Nur77 deficiency compromises myofiber growth, but not the regenerative capacity of myogenic progenitor cells. Collectively, the findings presented here demonstrate Nur77 as an important regulator of muscle growth both during prenatal and postnatal myogenesis.	[Cortez-Toledo, Omar; Schnair, Caitlin; Sangngern, Peer; Chao, Lily C.] Childrens Hosp Los Angeles, Ctr Endocrinol Diabet & Metab, Los Angeles, CA 90027 USA; [Metzger, Daniel] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104, INSERM U964, Illkirch Graffenstaden, France; [Chao, Lily C.] Univ Southern Calif, Keck Sch Med, Dept Biochem Mol Biol, Los Angeles, CA 90007 USA	Children's Hospital Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Southern California	Chao, LC (corresponding author), Childrens Hosp Los Angeles, Ctr Endocrinol Diabet & Metab, Los Angeles, CA 90027 USA.; Chao, LC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Biochem Mol Biol, Los Angeles, CA 90007 USA.	lchao@chla.usc.edu		Metzger, Daniel/0000-0002-5555-046X	Saban Research Institute	Saban Research Institute	The study was funded by The Saban Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bentzinger CF, 2013, BIOESSAYS, V35, P231, DOI 10.1002/bies.201200063; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clemmons DR, 2004, HORM RES, V62, P77, DOI 10.1159/000080763; Danon MJ, 2007, CLIN BIOCHEM, V40, P46, DOI 10.1016/j.clinbiochem.2006.09.002; Das S, 2015, CELL METAB, V21, P868, DOI 10.1016/j.cmet.2015.05.006; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Li MS, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0091-8; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; McCarthy JJ, 2010, CURR OPIN CLIN NUTR, V13, P230, DOI 10.1097/MCO.0b013e32833781b5; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; Pasut A, 2012, METHODS MOL BIOL, V798, P53, DOI 10.1007/978-1-61779-343-1_3; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; SMITH TH, 1992, DEV BIOL, V149, P16, DOI 10.1016/0012-1606(92)90260-N; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suetta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051238; Tando T, 2016, J BIOL CHEM, V291, P12184, DOI 10.1074/jbc.M115.680579; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Tsai S, 2015, J CLIN INVEST, V125, P2952, DOI 10.1172/JCI77361; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	68	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171268	10.1371/journal.pone.0171268	http://dx.doi.org/10.1371/journal.pone.0171268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170423	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500026
J	Jerng, JS; Huang, SF; Liang, HW; Chen, LC; Lin, CK; Huang, HF; Hsieh, MY; Sun, JS				Jerng, Jih-Shuin; Huang, Szu-Fen; Liang, Huey-Wen; Chen, Li-Chin; Lin, Chia-Kuei; Huang, Hsiao-Fang; Hsieh, Ming-Yuan; Sun, Jui-Sheng			Workplace interpersonal conflicts among the healthcare workers: Retrospective exploration from the institutional incident reporting system of a university-affiliated medical center	PLOS ONE			English	Article							TEAM PERFORMANCE; ADVERSE EVENTS; SATISFACTION; MANAGEMENT; VIOLENCE; NURSES; IMPACT; TASK	Objective There have been concerns about the workplace interpersonal conflict (WIC) among healthcare workers. As healthcare organizations have applied the incident reporting system (IRS) widely for safety-related incidents, we proposed that this system might provide a channel to explore the WICs. Methods We retrospectively reviewed the reports to the IRS from July 2010 to June 2013 in a medical center. We identified the WICs and typed these conflicts according to the two foci (task content/process and interpersonal relationship) and the three properties (disagreement, interference, and negative emotion), and analyzed relevant data. Results Of the 147 incidents with WIC, the most common related processes were patient transfer (20%), laboratory tests (17%), surgery (16%) and medical imaging (16%). All of the 147 incidents with WIC focused on task content or task process, but 41 (27.9%) also focused on the interpersonal relationship. We found disagreement, interference, and negative emotion in 91.2%, 88.4%, and 55.8% of the cases, respectively. Nurses (57%) were most often the reporting workers, while the most common encounter was the nurse-doctor interaction (33%), and the majority (67%) of the conflicts were experienced concurrently with the incidents. There was a significant difference in the distribution of worker job types between cases focused on the interpersonal relationship and those without (p = 0.0064). The doctors were more frequently as the reporter when the conflicts focused on the interpersonal relationship (34.1%) than not on it (17.0%). The distributions of worker job types were similar between those with and without negative emotion (p = 0.125). Conclusions The institutional IRS is a useful place to report the workplace interpersonal conflicts actively. The healthcare systems need to improve the channels to communicate, manage and resolve these conflicts.	[Jerng, Jih-Shuin; Huang, Szu-Fen; Liang, Huey-Wen; Chen, Li-Chin; Lin, Chia-Kuei; Huang, Hsiao-Fang; Hsieh, Ming-Yuan; Sun, Jui-Sheng] Natl Taiwan Univ Hosp, Ctr Qual Management, Taipei, Taiwan; [Jerng, Jih-Shuin] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Szu-Fen] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; [Liang, Huey-Wen] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Sun, Jui-Sheng] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Sun, JS (corresponding author), Natl Taiwan Univ Hosp, Ctr Qual Management, Taipei, Taiwan.; Sun, JS (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.	drjssun@ntuh.gov.tw	LIANG, HUEY-WEN/AAN-8083-2020	LIANG, HUEY-WEN/0000-0003-0186-3126				Association AM, 2009, PHYS DISR BEH; Baldwin DC, 2008, J INTERPROF CARE, V22, P573, DOI 10.1080/13561820802364740; Barki H, 2004, INT J CONFL MANAGE, V15, P216, DOI 10.1108/eb022913; Chan T, 2014, ACAD EMERG MED, V21, P308, DOI 10.1111/acem.12325; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; de Wit FRC, 2012, J APPL PSYCHOL, V97, P360, DOI 10.1037/a0024844; Fakhry SF, 2011, J AM SCI, V7, P808; Fassier T, 2010, CURR OPIN CRIT CARE, V16, P654, DOI 10.1097/MCC.0b013e32834044f0; Greer LL, 2012, MED EDUC, V46, P935, DOI 10.1111/j.1365-2923.2012.04321.x; Gross MA, 2013, INT J CONFL MANAGE, V24, P90, DOI 10.1108/10444061311296152; Guidroz AM, 2012, STRESS HEALTH, V28, P69, DOI 10.1002/smi.1405; Huang JC, 2012, INT J HUM RESOUR MAN, V23, P2126, DOI 10.1080/09585192.2012.664961; Jehn KA, 1997, ADMIN SCI QUART, V42, P530, DOI 10.2307/2393737; JEHN KA, 1995, ADMIN SCI QUART, V40, P256, DOI 10.2307/2393638; Kaitelidou D, 2012, J NURS MANAGE, V20, P571, DOI 10.1111/j.1365-2834.2011.01196.x; Katz JD, 2007, J CLIN ANESTH, V19, P152, DOI 10.1016/j.jclinane.2006.07.007; Lancman S, 2013, WORK, V45, P519, DOI 10.3233/WOR-131638; Leung K., 2002, ASIA PAC J MANAG, V19, P201, DOI [DOI 10.1023/A:1016287501806, 10.1023/A:1016287501806]; Marquis BL., 2009, LEADERSHIP ROLES MAN; McKenna BG, 2003, J ADV NURS, V42, P90, DOI 10.1046/j.1365-2648.2003.02583.x; Mills Mary Etta C, 2002, J Health Care Law Policy, V5, P502; Moye NA, 2004, INT J CONFL MANAGE, V15, P381, DOI 10.1108/eb022919; Nguyen HHD, 2012, INT J CONFL MANAGE, V23, P382, DOI 10.1108/10444061211267272; Niiyama E, 2009, STRESS HEALTH, V25, P3, DOI 10.1002/smi.1217; Olson TJP, 2013, JAMA SURG, V148, P29, DOI 10.1001/jamasurgery.2013.403; PIETRONI PC, 1994, BRIT MED J, V308, P1546, DOI 10.1136/bmj.308.6943.1546; Rosenstein AH, 2012, J EMERG MED, V43, P139, DOI 10.1016/j.jemermed.2011.01.019; Runciman W, 2009, INT J QUAL HEALTH C, V21, P18, DOI 10.1093/intqhc/mzn057; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Schneider B, 1991, ORG CLIMATE CULTURE, P542; Shaw R, 2005, QUAL SAF HEALTH CARE, V14, P279, DOI 10.1136/qshc.2004.010553; Solansky ST, 2014, NEGOT CONFL MANAG R, V7, P83, DOI 10.1111/ncmr.12027; Tjosvold D, 2005, HUM RELAT, V58, P341, DOI 10.1177/0018726705053426; WALL JA, 1995, J MANAGE, V21, P515, DOI 10.1016/0149-2063(95)90018-7; Walrath JM, 2013, J NURS CARE QUAL, V28, P110, DOI 10.1097/NCQ.0b013e318270d2ba; Wright Kevin B, 2011, J Healthc Qual, V33, P7, DOI 10.1111/j.1945-1474.2010.00094.x	37	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171696	10.1371/journal.pone.0171696	http://dx.doi.org/10.1371/journal.pone.0171696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166260	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100063
J	Perera, RS; Ding, XC; Tully, F; Oliver, J; Bright, N; Bell, D; Chiodini, PL; Gonzalez, IJ; Polley, SD				Perera, Rushini S.; Ding, Xavier C.; Tully, Frank; Oliver, James; Bright, Nigel; Bell, David; Chiodini, Peter L.; Gonzalez, Iveth J.; Polley, Spencer D.			Development and clinical performance of high throughput loop-mediated isothermal amplification for detection of malaria	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; BLOOD; LAMP; KIT; SENSITIVITY; POINT	Background Accurate and efficient detection of sub-microscopic malaria infections is crucial for enabling rapid treatment and interruption of transmission. Commercially available malaria LAMP kits have excellent diagnostic performance, though throughput is limited by the need to prepare samples individually. Here, we evaluate the clinical performance of a newly developed high throughput (HTP) sample processing system for use in conjunction with the Eiken malaria LAMP kit. Methods The HTP system utilised dried blood spots (DBS) and liquid whole blood (WB), with parallel sample processing of 94 samples per run. The system was evaluated using 699 samples of known infection status pre-determined by gold standard nested PCR. Results The sensitivity and specificity of WB-HTP-LAMP was 98.6% (95% CI, 95.7-100), and 99.7% (95% CI, 99.2-100); sensitivity of DBS-HTP-LAMP was 97.1% (95% CI, 93.1-100), and specificity 100% against PCR. At parasite densities greater or equal to 2 parasites/mu L, WB and DBS HTP-LAMP showed 100% sensitivity and specificity against PCR. At densities less than 2 p/mu L, WB-HTP-LAMP sensitivity was 88.9% (95% CI, 77.1-100) and specificity was 99.7% (95% CI, 99.2-100); sensitivity and specificity of DBS-HTP-LAMP was 77.8% (95% CI, 54.3-99.5) and 100% respectively. Conclusions The HTP-LAMP system is a highly sensitive diagnostic test, with the potential to allow large scale population screening in malaria elimination campaigns.	[Perera, Rushini S.; Chiodini, Peter L.] Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, Dept Clin Parasitol, London, England; [Ding, Xavier C.; Gonzalez, Iveth J.] FIND, CH-1202 Geneva, Switzerland; [Tully, Frank; Oliver, James] 42 Technol Ltd, St Ives, Cambs, England; [Bright, Nigel] Porvair Sci Ltd, Norwich, Norfolk, England; [Bell, David] Global Good Fund, Intellectual Ventures Lab, Bellevue, WA USA; [Chiodini, Peter L.] London Sch Hyg & Trop Med, Keppel St, London, England; [Chiodini, Peter L.; Polley, Spencer D.] Hlth Serv Labs LLP, Hosp Trop Dis, Dept Clin Parasitol, London, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; Foundation For Innovative New Diagnostics; Intellectual Ventures; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	Perera, RS (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Hosp Trop Dis, Dept Clin Parasitol, London, England.	Rushini.Perera@uclh.nhs.uk			BMBF (German Ministry of Research and Education) through KfW (German Development Bank) Grant name : BMBF Kfw [202060457]; National Institute for Health Research University College Londan Hospitals Biomedical Research Centre; FIND	BMBF (German Ministry of Research and Education) through KfW (German Development Bank) Grant name : BMBF Kfw; National Institute for Health Research University College Londan Hospitals Biomedical Research Centre; FIND	This work was supported by FIND, with funding from BMBF (German Ministry of Research and Education) through KfW (German Development Bank) Grant name: BMBF Kfw Grant number: 202060457. PLC is supported by the National Institute for Health Research University College Londan Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Schmidt B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169037; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Britton S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004443; Britton S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0848-3; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; FIND, MAN STAND OP PROC MA; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/erm.12.144, 10.1586/ERM.12.144]; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Lucchi N. W., 2016, PLOS ONE, V11; Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808; Modak SS, 2016, INFECT DIS RES TREAT, V9; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Padley DJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-139; Poirot E, 2013, COCHRANE DATABASE SY, V12; Polley SD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0558-x; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Polley SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-62; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Rakotonirina H, 2008, AM J TROP MED HYG, V78, P217, DOI 10.4269/ajtmh.2008.78.217; Shokoples SE, 2009, J CLIN MICROBIOL, V46; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Vallejo AF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003453; WHO, 1999, NEW PERSP MAL DIAGN; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2014, EV REV GROUP MAL DIA	34	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171126	10.1371/journal.pone.0171126	http://dx.doi.org/10.1371/journal.pone.0171126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166235	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000393700100025
J	Ruskin, DN; Murphy, MI; Slade, SL; Masino, SA				Ruskin, David N.; Murphy, Michelle I.; Slade, Sierra L.; Masino, Susan A.			Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder	PLOS ONE			English	Article							ADENYLOSUCCINATE LYASE DEFICIENCY; FETAL-BRAIN-DEVELOPMENT; OF-THE-LITERATURE; ADULT MICE; METABOLISM; ADENOSINE; INFECTION; EPILEPTOGENESIS; SYMPTOMS; CHILDREN	Prenatal factors influence autism spectrum disorder (ASD) incidence in children and can increase ASD symptoms in offspring of animal models. These may include maternal immune activation (MIA) due to viral or bacterial infection during the first trimesters. Unfortunately, regardless of ASD etiology, existing drugs are poorly effective against core symptoms. For nearly a century a ketogenic diet (KD) has been used to treat seizures, and recent insights into mechanisms of ASD and a growing recognition that immune/inflammatory conditions exacerbate ASD risk has increased interest in KD as a treatment for ASD. Here we studied the effects of KD on core ASD symptoms in offspring exposed to MIA. To produce MIA, pregnant C57BI/6 mice were injected with the viral mimic polyinosinic-polycytidylic acid; after weaning offspring were fed KD or control diet for three weeks. Consistent with an ASD phenotype of a higher incidence in males, control diet-fed MIA male offspring were not social and exhibited high levels of repetitive self-directed behaviors; female offspring were unaffected. However, KD feeding partially or completely reversed all MIA-induced behavioral abnormalities in males; it had no effect on behavior in females. KD-induced metabolic changes of reduced blood glucose and elevated blood ketones were quantified in offspring of both sexes. Prior work from our laboratory and others demonstrate KDs improve relevant behaviors in several ASD models, and here we demonstrate clear benefits of KD in the MIA model of ASD. Together these studies suggest a broad utility for metabolic therapy in improving core ASD symptoms, and support further research to develop and apply ketogenic and/or metabolic strategies in patients with ASD.	[Ruskin, David N.; Murphy, Michelle I.; Slade, Sierra L.; Masino, Susan A.] Trinity Coll, Dept Psychol, Neurosci Program, Hartford, CT 06106 USA	Trinity College	Ruskin, DN (corresponding author), Trinity Coll, Dept Psychol, Neurosci Program, Hartford, CT 06106 USA.	david.ruskin@trincoll.edu			National Institute of Neurological Disease and Stroke [NS066392, NS065957]; National Center for Complementary and Integrative Health [AT008742]; National Center for Complementary & Integrative Health [R15AT008742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065957, R15NS066392] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Complementary and Integrative Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work received support from the following sources: National Institute of Neurological Disease and Stroke, NS066392, NS 065957 (SAM), www.ninds.nih.gov/ and the National Center for Complementary and Integrative Health, AT008742 (DNR), https://nccih.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn Y, 2014, DEV NEUROSCI-BASEL, V36, P371, DOI 10.1159/000362645; Arvio Maria, 2010, Duodecim, V126, P557; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Castro K., 2016, NUTR NEUROS IN PRESS; Castro K, 2015, RES AUTISM SPECT DIS, V20, P31, DOI 10.1016/j.rasd.2015.08.005; Chen JY, 2016, J HUNTINGTONS DIS, V5, P65, DOI 10.3233/JHD-150181; Dupuis N, 2015, EPILEPSIA, V56, pe95, DOI 10.1111/epi.13038; Eapen V, 2011, AUTISM NEURODEVELOPM, P103; El-Ansary A, 2010, CLIN BIOCHEM, V43, P63, DOI 10.1016/j.clinbiochem.2009.09.008; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; Frye RE, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-37; GALEF BG, 1983, ANIM BEHAV, V31, P748, DOI 10.1016/S0003-3472(83)80232-2; Gano LB, 2014, J LIPID RES, V55, P2211, DOI 10.1194/jlr.R048975; Grindstaff JL, 2012, HORM BEHAV, V62, P337, DOI 10.1016/j.yhbeh.2012.04.005; HAAS RH, 1986, AM J MED GENET, V24, P225; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Herbert MR, 2013, J CHILD NEUROL, V28, P975, DOI 10.1177/0883073813488668; Jiang Y, 2012, NEUROSCI LETT, V508, P22, DOI 10.1016/j.neulet.2011.12.002; Jurecka A, 2014, NEUROPEDIATRICS, V45, P50, DOI 10.1055/s-0033-1337335; Kawamura M, 2014, J LIPID RES, V55, P2254, DOI 10.1194/jlr.M046755; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001; Liebhaber GM, 2003, J CHILD NEUROL, V18, P74, DOI 10.1177/08830738030180011801; Lusardi TA, 2015, NEUROPHARMACOLOGY, V99, P500, DOI 10.1016/j.neuropharm.2015.08.007; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Marie S, 2002, AM J HUM GENET, V71, P14, DOI 10.1086/341036; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; Masino S.A., 2015, HOMEOSTATIC CONTROL, P586; Masino SA, 2013, NEUROPHARMACOLOGY, V68, P116, DOI 10.1016/j.neuropharm.2012.08.013; Masino SA, 2011, NEUROSCI LETT, V500, P1, DOI 10.1016/j.neulet.2011.06.007; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Nandivada P, 2016, LIPIDS, V51, P703, DOI 10.1007/s11745-016-4156-7; Napoli E, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00069; Naviaux JC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.33; Naviaux RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057380; Oliveira G, 2005, DEV MED CHILD NEUROL, V47, P185, DOI 10.1017/S0012162205000332; Page T, 2002, PROG NEURO-PSYCHOPH, V26, P397, DOI 10.1016/S0278-5846(01)00249-4; Page T, 2000, BBA-MOL BASIS DIS, V1500, P291, DOI 10.1016/S0925-4439(99)00113-1; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruskin DN, 2017, PHYSIOL BEHAV, V168, P138, DOI 10.1016/j.physbeh.2016.10.023; Ruskin DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065021; Ruskin DN, 2013, J PAIN, V14, P467, DOI 10.1016/j.jpain.2012.12.015; Ruskin DN, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00033; Smith J, 2016, BEHAV BRAIN RES, V304, P67, DOI 10.1016/j.bbr.2016.02.015; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spilioti M, 2016, EUR J PAEDIATR NEURO, V20, P555, DOI 10.1016/j.ejpn.2016.04.003; Spilioti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00858; Todorova MT, 2000, EPILEPSIA, V41, P933, DOI 10.1111/j.1528-1157.2000.tb00275.x; Verpeut JL, 2016, PHYSIOL BEHAV, V161, P90, DOI 10.1016/j.physbeh.2016.04.001; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Xuan ICY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104433; Zerbo O, 2015, J AUTISM DEV DISORD, V45, P4015, DOI 10.1007/s10803-013-2016-3; Zilkha N, NEUROSCIENC IN PRESS; [No title captured]	60	58	58	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171643	10.1371/journal.pone.0171643	http://dx.doi.org/10.1371/journal.pone.0171643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166277	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100058
J	Airi, V; Prantoni, S; Calegari, M; Baldi, VL; Gizzi, F; Marchini, C; Levy, O; Falini, G; Dubinsky, Z; Goffredo, S				Airi, Valentina; Prantoni, Selena; Calegari, Marco; Baldi, Veronica Lisini; Gizzi, Francesca; Marchini, Chiara; Levy, Oren; Falini, Giuseppe; Dubinsky, Zvy; Goffredo, Stefano			Reproductive output of a non-zooxanthellate temperate coral is unaffected by temperature along an extended latitudinal gradient	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BALANOPHYLLIA-EUROPAEA SCLERACTINIA; LEPTOPSAMMIA-PRUVOTI SCLERACTINIA; CLIMATE-CHANGE IMPACTS; SEXUAL REPRODUCTION; GROWTH; DENDROPHYLLIIDAE; MORTALITY; PATTERNS; WINNERS	Global environmental change, in marine ecosystems, is associated with concurrent shifts in water temperature, circulation, stratification, and nutrient input, with potentially wide-ranging biological effects. Variations in seawater temperature might alter physiological functioning, reproductive efficiency, and demographic traits of marine organisms, leading to shifts in population size and abundance. Differences in temperature tolerances between organisms can identify individual and ecological characteristics, which make corals able to persist and adapt in a climate change context. Here we investigated the possible effect of temperature on the reproductive output of the solitary non-zooxanthellate temperate coral Leptopsammia pruvoti, along an 8 degrees latitudinal gradient. Samples have been collected in six populations along the gradient and each polyp was examined using histological and cyto-histometric analyses. We coupled our results with previous studies on the growth, demography, and calcification of L. pruvoti along the same temperature gradient, and compared them with those of another sympatric zooxanthellate coral Balanophyllia europaea to understand which trophic strategy makes the coral more tolerant to increasing temperature. The nonzooxanthellate species seemed to be quite tolerant to temperature increases, probably due to the lack of the symbiosis with zooxanthellae. To our knowledge, this is the first field investigation of the relationship between reproductive output and temperature increase of a temperate asymbiotic coral, providing novel insights into the poorly studied non-zooxanthellate scleractinians.	[Airi, Valentina; Prantoni, Selena; Calegari, Marco; Baldi, Veronica Lisini; Gizzi, Francesca; Marchini, Chiara; Goffredo, Stefano] Univ Bologna, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Falini, Giuseppe] Univ Bologna, Dept Chem Giacomo Ciamician, Bologna, Italy	University of Bologna; Bar Ilan University; University of Bologna	Goffredo, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy.; Dubinsky, Z (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	zvykalmog@gmail.com; s.goffredo@unibo.it	Gizzi, Francesca/Q-4866-2019	Gizzi, Francesca/0000-0001-9447-8694; Airi, Valentina/0000-0002-6118-7441; goffredo, stefano/0000-0002-5022-9503	European Research Council under the European Union [249930]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no 249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091792; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Ateweberhan M, 2013, MAR POLLUT BULL, V74, P526, DOI 10.1016/j.marpolbul.2013.06.011; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Caroselli E, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-32; Caroselli E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037848; Caroselli E, 2011, ZOOLOGY, V114, P255, DOI 10.1016/j.zool.2011.04.003; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, CORAL REEFS, V23, P433, DOI 10.1007/s00338-004-0395-9; Goffredo S, 2007, MAR BIOL, V152, P351, DOI 10.1007/s00227-007-0695-z; Goffredo S, 2010, MAR BIOL, V157, P2603, DOI 10.1007/s00227-010-1522-5; Goffredo S, 2009, ISR J ECOL EVOL, V55, P99, DOI 10.1560/IJEE.55.2.99; Goffredo S, 2009, LIMNOL OCEANOGR, V54, P930, DOI 10.4319/lo.2009.54.3.0930; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Howells EJ, 2013, ECOLOGY, V94, P1078, DOI 10.1890/12-1257.1; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Kersting DK, 2013, MAR ECOL PROG SER, V486, P165, DOI 10.3354/meps10356; Kleypas JA, 1999, AM ZOOL, V39, P146; Korta M, 2010, FISH RES, V104, P56, DOI 10.1016/j.fishres.2010.01.010; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Linares C, 2013, MAR ENVIRON RES, V89, P45, DOI 10.1016/j.marenvres.2013.04.009; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; Roth L, 2010, MAR ECOL PROG SER, V411, P73, DOI 10.3354/meps08640; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203	39	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171051	10.1371/journal.pone.0171051	http://dx.doi.org/10.1371/journal.pone.0171051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158213	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700025
J	Lee, CH; Huang, G; Chan, PH; Hai, J; Yeung, CY; Fong, CHY; Woo, YC; Ho, KL; Yiu, MK; Leung, F; Lau, TW; Tse, HF; Lam, KSL; Siu, CW				Lee, Chi-Ho; Huang, Gang; Chan, Pak-Hei; Hai, Jojo; Yeung, Chun-Yip; Fong, Carol Ho-Yi; Woo, Yu-Cho; Ho, Kwan Lun; Yiu, Ming-Kwong; Leung, Frankie; Lau, Tak-Wing; Tse, Hung-Fat; Lam, Karen Siu-Ling; Siu, Chung-Wah			Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma	PLOS ONE			English	Article							BONE-MINERAL DENSITY; RACIAL-DIFFERENCES; CANCER PATIENTS; MEN; TRENDS	Objective Androgen deprivation therapy (ADT) increases fracture risk in men with carcinoma of the prostate, but little is known about the fracture risk for different types of ADT. We studied the fracture risk amongst Chinese patients with carcinoma of the prostate prescribed different ADT regimens. Subjects and methods This was a single-centered observational study that involved 741 patients with carcinoma of the prostate from January 2001 to December 2011. Results After a median follow-up of 5 years, 71.7% of the study cohort received ADT and the incidence rate of fracture was 8.1%. Multivariable Cox regression analysis revealed that use of ADT was significantly associated with risk of incident fracture (Hazard Ratio [HR] 3.60; 95% Confidence Interval [95% CI] 1.41-9.23; p = 0.008), together with aged > 75 years and type 2 diabetes. Compared with no ADT, all three types of ADT were independently associated with the risk of incident fracture: anti-androgen monotherapy (HR 4.47; 95% CI 1.47-13.7; p = 0.009), bilateral orchiectomy +/- anti-androgens (HR 4.01; 95% CI 1.46-11.1; p = 0.007) and luteinizing hormone-releasing hormone agonists +/- anti-androgens (HR 3.16; 95% CI 1.18-8.43; p = 0.022). However, there was no significant difference in the relative risks among the three types of ADT. Conclusions Fracture risk increases among all types of ADT. Clinicians should take into account the riskbenefit ratio when prescribing ADT, especially in elderly patients with type 2 diabetes.	[Lee, Chi-Ho; Yeung, Chun-Yip; Fong, Carol Ho-Yi; Woo, Yu-Cho; Lam, Karen Siu-Ling] Univ Hong Kong, Li Ka Shing Fac Med, Div Endocrinol & Metab, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Gang; Chan, Pak-Hei; Hai, Jojo; Tse, Hung-Fat; Siu, Chung-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Huang, Gang] Second Peoples Hosp Chengdu, Dept Cardiol, Chengdu, Peoples R China; [Ho, Kwan Lun; Yiu, Ming-Kwong] Univ Hong Kong, Li Ka Shing Fac Med, Div Urol, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Leung, Frankie; Lau, Tak-Wing] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Siu, CW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China.	cwdsiu@hku.hk	Tse, Hung-Fat/C-4426-2009; Siu, Chung Wah/C-6947-2011; Lee, Chi HO/AAS-7948-2021; Lee, Paul Chi-Ho/GZG-6173-2022	Tse, Hung-Fat/0000-0002-9578-7808; Tse, Hung Fat/0000-0003-4665-7887; Lee, Chi-Ho/0000-0002-7569-409X				Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Cauley JA, 2010, J CLIN ENDOCR METAB, V95, P4314, DOI 10.1210/jc.2009-2635; Cheng SY, 2011, OSTEOPOROSIS INT, V22, P2575, DOI 10.1007/s00198-011-1596-z; Cooper C, 1997, AM J MED, V103, pS12, DOI [10.1016/S0002-9343(97)90022-X, DOI 10.1016/S0002-9343(97)90022-X]; CUMMINGS SR, 1994, OSTEOPOROSIS INT, V4, P226, DOI 10.1007/BF01623243; Garcia-Fontana B, 2014, OSTEOPOROSIS INT, V25, P645, DOI 10.1007/s00198-013-2462-y; Grossmann M, 2011, CLIN ENDOCRINOL, V74, P289, DOI 10.1111/j.1365-2265.2010.03939.x; Huang G, 2014, J ONCOL, V2014, DOI 10.1155/2014/529468; Hussain S, 2008, BJU INT, V101, P547, DOI 10.1111/j.1464-410X.2007.07338.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lopez AM, 2005, OSTEOPOROSIS INT, V16, P707, DOI 10.1007/s00198-004-1799-7; Melton LJ, 2003, J UROLOGY, V169, P1747, DOI 10.1097/01.ju.0000059281.67667.97; Mittan D, 2002, J CLIN ENDOCR METAB, V87, P3656, DOI 10.1210/jc.87.8.3656; Morgans AK, 2012, J UROLOGY, V187, P889, DOI 10.1016/j.juro.2011.10.136; Moseley KF, 2012, CURR OPIN ENDOCRINOL, V19, P128, DOI 10.1097/MED.0b013e328350a6e1; Mottet N, 2016, EUR UROL; Nakai Y, 2015, HORM CANC; Ngan RK, 2014, OVERVIEW 2012 HONG K; Oefelein MG, 2002, J UROLOGY, V168, P1005, DOI 10.1016/S0022-5347(05)64561-2; Pagliarulo V, 2012, EUR UROL, V61, P11, DOI 10.1016/j.eururo.2011.08.026; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Payne H, 2011, BRIT J CANCER, V105, P1628, DOI 10.1038/bjc.2011.385; Saad F, 2004, EUR UROL, V46, P731, DOI 10.1016/j.eururo.2004.08.016; Schroder F, 2012, BJU INT, V109, P1, DOI 10.1111/j.1464-410X.2012.11215.x; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908; Teoh JY, 2015, AGING MALE, P1; Wadhwa VK, 2009, BJU INT, V104, P800, DOI 10.1111/j.1464-410X.2009.08483.x; Wang W, 2008, ENDOCR-RELAT CANCER, V15, P943, DOI 10.1677/ERC-08-0116; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045; Wu CT, 2015, OSTEOPOROS INT; Xie WC, 2012, ASIAN PAC J CANCER P, V13, P3911, DOI 10.7314/APJCP.2012.13.8.3911	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171495	10.1371/journal.pone.0171495	http://dx.doi.org/10.1371/journal.pone.0171495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158241	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700085
J	Nora, A; Karvonen, L; Renvall, H; Parviainen, T; Kim, JY; Service, E; Salmelin, R				Nora, Anni; Karvonen, Leena; Renvall, Hanna; Parviainen, Tiina; Kim, Jeong-Young; Service, Elisabet; Salmelin, Riitta			Children show right-lateralized effects of spoken word-form learning	PLOS ONE			English	Article							EARLY LANGUAGE-ACQUISITION; SURFACE-BASED ANALYSIS; CEREBRAL LATERALIZATION; HEMISPHERIC-ASYMMETRY; DEVELOPMENTAL-CHANGES; PHONOLOGICAL STM; VOCABULARY SIZE; FUNCTIONAL MRI; YOUNG-CHILDREN; HUMAN BRAIN	It is commonly thought that phonological learning is different in young children compared to adults, possibly due to the speech processing system not yet having reached full native-language specialization. However, the neurocognitive mechanisms of phonological learning in children are poorly understood. We employed magnetoencephalography (MEG) to track cortical correlates of incidental learning of meaningless word forms over two days as 6-8year- olds overtly repeated them. Native (Finnish) pseudowords were compared with words of foreign sound structure (Korean) to investigate whether the cortical learning effects would be more dependent on previous proficiency in the language rather than maturational factors. Half of the items were encountered four times on the first day and once more on the following day. Incidental learning of these recurring word forms manifested as improved repetition accuracy and a correlated reduction of activation in the right superior temporal cortex, similarly for both languages and on both experimental days, and in contrast to a salient left-hemisphere emphasis previously reported in adults. We propose that children, when learning new word forms in either native or foreign language, are not yet constrained by left-hemispheric segmental processing and established sublexical native-language representations. Instead, they may rely more on supra-segmental contours and prosody.	[Nora, Anni; Karvonen, Leena; Renvall, Hanna; Salmelin, Riitta] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Nora, Anni; Karvonen, Leena; Renvall, Hanna; Salmelin, Riitta] Aalto Univ, Aalto Neurolmaging, Espoo, Finland; [Parviainen, Tiina] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Kim, Jeong-Young] Univ Helsinki, Dept World Cultures, Helsinki, Finland; [Service, Elisabet] McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada	Aalto University; Aalto University; University of Jyvaskyla; University of Helsinki; McMaster University	Nora, A (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland.; Nora, A (corresponding author), Aalto Univ, Aalto Neurolmaging, Espoo, Finland.	anni.nora@aalto.fi	Service, Elisabet/M-7686-2015; Parviainen, Tiina/I-4803-2016; Salmelin, Riitta H/I-7044-2012	Service, Elisabet/0000-0002-7698-1189; Parviainen, Tiina/0000-0001-6992-5157; Salmelin, Riitta H/0000-0003-2499-193X; Jeong-Young, jeong-young.kim@helsinki.fi/0000-0002-0169-3596	Academy of Finland [255349, 256459, 283071, 292552, 127401]; Doctoral Program Brain and Mind; Foundation for Aalto University Science and Technology; Sigrid Juselius Foundation; National Sciences and Engineering Research Council of Canada (NSERC) [245327]	Academy of Finland(Academy of Finland); Doctoral Program Brain and Mind; Foundation for Aalto University Science and Technology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Academy of Finland (grant numbers #255349, #256459, #283071, and #292552 to RS, #127401 to HR), the Doctoral Program Brain and Mind (to AN), the Foundation for Aalto University Science and Technology (to AN), the Sigrid Juselius Foundation (to RS), and the National Sciences and Engineering Research Council of Canada (NSERC; grant number #245327 to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Aoyama K., 2008, IRAL-INT REV APPL LI, V46, P61, DOI DOI 10.1515/IRAL.2008.003; Berl MM, 2014, HUM BRAIN MAPP, V35, P270, DOI 10.1002/hbm.22179; Bishop D. V. M., 2012, PLOS ONE, V7; Bishop DVM, 2007, DEVELOPMENTAL SCI, V10, P565, DOI 10.1111/j.1467-7687.2007.00619.x; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Bonte M, 2004, CLIN NEUROPHYSIOL, V115, P409, DOI 10.1016/S1388-2457(03)00361-4; Conboy BT, 2006, DEVELOPMENTAL SCI, V9, pF1, DOI 10.1111/j.1467-7687.2005.00453.x; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dehaene S, 2015, NAT REV NEUROSCI, V16, P234, DOI 10.1038/nrn3924; Dehaene-Lambertz G, 2006, TRENDS NEUROSCI, V29, P367, DOI 10.1016/j.tins.2006.05.011; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FLEGE JE, 1987, APPLIED LINGUISTICS, V8, P162, DOI DOI 10.1093/APPLIN/8.2.162; Friederici AD, 2005, TRENDS COGN SCI, V9, P481, DOI 10.1016/j.tics.2005.08.008; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARI R, 1990, ELECTROEN CLIN NEURO, P3; Hazan V, 2000, J PHONETICS, V28, P377, DOI 10.1006/jpho.2000.0121; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; Kooijman V, 2005, COGNITIVE BRAIN RES, V24, P109, DOI 10.1016/j.cogbrainres.2004.12.009; Kovacs G, 2008, LANG LEARN, V58, P597, DOI 10.1111/j.1467-9922.2008.00451.x; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lonnrot E., 1874, FINSKT SVENSKT LEXIC; Majerus S, 2005, BRAIN LANG, V92, P320, DOI 10.1016/j.bandl.2004.07.003; Majerus S, 2004, J MEM LANG, V51, P297, DOI 10.1016/j.jml.2004.05.002; Makela J P, 1990, Adv Neurol, V54, P177; McNealy K, 2011, DEVELOPMENTAL SCI, V14, P1261, DOI 10.1111/j.1467-7687.2011.01075.x; Mills DL, 2005, COGNITIVE DEV, V20, P19, DOI 10.1016/j.cogdev.2004.07.001; Mills DL, 1997, DEV NEUROPSYCHOL, V13, P397, DOI 10.1080/87565649709540685; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Nora A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126652; Nora A, 2012, NEUROIMAGE, V63, P789, DOI 10.1016/j.neuroimage.2012.07.026; Oh GE, 2011, J PHONETICS, V39, P156, DOI 10.1016/j.wocn.2011.01.002; Ojima S, 2011, J COGNITIVE NEUROSCI, V23, P183, DOI 10.1162/jocn.2010.21425; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parviainen T, 2011, HUM BRAIN MAPP, V32, P2193, DOI 10.1002/hbm.21181; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Perani D, 2011, P NATL ACAD SCI USA, V108, P16056, DOI 10.1073/pnas.1102991108; Pierce LJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10073; Plante E, 2015, LATERALITY, V20, P306, DOI 10.1080/1357650X.2014.963597; Plaut DC, 1999, CARN S COGN, P381; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Rauschecker AM, 2008, HUM BRAIN MAPP, V29, P1231, DOI 10.1002/hbm.20460; Rigler H, 2015, DEV PSYCHOL, V51, P1690, DOI 10.1037/dev0000044; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; SERVICE E, 1992, Q J EXP PSYCHOL-A, V45, P21, DOI 10.1080/14640749208401314; Service E, 2014, LANG LEARN, V64, P215, DOI 10.1111/lang.12051; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Szaflarski JP, 2006, ANN NEUROL, V59, P796, DOI 10.1002/ana.20817; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Thompson EC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19737; Torkildsen JV, 2009, BRAIN LANG, V108, P73, DOI 10.1016/j.bandl.2008.09.005; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Uutela K, 2001, NEUROIMAGE, V14, P1424, DOI 10.1006/nimg.2001.0915; Vanvooren S, 2014, J NEUROSCI, V34, P1523, DOI 10.1523/JNEUROSCI.3209-13.2014; Walley A. C., 2003, READ WRIT, V16, P5, DOI [DOI 10.1023/A:1021789804977, 10.1023/a:1021789804977]; Weighall A., 2016, BRAIN LANG; Weiss-Croft LJ, 2015, NEUROIMAGE, V123, P269, DOI 10.1016/j.neuroimage.2015.07.046; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008; Yoncheva Y, 2014, NEUROIMAGE, V97, P262, DOI 10.1016/j.neuroimage.2014.04.006; Yoshimura Y, 2014, NEUROIMAGE, V101, P440, DOI 10.1016/j.neuroimage.2014.07.034; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	69	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171034	10.1371/journal.pone.0171034	http://dx.doi.org/10.1371/journal.pone.0171034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158201	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700024
J	Polimene, L; Clark, D; Kimmance, S; McCormack, P				Polimene, Luca; Clark, Darren; Kimmance, Susan; McCormack, Paul			A substantial fraction of phytoplankton-derived DON is resistant to degradation by a metabolically versatile, widely distributed marine bacterium	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; AMMONIUM REGENERATION; ATLANTIC-OCEAN; CARBON; MICROBES; PICOPLANKTON; POPULATIONS; DYNAMICS; MODEL	The capacity of bacteria for degrading dissolved organic nitrogen (DON) and remineralising ammonium is of importance for marine ecosystems, as nitrogen availability frequently limits productivity. Here, we assess the capacity of a widely distributed and metabolically versatile marine bacterium to degrade phytoplankton-derived dissolved organic carbon (DOC) and nitrogen. To achieve this, we lysed exponentially growing diatoms and used the derived dissolved organic matter (DOM) to support an axenic culture of Alteromonas sp.. Bacterial biomass (as particulate carbon and nitrogen) was monitored for 70 days while growth dynamics (cell count), DOM (DOC, DON) and dissolved nutrient concentrations were monitored for up to 208 days. Bacterial biomass increased rapidly within the first 7 days prior to a period of growth/death cycles potentially linked to rapid nutrient recycling. We found that approximate to 75% of the initial DOC and approximate to 35% of the initial DON were consumed by bacteria within 40 and 4 days respectively, leaving a significant fraction of DOM resilient to degradation by this bacterial species. The different rates and extents to which DOC and DON were accessed resulted in changes in DOM stoichiometry and the iterative relationship between DOM quality and bacterial growth over time influenced bacterial cell C: N molar ratio. C: N values increased to 10 during the growth phase before decreasing to values of approximate to 5, indicating a change from relative N-limitation/C-sufficiency to relative C-limitation/ N-sufficiency. Consequently, despite its reported metabolic versatility, we demonstrate that Alteromonas sp. was unable to access all phytoplankton derived DOM and that a bacterial community is likely to be required. By making the relatively simple assumption that an experimentally derived fraction of DOM remains resilient to bacterial degradation, these experimental results were corroborated by numerical simulations using a previously published model describing the interaction between DOM and bacteria in marine systems, thus supporting our hypothesis.	[Polimene, Luca; Clark, Darren; Kimmance, Susan] Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England; [McCormack, Paul] Univ Plymouth, Petr & Environm Geochem Grp, Biogeochem Res Ctr, Plymouth, Devon, England	Plymouth Marine Laboratory; University of Plymouth	Polimene, L (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	luca@pml.ac.uk	McCormack, Paul/AAJ-2420-2021	McCormack, Paul/0000-0001-9775-7904	UK NERC; NERC/Defra Shelf Seas Biogeochemistry program (NERC project) [NE/K001876/1]; NERC [CC059]; Natural Environment Research Council [pml010010, NE/K001876/1, pml010002] Funding Source: researchfish; NERC [pml010010, NE/K001876/1, pml010002] Funding Source: UKRI	UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC/Defra Shelf Seas Biogeochemistry program (NERC project); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	LP, DC and SK were part funded through the UK NERC (www.nerc.ac.uk/) national capability in sustained observation and marine modelling. LP was part funded through the NERC/Defra Shelf Seas Biogeochemistry program (NERC project number NE/K001876/1). We gratefully acknowledge support from the NERC (2014 Capital Investment award number CC059) for an Ultra High Performance Liquid Chromatograph-Time of Flight-Mass Spectrometer (uHPLC-TOF-MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH, P429, DOI DOI 10.1016/B978-012088426-1/50027-5; Arrieta JM, 2015, SCIENCE, V348, P331, DOI 10.1126/science.1258955; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Berg GM, 2006, AQUAT MICROB ECOL, V42, P215, DOI 10.3354/ame042215; Blackford JC, 2004, J MARINE SYST, V52, P191, DOI 10.1016/j.jmarsys.2004.02.004; Brussaard Corina P. D., 2009, V501, P97, DOI 10.1007/978-1-60327-164-6_11; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Butenschoen M, 2016, GEOSCI MODEL DEV, V9, P1293, DOI 10.5194/gmd-9-1293-2016; Carlson CA, 2007, OCEANOGRAPHY, V20, P89, DOI 10.5670/oceanog.2007.52; Clark DR, 2008, LIMNOL OCEANOGR, V53, P52, DOI 10.4319/lo.2008.53.1.0052; GOLDMAN JC, 1987, LIMNOL OCEANOGR, V32, P1239, DOI 10.4319/lo.1987.32.6.1239; GUO LD, 1994, MAR CHEM, V45, P105, DOI 10.1016/0304-4203(94)90095-7; Hansell D.A., 2005, EOS T AM GEOPHYS UN, V86, P318, DOI DOI 10.1029/2005EO350003; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Hopkinson CS, 2005, NATURE, V433, P142, DOI 10.1038/nature03191; Jiao NZ, 2011, APPL ENVIRON MICROB, V77, P7439, DOI 10.1128/AEM.05640-11; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; KEPKAY PE, 1993, MAR ECOL PROG SER, V100, P233, DOI 10.3354/meps100233; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Meon B, 2001, MAR CHEM, V75, P185, DOI 10.1016/S0304-4203(01)00036-6; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Nagata T, 1996, MAR ECOL PROG SER, V132, P241, DOI 10.3354/meps132241; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Pedler BE, 2014, PNAS; Polimene L, 2006, AQUAT MICROB ECOL, V43, P127, DOI 10.3354/ame043127; Polimene L, 2012, BIOGEOCHEMISTRY, V110, P243, DOI 10.1007/s10533-011-9674-z; Schuster S, 1998, MAR ECOL PROG SER, V166, P99, DOI 10.3354/meps166099; Sipler RE, 2015, BIOGEOCHEMISTRY OF MARINE DISSOLVED ORGANIC MATTER, 2ND EDITION, P127, DOI 10.1016/B978-0-12-405940-5.00004-2; Stoderegger K, 1998, LIMNOL OCEANOGR, V43, P877, DOI 10.4319/lo.1998.43.5.0877; Tarran GA, 2015, PROG OCEANOGR, V137, P446, DOI 10.1016/j.pocean.2015.04.024; Therkildsen MS, 1997, AQUAT MICROB ECOL, V13, P213, DOI 10.3354/ame013213; TRANVIK LJ, 1993, FEMS MICROBIOL ECOL, V12, P177; VernonClark R. N., 1995, CHEM ECOL, V11, P69; Woodward EMS, 2001, DEEP-SEA RES PT II, V48, P775, DOI 10.1016/S0967-0645(00)00097-7	39	1	1	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171391	10.1371/journal.pone.0171391	http://dx.doi.org/10.1371/journal.pone.0171391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158278	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000396161700072
J	Sinapayen, L; Masumori, A; Ikegami, T				Sinapayen, Lana; Masumori, Atsushi; Ikegami, Takashi			Learning by stimulation avoidance: A principle to control spiking neural networks dynamics	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; CORTICAL-NEURONS; VISUAL-CORTEX; MODEL; STDP; MEMORY; RAT	Learning based on networks of real neurons, and learning based on biologically inspired models of neural networks, have yet to find general learning rules leading to widespread applications. In this paper, we argue for the existence of a principle allowing to steer the dynamics of a biologically inspired neural network. Using carefully timed external stimulation, the network can be driven towards a desired dynamical state. We term this principle "Learning by Stimulation Avoidance" (LSA). We demonstrate through simulation that the minimal sufficient conditions leading to LSA in artificial networks are also sufficient to reproduce learning results similar to those obtained in biological neurons by Shahaf and Marom, and in addition explains synaptic pruning. We examined the underlying mechanism by simulating a small network of 3 neurons, then scaled it up to a hundred neurons. We show that LSA has a higher explanatory power than existing hypotheses about the response of biological neural networks to external simulation, and can be used as a learning rule for an embodied application: learning of wall avoidance by a simulated robot. In other works, reinforcement learning with spiking networks can be obtained through global reward signals akin simulating the dopamine system; we believe that this is the first project demonstrating sensory- motor learning with random spiking networks through Hebbian learning relying on environmental conditions without a separate reward system.	[Sinapayen, Lana; Masumori, Atsushi; Ikegami, Takashi] Univ Tokyo, Ikegami Lab, Tokyo, Japan; [Sinapayen, Lana] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan	University of Tokyo; University of Tokyo	Sinapayen, L (corresponding author), Univ Tokyo, Ikegami Lab, Tokyo, Japan.; Sinapayen, L (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	lana@sacral.c.u-tokyo.ac.jp		Sinapayen, Lana/0000-0003-2270-2954; Masumori, Atsushi/0000-0001-7150-0684	 [24300080]		This work was supported by Grant-in-Aid for Scientific Research (Studies on 343 HomeoDynamics with Cultivated Neural Circuits and Embodied Artificial Neural Net-344 works; 24300080).	Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Bush D, 2010, NEURAL COMPUT, V22, P2059, DOI 10.1162/NECO_a_00003-Bush; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chadderdon GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047251; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; GUTHRIE ER, 1946, PSYCHOL BULL, V43, P1, DOI 10.1037/h0061712; Hebb Donald O., 1949, ORG BEHAV; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Lisman J., 2010, SPIKE TIMING DEPENDE, V26, P53; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masumori A, 2015, 13 EUR C ART LIF ECA, P373; MEINECKE DL, 1987, J COMP NEUROL, V261, P388, DOI 10.1002/cne.902610305; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Neymotin SA, 2013, NEURAL COMPUT, V25, P3263, DOI 10.1162/NECO_a_00521; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Sinapayen L, 2015, 13 EUR C ART LIF ECA, P175; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005	28	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170388	10.1371/journal.pone.0170388	http://dx.doi.org/10.1371/journal.pone.0170388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158309	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700011
J	Zhang, G; Gao, F				Zhang, Ge; Gao, Feng			Quantitative analysis of correlation between AT and GC biases among bacterial genomes	PLOS ONE			English	Article							ASYMMETRIC SUBSTITUTION PATTERNS; REPLICATION FORK; LAGGING STRANDS; ORIC REGIONS; DIRECTION; DATABASE; SKEW	Due to different replication mechanisms between the leading and lagging strands, nucleotide composition asymmetries widely exist in bacterial genomes. A general consideration reveals that the leading strand is enriched in Guanine (G) and Thymine (T), and the lagging strand shows richness in Adenine (A) and Cytosine (C). However, some bacteria like Bacillus subtilis have been discovered composing more A than T in the leading strand. To investigate the difference, we analyze the nucleotide asymmetry from the aspect of AT and GC bias correlations. In this study, we propose a windowless method, the Z-curve Correlation Coefficient (ZCC) index, based on the Z-curve method, and analyzed more than 2000 bacterial genomes. We find that the majority of bacteria reveal negative correlations between AT and GC biases, while most genomes in Firmicutes and Tenericutes have positive ZCC indexes. The presence of PolC, purine asymmetry and stronger genes preference in the leading strand are not confined to Firmicutes, but also likely to happen in other phyla dominated by positive ZCC indexes. This method also provides a new insight into other relevant features like aerobism, and can be applied to analyze the correlation between RY (Purine and Pyrimidine) and MK (Amino and Keto) bias and so on.	[Zhang, Ge; Gao, Feng] Tianjin Univ, Dept Phys, Tianjin, Peoples R China; [Gao, Feng] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin, Peoples R China; [Gao, Feng] Tianjin Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, SynBio Res Platform, Tianjin, Peoples R China	Tianjin University; Tianjin University; Tianjin University	Gao, F (corresponding author), Tianjin Univ, Dept Phys, Tianjin, Peoples R China.; Gao, F (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin, Peoples R China.; Gao, F (corresponding author), Tianjin Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, SynBio Res Platform, Tianjin, Peoples R China.	fgao@tju.edu.cn	Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841	National Natural Science Foundation of China [31571358, 21621004, 31171238]; China National 863 High-Tech Program [2015AA020101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National 863 High-Tech Program(National High Technology Research and Development Program of China)	This work was funded by National Natural Science Foundation of China (Grant Nos. 31571358, 21621004, and 31171238) and the China National 863 High-Tech Program (2015AA020101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Gao F, 2014, CURR GENOMICS, V15, P104, DOI 10.2174/1389202915999140328162938; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guo FB, 2012, CURR GENOMICS, V13, P2, DOI 10.2174/138920212799034794; Higgins HP., 2007, MOL MICROBIOL, V64, P42, DOI [10.1111/j.1365-2958.2007.05596.x, DOI 10.1111/J.1365-2958.2007.05596.X]; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hu JF, 2007, GENOMICS, V90, P186, DOI 10.1016/j.ygeno.2007.04.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lao PJ, 2000, GENOME RES, V10, P228, DOI 10.1101/gr.10.2.228; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Ludwig W., 2009, BERGEYS MANUAL SYSTE; Marin A, 2008, J THEOR BIOL, V253, P508, DOI 10.1016/j.jtbi.2008.04.004; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Qu HZ, 2010, RES MICROBIOL, V161, P838, DOI 10.1016/j.resmic.2010.09.015; Saha SK, 2014, BMC GENOMICS, V164, P828; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Timinskas K, 2014, NUCLEIC ACIDS RES, V42, P1393, DOI 10.1093/nar/gkt900; Zhang R, 2014, CURR GENOMICS, V15, P78, DOI 10.2174/1389202915999140328162433; Zhang Z, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-63	28	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171408	10.1371/journal.pone.0171408	http://dx.doi.org/10.1371/journal.pone.0171408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158313	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700075
J	Akil, H; Huang, AS; Francis, BA; Sadda, SR; Chopra, V				Akil, Handan; Huang, Alex S.; Francis, Brian A.; Sadda, Sirinivas R.; Chopra, Vikas			Retinal vessel density from optical coherence tomography angiography to differentiate early glaucoma, pre-perimetric glaucoma and normal eyes	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR BLOOD-FLOW; FIBER LAYER LOSS; VISUAL-FIELD; NERVE HEAD; DISC PERFUSION; PRESSURE; DEFECTS	Purpose To evaluate optic nerve vascular density using swept source optical coherence tomography angiography (OCTA) in patients with early primary open angle glaucoma (POAG), pre-perimetric glaucoma and normal eyes. Methods This is a prospective, observational study including 56 eyes in total and divided into 3 groups; 20 eyes with mild POAG, 20 pre-perimetric glaucoma eyes, and 16 age-matched normal eyes as controls. The optic disc region was imaged by a 1050-nm-wavelength swept-source OCT system (DRI OCT Triton, TOPCON). Vessel density was assessed as the ratio of the area occupied by the vessels in 3 distinct regions: 1) within the optic nerve head; 2) in the 3 mm papillary region around the optic disc; and 3) in the peripapillary region, defined as a 700-mu m-wide elliptical annulus around the disc. The potential associations between vessel density and structural, functional measures were analyzed. Results There was a statistically significant difference for the peripapillary vessel density, optic nerve head vessel density, and papillary vessel density among all the groups (p<0.001). Control eyes showed a significant difference for all measured vessel densities compared to glaucomatous eyes (p values from 0.001 to 0.024). There was a statistically significant difference between control and pre-perimetric glaucoma eyes for peripapillary, optic nerve head and papillary vessel density values (p values from 0.001 to 0.007). The optic nerve head vessel density, superior and inferior papillary area vessel density (Pearson r = 0.512, 0.436, 0.523 respectively) were highly correlated with mean overall, superior and inferior RNFL thickness in POAG eyes (p = 0.04, p = 0.02 and p = 0.04 respectively). Multiple linear regression analysis of POAG group showed that optic nerve head vessel density in POAG group was more strongly linked to RNFL thickness than to any other variables. Conclusions Eyes with mild POAG could be differentiated from pre-perimetric glaucoma eyes, which also could be differentiated from normal eyes using OCTA-derived retinal vessel density measurements.	[Akil, Handan; Huang, Alex S.; Francis, Brian A.; Sadda, Sirinivas R.; Chopra, Vikas] Doheny Image Reading Ctr, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Akil, Handan; Huang, Alex S.; Francis, Brian A.; Sadda, Sirinivas R.; Chopra, Vikas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chopra, V (corresponding author), Doheny Image Reading Ctr, Doheny Eye Inst, Los Angeles, CA 90033 USA.; Chopra, V (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.	VChopra@doheny.org			NEI NIH HHS [K08 EY024674] Funding Source: Medline; NATIONAL EYE INSTITUTE [K08EY024674] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson D., 1998, AUTOMATED STATIC PER, V2nd ed.; Boland MV, 2008, OPHTHALMOLOGY, V115, P239, DOI 10.1016/j.ophtha.2007.03.086; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Cantor L. B., 1998, COLOR ATLAS GLAUCOMA, V1998, P155; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Fan N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/308505; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Gracitelli CPB, 2015, JAMA OPHTHALMOL, V133, P384, DOI 10.1001/jamaophthalmol.2014.5319; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Kerr J, 1998, AM J OPHTHALMOL, V126, P42, DOI 10.1016/S0002-9394(98)00074-9; Kuehlewein L, 2015, EYE, V29, P932, DOI 10.1038/eye.2015.80; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Mayama C, 2013, JPN J OPHTHALMOL, V57, P133, DOI 10.1007/s10384-012-0220-x; Pereira I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120378; Piltz-Seymour IR, 2001, AM J OPHTHALMOL, V132, P63, DOI 10.1016/S0002-9394(01)00871-6; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; SCHWARTZ B, 1977, ARCH OPHTHALMOL-CHIC, V95, P1961; Spaide RF, 2014, JAMA OPHTHALMOL, V133, pE1; Tanna AP, 2011, OPHTHALMOLOGY, V118, P60, DOI 10.1016/j.ophtha.2010.04.038; Tobe LA, 2015, BRIT J OPHTHALMOL, V99, P609, DOI 10.1136/bjophthalmol-2014-305780; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Wu HJ, 2012, AM J OPHTHALMOL, V153, P815, DOI 10.1016/j.ajo.2011.09.032; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204	24	101	104	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170476	10.1371/journal.pone.0170476	http://dx.doi.org/10.1371/journal.pone.0170476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152070	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200023
J	von Ossowski, L; Li, LL; Moykkynen, T; Coleman, SK; Courtney, MJ; Keinanen, K				von Ossowski, Lotta; Li, Li-Li; Moykkynen, Tommi; Coleman, Sarah K.; Courtney, Michael J.; Keinanen, Kari			Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors	PLOS ONE			English	Article							SYNAPSE-ASSOCIATED PROTEIN-97; NITRIC-OXIDE PRODUCTION; S-NITROSYLATION; PDZ DOMAINS; GLUTAMATE RECEPTORS; SUBUNIT COMPOSITION; SURFACE EXPRESSION; ACID RECEPTOR; GLUR1 SUBUNIT; SAP97	Recent studies indicate that glutamatergic signaling involves, and is regulated by, thiol modifying and redox-active compounds. In this study, we examined the role of a reactive cysteine residue, Cys-893, in the cytosolic C-terminal tail of GluA1 AMPA receptor as a potential regulatory target. Elimination of the thiol function by substitution of serine for Cys-893 led to increased steady-state expression level and strongly reduced interaction with SAP97, a major cytosolic interaction partner of GluA1 C-terminus. Moreover, we found that of the three cysteine residues in GluA1 C-terminal tail, Cys-893 is the predominant target for Snitrosylation induced by exogenous nitric oxide donors in cultured cells and lysates. Co-precipitation experiments provided evidence for native association of SAP97 with neuronal nitric oxide synthase (nNOS) and for the potential coupling of Ca2+- permeable GluA1 receptors with nNOS via SAP97. Our results show that Cys-893 can serve as a molecular target for regulatory thiol modifications of GluA1 receptors, including the effects of nitric oxide.	[von Ossowski, Lotta; Moykkynen, Tommi; Coleman, Sarah K.; Keinanen, Kari] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, Helsinki, Finland; [Li, Li-Li; Courtney, Michael J.] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland; [Li, Li-Li; Courtney, Michael J.] Univ Turku, Turku, Finland; [Li, Li-Li] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Coleman, Sarah K.] Univ Westminster, Dept Life Sci, London, England	University of Helsinki; Abo Akademi University; University of Turku; University of Turku; University of Eastern Finland; University of Westminster	Keinanen, K (corresponding author), Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, Helsinki, Finland.	kari.keinanen@helsinki.fi	Courtney, Michael J/D-6648-2016	Courtney, Michael J/0000-0001-8693-3933; Li, Li-Li/0000-0002-8888-153X; Coleman, Sarah/0000-0002-1066-8296	Magnus Ehrnrooth Foundation; Alfred Kordelin Foundation; Orion Research Foundation	Magnus Ehrnrooth Foundation; Alfred Kordelin Foundation; Orion Research Foundation	This work was supported by The Magnus Ehrnrooth Foundation (LvO), The Alfred Kordelin Foundation (LL), and Orion Research Foundation (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; Chang BH, 2011, CHEM BIOL, V18, P1143, DOI 10.1016/j.chembiol.2011.06.013; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Grossi L, 2002, J ORG CHEM, V67, P8625, DOI 10.1021/jo026154+; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Komiyama T, 1997, BIOORG MED CHEM LETT, V7, P175, DOI 10.1016/S0960-894X(96)00608-7; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li LL, 2013, J NEUROSCI, V33, P8185, DOI 10.1523/JNEUROSCI.4578-12.2013; Lin LH, 2001, NEUROSCIENCE, V106, P801, DOI 10.1016/S0306-4522(01)00331-1; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nakamura T, 2011, ANTIOXID REDOX SIGN, V14, P1479, DOI 10.1089/ars.2010.3570; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Radenovic L, 2005, BRAIN RES BULL, V67, P133, DOI 10.1016/j.brainresbull.2005.06.019; Reimers JM, 2011, BRAIN RES, V1367, P223, DOI 10.1016/j.brainres.2010.10.016; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shen L, 2000, J NEUROSCI, V20, P7932; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uchino S, 2006, J NEUROCHEM, V97, P1203, DOI 10.1111/j.1471-4159.2006.03831.x; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Yamada K, 1997, NEUROSCI RES, V28, P93, DOI 10.1016/S0168-0102(97)00032-1; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	41	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171489	10.1371/journal.pone.0171489	http://dx.doi.org/10.1371/journal.pone.0171489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152104	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200147
J	Hamasaki, T; Harada, G; Nakamichi, N; Kabayama, S; Teruya, K; Fugetsu, B; Gong, W; Sakata, I; Shirahata, S				Hamasaki, Takeki; Harada, Gakuro; Nakamichi, Noboru; Kabayama, Shigeru; Teruya, Kiichiro; Fugetsu, Bunshi; Gong, Wei; Sakata, Ichiro; Shirahata, Sanetaka			Electrochemically reduced water exerts superior reactive oxygen species scavenging activity in HT1080 cells than the equivalent level of hydrogen-dissolved water	PLOS ONE			English	Article							MOLECULAR-HYDROGEN; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; ANTIOXIDANT; MECHANISM; DAMAGE; MICE; NANOPARTICLES; EXTENSION	Electrochemically reduced water (ERW) is produced near a cathode during electrolysis and exhibits an alkaline pH, contains richly dissolved hydrogen, and contains a small amount of platinum nanoparticles. ERW has reactive oxygen species (ROS)-scavenging activity and recent studies demonstrated that hydrogen-dissolved water exhibits ROS-scavenging activity. Thus, the antioxidative capacity of ERW is postulated to be dependent on the presence of hydrogen levels; however, there is no report verifying the role of dissolved hydrogen in ERW. In this report, we clarify whether the responsive factor for antioxidative activity in ERW is dissolved hydrogen. The intracellular ROS scavenging activity of ERW and hydrogen-dissolved water was tested by both fluorescent stain method and immuno spin trapping assay. We confirm that ERW possessed electrolysis intensity-dependent intracellular ROS-scavenging activity, and ERW exerts significantly superior ROS-scavenging activity in HT1080 cells than the equivalent level of hydrogen-dissolved water. ERW retained its ROS-scavenging activity after removal of dissolved hydrogen, but lost its activity when autoclaved. An oxygen radical absorbance capacity assay, the 2,2-diphenyl-1-picrylhydrazyl assay and chemiluminescence assay could not detect radical-scavenging activity in both ERW and hydrogen-dissolved water. These results indicate that ERW contains electrolysis-dependent hydrogen and an additional antioxidative factor predicted to be platinum nanoparticles.	[Hamasaki, Takeki; Harada, Gakuro; Nakamichi, Noboru; Teruya, Kiichiro; Shirahata, Sanetaka] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Higashi Ku, Fukuoka, Japan; [Kabayama, Shigeru] Nihon Trim Co Ltd, Kita Ku, Osaka, Japan; [Fugetsu, Bunshi; Gong, Wei] Univ Tokyo, IPRC, Bunkyo Ku, Tokyo, Japan; [Sakata, Ichiro] Univ Tokyo, Policy Alternat Res Inst, Bunkyo Ku, Tokyo, Japan	Kyushu University; University of Tokyo; University of Tokyo	Shirahata, S (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Higashi Ku, Fukuoka, Japan.	sirahata@grt.kyushu-u.ac.jp	Takeki, Tomikawa/AAC-8060-2019; Fugetsu, Bunshi/AAC-2514-2021	Gong, Wei/0000-0002-6990-3107; SAKATA, ICHIRO/0000-0001-5881-3790				Bisko A., 2007, ACS-AGR CONSPEC SCI, V72, P279; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; CARPENTER JH, 1966, LIMNOL OCEANOGR, V11, P264, DOI 10.4319/lo.1966.11.2.0264; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Duhin A, 2014, APPL SURF SCI, V313, P159, DOI 10.1016/j.apsusc.2014.05.178; Hamasaki T, 2008, LANGMUIR, V24, P7354, DOI 10.1021/la704046f; Hamasaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102218; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Huang KC, 2003, KIDNEY INT, V64, P704, DOI 10.1046/j.1523-1755.2003.00118.x; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kashiwagi T, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/869121; Li YP, 2002, CYTOTECHNOLOGY, V40, P139, DOI 10.1023/A:1023936421448; Li YP, 2011, CYTOTECHNOLOGY, V63, P119, DOI 10.1007/s10616-010-9317-6; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Nakayama M, 2010, NEPHROL DIAL TRANSPL, V25, P3026, DOI 10.1093/ndt/gfq196; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; REETZ MT, 1994, J AM CHEM SOC, V116, P7401, DOI 10.1021/ja00095a051; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Shirahata S, 1997, BIOCHEM BIOPH RES CO, V234, P269, DOI 10.1006/bbrc.1997.6622; Shirahata S, 2012, TRENDS FOOD SCI TECH, V23, P124, DOI 10.1016/j.tifs.2011.10.009; Song GH, 2015, FREE RADICAL BIO MED, V87, P58, DOI 10.1016/j.freeradbiomed.2015.06.018; Spulber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042078; Tsai CF, 2009, FOOD CHEM TOXICOL, V47, P2031, DOI 10.1016/j.fct.2009.05.021; Uscatequi AV, 2013, ELECTROCHIM ACTA, V109, P283; Yan HX, 2011, BIOSCI BIOTECH BIOCH, V75, P1295, DOI 10.1271/bbb.110072; Yan HX, 2010, BIOSCI BIOTECH BIOCH, V74, P2011, DOI 10.1271/bbb.100250; Yano Research Institute Ltd, 2014, FACT VIEW WAT COND W, P60; Yokota T, 2015, CLIN EXP OPHTHALMOL, V43, P568, DOI 10.1111/ceo.12525; Yu JH, 2015, TOXICOL LETT, V238, P11, DOI 10.1016/j.toxlet.2015.08.010; Zhai Y, 2015, EXP MOL PATHOL, V98, P268, DOI 10.1016/j.yexmp.2015.03.005	30	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171192	10.1371/journal.pone.0171192	http://dx.doi.org/10.1371/journal.pone.0171192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182635	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800042
J	Fix, B				Fix, Blair			Energy and institution size	PLOS ONE			English	Article							FIRM SIZE; GROWTH; EVOLUTION; BUSINESS; DISTRIBUTIONS; ENERGETICS; RESOURCES; ECONOMY; POWER; LAW	Why do institutions grow? Despite nearly a century of scientific effort, there remains little consensus on this topic. This paper offers a new approach that focuses on energy consumption. A systematic relation exists between institution size and energy consumption per capita: as energy consumption increases, institutions become larger. I hypothesize that this relation results from the interplay between technological scale and human biological limitations. I also show how a simple stochastic model can be used to link energy consumption with firm dynamics.	[Fix, Blair] York Univ, Fac Environm Studies, Toronto, ON, Canada	York University - Canada	Fix, B (corresponding author), York Univ, Fac Environm Studies, Toronto, ON, Canada.	blairfix@gmail.com		Fix, Blair/0000-0001-5898-9980	Social Sciences and Humanities Research Council of Canada [767-2015-2015]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by the Social Sciences and Humanities Research Council of Canada (767-2015-2015, sshrc-crsh.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RN, 1978, AM ANTHROPOL, V80, P297, DOI 10.1525/aa.1978.80.2.02a00030; Ahlborn BK, 2005, J NONEQUILIBRIUM THE, V25, P87; Angelini P, 2008, AM ECON REV, V98, P426, DOI 10.1257/aer.98.1.426; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Ayres R. U., 2009, EC GROWTH ENGINE ENE; Ayres RU, 2003, ENERGY, V28, P219, DOI 10.1016/S0360-5442(02)00089-0; Bardi U, 2009, ENERGIES, V2, P646, DOI 10.3390/en20300646; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Beck T, 2003, FINANCIAL LEGAL I FI, P2997; Biggs T, 1986, EMPLOYMENT ENTERPRIS; Biham O, 1998, PHYS REV E, V58, P1352, DOI 10.1103/PhysRevE.58.1352; Boltzmann L., 2011, POPULARE SCHRIFTEN; Bottazzi G, 2003, ECON LETT, V80, P415, DOI 10.1016/S0165-1765(03)00142-3; Bottazzi G, 2006, RAND J ECON, V37, P235, DOI 10.1111/j.1756-2171.2006.tb00014.x; Brennan Geoffrey., 1980, POWER TAX ANAL FDN F; Cabral LMB, 2003, AM ECON REV, V93, P1075, DOI 10.1257/000282803769206205; Chaisson E., 2002, COSMIC EVOLUTION RIS; CLEVELAND CJ, 1984, SCIENCE, V225, P890, DOI 10.1126/science.225.4665.890; Coase RH, 1937, ECONOMICA-NEW SER, V4, P386, DOI 10.1111/j.1468-0335.1937.tb00002.x; Cottrell F., 2009, ENERGY SOC REVISED R; de Wit G, 2005, INT J IND ORGAN, V23, P423, DOI 10.1016/j.ijindorg.2005.01.012; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Fix B, 2015, RETHINKING EC GROWTH; Fu DF, 2005, P NATL ACAD SCI USA, V102, P18801, DOI 10.1073/pnas.0509543102; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gaffeo E, 2003, PHYSICA A, V324, P117, DOI 10.1016/S0378-4371(02)01890-3; Georgescu-Roegen Nicholas, 1971, ENTROPY LAW EC PROCE, DOI DOI 10.4159/HARVARD.9780674281653; Geroski PA, 1999, GROWTH FIRMS THEORY, P2092; Giampietro M., 2012, METABOLIC PATTERN SO; Gibrat R., 1931, INEGALITES EC; Gollin D, 2008, J MONETARY ECON, V55, P219, DOI 10.1016/j.jmoneco.2007.11.003; Gomes PM, 2014, IZA DISCUSSION PAPER; Hall C, 2003, NATURE, V426, P318, DOI 10.1038/nature02130; Hall CAS, 2012, ENERGY AND THE WEALTH OF NATIONS: UNDERSTANDING THE BIOPHYSICAL ECONOMY, P1, DOI 10.1007/978-1-4419-9398-4; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; HART PE, 1962, ECONOMICA, V29, P29, DOI 10.2307/2601518; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; HYMER S, 1962, J POLIT ECON, V70, P556, DOI 10.1086/258716; KESTEN H, 1973, ACTA MATH-DJURSHOLM, V131, P207, DOI 10.1007/BF02392040; Kondepudi D, 1998, MODERN THERMODYNAMIC; Kummel R., 2000, INDIAN J APPL EC, V8, P1; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Leslie White, 1943, AM ANTHROPOL, V45, P335, DOI DOI 10.1525/AA.1943.45.3.02A00010; LUCAS RE, 1978, BELL J ECON, V9, P508, DOI 10.2307/3003596; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; MELTZER AH, 1981, J POLIT ECON, V89, P914, DOI 10.1086/261013; Niskanen W.A., 1974, BUREAUCRACY REPRESEN; Nitzan Jonathan, 2009, CAPITAL POWER STUDY; Odum H.T., 1983, SYSTEMS ECOLOGY INTR; PELTZMAN S, 1980, J LAW ECON, V23, P209, DOI 10.1086/466962; PETERAF MA, 1993, STRATEGIC MANAGE J, V14, P179, DOI 10.1002/smj.4250140303; Pimentel D., 2007, FOOD ENERGY SOC, V3rd ed.; Poschke M, 2014, IZA DISCUSSION PAPER, P7991; Priem RL, 2001, ACAD MANAGE REV, V26, P57, DOI 10.2307/259394; SIMON HA, 1958, AM ECON REV, V48, P607; SINGH A, 1975, REV ECON STUD, V42, P15, DOI 10.2307/2296816; Smil Vaclav, 2008, ENERGY NATURE SOC GE; Soddy F., 1926, VIRTUAL WEALTH DEBT; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; STRAUSS G, 1957, J BUS, V30, P202, DOI 10.1086/294147; Sutton J, 1997, J ECON LIT, V35, P40; Turchin P, 2009, SOC EVOL HIST, V8, P167	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171823	10.1371/journal.pone.0171823	http://dx.doi.org/10.1371/journal.pone.0171823			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178339	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000393712500072
J	Massafra, V; Milona, A; Vos, HR; Burgering, BMT; van Mil, SWC				Massafra, Vittoria; Milona, Alexandra; Vos, Harmjan R.; Burgering, Boudewijn M. T.; van Mil, Saskia W. C.			Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSFORMING GROWTH-FACTOR-BETA-1; HEME OXYGENASE-1; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; BREAST-CANCER; X RECEPTOR; TRANSGENIC MICE; CELLS	Fibroblast growth factor 19 (FGF19) is a gut -derived peptide hormone that is produced following activation of Farnesoid X Receptor (FXR). FGF19 is secreted and signals to the liver, where it contributes to the homeostasis of bile acid (BA), lipid and carbohydrate metabolism. FGF19 is a promising therapeutic target for the metabolic syndrome and cholestatic diseases, but enthusiasm for its use has been tempered by FGF19-mediated induction of proliferation and hepatocellular carcinoma. To inform future rational design of FGF19-variants, we have conducted temporal quantitative proteomic and gene expression analyses to identify FGF19-targets related to metabolism and proliferation. Mice were fasted for 16 hours, and injected with human FGF19 (1 mg/kg body weight) or vehicle. Liver protein extracts (containing "light" lysine) were mixed 1:1 with a spike-in protein extract from C-13(6) -lysine metabolically labelled mouse liver (containing "heavy" lysine) and analysed by LC-MS/MS. Our analyses provide a resource of FGF19 target proteins in the liver. 189 proteins were upregulated (>= 1.5 folds) and 73 proteins were downregulated (<= -1.5 folds) by FGF19. FGF19 treatment decreased the expression of proteins involved in fatty acid (FA) synthesis, i.e., Fabp5, Scd1, and Acsl3 and increased the expression of Acox1, involved in FA oxidation. As expected, FGF19 increased the expression of proteins known to drive proliferation (i.e., Tgfbi, Vcam1, Anxa2 and Hdlbp). Importantly, many of the FGF19 targets (i.e., Pdk4, Apoa4, Fas and Stat3) have a dual function in both metabolism and cell proliferation. Therefore, our findings challenge the development of FGF19-variants that fully uncouple metabolic benefit from mitogenic potential.	[Massafra, Vittoria; Milona, Alexandra; Vos, Harmjan R.; Burgering, Boudewijn M. T.; van Mil, Saskia W. C.] UMC Utrecht, Ctr Mol Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Mil, SWC (corresponding author), UMC Utrecht, Ctr Mol Med, Utrecht, Netherlands.	S.W.C.vanMil@umcutrecht.nl	van Mil, Saskia WC/C-3751-2009	van Mil, Saskia WC/0000-0002-7850-5012; Vos, Harmjan/0000-0002-4696-6068	Netherlands Organization for Scientific Research (NWO) [917.11.365]; FP7 Marie Curie Actions IAPP (FXR-IBD) [611979]; Utrecht University Support Grant; Wilhelmina Children's Hospital Research Fund; Proteins At Work (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); FP7 Marie Curie Actions IAPP (FXR-IBD); Utrecht University Support Grant; Wilhelmina Children's Hospital Research Fund; Proteins At Work (NWO)	S.W.C.v.M. is supported by the Netherlands Organization for Scientific Research (NWO) Project VIDI (917.11.365), FP7 Marie Curie Actions IAPP (FXR-IBD, 611979), the Utrecht University Support Grant, Wilhelmina Children's Hospital Research Fund. H.R.V. is supported by Proteins At Work (NWO).	Argmann CA, 2001, ARTERIOSCL THROM VAS, V21, P2011, DOI 10.1161/hq1201.099426; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Grabias BM, 2012, FASEB J, V26, P4131, DOI 10.1096/fj.12-207324; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Han B, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0335-z; Hill-Kapturczak N, 2000, J BIOL CHEM, V275, P40904, DOI 10.1074/jbc.M006621200; Hirschey MD, 2015, SEMIN CANCER BIOL, V35, pS129, DOI 10.1016/j.semcancer.2015.10.002; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Ilyas M, 1999, P NATL ACAD SCI USA, V96, P3087, DOI 10.1073/pnas.96.6.3087; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; Latasa MU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052711; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Lin CC, 2007, EUR J PHARMACOL, V560, P101, DOI 10.1016/j.ejphar.2007.01.025; Luo J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009098; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Miyata M, 2011, BIOL PHARM BULL, V34, P1885, DOI 10.1248/bpb.34.1885; Miyazaki YJ, 2002, ONCOGENE, V21, P798, DOI 10.1038/sj.onc.1205126; Murase S, 2013, J BIOL CHEM, V288, P20151, DOI 10.1074/jbc.M113.470583; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Pellacani A, 1998, CIRC RES, V83, P396, DOI 10.1161/01.RES.83.4.396; Pilbeam C, 1997, ENDOCRINOLOGY, V138, P4672, DOI 10.1210/en.138.11.4672; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Uriarte I, 2015, INT J CANCER, V136, P2469, DOI 10.1002/ijc.29287; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Weeks BH, 2001, CANCER RES, V61, P7435; Wilson CA, 2005, BREAST CANCER RES, V7, pR1058, DOI 10.1186/bcr1343; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Wu B, 2012, CELL PROLIFERAT, V45, P189, DOI 10.1111/j.1365-2184.2012.00820.x; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Xie Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18751; Zhang F, 2009, J PROTEOME RES, V8, P5041, DOI 10.1021/pr900461c; Zhang Zheng, 2012, Mol Biol (Mosk), V46, P628; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	64	24	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171185	10.1371/journal.pone.0171185	http://dx.doi.org/10.1371/journal.pone.0171185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178326	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500031
J	Ramsey, M; Bencsik, M; Newton, MI				Ramsey, Michael; Bencsik, Martin; Newton, Michael I.			Long-term trends in the honeybee 'whooping signal' revealed by automated detection	PLOS ONE			English	Article							APIS-MELLIFERA; BEE; VIBRATION; DANCE; COMMUNICATION; BEHAVIOR	It is known that honeybees use vibrational communication pathways to transfer information. One honeybee signal that has been previously investigated is the short vibrational pulse named the 'stop signal', because its inhibitory effect is generally the most accepted interpretation. The present study demonstrates long term (over 9 months) automated in-situ non-invasive monitoring of a honeybee vibrational pulse with the same characteristics of what has previously been described as a stop signal using ultra-sensitive accelerometers embedded in the honeycomb located at the heart of honeybee colonies. We show that the signal is very common and highly repeatable, occurring mainly at night with a distinct decrease in instances towards midday, and that it can be elicited en masse from bees following the gentle shaking or knocking of their hive with distinct evidence of habituation. The results of our study suggest that this vibrational pulse is generated under many different circumstances, thereby unifying previous publication's conflicting definitions, and we demonstrate that this pulse can be generated in response to a surprise stimulus. This work suggests that, using an artificial stimulus and monitoring the changes in the features of this signal could provide a sensitive tool to assess colony status.	[Ramsey, Michael; Bencsik, Martin; Newton, Michael I.] Nottingham Trent Univ, Dept Math & Phys, Sch Sci & Technol, Clifton Lane, Nottingham, England	Nottingham Trent University	Bencsik, M (corresponding author), Nottingham Trent Univ, Dept Math & Phys, Sch Sci & Technol, Clifton Lane, Nottingham, England.	martin.bencsik@ntu.ac.uk	Newton, Michael I/B-8866-2008	Newton, Michael I/0000-0003-4231-1002				Bencsik M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141926; Bodenheimer FS, 1937, Q REV BIOL, V12, P406, DOI 10.1086/394540; ESCH H, 1964, Z VERGL PHYSIOL, V48, P534; FRINGS H, 1957, SCIENCE, V125, P122, DOI 10.1126/science.125.3238.122; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; Kietzman PM, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00014; KIRCHNER WH, 1993, APIDOLOGIE, V24, P297, DOI 10.1051/apido:19930309; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Lau CW, 2010, APIDOLOGIE, V41, P87, DOI 10.1051/apido/2009052; MICHELSEN A, 1986, J COMP PHYSIOL A, V158, P605, DOI 10.1007/BF00603817; MICHELSEN A, 1986, BEHAV ECOL SOCIOBIOL, V18, P207, DOI 10.1007/BF00290824; Michelsen A., 2014, MECH SIGNALS HONEYBE, P333; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; NIEH JC, 1993, BEHAV ECOL SOCIOBIOL, V33, P51, DOI 10.1007/BF00164346; OHTANI T, 1980, J APICULT RES, V19, P154, DOI 10.1080/00218839.1980.11100016; OMHOLT SW, 1987, J THEOR BIOL, V128, P219, DOI 10.1016/S0022-5193(87)80170-4; Pastor KA, 2005, ETHOLOGY, V111, P775, DOI 10.1111/j.1439-0310.2005.01116.x; Pratt SC, 1996, APIDOLOGIE, V27, P13, DOI 10.1051/apido:19960102; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Sandeman DC, 1996, J EXP BIOL, V199, P2585; Sauer S, 2003, J COMP PHYSIOL A, V189, P599, DOI 10.1007/s00359-003-0436-9; SCHNEIDER SS, 1986, ANIM BEHAV, V34, P377, DOI 10.1016/S0003-3472(86)80105-1; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Seeley TD, 2001, J COMP PHYSIOL A, V187, P667, DOI 10.1007/s00359-001-0243-0; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; SPANGLER HG, 1969, J ECON ENTOMOL, V62, P1185, DOI 10.1093/jee/62.5.1185; Srinivasan M. V., 2010, CURR BIOL, V20, P336; Tan K, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002423; Thom C, 2003, BEHAV ECOL SOCIOBIOL, V53, P199, DOI 10.1007/s00265-002-0567-y; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONFRISCH K, 1946, OSTERR ZOOL Z, V1, P1; Winston M. L., 1987, BIOL HONEY BEE, P214	33	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171162	10.1371/journal.pone.0171162	http://dx.doi.org/10.1371/journal.pone.0171162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178291	Green Accepted, Green Published, gold			2022-12-27	WOS:000393712500028
J	Le Parc, A; Karav, S; Rouquie, C; Maga, EA; Bunyatratchata, A; Barile, D				Le Parc, Annabelle; Karav, Sercan; Rouquie, Camille; Maga, Elizabeth A.; Bunyatratchata, Apichaya; Barile, Daniela			Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows	PLOS ONE			English	Article							LARGE-SCALE PRODUCTION; LIQUID-CHROMATOGRAPHY; BREAST-MILK; GLYCOSYLATION; OLIGOSACCHARIDES; SUPPLEMENTATION; PROTEINS; INFANTS; CLONING	Lactoferrin (LF) is one of the most abundant bioactive glycoproteins in human milk. Glycans attached through N-glycosidic bonds may contribute to Lactoferrin functional activities. In contrast, LF is present in trace amounts in bovine milk. Efforts to increase LF concentration in bovine milk led to alternative approaches using transgenic cows to express human lactoferrin (hLF). This study investigated and compared N-glycans in recombinant human lactoferrin (rhLF), bovine lactoferrin (bLF) and human lactoferrin by Nano-LC-Chip-Q-TOF Mass Spectrometry. The results revealed a high diversity of N-glycan structures, including fucosylated and sialylated complex glycans that may contribute additional bioactivities. rhLF, bLF and hLF had 23, 27 and 18 N-glycans respectively with 8 N-glycan in common overall. rhLF shared 16 N-glycan with bLF and 9 N-glycan with hLF while bLF shared 10 N-glycan with hLF. Based on the relative abundances of N-glycan types, rhLF and hLF appeared to contain mostly neutral complex/ hybrid N-glycans (81% and 52% of the total respectively) whereas bLF was characterized by high mannose glycans (65%). Interestingly, the majority of hLF N-glycans were fucosylated (88%), whereas bLF and rhLF had only 9% and 20% fucosylation, respectively. Overall, this study suggests that rhLF N-glycans share more similarities to bLF than hLF.	[Le Parc, Annabelle; Rouquie, Camille; Bunyatratchata, Apichaya; Barile, Daniela] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Karav, Sercan] Canakkale 18 Mart Univ, Dept Mol Biol & Genet, Canakkale, Turkey; [Maga, Elizabeth A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Barile, Daniela] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA	University of California System; University of California Davis; Canakkale Onsekiz Mart University; University of California System; University of California Davis; University of California System; University of California Davis	Barile, D (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.; Barile, D (corresponding author), Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.	dbarile@ucdavis.edu	barile, daniela/AAA-3892-2020	barile, daniela/0000-0002-3889-1596; Rouquie, Camille/0000-0002-8290-7778	National Institutes of Health [R01AT007079, R01AT008759]; USDA NIFA Hatch project [232719]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA NIFA Hatch project	Support was provided by the National Institutes of Health awards R01AT007079 and R01AT008759, USDA NIFA Hatch project 232719.	Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edde L, 2001, AM J PHYSIOL-GASTR L, V281, pG1140, DOI 10.1152/ajpgi.2001.281.5.G1140; Field CJ, 2005, J NUTR, V135, P1; HENNART PF, 1991, AM J CLIN NUTR, V53, P32, DOI 10.1093/ajcn/53.1.32; Jantscher-Krenn E, 2012, BRIT J NUTR, V108, P1839, DOI 10.1017/S0007114511007392; Karav S, 2015, BIOTECHNOLOGY PROGR; Karav S, 2016, APPL ENVIRON MICROB; Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16; Karav S, 2015, ENZYME MICROB TECH, V77, P46, DOI 10.1016/j.enzmictec.2015.05.007; Krenkova J, 2009, J CHROMATOGR A, V1216, P3252, DOI 10.1016/j.chroma.2009.02.036; Kronewitter SR, 2010, J PROTEOME RES, V9, P4952, DOI 10.1021/pr100202a; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; L Parc A, 2015, BIOTECHNOL PROGR, V31, P1323, DOI [10.1002/btpr.2133, DOI 10.1002/BTPR.2133]; L Parc A, 2015, BIOTECHNOLOGY PROGR; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Parc A, 2014, ELECTROPHORESIS, V35, P1560, DOI 10.1002/elps.201300619; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Li QL, 2014, MOL BIOL REP, V41, P2119, DOI 10.1007/s11033-014-3061-5; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Nwosu CC, 2012, J PROTEOME RES, V11, P2912, DOI 10.1021/pr300008u; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patel BK, 2012, ISRN GASTROENTEROLOG, V2012; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Samyn-Petit B, 2003, EUR J BIOCHEM, V270, P3235, DOI 10.1046/j.1432-1033.2003.03706.x; SANCHEZ L, 1992, J FOOD SCI, V57, P873, DOI 10.1111/j.1365-2621.1992.tb14313.x; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Silva SV, 2005, INT DAIRY J, V15, P1, DOI 10.1016/j.idairyj.2004.04.009; Stefanova G, 2008, BIOL PLANTARUM, V52, P423, DOI 10.1007/s10535-008-0086-4; Suzuki YA, 2003, J PEDIATR GASTR NUTR, V36, P190, DOI 10.1097/00005176-200302000-00007; Thomassen EAJ, 2005, TRANSGENIC RES, V14, P397, DOI 10.1007/s11248-005-3233-0; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Varki A., 2009, BIOL ROLES GLYCANS; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yu HQ, 2012, J BIOTECHNOL, V161, P198, DOI 10.1016/j.jbiotec.2012.06.035; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151	43	26	26	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171477	10.1371/journal.pone.0171477	http://dx.doi.org/10.1371/journal.pone.0171477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170415	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500039
J	Li, XM; Wang, JR; Shen, T; Gao, SS; He, XS; Li, JN; Yang, TY; Zhang, S; Gan, WJ; Li, JM; Wu, H				Li, Xiu-Ming; Wang, Jing-Ru; Shen, Tong; Gao, Shang-Shang; He, Xiao-Shun; Li, Jiang-Nan; Yang, Tian-Yu; Zhang, Shen; Gan, Wen-Juan; Li, Jian-Ming; Wu, Hua			Nur77 deficiency in mice accelerates tumor invasion and metastasis by facilitating TNF alpha secretion and lowering CSF-1R expression	PLOS ONE			English	Article							CELL-MIGRATION; CANCER; INFLAMMATION; MACROPHAGES; RECEPTORS	Nur77, an orphan member of the nuclear receptor superfamily, plays critical roles in inflammation and immunity. However, the role of Nur77 in tumor microenvironment remains elusive. Results showed that deletion of Nur77 strikingly enhanced tumor metastasis compared to WT mice. Additionally, compared to the conditioned media derived from Nur77(+/+) peritoneal macrophages (CM1), the conditioned media derived from Nur77 -/-peritoneal macrophages (CM2) significantly promoted the EMT of cancer cells, and greatly enhanced the migratory and invasive abilities of cancer cells. Moreover, studies using TNF-alpha blocking antibody demonstrated that pro-inflammatory cytokine TNF-alpha was indispensable in supporting CM2-induced EMT to drive cancer cells migration and invasion. Furthermore, we found that Nur77 promoted the expression of CSF-1R, a novel downstream target gene of Nur77, and subsequently enhanced the migration of inflammatory cells. Notably, infiltration of inflammatory cells in the tumors of Nur77(-/-) mice was markedly abrogated compared to Nur77(+/+) mice. Collectively, these results revealed that host Nur77 expression was pivotal in antitumor immune response, and in inhibiting tumor metastasis.	[Li, Xiu-Ming; Wang, Jing-Ru; Shen, Tong; Gao, Shang-Shang; Li, Jiang-Nan; Yang, Tian-Yu; Zhang, Shen; Wu, Hua] Soochow Univ, Pathol Ctr, Suzhou, Peoples R China; [He, Xiao-Shun; Gan, Wen-Juan] Soochow Univ, Affiliated Hosp 1, Dept Pathol, Suzhou, Peoples R China; [Li, Jian-Ming] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Soochow University - China; Soochow University - China; Sun Yat Sen University	Wu, H (corresponding author), Soochow Univ, Pathol Ctr, Suzhou, Peoples R China.; Li, JM (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	jianmingli@suda.edu.cn; wuhua@suda.edu.cn	Wu, Hua/W-4204-2019		Natural Science Foundation of Jiangsu Province [BK20140364, BK20140329, BK20161206, BE2016666]; National Natural Science Foundation of China [81372574, 31300630, 31540036, 81272300, 31570753, 81525020, 81401942]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by Natural Science Foundation of Jiangsu Province (BK20140364 to T.S., BK20140329 to S.-S.G., BK20161206 to W.-J.G., BE2016666 to J.-M.L.) and National Natural Science Foundation of China (81372574, 31300630, 31540036 to H.W., 81272300, 31570753, 81525020 to J.-M.L. and 81401942 to W.-J.G). This work was also supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Abraham D, 2010, INT J CANCER, V126, P1339, DOI 10.1002/ijc.24859; Adinolfi E, CANC RES, V75, P635; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Cho SD, 2010, MOL PHARMACOL, V77, P396, DOI 10.1124/mol.109.061143; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Digiacomo G, 2015, FASEB J, V29, P2545, DOI 10.1096/fj.14-258939; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Guo PD, 2016, CANCER RES, V76, P3813, DOI 10.1158/0008-5472.CAN-15-2882; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Han YH, 2009, J BIOL CHEM, V284, P18503, DOI 10.1074/jbc.M109.007708; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Li XB, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0115-y; Li XM, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0085-0; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Shaked I, 2015, NAT IMMUNOL, V16, P1228, DOI 10.1038/ni.3321; Szlosarek PW, 2006, MOL CANCER THER, V5, P382, DOI 10.1158/1535-7163.MCT-05-0303; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu H., 2015, HINDAWI PUBLISHING C, V2015, P1, DOI DOI 10.1155/2015/471342; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xing C, CANCER RES, V76, P83, DOI [10.1158/0008-5472.CAN-14-3595PMID:26669864, DOI 10.1158/0008-5472]; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhan YY, 2013, CANCER LETT, V329, P37, DOI 10.1016/j.canlet.2012.09.022	36	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171347	10.1371/journal.pone.0171347	http://dx.doi.org/10.1371/journal.pone.0171347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170411	gold, Green Published			2022-12-27	WOS:000393705500035
J	Li, YH; Song, ZH; Kerr, KA; Moeser, AJ				Li, Yihang; Song, Zehe; Kerr, Katelyn A.; Moeser, Adam J.			Chronic social stress in pigs impairs intestinal barrier and nutrient transporter function, and alters neuro-immune mediator and receptor expression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; IRRITABLE-BOWEL-SYNDROME; MAST-CELL ACTIVATION; DSS-INDUCED COLITIS; PSYCHOLOGICAL STRESS; GROWING PIGS; VISCERAL HYPERALGESIA; EPITHELIAL BARRIER; SIGNALING PATHWAYS; SPACE ALLOWANCE	Psychosocial stress is a major factor driving gastrointestinal (GI) pathophysiology and disease susceptibility in humans and animals. The mechanisms governing susceptibility to stress-induced GI disease remain poorly understood. In the present study, we investigated the influence of chronic social stress (CSS) in pigs, induced by 7 d of chronic mixing/crowding stress, on intestinal barrier and nutrient transport function, corticotropin releasing factor (CRF) signaling and immunological responses. Results from this study showed that CSS resulted in a significant impairment of ileal and colonic barrier function indicated by reduced transepithelial electrical resistance (TER) in the ileum and increased FD4 flux in the ileum (by 0.8 fold) and colon (by 0.7 fold). Ileal sodium glucose linked transporter 1 (SGLT-1) function, measured as glucose-induced changes in short-circuit current (I-sc), was diminished (by 52%) in CSS pigs, associated with reduced body weight gain and feed efficiency. Although reductions in SGLT-1 function were observed in CSS pigs, mRNA expression for SGLT-1, villus heights were increased in CSS pigs. Corticotropin releasing factor (CRF) mRNA was upregulated (by 0.9 fold) in the ileum of CSS pigs but not in the colon. Urocortin 2 (Ucn2) mRNA was upregulated (by 1.5 fold) in the colon of CSS pigs, but not in the ileum. In CSS pigs, a downregulation of pro-inflammatory cytokines mRNA (IL1B, TNFA, IL8, and IL6) was observed in both ileum and colon, compared with controls. In contrast CSS induced a marked upregulation of mRNA for IL10 and mast cell chymase gene (CMA1) in the ileum and colon. Together, these data demonstrate that chronic stress in pigs results in significant alterations in intestinal barrier and nutrient transport function and neuro-immune mediator and receptor expression.	[Li, Yihang; Kerr, Katelyn A.; Moeser, Adam J.] Michigan State Univ, Gastrointestinal Stress Biol Lab, E Lansing, MI 48824 USA; [Li, Yihang; Moeser, Adam J.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Song, Zehe] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Moeser, Adam J.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Moeser, Adam J.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Zhejiang University; Michigan State University; Michigan State University	Moeser, AJ (corresponding author), Michigan State Univ, Gastrointestinal Stress Biol Lab, E Lansing, MI 48824 USA.; Moeser, AJ (corresponding author), Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA.; Moeser, AJ (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Moeser, AJ (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	moeserad@cvm.msu.edu		Moeser, Adam/0000-0003-3068-627X	Foundation for the National Institutes of Health [HD072968, DK084313]	Foundation for the National Institutes of Health	This research was supported by the Foundation for the National Institutes of Health grants HD072968 and DK084313. Adam Moeser is the Matilda R. Wilson Endowed Chair of Large Animal Clinical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini A, 2010, PSYCHOSOMATICS, V51, P14, DOI 10.1176/appi.psy.51.1.14; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Boudry G, 2007, AM J PHYSIOL-REG I, V292, pR862, DOI 10.1152/ajpregu.00655.2006; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Castagliuolo I, 1996, AM J PHYSIOL-GASTR L, V271, pG884, DOI 10.1152/ajpgi.1996.271.5.G884; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Guilarte M, 2007, GUT, V56, P203, DOI 10.1136/gut.2006.100594; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hardin J, 2000, GUT, V47, P184, DOI 10.1136/gut.47.2.184; Hasdemir B, 2016, AM J PHYSIOL REGUL I; Hoffman JM, 2016, AM J PATHOL, V186, P134, DOI 10.1016/j.ajpath.2015.09.013; Hyun Y, 1998, J ANIM SCI, V76, P2771; Kiank C, 2006, BRAIN BEHAV IMMUN, V20, P359, DOI 10.1016/j.bbi.2005.10.151; Kirshenbaum AS, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-45; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; Larauche M, 2008, AM J PHYSIOL-GASTR L, V294, pG1033, DOI 10.1152/ajpgi.00507.2007; Lee CY, 2013, CLIN EXP PHARMACOL P, V40, P385, DOI 10.1111/1440-1681.12096; Lennon EM, 2013, INFLAMM BOWEL DIS, V19, P712, DOI 10.1097/MIB.0b013e3182802a4e; Li YH, 2016, J NUTR, V146, P1499, DOI 10.3945/jn.116.231621; Li YH, 2014, J NUTR, V144, P1935, DOI 10.3945/jn.114.194787; Liu S, 2016, NEUROGASTROENT MOTIL, V28, P281, DOI 10.1111/nmo.12725; McLamb BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059838; Medland JE, 2016, NEUROGASTROENTEROL M; Melgar S, 2008, STRESS, V11, P348, DOI 10.1080/10253890701820166; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2004.051391; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Moss AC, 2007, GUT, V56, P1210, DOI 10.1136/gut.2006.110668; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Pearce SC, 2014, J ANIM SCI, V92, P5444, DOI 10.2527/jas.2014-8407; Perry SJ, 2005, J BIOL CHEM, V280, P11560, DOI 10.1074/jbc.M412914200; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Reber SO, 2008, STRESS, V11, P225, DOI 10.1080/10253890701733351; Rupp B, 2000, EUR J IMMUNOL, V30, P2954, DOI 10.1002/1521-4141(200010)30:10<2954::AID-IMMU2954>3.0.CO;2-S; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Schweer WP, 2016, J ANIM SCI, V94, P523, DOI 10.2527/jas.2015-9836; Schwetz I, 2005, AM J PHYSIOL-GASTR L, V289, pG704, DOI 10.1152/ajpgi.00498.2004; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Tache Y, 1999, Can J Gastroenterol, V13 Suppl A, p18A; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Tache Y, 2015, J NEUROGASTROENTEROL, V21, P8, DOI 10.5056/jnm14162; Vicario M, 2012, PSYCHONEUROENDOCRINO, V37, P65, DOI 10.1016/j.psyneuen.2011.05.005; Videlock EJ, 2009, GASTROENTEROLOGY, V137, P1954, DOI 10.1053/j.gastro.2009.08.058; Wolter BF, 2000, J ANIM SCI, V78, P2062; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	56	31	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171617	10.1371/journal.pone.0171617	http://dx.doi.org/10.1371/journal.pone.0171617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170426	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500046
J	Gayrard, N; Ficheux, A; Duranton, F; Guzman, C; Szwarc, I; Vetromile, F; Cazevieille, C; Brunet, P; Servel, MF; Argiles, A; Le Quintrec, M				Gayrard, Nathalie; Ficheux, Alain; Duranton, Flore; Guzman, Caroline; Szwarc, Ilan; Vetromile, Fernando; Cazevieille, Chantal; Brunet, Philippe; Servel, Marie-Francoise; Argiles, Angel; Le Quintrec, Moglie			Consequences of increasing convection onto patient care and protein removal in hemodialysis	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; ONLINE HEMODIAFILTRATION; ULTRAFILTRATION COEFFICIENT; SERUM-ALBUMIN; UREMIC TOXINS; DIALYSIS; POSTDILUTION; EFFICIENCY; MODALITY	Introduction Recent randomised controlled trials suggest that on-line hemodiafiltration (OL-HDF) improves survival, provided that it reaches high convective volumes. However, there is scant information on the feasibility and the consequences of modifying convection volumes in clinics. Methods Twelve stable dialysis patients were treated with high-flux 1.8 m(2) polysulphone dialyzers and 4 levels of convection flows (Q(UF)) based on K-G(D-UF) monitoring of the system, for 1 week each. The consequences on dialysis delivery (transmembrane pressure (TMP), number of alarms, % of achieved prescribed convection) and efficacy (mass removal of low and high molecular weight compounds) were analysed. Results TMP increased exponentially with Q(UF) (p < 0.001 for N > 56,000 monitoring values). Beyond 21 L/session, this resulted into frequent TMP alarms requiring nursing staff interventions (mean +/- SEM: 10.3 +/- 2.2 alarms per session, p < 0.001 compared to lower convection volumes). Optimal convection volumes as assessed by K-G(D-UF)-max were 20.6 +/- 0.4 L/session, whilst 4 supplementary litres were obtained in the maximum situation (24.5 +/- 0.6 L/session) but the proportion of sessions achieving the prescribed convection volume decreased from 94% to only 33% (p < 0.001). Convection increased high molecular weight compound removal and shifted the membrane cut-off towards the higher molecular weight range. Conclusions Reaching high convection volumes as recommended by the recent RCTs (> 20L) is feasible by setting an HDF system at its optimal conditions based upon the K-G(D-UF) monitoring. Prescribing higher convection volumes resulted in instability of the system, provoked alarms, was bothersome for the nursing staff and the patients, rarely achieved the prescribed convection volumes and increased removal of high molecular weight compounds, notably albumin.	[Gayrard, Nathalie; Ficheux, Alain; Duranton, Flore; Guzman, Caroline; Argiles, Angel] Univ Montpellier, RD Nephrol, Montpellier, France; [Gayrard, Nathalie; Ficheux, Alain; Duranton, Flore; Guzman, Caroline; Argiles, Angel] Univ Montpellier, EA7288, Montpellier, France; [Szwarc, Ilan; Vetromile, Fernando; Servel, Marie-Francoise; Argiles, Angel] Ctr Dialyse Nephrol Dialyse St Guilhem, Sete, France; [Cazevieille, Chantal] INM Montpellier, CoMET, NRI Facil, Montpellier, France; [Brunet, Philippe] Univ Aix Marseille, Hop La Concept, Serv Nephrol, Marseille, France; [Brunet, Philippe; Argiles, Angel] ERA EDTA EUTox, European Uraem Toxin Working Grp ESAO, Krems, Austria; [Le Quintrec, Moglie] CHU Montpellier, Hop Lapeyronie, Serv Nephrol & Transplantat, Montpellier, France	Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier	Argiles, A (corresponding author), Univ Montpellier, RD Nephrol, Montpellier, France.; Argiles, A (corresponding author), Univ Montpellier, EA7288, Montpellier, France.; Argiles, A (corresponding author), Ctr Dialyse Nephrol Dialyse St Guilhem, Sete, France.; Argiles, A (corresponding author), ERA EDTA EUTox, European Uraem Toxin Working Grp ESAO, Krems, Austria.	oargiles@rd-n.org	gayrard, nathalie/AAO-2888-2020; FICHEUX, Alain/ABD-6370-2021; Duranton, Flore/ABB-6225-2021	gayrard, nathalie/0000-0001-8283-8429; FICHEUX, Alain/0000-0003-3958-4210; Duranton, Flore/0000-0003-3202-0551; Le Quintrec, Moglie/0000-0002-5857-1207; Argiles, Angel/0000-0001-7029-4532				Ahrenholz P, 1997, INT J ARTIF ORGANS, V20, P81, DOI 10.1177/039139889702000206; Ahrenholz PG, 2004, CLIN NEPHROL, V62, P21; Argiles A, 1997, KIDNEY INT, V52, P530, DOI 10.1038/ki.1997.364; ARGILES A, 1987, KIDNEY INT, V32, P714, DOI 10.1038/ki.1987.265; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; ERA-EDTA Registry, 2012, ERA EDTA REG ANN REP; Ficheux A, 2000, KIDNEY INT, V57, P1755, DOI 10.1038/sj.ki.4495464; Ficheux A, 2016, NEPHROL DIAL TRANSPL; Ficheux A, 2015, NEPHROL DIAL TRANSPL, V30, P204, DOI 10.1093/ndt/gft493; Ficheux A, 2011, NEPHROL DIAL TRANSPL, V26, P636, DOI 10.1093/ndt/gfq510; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; HENDERSON LW, 1975, J LAB CLIN MED, V85, P372; Henderson LW, 1967, ASAIO J, V13, P216; Joyeux V, 2008, INT J ARTIF ORGANS, V31, P928, DOI 10.1177/039139880803101102; KERR PB, 1992, KIDNEY INT, V41, P1035, DOI 10.1038/ki.1992.157; Krieter DH, 2005, KIDNEY INT, V67, P349, DOI 10.1111/j.1523-1755.2005.00088.x; Maduell F, 2015, NEFROLOGIA, V35, P50, DOI 10.3265/Nefrologia.pre2014.Sep.12726; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; NIWA T, 1995, AM J NEPHROL, V15, P463, DOI 10.1159/000168887; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Panichi V, 2012, INT J ARTIF ORGANS, V35, P435, DOI 10.5301/ijao.5000106; Polkinghorne K, ANZDATA REGISTRY REP; Sichart JM, 2011, CONTRIB NEPHROL, V175, P163, DOI 10.1159/000333634; Smith JR, 2016, AM J KIDNEY DIS; Takahashi R, 2012, AM J NEPHROL, V36, P136, DOI 10.1159/000339940; Tattersall J, 2007, NEPHROL DIAL TRANSPL, V22, P5, DOI 10.1093/ndt/gfm022; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x	30	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171179	10.1371/journal.pone.0171179	http://dx.doi.org/10.1371/journal.pone.0171179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166268	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100028
J	Wang, R; Li, FQ; Zhang, W; Zhang, XM; Qu, C; Tetreau, G; Sun, LJ; Luo, C; Zhou, JJ				Wang, Ran; Li, Fengqi; Zhang, Wei; Zhang, Xiaoman; Qu, Cheng; Tetreau, Guillaume; Sun, Lujuan; Luo, Chen; Zhou, Jingjiang			Identification and expression profile analysis of odorant binding protein and chemosensory protein genes in Bemisia tabaci MED by head transcriptome	PLOS ONE			English	Article							PHEROMONE-BINDING; CHILO-SUPPRESSALIS; SEX-PHEROMONES; HEMIPTERA; BIOTYPE; ANNOTATION; RECEPTORS; INSECTS; CLONING; CHINA	Odorant binding proteins (OBPs) and chemosensory proteins (CSPs) of arthropods are thought to be involved in chemical recognition which regulates pivotal behaviors including host choice, copulation and reproduction. In insects, OBPs and CSPs located mainly in the antenna but they have not been systematically characterized yet in Bemisia tabaci which is a cryptic species complex and could damage more than 600 plant species. In this study, among the 106,893 transcripts in the head assembly, 8 OBPs and 13 CSPs were identified in B. tabaci MED based on head transcriptomes of adults. Phylogenetic analyses were conducted to investigate the relationships of B. tabaci OBPs and CSPs with those from several other important Hemipteran species, and the motif-patterns between Hemiptera OBPs and CSPs were also compared by MEME. The expression profiles of the OBP and CSP genes in different tissues of B. tabaci MED adults were analyzed by real-time qPCR. Seven out of the 8 OBPs found in B. tabaci MED were highly expressed in the head. Conversely, only 4 CSPs were enriched in the head, while the other nine CSPs were specifically expressed in other tissues. Our findings pave the way for future research on chemical recognition of B. tabaci at the molecular level.	[Wang, Ran; Li, Fengqi; Zhang, Wei; Zhang, Xiaoman; Qu, Cheng; Luo, Chen] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Tetreau, Guillaume] Univ Perpignan, Lab Interact Hotes Pathogenes Environm, Perpignan, France; [Sun, Lujuan] Chinese Acad Agr Sci, Agr Informat Inst, Beijing, Peoples R China; [Zhou, Jingjiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	Beijing Academy of Agriculture & Forestry; Ifremer; Universite Perpignan Via Domitia; Chinese Academy of Agricultural Sciences; Agriculture Information Institute, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Luo, C (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.	luochen1010@126.com	Tetreau, Guillaume/K-1283-2012	Tetreau, Guillaume/0000-0003-3360-4786; Wang, Ran/0000-0002-8199-6895	National Natural Science Foundation of China [31471773, 31601635]; Beijing Academy of Agriculture and Forestry Sciences [QNJJ201610]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Academy of Agriculture and Forestry Sciences	This work was supported partly by National Natural Science Foundation of China (31471773 and 31601635) and the earmarked fund from Beijing Academy of Agriculture and Forestry Sciences (QNJJ201610).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Blackman RL, 1998, B ENTOMOL RES, V88, P213, DOI 10.1017/S0007485300025785; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui HH, 2016, COMP BIOCH PHYSL D; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Gotzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016289; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13800; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Gu XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125159; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Hull JJ, 2014, INSECT MOL BIOL, V23, P78, DOI 10.1111/imb.12064; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li RH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/743716; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Liu NY, 2015, INT J BIOL SCI, V11, P1036, DOI 10.7150/ijbs.12020; Liu NY, 2015, COMP BIOCHEM PHYS A, V180, P23, DOI 10.1016/j.cbpa.2014.11.005; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Ma L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149591; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; MOHANTY A K, 1987, Journal of Entomological Research (New Delhi), V11, P15; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nateshan HM, 1996, ANN APPL BIOL, V26, P179; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Paula DP, 2016, INSECT MOL BIOL, V25, P580, DOI 10.1111/imb.12243; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Rebijith KB, 2016, APPL BIOCHEM BIOTECH, V178, P251, DOI 10.1007/s12010-015-1869-7; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tunstall NE, 2012, ADV EXP MED BIOL, V739, P59, DOI 10.1007/978-1-4614-1704-0_4; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wang R, 2016, J ASIA-PAC ENTOMOL, V19, P195, DOI 10.1016/j.aspen.2016.01.005; Wang Ran, 2016, Journal of Plant Protection, V43, P32; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Xie W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04088; Xu PJ, 2010, MOL BIOL REP, V37, P2265, DOI 10.1007/s11033-009-9715-z; Xu Ya-Long, 2009, BMC Genomics, V10, P1; Xue WX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161839; Yang K, 2016, GENE, V591, P425, DOI 10.1016/j.gene.2016.06.052; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140562; Zhao X., 2015, PLOS ONE, V10, pE137166; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002	69	38	41	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171739	10.1371/journal.pone.0171739	http://dx.doi.org/10.1371/journal.pone.0171739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166541	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100068
J	Neofytou, MC; Tsangaras, K; Kypri, E; Loizides, C; Ioannides, M; Achilleos, A; Mina, P; Keravnou, A; Sismani, C; Koumbaris, G; Patsalis, PC				Neofytou, Maria C.; Tsangaras, Kyriakos; Kypri, Elena; Loizides, Charalambos; Ioannides, Marios; Achilleos, Achilleas; Mina, Petros; Keravnou, Anna; Sismani, Carolina; Koumbaris, George; Patsalis, Philippos C.			Targeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplications	PLOS ONE			English	Article							CELL-FREE DNA; MATERNAL PLASMA; FETAL FRACTION; DIGITAL PCR; DIAGNOSIS; MICRODELETION; ABNORMALITIES; TRISOMY-21; ANEUPLOIDY; 22Q11.2	Noninvasive prenatal testing (NIPT) using whole genome and targeted sequencing has become increasingly accepted for clinical detection of Trisomy 21 and sex chromosome aneuploidies. Few studies have shown that sub-chromosomal deletions or duplications associated with genetic syndromes can also be detected in the fetus noninvasively. There are still limitations on these methodologies such as the detection of variants of unknown clinical significance, high number of false positives, and difficulties to detect small aberrations. We utilized a recently developed targeted sequencing approach for the development of a NIPT assay, for large and small size deletions/duplications, which overcomes these existing limitations. Artificial pregnancies with microdeletion/microduplication syndromes were created by spiking DNA from affected samples into cell free DNA (cfDNA) from non-pregnant samples. Unaffected spiked samples and normal pregnancies were used as controls. Target Capture Sequences (TACS) for seven syndromes were designed and utilized for targeted capture enrichment followed by sequencing. Data was analyzed using a statistical pipeline to identify deletions or duplications on targeted regions. Following the assay development a proof of concept study using 33 normal pregnancies, 21 artificial affected and 17 artificial unaffected pregnancies was carried out to test the sensitivity and specificity of the assay. All 21 abnormal spiked-in samples were correctly classified as subchromosomal aneuploidies while the 33 normal pregnancies or 17 normal spiked-in samples resulted in a false positive result. We have developed an NIPT assay for the detection of sub-chromosomal deletions and duplications using the targeted capture enrichment technology. This assay demonstrates high accuracy, high read depth of the genomic region of interest, and can identify deletions/duplications as small as 0.5 Mb. NIPT of fetal microdeletion/microduplication syndromes can be of enormous benefit in the management of pregnancies at risk both for prospective parents and health care providers.	[Neofytou, Maria C.; Kypri, Elena; Keravnou, Anna; Koumbaris, George; Patsalis, Philippos C.] Cyprus Inst Neurol & Genet, Translat Genet Team, Nicosia, Cyprus; [Tsangaras, Kyriakos; Kypri, Elena; Loizides, Charalambos; Ioannides, Marios; Achilleos, Achilleas; Mina, Petros; Koumbaris, George; Patsalis, Philippos C.] NIPD Genet Ltd, Nicosia, Cyprus; [Sismani, Carolina] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus		Patsalis, PC (corresponding author), Cyprus Inst Neurol & Genet, Translat Genet Team, Nicosia, Cyprus.; Patsalis, PC (corresponding author), NIPD Genet Ltd, Nicosia, Cyprus.	p.patsalis@nipd.com						Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Bustamante-Aragones A, 2008, HAEMOPHILIA, V14, P593, DOI 10.1111/j.1365-2516.2008.01670.x; Canick JA, 2013, PRENATAL DIAG, V33, P667, DOI 10.1002/pd.4126; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Comm Genetics, 2015, OBSTET GYNECOL, V126, P691, DOI 10.1097/01.AOG.0000471171.86798.ac; Dondorp W, 2015, EUR J HUM GENET, V23, P1438, DOI 10.1038/ejhg.2015.57; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Grati FR, 2015, PRENATAL DIAG, V35, P801, DOI 10.1002/pd.4613; Gropman AL, 2010, J DEV BEHAV PEDIATR, V31, P582, DOI 10.1097/DBP.0b013e3181ee384e; Gross SJ, 2016, ULTRASOUND OBST GYN, V47, P177, DOI 10.1002/uog.15754; Holland BJ, 2015, ULTRASOUND OBST GYN, V45, P631, DOI 10.1002/uog.14882; Hui L, 2016, ULTRASOUND OBST GYN, V47, P137, DOI 10.1002/uog.15845; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koumbaris G, 2016, CLIN CHEM, V62, P848, DOI 10.1373/clinchem.2015.252502; Kyriakou S, 2013, PRENATAL DIAG, V33, P650, DOI 10.1002/pd.4140; Lee Mi-Young, 2014, Obstet Gynecol Sci, V57, P11, DOI 10.5468/ogs.2014.57.1.11; Lefkowitz RB, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li R, 2016, ULTRASOUND OBST GYN, V47, P53, DOI 10.1002/uog.14911; Lo KK, 2016, AM J HUM GENET, V98, P34, DOI 10.1016/j.ajhg.2015.11.016; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maya I, 2010, PRENATAL DIAG, V30, P1131, DOI 10.1002/pd.2626; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Nicolaides KH, 2011, PRENATAL DIAG, V31, P7, DOI 10.1002/pd.2637; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Papageorgiou EA, 2014, GENES-BASEL, V5, P310, DOI 10.3390/genes5020310; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Sahoo T, 2006, GENET MED, V8, P719, DOI 10.1097/01.gim.0000245576.47154.63; Souka AP, 2001, ULTRASOUND OBST GYN, V18, P9, DOI 10.1046/j.1469-0705.2001.00454.x; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095633; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; Wapner RJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.041; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Watson CT, 2014, ANNU REV GENOM HUM G, V15, P215, DOI 10.1146/annurev-genom-091212-153408; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yaron Y, 2015, OBSTET GYNECOL, V126, P1095, DOI 10.1097/AOG.0000000000001091; Yin AH, 2015, P NATL ACAD SCI USA, V112, P14670, DOI 10.1073/pnas.1518151112; Zhao C, 2015, CLIN CHEM, V61, P608, DOI 10.1373/clinchem.2014.233312; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	54	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171319	10.1371/journal.pone.0171319	http://dx.doi.org/10.1371/journal.pone.0171319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158220	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700060
J	Ning, SY; Wei, JF; Feng, JN				Ning, Shuoying; Wei, Jiufeng; Feng, Jinian			Predicting the current potential and future world wide distribution of the onion maggot, Delia antiqua using maximum entropy ecological niche modeling	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; DIPTERA ANTHOMYIIDAE; TEMPERATURE; PERFORMANCE; COLEOPTERA; PHENOLOGY; VOLTINISM; RANGES; MAXENT	Climate change will markedly impact biology, population ecology, and spatial distribution patterns of insect pests because of the influence of future greenhouse effects on insect development and population dynamics. Onion maggot, Delia antiqua, larvae are subterranean pests with limited mobility, that directly feed on bulbs of Allium sp. and render them completely unmarketable. Modeling the spatial distribution of such a widespread and damaging pest is crucial not only to identify current potentially suitable climactic areas but also to predict where the pest is likely to spread in the future so that appropriate monitoring and management programs can be developed. In this study, Maximum Entropy Niche Modeling was used to estimate the current potential distribution of D. antiqua and to predict the future distribution of this species in 2030, 2050, 2070 and 2080 by using emission scenario (A2) with 7 climate variables. The results of this study show that currently highly suitable habitats for D. antiqua occur throughout most of East Asia, some regions of North America, Western Europe, and Western Asian countries near the Caspian sea and Black Sea. In the future, we predict an even broader distribution of this pest spread more extensively throughout Asia, North America and Europe, particularly in most of European countries, Central regions of United States and much of East Asia. Our present day and future predictions can enhance strategic planning of agricultural organizations by identifying regions that will need to develop Integrated Pest Management programs to manage the onion maggot. The distribution forecasts will also help governments to optimize economic investments in management programs for this pest by identifying regions that are or will become less suitable for current and future infestations.	[Ning, Shuoying; Feng, Jinian] Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ,Entomol Museum, Yangling, Shaanxi, Peoples R China; [Wei, Jiufeng] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China; [Ning, Shuoying; Feng, Jinian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Shanxi Agricultural University; Northwest A&F University - China	Feng, JN (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Plant Protect Resources & Pest Management, Minist Educ,Entomol Museum, Yangling, Shaanxi, Peoples R China.; Feng, JN (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	jinianf@nwsuaf.edu.cn	JIufeng, Wei/ABD-4026-2020		Special Fund for Agro-scientific Research in Public Interest [201303027]	Special Fund for Agro-scientific Research in Public Interest	This research was financially supported by the Special Fund for Agro-scientific Research in Public Interest (Grant No. 201303027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Duan JJ, 2014, BIOCONTROL, V59, P659, DOI 10.1007/s10526-014-9604-9; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Eckenrode C. J., 1995, NEW YORKS FOOD LIFE; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ellis P.R., 1979, Bulletin of the Entomological Society of America, V25, P151; Faccoli M, 2009, ENVIRON ENTOMOL, V38, P307, DOI 10.1603/022.038.0202; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FINCH S, 1989, ANNU REV ENTOMOL, V34, P117, DOI 10.1146/annurev.en.34.010189.001001; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Frodsham A. C., 1996, NEW YORK STATE IPM P, V119; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hill D. S., 1987, AGRI INSECT PESTS TE; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Hof AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052574; IPCC, 2007, CONTRIBUTION WORKING; Ishikawa Y, 2000, J INSECT PHYSIOL, V46, P161, DOI 10.1016/S0022-1910(99)00112-2; Jerzy S., 2009, VEGETABLE CROPS RES, V71, P5; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kausrud K, 2012, BIOL REV, V87, P34, DOI 10.1111/j.1469-185X.2011.00183.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Latinne A., 2015, J MODERN OPTICS, P1; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; LIU HJ, 1982, ENVIRON ENTOMOL, V11, P751, DOI 10.1093/ee/11.3.751; McDonald RS, 1997, ENVIRON ENTOMOL, V26, P624, DOI 10.1093/ee/26.3.624; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nault BA, 2006, CROP PROT, V25, P58, DOI 10.1016/j.cropro.2005.03.020; Nault BA, 2006, J ECON ENTOMOL, V99, P1375, DOI 10.1603/0022-0493-99.4.1375; Nault BA, 2011, J ECON ENTOMOL, V104, P1622, DOI 10.1603/EC11175; Nomura M, 2000, J INSECT PHYSIOL, V46, P373, DOI 10.1016/S0022-1910(99)00120-1; PERRON J. P., 1961, CANADIAN ENT, V93, P101; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poprawski T. V., 1985, APPL ENTOMOL ZOOL, V20, P801; Rodriguez-Castaneda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044402; Severin HHP, 1915, J ECON ENTOMOL, V8, P342, DOI 10.1093/jee/8.3.342; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032202; Stevnbak K., 2009, EARTH ENV SCI, V4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; Ungerer MJ, 1999, J BIOGEOGR, V26, P1133, DOI 10.1046/j.1365-2699.1999.00363.x; Wang DB, 2005, ACTA HORTIC, P327; Watari Y, 2014, ENTOMOL SCI, V17, P191, DOI 10.1111/ens.12034; Watari Y, 2010, J INSECT PHYSIOL, V56, P1192, DOI 10.1016/j.jinsphys.2010.03.022; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893; Williams DW, 2002, AGR FOREST ENTOMOL, V4, P87, DOI 10.1046/j.1461-9563.2002.00124.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yousuf F, 2014, BIOL CONTROL, V79, P67, DOI 10.1016/j.biocontrol.2014.08.007; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	62	15	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171190	10.1371/journal.pone.0171190	http://dx.doi.org/10.1371/journal.pone.0171190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158259	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700040
J	Boudon, SM; Vuorinen, A; Geotti-Bianchini, P; Wandeler, E; Kratschmar, DV; Heldl, M; Campiche, R; Jackson, E; Odermatt, A				Boudon, Stephanie M.; Vuorinen, Anna; Geotti-Bianchini, Piero; Wandeler, Eliane; Kratschmar, Denise V.; Heldl, Marc; Campiche, Remo; Jackson, Eileen; Odermatt, Alex			Novel 11 beta-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR; ULTRAVIOLET-RADIATION; MOLECULAR-MECHANISMS; CYTOKINE PRODUCTION; AGED SKIN; IN-VIVO; TYPE-1; CORTICOSTEROIDS; STIMULATION	Activity and selectivity assessment of new bi-aryl amide 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) inhibitors, prepared in a modular manner via Suzuki cross-coupling, are described. Several compounds inhibiting 11 beta-HSD1 at nanomolar concentrations were identified. Compounds 2b, 3e, 7b and 12e were shown to selectively inhibit 11 beta-HSD1 over 11 beta-HSD2, 17 beta-HSD1 and 17 beta-HSD2. These inhibitors also potently inhibited 11 beta-HSD1 activity in intact HEK293 cells expressing the recombinant enzyme and in intact primary human keratinocytes expressing endogenous 11 beta-HSD1. Moreover, compounds 2b, 3e and 12e were tested for their activity in human skin biopsies. They were able to prevent, at least in part, both the cortisone- and the UV-mediated decreases in collagen content. Thus, inhibition of 11 beta-HSD1 by these compounds can be further investigated to delay or prevent UV-mediated skin damage and skin aging.	[Boudon, Stephanie M.; Geotti-Bianchini, Piero; Wandeler, Eliane; Heldl, Marc; Campiche, Remo; Jackson, Eileen] DSM Nutr Prod Ltd, Kaiseraugst, Switzerland; [Vuorinen, Anna; Kratschmar, Denise V.; Odermatt, Alex] Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, Basel, Switzerland	DSM NV; University of Basel	Jackson, E (corresponding author), DSM Nutr Prod Ltd, Kaiseraugst, Switzerland.; Odermatt, A (corresponding author), Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, Basel, Switzerland.	eileen.jackson@dsm.com; alex.odermatt@unibas.ch	Campiche, Remo/AAW-2700-2020	Campiche, Remo/0000-0002-2216-7851; Winter, denise V./0000-0002-3764-1747	Swiss National Science Foundation [31003A-159454]; DSM Nutritional Products Ltd; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DSM Nutritional Products Ltd; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (www.snf.ch) grant number 31003A-159454 to AO (AO, AV, DVK), and by DSM Nutritional Products Ltd (SB, PGB, EW, MH, RC, EJ). The Swiss National Science Foundation provided support in the form of finances for consumables for AO, AV, DVK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DSM Nutritional Products Ltd provided support in the form of salaries for authors [SB, PGB, EW, MH, RC, EJ], and was involved in the decision of the study design and the selection of compounds to be synthesized, but did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Averbeck M, 2010, EXP DERMATOL, V19, P757, DOI 10.1111/j.1600-0625.2010.01099.x; Baker ME, 2004, FEBS LETT, V574, P167, DOI 10.1016/j.febslet.2004.08.023; Barf T, 2002, J MED CHEM, V45, P3813, DOI 10.1021/jm025530f; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BURK MJ, 1994, J AM CHEM SOC, V116, P10847, DOI 10.1021/ja00102a085; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Chebotaev DV, 2007, J INVEST DERMATOL, V127, P2749, DOI 10.1038/sj.jid.5700992; Cirillo N, 2011, J CELL BIOCHEM, V112, P1499, DOI 10.1002/jcb.23081; Del Bino S, 2006, PIGM CELL RES, V19, P606, DOI 10.1111/j.1600-0749.2006.00338.x; Gumy C, 2009, FITOTERAPIA; Haapasaari KM, 1997, SKIN PHARMACOL, V10, P261; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; KIRNBAUER R, 1991, J INVEST DERMATOL, V96, P484, DOI 10.1111/1523-1747.ep12470181; Korolev DN, 2005, TETRAHEDRON LETT, V46, P5751, DOI 10.1016/j.tetlet.2005.06.085; Korting HC, 2002, SKIN PHARMACOL APPL, V15, P85, DOI 10.1159/000049394; Labrie F, 2000, HORM RES, V54, P218, DOI 10.1159/000053264; LAVKER RM, 1979, J INVEST DERMATOL, V73, P59, DOI 10.1111/1523-1747.ep12532763; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; OIKARINEN A, 1992, J INVEST DERMATOL, V98, P220, DOI 10.1111/1523-1747.ep12555884; Oishi Y, 2002, BRIT J DERMATOL, V147, P859, DOI 10.1046/j.1365-2133.2002.04949.x; SCHWARZ T, 1989, J PHOTOCH PHOTOBIO B, V4, P1, DOI 10.1016/1011-1344(89)80097-1; Schweizer RAS, 2003, MOL CELL ENDOCRINOL, V212, P41, DOI 10.1016/j.mce.2003.09.027; Scott JS, 2014, J MED CHEM, V57, P4466, DOI 10.1021/jm4014746; Skarydova L, 2012, DRUG METAB REV, V44, P173, DOI 10.3109/03602532.2011.638304; Sklar LR, 2013, PHOTOCH PHOTOBIO SCI, V12, P54, DOI 10.1039/c2pp25152c; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; Slominski A, 2005, J NEUROIMMUNOL, V162, P97, DOI 10.1016/j.jneuroim.2005.01.014; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Sun DQ, 2011, CURR TOP MED CHEM, V11, P1464, DOI 10.2174/156802611795860988; Terao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093051; Terao M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025039; Tiganescu A, 2013, J CLIN INVEST, V123, P3051, DOI 10.1172/JCI64162; Tiganescu A, 2011, J INVEST DERMATOL, V131, P30, DOI 10.1038/jid.2010.257; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Venkatraj M, 2012, BIOORGAN MED CHEM, V20, P1557, DOI 10.1016/j.bmc.2011.12.040; Vuorinen A, 2014, J MED CHEM, V57, P5995, DOI 10.1021/jm5004914; Werth VP, 1998, ARCH DERMATOL RES, V290, P388, DOI 10.1007/s004030050322; Wikstrom AC, 2003, J ENDOCRINOL, V178, P331, DOI 10.1677/joe.0.1780331	49	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171079	10.1371/journal.pone.0171079	http://dx.doi.org/10.1371/journal.pone.0171079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152550	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000396161200086
J	Oh, PC; Lee, K; Kim, TH; Moon, J; Park, HW; Jang, HJ; Park, SD; Kwon, SW; Suh, J; Kang, WC				Oh, Pyung Chun; Lee, Kyounghoon; Kim, Tae-Hoon; Moon, Jeonggeun; Park, Hyun Woo; Jang, Ho-Jun; Park, Sang-Don; Kwon, Sung Woo; Suh, Jon; Kang, Woong Chol			Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction	PLOS ONE			English	Article							MAINTENANCE HEMODIALYSIS-PATIENTS; C-REACTIVE PROTEIN; VASCULAR CALCIFICATION; ARTERY-DISEASE; ASSOCIATION; MORTALITY; PREDICTOR; OUTCOMES; MEN	Background Serum alkaline phosphatase (ALP) has been shown to be a prognostic factor in several subgroups of patients due to its promotion of vascular calcification. However, the prognostic impact of serum ALP level in ST-segment elevation myocardial infarction (STEMI) patients with a relatively low calcification burden has not been determined. We aimed to investigate the association of ALP level measured at time of presentation on clinical outcomes in patients with STEMI requiring primary percutaneous coronary intervention (PCI). Methods A total of 1178 patients with STEMI undergoing primary PCI between 2007 and 2014 were retrospectively enrolled from the INTERSTELLAR registry and classified into tertiles by ALP level (<64, 65-82, or >83 IU/L). The primary study outcome was a major adverse cardiac or cerebrovascular event (MACCE), defined as the composite of all-cause death, non-fatal myocardial infarction, non-fatal stroke, and ischemia-driven revascularization. Results Median follow-up duration was 25 months (interquartile range, 10-39 months). The incidence of MACCE significantly increased as ALP level increased, that is, for the <64, 65-82, and >83 IU/L tertiles incidences were 8.7%, 11.7%, and 15.7%, respectively; p for trend = 0.003). After adjustment for potential confounders, the adjusted hazard ratios for MACCE in the middle and highest tertiles were 1.69 (95% CI 1.01-2.81) and 2.46 (95% CI 1.48-4.09), respectively, as compared with the lowest ALP tertile. Conclusions Elevated ALP level at presentation, but within the higher limit of normal, was found to be independently associated with higher risk of MACCE after primary PCI in patients with STEMI.	[Oh, Pyung Chun; Lee, Kyounghoon; Moon, Jeonggeun; Kang, Woong Chol] Gachon Univ, Gil Med Ctr, Cardiol, Incheon, South Korea; [Kim, Tae-Hoon; Jang, Ho-Jun] Sejong Gen Hosp, Cardiol, Bucheon, South Korea; [Park, Hyun Woo; Suh, Jon] Soon Chun Hyang Univ, Bucheon Hosp, Cardiol, Bucheon, South Korea; [Park, Sang-Don; Kwon, Sung Woo] Inha Univ Hosp, Cardiol, Incheon, South Korea	Gachon University; Sejong General Hospital; Soonchunhyang University; Inha University; Inha University Hospital	Kang, WC (corresponding author), Gachon Univ, Gil Med Ctr, Cardiol, Incheon, South Korea.; Suh, J (corresponding author), Soon Chun Hyang Univ, Bucheon Hosp, Cardiol, Bucheon, South Korea.	immanuel@schmc.ac.kr; kangwch@gilhospital.com	Kim, Tae-Hoon/AAG-3292-2021	Kim, Tae-Hoon/0000-0002-4032-1285	Boryung Pharmaceutical Company, Republic of Korea	Boryung Pharmaceutical Company, Republic of Korea	This work was supported by research grant from the Boryung Pharmaceutical Company, Republic of Korea (P.C.O.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AM, 2011, INT J ANGIOL, V20, P135, DOI 10.1055/s-0031-1284434; Birrer R, 2007, INTERNAL MED, V46, P1063, DOI 10.2169/internalmedicine.46.0059; Borekci A, 2016, KOREAN CIRC J, V46, P15, DOI 10.4070/kcj.2016.46.1.15; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kovesdy CP, 2010, NEPHROL DIAL TRANSPL, V25, P3003, DOI 10.1093/ndt/gfq144; Lee SJ, 2013, KOREAN CIRC J, V43, P73, DOI 10.4070/kcj.2013.43.2.73; Moon J, 2016, AM J CARDIOLOGY; Moon J, 2014, INT J CARDIOL, V177, P442, DOI 10.1016/j.ijcard.2014.09.002; Park JB, 2013, EUR HEART J, V34, P920, DOI 10.1093/eurheartj/ehs419; Park SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159416; Regidor DL, 2008, J AM SOC NEPHROL, V19, P2193, DOI 10.1681/ASN.2008010014; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schenker MP, 2008, CIRCULATION, V117, P1693, DOI 10.1161/CIRCULATIONAHA.107.717512; Schoppet M, 2008, KIDNEY INT, V73, P989, DOI 10.1038/ki.2008.104; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108; Tomoda H, 2000, AM HEART J, V140, P324, DOI 10.1067/mhj.2000.108244; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Webber M, 2010, CLIN CHEM LAB MED, V48, P167, DOI 10.1515/CCLM.2010.052	24	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171914	10.1371/journal.pone.0171914	http://dx.doi.org/10.1371/journal.pone.0171914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182682	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800133
J	Sugrue, KF; Zohn, IE				Sugrue, Kelsey F.; Zohn, Irene E.			Mechanism for generation of left isomerism in Ccdc40 mutant embryos	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; LATERAL PLATE; INTRAFLAGELLAR TRANSPORT; SIGNALING PATHWAY; SONIC-HEDGEHOG; PRIMARY CILIUM; MOUSE EMBRYOS; FLUID-FLOW; DEFECTS	Leftward fluid flow in the mouse node is generated by cilia and is critical for initiating asymmetry of the left-right axis. Coiled-coil domain containing-40 (Ccdc40) plays an evolutionarily conserved role in the assembly of motile cilia and establishment of the left-right axis. Approximately one-third of Ccdc40(lnks) mutant embryos display situs defects and here we investigate the underlying mechanism. Ccdc40(lnks) mutants show delayed induction of markers of the left-lateral plate mesoderm (L-LPM) including Lefty1, Lefty2 and Nodal. Consistent with defective cilia motility compromising fluid flow across the node, initiation of asymmetric perinodal Cerberus like-2 (Cerl2) expression is delayed and then randomized. This is followed by delayed and then randomized asymmetric Nodal expression around the node. We propose a model to explain how left isomerism arises in a proportion of Ccdc40(lnks) mutants. We postulate that with defective motile cilia, Cerl2 expression remains symmetric and Nodal is antagonized equally on both sides of the node. This effectively reduces Nodal activation bilaterally, leading to reduced and delayed activation of Nodal and its antagonists in the LPM. This model is further supported by the failure to establish Nodal expression in the left-LPM with reduced Nodal gene dosage in Ccdc40(lnks/lnks); Nodal(LacZ/+) mutants causing a predominance of right not left isomerism. Together these results suggest a model where cilia generated fluid flow in the node functions to ensure robust Nodal activation and a timely left-sided developmental program in the LPM.	[Sugrue, Kelsey F.] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Sugrue, Kelsey F.; Zohn, Irene E.] Childrens Natl Med Ctr, Ctr Neurosci Res, Childrens Res Inst, Washington, DC 20010 USA	George Washington University; Children's National Health System	Zohn, IE (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci Res, Childrens Res Inst, Washington, DC 20010 USA.	izohn@cnmcresearch.org		Sugrue, Kelsey/0000-0001-8629-0958; Zohn, Irene/0000-0001-7688-682X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090257] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD090257] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antony D, 2013, HUM MUTAT, V34, P462, DOI 10.1002/humu.22261; Aylsworth AS, 2001, AM J MED GENET, V101, P345, DOI 10.1002/ajmg.1219.abs; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Becker-Heck A, 2012, DYNEINS STRUCTURE BI; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brueckner M, 2007, CIRCULATION, V115, P2793, DOI 10.1161/CIRCULATIONAHA.107.699256; Casey B, 1998, HUM MOL GENET, V7, P1565, DOI 10.1093/hmg/7.10.1565; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hogan B, 1994, MANIPULATING THE MOU; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Kitajima K, 2013, DEV BIOL, V380, P222, DOI 10.1016/j.ydbio.2013.05.011; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Larkins CE, 2012, DEV BIOL, V367, P15, DOI 10.1016/j.ydbio.2012.04.011; Leitch CC, 2014, J CELL SCI, V127, P2407, DOI 10.1242/jcs.130344; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nakamura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2319; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Norris DP, 2002, DEVELOPMENT, V129, P3455; Oh SP, 2002, DEV DYNAM, V224, P279, DOI 10.1002/dvdy.10103; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Oki S, 2009, DEVELOPMENT, V136, P3917, DOI 10.1242/dev.039305; Peeters H, 2006, EUR J MED GENET, V49, P349, DOI 10.1016/j.ejmg.2005.12.003; Pennekamp Petra, 2015, Cilia, V4, P1, DOI 10.1186/s13630-014-0010-9; Praveen Kavita, 2015, F1000Prime Rep, V7, P36, DOI 10.12703/P7-36; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; RASHBASS P, 1991, NATURE, V353, P348, DOI 10.1038/353348a0; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Supp DM, 1999, DEVELOPMENT, V126, P5495; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Yamamoto M, 2003, DEVELOPMENT, V130, P1795, DOI 10.1242/dev.00408; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	71	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171180	10.1371/journal.pone.0171180	http://dx.doi.org/10.1371/journal.pone.0171180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182636	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800040
J	Wang, DY; Wang, Q; Wang, YL; Xiang, XG; Huang, LQ; Jin, XH				Wang, De-Yi; Wang, Qiang; Wang, Ying-Li; Xiang, Xiao-Guo; Huang, Lu-Qi; Jin, Xiao-Hua			Evaluation of DNA barcodes in Codonopsis (Campanulaceae) and in some large angiosperm plant genera	PLOS ONE			English	Article							LAND PLANTS; IDENTIFICATION; ORCHIDACEAE; COMPLEMENTS; EVOLUTION; TAXONOMY; HISTORY; GENOMES; PROMISE; SPACER	DNA barcoding is expected to be one of the most promising tools in biological taxonomy. However, there have been no agreements on which core barcode should be used in plants, especially in species-rich genera with wide geographical distributions. To evaluate their discriminatory power in large genera, four of the most widely used DNA barcodes, including three plastid regions (matK, rbcL, trnH-psbA) and nuclear internal transcribed spacer (nrITS), were tested in seven species-rich genera (Ficus, Pedicularis, Rhodiola, Rhododendron, Viburnum, Dendrobium and Lysimachia) and a moderate size genus, Codonopsis. All of the sequences from the aforementioned seven large genera were downloaded from NCBI. The related barcodes for Codonopsis were newly generated in this study. Genetics distances, DNA barcoding gaps and phylogenetic trees of the four single barcodes and their combinations were calculated and compared in the seven genera. As for single barcode, nrITS has the most variable sites, the clearest intra- and inter-specific divergences and the highest discrimination rates in the seven genera. Among the combinations of barcodes, ITS +matK performed better than all the single barcodes in most cases and even the three- and four-loci combinations in the seven genera. Therefore, we recommend ITS+matK as the core barcodes for large plant genera.	[Wang, De-Yi; Wang, Qiang; Xiang, Xiao-Guo; Jin, Xiao-Hua] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Wang, De-Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Ying-Li] Baotou Med Coll, Baotou City, Inner Mongolia, Peoples R China; [Huang, Lu-Qi] China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China; [Jin, Xiao-Hua] Chinese Acad Sci, SEABRI, Southeast Asia Biodivers Res Inst, Mengla, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Baotou Medical College; China Academy of Chinese Medical Sciences; National Resource Center for Chinese Materia Medica, CACMS; Chinese Academy of Sciences	Jin, XH (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.; Huang, LQ (corresponding author), China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing, Peoples R China.; Jin, XH (corresponding author), Chinese Acad Sci, SEABRI, Southeast Asia Biodivers Res Inst, Mengla, Yunnan, Peoples R China.	huangluqi01@163.com; xiaohuajin@ibcas.ac.cn		Deyi, Wang/0000-0003-2140-2482				Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Averyanov LV, 2016, PHYTOTAXA, V266, P289, DOI 10.11646/phytotaxa.266.4.6; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Dong WP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08348; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Guo YW, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156323, 10.1007/s11468-015-0008-1]; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hossen MJ, 2016, PHYTOTHER RES, V30, P347, DOI 10.1002/ptr.5553; IBM Corp, 2010, IBM SPSS STAT WIND V; Jiao Li-Juan, 2013, Plant Diversity and Resources, V35, P715, DOI 10.7677/ynzwyj201313064; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knox EB, 2014, P NATL ACAD SCI USA, V111, P11097, DOI 10.1073/pnas.1403363111; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li CY, 2009, J CHROMATOGR A, V1216, P2124, DOI 10.1016/j.chroma.2008.10.080; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153008; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Morris KE, 1997, BOT BULL ACAD SINICA, V38, P277; Ojeda DI, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu050; Podlech XLD, 2010, FLORA CHINA, V25, P328; Raskoti BB, 2015, CLADISTICS; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YL, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-015-0072-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Van der Niet T, 2014, ANN BOT-LONDON, V113, P301, DOI 10.1093/aob/mct193; Vassou SL, 2015, GENE, V559, P86, DOI 10.1016/j.gene.2015.01.025; Von Raab-Straube E, 2014, WILLDENOWIA, V44, P287, DOI 10.3372/wi.44.44211; Wang Q, 2014, J SYST EVOL, V52, P541, DOI 10.1111/jse.12096; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Xu SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115168; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zhang JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119921; Zhao YB, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00696; Zheng SH, 2014, EVIDENCE BASED COMPL	60	9	12	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170286	10.1371/journal.pone.0170286	http://dx.doi.org/10.1371/journal.pone.0170286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182623	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800009
J	Wang, JH; Yu, JL; Fan, J; He, Y; Dong, WH; Wang, ZL				Wang, Jianhui; Yu, Jialin; Fan, Juan; He, Yu; Dong, Wenhui; Wang, Zhengli			Evaluation of altitude-appropriate reference ranges for neutrophils in diagnosis of sepsis in very low birth weight infants: A multicenter retrospective study	PLOS ONE			English	Article							ONSET NEONATAL SEPSIS; BLOOD-CELL COUNT; NEWBORN-INFANTS; CIRCULATING NEUTROPHILS; LEUKOCYTE COUNTS; DEMARGINATION; INFECTIONS; HYPOXIA; RATS	Background The circulating neutrophil count was commonly believed to be influenced by altitude. At present, neutrophil reference ranges (RRs) for very low birth weight (VLBW) neonates are only available from the sea level and from high altitude. This study aimed to construct RRs for neutrophils in VLBW infants in an intermediate-altitude area and assess its usefulness in evaluation for sepsis. Methods This was a multicenter retrospective study of 2173 VLBW infants admitted to 20 hospitals in Chongqing in southwest of China with altitude from 1000 to 2600 feet. The RRs for absolute total neutrophils (ATN), absolute total immature neutrophils (ATI), and immature: total neutrophil proportion were constructed based on "normal" neonates (unlikely infection). Values of neutrophil from septic and uninfected neonates were respectively assessed using the revised RRs and the previous Mouzinho's and Schmutz's RRs. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were compared using the McNemar's test or chi(2) test. Results The upper limits for ATN and ATI using the revised RRs were much higher than those using Mouzinho's RRs, but lower than those using Schmutz's RRs. The revised RRs and Mouzinho's RRs had higher sensitivities than Schmutz's RRs at 73-672 h. The revised RRs had a higher specificity than Mouzinho's RRs at both 0-72 h and 73-672 h. The NPV for any abnormality in neutrophil values was high at both 0-72 h and 73-672 h irrespective of the RRs used. Conclusion Altitude-appropriate RRs for neutrophils is more suitable to guide the diagnosis and management of neonatal sepsis in VLBW infants.	[Wang, Jianhui; Yu, Jialin; Fan, Juan; Dong, Wenhui; Wang, Zhengli] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Wang, Jianhui; Yu, Jialin; He, Yu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Wang, Jianhui; Yu, Jialin; He, Yu] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Wang, Jianhui; Yu, Jialin; He, Yu; Dong, Wenhui; Wang, Zhengli] Chongqing Key Lab Child Infect & Immun, Chongqing, Peoples R China	Chongqing Medical University	Yu, JL (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Yu, JL (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Yu, JL (corresponding author), China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China.; Yu, JL (corresponding author), Chongqing Key Lab Child Infect & Immun, Chongqing, Peoples R China.	yujialin486@126.com			National Nature Science Foundation of China [81370744, 81571483]; Chinese Ministry of Education [20135503110009]; State key clinic discipline project [2011-873]; Clinical Research Foundation of Children's Hospital of Chongqing Medical University [[2014] 254-lcyj2014-11]; Research Project of Chongqing Department of Health and Family Planning Commission [2015MSXM039]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); State key clinic discipline project; Clinical Research Foundation of Children's Hospital of Chongqing Medical University; Research Project of Chongqing Department of Health and Family Planning Commission	JLY was supported by the National Nature Science Foundation of China (Nos. 81370744, 81571483, http://www.nsfc.gov.cn), Doctoral Degree Funding from Chinese Ministry of Education (No. 20135503110009, http://www.moe.gov.cn), State key clinic discipline project (No. 2011-873, http://www.nhfpc.gov.cn), Clinical Research Foundation of Children's Hospital of Chongqing Medical University ([2014] 254-lcyj2014-11, http://www.chcmu.com). JHW was supported by the Research Project of Chongqing Department of Health and Family Planning Commission (No. 2015MSXM039, http://183.230.146.1:9117/kysystem). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKENZUA GI, 1974, PEDIATRICS, V54, P38; [Anonymous], 2015, RED BOOK 2015 REPORT; Bender L, 2008, DAN MED BULL, V55, P219; CARBALLO C, 1991, J PEDIATR-US, V119, P464, DOI 10.1016/S0022-3476(05)82065-7; CHAN PCY, 1985, ANN TROP PAEDIATR, V5, P153, DOI 10.1080/02724936.1985.11748382; CHRISTENSEN RD, 1989, PEDIATR RES, V26, P531, DOI 10.1203/00006450-198912000-00001; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Engle WD, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.3.e10; Gonzalez NC, 2010, ADV EXP MED BIOL, V662, P27, DOI 10.1007/978-1-4419-1241-1_3; GUILLOIS B, 1989, ACTA PAEDIATR SCAND, V78, P369, DOI 10.1111/j.1651-2227.1989.tb11094.x; Hillman Noah H, 2012, Clin Perinatol, V39, P769, DOI 10.1016/j.clp.2012.09.009; Hornik CP, 2012, PEDIATR INFECT DIS J, V31, P803, DOI 10.1097/INF.0b013e31825691e4; Hornik CP, 2012, PEDIATR INFECT DIS J, V31, P799, DOI 10.1097/INF.0b013e318256905c; Lambert RM, 2009, J PERINATOL, V29, P822, DOI 10.1038/jp.2009.3; Lim EM, 2010, INT J LAB HEMATOL, V32, P590, DOI 10.1111/j.1751-553X.2010.01223.x; Lim WH, 2012, PEDIATR NEONATOL, V53, P228, DOI 10.1016/j.pedneo.2012.06.003; Maheshwari A, 2002, ACTA PAEDIATR, V91, P98, DOI 10.1080/080352502320764265; MANROE BL, 1979, J PEDIATR-US, V95, P89, DOI 10.1016/S0022-3476(79)80096-7; MAYNARD EC, 1993, J PEDIATR-US, V122, P990, DOI 10.1016/S0022-3476(09)90037-3; Melvan JN, 2010, INT REV IMMUNOL, V29, P315, DOI 10.3109/08830181003792803; MOUZINHO A, 1994, PEDIATRICS, V94, P76; Murphy K, 2012, PEDIATR INFECT DIS J, V31, P16, DOI 10.1097/INF.0b013e31822ffc17; Pammi M, 2015, EXPERT REV ANTI-INFE, V13, P487, DOI 10.1586/14787210.2015.1008450; Radom-Aizik S, 2013, PEDIATR RES, V74, P111, DOI 10.1038/pr.2013.80; Rubin LG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e42; SCHAFFNER A, 1981, SCAND J HAEMATOL, V27, P225; Schlapbach LJ, 2013, INTENS CARE MED, V39, P754, DOI 10.1007/s00134-012-2798-3; Schmutz N, 2008, J PERINATOL, V28, P275, DOI 10.1038/sj.jp.7211916; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Suwa T, 2000, AM J PHYSIOL-HEART C, V279, pH2954, DOI 10.1152/ajpheart.2000.279.6.H2954; Thake CD, 2004, AVIAT SPACE ENVIR MD, V75, P811; ULICH TR, 1989, J LEUKOCYTE BIOL, V45, P546, DOI 10.1002/jlb.45.6.546; Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157	33	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171571	10.1371/journal.pone.0171571	http://dx.doi.org/10.1371/journal.pone.0171571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182674	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800075
J	Yang, YF; Tan, MJ; Dai, YW				Yang, Yifei; Tan, Minjia; Dai, Yuewei			An improved CS-LSSVM algorithm-based fault pattern recognition of ship power equipments	PLOS ONE			English	Article							LOCATION	A ship power equipments' fault monitoring signal usually provides few samples and the data's feature is non-linear in practical situation. This paper adopts the method of the least squares support vector machine (LSSVM) to deal with the problem of fault pattern identification in the case of small sample data. Meanwhile, in order to avoid involving a local extremum and poor convergence precision which are induced by optimizing the kernel function parameter and penalty factor of LSSVM, an improved Cuckoo Search (CS) algorithm is proposed for the purpose of parameter optimization. Based on the dynamic adaptive strategy, the newly proposed algorithm improves the recognition probability and the searching step length, which can effectively solve the problems of slow searching speed and low calculation accuracy of the CS algorithm. A benchmark example demonstrates that the CS-LSSVM algorithm can accurately and effectively identify the fault pattern types of ship power equipments.	[Yang, Yifei; Dai, Yuewei] Nanjing Univ Sci & Technol, Sch Automat, Nanjing, Jiangsu, Peoples R China; [Yang, Yifei; Tan, Minjia; Dai, Yuewei] Jiangsu Univ Sci & Technol, Sch Elect & Informat, Zhenjiang, Jiangsu, Peoples R China	Nanjing University of Science & Technology; Jiangsu University of Science & Technology	Yang, YF (corresponding author), Nanjing Univ Sci & Technol, Sch Automat, Nanjing, Jiangsu, Peoples R China.; Yang, YF (corresponding author), Jiangsu Univ Sci & Technol, Sch Elect & Informat, Zhenjiang, Jiangsu, Peoples R China.	seayyf@163.com		Tan, Minjia/0000-0003-1946-6516				Aminian F, 2002, IEEE T INSTRUM MEAS, V51, P544, DOI 10.1109/TIM.2002.1017726; Cao S.-G., 2008, J CHINA U MIN TECHNO, V18, P172; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Gencoglu MT, 2009, EXPERT SYST APPL, V36, P10789, DOI 10.1016/j.eswa.2009.02.021; Gu Yanping, 2010, Journal of Tsinghua University (Science and Technology), V50, P1063; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; [贺淼 He Miao], 2014, [计算机与应用化学, Computers and Applied Chemistry], V31, P961; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Ji RR, 2016, PATTERN RECOGN, V59, P268, DOI 10.1016/j.patcog.2016.03.016; Ji RR, 2015, ACM T INTEL SYST TEC, V6, DOI 10.1145/2597181; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Li HL, 2015, THESIS; Liu Xin-ni, 2013, Computer Engineering, V39, P274, DOI 10.3969/j.issn.1000-3428.2013.07.061; MANTEGNA RN, 1994, PHYS REV E, V49, P4677, DOI 10.1103/PhysRevE.49.4677; Pan HL, 2016, NEUROCOMPUTING, V175, P644, DOI 10.1016/j.neucom.2015.10.104; Shen MH, 2006, TELCOMMUNICATION ENG, V04, P9; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zheng Hongqing, 2013, Computer Engineering and Applications, V49, P68, DOI 10.3778/j.issn.1002-8331.1112-0292	20	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171246	10.1371/journal.pone.0171246	http://dx.doi.org/10.1371/journal.pone.0171246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182678	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800050
J	de Freitas, JR; Bennie, J; Mantovani, W; Gaston, KJ				de Freitas, Juliana Ribeirao; Bennie, Jon; Mantovani, Waldir; Gaston, Kevin J.			Exposure of tropical ecosystems to artificial light at night: Brazil as a case study	PLOS ONE			English	Article							PROTECTED AREA; ORIENTATION; POLLUTION; COLEOPTERA; EROSION; BATS	Artificial nighttime lighting from streetlights and other sources has a broad range of biological effects. Understanding the spatial and temporal levels and patterns of this lighting is a key step in determining the severity of adverse effects on different ecosystems, vegetation, and habitat types. Few such analyses have been conducted, particularly for regions with high biodiversity, including the tropics. We used an intercalibrated version of the Defense Meteorological Satellite Program's Operational Linescan System (DMSP/OLS) images of stable nighttime lights to determine what proportion of original and current Brazilian vegetation types are experiencing measurable levels of artificial light and how this has changed in recent years. The percentage area affected by both detectable light and increases in brightness ranged between 0 and 35% for native vegetation types, and between 0 and 25% for current vegetation (i.e. including agriculture). The most heavily affected areas encompassed terrestrial coastal vegetation types (restingas and mangroves), Semideciduous Seasonal Forest, and Mixed Ombrophilous Forest. The existing small remnants of Lowland Deciduous and Semideciduous Seasonal Forests and of Campinarana had the lowest exposure levels to artificial light. Light pollution has not often been investigated in developing countries but our data show that it is an environmental concern.	[de Freitas, Juliana Ribeirao; Mantovani, Waldir] Univ Sao Paulo, IEE Inst Energia & Ambiente, Sao Paulo, SP, Brazil; [Bennie, Jon] Univ Exeter, Coll Life & Environm Sci, Ctr Geog Environm & Soc, Penryn, Cornwall, England; [Bennie, Jon; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Universidade de Sao Paulo; University of Exeter; University of Exeter	de Freitas, JR (corresponding author), Univ Sao Paulo, IEE Inst Energia & Ambiente, Sao Paulo, SP, Brazil.	freitasjuliana.r@yahoo.com	MANTOVANI, WALDIR/C-5177-2014	MANTOVANI, WALDIR/0000-0002-9394-6860; Gaston, Kevin J./0000-0002-7235-7928	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [99999.008943/2014-01]; European Research Council through the European Union's Seventh Framework Programme/ERC [268504]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Research Council through the European Union's Seventh Framework Programme/ERC	This research was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through scholarship granted to J.R.F under the overseas exchange program PDSE-Programa de doutorado Sanduiche no exterior, process number 99999.008943/2014-01. See http://www.capes. gov.br/component/content/article?id=4561. It was also supported by the European Research Council through the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 268504 to K.J.G. The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Arendt J, 1998, REV REPROD, V3, P13, DOI 10.1530/revreprod/3.1.13; Ashkenazi L, 2012, J EXP BIOL, V215, P4034, DOI 10.1242/jeb.073429; Bennie J, 2015, REMOTE SENS-BASEL, V7, P2715, DOI 10.3390/rs70302715; Bennie J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0131; Bennie J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03789; Bennie JJ, 2014, P NATL ACAD SCI USA, V111, P13727, DOI 10.1073/pnas.1216063110; Buurman M, 2015, DESCRIPTION GLOBIOM, P1; Byrne M, 2003, J COMP PHYSIOL A, V189, P411, DOI 10.1007/s00359-003-0415-1; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Costa C, 2000, MONGR TERC MILENIO, V1, P99; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Dacke M, 2013, CURR BIOL, V23, P298, DOI 10.1016/j.cub.2012.12.034; Davies TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01722; Day J, 2015, ANIM CONSERV, V18, P512, DOI 10.1111/acv.12200; Duffy JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12042; Falchi F, 2016, NEW WORLD ATLAS ARTI, P1; FAO, 2007, 153 FAO; Gaston KJ, 2015, CONSERV BIOL, V29, P1132, DOI 10.1111/cobi.12462; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gaston KJ, 2014, ENVIRON REV, V22, P323, DOI 10.1139/er-2014-0005; Gaston KJ, 2014, OECOLOGIA, V176, P917, DOI 10.1007/s00442-014-3088-2; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Hagen O., 2015, ADV ENTOMOLOGY, V03, P24, DOI [10.4236/ae.2015.31004, DOI 10.4236/AE.2015.31004]; Han B, 2015, SEOUL, V29, P441; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Renovaveis, 1995, DIAR OF UN BRAS PROI; IBGE, 2013, ATL CENS DEM 2010; IBGE, 2004, MAP VEG BRAS; IBGE [Instituto Brasileiro de Geografia e Estatistica], 2012, MAN TECN GEOC, V2nd; Kyba CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08409; Kyba CCM, 2013, LANDSCAPE ECOL, V28, P1637, DOI 10.1007/s10980-013-9936-3; Le Tallec T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079250; Lewanzik D, 2014, J APPL ECOL, V51, P388, DOI 10.1111/1365-2664.12206; Lewinsohn TM, 2005, CONSERV BIOL, V19, P619, DOI 10.1111/j.1523-1739.2005.00680.x; Lins J, 2009, CHECK LIST, V5, P364; Lorne Jacquelyn Kay, 2007, Endangered Species Research, V3, P23, DOI 10.3354/esr003023; Luz JL, 2011, BIOTA NEOTROP, V11, P161, DOI 10.1590/S1676-06032011000400016; Ma T, 2012, REMOTE SENS ENVIRON, V124, P99, DOI 10.1016/j.rse.2012.04.018; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Matzke EB, 1936, AM J BOT, V23, P446, DOI 10.2307/2436035; Miller MW, 2006, CONDOR, V108, P130, DOI 10.1650/0010-5422(2006)108[0130:AEOLPO]2.0.CO;2; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oprea M, 2009, BRAZ J BIOL, V69, P1073, DOI 10.1590/S1519-69842009000500010; Picchi MS, 2013, J INSECT CONSERV, V17, P797, DOI 10.1007/s10841-013-9562-z; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; van Geffen KG, 2014, ECOL EVOL, V4, P2082, DOI 10.1002/ece3.1090; van Langevelde F, 2011, BIOL CONSERV, V144, P2274, DOI 10.1016/j.biocon.2011.06.004; Viviani VR, 2010, BIOTA NEOTROP, V10, P103, DOI 10.1590/S1676-06032010000200013; World Bank Group, 2016, IL CID BRAS MOD NEG	53	18	18	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171655	10.1371/journal.pone.0171655	http://dx.doi.org/10.1371/journal.pone.0171655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178352	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500057
J	Ito, R; Narita, S; Huang, M; Nara, T; Numakura, K; Takayama, K; Tsuruta, H; Maeno, A; Saito, M; Inoue, T; Tsuchiya, N; Satoh, S; Habuchi, T				Ito, Ryuichi; Narita, Shintaro; Huang, Mingguo; Nara, Taketoshi; Numakura, Kazuyuki; Takayama, Koichiro; Tsuruta, Hiroshi; Maeno, Atsushi; Saito, Mitsuru; Inoue, Takamitsu; Tsuchiya, Norihiko; Satoh, Shigeru; Habuchi, Tomonori			The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox"	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; BODY-MASS INDEX; SERUM ADIPONECTIN; APOPTOSIS; PROLIFERATION; EXPRESSION; SURVIVAL; RECEPTOR	Although obesity increases the risk of renal cell carcinoma (RCC), obese patients with RCC experience longer survival than non-obese patients. However, the mechanism of this "obesity paradox" is unknown. We examined the impact of preoperative BMI, serum total adiponectin (sAd) level, total adiponectin secretion from perinephric adipose tissue, and intratumoral expression of adiponectin receptors on RCC aggressiveness and survival. We also investigated the mechanism underlying enhanced cancer aggressiveness in RCC cells stimulated with exogenous adiponectin. Overweight and obese patients had significantly lower grade cancers than normal patients in all patients and in those without metastasis (p = 0.003 and p = 0.027, respectively). Cancer-specific survival was significantly longer in overweight and obese patients than in normal patients in all patients (p = 0.035). There was a weak inverse correlation between sAd level and BMI in RCC patients (r = -0.344, p = 0.002). Tumor size was slightly correlated with sAd level, and high sAd was significantly associated with poor overall survival rates in patients with non-metastatic RCC (p = 0.035). Adiponectin levels in perinephric adipose tissue and intratumoral AdipoRl/R2 expression were not correlated with RCC aggressiveness or survival. Proliferation significantly increased in 786-0 and Caki-2 cells exposed to exogenous adiponectin, whereas cell invasion and migration were unaffected. In addition, exogenous adiponectin significantly inhibited starvation-and metformin-induced apoptosis, and up-regulated p-AMPK and Bcl-xL levels. In summary, low BMI and high adiponectin levels are associated with aggressive cell behaviors and poor survival in surgically-treated RCC patients. The effects of adiponectin on proliferation and apoptosis might underlie the "obesity paradox" of RCC.	[Ito, Ryuichi; Narita, Shintaro; Huang, Mingguo; Numakura, Kazuyuki; Takayama, Koichiro; Tsuruta, Hiroshi; Maeno, Atsushi; Saito, Mitsuru; Inoue, Takamitsu; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan; [Narita, Shintaro; Huang, Mingguo; Inoue, Takamitsu; Habuchi, Tomonori] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan; [Nara, Taketoshi] Yamagata Univ, Dept Urol, Grad Sch Med, Yamagata, Japan; [Satoh, Shigeru] Akita Univ Hosp, Ctr Kidney Dis & Transplantat, Akita, Japan	Akita University; Yamagata University; Akita University	Narita, S (corresponding author), Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan.; Narita, S (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.	nari6202@gipc.akita-u.ac.jp	Tsuchiya, Norihiko/H-6538-2019; Narita, Shintaro/H-3017-2019	Inoue, Takamitsu/0000-0002-1362-4344	Kakenhi Grant for scientific research by the Japan Society for the Promotion of Science [25462466, 26670695, 16H02679]; Japan Agency for Medical Research and Development	Kakenhi Grant for scientific research by the Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by a Kakenhi Grant for scientific research by the Japan Society for the Promotion of Science (No. 25462466, 26670695 and 16H02679) and Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Chou Sharon H., 2010, Hormones & Cancer, V1, P136, DOI 10.1007/s12672-010-0017-7; de Martino M, 2016, EUR UROL FOCUS, V2, P197, DOI 10.1016/j.euf.2015.06.012; Donin NM, 2016, CANCER EPIDEM BIOMAR, V25, P1326, DOI 10.1158/1055-9965.EPI-16-0226; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Finley DS, 2009, J UROLOGY, V182, P1621, DOI 10.1016/j.juro.2009.06.015; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gandhi R, 2016, J OBES, V2016, DOI 10.1155/2016/8746268; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; Gobe G, 2002, CANCER INVEST, V20, P324, DOI 10.1081/CNV-120001177; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Horiguchi A, 2008, JPN J CLIN ONCOL, V38, P106, DOI 10.1093/jjco/hym158; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Jaramillo S, 2010, J AGR FOOD CHEM, V58, P10869, DOI 10.1021/jf102669p; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Laurent V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10230; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nagaprashantha LD, 2011, CARCINOGENESIS, V32, P568, DOI 10.1093/carcin/bgr021; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; Phillips SA, 2003, DIABETES, V52, P667, DOI 10.2337/diabetes.52.3.667; Pinthus JH, 2008, EUR UROL, V54, P866, DOI 10.1016/j.eururo.2008.02.044; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Sun YY, 2010, BIOFACTORS, V36, P179, DOI 10.1002/biof.83; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zadra G, 2015, MOL CANCER RES, V13, P1059, DOI 10.1158/1541-7786.MCR-15-0068; Zhang XL, 2015, INT J CLIN EXP PATHO, V8, P2823	30	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171615	10.1371/journal.pone.0171615	http://dx.doi.org/10.1371/journal.pone.0171615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178338	gold, Green Submitted, Green Published			2022-12-27	WOS:000393712500053
J	Keshtidar, M; Behzadnia, B				Keshtidar, Mohammad; Behzadnia, Behzad			Prediction of intention to continue sport in athlete students: A self-determination theory approach	PLOS ONE			English	Article							PHYSICAL-ACTIVITY INTENTIONS; ACHIEVEMENT GOAL FRAMEWORK; PERCEIVED AUTONOMY SUPPORT; BEHAVIORAL REGULATIONS; INTRINSIC MOTIVATION; HEALTH-BENEFITS; EDUCATION; MODEL; ORIENTATIONS; ATTAINMENT	Grounded on the self-determination theory (Deci & Ryan, 1985, 2000) and achievement goals theory (Ames, 1992; Nicholls, 1989), this study via structural equation modelling, predicted intention to continue in sport from goal orientations and motivations among athlete students. 268 athlete students (M-age = 21.9), in Iranian universities completed a multi -section questionnaire tapping the targeted variables. Structural equation modelling (SEM) offered an overall support for the proposed model. The results showed that there are positive relationships between intention to continue in sport and both orientations as well as both motivations. A task-involving orientation emerged as a positive predictor of the autonomous motivation, while an ego-involving orientation was a positive predictor controlled motivation as well as autonomous motivation. The results also support positive paths between autonomous motivation and future intention to participate in sport. Autonomous motivation also was a positive mediator in relationship between task orientation and the intentions. As a conclusion, the implications of the task-involving orientation are discussabled in the light of its importance for the quality and potential maintenance of sport involvement among athlete students.	[Keshtidar, Mohammad] Univ Birjand, Fac Phys Educ & Sport Sci, Birjand, Iran; [Behzadnia, Behzad] Univ Tabriz, Dept Motor Behav, Tabriz, Iran; [Keshtidar, Mohammad] Birjand Univ, Fac Sport Sci, Birjand, South Khorasan, Iran	University of Birjand; University of Tabriz; University of Birjand	Keshtidar, M (corresponding author), Univ Birjand, Fac Phys Educ & Sport Sci, Birjand, Iran.; Behzadnia, B (corresponding author), Univ Tabriz, Dept Motor Behav, Tabriz, Iran.; Keshtidar, M (corresponding author), Birjand Univ, Fac Sport Sci, Birjand, South Khorasan, Iran.	mkeshtidar@birjand.ac.ir; behzadniaa@gmail.com	Behzadnia, Behzad/P-4268-2016; Behzadnia, Behzad/E-5790-2017; keshtidar, mohammad/AAC-2707-2021	Behzadnia, Behzad/0000-0001-6875-451X; Behzadnia, Behzad/0000-0001-6875-451X; keshtidar, Mohammad/0000-0002-1705-4940				Ahmadi M, 2015, SPORT PSYCHOL STUDIE, V3, P99; Ahmadi M, 2016, APPL RES SPORT MANAG, V4, P85; Ames C., 1995, ACHIEVEMENT GOALS MO; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Brunel PC, 1999, SCAND J MED SCI SPOR, V9, P365; Chatzisarantis NLD, 1997, BRIT J HEALTH PSYCH, V2, P343, DOI 10.1111/j.2044-8287.1997.tb00548.x; Cury F, 2006, J PERS SOC PSYCHOL, V90, P666, DOI 10.1037/0022-3514.90.4.666; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deci EL, 1991, NEBR SYM MOTIV, P237; Deci EL, 1985, INTRINSIC MOTIVATION; DUDA JL, 1992, J EDUC PSYCHOL, V84, P290, DOI 10.1037/0022-0663.84.3.290; Elliot AJ, 2006, J SPORT EXERCISE PSY, V28, P344, DOI 10.1123/jsep.28.3.344; Hagger M., 2007, HUMAN KINETICS; Hagger MS, 2003, J EDUC PSYCHOL, V95, P784, DOI 10.1037/0022-0663.95.4.784; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hein V, 2007, J SPORT SCI, V25, P149, DOI 10.1080/02640410600598315; Kline RB, 2005, PRINCIPLES PRACTICE; Koestner R, 2008, J PERS, V76, P1201, DOI 10.1111/j.1467-6494.2008.00519.x; Lepper M. R., 1997, ADV LEARNING TEACHIN, P108; Lim BSC, 2009, PSYCHOL SPORT EXERC, V10, P52, DOI 10.1016/j.psychsport.2008.06.003; Lonsdale C, 2008, J SPORT EXERCISE PSY, V30, P323, DOI 10.1123/jsep.30.3.323; Nicholls J.G., 1989, COMPETITIVE ETHOS DE; [Organization US USO], 2013, HLTH CTR SPORT COUNS; Papaioannou A, 2006, J SPORT SCI, V24, P367, DOI 10.1080/02640410400022060; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ryan R., 2007, INTRINSIC MOTIVATION, P1; Ryan Richard M., 2017, SELF DETERMINATION T; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; RYAN RM, 1995, J PERS, V63, P397, DOI 10.1111/j.1467-6494.1995.tb00501.x; Sarrazin P, 2002, EUR J SOC PSYCHOL, V32, P395, DOI 10.1002/ejsp.98; Shafi'zadeh M., 2007, RES SPORT SCI, V5, P15; Sheldon KM, 1998, PERS SOC PSYCHOL B, V24, P546, DOI 10.1177/0146167298245010; Alvarez MS, 2012, J CLIN SPORT PSYCHOL, V6, P166, DOI 10.1123/jcsp.6.2.166; Standage M, 2003, J EDUC PSYCHOL, V95, P97, DOI 10.1037/0022-0663.95.1.97; Standage M., 2012, ADV MOTIVATION SPORT, P233, DOI DOI 10.5040/; Treasure DC, 2001, RES Q EXERCISE SPORT, V72, P165, DOI 10.1080/02701367.2001.10608946; Vallerand RJ, 1997, ADV EXP SOC PSYCHOL, V29, P271, DOI 10.1016/S0065-2601(08)60019-2; Wang CKJ, 2007, PSYCHOL SPORT EXERC, V8, P147, DOI 10.1016/j.psychsport.2005.08.012; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; World Health Organization, 2010, REPR H MED EL CRIT C	41	15	15	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171673	10.1371/journal.pone.0171673	http://dx.doi.org/10.1371/journal.pone.0171673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178308	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500059
J	Tayabali, AF; Coleman, G; Crosthwait, J; Nguyen, KC; Zhang, Y; Shwed, P				Tayabali, Azam F.; Coleman, Gordon; Crosthwait, Jennifer; Nguyen, Kathy C.; Zhang, Yan; Shwed, Philip			Composition and pathogenic potential of a microbial bioremediation product used for crude oil degradation	PLOS ONE			English	Article							COMAMONAS-KERSTERSII; BACTERIAL CONSORTIUM; BISPHENOL-A; SOIL; BIODEGRADATION	A microbial bioremediation product (MBP) used for large-scale oil degradation was investigated for microbial constituents and possible pathogenicity. Aerobic growth on various media yielded >10(8) colonies mL(-1). Full-length 16S rDNA sequencing and fatty acid profiling from morphologically distinct colonies revealed >= 13 distinct genera. Full-length 16S rDNA library sequencing, by either Sanger or long-read PacBio technology, suggested that up to 21% of the MBP was composed of Arcobacter. Other high abundance microbial constituents (>6%) included the genera Proteus, Enterococcus, Dysgonomonas and several genera in the order Bacteroidales. The MBP was most susceptible to ciprofloxacin, doxycycline, gentamicin, and meropenam. MBP exposure of human HT29 and A549 cells caused significant cytotoxicity, and bacterial growth and adherence. An acellular MBP filtrate was also cytotoxic to HT29, but not A549. Both MBP and filtrate exposures elevated the neutrophil chemoattractant IL-8. In endotracheal murine exposures, bacterial pulmonary clearance was complete after one-week. Elevation of pro-inflammatory cytokines IL-1 beta, IL-6, and TNF-alpha, and chemokines KC and MCP-1 occurred between 2h and 48h post-exposure, followed by restoration to baseline levels at 96h. Cytokine/chemokine signalling was accompanied by elevated blood neutrophils and monocytes at 4h and 48h, respectively. Peripheral acute phase response markers were maximal at 24h. All indicators examined returned to baseline values by 168h. In contrast to HT29, but similar to A549 observations, MBP filtrate did not induce significant murine effects with the indicators examined. The results demonstrated the potentially complex nature of MBPs and transient immunological effects during exposure. Products containing microbes should be scrutinized for pathogenic components and subjected to characterisation and quality validation prior to commercial release.	[Tayabali, Azam F.; Coleman, Gordon; Crosthwait, Jennifer; Nguyen, Kathy C.; Zhang, Yan; Shwed, Philip] Hlth Canada, Ctr Environm Hlth, Hlth Environm & Consumer Safety Branch, Biotechnol Lab,Environm Hlth Sci & Res Bur, Ottawa, ON, Canada	Health Canada	Tayabali, AF (corresponding author), Hlth Canada, Ctr Environm Hlth, Hlth Environm & Consumer Safety Branch, Biotechnol Lab,Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.	azam.tayabali@canada.ca		Shwed, Philip/0000-0002-8009-2085	Health Canada intramural funds	Health Canada intramural funds	Financial support for this research was provided by Health Canada intramural funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almuzara MN, 2013, J CLIN MICROBIOL, V51, P1998, DOI 10.1128/JCM.00659-13; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Biswas JS, 2014, J CLIN MICROBIOL, V52, P3134, DOI 10.1128/JCM.00909-14; Cangelosi GA, 2014, APPL ENVIRON MICROB, V80, P5884, DOI 10.1128/AEM.01763-14; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ebringer A, 2014, APMIS, V122, P363, DOI 10.1111/apm.12154; Ferreira S, 2016, CRIT REV MICROBIOL, V42, P364, DOI 10.3109/1040841X.2014.954523; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Herold S, 2011, ACUTE LUNG INJURY MA, V2; Juwarkar AA, 2010, REV ENVIRON SCI BIO, V9, P215, DOI 10.1007/s11157-010-9215-6; Kalra A, 2011, TREATMENT ENDOCARDIT, V15, pe222; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lade H, 2015, EXCLI J, V14, P158, DOI 10.17179/excli2014-642; Leng T, 2009, RETINA-J RET VIT DIS, V29, P1019, DOI 10.1097/01.iae.0000357756.22868.2d; Li B, 2014, FUTURE MICROBIOL, V9, P1071, DOI [10.2217/FMB.14.48, 10.2217/fmb.14.48]; Luber P, 2003, J CLIN MICROBIOL, V41, P1062, DOI 10.1128/JCM.41.3.1062-1068.2003; Mackova M, 2009, ENVIRON SCI POLLUT R, V16, P817, DOI 10.1007/s11356-009-0240-3; Matsumura Y, 2015, BIOCONTROL SCI, V20, P35, DOI 10.4265/bio.20.35; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Opota O, 2014, J CLIN MICROBIOL, V52, P1009, DOI 10.1128/JCM.02942-13; Patel VR, 2015, WATER SCI TECHNOL, V72, P311, DOI 10.2166/wst.2015.208; Peng YH, 2015, J HAZARD MATER, V286, P285, DOI 10.1016/j.jhazmat.2014.12.051; Qiao J, 2014, FRONT ENV SCI ENG, V8, P293, DOI 10.1007/s11783-013-0561-9; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Samarajeewa AD, 2015, J MICROBIOL METH, V108, P103, DOI 10.1016/j.mimet.2014.11.013; Seligy VL, 1999, J IND MICROBIOL BIOT, V22, P565, DOI 10.1038/sj.jim.2900625; Shah AH, 2011, TRENDS FOOD SCI TECH, V22, P225, DOI 10.1016/j.tifs.2011.01.010; Shong J, 2012, CURR OPIN BIOTECH, V23, P798, DOI 10.1016/j.copbio.2012.02.001; Tayabali AF, 2000, ENVIRON HEALTH PERSP, V108, P919, DOI 10.2307/3435049; Tayabali AF, 2012, COMP VIRULENCE POTEN, V7; Tayabali AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143604; Tayabali AF, 2011, TOXICOL ENVIRON CHEM, V93, P314, DOI 10.1080/02772248.2010.526784; Tsui TL, 2011, J MICROBIOL IMMUNOL, V44, P67, DOI 10.1016/j.jmii.2011.01.013; Wang Gang, 2008, 2008 7th IEEE International Symposium on Network Computing and Applications (NCA), P93, DOI 10.1109/NCA.2008.27; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb	35	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171911	10.1371/journal.pone.0171911	http://dx.doi.org/10.1371/journal.pone.0171911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178315	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500078
J	Yamamoto, D; Hernandes, RT; Liberatore, AMA; Abe, CM; de Souza, RB; Romao, FT; Sperandio, V; Koh, IH; Gomes, TAT				Yamamoto, Denise; Hernandes, Rodrigo T.; Liberatore, Ana Maria A.; Abe, Cecilia M.; de Souza, Rodrigo B.; Romao, Fabiano T.; Sperandio, Vanessa; Koh, Ivan H.; Gomes, Tania A. T.			Escherichia albertii, a novel human enteropathogen, colonizes rat enterocytes and translocates to extra-intestinal sites	PLOS ONE			English	Article							M-CELLS; COLI STRAINS; BACTERIAL TRANSLOCATION; EPITHELIAL-CELLS; EPEC SEROGROUPS; CACO-2 CELLS; PEYERS PATCH; CARRY EAE; ADHERENCE; INVASION	Diarrhea is the second leading cause of death of children up to five years old in the developing countries. Among the etiological diarrheal agents are atypical enteropathogenic Escherichia coli (aEPEC), one of the diarrheagenic E. coli pathotypes that affects children and adults, even in developed countries. Currently, genotypic and biochemical approaches have helped to demonstrate that some strains classified as aEPEC are actually E. albertii, a recently recognized human enteropathogen. Studies on particular strains are necessary to explore their virulence potential in order to further understand the underlying mechanisms of E. albertii infections. Here we demonstrated for the first time that infection of fragments of rat intestinal mucosa is a useful tool to study the initial steps of E. albertii colonization. We also observed that an E. albertii strain can translocate from the intestinal lumen to Mesenteric Lymph Nodes and liver in a rat model. Based on our finding of bacterial translocation, we investigated how E. albertii might cross the intestinal epithelium by performing infections of M-like cells in vitro to identify the potential in vivo translocation route. Altogether, our approaches allowed us to draft a general E. albertii infection route from the colonization till the bacterial spreading in vivo.	[Yamamoto, Denise; Hernandes, Rodrigo T.; Romao, Fabiano T.; Gomes, Tania A. T.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil; [Hernandes, Rodrigo T.] Univ Estadual Paulista, UNESP, Dept Microbiol & Imunol, Inst Biociencia, Botucatu, SP, Brazil; [Liberatore, Ana Maria A.; de Souza, Rodrigo B.; Koh, Ivan H.] Univ Fed Sao Paulo, Dept Cirurgia, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil; [Abe, Cecilia M.] Inst Butantan, Lab Biol Celular, Sao Paulo, Brazil; [Romao, Fabiano T.; Sperandio, Vanessa] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol & Biochem, Dallas, TX 75390 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yamamoto, D; Gomes, TAT (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med UNIFESP EPM, Sao Paulo, Brazil.	dyamamoto@unifesp.br; tatg.amaral@unifesp.br	Liberatore, Ana M.A./K-9208-2013; Abe, Cecilia/F-1518-2013; Alvim Liberatore, Ana Maria/AAE-5587-2022; de Souza, Rodrigo Barbosa/AAV-8234-2021; Gomes, Tânia Aparecida Tardelli/H-3950-2012; Abe, Cecilia/AAM-6374-2021; Hernandes, Rodrigo T./AAW-5835-2020; Koh, ivan/ABB-2084-2021	Liberatore, Ana M.A./0000-0003-2626-973X; Abe, Cecilia/0000-0003-0218-9372; Alvim Liberatore, Ana Maria/0000-0003-2626-973X; Gomes, Tânia Aparecida Tardelli/0000-0002-4525-8705; Koh, ivan/0000-0001-5076-789X; Barbosa de Souza, Rodrigo/0000-0002-7068-3906; Reis, AlessanRSS/0000-0001-8486-7469	FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP) [2011/12664-5]; COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL SUPERIOR (CAPES) [AUX-PE-PNPD 2350/2011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI053067] Funding Source: NIH RePORTER	FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL SUPERIOR (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (FAPESP 2011/12664-5) to TATG and COORDENACAO DE APERFEICOAMENTO DE PESSOAL DE NIVEL SUPERIOR (CAPES AUX-PE-PNPD 2350/2011) to TATG and DY. The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2003, J CLIN MICROBIOL; Albert MJ, 1992, J MED MICROBIOL; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cieza RJ, 2015, INFECT IMMUN, V83, P1904, DOI 10.1128/IAI.03003-14; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; DONNENBERG MS, 1992, INFECT IMMUN, V60, P3953, DOI 10.1128/IAI.60.10.3953-3961.1992; Dupont A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005616; Elliott SJ, 1997, MICROB PATHOGENESIS, V23, P113, DOI 10.1006/mpat.1997.0135; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; Fitzhenry RJ, 2002, INFECT IMMUN, V70, P4362, DOI 10.1128/IAI.70.8.4362-4368.2002; GANNON VPJ, 1993, J CLIN MICROBIOL, V31, P1268, DOI 10.1128/JCM.31.5.1268-1274.1993; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gill N, 2011, CELL MICROBIOL, V13, P660, DOI 10.1111/j.1462-5822.2011.01578.x; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hernandes RT, 2013, INFECT IMMUN, V81, P3793, DOI 10.1128/IAI.00620-13; Hernandes RT, 2011, APPL ENVIRON MICROB, V77, P8391, DOI 10.1128/AEM.05376-11; Hernandes RT, 2009, FEMS MICROBIOL LETT, V297, P137, DOI 10.1111/j.1574-6968.2009.01664.x; Hernandes RT, 2008, CELL MICROBIOL, V10, P415, DOI 10.1111/j.1462-5822.2007.01054.x; Huys G, 2003, INT J SYST EVOL MICR, V53, P807, DOI 10.1099/ijs.0.02475-0; INMAN LR, 1983, J CLIN INVEST, V71, P1, DOI 10.1172/JCI110737; Jepson MA, 2003, CELLULAR MICROBIOLOG; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; KNUTTON S, 1995, METHOD ENZYMOL, V253, P145; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Koh IHJ, 1996, TRANSPLANT P, V28, P2667; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; La Ragione RM, 2002, APPL ENV MICROBIOL; Law RJ, 2013, IN VITRO IN VIVO MOD, DOI [10.1101/cshperspect.a009977, DOI 10.1101/CSHPERSPECT.A009977]; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Liberatore AMA, 2011, BRAZ J MED BIOL RES, V44, P1018, DOI 10.1590/S0100-879X2011007500105; Luck SN, 2005, INFECT IMMUN, V73, P3063, DOI 10.1128/IAI.73.5.3063-3071.2005; Martinez-Argudo I, 2007, CELL MICROBIOL, V9, P1538, DOI 10.1111/j.1462-5822.2007.00891.x; McCormick BA, 1998, INFECT IMMUN, V66, P4237; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Navarro-Garcia F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/374395; Oaks JL, 2010, EMERG INFECT DIS; Ooka T, 2015, GENOME BIOL EVOL, V7, P3170, DOI 10.1093/gbe/evv211; Ooka T, 2013, EMERG INFECT DIS, V19, P144, DOI 10.3201/eid1901.120646; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Pacheco VCR, 2014, PATHOG DIS, V70, P167, DOI 10.1111/2049-632X.12112; Peralta-Ramirez J, ESPF INTERACTS NUCL, DOI [10.1128/IAI.00072-08, DOI 10.1128/IAI.00072-08]; Pielage JF, 2007, INT J BIOCHEM CELL B, V39, P1886, DOI 10.1016/j.biocel.2007.05.009; Romao FT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0299-y; Rosa ACP, 2001, FEMS MICROBIOL LETT, V200, P117, DOI 10.1016/S0378-1097(01)00212-9; Sampaio Suely C F, 2011, Open Microbiol J, V5, P65, DOI 10.2174/1874285801105010065; Sansonetti Philippe J, 2006, Can J Infect Dis Med Microbiol, V17, P117; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Vieira MAM, 2001, J INFECT DIS, V183, P762, DOI 10.1086/318821; Weflen AW, 2010, CELL MICROBIOL, V12, P919, DOI 10.1111/j.1462-5822.2010.01440.x; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yamamoto D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-146	62	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171385	10.1371/journal.pone.0171385	http://dx.doi.org/10.1371/journal.pone.0171385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178312	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500039
J	Zhang, XD; Gohlich, D				Zhang, Xudong; Goehlich, Dietmar			A hierarchical estimator development for estimation of tire-road friction coefficient	PLOS ONE			English	Article							EXTENDED KALMAN FILTER; NEURAL-NETWORK; VEHICLE; STATE	The effect of vehicle active safety systems is subject to the friction force arising from the contact of tires and the road surface. Therefore, an adequate knowledge of the tire-road friction coefficient is of great importance to achieve a good performance of these control systems. This paper presents a tire-road friction coefficient estimation method for an advanced vehicle configuration, four-motorized-wheel electric vehicles, in which the longitudinal tire force is easily obtained. A hierarchical structure is adopted for the proposed estimation design. An upper estimator is developed based on unscented Kalman filter to estimate vehicle state information, while a hybrid estimation method is applied as the lower estimator to identify the tire-road friction coefficient using general regression neural network (GRNN) and Bayes' theorem. GRNN aims at detecting road friction coefficient under small excitations, which are the most common situations in daily driving. GRNN is able to accurately create a mapping from input parameters to the friction coefficient, avoiding storing an entire complex tire model. As for large excitations, the estimation algorithm is based on Bayes' theorem and a simplified "magic formula" tire model. The integrated estimation method is established by the combination of the above-mentioned estimators. Finally, the simulations based on a high-fidelity CarSim vehicle model are carried out on different road surfaces and driving maneuvers to verify the effectiveness of the proposed estimation method.	[Zhang, Xudong; Goehlich, Dietmar] Tech Univ Berlin, Prod Dev Methods & Mechatron, Berlin, Germany	Technical University of Berlin	Zhang, XD (corresponding author), Tech Univ Berlin, Prod Dev Methods & Mechatron, Berlin, Germany.	xudong.zhang@campus.tu-berlin.de	Zhang, Xudong/AAO-6455-2020	Zhang, Xudong/0000-0002-3943-1428	China Sponsorship Council [201306030007]; Technische Universitat Berlin	China Sponsorship Council; Technische Universitat Berlin	Funded by: China Sponsorship Council Award Number: 201306030007. Grant Recipient: Xudong Zhang. Technische Universitat Berlin Award Number: N/A. Grant Recipient: Dietmar Gohlich. Open Access Publication Funds of Technische Universitat Berlin Award Number: N/A. Grant Recipient: Xudong Zhang.	Ahn C, 2009, AM CONTR C 2009 ACC; Antonov S, 2011, VEHICLE SYST DYN, V49, P1497, DOI 10.1080/00423114.2010.527994; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Chen Y, 2011, IEEE T VEH TECHNOL, V60, P839, DOI 10.1109/TVT.2011.2106811; Cho K, 2012, CONTR APPL CCA 2012; Esmailzadeh E, 2001, VEHICLE SYST DYN, V35, P163, DOI 10.1076/vesd.35.3.163.2047; Gao S, 2015, P INT C MOD SIM APPL; He HW, 2014, ENERGIES, V7, P3748, DOI 10.3390/en7063748; Holzmann Frederic, 2006, COMP AID CONTR SYST; Hsu Y-HJ, 2006, INT S ADV VEH CONTR; Julier S. J., 1997, AEROSENSE 97; Kandepu R, 2008, J PROCESS CONTR, V18, P753, DOI 10.1016/j.jprocont.2007.11.004; Muller S, 2003, J DYN SYST-T ASME, V125, P607, DOI 10.1115/1.1636773; Pacejka HB, 2005, TYRE VEHICLE DYNAMIC, V2nd; Pasterkamp WR, 1997, VEHICLE SYST DYN, V27, P409, DOI 10.1080/00423119708969339; Pingping GHWBL, 2014, CHINESE J MECH ENG, V27, P1; Rajamani R, 2010, IEEE CONTR SYST MAG, V30, P54, DOI 10.1109/MCS.2010.937006; Ray LR, 1997, AUTOMATICA, V33, P1819, DOI 10.1016/S0005-1098(97)00093-9; Ray LR, 1995, AM CONTR C P 1995; Ren HB, 2014, VEHICLE SYST DYN, V52, P1047, DOI 10.1080/00423114.2014.918629; Riehm M, 2012, COLD REG SCI TECHNOL, V83-84, P71, DOI 10.1016/j.coldregions.2012.06.004; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Van Zanten AT, 2000, BOSCH ESP SYSTEMS 5; Wan E., 2000, AD SYST SIGN PROC CO; Wang RR, 2013, CONTROL ENG PRACT, V21, P65, DOI 10.1016/j.conengprac.2012.09.009; Zareian A, 2016, P I MECH ENG K-J MUL, V230, P52, DOI 10.1177/1464419315573353	27	20	21	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171085	10.1371/journal.pone.0171085	http://dx.doi.org/10.1371/journal.pone.0171085			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178332	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500023
J	Bai, SF; Chen, HH; Zhu, LY; Liu, W; Yu, HWD; Wang, X; Yin, YS				Bai, Shaofeng; Chen, Huahai; Zhu, Liying; Liu, Wei; Yu, Hongwei D.; Wang, Xin; Yin, Yeshi			Comparative study on the in vitro effects of Pseudomonas aeruginosa and seaweed alginates on human gut microbiota	PLOS ONE			English	Article							MUCOID CONVERSION; FATTY-ACIDS; SENSITIVITY; PROTEOLYSIS; DISEASE	Alginates pertain to organic polysaccharides that have been extensively used in food- and medicine-related industries. The present study obtained alginates from an alginate overproducing Pseudomonas aeruginosa PAO1 mutant by screening transposon mutagenesis libraries. The interaction between bacterial and seaweed alginates and gut microbiota were further studied by using an in vitro batch fermentation system. Thin-layer chromatography (TLC) analysis indicated that both bacterial and seaweed alginates can be completely degraded by fecal bacteria isolated from study volunteers, indicating that a minor structural difference between bacterial and seaweed alginates (O-acetylation and lack of G-G blocks) didn't affect the digestion of alginates by human microbiota. Although, the digestion of bacterial and seaweed alginates was attributed to different Bacteroides xylanisolvens strains, they harbored similar alginate lyase genes. Genus Bacteroides with alginate-degrading capability were enriched in growth medium containing bacterial or seaweed alginates after in vitro fermentation. Short-chain fatty acid (SCFA) production in both bacterial and seaweed alginates was also comparable, but was significantly higher than the same medium using starch. In summary, the present study has isolated an alginate-overproducing P. aeruginosa mutant strain. Both seaweed and bacterial alginates were degraded by human gut microbiota, and their regulatory function on gut microbiota was similar.	[Bai, Shaofeng; Chen, Huahai; Zhu, Liying; Liu, Wei; Wang, Xin; Yin, Yeshi] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Bai, Shaofeng; Chen, Huahai; Zhu, Liying; Liu, Wei; Wang, Xin; Yin, Yeshi] Zhejiang Acad Agr Sci, Key Lab Food Microbial Technol Zhejiang Prov, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Bai, Shaofeng] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Yu, Hongwei D.] Marshall Univ, Dept Biomed Sci, Joan C Edwards Sch Med, Pediat, Huntington, WV USA; [Yu, Hongwei D.] Progenesis Technol LLC, Robert C Byrd Biotechnol Sci Ctr, One John Marshall Dr, Huntington, WV USA	Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University; Marshall University	Yin, YS (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.; Yin, YS (corresponding author), Zhejiang Acad Agr Sci, Key Lab Food Microbial Technol Zhejiang Prov, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China.	yinyeshi@126.com	Liu, Wei/V-2273-2017	Yu, Hongwei/0000-0002-8546-0158	National High Technology Research and Development Program of China (863 Program) [2015AA020701]; State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control [2010DS700124-ZZ1604]; National Institutes of Health (NIH) [UL1TR000117, NIH P20GM103434, 1R43GM113545-01A1]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National High Technology Research and Development Program of China (863 Program, NO. 2015AA020701) and the State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (No. 2010DS700124-ZZ1604) supported this study. Hongwei Yu was supported by National Institutes of Health (NIH) through Grants UL1TR000117, NIH P20GM103434 and 1R43GM113545-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The National High Technology Research and Development Program of China (863 Program, NO. 2015AA020701) and the State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control (No. 2010DS700124-ZZ1604) supported this study. HDY was supported by National Institutes of Health (NIH) through Grants UL1TR000117, NIH P20GM103434 and 1R43GM113545-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HDY is also a co-founder and Chief Science Officer of Progenesis Technologies, LLC. We would like to thank Haichun Gao of Zhejiang University for providing the marine transposon plasmid pFAC. We are also grateful to all the volunteers who participated in this project. The authors thank Let-Pub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.	Buchinger E, 2014, J BIOL CHEM, V289, P31382, DOI 10.1074/jbc.M114.567008; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Chen XL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01120; Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021; Damron FH, 2012, MOL MICROBIOL, V84, P595, DOI 10.1111/j.1365-2958.2012.08049.x; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Ertesvag H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00523; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; Han WJ, 2016, APPL ENVIRON MICROB, V82, P364, DOI 10.1128/AEM.03022-15; Hay ID, 2013, MICROB BIOTECHNOL, V6, P637, DOI 10.1111/1751-7915.12076; Jana S, 2016, CURR PHARM DESIGN, V22, P3399, DOI 10.2174/1381612822666160510125718; JENSEN A, 1993, HYDROBIOLOGIA, V261, P15; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; Lopes M, 2017, EXPERT OPIN DRUG DEL, V14, P769, DOI 10.1080/17425247.2016.1214564; Maleki S, 2016, N BIOTECHNOL S, VS1871-6784, P32392; Marinho-Soriano E, 2006, BIORESOURCE TECHNOL, V97, P2402, DOI 10.1016/j.biortech.2005.10.014; Mitsuoka TT, 2009, MICROBIAL ECOLOGY HL, V8, P259; Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Qiu DR, 2008, MICROBIOL-SGM, V154, P2119, DOI 10.1099/mic.0.2008/017368-0; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; Rehm BHA, 2008, ALGINATES BIOL APPL; Rycroft CE, 2001, LETT APPL MICROBIOL, V32, P156, DOI 10.1046/j.1472-765x.2001.00875.x; Tanaka R, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01312-16; Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5; Verspreet J, 2016, ANNU REV FOOD SCI T, V7, P167, DOI 10.1146/annurev-food-081315-032749; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191; Yang LN, 2014, ASIAN AUSTRAL J ANIM, V27, P898, DOI 10.5713/ajas.2013.13621; Yin YS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-232; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; YU H, 1995, J BACTERIOL, V177, P3259, DOI 10.1128/jb.177.11.3259-3268.1995; Zhang CH, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0304-1	34	25	27	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171576	10.1371/journal.pone.0171576	http://dx.doi.org/10.1371/journal.pone.0171576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170428	gold, Green Published, Green Submitted			2022-12-27	WOS:000393705500043
J	Berger, J				Berger, Joel			Are Luxury Brand Labels and "Green" Labels Costly Signals of Social Status? An Extended Replication	PLOS ONE			English	Article							COMPETITIVE ALTRUISM; PARTNER CHOICE; BENEFITS; TRUSTWORTHINESS; COOPERATION; RECIPROCITY; REPUTATION; SELECTION; GAME	Costly signaling theory provides an explanation for why humans are willing to a pay a premium for conspicuous products such as luxury brand-labeled clothing or conspicuous environmentally friendly cars. According to the theory, the extra cost of such products is a signal of social status and wealth and leads to advantages in social interactions for the signaler. A previous study found positive evidence for the case of luxury brand labels. However, an issue of this study was that some of the experiments were not conducted in a perfectly double-blind manner. I resolved this by replicating variations of the original design in a double-blind procedure. Additionally, besides the luxury label condition, I introduced a "green" label condition. Thus, the hypothesis that signaling theory is able to explain pro-environmental behavior was tested for the first time in a natural field setting. Further, I conducted experiments in both average and below-average socioeconomic neighborhoods, where, according to signaling theory, the effects of luxury signals should be even stronger. In contrast to the original study, I did not find positive effects of the luxury brand label in any of the five experiments. Nor did I find evidence for a green-signaling effect. Moreover, in poor neighborhoods a negative tendency of the luxury label actually became evident. This suggests that a signaling theory explanation of costly labels must take into account the characteristics of the observers, e.g. their social status.	[Berger, Joel] Univ Utrecht, Dept Sociol, Utrecht, Netherlands; [Berger, Joel] Univ Zurich, Inst Sociol, Zurich, Switzerland	Utrecht University; University of Zurich	Berger, J (corresponding author), Univ Utrecht, Dept Sociol, Utrecht, Netherlands.; Berger, J (corresponding author), Univ Zurich, Inst Sociol, Zurich, Switzerland.	berger@soziologie.uzh.ch	Berger, Joël/AAB-6309-2020	Berger, Joël/0000-0001-8148-1093	Swiss National Science Foundation grant (Investigating Signaling Theory Explanations of Pro Environmental Behavior by Means of Laboratory and Field Experiments) [P0EZP1_148998]	Swiss National Science Foundation grant (Investigating Signaling Theory Explanations of Pro Environmental Behavior by Means of Laboratory and Field Experiments)(Swiss National Science Foundation (SNSF))	This project was funded by a Swiss National Science Foundation grant (Investigating Signaling Theory Explanations of Pro Environmental Behavior by Means of Laboratory and Field Experiments [P0EZP1_148998]).	Anderson C, 2009, CURR DIR PSYCHOL SCI, V18, P295, DOI 10.1111/j.1467-8721.2009.01655.x; Barclay P, 2004, EVOL HUM BEHAV, V25, P209, DOI 10.1016/j.evolhumbehav.2004.04.002; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; Bereczkei T, 2010, EVOL HUM BEHAV, V31, P95, DOI 10.1016/j.evolhumbehav.2009.07.004; Bird RB, 2005, CURR ANTHROPOL, V46, P221, DOI 10.1086/427115; Boone JL, 1998, HUM NATURE-INT BIOS, V9, P1, DOI 10.1007/s12110-998-1009-y; Bourdieu P., 1984, DISTINCTION SOCIAL C; Bouska M, 1968, B PSYCHONOMIC SOC, V11, P235; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Chiang YS, 2010, EVOL HUM BEHAV, V31, P265, DOI 10.1016/j.evolhumbehav.2010.03.003; Delgado MS, 2015, ECOL ECON, V111, P1, DOI 10.1016/j.ecolecon.2014.12.021; DOOB AN, 1968, J SOC PSYCHOL, V76, P213, DOI 10.1080/00224545.1968.9933615; Ellingsen T, 2011, J PUBLIC ECON, V95, P1131, DOI 10.1016/j.jpubeco.2011.05.002; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehrler S, 2013, EVOL HUM BEHAV, V34, P139, DOI 10.1016/j.evolhumbehav.2012.11.005; Furlong K, 2011, THESIS; Gambetta D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097533; Gambetta Diego, 2017, OXFORD HDB ANAL SOCI, P170, DOI [10.1093/oxfordhb/9780199215362.013.8, DOI 10.1093/OXFORDHB/9780199215362.013.8]; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Glazer A, 1996, AM ECON REV, V86, P1019; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Griskevicius V, 2012, J PUBLIC POLICY MARK, V31, P115, DOI 10.1509/jppm.11.040; Griskevicius V, 2010, J PERS SOC PSYCHOL, V98, P392, DOI 10.1037/a0017346; Harbaugh WT, 1998, AM ECON REV, V88, P277; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; HAWKES K, 1993, CURR ANTHROPOL, V34, P341, DOI 10.1086/204182; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Klapwijk A, 2009, J PERS SOC PSYCHOL, V96, P83, DOI 10.1037/a0012823; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Massen JJM, 2014, EVOL HUM BEHAV, V35, P1, DOI 10.1016/j.evolhumbehav.2013.08.008; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Miller G, 2009, SPENT SEX EVOLUTION; Nelissen RMA, 2011, EVOL HUM BEHAV, V32, P343, DOI 10.1016/j.evolhumbehav.2010.12.002; Nettle D, 2013, EVOL HUM BEHAV, V34, P35, DOI 10.1016/j.evolhumbehav.2012.08.004; Raihani NJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160510; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Saad G., 2001, Journal of Bioeconomics, V3, P171, DOI 10.1023/A:1020583425623; Saad G., 2007, EVOLUTIONARY BASES C; Sexton SE, 2014, J ENVIRON ECON MANAG, V67, P303, DOI 10.1016/j.jeem.2013.11.004; Sieg H, 2012, INT ECON REV, V53, P349, DOI 10.1111/j.1468-2354.2012.00684.x; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; Thaler R.H., 2021, NUDGE FINAL EDITION; Van Vugt M, 2010, GROUP PROCESS INTERG, V13, P101, DOI 10.1177/1368430209342258; Veblen T., 1965, THEORY LEISURE CLASS; Whitfield J, 2011, NAT CLIM CHANGE, V1, P323; Willer R, 2009, AM SOCIOL REV, V74, P23, DOI 10.1177/000312240907400102; Wright J, 1997, ANIM BEHAV, V54, P1439, DOI 10.1006/anbe.1997.0563; Wright J, 2001, P ROY SOC B-BIOL SCI, V268, P821, DOI 10.1098/rspb.2000.1574; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A., 1990, P103, DOI 10.1017/CBO9780511752452.005; Zahavi A, 1989, LIFETIME REPROD BIRD, P254	58	28	29	9	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170216	10.1371/journal.pone.0170216	http://dx.doi.org/10.1371/journal.pone.0170216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170399	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500003
J	Shang, XP; Fu, XF; Zhang, P; Sheng, MY; Song, JQ; He, F; Qiu, YW; Wu, HC; Lu, QB; Feng, Y; Lin, JF; Chen, EF; Chai, CL				Shang, Xiaopeng; Fu, Xiaofei; Zhang, Peng; Sheng, Minyang; Song, Jianqiang; He, Fan; Qiu, Yinwei; Wu, Haocheng; Lu, Qinbao; Feng, Yan; Lin, Junfen; Chen, Enfu; Chai, Chengliang			An outbreak of norovirus-associated acute gastroenteritis associated with contaminated barrelled water in many schools in Zhejiang, China	PLOS ONE			English	Article							UNITED-STATES; BOARDING SCHOOL; SOUTH CHINA; SURVEILLANCE; AUSTRIA	Objectives More than 900 students and teachers at many schools in Jiaxing city developed acute gastroenteritis in February 2014. An immediate epidemiological investigation was conducted to identify the pathogen, infection sources and route of transmission. Methods The probable cases and confirmed cases were defined as students or teachers with diarrhoea or vomiting present since the term began in February 2014. An active search was conducted for undiagnosed cases among students and teachers. Details such as demographic characteristics, gastrointestinal symptoms, and drinking water preference and frequency were collected via a uniform epidemiological questionnaire. A case-control study was implemented, and odds ratios (ORs) and 95% confidence intervals were calculated. Rectal swabs from several patients, food handlers and barrelled water factory workers, as well as water and food samples, were collected to test for potential bacteria and viruses. Results A total of 924 cases fit the definition of the probable case, including 8 cases of laboratory-confirmed norovirus infection at 13 schools in Jiaxing city between February 12 and February 21, 2014. The case-control study demonstrated that barrelled water was a risk factor (OR: 20.15, 95% CI: 2.59-156.76) and that bottled water and boiled barrelled water were protective factors (OR: 0.31, 95% CI: 0.13-0.70, and OR: 0.36, 95% CI: 0.16-0.77). A total of 11 rectal samples and 8 barrelled water samples were detected as norovirus-positive, and the genotypes of viral strains were the same (GII). The norovirus that contaminated the barrelled water largely came from the asymptomatic workers. Conclusions This acute gastroenteritis outbreak was caused by barrelled water contaminated by norovirus. The outbreak was controlled after stopping the supply of barrelled water. The barrelled water supply in China represents a potential source of acute gastroenteritis outbreaks due to the lack of surveillance and supervision. Therefore, more attention should be paid to this area.	[Shang, Xiaopeng; He, Fan; Qiu, Yinwei; Wu, Haocheng; Lu, Qinbao; Feng, Yan; Lin, Junfen; Chen, Enfu; Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, Hangzhou, Zhejiang, Peoples R China; [Fu, Xiaofei] Ctr Dis Jiaxing City, Dept Communicable Dis Control & Prevent, Jiaxing, Zhejiang, Peoples R China; [Zhang, Peng] Ctr Dis Control & Prevent Huzhou City, Dept Ctr Off, Huzhou, Zhejiang, Peoples R China; [Sheng, Minyang] Ctr Dis Control & Prevent Haining Cty, Dept Ctr Off, Jiaxing, Zhejiang, Peoples R China; [Song, Jianqiang] Ctr Dis Control & Prevent Haiyan Cty, Dept Ctr Off, Jiaxing, Zhejiang, Peoples R China; [Feng, Yan; Chen, Enfu] Zhejiang Prov Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Dept TB Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention	Chen, EF; Chai, CL (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Publ Hlth Surveillance & Advisory, Hangzhou, Zhejiang, Peoples R China.; Chen, EF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Chai, CL (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept TB Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	enfchen@cdc.zj.cn; chaicl0428@163.com		SHANG, XIAOPENG/0000-0002-6500-8762	Medical Research Program of Zhejiang province [2017KY283, 2015ZHA003, 2015RCB008]	Medical Research Program of Zhejiang province	This research was supported by the Medical Research Program of Zhejiang province (2017KY283, 2015ZHA003, 2015RCB008). As the first author of this manuscript, Xiaopeng Shang received the program (2017KY283). Haocheng Wu and Qinbao Lu received the programs (2015ZHA003, 2015RCB008), and they contributed analysis tools and analyzed the data of the manuscript.	Amy Zlot, 2015, AM J TRANSPLANT, V15, P2001, DOI [10.1111/ajt.13404, DOI 10.1111/AJT.13404]; Di Bartolo I, 2015, NEW MICROBIOL, V38, P109; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Gao Shi-Gen, 2011, HIN J SCH HLTH, V32, P1530; He YQ, 2010, FOOD ENVIRON VIROL, V2, P207, DOI 10.1007/s12560-010-9047-0; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Hua Ding, 2010, DIS SURVEILLANCE, V25, P279; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; Kuo HW, 2009, WIEN KLIN WOCHENSCHR, V121, P120, DOI 10.1007/s00508-008-1131-1; Lee RM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-446; Li Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-283; Lin YC, 2015, INT J INFECT DIS, V37, P25, DOI 10.1016/j.ijid.2015.05.021; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Mei Lin, 2007, J APPL PREVENTIVE ME, V13, P11; Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439; Robilotti E, 2015, CLIN MICROBIOL REV, V28, P134, DOI 10.1128/CMR.00075-14; Seitz SR, 2011, APPL ENVIRON MICROB, V77, P6884, DOI 10.1128/AEM.05806-11; Song Jian-Qiang, 2015, ZHEJIANG J PREVENTIV, P1045; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426; Xue CY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1092; Zhang Rui, 2013, Comput Math Methods Med, V2013, P834192, DOI 10.1155/2013/834192	22	13	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171307	10.1371/journal.pone.0171307	http://dx.doi.org/10.1371/journal.pone.0171307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170414	gold, Green Published			2022-12-27	WOS:000393705500032
J	Chen, Y; Luo, Y; Curry, P; Timme, R; Melka, D; Doyle, M; Parish, M; Hammack, TS; Allard, MW; Brown, EW; Strain, EA				Chen, Yi; Luo, Yan; Curry, Phillip; Timme, Ruth; Melka, David; Doyle, Matthew; Parish, Mickey; Hammack, Thomas S.; Allard, Marc W.; Brown, Eric W.; Strain, Errol A.			Assessing the genome level diversity of Listeria monocytogenes from contaminated ice cream and environmental samples linked to a listeriosis outbreak in the United States	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MOBILE GENETIC ELEMENTS; PROCESSING PLANTS; SEQUENCE DATA; STRAINS; PHYLOGENIES; VIRULENCE; CLONES; PHAST; FOOD	A listeriosis outbreak in the United States implicated contaminated ice cream produced by one company, which operated 3 facilities. We performed single nucleotide polymorphism (SNP)-based whole genome sequencing (WGS) analysis on Listeria monocytogenes from food, environmental and clinical sources, identifying two clusters and a single branch, belonging to PCR serogroup IIb and genetic lineage I. WGS Cluster I, representing one outbreak strain, contained 82 food and environmental isolates from Facility I and 4 clinical isolates. These isolates differed by up to 29 SNPs, exhibited 9 pulsed-field gel electrophoresis (PFGE) profiles and multilocus sequence typing (MLST) sequence type (ST) 5 of clonal complex 5 (CC5). WGS Cluster II contained 51 food and environmental isolates from Facility II, 4 food isolates from Facility I and 5 clinical isolates. Among them the isolates from Facility II and clinical isolates formed a clade and represented another outbreak strain. Isolates in this clade differed by up to 29 SNPs, exhibited 3 PFGE profiles and ST5. The only isolate collected from Facility III belonged to singleton ST489, which was in a single branch separate from Clusters I and II, and was not associated with the outbreak. WGS analyses clustered together outbreak-associated isolates exhibiting multiple PFGE profiles, while differentiating them from epidemiologically unrelated isolates that exhibited outbreak PFGE profiles. The complete genome of a Cluster I isolate allowed the identification and analyses of putative prophages, revealing that Cluster I isolates differed by the gain or loss of three putative prophages, causing the banding pattern differences among all 3 AscI-PFGE profiles observed in Cluster I isolates. WGS data suggested that certain ice cream varieties and/or production lines might have contamination sources unique to them. The SNP-based analysis was able to distinguish CC5 as a group from non-CC5 isolates and differentiate among CC5 isolates from different outbreaks/incidents.	[Chen, Yi; Luo, Yan; Curry, Phillip; Timme, Ruth; Melka, David; Doyle, Matthew; Parish, Mickey; Hammack, Thomas S.; Allard, Marc W.; Brown, Eric W.; Strain, Errol A.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Chen, Y (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	yi.chen@fda.hhs.gov		Doyle, Matthew/0000-0002-6779-5704; Timme, Ruth/0000-0002-9705-5897				Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Allard MW, 2016, J CLIN MICROBIOL; [Anonymous], 2006, THESIS U TEXAS AUSTI; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P961, DOI 10.1128/AEM.71.2.961-967.2005; CDC (Centers for Disease Control and Prevention), 2014, MULT OUTBR LIST LINK; Centers for Disease Control and Prevention, 2015, MULT OUTBR LIST LINK, DOI [10.3201/eid1901.121167, DOI 10.3201/EID1901.121167]; Centers for Disease Control and Prevention, 2015, MULT OUTBR LIST LINK; Chen Y, 2016, INT J FOOD MICROBIOL, V241, P15, DOI [10.1016/j.ijfoodmicro, DOI 10.1016/J.IJFOODMICRO]; Chen Y, 2016, APPL ENVIRON MICROB, DOI [10.3201/eid2012.140993, DOI 10.3201/EID2012.140993]; Chen Y, 2008, J CLIN MICROBIOL, V46, P1478, DOI 10.1128/JCM.01873-07; Chen Y, 2016, J FOOD PROTECT, V79, P1828, DOI 10.4315/0362-028X.JFP-16-208; Chen Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00764; Chen YY, 2016, APPL ENVIRON MICROB, V82, P2156, DOI 10.1128/AEM.03718-15; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; den Bakker HC, 2012, APPL ENVIRON MICROB, V78, P1876, DOI 10.1128/AEM.06969-11; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Goff H.D., 2013, ICE CREAM, V7th, DOI DOI 10.1007/978-1-4614-6096-1; Gorski L, 2006, APPL ENVIRON MICROB, V72, P776, DOI 10.1128/AEM.72.1.776-783.2006; Hitchins A. D., 2016, DETECTION AND ENUMER; Holch A, 2013, APPL ENVIRON MICROB, V79, P2944, DOI 10.1128/AEM.03715-12; Jackson B. R., 2016, CLIN INFECT DIS; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P282; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kvistholm Jensen A, 2016, CLIN INFECT DIS, DOI [10.1128/AEM.03715-12, DOI 10.1128/AEM.03715-12]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lomonaco S, 2013, EMERG INFECT DIS, V19, P147, DOI 10.3201/eid1901.121167; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Moura A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.185; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Perez-Trallero E, 2014, EMERG INFECT DIS, V20, P2155, DOI 10.3201/eid2012.140993; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.620; Pightling Arthur W, 2015, BMC Res Notes, V8, P748, DOI 10.1186/s13104-015-1689-4; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; Schmitz-Esser S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00380; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Wang QN, 2015, J CLIN MICROBIOL, V53, P3492, DOI 10.1128/JCM.00202-15; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zilelidou E, 2016, APPL ENV MICROBIOL	46	45	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171389	10.1371/journal.pone.0171389	http://dx.doi.org/10.1371/journal.pone.0171389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166293	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100037
J	Nagoshi, RN; Fleischer, S; Meagher, RL; Hay-Roe, M; Khan, A; Murua, MG; Silvie, P; Vergara, C; Westbrook, J				Nagoshi, Rodney N.; Fleischer, Shelby; Meagher, Robert L.; Hay-Roe, Mirian; Khan, Ayub; Murua, M. Gabriela; Silvie, Pierre; Vergara, Clorinda; Westbrook, John			Fall armyworm migration across the Lesser Antilles and the potential for genetic exchanges between North and South American populations	PLOS ONE			English	Article							FRUGIPERDA LEPIDOPTERA-NOCTUIDAE; CORN-STRAIN POPULATIONS; HOST STRAINS; PUERTO-RICO; UNITED-STATES; BT MAIZE; TEXAS; RESISTANCE; FLORIDA; PATTERNS	The fall armyworm, Spodoptera frugiperda (J.E. Smith)(Lepidoptera: Noctuidae), is an important agricultural pest of the Western Hemisphere noted for its broad host range, long distance flight capabilities, and a propensity to develop resistance to pesticides that includes a subset of those used in genetically modified corn varieties. These characteristics exacerbate the threat fall armyworm poses to agriculture, with the potential that a resistance trait arising in one geographical location could rapidly disseminate throughout the hemisphere. A region of particular concern is the Caribbean, where a line of islands that extends from Florida to Venezuela provides a potential migratory pathway between populations from North and South America that could allow for consistent and substantial genetic interactions. In this study, surveys of populations from Peru, Bolivia, Paraguay, and Trinidad & Tobago expand on previous work in South America that indicates a generally homogeneous population with respect to haplotype markers. This population differs from that found in most of the Lesser Antilles where a combination of genetic and meteorological observations is described that indicate fall armyworm migration from Puerto Rico to as far south as Barbados, but does not support significant incursion into Trinidad & Tobago and South America. Air transport projections demonstrate that the wind patterns in the Caribbean region are not conducive to consistent flight along the north-south orientation of the Lesser Antilles, supporting the conclusion that such migration is minor and sporadic, providing few opportunities for genetic exchanges. The implications of these findings on the dissemination of deleterious traits between the two Western Hemisphere continents are discussed.	[Nagoshi, Rodney N.; Meagher, Robert L.; Hay-Roe, Mirian] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Fleischer, Shelby] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Khan, Ayub] Univ West Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Murua, M. Gabriela] Consejo Nacl Invest Cient & Tecn, Inst Tecnol Agroind Noroeste Argentino ITANOA, EEAOC, San Miguel De Tucuman, Argentina; [Silvie, Pierre] CIRAD, UPR Agroecol & Intensificat Durable Cultures Annu, F-34398 Montpellier, France; [Silvie, Pierre] IRD, UR 072, Lab Evolut Genomes & Speciat, Orsay, France; [Vergara, Clorinda] Univ Agraria La Molina, Museo Entomol Klaus Raven Buller, Lima, Peru; [Westbrook, John] USDA ARS, Insect Control & Cotton Dis Res Unit, College Stn, TX USA	United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University West Indies Mona Jamaica; University West Indies Saint Augustine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CIRAD; Institut de Recherche pour le Developpement (IRD); University Nacional Agraria La Molina; United States Department of Agriculture (USDA)	Nagoshi, RN (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	rodney.nagoshi@ars.usda.gov	Fleischer, Shelby/AAD-6663-2020; Fleischer, Shelby/AAN-1392-2020; Khan, Ayub/AAC-3210-2019	VERGARA COBIAN, CLORINDA/0000-0002-9321-9532	National Institute of Food and Agriculture, U.S. Department of Agriculture [2011-6700330209]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	Support was provided by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under Agreement No. 2011-6700330209.	Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Balbi EI, 2015, EVALUACION CAUSADO C; BEERWINKLE KR, 1995, SOUTHWEST ENTOMOL, P63; Belay DK, 2012, FLA ENTOMOL, V95, P476, DOI 10.1653/024.095.0232; Campetella CM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015451; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Draxler RR, 2013, HYBRID SINGLE PARTIC; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; FRANK JH, 1995, FLA ENTOMOL, V78, P1, DOI 10.2307/3495661; FRANK JH, 1992, FLA ENTOMOL, V75, P1, DOI 10.2307/3495477; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; Meagher RL, 2004, ECOL ENTOMOL, V29, P614, DOI 10.1111/j.0307-6946.2004.00629.x; Meagher RL, 2013, FLA ENTOMOL, V96, P729, DOI 10.1653/024.096.0305; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P1569, DOI 10.1603/0022-0493(2007)100[1569:USIATE]2.0.CO;2; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P954, DOI 10.1603/0022-0493(2007)100[954:COHFDF]2.0.CO;2; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2008, J ECON ENTOMOL, V101, P742, DOI 10.1603/0022-0493(2008)101[742:UHTMTM]2.0.CO;2; Nagoshi RN, 2015, J ECON ENTOMOL, V108, P135, DOI 10.1093/jee/tou044; Nagoshi RN, 2014, J ECON ENTOMOL, V107, P1462, DOI 10.1603/EC14124; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2012, J ECON ENTOMOL, V105, P418, DOI 10.1603/EC11332; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Niu Y, 2013, FLA ENTOMOL, V96, P701, DOI 10.1653/024.096.0302; PAIR SD, 1995, SOUTHWEST ENTOMOL, P101; Pair SD, 1986, USDA MISC PUBL, P25; Pashley D.P., 1989, Systematics Association Special Volume Series, P103; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Reisig DD, 2015, J ECON ENTOMOL, V108, P157, DOI 10.1093/jee/tou009; Reynolds DR, 2005, B ENTOMOL RES, V95, P259, DOI 10.1079/BER2004358; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Trumper E.V, 2014, Agriscientia, V31, P109; Wang CZ, 2007, CLIM DYNAM, V29, P411, DOI 10.1007/s00382-007-0243-z; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x; WESTBROOK JK, 1995, AGR FOREST METEOROL, V73, P67, DOI 10.1016/0168-1923(94)02171-F; Westbrook JK, 2008, INTEGR COMP BIOL, V48, P99, DOI 10.1093/icb/icn040; Whyte FS, 2008, INT J CLIMATOL, V28, P119, DOI 10.1002/joc.1510; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7	51	69	75	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171743	10.1371/journal.pone.0171743	http://dx.doi.org/10.1371/journal.pone.0171743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166292	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100069
J	Lovelace, ES; Maurice, NJ; Miller, HW; Slichter, CK; Harrington, R; Magaret, A; Prlic, M; De Rosa, S; Polyak, SJ				Lovelace, Erica S.; Maurice, Nicholas J.; Miller, Hannah W.; Slichter, Chloe K.; Harrington, Robert; Magaret, Amalia; Prlic, Martin; De Rosa, Stephen; Polyak, Stephen J.			Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; T-CELLS; MICROBIAL TRANSLOCATION; DISEASE PROGRESSION; INFECTED PATIENTS; IN-VITRO; HIV; SILIBININ; RESPONSES; CD4(+)	Silymarin (SM), and its flavonolignan components, alter cellular metabolism and inhibit inflammatory status in human liver and T cell lines. In this study, we hypothesized that SM suppresses both acute and chronic immune activation (CIA), including in the context of HIV infection. SM treatment suppressed the expression of T cell activation and exhaustion markers on CD4+ and CD8+ T cells from chronically-infected, HIV-positive subjects. SM also showed a trend towards modifying CD4+ T cell memory subsets from HIV+ subjects. In the HIV-negative setting, SM treatment showed trends towards suppressing pro-inflammatory cytokines from non-activated and pathogen-associated molecular pattern (PAMP)-activated primary human monocytes, and non-activated and cytokine-and T cell receptor (TCR)-activated mucosal-associated invariant T (MAIT) cells. The data suggest that SM elicits broad anti-inflammatory and immunoregulatory activity in primary human immune cells. By using novel compounds to alter cellular inflammatory status, it may be possible to regulate inflammation in both non-disease and disease states.	[Lovelace, Erica S.; Magaret, Amalia; Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Maurice, Nicholas J.; Miller, Hannah W.; Slichter, Chloe K.; Magaret, Amalia; Prlic, Martin; De Rosa, Stephen] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Slichter, Chloe K.; Prlic, Martin; Polyak, Stephen J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Harrington, Robert] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Magaret, Amalia] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Polyak, Stephen J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Polyak, SJ (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.; Polyak, SJ (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Polyak, SJ (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	polyak@uw.edu		Maurice, Nicholas/0000-0002-2667-472X	National Center for Complementary and Integrative Health (NCCIH) [5R01AT006842]; National Institute of Allergy and Infectious Diseases (NIAID) [T32 AI007509]; University of Washington Center for AIDS Research under National Institutes of Health (NIH) [P30AI027757]	National Center for Complementary and Integrative Health (NCCIH); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research under National Institutes of Health (NIH)	This work was supported by grant 5R01AT006842 to SJP from National Center for Complementary and Integrative Health (NCCIH) https://nccih.nih.gov/; Grant T32 AI007509 to CKS from the National Institute of Allergy and Infectious Diseases (NIAID) https://www.niaid.nih.gov/; Pilot funding to SJP from the University of Washington Center for AIDS Research under National Institutes of Health (NIH) award number P30AI027757 (from NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK) https://www.niaid.nih.gov/ research/centers aids research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beinhardt S, 2012, J HEPATOL, V56, pS77, DOI 10.1016/S0168-8278(12)60191-3; Beinhardt S, 2011, J HEPATOL, V54, P591, DOI 10.1016/j.jhep.2010.09.009; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; De Wit S, 2011, AIDS, V25, P1332, DOI 10.1097/QAD.0b013e328347c083; Ferenci P, 2008, GASTROENTEROLOGY, V135, P1561, DOI 10.1053/j.gastro.2008.07.072; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Graf TN, 2007, PLANTA MED, V73, P1495, DOI 10.1055/s-2007-990239; Graf TN, 2016, J PHARMACEUT BIOMED, V126, P26, DOI 10.1016/j.jpba.2016.04.028; Hearps AC, 2014, CURR HIV-AIDS REP, V11, P20, DOI 10.1007/s11904-013-0190-8; HO HN, 1993, J IMMUNOL, V150, P3070; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ipp H, 2014, CRIT REV CL LAB SCI, V51, P98, DOI 10.3109/10408363.2013.865702; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kamat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030881; KANELLOPOULOS JM, 1983, EMBO J, V2, P1807, DOI 10.1002/j.1460-2075.1983.tb01662.x; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Larbi A, 2014, STEM CELLS DEV, V23, P2983, DOI 10.1089/scd.2014.0171; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; LEVACHER M, 1992, CLIN EXP IMMUNOL, V90, P376; Lovelace ES, 2015, J NAT PROD; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; McClure J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041832; McComsey GA, 2001, AIDS, V15, P321, DOI 10.1097/00002030-200102160-00004; McKinney EF, 2016, IMMUNOL CELL BIOL, V94, P935, DOI 10.1038/icb.2016.81; Moncunill G, 2015, CYTOM PART A, V87A, P289, DOI 10.1002/cyto.a.22590; Morishima C, 2010, GASTROENTEROLOGY, V138, P671, DOI 10.1053/j.gastro.2009.09.021; Murray SM, 2010, J VIROL, V84, P12082, DOI 10.1128/JVI.01466-10; Napier RJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00344; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuman UP, 2010, J HEPATOL, V52, P951, DOI 10.1016/j.jhep.2010.02.002; Nordell AD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000844; O'Brien M, 2013, JOURNAL OF ACQUIRED; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Polyak SJ, 2013, ANTIVIR THER, V18, P141, DOI 10.3851/IMP2402; Polyak SJ, 2013, HEPATOLOGY, V57, P1262, DOI 10.1002/hep.26179; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seeff LB, 2008, HEPATOLOGY, V47, P605, DOI 10.1002/hep.22044; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Slichter CK, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86292; Stuart JWTC, 2000, J ACQ IMMUN DEF SYND, V25, P203, DOI 10.1097/00126334-200011010-00001; Taiwo B, 2013, CURR HIV-AIDS REP, V10, P21, DOI 10.1007/s11904-012-0147-3; THOMAS Y, 1984, J MOL CELL IMMUNOL, V1, P103; Utay NS, 2016, CURR OPIN HIV AIDS, V11, P131, DOI 10.1097/COH.0000000000000242; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wagoner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016464; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171139	10.1371/journal.pone.0171139	http://dx.doi.org/10.1371/journal.pone.0171139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158203	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700033
J	Someya, S; Kujoth, GC; Kim, MJ; Hacker, TA; Vermulst, M; Weindruch, R; Prolla, TA				Someya, Shinichi; Kujoth, Gregory C.; Kim, Mi-Jung; Hacker, Timothy A.; Vermulst, Marc; Weindruch, Richard; Prolla, Tomas A.			Effects of calorie restriction on the lifespan and healthspan of POLG mitochondrial mutator mice	PLOS ONE			English	Article							OXIDATIVE DAMAGE; DNA POLYMERASE; AGED RAT; MUTATIONS; OVEREXPRESSION; MUSCLE; REPLICATION; PHENOTYPES; STRESS; BRAIN	Mitochondrial DNA (mtDNA) mutations are thought to have a causative role in age-related pathologies. We have shown previously that mitochondrial mutator mice (Polg(D257A/D257A)), harboring a proofreading-deficient version of the mtDNA polymerase gamma (POLG), accumulate mtDNA mutations in multiple tissues and display several features of accelerated aging. Calorie restriction (CR) is known to delay the onset of age-related diseases and to extend the lifespan of a variety of species, including rodents. In the current study we investigated the effects of CR on the lifespan and healthspan of mitochondrial mutator mice. Longterm CR did not increase the median or maximum lifespan of Polg(D257A/D257A) mice. Furthermore, CR did not reduce mtDNA deletions in the heart and muscle, accelerated sarcopenia, testicular atrophy, nor improve the alterations in cardiac parameters that are present in aged mitochondrial mutator mice. Therefore, our findings suggest that accumulation of mtDNA mutations may interfere with the beneficial action of CR in aging retardation.	[Someya, Shinichi; Kim, Mi-Jung] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Kujoth, Gregory C.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA; [Hacker, Timothy A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Vermulst, Marc] Univ Penn, Ctr Mitochondrial & Epigen Med, Philadelphia, PA 19104 USA; [Weindruch, Richard] Univ Wisconsin, Geriatr Res Educ & Clin Ctr, Vet Adm Hosp, Madison, WI USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.; Prolla, TA (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.	taprolla@wisc.edu		Someya, Shinichi/0000-0001-9895-6227	NIH [RO1 AG021905, RO1 DC012552, R01 DC014437, R03 DC011840]; American Federation for Aging Research Grant; NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award; NATIONAL INSTITUTE ON AGING [R01AG021905, P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011840, R01DC012552, R01DC014437] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research Grant; NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH grants RO1 AG021905 (T.A.P.), RO1 DC012552 (S.S.), R01 DC014437 (S.S.) and R03 DC011840 (S.S.), American Federation for Aging Research Grant (S.S.), and NIH/NIA Claude D. Pepper Older Americans Independence Center Junior Scholar Award (S.S.).	Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Alderman JM, 2010, GERONTOLOGY, V56, P404, DOI 10.1159/000235720; Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006; Diderich K, 2011, DNA REPAIR, V10, P772, DOI 10.1016/j.dnarep.2011.04.025; FINDLAY WA, 1995, BIOCHEMISTRY-US, V34, P2087, DOI 10.1021/bi00007a001; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011; Hamilton R, 2016, J NEUROL SCI, V370, P47, DOI 10.1016/j.jns.2016.09.021; Han C, 2013, EXP GERONTOL, V48, P1091, DOI 10.1016/j.exger.2013.02.014; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kolesar JE, 2014, FREE RADICAL BIO MED, V75, P241, DOI 10.1016/j.freeradbiomed.2014.07.038; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Lezza AMS, 2008, NEUROCHEM RES, V33, P2609, DOI 10.1007/s11064-008-9866-7; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; McKiernan SH, 2011, EXP GERONTOL, V46, P23, DOI 10.1016/j.exger.2010.09.011; Muller FL, 2007, AM J PHYSL REGUL INT, V293; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407	36	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171159	10.1371/journal.pone.0171159	http://dx.doi.org/10.1371/journal.pone.0171159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158260	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700034
J	Siu, TSC; Cheung, H				Siu, Tik-Sze Carrey; Cheung, Him			Infants' sensitivity to emotion in music and emotion-action understanding	PLOS ONE			English	Article							GOAL-DIRECTED ACTION; INTENTIONAL ACTION; ATTENTION; EXPRESSION; LULLABIES; ABILITY; TEMPO; DISCRIMINATION; 18-MONTH-OLDS; COMMUNICATION	Emerging evidence has indicated infants' early sensitivity to acoustic cues in music. Do they interpret these cues in emotional terms to represent others' affective states? The present study examined infants' development of emotional understanding of music with a violation-of- expectation paradigm. Twelve-and 20-month-olds were presented with emotionally concordant and discordant music-face displays on alternate trials. The 20-month-olds, but not the 12-month-olds, were surprised by emotional incongruence between musical and facial expressions, suggesting their sensitivity to musical emotion. In a separate non-music task, only the 20-month-olds were able to use an actress's affective facial displays to predict her subsequent action. Interestingly, for the 20-month-olds, such emotion-action understanding correlated with sensitivity to musical expressions measured in the first task. These two abilities however did not correlate with family income, parental estimation of language and communicative skills, and quality of parent-child interaction. The findings suggest that sensitivity to musical emotion and emotion-action understanding may be supported by a generalised common capacity to represent emotion from social cues, which lays a foundation for later social-communicative development.	[Siu, Tik-Sze Carrey] Educ Univ Hong Kong, Dept Early Childhood Educ, Tai Po, Hong Kong, Peoples R China; [Cheung, Him] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China	Education University of Hong Kong (EdUHK); Chinese University of Hong Kong	Cheung, H (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	hcheung@psy.cuhk.edu.hk		Cheung, Him/0000-0002-1553-2339; SIU, Tik Sze, Carrey/0000-0002-9092-0032	Social Sciences Panel, Chinese University of Hong Kong [4052003]	Social Sciences Panel, Chinese University of Hong Kong	Funded by Direct Grant for Research to Dr. Him Cheung, Social Sciences Panel, Chinese University of Hong Kong (project number: 4052003).	[Anonymous], 1998, ADV INFANCY RES; Aschersleben G, 2008, DEVELOPMENTAL SCI, V11, P862, DOI 10.1111/j.1467-7687.2008.00736.x; Baillargeon R, 2013, NAVIGATING SOCIAL WO, P85; Baillargeon R, 2016, ANNU REV PSYCHOL, V67, P159, DOI 10.1146/annurev-psych-010213-115033; Buresh JS, 2007, COGNITION, V104, P287, DOI 10.1016/j.cognition.2006.07.001; CARON RF, 1985, CHILD DEV, V56, P1552, DOI 10.2307/1130474; Cheung H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046168; Conrad NJ, 2011, CAN J EXP PSYCHOL, V65, P168, DOI 10.1037/a0023296; Dalla Bella S, 2001, COGNITION, V80, pB1, DOI 10.1016/S0010-0277(00)00136-0; Dolgin K., 1990, PSYCHOL MUSIC, V18, P87, DOI DOI 10.1177/0305735690181007; Ekman P., 1975, UNMASKING FACE; Fenson L, 2000, APPL PSYCHOLINGUIST, V21, P95, DOI 10.1017/S0142716400001053; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; FERNALD A, 1993, CHILD DEV, V64, P657, DOI 10.2307/1131209; Fernald A., 1991, ANN CHILD DEV, V8, P43; Flom R, 2012, INFANT BEHAV DEV, V35, P697, DOI 10.1016/j.infbeh.2012.07.022; Flom R, 2008, INFANT BEHAV DEV, V31, P716, DOI 10.1016/j.infbeh.2008.04.004; Gabrielsson A, 2003, SER AFFECTIVE SCI, P503; GUNNAR MR, 1984, CHILD DEV, V55, P1231, DOI 10.2307/1129992; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hepach R, 2013, J EXP CHILD PSYCHOL, V115, P16, DOI 10.1016/j.jecp.2012.12.013; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2001, MUSIC EMOTION THEORY; KASTNER MP, 1990, MUSIC PERCEPT, V8, P189; Kratus J., 1993, PSYCHOL MUSIC, V21, P3, DOI DOI 10.1177/030573569302100101; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Luo YY, 2011, DEVELOPMENTAL SCI, V14, P453, DOI 10.1111/j.1467-7687.2010.00995.x; Luo YY, 2010, CURR DIR PSYCHOL SCI, V19, P301, DOI 10.1177/0963721410386679; Luo YY, 2010, INFANCY, V15, P392, DOI 10.1111/j.1532-7078.2009.00019.x; Martin A, 2012, COGNITION, V123, P50, DOI 10.1016/j.cognition.2011.12.003; Mohn C, 2011, PSYCHOL MUSIC, V39, P503, DOI 10.1177/0305735610378183; Mote J, 2011, EMOTION, V11, P618, DOI 10.1037/a0022573; Nawrot ES., 2003, PSYCHOL MUSIC, V31, P75, DOI [10.1177/0305735603031001325, DOI 10.1177/0305735603031001325]; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rock AML, 1999, DEV PSYCHOL, V35, P527, DOI 10.1037/0012-1649.35.2.527; Siu TSC, 2016, DEVELOPMENTAL SCI, V19, P933, DOI 10.1111/desc.12348; Song HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092387; STIFTER CA, 1987, J NONVERBAL BEHAV, V11, P43, DOI 10.1007/BF00999606; Terwogt M. M., 1991, PSYCHOL MUSIC, V19, P99, DOI [10.1177/0305735691192001, DOI 10.1177/0305735691192001]; Trainor LJ, 2010, SPRINGER HANDB AUDIT, V36, P89, DOI 10.1007/978-1-4419-6114-3_4; Trainor LJ, 2002, MUSIC PERCEPT, V20, P187, DOI 10.1525/mp.2002.20.2.187; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Trehub S., 2003, COGNITIVE NEUROSCIEN, P3; Trehub SE, 2007, CHILD MUSICIAN HDB M, P33; Tsang CD, 2010, INFANT BEHAV DEV, V33, P96, DOI 10.1016/j.infbeh.2009.11.006; Vaish A, 2010, INFANT BEHAV DEV, V33, P79, DOI 10.1016/j.infbeh.2009.11.003; WALDEN TA, 1988, CHILD DEV, V59, P1230, DOI 10.2307/1130486; Wellman HA, 2008, DEV PSYCHOL, V44, P618, DOI 10.1037/0012-1649.44.2.618; Wellman HM, 2004, DEVELOPMENTAL SCI, V7, P283, DOI 10.1111/j.1467-7687.2004.00347.x; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 2003, DEVELOPMENTAL SCI, V6, P297, DOI 10.1111/1467-7687.00286; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2	56	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171023	10.1371/journal.pone.0171023	http://dx.doi.org/10.1371/journal.pone.0171023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN7DB	28152081	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200074
J	Hromadnikova, I; Kotlabova, K; Ivankova, K; Krofta, L				Hromadnikova, Ilona; Kotlabova, Katerina; Ivankova, Katarina; Krofta, Ladislav			First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR	PLOS ONE			English	Article							PLACENTA-SPECIFIC MICRORNAS; HUMAN CHORIONIC-GONADOTROPIN; PREGNANCY-ASSOCIATED MICRORNAS; EXPRESSION PROFILES; PLASMA-PROTEIN; MATERNAL CIRCULATION; GROWTH RESTRICTION; MESSENGER-RNA; CELL MICRORNA; PAPP-A	Objectives A nested case control study of a longitudinal cohort comparing pregnant women enrolled at 10 to 13 gestational weeks was carried out to evaluate risk assessment for preeclampsia and IUGR based on circulating placental specific C19MC microRNAs in early pregnancy. Methods The expression of placental specific C19MC microRNAs (miR-516b-5p, miR-517-5p, miR-518b, miR-520a-5p, miR-520h, and miR-525-5p) was determined in plasma samples from pregnancies that subsequently developed preeclampsia (n = 21), IUGR (n = 18), and 58 normal pregnancies using real-time PCR and comparative Ct method relative to synthetic Caenorhabditis elegans microRNA (cel-miR-39). Results Circulating C19MC microRNAs were up-regulated (miR-517-5p, p = 0.005; miR-518b, p = 0.013; miR-520h, p = 0.021) or showed a trend toward up-regulation in patients destined to develop preeclampsia (miR-520a-5p, p = 0.067; miR-525-5p, p = 0.073). MiR-517-5p had the best predictive performance for preeclampsia with a sensitivity of 42.9%, a specificity of 86.2%, a PPV of 52.9% and a NPV of 80.6%. The combination of all examined circulating C19MC microRNAs had no advantage over using only the miR-517-5p biomarker to predict the occurrence of preeclampsia (a sensitivity of 20.6%, a specificity of 90.8%, a PPV of 44.8%, and a NPV of 76.0%). Conclusions Up-regulation of miR-517-5p, miR-518b and miR-520h was associated with a risk of later development of preeclampsia. First trimester screening of extracellular miR-517-5p identified a proportion of women with subsequent preeclampsia. No circulating C19MC microRNA biomarkers were identified that could predict later occurrence of IUGR.	[Hromadnikova, Ilona; Kotlabova, Katerina] Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague, Czech Republic; [Ivankova, Katarina; Krofta, Ladislav] Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague, Czech Republic	Charles University Prague; Charles University Prague	Hromadnikova, I (corresponding author), Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague, Czech Republic.	Ilona.Hromadnikova@lf3.cuni.cz	Hromadnikova, Ilona/E-1957-2017; Ivánková, Katarína/GYE-0290-2022	Hromadnikova, Ilona/0000-0002-4396-3304; Kotlabova, Katerina/0000-0002-8824-4653	Charles University research program PRVOUKP32 and PROGRES Q34	Charles University research program PRVOUKP32 and PROGRES Q34	Work was supported by the Charles University research program PRVOUKP32 and PROGRES Q34.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manus cript	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; ARBEILLE P, 1988, EUR J OBSTET GYN R B, V29, P261, DOI 10.1016/0028-2243(88)90066-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Canini S, 2008, FERTIL STERIL, V89, P174, DOI 10.1016/j.fertnstert.2007.02.024; Chambers AE, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-113; Chang YW, 2014, ANN SURG ONCOL, V21, pS687, DOI 10.1245/s10434-014-3812-5; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Crovetto F, 2016, ULTRASOUND OBSTET GY; DiFederico E, 1999, AM J PATHOL, V155, P293, DOI 10.1016/S0002-9440(10)65123-1; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Flor I, 2012, BIOCHEM BIOPH RES CO, V422, P411, DOI 10.1016/j.bbrc.2012.05.004; Frische EW, 2010, DEV BIOL, V340, P1, DOI 10.1016/j.ydbio.2009.12.043; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Hromadnikova I, 2016, THROMB RES, V137, P126, DOI 10.1016/j.thromres.2015.11.032; Hromadnikova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113735; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/186041; Hromadnikova I, 2012, DNA CELL BIOL, V31, P1221, DOI 10.1089/dna.2011.1530; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz Berthold, 2014, Pregnancy Hypertens, V4, P244, DOI [10.1016/j.preghy.2014.04.015, 10.1016/j.preghy.2014.04.016]; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Karahasanovic A, 2014, CLIN CHEM LAB MED, V52, P521, DOI 10.1515/cclm-2013-0338; Keung MH, 2016, J GINSENG RES, V40, P151, DOI 10.1016/j.jgr.2015.07.002; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leslie K, 2011, BEST PRACT RES CL OB, V25, P343, DOI 10.1016/j.bpobgyn.2011.01.002; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Nelson DM, 1996, PLACENTA, V17, P387, DOI 10.1016/S0143-4004(96)90019-3; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ong CYT, 2000, BRIT J OBSTET GYNAEC, V107, P1265, DOI 10.1111/j.1471-0528.2000.tb11618.x; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Oudejans CBM, 2003, PRENATAL DIAG, V23, P111, DOI 10.1002/pd.539; Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Portilho DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116853; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Rippe V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009485; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Scazzocchio E, 2016, ULTRASOUND OBSTET GY; Sedlackova L, 2011, SCAND J RHEUMATOL, V40, P354, DOI 10.3109/03009742.2011.552522; Sedlackova L, 2011, TUMOR BIOL, V32, P33, DOI 10.1007/s13277-010-0088-7; Smith GCS, 2002, J CLIN ENDOCR METAB, V87, P1762, DOI 10.1210/jc.87.4.1762; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; Spencer K, 2008, PRENATAL DIAG, V28, P7, DOI 10.1002/pd.1890; Su CM, 2016, ONCOGENE, V35, P1134, DOI 10.1038/onc.2015.168; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thompson LP, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142273; Ura B, 2014, TAIWAN J OBSTET GYNE, V53, P232, DOI 10.1016/j.tjog.2014.03.001; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x; Wang D, 2012, AUST NZ J OBSTET GYN, V52, P565, DOI 10.1111/j.1479-828X.2012.01481.x; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Whitley GSJ, 2007, AM J PATHOL, V170, P1903, DOI 10.2353/ajpath.2007.070006; Winger EE, 2015, J REPROD IMMUNOL, V110, P22, DOI 10.1016/j.jri.2015.03.005; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287; Wortelboer EJ, 2010, BJOG-INT J OBSTET GY, V117, P1384, DOI 10.1111/j.1471-0528.2010.02690.x; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yliniemi A, 2015, CLIN MED INSIGHTS-RE, V9, P13, DOI 10.4137/CMRH.S21865; Zhang MX, 2012, FEBS LETT, V586, P3508, DOI 10.1016/j.febslet.2012.08.007; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	89	71	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171756	10.1371/journal.pone.0171756	http://dx.doi.org/10.1371/journal.pone.0171756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182660	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800101
J	Hoes, OAC; Meijer, LJJ; van der Ent, RJ; de Giesen, NCV				Hoes, Olivier A. C.; Meijer, Lourens J. J.; van der Ent, Ruud J.; de Giesen, Nick C. van			Systematic high-resolution assessment of global hydropower potential	PLOS ONE			English	Article							CLIMATE-CHANGE; IMPACT; BASIN; RIVER; POWER	Population growth, increasing energy demand and the depletion of fossil fuel reserves necessitate a search for sustainable alternatives for electricity generation. Hydropower could replace a large part of the contribution of gas and oil to the present energy mix. However, previous high-resolution estimates of hydropower potential have been local, and have yet to be applied on a global scale. This study is the first to formally present a detailed evaluation of the hydropower potential of each location, based on slope and discharge of each river in the world. The gross theoretical hydropower potential is approximately 52 PWh/year divided over 11.8 million locations. This 52 PWh/year is equal to 33% of the annually required energy, while the present energy production by hydropower plants is just 3% of the annually required energy. The results of this study: all potentially interesting locations for hydroelectric power plants, are available online.	[Hoes, Olivier A. C.; Meijer, Lourens J. J.; van der Ent, Ruud J.; de Giesen, Nick C. van] Delft Univ Technol, Fac Civil Engn & Geosci, Dept Water Management, Delft, Netherlands; [Meijer, Lourens J. J.] Witteveen Bos Raadgevende Ingenieurs BV, Deventer, Netherlands; [van der Ent, Ruud J.] Univ Utrecht, Fac Geosci, Dept Phys Geog, Utrecht, Netherlands	Delft University of Technology; Utrecht University	Hoes, OAC; Meijer, LJJ; van der Ent, RJ (corresponding author), Delft Univ Technol, Fac Civil Engn & Geosci, Dept Water Management, Delft, Netherlands.; Meijer, LJJ (corresponding author), Witteveen Bos Raadgevende Ingenieurs BV, Deventer, Netherlands.; van der Ent, RJ (corresponding author), Univ Utrecht, Fac Geosci, Dept Phys Geog, Utrecht, Netherlands.	O.A.C.Hoes@tudelft.nl; Lourens.Meijer@witteveenbos.com; R.J.vanderEnt@uu.nl; N.C.vandeGiesen@tudelft.nl	van de Giesen, Nick C/B-5010-2008; van der Ent, Ruud J/K-8593-2016; van de Giesen, Nick/O-8137-2019	van de Giesen, Nick C/0000-0002-7200-3353; van der Ent, Ruud J/0000-0001-5450-4333; van de Giesen, Nick/0000-0002-7200-3353; Meijer, Lourens Jan Jakob/0000-0003-3712-6806; Hoes, Olivier/0000-0003-0676-3167	Witteveen+Bos Raadgevende ingenieurs B.V.	Witteveen+Bos Raadgevende ingenieurs B.V.	The funder (Witteveen+Bos Raadgevende ingenieurs B.V.) provided support in the form of salaries for author LJJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. LJJM performed most of his work when he was affiliated with Delft University of Technology as a student.	[Anonymous], 2008, SHELL EN SCEN 2050; [Anonymous], 2011, GMTED2010; Artner A, 1997, INT J HYDROPOWER DAM, P39; Bartle A, 2002, ENERG POLICY, V30, P1231, DOI 10.1016/S0301-4215(02)00084-8; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Coskun HG, 2010, WATER RESOUR MANAG, V24, P3757, DOI 10.1007/s11269-010-9632-x; Cuya DGP, 2013, RENEW ENERG, V50, P103, DOI 10.1016/j.renene.2012.06.019; Fekete BM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/1999GB001254; Hamududu B, 2012, ENERGIES, V5, P305, DOI 10.3390/en5020305; Hoes OAC, 2014, GLOBAL POTENTIAL HYD; Hoes OAC, 2014, 9 INT S LOWL TECHN S, P622; IEA (International Energy Agency), 2019, KEY WORLD EN STAT; IJHD, 2013, INT J HYDROPOWER DAM; IRENA RE. International renewable energy agency, 2012, RENEWABLE ENERGY TEC; Kareiva PM, 2012, P NATL ACAD SCI USA, V109, P5553, DOI 10.1073/pnas.1203263109; Kusre BC, 2010, APPL ENERG, V87, P298, DOI 10.1016/j.apenergy.2009.07.019; Lacombe G, 2014, WATER INT, V39, P649, DOI 10.1080/02508060.2014.956205; Larentis DG, 2010, ENERGY, V35, P4237, DOI 10.1016/j.energy.2010.07.014; Lehner B, 2005, ENERG POLICY, V33, P839, DOI 10.1016/j.enpol.2003.10.018; Lehner B, 2001, EUROWASSER MODEL BAS, P1; Li Bo, 2014, LAST REPORT CHINAS R; Mariusson J, 1997, STUDY IMPORTANCE HAR; Meijer LJJ, 2012, WORLD HYDROPOWER CAP; Mosier TM, 2016, RENEW ENERG, V97, P492, DOI 10.1016/j.renene.2016.06.002; Pokhrel Y. N., 2008, J CORROS SCI ENG, V52, P7; Raabe J., 1985, HYDROPOWER DESIGN US; Raadal HL, 2011, RENEW SUST ENERG REV, V15, P3417, DOI 10.1016/j.rser.2011.05.001; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; REN21, 2013, REN 2013 GLOB STAT R; Schumann GJP, 2014, NATURE, V507, P169, DOI 10.1038/507169e; UNITED NATIONS, 2014, ESAPWP235 UN; van Vliet MTH, 2016, GLOBAL ENVIRON CHANG, V40, P156, DOI 10.1016/j.gloenvcha.2016.07.007; Vince G, 2010, SCIENCE, V329, P384, DOI 10.1126/science.329.5990.384; WEC, 2013, WORLD EN RES 2013 SU; WEHRLI B, 2011, NAT GEOSCI, V4, P585; Yi CS, 2010, RENEW ENERG, V35, P852, DOI 10.1016/j.renene.2009.08.003; Zhou Y, 2015, ENERG ENVIRON SCI, V8, P2622, DOI 10.1039/c5ee00888c; [No title captured]	38	69	70	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171844	10.1371/journal.pone.0171844	http://dx.doi.org/10.1371/journal.pone.0171844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178329	Green Published, gold			2022-12-27	WOS:000393712500074
J	Akilimali, PZ; Musumari, PM; Kashala-Abotnes, E; Kayembe, PK; Lepira, FB; Mutombo, PB; Tylleskar, T; Ali, MM				Akilimali, Pierre Zalagile; Musumari, Patou Masika; Kashala-Abotnes, Esperance; Kayembe, Patrick Kalambayi; Lepira, Francois B.; Mutombo, Paulin Beya; Tylleskar, Thorkild; Ali, Mapatano Mala			Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from Goma, Democratic Republic of Congo	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; ADHERENCE; CHILDREN; REASONS; CONTEXT; KISUMU; UGANDA; YOUTH; CARE	Background The study aimed to identify the impact of non-disclosure of HIV status on the loss to follow-up (LTFU) of patients receiving anti-retroviral therapy. Methodology A historic cohort of HIV patients from 2 major hospitals in Goma, Democratic Republic of Congo was followed from 2004 to 2012. LTFU was defined as not taking an ART refill for a period of 3 months or longer since the last attendance, and had not yet been classified as 'dead' or 'transferred-out'. Kaplan-Meier plots were used to determine the probability of LTFU as a function of time as inclusive of the cohort. The log-rank test was used to compare survival curves based on determinants. Cox proportional hazard modeling was used to measure predictors of LTFU from the time of treatment induction until December 15th, 2012 (the end-point). Results The median follow-up time was 3.99 years (IQR = 2.33 to 5.59). Seventy percent of patients had shared their HIV status with others (95% CI: 66.3-73.1). The proportion of LTFU was 12% (95% CI: 9.6-14.4). Patients who did not share their HIV status (Adjusted HR 2.28, 95% CI 1.46-2.29), patients who did not live in the city of Goma (Adjusted HR 1.97, 95% CI 1.02-3.77), and those who attained secondary or higher education level (Adjusted HR 1.60, 95% CI 1.02-2.53) had a higher hazard of being LTFU. Conclusion This study shows the relationship between the non-disclosure HIV status and LTFU. Healthcare workers in similar settings should pay more attention to clients who have not disclosed their HIV status, and to those living far from health settings where they receive medication.	[Akilimali, Pierre Zalagile; Kayembe, Patrick Kalambayi; Mutombo, Paulin Beya; Ali, Mapatano Mala] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Musumari, Patou Masika] Kyoto Univ, Dept Global Hlth & Socioepidemiol, Sch Publ Hlth, Kyoto, Japan; [Kashala-Abotnes, Esperance; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Dept Global Hlth & Primary Care, Bergen, Norway; [Lepira, Francois B.] Univ Kinshasa, Dept Internal Med, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Kyoto University; University of Bergen; Universite de Kinshasa	Akilimali, PZ (corresponding author), Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO.	pierretulanefp@gmail.com	Akilimali, Pierre Z/D-2564-2018; Tylleskär, Thorkild/S-5529-2017	Akilimali, Pierre Z/0000-0002-3828-6214; Tylleskär, Thorkild/0000-0003-4801-4324				Ager A, 2008, J REFUG STUD, V21, P166, DOI 10.1093/jrs/fen016; Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Bird K, 2010, J INT DEV, V22, P1183, DOI 10.1002/jid.1754; Bott S, 2013, SAHARA J-J SOC ASP H, V10, pS5, DOI 10.1080/02664763.2012.755319; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Dessalegn M., 2014, J AIDS HIV RES, V7, P1; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Kenneth Mugisha, 2009, RETENTION HIV POSITI; Kyaddondo D, 2013, SAHARA J-J SOC ASP H, V10, pS37, DOI 10.1080/02664763.2012.755323; Mathews C, 1999, S AFR MED J, V89, P1238; Mberi MN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0912-2; McIvor Murray S, 2015, J INTERPERS VIOLENCE, P1; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P297; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Mulanga C, 2004, AIDS, V18, P832, DOI 10.1097/00002030-200403260-00024; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; Musumari PM, 2013, AIDS CARE PSYCHOL SO; Ndiaye C, 2008, World Health Popul, V10, P43; Ojwang' VO, 2016, AIDS CARE, V28, P500, DOI 10.1080/09540121.2015.1110234; Ojwang VO, 2015, AIDS CARE; Opuni M, 2010, AIDS BEHAV, V14, P807, DOI 10.1007/s10461-009-9584-4; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; [Republique Democratique du congo Ministere de la Sante], 2005, PROGR NAT LUTT CONTR; Seid Mohammed, 2012, Afr J Reprod Health, V16, P97; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Ssali SN, 2010, AIDS PATIENT CARE ST, V24, P675, DOI 10.1089/apc.2010.0062; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Tadesse K, 2014, J AIDS CLIN RES, V5, P12; Tang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115691; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; World Health Organization, 2006, ANT THER HIV INF AD	37	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171407	10.1371/journal.pone.0171407	http://dx.doi.org/10.1371/journal.pone.0171407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170410	Green Published, gold, Green Accepted			2022-12-27	WOS:000393705500037
J	Dai, WJ; Kaminga, AC; Tan, HZ; Wang, JR; Lai, ZW; Wu, X; Liu, AZ				Dai, Wenjie; Kaminga, Atipatsa C.; Tan, Hongzhuan; Wang, Jieru; Lai, Zhiwei; Wu, Xin; Liu, Aizhong			Long-term psychological outcomes of flood survivors of hard-hit areas of the 1998 Dongting Lake flood in China: Prevalence and risk factors	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH PROBLEMS; WENCHUAN EARTHQUAKE; SOCIAL SUPPORT; MAJOR TRAUMA; ANXIETY; DEPRESSION; PTSD	Background Although numerous studies have indicated that exposure to natural disasters may increase survivors' risk of post-traumatic stress disorder (PTSD) and anxiety, studies focusing on the long-term psychological outcomes of flood survivors are limited. Thus, this study aimed to estimate the prevalence of PTSD and anxiety among flood survivors 17 years after the 1998 Dongting Lake flood and to identify the risk factors for PTSD and anxiety. Methods This cross-sectional study was conducted in December 2015, 17 years after the 1998 Dongting Lake flood. Survivors in hard-hit areas of the flood disaster were enrolled in this study using a stratified, systematic random sampling method. Well qualified investigators conducted face-to-face interviews with participants using the PTSD Checklist-Civilian version, the Zung Self-Rating Anxiety Scale, the Chinese version of the Social Support Rating Scale and the Revised Eysenck Personality Questionnaire-Short Scale for Chinese to assess PTSD, anxiety, social support and personality traits, respectively. Logistic regression analyses were used to identify factors associated with PTSD and anxiety. Results A total of 325 participants were recruited in this study, and the prevalence of PTSD and anxiety was 9.5% and 9.2%, respectively. Multivariable logistic regression analyses indicated that female sex, experiencing at least three flood-related stressors, having a low level of social support, and having the trait of emotional instability were risk factors for long-term adverse psychological outcomes among flood survivors after the disaster. Conclusions PTSD and anxiety were common long-term adverse psychological outcomes among flood survivors. Early and effective psychological interventions for flood survivors are needed to prevent the development of PTSD and anxiety in the long run after a flood, especially for individuals who are female, experience at least three flood-related stressors, have a low level of social support and have the trait of emotional instability.	[Dai, Wenjie; Kaminga, Atipatsa C.; Tan, Hongzhuan; Wang, Jieru; Wu, Xin; Liu, Aizhong] Cent South Univ, Dept Epidemiol & Hlth Stat, Xiangya Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Kaminga, Atipatsa C.] Mzuzu Univ, Dept Math, Mzuzu, Malawi; [Wang, Jieru] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Lai, Zhiwei] Hunan Prov Ctr Dis Control & Prevent, Immune Planning Div, Changsha, Hunan, Peoples R China	Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, AZ (corresponding author), Cent South Univ, Dept Epidemiol & Hlth Stat, Xiangya Sch Publ Hlth, Changsha, Hunan, Peoples R China.	lazroy@live.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20130162110054]; Fundamental Research Funds for the Postgraduates of Central South University [2015zzts282]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Postgraduates of Central South University	This research was funded by the Specialized Research Fund for the Doctoral Program of Higher Education (20130162110054) and the Fundamental Research Funds for the Postgraduates of Central South University (2015zzts282).	Adelman CB, 2014, J CLIN PSYCHIAT, V75, pE695, DOI 10.4088/JCP.13r08894; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, V5th; BASOGLU M, 1994, JAMA-J AM MED ASSOC, V272, P357, DOI 10.1001/jama.272.5.357; Chen L, 2015, DISASTER MED PUBLIC, V9, P504, DOI 10.1017/dmp.2015.64; Chen L, 2015, DISASTER MED PUBLIC, V9, P329, DOI 10.1017/dmp.2015.17; Cherry KE, 2015, AGING MENT HEALTH, V19, P430, DOI 10.1080/13607863.2014.941325; Cui Y., 2015, FIXED POINT THEORY A, V2015, P40, DOI [DOI 10.1186/S13663-015-0288-3, 10.1186/s13663-015-0345-y, DOI 10.1186/S13663-015-0345-Y]; Dai WJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1097-x; Dai WJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0891-9; Dai WJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2871-x; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Feng SD, 2007, ANN EPIDEMIOL, V17, P827, DOI 10.1016/j.annepidem.2007.04.002; Geffen DB, 2003, LEUKEMIA LYMPHOMA, V44, P1925, DOI 10.1080/1042819031000123573; Groome D, 2004, BRIT J PSYCHOL, V95, P387, DOI 10.1348/0007126041528149; Hashemian F, 2006, JAMA-J AM MED ASSOC, V296, P560, DOI 10.1001/jama.296.5.560; Hashmi S, 2011, DISASTER MED PUBLIC, V5, P293, DOI 10.1001/dmp.2011.81; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Hou Y, 2014, INT UROL NEPHROL, V46, P1645, DOI 10.1007/s11255-014-0685-2; Huh J, 2014, ACM T COMPUT-HUM INT, V21, DOI 10.1145/2630067; Jaksic N, 2012, PSYCHIAT DANUB, V24, P256; Kar Nilamadhab, 2006, Clin Pract Epidemiol Ment Health, V2, P17, DOI 10.1186/1745-0179-2-17; Karakaya Isil, 2004, Turk Psikiyatri Derg, V15, P257; Kashdan TB, 2009, J ANXIETY DISORD, V23, P185, DOI 10.1016/j.janxdis.2008.06.006; Kolltveit S, 2012, J TRAUMA STRESS, V25, P164, DOI 10.1002/jts.21680; Kootker JA, 2016, ARCH PHYS MED REHAB, V97, P919, DOI 10.1016/j.apmr.2016.01.019; Kraemer B, 2009, AUST NZ J PSYCHIAT, V43, P420, DOI 10.1080/00048670902817653; Lamond JE, 2015, ENVIRON RES, V140, P325, DOI 10.1016/j.envres.2015.04.008; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Lin KH, 2014, J OCCUP REHABIL, V24, P1, DOI 10.1007/s10926-013-9431-3; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Misund AR, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-33; Muller G, 2016, INTENS CARE MED, V42, P370, DOI 10.1007/s00134-016-4223-9; Nagata D, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005145; Neria Y, 2010, J TRAUMA STRESS, V23, P474, DOI 10.1002/jts.20544; Paranjothy S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-145; Peng H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-207; Perrin M, 2014, SOC PSYCH PSYCH EPID, V49, P447, DOI 10.1007/s00127-013-0762-3; Polusny MA, 2014, J PSYCHIATR RES, V49, P1, DOI 10.1016/j.jpsychires.2013.09.016; Sijbrandij M, 2016, DEPRESS ANXIETY, V33, P783, DOI 10.1002/da.22533; Soler-Ferreria FB, 2014, REV ESP SALUD PUBLIC, V88, P17, DOI 10.4321/S1135-57272014000100003; Spinhoven P, 2014, CHILD ABUSE NEGLECT, V38, P1320, DOI 10.1016/j.chiabu.2014.01.017; Sundquist K, 2005, EUR PSYCHIAT, V20, P158, DOI 10.1016/j.eurpsy.2004.12.001; Tan H Z, 2004, Asia Pac J Public Health, V16, P126, DOI 10.1177/101053950401600209; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Wind TR, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6351; Wu J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1402-5; Wu ZB, 2016, PSYCHIAT RES, V237, P49, DOI 10.1016/j.psychres.2016.01.041; Xie RH, 2009, ANN EPIDEMIOL, V19, P637, DOI 10.1016/j.annepidem.2009.03.008; Xu HM, 2017, PSYCHOL HEALTH MED, V22, P37, DOI 10.1080/13548506.2016.1218031; Xu J, 2014, PUBLIC HEALTH, V128, P430, DOI 10.1016/j.puhe.2014.03.002; Yin WY, 2015, ADDICTION, V110, P51, DOI 10.1111/add.12780; Zaetta C, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8454; Zaffina S, 2014, MED LAV, V105, P163; Zhang Q, 2014, INT J ENV RES PUB HE, V11, P3787, DOI 10.3390/ijerph110403787; Zhang Z, 2012, PSYCHOL MED, V42, P1687, DOI 10.1017/S0033291711002844; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]; Zhang Z, 2012, STRESS HEALTH, V28, P61, DOI 10.1002/smi.1403; Zhang ZH, 2011, CLIN EXP HYPERTENS, V33, P281, DOI 10.3109/10641963.2010.531850; Zhao J, 2012, SEX TRANSM DIS, V39, P942, DOI 10.1097/OLQ.0b013e31826f356f; 钱铭怡, 2000, [心理学报, Acta Psychologica Sinica], V32, P317	66	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171557	10.1371/journal.pone.0171557	http://dx.doi.org/10.1371/journal.pone.0171557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170427	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500042
J	Orenstein, EW; Orenstein, LAV; Diarra, K; Djiteye, M; Sidibe, D; Haidara, FC; Doumbia, MF; Diallo, F; Coulibaly, F; Keita, AM; Onwuchekwa, U; Teguete, I; Tapia, MD; Sow, SO; Levine, MM; Rheingans, R				Orenstein, Evan W.; Orenstein, Lauren A. V.; Diarra, Kounandji; Djiteye, Mahamane; Sidibe, Diakaridia; Haidara, Fadima C.; Doumbia, Moussa F.; Diallo, Fatoumata; Coulibaly, Flanon; Keita, Adama M.; Onwuchekwa, Uma; Teguete, Ibrahima; Tapia, Milagritos D.; Sow, Samba O.; Levine, Myron M.; Rheingans, Richard			Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis	PLOS ONE			English	Article							SEASONAL INFLUENZA; PREGNANT-WOMEN; OUTPATIENT VISITS; ECONOMIC BURDEN; HOSPITALIZATIONS; VACCINATION; AFRICA; IMPACT	Background Maternal influenza immunization has gained traction as a strategy to diminish maternal and neonatal mortality. However, efforts to vaccinate pregnant women against influenza in developing countries will require substantial investment. We present cost-effectiveness estimates of maternal influenza immunization based on clinical trial data from Bamako, Mali. Methods We parameterized a decision-tree model using prospectively collected trial data on influenza incidence, vaccine efficacy, and direct and indirect influenza-related healthcare expenditures. Since clinical trial participants likely had better access to care than the general Malian population, we also simulated scenarios with poor access to care, including decreased healthcare resource utilization and worse influenza-related outcomes. Results Under base-case assumptions, a maternal influenza immunization program in Mali would cost $857 (95% UI: $188-$2358) per disability-adjusted life year (DALY) saved. Adjusting for poor access to care yielded a cost-effectiveness ratio of $486 (95% UI: $105-$1425) per DALY saved. Cost-effectiveness ratios were most sensitive to changes in the cost of a maternal vaccination program and to the proportion of laboratory-confirmed influenza among infants warranting hospitalization. Mean cost-effectiveness estimates fell below Mali's GDP per capita when the cost per pregnant woman vaccinated was $1.00 or less with no adjustment for access to care or $1.67 for those with poor access to care. Healthcare expenditures for lab-confirmed influenza were not significantly different than the cost of influenza-like illness. Conclusions Maternal influenza immunization in Mali would be cost-effective in most settings if vaccine can be obtained, managed, and administered for <=$1.00 per pregnant woman.	[Orenstein, Evan W.; Orenstein, Lauren A. V.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Orenstein, Evan W.; Orenstein, Lauren A. V.; Diarra, Kounandji; Djiteye, Mahamane; Sidibe, Diakaridia; Haidara, Fadima C.; Doumbia, Moussa F.; Diallo, Fatoumata; Coulibaly, Flanon; Keita, Adama M.; Onwuchekwa, Uma; Sow, Samba O.] Ctr Dev Vaccins Mali CVD Mali, Bamako, Mali; [Teguete, Ibrahima] Gabriel Toure Teaching Hosp, Dept Obstet & Gynecol, Bamako, Mali; [Tapia, Milagritos D.; Sow, Samba O.; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rheingans, Richard] Univ Florida, Dept Environm & Global Hlth, Gainesville, FL USA; [Orenstein, Evan W.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Orenstein, Lauren A. V.] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Rheingans, Richard] Appalachian State Univ, Dept Sustainable Dev, Boone, NC 28608 USA	Emory University; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; Appalachian State University	Orenstein, EW (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.; Orenstein, EW (corresponding author), Ctr Dev Vaccins Mali CVD Mali, Bamako, Mali.; Orenstein, EW (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.	Orenstein.Evan@gmail.com	Rheingans, Richard D/P-1638-2017; Orenstein, Evan/CAH-5618-2022; Orenstein, Evan/ABG-3276-2021	Orenstein, Evan/0000-0003-3756-8575	Bill & Melinda Gates Foundation [OPP1002744]; American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship; Infectious Diseases Society of America Medical Scholars program; Emory University Global Health Institute Field Scholars program; Alpha Omega Alpha Carolyn Kuckein Student Research Award	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship; Infectious Diseases Society of America Medical Scholars program; Emory University Global Health Institute Field Scholars program; Alpha Omega Alpha Carolyn Kuckein Student Research Award	The clinical trial and participation of all authors was supported by the Bill & Melinda Gates Foundation (grant OPP1002744). Evan Orenstein's participation was supported by the American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program. Lauren Orenstein's participation was supported by the Alpha Omega Alpha Carolyn Kuckein Student Research Award, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program. The funding sources had no role in data collection, analysis, interpretation, design, or writing of this manuscript.; The authors thank the study and local health center personnel and study participants who made this work possible. In addition to the support of the Bill & Melinda Gates Foundation, Evan Orenstein's participation was supported by the American Society of Tropical Medicine & Hygiene Benjamin Kean Fellowship, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program. Lauren Orenstein's participation was also supported by the Alpha Omega Alpha Carolyn Kuckein Student Research Award, the Infectious Diseases Society of America Medical Scholars program, and the Emory University Global Health Institute Field Scholars program.	[Anonymous], INFLUENZA OTHER RESP; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Bhuiyan MU, 2014, INFLUENZA OTHER RESP, V8, P406, DOI 10.1111/irv.12254; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118884; Dao CN, 2010, J INFECT DIS, V202, P881, DOI 10.1086/655904; de Francisco N, 2015, VACCINE, V33, P6537, DOI 10.1016/j.vaccine.2015.10.066; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Eick AA, 2011, ARCH PEDIATR ADOLESC, V165; Fell D, 2016, BJOG INT J OBSTET GY; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Griffiths UK, 2004, B WORLD HEALTH ORGAN, V82, P643; Healy CM, 2007, PEDIATR INFECT DIS J, V26, P945, DOI 10.1097/INF.0b013e318156c18c; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jit M, 2010, VACCINE, V29, P115, DOI 10.1016/j.vaccine.2010.08.078; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Matias G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3128-4; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Myers ER, 2011, AM J OBSTET GYNECOL, V204, pS128, DOI 10.1016/j.ajog.2011.04.009; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nunes MC, 2015, HUM VACC IMMUNOTHER, V11, P2538, DOI 10.1080/21645515.2015.1059976; Omer SB, 2015, VACCINE, V33, P3801, DOI 10.1016/j.vaccine.2015.05.077; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tapia MD, 2016, LANCET INFECT DIS; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	34	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171499	10.1371/journal.pone.0171499	http://dx.doi.org/10.1371/journal.pone.0171499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170416	Green Submitted, Green Published, gold			2022-12-27	WOS:000393705500041
J	Clements, CS; Hay, ME				Clements, Cody S.; Hay, Mark E.			Size matters: Predator outbreaks threaten foundation species in small Marine Protected Areas	PLOS ONE			English	Article							OF-THORNS STARFISH; CORAL-REEF MANAGEMENT; ACANTHASTER-PLANCI L; GREAT-BARRIER-REEF; L ECHINODERMATA; RESERVES; CONSERVATION; ASTEROIDEA; AGGREGATIONS; MESOPREDATOR	The unanticipated impacts of consumers in fragmented habitats are frequently a challenge for ecosystem management. On Indo-Pacific coral reefs, crown-of-thorns sea stars (Acanthaster spp.) are coral predators whose outbreaks cause precipitous coral decline. Across large spatial scales, Acanthaster densities are lower in large no-take Marine Protected Areas (MPAs) and reefs subject to limited human exploitation. However, using a combination of observational and manipulative experiments, we found that Acanthaster densities within a network of small, no-take MPAs on reef flats in Fiji were similar to 2-3.4 times greater inside MPAs than in adjacent fished areas an similar to 2-2.5 times greater than the upper threshold density indicative of an outbreak. This appeared to result from selective Acanthaster migration to the coral-rich MPAs from fished areas that are coral-poor and dominated by macroalgae. Small MPAs can dramatically increase the cover of foundation species like corals, but may selectively attract coral predators like Acanthaster due to greater food densities within MPAs or because the MPAs are too small to support Acanthaster enemies. As coral cover increases, their chemical and visual cues may concentrate Acanthasterto outbreak densities that cause coral demise, compromising the value of small MPAs. An understanding of predator dynamics as a function of habitat type, size, and fragmentation needs to be incorporated into MPA design and management.	[Clements, Cody S.; Hay, Mark E.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Hay, ME (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	NSF [OCE-0929119]; NIH ICBG [U19TW007401]; Teasley Endowment; FOGARTY INTERNATIONAL CENTER [U19TW007401] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH ICBG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Teasley Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Financial support provided by NSF grant OCE-0929119, NIH ICBG grant U19TW007401, and the Teasley Endowment to the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; BARNES DS, 1970, NATURE, V228, P342, DOI 10.1038/228342a0; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Bonaldo RM, PLOS ONE IN PRESS; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Bonito V, 2014, NA09NOS4630017 NOAA; Brashares Justin S., 2010, P221; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Christianen M.J.A., 2014, P R SOC B, V281, P1777; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clements C, 2012, MAR ECOL PROG SER, V449, P233, DOI 10.3354/meps09554; Clements CS, 2015, P ROY SOC B-BIOL SCI, V282, P221, DOI 10.1098/rspb.2015.0714; Costello MJ, 2015, TRENDS ECOL EVOL, V30, P507, DOI 10.1016/j.tree.2015.06.011; Cowan ZL, 2016, CORAL REEFS, V35, P1253, DOI 10.1007/s00338-016-1491-3; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DANA TF, 1972, PAC SCI, V26, P355; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Engelhardt U., 1999, 30 CRC REEF RES CTR; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FERLIN V, 1973, HELGOLAND WISS MEER, V24, P151, DOI 10.1007/BF01609507; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goodwin BJ, 1999, OIKOS, V84, P160, DOI 10.2307/3546877; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jupiter Stacy D., 2014, Pacific Conservation Biology, V20, P165; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kenyon JC, 2009, B MAR SCI, V84, P199; Landman M, 2014, ECOL APPL, V24, P2002, DOI 10.1890/14-0080.1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2003, ECOL APPL, V13, pS3; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; MORAN PJ, 1992, MAR BIOL, V113, P509, DOI 10.1007/BF00349178; Moutardier G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137605; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Ohgushi T, 2012, TRAIT MEDIATED INDIR; ORMOND RFG, 1973, NATURE, V246, P167, DOI 10.1038/246167a0; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Pratchett MS, 2005, CORAL REEFS, V24, P453, DOI 10.1007/s00338-005-0006-4; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Roberts CM, 2003, ECOL APPL, V13, pS199; Rocha JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134639; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; SCHEIBLING RE, 1981, J EXP MAR BIOL ECOL, V51, P173, DOI 10.1016/0022-0981(81)90127-1; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sigl R, 2016, SCI REP-UK, V6, DOI 10.1038/srep30834; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; ZANN L, 1987, B MAR SCI, V41, P561; Zollner PA, 1999, OIKOS, V84, P164, DOI 10.2307/3546878	55	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171569	10.1371/journal.pone.0171569	http://dx.doi.org/10.1371/journal.pone.0171569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166257	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100054
J	Pficer, JK; Dodic, S; Lazic, V; Trajkovic, G; Milic, N; Milicic, B				Pficer, Jovana Kuzmanovic; Dodic, Slobodan; Lazic, Vojkan; Trajkovic, Goran; Milic, Natasa; Milicic, Biljana			Occlusal stabilization splint for patients with temporomandibular disorders: Meta-analysis of short and long term effects	PLOS ONE			English	Article							GENERAL DENTAL PRACTICE; EVIDENCE-BASED MEDICINE; QUALITY-OF-LIFE; MYOFASCIAL PAIN; APPLIANCE THERAPY; MANAGEMENT; DYSFUNCTION; EFFICACY; INTERVENTIONS; DISPLACEMENT	Background Psychological discomfort, physical disability and functional limitations of the orofacial system have a major impact on everyday life of patients with temporomandibular disorders (TMDs). In this study we sought to determine short and long term effects of stabilization splint (SS) in treatment of TMDs, and to identify factors influencing its efficacy. Methods MEDLINE, Web of Science and EMBASE were searched for randomized controlled trials (RCTs) comparing SS to: non-occluding splint, occlusal oral appliances, physiotherapy, behavioral therapy, counseling and no treatment. Random effects method was used to summarize outcomes. The effect estimates were expressed as odds ratio (OR) or standardized mean difference (SMD) with 95% confidence interval. Subgroup analyses were carried out according to the use of Research Diagnostic Criteria (RDC/TMD) and TMDs origin. Strength of evidence was assessed by GRADE. Meta-regression was applied. Results Thirty three eligible RCTs were included in meta-analysis. In short term, SS presented positive overall effect on pain reduction (OR 2.08; p = 0.01) and pain intensity (SMD -0.33; p = 0.02). Subgroup analyses confirmed SS effect in studies used RDC/TMD and revealed its effect in patients with TMDs of muscular origin. Important decrease of muscle tenderness (OR 1.97; p = 0.03) and improvement of mouth opening (SMD -0.30; p = 0.04) were found. SS in comparison to oral appliances showed no difference (OR 0.74; p = 0.24). Meta-regression identified continuous use of SS during the day as a factor influencing efficacy (p = 0.01). Long term results showed no difference in observed outcomes between groups. Low quality of evidence was found for primary outcomes. Conclusion SS presented short term benefit for patients with TMDs. In long term follow up, the effect is equalized with other therapeutic modalities. Further studies based on appropriate use of standardized criteria for patient recruitment and outcomes under assessment are needed to better define SS effect persistence in long term.	[Pficer, Jovana Kuzmanovic; Milicic, Biljana] Univ Belgrade, Sch Dent Med, Dept Med Stat & Informat, Belgrade, Serbia; [Dodic, Slobodan; Lazic, Vojkan] Univ Belgrade, Sch Dent Med, Dept Prosthodont, Belgrade, Serbia; [Trajkovic, Goran; Milic, Natasa] Univ Belgrade, Sch Med, Dept Med Stat & Informat, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Pficer, JK (corresponding author), Univ Belgrade, Sch Dent Med, Dept Med Stat & Informat, Belgrade, Serbia.	jovana57@yahoo.com						Aggarwal V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008456.pub2; Al Quran FAM, 2006, ORAL SURG ORAL MED O, V101, P741, DOI 10.1016/j.tripleo.2005.04.021; Al-Ani MZ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002778.PUB2; Al-Ani Ziad, 2005, J Dent Educ, V69, P1242; Almoznino G, 2015, J ORAL FACIAL PAIN H, V29, P231, DOI 10.11607/ofph.1413; Carlson CR, 2001, J OROFAC PAIN, V15, P47; Christidis N, 2014, J ORAL FACIAL PAIN H, V28, P128, DOI 10.11607/ofph.1216; Clark G, 2004, J OROFAC PAIN, V18, P23; Conti PCR, 2012, J ORAL REHABIL, V39, P754, DOI 10.1111/j.1365-2842.2012.02327.x; DAHLSTROM L, 1985, ACTA ODONTOL SCAND, V43, P109, DOI 10.3109/00016358509046495; Daif ET, 2012, ACTA ODONTOL SCAND, V70, P72, DOI 10.3109/00016357.2011.597776; DAO TTT, 1994, PAIN, V56, P85, DOI 10.1016/0304-3959(94)90153-8; Doepel M, 2012, J ORAL REHABIL, V39, P252, DOI 10.1111/j.1365-2842.2011.02261.x; Drangsholt M, 1999, EPIDEMIOLOGY PAIN, P203; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Ebrahim S, 2012, J AM DENT ASSOC, V143, P847, DOI 10.14219/jada.archive.2012.0289; Ekberg E, 2004, ACTA ODONTOL SCAND, V62, P343, DOI 10.1080/00016350410010063; Ekberg E, 2003, J OROFAC PAIN, V17, P133; Ekberg E, 1998, ACTA ODONTOL SCAND, V56, P122, DOI 10.1080/00016359850136102; Ekberg E, 2002, INT J PROSTHODONT, V15, P564; Fillingim RB, 2011, J PAIN, V12, pT46, DOI 10.1016/j.jpain.2011.08.007; Forssell H, 2004, J OROFAC PAIN, V18, P9; Fricton J, 2010, J OROFAC PAIN, V24, P237; Glaros AG, 2007, J ORAL REHABIL, V34, P97, DOI 10.1111/j.1365-2842.2006.01660.x; Glaros AG, 2007, APPL PSYCHOPHYS BIOF, V32, P149, DOI 10.1007/s10484-007-9039-5; GLASS EG, 1993, CRANIO, V11, P25; GRAY RJM, 1991, BRIT DENT J, V170, P55, DOI 10.1038/sj.bdj.4807416; Greene CS, 2010, J AM DENT ASSOC, V141, P1086, DOI 10.14219/jada.archive.2010.0337; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Ismail F, 2007, J ORAL REHABIL, V34, P807, DOI 10.1111/j.1365-2842.2007.01748.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHANSSON A, 1991, ACTA ODONTOL SCAND, V49, P153, DOI 10.3109/00016359109005900; Katyayan Preeti Agarwal, 2014, J Indian Prosthodont Soc, V14, P251, DOI 10.1007/s13191-013-0320-4; Kreiner M, 2001, J AM DENT ASSOC, V132, P770, DOI 10.14219/jada.archive.2001.0274; Kuttila M, 2002, ACTA ODONTOL SCAND, V60, P248, DOI 10.1080/000163502760148034; List Thomas, 1993, Journal of Orofacial Pain, V7, P275; LUNDH H, 1992, ORAL SURG ORAL MED O, V73, P655, DOI 10.1016/0030-4220(92)90003-9; Macfarlane TV, 2001, J DENT, V29, P451, DOI 10.1016/S0300-5712(01)00041-0; Magnusson T, 2000, J OROFAC PAIN, V14, P310; Maixner W, 2011, J PAIN, V12, pT4, DOI 10.1016/j.jpain.2011.08.002; McNeill C, 1997, J PROSTHET DENT, V77, P510, DOI 10.1016/S0022-3913(97)70145-8; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mora MCS, 2013, CLIN J PAIN, V29, P1057, DOI 10.1097/AJP.0b013e3182850559; Niemela K, 2012, J ORAL REHABIL, V39, P799, DOI 10.1111/j.1365-2842.2012.02335.x; Nilner M, 2008, J OROFAC PAIN, V22, P209; Nitecka-Buchta A, 2014, ENDOKRYNOL POL, V65, P217, DOI 10.5603/EP.2014.0030; Oz S, 2010, J CRANIOFAC SURG, V21, P1722, DOI 10.1097/SCS.0b013e3181f3c76c; RAMFJORD SP, 1994, J ORAL REHABIL, V21, P491, DOI 10.1111/j.1365-2842.1994.tb01164.x; RAUSTIA AM, 1985, J PROSTHET DENT, V54, P581, DOI 10.1016/0022-3913(85)90440-8; Roldan-Barraza C, 2014, J ORAL FACIAL PAIN H, V28, P205, DOI 10.11607/ofph.1241; Rubinoff M S, 1987, Gen Dent, V35, P502; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Slade GD, 2013, J PAIN, V14, pT20, DOI 10.1016/j.jpain.2013.07.014; Stiesch-Scholz M, 2005, J ORAL REHABIL, V32, P474, DOI 10.1111/j.1365-2842.2005.01452.x; Truelove E, 2006, J AM DENT ASSOC, V137, P1099, DOI 10.14219/jada.archive.2006.0348; Turp JC, 2007, CLIN ORAL IMPLAN RES, V18, P127, DOI 10.1111/j.1600-0501.2007.01445.x; TURK DC, 1993, J PROSTHET DENT, V70, P158, DOI 10.1016/0022-3913(93)90012-D; Turp J C, 2004, Clin Oral Investig, V8, P179, DOI 10.1007/s00784-004-0265-4; Wassell RW, 2006, J AM DENT ASSOC, V137, P1089, DOI 10.14219/jada.archive.2006.0347; Wassell RW, 2004, BRIT DENT J, V197, P35, DOI 10.1038/sj.bdj.4811420; Zhang FY, 2013, CHINESE MED J-PEKING, V126, P2270, DOI 10.3760/cmaj.issn.0366-6999.20130613	63	65	65	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171296	10.1371/journal.pone.0171296	http://dx.doi.org/10.1371/journal.pone.0171296			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166255	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100032
J	Tian, ZB; Zheng, BH; Wang, LJ; Li, LQ; Wang, X; Li, H; Norra, S				Tian, Zebin; Zheng, Binghui; Wang, Lijing; Li, Liqiang; Wang, Xing; Li, Hong; Norra, Stefan			Long term (1997-2014) spatial and temporal variations in nitrogen in Dongting Lake, China	PLOS ONE			English	Article							3 GORGES DAM; YANGTZE-RIVER; WATER-QUALITY; POYANG LAKE; PHOSPHORUS; PHYTOPLANKTON; IMPACTS; PROJECT; PERIOD; TAIHU	In order to protect the water quality of Dongting Lake, it is significant to find out its nitrogen pollution characteristics. Using long-term monthly to seasonally data (1997-2014), we investigated the spatial and temporal variations in nitrogen in Dongting Lake, the second largest freshwater lake in China. The average concentrations of total nitrogen (TN) in the eastern, southern, and western parts of the lake were 1.77, 1.56, and 1.35 mg/L, respectively, in 2014. TN pollution was generally worse in the southern area than in the western area. Concentrations showed temporal variation, and were significantly higher during the dry season than during the wet season. Based on the concentration and growth rate of TN, three different stages were identified in the long term lake data, from 1997 to 2002, from 2003 to 2008, and from 2009 to 2014, during which the concentrations and the growth rate ranged from 1.09-1.51 mg/L and 22.09%-40.03%, 1.05-1.57 mg/L and -9.05%-7.74%, and 1.68-2.02 mg/L and 57.99%-60.41%, respectively. The main controls on the lake water TN concentrations were the quality and quantity of the lake inflows, spatial and temporal variations in hydrodynamic conditions within the lake (flow velocity, flow direction), and point and nonpoint inputs from human activities. Diffuse nutrient losses from agricultural land are a significant contributor. As a priority, the local government should aim to control the pollutant inputs from upstream and non-point nutrient losses from land.	[Tian, Zebin; Zheng, Binghui] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Tian, Zebin; Zheng, Binghui; Wang, Lijing; Wang, Xing; Li, Hong] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing, Peoples R China; [Li, Liqiang] Ecol & Environm Monitoring Ctr Dongting Lake Huna, Yueyang, Peoples R China; [Norra, Stefan] Karlsruhe Inst Technol, Inst Geog & Geoecol, Karlsruhe, Germany	Beijing Normal University; Chinese Research Academy of Environmental Sciences; Helmholtz Association; Karlsruhe Institute of Technology	Zheng, BH (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Zheng, BH (corresponding author), Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing, Peoples R China.	zhengbh@craes.org.cn	Li, Liqiang/H-9094-2013; Norra, Stefan/G-7867-2012	Li, Liqiang/0000-0001-8399-3957; 	National Science and Technology Pillar Program of China [2014BAC09B02]; National natural Science Foundation of China [51609225]; National Basic Research Program of China [2012CB417004]	National Science and Technology Pillar Program of China; National natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Science and Technology Pillar Program of China (2014BAC09B02), National natural Science Foundation of China (51609225) and National Basic Research Program of China (2012CB417004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaszuk P, 2005, ECOL ENG, V25, P429, DOI 10.1016/j.ecoleng.2005.06.013; Chang JA, 2010, J GEOGR SCI, V20, P771, DOI 10.1007/s11442-010-0810-9; Chen YW, 2003, HYDROBIOLOGIA, V506, P273, DOI 10.1023/B:HYDR.0000008604.09751.01; China Statistic Yearbook Compilation Committee, 1997, CHIN STAT YB; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Du Y, 2001, GEOMORPHOLOGY, V41, P171, DOI 10.1016/S0169-555X(01)00114-3; Fellman JB, 2007, WETLANDS, V27, P44, DOI 10.1672/0277-5212(2007)27[44:NAPMIT]2.0.CO;2; Gao W, 2015, SCI TOTAL ENVIRON, V505, P376, DOI 10.1016/j.scitotenv.2014.10.016; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hayashi S, 2008, J HYDRO-ENVIRON RES, V2, P148, DOI 10.1016/j.jher.2008.10.002; Hong B, 2011, ENVIRON MODELL SOFTW, V26, P623, DOI 10.1016/j.envsoft.2010.11.012; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Hu Q, 2007, J HYDROL, V347, P90, DOI 10.1016/j.jhydrol.2007.09.005; Huang DaiZhong, 2013, Research of Environmental Sciences, V26, P27; Huang Q, 2014, WATER RESOUR MANAG, V28, P5377, DOI 10.1007/s11269-014-0807-8; Ji XH, 2011, PEDOSPHERE, V21, P753, DOI 10.1016/S1002-0160(11)60179-3; Lai XJ, 2014, HYDROL PROCESS, V28, P150, DOI 10.1002/hyp.10077; Li MT, 2007, ESTUAR COAST SHELF S, V71, P3, DOI 10.1016/j.ecss.2006.08.013; Liu SM, 2003, BIOGEOCHEMISTRY, V62, P1, DOI 10.1023/A:1021162214304; Ma X, 2011, SCI TOTAL ENVIRON, V412, P154, DOI 10.1016/j.scitotenv.2011.09.034; Ni ZK, 2015, ECOL ENG, V79, P42, DOI 10.1016/j.ecoleng.2015.03.005; Novotny Vladimir, 2010, Environment Development and Sustainability, V12, P491, DOI 10.1007/s10668-009-9207-2; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Pan BZ, 2009, FRESEN ENVIRON BULL, V18, P1894; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin DiLan, 2012, Environmental Science & Technology (China), V35, P193; Shen Ruili, 2007, Hupo Kexue, V19, P677; Smith LED, 2015, AGR ECOSYST ENVIRON, V209, P15, DOI 10.1016/j.agee.2015.02.016; Sokal MA, 2010, ECOHYDROLOGY, V3, P41, DOI 10.1002/eco.93; Sun ZD, 2012, WATER RESOUR MANAG, V26, P3367, DOI 10.1007/s11269-012-0076-3; SUTTLE CA, 1988, J PHYCOL, V24, P13; Wang LiJing, 2013, Research of Environmental Sciences, V26, P1; Wang LQ, 2014, AQUAT GEOCHEM, V20, P501, DOI 10.1007/s10498-014-9232-0; Wang Yan, 2014, Research of Environmental Sciences, V27, P484; Wu LH, 2011, PROCEDIA ENVIRON SCI, V10, P1496, DOI 10.1016/j.proenv.2011.09.238; Xie Y, 2012, ECOHYDROLOG IN PRESS; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yang SQ, 2010, J GREAT LAKES RES, V36, P150, DOI 10.1016/j.jglr.2009.12.010; Yang Y, 2012, ENVIRON POLLUT, V168, P170, DOI 10.1016/j.envpol.2012.04.017; Yao X, 2015, ENVIRON SCI POLLUT R, V22, P3032, DOI 10.1007/s11356-014-3579-z; Yao ZQ, 2009, APPL GEOCHEM, P2186; Yu T, 2010, ESTUARINE COASTAL SH, V86, P345, DOI DOI 10.1016/J.ECSS.2009.05.014; Yuan YJ, 2015, J HYDROL, V525, P450, DOI 10.1016/j.jhydrol.2015.04.010; Zhang T, 2014, HYDROL EARTH SYST SC, V18, P1493, DOI 10.5194/hess-18-1493-2014	46	15	21	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170993	10.1371/journal.pone.0170993	http://dx.doi.org/10.1371/journal.pone.0170993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166245	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100018
J	Varnai, C; Burkoff, NS; Wild, DL				Varnai, Csilla; Burkoff, Nikolas S.; Wild, David L.			Improving protein-protein interaction prediction using evolutionary information from low-quality MSAs	PLOS ONE			English	Article							CORRELATED MUTATIONS; CONTACT PREDICTIONS; RESIDUE CONTACTS; SEQUENCE; COEVOLUTION; INTERFACES; COMPLEMENTARITY; LIKELIHOOD; PHYLOGENY; FAMILIES	Evolutionary information stored in multiple sequence alignments (MSAs) has been used to identify the interaction interface of protein complexes, by measuring either co-conservation or co-mutation of amino acid residues across the interface. Recently, maximum entropy related correlated mutation measures (CMMs) such as direct information, decoupling direct from indirect interactions, have been developed to identify residue pairs interacting across the protein complex interface. These studies have focussed on carefully selected protein complexes with large, good-quality MSAs. In this work, we study protein complexes with a more typical MSA consisting of fewer than 400 sequences, using a set of 79 intramolecular protein complexes. Using a maximum entropy based CMM at the residue level, we develop an interface level CMM score to be used in re-ranking docking decoys. We demonstrate that our interface level CMM score compares favourably to the complementarity trace score, an evolutionary information-based score measuring co-conservation, when combined with the number of interface residues, a knowledge-based potential and the variability score of individual amino acid sites. We also demonstrate, that, since co-mutation and co-complementarity in the MSA contain orthogonal information, the best prediction performance using evolutionary information can be achieved by combining the co-mutation information of the CMM with co-conservation information of a complementarity trace score, predicting a near-native structure as the top prediction for 41% of the dataset. The method presented is not restricted to small MSAs, and will likely improve interface prediction also for complexes with large and good-quality MSAs.	[Varnai, Csilla; Burkoff, Nikolas S.; Wild, David L.] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Varnai, Csilla] Babraham Inst, Nucl Dynam Programme, Cambridge, England	University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Wild, DL (corresponding author), Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England.	d.l.wild@warwick.ac.uk	Várnai, Csilla/AAB-6348-2022	Várnai, Csilla/0000-0003-0048-9507	Leverhulme Trust [F/00 215/BL]; Engineering and Science Research Council [EP/J020281/1]; Engineering and Physical Sciences Research Council [EP/J020281/1] Funding Source: researchfish; EPSRC [EP/J020281/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); Engineering and Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Leverhulme Trust (NSB, CV, DLW) F/00 215/BL and Engineering and Science Research Council (DLW) EP/J020281/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop JD, 2015, PROTEINS, V83, P1940, DOI 10.1002/prot.24788; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2009, PROTEINS, V74, P545, DOI 10.1002/prot.22168; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Burkoff NS, 2013, BIOINFORMATICS, V29, P580, DOI 10.1093/bioinformatics/btt005; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Choi SS, 2005, NAT GENET, V37, P1367, DOI 10.1038/ng1685; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Colwell LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107723; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dwyer RS, 2013, GENETICS, V195, P443, DOI 10.1534/genetics.113.155861; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Jaynes ET, 2007, PROBABILITY THEORY T; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landgraf R, 2001, J MOL BIOL, V307, P1487, DOI 10.1006/jmbi.2001.4540; Lapedes A, 2002, ARXIV12072484V1; Lapedes A.S., 1999, LECT NOTES MONOGR SE, V33, P236, DOI [10.1214/lnms/1215455556, DOI 10.1214/LNMS/1215455556]; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MacKay D. J. C., 2003, INFORM THEORY INFERE; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Saqi MAS, 1999, BIOINFORMATICS, V15, P521, DOI 10.1093/bioinformatics/15.6.521; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109; Taylor WR, 2013, CURR OPIN STRUC BIOL, V23, P473, DOI 10.1016/j.sbi.2013.04.001; van Dijk ADJ, 2005, PROTEINS, V60, P232, DOI 10.1002/prot.20563; Varnai C, 2013, J CHEM THEORY COMPUT, V9, P5718, DOI 10.1021/ct400628h; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106	56	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0169356	10.1371/journal.pone.0169356	http://dx.doi.org/10.1371/journal.pone.0169356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166227	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100001
J	Yamashiro, K; Tanaka, R; Urabe, T; Ueno, Y; Yamashiro, Y; Nomoto, K; Takahashi, T; Tsuji, H; Asahara, T; Hattori, N				Yamashiro, Kazuo; Tanaka, Ryota; Urabe, Takao; Ueno, Yuji; Yamashiro, Yuichiro; Nomoto, Koji; Takahashi, Takuya; Tsuji, Hirokazu; Asahara, Takashi; Hattori, Nobutaka			Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; CARDIOVASCULAR-DISEASE; INTESTINAL MICROBIOTA; SECULAR TRENDS; RISK-FACTORS; BACTERIA; PCR; PHOSPHATIDYLCHOLINE; ATHEROSCLEROSIS; ENDOTOXEMIA	The role of metabolic diseases in ischemic stroke has become a primary concern in both research and clinical practice. Increasing evidence suggests that dysbiosis is associated with metabolic diseases. The aim of this study was to investigate whether the gut microbiota, as well as concentrations of organic acids, the major products of dietary fiber fermentation by the gut microbiota, are altered in patients with ischemic stroke, and to examine the association between these changes and host metabolism and inflammation. We analyzed the composition of the fecal gut microbiota and the concentrations of fecal organic acids in 41 ischemic stroke patients and 40 control subjects via 16S and 23S rRNA-targeted quantitative reverse transcription (qRT)-PCR and high-performance liquid chromatography analyses, respectively. Multivariable linear regression analysis was subsequently performed to evaluate the relationships between ischemic stroke and bacterial counts and organic acid concentrations. Correlations between bioclinical markers and bacterial counts and organic acids concentrations were also evaluated. Although only the bacterial counts of Lactobacillus ruminis were significantly higher in stroke patients compared to controls, multivariable analysis showed that ischemic stroke was independently associated with increased bacterial counts of Atopobium cluster and Lactobacillus ruminis, and decreased numbers of Lactobacillus sakei subgroup, independent of age, hypertension, and type 2 diabetes. Changes in the prevalence of Lactobacillus ruminis were positively correlated with serum interleukin-6 levels. In addition, ischemic stroke was associated with decreased and increased concentrations of acetic acid and valeric acid, respectively. Meanwhile, changes in acetic acid concentrations were negatively correlated with the levels of glycated hemoglobin and low density lipoprotein cholesterol, whereas changes in valeric acid concentrations were positively correlated with the level of high sensitivity C-reactive protein and with white blood cell counts. Together, our findings suggest that gut dysbiosis in patients with ischemic stroke is associated with host metabolism and inflammation.	[Yamashiro, Kazuo; Tanaka, Ryota; Ueno, Yuji; Hattori, Nobutaka] Juntendo Univ, Dept Neurol, Sch Med, Tokyo, Japan; [Urabe, Takao] Juntendo Univ, Dept Neurol, Urayasu Hosp, Chiba, Japan; [Yamashiro, Yuichiro; Nomoto, Koji; Takahashi, Takuya] Juntendo Univ, Probiot Res Lab, Grad Sch Med, Tokyo, Japan; [Nomoto, Koji; Takahashi, Takuya; Tsuji, Hirokazu; Asahara, Takashi] Yakult Cent Inst, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Yakult Honsha Company, Limited	Yamashiro, K; Hattori, N (corresponding author), Juntendo Univ, Dept Neurol, Sch Med, Tokyo, Japan.	kazuo-y@juntendo.ac.jp; nhattori@juntendo.ac.jp	Ueno, Yuji/ABB-2492-2020; Hattori, Nobutaka/ACR-0069-2022	Hirokazu, Tsuji/0000-0003-2856-6447	Yakult Central Institute	Yakult Central Institute	This study was supported by Yakult Central Institute. The funder provided support in the form of salaries for authors [YY KN TT HT TA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham TM, 2015, DIABETES CARE, V38, P482, DOI 10.2337/dc14-1432; Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Cohen JD, 2010, AM J CARDIOL, V106, P969, DOI 10.1016/j.amjcard.2010.05.030; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Harmsen P, 2009, STROKE, V40, P2691, DOI 10.1161/STROKEAHA.109.550814; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Karlsson C, 2010, ATHEROSCLEROSIS, V208, P228, DOI 10.1016/j.atherosclerosis.2009.06.019; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Katano Y, 2012, STAND GENOMIC SCI, V6, P406, DOI 10.4056/sigs.2826118; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kondo T, 2009, BIOSCI BIOTECH BIOCH, V73, P1837, DOI 10.1271/bbb.90231; Kubo M, 2008, CIRCULATION, V118, P2672, DOI 10.1161/CIRCULATIONAHA.107.743211; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Stsepetova J, 2011, BRIT J NUTR, V105, P1235, DOI 10.1017/S0007114510004770; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verbeke KA, 2015, NUTR RES REV, V28, P42, DOI 10.1017/S0954422415000037; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498; Winek K, 2016, J CEREBR BLOOD F MET, V36, P891, DOI 10.1177/0271678X16636890; Yin J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002699; Zhou XL, 2014, NUTR RES, V34, P780, DOI 10.1016/j.nutres.2014.08.008; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	49	147	157	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171521	10.1371/journal.pone.0171521	http://dx.doi.org/10.1371/journal.pone.0171521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166278	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100050
J	Irure, J; Asensio, E; Rodrigo, E; Romon, I; Gomez, J; Arias, M; Lopez-Hoyos, M; Segundo, DS				Irure, Juan; Asensio, Esther; Rodrigo, Emilio; Romon, Inigo; Gomez, Javier; Arias, Manuel; Lopez-Hoyos, Marcos; Segundo, David San			Improvement in the definition of anti-HLA antibody profile in highly sensitized patients	PLOS ONE			English	Article							COMPLEMENT INTERFERENCE; KIDNEY-TRANSPLANT; STRENGTH	The definition of anti-HLA antibody profile in highly sensitized patients on a waiting list is crucial when virtual crossmatch is used in organ allocation systems, but also when used to identify the true deleterious anti-HLA antibodies. Here we propose different levels of risk based on the results of anti-HLA antibody testing in neat serum (N) and after sera dilution (DIL) and C1q test in 18 highly sensitized patients. This group was heterogeneous in terms of anti-HLA antibody titers and their ability to fix complement. After dilution, 15 out of 18 patients (83.3%) showed a reduction of positive bead counts whereas 4 patients showed a prozone effect and complement fixation was demonstrated. The high dilution of sera and ascertaining the complement fixation allow the accurate definition of risk anti-HLA antibody profiles in highly sensitized patients, as demonstrated in 5 of the sensitized patients who were transplanted.	[Irure, Juan; Asensio, Esther; Lopez-Hoyos, Marcos; Segundo, David San] Univ Hosp Marques de Valdecilla, Serv Immunol, IDIVAL, Santander, Spain; [Irure, Juan; Asensio, Esther; Romon, Inigo; Lopez-Hoyos, Marcos; Segundo, David San] Univ Hosp Marques de Valdecilla, Tissue Typing Lab, Santander, Spain; [Rodrigo, Emilio; Arias, Manuel] Univ Hosp Marques de Valdecilla, Serv Nephrol, IDIVAL, Santander, Spain; [Gomez, Javier] Univ Hosp Marques de Valdecilla, Pathol Serv, IDIVAL, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Segundo, DS (corresponding author), Univ Hosp Marques de Valdecilla, Serv Immunol, IDIVAL, Santander, Spain.; Segundo, DS (corresponding author), Univ Hosp Marques de Valdecilla, Tissue Typing Lab, Santander, Spain.	dsansegundo@humv.es	José Javier, Gómez-Román/AAC-8156-2021; López-Hoyos, Marcos/ABC-1024-2020; Romón, Iñigo/M-3497-2019; San Segundo, David/O-9499-2016	José Javier, Gómez-Román/0000-0002-2849-9435; López-Hoyos, Marcos/0000-0003-0562-427X; Romón, Iñigo/0000-0003-2428-4469; San Segundo, David/0000-0001-5745-9072				Berth M, 2015, AM J TRANSPLANTATION; Bray RA, 2009, CURR OPIN ORGAN TRAN, V14, P392, DOI 10.1097/MOT.0b013e32832d31c7; Endres RO, 2010, TRANSFUSION, V50, P1749, DOI 10.1111/j.1537-2995.2010.02589.x; Guidicelli G, 2013, TRANSPL IMMUNOL, V29, P17, DOI 10.1016/j.trim.2013.09.005; Jackson Annette M, 2014, Clin Transpl, P131; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; Minucci PB, 2011, EXP CLIN TRANSPLANT, V9, P381; Morris GP, 2010, HUM IMMUNOL, V71, P268, DOI 10.1016/j.humimm.2010.01.003; Tait BD, 2010, TISSUE ANTIGENS, V76, P87, DOI 10.1111/j.1399-0039.2010.01486.x; Tait BD, 2013, TRANSPLANTATION, V95, P19, DOI 10.1097/TP.0b013e31827a19cc; Tambur AR, 2015, AM J TRANSPLANT, V15, P2421, DOI 10.1111/ajt.13295; Tambur AR, 2009, AM J TRANSPLANT, V9, P1886, DOI 10.1111/j.1600-6143.2009.02724.x; Visentin J, 2015, AM J TRANSPLANT, V15, P3271, DOI 10.1111/ajt.13452; Visentin J, 2014, TRANSPLANTATION, V98, P625, DOI 10.1097/TP.0000000000000315	14	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171463	10.1371/journal.pone.0171463	http://dx.doi.org/10.1371/journal.pone.0171463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158255	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700082
J	Li, YH; Wang, HP; Yao, H; O'Bryant, P; Rapp, D; Guo, L; Waly, EA				Li, Yan-He; Wang, Han-Ping; Yao, Hong; O'Bryant, Paul; Rapp, Dean; Guo, Liang; Waly, Eman A.			De novo transcriptome sequencing and analysis of male, pseudo-male and female yellow perch, Perca flavescens	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; KINASE TYPE M2; PYRUVATE-KINASE; CELL-PROLIFERATION; GENE-EXPRESSION; TUMOR-GROWTH; ANNOTATION; MARKERS; GENOME; DIFFERENTIATION	Transcriptome sequencing could facilitate discovery of sex-biased genes, biological pathways and molecular markers, which could help clarify the molecular mechanism of sex determination and sexual dimorphism, and assist with selective breeding in aquaculture. Yellow perch has unique gonad system and sexual dimorphism and is an alternative model to study mechanism of sex determination, sexual dimorphism and sexual selection. In this study, we performed the de novo assembly of yellow perch gonads and muscle transcriptomes by high throughput Illumina sequencing. A total of 212,180 contigs were obtained, ranging from 127 to 64,876 bp, and N50 of 1,066 bp. The assembly RNA-Seq contigs (>= 200bp) were then used for subsequent analyses, including annotation, pathway analysis, and microsatellites discovery. No female-and pseudo-male-biased genes were involved in any pathways while male-biased genes were involved in 29 pathways, and neuroactive ligand receptor interaction and enzyme of trypsin (enzyme code, EC: 3.4.21.4) was highly involved. Pyruvate kinase (enzyme code, EC: 2.7.1.40), which plays important roles in cell proliferation, was highly expressed in muscles. In addition, a total of 183,939 SNPs, 11,286 InDels and 41,479 microsatellites were identified. This study is the first report on transcriptome information in Percids, and provides rich resources for conducting further studies on understanding the molecular basis of sex determinations, sexual dimorphism, and sexual selection in fish, and for population studies and marker-assisted selection in Percids.	[Li, Yan-He; Wang, Han-Ping; Yao, Hong; O'Bryant, Paul; Rapp, Dean; Guo, Liang; Waly, Eman A.] Ohio State Univ South Ctr, Fish Genet & Breeding Lab, Piketon, OH 45661 USA; [Li, Yan-He] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Wang, HP (corresponding author), Ohio State Univ South Ctr, Fish Genet & Breeding Lab, Piketon, OH 45661 USA.	wang.900@osu.edu		Abd El-Gawad, Eman/0000-0001-7516-2969; Li, Yanhe/0000-0001-6451-4527	National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture [2010-38879-20946]	National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture	This study was supported by the National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture, under Agreement 2010-38879-20946. Salaries and research support were provided by state and federal funds appropriated to The Ohio State University, Ohio Agricultural Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Blazer VS, 2013, SCI TOTAL ENVIRON, V447, P198, DOI 10.1016/j.scitotenv.2012.12.088; Buermans H. P., 2014, BIOCH BIOPHYSICA ACT; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Carmichael SN, 2013, BIOMED RES INT, V14, P408, DOI DOI 10.1155/2014/291067; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; de Cerio OD, 2012, ENVIRON SCI TECHNOL, V46, P7763, DOI 10.1021/es301132b; Doll JC, 2013, T AM FISH SOC, V142, P1012, DOI 10.1080/00028487.2013.793615; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Gruning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017; Grzybowski M, 2010, T AM FISH SOC, V139, P270, DOI 10.1577/T07-276.1; Guo WH, 2011, J CANCER RES CLIN, V137, P65, DOI 10.1007/s00432-010-0860-5; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Henderson BA, 2003, CAN J FISH AQUAT SCI, V60, P1345, DOI 10.1139/F03-115; Hood L, 2014, GENETICS GENES GENOM; Krist'an J, 2012, TURK J FISH AQUAT SC, V12, P191, DOI 10.4194/1303-2712-v12_2_01; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Lu JG, 2014, PHYSIOL GENOMICS, V46, P798, DOI 10.1152/physiolgenomics.00088.2014; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Lynn SG, 2006, THESIS; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; MALISON JA, 1986, CAN J FISH AQUAT SCI, V43, P26, DOI 10.1139/f86-004; Manousaki T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-655; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Munro Cathy L., 2012, Proceedings of the Nova Scotian Institute of Science, V47, P131; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoenebeck C, 2012, T AM FISH SOC, V141, P199, DOI 10.1080/00028487.2012.655119; Sharma E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-400; Sun LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050676; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Uphoff CS, 2012, J FRESHWATER ECOL, V27, P507, DOI 10.1080/02705060.2012.684893; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Wei J, 2013, PHYSIOL GENOMICS, V45, P171, DOI 10.1152/physiolgenomics.00139.2011; Wu CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6227; Xue P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144458; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	49	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171187	10.1371/journal.pone.0171187	http://dx.doi.org/10.1371/journal.pone.0171187			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158238	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700038
J	Pieters, M; Barnard, SA; Loots, DT; Rijken, DC				Pieters, Marlien; Barnard, Sunelle A.; Loots, Du Toit; Rijken, Dingeman C.			RETRACTED: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays (Retracted article. See vol. 13, art. e0202381, 2018)	PLOS ONE			English	Article; Retracted Publication							ATHEROSCLEROSIS; PAI-1	Due to controversial evidence in the literature pertaining to the activity of plasminogen activator inhibitor-1 in platelets, we examined the effects of residual platelets present in plasma (a potential pre-analytical variable) on various plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays. Blood samples were collected from 151 individuals and centrifuged at 352 and 1500 g to obtain plasma with varying numbers of platelet. In a follow-up study, blood samples were collected from an additional 23 individuals, from whom platelet-poor (2000 g), platelet-containing (352 g) and platelet-rich plasma (200 g) were prepared and analysed as fresh-frozen and after five defrost-refreeze cycles (to determine the contribution of in vitro platelet degradation). Plasminogen activator inhibitor-1 activity, plasminogen activator inhibitor-1 antigen, tissue plasminogen activator/plasminogen activator inhibitor-1 complex, plasma clot lysis time, beta-thromboglobulin and plasma platelet count were analysed. Platelet a-granule release (plasma beta-thromboglobulin) showed a significant association with plasminogen activator inhibitor-1 antigen levels but weak associations with plasminogen activator inhibitor-1 activity and a functional marker of fibrinolysis, clot lysis time. Upon dividing the study population into quartiles based on beta-thromboglobulin levels, plasminogen activator inhibitor-1 antigen increased significantly across the quartiles while plasminogen activator inhibitor-1 activity and clot lysis time tended to increase in the 4(th) quartile only. In the follow-up study, plasma plasminogen activator inhibitor-1 antigen was also significantly influenced by platelet count in a concentration-dependent manner. Plasma plasminogen activator inhibitor-1 antigen levels increased further after complete platelet degradation. Residual platelets in plasma significantly influence plasma plasminogen activator inhibitor-1 antigen levels mainly through release of latent plasminogen activator inhibitor-1 with limited effects on plasminogen activator inhibitor-1 activity, tissue plasminogen activator/plasminogen activator inhibitor-1 complex or plasma clot lysis time. Platelets may however also have functional effects on plasma fibrinolytic potential in the presence of high platelet counts, such as in platelet-rich plasma.	[Pieters, Marlien; Barnard, Sunelle A.] North West Univ, Ctr Excellence Nutr, Potchefstroom, North West Prov, South Africa; [Loots, Du Toit] North West Univ, Human Metabol, Potchefstroom, North West Prov, South Africa; [Rijken, Dingeman C.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands	North West University - South Africa; North West University - South Africa; Erasmus University Rotterdam; Erasmus MC	Pieters, M (corresponding author), North West Univ, Ctr Excellence Nutr, Potchefstroom, North West Prov, South Africa.	marlien.pieters@nwu.ac.za	Pieters, Marlien/AAI-1711-2020; Loots, Du Toit/U-1360-2017	Pieters, Marlien/0000-0003-2849-6370; Loots, Du Toit/0000-0002-0339-6237; Barnard, Sunelle/0000-0001-5384-7326	National Research Foundation (NRF) of South Africa [94213]; South African Medical Research Council	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Research Foundation (NRF) of South Africa (Grant UID: 94213) (http://www.nrf.ac.za) and the South African Medical Research Council (http://www.mrc.ac.za). Opinions expressed and conclusions arrived at, are those of the authors and are not to be attributed to the NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Bastard JP, 1999, BIOMED PHARMACOTHER, V53, P455, DOI 10.1016/S0753-3322(00)88103-2; Bath PMW, 1996, BLOOD COAGUL FIBRIN, V7, P157, DOI 10.1097/00001721-199603000-00011; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Brogren H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026762; DECLERCK P J, 1988, Blood, V71, P220; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; Gils A, 2004, CURR MED CHEM, V11, P2323, DOI 10.2174/0929867043364595; Gurney D, 2002, AM J HEMATOL, V70, P139, DOI 10.1002/ajh.10097; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; JUHANVAGUE I, 1987, THROMB HAEMOSTASIS, V58, P1096; Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515; KRUITHOF EKO, 1988, ENZYME, V40, P113, DOI 10.1159/000469153; Lisman T, 2005, BLOOD, V105, P1102, DOI 10.1182/blood-2004-08-3253; Loskutoff DJ, 1999, APMIS, V107, P54, DOI 10.1111/j.1699-0463.1999.tb01526.x; LOSKUTOFF DJ, 1990, ANN NY ACAD SCI, V598, P238, DOI 10.1111/j.1749-6632.1990.tb42296.x; Merolla M, 2012, INT J LAB HEMATOL, V34, P81, DOI 10.1111/j.1751-553X.2011.01360.x; Nordenhem A, 1997, SCAND J CLIN LAB INV, V57, P453, DOI 10.3109/00365519709084594; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; Peng YM, 2008, NEPHROLOGY, V13, P579, DOI 10.1111/j.1440-1797.2008.00987.x; Rifkin DB, 1999, APMIS, V107, P80, DOI 10.1111/j.1699-0463.1999.tb01529.x; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284; SANCHO E, 1994, EUR J BIOCHEM, V224, P125, DOI 10.1111/j.1432-1033.1994.tb20003.x; SERIZAWA K, 1993, THROMB RES, V71, P289, DOI 10.1016/0049-3848(93)90198-W; Smith A, 2005, CIRCULATION, V112, P3080, DOI 10.1161/CIRCULATIONAHA.105.557132; SPRENGERS ED, 1987, BLOOD, V69, P381	27	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171271	10.1371/journal.pone.0171271	http://dx.doi.org/10.1371/journal.pone.0171271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158230	Green Published, gold			2022-12-27	WOS:000396161700050
J	Pornsuwan, S; Maenpuen, S; Kamutira, P; Watthaisong, P; Thotsaporn, K; Tongsook, C; Juttulapa, M; Nijvipakul, S; Chaiyen, P				Pornsuwan, Soraya; Maenpuen, Somchart; Kamutira, Philaiwarong; Watthaisong, Pratchaya; Thotsaporn, Kittisak; Tongsook, Chanakan; Juttulapa, Maneerat; Nijvipakul, Sarayut; Chaiyen, Pimchai			3,4-Dihydroxyphenylacetate 2,3-dioxygenase from Pseudomonas aeruginosa: An Fe(II)containing enzyme with fast turnover	PLOS ONE			English	Article							2-HIS-1-CARBOXYLATE FACIAL TRIAD; CLEAVING CATECHOL DIOXYGENASE; NONHEME IRON(II) ENZYMES; HOMOPROTOCATECHUATE 2,3-DIOXYGENASE; ESCHERICHIA-COLI; 2,3-DIHYDROXYPHENYLPROPIONATE 1,2-DIOXYGENASE; ACINETOBACTER-BAUMANNII; DEPENDENT DIOXYGENASES; EXTRADIOL DIOXYGENASE; BREVIBACTERIUM FUSCUM	3,4-dihydroxyphenylacetate (DHPA) dioxygenase (DHPAO) from Pseudomonas aeruginosa (PaDHPAO) was overexpressed in Escherichia coli and purified to homogeneity. As the enzyme lost activity over time, a protocol to reactivate and conserve PaDHPAO activity has been developed. Addition of Fe(II), DTT and ascorbic acid or ROS scavenging enzymes (catalase or superoxide dismutase) was required to preserve enzyme stability. Metal content and activity analyses indicated that PaDHPAO uses Fe(II) as a metal cofactor. NMR analysis of the reaction product indicated that PaDHPAO catalyzes the 2,3-extradiol ring-cleavage of DHPA to form 5-carboxymethyl-2-hydroxymuconate semialdehyde (CHMS) which has a molar absorptivity of 32.23 mM(-1) cm(-1) at 380 nm and pH 7.5. Steady-state kinetics under air-saturated conditions at 25 degrees C and pH 7.5 showed a Km for DHPA of 58 +/- 8 mu M and a k(cat) of 64 s(-1), indicating that the turnover of PaDHPAO is relatively fast compared to other DHPAOs. The pH-rate profile of the PaDHPAO reaction shows a bell-shaped plot that exhibits a maximum activity at pH 7.5 with two pK(a) values of 6.5 +/- 0.1 and 8.9 +/- 0.1. Study of the effect of temperature on PaDHPAO activity indicated that the enzyme activity increases as temperature increases up to 55 degrees C. The Arrhenius plot of ln(k'(cat)) versus the reciprocal of the absolute temperature shows two correlations with a transition temperature at 35 degrees C. Two activation energy values (Ea) above and below the transition temperature were calculated as 42 and 14 kJ/mol, respectively. The data imply that the rate determining steps of the PaDHPAO reaction at temperatures above and below 35 degrees C may be different. Sequence similarity network analysis indicated that PaDHPAO belongs to the enzyme clusters that are largely unexplored. As PaDHPAO has a high turnover number compared to most of the enzymes previously reported, understanding its biochemical and biophysical properties should be useful for future applications in biotechnology.	[Pornsuwan, Soraya] Mahidol Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [Maenpuen, Somchart; Kamutira, Philaiwarong] Burapha Univ, Dept Biochem, Fac Sci, Chon Buri, Thailand; [Watthaisong, Pratchaya; Tongsook, Chanakan; Juttulapa, Maneerat; Nijvipakul, Sarayut; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Watthaisong, Pratchaya; Tongsook, Chanakan; Juttulapa, Maneerat; Nijvipakul, Sarayut; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand; [Thotsaporn, Kittisak] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok, Thailand	Mahidol University; Burapha University; Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Prot & Enzyme Technol, Bangkok, Thailand.	pimchai.cha@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604; Maenpuen, Somchart/0000-0001-7770-4178; Watthaisong, Pratchaya/0000-0001-7340-7715	Thailand Research Fund [MRG5280150, RTA5980001, MRG5980001]; Mahidol University; Burapha University	Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Burapha University	Financial support by the Thailand Research Fund (Grants MRG5280150 (to S.P.), RTA5980001 (to P.C.), MRG5980001 (to S.M.)), Mahidol University (to P.C.), and Burapha University (to S.M.) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1964, BIOCHIM BIOPHYS ACTA, V93, P483, DOI 10.1016/0304-4165(64)90332-0; Alcalde M, 2015, TRENDS BIOTECHNOL, V33, P155, DOI 10.1016/j.tibtech.2014.12.007; BOLDT YR, 1995, J BACTERIOL, V177, P1225, DOI 10.1128/jb.177.5.1225-1232.1995; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; BUGG TDH, 1993, BIOCHIM BIOPHYS ACTA, V1202, P258, DOI 10.1016/0167-4838(93)90013-H; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Colaco HG, 2016, METALLOMICS, V8, P327, DOI 10.1039/c5mt00291e; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emerson JP, 2007, ANGEW CHEM INT EDIT, V46, P8553, DOI 10.1002/anie.200703057; Fersht A, 1999, STRUCTURE AND MECHAN; Fielding AJ, 2014, J BIOL INORG CHEM, V19, P491, DOI 10.1007/s00775-014-1122-9; Fielding AJ, 2012, J AM CHEM SOC, V134, P796, DOI 10.1021/ja2095365; Fielding AJ, 2011, J BIOL INORG CHEM, V16, P341, DOI 10.1007/s00775-010-0732-0; GIBELLO A, 1994, BIOCHEM J, V301, P145, DOI 10.1042/bj3010145; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; JAMALUDDIN MP, 1977, J BACTERIOL, V129, P690, DOI 10.1128/JB.129.2.690-697.1977; Johnson CW, 2015, METAB ENG, V28, P240, DOI 10.1016/j.ymben.2015.01.005; KIM K, 1985, J BIOL CHEM, V260, P5394; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; KITA H, 1965, J BIOCHEM-TOKYO, V58, P116, DOI 10.1093/oxfordjournals.jbchem.a128172; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, BIOCHEMISTRY-US, V47, P11168, DOI 10.1021/bi801459q; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Li DF, 2013, ACTA CRYSTALLOGR D, V69, P32, DOI 10.1107/S0907444912042072; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Maenpuen S, 2016, ADV BIOTECHNOLGY EM; Mbughuni MM, 2010, P NATL ACAD SCI USA, V107, P16788, DOI 10.1073/pnas.1010015107; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; OLSON PE, 1992, APPL ENVIRON MICROB, V58, P2820, DOI 10.1128/AEM.58.9.2820-2826.1992; ONOKAMIMOTO M, 1973, J BIOCHEM, V74, P1049; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Pollegioni L, 2015, FEBS J, V282, P1190, DOI 10.1111/febs.13224; QUE L, 1981, J BIOL CHEM, V256, P941; Reynolds MF, 2003, J BIOL INORG CHEM, V8, P263, DOI 10.1007/s00775-002-0411-x; ROPER DI, 1990, FEBS LETT, V275, P53, DOI 10.1016/0014-5793(90)81437-S; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thotsaporn K, 2016, J MOL CATAL B-ENZYM, V134, P353, DOI 10.1016/j.molcatb.2016.09.003; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Wang YZ, 1997, PROTEIN EXPRES PURIF, V10, P1, DOI 10.1006/prep.1996.0703; Whiting AK, 1996, BIOCHEMISTRY-US, V35, P160, DOI 10.1021/bi951979h; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	49	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171135	10.1371/journal.pone.0171135	http://dx.doi.org/10.1371/journal.pone.0171135			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158217	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700031
J	Toft-Petersen, AP; Torp-Pedersen, C; Weinreich, UM; Rasmussen, BS				Toft-Petersen, Anne Pernille; Torp-Pedersen, Christian; Weinreich, Ulla Moller; Rasmussen, Bodil Steen			Trends in assisted ventilation and outcome for obstructive pulmonary disease exacerbations. A nationwide study	PLOS ONE			English	Article							ACUTE RESPIRATORY-FAILURE; INTENSIVE-CARE-UNIT; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; COPD EXACERBATIONS; MORTALITY; HOSPITALIZATION; EPIDEMIOLOGY; METAANALYSIS; PREVALENCE	Background Non-invasive ventilation (NIV) has been used for decades in treatment of exacerbations of chronic obstructive pulmonary disease (COPD). The impact of the changing use of assisted ventilation in acute exacerbations on outcomes has not been fully elucidated and we aimed to describe these changes in the Danish population and describe their consequences for mortality. Methods A register-based study was conducted of a cohort of 12,847 patients admitted for acute exacerbation of COPD (AECOPD) from 2004 through 2011, treated with invasive mechanical ventilation (IMV) or NIV for the first time. Age, sex, in-hospital mortality rates, time to death or readmission for AECOPD were established and changes over time tracked. Results The number of admissions for AECOPD where assisted ventilation was used was 1,130 in 2004 and had increased by 145% in 2011. First time ventilations increased by 88%. This was mainly due to an increase in use of NIV accounting for 36% of the total number of assisted ventilations in 2004 and 67% in 2011. The number of IMV with or without NIV treatments remained constant. The mean age of NIV patients increased from 71.5 to 73.6 years, but remained constant at 70.0 years in IMV patients. Mortality rates both in hospital and after discharge for patients receiving NIV remained constant throughout the period. In-hospital mortality following IMV increased from 30% to 38%, but mortality after discharge remained stable. Conclusion Assisted ventilation has been increasingly used in a broader spectrum of AECOPD patients since the introduction of NIV. The changes in treatment strategies have been followed by shifts in in-hospital mortality rates following IMV.	[Toft-Petersen, Anne Pernille; Torp-Pedersen, Christian; Weinreich, Ulla Moller; Rasmussen, Bodil Steen] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Weinreich, Ulla Moller] Aalborg Univ Hosp, Dept Resp Dis, Aalborg, Denmark; [Rasmussen, Bodil Steen] Aalborg Univ Hosp, Dept Anaesthesia & Intens Care, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Toft-Petersen, AP (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	aptp@rn.dk; ctp@heart.dk	Weinreich, Ulla M/L-9069-2013	Weinreich, Ulla M/0000-0003-1975-3654; Rasmussen, Bodil Steen/0000-0003-2190-145X; Toft-Petersen, Anne Pernille/0000-0001-6029-255X				Blichert-Hansen Linea, 2013, Clin Epidemiol, V5, P9, DOI 10.2147/CLEP.S37763; Carpe-Carpe B, 2013, ARCH BRONCONEUMOL, V49, P330, DOI 10.1016/j.arbres.2013.04.006; Chandra D, 2012, AM J RESP CRIT CARE, V185, P152, DOI 10.1164/rccm.201106-1094OC; Conti G, 2002, INTENS CARE MED, V28, P1701, DOI 10.1007/s00134-002-1478-0; de Miguel-Diez J, 2013, RESP MED, V107, P717, DOI 10.1016/j.rmed.2013.01.007; Dres M, 2013, CRIT CARE MED, V41, P1884, DOI 10.1097/CCM.0b013e31828a2bd8; Fiorino S, 2015, INTERN MED J; Funk GC, 2013, EUR RESPIR J, V41, P792, DOI 10.1183/09031936.00226411; Gacouin A, 2015, RESP CARE, V60, P210, DOI 10.4187/respcare.03467; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOBAL STRATEGY DIAG; Husted MG, 2014, BMJ SUPPORT PALLIAT, V4, P146, DOI 10.1136/bmjspcare-2013-000601; Johannesdottir Sigrun A, 2013, J Med Econ, V16, P897, DOI 10.3111/13696998.2013.800525; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; Jurjevic M, 2009, COLLEGIUM ANTROPOL, V33, P791; Kaul S, 2009, COPD, V6, P171, DOI 10.1080/15412550902902646; Larsen OB, 2005, SUNDHEDSSTYRELSEN KL; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Lindenauer PK, 2014, JAMA INT MED, V1-12; Lykkegaard J, 2012, RESP MED, V106, P1396, DOI 10.1016/j.rmed.2012.06.004; Lykkegaard J, 2012, RESP MED, V106, P549, DOI 10.1016/j.rmed.2011.11.001; Mery E, 2013, CRIT CARE, V17, DOI 10.1186/cc12688; Ongel EA, 2014, INT J CHRONIC OBSTR, V9, P1187, DOI 10.2147/COPD.S70257; Pierson DJ, 2009, RESP CARE, V54, P40; Quintana JM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-66; Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588; Roberts CM, 2011, THORAX, V66, P43, DOI 10.1136/thx.2010.153114; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Stefan MS, 2014, CHEST J; Stefan MS, 2015, CRIT CARE MED, V1; Stelfox HT, 2012, ARCH INTERN MED, V172, P467, DOI 10.1001/archinternmed.2011.2315; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Titlestad IL, 2013, INT J CHRONIC OBSTR, V8, P215, DOI 10.2147/COPD.S42632; Titlestad Ingrid Louise, 2008, Ugeskr Laeger, V170, P240; Tottenborg SS, 2013, DAN MED J, V60; Walkey Allan J, 2013, Ann Am Thorac Soc, V10, P10, DOI 10.1513/AnnalsATS.201206-034OC	37	9	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171713	10.1371/journal.pone.0171713	http://dx.doi.org/10.1371/journal.pone.0171713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158267	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700119
J	Liu, XF; Xue, NY; Yuan, Y				Liu, Xiaofeng; Xue, Naiyu; Yuan, Ye			Aircraft engine sensor fault diagnostics using an on-line OBEM update method	PLOS ONE			English	Article								This paper proposed a method to update the on-line health reference baseline of the On-Board Engine Model (OBEM) to maintain the effectiveness of an in-flight aircraft sensor Fault Detection and Isolation (FDI) system, in which a Hybrid Kalman Filter (HKF) was incorporated. Generated from a rapid in-flight engine degradation, a large health condition mismatch between the engine and the OBEM can corrupt the performance of the FDI. Therefore, it is necessary to update the OBEM online when a rapid degradation occurs, but the FDI system will lose estimation accuracy if the estimation and update are running simultaneously. To solve this problem, the health reference baseline for a nonlinear OBEM was updated using the proposed channel controller method. Simulations based on the turbojet engine Linear-Parameter Varying (LPV) model demonstrated the effectiveness of the proposed FDI system in the presence of substantial degradation, and the channel controller can ensure that the update process finishes without interference from a single sensor fault.	[Liu, Xiaofeng; Xue, Naiyu] Beijing Univ Aeronaut & Astronaut, Sch Transportat Sci & Engn, Beijing, Peoples R China; [Liu, Xiaofeng] Collaborat Innovat Ctr Adv Aeroengine, Beijing, Peoples R China; [Liu, Xiaofeng] Aircraft Engine Integrated Syst Safety Beijing Ke, Beijing, Peoples R China; [Yuan, Ye] Beijing Univ Aeronaut & Astronaut, Sch Energy & Power Engn, Beijing, Peoples R China	Beihang University; Beihang University	Xue, NY (corresponding author), Beijing Univ Aeronaut & Astronaut, Sch Transportat Sci & Engn, Beijing, Peoples R China.	xuenaiyu@buaa.edu.cn						Armstrong J.B., 2012, NASATM2012217806; Brotherton T, 2003, AEROSP CONF PROC, P3075; Grindle TJ, 2003, NASATM2003212030; Hajiyev C, 2000, AEROSP SCI TECHNOL, V4, P415, DOI 10.1016/S1270-9638(00)00143-7; Jaw LC, 2009, AIRCRAFT ENGINE CONT; Jee SC, 2012, NONLINEAR DYNAM, V67, P2343, DOI 10.1007/s11071-011-0148-6; Jeffrey A, 2011, 47 AIAA ASME SAE ASE; Kobayashi T., 2006, NASATM2006214491; Kobayashi T., 2003, TURBO EXPO POWER LAN, V1, P461, DOI [10.1115/GT2003-38550, DOI 10.1115/GT2003-38550]; Kobayashi T., 2003, AIRCRAFT ENGINE SENS; Kobayashi T, 2007, PROCEEDINGS OF THE ASME TURBO EXPO 2007, VOL 1, P649; Kobayashi T, 2005, Proceedings of the ASME Turbo Expo 2005, Vol 1, P617; Kobayashi T, 2007, J ENG GAS TURB POWER, V129, P746, DOI 10.1115/1.2718572; Liu X, 2016, CHIN CONTR DEC C 201; Liu XF, 2012, CHINESE J AERONAUT, V25, P663, DOI 10.1016/S1000-9361(11)60432-9; Luo G, 2007, NUMERICAL METHODS AV, P49; Luppold R., 1989, PROC 25 JOINT PROPUL, P2584; Marcos A, 2012, J GUIDANCE CONTROL D, V27, P218; Pham DT, 1998, CR ACAD SCI II A, V326, P255, DOI 10.1016/S1251-8050(97)86815-2; Rinehart AW, 2014, 50 AIAA ASME SAE ASE; Simon DL, 2012, PROCEEDINGS OF THE ASME TURBO EXPO 2012, VOL 1, P935; Tayarani-Bathaie SS, 2015, J PROCESS CONTR, V36, P22, DOI 10.1016/j.jprocont.2015.08.007; Turso JA, 2012, J AEROSPACE COMPUTIN, V2, P291; Van Eykeren L, 2014, CONTROL ENG PRACT, V31, P200, DOI 10.1016/j.conengprac.2014.02.017; Xue W, 2009, CHINESE J AERONAUT, V22, P18, DOI 10.1016/S1000-9361(08)60064-3; Zou CF, 2016, J POWER SOURCES, V335, P121, DOI 10.1016/j.jpowsour.2016.10.040	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171037	10.1371/journal.pone.0171037	http://dx.doi.org/10.1371/journal.pone.0171037			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182692	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800028
J	Yanagawa, Y; Kawano, H; Kobayashi, T; Miyahara, H; Okino, A; Mitsuhara, I				Yanagawa, Yuki; Kawano, Hiroaki; Kobayashi, Tomohiro; Miyahara, Hidekazu; Okino, Akitoshi; Mitsuhara, Ichiro			Direct protein introduction into plant cells using a multi-gas plasma jet	PLOS ONE			English	Article							INACTIVATION; BACTERIA; DELIVERY	Protein introduction into cells is more difficult in plants than in mammalian cells, although it was reported that protein introduction was successful in shoot apical meristem and leaves only together with a cell-penetrating peptide. In this study, we tried to introduce superfolder green fluorescent protein (sGFP)-fused to adenylate cyclase as a reporter protein without a cell-penetrating peptide into the cells of tobacco leaves by treatment with atmospheric nonthermal plasmas. For this purpose, CO2 or N-2 plasma was generated using a multi-gas plasma jet. Confocal microscopy indicated that sGFP signals were observed inside of leaf cells after treatment with CO2 or N-2 plasma without substantial damage. In addition, the amount of cyclic adenosine monophosphate (cAMP) formed by the catalytic enzyme adenylate cyclase, which requires cellular calmodulin for its activity, was significantly increased in leaves treated with CO2 or N-2 plasma, also indicating the introduction of sGFP-fused adenylate cyclase into the cells. These results suggested that treatment with CO2 or N-2 plasma could be a useful technique for protein introduction into plant tissues.	[Yanagawa, Yuki; Mitsuhara, Ichiro] NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Kawano, Hiroaki; Kobayashi, Tomohiro; Miyahara, Hidekazu; Okino, Akitoshi] Tokyo Inst Technol, Inst Innovat Res, FIRST, Midori Ku, Yokohama, Kanagawa, Japan	National Agriculture & Food Research Organization - Japan; Tokyo Institute of Technology	Yanagawa, Y; Mitsuhara, I (corresponding author), NARO, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	yyana@affrc.go.jp; mituhara@affrc.go.jp	Yanagawa, Yuki/A-7092-2016; Okino, Akitoshi/O-1804-2013	Okino, Akitoshi/0000-0002-8949-294X	KAKENHI [25440057]; Cabinet Office, Governmental of Japan; Bio-oriented Technology Research Advancement Institution, NARO	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cabinet Office, Governmental of Japan; Bio-oriented Technology Research Advancement Institution, NARO	This work was partly supported by KAKENHI (25440057) and Cabinet Office, Governmental of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP), Technologies for creating next-generation agriculture, forestry and fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) to YY and IM, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dobrynin D, 2010, IEEE T PLASMA SCI, V38, P1878, DOI 10.1109/TPS.2010.2041938; Hasadsri L, 2009, J BIOL CHEM, V284, P6972, DOI 10.1074/jbc.M805956200; Hendriks W. T., 2015, CURR PROTOC STEM CEL, V34; Hofmann S, 2013, J PHYS D, V46; Ishaq M, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4933366; Iwai T, 2014, J ANAL ATOM SPECTROM, V29, P2108, DOI 10.1039/c4ja00205a; Iwai T, 2013, ANAL SCI, V29, P1141, DOI 10.2116/analsci.29.1141; Ji SH, 2015, PLASMA PROCESS POLYM, V12, P1164, DOI 10.1002/ppap.201500021; Jia JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091547; Jokinen V, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3673251; Kaburaki Y, 2013, ANAL SCI, V29, P1147, DOI 10.2116/analsci.29.1147; Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5; Kondo Y, 2008, J IMMUNOL METHODS, V332, P10, DOI 10.1016/j.jim.2007.12.008; Lakshmanan M, 2013, BIOMACROMOLECULES, V14, P10, DOI 10.1021/bm301275g; Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070; Lu X, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034005; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Ng KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154081; Numata K, 2014, PLANT BIOTECHNOL J, V12, P1027, DOI 10.1111/pbi.12208; Oshita T, 2015, IEEE T PLASMA SCI, V43, P1987, DOI 10.1109/TPS.2015.2428696; Polak M, 2012, PLASMA PROCESS POLYM, V9, P67, DOI 10.1002/ppap.201000163; Sakakita Hajime, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.S2117; Shigeta K, 2010, IEEJ T FUNDAMENTALS, V130, P955; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Takamatsu T, 2016, CURRENT MICROBIOLOGY, P1; Takamatsu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135546; Takamatsu T, 2015, AIP ADV, V5, DOI 10.1063/1.4928034; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Takamatsu T, 2014, J TOXICOL SCI, V39, P281, DOI 10.2131/jts.39.281; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tamura T, 2011, IEEE T PLASMA SCI, V39, P1684, DOI 10.1109/TPS.2011.2155103; Tsuji H, 2013, Japan Patent, Patent No. [2013-053043, 2013053043]; von Keudell A, 2010, PLASMA PROCESS POLYM, V7, P327, DOI 10.1002/ppap.200900121; von Woedtke T, 2014, CONTRIB PLASM PHYS, V54, P104, DOI 10.1002/ctpp.201310068; Wang D, 2010, Japan Patent, Patent No. [2010-119524, 2010119524]	35	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171942	10.1371/journal.pone.0171942	http://dx.doi.org/10.1371/journal.pone.0171942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182666	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800135
J	Yao, YF; Song, XY; Wortley, AH; Wang, YF; Blackmore, S; Li, CS				Yao, Yi-Feng; Song, Xiao-Yan; Wortley, Alexandra H.; Wang, Yu-Fei; Blackmore, Stephen; Li, Cheng-Sen			Pollen-based reconstruction of vegetational and climatic change over the past similar to 30 ka at Shudu Lake in the Hengduan Mountains of Yunnan, southwestern China	PLOS ONE			English	Article							HOLOCENE VEGETATION; ENVIRONMENTAL-CHANGE; PROVINCE; HISTORY; PLEISTOCENE; DYNAMICS; RECORD; ASIA; KYR	The Hengduan Mountains, with a distinct altitudinal differentiation and strong vertical vegetation zonation, occupy an important position in southwestern China as a global hotspot of biodiversity. Pollen analysis of lake sediments sampled along an altitudinal gradient in this region helps us to understand how this vegetation zonation arose and how it has responded to climate change and human impacts through time. Here we present a similar to 30-ka pollen record and interpret it in terms of vegetational and climatic change from a 310 cm-long core from Shudu Lake, located in the Hengduan Mountains region. Our results suggest that from 30 to 22 cal. ka BP, the vegetation was dominated by steppe/grassland (comprising mainly Artemisia, Poaceae and Polygonaceae) and broad-leaved forest (primarily Quercus, Betula and Castanopsis) in the lake catchment, reflecting a relatively warm, wet climate early in this phase and slightly warmer, drier conditions late in the phase. The period between 22 and 13.9 cal. ka BP was marked by a large expansion of needle-and broad-leaved mixed forest (Pinus, Abies and Quercus) and a decline in the extent of steppe/grassland, indicating warming, drying climatic conditions followed by a cold, wet period. Between 13.9 and 3 cal. ka BP, steppe/grassland expanded and the area covered by needle-and broad-leaved mixed forest reduced, implying a fluctuating climate dominated by warm and humid conditions. After 3 cal. ka BP, the vegetation was characterized by an increase in needle-leaved forest and reduction in steppe/grassland, suggesting warming and drying climate. A synthesis of palynological investigations from this and other sites suggests that the vegetation succession patterns seen along an altitudinal gradient in northwestern Yunnan since the Late Pleistocene are comparable, but that each site has its own characteristics probably due to the influences of altitude, topography, microclimate and human impact.	[Yao, Yi-Feng; Wang, Yu-Fei; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Song, Xiao-Yan] Shanxi Agr Univ, Taigu, Shanxi, Peoples R China; [Wortley, Alexandra H.; Blackmore, Stephen] Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh, Midlothian, Scotland	Chinese Academy of Sciences; Institute of Botany, CAS; Shanxi Agricultural University	Yao, YF; Li, CS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yaoyf@ibcas.ac.cn; lics@ibcas.ac.cn	Wortley, Alexandra/AAQ-5568-2021		China National Key Basic Research Program [2014CB954201]; National Natural Science Foundation of China [41271222]; China Scholarship Council [201204910043]	China National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by the China National Key Basic Research Program (No. 2014CB954201), National Natural Science Foundation of China (No. 41271222), and the visiting scholarship funded by China Scholarship Council (No. 201204910043).	An CB, 2013, J PALEOLIMNOL, V49, P145, DOI 10.1007/s10933-012-9649-7; Boufford DE, 2000, HOTSPOTS EARTHS BIOL; Bronk R, 2005, OXCAL PROGRAM V3 10; Cao XY, 2013, REV PALAEOBOT PALYNO, V194, P21, DOI 10.1016/j.revpalbo.2013.02.003; Chaplin George, 2005, Proceedings of the California Academy of Sciences, V56, P527; Cook CG, 2013, BOREAS, V42, P224, DOI 10.1111/j.1502-3885.2012.00287.x; Cook CG, 2012, QUATERNARY RES, V77, P132, DOI 10.1016/j.yqres.2011.09.011; Cook CG, 2011, QUATERNARY SCI REV, V30, P808, DOI 10.1016/j.quascirev.2011.01.003; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Foster GC, 2008, HOLOCENE, V18, P935, DOI 10.1177/0959683608091799; Grimm EC, 2004, TILIA TILIA GRAPH 2; IBCAS (Institute of Botany Chinese Academy of Sciences), 1976, SPOR PTER SIN; IBSCIBCAS (Institute of Botany and South China Institute of Botany Chinese Academy of Sciences), 1982, ANG POLL FLOR TROP S; Jiang X. Z., 1998, J LAKE SCI, V10, P10; Jones RT, 2012, HYDROBIOLOGIA, V693, P223, DOI 10.1007/s10750-012-1124-y; Li Xi-Wen, 1994, Acta Botanica Yunnanica, V16, P221; Li XQ, 2011, QUATERNARY SCI REV, V30, P3457, DOI 10.1016/j.quascirev.2011.09.010; Li XQ, 1999, ACTA BOT SIN, V41, P782; LIN SM, 1986, J BIOGEOGR, V13, P419; MOOK WG, 1986, RADIOCARBON, V28, P799, DOI 10.1017/S0033822200008043; Moore P.D., 1991, BLACKWELL SCI PUBLI; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nature Conservancy Council, 2011, CHIN PLAC WE PROT CH; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Shen J, 2006, HOLOCENE, V16, P265, DOI 10.1191/0959683606hl923rp; [石胜强 SHI Shengqiang], 2011, [中国岩溶, Carsologica Sinica], V30, P119; Song XY, 2012, CLIMATIC CHANGE, V113, P841, DOI 10.1007/s10584-011-0364-6; UNESCO, 2011, WORLD HER LIST 3 PAR; Wang FX, 1995, POLLEN FLORA CHINA; WGYV (Writing Group of Yunnan Vegetation), 1987, VEG OF YUNN; Xiao XY, 2014, QUATERNARY SCI REV, V86, P35, DOI 10.1016/j.quascirev.2013.12.023; Yao YF, 2015, BIOGEOSCIENCES, V12, P1525, DOI 10.5194/bg-12-1525-2015; [姚远 Yao Yuan], 2008, [沉积学报, Acta Sedimentologica Sinica], V26, P294; Yao Yuan, 2007, Marine Geology & Quaternary Geology, V27, P115; Yao Yuan, 2008, Hupo Kexue, V20, P486; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhao Y, 2007, REV PALAEOBOT PALYNO, V145, P275, DOI 10.1016/j.revpalbo.2006.12.002	37	7	10	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171967	10.1371/journal.pone.0171967	http://dx.doi.org/10.1371/journal.pone.0171967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182711	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800139
J	Balekouzou, A; Yin, P; Afewerky, HK; Bekolo, C; Pamatika, CM; Nambei, SW; Djeintote, M; Doumgba, AD; Mossoro-Kpinde, CD; Shu, C; Yin, MH; Fu, Z; Qing, TT; Yan, MM; Zhang, JY; Chen, SJ; Li, HY; Xu, ZY; Koffi, B				Balekouzou, Augustin; Yin, Ping; Afewerky, Henok Kessete; Bekolo, Cavin; Pamatika, Christian Maucler; Nambei, Sylvain Wilfrid; Djeintote, Marceline; Doumgba, Antoine Doui; Mossoro-Kpinde, Christian Diamont; Shu, Chang; Yin, Minghui; Fu, Zhen; Qing, Tingting; Yan, Mingming; Zhang, Jianyuan; Chen, Shaojun; Li, Hongyu; Xu, Zhongyu; Koffi, Boniface			Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; WOMEN; EPIDEMIOLOGY; POPULATION; ALCOHOL; AREAS; URBAN	Breast cancer is recognized as a major public health problem in developing countries; however, there is very little evidence of behavioral factors associated with breast cancer risk. This study was conducted to identify lifestyles as risk factors for breast cancer among Central African women. A case-control study was conducted with 174 cases confirmed histologically by the pathology unit of the National Laboratory and 348 age-matched controls. Data collection tools included a questionnaire with interviews and medical records of patients. Data were analyzed using SPSS software version 20. Odd ratio (OR) and 95% confidence intervals (95% CI) were obtained by unconditional logistic regression. In total, 522 women were studied with a mean age of 45.8 (SD = 13.4) years. By unconditional logistic regression model, women with breast cancer were more likely to have attained illiterate and elementary education level [11.23 (95% CI, 4.65-27.14) and 2.40 (95% CI, 1.15-4.99)], married [2.09 (95% CI, 1.18-3.71)], positive family history [2.31 (95% CI, 1.36-3.91)], radiation exposure [8.21 (95% CI, 5.04-13.38)], consumption charcuterie [10.82 (95% CI, 2.39-48.90)], fresh fish consumption [4.26 (95% CI, 1.56-11.65)], groundnut consumption [6.46 (95% CI, 2.57-16.27)], soybean consumption [16.74 (95% CI, 8.03-39.84)], alcohol [2.53 (95% CI, 1.39-4.60)], habit of keeping money in bras[3.57 (95% CI, 2.24-5.69)], overweight [5.36 (95% CI, 4.46-24.57)] and obesity [3.11(95% CI, 2.39-20.42)]. However, decreased risk of breast cancer was associated with being employed [0.32 (95% CI, 0.19-0.56)], urban residence [0.16 (95% CI, 0.07-0.37)], groundnut oil consumption [0.05 (95% CI, 0.02-0.14)], wine consumption [0.16 (95% CI, 0.09-0.26)], non habit of keeping cell phone in bras [0.56 (95% CI, 0.35-0.89)] and physical activity [0.71(95% CI, 0.14-0.84)]. The study showed that little or no education, marriage, positive family history of cancer, radiation exposure, charcuterie, fresh fish, groundnut, soybean, alcohol, habit of keeping money in bras, overweight and obesity were associated with breast cancer risk among Central African women living in Bangui. Women living in Bangui should be more cautious on the behavioral risk associated with breast cancer.	[Balekouzou, Augustin; Yin, Ping; Shu, Chang; Yin, Minghui; Fu, Zhen; Qing, Tingting; Yan, Mingming; Zhang, Jianyuan; Chen, Shaojun; Li, Hongyu; Xu, Zhongyu] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan, Peoples R China; [Afewerky, Henok Kessete] Huazhong Univ Sci & Technol, Dept Pathol & Pathophysiol, Tongji Med Coll, Wuhan, Peoples R China; [Bekolo, Cavin] Ctr Med Arrondissement Bare, Minist Publ Hlth, Yaounde, Cameroon; [Pamatika, Christian Maucler] Hosp Lab Friendship Bangui, Bangui, Cent Afr Republ; [Nambei, Sylvain Wilfrid; Doumgba, Antoine Doui] Univ Bangui, Fac Hlth Sci, Bangui, Cent Afr Republ; [Djeintote, Marceline; Mossoro-Kpinde, Christian Diamont; Koffi, Boniface] Natl Lab Clin Biol & Publ Hlth, Bangui, Cent Afr Republ	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan, Peoples R China.	pingyin2000@126.com	Yan, Mingming/ABG-1298-2021; Bekolo, Cavin Epie/HIR-2638-2022; Afewerky, Henok Kessete/AAD-4371-2022	Bekolo, Cavin Epie/0000-0002-9845-9842; Afewerky, Henok Kessete/0000-0001-7030-3224				Ahmed Kawsar, 2015, Asian Pac J Cancer Prev, V16, P7507; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; [Anonymous], 2014, REP WCRFIAIFCRCUP DI; Ayari I, 2013, MOL MED REP, V7, P280, DOI 10.3892/mmr.2012.1164; Bhadoria AS, 2013, INDIAN J CANCER, V50, P316, DOI 10.4103/0019-509X.123606; Boffetta P, 2014, SPRING CANC RES, P11, DOI 10.1007/978-3-319-05068-3_3; Boice JD, 1996, MED PEDIATR ONCOL, P29; Bratten T, 2004, INT J CANCER, V110, P579, DOI 10.1002/ijc.20141; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Carmichael AR, 2010, EJSO-EUR J SURG ONC, V36, P1139, DOI 10.1016/j.ejso.2010.09.011; Chan SW, 2016, ASIAN J SURG, pS1015; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; COLDITZ GA, 2006, CANC EPIDEMIOLOGY PR, P995; Cunningham R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-674; Ekenga CC, 2015, CANCER CAUSE CONTROL, V26, P1779, DOI 10.1007/s10552-015-0671-8; Elgaili EM, 2010, INT J WOMENS HEALTH, V2, P77; Ferlay J, 2013, IARC CANCERBASE; Galukande M, 2016, ONCOLOGY-BASEL, V90, P356, DOI 10.1159/000445379; Gao CM, 2014, ASIAN PAC J CANCER P, V15, P7879, DOI 10.7314/APJCP.2014.15.18.7879; Gathani T, 2014, BRIT J CANCER, V110, P224, DOI 10.1038/bjc.2013.632; Ghiasvand R, 2011, INT J CANCER, V129, P1443, DOI 10.1002/ijc.25748; Goldberg M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1931-4; Goncalves AK, 2014, J PHYS ACT HEALTH, V11, P445, DOI 10.1123/jpah.2011-0316; Hosseinzadeh M, 2014, J BREAST CANCER, V17, P236, DOI 10.4048/jbc.2014.17.3.236; Jatoi I, 2010, FUTURE ONCOL, V6, P1781, DOI 10.2217/FON.10.139; John CT, 2012, RES NETWORK SOCIOECO; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Koffi B, 2004, MED AFR NOIRE, V1, P112; Krueger J., 2001, INT ENCY SOCIAL BEHA, P14219; Linos E, 2010, CANCER EPIDEM BIOMAR, V19, P689, DOI 10.1158/1055-9965.EPI-09-0802; Liu XO, 2014, ASIAN PAC J CANCER P, V15, P1291, DOI 10.7314/APJCP.2014.15.3.1291; Lowcock EC, 2013, NUTR CANCER, V65, P398, DOI 10.1080/01635581.2013.768348; Ly M, 2011, B CANCER, V98, P797, DOI 10.1684/bdc.2011.1392; Mandal A, 2014, BREAST CANC EPIDEMIO; Sanchez-Zamorano LM, 2011, CANCER EPIDEM BIOMAR, V20, P912, DOI 10.1158/1055-9965.EPI-10-1036; Mayor S., 2011, BRIT J CANCER, V105, P1443; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Mohaghegh P, 2015, IRAN J CANCER PREV, V8, P53; Nagrani RT, 2014, INDIAN J CANCER, V51, P277, DOI 10.4103/0019-509X.146793; Neilson HK, 2009, CANCER EPIDEM BIOMAR, V18, P11, DOI 10.1158/1055-9965.EPI-08-0756; Ogundiran TO, 2010, AM J EPIDEMIOL, V172, P682, DOI 10.1093/aje/kwq180; Okobia M, 2006, INT J CANCER, V119, P2179, DOI 10.1002/ijc.22102; Qian F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106908; Sepandi M, 2014, ASIAN PAC J CANCER P, V15, P8499, DOI 10.7314/APJCP.2014.15.19.8499; Serdouma E, 2006, MED AFR NOIRE, V53, P572; Shaukat U, 2013, ASIAN PAC J CANCER P, V14, P5625, DOI 10.7314/APJCP.2013.14.10.5625; Si S, 2015, BREAST CANCER RES TR, V152, P449, DOI 10.1007/s10549-015-3489-x; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Soriano-Hernandez AD, 2015, GYNECOL OBSTET INVES, V80, P89, DOI 10.1159/000369997; Strand BH, 2007, EUR J CANCER, V43, P1200, DOI 10.1016/j.ejca.2007.01.021; Veisy Afsaneh, 2015, Asian Pac J Cancer Prev, V16, P451; Wang F, 2015, J INT MED RES, V43, P774, DOI 10.1177/0300060515592901; Wierzejska Regina, 2015, Rocz Panstw Zakl Hig, V66, P293; World Health Organization, 2014, COUNTR PROF CANC; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7; Yang DY, 2003, CANCER, V97, P2565, DOI 10.1002/cncr.11364; Zare N, 2013, J BREAST CANCER, V16, P214, DOI 10.4048/jbc.2013.16.2.214; Zhang CX, 2011, CANCER CAUSE CONTROL, V22, P115, DOI 10.1007/s10552-010-9681-8	58	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171154	10.1371/journal.pone.0171154	http://dx.doi.org/10.1371/journal.pone.0171154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178283	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500026
J	Ozawa, T; Yamada, K; Ichitani, Y				Ozawa, Takaaki; Yamada, Kazuo; Ichitani, Yukio			Differential requirements of hippocampal de novo protein and mRNA synthesis in two long-term spatial memory tests: Spontaneous place recognition and delay-interposed radial maze performance in rats	PLOS ONE			English	Article							APPETITIVE LEARNING-PARADIGM; WORKING-MEMORY; SYNTHESIS INHIBITOR; DORSAL HIPPOCAMPUS; OBJECT-LOCATION; APIS-MELLIFERA; FEAR MEMORY; RETRIEVAL; RECONSOLIDATION; CONSOLIDATION	Hippocampal de novo mRNA and protein synthesis has been suggested to be critical for long-term spatial memory. However, its requirement in each memory process (i.e. encoding, consolidation and retrieval) and the differences in the roles of de novo mRNA and protein synthesis in different situations where spatial memory is tested have not been thoroughly investigated. To address these questions, we examined the effects of hippocampal administration of the protein synthesis inhibitors, anisomycin (ANI) and emetine (EME), as well as that of an mRNA synthesis inhibitor, 5,6-dichlorobenzimidazole 1-I3-D-ribofuranoside (DRB), on rat performance in two long-term spatial memory tests. In a spontaneous place recognition test with a 6 h delay, ANI, administered either before or immediately after the sample phase, but not before the test phase, eliminated the exploratory preference for the object in a novel place. This amnesic effect was replicated by both EME and DRB. In a 6 h delay-interposed radial maze task, however, administering ANI before the first-half and before the second-half, but not immediately or 2 h after the first-half, impaired performance in the second-half. This disruptive effect of ANI was successfully replicated by EME. However, DRB administered before the first-half performance did not impair the second-half performance, while it did impair it if injected before the second-half. None of these drugs caused amnesic effects during the short (5 min)/non-delayed conditions in either tests. These results suggest that 1) hippocampal protein synthesis is required for the consolidation of spatial memory, while mRNA synthesis is not necessarily required, and 2) hippocampal mRNA and protein synthesis requirement for spatial memory retrieval depends on the types of memory tested, probably because their demands are different.	[Ozawa, Takaaki; Yamada, Kazuo; Ichitani, Yukio] Univ Tsukuba, Inst Psychol & Behav Neurosci, Tsukuba, Ibaraki, Japan; [Ozawa, Takaaki] Univ Geneva, Dept Basic Neurosci, Rue Michel Servet, Geneva, Switzerland	University of Tsukuba; University of Geneva	Ichitani, Y (corresponding author), Univ Tsukuba, Inst Psychol & Behav Neurosci, Tsukuba, Ibaraki, Japan.	y-ichit@human.tsukuba.ac.jp		Ozawa, Takaaki/0000-0003-3633-7062	Japan Society for the Promotion of Science [26590174, 16K04419, 15K04180]; Grants-in-Aid for Scientific Research [15K04180] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Japan Society for the Promotion of Science to Y.I. (26590174,16K04419) and to K.Y. (15K04180).	Bast T, 2005, J NEUROSCI, V25, P5845, DOI 10.1523/JNEUROSCI.0698-05.2005; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; Canal CE, 2007, P NATL ACAD SCI USA, V104, P12500, DOI 10.1073/pnas.0705195104; Da Silva WC, 2008, HIPPOCAMPUS, V18, P29, DOI 10.1002/hipo.20362; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Igaz LM, 2002, J NEUROSCI, V22, P6781; Kraus M, 2002, LEARN MEMORY, V9, P293, DOI 10.1101/lm.47502; Liang K C, 1994, Chin J Physiol, V37, P201; Lima RH, 2009, NEUROBIOL LEARN MEM, V91, P466, DOI 10.1016/j.nlm.2008.12.009; Lin CH, 2003, J NEUROSCI, V23, P8310; Lopez J, 2015, J NEUROSCI, V35, P2465, DOI 10.1523/JNEUROSCI.0735-14.2015; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MIZUMORI SJY, 1985, BEHAV NEUROSCI, V99, P220, DOI 10.1037/0735-7044.99.2.220; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OVERTON DA, 1974, FED PROC, V33, P1800; Ozawa T, 2011, NEUROSCI LETT, V497, P37, DOI 10.1016/j.neulet.2011.04.022; Parsons RG, 2006, EUR J NEUROSCI, V23, P1853, DOI 10.1111/j.1460-9568.2006.04723.x; PATTERSON TA, 1988, NEUROCHEM RES, V13, P643, DOI 10.1007/BF00973282; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Qi ZH, 2009, LEARN MEMORY, V16, P308, DOI 10.1101/lm.1333409; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Rodriguez-Ortiz CJ, 2008, NEUROBIOL LEARN MEM, V89, P352, DOI 10.1016/j.nlm.2007.10.004; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rossato JI, 2015, NEUROBIOL LEARN MEM, V125, P146, DOI 10.1016/j.nlm.2015.09.001; Sajadi AA, 2006, BEHAV BRAIN RES, V173, P158, DOI 10.1016/j.bbr.2006.06.018; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Solntseva S, 2012, BRAIN RES, V1467, P42, DOI 10.1016/j.brainres.2012.05.051; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Stollhoff N, 2008, NEUROBIOL LEARN MEM, V89, P419, DOI 10.1016/j.nlm.2007.10.003; Wanisch K, 2008, BEHAV BRAIN RES, V186, P191, DOI 10.1016/j.bbr.2007.08.008; Yoshihara T, 2004, NEUROSCIENCE, V129, P1, DOI 10.1016/j.neuroscience.2004.07.030	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171629	10.1371/journal.pone.0171629	http://dx.doi.org/10.1371/journal.pone.0171629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178292	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500055
J	Sapkota, A; Gaire, BP; Cho, KS; Jeon, SJ; Kwon, OW; Jang, DS; Kim, SY; Ryu, JH; Choi, JW				Sapkota, Arjun; Gaire, Bhakta Prasad; Cho, Kyu Suk; Jeon, Se Jin; Kwon, Oh Wook; Jang, Dae Sik; Kim, Sun Yeou; Ryu, Jong Hoon; Choi, Ji Woong			Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation	PLOS ONE			English	Article							NF-KAPPA-B; CELL-DEATH; STROKE; EXPRESSION; NEUROINFLAMMATION; MECHANISMS; EXTRACT; DAMAGE; NEUROTOXICITY; INHIBITION	Microglial activation and its-driven neuroinflammation are characteristic pathogenetic features of neurodiseases, including focal cerebral ischemia. The Artemisia asiatica (Asteraceae) extract and its active component, eupatilin, are well-known to reduce inflammatory responses. But the therapeutic potential of eupatilin against focal cerebral ischemia is not known, along with its anti-inflammatory activities on activated microglia. In this study, we investigated the neuroprotective effect of eupatilin on focal cerebral ischemia through its anti-inflammation, particularly on activated microglia, employing a transient middle cerebral artery occlusion/reperfusion (tMCAO), combined with lipopolysaccharide-stimulated BV2 microglia. Eupatilin exerted anti-inflammatory responses in activated BV2 microglia, in which it reduced secretion of well-known inflammatory markers, including nitrite, IL-6, TNF-alpha, and PGE(2), in a concentration-dependent manner. These observed in vitro effects of eupatilin led to in vivo neuroprotection against focal cerebral ischemia. Oral administration of eupatilin (10 mg/kg) in a therapeutic paradigm significantly reduced brain infarction and improved neurological functions in tMCAO-challenged mice. The same benefit was also observed when eupatilin was given even within 5 hours after MCAO induction. In addition, the neuroprotective effects of a single administration of eupatilin (10 mg/kg) immediately after tMCAO challenge persisted up to 3 days after tMCAO. Eupatilin administration reduced the number of Iba1-immunopositive cells across ischemic brain and induced their morphological changes from amoeboid into ramified in the ischemic core, which was accompanied with reduced microglial proliferation in ischemic brain. Eupatilin suppressed NF-kappa B signaling activities in ischemic brain by reducing IKK alpha/beta phosphorylation, I kappa B alpha phosphorylation, and I kappa B alpha degradation. Overall, these data indicate that eupatilin is a neuroprotective agent against focal cerebral ischemia through the reduction of microglial activation.	[Sapkota, Arjun; Gaire, Bhakta Prasad; Kwon, Oh Wook; Kim, Sun Yeou; Choi, Ji Woong] Gachon Univ, Coll Pharm, Incheon, South Korea; [Sapkota, Arjun; Gaire, Bhakta Prasad; Kwon, Oh Wook; Kim, Sun Yeou; Choi, Ji Woong] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea; [Cho, Kyu Suk; Jeon, Se Jin; Jang, Dae Sik; Ryu, Jong Hoon] Kyung Hee Univ, Dept Oriental Pharmaceut Sci, Coll Pharm, Seoul, South Korea	Gachon University; Gachon University; Kyung Hee University	Choi, JW (corresponding author), Gachon Univ, Coll Pharm, Incheon, South Korea.; Choi, JW (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea.	pharmchoi@gachon.ac.kr	Jang, Dae Sik/AAI-4526-2020; Gaire, Bhakta Prasad/I-7776-2019; Gaire, Bhakta Prasad/AAA-4211-2020; Jeon, Sejin/GWU-7864-2022		National Research Foundation; Ministry of Health and Welfare - Korean government [NRF-2013R1A1A1A05005520, NRF-2014M3A9B6069339, HI13C18200000]	National Research Foundation; Ministry of Health and Welfare - Korean government	This work was supported by grants from the National Research Foundation and Ministry of Health and Welfare funded by the Korean government to JWC (NRF-2013R1A1A1A05005520, NRF-2014M3A9B6069339, and HI13C18200000).	Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Cai M, 2012, EUR J PHARMACOL, V689, P104, DOI 10.1016/j.ejphar.2012.05.042; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Choi EJ, 2008, PHARM RES, V25, P1355, DOI 10.1007/s11095-008-9531-5; Choi EJ, 2011, LIFE SCI, V88, P1121, DOI 10.1016/j.lfs.2011.04.011; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Gaire BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120203; Gao SF, 2016, NEUROPHARMACOLOGY, V103, P44, DOI 10.1016/j.neuropharm.2015.12.002; Hahm KB, 1998, PANCREAS, V17, P153, DOI 10.1097/00006676-199808000-00007; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jeon JI, 2015, SCAND J IMMUNOL, V81, P166, DOI 10.1111/sji.12263; Jeong D, 2014, J ETHNOPHARMACOL, V152, P487, DOI 10.1016/j.jep.2014.01.030; Jeong HJ, 2015, ARCH PHARM RES, V38, P1223, DOI 10.1007/s12272-014-0472-8; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jung J, 2012, IMMUNOLOGY, V137, P98, DOI 10.1111/j.1365-2567.2012.03618.x; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kim EK, 2015, J MED FOOD, V18, P921, DOI 10.1089/jmf.2014.3344; Kim JM, 2009, CLIN EXP IMMUNOL, V155, P541, DOI 10.1111/j.1365-2249.2008.03849.x; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lee S, 2008, FOOD CHEM TOXICOL, V46, P2865, DOI 10.1016/j.fct.2008.05.026; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Lim BO, 2008, PHYTOTHER RES, V22, P279, DOI 10.1002/ptr.2304; Min SW, 2009, J ETHNOPHARMACOL, V125, P497, DOI 10.1016/j.jep.2009.06.001; Nam Y, 2013, PHYTOTHER RES, V27, P404, DOI 10.1002/ptr.4737; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Park JM, 2015, J CLIN BIOCHEM NUTR, V56, P132, DOI 10.3164/jcbn.14-76; Park SW, 2008, J GASTROEN HEPATOL, V23, P976, DOI 10.1111/j.1440-1746.2008.05333.x; Pereira MP, 2006, J CEREBR BLOOD F MET, V26, P218, DOI 10.1038/sj.jcbfm.9600182; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Ryu BK, 1998, ARCH PHARM RES, V21, P508, DOI 10.1007/BF02975366; Ryu Ri, 2013, Prev Nutr Food Sci, V18, P181, DOI 10.3746/pnf.2013.18.3.181; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shah IM, 2009, CURR MOL MED, V9, P336, DOI 10.2174/156652409787847236; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14	39	42	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171479	10.1371/journal.pone.0171479	http://dx.doi.org/10.1371/journal.pone.0171479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178289	gold, Green Submitted, Green Published			2022-12-27	WOS:000393712500045
J	Eroh, GD; Clayton, FC; Florell, SR; Cassidy, PB; Chirife, A; Maron, CF; Valenzuela, LO; Campbell, MS; Seger, J; Rowntree, VJ; Leachman, SA				Eroh, Guy D.; Clayton, Fred C.; Florell, Scott R.; Cassidy, Pamela B.; Chirife, Andrea; Maron, Carina F.; Valenzuela, Luciano O.; Campbell, Michael S.; Seger, Jon; Rowntree, Victoria J.; Leachman, Sancy A.			Cellular and ultrastructural characterization of the grey-morph phenotype in southern right whales (Eubalaena australis)	PLOS ONE			English	Article							WAARDENBURG-SYNDROME TYPE-2; NEURAL CREST; TRANSCRIPTION FACTOR; HUMAN PIEBALDISM; MITF GENE; EVOLUTIONARY SIGNIFICANCE; ULTRAVIOLET-RADIATION; HIRSCHSPRUNG-DISEASE; HOMOZYGOUS MUTATION; ENDOTHELIN-3 GENE	Southern right whales (SRWs, Eubalena australis) are polymorphic for an X-linked pigmentation pattern known as grey morphism. Most SRWs have completely black skin with white patches on their bellies and occasionally on their backs; these patches remain white as the whale ages. Grey morphs (previously referred to as partial albinos) appear mostly white at birth, with a splattering of rounded black marks; but as the whales age, the white skin gradually changes to a brownish grey color. The cellular and developmental bases of grey morphism are not understood. Here we describe cellular and ultrastructural features of grey-morph skin in relation to that of normal, wild-type skin. Melanocytes were identified histologically and counted, and melanosomes were measured using transmission electron microscopy. Grey-morph skin had fewer melanocytes when compared to wild-type skin, suggesting reduced melanocyte survival, migration, or proliferation in these whales. Grey-morph melanocytes had smaller melanosomes relative to wild-type skin, normal transport of melanosomes to surrounding keratinocytes, and normal localization of melanin granules above the keratinocyte nuclei. These findings indicate that SRW grey-morph pigmentation patterns are caused by reduced numbers of melanocytes in the skin, as well as by reduced amounts of melanin production and/or reduced sizes of mature melanosomes. Grey morphism is distinct from piebaldism and albinism found in other species, which are genetic pigmentation conditions resulting from the local absence of melanocytes, or the inability to synthesize melanin, respectively.	[Eroh, Guy D.; Cassidy, Pamela B.; Leachman, Sancy A.] Huntsman Canc Inst, Salt Lake City, UT 84103 USA; [Eroh, Guy D.] Univ Georgia, Athens, GA 30602 USA; [Clayton, Fred C.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Florell, Scott R.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Cassidy, Pamela B.; Leachman, Sancy A.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Chirife, Andrea] Programa Monitoreo Sanitario Ballena Franca Austr, Puerto Madryn, Chubut, Argentina; [Maron, Carina F.; Valenzuela, Luciano O.; Seger, Jon; Rowntree, Victoria J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Rowntree, Victoria J.] Inst Conservac Ballenas, Buenos Aires, DF, Argentina; [Valenzuela, Luciano O.] Univ Nacl Ctr Prov Buenos Aires, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Sociales, Buenos Aires, DF, Argentina; [Campbell, Michael S.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Campbell, Michael S.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Rowntree, Victoria J.] Ocean Alliance Whale Conservat Inst, Gloucester, MA USA	Huntsman Cancer Institute; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Utah System of Higher Education; University of Utah; Comision Nacional de Energia Atomica (CNEA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Utah System of Higher Education; University of Utah; Cold Spring Harbor Laboratory	Leachman, SA (corresponding author), Huntsman Canc Inst, Salt Lake City, UT 84103 USA.; Leachman, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	leachmas@ohsu.edu		Valenzuela, Luciano/0000-0002-5024-6581	Division Of Environmental Biology [1051491] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; BALDWIN CT, 1995, AM J MED GENET, V58, P115, DOI 10.1002/ajmg.1320580205; Baxter LL, 2013, WIRES DEV BIOL, V2, P379, DOI 10.1002/wdev.72; Baxter LL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq025; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; BEST PB, 1990, S AFR J ZOOL, V25, P114; Bonaventure J, 2013, PIGM CELL MELANOMA R, V26, P316, DOI 10.1111/pcmr.12080; Bondanza S, 2007, J INVEST DERMATOL, V127, P676, DOI 10.1038/sj.jid.5700639; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; BREATHNACH AS, 1965, J INVEST DERMATOL, V45, P28, DOI 10.1038/jid.1965.87; BRUMBAUGH JA, 1971, DEV BIOL, V24, P392, DOI 10.1016/0012-1606(71)90088-1; COMMINGS DE, 1966, J AMER MED ASSOC, V195, P519; DASILVA EO, 1991, AM J MED GENET, V40, P65, DOI 10.1002/ajmg.1320400113; Desmoulins A., 1822, DICT CLASSIQUE HIST, V2, P161; Dessinioti C, 2009, EXP DERMATOL, V18, P741, DOI 10.1111/j.1600-0625.2009.00896.x; Domyan ET, 2014, CURR BIOL, V24, P459, DOI 10.1016/j.cub.2014.01.020; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Dumaz N, 2014, MELANOMA RES; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; Gonzalez-Conejero R, 2003, BRIT J HAEMATOL, V123, P132, DOI 10.1046/j.1365-2141.2003.04557.x; Hodgkinson CA, 1998, HUM MOL GENET, V7, P703, DOI 10.1093/hmg/7.4.703; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOTH CF, 1993, AM J HUM GENET, V52, P455; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Kaliszewska ZA, 2005, MOL ECOL, V14, P3439, DOI 10.1111/j.1365-294X.2005.02664.x; Kos R, 2001, DEVELOPMENT, V128, P1467; Kronforst MR, 2012, PIGM CELL MELANOMA R, V25, P411, DOI 10.1111/j.1755-148X.2012.01014.x; KUGELMAN TP, 1961, YALE J BIOL MED, V33, P407; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Martinez-Levasseur LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02386; McAloose D, 2016, DIS AQUAT ORGAN, V119, P17, DOI 10.3354/dao02986; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Morey Celine, 2010, Ann N Y Acad Sci, V1214, pE18, DOI 10.1111/j.1749-6632.2010.05943.x; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Nitzan E, 2013, P NATL ACAD SCI USA, V110, P12709, DOI 10.1073/pnas.1306287110; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Payne R., 1983, COMMUNICATION BEHAV, P371; Pfeiffer CJ, 1996, J SUBMICR CYTOL PATH, V28, P277; Picardo M, 2011, J INVEST DERMATOL, V131, P1182, DOI 10.1038/jid.2011.67; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Plouhinec JL, 2014, DEV BIOL, V386, P461, DOI 10.1016/j.ydbio.2013.12.010; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; Schaeff CM, 1999, J HERED, V90, P464, DOI 10.1093/jhered/90.4.464; Schaeff CM, 1999, MAR MAMMAL SCI, V15, P701, DOI 10.1111/j.1748-7692.1999.tb00837.x; Schell DM, 2000, CAN J ZOOL, V78, P721, DOI 10.1139/cjz-78-5-721; Sironi M, 2012, INT WHAL COMM UNPUB; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Tompkins N, 2014, P NATL ACAD SCI USA, V111, P4397, DOI 10.1073/pnas.1322005111; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Verheij JBGM, 2002, AM J MED GENET, V108, P223, DOI 10.1002/ajmg.10172; Watanabe KI, 2002, PIGM CELL RES, V15, P201, DOI 10.1034/j.1600-0749.2002.01080.x; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051	70	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171449	10.1371/journal.pone.0171449	http://dx.doi.org/10.1371/journal.pone.0171449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170433	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000393705500038
J	Chiu, S; Williams, PT; Krauss, RM				Chiu, Sally; Williams, Paul T.; Krauss, Ronald M.			Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; LIPOPROTEIN SUBCLASSES; SERUM-LIPIDS; CARDIOVASCULAR-DISEASE; SIZE DISTRIBUTION; LOW-CARBOHYDRATE; TRANSFER PROTEIN; ARTERY-DISEASE; HEPATIC LIPASE	Background Previous studies have shown that increases in LDL-cholesterol resulting from substitution of dietary saturated fat for carbohydrate or unsaturated fat are due primarily to increases in large cholesterol-enriched LDL, with minimal changes in small, dense LDL particles and apolipoprotein B. However, individuals can differ by their LDL particle distribution, and it is possible that this may influence LDL subclass response. Objective The objective of this study was to test whether the reported effects of saturated fat apply to individuals with atherogenic dyslipidemia as characterized by a preponderance of small LDL particles (LDL phenotype B). Methods Fifty-three phenotype B men and postmenopausal women consumed a baseline diet (55%E carbohydrate, 15%E protein, 30%E fat, 8%E saturated fat) for 3 weeks, after which they were randomized to either a moderate carbohydrate, very high saturated fat diet (HSF; 39% E carbohydrate, 25%E protein, 36%E fat, 18%E saturated fat) or low saturated fat diet (LSF; 37%E carbohydrate, 25%E protein, 37%E fat, 9%E saturated fat) for 3 weeks. Results Compared to the LSF diet, consumption of the HSF diet resulted in significantly greater increases from baseline (% change; 95% CI) in plasma concentrations of apolipoprotein B (HSF vs. LSF: 9.5; 3.6 to 15.7 vs. -6.8; -11.7 to -1.76; p = 0.0003) and medium (8.8; -1.3 to 20.0 vs. -7.3; -15.7 to 2.0; p = 0.03), small (6.1; -10.3 to 25.6 vs. -20.8; -32.8 to -6.7; p = 0.02), and total LDL (3.6; -3.2 to 11.0 vs. -7.9; -13.9 to -1.5; p = 0.03) particles, with no differences in change of large and very small LDL concentrations. As expected, total-cholesterol (11.0; 6.5 to 15.7 vs. -5.7; -9.4 to -1.8; p<0.0001) and LDL-cholesterol (16.7; 7.9 to 26.2 vs. -8.7; -15.4 to -1.4; p = 0.0001) also increased with increased saturated fat intake. Conclusions Because medium and small LDL particles are more highly associated with cardiovascular disease than are larger LDL, the present results suggest that very high saturated fat intake may increase cardiovascular disease risk in phenotype B individuals.	[Chiu, Sally; Williams, Paul T.; Krauss, Ronald M.] Childrens Hosp Oakland Res Inst, Oakland, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Krauss, RM (corresponding author), Childrens Hosp Oakland Res Inst, Oakland, CA USA.	rkrauss@chori.org		Krauss, Ronald/0000-0002-1238-3489	Dairy Management Inc; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [UL1 RR024131]	Dairy Management Inc; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI	This research was funded by Dairy Management Inc and was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. This was an investigator-initiated study, and its funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; BENNETT AJ, 1995, BIOCHEM J, V311, P167, DOI 10.1042/bj3110167; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; CAMPOS H, 1995, J LIPID RES, V36, P462; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P1410, DOI 10.1161/01.ATV.12.12.1410; Caulfield MP, 2008, CLIN CHEM, V54, P1307, DOI 10.1373/clinchem.2007.100586; Chiu S, 2016, AM J CLIN NUTR, V103, P341, DOI 10.3945/ajcn.115.123281; Choi YJ, 2012, ATHEROSCLEROSIS, V220, P470, DOI 10.1016/j.atherosclerosis.2011.10.029; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Dreon DM, 1998, AM J CLIN NUTR, V67, P828, DOI 10.1093/ajcn/67.5.828; Egert S, 2011, EUR J NUTR, V50, P71, DOI 10.1007/s00394-010-0116-9; Forsythe CE, 2010, LIPIDS, V45, P947, DOI 10.1007/s11745-010-3467-3; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fusegawa Y, 2001, J LIPID RES, V42, P1849; Gill JMR, 2003, AM J CLIN NUTR, V78, P47, DOI 10.1093/ajcn/78.1.47; GROENER JEM, 1991, ATHEROSCLEROSIS, V87, P221, DOI 10.1016/0021-9150(91)90024-W; Guay V, 2012, METABOLISM, V61, P76, DOI 10.1016/j.metabol.2011.06.002; Jakobsen MU, 2010, AM J CLIN NUTR, V91, P1764, DOI 10.3945/ajcn.2009.29099; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jansen S, 2000, AM J CLIN NUTR, V72, P36; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; Kratz M, 2002, J NUTR, V132, P715, DOI 10.1093/jn/132.4.715; Krauss RM, 2005, ARTERIOSCL THROM VAS, V25, P2265, DOI 10.1161/01.ATV.0000186365.73973.f0; Krauss RM, 2001, ANNU REV NUTR, V21, P283, DOI 10.1146/annurev.nutr.21.1.283; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025, DOI 10.1093/ajcn/83.5.1025; Lagrost L, 1999, ATHEROSCLEROSIS, V142, P395, DOI 10.1016/S0021-9150(98)00244-5; Mangravite LM, 2011, J NUTR, V141, P2180, DOI 10.3945/jn.111.139477; Mauger JF, 2003, AM J CLIN NUTR, V78, P370, DOI 10.1093/ajcn/78.3.370; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; RIFAI N, 1986, CLIN CHEM, V32, P957; Rivellese AA, 2003, ATHEROSCLEROSIS, V167, P149, DOI 10.1016/S0021-9150(02)00424-0; Rizzo M, 2004, ARTERIOSCL THROM VAS, V24, P141, DOI 10.1161/01.ATV.0000107027.73816.ce; Siri-Tarino PW, 2010, CURR ATHEROSCLER REP, V12, P384, DOI 10.1007/s11883-010-0131-6; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Siri-Tarino PW, 2010, OBESITY, V19, P610; Sjogren P, 2004, J NUTR, V134, P1729, DOI 10.1093/jn/134.7.1729; SMITH SJ, 1987, CLIN CHEM, V33, P2240; Sonestedt E, 2012, BRIT J NUTR, V107, P1062, DOI 10.1017/S0007114511003783; St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f4; Thijssen MA, 2005, AM J CLIN NUTR, V82, P510, DOI 10.1093/ajcn/82.3.510; Wang L, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001355; Westman EC, 2006, INT J CARDIOL, V110, P212, DOI 10.1016/j.ijcard.2005.08.034; Williams PT, 2014, ATHEROSCLEROSIS, V233, P713, DOI 10.1016/j.atherosclerosis.2014.01.034; WOOLLETT LA, 1992, J LIPID RES, V33, P77; ZAMBON A, 1993, ARTERIOSCLER THROMB, V13, P147, DOI 10.1161/01.ATV.13.2.147	51	41	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170664	10.1371/journal.pone.0170664	http://dx.doi.org/10.1371/journal.pone.0170664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166253	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100013
J	Cristea, IA; Gentili, C; Pietrini, P; Cuijpers, P				Cristea, Ioana A.; Gentili, Claudio; Pietrini, Pietro; Cuijpers, Pim			Is investigator background related to outcome in head to head trials of psychotherapy and pharmacotherapy for adult depression? A systematic review and meta-analysis	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIALS; BIAS	Background The influence of factors related to the background of investigators conducting trials comparing psychotherapy and pharmacotherapy has remained largely unstudied. Specializations emphasizing biological determinants of mental disorders, like psychiatry, might favor pharmacotherapy, while others stressing psychosocial factors, like psychology, could promote psychotherapy. Yet financial conflict of interest (COI) could be a confounding factor as authors with a medical specialization might receive more sponsoring from the pharmaceutical industry. Method We conducted a meta-analysis with subgroup and meta-regression analysis examining whether the specialization and affiliation of trial authors were associated to outcomes in the direct comparison of psychotherapy and pharmacotherapy for the acute treatment of depression. Meta-regression analysis also included trial risk of bias and author conflict of interest in relationship to the pharmaceutical industry. Results We included 45 trials. In half, the first author was psychologist. The last author was psychiatrist/MD in half of the trials, and a psychologist or statistician/other technical in the rest. Most lead authors had medical affiliations. Subgroup analysis indicated that studies with last authors statisticians favored pharmacotherapy. Univariate analysis showed a negative relationship between the presence of statisticians and outcomes favoring psychotherapy. Multivariate analysis showed that trials including authors with financial COI reported findings more favorable to pharmacotherapy. Discussion We report the first detailed overview of the background of authors conducting head to head trials for depression. Trials co-authored by statisticians appear to subtly favor pharmacotherapy. Receiving funding from the industry is more closely related to finding better outcomes for the industry's elective treatment than are factors related to authors' background. Limitations For a minority of authors we could not retrieve background information. The number of trials was insufficient to evidence subtler effects.	[Cristea, Ioana A.] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania; [Cristea, Ioana A.] Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Gentili, Claudio] Univ Padua, Dept Gen Psychol, Padua, Italy; [Pietrini, Pietro] IMT Inst Adv Studies, Lucca, Italy; [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Cuijpers, Pim] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Babes Bolyai University from Cluj; Stanford University; University of Padua; IMT School for Advanced Studies Lucca; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Cristea, IA (corresponding author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca, Romania.; Cristea, IA (corresponding author), Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA.	ioana.cristea@ubbcluj.ro	Pietrini, Pietro/Z-4202-2019; Cuijpers, Pim/G-1703-2013; Cristea, Ioana Alina/E-7490-2011	Cristea, Ioana Alina/0000-0002-9854-7076; Gentili, Claudio/0000-0002-2579-8755; Pietrini, Pietro/0000-0002-6768-5556	Romanian National Authority for Scientific Research and Innovation (Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii) CNCS - UEFISCDI [PN-II-RU-TE-2014-4-1316]	Romanian National Authority for Scientific Research and Innovation (Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii) CNCS - UEFISCDI	Ioana A. Cristea was supported for this work by a grant of the Romanian National Authority for Scientific Research and Innovation (Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii) CNCS - UEFISCDI, project number PN-II-RU-TE-2014-4-1316 awarded to Ioana A. Cristea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borenstein M, 2009, INTRO META ANAL; Cristea IA, 2016, BR J PSYCHIAT; Cuijpers P, 2016, EPIDEMIOL PSYCH SCI, V25, P428, DOI 10.1017/S2045796015000864; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eisner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142803; Gournay K, 2000, J ADV NURS, V32, P343, DOI 10.1046/j.1365-2648.2000.01482.x; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Imel ZE, 2008, J AFFECT DISORDERS, V110, P197, DOI 10.1016/j.jad.2008.03.018; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Krogh J, 2015, J AFFECT DISORDERS, V179, P121, DOI 10.1016/j.jad.2015.03.042; Orsini N., 2006, HETEROGI STATA MODUL; Peron J, 2013, ANTI-CANCER DRUG, V24, P306, DOI 10.1097/CAD.0b013e32835c3561; Siddiqui O, 2009, J BIOPHARM STAT, V19, P227, DOI 10.1080/10543400802609797; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	21	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171654	10.1371/journal.pone.0171654	http://dx.doi.org/10.1371/journal.pone.0171654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158281	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396161700118
J	Hung, MS; Chen, IC; Lee, CP; Huang, RJ; Chen, PC; Tsai, YH; Yang, YH				Hung, Ming-Szu; Chen, I-Chuan; Lee, Chuan-Pin; Huang, Ru-Jiun; Chen, Pau-Chung; Tsai, Ying-Huang; Yang, Yao-Hsu			Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study	PLOS ONE			English	Article							OVERCOMES GEFITINIB RESISTANCE; TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; 1ST-LINE TREATMENT; RISK-FACTORS; CHEMOTHERAPY; METAANALYSIS; THERAPY; COHORT; IMPACT	Long-term use of statins has been reported to reduce the risk of death in patients with lung cancer. This study investigated the effect of statin use among patients with lung cancer receiving epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) therapy. A nationwide, population-based case-control study was conducted using the Taiwan National Health Insurance Research Database. From January 1, 1997 to December 31, 2012, a total of 1,707 statin and 6,828 non-statin matched lung cancer cohorts with EGFR-TKIs treatment were studied. Statin use was associated with a reduced risk of death (HR: 0.58, 95% CI: 0.54-0.62, p < 0.001). In addition, statin use was associated with a significantly longer median progression-free survival (8.3 months, 95% CI: 7.6-8.9 vs. 6.1 months, 95% CI: 6.0-6.4, p < 0.001) and median overall survival (35.5 months, 95% CI: 33.8-38.1 vs. 23.9 months, 95% CI: 23.4-24.7, p < 0.001). In conclusion, statins might potentially enhance the therapeutic effect and increase survival in patients with lung cancer receiving EGFR-TKI therapy.	[Hung, Ming-Szu; Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Div Thorac Oncol, Chiayi Branch, Chiayi, Taiwan; [Hung, Ming-Szu] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Hung, Ming-Szu] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Chiayi Branch, Chiayi, Taiwan; [Chen, I-Chuan] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan; [Lee, Chuan-Pin; Huang, Ru-Jiun] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Chen, Pau-Chung; Yang, Yao-Hsu] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Tsai, Ying-Huang] Chang Gung Univ, Dept Resp Care, Coll Med, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi Branch, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Tsai, YH (corresponding author), Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Div Thorac Oncol, Chiayi Branch, Chiayi, Taiwan.; Yang, YH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.; Tsai, YH (corresponding author), Chang Gung Univ, Dept Resp Care, Coll Med, Taoyuan, Taiwan.; Yang, YH (corresponding author), Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi Branch, Chiayi, Taiwan.; Yang, YH (corresponding author), Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan.	chestmed@cgmh.org.tw; r95841012@ntu.edu.tw	楊, 曜旭/A-3450-2019; Chen, Pau-Chung/H-5686-2011	楊, 曜旭/0000-0002-8080-0504; Chen, Pau-Chung/0000-0002-6242-5974	Chang Gung Memorial Hospital, Chiayi Branch, Taiwan [CORPG6D0161]	Chang Gung Memorial Hospital, Chiayi Branch, Taiwan	This study was supported by a grant from Chang Gung Memorial Hospital, Chiayi Branch (CORPG6D0161) (to YHY), Taiwan (R.O.C.).	Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Chang CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000444; Chen J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.312; Chen J, 2012, MOL ONCOL, V6, P62, DOI 10.1016/j.molonc.2011.11.003; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; D'Antonio C, 2014, THER ADV MED ONCOL, V6, P101, DOI 10.1177/1758834014521110; Fiala O, 2015, TUMOR BIOL, V36, P5801, DOI 10.1007/s13277-015-3249-x; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Han JY, 2011, CLIN CANCER RES, V17, P1553, DOI 10.1158/1078-0432.CCR-10-2525; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Hsu CL, 2015, J GERIATR ONCOL, V6, P38, DOI 10.1016/j.jgo.2014.09.178; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Huang W, 2016, ONCOTARGET; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Hwang KE, 2011, INVEST NEW DRUG, V29, P945, DOI 10.1007/s10637-010-9450-2; Khullar OV, 2015, J AM COLL SURGEONS, V220, P156, DOI 10.1016/j.jamcollsurg.2014.10.009; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; Lee CK, 2015, J CLIN ONCOL, V33, P1958, DOI 10.1200/JCO.2014.58.1736; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McDavid K, 2003, ARCH INTERN MED, V163, P2135, DOI 10.1001/archinte.163.18.2135; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Park IH, 2010, INVEST NEW DRUG, V28, P791, DOI 10.1007/s10637-009-9319-4; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vallianou NG, 2014, ANTI-CANCER AGENT ME, V14, P706, DOI 10.2174/1871520613666131129105035; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Zhou C, 2015, ANN ONCOL, V26, P1877, DOI 10.1093/annonc/mdv276; Zhu LH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003528	41	45	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171137	10.1371/journal.pone.0171137	http://dx.doi.org/10.1371/journal.pone.0171137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158206	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700032
J	Hsieh, CC; Chou, MJ; Wang, CH				Hsieh, Chia-Chien; Chou, Mei-Jia; Wang, Chih-Hsuan			Lunasin attenuates obesity-related inflammation in RAW264.7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; PEPTIDE LUNASIN; LEPTIN; IMMUNE; MACROPHAGES; DYSFUNCTION; MODULATION; ACTIVATION; FOCUS	Obesity has become a major threat to public health and is accompanied by chronic low-grade inflammation, which leads to various pathological developments. Lunasin, a natural seed peptide, exhibits several biological activities, such as anti-carcinogenesis, anti-inflammatory, and antioxidant activities. However, the mechanism of action of lunasin in obesity-related inflammation has not been investigated. The aim of this study was to explore whether lunasin could reduce the inflammation induced by obesity-related mediators in RAW264.7 cells and 3T3-L1 adipocytes and whether it could attenuate the crosstalk between the two cell lines. RAW264.7 cells were cultured in leptin-containing medium, adipocyte-conditioned medium (Ad-CM), or co-cultured with 3T3-L1 cells to mimic the physiology of obesity. The data showed that the secretion of pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) was inhibited by lunasin after leptin activation of RAW264.7 cells. In addition, lunasin decreased monocyte chemoattractant protein-1 (MCP-1) and IL-1 beta secretions in the Ad-CM model. Cytokine MCP-1, IL-6, tumor necrosis factor (TNF)-alpha, and IL-1 beta secretions were significantly decreased by leptin or Ad-CM plus lipopolysaccharide stimulation. Subsequently, the co-culture of the two cells refined the direct relation between them, resulting in apparently increased MCP-1, and decreased IL-6 levels after lunasin treatment. In 3T3-L1 adipocytes, lunasin also exhibited anti-inflammatory property by inhibiting MCP-1, plasminogen activator inhibitor-1, and leptin productions stimulated by (TNF)-alpha, lipopolysaccharide, or RAW264.7 cell-conditioned medium. This result revealed that lunasin acts as a potential anti-inflammatory agent not only in macrophages but also in adipocytes, disrupting the crosstalk between these two cells. Therefore, this study suggests the intake of lunasin from diet or as a supplement, for auxiliary prevention or therapy in obesity-related inflammatory applications.	[Hsieh, Chia-Chien; Chou, Mei-Jia; Wang, Chih-Hsuan] Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan	National Taiwan Normal University	Hsieh, CC (corresponding author), Natl Taiwan Normal Univ, Dept Human Dev & Family Studies, Taipei, Taiwan.	hsieh@ntnu.edu.tw		Hsieh, Chia-Chien/0000-0003-3993-0144	Ministry of Science and Technology, Taiwan [MOST103-2 320-B-003-003-MY3]; National Taiwan Normal University, Taiwan [T10507000723]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan Normal University, Taiwan	This work was supported by Ministry of Science and Technology, Taiwan (MOST103-2 320-B-003-003-MY3), https://www.most.gov.tw/en/public; and National Taiwan Normal University, T10507000723, Taiwan, http://en.ntnu.edu.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achek A, 2016, ARCH PHARM RES, V39, P1032, DOI 10.1007/s12272-016-0806-9; Andrade-Oliveira V, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/681612; Apostolopoulos V, 2016, MOL NUTR FOOD RES, V60, P43, DOI 10.1002/mnfr.201500272; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005; Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020; Bremer AA, 2013, J OBES, V2013, DOI 10.1155/2013/393192; Cam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072115; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Dam V, 2016, OBES REV, V17, P1, DOI 10.1111/obr.12335; Dawson DR, 2014, PERIODONTOL 2000, V64, P161, DOI 10.1111/j.1600-0757.2012.00458.x; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Delort L, 2015, LIFE SCI, V140, P37, DOI 10.1016/j.lfs.2015.04.012; Dia VP, 2009, FOOD CHEM, V114, P108, DOI 10.1016/j.foodchem.2008.09.023; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Galvez AF, 2013, LUNASIN ENRICHED SOY; Galvez AF, 2012, CIRCULATION, V126; Hall A, 2015, PEERJ, V3, DOI 10.7717/peerj.1428; Hernandez-Ledesma B, 2013, PROTEIN PEPTIDE LETT, V20, P424, DOI 10.2174/092986613805290327; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; HSIEH CC, 2016, INT J MOL SCI, V17; Hsieh CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147161; Jia SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/346839; Jiang QQ, 2016, ONCOL REP, V36, P253, DOI 10.3892/or.2016.4798; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Onat A, 2008, INT J BIOL SCI, V4, P208; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Patel PS, 2013, J OBES, V2013, DOI 10.1155/2013/616193; Procaccini C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00332; Rose DP, 2015, CANCERS, V7, P2147, DOI 10.3390/cancers7040883; Ruiz-Canela M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081265; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Strong AL, 2015, STEM CELLS, V33, P318, DOI 10.1002/stem.1857; Tian YF, 2014, LIFE SCI, V116, P51, DOI 10.1016/j.lfs.2014.07.039; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; World Health Organization (WHO) Media Center Geneva, 2015, OB OV FACTS OV OB; Yang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115330	48	25	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171969	10.1371/journal.pone.0171969	http://dx.doi.org/10.1371/journal.pone.0171969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182687	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800140
J	Jiang, DQ; Wang, Y; Zhou, D				Jiang, Da-Quan; Wang, Yue; Zhou, Da			Phenotypic equilibrium as probabilistic convergence in multi-phenotype cell population dynamics	PLOS ONE			English	Article							CANCER STEM-CELLS; LIMIT-THEOREMS; BRANCHING-PROCESS; MODEL; DISTRIBUTIONS; GROWTH	We consider the cell population dynamics with n different phenotypes. Both the Markovian branching process model (stochastic model) and the ordinary differential equation (ODE) system model (deterministic model) are presented, and exploited to investigate the dynamics of the phenotypic proportions. We will prove that in both models, these proportions will tend to constants regardless of initial population states ("phenotypic equilibrium") under weak conditions, which explains the experimental phenomenon in Gupta et al.'s paper. We also prove that Gupta et al.'s explanation is the ODE model under a special assumption. As an application, we will give sufficient and necessary conditions under which the proportion of one phenotype tends to 0 (die out) or 1 (dominate). We also extend our results to non-Markovian cases.	[Jiang, Da-Quan] Peking Univ, Sch Math Sci, LMAM, Beijing 100871, Peoples R China; [Jiang, Da-Quan] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China; [Wang, Yue] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Zhou, Da] Xiamen Univ, Sch Math Sci, Xiamen 361005, Peoples R China	Peking University; Peking University; University of Washington; University of Washington Seattle; Xiamen University	Wang, Y (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	yuewang@uw.edu	Wang, Yue/GZG-6184-2022	Wang, Yue/0000-0001-5918-7525; Zhou, Da/0000-0002-0272-6644				Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; ATHREYA KB, 1968, ANN MATH STAT, V39, P347, DOI 10.1214/aoms/1177698395; Athreya KB, 1972, BRANCHING PROCESSES, P199; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cox DR, 1965, THEORY STOCHASTIC PR, P257; dos Santos RV, 2013, J THEOR BIOL, V335, P79, DOI 10.1016/j.jtbi.2013.06.025; Durrett R, 2010, PROBABILITY THEORY E, P58; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Golubev A, 2010, J THEOR BIOL, V262, P257, DOI 10.1016/j.jtbi.2009.10.005; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; JAGERS P, 1969, J APPL PROBAB, V6, P249, DOI 10.2307/3211996; Karlin S, 1975, 1 COURSE STOCHASTIC, P547; KESTEN H, 1967, J MATH ANAL APPL, V17, P309, DOI 10.1016/0022-247X(67)90155-2; Kimmel M, 2002, BRANCHING PROCESSES, P103; Kimmel M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00089; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Mcdonald TO, 2015, J APPL PROBAB, V52, P864, DOI 10.1017/S002190020011349X; Mode CJ, 1971, MULTITYPE BRANCHING, V34, P138; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Norris JR, 1997, MARKOV CHAINS, p[11, 122]; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Seneta E, 1981, NONNEGATIVE MATRICES, P22; Smythe RT, 1996, STOCH PROC APPL, V65, P115, DOI 10.1016/S0304-4149(96)00094-4; Yakovlev AY, 2010, STOCH ANAL APPL, V28, P1040, DOI 10.1080/07362994.2010.515486; Yakovlev AY, 2009, ANN APPL PROBAB, V19, P1, DOI 10.1214/08-AAP539; Yakovlev AY, 1998, J MATH BIOL, V37, P49, DOI 10.1007/s002850050119; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Zhou D, 2014, J THEOR BIOL, V357, P35, DOI 10.1016/j.jtbi.2014.04.039; Zhou DC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03547; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	36	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170916	10.1371/journal.pone.0170916	http://dx.doi.org/10.1371/journal.pone.0170916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182672	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800022
J	Kugelman, JR; Wiley, MR; Nagle, ER; Reyes, D; Pfeffer, BP; Kuhn, JH; Sanchez-Lockhart, M; Palacios, GF				Kugelman, Jeffrey R.; Wiley, Michael R.; Nagle, Elyse R.; Reyes, Daniel; Pfeffer, Brad P.; Kuhn, Jens H.; Sanchez-Lockhart, Mariano; Palacios, Gustavo F.			Error baseline rates of five sample preparation methods used to characterize RNA virus populations	PLOS ONE			English	Article							LIBRARY PREPARATION; QUALITY-CONTROL; DNA; REPLICATION; VARIANTS	Individual RNA viruses typically occur as populations of genomes that differ slightly from each other due to mutations introduced by the error-prone viral polymerase. Understanding the variability of RNA virus genome populations is critical for understanding virus evolution because individual mutant genomes may gain evolutionary selective advantages and give rise to dominant sub populations, possibly even leading to the emergence of viruses resistant to medical countermeasures. Reverse transcription of virus genome populations followed by next-generation sequencing is the only available method to characterize variation for RNA viruses. However, both steps may lead to the introduction of artificial mutations, thereby skewing the data. To better understand how such errors are introduced during sample preparation, we determined and compared error baseline rates of five different sample preparation methods by analyzing in vitro transcribed Ebola virus RNA from an artificial plasmid-based system. These methods included: shotgun sequencing from plasmid DNA or in vitro transcribed RNA as a basic "no amplification" method, amplicon sequencing from the plasmid DNA or in vitro transcribed RNA as a "targeted" amplification method, sequenceindependent single-primer amplification (SISPA) as a "random" amplification method, rolling circle reverse transcription sequencing (CirSeq) as an advanced "no amplification" method, and Illumina TruSeq RNA Access as a "targeted" enrichment method. The measured error frequencies indicate that RNA Access offers the best tradeoff between sensitivity and sample preparation error (1.4(-5)) of all compared methods.	[Kugelman, Jeffrey R.; Wiley, Michael R.; Nagle, Elyse R.; Reyes, Daniel; Pfeffer, Brad P.; Sanchez-Lockhart, Mariano; Palacios, Gustavo F.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, NIH, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Palacios, GF (corresponding author), US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.	gustavo.f.palacios.ctr@mail.mil	Palacios, Gustavo/I-7773-2015; Sanchez-Lockhart, Mariano/H-1321-2019; Kuhn, Jens H./B-7615-2011; Sanchez-Lockhart, Mariano/M-6446-2019	Palacios, Gustavo/0000-0001-5062-1938; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Kuhn, Jens H./0000-0002-7800-6045; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Wiley, Michael/0000-0001-6688-007X	Defense Threat Reduction Agency; Battelle Memorial Institute's prime; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]; Tunnell Government Services, Inc.	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Battelle Memorial Institute's prime; US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tunnell Government Services, Inc.	This work was supported by Defense Threat Reduction Agency and Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID)under Contract No. HHSN272200700016I (J.H.K.). A subcontractor to Battelle Memorial Institute who performed this work is : J.H.K., an employee of Tunnell Government Services, Inc.	Acevedo A, 2014, NAT PROTOC, V9, P1760, DOI 10.1038/nprot.2014.118; Altmann A, 2011, BIOINFORMATICS, V27, pI77, DOI 10.1093/bioinformatics/btr205; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holmes EC, 2009, EVOLUTION EMERGENCES; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Koboldt DC, 2012, METHODS MOL BIOL, V838, P369, DOI 10.1007/978-1-61779-507-7_18; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Ladner JT, 2016, REV SCI TECH OIE, V35, P43, DOI 10.20506/rst.35.1.2416; Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Potter J, 2003, FOCUS, V25, P19; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Yang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-33; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	34	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171333	10.1371/journal.pone.0171333	http://dx.doi.org/10.1371/journal.pone.0171333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182717	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800055
J	Place, ES; Smith, JC				Place, Elsie S.; Smith, James C.			Zebrafish atoh8 mutants do not recapitulate morpholino phenotypes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ATOH8; GENE-EXPRESSION; SHEAR-STRESS; DIFFERENTIATION; PROTEINS; EMBRYOS; FAMILY; FRIEND; MATH6; HEMATOPOIESIS	Atoh8 is a bHLH transcription factor expressed in pancreas, skeletal muscle, the nervous system, and cardiovascular tissues during embryological development. Although it has been implicated in the regulation of pancreatic and endothelial cell differentiation, the phenotypic consequences of Atoh8 loss are uncertain. Conclusions from knockout studies in the mouse differ widely depending on the targeting strategy used, while atoh8 knockdown by interfering morpholino oligonucleotides (morpholinos) in zebrafish has led to a range of developmental defects. This study characterised zebrafish embryos homozygous for atoh8(sa1465), a loss-of-function allele of atoh8, in order to provide genetic evidence for the developmental role of Atoh8 in this species. Embryos homozygous for atoh8(sa1465) present normal body morphology, swimbladder inflation, and heart looping, and survive to adulthood. These embryos do not develop pericardial oedema by 72 hpf and are not sensitised to the loss of Fog1 protein, suggesting that this previously described abnormality is not a specific phenotype. Vascular patterning and primitive haematopoiesis are unaffected in atoh8(sa1465/sa1465) mutant embryos. Together, the data suggest that Atoh8 is dispensible for zebrafish development under standard laboratory conditions.	[Place, Elsie S.; Smith, James C.] Francis Crick Inst, Dev Biol Lab, London, England	Francis Crick Institute	Smith, JC (corresponding author), Francis Crick Inst, Dev Biol Lab, London, England.	jim.smith@crick.ac.uk		Smith, Jim/0000-0003-2413-9392	The Francis Crick Institute [10158, 10157] Funding Source: researchfish; Medical Research Council [MC_U117597140] Funding Source: Medline; MRC [MC_U117597140] Funding Source: UKRI	The Francis Crick Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahuja S, 2016, DEV BIOL, V412, P71, DOI 10.1016/j.ydbio.2016.02.003; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Bagu ET, 2011, J MOL ENDOCRINOL, V47, P299, DOI 10.1530/JME-11-0060; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Busch-Nentwich E., 2012, SANGER I ZEBRAFISH M; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chen J, 2013, ZEBRAFISH, V10, P389, DOI 10.1089/zeb.2013.0875; Chen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023005; Cooney JD, 2013, DEV BIOL, V373, P431, DOI 10.1016/j.ydbio.2012.08.015; Ejarque M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146273; Ejarque M, 2013, BBA-GENE REGUL MECH, V1829, P1175, DOI 10.1016/j.bbagrm.2013.08.003; Fang F, 2014, J CELL SCI, V127, P1428, DOI 10.1242/jcs.136358; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kim J, 2012, CONTEXT DEPENDENT PR, V2, P441; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kubo F, 2010, DEV DYNAM, V239, P2492, DOI 10.1002/dvdy.22381; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Patel N, 2014, BRIT J HAEMATOL, V164, P586, DOI 10.1111/bjh.12649; Rawnsley DR, 2013, J BIOL CHEM, V288, P24429, DOI 10.1074/jbc.M113.463083; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Stevens JD, 2008, DIFFERENTIATION, V76, P1006, DOI 10.1111/j.1432-0436.2008.00285.x; Thisse B., 2001, EXPRESSION ZEBRAFISH; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walton RZ, 2006, DEV BIOL, V289, P482, DOI 10.1016/j.ydbio.2005.10.040; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; Westerfield M., 2007, THE ZEBRAFISH BOOK; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945	42	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171143	10.1371/journal.pone.0171143	http://dx.doi.org/10.1371/journal.pone.0171143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182631	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800038
J	Lonhienne, T; Garcia, MD; Fraser, JA; Williams, CM; Guddat, LW				Lonhienne, Thierry; Garcia, Mario D.; Fraser, James A.; Williams, Craig M.; Guddat, Luke W.			The 2.0 angstrom X-ray structure for yeast acetohydroxyacid synthase provides new insights into its cofactor and quaternary structure requirements	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ACETOLACTATE; FLAVIN; SYSTEM; FORM	Acetohydroxyacid synthase (AHAS) catalyzes the first step of branched-chain amino acid biosynthesis, a pathway essential to the life-cycle of plants and micro-organisms. The catalytic subunit has thiamin diphosphate (ThDP) and flavin adenine dinucleotide (FAD) as indispensable co-factors. A new, high resolution, 2.0 angstrom crystal structure of Saccharomyces cerevisiae AHAS reveals that the dimer is asymmetric, with the catalytic centres having distinct structures where FAD is trapped in two different conformations indicative of different redox states. Two molecules of oxygen (O-2) are bound on the surface of each active site and a tunnel in the polypeptide appears to passage O-2 to the active site independently of the substrate. Thus, O-2 appears to play a novel "co-factor " role in this enzyme. We discuss the functional implications of these features of the enzyme that have not previously been described.	[Lonhienne, Thierry; Garcia, Mario D.; Fraser, James A.; Williams, Craig M.; Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Lonhienne, T; Guddat, LW (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	t.lonhienne@uq.edu.au; luke.guddat@uq.edu.au	Guddat, Luke/AAI-2930-2021; Fraser, James A/B-4918-2012; Williams, Craig M./J-2379-2014	Fraser, James A/0000-0001-5724-5285; Williams, Craig M./0000-0002-3834-7398; Garcia, Mario/0000-0001-8378-7475	National Health and Medical Research Council [1008736]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by Grant number 1008736 from the National Health and Medical Research Council received by LWG, CW, and JF.; X-ray data were measured at the University of Queensland Remote-Operation Crystallization and X-ray diffraction facility (UQROCX) and using beam line MX1, Australian Synchrotron, Clayton, Victoria. The work was supported by funds Grant number 1008736 from the National Health and Medical Research Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baig IA, 2013, ENZYME MICROB TECH, V53, P243, DOI 10.1016/j.enzmictec.2013.05.006; Chipman DM, 2005, CURR OPIN CHEM BIOL, V9, P475, DOI 10.1016/j.cbpa.2005.07.002; Duggleby RG, 2003, EUR J BIOCHEM, V270, P2895, DOI 10.1046/j.1432-1033.2003.03671.x; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Pang SS, 2002, J MOL BIOL, V317, P249, DOI 10.1006/jmbi.2001.5419; Pang SS, 2001, ACTA CRYSTALLOGR D, V57, P1321, DOI 10.1107/S0907444901011635; STORMER FC, 1964, BIOCHEM BIOPH RES CO, V17, P587, DOI 10.1016/0006-291X(64)90071-3; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tittmann K, 2004, BIOCHEMISTRY-US, V43, P8652, DOI 10.1021/bi049897t; TSE JMT, 1993, BIOCHEMISTRY-US, V32, P10398, DOI 10.1021/bi00090a015; UKessays, 2015, FLAV ENZ BIOL FUNCT	20	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171443	10.1371/journal.pone.0171443	http://dx.doi.org/10.1371/journal.pone.0171443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178302	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500042
J	Ewen, M; Zweekhorst, M; Regeer, B; Laing, R				Ewen, Margaret; Zweekhorst, Marjolein; Regeer, Barbara; Laing, Richard			Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases	PLOS ONE			English	Article							ACCESS	Background WHO has set a voluntary target of 80% availability of affordable essential medicines, including generics, to treat major non-communicable diseases (NCDs), in the public and private sectors of countries by 2025. We undertook a secondary analysis of data from 30 surveys in low-and middle-income countries, conducted from 2008-2015 using the World Health Organization (WHO)/Health Action International (HAI) medicine availability and price survey methodology, to establish a baseline for this target. Methods Data for 49 medicines (lowest priced generics and originator brands) to treat cardiovascular diseases (CVD), diabetes, chronic obstructive pulmonary diseases (COPD) and central nervous system (CNS) conditions were analysed to determine their availability in healthcare facilities and pharmacies, their affordability for those on low incomes (based on median patient prices of each medicine), and the percentage of medicines that were both available and affordable. Affordability was expressed as the number of days' wages of the lowest-paid unskilled government worker needed to purchase 30 days' supply using standard treatment regimens. Paying more than 1 days' wages was considered unaffordable. Findings In low-income countries, 15.2% and 18.9% of lowest-priced generics met WHO's target in the public and private sectors, respectively, and 2.6% and 5.2% of originator brands. In lower-middle income countries, 23.8% and 23.2% of lowest priced generics, and 0.8% and 1.4% of originator brands, met the target in the public and private sectors, respectively. In upper-middle income countries, the situation was better for generics but still suboptimal as 36.0% and 39.4% met the target in public and private sectors, respectively. For originator brands in upper-middle income countries, none reached the target in the public sector and 13.7% in the private sector. Across the therapeutic groups for lowest priced generics, CVD medicines in low-income countries (11.9%), and CNS medicines in lower-middle (10.2%) and upper-middle income countries (33.3%), were least available and affordable in the public sector. In the private sector for lowest priced generics, CNS medicines were least available and affordable in all three country income groups (11.4%, 5.8% and 29.3% in low-, lower-middle and upper-middle income countries respectively). Interpretation This data, which can act as a baseline for the WHO target, shows low availability and/or poor affordability is resulting in few essential NCD medicines meeting the target in low-and middle-income countries. In the era of Sustainable Development Goals, and as countries work to achieve Universal Health Coverage, increased commitments are needed by governments to improve the situation through the development of evidence-informed, nationally-contextualised interventions, with regular monitoring of NCD medicine availability, patient prices and affordability.	[Ewen, Margaret] Hlth Act Int, Amsterdam, Netherlands; [Zweekhorst, Marjolein; Regeer, Barbara] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Laing, Richard] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Laing, Richard] Univ Western Cape, Cape Town, South Africa	Vrije Universiteit Amsterdam; Boston University; University of the Western Cape	Ewen, M (corresponding author), Hlth Act Int, Amsterdam, Netherlands.	marg@haiweb.org	Regeer, Barbara J/M-1207-2018	Regeer, Barbara J/0000-0002-9044-9367				[Anonymous], 2013, PRIC AV AFF PRIC COM; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P279; Cameron A, 2012, EPILEPSIA, V53, P962, DOI 10.1111/j.1528-1167.2012.03446.x; Gelders S., 2006, PRICE AVAILABILITY A; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; International Diabetes Federation, 2013, INT DIAB FED DIAB AT; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Niens LM, 2012, B WORLD HEALTH ORGAN, V90, P219, DOI 10.2471/BLT.10.084087; UN General Assembly, 2012, 662 UN GEN ASS; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Volman B, 2008, DIRECT COSTS AVAILAB; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; WHO, 2015, Q AS ON HYP; World Bank/WHO EMRO/HAI, 2013, PRIC AFF MED TREAT N; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization/Health Action International, 2008, MEAS MED PRIC AV AFF	17	73	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171284	10.1371/journal.pone.0171284	http://dx.doi.org/10.1371/journal.pone.0171284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170413	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500028
J	Llado, S; Baldrian, P				Llado, Salvador; Baldrian, Petr			Community-level physiological profiling analyses show potential to identify the copiotrophic bacteria present in soil environments	PLOS ONE			English	Article							SUBSTRATE UTILIZATION PATTERNS; MICROBIAL COMMUNITIES; RIBOSOMAL-RNA; SP NOV.; FOREST; DIVERSITY; CLASSIFICATION; ABUNDANT	Community-level physiological profiling (CLPP) analyses from very diverse environments are frequently used with the aim of characterizing the metabolic versatility of whole environmental bacterial communities. While the limitations of the methodology for the characterization of whole communities are well known, we propose that CLPP combined with highthroughput sequencing and qPCR can be utilized to identify the copiotrophic, fast-growing fraction of the bacterial community of soil environments, where oligotrophic taxa are usually dominant. In the present work we have used this approach to analyze samples of litter and soil from a coniferous forest in the Czech Republic using BIOLOG GN2 plates. Monosaccharides and amino acids were utilized significantly faster than other C substrates, such as organic acids, in both litter and soil samples. Bacterial biodiversity in CLPP wells was significantly lower than in the original community, independently of the carbon source. Bacterial communities became highly enriched in taxa that typically showed low abundance in the original soil, belonging mostly to the Gammaproteobacteria and the genus Pseudomonas, indicating that the copiotrophic strains, favoured by the high nutrient content, are rare in forest litter and soil. In contrast, taxa abundant in the original samples were rarely found to grow at sufficient rates under the CLPP conditions. Our results show that CLPP is useful to detect copiotrophic bacteria from the soil environments and that bacterial growth is substrate specific.	[Llado, Salvador; Baldrian, Petr] Inst Microbiol CAS, Lab Environm Microbiol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Llado, S (corresponding author), Inst Microbiol CAS, Lab Environm Microbiol, Prague, Czech Republic.	vador21@gmail.com	Baldrian, Petr/A-9170-2009; Lladó, Salvador/ABB-3647-2020	Baldrian, Petr/0000-0002-8983-2721; 	Czech Science Foundation [14-09040P]; Ministry of Education, Youth and Sports of the Czech Republic [LD15086]; Research Concept of the Institute of Microbiology of the CAS [RV061388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Research Concept of the Institute of Microbiology of the CAS	This work was supported by the Czech Science Foundation (14-09040P), by the Ministry of Education, Youth and Sports of the Czech Republic (LD15086) and by the Research Concept of the Institute of Microbiology of the CAS (RV061388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Baldrian P, 2017, FEMS MICROBIOL REV, V41, P109, DOI 10.1093/femsre/fuw040; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Baldrian P, 2010, BIOL FERT SOILS, V46, P717, DOI 10.1007/s00374-010-0478-4; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Carson JK, 2009, FEMS MICROBIOL ECOL, V67, P381, DOI 10.1111/j.1574-6941.2008.00645.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Collins B, 2004, ECOL ENG, V23, P107, DOI 10.1016/j.ecoleng.2004.07.005; Cummings SP, 2010, METHODS MOL BIOL, V599, P1; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ernebjerg M, 2012, APPL ENVIRON MICROB, V78, P1345, DOI 10.1128/AEM.06585-11; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00614; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Gamo M, 1999, APPL ENVIRON MICROB, V65, P4419; Garcia-Fraile P, 2016, APPL ENVIRON MICROB, V82, P560, DOI 10.1128/AEM.03353-15; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Konopka A, 1998, MICROBIAL ECOL, V35, P103, DOI 10.1007/s002489900065; Kuzyakov Y, 2015, SOIL BIOL BIOCHEM, V83, P184, DOI 10.1016/j.soilbio.2015.01.025; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu B, 2015, EUR J SOIL BIOL, V68, P69, DOI 10.1016/j.ejsobi.2015.01.002; Llado S, 2016, SYST APPL MICROBIOL, V39, P14, DOI 10.1016/j.syapm.2015.12.005; Llado S, 2016, BIOL FERT SOILS, V52, P251, DOI 10.1007/s00374-015-1072-6; Lyons MM, 2010, AQUAT MICROB ECOL, V60, P1, DOI 10.3354/ame01417; Mangalassery S, 2015, EUR J SOIL BIOL, V68, P9, DOI 10.1016/j.ejsobi.2015.03.001; Mastrogianni A, 2014, APPL SOIL ECOL, V80, P51, DOI 10.1016/j.apsoil.2014.03.009; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Pierce ML, 2014, J MICROBIOL METH, V97, P20, DOI 10.1016/j.mimet.2013.12.002; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; Smalla K, 1998, APPL ENVIRON MICROB, V64, P1220; Starke R, 2016, SOIL BIOL BIOCHEM, V96, P30, DOI 10.1016/j.soilbio.2016.01.009; Urbanova M, 2011, FEMS MICROBIOL ECOL, V78, P59, DOI 10.1111/j.1574-6941.2011.01164.x; Vetrovsky T, 2013, BIOL FERT SOILS, V49, P1027, DOI 10.1007/s00374-013-0801-y; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Weber KP, 2008, WATER RES, V42, P180, DOI 10.1016/j.watres.2007.06.055; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Zifcakova L, 2016, ENVIRON MICROBIOL, V18, P288, DOI 10.1111/1462-2920.13026	47	44	45	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171638	10.1371/journal.pone.0171638	http://dx.doi.org/10.1371/journal.pone.0171638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170446	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500049
J	Renzaho, AMN; Dhingra, N; Georgeou, N				Renzaho, Andre M. N.; Dhingra, Nidhi; Georgeou, Nichole			Youth as contested sites of culture: The intergenerational acculturation gap amongst new migrant communities- Parental and young adult perspectives	PLOS ONE			English	Article							FAMILY; CHILDREN; IMMIGRATION; MIGRATION; SCHOOLS	Background Immigration often results in changes in family dynamics, and within this process of dynamic relational adjustment youth can be conceptualised as contested sites of culture and associated intergenerational conflicts. This paper considers the experiences of migrant youth in Greater Western Sydney, New South Wales, Australia using conflict as a useful lens through which to view issues of migrant youth identity and their sense of social connectedness, belonging, and agency. The aim of this study was twofold: 1) to explore how migrant youth cope with acculturative stress and intergenerational conflicts, and 2) to better understand the systemic and family-related factors that facilitate positive settlement experiences for migrant youth. Methods A total of 14 focus group discussions, comprising 164 people, were carried out in Greater Western Sydney, New South Wales, Australia. These focus groups targeted newly arrived migrant parents and young adults (aged 18-24) of African, Burmese, Nepalese, Indian, Afghani, Bangladeshi and Iraqi backgrounds. Each focus group was 1.5 hours in duration and was conducted by a team of three people (an experienced facilitator, an accredited interpreter/bilingual worker, and a note taker). Data were collected using a standard interview schedule, and an accredited interpreter/bilingual worker asked the questions in the appropriate language and translated participant responses into English. Results The findings highlight how youth in new migrant families become contested sites of culture as they try to balance integration into the new culture while maintaining their originating country's cultural values. Two themes and four subthemes emerged from the analysis: Intergenerational acculturation gap (loss of family capital and intergenerational conflicts); and factors that successfully protected positive family values while still allowing young people to integrate (the legal system that disarm authoritarian parenting practices and family rules; and parental use of children's increased knowledge of the new environment to navigate their new environment). Migrant families conceptualised family capital as the social solidarity, influence, and control governing obligations and expectations, intergenerational knowledge transmission and information flow, social norms, and cultural identity. The loss of family capital was characterised by children's refusal to associate with or meet family members, preferring to be alone in their rooms and private space. Migrant youth find themselves caught between and negotiating two cultures, with unwanted negative consequences at the family level in the form of intergenerational conflicts. The new found freedom among children and their rapid transition into the Australian society gives children an increased sense of agency, which in turn threatens parental authority, allowing children to exercise three forms of power: increased assertiveness due to legal protection of children against any corporal punishment; and English language fluency and greater understanding of the functioning of Australian social institutions. Conclusion Our findings suggest the need for an inter-generational approach to healthy family dynamics within migrant communities when dealing with youth negotiating the complexity and sensitivity of forging their cultural identity.	[Renzaho, Andre M. N.; Dhingra, Nidhi; Georgeou, Nichole] Univ Western Sydney, Sch Social Sci & Psychol, Humanitarian & Dev Res Initiat, Sydney, NSW, Australia	Western Sydney University	Renzaho, AMN (corresponding author), Univ Western Sydney, Sch Social Sci & Psychol, Humanitarian & Dev Res Initiat, Sydney, NSW, Australia.	andre.renzaho@westernsydney.edu.au	Renzaho, Andre M.N./AAH-7679-2021; Georgeou, Nichole/C-6881-2017	Georgeou, Nichole/0000-0001-7434-025X; RENZAHO, ANDRE/0000-0002-6844-0833	seed grant from the school of Social Sciences and Psychology, Western Sydney University; Australian Research Council Future Fellowship [FT110100345]	seed grant from the school of Social Sciences and Psychology, Western Sydney University; Australian Research Council Future Fellowship(Australian Research Council)	The study was funded by a seed grant from the school of Social Sciences and Psychology, Western Sydney University. Author AR is supported by an Australian Research Council Future Fellowship (FT110100345). The specific roles of this author are articulated in the 'author contributions' section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Professor Andre Renzaho is supported by an Australian Research Council Future Fellowship (FT110100345). The research team would like to acknowledge the Migrant Review Panel and all organisations that helped during data collection. We acknowledge and appreciate the study participants for being generous with their time.	[Anonymous], INT ED J COMP PERSPE; [Anonymous], 2009, THEORISING SOCIAL EX; [Anonymous], 6201011 PARL AUSTR; [Anonymous], BOOST EMPL PUBL WORK; [Anonymous], 2011, INT J EDUC RES, DOI DOI 10.1016/J.IJER.2011.10.001; [Anonymous], 2006, NEGOTIATING TRANSCUL; [Anonymous], GLOBAL MIGRATION ED; [Anonymous], J FAMILY STUDIES; [Anonymous], 2013, GUIDE CANADAS CHANGI; [Anonymous], 2007, J YOUTH STUD, DOI DOI 10.1080/13676260600881474; [Anonymous], 2014, MIGR REF YOUNG PEOPL; [Anonymous], STRUGGLE IDENTITY IN; [Anonymous], CULTURAL DIFFERENCES; [Anonymous], 2000, SITUATED LITERACIES; [Anonymous], ENCY EARLY CHILDHOOD; [Anonymous], INT J HUMANITIES SOC; [Anonymous], 1991, SMALL DIFFERENCES MA; [Anonymous], GREAT W SYDN POP DWE; [Anonymous], DIVERSE ISSUES HIGHE; [Anonymous], THEORISING SOCIAL EX; Baker C., 2011, FDN BILINGUAL ED BIL; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; Baumrind D., 2013, AUTHORITATIVE PARENT, P11; Baumrind D., 1989, CHILD DEV TODAY TOMO; Berry J W, 1990, Arctic Med Res, V49, P142; Berry J. W., 2006, CAMBRIDGE HDB ACCULT, P43, DOI DOI 10.1017/CBO9780511489891.007; Berry J. W., 2002, CROSS CULTURAL PSYCH, DOI DOI 10.1017/CBO9780511974274; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Birman D, 2006, J CROSS CULT PSYCHOL, V37, P568, DOI 10.1177/0022022106290479; Borawski EA, 2003, J ADOLESCENT HEALTH, V33, P60, DOI 10.1016/S1054-139X(03)00100-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buriel R, 1998, HISPANIC J BEHAV SCI, V20, P283, DOI 10.1177/07399863980203001; Corona R, 2012, J CHILD FAM STUD, V21, P788, DOI 10.1007/s10826-011-9536-2; Devine D, 2009, BRIT J SOCIOL EDUC, V30, P521, DOI 10.1080/01425690903101023; Dishion T J, 1998, Clin Child Fam Psychol Rev, V1, P61, DOI 10.1023/A:1021800432380; Harris A, 2010, J INTERCULT STUD, V31, P573, DOI 10.1080/07256868.2010.513424; HESS RD, 1984, REV CHILD DEV RES, V7, P179; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Hollifield J., 2014, CONTROLLING IMMIGRAT; Holloway I., 2010, QUALITATIVE RES NURS; Hwang WC, 2006, PSYCHOTHERAPY, V43, P397, DOI 10.1037/0033-3204.43.4.397; Kagitcibasi C., 1997, HDB CROSS CULTURAL P, V3, P1; Kelly P, 2006, ENVIRON PLANN A, V38, P831, DOI 10.1068/a37214; Komarraju M, 2008, CULT DIVERS ETHN MIN, V14, P336, DOI 10.1037/1099-9809.14.4.336; Mansouri F, 2017, J SOCIOL, V53, P127, DOI 10.1177/1440783316636244; Massey DS, 2002, POPUL RES POLICY REV, V21, P473, DOI 10.1023/A:1022914700681; Miller PW, 1999, AM ECON REV, V89, P192, DOI 10.1257/aer.89.2.192; Moskal M, 2014, J YOUTH STUD, V17, P279, DOI 10.1080/13676261.2013.815705; Ong, 2002, ORALITY LITERACY; Orellana MF, 2001, HARVARD EDUC REV, V71, P366, DOI 10.17763/haer.71.3.52320g7n21922hw4; Parahoo K., 2014, NURSING RES PRINCIPL; Renzaho AMN, 2008, INT J OBESITY, V32, P594, DOI 10.1038/ijo.2008.2; Renzaho AMN, 2011, INT J INTERCULT REL, V35, P416, DOI 10.1016/j.ijintrel.2010.09.001; Renzaho AMN, 2012, QUAL HEALTH RES, V22, P740, DOI 10.1177/1049732311425051; Renzaho AMN, 2011, CHILD FAM SOC WORK, V16, P228, DOI 10.1111/j.1365-2206.2010.00736.x; Rodriguez ML, 2010, SOC IDENT, V16, P339, DOI 10.1080/13504630.2010.482422; Ryan L, 2015, MIGR DIASP CITIZEN, P1, DOI 10.1057/9781137348807; Ryan L, 2011, SOCIOL REV, V59, P707, DOI 10.1111/j.1467-954X.2011.02030.x; SHAPIRO BS, 1995, PAIN, V61, P139, DOI 10.1016/0304-3959(94)00164-A; Shields MK, 2004, FUTURE CHILD, V14, P4, DOI 10.2307/1602791; SZAPOCZNIK J, 1986, HISPANIC J BEHAV SCI, V8, P303, DOI 10.1177/07399863860084001; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; van de Ven J, 2015, IZA J MIGR, V4, DOI 10.1186/s40176-015-0045-8; WAKIL SP, 1981, J MARRIAGE FAM, V43, P929, DOI 10.2307/351349; Warr DJ, 2005, QUAL INQ, V11, P200, DOI 10.1177/10778004042734112; Weisskirch RS, 2002, HISPANIC J BEHAV SCI, V24, P369, DOI 10.1177/0739986302024003007	66	36	36	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170700	10.1371/journal.pone.0170700	http://dx.doi.org/10.1371/journal.pone.0170700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170406	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500008
J	Ruzic-Sabljic, E; Maraspin, V; Stupica, D; Rojko, T; Bogovic, P; Strle, F; Cerar, T				Ruzic-Sabljic, Eva; Maraspin, Vera; Stupica, Dasa; Rojko, Tereza; Bogovic, Petra; Strle, Franc; Cerar, Tjasa			Comparison of MKP and BSK-H media for the cultivation and isolation of Borrelia burgdorferi sensu lato	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; FIELD GEL-ELECTROPHORESIS; LYME-BORRELIOSIS; ERYTHEMA MIGRANS; PLASMID CONTENT; II MEDIUM; DIAGNOSIS; CULTURE; DISEASE; RESTRICTION	The isolation of B. burgdorferi sensu lato requires the use of complex cultivation media. The aim of the study was to compare the usefulness of BSK-H (a commercial medium produced by HiMedia, India) and MKP medium. MKP and BSK-H media were prepared in accordance with the relevant protocols. Borrelia strains and skin culture biopsies were simultaneously inoculated into both media, incubated and checked for growth. Borrelial growth characteristics, isolation rates and characteristics of the isolated borreliae were analysed and compared. Initially, numbers of spirochaetes were higher in BSK-H than in MKP; however, in comparison with MKP, the strains subcultured in BSK-H medium were more frequently irregular, thin and non-motile, and rapidly died. In addition, the borrelial isolation rate from erythema migrans skin samples was higher in MKP than in BSK-H medium (108/171, 63.2% versus 70/171, 40.9%; p < 0.0001). The far most frequently isolated species was Borrelia afzelii (92.9% and 97.2% strains isolated from BSK-H and MKP, respectively). Comparison of strains cultured from individual patients in both media showed differences in plasmid contents in 9/46 (19.6%) strain pairs, and protein profiles differed in 30/43 (69.8%) strain pairs, most often in the expression of OspC (in 27/28 patients OspC was expressed only in strains growing in MKP). BSK-H medium supports the growth of borrelial strains but MKP is superior with regard to the isolation rate, morphology and motility of strains. BSK-H medium supports fast initial growth of borreliae but this is followed by rapid deformation and death of the spirochaetes.	[Ruzic-Sabljic, Eva; Cerar, Tjasa] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Maraspin, Vera; Stupica, Dasa; Rojko, Tereza; Bogovic, Petra; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Ruzic-Sabljic, E (corresponding author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia.	eva.ruzic-sabljic@mf.uni-lj.si		Cerar Kisek, Tjasa/0000-0002-4053-5590				Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Babb K, 2001, INFECT IMMUN, V69, P4146, DOI 10.1128/IAI.69.6.4146-4153.2001; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Biskup UG, 2011, PLASMID, V66, P1, DOI 10.1016/j.plasmid.2011.02.006; BUSCH U, 1995, ELECTROPHORESIS, V16, P744, DOI 10.1002/elps.11501601122; Glinsek U, 2009, WORLD J MICROB BIOT, V25, P1287, DOI 10.1007/s11274-009-0015-5; Iyer R, 2003, INFECT IMMUN, V71, P3699, DOI 10.1128/IAI.71.7.3699-3706.2003; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Marconi RT, 1996, J BACTERIOL, V178, P3357, DOI 10.1128/jb.178.11.3357-3361.1996; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Nacionalni institut za javno zdravje (NIJZ). [National Institute for Public Health], 2016, EP SPREMLJ NAL BOL S, DOI 10.1016/S0140-6736d1160103-7; Norris DE, 1997, J CLIN MICROBIOL, V35, P2359, DOI 10.1128/JCM.35.9.2359-2364.1997; PACHNER AR, 1993, J CLIN MICROBIOL, V31, P208, DOI 10.1128/JCM.31.2.208-214.1993; Picken MM, 1997, J CLIN PATHOL-MOL PA, V50, P186, DOI 10.1136/mp.50.4.186; Picken MM, 1996, EUR J CLIN MICROBIOL, V15, P489, DOI 10.1007/BF01691317; Piesman J., 2010, BORRELIA MOL BIOL HO, P251; POLLACK RJ, 1993, J CLIN MICROBIOL, V31, P1251, DOI 10.1128/JCM.31.5.1251-1255.1993; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; PREACMURSIC V, 1986, ZBL BAKT-INT J MED M, V263, P112; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Ruzic-Sabljic E, 2014, CLIN MICROBIOL INFEC, V20, P636, DOI 10.1111/1469-0691.12457; Ruzic-Sabljic ER, 2004, INT J MED MICROBIOL, V294, P407, DOI 10.1016/j.ijmm.2004.08.002; Ruzic-Sabljic E, 2008, RES MICROBIOL, V159, P441, DOI 10.1016/j.resmic.2008.05.005; Ruzic-Sabljic E, 2006, INT J MED MICROBIOL, V296, P267, DOI 10.1016/j.ijmm.2006.01.005; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Stupica D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136600; WILSKE B, 1988, ANN NY ACAD SCI, V539, P126, DOI 10.1111/j.1749-6632.1988.tb31846.x; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wormser GP, 2000, J CLIN MICROBIOL, V38, P1648, DOI 10.1128/JCM.38.4.1648-1650.2000; Yang XF, 2001, INFECT IMMUN, V69, P4159, DOI 10.1128/IAI.69.6.4159-4163.2001; Zore A, 2002, WIEN KLIN WOCHENSCHR, V114, P606	31	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171622	10.1371/journal.pone.0171622	http://dx.doi.org/10.1371/journal.pone.0171622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170447	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500047
J	Zhang, C; Hua, R; Cui, YY; Wang, SS; Yan, HQ; Li, DM; Zhang, YH; Tu, ZK; Hao, P; Chen, XY; Zhong, J; Niu, JQ; Jin, X				Zhang, Chao; Hua, Rui; Cui, Yuanyuan; Wang, Shasha; Yan, Hongqing; Li, Dongmei; Zhang, Yonghong; Tu, Zhengkun; Hao, Pei; Chen, Xinyue; Zhong, Jin; Niu, Junqi; Jin, Xia			Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance	PLOS ONE			English	Article							IMMUNITY; THERAPY; DETERMINANTS; PERSISTENCE; EXHAUSTION; INDUCTION	Elucidating protective immunity against HCV is important for the development of a preventative vaccine. We hypothesize that spontaneous resolution of acute HCV infection offers clue to protective immune responses, and that DAA therapy affects the quality and quantity of HCV-specific T cell responses. To test these hypotheses, we performed T cell epitope mapping in 111 HCV-infected individuals including 61 chronically HCV-1b (CHC-1b) infected, 24 chronically HCV-2a (CHC-2a) infected and 26 spontaneously recovered (SPR) patients with 376 overlapping peptides covering the entire HCV polyprotein. Selected T cell epitopes were then used to evaluate T cell responses in another 22 chronically HCV-1b infected patients on DAA therapy. Results showed that SPR had better HCV-specific T cell responses than CHC, as manifested by higher response rate, greater magnitude and broader epitope coverage. In addition, SPR recognized novel epitopes in Core, E1, E2, NS4B, NS5A regions that were not present in the CHC. Furthermore, during the first 24 weeks of DAA therapy, there was no functional immune reconstitution of HCV-specific T cells. These results indicate that T cell responses may be a correlate of protection. Therefore, effective preventative vaccines should elicit a robust T cell response. Although various DAA regimens efficiently cleared viruses from the blood of HCV-infected patients, there was no contemporaneous early T cell immune reconstitution, suggesting that early treatment is needed for preserving the functions of HCV-specific T cells.	[Zhang, Chao; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Unit, Shanghai, Peoples R China; [Hua, Rui; Cui, Yuanyuan; Wang, Shasha; Yan, Hongqing; Li, Dongmei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin, Peoples R China; [Zhang, Yonghong; Chen, Xinyue] Capital Med Univ, Beijing Youan Hosp, Dept Hepatol, Beijing, Peoples R China; [Tu, Zhengkun; Niu, Junqi] Jilin Univ, Hosp 1, Inst Translat Med, Changchun, Jilin, Peoples R China; [Hao, Pei] Chinese Acad Sci, Inst Pasteur Shanghai, Bioinformat Core, Shanghai, Peoples R China; [Zhong, Jin] Chinese Acad Sci, Viral Hepatitis Unit, Inst Pasteur Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Jilin University; Capital Medical University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Unit, Shanghai, Peoples R China.	xjin@ips.ac.cn	Zhong, Jin/J-4613-2019; chen, xinyue/HHR-9308-2022; Zhong, Jin/M-6859-2018	Zhang, Chao/0000-0001-6292-7651; Zhong, Jin/0000-0002-3554-1275; Tu, Zhengkun/0000-0001-6803-2015; Hao, Pei/0000-0002-1498-7059	Chinese Ministry of Science and Technology 973 Grant [2015CB554304]; National Science and Technology Major Project [2012ZX10002007]; Natural Science Foundation of China of the First Hospital of Jilin University [81373143, 81571535]; Capital Characteristic Clinical Application Research [Z161100000516018]; Capital Health and Development Research Fund of the Beijing You'an Hospital of Capital Medical University [2016-1-2183]	Chinese Ministry of Science and Technology 973 Grant; National Science and Technology Major Project; Natural Science Foundation of China of the First Hospital of Jilin University; Capital Characteristic Clinical Application Research; Capital Health and Development Research Fund of the Beijing You'an Hospital of Capital Medical University	This study was supported by grants from the Chinese Ministry of Science and Technology 973 Grant (#2015CB554304), National Science and Technology Major Project (#2012ZX10002007) and Natural Science Foundation of China (#81373143, #81571535) of the First Hospital of Jilin University, the Capital Characteristic Clinical Application Research (#Z161100000516018) and the Capital Health and Development Research Fund (#2016-1-2183) of the Beijing You'an Hospital of Capital Medical University. The funders have been involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anthony DD, 2003, METHODS, V29, P260, DOI 10.1016/S1046-2023(02)00348-1; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Beattie T, 2004, AIDS, V18, P1595, DOI 10.1097/01.aids.0000131362.82951.b2; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Burchill MA, 2015, J VIRAL HEPATITIS, V22, P983, DOI 10.1111/jvh.12465; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gruner NH, 2000, J INFECT DIS, V181, P1528, DOI 10.1086/315450; Hengst J, 2016, J INFECT DIS, V214, P1965, DOI 10.1093/infdis/jiw457; Humphreys IS, 2012, GUT, V61, P1589, DOI 10.1136/gutjnl-2011-300650; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Kelly C, 2016, HEPATOLOGY, V63, P1455, DOI 10.1002/hep.28294; Kurktschiev PD, 2014, J EXP MED, V211, P2047, DOI 10.1084/jem.20131333; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Neumann-Haefelin C, 2008, HEPATOLOGY, V47, P1824, DOI 10.1002/hep.22242; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Rehermann B, 2015, HEPATOLOGY, V61, P712, DOI 10.1002/hep.27323; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Urbani S, 2001, HEPATOLOGY, V33, P1533, DOI 10.1053/jhep.2001.25091; Urbani S, 2006, HEPATOLOGY, V44, P126, DOI 10.1002/hep.21242; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wieland D, 2016, HEPATOLOGY, V63, P1411, DOI 10.1002/hep.28388; Xu HQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2299-8; Zeisel MB, 2008, HEPATOLOGY, V48, P299, DOI 10.1002/hep.22307; Zhang C., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1089/CBR.2014.1653	33	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171217	10.1371/journal.pone.0171217	http://dx.doi.org/10.1371/journal.pone.0171217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170421	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500024
J	Ng, MY; Wang, M; Casey, PJ; Gan, YH; Hagen, T				Ng, Mei Ying; Wang, Mei; Casey, Patrick J.; Gan, Yunn-Hwen; Hagen, Thilo			Activation of MAPK/ERK signaling by Burkholderia pseudomallei cycle inhibiting factor (Cif)	PLOS ONE			English	Article							HOST-CELL CYCLE; NEDD8-ACTIVATING ENZYME; UBIQUITIN LIGASES; EFFECTOR FAMILY; PHOSPHORYLATION; DEGRADATION; P27(KIP1); RAS; DEAMIDATION; COMPLEX	Cycle inhibiting factors (Cifs) are virulence proteins secreted by the type III secretion system of some Gram-negative pathogenic bacteria including Burkholderia pseudomallei. Cif is known to function to deamidate Nedd8, leading to inhibition of Cullin E3 ubiquitin ligases (CRL) and consequently induction of cell cycle arrest. Here we show that Cif can function as a potent activator of MAPK/ERK signaling without significant activation of other signaling pathways downstream of receptor tyrosine kinases. Importantly, we found that the ability of Cif to activate ERK is dependent on its deamidase activity, but independent of Cullin E3 ligase inhibition. This suggests that apart from Nedd8, other cellular targets of Cif dependent deamidation exist. We provide evidence that the mechanism involved in Cif mediated ERK activation is dependent on recruitment of the Grb2-SOS1 complex to the plasma membrane. Further investigation revealed that Cif appears to modify the phosphorylation status of SOS1 in a region containing the CDC25-H and proline-rich domains. It is known that prolonged Cullin E3 ligase inhibition leads to cellular apoptosis. Therefore, we hypothesize that ERK activation is an important mechanism to counter the pro-apoptotic effects of Cif. Indeed, we show that Cif dependent ERK activation promotes phosphorylation of the proapoptotic protein Bim, thereby potentially conferring a pro-survival signal. In summary, we identified a novel deamidation-dependent mechanism of action of the B. pseudomallei virulence factor Cif/CHBP to activate MAPK/ERK signaling. Our study demonstrates that bacterial proteins such as Cif can serve as useful molecular tools to uncover novel aspects of mammalian signaling pathways.	[Ng, Mei Ying; Wang, Mei; Gan, Yunn-Hwen; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Wang, Mei; Casey, Patrick J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore	National University of Singapore; National University of Singapore	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.	bchth@nus.edu.sg	Gan, Yunn-Hwen/AAH-8515-2021	Wang, Mei/0000-0001-6887-6840; Casey, Patrick/0000-0002-7366-9309				Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boh BK, 2011, J MOL BIOL, V413, P430, DOI 10.1016/j.jmb.2011.08.030; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chew EH, 2007, CELL SIGNAL, V19, P1071, DOI 10.1016/j.cellsig.2006.12.002; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Douville E, 1997, ONCOGENE, V15, P373, DOI 10.1038/sj.onc.1201214; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Hall BE, 2002, FRONT BIOSCI, V7, pD288, DOI 10.2741/hall; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Jubelin G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004855; Kamioka Y, 2010, J BIOL CHEM, V285, P33540, DOI 10.1074/jbc.M110.135517; Kim JH, 1998, ONCOGENE, V16, P2597, DOI 10.1038/sj.onc.1201822; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; McCormack RM, 2015, ELIFE, V4, DOI 10.7554/eLife.06505; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Morikawa H, 2010, BIOCHEM BIOPH RES CO, V401, P268, DOI 10.1016/j.bbrc.2010.09.048; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Taieb F, 2011, TOXINS, V3, P356, DOI 10.3390/toxins3040356; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10053	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171464	10.1371/journal.pone.0171464	http://dx.doi.org/10.1371/journal.pone.0171464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166272	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100044
J	Papasotiriou, I; Pantopikou, K; Apostolou, P				Papasotiriou, Ioannis; Pantopikou, Katerina; Apostolou, Panagiotis			L1 retrotransposon expression in circulating tumor cells	PLOS ONE			English	Article							LINE-1 RETROTRANSPOSITION	Long interspersed nuclear element 1 (LINE-1 or L1) belongs to the non-long terminal repeat (non-LTR) retrotransposon family, which has been implicated in carcinogenesis and disease progression. Circulating tumor cells (CTCs) are also known to be involved in cancer progression. The present study aimed to compare the L1 expression between circulating tumor cells and non-cancerous samples. Blood samples were collected from 10 healthy individuals and 22 patients with different types of cancer. The whole blood cells were isolated using enrichment protocols and the DNA and RNA were extracted. RT-qPCR was performed for L1-ORF1 (open reading frame 1) and L1-ORF2, using 18S rRNA as the reference gene. The data were analyzed with the Livak method and statistical analyses were carried out with the Mann-Whitney and Kruskal-Wallis tests. In parallel with the above molecular biology experiments, FISH experiments were performed on the interphase nuclei of the cells for the detection of ORF2 RNA. DNA analysis revealed the presence of both ORF1 and ORF2 in all samples. RNA expression experiments demonstrated that ORF1 was not expressed in all samples, while ORF2 was expressed at varying levels in the non-cancer samples and the samples representing the different cancer types. A significant difference in ORF2 expression was observed between the CTCs and non-cancer samples (p = 0,00043), and significant differences were also observed between normal and lung (p = 0,034), pancreatic (p = 0,022), prostate (p = 0,014), and unknown primary of origin (p = 0,0039) cancer samples. Cytogenetic analysis revealed higher levels of ORF2 in the nuclei of CTCs than in normal samples. This study highlights the significant difference in L1-ORF2 expression between CTCs and normal samples. The increased expression levels observed for CTCs may be correlated with the characteristic features of these cells.	[Papasotiriou, Ioannis; Pantopikou, Katerina; Apostolou, Panagiotis] Res Genet Canc Ctr SA, Ind Area, Florina, Greece		Papasotiriou, I (corresponding author), Res Genet Canc Ctr SA, Ind Area, Florina, Greece.	papasotiriou.ioannis@rgcc-genlab.com		PAPASOTIRIOU, IOANNIS/0000-0002-6145-946X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apostolou P, 2015, CELL COMMUN ADHES, V22, P1, DOI 10.3109/15419061.2014.970270; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; Bojang P, 2014, GENOMICS, V104, P96, DOI 10.1016/j.ygeno.2014.07.001; Carreira PE, 2014, FEBS J, V281, P63, DOI 10.1111/febs.12601; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; De Luca C, 2016, ONCOTARGET, V7, P4048, DOI 10.18632/oncotarget.6767; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Freshney RI, 2005, SAFETY BIOETHICS VAL; Garcia-Perez JL, 2010, NATURE, V466, P769, DOI 10.1038/nature09209; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Klawitter S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10286; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Patnala R, 2014, BREAST CANCER RES TR, V143, P239, DOI 10.1007/s10549-013-2812-7; Sciamanna I, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00006; Scott EC, 2016, GENOME RES, V26, P745, DOI 10.1101/gr.201814.115; Theodoropoulos PA, 2010, CANCER LETT, V288, P99, DOI 10.1016/j.canlet.2009.06.027; Vasil'ev S A, 2015, Mol Biol (Mosk), V49, P165; Williams SCP, 2013, P NATL ACAD SCI USA, V110, P4861, DOI 10.1073/pnas.1304186110	23	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171466	10.1371/journal.pone.0171466	http://dx.doi.org/10.1371/journal.pone.0171466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166262	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100045
J	Seong, KM; Kwon, T; Seo, S; Lee, D; Park, S; Jin, YW; Lee, SS				Seong, Ki Moon; Kwon, TaeWoo; Seo, Songwon; Lee, Dalnim; Park, Sunhoo; Jin, Young Woo; Lee, Seung-Sook			Perception of low dose radiation risks among radiation researchers in Korea	PLOS ONE			English	Article							IONIZING-RADIATION; CANCER; EXPOSURE; PLANT; CONSEQUENCES; BIOLOGY; EXPERTS	Expert's risk evaluation of radiation exposure strongly influences the public's risk perception. Experts can inform laypersons of significant radiation information including health knowledge based on experimental data. However, some experts' radiation risk perception is often based on non-conclusive scientific evidence (i.e., radiation levels below 100 millisievert), which is currently under debate. Examining perception levels among experts is important for communication with the public since these individual's opinions have often exacerbated the public's confusion. We conducted a survey of Korean radiation researchers to investigate their perceptions of the risks associated with radiation exposure below 100 millisievert. A linear regression analysis revealed that having >= 11 years' research experience was a critical factor associated with radiation risk perception, which was inversely correlated with each other. Increased opportunities to understand radiation effects at < 100 millisievert could alter the public's risk perception of radiation exposure. In addition, radiation researchers conceived that more scientific evidence reducing the uncertainty for radiation effects < 100 millisievert is necessary for successful public communication. We concluded that sustained education addressing scientific findings is a critical attribute that will affect the risk perception of radiation exposure.	[Seong, Ki Moon; Kwon, TaeWoo; Seo, Songwon; Lee, Dalnim; Park, Sunhoo; Jin, Young Woo; Lee, Seung-Sook] Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Low Dose Risk Assessment, Seoul, South Korea; [Park, Sunhoo; Lee, Seung-Sook] Korea Inst Radiol & Med Sci, Dept Pathol, Korea Canc Ctr Hosp, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; National Cancer Center - Korea (NCC)	Lee, SS (corresponding author), Korea Inst Radiol & Med Sci, Natl Radiat Emergency Med Ctr, Lab Low Dose Risk Assessment, Seoul, South Korea.; Lee, SS (corresponding author), Korea Inst Radiol & Med Sci, Dept Pathol, Korea Canc Ctr Hosp, Seoul, South Korea.	sslee@kirams.re.kr	Seong, Ki Moon/Y-6083-2019		Nuclear Safety & Security Commission (NSSC) [1501007]; Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [50586-2016]	Nuclear Safety & Security Commission (NSSC); Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea	This study was financially supported in part by a grant of 1501007 from Nuclear Safety & Security Commission (NSSC), and a grant of 50586-2016 by the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 2012, BIOL MECH RAD ACT LO; [Anonymous], 2005, ANN ICRP, V35, P1; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2011, NATURE; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Bromet EJ, 2012, J RADIOL PROT, V32, pN71, DOI 10.1088/0952-4746/32/1/N71; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Hendry J. H., 2012, Annals of the ICRP, V41, P64, DOI 10.1016/j.icrp.2012.06.013; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kim Y, 2011, BRIT J PSYCHIAT, V199, P411, DOI 10.1192/bjp.bp.110.085472; Kim Y, 2016, J KOREAN MED SCI, V31, pS88, DOI 10.3346/jkms.2016.31.S1.S88; KRAUS N, 1992, RISK ANAL, V12, P215, DOI 10.1111/j.1539-6924.1992.tb00669.x; Leuraud K, 2015, LANCET HAEMATOL, V2, pE276, DOI 10.1016/S2352-3026(15)00094-0; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Miura M, 2016, HEALTH PHYS, V110, P558, DOI 10.1097/HP.0000000000000486; Normile D, 2011, SCIENCE, V332, P908, DOI 10.1126/science.332.6032.908; Ozasa K, 2016, J RADIAT RES, V57, pI112, DOI 10.1093/jrr/rrw005; Perko T, 2014, J ENVIRON RADIOACTIV, V133, P86, DOI 10.1016/j.jenvrad.2013.04.005; Sacks Bill, 2016, Biological Theory, V11, P69, DOI 10.1007/s13752-016-0244-4; Siegrist M, 2007, RISK ANAL, V27, P59, DOI 10.1111/j.1539-6924.2006.00859.x; Slovic P, 1996, RADIAT PROT DOSIM, V68, P165, DOI 10.1093/oxfordjournals.rpd.a031860; Slovic P, 2012, B ATOM SCI, V68, P67, DOI 10.1177/0096340212444870; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; Visschers VHM, 2013, RISK ANAL, V33, P333, DOI 10.1111/j.1539-6924.2012.01861.x; Wing S, 1997, ENVIRON HEALTH PERSP, V105, P52, DOI 10.2307/3433062; Zeleznik N, 2016, J RADIOL PROT, V36, pS102, DOI 10.1088/0952-4746/36/2/S102; 박방주, 2012, [Journal of Radiation Protection and Research, 방사선방어학회지], V37, P1	29	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171777	10.1371/journal.pone.0171777	http://dx.doi.org/10.1371/journal.pone.0171777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166286	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100072
J	Varbanov, HP; Kuttler, F; Banfi, D; Turcatti, G; Dyson, PJ				Varbanov, Hristo P.; Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo; Dyson, Paul J.			Repositioning approved drugs for the treatment of problematic cancers using a screening approach	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; PANCREATIC-CANCER; SELECTIVE OPTIMIZATION; SIDE ACTIVITIES; CELL-LINES; IN-VITRO; MEBENDAZOLE; VORINOSTAT; CYTOTOXICITY; DOXORUBICIN	Advances in treatment strategies together with an earlier diagnosis have considerably increased the average survival of cancer patients over the last four decades. Nevertheless, despite the growing number of new antineoplastic agents introduced each year, there is still no adequate therapy for problematic malignancies such as pancreatic, lung and stomach cancers. Consequently, it is important to ensure that existing drugs used to treat other types of cancers, and potentially other diseases, are not overlooked when searching for new chemotherapy regimens for these problematic cancer types. We describe a screening approach that identifies chemotherapeutics for the treatment of lung and pancreatic cancers, based on drugs already approved for other applications. Initially, the 1280 chemically and pharmacologically diverse compounds from the Prestwick Chemical Library (R) (PCL) were screened against A549 (lung cancer) and PANC-1 (pancreatic carcinoma) cells using the PrestoBlue fluorescent-based cell viability assay. More than 100 compounds from the PCL were identified as hits in one or both cell lines (80 of them, being drugs used to treat diseases other than cancer). Selected PCL hits were further evaluated in a dose-response manner. Promising candidates for repositioning emanating from this study include antiparasitics, cardiac glycosides, as well as the anticancer drugs vorinostat and topotecan.	[Varbanov, Hristo P.; Dyson, Paul J.] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland; [Varbanov, Hristo P.; Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo] Ecole Polytech Fed Lausanne, Biomol Screening Facil, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Varbanov, HP; Dyson, PJ (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland.; Varbanov, HP (corresponding author), Ecole Polytech Fed Lausanne, Biomol Screening Facil, Lausanne, Switzerland.	hristo.varbanov@univie.ac.at; paul.dyson@epfl.ch	Dyson, Paul/AAB-9075-2019; Varbanov, Hristo P./O-3973-2017	Dyson, Paul/0000-0003-3117-3249; Varbanov, Hristo P./0000-0003-4450-7332; Kuttler, Fabien/0000-0003-2575-1989	Austrian Science Fund (FWF) [J3577-B13]; BSF-ACCESS screening platform at the EPFL; Austrian Science Fund (FWF) [J 3577] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); BSF-ACCESS screening platform at the EPFL; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	H.V. is indebted to the Austrian Science Fund (FWF) for the financial support (Schrodinger fellowship, Project number: J3577-B13). We acknowledge the Swiss National Center for Competence (NCCR) in Chemical Biology for providing access to the chemical libraries and screening facilities.; We acknowledge the BSF-ACCESS screening platform at the EPFL for support, in particular we are thankful to Julien Bortoli Chapalay for dispensing the PCL with the Echo acoustic liquid handler and to Antoine Gibelin for the quality control with LC-MS.	Arai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162394; Bai RY, 2011, NEURO-ONCOLOGY, V13, P974, DOI 10.1093/neuonc/nor077; Banuls LMY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-33; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Bray F, GLOBOCAN 2012 V1 0 C; Cancer Research UK, CANC SURV COMM CANC; Cancer Research UK, STER CANC TREATM; Chan E, 2016, RADIOTHER ONCOL, V119, P312, DOI 10.1016/j.radonc.2016.04.013; Chien WW, 2014, MOL CARCINOGEN, V53, P722, DOI 10.1002/mc.22024; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Doudican N, 2008, MOL CANCER RES, V6, P1308, DOI 10.1158/1541-7786.MCR-07-2159; Elbaz HA, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-4; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Herdrich K, 2010, SELECTED SCHEDULES T; Huggett MT, 2014, BRIT J CANCER, V110, P1698, DOI 10.1038/bjc.2014.95; Ishii I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00137; John R, GLOBAL EC COST CANC; Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1831, DOI 10.1016/j.drudis.2014.08.007; Kumagai T, 2007, INT J CANCER, V121, P656, DOI 10.1002/ijc.22558; Li H, 2016, ONCOTARGET, V7, P3548, DOI 10.18632/oncotarget.6516; LIEBMANN JE, 1993, BRIT J CANCER, V68, P1104, DOI 10.1038/bjc.1993.488; Lin SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123305; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Meredith AM, 2016, J PHARM PHARMACOL, V68, P729, DOI 10.1111/jphp.12539; Michaelis M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08202; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Miyanaga A, 2008, MOL CANCER THER, V7, P1923, DOI 10.1158/1535-7163.MCT-07-2140; Mukhopadhyay T, 2002, CLIN CANCER RES, V8, P2963; National cancer Institute, WHAT IS CANC; Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a; Nygren P, 2013, J CANCER RES CLIN, V139, P2133, DOI 10.1007/s00432-013-1539-5; Owonikoko TK, 2010, INT J CANCER, V126, P743, DOI 10.1002/ijc.24759; Pantziarka P, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.443; Petersen GH, 2016, J CONTROL RELEASE, V232, P255, DOI 10.1016/j.jconrel.2016.04.028; Pongrakhananon V., 2013, ANTICANCER PROPERTIE, P65; Prassas I, 2011, MOL CANCER THER, V10, P2083, DOI 10.1158/1535-7163.MCT-11-0421; Price P, 2008, TREATMENT OF CANC; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Sasaki J, 2002, MOL CANCER THER, V1, P1201; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sweetman, 2009, COMPLETE DRUG REFERE; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; Varghese E, 2014, CANCERS, V6, P2243, DOI 10.3390/cancers6042243; VOGLER WR, 1992, J CLIN ONCOL, V10, P1103, DOI 10.1200/JCO.1992.10.7.1103; Weinberg BA, 2015, ONCOLOGY-NY, V29, P809; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Wermuth CG, 2004, J MED CHEM, V47, P1303, DOI 10.1021/jm030480f; Yang W., 2013, NUCL ACIDS RES, V41; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	34	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171052	10.1371/journal.pone.0171052	http://dx.doi.org/10.1371/journal.pone.0171052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166232	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100021
J	Lee, JW; Lee, KE; Park, DJ; Kim, SH; Nah, SS; Lee, JH; Kim, SK; Lee, YA; Hong, SJ; Kim, HS; Lee, HS; Kim, HA; Joung, CI; Kim, SH; Lee, SS				Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Kim, Seong-Ho; Nah, Seong-Su; Lee, Ji Hyun; Kim, Seong-Kyu; Lee, Yeon-Ah; Hong, Seung-Jae; Kim, Hyun-Sook; Lee, Hye-Soon; Kim, Hyoun Ah; Joung, Chung-Il; Kim, Sang-Hyon; Lee, Shin-Seok			Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach	PLOS ONE			English	Article							SELF-EFFICACY; RHEUMATOID-ARTHRITIS; HEALTH-STATUS; GENERAL-POPULATION; KOREAN VERSION; ANXIETY; WOMEN; IMPACT; SF-36; CLASSIFICATION	Objective Health-related quality of life (HRQOL) in patients with fibromyalgia (FM) is lower than in patients with other chronic diseases and the general population. Although various factors affect HRQOL, no study has examined a structural equation model of HRQOL as an outcome variable in FM patients. The present study assessed relationships among physical function, social factors, psychological factors, and HRQOL, and the effects of these variables on HRQOL in a hypothesized model using structural equation modeling (SEM). Methods HRQOL was measured using SF-36, and the Fibromyalgia Impact Questionnaire (FIQ) was used to assess physical dysfunction. Social and psychological statuses were assessed using the Beck Depression Inventory (BDI), the State-Trait Anxiety Inventory (STAI), the Arthritis Self-Efficacy Scale (ASES), and the Social Support Scale. SEM analysis was used to test the structural relationships of the model using the AMOS software. Results Of the 336 patients, 301 (89.6%) were women with an average age of 47.9 +/- 10.9 years. The SEM results supported the hypothesized structural model (chi 2 = 2.336, df = 3, p = 0.506). Tfhe final model showed that Physical Component Summary (PCS) was directly related to self-efficacy and inversely related to FIQ, and that Mental Component Summary (MCS) was inversely related to FIQ, BDI, and STAI. Conclusions In our model of FM patients, HRQOL was affected by physical, social, and psychological variables. In these patients, higher levels of physical function and self-efficacy can improve the PCS of HRQOL, while physical function, depression, and anxiety negatively affect the MCS of HRQOL.	[Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Lee, Shin-Seok] Chonnam Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea; [Lee, Jeong-Won; Lee, Kyung-Eun; Park, Dong-Jin; Lee, Shin-Seok] Sch Med, Gwangju, South Korea; [Kim, Seong-Ho] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Rheumatol, Busan, South Korea; [Nah, Seong-Su] Soonchunhyang Univ, Coll Med, Dept Internal Med, Div Rheumatol, Cheonan, South Korea; [Lee, Ji Hyun] Maryknoll Med Ctr, Dept Internal Med, Div Rheumatol, Busan, South Korea; [Kim, Seong-Kyu] Catholic Univ Daegu, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Lee, Yeon-Ah; Hong, Seung-Jae] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Kim, Hyun-Sook] Soonchunhyang Univ, Seoul Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Hye-Soon] Hanyang Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Hye-Soon] Hosp Rheumat Dis, Seoul, South Korea; [Kim, Hyoun Ah] Ajou Univ, Sch Med, Ajou Univ Hosp, Div Rheumatol,Dept Internal Med, Suwon, South Korea; [Joung, Chung-Il] Konyang Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daejeon, South Korea; [Kim, Sang-Hyon] Keimyung Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea	Chonnam National University; Chonnam National University Hospital; Inje University; Soonchunhyang University; Catholic University of Daegu; Kyung Hee University; Soonchunhyang University; Hanyang University; Ajou University; Ajou University Hospital; Konyang University; Konyang University Hospital; Keimyung University	Lee, SS (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea.; Lee, SS (corresponding author), Sch Med, Gwangju, South Korea.	shinseok@chonnam.ac.kr	Lee, Shin-Seok/AAC-6779-2021		Chonnam National University Hospital Biomedical Research Institute [CRI13904-24.3]	Chonnam National University Hospital Biomedical Research Institute	This work was supported by Chonnam National University Hospital Biomedical Research Institute (grant number CRI13904-24.3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alok R, 2014, JCR-J CLIN RHEUMATOL, V20, P314, DOI 10.1097/RHU.0000000000000130; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bernardy K, 2010, J RHEUMATOL, V37, P1991, DOI 10.3899/jrheum.100104; Bernik M, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0358-3; Birtane M, 2007, CLIN RHEUMATOL, V26, P679, DOI 10.1007/s10067-006-0359-2; Borsbo B, 2010, DISABIL REHABIL, V32, P1387, DOI 10.3109/09638280903419269; Buckelew SP, 1996, ARTHRIT CARE RES, V9, P97, DOI 10.1002/1529-0131(199604)9:2<97::AID-ANR1790090205>3.0.CO;2-F; BURCKHARDT CS, 1993, J RHEUMATOL, V20, P475; Campos RP, 2012, CLIN RHEUMATOL, V31, P347, DOI 10.1007/s10067-011-1870-7; Chin YR, 2014, ASIAN NURS RES, V8, P267, DOI 10.1016/j.anr.2014.10.002; Consoli G, 2012, COMPR PSYCHIAT, V53, P962, DOI 10.1016/j.comppsych.2012.03.008; Da Costa D, 2000, J RHEUMATOL, V27, P365; Han CW, 2004, TOHOKU J EXP MED, V203, P189, DOI 10.1620/tjem.203.189; Hoffman DL, 2008, INT J CLIN PRACT, V62, P115, DOI 10.1111/j.1742-1241.2007.01638.x; Jones GT, 2015, ARTHRITIS RHEUMATOL, V67, P568, DOI 10.1002/art.38905; Kaplan RM, 2000, J RHEUMATOL, V27, P785; Kasil O, 2008, J KOREAN ACAD NURS, V38, P881, DOI 10.4040/jkan.2008.38.6.881; Kim JT, 1978, NEW MED J, V21, P69; Kim YA, 2002, J KOREAN MED SCI, V17, P220, DOI 10.3346/jkms.2002.17.2.220; Kurtze N, 1999, BRIT J MED PSYCHOL, V72, P471, DOI 10.1348/000711299160185; LEE HR, 2000, J KOREAN ACAD ADULT, V12, P5; Martinez JE, 2001, DISABIL REHABIL, V23, P64, DOI 10.1080/769983632; Mease P, 2005, J RHEUMATOL, V32, P6; Nuesch E, 2013, ANN RHEUM DIS, V72, P955, DOI 10.1136/annrheumdis-2011-201249; Okifuji A, 1997, J RHEUMATOL, V24, P377; Pae CU, 2008, CURR MED RES OPIN, V24, P2359, DOI 10.1185/03007990802288338; Pagano Tathiana, 2004, Sao Paulo Med. J., V122, P252; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Reisine S, 2004, WOMEN HEALTH, V39, P1, DOI 10.1300/J013v39n04_01; Reisine S, 2003, J RHEUMATOL, V30, P2045; Rhee M. K., 1995, KOR J PSYCHOPATHOL, V4, P77; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, pS67; Salaffi F, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-25; Schoofs Nancy, 2004, Orthop Nurs, V23, P364; Tander B, 2008, RHEUMATOL INT, V28, P859, DOI 10.1007/s00296-008-0551-6; Linares MDU, 2008, CLIN RHEUMATOL, V27, P613, DOI 10.1007/s10067-007-0756-1; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	38	45	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171186	10.1371/journal.pone.0171186	http://dx.doi.org/10.1371/journal.pone.0171186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158289	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700037
J	Mahlaba, TAM; Monadjem, A; McCleery, R; Belmain, SR				Mahlaba, Themb'alilahlwa A. M.; Monadjem, Ara; McCleery, Robert; Belmain, Steven R.			Domestic cats and dogs create a landscape of fear for pest rodents around rural homesteads	PLOS ONE			English	Article							PREDATOR ODORS; FELIS-CATUS; RATS; MANAGEMENT; RISK; KNOWLEDGE; ATTITUDES; WILDLIFE; BEHAVIOR; SCENT	Using domestic predators such as cats to control rodent pest problems around farms and homesteads is common across the world. However, practical scientific evidence on the impact of such biological control in agricultural settings is often lacking. We tested whether the presence of domestic cats and/or dogs in rural homesteads would affect the foraging behaviour of pest rodents. We estimated giving up densities (GUDs) from established feeding patches and estimated relative rodent activity using tracking tiles at 40 homesteads across four agricultural communities. We found that the presence of cats and dogs at the same homestead significantly reduced activity and increased GUDs (i.e. increased perception of foraging cost) of pest rodent species. However, if only cats or dogs alone were present at the homestead there was no observed difference in rodent foraging activity in comparison to homesteads with no cats or dogs. Our results suggest that pest rodent activity can be discouraged through the presence of domestic predators. When different types of predator are present together they likely create a heightened landscape of fear for foraging rodents.	[Mahlaba, Themb'alilahlwa A. M.; Monadjem, Ara] Univ Swaziland, Dept Biol Sci, Private Bag 4, Kwaluseni, Swaziland; [Monadjem, Ara] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Private Bag 20, Pretoria, South Africa; [McCleery, Robert] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Belmain, Steven R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	University of Pretoria; State University System of Florida; University of Florida; University of Greenwich	Mahlaba, TAM (corresponding author), Univ Swaziland, Dept Biol Sci, Private Bag 4, Kwaluseni, Swaziland.	tmahlaba@uniswa.sz	Belmain, Steven R/F-7758-2012; Monadjem, Ara/K-7279-2014	Belmain, Steven R/0000-0002-5590-7545; McCleery, Robert/0000-0001-7018-005X; Monadjem, Ara/0000-0003-1906-4023	ACP-EU Co-operation Programme in Science and Technology (ST II); Intra-ACP envelope of the 10th European Development Budget Line [2011 21.06.02]; StopRats: Sustainable Technologies to Overcome Rodents in Africa Through Science [EuropeAid/133437/D/ACT/ACPTPS, FED2013330-223]	ACP-EU Co-operation Programme in Science and Technology (ST II); Intra-ACP envelope of the 10th European Development Budget Line; StopRats: Sustainable Technologies to Overcome Rodents in Africa Through Science	This work was supported by the ACP-EU Co-operation Programme in Science and Technology (S&T II); Intra-ACP envelope of the 10th European Development & Budget Line 2011 21.06.02; Reference: EuropeAid/133437/D/ACT/ACPTPS StopRats: Sustainable Technologies to Overcome Rodents in Africa Through Science, Contract number: FED2013330-223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; ARMSTRONG AK, 1987, STUD FAMILY PLANN, V18, P371, DOI 10.2307/1966603; Baker PJ, 2003, MAMMAL REV, V33, P95, DOI 10.1046/j.1365-2907.2003.00003.x; Banks Peter B., 2003, Australian Zoologist, V32, P406; Barbosa P., 2005, ECOLOGY PREDATOR PRE; Bedoya-Perez MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1541, DOI 10.1007/s00265-013-1609-3; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Brown JS, 1999, EVOL ECOL RES, V1, P49; Brown PR, 2008, INT J PEST MANAGE, V54, P69, DOI 10.1080/09670870701474047; Burwash MD, 1998, J CHEM ECOL, V24, P49, DOI 10.1023/A:1022384728170; Butler JRA, 2002, ANIM CONSERV, V5, P29, DOI 10.1017/S136794300200104X; Bytheway JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P715, DOI 10.1007/s00265-013-1494-9; Campos CB, 2007, J ZOOL, V273, P14, DOI 10.1111/j.1469-7998.2007.00291.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CHILDS JE, 1986, J MAMMAL, V67, P196, DOI 10.2307/1381025; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Emerson SE, 2011, ANIM BEHAV, V81, P455, DOI 10.1016/j.anbehav.2010.11.018; Engeman R, 2006, INT BIODETER BIODEGR, V58, P2, DOI 10.1016/j.ibiod.2006.03.004; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kays R. W., 2004, ANIMAL CONSERVATION, V7, P1; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lindgren P. M. F., 1995, NAT WILDL RES CTR RE; MacDonald D. W., 1995, P199; Macdonald D.W., 2006, ENCY MAMMALS; Makundi RH, 2005, BELG J ZOOL, V135, P153; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; Mazerolle M.J, 2016, AICCMODAVG MODEL SEL; Monadjem A, 2011, WILDLIFE RES, V38, P603, DOI 10.1071/WR10130; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; PAQUET PC, 1991, CAN J ZOOL, V69, P1721, DOI 10.1139/z91-240; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schmidt K, 2015, MAMMAL RES, V60, P275, DOI 10.1007/s13364-015-0229-x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silmi M., 2013, J INDONES NAT HIST, V1, P31; Skaug H, 2012, GLMMADMB GEN LINEAR; Strauss A, 2008, BEHAV ECOL SOCIOBIOL, V62, P1551, DOI 10.1007/s00265-008-0584-6; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Taylor PJ, 2012, WILDLIFE RES, V39, P51, DOI 10.1071/WR11111; van der Merwe M, 2008, J MAMMAL, V89, P1162, DOI 10.1644/08-MAMM-A-035.1; Vigne JD, 2004, SCIENCE, V304, P259, DOI 10.1126/science.1095335; Wheeler HC, 2014, ANIM BEHAV, V95, P1, DOI 10.1016/j.anbehav.2014.06.005; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; WODZICKI K, 1973, B WORLD HEALTH ORGAN, V48, P461; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x; Yonas M, 2010, CROP PROT, V29, P532, DOI 10.1016/j.cropro.2009.12.006	49	47	50	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171593	10.1371/journal.pone.0171593	http://dx.doi.org/10.1371/journal.pone.0171593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158266	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000396161700105
J	Tokubuchi, I; Tajiri, Y; Iwata, S; Hara, K; Wada, N; Hashinaga, T; Nakayama, H; Mifune, H; Yamada, K				Tokubuchi, Ichiro; Tajiri, Yuji; Iwata, Shimpei; Hara, Kento; Wada, Nobuhiko; Hashinaga, Toshihiko; Nakayama, Hitomi; Mifune, Hiroharu; Yamada, Kentaro			Beneficial effects of metformin on energy metabolism and visceral fat volume through a possible mechanism of fatty acid oxidation in human subjects and rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT DIABETES-MELLITUS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; AMP; PHOSPHORYLATION; GLUCOSE; OBESITY; WEIGHT; MICE	Objective Metformin is known to have a beneficial effect on body weight and body composition, although the precise mechanism has not been elucidated yet. The aim of this study is to investigate the effects of metformin on energy metabolism and anthropometric factors in both human subjects and rats. Methods In human studies, metformin (1500mg/day) was administered to 23 healthy subjects and 18 patients with type 2 diabetes for 2 weeks. Metabolic parameters and energy metabolism were measured during a meal tolerance test in the morning before and after the treatment of metformin. In animal studies, 13 weeks old SD rats were fed 25-26 g of standard chow only during 12-hours dark phase with either treated by metformin (2.5mg/ml in drinking water) or not for 2 weeks, and metabolic parameters, anthropometric factors and energy metabolism together with expressions related to fat oxidation and adaptive thermogenesis were measured either in fasting or post-prandial state at 15 weeks old. Results Post-prandial plasma lactate concentration was significantly increased after the metformin treatment in both healthy subjects and diabetic patients. Although energy expenditure (EE) did not change, baseline respiratory quotient (RQ) was significantly decreased and postprandial RQ was significantly increased vice versa following the metformin treatment in both groups. By the administration of metformin to SD rats for 2 weeks, plasma levels of lactate and pyruvate were significantly increased in both fasting and post-prandial states. RQ during a fasting state was significantly decreased in metformin-treated rats compared to controls with no effect on EE. Metformin treatment brought about a significant reduction of visceral fat mass compared to controls accompanied by an up-regulation of fat oxidation related enzyme in the liver, UCP-1 in the brown adipose tissue and UCP-3 in the skeletal muscle. Conclusion From the results obtained, beneficial effects of metformin on visceral fat reduction has been demonstrated probably through a mechanism for a potential shift of fuel resource into fat oxidation and an upregulation of adaptive thermogenesis independent of an anorexigenic effect of this drug.	[Tokubuchi, Ichiro; Tajiri, Yuji; Iwata, Shimpei; Hara, Kento; Wada, Nobuhiko; Hashinaga, Toshihiko; Nakayama, Hitomi; Yamada, Kentaro] Kurume Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kurume, Fukuoka, Japan; [Mifune, Hiroharu] Kurume Univ, Sch Med, Inst Anim Experimentat, Kurume, Fukuoka, Japan	Kurume University; Kurume University	Tajiri, Y (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kurume, Fukuoka, Japan.	tajiriy@med.kurume-u.ac.jp						Aghili R, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0088-z; Avignon A, 2000, DIABETES OBES METAB, V2, P229, DOI 10.1046/j.1463-1326.2000.00082.x; Bruckbauer A, 2013, DIABETES METAB SYNDR, V6, P93, DOI 10.2147/DMSO.S40840; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chan JCN, 2014, DIABETES RES CLIN PR, V103, P244, DOI 10.1016/j.diabres.2013.11.012; Dulloo AG, 2001, BRIT J NUTR, V86, P123, DOI 10.1079/BJN2001412; Fery F, 1997, METABOLISM, V46, P227, DOI 10.1016/S0026-0495(97)90307-3; Fruehwald-Schultes B, 2002, METABOLISM, V51, P531, DOI 10.1053/meta.2002.31332; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hauton D, 2011, METABOLISM, V60, P32, DOI 10.1016/j.metabol.2009.12.015; Helvaci MR, 2008, INTERNAL MED, V47, P697, DOI 10.2169/internalmedicine.47.0787; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Ke JY, 2015, NUTR METAB, V12, DOI 10.1186/1743-7075-12-1; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim HJ, 2013, AM J PHYSIOL-REG I, V305, pR499, DOI 10.1152/ajpregu.00099.2013; Lee AJ, 1996, PHARMACOTHERAPY, V16, P327; Lee CK, 2012, DIABETES METAB J, V36, P293, DOI 10.4093/dmj.2012.36.4.293; Lusk G, 1924, J BIOL CHEM, V59, P41; Mandavilli A, 2004, NAT MED, V10, P325, DOI 10.1038/nm0404-325; MATTHAEI S, 1993, ENDOCRINOLOGY, V133, P304, DOI 10.1210/en.133.1.304; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Rouquet T, 2014, OBESITY, V22, P2552, DOI 10.1002/oby.20902; Schimmack G, 2006, DIABETES OBES METAB, V8, P591, DOI 10.1111/j.1463-1326.2005.00561.x; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; TAYLOR KG, 1979, DIABETOLOGIA, V16, P313, DOI 10.1007/BF01223620; Tessari P, 2008, ACTA DIABETOL, V45, P143, DOI 10.1007/s00592-008-0032-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Velasco G, 1997, ARCH BIOCHEM BIOPHYS, V337, P169, DOI 10.1006/abbi.1996.9784; Wada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067712; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	64	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171293	10.1371/journal.pone.0171293	http://dx.doi.org/10.1371/journal.pone.0171293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158227	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161700054
J	Abizari, AR; Azupogo, F; Brouwer, ID				Abizari, Abdul-Razak; Azupogo, Fusta; Brouwer, Inge D.			Subclinical inflammation influences the association between vitamin A- and iron status among schoolchildren in Ghana	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; SCHOOL-AGED CHILDREN; DEFICIENCY ANEMIA; A SUPPLEMENTATION; SERUM RETINOL; NUTRITIONAL-STATUS; FERRITIN; INFECTION; IODINE; ASSAY	Background and objective In resource-poor settings, micronutrient deficiencies such as vitamin A deficiency may coexist with iron-deficiency. In this study we assessed the iron and vitamin A status of schoolchildren and the association between vitamin A and iron status. Methods A cross-sectional design using the baseline data of a dietary intervention trial conducted among randomly selected 5-12 years old schoolchildren (n = 224) from 2 rural schools in northern Ghana. Hemoglobin (Hb), serum ferritin (SF) and serum transferrin receptor (sTfR) concentrations were used as measures of iron status. Retinol binding protein (RBP) was used as a measure of vitamin A status. Subclinical inflammation (SCI) was measured using C-reactive protein (CRP) and alpha(1)-acid glycoprotein (AGP) concentrations. We examined the cross-sectional association between vitamin A and iron status biomarkers with multiple linear regressions. Results The proportions of schoolchildren with anemia (WHO criteria), iron-deficiency (ID, SF<15 mu g/l and/orsTfR>8.5mg/l) and iron-deficiency anemia (IDA, concurrent anemia and ID) were 63.8%, 68.3% and 46.4% respectively. Low or marginal vitamin A status (0.70 mu mol/l <= RBP < 1.05 mu mol/l) was present in 48.2% while 37.5% of the schoolchildren had vitamin A deficiency (VAD, RBP < 0.70 mu mol/l). The prevalence of SCI as well as concurrent VAD and ID were 48.7% and 25% respectively. RBP was associated with Hb (beta = 7.2, P = 0.05) but not SF (beta = 20.7, P = 0.33) and sTfR concentration (beta = 12.0, P = 0.63). In the presence of SCI, RBP was not associated with hemoglobin status but a significant positive association was observed among children without SCI. Conclusions The study shows that RBP is significantly associated with Hb concentration but not with SF and sTfR. The observed relationship between RBP and Hb is only significant in the absence of SCI.	[Abizari, Abdul-Razak] Univ Dev Studies, Sch Allied Hlth Sci, Dept Community Nutr, Tamale, Ghana; [Azupogo, Fusta] Univ Dev Studies, Dept Family & Consumer Sci, Fac Agr, Tamale, Ghana; [Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	University for Development Studies; University for Development Studies; Wageningen University & Research	Abizari, AR (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Dept Community Nutr, Tamale, Ghana.	abizaria@yahoo.com	Brouwer, Inge D/K-8455-2013	Brouwer, Inge/0000-0002-2554-7227; Azupogo, Fusta/0000-0003-0467-0856	Nestle Foundation for Nutrition Research [FN4042]	Nestle Foundation for Nutrition Research(Nestle SA)	Funding for this research was received from Nestle Foundation for Nutrition Research with grant number FN4042. The grant was received by Abdul-Razak Abizari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585; Abizari AR, 2012, J NUTR, V142, P1836, DOI 10.3945/jn.112.165753; Ahmed F, 2006, PUBLIC HEALTH NUTR, V9, P345, DOI 10.1079/PHN2006858; Al-Mekhlafi HM, 2014, NUTRIENTS, V6, P190, DOI 10.3390/nu6010190; [Anonymous], NUTR ANEMIA; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2008, WORLDW PREV AN 1993; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Atimati a O, 2013, NIGER J PAEDIAT, V40, P379; Avornyo VK, 2015, ANN M AM SOC AGR, P1; Baeten JM, 2004, AM J CLIN NUTR, V79, P218; Batra J, 2005, INDIAN J CLIN BIOCHE, V20, P119, DOI 10.1007/BF02867410; BLOEM MW, 1995, P NUTR SOC, V54, P501, DOI 10.1079/PNS19950018; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Cogill B, 2003, ANTHROPOMETRIC INDIC; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Silva Lara Lívia Santos da, 2015, Rev. bras. epidemiol., V18, P490, DOI 10.1590/1980-5497201500020016; Edwin AK, 2011, PAN AFR MED J, V10; Egbi G., 2012, African Journal of Food, Agriculture, Nutrition and Development, V12, P5946; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Gebremedhin S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-79; ghanadistrict.com, 2006, GHAN DISTR REP ALL D; Gibson RS, 2006, P NUTR SOC, V65, P160, DOI 10.1079/PNS2006489; Gibson RS, 2015, FOOD NUTR BULL, V31, P134; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Hashizume M, 2005, PUBLIC HEALTH NUTR, V8, P564, DOI 10.1079/PHN2004717; Herrador Z, 2014, PLOS ONE, V9, P1; Hettiarachchi M, 2012, MATERN CHILD NUTR, V8, P259, DOI 10.1111/j.1740-8709.2010.00290.x; Htet MK, 2013, PUBLIC HEALTH NUTR, V17, P1; Jauregui-Lobera I, 2014, NEUROPSYCH DIS TREAT, V10, P2087, DOI 10.2147/NDT.S72491; Kennedy G., 2013, GUID MEAS HOUS IND D; Lulla RR, 2010, PEDIATR BLOOD CANCER, V55, P141, DOI 10.1002/pbc.22471; Marasinghe E, 2015, ASIA PAC J CLIN NUTR, V24, P144, DOI 10.6133/apjcn.2015.24.1.17; Mariath AB, 2010, CIENC SAUDE COLETIVA, V15, P509, DOI 10.1590/S1413-81232010000200027; Mwanri L, 2000, J NUTR, V130, P2691, DOI 10.1093/jn/130.11.2691; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Otupiri E, 2012, J SCI TECHNOL, V32, P1; Palafox NA, 2003, NUTRITION, V19, P405, DOI 10.1016/S0899-9007(02)01104-8; Persson V, 2000, PUBLIC HEALTH NUTR, V3, P83, DOI 10.1017/S1368980000000100; Pfeiffer CM, 2007, CLIN CHIM ACTA, V382, P112, DOI 10.1016/j.cca.2007.04.008; Righetti AA, 2013, AM J CLIN NUTR, V97, P1364, DOI 10.3945/ajcn.112.050302; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sales MC, 2013, NUTR HOSP, V28, P734, DOI 10.3305/nh.2013.28.3.6396; Sanghvi T, 2007, FOOD NUTR BULL, V28, pS160; Sanjoaquin MA, 2009, MALARIA J, V8, P1; Semba RD, 2008, NUTR HEALTH SER, P1, DOI 10.1007/978-1-59745-464-3; Semba RD, 2010, NUTRITION, V26, P958, DOI 10.1016/j.nut.2009.08.010; Singh V, 2004, EUR J CLIN NUTR, V58, P1342, DOI 10.1038/sj.ejcn.1601973; Sommer A., 1998, AM J EPIDEMIOL, V147, P1175, DOI [10.1093/oxfordjournals. aje.a009416, DOI 10.1093/OXFORDJOURNALS.AJE.A009416]; Swati K, 2012, NATL J MED RES, V2, P188; Talsma EF, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0256-5; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; UNICEF and Micronutrient Initiative, 2004, VIT MIN DEF GLOB PRO; Villamor E, 2000, J INFECT DIS, V182, pS122, DOI 10.1086/315921; Wessells KR, 2014, J NUTR, V144, P2050, DOI 10.3945/jn.114.200345; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; WHO, 2010, PRIOR ASS VIT A IR S; *WHO, 1996, IND ASS VIT A DEF TH; Wieringa FT, 2003, AM J CLIN NUTR, V77, P651, DOI 10.1093/ajcn/77.3.651; Willows ND, 2003, NUTR RES, V23, P891, DOI 10.1016/S0271-5317(03)00076-9; Zimmermann M, 2000, AM J CLIN NUTR, V71, P88; Zimmermann MB, 2004, AM J CLIN NUTR, V80, P1283, DOI 10.1093/ajcn/80.5.1283; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; Zimmermann MB, 2006, AM J CLIN NUTR, V84, P580, DOI 10.1093/ajcn/84.3.580	67	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170747	10.1371/journal.pone.0170747	http://dx.doi.org/10.1371/journal.pone.0170747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152069	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200041
J	Liang, WC; Tian, X; Yuo, CY; Chen, WZ; Kan, TM; Su, YN; Nishino, I; Wong, LJC; Jong, YJ				Liang, Wen-Chen; Tian, Xia; Yuo, Chung-Yee; Chen, Wan-Zi; Kan, Tsu-Min; Su, Yi-Ning; Nishino, Ichizo; Wong, Lee-Jun C.; Jong, Yuh-Jyh			Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan	PLOS ONE			English	Article							WALKER-WARBURG SYNDROME; COLLAGEN VI MYOPATHIES; ALPHA-DYSTROGLYCAN; BETHLEM MYOPATHY; MUTATIONS CAUSE; MUSCLE; DEFICIENCY; PHENOTYPE; GLYCOSYLATION; SPECTRUM	Purpose Congenital muscular dystrophy (CMD) is a heterogeneous disease entity. The detailed clinical manifestation and causative gene for each subgroup of CMD are quite variable. This study aims to analyze the phenotypes and genotypes of Taiwanese patients with CMD as the epidemiology of CMD varies among populations and has been scantly described in Asia. Methods A total of 48 patients suspected to have CMD were screened and categorized by histochemistry and immunohistochemistry studies. Different genetic analyses, including next-generation sequencing (NGS), were selected, based on the clinical and pathological findings. Results We identified 17 patients with sarcolemma-specific collagen VI deficiency (SSCD), 6 patients with merosin deficiency, two with reduced alpha-dystroglycan staining, and two with striking lymphocyte infiltration in addition to dystrophic change on muscle pathology. Fourteen in 15 patients with SSCD, were shown to have COL6A1, COL6A2 or COL6A3 mutations by NGS analysis; all showed marked distal hyperlaxity and normal intelligence but the overall severity was less than in previously reported patients from other populations. All six patients with merosin deficiency had mutations in LAMA2. They showed relatively uniform phenotype that were compatible with previous studies, except for higher proportion of mental retardation with epilepsy. With reduced alpha-dystroglycan staining, one patient was found to carry mutations in POMT1 while another patient carried mutations in TRAPPC11. LMNA mutations were found in the two patients with inflammatory change on muscle pathology. They were clinically characterized by neck flexion limitation and early joint contracture, but no cardiac problem had developed yet. Conclusion Muscle pathology remains helpful in guiding further molecular analyses by direct sequencing of certain genes or by target capture/NGS as a second-tier diagnostic tool, and is crucial for establishing the genotype-phenotype correlation. We also determined the frequencies of the different types of CMD in our cohort which is important for the development of a specific care system for each disease.	[Liang, Wen-Chen; Kan, Tsu-Min; Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Liang, Wen-Chen] Kaohsiung Med Univ, Coll Med, Dept Pediat Sch Med, Kaohsiung, Taiwan; [Tian, Xia; Wong, Lee-Jun C.] Baylor Genet, Houston, TX USA; [Tian, Xia; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA; [Yuo, Chung-Yee] Kaohsiung Med Univ, Coll Life Sci, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chen, Wan-Zi] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Su, Yi-Ning] Sofiva Genom Co Ltd, Taipei, Taiwan; [Su, Yi-Ning] Dianthus Maternal Fetal Med Clin, Taipei, Taiwan; [Su, Yi-Ning] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Dept Genome Med Dev, Tokyo, Japan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Jong, Yuh-Jyh] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Baylor College of Medicine; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University	Jong, YJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Jong, YJ (corresponding author), Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan.	yjjong@gap.kmu.edu.tw	Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X; Jong, Yuh-Jyh/0000-0002-1735-1101				Ball S, 2003, J BIOL CHEM, V278, P15326, DOI 10.1074/jbc.M209977200; Bogershausen N, 2013, AM J HUM GENET, V93, P181, DOI 10.1016/j.ajhg.2013.05.028; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Butterfield RJ, 2013, HUM MUTAT, V34, P1558, DOI 10.1002/humu.22429; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Carboni Nicola, 2013, Acta Myol, V32, P7; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; CHU ML, 1988, J BIOL CHEM, V263, P18601; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Collins J, 2012, NEUROLOGY, V79, P2158, DOI 10.1212/WNL.0b013e3182752ebc; Di Costanzo S, 2014, HUM MOL GENET, V23, P5781, DOI 10.1093/hmg/ddu296; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; HAYASHI YK, 1995, MUSCLE NERVE, V18, P1027, DOI 10.1002/mus.880180918; Kaplan JC, 2014, NEUROMUSCULAR DISORD, V24, P1123, DOI 10.1016/j.nmd.2014.11.001; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Komaki H, 2011, NEUROMUSCULAR DISORD, V21, P563, DOI 10.1016/j.nmd.2011.04.010; Liang WC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0056-4; Liang WC, 2013, NEUROMUSCULAR DISORD, V23, P675, DOI 10.1016/j.nmd.2013.05.010; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Matalonga L, HUM MUTAT; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P303, DOI 10.1016/j.nmd.2005.01.004; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; Nishikawa A, 2016, J MED GENET; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Pane M, 2012, NEUROMUSCULAR DISORD, V22, P685, DOI 10.1016/j.nmd.2012.05.006; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Qin L, 2016, J MOL DIAGN, V18, P446, DOI 10.1016/j.jmoldx.2016.01.002; Quijano-Roy S, 2008, ANN NEUROL, V64, P177, DOI 10.1002/ana.21417; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Shaheen R, 2013, NEUROGENETICS, V14, P243, DOI 10.1007/s10048-013-0367-8; Su YN, 2005, HUM MUTAT, V25, P460, DOI 10.1002/humu.20160; Tian X, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000015; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Xiong H, 2015, CLIN GENET, V87, P233, DOI 10.1111/cge.12366; Yonekawa T, 2013, J NEUROL NEUROSUR PS, V84, P982, DOI 10.1136/jnnp-2012-304710; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	39	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170517	10.1371/journal.pone.0170517	http://dx.doi.org/10.1371/journal.pone.0170517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182637	gold, Green Published			2022-12-27	WOS:000394231800012
J	Shao, LY; Zhang, LJ; Zhen, Z				Shao, Liyang; Zhang, Lianjun; Zhen, Zhen			Interrupted time series analysis of children's blood lead levels: A case study of lead hazard control program in Syracuse, New York	PLOS ONE			English	Article							INTELLECTUAL IMPAIRMENT; EXPOSURE	Children's blood lead concentrations have been closely monitored over the last two decades in the United States. The bio-monitoring surveillance data collected in local agencies reflected the local temporal trends of children's blood lead levels (BLLs). However, the analysis and modeling of the long-term time series of BLLs have rarely been reported. We attempted to quantify the long-term trends of children's BLLs in the city of Syracuse, New York and evaluate the impacts of local lead poisoning prevention programs and Lead Hazard Control Program on reducing the children's BLLs. We applied interrupted time series analysis on the monthly time series of BLLs surveillance data and used ARMA (autoregressive and moving average) models to measure the average children's blood lead level shift and detect the seasonal pattern change. Our results showed that there were three intervention stages over the past 20 years to reduce children's BLLs in the city of Syracuse, NY. The average of children's BLLs was significantly decreased after the interventions, declining from 8.77 mu g/dL to 3.94 mu g/dL during1992 to 2011. The seasonal variation diminished over the past decade, but more short term influences were in the variation. The lead hazard control treatment intervention proved effective in reducing the children's blood lead levels in Syracuse, NY. Also, the reduction of the seasonal variation of children's BLLs reflected the impacts of the local lead-based paint mitigation program. The replacement of window and door was the major cost of lead house abatement. However, soil lead was not considered a major source of lead hazard in our analysis.	[Shao, Liyang; Zhang, Lianjun] SUNY Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA; [Zhen, Zhen] Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Northeast Forestry University - China	Zhen, Z (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China.	zhzhen@syr.edu	Shao, Liyang/B-2921-2009	Shao, Liyang/0000-0003-1272-1959	National Natural Science Foundation of China [31400491]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by National Natural Science Foundation of China, Project "Three-dimensional individual tree crown delineation based on mutiple remotely sensed data sources and tree competition mechanism (31400491)".	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P513; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Center for Disease Control and Prevention (CDC), 2013, CDC UPD GUID CHILDR; Dixon SL, 2012, ENVIRON RES, V113, P14, DOI 10.1016/j.envres.2012.01.005; Griffith DA, 1998, ANN ASSOC AM GEOGR, V88, P640, DOI 10.1111/0004-5608.00116; Haley Valerie B, 2004, BMC Pediatr, V4, P8, DOI 10.1186/1471-2431-4-8; HARTMANN DP, 1980, J APPL BEHAV ANAL, V13, P543, DOI 10.1901/jaba.1980.13-543; Johnston J., 1997, ECONOMETRICS METHODS, V4th ed.; Jones RL, 2009, PEDIATRICS, V123, pe376, DOI 10.1542/peds.2007-3608; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Laidlaw MAS, 2005, ENVIRON HEALTH PERSP, V113, P793, DOI 10.1289/ehp.7759; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Liu L-M, 2006, TIME SERIES ANAL FOR; Meyer Pamela A, 2003, MMWR Surveill Summ, V52, P1; SAS Institute Inc, 2011, SAS 9 3 HELP DOC; Strauss W, 2005, ENVIRON RES, V99, P214, DOI 10.1016/j.envres.2005.02.005; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yiin LM, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.2307/3454518	21	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171778	10.1371/journal.pone.0171778	http://dx.doi.org/10.1371/journal.pone.0171778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182688	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800107
J	Yuan, Y; Sun, Z; Chen, Y; Zheng, YX; Xie, KL; He, Y; Wang, ZF; Wang, GL; Yu, YH				Yuan, Yuan; Sun, Zhe; Chen, Yi; Zheng, Yuxin; Xie, Ke-liang; He, Ying; Wang, Zhifen; Wang, Guo-lin; Yu, Yong-hao			Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine via Regulating the Trafficking and Function of Spinal NMDA Receptors as well as PKC and CaMKII Level In Vivo and In Vitro	PLOS ONE			English	Article							PROTEIN-KINASE-C; OPIOID-INDUCED HYPERALGESIA; D-ASPARTATE RECEPTOR; SYNAPTIC-TRANSMISSION; PAIN; RAT; CALCIUM/CALMODULIN; ACTIVATION; MECHANISMS; ANALGESIA	Remifentanil-induced secondary hyperalgesia has been demonstrated in both animal experiments and clinical trials. Enhancement of N-methyl-D-aspartate (NMDA) receptor trafficking as well as protein kinase C (PKC) and calmodulin- dependent protein kinase II (CaMKII) have been reported to be involved in the induction and maintenance of central sensitization. In the current study, it was demonstrated that dexmedetomidine could prevent remifentanilinduced hyperalgesia (RIH) via regulating spinal NMDAR-PKC-Ca2+/CaMKII pathway in vivo and in vitro. We firstly investigated the effect of dexmedetomidine, a highly selective a2-adrenergic receptor agonist, on mechanical and thermal hyperalgesia using a rat model of RIH. NMDA receptor subunits (NR1, NR2A and NR2B) expression and membrane trafficking as well as PKC and CaMKII expression in spinal cord L4-L5 segments were measured by Western blot analysis. The expression of NMDA receptor subunits (NR1, NR2A and NR2B) were also detected by immunohistochemistry. Further more, the effect of dexmedetomidine on NMDA receptor current amplitude and frequency in spinal cord slices were investigated by whole-cell patch-clamp recording. We found that remifentail infusion at 1.2 mu g. kg(-1). min(-1) for 90 min caused mechanical and thermal hyperalgesia, up-regulated NMDA receptor subunits NR1 and NR2B expression in both membrane fraction and total lysate as well as increased PKC and CaMKII expression in spinal cord dorsal horn. Subcutaneously injection of dexmedetomidine at the dose of 50 mu g/kg at 30 min before plantar incision significantly attenuated remifentanil-induced mechanical and thermal hyperalgesia from 2 h to 48 h after infusion, and this was associated with reversal of up-regulated NR1 and NR2B subunits in both membrane fraction and total lysate as well as increased PKC and CaMKII expression in spinal cord dorsal horn. Furthermore, remifentanil incubation increased amplitude and frequency of NMDA receptor-induced current in dorsal horn neurons, which was dose-dependently attenuated by dexmedetomidine. These results suggest that dexmedetomidine can significantly ameliorate RIH via modulating the expression, membrane trafficking and function of NMDA receptors as well as PKC and CaMKII level in spinal dorsal horn, which present useful insights into the mechanistic action of dexmedetomidine as a potential anti-hyperalgesic agents for treating RIH. increased amplitude and frequency of NMDA receptor-induced current in dorsal horn neurons, which was dose-dependently attenuated by dexmedetomidine. These results suggest that dexmedetomidine can significantly ameliorate RIH via modulating the expression, membrane trafficking and function of NMDA receptors as well as PKC and CaMKII level in spinal dorsal horn, which present useful insights into the mechanistic action of dexmedetomidine as a potential anti-hyperalgesic agents for treating RIH.	[Yuan, Yuan; Sun, Zhe; Chen, Yi; Zheng, Yuxin; Xie, Ke-liang; He, Ying; Wang, Zhifen; Wang, Guo-lin; Yu, Yong-hao] Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Yuan, Yuan; Sun, Zhe; Chen, Yi; Zheng, Yuxin; Xie, Ke-liang; He, Ying; Wang, Zhifen; Wang, Guo-lin; Yu, Yong-hao] Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University	Yu, YH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China.; Yu, YH (corresponding author), Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China.	family2480@126.com			National Natural Science Foundation of China [81300960]; Application foundation and advanced technology research program of Tianjin [14JCQNJC12800]; science foundation of Tianjin Health Bureau [2012KZ102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Application foundation and advanced technology research program of Tianjin; science foundation of Tianjin Health Bureau	National Natural Science Foundation of China (81300960), Yuan Yuan; Application foundation and advanced technology research program of Tianjin (14JCQNJC12800), Yuan Yuan; The science foundation of Tianjin Health Bureau (2012KZ102), Yi Chen. 2. Yuan Yuan : This author helped design the study, analyze the data, and write the manuscript; Yi Chen : This author helped design the study and analyze the data.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; Belgrade M, 2010, PAIN MED, V11, P1819, DOI 10.1111/j.1526-4637.2010.00973.x; Bongha H, 2014, KOREAN J ANESTHESIOL, V66, P39, DOI [10.4097/kjae.2014.66.1.39, DOI 10.4097/KJAE.2014.66.1.39]; Brennan Timothy J, 2005, Anesthesiol Clin North Am, V23, P1, DOI 10.1016/j.atc.2004.11.009; Bruggemann I, 2000, MOL BRAIN RES, V85, P239, DOI 10.1016/S0169-328X(00)00265-5; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chen Y, 2010, J NEUROSCI, V30, P38, DOI 10.1523/JNEUROSCI.4346-09.2010; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Evelyne C, 2004, NEUROPHARMACOLOGY, V46, P264; Faber ESL, 1998, BRIT J PHARMACOL, V124, P507, DOI 10.1038/sj.bjp.0701873; Ferreira J, 2005, PAIN, V117, P171, DOI 10.1016/j.pain.2005.06.001; Gu XP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-76; Guo H, 2001, J PHYSIOL-LONDON, V537, P115, DOI 10.1111/j.1469-7793.2001.0115k.x; Hahnenkamp K, 2006, BRIT J ANAESTH, V96, P77, DOI 10.1093/bja/aei271; Harald L, 2011, PAIN, V152, P1289, DOI [10.1016/j.pain.2011.02.007, DOI 10.1016/J.PAIN.2011.02.007]; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Hughes AS, 2008, NEUROSCIENCE, V153, P507, DOI 10.1016/j.neuroscience.2008.01.082; Hwang W, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0004-1; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Koppert W, 2007, BEST PRACT RES-CLIN, V21, P65, DOI 10.1016/j.bpa.2006.12.004; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Lei T, 2007, BRAIN RES, V1143, P78, DOI [10.1016/j.brainres.2007.01.058, DOI 10.1016/J.BRAINRES.2007.01.058]; Li YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077790; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; Liao GY, 2000, J NEUROCHEM, V75, P282, DOI 10.1046/j.1471-4159.2000.0750282.x; Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Malcangio M, 1998, BRIT J PHARMACOL, V125, P1625, DOI 10.1038/sj.bjp.0702260; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; McQueen-Shadfar LA, 2011, CURR MED RES OPIN, V27, P2091, DOI 10.1185/03007995.2011.618491; Patel A, 2010, ANESTH ANALG, V111, P1004, DOI 10.1213/ANE.0b013e3181ee82fa; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Tian YT, 2010, NEUROSCI RES, V68, P167, DOI 10.1016/j.neures.2010.07.2030; Tufanogullari B, 2008, ANESTH ANALG, V106, P1741, DOI 10.1213/ane.0b013e318172c47c; Velazquez KT, 2007, PHARMACOL RES, V55, P578, DOI 10.1016/j.phrs.2007.04.006; Wang CY, 2015, BRAIN RES BULL, V110, P30, DOI 10.1016/j.brainresbull.2014.12.001; Yang QA, 2011, BRAIN RES BULL, V84, P137, DOI 10.1016/j.brainresbull.2010.12.009; Yuan Y, 2013, ANESTH ANALG, V116, P473, DOI 10.1213/ANE.0b013e318274e3f1	40	18	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171348	10.1371/journal.pone.0171348	http://dx.doi.org/10.1371/journal.pone.0171348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182698	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800056
J	De Plecker, E; Zachariah, R; Kumar, AMV; Trelles, M; Caluwaerts, S; van den Boogaard, W; Manirampa, J; Tayler-Smith, K; Manzi, M; Nanan-N'zeth, K; Duchenne, B; Ndelema, B; Etienne, W; Alders, P; Veerman, R; Van den Bergh, R				De Plecker, E.; Zachariah, R.; Kumar, A. M. V.; Trelles, M.; Caluwaerts, S.; van den Boogaard, W.; Manirampa, J.; Tayler-Smith, K.; Manzi, M.; Nanan-N'zeth, K.; Duchenne, B.; Ndelema, B.; Etienne, W.; Alders, P.; Veerman, R.; Van den Bergh, R.			Emergency obstetric care in a rural district of Burundi: What are the surgical needs?	PLOS ONE			English	Article							MATERNAL MORTALITY; AFRICA	Objectives In a rural district hospital in Burundi offering Emergency Obstetric care-(EmOC), we assessed the a) characteristics of women at risk of, or with an obstetric complication and their types b) the number and type of obstetric surgical procedures and anaesthesia performed c) human resource cadres who performed surgery and anaesthesia and d) hospital exit outcomes. Methods A retrospective analysis of EmOC data (2011 and 2012). Results A total of 6084 women were referred for EmOC of whom 2534(42%) underwent a major surgical procedure while 1345(22%) required a minor procedure (36% women did not require any surgical procedure). All cases with uterine rupture(73) and extra-uterine pregnancy(10) and the majority with pre-uterine rupture and foetal distress required major surgery. The two most prevalent conditions requiring a minor surgical procedure were abortions (61%) and normal delivery (34%). A total of 2544 major procedures were performed on 2534 admitted individuals. Of these, 1650(65%) required spinal and 578(23%) required general anaesthesia; 2341(92%) procedures were performed by 'general practitioners with surgical skills' and in 2451(96%) cases, anaesthesia was provided by nurses. Of 2534 hospital admissions related to major procedures, 2467(97%) were discharged, 21(0.8%) were referred to tertiary care and 2(0.1%) died. Conclusion Overall, the obstetric surgical volume in rural Burundi is high with nearly six out of ten referrals requiring surgical intervention. Nonetheless, good quality care could be achieved by trained, non-specialist staff. The post-2015 development agenda needs to take this into consideration if it is to make progress towards reducing maternal mortality in Africa.	[De Plecker, E.; Trelles, M.; Caluwaerts, S.] Med Sans Frontieres, Brussels Operat Ctr, Dept Med, Brussels, Belgium; [Zachariah, R.; Tayler-Smith, K.; Manzi, M.; Van den Bergh, R.] Med Sans Frontieres, MSF Luxembourg, Operat Ctr Brussels, Med Dept Operat Res, Luxembourg, Luxembourg; [Kumar, A. M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [van den Boogaard, W.; Nanan-N'zeth, K.; Duchenne, B.; Ndelema, B.] Med Sans Frontieres, Bujumbura, Burundi; [Manirampa, J.] Minist Hlth, Kabezi Dist, Burundi; [Etienne, W.; Alders, P.; Veerman, R.] Med Sans Frontieres, Operat Dept, Brussels Operat Ctr, Brussels, Belgium	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	De Plecker, E (corresponding author), Med Sans Frontieres, Brussels Operat Ctr, Dept Med, Brussels, Belgium.	eva.deplecker@brussels.msf.org		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; zachariah, rony/0000-0002-2915-9328	MSF, The Union; La Fondation Veuve Emile Metr-Tesch (Luxembourg)	MSF, The Union; La Fondation Veuve Emile Metr-Tesch (Luxembourg)	The programme was funded by MSF, The Union, and La Fondation Veuve Emile Metr-Tesch (Luxembourg). La Fondation Veuve Emile Metz-Tesch supported open access publications costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burundi Ministry of Health, 2011, ANN STAT DONN CTR SA; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chu K, 2015, WORLD J SURG, V39, P350, DOI 10.1007/s00268-014-2840-4; Dubowitz G, 2010, WORLD J SURG, V34, P438, DOI 10.1007/s00268-009-0229-6; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; PLOS Medicine Editors, 2008, PLOS MED, V5, pe182, DOI [10.1371/journal.pmed.0050182, DOI 10.1371/JOURNAL.PMED.0050182]; ROUND UP, 2007, MAT MORT MORB NONPH, V15, P239; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; [UN Population Division The World Bank UNICEF WHO MMEIG], 2014, TRENDS MAT MORT 1990; World Health Organization, 2014, HLTH STAT INF SYST; World Health Organization, 2015, HLTH 2015 MDGS MILL, P204; Zuniga I, 2013, PUBLIC HEALTH ACTION, V3, P276, DOI 10.5588/pha.13.0050	14	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170882	10.1371/journal.pone.0170882	http://dx.doi.org/10.1371/journal.pone.0170882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170398	Green Published, gold			2022-12-27	WOS:000393705500012
J	Liu, ZH; Li, XP; Xie, W				Liu, Zhenhua; Li, Xinping; Xie, Wei			Carrageenan as a dry strength additive for papermaking	PLOS ONE			English	Article							WET-END ADDITIVES; CATIONIC STARCH; RED ALGAE; GUAR GUM; FIBERS; RETENTION; FILLER; GEL	Carrageenans are commercially important sulfated gums found in various species of red seaweeds (Rhodophyta), wherein they serve a structural function similar to that of pectins in land plants. In this study, carrageenan was used independently or in combination with cationic polyacrylamide (CPAM) and/or Al-2(SO4)(3) to explore its application as a dry strength additive in papermaking. Strength index determination, ash content detection, FTIR characterization and SEM observation were performed on prepared handsheets. The results showed that with 0.6% Al-2(SO4)(3) and 0.2% carrageenan as additives, the tensile index increased by 13.53% and precipitated calcium carbonate (PCC) retention increased by 57.06%. With 0.6% Al-2(SO4)(3), 0.2% carrageenan and 0.03% CPAM as additives, PCC retention increased by 121% while the tensile index did not fall compared to handsheets without additives, indicating that carrageenan could enhance the strength of handsheets and be used as an anionic dry strength agent.	[Liu, Zhenhua; Xie, Wei] Wuzhou Univ, Sch Chem Engn, Wuzhou, Guangxi Provinc, Peoples R China; [Liu, Zhenhua; Li, Xinping] Shanxi Univ Sci & Technol, Coll Bioresources Chem & Mat Engn, Xian, Shanxi, Peoples R China	Wuzhou University; Shaanxi University of Science & Technology	Xie, W (corresponding author), Wuzhou Univ, Sch Chem Engn, Wuzhou, Guangxi Provinc, Peoples R China.	1272150322@qq.com			Research Fund of Wuzhou University [2015B007]; Guangxi Training Programs of Innovation and Entrepreneurship for Undergraduates [201611354076]	Research Fund of Wuzhou University; Guangxi Training Programs of Innovation and Entrepreneurship for Undergraduates	This research was financially supported by Research Fund of Wuzhou University, Grant No. 2015B007, http://www.gxuwz.edu.cn/; Guangxi Training Programs of Innovation and Entrepreneurship for Undergraduates, Grant No. 201611354076, http://www.gxedu.gov.cn/. This funding was received by Wei Xie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashori A, 2012, COMPOSITES B, V45, P1595; Cadirci E, 2016, PEPTIDES, V82, P35, DOI 10.1016/j.peptides.2016.05.006; Cadotte M, 2007, CAN J CHEM ENG, V85, P240; Chen YW, 2016, CARBOHYD POLYM, V151, P1210, DOI 10.1016/j.carbpol.2016.06.083; Chertanova L, 1996, ACTA CRYSTALLOGR B, V52, P677, DOI 10.1107/S0108768196003035; Fatehi P, 2009, BIORESOURCE TECHNOL, V100, P749, DOI 10.1016/j.biortech.2008.07.042; Ghasemian A, 2012, CARBOHYD POLYM, V87, P1269, DOI 10.1016/j.carbpol.2011.09.010; Hamzeh Y, 2013, IND CROP PROD, V43, P365, DOI 10.1016/j.indcrop.2012.07.047; Hubbe MA, 2006, BIORESOURCES, V1, P281; Huq T, 2012, CARBOHYD POLYM, V90, P1757, DOI 10.1016/j.carbpol.2012.07.065; Lima DU, 2003, CARBOHYD POLYM, V52, P367, DOI 10.1016/S0144-8617(03)00008-0; Lin JH, 2016, FOOD HYDROCOLLOID, V60, P509, DOI 10.1016/j.foodhyd.2016.04.024; McLean D, 2011, BIORESOURCES, V6, P4168; Necas J, 2013, VET MED-CZECH, V58, P187, DOI 10.17221/6758-VETMED; Nystrom R, 2005, COLLOID SURFACE A, V252, P135, DOI 10.1016/j.colsurfa.2004.10.077; Przybysz P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155809; Rojas OJ, 1999, COLLOID SURFACE A, V155, P419, DOI 10.1016/S0927-7757(99)00040-0; Seo YB, 2010, BIORESOURCE TECHNOL, V101, P2549, DOI 10.1016/j.biortech.2009.11.088; STRAZDINS E, 1986, TAPPI J, V69, P111; Taggart TE, 1992, PAPERMAKING USING CA; Thombare N, 2016, INT J BIOL MACROMOL, V88, P361, DOI 10.1016/j.ijbiomac.2016.04.001; Xie W, 2016, CARBOHYD POLYM, V150, P114, DOI 10.1016/j.carbpol.2016.05.010; Yuan C, 2016, FOOD CHEM, V210, P600, DOI 10.1016/j.foodchem.2016.05.014; Zhang WW, 2016, CARBOHYD POLYM, V150, P232, DOI 10.1016/j.carbpol.2016.05.032	24	3	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171326	10.1371/journal.pone.0171326	http://dx.doi.org/10.1371/journal.pone.0171326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170422	gold, Green Published, Green Submitted			2022-12-27	WOS:000393705500033
J	Xu, K; Kuntz, LA; Foehr, P; Kuempel, K; Wagner, A; Tuebel, J; Deimling, CV; Burgkart, RH				Xu, Kai; Kuntz, Lara A.; Foehr, Peter; Kuempel, Katharina; Wagner, Alexandra; Tuebel, Jutta; Deimling, Constantin V.; Burgkart, Rainer H.			Efficient decellularization for tissue engineering of the tendon-bone interface with preservation of biomechanics	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX SCAFFOLDS; EXTRACTION TECHNIQUES; ATTACHMENT SITES; PATELLAR TENDON; RAT MODEL; ENTHESES; REPAIR; RECONSTRUCTION; REGENERATION	Interfaces between tendon/ligament and bone ("entheses") are highly specialized tissues that allow for stress transfer between mechanically dissimilar materials. Entheses show very low regenerative capacity resulting in high incidences of failure after surgical repair. Tissue engineering is a promising approach to recover functionality of entheses. Here, we established a protocol to decellularize porcine entheses as scaffolds for enthesis tissue engineering. Chemical detergents as well as physical treatments were investigated with regard to their efficiency to decellularize 2 mm thick porcine Achilles tendon entheses. A two-phase approach was employed: study 1 investigated the effect of various concentrations of sodium dodecyl sulfate (SDS) and t-octylphenoxypolyethoxy-ethanol (Triton X-100) as decellularization agents. The most efficient combination of SDS and Triton was then carried forward into study 2, where different physical methods, including freeze-thaw cycles, ultrasound, perfusion, and hydrostatic washing were used to enhance the decellularization effect. Cell counts, DNA quantification, and histology showed that washing with 0.5% SDS + 1% Triton X-100 for 72 h at room temperature could remove similar to 98% cells from the interface. Further investigation of physical methods proved that washing under 200 mmHg hydrostatic pressure shortened the detergent exposing time from 72 h to 48 h. Biomechanical tensile testing showed that the biomechanical features of treated samples were preserved. Washing under 200 mmHg hydrostatic pressure with 0.5% SDS + 1% Triton X-100 for 48 h efficiently decellularized entheses with preservation of matrix structure and biomechanical features. This protocol can be used to efficiently decellularize entheses as scaffolds for tissue engineering.	[Xu, Kai; Kuntz, Lara A.; Foehr, Peter; Kuempel, Katharina; Wagner, Alexandra; Tuebel, Jutta; Deimling, Constantin V.; Burgkart, Rainer H.] Tech Univ Munich, Dept Orthopaed & Sportsorthopaed, Klinikum Rechts Isar, Munich, Germany; [Xu, Kai] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Orthoped, Wuhan, Peoples R China	Technical University of Munich; Huazhong University of Science & Technology	Kuntz, LA; Burgkart, RH (corresponding author), Tech Univ Munich, Dept Orthopaed & Sportsorthopaed, Klinikum Rechts Isar, Munich, Germany.	kuntz@tum.de; burgkart@tum.de		Foehr, Peter/0000-0003-1042-546X; Tuebel, Jutta/0000-0001-5033-2191	International Graduate School of Science and Engineering; German Research Foundation (DFG); Technical University of Munich (TUM) in the framework of the Open Access Publishing Program	International Graduate School of Science and Engineering; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM) in the framework of the Open Access Publishing Program	Research was supported by the International Graduate School of Science and Engineering. This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by the International Graduate School of Science and Engineering. The authors acknowledge the continuous support of the German Research Foundation (DFG). This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. Further, the authors thank Carmen Marthen for support with histological analyses and the Chinese oversea training foundation, Prof. Anmin Chen and Prof. Feng Li for support of Dr. Kai Xu.	Angeline ME, 2012, CLIN SPORT MED, V31, P645, DOI 10.1016/j.csm.2012.07.003; ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217, DOI 10.2106/00004623-198264020-00011; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; Benjamin M, 2009, SCAND J MED SCI SPOR, V19, P520, DOI 10.1111/j.1600-0838.2009.00906.x; BISSELL DM, 1986, EUR J CELL BIOL, V40, P72; Bronstein JA, 2013, PLAST RECONSTR SURG, V132, P94, DOI 10.1097/PRS.0b013e318290f5fc; Burgkart R, 2014, TISSUE ENG PART C-ME, V20, P553, DOI [10.1089/ten.tec.2013.0270, 10.1089/ten.TEC.2013.0270]; Burk J, 2014, TISSUE ENG PART C-ME, V20, P276, DOI [10.1089/ten.tec.2012.0760, 10.1089/ten.TEC.2012.0760]; Cartmell JS, 2004, TISSUE ENG, V10, P1065, DOI 10.1089/1076327041887682; Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005; Chen KL, 2016, J TISSUE ENG REGEN M, V10, P294, DOI 10.1002/term.1716; Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012; Dohmen PM, 2011, ANN THORAC SURG, V92, P1308, DOI 10.1016/j.athoracsur.2011.06.009; Dong SW, 2009, BIOSCI BIOTECH BIOCH, V73, P2226, DOI 10.1271/bbb.90329; Dong XC, 2009, J MATER SCI-MATER M, V20, P2327, DOI 10.1007/s10856-009-3791-4; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Fan Heng-hua, 2005, Zhonghua Wai Ke Za Zhi, V43, P870; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Guo LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144240; Hjorthaug GA, 2015, J ORTHOP RES, V33, P216, DOI 10.1002/jor.22756; Ingavle GC, 2013, TISSUE ENG PT A, V19, P1349, DOI [10.1089/ten.tea.2012.0160, 10.1089/ten.TEA.2012.0160]; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Kutten JC, 2015, TISSUE ENG PT A, V21, P75, DOI [10.1089/ten.tea.2014.0089, 10.1089/ten.TEA.2014.0089]; LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001; Lu HH, 2013, ANNU REV BIOMED ENG, V15, P201, DOI 10.1146/annurev-bioeng-071910-124656; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x; Mohan N, 2014, BIOTECHNOL BIOENG, V111, P829, DOI 10.1002/bit.25145; Oguma H, 2001, J ORTHOP RES, V19, P873, DOI 10.1016/S0736-0266(01)00021-3; Ohtera K, 2000, CRIT REV BIOMED ENG, V28, P115, DOI 10.1615/CritRevBiomedEng.v28.i12.190; Paxton J.Z., 2012, ORTHOPEDIC MUSCUL S, VS1; Paxton JZ, 2009, TISSUE ENG PT A, V15, P1201, DOI 10.1089/ten.tea.2008.0105; Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI 10.1073/pnas.0B019BB105; Saccomanni Bernardino, 2011, Musculoskelet Surg, V95, P183, DOI 10.1007/s12306-011-0137-4; Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]; Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437; Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073; Spalazzi Jeffrey P, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P525; Stapleton TW, 2011, TISSUE ENG PT A, V17, P231, DOI [10.1089/ten.tea.2009.0807, 10.1089/ten.TEA.2009.0807]; Sun XH, 2009, CELL MOL NEUROBIOL, V29, P347, DOI 10.1007/s10571-008-9326-6; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Weeks Kenneth D 3rd, 2014, Instr Course Lect, V63, P443; Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066; Wu LC, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0118-z; Xing SX, 2014, EXP THER MED, V8, P628, DOI 10.3892/etm.2014.1742; Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723; Xu Y, 2015, J BIOMED MATER RES B, V103, P670, DOI 10.1002/jbm.b.33231; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005	60	33	33	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171577	10.1371/journal.pone.0171577	http://dx.doi.org/10.1371/journal.pone.0171577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170430	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500044
J	Al-Kindi, KM; Kwan, P; Andrew, NR; Welch, M				Al-Kindi, Khalifa M.; Kwan, Paul; Andrew, Nigel R.; Welch, Mitchell			Impacts of human-related practices on Ommatissus lybicus infestations of date palm in Oman	PLOS ONE			English	Article							DUBAS BUG	Date palm cultivation is economically important in the Sultanate of Oman, with significant financial investments coming from both the government and private individuals. However, a widespread Dubas bug (DB) (Ommatissus lybicus Bergevin) infestation has impacted regions including the Middle East, North Africa, Southeast Russia, and Spain, resulting in widespread damages to date palms. In this study, techniques in spatial statistics including ordinary least squares (OLS), geographically weighted regression (GRW), and exploratory regression (ER) were applied to (a) model the correlation between DB infestations and human-related practices that include irrigation methods, row spacing, palm tree density, and management of undercover and intercropped vegetation, and (b) predict the locations of future DB infestations in northern Oman. Firstly, we extracted row spacing and palm tree density information from remote sensed satellite images. Secondly, we collected data on irrigation practices and management by using a simple questionnaire, augmented with spatial data. Thirdly, we conducted our statistical analyses using all possible combinations of values over a given set of candidate variables using the chosen predictive modelling and regression techniques. Lastly, we identified the combination of human-related practices that are most conducive to the survival and spread of DB. Our results show that there was a strong correlation between DB infestations and several human-related practices parameters (R-2 = 0.70). Variables including palm tree density, spacing between trees (less than 5 x 5 m), insecticide application, date palm and farm service (pruning, dethroning, remove weeds, and thinning), irrigation systems, offshoots removal, fertilisation and labour (non-educated) issues, were all found to significantly influence the degree of DB infestations. This study is expected to help reduce the extent and cost of aerial and ground sprayings, while facilitating the allocation of date palm plantations. An integrated pest management (IPM) system monitoring DB infestations, driven by GIS and remote sensed data collections and spatial statistical models, will allow for an effective DB management program in Oman. This will in turn ensure the competitiveness of Oman in the global date fruits market and help preserve national yields.	[Al-Kindi, Khalifa M.; Kwan, Paul; Welch, Mitchell] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Andrew, Nigel R.] Univ New England, Zool, Ctr Behav & Physiol Ecol, Armidale, NSW, Australia	University of New England; University of New England	Al-Kindi, KM (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	kalkindi@myune.edu.au	Andrew, Nigel/B-7162-2008; Alkindi, Khalifa/AAK-4998-2020	Andrew, Nigel/0000-0002-2850-2307; Welch, Mitchell/0000-0003-4220-8734; Kwan, Paul Wing Hing/0000-0002-4959-5274				ABDULLAH S.K, 2010, BASRAH J DATE PALM R, V9, P40; AI-Khatri S. A., 2004, P DAT PALM REG WORKS, P84; Al Sarai Al Alawi M, 2015, STUDIES CONTROL DUBA; Al-Farsi M, 2007, FOOD CHEM, V104, P943, DOI 10.1016/j.foodchem.2006.12.051; Al-Kharusi LM, 2009, INT J AGRIC BIOL, V11, P290; Al-Kindi K, 2016, REV ANAL TECHN UNPUB; Al-Kindi K, 2016, IMPACT ENV VAR UNPUB; Al-Kindi KM, 2017, CROP PROT, V93, P113, DOI 10.1016/j.cropro.2016.11.033; Al-Marshudi A. S., 2002, Tropicultura, V20, P203; Al-Rumaihi M, 1975, J GULF ARABIAN PENIN, V1; Al-Samarrie AI, 2011, AGRIC BIOL JN AM, V12, P1416; Al-Yahyai R., 2015, DATE PALM GENETIC RE, P207, DOI [10.1007/978-94-017-9707-8_6, DOI 10.1007/978-94-017-9707-8_6]; Al-Yahyai R, 2008, AFR J AGR RES, V3, P389; Al-Zadjali T. S., 2006, Egyptian Journal of Agricultural Research, V84, P51; Ali A-S, 2010, FUTURE VISIONS INFLU, P929; Ali HG, 2010, DEV DATE PALM CULTIV, P29; [Anonymous], 2016, OUTLOOKS PEST MANAG; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; El-Hadrami A., 2012, Emirates Journal of Food and Agriculture, V24, P371; El-Shafie HAF, 2015, SUST PLANT CROP PRO, P169, DOI 10.1007/978-3-319-24397-9_7; Elwan A. S. A., 1999, Egyptian Journal of Agricultural Research, V77, P1547; Hill D, 1990, PEST DIS TROPICAL CR, V2; Howard F. W., 2001, Pesticide Outlook, V12, P240, DOI 10.1039/b110547g; Hunter-Jones P. J. T, 1972, AGR OMAN CTR OVERS P; HUSSAIN A. A., 1963, Bulletin of Entomological Research, V53, P737, DOI 10.1017/S0007485300048458; Jasim H, 2010, EGGS DISTRIBUTION OL, P465; Johnson G, 1996, PRECIS AGRIC, P589; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Khalaf M. Z., 2015, J ENTOMOL RES, V3, P9; Khan A, 2001, P 2 INT C DAT PALMS, P211; KLEIN M, 1985, PHYTOPARASITICA, V13, P95, DOI 10.1007/BF02980886; Liao D, 2012, SURV METHODOL, V38, P53; Lyon JD, 1996, J ROY STAT SOC D-STA, V45, P337; Mahmoudi M, 2015, J AGR SCI TECH-IRAN, V17, P263; Manickavasagan A, 2012, OVERVIEW DATE PALM P, P3; Mokhtar AM, 2010, EUR J ENTOMOL, V107, P681, DOI 10.14411/eje.2010.076; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Robertson C, 2008, FOREST ECOL MANAG, V256, P900, DOI 10.1016/j.foreco.2008.05.054; Rosenshein L., 2011, EXPLORATORY REGRESSI, V1; Shah A, 2013, J INSECT BEHAV, V26, P371, DOI 10.1007/s10905-012-9354-4; STINE RA, 1995, AM STAT, V49, P53, DOI 10.2307/2684812; Thacker JRM, 2003, BCPC INTERNATIONAL CONGRESS CROP SCIENCE & TECHNOLOGY 2003, VOL 1 AND 2, CONGRESS PROCEEDINGS, P987; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Wang Q, 2005, GLOBAL ECOL BIOGEOGR, V14, P379, DOI 10.1111/j.1466-822x.2005.00153.x; Wheeler D., 2005, J GEOGRAPHICAL SYSTE, V7, P161, DOI [DOI 10.1007/S10109-005-0155-6, 10.1007/s10109-005-0155-6]	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171103	10.1371/journal.pone.0171103	http://dx.doi.org/10.1371/journal.pone.0171103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166300	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100023
J	Bos-Touwen, ID; Trappenburg, JCA; van der Wulp, I; Schuurmans, MJ; de Wit, NJ				Bos-Touwen, Irene D.; Trappenburg, Jaap C. A.; van der Wulp, Ineke; Schuurmans, Marieke J.; de Wit, Niek J.			Patient factors that influence clinicians' decision making in self-management support: A clinical vignette study	PLOS ONE			English	Article							ILLNESS PERCEPTIONS; PHYSICIAN PRACTICE; DATA METAANALYSIS; BEHAVIOR-CHANGE; HEALTH; INTERVENTIONS; COPD; PEOPLE; MODEL; WORK	Background and aim Self-management support is an integral part of current chronic care guidelines. The success of self-management interventions varies between individual patients, suggesting a need for tailored self-management support. Understanding the role of patient factors in the current decision making of health professionals can support future tailoring of self-management interventions. The aim of this study is to identify the relative importance of patient factors in health professionals' decision making regarding self-management support. Method A factorial survey was presented to primary care physicians and nurses. The survey consisted of clinical vignettes (case descriptions), in which 11 patient factors were systematically varied. Each care provider received a set of 12 vignettes. For each vignette, they decided whether they would give this patient self-management support and whether they expected this support to be successful. The associations between respondent decisions and patient factors were explored using ordered logit regression. Results The survey was completed by 60 general practitioners and 80 nurses. Self-management support was unlikely to be provided in a third of the vignettes. The most important patient factor in the decision to provide self-management support as well as in the expectation that self-management support would be successful was motivation, followed by patient-provider relationship and illness perception. Other factors, such as depression or anxiety, education level, self-efficacy and social support, had a small impact on decisions. Disease, disease severity, knowledge of disease, and age were relatively unimportant factors. Conclusion This is the first study to explore the relative importance of patient factors in decision making and the expectations regarding the provision of self-management support to chronic disease patients. By far, the most important factor considered was patient's motivation; unmotivated patients were less likely to receive self-management support. Future tailored interventions should incorporate strategies to enhance motivation in unmotivated patients. Furthermore, care providers should be better equipped to promote motivational change in their patients.	[Bos-Touwen, Irene D.; Trappenburg, Jaap C. A.; Schuurmans, Marieke J.; de Wit, Niek J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Wulp, Ineke] Vrije Univ Amsterdam Med Ctr, EMGO Res Inst, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bos-Touwen, ID (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	d.touwen-3@umcutrecht.nl		Trappenburg, Jaap/0000-0003-0489-7401	ZonMw; Netherlands Organization for Health Research and Development [520001002]	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This project was funded by ZonMw, The Netherlands Organization for Health Research and Development, Grant 520001002 (Grant received by MS and JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A, 1977, PSYCHOL REV, V03, P84; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Bos-Touwen ID, 2015, 20 WONCA EUR C 2015; Bos-Touwen I, 2015, NURS RES, V64, P282, DOI 10.1097/NNR.0000000000000103; Bos-Touwen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126400; Bowling A., 1997, RES METHODS HLTH; Burns N., 2005, PRACTICE NURSING RES; CBO, 2014, ZORGM ZELFM 1 0; Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; Coventry PA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0536-y; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Effing TW, 2012, CHRON RESP DIS, V9, P27, DOI 10.1177/1479972311433574; Gijsen R, 2013, 417 RIVM NAT KOMP VO; Haas L, 2014, DIABETES CARE, V37, pS144, DOI 10.2337/dc14-S144; Hawkins RP, 2008, HEALTH EDUC RES, V23, P454, DOI 10.1093/her/cyn004; IBM Corp, IBM SPSS STAT WINDOW; Jonkman NH, 2016, INT J CHRONIC OBSTR, V11, P2063, DOI 10.2147/COPD.S107884; Jonkman NH, 2016, CIRCULATION, V133, P1189, DOI 10.1161/CIRCULATIONAHA.115.018006; Jonkman NH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005220; Kaptein AA, 2008, J ASTHMA, V45, P625, DOI 10.1080/02770900802127048; Kaptein AA, 2014, INT J CHRONIC OBSTR, V9, P1, DOI 10.2147/COPD.S49622; Lauder W., 2002, NURSING TIMES RES, V7, P35, DOI DOI 10.1177/136140960200700106; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Louviere J., 2010, STATED CHOICE METHOD; Ludwick R, 2004, ADV NURS SCI, V27, P224, DOI 10.1097/00012272-200407000-00007; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128; Noordman J, 2013, FAM PRACT, V30, P332, DOI 10.1093/fampra/cms077; Noordman Janneke, 2012, J Clin Med Res, V4, P393, DOI 10.4021/jocmr1120w; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; R Core Team, 2013, LANG ENV STAT COMP; Rollnick S., 2008, MOTIVATIONAL INTERVI; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Taylor BJ, 2006, BRIT J SOC WORK, V36, P1187, DOI 10.1093/bjsw/bch345; Trappenburg J, 2013, PATIENT EDUC COUNS, V92, P134, DOI 10.1016/j.pec.2013.02.009; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Wheeler R. E, 2009, COMMENTS ALGORITHMIC	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171251	10.1371/journal.pone.0171251	http://dx.doi.org/10.1371/journal.pone.0171251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166244	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100030
J	d'Almeida, TC; Sadissou, I; Milet, J; Cottrell, G; Mondiere, A; Avokpaho, E; Gineau, L; Sabbagh, A; Massougbodji, A; Moutairou, K; Donadi, EA; Favier, B; Carosella, E; Moreau, P; Rouas-Freiss, N; Courtin, D; Garcia, A				d'Almeida, Tania C.; Sadissou, Ibrahim; Milet, Jacqueline; Cottrell, Gilles; Mondiere, Amandine; Avokpaho, Euripide; Gineau, Laure; Sabbagh, Audrey; Massougbodji, Achille; Moutairou, Kabirou; Donadi, Eduardo A.; Favier, Benoit; Carosella, Edgardo; Moreau, Philippe; Rouas-Freiss, Nathalie; Courtin, David; Garcia, Andre			Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight	PLOS ONE			English	Article							HLA-G; PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; MATERNAL BLOOD; G MOLECULES; IN-VITRO; RECEPTOR; CELLS; PROGRESSION; INHIBITION	Human leukocyte antigen (HLA) G is a tolerogenic molecule involved in the maternal-fetal immune tolerance phenomenon. Its expression during some infectious diseases leading to immune evasion has been established. A first study conducted in Benin has shown that the production of soluble HLA-G (sHLA-G) during the first months of life is strongly correlated with the maternal level at delivery and associated with low birth weight and malaria. However sHLA-G measurements during pregnancy were not available for mothers and furthermore, to date the evolution of sHLA-G in pregnancy is not documented in African populations. To extend these previous findings, between January 2010 and June 2013, 400 pregnant women of a malaria preventive trial and their newborns were followed up in Benin until the age of 2 years. Soluble HLA-G was measured 3 times during pregnancy and repeatedly during the 2 years follow-up to explore how sHLA-G evolved and the factors associated. During pregnancy, plasma levels of sHLA-G remained stable and increased significantly at delivery (p<0.001). Multigravid women seemed to have the highest levels (p = 0.039). In infants, the level was highest in cord blood and decreased before stabilizing after 18 months (p<0.001). For children, a high level of sHLA-G was associated with malaria infection during the follow-up (p = 0.02) and low birth weight (p = 0.06). The mean level of sHLA-G during infancy was strongly correlated with the mother's level during pregnancy (<0.001), and not only at delivery. Moreover, mothers with placental malaria infection had a higher probability of giving birth to a child with a high level of sHLA-g (p = 0.006). High sHLA-G levels during pregnancy might be associated with immune tolerance related to placental malaria. Further studies are needed but this study provides a first insight concerning the potential role of sHLA-G as a biomarker of weakness for newborns and infants.	[d'Almeida, Tania C.; Garcia, Andre] Univ Paris 06, Paris, France; [d'Almeida, Tania C.; Sadissou, Ibrahim; Milet, Jacqueline; Cottrell, Gilles; Gineau, Laure; Sabbagh, Audrey; Courtin, David; Garcia, Andre] Univ Paris 05, Sorbonne Paris Cite, Inst Rech Dev, Fac Pharm,UMR MERIT 216, Paris, France; [Sadissou, Ibrahim; Garcia, Andre] Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Sadissou, Ibrahim; Massougbodji, Achille; Moutairou, Kabirou] Univ Abomey Calavi, Cotonou, Benin; [Sadissou, Ibrahim] Univ Sao Paulo, Sch Med Ribeirao Preto, Div Clin Immunol, BR-05508 Sao Paulo, Brazil; [Milet, Jacqueline; Cottrell, Gilles; Courtin, David] Univ Paris 05, Sorbonne Paris Cite, Paris, Benin; [Mondiere, Amandine] ISBA, Campus Fac Sci Sante FSS, UMR MERIT 216, Inst Rech Dev, Cotonou, Benin; [Avokpaho, Euripide] Ecole Pasteur, CNAM Sante Publ, Paris, France; [Favier, Benoit; Carosella, Edgardo; Moreau, Philippe; Rouas-Freiss, Nathalie] Hop St Louis, IUH, SRHI, IMETI,CEA, Paris, France; [Favier, Benoit; Carosella, Edgardo; Moreau, Philippe; Rouas-Freiss, Nathalie] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, UMR E5,IUH, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; Universidade de Sao Paulo; Institut de Recherche pour le Developpement (IRD); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	d'Almeida, TC (corresponding author), Univ Paris 06, Paris, France.; d'Almeida, TC (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst Rech Dev, Fac Pharm,UMR MERIT 216, Paris, France.	carennedalmeida@gmail.com	donadi, eduardo A/H-7080-2013; Sadissou, IBRAHIM/AAT-2692-2020; Garcia, Andre/ABA-1820-2020; Gineau, Laure/G-2446-2016; courtin, david/A-1584-2017; FAVIER, Benoit/W-7379-2019; Garcia, Andre/S-2959-2016	donadi, eduardo A/0000-0002-9457-9601; Sadissou, IBRAHIM/0000-0001-7300-3753; Garcia, Andre/0000-0002-1808-472X; courtin, david/0000-0002-5263-4430; Garcia, Andre/0000-0002-1808-472X; Cottrell, Gilles/0000-0002-7964-8963; SABBAGH, Audrey/0000-0003-0283-8803; Gineau, Laure/0000-0002-3863-1671; MILET, Jacqueline/0000-0003-2710-1517; Moreau, Philippe/0000-0002-2868-7401	Agence Nationale de la Recherche (ANR) [project 2006/040/001]; Programa Cienca sem Fronteiras Pesquisador Visitante Especial [406594/2013-9]; iDEX Sorbonne Paris Cite mobilite internationale Bresil; Fondation pour la Recherche Medicale [FDM20130727043]; Institut de Recherche pour le Developpement (IRD); European Developing Countries Clinical Trials Partnership (EDCTP) the Malaria in Pregnancy Consortium [IP.2007.31080.002]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Programa Cienca sem Fronteiras Pesquisador Visitante Especial; iDEX Sorbonne Paris Cite mobilite internationale Bresil; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut de Recherche pour le Developpement (IRD); European Developing Countries Clinical Trials Partnership (EDCTP) the Malaria in Pregnancy Consortium	This study was supported by the Agence Nationale de la Recherche (ANR) (project 2006/ 040/001), Programa Cienca sem Fronteiras << Pesquisador Visitante Especial >> (grant 406594/2013-9) and iDEX Sorbonne Paris Cite << mobilite internationale Bresil 2015 >>. Tania C d'Almeida was partly supported by grants from << Fondation pour la Recherche Medicale >> (Grant FDM20130727043) and by Institut de Recherche pour le Developpement (IRD). The clinical trial in which the study was nested was funded by the European Developing Countries Clinical Trials Partnership (EDCTP; IP.2007.31080.002), the Malaria in Pregnancy Consortium.	Alegre E, 2007, HUM IMMUNOL, V68, P661, DOI 10.1016/j.humimm.2007.04.007; AMEMIYA T, 1973, ECONOMETRICA, V41, P997, DOI 10.2307/1914031; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Baudhuin J, 2013, P NATL ACAD SCI USA, V110, P17957, DOI 10.1073/pnas.1221535110; Baudhuin J, 2012, EUR J IMMUNOL, V42, P700, DOI 10.1002/eji.201141930; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Buzzi M, 2012, HUM IMMUNOL, V73, P150, DOI 10.1016/j.humimm.2011.12.003; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carosella ED, 2015, ADV IMMUNOL, V127, P33, DOI 10.1016/bs.ai.2015.04.001; Carosella ED, 2011, CELL MOL LIFE SCI, V68, P353, DOI 10.1007/s00018-010-0579-0; Celsi F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/693643; d'Almeida T. C., 2016, Malaria Journal, V15; Dahl M, 2015, HUM IMMUNOL, V76, P260, DOI 10.1016/j.humimm.2015.01.015; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Favier B, 2016, IMMUNOL REV, V273, P140, DOI 10.1111/imr.12457; Gineau L, 2015, GENES IMMUN, V16, P57, DOI 10.1038/gene.2014.63; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; He Y, 2015, J PERINAT MED; He YD, 2016, J PERINAT MED, V44, P283, DOI 10.1515/jpm-2015-0062; Hunt JS, 2000, AM J OBSTET GYNECOL, V183, P682, DOI 10.1067/mob.2000.106762; Klitkou L, 2015, HUM IMMUNOL, V76, P254, DOI 10.1016/j.humimm.2015.01.013; Knafel A, 2009, NEUROENDOCRINOL LETT, V30, P67; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Lesport E, 2009, HUM IMMUNOL, V70, P1000, DOI 10.1016/j.humimm.2009.07.019; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; McCulloch CE, 2003, C BOARD MATH SCI NAT, Vviii; Menier C, 2003, HUM IMMUNOL, V64, P315, DOI 10.1016/S0198-8859(02)00821-2; Moreau P, 1998, AM J REPROD IMMUNOL, V40, P136; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Naji A, 2014, J IMMUNOL, V192, P1536, DOI 10.4049/jimmunol.1300438; Ntuli Sam Thembelihle, 2013, Glob J Health Sci, V5, P95, DOI 10.5539/gjhs.v5n3p95; Ouedraogo S, 2013, AM J TROP MED HYG, V88, P292, DOI 10.4269/ajtmh.12-0195; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Rebmann V, 2007, HUM IMMUNOL, V68, P251, DOI 10.1016/j.humimm.2006.11.003; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Rizzo R, 2007, J REPROD IMMUNOL, V74, P133, DOI 10.1016/j.jri.2007.02.005; Rizzo R, 2009, AM J REPROD IMMUNOL, V61, P368, DOI 10.1111/j.1600-0897.2009.00703.x; Sadissou I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-312; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P13312, DOI 10.1073/pnas.1517724112; Wang W, 2015, STAT METHODS MED RES; Weng PJ, 2011, HUM IMMUNOL, V72, P406, DOI 10.1016/j.humimm.2011.02.008; Yie SM, 2005, AM J OBSTET GYNECOL, V193, P204, DOI 10.1016/j.ajog.2004.11.062	50	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171117	10.1371/journal.pone.0171117	http://dx.doi.org/10.1371/journal.pone.0171117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166246	Green Published, gold			2022-12-27	WOS:000393700100024
J	Koutroumani, M; Papadopoulos, GE; Vlassi, M; Nikolakaki, E; Giannakouros, T				Koutroumani, Maria; Papadopoulos, Georgios E.; Vlassi, Metaxia; Nikolakaki, Eleni; Giannakouros, Thomas			Evidence for disulfide bonds in SR Protein Kinase 1 (SRPK1) that are required for activity and nuclear localization	PLOS ONE			English	Article							ESCHERICHIA-COLI CYTOPLASM; SUBSTRATE SPECIFICITIES; MOLECULAR-DYNAMICS; SPLICING FACTORS; PHOSPHORYLATION; CYSTEINE; PREDICTION; MECHANISM; SWITCHES; BRIDGES	Serine/arginine protein kinases (SRPKs) phosphorylate Arg/Ser dipeptide-containing proteins that play crucial roles in a broad spectrum of basic cellular processes. The existence of a large internal spacer sequence that separates the bipartite kinase catalytic core is a unique structural feature of SRPKs. Previous structural studies on a catalytically active fragment of SRPK1, which lacks the main part of the spacer domain, revealed that SRPK1 remains in an active state without any post-translational modifications or specific intra-protein interactions, while the spacer domain is depicted as a loop structure, outside the kinase core. Using systematic mutagenesis we now provide evidence that replacement of any individual cysteine residue in the spacer, apart from Cys414, or in its proximal flaking ends of the two kinase catalytic domains has an impact on kinase activity. Furthermore, the cysteine residues are critical for nuclear translocation of SRPK1 in response to genotoxic stress and SRPK1-dependent splicing of a reporter gene. While replacement of Cys207, Cys502 and Cys539 of the catalytic domains is predicted to distort the kinase active structure, our findings suggest that Cys356, Cys386, Cys427 and Cys455 of the spacer domain and Cys188 of the first catalytic domain are engaged in disulfide bridging. We propose that such a network of intramolecular disulfide bonds mediates the bending of the spacer region thus allowing the proximal positioning of the two catalytic subunits which is a prerequisite for SRPK1 activity.	[Koutroumani, Maria; Nikolakaki, Eleni; Giannakouros, Thomas] Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, Thessaloniki, Greece; [Papadopoulos, Georgios E.] Univ Thessaly, Dept Biochem & Biotechnol, Mezourlo, Larisa, Greece; [Vlassi, Metaxia] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece	Aristotle University of Thessaloniki; University of Thessaly; National Centre of Scientific Research "Demokritos"	Nikolakaki, E; Giannakouros, T (corresponding author), Aristotle Univ Thessaloniki, Dept Chem, Biochem Lab, Thessaloniki, Greece.	nikol@chem.auth.gr; giannako@chem.auth.gr	GIANNAKOUROS, THOMAS/R-3204-2019; Vlassi, Metaxia/B-8692-2013	Papadopoulos, Georgios/0000-0002-2742-8467; Vlassi, Metaxia/0000-0003-0931-2660	THALES Programme [379440]; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	THALES Programme(Thales Group); European Union (European Social Fund ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	Thomas Giannakouros was funded by the THALES Programme (http//excellence.minedu.gov.gr/thales; grant number 379440), co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF). Maria Koutroumani received a salary from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREADIS A, 1995, NUCLEIC ACIDS RES, V23, P3585, DOI 10.1093/nar/23.17.3585; Aubol BE, 2012, BIOCHEMISTRY-US, V51, P6584, DOI 10.1021/bi300876h; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Ding JH, 2006, MOL BIOL CELL, V17, P876, DOI 10.1091/mbc.E05-10-0963; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Fariselli P, 1999, PROTEINS, V36, P340; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Mylonis I, 2003, BIOCHEM BIOPH RES CO, V301, P650, DOI 10.1016/S0006-291X(02)03055-3; Ngo JCK, 2007, STRUCTURE, V15, P123, DOI 10.1016/j.str.2006.11.011; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Nikolakaki E, 2001, J BIOL CHEM, V276, P40175, DOI 10.1074/jbc.M104755200; Nolen B, 2001, NAT STRUCT BIOL, V8, P176, DOI 10.1038/84178; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Papoutsopoulou S, 1999, BIOCHEM BIOPH RES CO, V255, P602, DOI 10.1006/bbrc.1999.0249; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plocinik RM, 2011, J MOL BIOL, V410, P131, DOI 10.1016/j.jmb.2011.04.077; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Sanidas I, 2010, BBA-MOL CELL RES, V1803, P1319, DOI 10.1016/j.bbamcr.2010.07.008; Sellis D, 2012, BBA-GEN SUBJECTS, V1820, P44, DOI 10.1016/j.bbagen.2011.10.010; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tsianou D, 2009, FEBS J, V276, P5212, DOI 10.1111/j.1742-4658.2009.07217.x; Voukkalis N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154198; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; WETZEL R, 1987, TRENDS BIOCHEM SCI, V12, P478, DOI 10.1016/0968-0004(87)90234-9; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	41	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171328	10.1371/journal.pone.0171328	http://dx.doi.org/10.1371/journal.pone.0171328			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166275	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100035
J	Schmithals, A; Kuhn, N				Schmithals, Anja; Kuehn, Norbert			To mulch or not to mulch? Effects of gravel mulch toppings on plant establishment and development in ornamental prairie plantings	PLOS ONE			English	Article							ECOSYSTEM	In recent years, North American prairie vegetation has served as a design model for highly attractive, low-cost and low-maintenance plantings in German urban green spaces. Where mixed-planting techniques, gravel mulch toppings and non-selective maintenance techniques such as mowing are used, prairie plantings are considered to be cost-effective alternative design concepts for public green space management. In this study, we investigated the establishment success of different mixtures of prairie species plantings on two sites with different soil conditions: topsoil and topsoil with graywacke gravel topping. We documented significantly higher average mortality rates on gravel mulch sites in the first year after establishment. Further development of mortality was not significantly different between sites. Weed species were always more numerous on topsoil sites and had an obvious effect on the visual impact of the plantings. The mulch created an effective barrier for wind-dispersed germinators. Soil temperatures down to 30 cm were significantly higher on gravel mulch sites throughout the year, stimulating more vital plant growth and a prolonged growing season. Our results emphasize the importance of considering these kinds of practical issues during the planning process as they are critical to the success or failure of the design.	[Schmithals, Anja; Kuehn, Norbert] Tech Univ Berlin, Dept Landscape Architecture & Environm Planning, Berlin, Germany	Technical University of Berlin	Schmithals, A (corresponding author), Tech Univ Berlin, Dept Landscape Architecture & Environm Planning, Berlin, Germany.	anja.schmithals@tu-berlin.de			Deutsche Forschungsgemeinschaft [KU 1462/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, http://kmv.dfg.de/, grant number KU 1462/4-1 (NK).	Albert KR, 2011, PLANT CELL ENVIRON, V34, P1207, DOI 10.1111/j.1365-3040.2011.02320.x; Bullock JM, 2001, SEEDS ECOLOGY REGENE, P375; Busse N., 2005, GARTENPRAXIS, V10, P55; CURTIS JT, 1971, VEGETATION WISCONSIN; de la Fleur M, 2001, GARTENPRAXIS, V10, P29; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; Elsner AK, 2007, GARTEN LANDSCHAFT, V5, P16; Eppel-Hotz A, 1997, LA LANDSCHAFTSARCHIT, V10, P12; Eppel-Hotz A., 2010, NEUE LANDSCHAFT, V10, P35; Gardner HW, 2011, TALLGRASS PRAIRIE RESTORATION IN THE MIDWESTERN AND EASTERN UNITED STATES: A HANDS-ON GUIDE, P3, DOI 10.1007/978-1-4419-7427-3_1; Hansen R., 1981, STAUDEN IHRE LEBENSB; Hertle B., 1995, THESIS; Hertlein-Rieder V, 2006, GARTEN LANDSCHAFT, V1, P10; Kircher W, 2002, GARTEN LANDSCHAFT, V5, P24; Kircher W., 2005, PFLANZEN EXTREME STA, P92; Kircher W., 2001, STADT GRUN, V5, P355; Kunick W., 1999, NEUE LANDSCHAFT, V3, P164; Kuntze H., 1994, BODENKUNDE; Luz H., 2005, GARTEN LANDSCHAFT, V5, P16; Luz H., 2004, GRUNFORUMLA, V11, P24; Menhusen BR, 1963, T KANSAS ACAD SCI, V661, P107; Messer U., 2003, STADT GRUN, V12, P44; Messer UJ, 2004, ACTA HORTIC, P157, DOI 10.17660/ActaHortic.2004.643.19; Missouri Botanical Garden. Asclepias tuberosa, 2016, ASCL TUB; Missouri Botanical Garden. Bouteloua curtipendula, 2016, BOUT CURT; Oehmichen F, 2000, GARTENPRAXIS, V4, P39; Palm M., 1993, GARTENPRAXIS, V5, P16; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; R Core Team, 2021, R LANGUAGE ENV STAT; ROBER R. UND H. SCHACHT, 2008, PFLANZENERNAHRUNG GA, V4; Rothmund S, 2000, GARTENPRAXIS, V12, P31; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Scheffer P., 1998, LEHRBUCH BODENKUNDE, V14; Schmidt C, 2004, GARTENPRAXIS, V5, P32; Schmidt C, 2004, GARTENPRAXIS, V7, P17; Schmidt C, 2004, DEGA, V11, P12; Schmidt C, 2003, GRUNFORUMLA, V3, P18; Schmidt C., 2009, GARTENPRAXIS, V6, P22; Schmithals A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108588; Schonfeld P., 2001, CAMPOS, V3, P20; Sharon Y., 2014, WHORLED MILKWEED ASC; Simon H., 1991, GARTENPRAXIS, V5, P19; Sullivan AT, 2011, OECOLOGIA, V165, P1007, DOI 10.1007/s00442-010-1815-x; University of Wisconsin-Madison Arboretum. Plants of Southern Wisconsin, 2013, PLANTS SO WISC; USDA  NRCS, 2016, PLANTS DAT; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; WEAVER J. E., 1934, ECOL MONOGR, V4, P109, DOI 10.2307/1943575	48	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171533	10.1371/journal.pone.0171533	http://dx.doi.org/10.1371/journal.pone.0171533			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166269	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100052
J	Adomako-Ankomah, Y; Chenoweth, MS; Durfee, K; Doumbia, S; Konate, D; Doumbouya, M; Keita, AS; Nikolaeva, D; Tullo, GS; Anderson, JM; Fairhurst, RM; Daniels, R; Volkman, SK; Diakite, M; Miura, K; Long, CA				Adomako-Ankomah, Yaw; Chenoweth, Matthew S.; Durfee, Katelyn; Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Keita, Abdoul S.; Nikolaeva, Daria; Tullo, Gregory S.; Anderson, Jennifer M.; Fairhurst, Rick M.; Daniels, Rachel; Volkman, Sarah K.; Diakite, Mahamadou; Miura, Kazutoyo; Long, Carole A.			High Plasmodium falciparum longitudinal prevalence is associated with high multiclonality and reduced clinical malaria risk in a seasonal transmission area of Mali	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SENEGALESE CHILDREN; ENDEMIC AREA; INFECTION; COHORT; EPIDEMIOLOGY; POPULATION; PARASITES; COMPLEXITY; TRACKING	The effects of persistent Plasmodium falciparum (Pf) infection and multiclonality on subsequent risk of clinical malaria have been reported, but the relationship between these 2 parameters and their relative impacts on the clinical outcome of infection are not understood. A longitudinal cohort study was conducted in a seasonal and high-transmission area of Mali, in which 500 subjects aged 1-65 years were followed for 1 year. Blood samples were collected every 2 weeks, and incident malaria cases were diagnosed and treated. Pf infection in each individual at each time point was assessed by species-specific nestedPCR, and Pf longitudinal prevalence per person (PfLP, proportion of Pf-positive samples over 1 year) was calculated. Multiclonality of Pf infection was measured using a 24-SNP DNA barcoding assay at 4 time-points (two in wet season, and two in dry season) over one year. PfLP was positively correlated with multiclonality at each time point (all r >= 0.36; all P <= 0.011). When host factors (e. g., age, gender), PfLP, and multiclonality (at the beginning of the transmission season) were analyzed together, only increasing age and high PfLP were associated with reduced clinical malaria occurrence or reduced number of malaria episodes (for both outcomes, P<0.001 for age, and P = 0.005 for PfLP). When age, PfLP and baseline Pf positivity were analyzed together, the effect of high PfLP remained significant even after adjusting for the other two factors (P = 0.001 for malaria occurrence and P<0.001 for number of episodes). In addition to host age and baseline Pf positivity, both of which have been reported as important modifiers of clinical malaria risk, our results demonstrate that persistent parasite carriage, but not baseline multiclonality, is associated with reduced risk of clinical disease in this population. Our study emphasizes the importance of considering repeated parasite exposure in future studies that evaluate clinical malaria risk.	[Adomako-Ankomah, Yaw; Chenoweth, Matthew S.; Nikolaeva, Daria; Tullo, Gregory S.; Anderson, Jennifer M.; Fairhurst, Rick M.; Miura, Kazutoyo; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Durfee, Katelyn; Daniels, Rachel; Volkman, Sarah K.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Keita, Abdoul S.; Diakite, Mahamadou] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Daniels, Rachel] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Daniels, Rachel; Volkman, Sarah K.] Broad Inst MIT & Harvard, Program Infect Dis, Cambridge, MA USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Harvard T.H. Chan School of Public Health; University of Science & Technology of Bamako; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Simmons University	Miura, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	kmiura@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020	Miura, Kazutoyo/0000-0003-4455-2432	National Institute of Allergy and Infectious Diseases National Institutes of Health; Bill and Melinda Gates Foundation, Seattle, WA [OPP1053604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062, ZIAAI001020, ZIAAI001000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases National Institutes of Health and the Bill and Melinda Gates Foundation, Seattle, WA [award no. OPP1053604]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Babiker HA, 2013, DRUG RESIST UPDATE, V16, P1, DOI 10.1016/j.drup.2013.02.001; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Baniecki ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003539; Bei AK, 2015, INFECT IMMUN, V83, P276, DOI 10.1128/IAI.01979-14; Betuela I, 2012, TROP MED INT HEALTH, V17, P1181, DOI 10.1111/j.1365-3156.2012.03062.x; Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112; Donnelly B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1299-1; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; Galinsky K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-4; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Hofmann N, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001788; Jenkins R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0781-5; Kaisar MMM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-169; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Le Port A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-193; Liljander A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016940; Liljander A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013649; Lopera-Mesa TM, 2015, LANCET HAEMATOL, V2, pE140, DOI 10.1016/S2352-3026(15)00043-5; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Mharakurwa S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-89; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060182; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Pemberton-Ross P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0805-1; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Pinkevych M, 2014, J INFECT DIS, V209, P1136, DOI 10.1093/infdis/jit613; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sonden K, 2015, J INFECT DIS, V212, P608, DOI 10.1093/infdis/jiv088; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Wampfler R, 2014, J INFECT DIS, V210, P1188, DOI 10.1093/infdis/jiu236; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; World Health Organization, 2015, WORLD MAL REP 2015	41	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170948	10.1371/journal.pone.0170948	http://dx.doi.org/10.1371/journal.pone.0170948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158202	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700020
J	Nordholm, AC; Soborg, B; Andersson, M; Hoffmann, S; Skinhoj, P; Koch, A				Nordholm, Anne Christine; Soborg, Bolette; Andersson, Mikael; Hoffmann, Steen; Skinhoj, Peter; Koch, Anders			CNS infections in Greenland: A nationwide register-based cohort study	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; ACUTE BACTERIAL-MENINGITIS; EPIDEMIOLOGY; POPULATION; DIAGNOSIS; INFANTS; SYSTEM	Background Indigenous Arctic people suffer from high rates of infectious diseases. However, the burden of central nervous system (CNS) infections is poorly documented. This study aimed to estimate incidence rates and mortality of CNS infections among Inuits and non-Inuits in Greenland and in Denmark. Methods We conducted a nationwide cohort study using the populations of Greenland and Denmark 1990-2012. Information on CNS infection hospitalizations and pathogens was retrieved from national registries and laboratories. Incidence rates were estimated as cases per 100,000 person-years. Incidence rate ratios were calculated using log-linear Poisson-regression. Mortality was estimated using Kaplan-Meier curves and Log Rank test. Results The incidence rate of CNS infections was twice as high in Greenland (35.6 per 100,000 person years) as in Denmark (17.7 per 100,000 person years), but equally high among Inuits in Greenland and Denmark (38.2 and 35.4, respectively). Mortality from CNS infections was 2 fold higher among Inuits (10.5%) than among non-Inuits (4.8%) with a fivefold higher case fatality rate in Inuit toddlers. Conclusion Overall, Inuits living in Greenland and Denmark suffer from twice the rate of CNS infections compared with non-Inuits, and Inuit toddlers carried the highest risk of mortality. Further studies regarding risk factors such as genetic susceptibility, life style and socioeconomic factors are warranted.	[Nordholm, Anne Christine; Soborg, Bolette; Andersson, Mikael; Koch, Anders] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Hoffmann, Steen] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Skinhoj, Peter] Rigshosp, Dept Infect Dis, Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut; Rigshospitalet; University of Copenhagen	Nordholm, AC (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.	anch@ssi.dk	Nordholm, Anne Christine/AAX-8990-2021	Nordholm, Anne Christine/0000-0001-7702-6020; Koch, Anders/0000-0001-9205-1048	Lundbeck Foundation [9688-9325]; Aase and Ejnar Danielsens Foundation [9688-9341]	Lundbeck Foundation(Lundbeckfonden); Aase and Ejnar Danielsens Foundation	This work was supported by the Lundbeck Foundation (Grant number 9688-9325) and the Aase and Ejnar Danielsens Foundation (Grant number 9688-9341). None of these sponsors had any role in the preparation or submission of this study.	Agrawal S, 2011, PEDIATR DRUGS, V13, P385, DOI 10.2165/11593340-000000000-00000; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2013, BELYSNING GRONQENDED; Bjerregaard PMD, 2008, HLTH TRANSITIONS ARC; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Bruce MG, 2008, EMERG INFECT DIS, V14, P25, DOI 10.3201/eid1401.071315; Christiansen J, 2004, SCAND J INFECT DIS, V36, P325, DOI 10.1080/00365540410020460; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; GILSDORF JR, 1977, AM J EPIDEMIOL, V106, P388, DOI 10.1093/oxfordjournals.aje.a112480; Goldacre MJ, 2014, EPIDEMIOL INFECT, V142, P371, DOI 10.1017/S095026881300099X; Gounder PP, 2015, J INFECTION, V71, P179, DOI 10.1016/j.jinf.2015.04.001; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; JUEL K, 2004, MORTALITY DENMARK 10; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Koch A, 2003, AM J EPIDEMIOL, V158, P374, DOI 10.1093/aje/kwg143; Koch A, 2011, VALIDERING GRONLANDS; Koch A, 2011, INFECT DIS GEOGRAPHI; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Meyer A, 2008, EMERG INFECT DIS, V14, P76, DOI 10.3201/eid1401.071240; Michelsen SW, 2014, THORAX, V69, P851, DOI 10.1136/thoraxjnl-2014-205688; NICOLLE LE, 1982, J INFECT DIS, V145, P103, DOI 10.1093/infdis/145.1.103; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; SCHLECH WF, 1985, JAMA-J AM MED ASSOC, V253, P1749, DOI 10.1001/jama.253.12.1749; Singleton R, 2013, PEDIATR INFECT DIS J, V32, P257, DOI 10.1097/INF.0b013e3182748ada; The Danish Health Authority, 2000, CHILDH VACC PROGR DE; Thomson RB, 2001, INFECT DIS CLIN N AM, V15, P1047, DOI 10.1016/S0891-5520(05)70186-0; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; WOTTON KA, 1981, CAN MED ASSOC J, V124, P887	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171094	10.1371/journal.pone.0171094	http://dx.doi.org/10.1371/journal.pone.0171094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158207	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700029
J	Chou, CH; Chou, YE; Chuang, CY; Yang, SF; Lin, CW				Chou, Chia-Hsuan; Chou, Ying-Erh; Chuang, Chun-Yi; Yang, Shun-Fa; Lin, Chiao-Wen			Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; AURORA-KINASE; BETEL QUID; PHE31ILE POLYMORPHISM; SUSCEPTIBILITY GENE; COLORECTAL CANCERS; BREAST-CARCINOMA; RISK; ASSOCIATION; METAANALYSIS	Background Oral squamous cell carcinoma (OSCC) is the sixth and fourth most common cause of cancer death in men worldwide and in Taiwan, respectively. AURKA, which encodes a centrosome-related serine/threonine kinase, is frequently amplified and overexpressed in many human cancers, particularly advanced OSCC. We conducted a hospital-based case-control study to estimate AURKA single-nucleotide polymorphisms (SNPs) and environmental risk factors to determine OSCC susceptibility and clinicopathological characteristics. Methodology/Principal findings We enrolled a total of 876 OSCC patients and 1200 controls. Four SNPs of AURKA, namely rs1047972, rs2273535, rs2064863, and rs6024836, were analyzed using realtime polymerase chain reaction (PCR). Among the 1420 smokers, the AURKA polymorphism carriers with the betel nut chewing habit had a higher risk of oral cancer than AURKA wild-type (WT) carriers without the betel nut chewing habit. Patients with the AURKA rs2064863 gene had a 1.365-fold higher risk of stage III or IV OSCC (95% confidence interval [CI] 1.029-1.811) than those with the rs2064863 WT gene. Furthermore, carriers of the AURKA rs1047972/rs2273535/rs2064863 C-A-T haplotype had a 1.736-fold (95% CI 1.110-2.715) higher risk of OSCC than controls (C-T-T, the most common haplotype). Among patients with the betel quid chewing habit, carriers of other haplotypes (C-T-T, C-A-G, T-A-T, T-A-G, T-T-T, and C-T-G) had a 12.857-fold (95% CI 10.731-15.404) increased risk, and carriers of the C-A-T haplotype had the highest risk (AOR: 31.120; 95% CI 13.864-69.850) of OSCC, compared with those without the betel quid chewing who harbored other haplotypes. Conclusions In conclusion, betel nut chewing combined with the AURKA C-A-T haplotypes lead to a high risk of OSCC. These findings reveal a novel genetic-environmental predisposition for oral tumorigenesis.	[Chou, Chia-Hsuan; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chou, Chia-Hsuan; Chou, Ying-Erh; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chou, Ying-Erh; Chuang, Chun-Yi] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chuang, Chun-Yi] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lin, CW (corresponding author), Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.; Lin, CW (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cwlin@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	Chung Shan Medical University Hospital Taiwan [CSH-2016-E-002-Y2]	Chung Shan Medical University Hospital Taiwan	This study was supported by CSH-2016-E-002-Y2 from Chung Shan Medical University Hospital Taiwan, respectively. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Cheng HL, 2016, ONCOTARGET, V7, P69384, DOI 10.18632/oncotarget.12082; Chien MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060283; Chiu CC, 2010, BIOCHEM BIOPH RES CO, V399, P60, DOI 10.1016/j.bbrc.2010.07.042; Chou YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093692; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; Chuang TP, 2016, ONCOTARGET; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Cox DG, 2006, CANCER CAUSE CONTROL, V17, P81, DOI 10.1007/s10552-005-0429-9; Dai ZJ, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0091-y; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Goos JACM, 2013, BRIT J CANCER, V109, P2445, DOI 10.1038/bjc.2013.608; Guo XG, 2014, ASIAN PAC J CANCER P, V15, P6709, DOI 10.7314/APJCP.2014.15.16.6709; Hamad HMA, 2006, ANN ONCOL, V17, P32, DOI 10.1093/annonc.mdl985; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; Jia L, 2014, MOL CANCER RES, V12, P1779, DOI 10.1158/1541-7786.MCR-14-0191; Jin YT, 1996, ORAL ONCOL, V32B, P343, DOI 10.1016/0964-1955(96)00018-8; Ju H, 2006, CANCER LETT, V242, P273, DOI 10.1016/j.canlet.2005.11.015; Kao SY, 2015, CHIN J DENT RES, V18, P7, DOI 10.3290/j.cjdr.a33965,PubMed:25815378; Kao SY, 2010, J PATHOL, V222, P99, DOI 10.1002/path.2737; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; KUO MYP, 1994, J ORAL PATHOL MED, V23, P70, DOI 10.1111/j.1600-0714.1994.tb00259.x; Lee CP, 2015, CLIN ORAL INVEST, V19, P1825, DOI 10.1007/s00784-015-1432-5; LeeChen SF, 1996, MUTAGENESIS, V11, P519, DOI 10.1093/mutage/11.5.519; Li YD, 2015, TUMOR BIOL, V36, P3557, DOI 10.1007/s13277-014-2992-8; Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w; Lin CW, 2015, HEAD NECK-J SCI SPEC, V37, P1425, DOI 10.1002/hed.23771; Liu TY, 1996, MUTAT RES-GENET TOX, V367, P25, DOI 10.1016/S0165-1218(96)90018-X; Matarasso N, 2007, NEOPLASIA, V9, P707, DOI 10.1593/neo.07322; Miao XP, 2004, CANCER RES, V64, P2680, DOI 10.1158/0008-5472.CAN-04-0651; Pickhard A, 2014, ONCOTARGET, V5, P5428, DOI 10.18632/oncotarget.2117; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Su CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002092; Su SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159585; Sun T, 2004, CARCINOGENESIS, V25, P2225, DOI 10.1093/carcin/bgh244; Taylor NJ, 2015, MOL CARCINOGEN, V54, P1668, DOI 10.1002/mc.22238; Treekitkarnmongkol W, 2016, CARCINOGENESIS; Wang C, 2016, TARGETED ONCOLOGY; Wang CK, 1996, MUTAT RES-ENVIR MUTA, V360, P165, DOI 10.1016/S0165-1161(96)90013-8; Xu LZ, 2014, ONCOTARGET, V5, P7498, DOI 10.18632/oncotarget.2241; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	48	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171583	10.1371/journal.pone.0171583	http://dx.doi.org/10.1371/journal.pone.0171583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152093	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161200156
J	Contreras-Soto, RI; Mora, F; de Oliveira, MAR; Higashi, W; Scapim, CA; Schuster, I				Contreras-Soto, Rodrigo Ivan; Mora, Freddy; Rott de Oliveira, Marco Antonio; Higashi, Wilson; Scapim, Carlos Alberto; Schuster, Ivan			A Genome-Wide Association Study for Agronomic Traits in Soybean Using SNP Markers and SNP-Based Haplotype Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; LINKAGE DISEQUILIBRIUM; GLYCINE-MAX; QUANTITATIVE TRAITS; YIELD QTL; MODEL; LOCI; POPULATIONS; ENVIRONMENT; GERMPLASM	Mapping quantitative trait loci through the use of linkage disequilibrium (LD) in populations of unrelated individuals provides a valuable approach for dissecting the genetic basis of complex traits in soybean (Glycine max). The haplotype-based genome-wide association study (GWAS) has now been proposed as a complementary approach to intensify benefits from LD, which enable to assess the genetic determinants of agronomic traits. In this study a GWAS was undertaken to identify genomic regions that control 100-seed weight (SW), plant height (PH) and seed yield (SY) in a soybean association mapping panel using single nucleotide polymorphism (SNP) markers and haplotype information. The soybean cultivars (N = 169) were field-evaluated across four locations of southern Brazil. The genome-wide haplotype association analysis (941 haplotypes) identified eleven, seventeen and fifty-nine SNP-based haplotypes significantly associated with SY, SW and PH, respectively. Although most marker-trait associations were environment and trait specific, stable haplotype associations were identified for SY and SW across environments (i. e., haplotypes Gm12_ Hap12). The haplotype block 42 on Chr19 (Gm19_ Hap42) was confirmed to be associated with PH in two environments. These findings enable us to refine the breeding strategy for tropical soybean, which confirm that haplotype-based GWAS can provide new insights on the genetic determinants that are not captured by the single-marker approach.	[Contreras-Soto, Rodrigo Ivan; Scapim, Carlos Alberto] Univ Estadual Maringa, Dept Agron, Ave Colombo, Maringa, PR, Brazil; [Mora, Freddy] Univ Talca, Inst Biol Sci, Casilla, Talca, Chile; [Rott de Oliveira, Marco Antonio; Higashi, Wilson] COODETEC, BR, Cascavel, PR, Brazil; [Schuster, Ivan] Dow Agrosci, Rod Anhanguera, Cravinhos, SP, Brazil	Universidade Estadual de Maringa; Universidad de Talca	Contreras-Soto, RI (corresponding author), Univ Estadual Maringa, Dept Agron, Ave Colombo, Maringa, PR, Brazil.	contrerasudec@gmail.com	scapim, Carlos/ABE-6461-2020; Mora-Poblete, Freddy/AAZ-1585-2020; Contreras-Soto, Rodrigo/N-5664-2019; Schuster, Ivan/C-7941-2015	Contreras-Soto, Rodrigo/0000-0001-6468-9394; Schuster, Ivan/0000-0002-5781-2339	CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico); COODETEC; Dow Agrosciences	CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); COODETEC; Dow Agrosciences	CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico) provided the funding to support all genotyping made for this study. Marco Antonio Rott de Oliveira and Wilson Higashi receive a salary from COODETEC. Ivan Schuster receives a salary from Dow Agrosciences. COODETEC made the field assays and data collection. Dow Agrosciences did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Shafy H, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-35; Alliprandini LF, 2009, CROP SCI, V49, P801, DOI 10.2135/cropsci2008.07.0390; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cappa EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081267; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cober ER, 2000, CAN J PLANT SCI, V80, P527, DOI 10.4141/P99-146; Concibido VC, 2003, THEOR APPL GENET, V106, P575, DOI 10.1007/s00122-002-1071-5; Embrapa, 2011, SIST PROD EMBR SOJ; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Fischer-Kilbienski I, 2010, PLANT MOL BIOL, V73, P379, DOI 10.1007/s11103-010-9618-3; Fox CM, 2015, CROP SCI, V55, P992, DOI 10.2135/cropsci2014.10.0688; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Garner C, 2003, GENET EPIDEMIOL, V24, P57, DOI 10.1002/gepi.10217; Greenspan G, 2004, J COMPUT BIOL, V11, P495, DOI 10.1089/1066527041410300; Hamblin MT, 2011, PLANT GENOME-US, V4, P145, DOI 10.3835/plantgenome2011.03.0008; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Holland JB, 2006, CROP SCI, V46, P642, DOI 10.2135/cropsci2005.0191; Hwang EY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kim KS, 2012, THEOR APPL GENET, V125, P1353, DOI 10.1007/s00122-012-1944-1; Kim YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-477; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee SH, 1996, CROP SCI, V36, P728, DOI 10.2135/cropsci1996.0011183X003600030035x; Liang HZ, 2010, AGR SCI CHINA, V9, P1108, DOI 10.1016/S1671-2927(09)60197-8; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Lorenz AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014079; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; MANSUR LM, 1993, THEOR APPL GENET, V86, P907, DOI 10.1007/BF00211040; Mora F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00909; Mora F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0264-y; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Recker JR, 2014, CROP SCI, V54, P939, DOI 10.2135/cropsci2013.07.0447; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuster I, 2011, CROP BREED APPL BIOT, V11, P50, DOI 10.1590/S1984-70332011000500008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Song QJ, 2015, G3-GENES GENOM GENET, V5, P1999, DOI 10.1534/g3.115.019000; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; SoyBase, 2016, USDA ARS SOYB GEN GE; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Sun YN, 2012, MOL BIOL REP, V39, P9435, DOI 10.1007/s11033-012-1808-4; Swain SM, 2002, PLANT PHYSIOL, V129, P605, DOI 10.1104/pp.020002; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang K, 2011, GENES GENOM, V33, P685, DOI 10.1007/s13258-011-0043-z; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang JP, 2016, THEOR APPL GENET, V129, P117, DOI 10.1007/s00122-015-2614-x; Zhao FP, 2012, G3-GENES GENOM GENET, V2, P779, DOI 10.1534/g3.112.002980	56	80	89	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171105	10.1371/journal.pone.0171105	http://dx.doi.org/10.1371/journal.pone.0171105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152092	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200089
J	Dickson, BJ; Gatie, MI; Spice, DM; Kelly, GM				Dickson, Benjamin J.; Gatie, Mohamed I.; Spice, Danielle M.; Kelly, Gregory M.			NOX1 and NOX4 are required for the differentiation of mouse F9 cells into extraembryonic endoderm	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; NADPH OXIDASES; OXIDATIVE STRESS; REDOX REGULATION; CARCINOMA-CELLS; REACTIVE OXYGEN; ACTIVATION; NUCLEOREDOXIN; PROTEIN; TRANSCRIPTION	Mouse F9 cells differentiate to primitive endoderm (PrE) when treated with retinoic acid (RA). Differentiation is accompanied by increased reactive oxygen species (ROS) levels, and while treating F9 cells with antioxidants attenuates differentiation, H2O2 treatment alone is sufficient to induce PrE. We identified the NADPH oxidase (NOX) complexes as candidates for the source of this endogenous ROS, and within this gene family, and over the course of differentiation, Nox1 and Nox4 show the greatest upregulation induced by RA. Gata6, encoding a master regulator of extraembryonic endoderm is also up-regulated by RA and we provide evidence that NOX1 and NOX4 protein levels increase in F9 cells overexpressing Gata6. Pan-NOX and NOX1-specific inhibitors significantly reduced the ability of RA to induce PrE, and this was recapitulated using a genetic approach to knockdown Nox1 and/or Nox4 transcripts. Interestingly, overexpressing either gene in untreated F9 cells did not induce differentiation, even though each elevated ROS levels. Thus, the data suggests that ROS produced during PrE differentiation is dependent in part on increased NOX1 and NOX4 levels, which is under the control of GATA6. Furthermore, these results suggest that the combined activity of multiple NOX proteins is necessary for the differentiation of F9 cells to primitive endoderm.	[Dickson, Benjamin J.; Gatie, Mohamed I.; Spice, Danielle M.; Kelly, Gregory M.] Western Univ, Dept Biol, Mol Genet Unit, London, ON, Canada; [Kelly, Gregory M.] Child Hlth Res Inst, London, ON, Canada; [Kelly, Gregory M.] Ontario Inst Regenerat Med, Toronto, ON, Canada; [Dickson, Benjamin J.] Proteocyte Diagnost, Toronto, ON, Canada	Western University (University of Western Ontario)	Kelly, GM (corresponding author), Western Univ, Dept Biol, Mol Genet Unit, London, ON, Canada.; Kelly, GM (corresponding author), Child Hlth Res Inst, London, ON, Canada.; Kelly, GM (corresponding author), Ontario Inst Regenerat Med, Toronto, ON, Canada.	gkelly@uwo.ca	Kelly, Gregory/AAF-3400-2020	Kelly, Gregory/0000-0001-8612-364X; Spice, Danielle/0000-0002-7038-0067; Gatie, Mohamed I./0000-0001-8500-5609; Dickson, Barry/0000-0003-0715-892X	Natural Sciences and Engineering Research Council of Canada [R2615A02004]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Support was provided by the Natural Sciences and Engineering Research Council of Canada, Discovery Grant R2615A02004 [http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp].	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bahn YJ, 2015, J LIPID RES, V56, P294, DOI 10.1194/jlr.M054056; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Brewer AC, 2006, FREE RADICAL BIO MED, V40, P260, DOI 10.1016/j.freeradbiomed.2005.08.022; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Funato Y, 2010, FREE RADICAL RES, V44, P379, DOI 10.3109/10715761003610745; Golenia G G M. I., 2016, BIOCH CELL IN PRESS; Hagiwara N, 2013, CELL TISSUE RES, V354, P581, DOI 10.1007/s00441-013-1680-0; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hwang JTK, 2012, STEM CELLS DEV, V21, P3220, DOI 10.1089/scd.2011.0492; Inoue A, 2009, BIOCHEM BIOPH RES CO, V390, P564, DOI 10.1016/j.bbrc.2009.10.005; Kajla S, 2012, FASEB J, V26, P2049, DOI 10.1096/fj.11-196360; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Krawetz R, 2008, CELL SIGNAL, V20, P506, DOI 10.1016/j.cellsig.2007.11.001; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Landry WD, 2014, BIOCHEM SOC T, V42, P934, DOI 10.1042/BST20140060; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Murray TVA, 2013, J BIOL CHEM, V288, P15745, DOI 10.1074/jbc.M112.439844; Pekarcikova L, 2016, CELL SIGNAL, V28, P924, DOI [10.1016/j.cellsig2016.04.007, 10.1016/j.cellsig.2016.04.007]; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Rezende F, 2016, ANTIOXID REDOX SIGN, V24, P392, DOI 10.1089/ars.2015.6314; Riganti C, 2004, J BIOL CHEM, V279, P47726, DOI 10.1074/jbc.M406314200; Sandieson L, 2014, STEM CELLS DEV, V23, P1037, DOI 10.1089/scd.2014.0010; Sattayakhom A, 2011, J CANCER RES CLIN, V137, P1669, DOI 10.1007/s00432-011-1041-x; Schlupf J, 2014, DIFFERENTIATION, V87, P209, DOI 10.1016/j.diff.2014.07.003; Sirokmany G, 2016, TRENDS PHARMACOL SCI, V37, P318, DOI 10.1016/j.tips.2016.01.006; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Wen JWH, 2012, CELL SIGNAL, V24, P2337, DOI 10.1016/j.cellsig.2012.07.024; Wingler K, 2012, CELL MOL LIFE SCI, V69, P3159, DOI 10.1007/s00018-012-1107-1; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008	39	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170812	10.1371/journal.pone.0170812	http://dx.doi.org/10.1371/journal.pone.0170812			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152080	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200045
J	Kusuma, GD; Brennecke, SP; O'Connor, AJ; Kalionis, B; Heath, DE				Kusuma, Gina D.; Brennecke, Shaun P.; O'Connor, Andrea J.; Kalionis, Bill; Heath, Daniel E.			Decellularized extracellular matrices produced from immortal cell lines derived from different parts of the placenta support primary mesenchymal stem cell expansion	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; CHORIONIC VILLI; OXIDATIVE STRESS; PROGENITOR CELLS; EX-VIVO; FETAL; CULTURE; PROLIFERATION; DECIDUA	Mesenchymal stem/stromal cells (MSCs) exhibit undesired phenotypic changes during ex vivo expansion, limiting production of the large quantities of high quality primary MSCs needed for both basic research and cell therapies. Primary MSCs retain many desired MSC properties including proliferative capacity and differentiation potential when expanded on decellularized extracellular matrix (dECM) prepared from primary MSCs. However, the need to use low passage number primary MSCs (passage 3 or lower) to produce the dECM drastically limits the utility and impact of this technology. Here, we report that primary MSCs expanded on dECM prepared from high passage number (passage 25) human telomerase reverse transcriptase (hTERT) transduced immortal MSC cell lines also exhibit increased proliferation and osteogenic differentiation. Two hTERT-transduced placenta-derived MSC cell lines, CMSC29 and DMSC23 [derived from placental chorionic villi (CMSCs) and decidua basalis (DMSCs), respectively], were used to prepare dECM-coated substrates. These dECM substrates showed structural and biochemical differences. Primary DMSCs cultured on dECM-DMSC23 showed a three-fold increase in cell number after 14 days expansion in culture and increased osteogenic differentiation compared with controls. Primary CMSCs cultured on the dECM-DMSC23 exhibited a two-fold increase in cell number and increased osteogenic differentiation. We conclude that immortal MSC cell lines derived from different parts of the placenta produce dECM with varying abilities for supporting increased primary MSC expansion while maintaining important primary MSC properties. Additionally, this is the first demonstration of using high passage number cells to produce dECM that can promote primary MSC expansion, and this advancement greatly increases the feasibility and applicability of dECM-based technologies.	[Kusuma, Gina D.; Brennecke, Shaun P.; Kalionis, Bill] Royal Womens Hosp, Dept Maternal Fetal Med, Pregnancy Res Ctr, Parkville, Vic, Australia; [Kusuma, Gina D.; O'Connor, Andrea J.; Heath, Daniel E.] Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluids Proc Ctr, Parkville, Vic, Australia; [Brennecke, Shaun P.; Kalionis, Bill] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Kalionis, B (corresponding author), Royal Womens Hosp, Dept Maternal Fetal Med, Pregnancy Res Ctr, Parkville, Vic, Australia.; Heath, DE (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluids Proc Ctr, Parkville, Vic, Australia.; Kalionis, B (corresponding author), Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic, Australia.	bill.kalionis@thewomensu.org.au; daniel.heath@unimelb.edu.au	KALIONIS, BILL/B-4766-2011; Brennecke, Shaun/AFV-3919-2022; O'Connor, Andrea J/B-1225-2011; Kusuma, Gina/AAF-3381-2019	Brennecke, Shaun/0000-0003-3070-6971; O'Connor, Andrea J/0000-0001-6925-885X; Kusuma, Gina/0000-0001-7042-3795; Heath, Daniel/0000-0003-3171-886X	University of Melbourne	University of Melbourne(University of Melbourne)	Funding was provided through the University of Melbourne Early Career Researcher scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Abumaree MH, 2013, STEM CELL REV REP, V9, P16, DOI 10.1007/s12015-012-9385-4; Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Braekke K, 2006, PEDIATR RES, V60, P560, DOI 10.1203/01.pdr.0000242299.01219.6a; Burns JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021888; Castrechini NM, 2010, PLACENTA, V31, P203, DOI 10.1016/j.placenta.2009.12.006; Castrechini NM, 2012, REPROD SCI; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fierabracci A, 2015, EXPERT OPIN BIOL TH, P1; Fitzpatrick LE, 2015, BIOMATER SCI-UK, V3, P12, DOI [10.1039/C4BM00246F, 10.1039/c4bm00246f]; Haddad R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/216806; Heath DE, 2015, LAB CHIP, V15, P2073, DOI 10.1039/c4lc01416b; Heath DE, 2012, ACTA BIOMATER, V8, P2899, DOI 10.1016/j.actbio.2012.03.052; Heath DE, 2010, J BIOMED MATER RES A, V94A, P1195, DOI 10.1002/jbm.a.32802; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jung S., 2012, STEM CELLS INT, V2012, DOI [DOI 10.1155/2012/123030, 10.1155/2012/123030]; Kanematsu D, 2011, DIFFERENTIATION, V82, P77, DOI 10.1016/j.diff.2011.05.010; Kusuma GD, 2015, PLACENTA, V36, P312, DOI 10.1016/j.placenta.2014.12.014; Kusuma GD, 2016, STEM CELL REV REP, V12, P285, DOI 10.1007/s12015-016-9649-5; Kusuma GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141246; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Londono R, 2015, ANN BIOMED ENG, V43, P577, DOI 10.1007/s10439-014-1103-8; Marcantonio NA, 2009, BIOMATERIALS, V30, P4629, DOI 10.1016/j.biomaterials.2009.05.061; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Ng CP, 2014, BIOMATERIALS, V35, P4046, DOI 10.1016/j.biomaterials.2014.01.081; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pattabhi SR, 2014, DIFFERENTIATION, V88, P131, DOI 10.1016/j.diff.2014.12.005; Qin SQ, 2016, PLACENTA, V39, P134, DOI 10.1016/j.placenta.2016.01.018; Rakian R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0235-6; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang X, 2012, J BIOMED MATER RES A, V100A, P794, DOI 10.1002/jbm.a.34026; Whitfield MJ, 2013, STEM CELL RES, V11, P1365, DOI 10.1016/j.scr.2013.09.004; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436	46	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171488	10.1371/journal.pone.0171488	http://dx.doi.org/10.1371/journal.pone.0171488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152107	gold, Green Published			2022-12-27	WOS:000396161200146
J	Zhang, RS; Qi, H; Sun, YZ; Xiao, S; Lim, BL				Zhang, Renshan; Qi, Hua; Sun, Yuzhe; Xiao, Shi; Lim, Boon Leong			Transgenic Arabidopsis thaliana containing increased levels of ATP and sucrose is more susceptible to Pseudomonas syringae	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; NUCLEOTIDE-BINDING SITE; GATED ION-CHANNEL; INNATE IMMUNITY; MICROBIAL PATHOGENS; SIGNALING PATHWAYS; DEFENSE RESPONSES; SALICYLIC-ACID; FITNESS COSTS; CROSS-TALK	Disease resistance exerts a fitness cost on plants, presumably due to the extra consumption of energy and carbon. In this study, we examined whether transgenic Arabidopsis thaliana with increased levels of ATP and sucrose is more resistant or susceptible to pathogen infection. Lines of A. thaliana over-expressing purple acid phosphatase 2 (AtPAP2) (OE lines) contain increased levels of ATP and sucrose, with improved growth rate and seed production. Compared to wild type (WT) and pap2 lines, the OE lines were more susceptible to several Pseudomonas syringae pv. tomato (Pst) strains carrying AvrRpm1, AvrRpt2 AvrRps4, AvrPtoB, HrcC and WT strain DC3000. The increased susceptibility of the OE lines to Pst strains cannot solely be attributed to the suppressed expression of R-genes but must also be attributed to the suppression of downstream signaling components, such as MOS2, EDS1 and EDS5. Before infection, the levels of salicylic acid (SA) and jasmonic acid (JA) precursor OPDA were similar in the leaves of OE, pap2 and WT plants, whereas the levels of JA and its derivative JA-Ile were significantly lower in the leaves of OE lines and higher in the pap2 line. The expression of JA marker defense gene PDF1.2 was up-regulated in the OE lines compared to the WT prior to Pst DC3000 infection, but its expression was lower in the OE lines after infection. In summary, high fitness Arabidopsis thaliana exhibited altered JA metabolism and broad suppression of R-genes and downstream genes as well as a higher susceptibility to Pst infections.	[Zhang, Renshan; Sun, Yuzhe; Lim, Boon Leong] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Qi, Hua; Xiao, Shi] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Qi, Hua; Xiao, Shi] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Lim, Boon Leong] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Zhang, Renshan] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China	University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lim, BL (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.; Lim, BL (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	bllim@hku.hk	; Lim, Boon Leong/D-3104-2009	Zhang, Renshan/0000-0002-5705-8030; Lim, Boon Leong/0000-0002-2720-2353	Woo Ting Sang Agricultural Development Research Fund; General Research Fund [HKU772012M]; Innovation and Technology Fund of the HKSAR	Woo Ting Sang Agricultural Development Research Fund; General Research Fund; Innovation and Technology Fund of the HKSAR	This work was supported by the Woo Ting Sang Agricultural Development Research Fund, the General Research Fund (HKU772012M) and the Innovation and Technology Fund (Funding Support to Partner State Key Laboratories in Hong Kong) of the HKSAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Brouwer M, 2003, FEMS MICROBIOL LETT, V228, P241, DOI 10.1016/S0378-1097(03)00759-6; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; CRUTE I, 1994, MONOGRAPH COLD SPRIN, V27, P705; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Law YS, 2015, PLANT PHYSIOL, V169, P1344, DOI 10.1104/pp.15.01115; Liang C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00922; Liang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-116; Lin NC, 2007, MOL PLANT MICROBE IN, V20, P806, DOI 10.1094/MPMI-20-7-0806; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Monaghan J, 2010, CAN J PLANT PATHOL, V32, P35, DOI 10.1080/07060661003621001; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Murillo I, 2003, PLANT J, V36, P330, DOI 10.1046/j.1365-313X.2003.01880.x; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; PRIMACK RB, 1989, ANNU REV ECOL SYST, V20, P367, DOI 10.1146/annurev.es.20.110189.002055; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Shirano Y, 2002, PLANT CELL, V14, P3149, DOI 10.1105/tpc.005348; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Sun F, 2013, BMC GENOMICS, P14; Sun F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-752; Sun F, 2012, PLANT SIGNAL BEHAV, V7, P927, DOI 10.4161/psb.20769; Sun F, 2012, NEW PHYTOL, V194, P206, DOI 10.1111/j.1469-8137.2011.04026.x; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Thibaud MC, 2004, PLANT PHYSIOL BIOCH, V42, P81, DOI 10.1016/j.plaphy.2003.10.012; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Vila-Aiub MM, 2015, WEED SCI, V63, P203, DOI 10.1614/WS-D-14-00062.1; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wasternack C, 2002, PROG NUCLEIC ACID RE, V72, P165, DOI 10.1016/S0079-6603(02)72070-9; Zhang RS, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1239687; Zhang YL, 2005, CURR BIOL, V15, P1936, DOI 10.1016/j.cub.2005.09.038; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	55	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171040	10.1371/journal.pone.0171040	http://dx.doi.org/10.1371/journal.pone.0171040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152090	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200078
J	Adams, EJ; Esliger, DW; Taylor, IM; Sherar, LB				Adams, Emma J.; Esliger, Dale W.; Taylor, Ian M.; Sherar, Lauren B.			Individual, employment and psychosocial factors influencing walking to work: Implications for intervention design	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; ACTIVE TRAVEL; HEALTH-PROMOTION; PLANNED BEHAVIOR; WORKPLACE TRAVEL; BLOOD-PRESSURE; RISK-FACTORS; ILL HEALTH; ADULTS; METAANALYSIS	Background Promoting walking for the journey to and from work (commuter walking) is a potential strategy for increasing physical activity. Understanding the factors influencing commuter walking is important for identifying target groups and designing effective interventions. This study aimed to examine individual, employment-related and psychosocial factors associated with commuter walking and to discuss the implications for targeting and future design of interventions. Methods 1,544 employees completed a baseline survey as part of the 'Walking Works' intervention project (33.4% male; 36.3% aged < 30 years). Multivariate logistic regression was used to examine the associations of individual (age, ethnic group, educational qualifications, number of children < 16 and car ownership), employment-related (distance lived from work, free car parking at work, working hours, working pattern and occupation) and psychosocial factors (perceived behavioural control, intention, social norms and social support from work colleagues) with commuter walking. Results Almost half of respondents (n = 587, 49%) were classified as commuter walkers. Those who were aged < 30 years, did not have a car, had no free car parking at work, were confident of including some walking or intended to walk to or from work on a regular basis, and had support from colleagues for walking were more likely to be commuter walkers. Those who perceived they lived too far away from work to walk, thought walking was less convenient than using a car for commuting, did not have time to walk, needed a car for work or had always travelled the same way were less likely to be commuter walkers. Conclusions A number of individual, employment-related and psychosocial factors were associated with commuter walking. Target groups for interventions to promote walking to and from work may include those in older age groups and those who own or have access to a car. Multilevel interventions targeting individual level behaviour change, social support within the workplace and organisational level travel policies may be required in order to promote commuter walking.	[Adams, Emma J.; Esliger, Dale W.; Taylor, Ian M.; Sherar, Lauren B.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Sport & Exercise Med, Loughborough, Leics, England	Loughborough University	Adams, EJ (corresponding author), Univ Loughborough, Sch Sport Exercise & Hlth Sci, Natl Ctr Sport & Exercise Med, Loughborough, Leics, England.	e.j.adams@lboro.ac.uk		Adams, Emma J/0000-0002-5444-6951	Big Lottery Fund's Wellbeing Programme [WB/2/010250147]	Big Lottery Fund's Wellbeing Programme	EA was commissioned by Living Streets (www.livingstreets.org.uk) to undertake an independent evaluation of the Walking Works Pathfinder Employers Scheme. The Walking Works project was managed and delivered by Living Streets as part of a portfolio of projects being delivered by a consortium of the leading walking, cycling and health organisations in England and funded through the Big Lottery Fund's Wellbeing Programme (www.biglotteryfund.org.uk) (Grant number WB/2/010250147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2012, EVALUATION LIVING ST; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Altman DG., 1999, PRACTICAL STAT MED R; Arnott B, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0133-9; Audrey S, 2015, PUBLIC HEALTH RESEAR, V3, DOI [10.3310/phr03040, DOI 10.3310/phr03040]; Audrey S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-37; Bird EL, 2013, HEALTH PSYCHOL, V32, P829, DOI 10.1037/a0032078; Bopp M, 2014, J AGING PHYS ACTIV, V22, P199, DOI [10.1123/JAPA.2012-0236, 10.1123/japa.2012-0236]; Bopp M, 2013, AM J HEALTH BEHAV, V37, P543, DOI 10.5993/AJHB.37.4.12; Bopp M, 2012, PREV MED, V54, P237, DOI 10.1016/j.ypmed.2012.01.016; Breslow L, 1996, AM J HEALTH PROMOT, V10, P253, DOI 10.4278/0890-1171-10.4.253; Brockman R, 2011, PUBLIC HEALTH, V125, P210, DOI 10.1016/j.puhe.2011.01.005; Cairns S, 2010, TRANSPORT RES A-POL, V44, P473, DOI 10.1016/j.tra.2010.03.010; Campbell ME, 2013, J PUBLIC HEALTH MAN, V19, P521, DOI 10.1097/PHH.0b013e31828a83e6; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig R, 2013, HLTH SURVEY ENGLAND; Dalton AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067575; de Bruijn GJ, 2009, AM J PREV MED, V36, P189, DOI 10.1016/j.amepre.2008.10.019; Department for Transport, 2015, NAT TRAV SURV ENGL 2; Department for Transport, 2004, WALK CYCL ACT PLAN; Department of Health, 2011, START ACT STAY ACT R; Flint E, 2016, LANCET DIABETES ENDO, V4, P420, DOI 10.1016/S2213-8587(16)00053-X; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Krizek KJ, 2009, ENVIRON PLANN B, V36, P725, DOI 10.1068/b34023; Kwasniewska M, 2010, PREV MED, V50, P257, DOI 10.1016/j.ypmed.2010.02.011; Laverty AA, 2013, AM J PREV MED, V45, P282, DOI 10.1016/j.amepre.2013.04.012; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee LL, 2010, INT J NURS STUD, V47, P1545, DOI 10.1016/j.ijnurstu.2010.08.008; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lemieux M, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-12; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Martin A, 2014, PREV MED, V69, P296, DOI 10.1016/j.ypmed.2014.08.023; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Murtagh EM, 2015, PREV MED, V72, P34, DOI 10.1016/j.ypmed.2014.12.041; Office for National Statistics, 2011, METH TRAV WORK ENGL; Office for National Statistics, 2016, LAB MARK STAT; Oja P, 1998, PATIENT EDUC COUNS, V33, pS87, DOI 10.1016/S0738-3991(98)00013-5; Panter J, 2013, PREV MED, V57, P776, DOI 10.1016/j.ypmed.2013.07.020; Panter J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-124; Panter JR, 2010, J PHYS ACT HEALTH, V7, P551, DOI 10.1123/jpah.7.4.551; Petrunoff N, 2015, J TRANSP HEALTH, V2, P563, DOI 10.1016/j.jth.2015.06.007; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Robertson R., 2012, MENT HEALTH PHYS ACT, V5, P66, DOI DOI 10.1016/J.MHPA.2012.03.002; Sahlqvist S, 2012, PREV MED, V55, P206, DOI 10.1016/j.ypmed.2012.06.028; Sallis JF, 1998, AM J PREV MED, V15, P379, DOI 10.1016/S0749-3797(98)00076-2; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Yang L, 2012, PREV MED, V55, P453, DOI 10.1016/j.ypmed.2012.08.019	55	16	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171374	10.1371/journal.pone.0171374	http://dx.doi.org/10.1371/journal.pone.0171374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182714	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800057
J	Haft, DR; Haft, DH				Haft, David Renfrew; Haft, Daniel H.			A comprehensive software suite for protein family construction and functional site prediction	PLOS ONE			English	Article							COMPARATIVE GENOMICS; MICROBIOLOGY; ANNOTATION	In functionally diverse protein families, conservation in short signature regions may outperform full-length sequence comparisons for identifying proteins that belong to a subgroup within which one specific aspect of their function is conserved. The SIMBAL workflow (Sites Inferred by Metabolic Background Assertion Labeling) is a data-mining procedure for finding such signature regions. It begins by using clues from genomic context, such as co-occurrence or conserved gene neighborhoods, to build a useful training set from a large number of uncharacterized but mutually homologous proteins. When training set construction is successful, the YES partition is enriched in proteins that share function with the user's query sequence, while the NO partition is depleted. A selected query sequence is then mined for short signature regions whose closest matches overwhelmingly favor proteins from the YES partition. High-scoring signature regions typically contain key residues critical to functional specificity, so proteins with the highest sequence similarity across these regions tend to share the same function. The SIMBAL algorithm was described previously, but significant manual effort, expertise, and a supporting software infrastructure were required to prepare the requisite training sets. Here, we describe a new, distributable software suite that speeds up and simplifies the process for using SIMBAL, most notably by providing tools that automate training set construction. These tools have broad utility for comparative genomics, allowing for flexible collection of proteins or protein domains based on genomic context as well as homology, a capability that can greatly assist in protein family construction. Armed with this new software suite, SIMBAL can serve as a fast and powerful in silico alternative to direct experimentation for characterizing proteins and their functional interactions.	[Haft, David Renfrew] J Craig Venter Inst, Rockville, MD USA; [Haft, Daniel H.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Haft, DH (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	daniel.haft@nih.gov			National Science Foundationunder [1458808]; Div Of Biological Infrastructure [1458808] Funding Source: National Science Foundation	National Science Foundationunder(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundationunder Grant No.1458808 to the J.Craig Venter Institute and by the Intramural Research Program of the NIH, National Library of Medicine. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Basu MK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-434; Bruender NA, 2016, BIOCHEMISTRY-US, V55, P2122, DOI 10.1021/acs.biochem.6b00145; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; Haft DH, 2015, CURR OPIN MICROBIOL, V23, P189, DOI 10.1016/j.mib.2014.11.017; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Haft DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028886; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2005, BIOINFORMATICS, V21, P293, DOI 10.1093/bioinformatics/bti015; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Selengut JD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-52; Sikic K, 2010, BIOINFORMATION, V5, P234, DOI 10.6026/97320630005234; Szklarczyk D., 2016, NUCL ACIDS RES	22	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171758	10.1371/journal.pone.0171758	http://dx.doi.org/10.1371/journal.pone.0171758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182651	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800102
J	Gucluler, G; Adiguzel, E; Gungor, B; Kahraman, T; Gursel, M; Yilmaz, B; Gursel, I				Gucluler, Gozde; Adiguzel, Emre; Gungor, Bilgi; Kahraman, Tamer; Gursel, Mayda; Yilmaz, Bilge; Gursel, Ihsan			Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; CHRONIC INFLAMMATION; PATTERN-RECOGNITION; INNATE IMMUNITY; SYSTEM FUNCTION; MORTALITY; SCI	Reduced immune activation or immunosuppression is seen in patients withneurological diseases. Urinary and respiratory infections mainly manifested as septicemia and pneumonia are the most frequent complications following spinal cord injuries and they account for the majority of deaths. The underlying reason of these losses is believed to arise due to impaired immune responses to pathogens. Here, we hypothesized that susceptibility to infections of chronic spinal cord injured (SCI) patients might be due to impairment in recognition of pathogen associated molecular patterns and subsequently declining innate and adaptive immune responses that lead to immune dysfunction. We tested our hypothesis on healthy and chronic SCI patients with a level of injury above T-6. Donor PBMCs were isolated and stimulated with different toll like receptor ligands and T-cell inducers aiming to investigate whether chronic SCI patients display differential immune activation to multiple innate and adaptive immune cell stimulants. We demonstrate that SCI patients' B-cell and plasmacytoid dendritic cells retain their functionality in response to TLR7 and TLR9 ligand stimulation as they secreted similar levels of IL6 and IFN alpha. The immune dysfunction is not probably due to impaired T-cell function, since neither CD4(+) T-cell dependent IFN. producing cell number nor IL10 producing regulatory T-cells resulted different outcomes in response to PMA-Ionomycin and PHA-LPS stimulation, respectively. We showed that TLR7 dependent IFN gamma and IP10 levels and TLR9 mediated APC function reduced substantially in SCI patients compared to healthy subjects. More importantly, IP10 producing monocytes were significantly fewer compared to healthy subjects in response to TLR7 and TLR9 stimulation of SCI PBMCs. When taken together this work implicated that these defects could contribute to persistent complications due to increased susceptibility to infections of chronic SCI patients.	[Gucluler, Gozde; Kahraman, Tamer; Gursel, Ihsan] Bilkent Univ, Dept Mol Biol & Genet, THORLAB, Ankara, Turkey; [Adiguzel, Emre; Yilmaz, Bilge] Gaziler Phys Med & Rehabil Educ & Res Hosp, Ankara, Turkey; [Gungor, Bilgi; Gursel, Mayda] Middle East Tech Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Yilmaz, Bilge] Univ Hlth Sci, Gaziler Phys Med & Rehabil Educ & Res Hosp, Dept Phys Med & Rehabil, Gulhane Med Sch, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Gaziler Physical Therapy & Research Hospital; Middle East Technical University; Gaziler Physical Therapy & Research Hospital; University of Health Sciences Turkey	Gursel, I (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, THORLAB, Ankara, Turkey.; Yilmaz, B (corresponding author), Gaziler Phys Med & Rehabil Educ & Res Hosp, Ankara, Turkey.; Yilmaz, B (corresponding author), Univ Hlth Sci, Gaziler Phys Med & Rehabil Educ & Res Hosp, Dept Phys Med & Rehabil, Gulhane Med Sch, Ankara, Turkey.	biyilmaz@gata.edu.tr; ihsangursel@bilkent.edu.tr	YILMAZ, Bilge/A-7428-2013; Gursel, Ihsan/AAT-7168-2021; YILMAZ, Bilge/W-6481-2019; Gursel, M/H-1812-2012; Adiguzel, Emre/G-9138-2015	YILMAZ, Bilge/0000-0003-1173-9399; YILMAZ, Bilge/0000-0003-1173-9399; Gursel, M/0000-0003-0044-9054; Kahraman, Tamer/0000-0002-5527-7336; Gursel, Ihsan/0000-0003-3761-1166; Adiguzel, Emre/0000-0002-2447-5065	Bilkent University	Bilkent University(Ihsan Dogramaci Bilkent University)	This study is partly supported by Bilkent University account to IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DJ, 2015, SPINAL CORD, V53, P14, DOI 10.1038/sc.2014.184; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; Campagnolo D I, 2000, J Spinal Cord Med, V23, P121; CAMPAGNOLO DI, 1994, AM J PHYS MED REHAB, V73, P387, DOI 10.1097/00002060-199411000-00003; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Fallarino F, 2016, METHODS MOL BIOL, V1390, P383, DOI 10.1007/978-1-4939-3335-8_23; Gibson AE, 2008, SPINAL CORD, V46, P616, DOI 10.1038/sc.2008.32; Held KS, 2010, EXP NEUROL, V226, P242, DOI 10.1016/j.expneurol.2010.08.036; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Liang HF, 2008, ARCH PHYS MED REHAB, V89, P36, DOI 10.1016/j.apmr.2007.08.121; Lidal IB, 2007, J REHABIL MED, V39, P145, DOI 10.2340/16501977-0017; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171003	10.1371/journal.pone.0171003	http://dx.doi.org/10.1371/journal.pone.0171003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170444	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500018
J	Vaze, ND; Park, S; Brooks, AD; Fridman, A; Joshi, SG				Vaze, Nachiket D.; Park, Sin; Brooks, Ari D.; Fridman, Alexander; Joshi, Suresh G.			Involvement of multiple stressors induced by non-thermal plasma-charged aerosols during inactivation of airborne bacteria	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BARRIER DISCHARGE PLASMA; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; MOLECULAR EPIDEMIOLOGY; RAPID INACTIVATION; HYPOCHLOROUS ACID; OXYR	A lab-scale, tunable, single-filament, point-to-point nonthermal dieletric-barrier discharge (DBD) plasma device was built to study the mechanisms of inactivation of aerosolized bacterial pathogens. The system inactivates airborne antibiotic-resistant pathogens efficiently. Nebulization mediated pre-optimized (4 log and 7 log) bacterial loads were challenged to plasma-charged aerosols, and lethal and sublethal doses determined using colony assay, and cell viability assay; and the loss of membrane potential and cellular respiration were determined using cell membrane potential assay and XTT assay. Using the strategies of Escherichia coli wildtype, over-expression mutant, deletion mutants, and peroxide and heat stress scavenging, we analyzed activation of intracellular reactive oxygen species (ROS) and heat shock protein (hsp) chaperons. Superoxide dismutase deletion mutants (Delta sodA, Delta sodB, Delta sodA Delta sodB) and catalase mutants Delta katG and Delta katE Delta katG did not show significant difference from wildtype strain, and Delta katE and Delta ahpC was found significantly more susceptible to cell death than wildtype. The oxyR regulon was found to mediate plasma-charged aerosol-induced oxidative stress in bacteria. Hsp deficient E. coli (Delta htpG, Delta groEL, Delta cIpX, Delta grpE) showed complete inactivation of cells at ambient temperature, and the treatment at cold temperature (4 degrees C) significantly protected hsp deletion mutants and wildtype cells, and indicate a direct involvement of hsp in plasma-charged aerosol mediated E. coli cell death.	[Vaze, Nachiket D.; Brooks, Ari D.; Fridman, Alexander; Joshi, Suresh G.] Drexel Univ, Coll Med, Ctr Surg Infect & Biofilm, Philadelphia, PA 19104 USA; [Vaze, Nachiket D.; Joshi, Suresh G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Park, Sin; Fridman, Alexander; Joshi, Suresh G.] Drexel Univ, AJ Drexel Plasma Inst, Philadelphia, PA 19104 USA; [Vaze, Nachiket D.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Brooks, Ari D.] Univ Penn Hlth Syst, Dept Surg, Philadelphia, PA USA	Drexel University; Drexel University; Drexel University; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania	Joshi, SG (corresponding author), Drexel Univ, Coll Med, Ctr Surg Infect & Biofilm, Philadelphia, PA 19104 USA.; Joshi, SG (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.; Joshi, SG (corresponding author), Drexel Univ, AJ Drexel Plasma Inst, Philadelphia, PA 19104 USA.	suresh.joshi@drexelmed.edu	Joshi, Suresh G./AAT-1354-2021	Joshi, Suresh G./0000-0002-7838-4898	Drexel University College of Medicine for Surgical Infection Control Research	Drexel University College of Medicine for Surgical Infection Control Research	This research was carried out through intramural research support from the Drexel University College of Medicine for Surgical Infection Control Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos J, 2013, MOL MICROBIOL, V90, P167, DOI 10.1111/mmi.12356; AMBROSIO G, 1992, CARDIOVASC DRUG THER, V6, P623, DOI 10.1007/BF00052564; Arjunan KP, 2011, IEEE ENG MED BIO, P2447, DOI 10.1109/IEMBS.2011.6090680; Asad NR, 1998, MUTAT RES-DNA REPAIR, V407, P253, DOI 10.1016/S0921-8777(98)00010-X; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; COOMBS AML, 1987, INT J RADIAT BIOL, V51, P493, DOI 10.1080/09553008714550971; Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Dukan S, 1996, J BACTERIOL, V178, P6145, DOI 10.1128/jb.178.21.6145-6150.1996; Eduard W, 1998, AM IND HYG ASSOC J, V59, P113, DOI 10.1080/15428119891010370; Gallagher MJ, 2007, IEEE T PLASMA SCI, V35, P1501, DOI 10.1109/TPS.2007.905209; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Guan TJ, 2010, J AEROSOL SCI, V41, P611, DOI 10.1016/j.jaerosci.2010.03.002; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hwang D, 2015, SCI REP-UK, V5, DOI 10.1038/srep10029; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; JUOZAITIS A, 1994, APPL ENVIRON MICROB, V60, P861, DOI 10.1128/AEM.60.3.861-870.1994; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim NH, 2006, J BIOCHEM MOL BIOL, V39, P452; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Liang JL, 2012, J AEROSOL SCI, V54, P103, DOI 10.1016/j.jaerosci.2012.07.009; Liang YD, 2012, ENVIRON SCI TECHNOL, V46, P3360, DOI 10.1021/es203770q; McCormick ML, 1998, J BACTERIOL, V180, P622, DOI 10.1128/JB.180.3.622-625.1998; McDonald KF, 2002, IEEE T PLASMA SCI, V30, P1986, DOI 10.1109/TPS.2002.805378; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Moritz M, 2001, INT J HYG ENVIR HEAL, V203, P401, DOI 10.1078/1438-4639-00054; Nair N, 2011, INFECT CONT HOSP EP, V32, P1057, DOI 10.1086/662178; Noor R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1415-7; OGG JE, 1956, J BACTERIOL, V72, P494, DOI 10.1128/JB.72.4.494-496.1956; Panek HR, 2004, J BACTERIOL, V186, P7874, DOI 10.1128/JB.186.23.7874-7880.2004; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Schmid S, 2013, J HAZARD MATER, V256, P76, DOI 10.1016/j.jhazmat.2013.04.021; SCHWARTZ CE, 1983, J BIOL CHEM, V258, P6277; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shi Xing-min, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2033; Theodore A, 2013, GENETICS; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Uhlich GA, 2009, MICROBIOL-SGM, V155, P3589, DOI 10.1099/mic.0.031435-0; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P31, DOI 10.1016/j.vetmic.2008.09.042; VANDERHEIDE RS, 1987, J MOL CELL CARDIOL, V19, P615, DOI 10.1016/S0022-2828(87)80367-X; Vaze ND, 2010, IEEE T PLASMA SCI, V38, P3234, DOI 10.1109/TPS.2010.2072788; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Warnes SL, 2012, ENVIRON MICROBIOL, V14, P1730, DOI 10.1111/j.1462-2920.2011.02677.x; WASIL M, 1987, BIOCHEM J, V243, P867, DOI 10.1042/bj2430867; Weir SK, 2012, J CLIN MICROBIOL, V50, P3283, DOI 10.1128/JCM.01143-12; Yamazaki H, 2011, DENT MATER J, V30, P384, DOI 10.4012/dmj.2010-190; Yao M, 2005, ENVIRON SCI TECHNOL, V39, P3338, DOI 10.1021/es048808x; Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297; Yost AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139903; Zerrouki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116083; Zhang Q, 2010, J AEROSOL SCI, V41, P880, DOI 10.1016/j.jaerosci.2010.06.001	59	19	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171434	10.1371/journal.pone.0171434	http://dx.doi.org/10.1371/journal.pone.0171434			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166240	gold, Green Submitted, Green Published			2022-12-27	WOS:000393700100042
J	Vijayakumar, P; Hoyer, A; Nelson, RG; Brinks, R; Pavkov, ME				Vijayakumar, Pavithra; Hoyer, Annika; Nelson, Robert G.; Brinks, Ralph; Pavkov, Meda E.			Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes	PLOS ONE			English	Article							PIMA-INDIANS; RISK-FACTORS; ESRD; ALBUMINURIA; POPULATION; ANTIBODIES; REMISSION; MELLITUS	The objective was to estimate chronic kidney disease (CKD) incidence rates from prevalence and mortality data, and compare the estimates with observed (true) incidence rates in a well-characterized population with diabetes. Pima Indians aged 20 years and older with type 2 diabetes were followed from 1982 through 2007. CKD was defined by estimated GFR (eGFR) <60 ml/min/1.72 m(2) or albumin-to-creatinine ratio (ACR) >= 30 mg/g. True CKD incidence and mortality rates were computed for the whole study period, and prevalence for the intervals 1982-1994 and 1995-2007. Estimated age-sex stratified CKD incidence rates were computed using illness-death models of the observed prevalences, and of the whole period mortality rate ratio of CKD to non-CKD persons. Among 1201 participants, 616 incident events of CKD occurred during a median follow-up of 5.6 years. Observed CKD prevalence was 56.9% (95%X153.7-60.0) and 48.0% (95%X145.2-50.8) in women; 54.0% (95% CI 49.9-58.1) and 49.6% (95%C 46.0-53.3) in men, across the two periods. Mortality rate was 2.5 (95%CI 11.9-3.3) times as high in women with CKD and 1.6 (95%Cl 1.3-2.1) times as high in men with CKD, compared to women or men without CKD. In women, estimated CKD incidence increased linearly from 25.6 (95%CI14.2-53.0) to 128.6 (95%CI177.1-196.6) with each 5-year age group up to 69 years, and to 99.8 (95% CI 38.7-204.7) at age >= 70. In men, estimated CKD incidence increased form 28.5 (95% CI13.8-71.2) at age 20-24 years to 118.7 (95%CI123.6-336.7) at age >= 70. Age-sex-stratified estimated incidence reflected the magnitude and directional trend of the true incidence and were similar to the true incidence rates (p>0.05 for difference) except for age 20-24 in women (p = 0.008) and age 2529 in men (p = 0.002). In conclusion, the estimated and observed incidence rates of CKD agree well over 25 years of observation in this well characterized population with type 2 diabetes.	[Vijayakumar, Pavithra; Nelson, Robert G.] NIDDK, NIH, Phoenix, AZ USA; [Hoyer, Annika; Brinks, Ralph] German Diabet Ctr Duesseldorf, Inst Epidemiol & Biometry, Dusseldorf, Germany; [Pavkov, Meda E.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA; [Pavkov, Meda E.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Deutsches Diabetes-Zentrum (DDZ); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Pavkov, ME (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA.; Pavkov, ME (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	mpavkov@cdc.gov		Pavkov, Meda/0000-0002-6203-1772	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069062] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The authors received no specific funding for this work. There was no additional external funding received for this study.	Araki S, 2005, DIABETES, V54, P2983, DOI 10.2337/diabetes.54.10.2983; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Brinks R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152046; Brinks R, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0094-y; Brinks R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118955; Brinks R, 2013, STAT MED, V32, P2070, DOI 10.1002/sim.5651; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; CHASSON A L, 1960, Tech Bull Regist Med Technol, V30, P207; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dabelea D, 1999, DIABETOLOGIA, V42, P1265; Gaede P, 2004, NEPHROL DIAL TRANSPL, V19, P2784, DOI 10.1093/ndt/gfh470; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Hanson RL, 1997, DIABETES S1, V46, pA51; JANSSEN RC, 1994, DIABETES, V43, P558, DOI 10.2337/diabetes.43.4.558; KEIDING N, 1989, AM J EPIDEMIOL, V130, P588, DOI 10.1093/oxfordjournals.aje.a115373; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KNOWLER WC, 1979, DIABETOLOGIA, V17, P161, DOI 10.1007/BF01219743; Landwehr S, 2016, STAT MED, V35, P768, DOI 10.1002/sim.6736; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Muller YHL, 2005, DIABETES, V54, P3035, DOI 10.2337/diabetes.54.10.3035; Pavkov ME, 2008, AM J KIDNEY DIS, V51, P759, DOI 10.1053/j.ajkd.2008.01.011; Pavkov ME, 2007, DIABETES CARE, V30, P1758, DOI 10.2337/dc06-2010; Rebholz CM, 2015, AM J KIDNEY DIS, V66, P231, DOI 10.1053/j.ajkd.2015.01.016; Salinero-Fort MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122030; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; United States Renal Data System, 2015, 2015 USRDS ANN DAT R	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171027	10.1371/journal.pone.0171027	http://dx.doi.org/10.1371/journal.pone.0171027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166298	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100020
J	Ji, JP; Zhang, YP; Redon, CE; Reinhold, WC; Chen, AP; Fogli, LK; Holbeck, SL; Parchment, RE; Hollingshead, M; Tomaszewski, JE; Dudon, Q; Pommier, Y; Doroshow, JH; Bonner, WM				Ji, Jiuping; Zhang, Yiping; Redon, Christophe E.; Reinhold, William C.; Chen, Alice P.; Fogli, Laura K.; Holbeck, Susan L.; Parchment, Ralph E.; Hollingshead, Melinda; Tomaszewski, Joseph E.; Dudon, Quentin; Pommier, Yves; Doroshow, James H.; Bonner, William M.			Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; HISTONE VARIANTS; STRAND BREAKS; LINE SET; PHASE-I; GAMMA-H2AX; REPAIR; INHIBITOR; XENOGRAFTS; OLAPARIB	Phosphorylated H2AX (gamma-H2AX) is a sensitive marker for DNA double-strand breaks (DSBs), but the variability of H2AX expression in different cell and tissue types makes it difficult to interpret the meaning of the gamma-H2AX level. Furthermore, the assays commonly used for gamma-H2AX detection utilize laborious and low-throughput microscopy-based methods. We describe here an ELISA assay that measures both phosphorylated H2AX and total H2AX absolute amounts to determine the percentage of gamma-H2AX, providing a normalized value representative of the amount of DNA damage. We demonstrate the utility of the assay to measure DSBs introduced by either ionizing radiation or DNA-damaging agents in cultured cells and in xenograft models. Furthermore, utilizing the NCI-60 cancer cell line panel, we show a correlation between the basal fraction of gamma-H2AX and cellular mutation levels. This additional application highlights the ability of the assay to measure gamma-H2AX levels in many extracts at once, making it possible to correlate findings with other cellular characteristics. Overall, the gamma-H2AX ELISA represents a novel approach to quantifying DNA damage, which may lead to a better understanding of mutagenic pathways in cancer and provide a useful biomarker for monitoring the effectiveness of DNA-damaging anticancer agents.	[Ji, Jiuping; Zhang, Yiping; Parchment, Ralph E.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Frederick, MD 21701 USA; [Redon, Christophe E.; Reinhold, William C.; Dudon, Quentin; Pommier, Yves; Doroshow, James H.; Bonner, William M.] NCI, Dev Therapeut Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Chen, Alice P.] NCI, Early Clin Trials Dev Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Fogli, Laura K.; Holbeck, Susan L.; Hollingshead, Melinda; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, JP (corresponding author), Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Appl Dev Res Directorate, Frederick, MD 21701 USA.	jijiupi@mail.nih.gov	Chen, Alice/AAG-9400-2020; Reinhold, William/J-6704-2017	Chen, Alice/0000-0002-1426-853X; Reinhold, William/0000-0001-5513-9323	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program at the Center for Cancer Research at National Cancer Institute [Z01BC006150]; Radiation and Nuclear Countermeasures Program at the National Institute of Allergy and Infectious Diseases; federal government; Kelly Government Solutions, a division of Kelly Services; NATIONAL CANCER INSTITUTE [ZIABC011078] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program at the Center for Cancer Research at National Cancer Institute; Radiation and Nuclear Countermeasures Program at the National Institute of Allergy and Infectious Diseases; federal government; Kelly Government Solutions, a division of Kelly Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was also supported by the Intramural Research Program at the Center for Cancer Research at National Cancer Institute [Z01BC006150] and by the Radiation and Nuclear Countermeasures Program at the National Institute of Allergy and Infectious Diseases. The Frederick National Laboratory for Cancer Research, which is funded by the federal government and operated by Leidos Biomedical Research, Inc., provided support in the form of salaries for authors J.J., Y.Z., and R.E.P. Leidos Biomedical Research, Inc., is prime contractor for the operation of Frederick National Laboratory and is therefore precluded from conducting any business that represents a conflict of interest with this contract. L.K.F., who is a government contractor at the National Cancer Institute, received support in the form of a salary from Kelly Government Solutions, a division of Kelly Services. The specific roles of all authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antony S, 2005, MOL PHARMACOL, V67, P523, DOI 10.1124/mol.104.003889; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belin BJ, 2015, ELIFE, V4, DOI [10.7554/eLife.07735, 10.7554/eLife.11935]; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bourton EC, 2012, CYTOM PART A, V81A, P130, DOI 10.1002/cyto.a.21171; Chen EX, 2016, INVEST NEW DRUG, V34, P450, DOI 10.1007/s10637-016-0351-x; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; DINCALCI M, 1986, EUR J BIOCHEM, V154, P273, DOI 10.1111/j.1432-1033.1986.tb09393.x; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Ferry-Galow KV, 2016, SEMIN ONCOL, V43, P492, DOI 10.1053/j.seminoncol.2016.06.007; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hehlgans S, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0507-4; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jeggo PA, 2016, NAT REV CANCER, V16, P35, DOI 10.1038/nrc.2015.4; Ji JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026152; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kinders RJ, 2010, CLIN CANCER RES, V16, P5447, DOI 10.1158/1078-0432.CCR-09-3076; Kummar S, 2011, CANCER RES, V71, P5626, DOI 10.1158/0008-5472.CAN-11-1227; Matsuzaki K, 2010, MUTAT RES-GEN TOX EN, V700, P71, DOI 10.1016/j.mrgentox.2010.05.009; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Redon CE, 2012, BBA-GENE REGUL MECH, V1819, P743, DOI 10.1016/j.bbagrm.2012.02.021; Redon CE, 2011, AGING-US, V3, P168, DOI 10.18632/aging.100284; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Reinhold WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101670; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Samol J, 2012, INVEST NEW DRUG, V30, P1493, DOI 10.1007/s10637-011-9682-9; Schettino Clorinda, 2008, Expert Rev Respir Med, V2, P167, DOI 10.1586/17476348.2.2.167; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shinagawa T, 2014, CELL STEM CELL, V14, P217, DOI 10.1016/j.stem.2013.12.015; Singh R, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9095-4; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Tahara M, 2014, MOL CANCER THER, V13, P1170, DOI 10.1158/1535-7163.MCT-13-0683; Tsuruo T, 2003, CANCER SCI, V94, P15, DOI 10.1111/j.1349-7006.2003.tb01345.x; Varma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092047; Voigt W, 1998, ANTICANCER RES, V18, P3499; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WU RS, 1983, BIOCHEMISTRY-US, V22, P3868, DOI 10.1021/bi00285a023; Wu Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7593787; Xu Y, 2015, BIOMOLECULES, V5, P1652, DOI 10.3390/biom5031652; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	52	56	60	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171582	10.1371/journal.pone.0171582	http://dx.doi.org/10.1371/journal.pone.0171582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158293	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700102
J	van Rijnberk, LM; van der Horst, SEM; van den Heuvel, S; Ruijtenberg, S				van Rijnberk, Lotte M.; van der Horst, Suzanne E. M.; van den Heuvel, Sander; Ruijtenberg, Suzan			A dual transcriptional reporter and CDK-activity sensor marks cell cycle entry and progression in C-elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DEVELOPMENTAL REGULATION; DEPENDENT KINASE; GENE-EXPRESSION; S-PHASE; PROLIFERATION; INHIBITION; UNDERLIES; PROTEIN; POINT	Development, tissue homeostasis and tumor suppression depend critically on the correct regulation of cell division. Central in the cell division process is the decision whether to enter the next cell cycle and commit to going through the S and M phases, or to remain temporarily or permanently arrested. Cell cycle studies in genetic model systems could greatly benefit from visualizing cell cycle commitment in individual cells without the need of fixation. Here, we report the development and characterization of a reporter to monitor cell cycle entry in the nematode C. elegans. This reporter combines the mcm-4 promoter, to reveal Rb/E2F-mediated transcriptional control, and a live-cell sensor for CDK-activity. The CDK sensor was recently developed for use in human cells and consists of a DNA Helicase fragment fused to eGFP. Upon phosphorylation by CDKs, this fusion protein changes in localization from the nucleus to the cytoplasm. The combined regulation of transcription and subcellular localization enabled us to visualize the moment of cell cycle entry in dividing seam cells during C. elegans larval development. This reporter is the first to reflect cell cycle commitment in C. elegans and will help further genetic studies of the mechanisms that underlie cell cycle entry and exit.	[van Rijnberk, Lotte M.; van der Horst, Suzanne E. M.; van den Heuvel, Sander; Ruijtenberg, Suzan] Univ Utrecht, Fac Sci, Dept Biol, Dev Biol, Padualaan 8, Utrecht, Netherlands; [van Rijnberk, Lotte M.; Ruijtenberg, Suzan] Hubrecht Inst, Uppsalalaan 8, Utrecht, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	van den Heuvel, S; Ruijtenberg, S (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Dev Biol, Padualaan 8, Utrecht, Netherlands.; Ruijtenberg, S (corresponding author), Hubrecht Inst, Uppsalalaan 8, Utrecht, Netherlands.	s.j.l.vandenheuvel@uu.nl; s.ruijtenberg@hubrecht.eu	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; van der Horst, Suzanne/0000-0001-6495-3482	CW ECHO grant - Netherlands Organization for Scientific Research (NWO) [711.011.010]; NIH Office of Research Infrastructure Programs [P40 OD010440]	CW ECHO grant - Netherlands Organization for Scientific Research (NWO); NIH Office of Research Infrastructure Programs	This research was part of CW ECHO grant 711.011.010 (SvdH) financed by the Netherlands Organization for Scientific Research (NWO). Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AR, 2016, CELL SYST, V2, P27, DOI 10.1016/j.cels.2016.01.001; Boxem M, 1999, DEVELOPMENT, V126, P2227; Boxem M, 2001, DEVELOPMENT, V128, P4349; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; Cappell SD, 2016, CELL, V166, P167, DOI 10.1016/j.cell.2016.05.077; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Euling S, 1996, CELL, V84, P667, DOI 10.1016/S0092-8674(00)81045-4; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Hong Y, 1998, DEVELOPMENT, V125, P3585; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kim J, 2007, CURR BIOL, V17, P966, DOI 10.1016/j.cub.2007.04.055; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Korzelius J, 2011, DEV BIOL, V350, P358, DOI 10.1016/j.ydbio.2010.12.009; Park M, 1999, DEVELOPMENT, V126, P4849; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Ruijtenberg S, 2016, CELL CYCLE, V15, P196, DOI 10.1080/15384101.2015.1120925; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Sulston J. E., 1977, CAENORHABDITIS ELEGA, V156, P110; The I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6906; van den Heuvel S, 2012, METHOD CELL BIOL, V107, P265, DOI 10.1016/B978-0-12-394620-1.00009-6; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171600	10.1371/journal.pone.0171600	http://dx.doi.org/10.1371/journal.pone.0171600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158315	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700107
J	Xian, Y; Zhu, BW; Zhang, X; Ma, P; Wei, Y; Xia, HL; Jiang, WJ; Yang, CQ; Meng, XJ; Peng, P; Yang, Y; Jiang, LY; Chu, MJ; Zhuang, X				Xian, Yun; Zhu, Bowen; Zhang, Xuan; Ma, Ping; Wei, Ye; Xia, Hongli; Jiang, Wenjie; Yang, Changqing; Meng, Xiaojun; Peng, Peng; Yang, Yue; Jiang, Liying; Chu, Minjie; Zhuang, Xun			Risk factors associated with sexually transmitted infections among HIV infected men who have sex with men	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; PREVENTION; CHINA; EPIDEMIOLOGY; MUTATIONS	To investigate the factors associated with sexually transmitted infection and Human Immunodeficiency Virus (STI-HIV) co-infection among men who have sex with men (MSM). A total of 357 HIV-infected participants (84 STI-HIV co-infection and 273 HIV infections only) were recruited from Jiangsu, China. Logistic regression analyses were used to estimate the related factors associated with STI-HIV co-infection. Marginal structural models were adopted to estimate the effect of transmission drug resistance (TDR) on STI-HIV co-infection. For all participants, logistic regression analyses revealed that those who diagnosed with HIV-1 for longer duration (>= 1.8 years) were significantly associated with reduced STI-HIV co-infection risk (OR = 0.55, 95% CI: 0.32-0.96, P = 0.036). In further stratification analysis by antiretroviral therapy (ART), individuals with longer duration showed consistent significant associations with STI-HIV co-infection risk (OR = 0.46, 95% CI: 0.26-0.83, P = 0.010) among MSM with ART-naive status. In addition, significant reduced risk for STI-HIV co-infection (OR = 0.98, 95% CI: 0.96-0.99, P = 0.010) were observed in younger (under the average age of 31.03) MSM of the same group. Interestingly, we also found TDR was significantly associated with an increased risk of STI-HIV co-infection risk (OR = 3.84, 95% CI: 1.05-14.03, P = 0.042) in ART-naive group. Our study highlights a pattern of STI-HIV coinfection among MSM in China and indicates that targeted interventions aimed at encouraging TDR monitoring in MSM with early HIV infection are warranted.	[Xian, Yun; Zhu, Bowen; Peng, Peng; Yang, Yue; Jiang, Liying; Chu, Minjie; Zhuang, Xun] Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nantong City, Jiangsu, Peoples R China; [Zhang, Xuan; Meng, Xiaojun] Wuxi Ctr Dis Control & Prevent, Wuxi City, Jiangsu, Peoples R China; [Ma, Ping; Wei, Ye; Xia, Hongli] Nantong Ctr Dis Control & Prevent, Nantong City, Jiangsu, Peoples R China; [Jiang, Wenjie] Univ Bath, Dept Management Studies, Bath, Avon, England; [Yang, Changqing] Yancheng Ctr Dis Control & Prevent, Yancheng City, Jiangsu, Peoples R China; [Zhuang, Xun] Nantong Univ, Sch Publ Hlth, Dept Epidemiol, Nantong, Peoples R China	Nantong University; University of Bath; Nantong University	Zhuang, X (corresponding author), Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nantong City, Jiangsu, Peoples R China.; Zhuang, X (corresponding author), Nantong Univ, Sch Publ Hlth, Dept Epidemiol, Nantong, Peoples R China.	xzhuang@ntu.edu.cn						Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bruner KM, 2016, NATURE MED; Castillo JJ, 2015, CANCER; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Silva MCF, 2009, REV INST MED TROP SP, V51, P135, DOI 10.1590/S0036-46652009000300003; Frentz D, 2012, AIDS REV, V14, P17; Gulov K, 2016, AIDS BEHAV; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Jensen A K, 2016, STAT MED; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Li ZP, 2013, J ANTIMICROB CHEMOTH, V68, P2521, DOI 10.1093/jac/dkt228; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manosuthi W, 2013, J MED VIROL, V85, P194, DOI 10.1002/jmv.23452; Mendoza Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154317; Ostrowski M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv138; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Schiffer JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155124; Schnarrs PW, 2016, J HOMOSEXUAL, P1; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Tang W, 2016, SEXUALLY TRANSMITTED; Tang ZZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000902; Vermund SH, 2013, CURR HIV-AIDS REP, V10, P169, DOI 10.1007/s11904-013-0155-y; White MK, 2006, VIROLOGY, V352, P1, DOI 10.1016/j.virol.2006.04.006; Winand R, 2015, AIDS, V29, P2045, DOI 10.1097/QAD.0000000000000811; Zheng WJ, 2016, INT J BIOSTAT, V12, P233, DOI 10.1515/ijb-2015-0036; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196; Zhou Q, 2016, AIDS CARE, V21, P1	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170635	10.1371/journal.pone.0170635	http://dx.doi.org/10.1371/journal.pone.0170635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158317	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700016
J	Hollo, G				Hollo, Gabor			Relationship between optical coherence tomography sector peripapillary angioflow-density and Octopus visual field cluster mean defect values	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; FIBER LAYER THICKNESS; OPEN-ANGLE GLAUCOMA; VESSEL DENSITY; BLOOD-FLOW; OCT ANGIOGRAPHY; NERVE HEAD; EYES; DISK; SEVERITY	Purpose To compare the relationship of Octopus perimeter cluster mean-defect (cluster MD) values with the spatially corresponding optical coherence tomography (OCT) sector peripapillary angioflow vessel-density (PAFD) and sector retinal nerve fiber layer thickness (RNFLT) values. Methods High quality PAFD and RNFLT images acquired on the same day with the Angiovue/RTVueXR Avanti OCT (Optovue Inc., Fremont, USA) on 1 eye of 27 stable early-to-moderate glaucoma, 22 medically controlled ocular hypertensive and 13 healthy participants were analyzed. Octopus G2 normal visual field test was made within 3 months from the imaging. Results Total peripapillary PAFD and RNFLT showed similar strong positive correlation with global mean sensitivity (r-values: 0.6710 and 0.6088, P< 0.0001), and similar (P = 0.9614) strong negative correlation (r-values: -0.4462 and -0.4412, P <= 0.004) with global MD. Both inferotemporal and superotemporal sector PAFD were significantly (<= 0.039) lower in glaucoma than in the other groups. No significant difference between the corresponding inferotemporal and superotemporal parameters was seen. The coefficient of determination (R-2) calculated for the relationship between inferotemporal sector PAFD and superotemporal cluster MD (0.5141, P< 0.0001) was significantly greater than that between inferotemporal sector RNFLT and superotemporal cluster MD (0.2546, P = 0.0001). The R-2 values calculated for the relationships between superotemporal sector PAFD and RNFLT, and inferotemporal cluster MD were similar (0.3747 and 0.4037, respectively, P< 0.0001). Conclusion In the current population the relationship between inferotemporal sector PAFD and superotemporal cluster MD was strong. It was stronger than that between inferotemporal sector RNFLT and superotemporal cluster MD. Further investigations are necessary to clarify if our results are valid for other populations and can be usefully applied for glaucoma research.	[Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary	Semmelweis University	Hollo, G (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	hollo.gabor@med.semmelweis-univ.hu						AIRAKSINEN PJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P206, DOI 10.1001/archopht.1992.01080140062028; Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Costa VP, 2014, ACTA OPHTHALMOL, V92, pe252, DOI 10.1111/aos.12298; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Hollo G, 1997, INT OPHTHALMOL, V20, P71, DOI 10.1007/BF00212949; Hollo G, 1997, INT OPHTHALMOL, V20, P63; Hollo G, 2017, BRIT J OPHTHALMOL, V101, P150, DOI 10.1136/bjophthalmol-2015-307759; Hollo G, 2016, INT OPHTHALMOL, V36, P915, DOI 10.1007/s10792-016-0207-6; Hollo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161631; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P522, DOI 10.1007/BF02169199; Kiumehr S, 2012, ARCH OPHTHALMOL-CHIC, V130, P552, DOI 10.1001/archopthalmol.2011.1309; Leveque PM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6956717; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Naghizadeh F, 2014, J GLAUCOMA, V23, P11, DOI 10.1097/IJG.0b013e318264cda2; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Pinto LA, 2016, ACTA OPHTHALMOL, V94, P592, DOI 10.1111/aos.12962; Quaranta L, 2013, SURV OPHTHALMOL, V58, P26, DOI 10.1016/j.survophthal.2012.05.003; QUIGLEY HA, 1984, INVEST OPHTH VIS SCI, V25, P918; Tektas OY, 2010, INVEST OPHTH VIS SCI, V51, P5083, DOI 10.1167/iovs.09-5101; TUULONEN A, 1991, AM J OPHTHALMOL, V111, P485, DOI 10.1016/S0002-9394(14)72385-2; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Werne A, 2008, SURV OPHTHALMOL, V53, P559, DOI 10.1016/j.survophthal.2008.08.021; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944	32	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171541	10.1371/journal.pone.0171541	http://dx.doi.org/10.1371/journal.pone.0171541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152106	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200154
J	Kim, DJ; Lee, MW; Choi, JS; Lee, SG; Park, JY; Kim, SW				Kim, Dae Jin; Lee, Min Woo; Choi, Jeong Su; Lee, Seung Gwan; Park, Jee Yoon; Kim, Suhng Wook			Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species	PLOS ONE			English	Article							ALBICANS BIOFILMS; ESSENTIAL OIL; PLANT-ORIGIN; INFECTIONS; TERPENOIDS; COMPONENTS; LINALOOL; GROWTH	The aim of this study was to investigate the ability of hinokitiol to inhibit the formation of Candida biofilms. Biofilm inhibition was evaluated by quantification of the biofilm metabolic activity with XTT assay. Hinokitiol efficiently prevented biofilm formation in both fluconazole-susceptible and fluconazole-resistant strains of Candida species. We determined the expression levels of specific genes previously implicated in biofilm development of C. albicans cells by realtime RT-PCR. The expression levels of genes associated with adhesion process, HWP1 and ALS3, were downregulated by hinokitiol. Transcript levels of UME6 and HGC1, responsible for long-term hyphal maintenance, were also decreased by hinokitiol. The expression level of CYR1, which encodes the component of signaling pathway of hyphal formation-cAMP-PKA was suppressed by hinokitiol. Its upstream general regulator RAS1 was also suppressed by hinokitiol. These results indicate that hinokitiol may have therapeutic potential in the treatment and prevention of biofilm-associated Candida infections.	[Kim, Dae Jin; Lee, Min Woo; Choi, Jeong Su; Lee, Seung Gwan; Kim, Suhng Wook] Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul, South Korea; [Park, Jee Yoon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea	Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SW (corresponding author), Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul, South Korea.	swkimkorea@korea.ac.kr	Park, Jee Yoon/ABC-3368-2021		Korea University [K1508301]	Korea University	This research was supported by a grant from Korea University (K1508301).	Al-Fattani MA, 2004, ANTIMICROB AGENTS CH, V48, P3291, DOI 10.1128/AAC.48.9.3291-3297.2004; Bujdakova H, 2016, FUTURE MICROBIOL, V11, P235, DOI 10.2217/fmb.15.139; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Clinical and Laboratory Standards Institute, 2008, APPROVED STANDARD M2; Doke SK, 2014, J GEN APPL MICROBIOL, V60, P163, DOI 10.2323/jgam.60.163; Gilbard JP, 2010, CORNEA, V29, P559, DOI 10.1097/ICO.0b013e3181bd9f79; Holcombe LJ, 2010, MICROBIOL-SGM, V156, P1476, DOI 10.1099/mic.0.037549-0; Hsu CC, 2013, MED MYCOL, V51, P473, DOI 10.3109/13693786.2012.743051; Inamori Y, 2000, BIOL PHARM BULL, V23, P995, DOI 10.1248/bpb.23.995; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Komaki N, 2008, BIOL PHARM BULL, V31, P735, DOI 10.1248/bpb.31.735; Krenn BM, 2009, J VIROL, V83, P58, DOI 10.1128/JVI.01543-08; Kucharikova S, 2013, ANTIMICROB AGENTS CH, V57, P2365, DOI 10.1128/AAC.02288-12; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Liu SC, 2006, BIOCHEM BIOPH RES CO, V351, P26, DOI 10.1016/j.bbrc.2006.09.166; McCarty TP, 2016, INFECT DIS CLIN N AM, V30, P103, DOI 10.1016/j.idc.2015.10.013; Morita Y, 2004, BIOL PHARM BULL, V27, P899, DOI 10.1248/bpb.27.899; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Niu C, 2004, APPL ENVIRON MICROB, V70, P6951, DOI 10.1128/AEM.70.12.6951-6956.2004; O'Connor L, 2010, EUKARYOT CELL, V9, P1383, DOI 10.1128/EC.00042-10; Olsen I, 2015, EUR J CLIN MICROBIOL, V34, P877, DOI 10.1007/s10096-015-2323-z; Pierce CG, 2013, CURR OPIN PHARMACOL, V13, P726, DOI 10.1016/j.coph.2013.08.008; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001; Raut JS, 2013, BIOFOULING, V29, P87, DOI 10.1080/08927014.2012.749398; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Tampieri MP, 2005, MYCOPATHOLOGIA, V159, P339, DOI 10.1007/s11046-003-4790-5; Tang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099103; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Uppuluri P, 2009, J CLIN MICROBIOL, V47, P4078, DOI 10.1128/JCM.01377-09; Yapar N, 2011, MED MYCOL, V49, P26, DOI 10.3109/13693786.2010.501344; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	32	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171244	10.1371/journal.pone.0171244	http://dx.doi.org/10.1371/journal.pone.0171244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152096	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200113
J	Kohler, EC; Hart, E; Klaunzer, M				Koehler, E. Christiana; Hart, Elizabeth; Klaunzer, Michael			Wadi el-Sheikh: A new archaeological investigation of ancient Egyptian chert mines	PLOS ONE			English	Article								This article provides an overview of the first results from archaeological investigations at Wadi el-Sheikh in Egypt by the University of Vienna Middle Egypt Project. Chert was an important raw material used to produce tools, implements and jewelry in ancient times. Wadi el-Sheikh was exploited over thousands of years as it was probably the most important source of chert in Pharaonic civilization. The results of our new investigations that involved surveys and test excavations indicate the presence of large scale mining activities in the first half of the 3rd Millennium B.C.E. which allow for detailed insights into the amount of raw material extracted, the mining methods used and the lithic products manufactured in this area. These aspects are contextualized on the background of ancient Egyptian state-organized resource acquisition strategies and economy.	[Koehler, E. Christiana] Univ Vienna, Inst Egyptol, Vienna, Austria; [Hart, Elizabeth] Univ Virginia, Dept Anthropol, Charlottesville, VA USA; [Klaunzer, Michael] Deutsch Bergbau Museum Bochum, Bochum, Germany	University of Vienna; University of Virginia; Deutsches Bergbau Museum Bochum (DBM)	Kohler, EC (corresponding author), Univ Vienna, Inst Egyptol, Vienna, Austria.	e.christiana.koehler@univie.ac.at			University of Vienna; Open Access Publishing Fund of the University of Vienna	University of Vienna; Open Access Publishing Fund of the University of Vienna	The University of Vienna is fully funding the University of Vienna Middle Egypt Project, of which the current research is part, via a personal research budget granted to E.G. Kohler. In 2015 until June 2016 M. Klaunzer was a part-time member of staff at the Deutsches Bergbau-Museum employed for the purpose of conducting the relevant fieldwork. This article was supported by the Open Access Publishing Fund of the University of Vienna.	[Anonymous], 1964, GESTURE SPEECH; Barket TM, 2011, LITHIC TECHNOL, V36, P27, DOI 10.1179/lit.2011.36.1.27; Biagi P., 2014, QUARRIES HARAPPA ENC; Boesneck J., 1989, MAADI 3 NONLITHIC SM, P87; Briois F, 2015, RAPPORT ACTIVITE 201, V115, P49; Briois F., 2014, B LINSTITUT FRANCAIS, V114, P73; Caton-Thompson G, 1934, THE DESERT FAYUM, P21; Djara Kindermann K., 2010, AFRICA PRAEHISTORICA, V23, P43; Eichler Elmar, 1993, UNTERSUCHUNGEN ZUM E; Feinman G. M., 2004, ARCHAEOLOGICAL PERSP; Forster Frank, 2015, AFRICA PRAEHISTORICA, V28; Forster Frank, 2013, AFRICA PRAEHISTORICA, V27; Friedman R., 1999, NEKHEN NEWS, V11, P7; GRAVES-BROWN Carolyn Anne, 2010, THESIS; Harrell JA, 2012, UCLA ENCY EGYPTOLOGY, V1; HESTER TR, 1984, WORLD ARCHAEOL, V16, P157, DOI 10.1080/00438243.1984.9979925; Jeuthe C., 2015, EGYPT LEVANT, V25, P68; Kobusiewicz M., 2015, PRODUCTION USE IMPOR; KOHLER E.C., 2010, EGYPTIAN ARCHAEOLOGY, P36; Kohler E.C., 2004, CAIRO MUSEUM COLLECT; Monson Andrew, 2015, FISCAL REGIMES POLIT; Negro G, 2010, SAHARA, V21, P107; Pawlik AF., 2006, STONE AGE MINING AGE, V19, P545; Petrie WMF., 1901, DIOSPOLIS PARVA CEME, p: 36; Petrie WMF., 1896, NAGADA AND BALLAS, P59; Rossel S, 2008, P NATL ACAD SCI USA, V105, P3715, DOI 10.1073/pnas.0709692105; Schmidt K., 1987, MDAIK, V43, P297; Sellet F., 1993, LITHIC TECHNOLOGY, V18, P106, DOI [10.1080/01977261.1993.11720900, DOI 10.1080/01977261.1993.11720900]; Seton-Karr H. W., 1898, J ROYAL I GREAT BRIT, V27, P90; Seyfried K-J, 1981, BEITRAGE EXPEDITIONE; Smith ME, 2004, ANNU REV ANTHROPOL, V33, P73, DOI 10.1146/annurev.anthro.33.070203.144016; Soressi M., 2011, PALEOANTHROPOLOGY, V334, P334, DOI DOI 10.4207/PA.2011.ART63; Th Hikade, 2001, SAGA, V21; Tillmann A., 1994, PHARAONEN FREMDE DYN, P105; Vermeersch P.M., 2002, PALAEOLITHIC QUARRYI; Vermeersch Pierre, 1989, SAHARA, V2, P95; Vermeersch PM, 2004, ORIENT LOVAN ANAL, V138, P213; Vermeersch PM, 1993, STUDIES AFRICAN ARCH, V4, P337; Weiner J., 2011, ANSCHNITT, V63; Weiner J, 2011, ANSCHNITT, V63, P130; Weisgerber G., 1987, HUMAN USES FLINT CHE, P165; Weisgerber G, 1982, ANSCHNITT, V6, P186	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170840	10.1371/journal.pone.0170840	http://dx.doi.org/10.1371/journal.pone.0170840			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EN7DB	28152079	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200048
J	Toffoli, B; Gilardi, F; Winkler, C; Soderberg, M; Kowalczuk, L; Arsenijevic, Y; Bamberg, K; Bonny, O; Desvergne, B				Toffoli, Barbara; Gilardi, Federica; Winkler, Carine; Soderberg, Magnus; Kowalczuk, Laura; Arsenijevic, Yvan; Bamberg, Krister; Bonny, Olivier; Desvergne, Beatrice			Nephropathy in Pparg-null mice highlights PPAR gamma systemic activities in metabolism and in the immune system	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; LUPUS-ERYTHEMATOSUS; ANTIPHOSPHOLIPID SYNDROME; MOUSE MODEL; DIABETIC COMPLICATIONS; MECHANISMS; ANTIBODIES; DISEASE; LIPODYSTROPHY; INFLAMMATION	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response, and development. Totalbody deletion of the two Pparg alleles provoked generalized lipoatrophy along with severe type 2 diabetes. Herein, we explore the appearance and development of structural and functional alterations of the kidney, comparing Pparg null-mice to their littermate controls (carrying Pparg floxed alleles). We show that renal hypertrophy and functional alterations with increased glucosuria and albuminuria are already present in 3 weeks-old Pparg null-mice. Renal insufficiency with decreased creatinine clearance progress at 7 weeks of age, with the advance of the type 2 diabetes. At 52 weeks of age, these alterations are accompanied by signs of fibrosis and mesangial expansion. More intriguingly, aged Pparg null-mice concomitantly present an anti-phospholipid syndrome (APS), characterized by the late appearance of microthrombi and a mesangioproliferative pattern of glomerular injury, associated with significant plasmatic levels of anti-beta(2)-glycoprotein1 antibodies and renal deposition of IgG, IgM, and C3. Thus, in line with the role of PPAR gamma in metabolic homeostasis, Pparg nullmice first represent a potent model for studying the initiation and the development of diabetic nephropathy. Second, and in relation with the important PPAR gamma activity in inflammation and in immune system, these mice also highlight a new role for PPAR gamma signaling in the promotion of APS, a syndrome whose pathogenesis is poorly known and whose current treatment is limited to prevention of thrombosis events.	[Toffoli, Barbara; Gilardi, Federica; Winkler, Carine; Desvergne, Beatrice] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland; [Soderberg, Magnus; Bamberg, Krister] AstraZeneca R&D, Pepparredsleden 1, Molndal, Sweden; [Kowalczuk, Laura; Arsenijevic, Yvan] Univ Lausanne, Jules Gonin Eye Hosp, Fdn Asile Des Aveugles, Dept Ophthalmol,Unit Gene Therapy & Stem Cell Bio, Lausanne, Switzerland; [Bonny, Olivier] Univ Lausanne, Univ Lausanne Hosp, Serv Nephrol, Lausanne, Switzerland; [Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Toffoli, Barbara] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	University of Lausanne; AstraZeneca; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Trieste	Desvergne, B (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland.	Beatrice.Desvergne@unil.ch	Toffoli, Barbara/AAT-1101-2021; Kowalczuk, Laura/AAF-6230-2020; Desvergne, Beatrice/C-8892-2016	Desvergne, Beatrice/0000-0001-5483-288X; Toffoli, Barbara/0000-0002-6854-5782; Arsenijevic, Yvan/0000-0001-6960-1291; Gilardi, Federica/0000-0001-5421-2779; bonny, olivier/0000-0003-4123-4279	Swiss National Science Foundation [3100AO-120633/1]; Etat de Vaud, Faculte de Biologie et Medecine of University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Etat de Vaud, Faculte de Biologie et Medecine of University of Lausanne	This work was supported by grants from the Swiss National Science Foundation (3100AO-120633/1) to BD and the Etat de Vaud, Faculte de Biologie et Medecine of University of Lausanne (no speicifc grant numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprahamian TR, 2014, IMMUNOLOGY, V142, P363, DOI 10.1111/imm.12256; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Becarevic M, 2016, CLIN RHEUMATOL, V35, P2477, DOI 10.1007/s10067-016-3345-3; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Caballero CR, 2003, J AM ACAD DERMATOL, V49, P768, DOI 10.1067/S0190-9622(03)00789-8; Cortes S, 2008, LUPUS, V17, P977, DOI 10.1177/0961203308091539; De Angelis V, 2009, J AUTOIMMUN, V32, P60, DOI 10.1016/j.jaut.2008.11.002; de Groot PG, 2012, LUPUS, V21, P704, DOI 10.1177/0961203312438631; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gabriel CL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1313, DOI 10.1152/ajpendo.00665.2011; Horita S, 2015, PPAR RES, V2015, DOI 10.1155/2015/646423; Hu C, 2015, CURR MED CHEM, V22, P2858, DOI 10.2174/0929867322666150625095407; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; Kiremitci Saba, 2014, ScientificWorldJournal, V2014, P580620, DOI 10.1155/2014/580620; Martinez-Garcia C, 2012, DIS MODEL MECH, V5, P636, DOI 10.1242/dmm.009266; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Naito M, 2011, DIABETES, V60, P2265, DOI 10.2337/db10-1795; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Parker B, 2015, ANN RHEUM DIS, V74, P1530, DOI 10.1136/annrheumdis-2013-203933; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Rovin BH, 2014, AM J KIDNEY DIS, V63, P677, DOI 10.1053/j.ajkd.2013.11.023; Sciascia S, 2014, NAT REV NEPHROL, V10, P279, DOI 10.1038/nrneph.2014.38; Suganami T, 2004, FASEB J, V18, P127, DOI 10.1096/fj.04-2183fje; Szeles L, 2007, BBA-MOL CELL BIOL L, V1771, P1014, DOI 10.1016/j.bbalip.2007.02.005; Unlu O, 2016, EUR J RHEUMATOL, V3, P75, DOI 10.5152/eurjrheum.2015.0085; Venegas-Pont M, 2009, AM J PHYSIOL-REG I, V296, pR1282, DOI 10.1152/ajpregu.90992.2008; Xia LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147958; Yang JC, 2012, CURR OPIN NEPHROL HY, V21, P97, DOI 10.1097/MNH.0b013e32834de526; Yang JC, 2009, CLIN SCI, V116, P17, DOI 10.1042/CS20070462; Yavuz S, 2010, PEDIATR DERMATOL, V27, P504, DOI 10.1111/j.1525-1470.2010.01255.x; Zhao WP, 2009, J IMMUNOL, V183, P2729, DOI 10.4049/jimmunol.0804341	34	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171474	10.1371/journal.pone.0171474	http://dx.doi.org/10.1371/journal.pone.0171474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182703	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800062
J	Zimmermann, MT; Urrutia, R; Oliver, GR; Blackburn, PR; Cousin, MA; Bozeck, NJ; Klee, EW				Zimmermann, Michael T.; Urrutia, Raul; Oliver, Gavin R.; Blackburn, Patrick R.; Cousin, Margot A.; Bozeck, Nicole J.; Klee, Eric W.			Molecular modeling and molecular dynamic simulation of the effects of variants in the TGFBR2 kinase domain as a paradigm for interpretation of variants obtained by next generation sequencing	PLOS ONE			English	Article							MARFAN-SYNDROME; SRC KINASE; WEB SERVER; BETA; PROTEINS; NETWORK; FLEXIBILITY; QUALITY; MOTION; COOPERATIVITY	Variants in the TGFBR2 kinase domain cause several human diseases and can increase propensity for cancer. The widespread application of next generation sequencing within the setting of Individualized Medicine (IM) is increasing the rate at which TGFBR2 kinase domain variants are being identified. However, their clinical relevance is often uncertain. Consequently, we sought to evaluate the use of molecular modeling and molecular dynamics (MD) simulations for assessing the potential impact of variants within this domain. We documented the structural differences revealed by these models across 57 variants using independent MD simulations for each. Our simulations revealed various mechanisms by which variants may lead to functional alteration; some are revealed energetically, while others structurally or dynamically. We found that the ATP binding site and activation loop dynamics may be affected by variants at positions throughout the structure. This prediction cannot be made from the linear sequence alone. We present our structure-based analyses alongside those obtained using several commonly used genomics-based predictive algorithms. We believe the further mechanistic information revealed by molecular modeling will be useful in guiding the examination of clinically observed variants throughout the exome, as well as those likely to be discovered in the near future by clinical tests leveraging nextgeneration sequencing through IM efforts.	[Zimmermann, Michael T.; Oliver, Gavin R.; Cousin, Margot A.; Klee, Eric W.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Urrutia, Raul] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Urrutia, Raul] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Oliver, Gavin R.; Cousin, Margot A.; Bozeck, Nicole J.; Klee, Eric W.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Blackburn, Patrick R.] Mayo Clin, Ctr Individualized Med, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Klee, EW (corresponding author), Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Lab Epigenet & Chromatin Dynam, Gastroenterol Res Unit, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.; Urrutia, R (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Klee, EW (corresponding author), Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu; klee.eric@mayo.edu	Cousin, Margot/AAD-4591-2019	Cousin, Margot/0000-0002-6119-9346; Oliver, Gavin/0000-0002-9948-3799; Zimmermann, Michael/0000-0001-7073-0525	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052913] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], 2013, CANCER DISCOV, V3, P1320, DOI 10.1158/2159-8290.CD-NB2013-153; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOVIA, 2015, DASS SYST BIOVIA DIS; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Boyken SE, 2014, J MOL BIOL, V426, P3656, DOI 10.1016/j.jmb.2014.08.018; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; Foda ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6939; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao M., CRYSTAL STRUCTURES O; Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HUBER R, 1983, BIOPOLYMERS, V22, P261, DOI 10.1002/bip.360220136; Janin J, ASSESSING STRUCTURAL; Joseph RE, 2010, J MOL BIOL, V403, P231, DOI 10.1016/j.jmb.2010.08.035; Keskin O, 2002, BIOPHYS J, V83, P663, DOI 10.1016/S0006-3495(02)75199-0; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu X, 2015, HUM MUTAT; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Matyas G, 2006, HUM MUTAT, V27, P760, DOI 10.1002/humu.20353; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meng YL, 2014, J MOL BIOL, V426, P423, DOI 10.1016/j.jmb.2013.10.001; Mistry J, 2013, ACTA CRYSTALLOGR D, V69, P2186, DOI 10.1107/S0907444913027157; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Moult J, 2016, PROTEINS; Muller A, 2002, GENOME RES, V12, P1625, DOI 10.1101/gr.221202; Niu B, 2016, NAT GENET; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Potestio R, 2009, BIOPHYS J, V96, P4993, DOI 10.1016/j.bpj.2009.03.051; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Pucheta-Martinez E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24235; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ryadnov MG, 2010, FUTURE MED CHEM, V2, P1633, DOI 10.4155/FMC.10.256; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shen QC, 2016, NUCLEIC ACIDS RES, V44, pD527, DOI 10.1093/nar/gkv902; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stavropoulos DJ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.12; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Verstraeten A, 2016, HUM MUTAT, V37, P524, DOI 10.1002/humu.22977; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Woods NT, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.1; Xie L, 2005, PLOS COMPUT BIOL, V1, P222, DOI 10.1371/journal.pcbi.0010031; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zimmermann MT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-264	76	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170822	10.1371/journal.pone.0170822	http://dx.doi.org/10.1371/journal.pone.0170822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182693	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800019
J	Lykens, NM; Coughlin, DJ; Reddi, JM; Lutz, GJ; Tallent, MK				Lykens, Nicole M.; Coughlin, David J.; Reddi, Jyoti M.; Lutz, Gordon J.; Tallent, Melanie K.			AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE-OPERATED CHANNELS; CALCIUM-PERMEABLE AMPA; SYNAPTIC PLASTICITY; MESSENGER-RNAS; RECEPTOR SUBUNIT; MOUSE MODEL; EPILEPSY; EXPRESSION; GLUR1	Glutamate-activated alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA-Rs) mediate the majority of excitatory neurotransmission in brain and thus are major drug targets for diseases associated with hyperexcitability or neurotoxicity. Due to the critical nature of AMPA-Rs in normal brain function, typical AMPA-R antagonists have deleterious effects on cognition and motor function, highlighting the need for more precise modulators. A dramatic increase in the flip isoform of alternatively spliced AMPA-R GluA1 subunits occurs post-seizure in humans and animal models. GluA1-flip produces higher gain AMPA channels than GluA1-flop, increasing network excitability and seizure susceptibility. Splice modulating oligonucleotides (SMOs) bind to pre-mRNA to influence alternative splicing, a strategy that can be exploited to develop more selective drugs across therapeutic areas. We developed a novel SMO, GR1, which potently and specifically decreased GluA1flip expression throughout the brain of neonatal mice lasting at least 60 days after single intracerebroventricular injection. GR1 treatment reduced AMPA-R mediated excitatory postsynaptic currents at hippocampal CA1 synapses, without affecting long-term potentiation or long-term depression, cellular models of memory, or impairing GluA1-dependent cognition or motor function in mice. Importantly, GR1 demonstrated anti-seizure properties and reduced post-seizure hyperexcitability in neonatal mice, highlighting its drug candidate potential for treating epilepsies and other neurological diseases involving network hyperexcitability.	[Lykens, Nicole M.] Drexel Univ, Coll Med, Grad Program Pharmacol & Physiol, Philadelphia, PA 19104 USA; [Lykens, Nicole M.; Lutz, Gordon J.; Tallent, Melanie K.] LifeSplice Pharma, Malvern, PA 19355 USA; [Coughlin, David J.] Widener Univ, Dept Biol, Chester, PA 19013 USA; [Reddi, Jyoti M.; Tallent, Melanie K.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Lutz, Gordon J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University; Widener University; Drexel University; Drexel University	Tallent, MK (corresponding author), LifeSplice Pharma, Malvern, PA 19355 USA.; Tallent, MK (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	melanie.tallent@lifesplicepharma.com			Citizens United for Research in Epilepsy (CURE) Pediatric Epilepsy Multidisciplinary Grant; NIH [1R21NS064223]; Pennsylvania Department of Health DrexelMed Translational Tobacco Funds Grant; Epilepsy Foundation/American Epilepsy Society	Citizens United for Research in Epilepsy (CURE) Pediatric Epilepsy Multidisciplinary Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health DrexelMed Translational Tobacco Funds Grant; Epilepsy Foundation/American Epilepsy Society	This work was supported by Citizens United for Research in Epilepsy (CURE) Pediatric Epilepsy Multidisciplinary Grant (MKT and GJL), NIH 1R21NS064223 (GJL), Pennsylvania Department of Health DrexelMed Translational Tobacco Funds Grant (GJL), and an Epilepsy Foundation/American Epilepsy Society predoctoral fellowship (NML). Dr. Tallent left Drexel University to found LifeSplice Pharma prior to the completion of the presented work, but the company was virtual and did not provide any support in the form of funding for author salaries or funding of the experimental work presented in this manuscript. LifeSplice did not have any role in study design, data collection, or decision to publish. However, Dr. Tallent and Dr. Lutz were both affiliated with LifeSplice while supervising and performing some of the data analysis, figure making, and writing of the manuscript.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Baratta MV, 2002, J NEUROPHYSIOL, V88, P3078, DOI 10.1152/jn.00398.2002; Bolshakov K V, 2001, Neurosci Behav Physiol, V31, P219, DOI 10.1023/A:1005276627192; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coyle H, 2014, EPILEPSY BEHAV, V41, P193, DOI 10.1016/j.yebeh.2014.09.072; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; de Lanerolle NC, 1998, EUR J NEUROSCI, V10, P1687, DOI 10.1046/j.1460-9568.1998.00171.x; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; EASTWOOD SL, 1994, NEUROREPORT, V5, P1325, DOI 10.1097/00001756-199406270-00007; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faravelli I, 2015, NAT REV NEUROL, V11, P351, DOI 10.1038/nrneurol.2015.77; Finkel R. S, 2016, LANCET; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Granger Adam J, 2014, Front Synaptic Neurosci, V6, P15, DOI 10.3389/fnsyn.2014.00015; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Hache M, 2016, J CHILD NEUROL; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Ihara Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150095; Jensen FE, 2006, EPILEPSY RES, V68, P28, DOI 10.1016/j.eplepsyres.2005.09.013; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KAMPHUIS W, 1994, EUR J NEUROSCI, V6, P1119, DOI 10.1111/j.1460-9568.1994.tb00609.x; KAMPHUIS W, 1992, NEUROSCI LETT, V148, P51, DOI 10.1016/0304-3940(92)90802-E; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Langan YM, 2003, EPILEPSIA, V44, P46, DOI 10.1046/j.1528-1157.2003.128902.x; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOSCHER W, 1994, BRIT J PHARMACOL, V113, P1349; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; Penn AC, 2009, RNA BIOL, V6, P517, DOI 10.4161/rna.6.5.9552; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rennie JM, 2003, CURR OPIN NEUROL, V16, P177, DOI 10.1097/00019052-200304000-00010; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rosa MLNM, 1999, EPILEPSY RES, V36, P243, DOI 10.1016/S0920-1211(99)00055-8; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Selcher JC, 2012, BRAIN RES, V1435, P8, DOI 10.1016/j.brainres.2011.11.029; Shababi M., DRUG NEWS PERSPECTIV, V23, P475; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; Traa BS, 2008, PEDIATR RES, V64, P81, DOI 10.1203/PDR.0b013e318174e70e; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; YAMAGUCHI S, 1993, EPILEPSY RES, V15, P179, DOI 10.1016/0920-1211(93)90054-B; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zaccara G, 2013, EUR J NEUROL, V20, P1204, DOI 10.1111/ene.12170; Zaccara G, 2013, EXPERT REV NEUROTHER, V13, P647, DOI [10.1586/ern.13.46, 10.1586/ERN.13.46]; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	76	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171538	10.1371/journal.pone.0171538	http://dx.doi.org/10.1371/journal.pone.0171538			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178321	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500049
J	Vorobeychik, Y; Joveski, Z; Yu, SX				Vorobeychik, Yevgeniy; Joveski, Zlatko; Yu, Sixie			Does communication help people coordinate?	PLOS ONE			English	Article							LANGUAGE; EMERGENCE; EVOLUTION; NETWORKS; DYNAMICS; ANTS; GAME	Theoretical and experimental investigations have consistently demonstrated that collective performance in a variety of tasks can be significantly improved by allowing communication. We present the results of the first experiment systematically investigating the value of communication in networked consensus. The goal of all tasks in our experiments is for subjects to reach global consensus, even though nodes can only observe choices of their immediate neighbors. Unlike previous networked consensus tasks, our experiments allow subjects to communicate either with their immediate neighbors (locally) or with the entire network (globally). Moreover, we consider treatments in which essentially arbitrary messages can be sent, as well as those in which only one type of message is allowed, informing others about a node's local state. We find that local communication adds minimal value: fraction of games solved is essentially identical to treatments with no communication. Ability to communicate globally, in contrast, offers a significant performance improvement. In addition, we find that constraining people to only exchange messages about local state is significantly better than unconstrained communication. We observe that individual behavior is qualitatively consistent across settings: people clearly react to messages they receive in all communication settings. However, we find that messages received in local communication treatments are relatively uninformative, whereas global communication offers substantial information advantage. Exploring mixed communication settings, in which only a subset of agents are global communicators, we find that a significant number of global communicators is needed for performance to approach success when everyone communicates globally. However, global communicators have a significant advantage: a small tightly connected minority of globally communicating nodes can successfully steer outcomes towards their preferences, although this can be significantly mitigated when all other nodes have the ability to communicate locally with their neighbors.	[Vorobeychik, Yevgeniy; Joveski, Zlatko; Yu, Sixie] Vanderbilt Univ, Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Vorobeychik, Y (corresponding author), Vanderbilt Univ, Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	yevgeniy.vorobeychik@vanderbilt.edu			Office of Naval Research [N00014-15-1-2621]; National Science Foundation [1526860]	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF))	This work was funded by the Office of Naval Research (Grant #: N00014-15-1-2621, URL: http./Avww.onr.navy.mili) to YV and the National Science Foundation (Grant #: 1526860, URL: http//www.nsf.gov) to YV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowles S., 2001, SOCIAL DYNAMICS, P132; Choi S, 2014, J EUR ECON ASSOC, V12, P223, DOI 10.1111/jeea.12058; Clark H.H., 1996, USING LANGUAGE; COOPER R, 1989, RAND J ECON, V20, P568, DOI 10.2307/2555734; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Demichelis S, 2008, AM ECON REV, V98, P1292, DOI 10.1257/aer.98.4.1292; Ellingsen T, 2010, AM ECON REV, V100, P1695, DOI 10.1257/aer.100.4.1695; Farrell J, 1996, J ECON PERSPECT, V10, P103, DOI 10.1257/jep.10.3.103; FARRELL J, 1988, ECON LETT, V27, P209, DOI 10.1016/0165-1765(88)90172-3; Farrell J., 1987, J ECON, V18, P34; Fowler CA, 2008, UNDERST COMPLEX SYST, P261, DOI 10.1007/978-3-540-74479-5_13; Helbing D, 2015, J STAT PHYS, V158, P735, DOI 10.1007/s10955-014-1024-9; Judd S, 2010, P NATL ACAD SCI USA, V107, P14978, DOI 10.1073/pnas.1001280107; Kearns M, 2012, COMMUN ACM, V55, P56, DOI 10.1145/2347736.2347753; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; McCreery HF, 2016, J EXP BIOL, V219, P3366, DOI 10.1242/jeb.143818; Miller JH, 2004, COMPLEXITY, V9, P31, DOI 10.1002/cplx.20034; Olmstead AJ, 2009, Q J EXP PSYCHOL, V62, P2409, DOI 10.1080/17470210902846765; Reid CR, 2015, P NATL ACAD SCI USA, V112, P15113, DOI 10.1073/pnas.1512241112; Richerson PJ, 2010, BIOLINGUISTICS, V4, P289; Selten R, 2007, P NATL ACAD SCI USA, V104, P7361, DOI 10.1073/pnas.0702077104; Szamado Szabolcs, 2011, Biology Theory, V5, P366; Trenchard H, 2016, BIOSYSTEMS, V147, P40, DOI 10.1016/j.biosystems.2016.05.010; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899; Young H. Peyton, 2001, SOCIAL DYNAMICS, P132	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170780	10.1371/journal.pone.0170780	http://dx.doi.org/10.1371/journal.pone.0170780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178295	gold, Green Published, Green Submitted			2022-12-27	WOS:000393712500015
J	Farrell, JJ; Wang, H; Sampath, R; Lowery, KS; Bonomo, RA				Farrell, John Joseph; Wang, Huaping; Sampath, Rangarajan; Lowery, Kristin S.; Bonomo, Robert A.			The effect of empiric antimicrobial treatment duration on detection of bacterial DNA in sterile surgical specimens	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; SEVERE SEPSIS; SEPTIC SHOCK; PATHOGENS; OUTCOMES; PCR	Initial antimicrobial treatment of patients with deep seated or invasive infections is typically empiric. Usually, cultures of specimens obtained from the suspected source of infection are performed to identify pathogens and guide continued antimicrobial treatment. When patients present with signs and symptoms of infection, but sterile body fluid or tissue specimens cannot be obtained in a timely fashion, growth of bacterial pathogens in culture may be inhibited following initiation of empiric antibiotic treatment. To address this clinical dilemma, we performed a prospective evaluation of conventional culture vs. PCR coupled to electrospray ionization mass spectrometry (PCR/ESI-MS) on sterile body fluids and tissues submitted to the diagnostic microbiology lab following initiation of empiric antibiotic treatment for patients with suspected infection. In this series of surgical samples, PCR/ESI-MS identified bacterial pathogen(s) in 56% (49/87) of patients with non-diagnostic cultures. Examination of patients stratified by antibiotic treatment duration demonstrated that PCR/ESI-MS sustains high rates of bacterial DNA detection over time by generalized estimating equation models (p<0.0001).	[Farrell, John Joseph; Wang, Huaping] Univ Illinois, Coll Med, Dept Med, Peoria, IL 61656 USA; [Farrell, John Joseph] OSF Syst Lab, Div Clin Microbiol & Serol, Dept Lab Med, Peoria, IL 61603 USA; [Sampath, Rangarajan; Lowery, Kristin S.] Ibis Biosci, Carlsbad, CA USA; [Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	University of Illinois System; University of Illinois Peoria; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Farrell, JJ (corresponding author), Univ Illinois, Coll Med, Dept Med, Peoria, IL 61656 USA.; Farrell, JJ (corresponding author), OSF Syst Lab, Div Clin Microbiol & Serol, Dept Lab Med, Peoria, IL 61603 USA.	jjf@uic.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI063517, R01AI100560]; Antibiotic Resistance Leadership Group under National Institutes of Health [UM1AI104681]; NIH [R01AI072219]; Ibis Biosciences; Geriatric Research Education and Clinical Center VISN	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Antibiotic Resistance Leadership Group under National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ibis Biosciences; Geriatric Research Education and Clinical Center VISN	This work was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI063517 and R01AI100560 to RAB, as well as funds from the Antibiotic Resistance Leadership Group under National Institutes of Health award number UM1AI104681, and NIH award number R01AI072219. The specific roles of all of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. Ibis Biosciences provided support for RS strictly in the form of salary, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff at Ibis Biosciences for their assistance with PCR/ESI-MS, particularly Jenna Cromwell, as well as the staff of the OSF system lab and research department; particularly Lindsay O'Rourke, Ross Barton, Joshua Larson and Gwenn Selby, for their assistance with specimen processing and aerobic and anaerobic bacterial cultures, and Anna Bogner for her help generating figures for publication. We also acknowledge the staff of the research service of the Louis Stokes Cleveland Department of Veterans Affairs Medical Center for their assistance with manuscript review, especially Andrea M. Hujer. Funds provided by the Geriatric Research Education and Clinical Center VISN to RAB facilitated this work. This work was also supported by funds from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI063517 and R01AI100560 to RAB, and through the Antibiotic Resistance Leadership Group under National Institutes of Health award number UM1AI104681, and NIH award number R01AI072219. Funding organizations were not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. RS is employed by Ibis Biosciences, and KSL was formerly employed by Ibis Biosciences. Ibis Biosciences did not play a role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Davey P, 2013, COCHRANE DB SYST REV, V4, P1; Farrell JJ, 2013, J CLIN MICROBIOL, V51, P3464, DOI 10.1128/JCM.01343-13; Farrell JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066349; Flayhart D, 2007, J CLIN MICROBIOL, V45, P816, DOI 10.1128/JCM.02064-06; Hardin JW, 2012, GEN ESTIMATING EQUAT; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Previsdomini M, 2012, CROAT MED J, V53, P30, DOI 10.3325/cmj.2012.53.30; Vazquez-Guillamet C, 2014, CRIT CARE MED, V42, P2342, DOI 10.1097/CCM.0000000000000516; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171074	10.1371/journal.pone.0171074	http://dx.doi.org/10.1371/journal.pone.0171074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170436	Green Submitted, Green Published, gold			2022-12-27	WOS:000393705500021
J	Prajapati, HJ; Kim, HS				Prajapati, Hasmukh J.; Kim, Hyun S.			Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization	PLOS ONE			English	Article							DRUG-ELUTING BEADS; CONCURRENT TRANSARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; PREDICT SURVIVAL; LIVER-CANCER; PHASE-II; SORAFENIB; EFFICACY; SAFETY; COHORT	Purpose To develop the treatment algorithm from multivariate survival analyses (MVA) in patients with Barcelona clinic liver cancer (BCLC) C (advanced) Hepatocellular carcinoma (HCC) patients treated with Trans-arterial Chemoembolization (TACE). Methods Consecutive unresectable and non-tranplantable patients with advanced HCC, who received DEB TACE were studied. A total of 238 patients (mean age, 62.4yrs) was included in the study. Survivals were analyzed according to different parameters from the time of the 1st DEB TACE. Kaplan Meier and Cox Proportional Hazard model were used for survival analysis. The SS was constructed from MVA and named BCLC C HCC Prognostic (BCHP) staging system (SS). Results Overall median survival (OS) was 16.2 months. In HCC patients with venous thrombosis (VT) of large vein [main portal vein (PV), right or left PV, hepatic vein, inferior vena cava] (22.7%) versus small vein (segmental/subsegmental PV) (9.7%) versus no VT had OSs of 6.4 months versus 20 months versus 22.8 months respectively (p<0.001). On MVA, the significant independent prognostic factors (PFs) of survival were CP class, eastern cooperative oncology group (ECOG) performance status (PS), single HCC<5 cm, site of VT, metastases, serum creatinine and serum alpha-feto protein. Based on these PFs, the BCHP staging system was constructed. The OSs of stages I, II and III were 28.4 months, 11.8 months and 2.4 months accordingly (p<0.001). The treatment plan was proposed according to the different stages. Conclusion On MVA of patients with advanced HCC treated with TACE, significant independent prognostic factors (PFs) of survival were CP class, ECOG PS, single HCC<5 cm or others, site of VT, metastases, serum creatinine and serum alpha-feto protein. New BCHP SS was proposed based on MVA data to identify the suitable advanced HCC patients for TACE treatments.	[Prajapati, Hasmukh J.] Univ Tennessee, Hlth Sci Ctr, Div Pediat Intervent Radiol, Dept Radiol, Memphis, TN USA; [Kim, Hyun S.] Yale Univ, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06520 USA; [Kim, Hyun S.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA	University of Tennessee System; University of Tennessee Health Science Center; Yale University; Yale University	Kim, HS (corresponding author), Yale Univ, Dept Radiol & Biomed Imaging, Div Intervent Radiol, New Haven, CT 06520 USA.; Kim, HS (corresponding author), Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA.	kevin.kim@yale.edu		Kim, Hyun/0000-0002-3077-9989				Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Brown DB, 2004, J VASC INTERV RADIOL, V15, P1209, DOI 10.1097/01.RVI.0000128123.04554.C1; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chung YE, 2009, AM J ROENTGENOL, V193, pW7, DOI 10.2214/AJR.07.3947; Dhanasekaran R, 2010, HPB, V12, P174, DOI 10.1111/j.1477-2574.2009.00138.x; Hiraoka A, 2009, HEPATO-GASTROENTEROL, V56, P213; Hu HT, 2011, J VASC INTERV RADIOL, V22, P917, DOI 10.1016/j.jvir.2011.03.005; Hung H, 2005, CURR CANCER DRUG TAR, V5, P131, DOI 10.2174/1568009053202063; Huo TI, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-146; Jin B, 2011, AM J ROENTGENOL, V196, P919, DOI 10.2214/AJR.10.4770; Kalva SP, 2013, J VASC INTERV RADIOL, V24, P257, DOI 10.1016/j.jvir.2012.10.021; Kalva SP, 2013, CARDIOVASCULAR INTER, P1; Lance C, 2011, J VASC INTERV RADIOL, V22, P1697, DOI 10.1016/j.jvir.2011.08.013; Lewandowski RJ, 2010, RADIOLOGY, V255, P955, DOI 10.1148/radiol.10091473; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Malagari K, 2012, CARDIOVASC INTER RAD, V35, P1119, DOI 10.1007/s00270-012-0394-0; Olivo M, 2010, DIGEST LIVER DIS, V42, P515, DOI 10.1016/j.dld.2009.09.012; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Pinter M, 2012, RADIOLOGY, V263, P590, DOI 10.1148/radiol.12111550; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Prajapati HJ, 2013, J VASC INTERV RADIOL, V24, P307, DOI 10.1016/j.jvir.2012.11.026; Sellers MT, 2013, J VASC INTERV RADIOL, V24, P647, DOI 10.1016/j.jvir.2012.12.003; Shin BS, 2011, ACTA RADIOL, V52, P331, DOI 10.1258/ar.2010.100369; Uraki J, 2004, EUR J RADIOL, V51, P12, DOI 10.1016/S0720-048X(03)00219-5; Yau T, 2014, GASTROENTEROLOGY, V146, P1691, DOI 10.1053/j.gastro.2014.02.032	28	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170750	10.1371/journal.pone.0170750	http://dx.doi.org/10.1371/journal.pone.0170750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170405	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500010
J	Zhang, YL; Xu, WJ; Duan, PP; Cong, YH; An, TT; Yu, N; Zou, HT; Dang, XL; An, J; Fan, QF; Zhang, YL				Zhang, Yuling; Xu, Wenjing; Duan, Pengpeng; Cong, Yaohui; An, Tingting; Yu, Na; Zou, Hongtao; Dang, Xiuli; An, Jing; Fan, Qingfeng; Zhang, Yulong			Evaluation and simulation of nitrogen mineralization of paddy soils in Mollisols area of Northeast China under waterlogged incubation	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; SUBMERGED RICE SOILS; AMMONIUM PRODUCTION; N MINERALIZATION; COMMUNITY STRUCTURE; MICROBIAL BIOMASS; REDUCIBLE IRON; ARABLE SOIL; PH; PLANTS	Background Understanding the nitrogen (N) mineralization process and applying appropriate model simulation are key factors in evaluating N mineralization. However, there are few studies of the N mineralization characteristics of paddy soils in Mollisols area of Northeast China. Materials and methods The soils were sampled from the counties of Qingan and Huachuan, which were located in Mollisols area of Northeast China. The sample soil was incubated under waterlogged at 30 E C in a controlled temperature cabinet for 161 days (a 2: 1 water: soil ratio was maintained during incubation). Three models, i.e. the single first-order kinetics model, the double firstorder kinetics model and the mixed first-order and zero-order kinetics model were used to simulate the cumulative mineralised N (NH4+-N and TSN) in the laboratory and waterlogged incubation. Principal results During 161 days of waterlogged incubation, the average cumulative total soluble N (TSN), ammonium N (NH4+-N), and soluble organic N (SON) was 122.2 mg kg(-1), 85.9 mg kg(-1), and 36.3 mg kg(-1), respectively. Cumulative NH4+-N was significantly (P < 0.05) positively correlated with organic carbon (OC), total N (TN), pH, and exchangeable calcium (Ca), and cumulative TSN was significantly (P < 0.05) positively correlated with OC, TN, and exchangeable Ca, but was not significantly (P > 0.05) correlated with C/ N ratio, cation exchange capacity (CEC), extractable iron (Fe), clay, and sand. When the cumulative NH4+-N and TSN were simulated, the single first-order kinetics model provided the least accurate simulation. The parameter of the double first-order kinetics model also did not represent the actual data well, but the mixed first-order and zero-order kinetics model provided the most accurate simulation, as demonstrated by the estimated standard error, F statistic values, parameter accuracy, and fitting effect. Conclusions Overall, the results showed that SON was involved with N mineralization process, and the mixed first-order and zero-order kinetics model accurately simulates the N mineralization process of paddy soil in Mollisols area of Northeast China under waterlogged incubation.	[Zhang, Yuling; Xu, Wenjing; Duan, Pengpeng; Cong, Yaohui; An, Tingting; Yu, Na; Zou, Hongtao; Dang, Xiuli; An, Jing; Fan, Qingfeng; Zhang, Yulong] Shenyang Agr Univ, Coll Land & Environm Sci, Shenyang, Peoples R China; [Zhang, Yuling; Xu, Wenjing; Duan, Pengpeng; Cong, Yaohui; An, Tingting; Yu, Na; Zou, Hongtao; Dang, Xiuli; An, Jing; Fan, Qingfeng; Zhang, Yulong] Key Lab Northeast Arable Land Conservat Northest, Shenyang, Peoples R China	Shenyang Agricultural University	Zhang, YL (corresponding author), Shenyang Agr Univ, Coll Land & Environm Sci, Shenyang, Peoples R China.; Zhang, YL (corresponding author), Key Lab Northeast Arable Land Conservat Northest, Shenyang, Peoples R China.	ylzsau@163.com	An, Tingting/M-2186-2017; An, Tingting/V-9666-2017; dang, xiuli/ABG-4716-2021; Yu, Na/L-3811-2017	An, Tingting/0000-0002-5263-7375; An, Tingting/0000-0002-5263-7375; dang, xiuli/0000-0002-1702-9745; /0000-0001-6772-5338	National Natural Science Foundation of China [41571280, 41101276]; Agriculture Research and Achievements Industrialization Foundation of Science and Technology Department of Liaoning Province in China [2014213004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Research and Achievements Industrialization Foundation of Science and Technology Department of Liaoning Province in China	This study was financially supported by the National Natural Science Foundation of China (41571280, 41101276) and the Agriculture Research and Achievements Industrialization Foundation of Science and Technology Department of Liaoning Province in China (2014213004).	Abadin J, 2011, PLANT SOIL, V339, P193, DOI 10.1007/s11104-010-0568-y; Pietri JCA, 2009, SOIL BIOL BIOCHEM, V41, P1396, DOI 10.1016/j.soilbio.2009.03.017; Bird JA, 2006, BIOGEOCHEMISTRY, V79, P361, DOI 10.1007/s10533-005-5632-y; Bregliani MM, 2010, COMMUN SOIL SCI PLAN, V41, P1383, DOI 10.1080/00103621003759387; BREMNER JM, 1966, SOIL SCI SOC AM PRO, V30, P577, DOI 10.2136/sssaj1966.03615995003000050015x; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P63, DOI 10.2136/sssaj1993.03615995005700010012x; Cassman KG, 1996, PLANT SOIL, V182, P267, DOI 10.1007/BF00029058; Chen CR, 2005, PLANT SOIL, V277, P285, DOI 10.1007/s11104-005-7530-4; Colberg PJ, 1988, ANAEROBIC MICROBIAL; Cookson WR, 2004, SOIL BIOL BIOCHEM, V36, P2097, DOI 10.1016/j.soilbio.2004.05.013; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Dessureault-Rompre J, 2010, GEODERMA, V157, P97, DOI 10.1016/j.geoderma.2010.04.001; Dessureault-Rompre J, 2010, SOIL SCI SOC AM J, V74, P1218, DOI 10.2136/sssaj2009.0213; Devevre OC, 2001, SOIL SCI SOC AM J, V65, P499, DOI 10.2136/sssaj2001.652499x; Gil MV, 2011, BIORESOURCE TECHNOL, V102, P863, DOI 10.1016/j.biortech.2010.09.010; GONZALEZPRIETO SJ, 1992, PLANT SOIL, V144, P31, DOI 10.1007/BF00018842; Groffman PM, 1996, PLANT SOIL, V183, P61, DOI 10.1007/BF02185565; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Ju X, 2000, PLANT NUTR FERTILIZE, V6, P251; Kalbitz K, 2005, SOIL BIOL BIOCHEM, V37, P1319, DOI 10.1016/j.soilbio.2004.11.028; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li HL, 2003, GEODERMA, V115, P161, DOI 10.1016/S0016-7061(02)00358-0; Li S., 1999, ACTA U AGR BOREALI O, V27, P1; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Lu HL, 2008, SCI AGR SINICA, V10; Lu HongLing, 2008, Plant Nutrition and Fertilizer Science, V14, P1083; Lu HongLing, 2008, Agricultural Sciences in China, V7, P860, DOI 10.1016/S1671-2927(08)60124-8; Lu SB, 2012, GEODERMA, V170, P136, DOI 10.1016/j.geoderma.2011.11.023; Minick KJ, 2011, SOIL BIOL BIOCHEM, V43, P271, DOI 10.1016/j.soilbio.2010.10.009; Murphy DV, 2000, BIOL FERT SOILS, V30, P374, DOI 10.1007/s003740050018; Narteh LT, 1997, GEODERMA, V76, P145, DOI 10.1016/S0016-7061(96)00097-3; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Olk DC, 1996, EUR J SOIL SCI, V47, P293, DOI 10.1111/j.1365-2389.1996.tb01403.x; Peng YY, 2012, J SOIL WATER CONSERV, V5; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P797, DOI 10.1016/j.soilbio.2007.10.014; RICHTER J, 1980, PLANT SOIL, V54, P329, DOI 10.1007/BF02181829; Roden EE, 2002, LIMNOL OCEANOGR, V47, P198, DOI 10.4319/lo.2002.47.1.0198; Ros GH, 2011, SOIL BIOL BIOCHEM, V43, P1714, DOI 10.1016/j.soilbio.2011.04.017; Sahrawat KL, 2002, COMMUN SOIL SCI PLAN, V33, P229, DOI 10.1081/CSS-120002389; Sahrawat KL, 2004, COMMUN SOIL SCI PLAN, V35, P399, DOI 10.1081/CSS-120029721; Sahrawat KL, 2003, COMMUN SOIL SCI PLAN, V34, P1013, DOI 10.1081/CSS-120019106; Sahrawat KL, 2001, COMMUN SOIL SCI PLAN, V32, P1543, DOI 10.1081/CSS-100104211; SCHNITZER M, 1966, SOIL SCI, V102, P361, DOI 10.1097/00010694-196612000-00002; Schulten HR, 1997, BIOL FERT SOILS, V26, P1, DOI 10.1007/s003740050335; SMITH JL, 1980, SOIL SCI SOC AM J, V44, P996, DOI 10.2136/sssaj1980.03615995004400050025x; SMITH SJ, 1987, SOIL SCI SOC AM J, V51, P1191, DOI 10.2136/sssaj1987.03615995005100050018x; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Turrion MB, 2012, J ENVIRON MANAGE, V95, pS245, DOI 10.1016/j.jenvman.2010.10.020; Xu HJ, 2014, ENVIRON SCI TECHNOL, V48, P9391, DOI 10.1021/es5021058; Yamamoto T, 1986, JAPANESE J SOIL SCI; Zhang YL, 2008, CHINESE J SOIL SCI, V4; Zhao W, 2007, PLANT SOIL, V297, P213, DOI 10.1007/s11104-007-9334-1; Zhu Z.L., 1985, SOIL-GERMANY, V17, P2	57	14	17	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171022	10.1371/journal.pone.0171022	http://dx.doi.org/10.1371/journal.pone.0171022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170409	gold, Green Submitted, Green Published			2022-12-27	WOS:000393705500020
J	Desyibelew, HD; Fekadu, A; Woldie, H				Desyibelew, Hanna Demelash; Fekadu, Abel; Woldie, Haile			Recovery rate and associated factors of children age 6 to 59 months admitted with severe acute malnutrition at inpatient unit of Bahir Dar Felege Hiwot Referral hospital therapeutic feeding unite, northwest Ethiopia	PLOS ONE			English	Article							MALNOURISHED CHILDREN; MANAGEMENT; EXPERIENCE; NUTRITION	Background Despite numerous advances made in improving child health and the clinical management protocols for treating severe acute malnutrition at treatment centers, evidences concerning the treatment outcomes are scarce. Therefore, this study was conducted to assess the recovery rate and associated factors of severely acute malnourished children of age 6 to 59 months admitted to inpatient therapeutic feeding unit at Felege Hiwot Referral Hospital. Methods We conducted a hospital-based cross-sectional study including 401 severely malnourished children who were admitted from September 2012 to January 2016. Bivariable and a Multi variable logistic regression model were fitted to identify factors associated with recovery rate. Adjusted Odds ratio with its 95% CI was reported and P-value less than 0.05 was considered as significant. Results Fifty eight percent (58.4%) (95%Cl: 53.1-64.1) of admitted children were recovered with a mean recovery time of 18 ( 6.3) days. Being female, children who were fully and partially vaccinated, who had better MUAC measurement, who stayed longer in the hospital, and children who took routine vitamin-A supplementation had better recovery rate. However, children who had co-morbidity at admission, had human immune virus (HIV) and Tuberculosis (TB) infection, and who had edema were less likely to recover. Interpretation Recovery rate was low as compared to international SPHERE cutoff points (> 75% recovery rate). Interventions that could address the outlined factors would be helpful to improve treatment recovery rate of admitted children.	[Desyibelew, Hanna Demelash] Woldia Univ, Dept Publ Hlth, Fac Hlth Sci, Woldia, Ethiopia; [Fekadu, Abel] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Woldie, Haile] Univ Gondar, Inst Publ Hlth, Dept Human Nutr, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Fekadu, A (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia.	Fekten@yahoo.com	Dadi, Abel Fekadu/AAU-3433-2020	Dadi, Abel Fekadu/0000-0001-9967-7713	University of Gondar	University of Gondar	University of Gondar funded the project.	AHMED AU, 2013, BANGLADESH J CHILD H, V37, P5, DOI DOI 10.3329/bjch.v37i1.15345; Ahmed S, 2014, JCPSP-J COLL PHYSICI, V24, P493, DOI 07.2014/JCPSP.493497; Amsalu Solomon, 2006, Ethiop Med J, V44, P151; [Anonymous], 2009, WHO CHILD GROWTH STA; Briend A, 2010, INDIAN PEDIATR, V47, P655, DOI 10.1007/s13312-010-0094-2; Central Stastics Agency, 2014, ETH MIN DEM HLTH SUR; Chane T, 2014, J NUTR FOOD SCI, V2014; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Dereje N, 2014, J NUTR FOOD SCI, V2014; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Hamill PV, 1977, VITAL HLTH STAT, V11, p[1, i]; Irena AH, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-110; Jarso H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0398-4; Layton R, 2001, SPHER PROJ HUM CHART; Mekonnen L, 2013, SEVERITY MALNUTRITIO; Munthali T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0072-1; Puoane T, 2001, S AFR MED J, V91, P137; Shanka NA, 2015, J NUTR DISORDERS THE, V2015; Singh K, 2014, INDIAN PEDIATR, V51, P21, DOI 10.1007/s13312-014-0328-9; Union African, 2015, SOC EC IMP CHILD NUT; WHO WFP, 2007, COMM BAS MANG SEV AC	21	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171020	10.1371/journal.pone.0171020	http://dx.doi.org/10.1371/journal.pone.0171020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166247	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100019
J	Herrero, O; Morcillo, G; Planello, R				Herrero, Oscar; Morcillo, Gloria; Planello, Rosario			Transcriptional deregulation of genetic biomarkers in Chironomus riparius larvae exposed to ecologically relevant concentrations of di(2-ethylhexyl) phthalate (DEHP)	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FRESH-WATER BENTHOS; HEAT-SHOCK-PROTEIN; DAPHNIA-MAGNA; DI-2-ETHYLHEXYL PHTHALATE; AQUATIC ENVIRONMENT; HSP70 CHAPERONES; HEMOGLOBIN GENES; MESSENGER-RNA; EXPRESSION	Di(2-ethylhexyl) phthalate (DEHP) is a ubiquitous environmental pollutant used worldwide as a plasticizer and solvent in many formulations. Based on available toxicological data, it has been classified as toxic for reproduction and as an endocrine disruptor. Despite this, ecotoxicological studies in aquatic wildlife organisms are still scarce. In the present work, the toxic molecular alterations caused by DEHP in aquatic larvae of the midge Chironomus riparius have been studied, by analyzing the transcriptional activity of genes related to some vital cellular pathways, such as the ribosomal machinery (rpL4, rpL13), the cell stress response (hsc70, hsp70, hsp40, hsp27), the ecdysone hormone pathway (EcR), the energy metabolism (GAPDH), and detoxication processes (CYP4G). Environmentally relevant concentrations (10(-3) to 10(5) mu g/L) and exposure conditions (24 to 96 h) have been tested, as well as the toxic effects after DEHP withdrawal. Although the compound caused no mortality, significant changes were detected in almost all the studied biomarkers: e.g. strong repression of hsp70; general inhibition of EcR; GAPDH activity loss in long exposures; among others. Our data show a general transcriptional downregulation that could be associated with an adaptive response to cell damage. Besides, the activity of the compound as an ecdysone antagonist and its delayed effects over almost all the biomarkers analyzed are described as novel toxic targets in insects.	[Herrero, Oscar; Morcillo, Gloria; Planello, Rosario] Univ Nacl Educ Distancia, Fac Ciencias, Grp Biol & Toxicol Ambiental, Paseo Senda del Rey 9, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED)	Herrero, O (corresponding author), Univ Nacl Educ Distancia, Fac Ciencias, Grp Biol & Toxicol Ambiental, Paseo Senda del Rey 9, Madrid, Spain.	oscar.herrero@ccia.uned.es	Herrero, Óscar/B-3782-2012; Planelló, Rosario/AAQ-5881-2020; Planello, Rosario/V-1462-2019; Planelló, Rosario/E-9975-2015	Herrero, Óscar/0000-0002-1410-368X; Planelló, Rosario/0000-0003-3730-9549; Planelló, Rosario/0000-0003-3730-9549	Ministerio de Economia y Competitividad (Spain) [CTM2015-64913-R]	Ministerio de Economia y Competitividad (Spain)	This research was supported by Ministerio de Economia y Competitividad (Spain) contract grant number CTM2015-64913-R (http://www.idi.mineco.gob.es).; This research was supported by Ministerio de Economia y Competitividad (Spain) contract grant number CTM2015-64913-R. The authors thank Dr. A. Hidalgo and Dr. M. Casanova (CNIC, Madrid, Spain) for their help with spectrophotometry equipment used in enzyme activity tests.	Adams WJ, 1985, AQUATIC TOXICOLOGY H, P87; Anderson TD, 2008, AQUAT TOXICOL, V86, P148, DOI 10.1016/j.aquatox.2007.10.015; Aquilino M., 2014, REV TOXICOL; Aquilino M, 2016, AQUAT TOXICOL, V174, P179, DOI 10.1016/j.aquatox.2016.03.001; ATSDR, 2014, SUPP DOC 2013 PRIOR; ATSDR(AgencyforToxicSubstancesandDiseaseRegistry), 2002, TOX PROF DI 2 ETH PH; Brown D, 1998, CHEMOSPHERE, V36, P1367, DOI 10.1016/S0045-6535(97)10018-2; BROWN D, 1982, CHEMOSPHERE, V11, P427, DOI 10.1016/0045-6535(82)90046-7; BROWN D, 1982, CHEMOSPHERE, V11, P417, DOI 10.1016/0045-6535(82)90045-5; Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Cadogan D. F., 1993, PROGR RUBBER PLASTIC, V10, P1; Call DJ, 2001, ENVIRON TOXICOL CHEM, V20, P1805, DOI 10.1897/1551-5028(2001)020&lt;1805:AAOTTO&gt;2.0.CO;2; Call DJ, 2001, ENVIRON TOXICOL CHEM, V20, P1798, DOI [10.1002/etc.5620200825, 10.1897/1551-5028(2001)020&lt;1798:AAOTTO&gt;2.0.CO;2]; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; Clark K, 2003, HANDB ENVIRON CHEM, V3, P125; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; *EC, 2000, EST PRIOR LIST SUBST; ECB, 2008, EUR UN RISK ASS REP; ECHA-European Chemicals Agency (EChA), 2013, COMM RISK ASS RAC OP; EPA, 2012, 2012 ED DRINK WAT ST; EPA, 1994, WAT QUAL STAND HDB 2; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gao DW, 2016, SCI TOTAL ENVIRON, V541, P986, DOI 10.1016/j.scitotenv.2015.09.148; Gillesby BE, 1998, ENVIRON TOXICOL CHEM, V17, P3, DOI 10.1002/etc.5620170102; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Herrero O, 2012, MUTAT RES-GEN TOX EN, V743, P20, DOI 10.1016/j.mrgentox.2011.12.028; Herrero O, 2016, CHEMOSPHERE, V144, P1874, DOI 10.1016/j.chemosphere.2015.10.051; Herrero O, 2015, CHEMOSPHERE, V128, P266, DOI 10.1016/j.chemosphere.2015.01.059; International Agency for Research on Cancer, 2012, IARC MONOGRAPHS EVAL, V101; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; KNOWLES CO, 1987, ENVIRON TOXICOL CHEM, V6, P201, DOI 10.1897/1552-8618(1987)6[201:CEODPO]2.0.CO;2; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; LAUGHLIN RB, 1978, WATER AIR SOIL POLL, V9, P323; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; Lee SB, 2006, ENVIRON TOXICOL CHEM, V25, P3006, DOI 10.1897/05-601R1.1; Lee SW, 2008, ENVIRON TOXICOL CHEM, V27, P1118, DOI 10.1897/07-219.1; Lee SW, 2009, ENVIRON TOXICOL PHAR, V28, P269, DOI 10.1016/j.etap.2009.05.004; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; MacDonald MM, 2004, ENVIRON TOXICOL CHEM, V23, P2116, DOI 10.1897/03-449; Majumdar TN, 2012, J ENVIRON BIOL, V33, P139; Marinkovic M, 2012, ENVIRON SCI TECHNOL, V46, P12679, DOI 10.1021/es3033617; Martin-Folgar R, 2017, CHEMOSPHERE, V169, P485, DOI 10.1016/j.chemosphere.2016.11.067; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morales M, 2011, COMP BIOCHEM PHYS C, V153, P150, DOI 10.1016/j.cbpc.2010.10.003; Nair PMG, 2015, COMP BIOCHEM PHYS B, V190, P1, DOI 10.1016/j.cbpb.2015.08.004; Nair PMG, 2012, ENVIRON TOXICOL PHAR, V33, P98, DOI 10.1016/j.etap.2011.09.006; Net S, 2015, ENVIRON SCI TECHNOL, V49, P4019, DOI 10.1021/es505233b; *NTP CERHR, 2006, NTP CERHR MON POT HU; OECD, 2006, OECD SER TEST ASS, V55, P125; OECD, 2011, 40 YEARS CHEM SAF OE; OECD, 2008, SURF WAT QUAL REG EE; *OECD, 2004, TEST NO 219 SED WAT; OECD, 2010, TEST NO 233 SED WAT; OECD, 2011, TEST NO 235 CHIR AC; OECD, 2004, TEST NO 218 SED WAT; OEHHA, 2009, TOX PROF DI 2 ETH PH; Oehlmann J, 2003, PURE APPL CHEM, V75, P2207, DOI 10.1351/pac200375112207; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Ozaez I, 2016, SCI TOTAL ENVIRON, V557, P240, DOI 10.1016/j.scitotenv.2016.03.078; Ozaez I, 2014, ENVIRON POLLUT, V192, P19, DOI 10.1016/j.envpol.2014.04.038; Park K, 2014, SCI TOTAL ENVIRON, V470, P1003, DOI 10.1016/j.scitotenv.2013.10.052; Park K, 2012, COMP BIOCHEM PHYS C, V156, P113, DOI 10.1016/j.cbpc.2012.05.002; Park K, 2010, CHEMOSPHERE, V79, P934, DOI 10.1016/j.chemosphere.2010.03.002; Park K, 2008, CHEMOSPHERE, V74, P89, DOI 10.1016/j.chemosphere.2008.09.041; Peropadre A, 2015, TOXICOL IN VITRO, V30, P281, DOI 10.1016/j.tiv.2015.10.009; Peterson JSK, 2004, AQUAT TOXICOL, V66, P345, DOI 10.1016/j.aquatox.2003.10.005; Planello R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140239; Planello R, 2011, AQUAT TOXICOL, V105, P62, DOI 10.1016/j.aquatox.2011.05.011; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Servia MJ, 2006, ECOTOXICOLOGY, V15, P229, DOI 10.1007/s10646-005-0054-0; Shi YJ, 2015, COMP BIOCHEM PHYS C, V174, P32, DOI 10.1016/j.cbpc.2015.06.005; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Somparn A, 2015, J ENVIRON BIOL, V36, P1355; Staples C., 2003, PHTHALATE ESTERS; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; STREUFERT J M, 1980, Transactions of the Missouri Academy of Science, V14, P33; Sun X, 2015, J CELL MOL MED, V19, P581, DOI 10.1111/jcmm.12409; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; US EPA (United States Environmental Protection Agency), 1996, EC EFF TEST GUID OPP; US Food and Drug Administration, 2001, SAF ASS DI 2 ETH PHT; US-EPA, 2000, METH MEAS TOX BIOACC; World Health Organization, 2003, DI 2 ETH PHTHAL DRIN	89	28	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171719	10.1371/journal.pone.0171719	http://dx.doi.org/10.1371/journal.pone.0171719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166271	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100064
J	Lachance, CC; Jurkowski, MP; Dymarz, AC; Robinovitch, SN; Feldman, F; Laing, AC; Mackey, DC				Lachance, Chantelle C.; Jurkowski, Michal P.; Dymarz, Ania C.; Robinovitch, Stephen N.; Feldman, Fabio; Laing, Andrew C.; Mackey, Dawn C.			Compliant flooring to prevent fall-related injuries in older adults: A scoping review of biomechanical efficacy, clinical effectiveness, cost-effectiveness, and workplace safety	PLOS ONE			English	Review							BODY-MASS INDEX; FORCE ATTENUATION; IMPACT FORCE; RISK-FACTORS; BALANCE; COVERINGS; WALKING; CARPET; SURFACE; VINYL	Background Compliant flooring, broadly defined as flooring systems or floor coverings with some level of shock absorbency, may reduce the incidence and severity of fall-related injuries in older adults; however, a lack of synthesized evidence may be limiting widespread uptake. Methods Informed by the Arksey and O'Malley framework and guided by a Research Advisory Panel of knowledge users, we conducted a scoping review to answer: what is presented about the biomechanical efficacy, clinical effectiveness, cost-effectiveness, and workplace safety associated with compliant flooring systems that aim to prevent fall-related injuries in healthcare settings? We searched academic and grey literature databases. Any record that discussed a compliant flooring system and at least one of biomechanical efficacy, clinical effectiveness, cost-effectiveness, or workplace safety was eligible for inclusion. Two independent reviewers screened and abstracted records, charted data, and summarized results. Results After screening 3611 titles and abstracts and 166 full-text articles, we included 84 records plus 56 companion (supplementary) reports. Biomechanical efficacy records (n = 50) demonstrate compliant flooring can reduce fall-related impact forces with minimal effects on standing and walking balance. Clinical effectiveness records (n = 20) suggest that compliant flooring may reduce injuries, but may increase risk for falls. Preliminary evidence suggests that compliant flooring may be a cost-effective strategy (n = 12), but may also result in increased physical demands for healthcare workers (n = 17). Conclusions In summary, compliant flooring is a promising strategy for preventing fall-related injuries from a biomechanical perspective. Additional research is warranted to confirm whether compliant flooring (i) prevents fall-related injuries in real-world settings, (ii) is a cost-effective intervention strategy, and (iii) can be installed without negatively impacting workplace safety. Avenues for future research are provided, which will help to determine whether compliant flooring is recommended in healthcare environments.	[Lachance, Chantelle C.; Jurkowski, Michal P.; Robinovitch, Stephen N.; Feldman, Fabio; Mackey, Dawn C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Lachance, Chantelle C.; Robinovitch, Stephen N.; Feldman, Fabio; Mackey, Dawn C.] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Dymarz, Ania C.] Simon Fraser Univ, WAC Bennett Lib, Burnaby, BC, Canada; [Feldman, Fabio] Fraser Hlth Author, Patient Safety & Injury Prevent, Surrey, BC, Canada; [Laing, Andrew C.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada	Simon Fraser University; University of British Columbia; Simon Fraser University; University of Waterloo	Mackey, DC (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.; Mackey, DC (corresponding author), Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.	dmackey@sfu.ca	VARRECCHIA, TIWANA/AAJ-8712-2021; Lachance, Chantelle C/J-6641-2019	Lachance, Chantelle C/0000-0001-5755-5160; Robinovitch, Stephen/0000-0003-3881-6227; Dymarz, Ania/0000-0003-3942-9093	Knowledge Synthesis Grant from the Canadian Institutes of Health Research [KRS-140996]; Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships; AGE-WELL Graduate Student Award in Technology and Aging; Undergraduate Research Prize from the Department of Biomedical Physiology and Kinesiology at Simon Fraser University; Michael Smith Foundation for Health Research Scholar Award	Knowledge Synthesis Grant from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships(Canadian Institutes of Health Research (CIHR)); AGE-WELL Graduate Student Award in Technology and Aging; Undergraduate Research Prize from the Department of Biomedical Physiology and Kinesiology at Simon Fraser University; Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research)	This study was supported by a Knowledge Synthesis Grant from the Canadian Institutes of Health Research [KRS-140996 to DCM]. CCL is a recipient of Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarships and AGE-WELL Graduate Student Award in Technology and Aging. MPJ received support from an Undergraduate Research Prize from the Department of Biomedical Physiology and Kinesiology at Simon Fraser University. DCM received support from a Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1990, WALKING PATTERNS FAL; Al-Eisawi KW, 1999, APPL ERGON, V30, P235, DOI 10.1016/S0003-6870(98)00019-2; [Anonymous], 2003, Healthc Hazard Manage Monit, V16, P1; [Anonymous], 2016, YEARLY AVERAGE CURRE; [Anonymous], 2010, RUBB FLOOR LONG TERM; [Anonymous], 2016, GLOSS FUND REL TERMS; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Australian New Zealand Clinical Trials Registry, 2005, EXPL STUD EAS WALK P; Beach R, 2013, THESIS; Beach R, 2013, P 37 ANN C AM SOC BI; Bhan S, 2014, J BIOMECH, V47, P2391, DOI 10.1016/j.jbiomech.2014.04.026; Bhan S, 2013, J APPL BIOMECH, V29, P731, DOI 10.1123/jab.29.6.731; Birge S J, 1993, Clin Geriatr Med, V9, P69; Boyer J, 2013, APPL ERGON, V44, P48, DOI 10.1016/j.apergo.2012.04.008; Brawley EC, 1998, BEHAVIORS IN DEMENTIA, P107; Buschman J, 1998, P 40 ANN C AM SOC BI, P943; Casalena JA, 1998, J BIOMECH ENG-T ASME, V120, P527, DOI 10.1115/1.2798023; Casalena JA, 1998, J BIOMECH ENG-T ASME, V120, P518, DOI 10.1115/1.2798022; Chesney D A, 1996, IEEE Trans Rehabil Eng, V4, P182, DOI 10.1109/86.536773; Cogswell Lisa, 2005, Am J Nurs, V105, P16; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Das B, 2002, APPL ERGON, V33, P309, DOI 10.1016/S0003-6870(02)00018-2; Dickinson JI, 2002, GERONTOLOGIST, V42, P552, DOI 10.1093/geront/42.4.552; Dickinson JI, 2001, ENVIRON BEHAV, V33, P279, DOI 10.1177/00139160121972990; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Finlay O, 2007, PHYSIOTHERAPY, V93, P144, DOI 10.1016/j.physio.2006.11.014; Gardner TN, 1998, MED ENG PHYS, V20, P57, DOI 10.1016/S1350-4533(97)00041-6; GLASER RM, 1981, PARAPLEGIA, V19, P220, DOI 10.1038/sc.1981.45; Glinka MN, 2013, J APPL BIOMECH, V29, P563, DOI 10.1123/jab.29.5.563; Glinka MN, 2013, MED ENG PHYS, V35, P108, DOI 10.1016/j.medengphy.2012.04.006; Gustavsson J, 2015, THESIS; Gustavsson J, 2015, INJURY PREV, V21, P320, DOI 10.1136/injuryprev-2014-041468; Hales M, 2015, AATCC REV, V15, P44, DOI 10.14504/ar.15.6.4; Hanger HC, 2014, P 6 BIENN AUSTR NZ F, P66; Harris DD, 2015, HERD-HEALTH ENV RES, V8, P9, DOI 10.1177/1937586715573730; Healey F, 1994, Nurs Times, V90, P40; Heijnen M, 2014, P 22 INT SOC POST GA; Hernandez ME, 2007, P 31 ANN C AM SOC BI; Hester AL, 2015, AM NURSE TODAY, V10, P9; Kleiner AFR, 2013, P 24 BIENN C INT SOC; Knoefel FD, 2008, CAN J GERIATR, V11, P110; Knoefel F, 2013, J AM MED DIR ASSOC, V14, P303, DOI 10.1016/j.jamda.2012.12.077; Koontz AM, 2005, J REHABIL RES DEV, V42, P447, DOI 10.1682/JRRD.2004.08.0106; Kuwae Y, 2004, P ANN INT IEEE EMBS, V26, P4770; Lachance CC, 2016, HUM FACTORS; Lachance CC, 2016, INJURY PREV, P1; Lachance CC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011757; Laing ACT, 2004, J BONE MINER RES, V19, pS315; Laing AC, 2006, J ORTHOP RES, V24, P1405, DOI 10.1002/jor.20172; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Lange B, 2012, THESIS; Latimer N, 2013, AGE AGEING, V42, P641, DOI 10.1093/ageing/aft076; Li N, 2013, J BIOMECH, V46, P1140, DOI 10.1016/j.jbiomech.2013.01.007; LORD SR, 1991, AGE AGEING, V20, P175, DOI 10.1093/ageing/20.3.175; MAKI BE, 1990, APPL ERGON, V21, P107, DOI 10.1016/0003-6870(90)90132-H; Marras WS, 2009, ERGONOMICS, V52, P384, DOI 10.1080/00140130802376075; McGill SM, 1999, ACCIDENT ANAL PREV, V31, P85, DOI 10.1016/S0001-4575(98)00048-7; Mercer J, 2005, P 29 ANN M AM SOC BI, P169; Minns J, 2011, BRIT J OCCUP THER, V74, P41, DOI 10.4276/030802211X12947686093684; Minns Julian, 2004, Nurs Older People, V16, P16; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morse MA., 2012, MINIPIG REPLACE NONR; Nabhani F, 2004, J MATER PROCESS TECH, V153, P139, DOI 10.1016/j.jmatprotec.2004.04.211; Nabhani F, 2002, J MATER PROCESS TECH, V124, P311, DOI 10.1016/S0924-0136(02)00200-5; Njogu F, 2008, COST EFFECTIVENESS I; Okan J, 2015, THESIS; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Paka P, 2011, PROCEDIA ENGINEER, V13, P409, DOI 10.1016/j.proeng.2011.05.106; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Redfern MS, 1997, HUM FACTORS, V39, P445, DOI 10.1518/001872097778827043; Rigby J, 2012, INT J PALLIAT NURS, V18, P235, DOI 10.12968/ijpn.2012.18.5.235; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Ryen L, 2016, EUR J PUBLIC HEALTH, V26, P407, DOI 10.1093/eurpub/ckv197; Shimura Y, 2008, J AGING PHYS ACTIV, V16, pS46; Simpson AHRW, 2004, AGE AGEING, V33, P242, DOI 10.1093/ageing/afh071; Soangra R, 2010, P HUMAN FACTORS ERGO, V54, P2019, DOI [DOI 10.1518/107118110X12829370264042, 10.1177/154193121005402324, DOI 10.1177/154193121005402324]; Soangra R, 2012, BIOMED SCI INSTRUM, V48; Stephens JM, 1999, CLIN REHABIL, V13, P171, DOI 10.1191/026921599668553798; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Tideiksaar R, 1993, PRIDE I J LONG TREM; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1989, N ENGL J MED, V1055; Tricco AC, 2013, BMJ OPEN, V3, P1; van der Woude L. H. V., 2003, Journal of Medical Engineering & Technology, V27, P249, DOI 10.1080/0309190031000096630; Wahlstrom J, 2012, ERGONOMICS, V55, P248, DOI 10.1080/00140139.2011.583360; Warren CJ, 2013, CLIN REHABIL, V27, P258, DOI 10.1177/0269215512455530; Weaver TB, 2016, NAT FALLS PREV C; Wilk E, 2005, AM J NURS, V105, P16, DOI 10.1097/00000446-200510000-00008; WILLMOTT M, 1986, AGE AGEING, V15, P119, DOI 10.1093/ageing/15.2.119; Wright AD, 2014, GAIT POSTURE, V40, P160, DOI 10.1016/j.gaitpost.2014.03.015; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Wright AD, 2011, ACCIDENT ANAL PREV, V43, P1480, DOI 10.1016/j.aap.2011.02.028; Wynn T, 2011, ERGONOMIC APPRAISAL; Yarme J, 2001, NURS HOMES LONG TERM, V82; Zacker C, 1998, INT J TECHNOL ASSESS, V14, P446, DOI 10.1017/S0266462300011429	96	26	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171652	10.1371/journal.pone.0171652	http://dx.doi.org/10.1371/journal.pone.0171652			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166265	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100059
J	Monti, M; Iommelli, F; De Rosa, V; Carriero, MV; Miceli, R; Camerlingo, R; Di Minno, G; Del Vecchio, S				Monti, Marcello; Iommelli, Francesca; De Rosa, Viviana; Carriero, Maria Vincenza; Miceli, Roberta; Camerlingo, Rosa; Di Minno, Giovanni; Del Vecchio, Silvana			Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells	PLOS ONE			English	Article							BREAST-CANCER; PROMOTE; ALPHA(V)BETA(3); EXPRESSION; RECEPTOR; METASTASIS; ACTIVATION; MIGRATION; PAD4	Neutrophil extracellular traps (NETs), originally recognized as a host defense mechanism, were reported to promote thrombosis and metastatic dissemination of cancer cells. Here we tested the role of integrins alpha 5 beta 1 and alpha v beta 3 in the adhesion of cancer cells to NETs. Neutrophil-like cells stimulated with calcium ionophore (A23187) were used as a stable source of cell-free NETs-enriched suspensions. Using NETs as an adhesion substrate, two human K562 cell lines, differentially expressing alpha 5 beta 1 and alpha v beta 3 integrins, were subjected to adhesion assays in the presence or absence of DNAse 1, blocking antibodies against alpha 5 beta 1 or alpha v beta 3 alone or in combination with DNAse 1, and Proteinase K. As expected DNAse 1 treatment strongly inhibited adhesion of both cell lines to NETs. An equivalent significant reduction of cell adhesion to NETs was obtained after treatment of cells with blocking antibodies against alpha 5 beta 1 or alpha v beta 3 indicating that both integrins were able to mediate cell adhesion to NETs. Furthermore, the combination of DNAse 1 and anti-integrin antibody treatment almost completely blocked cell adhesion. Western blot analysis and immunoprecipitation experiments showed a dose-dependent increase of fibronectin levels in samples from stimulated neutrophil-like cells and a direct or indirect interaction of fibronectin with histone H3. Finally, co-immunolocalization studies with confocal microscopy showed that fibronectin and citrullinated histone H3 co-localize inside the web-structure of NETs. In conclusion, our study showed that alpha 5 beta 1 and alpha v beta 3 integrins mediate cell adhesion to NETs by binding to their common substrate fibronectin. Therefore, in addition to mechanical trapping and aspecific adsorption of different cell types driven by DNA/histone complexes, NETs may provide specific binding sites for integrin-mediated cell adhesion of neutrophils, platelets, endothelial and cancer cells thus promoting intimate interactions among these cells.	[Monti, Marcello; Di Minno, Giovanni] Univ Napoli Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy; [Iommelli, Francesca; De Rosa, Viviana; Del Vecchio, Silvana] CNR, Ist Biostrutture & Bioimmagini, Naples, Italy; [Carriero, Maria Vincenza; Miceli, Roberta; Camerlingo, Rosa] Fdn G Pascale, Ist Nazl Tumori, IRCCS, Dipartimento Oncol Sperimentale, Naples, Italy; [Del Vecchio, Silvana] Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; University of Naples Federico II	Del Vecchio, S (corresponding author), CNR, Ist Biostrutture & Bioimmagini, Naples, Italy.; Del Vecchio, S (corresponding author), Univ Napoli Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy.	delvecc@unina.it	Iommelli, Francesca/ABG-7721-2020; De Rosa, Viviana/AAC-3427-2022; Carriero, Maria Vincenza/K-1240-2018; Iommelli, Francesca/ABF-3573-2020; Camerlingo, Rosa/AAB-8349-2022	De Rosa, Viviana/0000-0002-0430-5608; Carriero, Maria Vincenza/0000-0002-9768-2997; Iommelli, Francesca/0000-0002-5132-3593; Camerlingo, Rosa/0000-0001-6488-9740; DEL VECCHIO, Silvana/0000-0002-5466-1213	Associazione Italiana per la Ricerca sul Cancro (AIRC project) [IG-17249]; Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale, Rete delle Biotecnologie Campane	Associazione Italiana per la Ricerca sul Cancro (AIRC project)(Fondazione AIRC per la ricerca sul cancro); Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale, Rete delle Biotecnologie Campane	This work was partly supported by no profit association and public governmental institution: Associazione Italiana per la Ricerca sul Cancro (AIRC project No. IG-17249); Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale 2007/2013, Rete delle Biotecnologie Campane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Gioconda Di Carluccio for her technical assistance in coimmunolocalization studies. This work was partly supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, project No. IG-17249) and Programma Operativo Regionale POR Campania, Fondo Europeo Sviluppo Regionale 2007/2013, Rete delle Biotecnologie Campane.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; [Anonymous], 2012, NATL ACAD SCI US, V109, P13076, DOI [10.1073/pnas.1200419109, DOI 10.1073/PNAS.1200419109]; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; BLYSTONE SD, 1995, J CELL BIOL, V130, P745, DOI 10.1083/jcb.130.3.745; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Carriero MV, 1999, CANCER RES, V59, P5307; Chiaradonna F, 1999, EMBO J, V18, P3013, DOI 10.1093/emboj/18.11.3013; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HOFFSTEIN ST, 1981, J CELL SCI, V50, P315; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; LAFLEUR M, 1987, J BIOL CHEM, V262, P2111; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Millius A, 2009, METHODS MOL BIOL, V571, P167, DOI 10.1007/978-1-60761-198-1_11; Najmeh S, 2015, JOVE-J VIS EXP, DOI 10.3791/52687; Ojo OO, 2015, AM J PHYSIOL-LUNG C, V309, pL1354, DOI 10.1152/ajplung.00054.2015; PANDE H, 1985, J BIOL CHEM, V260, P2301; POMMIER CG, 1984, BLOOD, V64, P858; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Tohme S, 2016, CANCER RES, V76, P1367, DOI 10.1158/0008-5472.CAN-15-1591; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Weber MR, 2016, THROMB RES, V140, pS27, DOI 10.1016/S0049-3848(16)30095-0; Zannetti A, 2009, CLIN CANCER RES, V15, P5224, DOI 10.1158/1078-0432.CCR-08-3270	37	35	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171362	10.1371/journal.pone.0171362	http://dx.doi.org/10.1371/journal.pone.0171362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166238	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100036
J	Tormos, AM; Rius-Perez, S; Jorques, M; Rada, P; Ramirez, L; Valverde, AM; Nebreda, AR; Sastre, J; Talens-Visconti, R				Tormos, Ana M.; Rius-Perez, Sergio; Jorques, Maria; Rada, Patricia; Ramirez, Lorena; Valverde, Angela M.; Nebreda, Angel R.; Sastre, Juan; Talens-Visconti, Raquel			p38 alpha regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; P38 MAPK; NUCLEAR ACTIN; CELL-PROLIFERATION; INDUCED ASSOCIATION; ANIMAL CYTOKINESIS; DOUBLE-BLIND; RHO-GTPASES; GROWTH; PHOSPHORYLATION	Background Hepatocyte poliploidization is an age-dependent process, being cytokinesis failure the main mechanism of polyploid hepatocyte formation. Our aim was to study the role of p38 alpha MAPK in the regulation of actin cytoskeleton and cytokinesis in hepatocytes during development and aging. Methods Wild type and p38 alpha liver-specific knock out mice at different ages (after weaning, adults and old) were used. Results We show that p38 alpha MAPK deficiency induces actin disassembly upon aging and also cytokinesis failure leading to enhanced binucleation. Although the steady state levels of cyclin D1 in wild type and p38 alpha knock out old livers remained unaffected, cyclin B1-alpha marker for G2/M transition-was significantly overexpressed in p38a knock out mice. Our findings suggest that hepatocytes do enter into S phase but they do not complete cell division upon p38 alpha a deficiency leading to cytokinesis failure and binucleation. Moreover, old liver-specific p38 alpha MAPK knock out mice exhibited reduced F-actin polymerization and a dramatic loss of actin cytoskeleton. This was associated with abnormal hyperactivation of RhoA and Cdc42 GTPases. Long-term p38 alpha deficiency drives to inactivation of HSP27, which seems to account for the impairment in actin cytoskeleton as Hsp27-silencing decreased the number and length of actin filaments in isolated hepatocytes. Conclusions p38 alpha MAPK is essential for actin dynamics with age in hepatocytes.	[Tormos, Ana M.; Rius-Perez, Sergio; Jorques, Maria; Sastre, Juan] Univ Valencia Burjassot, Dept Physiol, Valencia, Spain; [Rada, Patricia; Valverde, Angela M.] Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid, Spain; [Rada, Patricia; Valverde, Angela M.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Ramirez, Lorena; Nebreda, Angel R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Nebreda, Angel R.] ICREA, Barcelona, Spain; [Talens-Visconti, Raquel] Univ Valencia Burjassot, Dept Pharm & Pharmaceut Technol & Parasitol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Talens-Visconti, R (corresponding author), Univ Valencia Burjassot, Dept Pharm & Pharmaceut Technol & Parasitol, Valencia, Spain.	raquel.talens@uv.es	Taléns-Visconti, Raquel/P-6621-2019; PEREZ, SERGIO RIUS/T-7766-2017; Rada, Patricia/G-7300-2015; Nebreda, Angel Rodriguez/R-9594-2019; Taléns-Visconti, Raquel/A-9162-2018	Taléns-Visconti, Raquel/0000-0002-9816-9693; Rada, Patricia/0000-0002-6731-2098; Taléns-Visconti, Raquel/0000-0002-9816-9693; Martinez Valverde, Angela/0000-0003-1192-9045	Ministry of Economy and Competitiveness; postdoctoral contract Juan de la Cierva (MINECO, Spain); FEDER [SAF 2015-71208-R]; Spanish Ministry of Economy and Competitiveness (MINECO, Spain) [CSD-2007-00020]; Generalitat Valenciana [GV PROMETEO II 2014-056]; MINECO/FEDER; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII, Spain); MI NECO [BFU2010-17850]; European Commission [ERC 294665]; ICREA Funding Source: Custom	Ministry of Economy and Competitiveness; postdoctoral contract Juan de la Cierva (MINECO, Spain); FEDER(European Commission); Spanish Ministry of Economy and Competitiveness (MINECO, Spain)(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MINECO/FEDER(Spanish Government); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII, Spain); MI NECO(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); ICREA(ICREA)	AMT was recipient of a fellowship from the Ministry of Economy and Competitiveness. PR was recipient of a postdoctoral contract Juan de la Cierva (MINECO, Spain). This work was supported by Grants SAF 2015-71208-R with FEDER funds and CSD-2007-00020 from the Spanish Ministry of Economy and Competitiveness (MINECO, Spain, http://www.mineco.gob.es/portal/site/mineco/) and GV PROMETEO II 2014-056 from Generalitat Valenciana to JS and RTV, and by Grant SAF 2015-65267-R (MINECO/FEDER) and by Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII, Spain) to AMV. ARN was funded by grants from MI NECO (BFU2010-17850) and the European Commission (ERC 294665).	Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090; Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BENVENISTE R, 1988, CELL BIOCHEM FUNCT, V6, P231, DOI 10.1002/cbf.290060403; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bitar KN, 2002, J APPL PHYSIOL, V92, P41, DOI 10.1152/jappl.2002.92.1.41; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389; Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; Davies T, 2012, J CELL BIOL, V198, P769, DOI 10.1083/jcb.201207197; Dubroca C, 2005, HYPERTENSION, V45, P974, DOI 10.1161/01.HYP.0000164582.63421.2d; Duffy JP, 2011, ACS MED CHEM LETT, V2, P758, DOI 10.1021/ml2001455; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Fisk M, 2014, AM J CARDIOVASC DRUG, V14, P155, DOI 10.1007/s40256-014-0063-6; Gaffey K, 2013, EUR RESPIR J, V42, P28, DOI 10.1183/09031936.00170711; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04]; Guay J, 1997, J CELL SCI, V110, P357; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Guo K, 2008, CANCER SCI, V99, P486, DOI 10.1111/j.1349-7006.2007.00702.x; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kalendova A, 2014, HISTOCHEM CELL BIOL, V142, P139, DOI 10.1007/s00418-014-1243-9; Kato K, 2010, EXP THER MED, V1, P579, DOI 10.3892/etm_00000091; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293; Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Navas TA, 2006, LEUKEMIA, V20, P1017, DOI 10.1038/sj.leu.2404200; Newby LK, 2014, LANCET, V384, P1187, DOI 10.1016/S0140-6736(14)60417-7; Normand G, 2010, ADV EXP MED BIOL, V676, P27; Nunez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073; Patil SB, 2004, AM J PHYSIOL-GASTR L, V286, pG635, DOI 10.1152/ajpgi.00261.2003; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pongratz G, 2006, J IMMUNOL, V177, P2926, DOI 10.4049/jimmunol.177.5.2926; Rannou Y, 2012, J CELL SCI, V125, P2844, DOI 10.1242/jcs.058081; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Schiel JA, 2010, THESCIENTIFICWORLDJO, V10, P1424, DOI 10.1100/tsw.2010.129; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Svensson CI, 2005, NEUROSCI LETT, V379, P209, DOI 10.1016/j.neulet.2004.12.064; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tong SE, 2012, J CLIN PHARMACOL, V52, P717, DOI 10.1177/0091270011405496; Tormos AM, 2013, HEPATOLOGY, V57, P1950, DOI 10.1002/hep.26174; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Zeitlin SG, 2001, CURR BIOL, V11, pR514, DOI 10.1016/S0960-9822(01)00307-4; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	90	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171738	10.1371/journal.pone.0171738	http://dx.doi.org/10.1371/journal.pone.0171738			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166285	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100067
J	Martinez-Rincon, RO; Rivera-Perez, C; Diambra, L; Noriega, FG				Martinez-Rincon, Raul O.; Rivera-Perez, Crisalejandra; Diambra, Luis; Noriega, Fernando G.			Modeling the flux of metabolites in the juvenile hormone biosynthesis pathway using generalized additive models and ordinary differential equations	PLOS ONE			English	Article							CORPORA-ALLATA; FARNESOIC ACID; MEVALONATE PATHWAY; METHYL FARNESOATE; JH BIOSYNTHESIS; ENZYME; DEHYDROGENASE; ALLATOSTATIN; STIMULATION; EXPRESSION	Juvenile hormone (JH) regulates development and reproductive maturation in insects. The corpora allata (CA) from female adult mosquitoes synthesize fluctuating levels of JH, which have been linked to the ovarian development and are influenced by nutritional signals. The rate of JH biosynthesis is controlled by the rate of flux of isoprenoids in the pathway, which is the outcome of a complex interplay of changes in precursor pools and enzyme levels. A comprehensive study of the changes in enzymatic activities and precursor pool sizes have been previously reported for the mosquito Aedes aegypti JH biosynthesis pathway. In the present studies, we used two different quantitative approaches to describe and predict how changes in the individual metabolic reactions in the pathway affect JH synthesis. First, we constructed generalized additive models (GAMs) that described the association between changes in specific metabolite concentrations with changes in enzymatic activities and substrate concentrations. Changes in substrate concentrations explained 50% or more of the model deviances in 7 of the 13 metabolic steps analyzed. Addition of information on enzymatic activities almost always improved the fitness of GAMs built solely based on substrate concentrations. GAMs were validated using experimental data that were not included when the model was built. In addition, a system of ordinary differential equations (ODE) was developed to describe the instantaneous changes in metabolites as a function of the levels of enzymatic catalytic activities. The results demonstrated the ability of the models to predict changes in the flux of metabolites in the JH pathway, and can be used in the future to design and validate experimental manipulations of JH synthesis.	[Martinez-Rincon, Raul O.; Rivera-Perez, Crisalejandra] CONACYT, Ctr Invest Biol Noroeste CIBNOR, La Paz, Baja Calif Sur, Mexico; [Diambra, Luis] UNLP, CREG, La Plata, Buenos Aires, Argentina; [Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Noriega, Fernando G.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; National University of La Plata; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.; Noriega, FG (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.	fnoriega@fiu.edu	Martínez-Rincón, Raúl Octavio/AAJ-2658-2021; Rivera-Perez, Crisalejandra/AAM-1269-2021; L, Diambra/F-6319-2015; Martínez-Rincón, Raúl/E-6641-2019	Martínez-Rincón, Raúl Octavio/0000-0002-1204-716X; L, Diambra/0000-0001-8052-4880; Martínez-Rincón, Raúl/0000-0002-1204-716X	NIH-NIAID [2R01AI045545-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NIAID Grant No. 2R01AI045545-15 to FGN.	Agresti A., 2015, FDN LINEAR GEN LINEA; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; COUILLAUD F, 1991, INSECT BIOCHEM, V21, P131, DOI 10.1016/0020-1790(91)90042-D; Crawley MJ, 2013, R BOOK, P557; Evans G., 1993, PRACTICAL NUMERICAL; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; FEYEREISEN R, 1987, MOL CELL ENDOCRINOL, V53, P227, DOI 10.1016/0303-7207(87)90178-X; FEYEREISEN R, 1987, J BIOL CHEM, V262, P2676; FEYEREISEN R, 1981, INSECT BIOCHEM, V11, P401, DOI 10.1016/0020-1790(81)90073-1; FEYEREISEN R, 1981, EUR J BIOCHEM, V118, P231; Feyereisen R., 1985, P391; Goldbeter A, 2013, FEBS LETT, V587, P2778, DOI 10.1016/j.febslet.2013.07.031; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Hastie T., 2009, UNSUPERVISED LEARNIN; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Hernandez-Martinez S, 2015, J INSECT PHYSIOL, V72, P22, DOI 10.1016/j.jinsphys.2014.11.003; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Mayoral JG, 2009, P NATL ACAD SCI USA, V106, P21091, DOI 10.1073/pnas.0909938106; Mayoral JG, 2009, INSECT BIOCHEM MOLEC, V39, P31, DOI 10.1016/j.ibmb.2008.09.010; Nijhout HF, 2008, J INSECT PHYSIOL, V54, P255, DOI 10.1016/j.jinsphys.2007.09.008; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; Nouzova M, 2015, INSECT BIOCHEM MOLEC, V57, P20, DOI 10.1016/j.ibmb.2014.12.003; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Nyati P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143107; Rivera-Perez C, 2015, INSECT BIOCHEM MOLEC, V64, P44, DOI 10.1016/j.ibmb.2015.07.010; Rivera-Perez C, 2014, INSECT BIOCHEM MOLEC, V51, P1, DOI 10.1016/j.ibmb.2014.05.001; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Sutherland TD, 1996, MOL CELL ENDOCRINOL, V120, P115, DOI 10.1016/0303-7207(96)03825-7; Tobe SS, 2012, ADV I PHYS, V18, P305; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	38	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171516	10.1371/journal.pone.0171516	http://dx.doi.org/10.1371/journal.pone.0171516			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158248	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700091
J	Nishida, K; Hagio, S; Kibushi, B; Moritani, T; Kouzaki, M				Nishida, Koji; Hagio, Shota; Kibushi, Benio; Moritani, Toshio; Kouzaki, Motoki			Comparison of muscle synergies for running between different foot strike patterns	PLOS ONE			English	Article							SEQUENTIAL ACTIVATION; REARFOOT STRIKERS; SHOD RUNNERS; LOCOMOTION; FOREFOOT; BAREFOOT; WALKING; CAT; CONSTRUCTION; COMBINATIONS	It is well known that humans run with a fore-foot strike (FFS), a mid-foot strike (MFS) or a rear-foot strike (RFS). A modular neural control mechanism of human walking and running has been discussed in terms of muscle synergies. However, the neural control mechanisms for different foot strike patterns during running have been overlooked even though kinetic and kinematic differences between different foot strike patterns have been reported. Thus, we examined the differences in the neural control mechanisms of human running between FFS and RFS by comparing the muscle synergies extracted from each foot strike pattern during running. Muscle synergies were extracted using non-negative matrix factorization with electromyogram activity recorded bilaterally from 12 limb and trunk muscles in ten male subjects during FFS and RFS running at different speeds (5-15 km/h). Six muscle synergies were extracted from all conditions, and each synergy had a specific function and a single main peak of activity in a cycle. The six muscle synergies were similar between FFS and RFS as well as across subjects and speeds. However, some muscle weightings showed significant differences between FFS and RFS, especially the weightings of the tibialis anterior of the landing leg in synergies activated just before touchdown. The activation patterns of the synergies were also different for each foot strike pattern in terms of the timing, duration, and magnitude of the main peak of activity. These results suggest that the central nervous system controls running by sending a sequence of signals to six muscle synergies. Furthermore, a change in the foot strike pattern is accomplished by modulating the timing, duration and magnitude of the muscle synergy activity and by selectively activating other muscle synergies or subsets of the muscle synergies.	[Nishida, Koji; Hagio, Shota; Kibushi, Benio; Kouzaki, Motoki] Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Sakyo Ku, Kyoto, Japan; [Hagio, Shota; Kibushi, Benio] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Moritani, Toshio] Kyoto Univ, Grad Sch Human & Environm Studies, Appl Physiol Lab, Sakyo Ku, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University	Kouzaki, M (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Sakyo Ku, Kyoto, Japan.	kouzaki.motoki.4x@kyoto-u.ac.jp			Japanese Council for Science, Technology and Innovation (CSTI) [14533567]	Japanese Council for Science, Technology and Innovation (CSTI)	This work was supported by the Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567 Funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Cheung VCK, 2009, P NATL ACAD SCI USA, V106, P19563, DOI 10.1073/pnas.0910114106; Chvatal SA, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00048; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Gruber AH, 2013, J APPL PHYSIOL, V115, P194, DOI 10.1152/japplphysiol.01437.2012; Gunther M, 2002, J BIOMECH, V35, P1459, DOI 10.1016/S0021-9290(02)00183-5; Hagio S, 2015, EXP BRAIN RES, V233, P1811, DOI 10.1007/s00221-015-4253-5; Hagio S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00048; Hagio S, 2014, J NEUROPHYSIOL, V112, P316, DOI 10.1152/jn.00109.2014; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Kouzaki M, 2010, MUSCLE NERVE, V42, P78, DOI 10.1002/mus.21599; Krouchev N, 2006, J NEUROPHYSIOL, V96, P1991, DOI 10.1152/jn.00241.2006; Krouchev N, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00083; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lieberman DE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131354; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Markin SN, 2012, J NEUROPHYSIOL, V107, P2057, DOI 10.1152/jn.00865.2011; Martino G, 2015, J NEUROPHYSIOL, V114, P2867, DOI 10.1152/jn.00029.2015; Rooney BD, 2013, J BIOMECH, V46, P2201, DOI 10.1016/j.jbiomech.2013.06.022; Russo M, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00024; Shih Y, 2013, GAIT POSTURE, V38, P490, DOI 10.1016/j.gaitpost.2013.01.030; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Yakovenko S, 2015, J NEUROSCI, V35, P14476, DOI 10.1523/JNEUROSCI.1908-15.2015; Yakovenko S, 2011, J NEUROPHYSIOL, V105, P388, DOI 10.1152/jn.00469.2010; Yong JR, 2014, J BIOMECH, V47, P3593, DOI 10.1016/j.jbiomech.2014.10.015	31	23	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171535	10.1371/journal.pone.0171535	http://dx.doi.org/10.1371/journal.pone.0171535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158258	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700095
J	Theriault, BC; Woo, SK; Karimy, JK; Keledjian, K; Stokum, JA; Sarkar, A; Coksaygan, T; Ivanova, S; Gerzanich, V; Simard, JM				Theriault, Brianna Carusillo; Woo, Seung Kyoon; Karimy, Jason K.; Keledjian, Kaspar; Stokum, Jesse A.; Sarkar, Amrita; Coksaygan, Turhan; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J. Marc			Cerebral microbleeds in a neonatal rat model	PLOS ONE			English	Article							PERIVENTRICULAR WHITE-MATTER; AMEBOID MICROGLIAL CELLS; HYPOXIA-ISCHEMIA; BRAIN; HEMORRHAGE; PRETERM; MATRIX-METALLOPROTEINASE-9; ENCEPHALOPATHY; VULNERABILITY; INHIBITION	Background In adult humans, cerebral microbleeds play important roles in neurodegenerative diseases but in neonates, the consequences of cerebral microbleeds are unknown. In rats, a single pro-angiogenic stimulus in utero predisposes to cerebral microbleeds after birth at term, a time when late oligodendrocyte progenitors (pre-oligodendrocytes) dominate in the rat brain. We hypothesized that two independent pro-angiogenic stimuli in utero would be associated with a high likelihood of perinatal microbleeds that would be severely damaging to white matter. Methods Pregnant Wistar rats were subjected to intrauterine ischemia (IUI) and low-dose maternal lipopolysaccharide (mLPS) at embryonic day (E) 19. Pups were born vaginally or abdominally at E21-22. Brains were evaluated for angiogenic markers, microhemorrhages, myelination and axonal development. Neurological function was assessed out to 6 weeks. Results mRNA (Vegf, Cd31, Mmp2, Mmp9, Timp1, Timp2) and protein (CD31, MMP2, MMP9) for angiogenic markers, in situ proteolytic activity, and collagen IV immunoreactivity were altered, consistent with an angiogenic response. Vaginally delivered pups exposed to prenatal IUI+mLPS had spontaneous cerebral microbleeds, abnormal neurological function, and dysmorphic, hypomyelinated white matter and axonopathy. Pups exposed to the same pro-angiogenic stimuli in utero but delivered abdominally had minimal cerebral microbleeds, preserved myelination and axonal development, and neurological function similar to naive controls. Conclusions In rats, pro-angiogenic stimuli in utero can predispose to vascular fragility and lead to cerebral microbleeds. The study of microbleeds in the neonatal rat brain at full gestation may give insights into the consequences of microbleeds in human preterm infants during critical periods of white matter development.	[Theriault, Brianna Carusillo; Woo, Seung Kyoon; Karimy, Jason K.; Keledjian, Kaspar; Stokum, Jesse A.; Sarkar, Amrita; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Coksaygan, Turhan; Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu		Sarkar, Amrita/0000-0001-5925-4281; sarkar, amrita/0000-0002-5828-9682				Baburamani AA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00424; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 1998, J NEUROSCI, V18, P6241; Back SA, 2014, CLIN PERINATOL, V41, P1, DOI 10.1016/j.clp.2013.11.001; Bailey KR, 2009, METHODS BEHAV ANAL N; Ballabh P, 2007, NAT MED, V13, P477, DOI 10.1038/nm1558; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; Berger R, 2002, J SOC GYNECOL INVEST, V9, P319, DOI 10.1016/S1071-5576(02)00164-8; Bhatta SRC, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/186560; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Cai J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002379; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; DarleyUsmar V, 1996, PHARM RES-DORDR, V13, P649, DOI 10.1023/A:1016079012214; de Bruine FT, 2014, PEDIATR RADIOL, V44, P305, DOI 10.1007/s00247-013-2803-1; de Vries LS, 2015, NEUROPEDIATRICS, V46, P234, DOI 10.1055/s-0035-1554102; Dubrovskaya N M, 2010, Neurosci Behav Physiol, V40, P231, DOI 10.1007/s11055-009-9235-2; Ebersole JL, 2010, J PERIODONTAL RES, V45, P1, DOI 10.1111/j.1600-0765.2008.01169.x; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; James AH, 2010, HAEMOPHILIA, V16, P420, DOI 10.1111/j.1365-2516.2009.02142.x; Jantzie LL, 2015, DEV NEUROSCI-BASEL, V37, P277, DOI 10.1159/000371721; Kessel I, 2015, AM J PERINATOL; Kessel I, 2016, AM J PERINAT, V33, P130, DOI 10.1055/s-0035-1560042; Kinney HC, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/295389; Koltz MT, 2011, J NEUROSURG-PEDIATR, V8, P628, DOI 10.3171/2011.9.PEDS11174; Lee EJ, 2016, J STROKE, V18, P38, DOI 10.5853/jos.2015.01410; LEVITON A, 1991, J CHILD NEUROL, V6, P35, DOI 10.1177/088307389100600107; Loitfelder M, 2012, PANMINERVA MED, V54, P149; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Ma B, 2015, J TISSUE ENG REGEN M; Mackay LB, 2009, J PERINAT MED, V37, P313, DOI 10.1515/JPM.2009.075; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; McIntyre S, 2013, DEV MED CHILD NEUROL, V55, P499, DOI 10.1111/dmcn.12017; Okamoto T, 2010, EARLY HUM DEV, V86, P251, DOI 10.1016/j.earlhumdev.2010.03.007; Ozkan A, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-16; Rathnasamy G, 2016, MOL NEUROBIOL, V53, P4713, DOI 10.1007/s12035-015-9389-6; Rathnasamy G, 2014, NEUROPHARMACOLOGY, V77, P428, DOI 10.1016/j.neuropharm.2013.10.024; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Salomon L J, 2003, J Matern Fetal Neonatal Med, V13, P224; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P342, DOI 10.1196/annals.1306.027; Schulz CG, 2004, PEDIATR RES, V55, P794, DOI 10.1203/01.PDR.0000120683.68630.FB; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Sepehry AA, 2016, AM J NEURORADIOL, V37, P215, DOI 10.3174/ajnr.A4525; Shams S, 2016, BIOMARK MED, V10, P9, DOI 10.2217/bmm.15.101; Sie LTL, 2000, AM J NEURORADIOL, V21, P852; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Soul JS, 2009, J THORAC CARDIOV SUR, V138, P374, DOI 10.1016/j.jtcvs.2009.02.027; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tosun C, 2015, PEDIATR RES, V77, P663, DOI 10.1038/pr.2015.34; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Xue MZ, 2006, J NEUROSCI, V26, P10281, DOI 10.1523/JNEUROSCI.2806-06.2006; Xue MZ, 2005, BRAIN PATHOL, V15, P273; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009	55	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171163	10.1371/journal.pone.0171163	http://dx.doi.org/10.1371/journal.pone.0171163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158198	Green Submitted, gold, Green Published			2022-12-27	WOS:000396161700035
J	Umarov, RK; Solovyev, VV				Umarov, Ramzan Kh.; Solovyev, Victor V.			Recognition of prokaryotic and eukaryotic promoters using convolutional deep learning neural networks	PLOS ONE			English	Article							SEQUENCE; PREDICTION; ANNOTATION	Accurate computational identification of promoters remains a challenge as these key DNA regulatory regions have variable structures composed of functional motifs that provide gene-specific initiation of transcription. In this paper we utilize Convolutional Neural Networks (CNN) to analyze sequence characteristics of prokaryotic and eukaryotic promoters and build their predictive models. We trained a similar CNN architecture on promoters of five distant organisms: human, mouse, plant (Arabidopsis), and two bacteria (Escherichia coli and Bacillus subtilis). We found that CNN trained on sigma70 subclass of Escherichia coli promoter gives an excellent classification of promoters and non-promoter sequences (Sn = 0.90, Sp = 0.96, CC = 0.84). The Bacillus subtilis promoters identification CNN model achieves Sn = 0.91, Sp = 0.95, and CC = 0.86. For human, mouse and Arabidopsis promoters we employed CNNs for identification of two well-known promoter classes (TATA and non-TATA promoters). CNN models nicely recognize these complex functional regions. For human promoters Sn/Sp/CC accuracy of prediction reached 0.95/0.98/0,90 on TATA and 0.90/0.98/0.89 for non-TATA promoter sequences, respectively. For Arabidopsis we observed Sn/Sp/CC 0.95/0.97/0.91 (TATA) and 0.94/0.94/0.86 (non-TATA) promoters. Thus, the developed CNN models, implemented in CNNProm program, demonstrated the ability of deep learning approach to grasp complex promoter sequence characteristics and achieve significantly higher accuracy compared to the previously developed promoter prediction programs. We also propose random substitution procedure to discover positionally conserved promoter functional elements. As the suggested approach does not require knowledge of any specific promoter features, it can be easily extended to identify promoters and other complex functional regions in sequences of many other and especially newly sequenced genomes.	[Umarov, Ramzan Kh.] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Solovyev, Victor V.] Softberry Inc, Mt Kisco, NY 10549 USA	King Abdullah University of Science & Technology	Solovyev, VV (corresponding author), Softberry Inc, Mt Kisco, NY 10549 USA.	victor@softberry.com	Solovyev, Victor/C-4614-2013	Solovyev, Victor/0000-0001-8885-493X; Umarov, Ramzan/0000-0003-3477-7101	King Abdullah University of Science and Technology; Softberry Inc.	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Softberry Inc.	This study was supported by the King Abdullah University of Science and Technology and Softberry Inc. The King Abdullah University of Science and Technology provided support in the form of salaries for authors RU and VS. VS is employed by Softberry Inc. and provided support for VS in the form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; [Anonymous], 2008, 2008 IEEE Hot Chips 20 Symposium (HCS), DOI 10.1109/HOTCHIPS.2008.7476516; [Anonymous], 2012, ARXIV12115590; Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Azad AKM, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-19; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Chollet F., 2015, KERAS DEEP LEARNING; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Gordon L, 2003, BIOINFORMATICS, V19, P1964, DOI 10.1093/bioinformatics/btg265; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; Jacques PE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-423; Kingma DP., 2014, ADAM METHOD STOCHAST; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Meysman P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088717; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shahmuradov IA, 2005, NUCLEIC ACIDS RES, V33, P1069, DOI 10.1093/nar/gki247; Solovjev V, 2011, METAGENOMICITAPP, P61; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Suzuki A, 2015, NUCLEIC ACIDS RES, V43, pD87, DOI 10.1093/nar/gku1080; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tatarinova Tatiana, 2013, Quant Biol, V1, P261; Theano Development Team, 2016, ARXIV160502688; Wang HQ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-248; Yamamoto YY, 2007, NUCLEIC ACIDS RES, V35, P6219, DOI 10.1093/nar/gkm685; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	43	118	120	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171410	10.1371/journal.pone.0171410	http://dx.doi.org/10.1371/journal.pone.0171410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158264	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700076
J	Neudorf, CM; Smith, N; Lepofsky, D; Toniello, G; Lian, OB				Neudorf, Christina M.; Smith, Nicole; Lepofsky, Dana; Toniello, Ginevra; Lian, Olav B.			Between a rock and a soft place: Using optical ages to date ancient clam gardens on the Pacific Northwest	PLOS ONE			English	Article							BRITISH-COLUMBIA; STIMULATED LUMINESCENCE; SINGLE; QUARTZ; TERRACES; COAST; ENVIRONMENTS; AGRICULTURE; WASHINGTON; CHRONOLOGY	Rock-walled archaeological features are notoriously hard to date, largely because of the absence of suitable organic material for radiocarbon dating. This study demonstrates the efficacy of dating clam garden wall construction using optical dating, and uses optical ages to determine how sedimentation rates in the intertidal zone are affected by clam garden construction. Clam gardens are rock-walled, intertidal terraces that were constructed and maintained by coastal First Nation peoples to increase bivalve habitat and productivity. These features are evidence of ancient shellfish mariculture on the Pacific Northwest and, based on radiocarbon dating, date to at least the late Holocene. Optical dating exploits the luminescence signals of quartz or feldspar minerals to determine the last time the minerals were exposed to sunlight (i.e., their burial age), and thus does not require the presence of organic material. Optical ages were obtained from three clam garden sites on northern Quadra Island, British Columbia, and their reliability was assessed by comparing them to radiocarbon ages derived from shells underneath the clam garden walls, as well as below the terrace sediments. Our optical and radiocarbon ages suggest that construction of these clam garden walls commenced between similar to 1000 and similar to 1700 years ago, and our optical ages suggest that construction of the walls was likely incremental and increased sedimentation rates in the intertidal zone by up to fourfold. Results of this study show that when site characteristics are not amenable to radiocarbon dating, optical dating may be the only viable geochronometer. Furthermore, dating rock-walled marine management features and their geomorphic impact can lead to significant advances in our understanding of the intimate relationships that Indigenous peoples worldwide developed with their seascapes.	[Neudorf, Christina M.; Lian, Olav B.] Univ Fraser Valley, Dept Geog & Environm, Abbotsford, BC, Canada; [Neudorf, Christina M.] Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada; [Neudorf, Christina M.; Smith, Nicole; Lepofsky, Dana; Toniello, Ginevra; Lian, Olav B.] Hakai Inst, Heriot Bay, BC, Canada; [Lepofsky, Dana; Toniello, Ginevra] Simon Fraser Univ, Dept Archaeol, Burnaby, BC, Canada	University of Fraser Valley; Simon Fraser University; Hakai Institute; Simon Fraser University	Neudorf, CM (corresponding author), Univ Fraser Valley, Dept Geog & Environm, Abbotsford, BC, Canada.; Neudorf, CM (corresponding author), Simon Fraser Univ, Dept Geog, Burnaby, BC, Canada.; Neudorf, CM (corresponding author), Hakai Inst, Heriot Bay, BC, Canada.	christina.neudorf@ufv.ca		Neudorf, Christina/0000-0002-4449-2655	Hakai Postdoctoral Fellowship; Hakai Masters Student Fellowship; Natural Science and Engineering Research Council [311281]; Natural Science and Engineering Research Council Research Toolsand Instruments	Hakai Postdoctoral Fellowship; Hakai Masters Student Fellowship; Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Research Council Research Toolsand Instruments	This work was supported by a Hakai Postdoctoral Fellowship to CMN and a Hakai Masters Student Fellowship to GT (no grant number, https://www.hakai.org/), as well as a Natural Science and Engineering Research Council Grant (311281) and Natural Science and Engineering Research Council Research Toolsand Instruments Grant (nograntnumber) to OBL (http://www.nserc-crsng.gc.ca/index_eng.asp).	Acabado S. B., 2012, SENRI ETHNOLOGICAL S, V78, P285, DOI DOI 10.15021/00002522; Aitken M.J., 1998, INTRO OPTICAL DATING; Arnaez J, 2015, CATENA, V128, P122, DOI 10.1016/j.catena.2015.01.021; Augustine S, 2014, CAN GEOGR-GEOGR CAN, V58, P305, DOI 10.1111/cag.12084; Bevan A, 2011, ECOL MODEL, V222, P1303, DOI 10.1016/j.ecolmodel.2010.12.016; Clague JJ, 2011, DEV QUATER SCI, V15, P563, DOI 10.1016/B978-0-444-53447-7.00044-1; connaway J, 2007, 33 MISS DEP ARCH HIS; Davidovich U, 2012, J FIELD ARCHAEOL, V37, P192, DOI 10.1179/0093469012Z.00000000019; Deur D, 2015, HUM ECOL, V43, P201, DOI 10.1007/s10745-015-9743-3; Deur Douglas E., 2005, KEEPING IT LIVING TR, P296; Dortch J., 2006, AUST ARCHAEOL, V62, P38; Erickson CL, 2000, NATURE, V408, P190, DOI 10.1038/35041555; Fowler C.S., 2011, ETHNOBIOLOGY, P285, DOI DOI 10.1002/9781118015872.CH17; Frederick CD, 2000, LANDSCAPE LAND USE P; Freiesleben T, 2015, RADIAT MEAS, V81, P16, DOI 10.1016/j.radmeas.2015.02.004; Gadot Y, 2016, J ARCHAEOL SCI-REP, V6, P397, DOI 10.1016/j.jasrep.2016.02.028; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galbraith RF, 2005, RADIAT MEAS, V39, P289, DOI 10.1016/j.radmeas.2004.03.023; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Given M, 1999, J FIELD ARCHAEOL, V26, P19, DOI 10.1179/009346999792005152; Greilich S, 2005, ARCHAEOMETRY, V47, P645, DOI 10.1111/j.1475-4754.2005.00224.x; Groesbeck AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091235; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Hutchinson I, 2004, QUATERNARY RES, V61, P193, DOI 10.1016/j.yqres.2003.10.004; Jacobs Z, 2011, J ARCHAEOL SCI, V38, P3631, DOI 10.1016/j.jas.2011.08.033; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Lepofsky D, 1995, RADIOCARBON, V37, P917, DOI 10.1017/S0033822200014995; Lepofsky D., 1993, ASIAN PERSPECT, V32, P183; Lepofsky D, 2015, AM ANTIQUITY, V80, P236, DOI 10.7183/0002-7316.80.2.236; Lian OB, 1999, QUATERNARY SCI REV, V18, P1453, DOI 10.1016/S0277-3791(98)00085-7; LIAN OB, 1995, CAN J EARTH SCI, V32, P1194, DOI 10.1139/e95-098; Murray AS, 1997, EARTH PLANET SC LETT, V152, P163, DOI 10.1016/S0012-821X(97)00150-7; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Neudorf CM, 2012, RADIAT MEAS, V47, P696, DOI 10.1016/j.radmeas.2012.04.005; Neudorf CM, 2015, QUAT GEOCHRONOL, V30, P275, DOI 10.1016/j.quageo.2014.12.004; Price S, 2005, AM J ARCHAEOL, V109, P665, DOI 10.3764/aja.109.4.665; Puy A, 2013, J ARID ENVIRON, V89, P45, DOI 10.1016/j.jaridenv.2012.10.008; Reimann T, 2012, QUAT GEOCHRONOL, V11, P28, DOI 10.1016/j.quageo.2012.04.016; Roberts RG, 2000, RADIAT MEAS, V32, P459, DOI 10.1016/S1350-4487(00)00104-9; Roberts RG, 2015, NATURE, V520, P438, DOI 10.1038/520438a; Simms AR, 2011, QUAT GEOCHRONOL, V6, P50, DOI 10.1016/j.quageo.2010.06.004; Sohbati R, 2012, BOREAS, V41, P452, DOI 10.1111/j.1502-3885.2012.00249.x; Spencer JE, 1961, PAC VIEWPOINT, V2, P1; Vafiadou A, 2007, J ARCHAEOL SCI, V34, P1659, DOI 10.1016/j.jas.2006.12.004; White ES, 2009, J CALIF GT BASIN ANT, V29, P183; Wilkinson TJ, 2003, ARCHAEOLOGICAL LANDS; Yoshida H, 2000, RADIAT MEAS, V32, P439, DOI 10.1016/S1350-4487(99)00287-5	48	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171775	10.1371/journal.pone.0171775	http://dx.doi.org/10.1371/journal.pone.0171775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182645	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800106
J	Chetri, M; Odden, M; Wegge, P				Chetri, Madhu; Odden, Morten; Wegge, Per			Snow Leopard and Himalayan Wolf: Food Habits and Prey Selection in the Central Himalayas, Nepal	PLOS ONE			English	Article							LIVESTOCK DEPREDATION; UNGULATE COMMUNITIES; LARGE CARNIVORES; PANTHERA-UNCIA; WILD PREY; DIET; PERCEPTIONS; CONFLICT; PATTERNS; PREDATOR	Top carnivores play an important role in maintaining energy flow and functioning of the ecosystem, and a clear understanding of their diets and foraging strategies is essential for developing effective conservation strategies. In this paper, we compared diets and prey selection of snow leopards and wolves based on analyses of genotyped scats (snow leopards n = 182, wolves n = 57), collected within 26 sampling grid cells (5x5 km) that were distributed across a vast landscape of ca 5000 km(2) in the Central Himalayas, Nepal. Within the grid cells, we sampled prey abundances using the double observer method. We found that interspecific differences in diet composition and prey selection reflected their respective habitat preferences, i.e. snow leopards significantly preferred cliff-dwelling wild ungulates (mainly bharal, 57% of identified material in scat samples), whereas wolves preferred typically plain-dwellers (Tibetan gazelle, kiang and argali, 31%). Livestock was consumed less frequently than their proportional availability by both predators (snow leopard = 27%; wolf = 24%), but significant avoidance was only detected among snow leopards. Among livestock species, snow leopards significantly preferred horses and goats, avoided yaks, and used sheep as available. We identified factors influencing diet composition using Generalized Linear Mixed Models. Wolves showed seasonal differences in the occurrence of small mammals/birds, probably due to the winter hibernation of an important prey, marmots. For snow leopard, occurrence of both wild ungulates and livestock in scats depended on sex and latitude. Wild ungulates occurrence increased while livestock decreased from south to north, probably due to a latitudinal gradient in prey availability. Livestock occurred more frequently in scats from male snow leopards (males: 47%, females: 21%), and wild ungulates more frequently in scats from females (males: 48%, females: 70%). The sexual difference agrees with previous telemetry studies on snow leopards and other large carnivores, and may reflect a high-risk high-gain strategy among males.	[Chetri, Madhu; Odden, Morten] Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Campus Evenstad, Evenstad, Norway; [Chetri, Madhu] Natl Trust Nat Conservat, Khumaltar, Lalitpur, Nepal; [Wegge, Per] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Nepal	Inland Norway University of Applied Sciences	Chetri, M (corresponding author), Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Campus Evenstad, Evenstad, Norway.; Chetri, M (corresponding author), Natl Trust Nat Conservat, Khumaltar, Lalitpur, Nepal.	mchetri@gmail.com	Chetri, Madhu/AAI-6147-2020	Chetri, Madhu/0000-0003-4355-9640	United States Agency for International Development; Inland Norway University of Applied Sciences; Zoological Society of London (Nepal Program Office)	United States Agency for International Development(United States Agency for International Development (USAID)); Inland Norway University of Applied Sciences; Zoological Society of London (Nepal Program Office)	The United States Agency for International Development funded Hariyo Ban Program, Panthera-Kaplan Graduate Awards and National Trust for Nature Conservation supported logistic cost for the field work to MC. Inland Norway University of Applied Sciences and the Zoological Society of London (Nepal Program Office) funded the laboratory cost for the genetic part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BB, 1984, J WILDLIFE MANAGE, V48, P147, DOI 10.2307/3808462; Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; Bahuguna A., 2010, SPECIES IDENTIFICATI; Bailey I, 2013, BEHAV ECOL SOCIOBIOL, V67, P1, DOI 10.1007/s00265-012-1423-3; Brunner H., 1974, IDENTIFICATION MAMMA, DOI [10.1017/S0030605300014253, DOI 10.1017/S0030605300014253]; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chetri M, 2004, P INT C YAK; Chetri M, 2016, ZOOKEYS, P143, DOI 10.3897/zookeys.582.5966; Ciucci P, 2004, WILDLIFE BIOL, V10, P149, DOI 10.2981/wlb.2004.020; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Forsyth DM, 1997, NEW ZEAL J ECOL, V21, P97; Habib B., 2013, TR201301 WILDL I IND, P46; Hines JE, 1994, SCATMAN USGS PATUXAN; Jackson R., 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en; Jackson R. M., 1996, THESIS U LONDON, P233; Jackson Rodney M., 2010, P417; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Johansson O, 2016, BIOL CONSERV, V203, P1, DOI 10.1016/j.biocon.2016.08.034; Johansson O, 2015, BIOL CONSERV, V184, P251, DOI 10.1016/j.biocon.2015.02.003; Jumabay-Uulu K, 2014, ORYX, V48, P529, DOI 10.1017/S0030605313000306; Karmacharya Dibesh B., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-516; Khorozyan I, 2015, BIOL CONSERV, V192, P268, DOI 10.1016/j.biocon.2015.09.031; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LINK WA, 1994, ECOLOGY, V75, P2456, DOI 10.2307/1940899; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Lovari S, 2009, ANIM CONSERV, V12, P559, DOI 10.1111/j.1469-1795.2009.00285.x; Lyngdoh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088349; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCarthy TM, 2005, BIOL CONSERV, V124, P527, DOI 10.1016/j.biocon.2005.03.003; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Odden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079261; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; Oli MK, 1997, MAMMALIA, V61, P355; OLI MK, 1993, J ZOOL, V231, P365, DOI 10.1111/j.1469-7998.1993.tb01924.x; Pandey MR, 2005, OUR NATURE, V3, P42; Pereira P, 2012, ECOL RES, V27, P745, DOI 10.1007/s11284-012-0949-1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Pokharel A., 2006, OUR NAT, V4, P29, DOI [10.3126/on.v4i1.500, DOI 10.3126/ON.V4I1.500]; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Singh NJ, 2011, ORYX, V45, P38, DOI 10.1017/S0030605310000839; STEWART DRM, 1967, J APPL ECOL, V4, P83, DOI 10.2307/2401411; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Suryawanshi KR, 2012, OECOLOGIA, V169, P581, DOI 10.1007/s00442-011-2237-0; Wang J, 2014, CHINESE SCI BULL, V59, P3162, DOI 10.1007/s11434-014-0370-y; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; Wegge P, 2012, WILDLIFE BIOL, V18, P131, DOI 10.2981/11-049; Wingard GJ, 2011, WILDLIFE BIOL, V17, P93, DOI 10.2981/10-046; Yachi S, 2000, EVOL ECOL RES, V2, P957; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	58	57	60	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170549	10.1371/journal.pone.0170549	http://dx.doi.org/10.1371/journal.pone.0170549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178279	gold, Green Published, Green Accepted			2022-12-27	WOS:000393712500009
J	Voronova, V; Zhudenkov, K; Helmlinger, G; Peskov, K				Voronova, Veronika; Zhudenkov, Kirill; Helmlinger, Gabriel; Peskov, Kirill			Interpretation of metabolic memory phenomenon using a physiological systems model: What drives oxidative stress following glucose normalization?	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; INDUCED APOPTOSIS; EXPRESSION; ACTIVATION	Hyperglycemia is generally associated with oxidative stress, which plays a key role in diabetes -related complications. A complex, quantitative relationship has been established between glucose levels and oxidative stress, both in vitro and in vivo. For example, oxidative stress is known to persist after glucose normalization, a phenomenon described as metabolic memory. Also, uncontrolled glucose levels appear to be more detrimental to patients with diabetes (non-constant glucose levels) vs. patients with high, constant glucose levels. The objective of the current study was to delineate the mechanisms underlying such behaviors, using a mechanistic physiological systems modeling approach that captures and integrates essential underlying pathophysiological processes. The proposed model was based on a system of ordinary differential equations. It describes the interplay between reactive oxygen species production potential (ROS), ROS-induced cell alterations, and subsequent adaptation mechanisms. Model parameters were calibrated using different sources of experimental information, including ROS production in cell cultures exposed to various concentration profiles of constant and oscillating glucose levels. The model adequately reproduced the ROS excess generation after glucose normalization. Such behavior appeared to be driven by positive feedback regulations between ROS and ROS-induced cell alterations. The further oxidative stress-related detrimental effect as induced by unstable glucose levels can be explained by inability of cells to adapt to dynamic environment. Cell adaptation to instable high glucose declines during glucose normalization phases, and further glucose increase promotes similar or higher oxidative stress. In contrast, gradual ROS production potential decrease, driven by adaptation, is observed in cells exposed to constant high glucose.	[Voronova, Veronika; Zhudenkov, Kirill; Peskov, Kirill] M&S Decis LLC, Moscow, Russia; [Helmlinger, Gabriel] AstraZeneca, Quantitat Clin Pharmacol, Early Clin Dev, Innovat Med, Boston, MA USA	AstraZeneca	Voronova, V (corresponding author), M&S Decis LLC, Moscow, Russia.	veronika.voronova@msdecisions.ru	Voronova, Veronika/GSI-5604-2022; Zhudenkov, Kirill/AGG-2014-2022	Zhudenkov, Kirill/0000-0003-2991-6189; Peskov, Kirill/0000-0003-0678-5729	MS Decisions LLC; AstraZeneca	MS Decisions LLC; AstraZeneca(AstraZeneca)	V.V., K.Z. and K.P. are employed by M&S Decisions LLC, and G.H. is employed by AstraZeneca. The funders provided support in the form of salaries for authors V.V., K.Z., K.P. and G. H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkoshi S, 2014, LIBYAN J MED, V9, DOI 10.3402/ljm.v9.26236; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS39, DOI 10.2337/dc16-S008; Ceriello A, 2012, VASC PHARMACOL, V57, P133, DOI 10.1016/j.vph.2012.05.005; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Di Wu Q, 1999, AM J PHYSIOL-CELL PH, V277, pC1229, DOI 10.1152/ajpcell.1999.277.6.C1229; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Hou Q, 2015, CARDIOVASC TOXICOL, V15, P140, DOI 10.1007/s12012-014-9276-9; Hovorka R, 1998, J CLIN ENDOCR METAB, V83, P744, DOI 10.1210/jc.83.3.744; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Kowluru RA, 2004, ACTA DIABETOL, V41, P194, DOI 10.1007/s00592-004-0165-8; Kowluru RA, 2003, DIABETES, V52, P818, DOI 10.2337/diabetes.52.3.818; La Sala L, 2015, ACTA DIABETOL, V52, P505, DOI 10.1007/s00592-014-0670-3; Landgraf R, 2004, DIABETES-METAB RES, V20, pS9, DOI 10.1002/dmrr.517; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Meng X, 2008, CLIN EXP MED, V8, P43, DOI 10.1007/s10238-008-0155-1; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-142; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Schisano B, 2011, DIABETOLOGIA, V54, P1219, DOI 10.1007/s00125-011-2049-0; Sun JZ, 2010, MOL CELL BIOCHEM, V343, P27, DOI 10.1007/s11010-010-0495-5; Sun JZ, 2009, CELL BIOCHEM BIOPHYS, V55, P173, DOI 10.1007/s12013-009-9066-3; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang Lei, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P1253, DOI 10.11817/j.issn.1672-7347.2014.12.006; Zhu MM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-13	28	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171781	10.1371/journal.pone.0171781	http://dx.doi.org/10.1371/journal.pone.0171781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178319	gold, Green Published, Green Submitted			2022-12-27	WOS:000393712500071
J	Haliburton, JR; Shao, WJ; Deutschbauer, A; Arkin, A; Abate, AR				Haliburton, John R.; Shao, Wenjun; Deutschbauer, Adam; Arkin, Adam; Abate, Adam R.			Genetic interaction mapping with microfluidic-based single cell sequencing	PLOS ONE			English	Article							HIGH-THROUGHPUT; INTERACTION NETWORKS; SYSTEMS BIOLOGY; E. COLI; MICROORGANISMS; EPISTASIS	Genetic interaction mapping is useful for understanding the molecular basis of cellular decision making, but elucidating interactions genome-wide is challenging due to the massive number of gene combinations that must be tested. Here, we demonstrate a simple approach to thoroughly map genetic interactions in bacteria using microfluidic-based single cell sequencing. Using single cell PCR in droplets, we link distinct genetic information into single DNA sequences that can be decoded by next generation sequencing. Our approach is scalable and theoretically enables the pooling of entire interaction libraries to interrogate multiple pairwise genetic interactions in a single culture. The speed, ease, and low-cost of our approach makes genetic interaction mapping viable for routine characterization, allowing the interaction network to be used as a universal read out for a variety of biology experiments, and for the elucidation of interaction networks in non-model organisms.	[Haliburton, John R.; Abate, Adam R.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Shao, Wenjun; Deutschbauer, Adam; Arkin, Adam] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Deutschbauer, Adam; Arkin, Adam] EO Lawrence Berkeley Natl Lab, Berkeley, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Abate, AR (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	adam.abate@ucsf.edu	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931	National Science Foundation through a CAREER Award [DBI-1253293]; National Institutes of Health (NIH) [HG007233-01, R01-EB019453-01, DP2-AR068129-01]; Defense Advanced Research Projects Agency Living Foundries Program [HR0011-12-C-0065, N66001-12-C-4211, HR0011-12-C-0066]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP2AR068129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383, R01EB019453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Science Foundation through a CAREER Award(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency Living Foundries Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation through a CAREER Award [DBI-1253293]; National Institutes of Health (NIH) [HG007233-01, R01-EB019453-01, DP2-AR068129-01]; Defense Advanced Research Projects Agency Living Foundries Program [contract numbers HR0011-12-C-0065, N66001-12-C-4211, HR0011-12-C-0066]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appling DR, 1999, METHODS, V19, P338, DOI 10.1006/meth.1999.0861; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; BABA T, 2006, MOL SYSTEMS BIOL, V2, P2006, DOI DOI 10.1038/MSB4100050; Babu M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004120; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Baryshnikova A, 2013, ANNU REV GENOM HUM G, V14, P111, DOI 10.1146/annurev-genom-082509-141730; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; CHEVERUD JM, 1995, GENETICS, V139, P1455; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Kumar A, 2016, CELL REP, V14, P648, DOI 10.1016/j.celrep.2015.12.060; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Mordukhova EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110504; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Pritchard JR, 2014, ARTIST HIGH RESOLUTI; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Zeitoun RT, 2015, NATURE BIOTECHNOLOGY	29	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171302	10.1371/journal.pone.0171302	http://dx.doi.org/10.1371/journal.pone.0171302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170417	Green Submitted, Green Published, gold			2022-12-27	WOS:000393705500030
J	El Moujahid, L; Le Roux, X; Michalet, S; Bellvert, F; Weigelt, A; Poly, F				El Moujahid, Lamiae; Le Roux, Xavier; Michalet, Serge; Bellvert, Florian; Weigelt, Alexandra; Poly, Franck			Effect of plant diversity on the diversity of soil organic compounds	PLOS ONE			English	Article							SPECIES-DIVERSITY; PHENOLIC-COMPOUNDS; PRODUCTIVITY RELATIONSHIPS; MICROBIAL COMMUNITIES; CARBON; BIODIVERSITY; RHIZOSPHERE; SELECTION; GRADIENT; FOREST	The effect of plant diversity on aboveground organisms and processes was largely studied but there is still a lack of knowledge regarding the link between plant diversity and soil characteristics. Here, we analyzed the effect of plant identity and diversity on the diversity of extractible soil organic compounds (ESOC) using 87 experimental grassland plots with different levels of plant diversity and based on a pool of over 50 plant species. Two pools of low molecular weight organic compounds, LMW1 and LMW2, were characterized by GC-MS and HPLC-DAD, respectively. These pools include specific organic acids, fatty acids and phenolics, with more organic acids in LMW1 and more phenolics in LMW2. Plant effect on the diversity of LMW1 and LMW2 compounds was strong and weak, respectively. LMW1 richness observed for bare soil was lower than that observed for all planted soils; and the richness of these soil compounds increased twofold when dominant plant species richness increased from 1 to 6. Comparing the richness of LMW1 compounds observed for a range of plant mixtures and for plant monocultures of species present in these mixtures, we showed that plant species richness increases the richness of these ESOC mainly through complementarity effects among plant species associated with contrasted spectra of soil compounds. This could explain previously reported effects of plant diversity on the diversity of soil heterotrophic microorganisms.	[El Moujahid, Lamiae; Le Roux, Xavier; Michalet, Serge; Bellvert, Florian; Poly, Franck] Univ Lyon 1, CNRS, INRA, Lab Ecol Microbienne,UMR 5557,UMR 1418, Villeurbanne, France; [Michalet, Serge; Bellvert, Florian] Univ Lyon 1, CNRS, INRA, UMR5557,UMR 1418,Ctr Etud Subst Nat, Villeurbanne, France; [Weigelt, Alexandra] Univ Leipzig, Dept Systemat Bot & Funct Biodivers, Inst Biol, Leipzig, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Leipzig University	Le Roux, X (corresponding author), Univ Lyon 1, CNRS, INRA, Lab Ecol Microbienne,UMR 5557,UMR 1418, Villeurbanne, France.	xavier.le-roux@univ-lyon1.fr	; MICHALET, Serge/N-6899-2013	LE ROUX, Xavier/0000-0001-9695-0825; MICHALET, Serge/0000-0001-8393-3639	Agence Nationale de la Recherche ANR [ANR-05-BDIV-010-01]; Ecology Department of the National Research Institute for Agronomy Research (INRA EFPA); Ecology Institute of CNRS (CNRS INEE)	Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Ecology Department of the National Research Institute for Agronomy Research (INRA EFPA); Ecology Institute of CNRS (CNRS INEE)	This work was funded by the Agence Nationale de la Recherche ANR, part of the "Discover project (ANR-05-BDIV-010-01) and by the Ecology Department of the National Research Institute for Agronomy Research (INRA EFPA) and Ecology Institute of CNRS (CNRS INEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abalos D, 2014, GLOBAL CHANGE BIOL, V20, P265, DOI 10.1111/gcb.12350; Achkar J, 2005, J AM CHEM SOC, V127, P5332, DOI 10.1021/ja042340g; Allan E, 2013, OECOLOGIA, V173, P223, DOI 10.1007/s00442-012-2589-0; Attard E, 2016, SOIL BIOL BIOCHEM, V97, P31, DOI 10.1016/j.soilbio.2016.02.016; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardon C, 2014, NEW PHYTOL, V204, P620, DOI 10.1111/nph.12944; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Beck JJ, 2007, J NAT PROD, V70, P891, DOI 10.1021/np0605586; Broughton LC, 2000, OECOLOGIA, V125, P420, DOI 10.1007/s004420000456; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chacon ID, 2013, PHYTOCHEM REV, V12, P47, DOI 10.1007/s11101-012-9250-8; DeRito CM, 2005, APPL ENVIRON MICROB, V71, P7858, DOI 10.1128/AEM.71.12.7858-7865.2005; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Gruter D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-68; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Gunina A, 2015, SOIL BIOL BIOCHEM, V90, P87, DOI 10.1016/j.soilbio.2015.07.021; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hayes MHB, 2001, SOIL SCI, V166, P723, DOI 10.1097/00010694-200111000-00002; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; HINTEREGGER C, 1992, APPL MICROBIOL BIOT, V37, P252, DOI 10.1007/BF00178180; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Iyer B, 2016, MICROBIOL RES, V192, P211, DOI 10.1016/j.micres.2016.07.006; Jones DL, 2003, PLANT SOIL, V248, P31, DOI 10.1023/A:1022304332313; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kanani MR, 2011, CHEM BIODIVERS, V8, P503, DOI 10.1002/cbdv.201000148; Le Roux X, 2003, OECOLOGIA, V137, P417, DOI 10.1007/s00442-003-1367-4; Le Roux X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061069; Liu ZF, 2008, ECOL RES, V23, P511, DOI 10.1007/s11284-007-0405-9; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Makoi JHJR, 2007, AFR J BIOTECHNOL, V6, P1358; Martens DA, 2004, GLOBAL CHANGE BIOL, V10, P65, DOI 10.1046/j.1529-8817.2003.00722.x; Meier CL, 2008, OECOLOGIA, V158, P95, DOI 10.1007/s00442-008-1124-9; Meier CL, 2008, J ECOL, V96, P421, DOI 10.1111/j.1365-2745.2008.01356.x; Michalet S, 2013, PLANT PHYSIOL BIOCH, V72, P169, DOI 10.1016/j.plaphy.2013.05.003; Morley NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108144; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Niklaus PA, 2007, ECOLOGY, V88, P3153, DOI 10.1890/06-2100.1; Niklaus PA, 2016, OECOLOGIA, V181, P919, DOI 10.1007/s00442-016-3611-8; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Pelz O, 2005, BIOL FERT SOILS, V41, P153, DOI 10.1007/s00374-004-0826-3; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rovira P, 2010, BIOL FERT SOILS, V46, P355, DOI 10.1007/s00374-009-0437-0; Salles JF, 2009, ECOLOGY, V90, P3324, DOI 10.1890/09-0188.1; Sandnes A, 2005, SOIL BIOL BIOCHEM, V37, P259, DOI 10.1016/j.soilbio.2004.07.036; Sauheitl L, 2010, PLANT SOIL, V334, P353, DOI 10.1007/s11104-010-0387-1; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Shrivastava R, 2011, MICROBIOL-SGM, V157, P1531, DOI 10.1099/mic.0.047191-0; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Souto XC, 2000, J CHEM ECOL, V26, P2025, DOI 10.1023/A:1005504029243; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; van Hees PAW, 2005, SOIL BIOL BIOCHEM, V37, P1, DOI 10.1016/j.soilbio.2004.06.010; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Wardle DA, 1996, FUNCT ECOL, V10, P410, DOI 10.2307/2390291; Warembourg FR, 2003, PLANT SOIL, V256, P347, DOI 10.1023/A:1026147622800; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; WHITEHEAD DC, 1982, J APPL ECOL, V19, P579, DOI 10.2307/2403490; Williams AC, 2001, ECOL RES, V16, P29, DOI 10.1046/j.1440-1703.2001.00368.x; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x; Xie Z, 2014, SOIL BIOL BIOCHEM, V77, P89, DOI 10.1016/j.soilbio.2014.06.024; Zhang YB, 2011, FOREST ECOL MANAG, V262, P361, DOI 10.1016/j.foreco.2011.03.042	62	20	20	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170494	10.1371/journal.pone.0170494	http://dx.doi.org/10.1371/journal.pone.0170494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166250	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100010
J	Morishita, F; Garfin, AMCG; Lew, W; Oh, KH; Yadav, RP; Reston, JC; Infante, LL; Acala, MRC; Palanca, DL; Kim, HJ; Nishikiori, N				Morishita, Fukushi; Garfin, Anna Marie Celina Gonzales; Lew, Woojin; Oh, Kyung Hyun; Yadav, Rajendra-Prasad; Reston, Janeth Cuencaho; Infante, Lenie Lucio; Acala, Maria Rebethia Crueldad; Palanca, Dean Lim; Kim, Hee Jin; Nishikiori, Nobuyuki			Bringing state-of-the-art diagnostics to vulnerable populations: The use of a mobile screening unit in active case finding for tuberculosis in Palawan, the Philippines	PLOS ONE			English	Article							PREVALENCE SURVEY; URBAN SLUMS; RISK GROUPS; ADOLESCENTS; KAMPALA; BURDEN	Background Globally, case detection of tuberculosis (TB) has stabilized in recent years. Active case finding (ACF) has regained an increased attention as a complementary strategy to fill the case detection gap. In the Philippines, the DetecTB project implemented an innovative ACF strategy that offered a one-stop diagnostic service with a mobile unit equipped with enhanced diagnostic tools including chest X-ray (CXR) and Xpert (R) MTB/RIF (Xpert). The project targeted the rural poor, the urban poor, prison inmates, indigenous population and high school students. Methods This is a retrospective review of TB screening data from 25,103 individuals. A descriptive analysis was carried out to compare screening and treatment outcomes across target populations. Univariate and multivariate analyses were performed to identify predictors of TB for each population. The composition of bacteriologically-confirmed cases by smear and symptom status was further investigated. Results The highest yield with lowest number needed to screen NNS) was found in prison (6.2%, NNS: 16), followed by indigenous population (2.9%, NNS: 34), the rural poor (2.2%, NNS: 45), the urban poor (2.1%, NNS: 48), and high school (0.2%, NNS: 495). The treatment success rate for all populations was high with 89.5% in rifampicin-susceptible patients and 83.3% in rifampicin-resistant patients. A relatively higher loss to follow-up rate was observed in indigenous population (7.5%) and the rural poor (6.4%). Only cough more than two weeks showed a significant association with TB diagnosis in all target populations (Adjusted Odds Ratio ranging from 1.71 to 6.73) while other symptoms and demographic factors varied in their strength of association. The urban poor had the highest proportion of smear-positive patients with cough more than two weeks (72.0%). The proportion of smear-negative (Xpert-positive) patients without cough more than two weeks was the highest in indigenous population (39.3%), followed by prison inmates (27.7%), and the rural poor (22.8%). Conclusions The innovative ACF strategy using mobile unit yielded a substantial number of TB patients and achieved successful treatment outcomes. TB screening in prison, indigenous population, and urban and rural poor communities was found to be effective. The combined use of CXR and Xpert largely contributed to increased case detection.	[Morishita, Fukushi; Nishikiori, Nobuyuki] World Hlth Org Reg Off Western Pacific, Manila, Philippines; [Garfin, Anna Marie Celina Gonzales] Dept Hlth, Natl TB Control Programme, Manila, Philippines; [Lew, Woojin] World Hlth Org Representat Off Mongolia, Ulaanbaatar, Mongolia; [Oh, Kyung Hyun; Kim, Hee Jin] Korean Inst TB, Cheongju, South Korea; [Yadav, Rajendra-Prasad; Reston, Janeth Cuencaho; Infante, Lenie Lucio] World Hlth Org Representat Off Philippines, Manila, Philippines; [Acala, Maria Rebethia Crueldad] Prov Hlth Off Palawan, Puerto Princesa, Philippines; [Palanca, Dean Lim] City Hlth Off Puerto Princesa City, Puerto Princesa, Philippines	World Health Organization; Philippine Department Health; World Health Organization; World Health Organization	Morishita, F (corresponding author), World Hlth Org Reg Off Western Pacific, Manila, Philippines.	morishita.fukushi@gmail.com	Kim, Heejin/HII-8568-2022	Nishikiori, Nobuyuki/0000-0003-0962-8868; Yadav, Rajendra Prasad/0000-0002-0398-1313	Government of the Republic of Korea through the Korean Foundation for International Healthcare (KOFIH); Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Government of Japan through Ministry of Health, Labour and Welfare	Government of the Republic of Korea through the Korean Foundation for International Healthcare (KOFIH); Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Government of Japan through Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	The DetecTB project was funded by the Government of the Republic of Korea through the Korean Foundation for International Healthcare (KOFIH). This study was financially supported by the Government of the Republic of Korea through Korean Centers for Disease Control & Prevention, and the Government of Japan through Ministry of Health, Labour and Welfare. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the views of the authors' organization or affiliations.	Adetifa IMO, 2016, B WORLD HEALTH ORGAN, V94, P433, DOI 10.2471/BLT.14.151670; Banu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077721; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; CASSELS A, 1982, TUBERCLE, V63, P175, DOI 10.1016/S0041-3879(82)80028-7; Cavanaugh JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047855; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001057; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Department of Health Philippines, 2014, MAN PROC NAT TUB CON, V5th; Eang MT, 2012, BMC PUBLIC HEALTH, V12, P1; Fatima R, 2014, INT J TUBERC LUNG D, V18, P1099, DOI 10.5588/ijtld.14.0001; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; International Committee of the Red Cross, 2010, PHIL PROT DIGN PLAC; International Committee of the Red Cross, 2016, PHIL LARG MASS SCREE; International Union Against Tuberculosis and Lung Disease, 2009, PHIL TB SOC PUBL STU; John S, 2015, INT J TUBERC LUNG D, V19, P463, DOI 10.5588/ijtld.14.0679; Kapata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146392; Khanal S, 2016, PUBLIC HEALTH ACTION, V6, P136, DOI 10.5588/pha.16.0015; KNCV Tuberculosis Foundation, 2008, WORK DOC CHEST XRAY; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Law I, 2015, TROP MED INT HEALTH, V20, P1146, DOI 10.1111/tmi.12536; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lorent N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092754; Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652; Mahomed H, 2013, TUBERCULOSIS, V93, P357, DOI 10.1016/j.tube.2013.02.007; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Morishita F, 2016, PLOS ONE, V11; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; Mupere E, 2013, INT J TUBERC LUNG D, V17, P207, DOI 10.5588/ijtld.12.0160; Nduba V, 2015, INT J INFECT DIS, V35, P11, DOI 10.1016/j.ijid.2015.03.008; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Ogbudebe CL, 2015, INT J MYCOBACT, V4, P18, DOI 10.1016/j.ijmyco.2014.12.007; Prasad BM, 2016, PUBLIC HEALTH ACTION, V6, P15, DOI 10.5588/pha.15.0035; Romualdez AG, 2011, PHILIPPINES HLTH SYS; Santha T, 2003, INT J TUBERC LUNG D, V7, P258; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shapiro AE, SYST REV NUMBER NEED; Tollefson D, 2013, INT J TUBERC LUNG D, V17, P1139, DOI 10.5588/ijtld.12.0385; Tropical Disease Foundation Inc. Department of Health the Philippines, 2008, NAT TUB PREV SURV 20; United Nations, 2015, 2030 AG SUST DEV; Van't Hoog A, 2013, SYST REV SENSITIVITY; Vianzon R, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2012.3.4.022, 10.5365/wpsar.2012.3.4.022]; Waako J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-349; WHO, 2016, GLOB TUB REP; WHO, 2013, WHOHTMTB201304; World Health Organisation, 2015, WHOHTMTB201516; World Health Organization, 2013, DEFINITIONS REPORTIN; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	52	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171310	10.1371/journal.pone.0171310	http://dx.doi.org/10.1371/journal.pone.0171310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152082	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200124
J	Patino-Galindo, JA; Torres-Puente, M; Bracho, MA; Alastrue, I; Juan, A; Navarro, D; Galindo, MJ; Gimeno, C; Ortega, E; Gonzalez-Candelas, F				Patino-Galindo, Juana Angel; Torres-Puente, Manoli; Bracho, Maria Alma; Alastrue, Ignacio; Juan, Amparo; Navarro, David; Galindo, Maria Jose; Gimeno, Concepcion; Ortega, Enrique; Gonzalez-Candelas, Fernando			Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PERFORMANCE; REVEALS; TRENDS; SEX; MEN; ERA	We describe and characterize an exceptionally large HIV-1 subtype B transmission cluster occurring in the Comunidad Valenciana (CV, Spain). A total of 1806 HIV-1 protease-reverse transcriptase (PR/RT) sequences from different patients were obtained in the CV between 2004 and 2014. After subtyping and generating a phylogenetic tree with additional HIV-1 subtype B sequences, a very large transmission cluster which included almost exclusively sequences from the CV was detected (n = 143 patients). This cluster was then validated and characterized with further maximum-likelihood phylogenetic analyses and Bayesian coalescent reconstructions. With these analyses, the CV cluster was delimited to 113 patients, predominately men who have sex with men (MSM). Although it was significantly located in the city of Valencia (n = 105), phylogenetic analyses suggested this cluster derives from a larger HIV lineage affecting other Spanish localities (n = 194). Coalescent analyses estimated its expansion in Valencia to have started between 1998 and 2004. From 2004 to 2009, members of this cluster represented only 1.46% of the HIV-1 subtype B samples studied in Valencia (n = 5/143), whereas from 2010 onwards its prevalence raised to 12.64% (n = 100/791). In conclusion, we have detected a very large transmission cluster in the CV where it has experienced a very fast growth in the recent years in the city of Valencia, thus contributing significantly to the HIV epidemic in this locality. Its transmission efficiency evidences shortcomings in HIV control measures in Spain and particularly in Valencia.	[Patino-Galindo, Juana Angel; Torres-Puente, Manoli; Bracho, Maria Alma; Gonzalez-Candelas, Fernando] Univ Valencia, Unidad Mixta Infecc & Salud Publ FISABIO, CSISP, Valencia, Spain; [Patino-Galindo, Juana Angel; Torres-Puente, Manoli; Bracho, Maria Alma; Gonzalez-Candelas, Fernando] CIBER Epidemiol & Salud Publ, Valencia, Spain; [Alastrue, Ignacio; Juan, Amparo] Unidad Prevenc SIDA & Otras ITS, Valencia, Spain; [Navarro, David; Galindo, Maria Jose] Univ Valencia, Hosp Clin Univ, Valencia, Spain; [Gimeno, Concepcion; Ortega, Enrique] Hosp Gen Univ, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinic Universitari de Valencia; University of Valencia; Hospital Clinic Universitari de Valencia	Gonzalez-Candelas, F (corresponding author), Univ Valencia, Unidad Mixta Infecc & Salud Publ FISABIO, CSISP, Valencia, Spain.; Gonzalez-Candelas, F (corresponding author), CIBER Epidemiol & Salud Publ, Valencia, Spain.	fernando.gonzalez@uv.es	Candelas, Fernando Gonzalez/G-5681-2010; Bracho, Maria/K-6018-2014; Torres-Puente, Manuela/P-1791-2016	Candelas, Fernando Gonzalez/0000-0002-0879-5798; Bracho, Maria/0000-0002-9204-5526; Torres-Puente, Manuela/0000-0002-8352-180X; Patino-Galindo, Juan Angel/0000-0002-6832-7179	Ministerio de Economia y Competitividad (Spanish Government) [BFU2014-58565-R]; Ministerio de Sanidad y Consumo (Spanish Government) [CP07/00078]; Gilead Science SL	Ministerio de Economia y Competitividad (Spanish Government); Ministerio de Sanidad y Consumo (Spanish Government); Gilead Science SL(Gilead Sciences)	This work was partly supported by project BFU2014-58565-R from Ministerio de Economia y Competitividad (Spanish Government) to FGC, project CP07/00078 from Ministerio de Sanidad y Consumo (Spanish Government) to MAB, and Gilead Science SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; Bracho MA, 2014, JAIDS-J ACQ IMM DEF, V65, pE130, DOI 10.1097/01.qai.0000435602.73469.56; Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001898; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; DGSP, 2014, VIG EP VIH SIDA ENES; Diez M, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.47.20971; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holguin A, 2005, J MED VIROL, V75, P374, DOI 10.1002/jmv.20280; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Galindo JAP, 2015, J CLIN VIROL, V69, P146, DOI 10.1016/j.jcv.2015.06.094; Patino-Galindo JA, 2016, INFECT GENET EVOL, V40, P91, DOI 10.1016/j.meegid.2016.02.028; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2016, R FDN STAT COMP; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; UNAIDS/WHO, 2002, REP GLOB HIV AIDS EP; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171062	10.1371/journal.pone.0171062	http://dx.doi.org/10.1371/journal.pone.0171062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152089	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200081
J	van den Berg, EH; Amini, M; Schreuder, TCMA; Dullaart, RPF; Faber, KN; Alizadeh, BZ; Blokzijl, H				van den Berg, Eline H.; Amini, Marzyeh; Schreuder, Tim C. M. A.; Dullaart, Robin P. F.; Faber, Klaas Nico; Alizadeh, Behrooz Z.; Blokzijl, Hans			Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE VALUES; METABOLIC SYNDROME; HEPATIC STEATOSIS; RISK-FACTORS; INSULIN-RESISTANCE; RENAL-DISEASE; UNITED-STATES; STEATOHEPATITIS; ATHEROSCLEROSIS	Background & aims Non-alcoholic fatty liver disease is an increasing health issue that develops rather unnoticed with obesity, type 2 diabetes mellitus and metabolic syndrome. We investigated prevalence, determinants and associated metabolic abnormalities of non-alcoholic fatty liver disease in the largest population-based cohort to date. Methods Biochemical characteristics, type 2 diabetes mellitus and metabolic syndrome were determined in the Lifelines Cohort Study (N = 167,729), a population-based cohort in the North of the Netherlands. Non-alcoholic fatty liver disease was defined as Fatty Liver Index (FLI)>= 60. Exclusion criteria were age <18 years, immigrants, missing data to assess FLI and metabolic syndrome, excessive alcohol use, previous-diagnosed hepatitis or cirrhosis and nonfasting blood sampling. Results Out of 37,496 included participants (median age 44 years, 62.1% female), 8,259 (22.0%) had a FLI >= 60. Individuals with a FLI >= 60 were more often male, older, obese, had higher levels of hemoglobinA1c, fasting glucose, liver enzymes, total cholesterol, low-density lipoprotein cholesterol, triglycerides, c-reactive protein and leucocytes and lower high-density lipoprotein cholesterol (all P<0.0001). Participants with a FLI >= 60 showed higher prevalence of type 2 diabetes mellitus (9.3% vs. 1.4%), metabolic syndrome (54.2% vs. 6.2%), impaired renal function (20.1% vs. 8.7%) and cardiovascular disease (4.6% vs. 1.6%) (all P<0.0001). Multivariable logistic analysis showed that smoking, hemoglobin, leucocytes, c-reactive protein, platelets, alanine aminotransferase, alkaline phosphatase, albumin, impaired renal function (OR 1.27, 95% CI 1.15-1.41), metabolic syndrome (OR 11.89, 95% CI 11.03-12.82) and its individual components hyperglycemia (OR 2.53, 95% CI 2.34-2.72), hypertension (OR 1.89, 95% CI 1.77-2.01) and reduced high-density lipoprotein cholesterol (OR 3.44, 95% CI 3.22-3.68) were independently associated with suspected non-alcoholic fatty liver disease (all P<0.0001). Conclusion Twenty-two percent (22.0%) of the population in the North of the Netherlands is suspected to suffer from non-alcoholic fatty liver disease, coinciding with a significant increased risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease and impaired renal function.	[van den Berg, Eline H.; Schreuder, Tim C. M. A.; Faber, Klaas Nico; Alizadeh, Behrooz Z.; Blokzijl, Hans] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Amini, Marzyeh; Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van den Berg, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	e.h.van.den.berg@umcg.nl		van den Berg, Eline H./0000-0003-2703-2320	Netherlands Organization for Scientific Research [175.010.2007.006]; Economic Structure Enhancing Fund of the Dutch government; Ministry of Economic Affairs, Education, Culture and Science and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; BioSHaRE-EU consortium (KP7) [261433]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund of the Dutch government; Ministry of Economic Affairs, Education, Culture and Science and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; National Consortium for Healthy Ageing; BioSHaRE-EU consortium (KP7)	The Lifelines Cohort Study was supported by the Netherlands Organization for Scientific Research [grant 175.010.2007.006]; the Economic Structure Enhancing Fund of the Dutch government; the Ministry of Economic Affairs, Education, Culture and Science and Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces; the Province of Groningen; University Medical Center Groningen; the University of Groningen; the Dutch Kidney Foundation; the Dutch Diabetes Research Foundation and the National Consortium for Healthy Ageing and the BioSHaRE-EU consortium (KP7, project reference 261433). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Caballeria L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Day CP, 2006, CLIN MED, V6, P19, DOI 10.7861/clinmedicine.6-1-19; Dullaart RPF, 2015, CLIN BIOCHEM, V48, P1045, DOI 10.1016/j.clinbiochem.2015.06.016; EASL, 2016, J HEPATOL; Fedchuk L, 2014, ALIMENT PHARM THER, V40, P1209, DOI 10.1111/apt.12963; Foroughi Mehdi, 2016, Adv Biomed Res, V5, P28, DOI 10.4103/2277-9175.176368; Fracanzani AL, 2008, AM J MED, V121, P72, DOI 10.1016/j.amjmed.2007.08.041; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kanerva N, 2014, AM J CLIN NUTR, V100, P1133, DOI 10.3945/ajcn.114.086074; Klijs B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137203; Kotronen A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-237; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Loguercio C, 2001, J HEPATOL, V35, P568, DOI 10.1016/S0168-8278(01)00192-1; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Ludwig U, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0030-5; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Papatheodoridis GV, 2007, EUR J GASTROEN HEPAT, V19, P281, DOI 10.1097/MEG.0b013e328011438b; Pendino GM, 2005, HEPATOLOGY, V41, P1151, DOI 10.1002/hep.20689; Radu C, 2008, J GASTROINTEST LIVER, V17, P255; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Rockey DC, 2009, HEPATOLOGY BALTIMORE, P1017; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Suomela E, 2015, ANN MED, V47, P40, DOI 10.3109/07853890.2014.966752; Tarnoki AD, 2012, LIVER INT, V32, P1287, DOI 10.1111/j.1478-3231.2012.02823.x; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; van der Voort EAM, 2014, J AM ACAD DERMATOL, V70, P517, DOI 10.1016/j.jaad.2013.10.044; Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226; Volzke H, 2005, WORLD J GASTROENTERO, V11, P1848; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yilmaz Y, 2012, EUR J CLIN INVEST, V42, P411, DOI 10.1111/j.1365-2362.2011.02597.x; Younossi ZM, 2015, HEPATOLOGY; Yu CH, 2012, J HEPATOL, V56, P241, DOI 10.1016/j.jhep.2011.05.027; Yuan HW, 2009, J HEPATOL, V51, P535, DOI 10.1016/j.jhep.2009.03.026; Zois CD, 2010, WORLD J GASTROENTERO, V16, P3944, DOI 10.3748/wjg.v16.i31.3944	45	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171502	10.1371/journal.pone.0171502	http://dx.doi.org/10.1371/journal.pone.0171502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152105	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200149
J	Cerasa, A; Sarica, A; Martino, I; Fabbricatore, C; Tomaiuolo, F; Rocca, F; Caracciolo, M; Quattrone, A				Cerasa, Antonio; Sarica, Alessia; Martino, Iolanda; Fabbricatore, Carmelo; Tomaiuolo, Francesco; Rocca, Federico; Caracciolo, Manuela; Quattrone, Aldo			Increased cerebellar gray matter volume in head chefs	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; PERSONALITY-TRAITS; OLDER-ADULTS; PLASTICITY; MOTOR; COOKING; CORTEX; METAANALYSIS; MECHANISMS	Objective Chefs exert expert motor and cognitive performances on a daily basis. Neuroimaging has clearly shown that that long-term skill learning (i.e., athletes, musicians, chess player or sommeliers) induces plastic changes in the brain thus enabling tasks to be performed faster and more accurately. How a chef's expertise is embodied in a specific neural network has never been investigated. Methods Eleven Italian head chefs with long-term brigade management expertise and 11 demographically-/psychologically-matched non-experts underwent morphological evaluations. Results Voxel-based analysis performed with SUIT, as well as, automated volumetric measurement assessed with Freesurfer, revealed increased gray matter volume in the cerebellum in chefs compared to non-experts. The most significant changes were detected in the anterior vermis and the posterior cerebellar lobule. The magnitude of the brigade staff and the higher performance in the Tower of London test correlated with these specific gray matter increases, respectively. Conclusions We found that chefs are characterized by an anatomical variability involving the cerebellum. This confirms the role of this region in the development of similar expert brains characterized by learning dexterous skills, such as pianists, rock climbers and basketball players. However, the nature of the cellular events underlying the detected morphological differences remains an open question.	[Cerasa, Antonio; Sarica, Alessia; Martino, Iolanda; Rocca, Federico; Caracciolo, Manuela; Quattrone, Aldo] CNR, Ist Bioimmagini & Fisiol Mol, Catanzaro, Italy; [Fabbricatore, Carmelo] Ist Istruz Super Mancini, Cosenza, Italy; [Fabbricatore, Carmelo] Federaz Italiana Cuochi, Rome, Italy; [Tomaiuolo, Francesco] Fdn Volterra Ricerche Auxilium Vitae, Volterra, Italy; [Tomaiuolo, Francesco] Azienda Osped Univ, Unita Operat Psicol Clin, Pisa, Italy; [Quattrone, Aldo] Magna Graecia Univ Catanzaro, Ist Neurol, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Pisa; Azienda Ospedaliero Universitaria Pisana; Magna Graecia University of Catanzaro	Cerasa, A (corresponding author), CNR, Ist Bioimmagini & Fisiol Mol, Catanzaro, Italy.	antonio.cerasa76@gmail.com	cerasa, antonio/E-8614-2011; Tomaiuolo, Francesco/AAC-1534-2019; Sarica, Alessia/AAO-4750-2020; Sarica, Alessia/K-6483-2016	cerasa, antonio/0000-0002-8022-4770; Sarica, Alessia/0000-0003-1362-6718; Tomaiuolo, Fancesco/0000-0003-1230-2770				Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernard JA, 2013, CEREBELLUM, V12, P721, DOI 10.1007/s12311-013-0481-z; Bilalic M, 2011, J NEUROSCI, V31, P10206, DOI 10.1523/JNEUROSCI.5727-10.2011; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cannonieri GC, 2007, NEUROREPORT, V18, P1063, DOI 10.1097/WNR.0b013e3281a030e5; Cerasa A, 2009, AM J NEURORADIOL, V30, P1240, DOI 10.3174/ajnr.A1544; Cerasa A, 2016, PERS INDIV DIFFER, V95, P89, DOI 10.1016/j.paid.2016.02.040; Cerasa A, 2015, PARKINSONISM RELAT D, V21, P165, DOI 10.1016/j.parkreldis.2014.11.012; Cerasa A, 2014, SOC COGN AFFECT NEUR, V9, P1537, DOI 10.1093/scan/nst144; Cerasa A, 2012, EXP NEUROL, V237, P418, DOI 10.1016/j.expneurol.2012.07.020; Chang YM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00035; Costa PT, 2007, REVISED NEO PERSONAL; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; Culinary Institute of America, 2011, PROF CHEF; Di Paola M, 2013, HUM BRAIN MAPP, V34, P2707, DOI 10.1002/hbm.22095; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Doherty TA, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00022; Donzuso G, 2014, BRAIN BEHAV, V4, P504, DOI 10.1002/brb3.232; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00380; Escoffier A., 1903, GUIDE CULINAIRE AIDE; Fehr T, 2010, NEUROPSYCHOLOGIA, V48, P1407, DOI 10.1016/j.neuropsychologia.2010.01.007; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; Gaser C, 2003, J NEUROSCI, V23, P9240; Han Y, 2009, NEUROSCI LETT, V459, P3, DOI 10.1016/j.neulet.2008.07.056; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jung RE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00330; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Laricchiuta D, 2014, HUM BRAIN MAPP, V35, P285, DOI 10.1002/hbm.22174; Leggio M, 2015, CEREBELLUM, V14, P35, DOI 10.1007/s12311-014-0616-x; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; Manto M, 2012, CEREBELLUM, V11, P446, DOI 10.1007/s12311-011-0336-4; Miall RC, 2008, CEREBELLUM, V7, P572, DOI 10.1007/s12311-008-0072-6; Middleton FA, 1997, PROG BRAIN RES, V114, P553; Neumann N, 2016, HUM BRAIN MAPP, V37, P262, DOI 10.1002/hbm.23028; Newman SD, 2007, J CLIN EXP NEUROPSYC, V29, P333, DOI 10.1080/13803390701249051; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Poldrack RA, 2009, SOC COGN AFFECT NEUR, V4, P208, DOI 10.1093/scan/nsp011; Ramnani N, 2014, PROG BRAIN RES, V210, P255, DOI 10.1016/B978-0-444-63356-9.00010-8; Schall U, 2003, NEUROIMAGE, V20, P1154, DOI 10.1016/S1053-8119(03)00338-0; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Taylor JA, 2014, PROG BRAIN RES, V210, P217, DOI 10.1016/B978-0-444-63356-9.00009-1; Terracciano A, 2003, PERS INDIV DIFFER, V35, P1859, DOI 10.1016/S0191-8869(03)00035-7; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wang MY, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00228; Ward G, 2005, CURR ISS THINK REASO, P89; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	63	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171457	10.1371/journal.pone.0171457	http://dx.doi.org/10.1371/journal.pone.0171457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182712	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800061
J	Quaglia, D; Ebert, MCCJC; Mugford, PF; Pelletier, JN				Quaglia, Daniela; Ebert, Maximilian C. C. J. C.; Mugford, Paul F.; Pelletier, Joelle N.			Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening	PLOS ONE			English	Article							ANTARCTICA LIPASE; DIRECTED EVOLUTION; ACTIVE-SITE; PROTEIN; STRATEGIES; MUTATIONS; DIVERSITY; DESIGN; TOOL	The Golden Gate strategy entails the use of type IIS restriction enzymes, which cut outside of their recognition sequence. It enables unrestricted design of unique DNA fragments that can be readily and seamlessly recombined. Successfully employed in other synthetic biology applications, we demonstrate its advantageous use to engineer a biocatalyst. Hot-spots for mutations were individuated in three distinct regions of Candida antarctica lipase A (CalA), the biocatalyst chosen as a target to demonstrate the versatility of this recombination method. The three corresponding gene segments were subjected to the most appropriate method of mutagenesis (targeted or random). Their straightforward reassembly allowed combining products of different mutagenesis methods in a single round for rapid production of a series of diverse libraries, thus facilitating directed evolution. Screening to improve discrimination of short-chain versus long-chain fatty acid substrates was aided by development of a general, automated method for visual discrimination of the hydrolysis of varied substrates by whole cells.	[Quaglia, Daniela; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ, Canada; [Quaglia, Daniela; Ebert, Maximilian C. C. J. C.; Pelletier, Joelle N.] Univ Montreal, CGCC, Montreal, PQ, Canada; [Quaglia, Daniela; Ebert, Maximilian C. C. J. C.; Pelletier, Joelle N.] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Ebert, Maximilian C. C. J. C.; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ, Canada; [Mugford, Paul F.] DSM Nutr Prod, 101 Res Dr, Dartmouth, NS, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; DSM NV	Pelletier, JN (corresponding author), Univ Montreal, Dept Chim, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, CGCC, Montreal, PQ, Canada.; Pelletier, JN (corresponding author), PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.; Pelletier, JN (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ, Canada.	joelle.pelletier@umontreal.ca		Quaglia, Daniela/0000-0003-3756-3782; Ebert, Maximilian/0000-0002-8055-8404	Natural Sciences and Engineering Research Council of Canada [227853, 476466, 490749]; DSM Nutritional Supplements	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); DSM Nutritional Supplements	This work was supported by Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) grants 227853 to J. N. P and 476466 and 490749 to J. N. P and P. F. M., and DSM Nutritional Supplements (www.dsm.corn). The funders provided support in the form of salaries for authors [D.Q., P.F.M.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo-Rocha CG, 2015, SCI REP, V5, P1; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Bendl J, 2016, NUCLEIC ACIDS RES, V44, pW479, DOI 10.1093/nar/gkw416; Brundiek HB, 2012, ANGEW CHEM INT EDIT, V51, P412, DOI 10.1002/anie.201106126; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Davids T, 2013, CURR OPIN CHEM BIOL, V17, P215, DOI 10.1016/j.cbpa.2013.02.022; de Maria PD, 2005, J MOL CATAL B-ENZYM, V37, P36, DOI 10.1016/j.molcatb.2005.09.001; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Ericsson DJ, 2008, J MOL BIOL, V376, P109, DOI 10.1016/j.jmb.2007.10.079; Ferla MP, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0996-7; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Gao XZ, 2013, ANAL BIOCHEM, V437, P172, DOI 10.1016/j.ab.2013.02.028; Gillam EMJ, 2014, METHODS MOL BIOL, V1179, P1, DOI 10.1007/978-1-4939-1053-3; Goldsmith M, 2012, CURR OPIN STRUC BIOL, V22, P406, DOI 10.1016/j.sbi.2012.03.010; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; JETTE JF, 1994, ANAL BIOCHEM, V219, P256, DOI 10.1006/abio.1994.1265; Kazlauskas RJ, 2009, NAT CHEM BIOL, V5, P526, DOI 10.1038/nchembio0809-526; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kirchner SM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071030, 10.1371/journal.pone.0076117]; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Nyyssola A, 2015, INT DAIRY J, V41, P16, DOI 10.1016/j.idairyj.2014.09.003; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Reetz MT, 2013, ANGEW CHEM INT EDIT, V52, P2658, DOI 10.1002/anie.201207842; Rosenfeld L, 2016, TRENDS BIOCHEM SCI, V41, P421, DOI 10.1016/j.tibs.2016.03.002; Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Volpato JP, 2007, J MOL BIOL, V373, P599, DOI 10.1016/j.jmb.2007.07.076; Volpato JP, 2009, J BIOL CHEM, V284, P20079, DOI 10.1074/jbc.M109.018010; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Yan P, 2012, ANAL BIOCHEM, V430, P65, DOI 10.1016/j.ab.2012.07.029; Zhou LB, 2013, GENE, V523, P122, DOI 10.1016/j.gene.2013.03.140	36	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171741	10.1371/journal.pone.0171741	http://dx.doi.org/10.1371/journal.pone.0171741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178357	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500065
J	Rainwater-Lovett, K; Ziemniak, C; Watson, D; Luzuriaga, K; Siberry, G; Petru, A; Chen, YH; Uprety, P; McManus, M; Ho, YC; Lamers, SL; Persaud, D				Rainwater-Lovett, Kaitlin; Ziemniak, Carrie; Watson, Douglas; Luzuriaga, Katherine; Siberry, George; Petru, Ann; Chen, YaHui; Uprety, Priyanka; McManus, Margaret; Ho, Ya-Chi; Lamers, Susanna L.; Persaud, Deborah			Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection	PLOS ONE			English	Article							VIRUS TYPE-1 RECOMBINATION; CD4(+) T-CELLS; LATENT RESERVOIR; HIV-1-INFECTED CHILDREN; VIROLOGICAL CONTROL; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; REPLICATION; SUPPRESSION; CURE	The latent reservoir is a major barrier to HIV eradication. Reservoir size is emerging as an important biomarker to assess the likelihood of HIV remission in the absence of antiretroviral therapy (ART) and may be reduced by earlier initiation of ART that restricts HIV spread into CD4+ T cells. Reservoir size is traditionally measured with a quantitative viral outgrowth assay (QVOA) that induces replication-competent HIV production through in vitro stimulation of resting CD4+ T cells. However, the recent identification of replication-intact, non-induced proviral genomes (NIPG) suggests the QVOA significantly underestimates (by 62-fold) latent reservoir size in chronically-infected adults. Whether formation and persistence of Intact, NIPG is thwarted by early ART initiation and long-term virologic suppression in perinatal infection is unclear. Here, we show that the latent reservoir in 11 early treated, long-term suppressed perinatally infected children and adolescents was not inducible by QVOA and dominated by defective, NIPG. Single genome analysis of 164 NIPG from 232 million cultured resting CD4+ T cells revealed no replication-intact, near-full length sequences. Forty-three (26%) NIPG contained APOBEC3G-mediated hypermutation, 115 (70%) NIPG contained large internal deletions, one NIPG contained nonsense mutations and indels, and 5 (3%) NIPG were assigned as "Not Evaluable" due to multiple failed sequencing attempts that precluded further classification. The lack of replication competent inducible provirus and intact NIPG in this cohort indicate early, long-term ART of perinatal infection leads to marked diminution of replication-competent HIV-1 reservoirs, creating a favorable state towards interventions aimed at virologic remission.	[Rainwater-Lovett, Kaitlin; Ziemniak, Carrie; Chen, YaHui; Uprety, Priyanka; Persaud, Deborah] Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD 21218 USA; [Watson, Douglas] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Luzuriaga, Katherine; McManus, Margaret] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Siberry, George] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Maternal & Pediat Infect Dis Branch, Rockville, MD USA; [Petru, Ann] Childrens Hosp & Res Ctr Oakland, Dept Pediat Infect Dis, Oakland, CA USA; [Ho, Ya-Chi] Johns Hopkins Univ, Sch Med, Dept Med Infect Dis, Baltimore, MD USA; [Lamers, Susanna L.] Bioinfoexperts LLC, Thibodaux, LA USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Johns Hopkins University	Persaud, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Infect Dis, Baltimore, MD 21218 USA.	dpers@jhmi.edu		Ho, Ya-Chi/0000-0002-7046-0147; Rainwater-Lovett, Kaitlin/0000-0002-8707-7339	NIAID; NICHD [R01 HD080474]; Johns Hopkins Center for AIDS Research [P30 A1094189]; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network; NIAID [UM1 Al068632, UM1 Al068616, UM1 Al106716]; NICHD; NIMH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080474] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, P30AI094189, UM1AI106716, UM1AI068632] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Johns Hopkins Center for AIDS Research; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIAID and NICHD (R01 HD080474 to DP), the Johns Hopkins Center for AIDS Research (P30 A1094189), and subspecialty laboratory funding to DP from the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. Overall support for IMPAACT was provided by NIAID (UM1 Al068632, UM1 Al068616, and UM1 Al106716) with co-funding from NICHD and NIMH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder provided support in the form of salaries for authors [SL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ananworanich J, 2015, CURR OPIN HIV AIDS, V10, P18, DOI 10.1097/COH.0000000000000122; Ananworanich J, 2014, AIDS, V28, P1015, DOI 10.1097/QAD.0000000000000178; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Bitnun A, 2014, CLIN INFECT DIS, V59, P1012, DOI 10.1093/cid/ciu432; Bruner KM, 2016, NAT MED, P10; Chun TW, 2015, NAT IMMUNOL, V16, P584, DOI 10.1038/ni.3152; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deepayan S., 2008, LATTICE MULTIVARIATE; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Galli A, 2010, J VIROL, V84, P7651, DOI 10.1128/JVI.00276-10; Golden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100400; Henrich TJ, 2014, ANN INTERN MED; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Imamichi H, 2016, P NATL ACAD SCI USA, V113, P8783, DOI 10.1073/pnas.1609057113; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Luzuriaga K, 2014, J INFECT DIS, V210, P1529, DOI 10.1093/infdis/jiu297; Onafuwa A, 2003, J VIROL, V77, P4577, DOI 10.1128/JVI.77.8.4577-4587.2003; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Payne H, 2015, LANCET INFECT DIS, V15, P803, DOI 10.1016/S1473-3099(15)00087-0; Persaud D, 2000, J CLIN INVEST, V105, P995, DOI 10.1172/JCI9006; Persaud D, 2014, JAMA PEDIATR, V168, P1138, DOI 10.1001/jamapediatrics.2014.1560; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2012, AIDS, V26, P1483, DOI 10.1097/QAD.0b013e3283553638; Pinkevych M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005000; Rainwater-Lovett K, 2015, CURR OPIN HIV AIDS, V10, P4, DOI 10.1097/COH.0000000000000127; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Uprety P, 2015, CLIN INFECT DIS; van Zyl GU, 2015, J INFECT DIS, V212, P39, DOI 10.1093/infdis/jiu827; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	45	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170548	10.1371/journal.pone.0170548	http://dx.doi.org/10.1371/journal.pone.0170548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178277	Green Published, gold			2022-12-27	WOS:000393712500008
J	Roach, M				Roach, Michael			Encouraging entrepreneurship in university labs: Research activities, research outputs, and early doctorate careers	PLOS ONE			English	Article								This paper investigates how the encouragement of entrepreneurship within university research labs relates with research activities, research outputs, and early doctorate careers. Utilizing a panel survey of 6,840 science & engineering doctoral students at 39 R1 research universities, this study shows that entrepreneurship is widely encouraged across university research labs, ranging from 54% in biomedical engineering to 18% in particle physics, while only a small share of labs openly discourage entrepreneurship, from approximately 3% in engineering to approximately 12% in the life sciences. Within fields, there is no difference between labs that encourage entrepreneurship and those that do not with respect to basic research activity and the number of publications. At the same time, labs that encourage entrepreneurship are significantly more likely to report invention disclosures, particularly in engineering where such labs are 41% more likely to disclose inventions. With respect to career pathways, PhDs students in labs that encourage entrepreneurship do not differ from other PhDs in their interest in academic careers, but they are 87% more likely to be interested in careers in entrepreneurship and 44% more likely to work in a startup after graduation. These results persist even when accounting for individuals' pre-PhD interest in entrepreneurship and the encouragement of other non-academic industry careers.	[Roach, Michael] Cornell Univ, Cornell Coll Business, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA	Cornell University	Roach, M (corresponding author), Cornell Univ, Cornell Coll Business, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	michael.roach@cornell.edu		Roach, Michael/0000-0002-9781-8567	NSF [1262270]; Kauffman Foundation Junior Faculty Fellowship	NSF(National Science Foundation (NSF)); Kauffman Foundation Junior Faculty Fellowship	This work was supported by NSF Award 1262270; Kauffman Foundation Junior Faculty Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2002, MANAGE SCI, V48, P44, DOI 10.1287/mnsc.48.1.44.14279; Azoulay P, 2009, J IND ECON, V57, P637, DOI 10.1111/j.1467-6451.2009.00395.x; Bercovitz J, 2008, ORGAN SCI, V19, P69, DOI 10.1287/orsc.1070.0295; Boh WF, 2011, FAC STUD SPIN OFFS; Ding W, 2011, RES POLICY, V40, P69, DOI 10.1016/j.respol.2010.09.011; National Science Board, 2010, SCI ENG IND 2010; National Science Foundation, 2009, SURV EARN DOCT; Owen-Smith J, 2001, J TECHNOLOGY TRANSFE, V1, P99, DOI [10.1023/A:1007892413701, DOI 10.1023/A:1007892413701]; Roach M, 2015, MANAGE SCI, V61, P2160, DOI 10.1287/mnsc.2014.2100; Roach M, 2015, SCIENCE, V348, P1200, DOI 10.1126/science.aab2804; Sauermann H, 2013, RES POLICY, V42, P273, DOI 10.1016/j.respol.2012.05.003	11	17	17	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170444	10.1371/journal.pone.0170444	http://dx.doi.org/10.1371/journal.pone.0170444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178270	Green Published, gold			2022-12-27	WOS:000393712500005
J	Rodriguez, JD; Haq, S; Bachvaroff, T; Nowak, KF; Nowak, SJ; Morgan, D; Cherny, VV; Sapp, MM; Bernstein, S; Bolt, A; DeCoursey, TE; Place, AR; Smith, SME				Rodriguez, Juan D.; Haq, Saddef; Bachvaroff, Tsvetan; Nowak, Kristine F.; Nowak, Scott J.; Morgan, Deri; Cherny, Vladimir V.; Sapp, Maredith M.; Bernstein, Steven; Bolt, Andrew; DeCoursey, Thomas E.; Place, Allen R.; Smith, Susan M. E.			Identification of a vacuolar proton channel that triggers the bioluminescent flash in dinoflagellates	PLOS ONE			English	Article							HYDROGEN-ION CURRENTS; ALVEOLAR EPITHELIAL-CELLS; GATED H+ CURRENTS; BINDING PROTEIN; NADPH OXIDASE; VOLTAGE; PH; GONYAULAX; NOCTILUCA; SCINTILLONS	In 1972, J. Woodland Hastings and colleagues predicted the existence of a proton selective channel (H(v)1) that opens in response to depolarizing voltage across the vacuole membrane of bioluminescent dinoflagellates and conducts protons into specialized luminescence compartments (scintillons), thereby causing a pH drop that triggers light emission. H(v)1 channels were subsequently identified and demonstrated to have important functions in a multitude of eukaryotic cells. Here we report a predicted protein from Lingulodinium polyedrum that displays hallmark properties of bona fide H(v)1, including time-dependent opening with depolarization, perfect proton selectivity, and characteristic Delta pH dependent gating. Western blotting and fluorescence confocal microscopy of isolated L. polyedrum scintillons immunostained with antibody to LpH(v)1 confirm LpHvi's predicted organellar location. Proteomics analysis demonstrates that isolated scintillon preparations contain peptides that map to LpH(v)1. Finally, Zn2+ inhibits both LpH(v)1 proton current and the acid-induced flash in isolated scintillons. These results implicate LpH(v)1 as the voltage gated proton channel that triggers bioluminescence in L. polyedrum, confirming Hastings' hypothesis. The same channel likely mediates the action potential that communicates the signal along the tonoplast to the scintillon.	[Rodriguez, Juan D.; Nowak, Kristine F.; Nowak, Scott J.; Sapp, Maredith M.; Bernstein, Steven; Bolt, Andrew; Smith, Susan M. E.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA; [Haq, Saddef; Bachvaroff, Tsvetan; Place, Allen R.] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA; [Morgan, Deri; Cherny, Vladimir V.; DeCoursey, Thomas E.] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	University System of Georgia; Kennesaw State University; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Rush University	Smith, SME (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA.	susan.m.e.smith@kennesaw.edu	Nowak, Scott J/H-2974-2012; Place, Allen R/F-9267-2013; Nowak, Kristine F/A-8300-2013; DeCoursey, Thomas/A-6820-2009	Nowak, Scott J/0000-0001-8548-8356; DeCoursey, Thomas/0000-0002-4263-180X; Nowak, Kristine/0000-0001-7782-7813	NIH [GM102336, GM102826]; NSF [MCB-1242985, DBI-1229237]; Kennesaw State University Office of the Vice President for Research; a Birla Carbon Scholarship; OHH NIH [R01ES021949-01/NSFOCE1313888, NOAA-NOS-NCCOS-2012-2002987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102826, R01GM102336] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1242985] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Kennesaw State University Office of the Vice President for Research; a Birla Carbon Scholarship; OHH NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NIH grant GM102336 (https://grants.nih.gov/funding/index.htm) to TED and SMES, NSF grant MCB-1242985 (http://www.nsf.gov./funding/)to TED and SMES; a grant from the Kennesaw State University Office of the Vice President for Research (https://www.kennesaw.edu/research/ovprgrants.html) to SMES; a Birla Carbon Scholarship (http://csm.kennesaw.edu/research/birla-carbon-scholars.php) to MS; NIH grant GM102826 (https://grants.nih.gov/funding/index.htm) and NSF grant DBI-1229237 (http://www.nsf.gov/funding/) to SJN; and was funded in part by grants from OHH NIH R01ES021949-01/NSFOCE1313888 (https://grants.nih.gov/funding/index.htm) and NOAA-NOS-NCCOS-2012-2002987 (https://coastalscience.noaa.gov/funding) to ARP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2014, MOL PHYLOGENET EVOL, V70, P314, DOI 10.1016/j.ympev.2013.10.007; BARISH ME, 1984, J PHYSIOL-LONDON, V352, P243, DOI 10.1113/jphysiol.1984.sp015289; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Bezanilla F., 2014, PNAS, V111, P1950, DOI DOI 10.1073/PNAS; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Chaves G, 2016, FEBS J, V283, P1453, DOI 10.1111/febs.13680; Chen AK, 2007, AM J PHYSIOL-REG I, V292, pR2020, DOI 10.1152/ajpregu.00649.2006; Cherny VV, 2015, J GEN PHYSIOL, V146, P343, DOI 10.1085/jgp.201511456; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; Cherny VV, 2001, BIOL MEMBRANY, V18, P458; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P131, DOI 10.1007/s002329900092; DeCoursey TE, 2016, J GEN PHYSIOL, V148, P97, DOI 10.1085/jgp.201611619; DeCoursey TE, 2015, P NATL ACAD SCI USA, V112, P13430, DOI 10.1073/pnas.1518486112; DeCoursey TE, 2013, PHYSIOL REV, V93, P599, DOI 10.1152/physrev.00011.2012; DESJARDINS M, 1993, BIOCHEM CELL BIOL, V71, P176, DOI 10.1139/o93-028; Dudev T, 2015, SCI REP, V5; DUNLAP JC, 1981, BIOCHEMISTRY-US, V20, P983, DOI 10.1021/bi00507a052; ECKERT R, 1967, J GEN PHYSIOL, V50, P1429, DOI 10.1085/jgp.50.5.1429; ECKERT R, 1968, J GEN PHYSIOL, V52, P258, DOI 10.1085/jgp.52.2.258; FOGEL M, 1971, ARCH BIOCHEM BIOPHYS, V142, P310, DOI 10.1016/0003-9861(71)90289-X; FOGEL M, 1972, J CELL SCI, V11, P305; FOGEL M, 1972, P NATL ACAD SCI USA, V69, P690, DOI 10.1073/pnas.69.3.690; FRITZ L, 1990, J CELL SCI, V95, P321; Fujiwara Y, 2014, J GEN PHYSIOL, V143, P377, DOI 10.1085/jgp.201311082; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; HAMMAN JP, 1972, J CELL PHYSIOL, V80, P397, DOI 10.1002/jcp.1040800310; HASTINGS JW, 1986, METHOD ENZYMOL, V133, P307; Jin K, 2013, J PHYCOL, V49, P733, DOI 10.1111/jpy.12084; JOHNSON CH, 1985, J CELL BIOL, V100, P1435, DOI 10.1083/jcb.100.5.1435; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; KRAUSE RM, 1993, NEUROMUSCULAR DISORD, V3, P407, DOI 10.1016/0960-8966(93)90086-Y; KRIEGER N, 1968, SCIENCE, V161, P586, DOI 10.1126/science.161.3841.586; Kulleperuma K, 2013, J GEN PHYSIOL, V141, P445, DOI 10.1085/jgp.201210856; Latz MI, 1999, LIMNOL OCEANOGR, V44, P1423, DOI 10.4319/lo.1999.44.6.1423; LATZ MI, 1994, LIMNOL OCEANOGR, V39, P1424, DOI 10.4319/lo.1994.39.6.1424; Latz MI, 2008, J EXP BIOL, V211, P2865, DOI 10.1242/jeb.011890; LECUYER B, 1979, ARCH BIOCHEM BIOPHYS, V196, P371, DOI 10.1016/0003-9861(79)90288-1; Lee S-Y, 2010, J MOL BIOL, V387, P1055; Li Q, 2014, NAT STRUCT MOL BIOL; Li QF, 2015, P NATL ACAD SCI USA, V112, pE5926, DOI 10.1073/pnas.1515043112; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; MAHAUTSMITH MP, 1989, J EXP BIOL, V145, P455; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; MORSE D, 1989, J BIOL CHEM, V264, P11822; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; NAWATA T, 1976, PLANT CELL PHYSIOL, V17, P265; NAWATA T, 1979, J COMP PHYSIOL, V134, P137, DOI 10.1007/BF00610472; NICOLAS MT, 1987, J CELL BIOL, V105, P723, DOI 10.1083/jcb.105.2.723; NICOLAS MT, 1987, J CELL SCI, V87, P189; OAMI K, 1995, J COMP PHYSIOL A, V176, P625, DOI 10.1007/BF01021582; Orr RJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050004; Pozdnyakov I A, 2015, Tsitologiia, V57, P533; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHMITTER RE, 1976, J CELL PHYSIOL, V87, P123, DOI 10.1002/jcp.1040870115; Smith SME, 2013, PROG MOL BIOL TRANSL, V117, P335, DOI 10.1016/B978-0-12-386931-9.00012-X; Smith SME, 2011, P NATL ACAD SCI USA, V108, P18162, DOI 10.1073/pnas.1115405108; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Tesson B, 2015, BIOPHYS J, V108, P1341, DOI 10.1016/j.bpj.2015.02.009; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Topalov G, 2001, ANGEW CHEM INT EDIT, V40, P3892, DOI 10.1002/1521-3773(20011015)40:20<3892::AID-ANIE3892>3.0.CO;2-H; Villalba-Galea CA, 2014, BIOPHYS J, V107, P1564, DOI 10.1016/j.bpj.2014.08.017; von Dassow P, 2002, J EXP BIOL, V205, P2971	76	22	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171594	10.1371/journal.pone.0171594	http://dx.doi.org/10.1371/journal.pone.0171594			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178296	gold, Green Published			2022-12-27	WOS:000393712500052
J	Saha, D; Koli, S; Patgaonkar, M; Reddy, KVR				Saha, Debarchana; Koli, Swanand; Patgaonkar, Mandar; Reddy, Kudumula Venkata Rami			Expression of hemoglobin-alpha and beta subunits in human vaginal epithelial cells and their functional significance	PLOS ONE			English	Article							FEMALE GENITAL-TRACT; INNATE; GLOBIN; DIFFERENTIATION; TRANSCRIPTION; SECRETION; EVOLUTION; PEPTIDES; PATTERNS; IMMUNITY	Hemoglobin (Hb) is a major protein involved in transport of oxygen (O-2). It consists of Hb-alpha and Hb-beta subunits, which are normally expressed by cells of erythroid lineage. However, till recently, it was not known whether non-erythroid cells like vaginal cells synthesize Hb and whether it has any functional significance. Therefore, we designed the following objectives: (1) to establish in-vitro culture system of human primary vaginal epithelial cells (hPVECs), (2) to determine whether Hb-alpha and Hb-beta proteins are truly synthesized by hPVECs, (3) to evaluate the effect of LPS (lipopolysaccharide) on the expression of Hb-alpha and Hb-beta proteins (4) to decipher the significance of the Hb-alpha and Hb-beta expression in hPVECs and (5) to determine the molecular mechanism regulating the expression of Hb-alpha in hPVECs. To accomplish these studies, we applied a battery of assays such as RT-PCR, qRT-PCR, Flow cytometry, western blot, and immunofluorescence, Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP). The results revealed the expression of Hb-alpha and Hb-beta at both mRNA and protein level in hPVECs. The expression was significantly upregulated following LPS treatment (10 mu g/m1 for 6 hrs) and these results are comparable with the expression induced by LPS in human vaginal epithelial cell line (VK2/E6E7). These cells constitutively produced low levels of pro-inflammatory (IL-6) and anti-inflammatory (IL-10) cytokines. Also, the response of phosphorylated (p65)-NF-kappa B to LPS was upregulated with increased expression of IL-6, Toll-like receptor-4 (TLR4) and human beta defensin-1 (hBD-1) in hPVECs and VK2/E6E7 cells. However, Bay 11-7082 treatment (5 mu M for 24 hrs) could neutralize the effect of LPS-induced p65-NF-kappa B activity and represses the production'of Hb-alpha and Hb-beta. The results of EMSA revealed the presence of putative binding sites of NF-kappa B in the human Hb-alpha promoter region (nt-115 to-106). ChIP analysis confirmed the binding of NF-kappa B to Hb-alpha promoter. In conclusion, the present findings revealed for the first time that hPVECs synthesized Hb-alpha and Hb-beta and the expression is comparable with the expression of VK2/E6E7 cells. The identification of NF-KB regulatory sequences in Hb-alpha promoter, whose activation is associated with immune response of hPVECs, indicating Hb-alpha and Hb-beta may act as an endogenous antimicrobial defense protein against vaginal inflammation/infections.	[Saha, Debarchana; Koli, Swanand; Patgaonkar, Mandar; Reddy, Kudumula Venkata Rami] NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Reddy, KVR (corresponding author), NIRRH, Div Mol Immunol & Microbiol MIM, Mumbai, Maharashtra, India.	reddyk@nirrh.res.in		KOLI, SWANAND/0000-0002-4742-4439	NIRRH [NIRRH/MS/417/2016]; University Grant Commission (UGC), New Delhi	NIRRH; University Grant Commission (UGC), New Delhi(University Grants Commission, India)	The authors acknowledge NIRRH for providing necessary support (NIRRH/MS/417/2016). DS is grateful to the University Grant Commission (UGC), New Delhi for providing Senior Research Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha CC, 2008, CYTOKINE, V43, P63, DOI 10.1016/j.cyto.2008.04.005; Baron MH, 1997, BBA-GENE STRUCT EXPR, V1351, P51, DOI 10.1016/S0167-4781(96)00195-9; Bashir T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124839; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Carter AM, 2012, PHYSIOL REV, V92, P1543, DOI 10.1152/physrev.00040.2011; Chou SF, 2003, EUR J BIOCHEM, V270, P1855, DOI 10.1046/j.1432-1033.2003.03551.x; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Dassen H, 2008, HUM REPROD, V23, P635, DOI 10.1093/humrep/dem430; Deng LX, 2009, HUM REPROD, V24, P211, DOI 10.1093/humrep/den318; Du RJ, 2010, EMBO J, V29, P632, DOI 10.1038/emboj.2009.380; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Haase VH, 2008, J AM SOC NEPHROL, V19, P1440, DOI 10.1681/ASN.2008060594; Hardison R, 1998, J EXP BIOL, V201, P1099; Ishikawa N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-123; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054342; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Liu WS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024363, 10.1371/journal.pone.0024406]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak P, 2004, PEPTIDES, V25, P1839, DOI 10.1016/j.peptides.2004.06.015; Mak P, 2008, FRONT BIOSCI-LANDMRK, V13, P6859, DOI 10.2741/3194; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; PASSOW H, 1986, REV PHYSIOL BIOCH P, V103, P61; Patgaonkar MS, 2011, CLIN VACCINE IMMUNOL, V18, P1632, DOI 10.1128/CVI.00411-10; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Rifkind JM, 2013, ANTIOXID REDOX SIGN, V18, P2274, DOI 10.1089/ars.2012.4867; Saha D, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/803237; Sathe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083882; Sathe A, 2014, AM J REPROD IMMUNOL, V71, P137, DOI 10.1111/aji.12165; Schulte W, 2012, MEDIAT INFLAMM; Setton-Avruj CP, 2007, EXP NEUROL, V203, P568, DOI 10.1016/j.expneurol.2006.09.024; Taylor BN, 2000, MED MYCOL, V38, P419, DOI 10.1080/714030969; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tommila M, 2011, J MOL CELL BIOL, V3, P190, DOI 10.1093/jmcb/mjq036; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wicherek L, 2007, EUR J OBSTET GYN R B, V131, P97, DOI 10.1016/j.ejogrb.2006.03.012; Wira CR, 2011, MUCOSAL IMMUNOL, V4, P335, DOI 10.1038/mi.2010.72; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wride MA, 2003, MOL VIS, V9, P360	44	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171084	10.1371/journal.pone.0171084	http://dx.doi.org/10.1371/journal.pone.0171084			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178273	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500022
J	van Krugten, FCW; Kaddouri, M; Goorden, M; van Balkom, AJLM; Bockting, CLH; Peeters, FPML; Hakkaart-van Roijen, L				van Krugten, Frederique C. W.; Kaddouri, Meriam; Goorden, Maartje; van Balkom, Anton J. L. M.; Bockting, Claudi L. H.; Peeters, Frenk P. M. L.; Hakkaart-van Roijen, Leona		Decision Tool Unipolar Depression	Indicators of patients with major depressive disorder in need of highly specialized care: A systematic review	PLOS ONE			English	Review							MENTAL-HEALTH-SERVICES; RISK-STRATIFICATION; TREATMENT RESISTANCE; LIFE EVENTS; RECURRENCE; TERTIARY; COMORBIDITY; OUTPATIENTS; PREVALENCE; PREDICTORS	Objectives Early identification of patients with major depressive disorder (MDD) that cannot be managed by secondary mental health services and who require highly specialized mental healthcare could enhance need-based patient stratification. This, in turn, may reduce the number of treatment steps needed to achieve and sustain an adequate treatment response. The development of a valid tool to identify patients with MDD in need of highly specialized care is hampered by the lack of a comprehensive understanding of indicators that distinguish patients with and without a need for highly specialized MDD care. The aim of this study, therefore, was to systematically review studies on indicators of patients with MDD likely in need of highly specialized care. Methods A structured literature search was performed on the PubMed and PsycINFO databases following PRISMA guidelines. Two reviewers independently assessed study eligibility and determined the quality of the identified studies. Three reviewers independently executed data extraction by using a pre-piloted, standardized extraction form. The resulting indicators were grouped by topical similarity, creating a concise summary of the findings. Results The systematic search of all databases yielded a total of 7,360 references, of which sixteen were eligible for inclusion. The sixteen papers yielded a total of 48 unique indicators. Overall, a more pronounced depression severity, a younger age of onset, a history of prior poor treatment response, psychiatric comorbidity, somatic comorbidity, childhood trauma, psychosocial impairment, older age, and a socioeconomically disadvantaged status were that no competing interests exist. found to be associated with proxies of need for highly specialized MDD care. Conclusions Several indicators are associated with the need for highly specialized MDD care. These indicators provide easily measurable factors that may serve as a starting point for the development of a valid tool to identify patients with MDD in need of highly specialized care.	[van Krugten, Frederique C. W.; Kaddouri, Meriam; Goorden, Maartje; Hakkaart-van Roijen, Leona] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [van Krugten, Frederique C. W.; Kaddouri, Meriam; Goorden, Maartje; Hakkaart-van Roijen, Leona] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands; [van Balkom, Anton J. L. M.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [van Balkom, Anton J. L. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van Balkom, Anton J. L. M.] GGZ inGeest, Amsterdam, Netherlands; [Bockting, Claudi L. H.] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands; [Peeters, Frenk P. M. L.] Maastricht Univ, Dept Psychiat & Neuropsychol, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Maastricht University	van Krugten, FCW (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands.; van Krugten, FCW (corresponding author), Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands.	vankrugten@bmg.eur.nl	Bockting, Claudi L/K-3768-2019	Bockting, Claudi L/0000-0002-9220-9244; Hakkaart-van Roijen, Leona/0000-0003-0635-7388; Peeters, F/0000-0002-6167-8582	Dutch Network for Quality Development in mental health care [PV140004]	Dutch Network for Quality Development in mental health care	This work was funded by the Dutch Network for Quality Development in mental health care (http://www.kwaliteitsontwikkelingggz.nl), project number PV140004. LH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amital D, 2008, J AFFECT DISORDERS, V110, P260, DOI 10.1016/j.jad.2008.01.006; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bennabi D, 2015, J AFFECT DISORDERS, V171, P137, DOI 10.1016/j.jad.2014.09.020; Boenisch S, 2012, SOC PSYCH PSYCH EPID, V47, P475, DOI 10.1007/s00127-011-0355-y; Bos EH, 2005, J AFFECT DISORDERS, V87, P221, DOI 10.1016/j.jad.2005.04.001; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Butcher JN, 1989, MINESOTA MULTIPHASIC; Cochrane J, 2000, CAN J PSYCHIAT, V45, P185, DOI 10.1177/070674370004500210; Cooperberg MR, 2009, JNCI-J NATL CANCER I, V101, P878, DOI 10.1093/jnci/djp122; Dudek D, 2010, J AFFECT DISORDERS, V126, P268, DOI 10.1016/j.jad.2010.03.001; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Garg S, 2010, CIRC-CARDIOVASC INTE, V3, P317, DOI 10.1161/CIRCINTERVENTIONS.109.914051; Gerrits MMJG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-187; Gilmer WS, 2005, ACTA PSYCHIAT SCAND, V112, P425, DOI 10.1111/j.1600-0447.2005.00633.x; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Holzel L, 2011, J AFFECT DISORDERS, V129, P1, DOI 10.1016/j.jad.2010.03.025; Hollon SD, 2006, J PSYCHIATR RES, V40, P59, DOI 10.1016/j.jpsychires.2005.07.008; ISACSSON G, 1992, ACTA PSYCHIAT SCAND, V85, P444, DOI 10.1111/j.1600-0447.1992.tb03209.x; ISOMETSA ET, 1994, AM J PSYCHIAT, V151, P530; Kaplan MJ, 2000, J NERV MENT DIS, V188, P596, DOI 10.1097/00005053-200009000-00006; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kocsis JH, 2008, J AFFECT DISORDERS, V110, P55, DOI 10.1016/j.jad.2008.01.002; Lamers F, 2011, PSYCHIAT RES, V190, P226, DOI 10.1016/j.psychres.2011.07.005; Lee AS, 2003, PSYCHOL MED, V33, P769, DOI 10.1017/S003329170300802X; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Melartin TK, 2004, J CLIN PSYCHIAT, V65, P810; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1111/j.1553-2712.2003.tb01996.x; Meyers BS, 2002, ARCH GEN PSYCHIAT, V59, P729, DOI 10.1001/archpsyc.59.8.729; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; National Heart Blood and Lung Institute, 2014, QUAL ASS TOOL CAS CO; National Heart Blood and Lung Institute, 2014, QUAL ASS TOOL OBS CO; Oquendo MA, 2002, AM J PSYCHIAT, V159, P1746, DOI 10.1176/appi.ajp.159.10.1746; POLLACK MM, 1991, CRIT CARE MED, V19, P150, DOI 10.1097/00003246-199102000-00007; Riso LP, 2003, J ABNORM PSYCHOL, V112, P72, DOI 10.1037/0021-843X.112.1.72; Riso LP, 2002, J AFFECT DISORDERS, V70, P103, DOI 10.1016/S0165-0327(01)00376-7; Ryabchenko KA, 2004, DEPRESS ANXIETY, V20, P153, DOI 10.1002/da.20034; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Solomon DA, 2004, COMPR PSYCHIAT, V45, P423, DOI 10.1016/j.comppsych.2004.07.002; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062, DOI 10.4088/JCP.v68n0713; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Suominen KH, 1998, AM J PSYCHIAT, V155, P1778, DOI 10.1176/ajp.155.12.1778; Takahashi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071964; Takahashi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063756; van Weel-Baumgarten EM, 2000, J FAM PRACTICE, V49, P1113; VonVille HM, 2014, ORG SEARCH DATA METH; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Wang PS, 2003, INT J METH PSYCH RES, V12, P22, DOI 10.1002/mpr.139; Wasylenki D, 2000, CAN J PSYCHIAT, V45, P179, DOI 10.1177/070674370004500209; WHO, 2009, IMPR HLTH SYST SERV; Wiersma JE, 2011, J CLIN PSYCHIAT, V72, P288, DOI 10.4088/JCP.09m05735blu; Wiersma JE, 2009, J CLIN PSYCHIAT, V70, P983, DOI 10.4088/JCP.08m04521; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; World Health Organization, 1977, INT CLASS DIS	60	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171659	10.1371/journal.pone.0171659	http://dx.doi.org/10.1371/journal.pone.0171659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178306	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500058
J	Ertan, NZ; Bozfakioglu, S; Ugurel, E; Sinan, M; Yalcin, O				Ertan, Nesrin Zeynep; Bozfakioglu, Semra; Ugurel, Elif; Sinan, Mukaddes; Yalcin, Ozlem			Alterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysis	PLOS ONE			English	Article							OSMOTIC GRADIENT EKTACYTOMETRY; OXIDATIVE STRESS; ELONGATION INDEX; ANALYZER LORCA; HEMODIALYSIS; DEFORMABILITY; FAILURE; EFFICIENCY; SURVIVAL; CHANNELS	In this study, we investigated the effects of peritoneal dialysis on hemorheological and hematological parameters and their relations with oxidant and antioxidant status of uremic patients. Hemorheological parameters (erythrocyte deformability, erythrocyte aggregation, osmotic deformability, blood and plasma viscosity) were measured in patients with renal insufficiency undergoing peritoneal dialysis (PD) and volunteers. Erythrocyte deformability, osmotic deformability and aggregation in both autologous plasma and 3% dextran 70 were measured by laser diffraction ektacytometry. Enzyme activities of glutathione peroxidase, superoxide dismutase and catalase were studied in erythrocytes; lipid peroxidation was studied by measuring the amount of malondialdehyde in both erythrocytes and plasma samples. Blood viscosity at native hematocrit was significantly lower in PD patients at all measured shear rates compared to controls, but it was high in PD patients at corrected (45%) hematocrit. Erythrocyte deformability did not show any difference between the two groups. Osmotic deformability was significantly lower in PD patients compared to controls. Aggregation index values were significantly high in PD patients in plasma Catalase and glutathione peroxidase activities in erythrocytes were decreased in PD patients whereas superoxide dismutase activity was increased compared to controls. Malondialdehyde was significantly increased in erythrocytes and plasma samples of PD patients which also shows correlations with aggregation parameters. It has been concluded that erythrocytes in PD patients are more prone to aggregation and this tendency could be influenced by lipid peroxidation activity in patient's plasma. These results imply that uremic conditions, loss of plasma proteins and an increased risk of oxidative stress because of decreasing levels of antioxidant enzymes affect erythrocyte rheology during peritoneal dialysis. This level of distortion may have crucial effects, impairing the blood flow dynamics and causing inadequate microcirculatory perfusion.	[Ertan, Nesrin Zeynep; Sinan, Mukaddes] Istanbul Univ, Dept Physiol, Istanbul, Turkey; [Bozfakioglu, Semra] Istanbul Univ, Dept Nephrol, Istanbul, Turkey; [Ugurel, Elif; Yalcin, Ozlem] Koc Univ, Dept Physiol, Istanbul, Turkey	Istanbul University; Istanbul University; Koc University	Yalcin, O (corresponding author), Koc Univ, Dept Physiol, Istanbul, Turkey.	ozlemyalcin@ku.edu.tr	Yalcin, Ozlem/AAF-4036-2019	Yalcin, Ozlem/0000-0001-5547-6653	Seed Fund of Koc University [00006]; Research Foundation of Istanbul University [55613]	Seed Fund of Koc University; Research Foundation of Istanbul University(Istanbul University)	This study was supported by the Seed Fund of Koc University (No: 00006) and the Research Foundation of Istanbul University (No: 55613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi AF, 2004, SAUDI MED J, V25, P1186; Baskurt OK, 2009, SCAND J CLIN LAB INV, V69, P777, DOI 10.3109/00365510903266069; Borzych-Duzalka D, 2013, J AM SOC NEPHROL, V24, P665, DOI 10.1681/ASN.2012050433; CASATI S, 1989, NEPHROL DIAL TRANSPL, V4, P718, DOI 10.1093/ndt/4.8.718; CASATI S, 1987, BMJ-BRIT MED J, V295, P1017, DOI 10.1136/bmj.295.6605.1017; CLARK MR, 1983, BLOOD, V61, P899, DOI 10.1182/blood.V61.5.899.899; Clermont G, 2000, CARDIOVASC RES, V47, P618, DOI 10.1016/S0008-6363(00)00117-6; DORMANDY J, 1985, CLIN HEMORHEOL, V5, P975; FERIANI M, 1992, AM J KIDNEY DIS, V19, P131, DOI 10.1016/S0272-6386(12)70121-X; Fontana F, 2016, CLIN HEMORH IN PRESS; Guo CH, 2011, PERITON DIALYSIS INT, V31, P583, DOI 10.3747/pdi.2009.00225; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; HARDEMAN MR, 1994, CLIN HEMORHEOL, V14, P619; Heimburger O, 2015, HDB DIALYSIS, P408; Ibrahim FF, 2002, RENAL FAILURE, V24, P779, DOI 10.1081/JDI-120015680; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Lang KS, 2004, AM J PHYSIOL-RENAL, V286, pF1046, DOI 10.1152/ajprenal.00263.2003; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Ly J, 2004, AM J KIDNEY DIS, V44, P715, DOI 10.1053/j.ajkd.2004.06.018; Martin-Mateo MC, 1998, RENAL FAILURE, V20, P117, DOI 10.3109/08860229809045094; MCGRATH LT, 1995, CLIN CHIM ACTA, V235, P179, DOI 10.1016/0009-8981(95)06027-X; McGregor D, 2000, NEPHRON, V85, P215, DOI 10.1159/000045664; MOHANDAS N, 1980, J CLIN INVEST, V66, P563, DOI 10.1172/JCI109888; Nemeth N, 2015, SCAND J CLIN LAB INV, V75, P213, DOI 10.3109/00365513.2014.993695; Nowak-Piszczek E, 2003, CLIN HEMORHEOL MICRO, V28, P251; Piagnerelli M, 2003, INTENS CARE MED, V29, P1052, DOI 10.1007/s00134-003-1783-2; Pietrzycka A, 2010, NEPHROL DIAL POL, V14, P22; Puchades MJ, 2013, CLIN NEPHROL, V80, P177, DOI 10.5414/CN107639; Sotirakopoulos N, 2004, RENAL FAILURE, V26, P179, DOI 10.1081/JDI-120038517; Stepniewska J, 2014, BLOOD PURIFICAT, V37, P4, DOI 10.1159/000356806; Szikszai Z, 2003, CLIN HEMORHEOL MICRO, V28, P201; TAYLOR JE, 1992, PERITON DIALYSIS INT, V12, P221; Vos FE, 2011, AM J KIDNEY DIS, V58, P591, DOI 10.1053/j.ajkd.2011.03.031	34	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171371	10.1371/journal.pone.0171371	http://dx.doi.org/10.1371/journal.pone.0171371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158274	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700070
J	Hsieh, KLC; Tsai, RJ; Teng, YC; Lo, CM				Hsieh, Kevin Li-Chun; Tsai, Ruei-Je; Teng, Yu-Chuan; Lo, Chung-Ming			Effect of a computer-aided diagnosis system on radiologists' performance in grading gliomas with MRI	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIOBLASTOMA-MULTIFORME; GENE-EXPRESSION; BREAST MASSES; CLASSIFICATION; ASTROCYTOMA; POPULATION; TUMORS	The effects of a computer-aided diagnosis (CAD) system based on quantitative intensity features with magnetic resonance (MR) imaging (MRI) were evaluated by examining radiologists' performance in grading gliomas. The acquired MRI database included 71 lower-grade gliomas and 34 glioblastomas. Quantitative image features were extracted from the tumor area and combined in a CAD system to generate a prediction model. The effect of the CAD system was evaluated in a two-stage procedure. First, a radiologist performed a conventional reading. A sequential second reading was determined with a malignancy estimation by the CAD system. Each MR image was regularly read by one radiologist out of a group of three radiologists. The CAD system achieved an accuracy of 87% (91/105), a sensitivity of 79% (27/34), a specificity of 90% (64/71), and an area under the receiver operating characteristic curve (Az) of 0.89. In the evaluation, the radiologists' Az values significantly improved from 0.81, 0.87, and 0.84 to 0.90, 0.90, and 0.88 with p = 0.0011, 0.0076, and 0.0167, respectively. Based on the MR image features, the proposed CAD system not only performed well in distinguishing glioblastomas from lower-grade gliomas but also provided suggestions about glioma grading to reinforce radiologists' confidence rating.	[Hsieh, Kevin Li-Chun; Tsai, Ruei-Je; Teng, Yu-Chuan] Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Hsieh, Kevin Li-Chun] Taipei Med Univ, Coll Med, Res Ctr Translat Imaging, Taipei, Taiwan; [Lo, Chung-Ming] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Lo, CM (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan.	buddylo@tmu.edu.tw		Lo, Chung-Ming/0000-0001-5068-6002; Tsai, Ruei-Je/0000-0002-7403-9130	Ministry of Science and Technology in Taiwan [MOST 104-2218-E-038-004, MOST 105-2314-B-038-04]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Support was provided by The Ministry of Science and Technology in Taiwan [https://www.most.gov.tw/?l-en] (MOST 104-2218-E-038-004 and MOST 105-2314-B-038-04) to KH and CML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Baek HJ, 2012, RADIOLOGY, V264, P834, DOI 10.1148/radiol.12112120; Bai X, 2011, NEURORADIOLOGY, V53, P533, DOI 10.1007/s00234-011-0846-2; Blasberg RG, 2007, CLIN CANCER RES, V13, P3444, DOI 10.1158/1078-0432.CCR-07-0936; Boroczky L, 2013, AM J ROENTGENOL, V200, P277, DOI 10.2214/AJR.12.8718; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; BURGER PC, 1985, CANCER, V56, P1106, DOI 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Perez-Larraya JG, 2014, ONCOLOGIST, V19, P1258, DOI 10.1634/theoncologist.2014-0170; GROENEVELD RA, 1984, STATISTICIAN, V33, P391, DOI 10.2307/2987742; Gur D, 2006, AM J ROENTGENOL, V187, P1474, DOI 10.2214/AJR.06.1384; Guzman-De-Villoria JA, 2014, CANCER IMAGING, V14, DOI 10.1186/s40644-014-0035-8; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hsieh KLC, 2017, COMPUT METH PROG BIO, V139, P31, DOI 10.1016/j.cmpb.2016.10.021; Jackson A, 2007, CLIN CANCER RES, V13, P3449, DOI 10.1158/1078-0432.CCR-07-0238; Kim SH, 2011, CLIN NEUROPATHOL, V30, P328, DOI 10.5414/NP300404; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Litjens GJS, 2015, EUR RADIOL, V25, P3187, DOI 10.1007/s00330-015-3743-y; Lo CM, 2015, COMPUT METH PROG BIO, V122, P354, DOI 10.1016/j.cmpb.2015.09.004; Lo CM, 2015, ULTRASOUND MED BIOL, V41, P2039, DOI 10.1016/j.ultrasmedbio.2015.03.003; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; Moon WK, 2013, COMPUT METH PROG BIO, V111, P84, DOI 10.1016/j.cmpb.2013.03.017; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Osborn A.G., 2015, DIAGNOSTIC IMAGING B; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Scott JN, 2002, NEUROLOGY, V59, P947, DOI 10.1212/WNL.59.6.947; Upadhyay N, 2014, BRIT J RADIOLOGY	34	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171342	10.1371/journal.pone.0171342	http://dx.doi.org/10.1371/journal.pone.0171342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158235	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700063
J	Lama, A; Santoro, A; Corrado, B; Pirozzi, C; Paciello, O; Pagano, TB; Russo, S; Calignano, A; Raso, GM; Meli, R				Lama, Adriano; Santoro, Anna; Corrado, Bruno; Pirozzi, Claudio; Paciello, Orlando; Pagano, Teresa Bruna; Russo, Sergio; Calignano, Antonio; Raso, Giuseppina Mattace; Meli, Rosaria			Extracorporeal shock waves alone or combined with raloxifene promote bone formation and suppress resorption in ovariectomized rats	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; MINERAL DENSITY; CATHEPSIN-K; BODY-COMPOSITION; OSTEOPOROSIS; ESTROGEN; FRACTURES; THERAPY; DIFFERENTIATION; ADIPONECTIN	Osteoporosis is a metabolic skeletal disease characterized by an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation. We examined the beneficial effect of shock waves (SW) alone or in combination with raloxifene (RAL) on bone loss in ovariectomized rats (OVX). Sixteen weeks after surgery, OVX were treated for five weeks with SW at the antero-lateral side of the right hind leg, one session weekly, at 3 Hz (EFD of 0.33 mJ/mm2), or with RAL (5 mg/kg/die, per os) or with SW+RAL. Sera, femurs, tibiae and vertebrae were sampled for following biochemical and histological analysis. SW, alone or combined with RAL, prevented femur weight reduction and the deterioration of trabecular microarchitecture both in femur and vertebrae. All treatments increased Speed of Sound (SoS) values, improving bone mineral density, altered by OVX. Serum parameters involved in bone remodeling (alkaline phosphatase, receptor activator of nuclear factor kappa -B ligand, osteoprotegerin) and osteoblast proliferation (PTH), altered by ovariectomy, were restored by SW and RAL alone or in combination. In tibiae, SW+RAL significantly reduced cathepsin k and TNF-a levels, indicating the inhibition of osteoclast activity, while all treatments significantly increased runt -related transcription factor 2 and bone morphogenetic-2 expression, suggesting an increase in osteoblastogenic activity. Finally, in bone marrow from tibiae, SW or RAL reduced PPARy and adiponectin transcription, indicating a shift of mesenchymal cells toward osteoblastogenesis, without showing a synergistic effect. Our data indicate SW therapy, alone and in combination with raloxifene, as an innovative strategy to limit the hypoestrogenic bone loss, restoring the balance between bone formation and resorption.	[Lama, Adriano; Santoro, Anna; Pirozzi, Claudio; Calignano, Antonio; Raso, Giuseppina Mattace; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Santoro, Anna] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT USA; [Corrado, Bruno; Russo, Sergio] Univ Naples Federico II, Sch Med & Surg, Dept Publ Hlth, Naples, Italy; [Paciello, Orlando; Pagano, Teresa Bruna] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Naples Federico II; Yale University; University of Naples Federico II; University of Naples Federico II	Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	meli@unina.it	Pirozzi, Claudio/S-2760-2016; Corrado, Bruno/U-9495-2017; Lama, Adriano/AAC-1964-2020; Calignano, Antonio/K-2542-2018	Corrado, Bruno/0000-0003-0990-3428; Lama, Adriano/0000-0002-5816-1400; Meli, Rosaria/0000-0002-6246-6813; Pirozzi, Claudio/0000-0002-3409-5744; Santoro, Anna/0000-0002-2276-5659; Mattace Raso, Giuseppina/0000-0002-5254-139X	Storz Medical AG, Tagerwilen, Switzerland	Storz Medical AG, Tagerwilen, Switzerland	This study was supported by Storz Medical AG, Tagerwilen, Switzerland. This external company provided an economical support for fulfillment of the study, contributing to purchase of laboratory equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript which did not contribute to experimental model design, experiment realization, data analysis, results interpretation and manuscript writing. There was no additional external funding received for this study.	AMEND SR, 2016, JOVE-J VIS EXP, V110, DOI [DOI 10.3791/53936, 10.3791/53936]; Amo C, 1996, INVEST RADIOL, V31, P114, DOI 10.1097/00004424-199602000-00009; Appelman-Dijkstra NM, 2014, BEST PRACT RES CL EN, V28, P843, DOI 10.1016/j.beem.2014.07.003; Benayahu D, 2000, J CELL BIOCHEM, V79, P407, DOI 10.1002/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8; CHAUSSY C, 1982, J UROLOGY, V127, P417, DOI 10.1016/S0022-5347(17)53841-0; Cheng H, 2015, INT J SURG ONCOL, V2015, DOI 10.1155/2015/397260; D'Agostin MC, 2016, J BIOL REG HOMEOS AG, V30, P323; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dobnig H, 2004, EXPERT OPIN PHARMACO, V5, P1153, DOI 10.1517/eoph.5.5.1153.31088; Eastell R, 2014, J BONE MINER RES, V29, P458, DOI 10.1002/jbmr.2047; Engelke K, 2015, J BONE MINER RES, V30, P30, DOI 10.1002/jbmr.2292; Fu Y, 2014, CELL PROLIFERAT, V47, P604, DOI 10.1111/cpr.12131; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; ILAGAN J, 1993, J APPL PHYSIOL, V74, P2092, DOI 10.1152/jappl.1993.74.5.2092; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Luisetto G, 1999, J ULTRAS MED, V18, P225; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Mariotto S, 2009, CURR MED CHEM, V16, P2366, DOI 10.2174/092986709788682119; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129; Narasaki Kazuto, 2003, J Orthop Sci, V8, P474, DOI 10.1007/s00776-003-0664-4; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ng KW, 2014, CURR OPIN PHARMACOL, V16, P58, DOI 10.1016/j.coph.2014.03.004; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Pennypacker BL, 2011, J BONE MINER RES, V26, P252, DOI 10.1002/jbmr.223; Pietschmann P, 2015, WIEN MED WOCHENSCHR, V165, P47, DOI 10.1007/s10354-015-0347-8; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reginster JY, 2011, DRUGS, V71, P65, DOI 10.2165/11587570-000000000-00000; Richards JB, 2007, J CLIN ENDOCR METAB, V92, P1517, DOI 10.1210/jc.2006-2097; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Rubin KH, 2013, J BONE MINER RES, V28, P1701, DOI 10.1002/jbmr.1956; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Lacativa PGS, 2010, ARQ BRAS ENDOCRINOL, V54, P123, DOI 10.1590/S0004-27302010000200007; Sathishkumar S, 2008, J DENT RES, V87, P687, DOI 10.1177/154405910808700703; Schilling T, 2014, J STEROID BIOCHEM, V139, P252, DOI 10.1016/j.jsbmb.2012.12.006; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Somjen D, 2011, J ENDOCRINOL INVEST, V34, P106, DOI [10.1007/BF03347039, 10.3275/7108]; Syed FA, 2008, OSTEOPOROSIS INT, V19, P1323, DOI 10.1007/s00198-008-0574-6; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Troen BR, 2004, DRUG NEWS PERSPECT, V17, P19, DOI 10.1358/dnp.2004.17.1.829022; van der Jagt OP, 2011, J BONE JOINT SURG AM, V93A, P38, DOI 10.2106/JBJS.I.01535; van der Jagt OP, 2013, J ORTHOP RES, V31, P768, DOI 10.1002/jor.22258; van der Jagt OP, 2009, J ORTHOP RES, V27, P1528, DOI 10.1002/jor.20910; Vimalraj S, 2015, INT J BIOL MACROMOL, V78, P202, DOI 10.1016/j.ijbiomac.2015.04.008; Wagner N, 2010, DEV BIOL, V339, P1, DOI 10.1016/j.ydbio.2009.11.036; Wang CJ, 2009, NITRIC OXIDE-BIOL CH, V20, P298, DOI 10.1016/j.niox.2009.02.006; Wang CJ, 2001, CLIN ORTHOP RELAT R, P95; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Yin Tsung-Cheng, 2011, Chang Gung Med J, V34, P367	53	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171276	10.1371/journal.pone.0171276	http://dx.doi.org/10.1371/journal.pone.0171276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158228	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700051
J	Takeda, T; Yamamoto, H; Kanzaki, H; Suzawa, K; Yoshioka, T; Tomida, S; Cui, XJ; Murali, R; Namba, K; Sato, H; Torigoe, H; Watanabe, M; Shien, K; Soh, J; Asano, H; Tsukuda, K; Kitamura, Y; Miyoshi, S; Sendo, T; Toyooka, S				Takeda, Tatsuaki; Yamamoto, Hiromasa; Kanzaki, Hirotaka; Suzawa, Ken; Yoshioka, Takahiro; Tomida, Shuta; Cui, Xiaojiang; Murali, Ramachandran; Namba, Kei; Sato, Hiroki; Torigoe, Hidejiro; Watanabe, Mototsugu; Shien, Kazuhiko; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Kitamura, Yoshihisa; Miyoshi, Shinichiro; Sendo, Toshiaki; Toyooka, Shinichi			Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; LUNG-CANCER; RECEPTOR; HER2; SRC; INHIBITION; ACTIVATION; EXPRESSION; THERAPIES; CELLS	Background Overexpression of human epidermal growth factor receptor 2 (HER2) is observed in approximately 15-23% of breast cancers and these cancers are classified as HER2-positive breast cancer. Trastuzumab is the first-line targeted therapeutic drug for HER2-positive breast cancer and has improved patient overall survival. However, acquired resistance to trastuzumab is still a critical issue in breast cancer treatment. We previously established a trastuzumabresistant breast cancer cell line (named as BT-474-R) from a trastuzumab-sensitive HER2-amplified cell line BT-474. Lapatinib is also a molecular-targeted drug for HER2-positive breast cancer, which acquired the resistance to trastuzumab. Acquired resistance to lapatinib is also an issue to be conquered. Methods We established trastuzumab/lapatinib-dual resistant cell line (named as BT-474-RL2) by additionally treating BT-474-R with lapatinib. We analyzed the mechanisms of resistance to trastuzumab and lapatinib. Besides, we analyzed the effect of the detected resistance mechanism in HER2-positive breast cancer patients. Results Proto-oncogene tyrosine-protein kinase Yes1, which is one of the Src family members, was amplified, overexpressed and activated in BT-474-R and BT-474-RL2. Silencing of Yes1 by siRNA induced both BT-474-R and BT-474-RL2 to restore the sensitivity to trastuzumab and lapatinib. Pharmaceutical inhibition of Yes1 by the Src inhibitor dasatinib was also effective to restore the sensitivity to trastuzumab and lapatinib in the two resistant cell lines. Combination treatment with dasatinib and trastuzumab induced down-regulation of signaling molecules such as HER2 and Akt. Moreover, the combination treatments induced G1-phase cell-cycle arrest and apoptosis. Consistent with cell line data, high expression of Yes1 mRNA was correlated with worse prognosis in patients with HER2-positive breast cancer. Conclusion Yes1 plays an important role in acquired resistance to trastuzumab and lapatinib in HER2-positive breast cancer. Our data suggest that pharmacological inhibition of Yes1 may be an effective strategy to overcome resistance to trastuzumab and lapatinib.	[Takeda, Tatsuaki; Kanzaki, Hirotaka; Kitamura, Yoshihisa; Sendo, Toshiaki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Pharm, Okayama, Okayama, Japan; [Yamamoto, Hiromasa; Suzawa, Ken; Namba, Kei; Sato, Hiroki; Torigoe, Hidejiro; Watanabe, Mototsugu; Shien, Kazuhiko; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Okayama, Japan; [Yoshioka, Takahiro; Torigoe, Hidejiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama, Okayama, Japan; [Tomida, Shuta] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biobank, Okayama, Okayama, Japan; [Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Murali, Ramachandran] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Okayama University; Okayama University; Okayama University; Okayama University; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Toyooka, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama, Okayama, Japan.; Toyooka, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama, Okayama, Japan.	toyooka@md.okayama-u.ac.jp	Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; KITAMURA, Yoshihisa/B-2036-2011; Kitamura, Yoshihisa/HCH-9498-2022; Murali, Ramachandran/D-1132-2009; Tsukuda, Kazunori/AAY-2985-2020; Yamamoto, Hiromasa/A-3719-2012; Shien, Kazuhiko/B-8560-2012	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; KITAMURA, Yoshihisa/0000-0002-3652-3722; Murali, Ramachandran/0000-0002-8384-2793; Tsukuda, Kazunori/0000-0001-6293-1693; Yamamoto, Hiromasa/0000-0002-5330-5460; Shien, Kazuhiko/0000-0002-4959-4220	Japan Society for the Promotion of Science (JSPS KAKENHI) [25293302]; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI grant number: 25293302 to ST), [https://www.jsps.go/english/index.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WD, 2014, INT J CANCER, V135, P1356, DOI 10.1002/ijc.28782; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Dziadziuszko R, 2016, J THORAC ONCOL, V11, P1273, DOI 10.1016/j.jtho.2016.04.001; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Formisano L, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3650; Gori S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156221; Han SQ, 2014, MABS-AUSTIN, V6, P403, DOI 10.4161/mabs.27443; Hubalek M, 2010, WIEN MED WOCHENSCHR, V160, P506, DOI 10.1007/s10354-010-0838-6; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kanzaki Hirotaka, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P1, DOI 10.1089/mab.2015.0056; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Kute TE, 2009, CANCER IMMUNOL IMMUN, V58, P1889, DOI 10.1007/s00262-009-0700-0; Malvezzi M, 2016, ANN ONCOL, V27, P725, DOI 10.1093/annonc/mdw022; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Munagala R, 2011, INDIAN J PHARMACOL, V43, P236, DOI 10.4103/0253-7613.81497; Muthuswamy SK, 2011, NAT MED, V17, P416, DOI 10.1038/nm0411-416; Nagaraja V, 2015, J GASTROINTEST ONCOL, V6, P143, DOI 10.3978/j.issn.2078-6891.2014.107; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nagy P, 2005, CANCER RES, V65, P473; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pohlmann PR, 2009, CLIN CANCER RES, V15, P7479, DOI 10.1158/1078-0432.CCR-09-0636; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Rexer BN, 2013, CLIN CANCER RES, V19, P5390, DOI 10.1158/1078-0432.CCR-13-1038; Rowinsky EK, 2004, ANNU REV MED, V55, P433, DOI 10.1146/annurev.med.55.091902.104433; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Sharial MSNM, 2012, ANN ONCOL, V23, P3007, DOI 10.1093/annonc/mds200; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tang P, 2016, ARCH PATHOL LAB MED, V140, P806, DOI 10.5858/arpa.2015-0133-RA; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	39	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171356	10.1371/journal.pone.0171356	http://dx.doi.org/10.1371/journal.pone.0171356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158234	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700064
J	Field, JJ; Majerus, E; Ataga, KI; Vichinsky, EP; Schaub, R; Mashal, R; Nathan, DG				Field, Joshua J.; Majerus, Elaine; Ataga, Kenneth I.; Vichinsky, Elliot P.; Schaub, Robert; Mashal, Robert; Nathan, David G.			NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease	PLOS ONE			English	Article							KILLER T-CELLS; SECRETORY PHOSPHOLIPASE A(2); INVARIANT NKT CELLS; PULMONARY INFLAMMATION; MICROBIAL IMMUNITY; INFECTION; HYDROXYUREA; ANEMIA; INJURY; MICE	Invariant NKT (iNKT) cells can be activated to stimulate a broad inflammatory response. In murine models of sickle cell disease (SCD), interruption of iNKT cell activity prevents tissue injury from vaso-occlusion. NKTT120 is an anti-iNKT cell monoclonal antibody that has the potential to rapidly and specifically deplete iNKT cells and, potentially, prevent vaso-occlusion. We conducted an open-label, multi-center, single-ascending-dose study of NKTT120 to determine its pharmacokinetics, pharmacodynamics and safety in steady-state patients with SCD. Doses were escalated in a 3+3 study design over a range from 0.001 mg/kg to 1.0 mg/kg. Twenty-one adults with SCD were administered NKTT120 as part of 7 dose cohorts. Plasma levels of NKTT120 predictably increased with higher doses. Median half-life of NKTT120 was 263 hours. All subjects in the higher dose cohorts (0.1 mg/kg, 0.3 mg/ kg, and 1 mg/kg) demonstrated decreased iNKT cells below the lower limit of quantification within 6 hours after infusion, the earliest time point at which they were measured. In those subjects who received the two highest doses of NKTT120 (0.3, 1 mg/kg), iNKT cells were not detectable in the peripheral blood for a range of 2 to 5 months. There were no serious adverse events in the study deemed to be related to NKTT120. In adults with SCD, NKTT120 produced rapid, specific and sustained iNKT cell depletion without any infusional toxicity or attributed serious adverse events. The next step is a trial to determine NKTT120's ability to decrease rate of vaso-occlusive pain episodes.	[Field, Joshua J.] Blood Ctr Wisconsin, Inst Med Sci, Milwaukee, WI 53233 USA; [Field, Joshua J.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Majerus, Elaine] Washington Univ, Dept Med, St Louis, MO USA; [Ataga, Kenneth I.] Univ N Carolina, Chapel Hill, NC USA; [Vichinsky, Elliot P.] Childrens Hosp Oakland, Oakland, CA USA; [Schaub, Robert; Mashal, Robert] NKT Therapeut, Waltham, MA USA; [Nathan, David G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nathan, David G.] Boston Childrens Hosp, Boston, MA USA; [Nathan, David G.] Harvard Med Sch, Boston, MA USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Field, JJ (corresponding author), Blood Ctr Wisconsin, Inst Med Sci, Milwaukee, WI 53233 USA.; Field, JJ (corresponding author), Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.	joshua.field@bcw.edu	Vichinsky, Elliott P/F-8541-2011	Vichinsky, Elliott P/0000-0002-0500-9579	NKT Therapeutics Inc.; NKT Therapeutics	NKT Therapeutics Inc.; NKT Therapeutics	The study was funded by NKT Therapeutics Inc. NKT Therapeutics provided support in the form of salaries for RS and RM. JJF and DGN were consultants for NKT Therapeutics. The funders assisted in study design and data analysis. The funders helped to write and reviewed the manuscript for publication.	Balato A, 2009, J INVEST DERMATOL, V129, P1628, DOI 10.1038/jid.2009.30; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Cho YN, 2011, RHEUMATOLOGY, V50, P1054, DOI 10.1093/rheumatology/keq457; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Crough T, 2004, BRIT J CANCER, V91, P1880, DOI 10.1038/sj.bjc.6602218; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Dial EJ, 2010, SHOCK, V33, P634, DOI 10.1097/SHK.0b013e3181cb9266; Field JJ, 2015, HEMATOL-AM SOC HEMAT, P426, DOI 10.1182/asheducation-2015.1.426; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kinjo Y, 2013, J INFECT CHEMOTHER, V19, P560, DOI 10.1007/s10156-013-0638-1; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Lappas CM, 2006, J EXP MED, V203, P2639, DOI 10.1084/jem.20061097; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Levy O, 2003, J INFECT DIS, V188, P948, DOI 10.1086/378503; McEwen-Smith RM, 2015, CANCER IMMUNOL RES, V3, P425, DOI 10.1158/2326-6066.CIR-15-0062; Neidlinger NA, 2006, J BIOL CHEM, V281, P775, DOI 10.1074/jbc.M505790200; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Pei H, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.2697.2697; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Scheuplein F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140729; Scheuplein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076692; Shen L, 2015, EUR J IMMUNOL, V45, P612, DOI 10.1002/eji.201444760; Sireci G, 2007, EUR J IMMUNOL, V37, P425, DOI 10.1002/eji.200636695; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Styles LA, 1996, BLOOD, V87, P2573, DOI 10.1182/blood.V87.6.2573.bloodjournal8762573; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Van Kaer L, 2011, CELL TISSUE RES, V343, P43, DOI 10.1007/s00441-010-1023-3; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538	44	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171067	10.1371/journal.pone.0171067	http://dx.doi.org/10.1371/journal.pone.0171067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152086	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200083
J	Emrich, TE; Qi, Y; Lou, WDY; L'Abbe, MR				Emrich, Teri E.; Qi, Ying; Lou, Wendy Y.; L'Abbe, Mary R.			Traffic-light labels could reduce population intakes of calories, total fat, saturated fat, and sodium	PLOS ONE			English	Article							FOOD INFORMATION PROGRAM; HEALTHY FOOD; IMPACT; REFORMULATION; CHOICES; CANADA; DIET	Traffic-light labelling has been proposed as a public health intervention to improve the dietary intakes of consumers. OBJECTIVES: to model the potential impact of avoiding foods with red traffic lights on the label on the energy, total fat, saturated fat, sodium, and sugars intakes of Canadian adults. METHODS: Canadian adults aged 19 and older (n = 19,915) who responded to the Canadian Community Health Survey (CCHS), Cycle 2.2. The nutrient levels in foods consumed by Canadians in CCHS were profiled using the United Kingdom's criteria for traffic light labelling. Whenever possible, foods assigned a red traffic light for one or more of the profiled nutrients were replaced with a similar food currently sold in Canada, with nutrient levels not assigned any red traffic lights. Average intakes of calories, total fat, saturated fat, sodium, and sugars under the traffic light scenario were compared with actual intakes of calories and these nutrients (baseline) reported in CCHS. RESULTS: Under the traffic light scenario, Canadian's intake of energy, total fat, saturated fat, and sodium were significantly reduced compared to baseline; sugars intakes were not significantly reduced. Calorie intake was reduced by 5%, total fat 13%, saturated fat 14%, and sodium 6%. CONCLUSION: Governments and policy makers should consider the adoption of traffic light labelling as a population level intervention to improve dietary intakes and chronic disease risk.	[Emrich, Teri E.; L'Abbe, Mary R.] Univ Toronto, Dept Human Nutr, Toronto, ON, Canada; [Qi, Ying; Lou, Wendy Y.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto	L'Abbe, MR (corresponding author), Univ Toronto, Dept Human Nutr, Toronto, ON, Canada.	mary.labbe@utoronto.ca	labbe, mary/AAC-3392-2020					[Anonymous], 2015, CANADA GAZETTE 1; Balcombe K, 2010, FOOD POLICY, V35, P211, DOI 10.1016/j.foodpol.2009.12.005; Beland Y, 2005, P AM STAT ASS JT STA, V6, P2738; Brownell KD, 2011, NEW ENGL J MED, V364, P2373, DOI 10.1056/NEJMp1101033; Buttriss JL, 2013, P NUTR SOC, V72, P61, DOI 10.1017/S0029665112002868; Canadian Council of Food and Nutrition, 2008, TRACK NUTR TRENDS 6; Department of Health, 2013, GUID CREAT FRONT PAC, P27; Dos Santos BA, 2015, J FOOD SCI, V80, pS1093, DOI 10.1111/1750-3841.12847; Dummer Jane, 2012, Can J Diet Pract Res, V73, pe227, DOI 10.3148/73.1.2012.e227; Emrich TE, 2014, APPL PHYSIOL NUTR ME, V39, P417, DOI 10.1139/apnm-2013-0304; Felicio TL, 2016, FOOD CHEM; Food Standards Agency Welsh Government, 2013, SCOTT GOV D H FRONT; Goodman S, 2011, J NUTR EDUC BEHAV, V43, P356, DOI 10.1016/j.jneb.2011.02.008; Government of Canada Health Canada Communications Marketing and Consultation DirectorateM and CCD, 2014, CONS CAN MOD IMPR LA; Hawley K.L., 2012, PUBLIC HEALTH NUTR, V1, P1; Health Canada, 2006, GUID ACC INT INT DAT; Health Canada, 2008, CAN NUTR FIL 2007; Health Canada, 1985, LAB PROC FOOD CHEM L; McCullum C, 1997, ADOLESCENCE, V32, P181; Raine KD, 2005, CAN J PUBLIC HEALTH, V96, pS8, DOI 10.1007/BF03405195; Roodenburg AJC, 2009, NUTR BULL, V34, P318, DOI 10.1111/j.1467-3010.2009.01767.x; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Schermel A, 2013, APPL PHYSIOL NUTR ME, V38, P666, DOI 10.1139/apnm-2012-0386; Statistics Canada, 2008, CAN COMM HLTH SURV 2; Temme EHM, 2011, PUBLIC HEALTH NUTR, V14, P635, DOI 10.1017/S1368980010002089; The Strategic Counsel, 2012, CAN UND US NUTR FACT; Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002; Thorndike AN, 2012, AM J PUBLIC HEALTH, V102, P527, DOI 10.2105/AJPH.2011.300391; United States Department of Agriculture Agricultural Research Service, 2014, FOOD SURV AMPM USDA; van Raaij J, 2009, PUBLIC HEALTH NUTR, V12, P325, DOI 10.1017/S1368980008003376; Vyth EL, 2012, EUR J CLIN NUTR, V66, P510, DOI 10.1038/ejcn.2011.193; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Wartella EA, 2010, EXAMINATION FRONT PA; Williams P, 2003, HEALTH PROMOT INT, V18, P51, DOI 10.1093/heapro/18.1.51; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	36	43	44	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171188	10.1371/journal.pone.0171188	http://dx.doi.org/10.1371/journal.pone.0171188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182630	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800041
J	Gienger, CM; Brien, ML; Tracy, CR; Manolis, SC; Webb, GJW; Seymour, RS; Christian, KA				Gienger, C. M.; Brien, Matthew L.; Tracy, Christopher R.; Manolis, S. Charlie; Webb, Grahame J. W.; Seymour, Roger S.; Christian, Keith A.			Ontogenetic comparisons of standard metabolism in three species of crocodilians	PLOS ONE			English	Article							CROCODYLUS-POROSUS; ESTUARINE CROCODILE; GROWTH; ENERGETICS; EVOLUTION; BEHAVIOR; RATES; SIZE; FISH; MASS	Due in part to their large size, aggressive temperament, and difficulty in handling, there are few physiological studies of adult crocodilians in the literature. As a result, studies comparing individuals across an ontogenetic series and comparisons among species are also lacking. We addressed this gap in knowledge by measuring standard metabolic rates (SMR) of three species of crocodilians (Crocodylus porosus, C. johnsoni, and Alligator mississippiensis), and included individuals that ranged from 0.22 to 114 kg. Allometric scaling of SMR with body mass was similar among the species, but C. porosus had significantly higher SMR than did C. johnsoni or A. mississippiensis. Differences in SMR among species are potentially related to behavioural differences in levels of aggression; C. porosus are the most aggressive of the crocodilians measured, and have rates of standard metabolism that are approximately 36% higher at the grand mean body size than those measured for C. johnsoni or A. mississippiensis, which are among the least aggressive crocodilians.	[Gienger, C. M.; Brien, Matthew L.; Tracy, Christopher R.; Webb, Grahame J. W.; Christian, Keith A.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia; [Brien, Matthew L.; Manolis, S. Charlie; Webb, Grahame J. W.] Wildlife Management Int & Crocodylus Pk, Berrimah, NT, Australia; [Seymour, Roger S.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; Austin Peay State Univ, Dept Biol, Clarksville, TN 37044 USA; [Gienger, C. M.] Austin Peay State Univ, Ctr Excellence Field Biol, Clarksville, TN 37044 USA; [Brien, Matthew L.] Queensland Govt, Dept Environm & Heritage Protect, Cairns, Qld, Australia; [Tracy, Christopher R.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA	Charles Darwin University; University of Adelaide; Austin Peay State University; Austin Peay State University; California State University System; California State University Fullerton	Gienger, CM (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia.	giengerc@apsu.edu	; Gienger, Chris/D-1759-2010	Christian, Keith/0000-0001-6135-1670; Gienger, Chris/0000-0001-5045-3321				ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Beaupre SJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P757, DOI 10.1086/322965; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Brien ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080872; Britton Adam R. C., 2012, Herpetological Review, V43, P541; Brown JH, 2003, MAR FRESHW BEHAV PHY, V36, P31, DOI 10.1080/1023624021000054307; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2010, INTEGR COMP BIOL, V50, pE24; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; COULSON R A, 1983, Comparative Biochemistry and Physiology B, V74, P1; COULSON RA, 1989, AM ZOOL, V29, P921; COULSON TD, 1973, ZOOLOGICA STUTTGART, V58, P47; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; Cutts CJ, 2002, J FISH BIOL, V61, P1540, DOI [10.1006/jfbi.2002.2173, 10.1111/j.1095-8649.2002.tb02496.x]; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Franklin CE, 2003, J EXP ZOOL PART A, V298A, P86, DOI 10.1002/jez.a.10233; GARNETT ST, 1986, AUST J ZOOL, V34, P211, DOI 10.1071/ZO9860211; Gienger CM, 2011, AUST J ZOOL, V59, P416, DOI 10.1071/ZO12018; GRIGG GC, 1978, PHYSIOL ZOOL, V51, P354, DOI 10.1086/physzool.51.4.30160960; HEUSNER AA, 1985, ANNU REV NUTR, V5, P267, DOI 10.1146/annurev.nu.05.070185.001411; Hoogenboom MO, 2013, BEHAV ECOL, V24, P253, DOI 10.1093/beheco/ars161; Killen SS, 2016, AM NAT, V187, P592, DOI 10.1086/685893; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Lang J.W., 1987, P273; LEWIS LY, 1985, COMP BIOCHEM PHYS A, V80, P441, DOI 10.1016/0300-9629(85)90065-9; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; MARLER CA, 1995, BEHAV ECOL SOCIOBIOL, V37, P225, DOI 10.1007/s002650050185; Nagy KA, 2000, HERPETOL MONOGR, V14, P378, DOI 10.2307/1467052; Peucker SKJ, 2005, CROCODILE FARMING RE; Reinhold K, 1999, FUNCT ECOL, V13, P217, DOI 10.1046/j.1365-2435.1999.00300.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seymour RS, 2013, J COMP PHYSIOL B, V183, P491, DOI 10.1007/s00360-012-0732-1; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; WEBB GJW, 1989, AM ZOOL, V29, P953; WIESER W, 1984, RESP PHYSIOL, V55, P1, DOI 10.1016/0034-5687(84)90112-9; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Zar JH, 1999, BIOSTATISTICAL ANAL	38	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171082	10.1371/journal.pone.0171082	http://dx.doi.org/10.1371/journal.pone.0171082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182696	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800032
J	Zou, LY; Wang, HR; Xiao, ZJ; Fang, Q; Zhang, M; Li, T; Du, G; Liu, Y				Zou, Liye; Wang, Huiru; Xiao, ZhongJun; Fang, Qun; Zhang, Mark; Li, Ting; Du, Geng; Liu, Yang			Tai chi for health benefits in patients with multiple sclerosis: A systematic review	PLOS ONE			English	Review							QUALITY-OF-LIFE; OLDER-ADULTS; PHYSICAL-ACTIVITY; RISK-FACTORS; FATIGUE; EXERCISE; BALANCE; PEOPLE; IMPACT; CRITERIA	The aim of this systematic review was to evaluate the existing evidence on the effectiveness and safety of Tai chi, which is critical to provide guidelines for clinicians to improve symptomatic management in patients with multiple sclerosis (MS). After performing electronic and manual searches of many sources, ten relevant peer-reviewed studies that met the inclusion criteria were retrieved. The existing evidence supports the effectiveness of Tai chi on improving quality of life (QOL) and functional balance in MS patients. A small number of these studies also reported the positive effect of Tai chi on flexibility, leg strength, gait, and pain. The effect of Tai chi on fatigue is inconsistent across studies. Although the findings demonstrate beneficial effects on improving outcome measures, especially for functional balance and QOL improvements, a conclusive claim should be made carefully for reasons such as methodological flaws, small sample size, lack of specific-disease instruments, unclear description of Tai chi protocol, unreported safety of Tai chi, and insufficient follow-up as documented by the existing literature. Future research should recruit a larger number of participants and utilize the experimental design with a long-term follow-up to ascertain the benefits of Tai chi for MS patients.	[Zou, Liye] Tennessee Technol Univ, Dept Exercise Sci Phys Educ & Wellness, Cookeville, TN 38505 USA; [Wang, Huiru] Shanghai Jiao Tong Univ, Dept Sport Sci, Shanghai, Peoples R China; [Xiao, ZhongJun] Jishou Univ, Dept Foreign Language Teaching, Jishou, Hunan, Peoples R China; [Fang, Qun] Springfield Coll, Dept Phys Educ & Hlth Educ, Springfield, MA USA; [Zhang, Mark] Delaware State Univ, Dept Sport Management, Delaware, OH USA; [Li, Ting] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurol, Shanghai, Peoples R China; [Du, Geng] Wuhan Sport Univ, Dept Exercise Sci, Wuhan, Peoples R China; [Liu, Yang] Indiana Univ, Dept Knesiol, Sensorimotor Neurophysiol Lab, Bloomington, IN USA	Tennessee Technological University; Shanghai Jiao Tong University; Jishou University; Springfield College; Shanghai Jiao Tong University; Wuhan Sports University; Indiana University System; Indiana University Bloomington	Zou, LY (corresponding author), Tennessee Technol Univ, Dept Exercise Sci Phys Educ & Wellness, Cookeville, TN 38505 USA.	Liyezou123@gmail.com	Northcote, Matthew/L-1135-2019; Northcote, Matthew/B-8209-2019	Zou, Liye/0000-0001-6411-5710				Achiron A, 1997, CLIN NEUROL NEUROSUR, V99, P280, DOI 10.1016/S0303-8467(97)00103-0; Amato MP, 2001, MULT SCLER J, V7, P340, DOI 10.1191/135245801681138059; [Anonymous], 1998, FATIGUE MULTIPLE SCL; Azimzadeh E., 2013, HAYAT, V19, P1; Azimzadeh E, 2015, COMPLEMENT THER CLIN, V21, P57, DOI 10.1016/j.ctcp.2014.09.002; Baumstarck K, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/524894; Bird M, 2011, ARCH GERONTOL GERIAT, V52, P211, DOI 10.1016/j.archger.2010.03.021; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Branas P., 2000, HLTH TECHNOL ASSESS, V4, P1, DOI [DOI 10.3310/HTA4270, 10.3310/hta4270]; Burschka JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0165-4; Burschka JM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-161; Chen KL, 2013, STRESS HEALTH, V29, P108, DOI 10.1002/smi.2432; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Choi Hye-Jung, 2013, ISRN Neurol, V2013, P548240, DOI 10.1155/2013/548240; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Finlayson ML, 2006, ARCH PHYS MED REHAB, V87, P1274, DOI 10.1016/j.apmr.2006.06.002; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Ford HL, 2001, DISABIL REHABIL, V23, P516; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Freeman JA, 2001, NEUROLOGY, V57, P68, DOI 10.1212/WNL.57.1.68; Galantino ML, 2003, REHABIL ONCOL, V21, P17, DOI DOI 10.1097/01893697-200321010-00012; Gao Q, 2014, CLIN REHABIL, V28, P748, DOI 10.1177/0269215514521044; Hackney ME, 2008, GAIT POSTURE, V28, P456, DOI 10.1016/j.gaitpost.2008.02.005; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hebert JR, 2013, GAIT POSTURE, V38, P37, DOI 10.1016/j.gaitpost.2012.10.015; Hemmett L, 2004, QJM-INT J MED, V97, P671, DOI 10.1093/qjmed/hch105; Husted C, 1999, ALTERN THER HEALTH M, V5, P70; Irwin MR, 2008, SLEEP, V31, P1001; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; Karatepe AG, 2011, INT J REHABIL RES, V34, P290, DOI 10.1097/MRR.0b013e32834ad479; Kaur D, 2014, INT J CURRENT RES RE, V6, P24; Khan F, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00177; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Lee Kang-Yi, 2006, Taehan Kanho Hakhoe Chi, V36, P278; Lee MS, 2007, RHEUMATOLOGY, V46, P1648, DOI 10.1093/rheumatology/kem151; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mills N, 2000, GEN HOSP PSYCHIAT, V22, P425, DOI 10.1016/S0163-8343(00)00100-6; Mills N, 2000, J BODYW MOV THER, V4, P39, DOI DOI 10.1054/JBMT.1999.0139; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; MOHALI Z., 2013, MED SURG NURSING J, V2, P81; Nagaraj K, 2013, J NEUROSCI RURAL PRA, V4, P278, DOI 10.4103/0976-3147.118774; Nilsagard Y, 2009, CLIN REHABIL, V23, P259, DOI 10.1177/0269215508095087; Onitilo AA, 2014, CLIN MED RES, V12, P2, DOI 10.3121/cmr.2013.1188-1209; Parekh Vanisha, 2012, Nat Rev Neurol, V8, P179, DOI 10.1038/nrneurol.2012.38; Petajan JH, 1999, SPORTS MED, V27, P179, DOI 10.2165/00007256-199927030-00004; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rameh V, 2016, CLIN MED INSIGHTS-CA, V10, P23, DOI 10.4137/CMC.S36504; Roberts CK, 2005, J APPL PHYSIOL, V98, P3, DOI 10.1152/japplphysiol.00852.2004; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Solari Alessandra, 2005, Health Qual Life Outcomes, V3, P16, DOI 10.1186/1477-7525-3-16; Tavee Jinny, 2011, Int J MS Care, V13, P163, DOI 10.7224/1537-2073-13.4.163; Turner AM, 2013, PRIM CARE RESP J, V22, P72, DOI 10.4104/pcrj.2013.00013; van Emmerik REA, 2014, ADV EXP MED BIOL, V826, P251, DOI 10.1007/978-1-4939-1338-1_15; Verhagen AP, 2004, FAM PRACT, V21, P107, DOI 10.1093/fampra/cmh122; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wang HR, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/379451; Wayne PM, 2007, ARCH PHYS MED REHAB, V88, P673, DOI 10.1016/j.apmr.2007.02.012; Wolf SL, 1997, ARCH PHYS MED REHAB, V78, P886, DOI 10.1016/S0003-9993(97)90206-9; Yeh GY, 2009, J CARDIOPULM REHABIL, V29, P152, DOI 10.1097/HCR.0b013e3181a33379; Zhang TY, 2015, AM J PHYS MED REHAB, V94, P921, DOI 10.1097/PHM.0000000000000351; Zhou J, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/593263	64	37	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170212	10.1371/journal.pone.0170212	http://dx.doi.org/10.1371/journal.pone.0170212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182629	Green Published, gold			2022-12-27	WOS:000394231800008
J	Lu, LL; Wang, J; Zheng, PJ; Wang, W				Lu, Lili; Wang, Jian; Zheng, Pengjun; Wang, Wei			Network capacity with probit-based stochastic user equilibrium problem	PLOS ONE			English	Article							CONTROLLED ROAD NETWORK; SENSITIVITY-ANALYSIS; RESERVE CAPACITY; ASSIGNMENT MODEL; SIGNAL CONTROL; ROUTE CHOICE	Among different stochastic user equilibrium (SUE) traffic assignment models, the Logitbased stochastic user equilibrium (SUE) is extensively investigated by researchers. It is constantly formulated as the low-level problem to describe the drivers' route choice behavior in bi-level problems such as network design, toll optimization et al. The Probit-based SUE model receives far less attention compared with Logit-based model albeit the assignment result is more consistent with drivers' behavior. It is well-known that due to the identical and irrelevant alternative (IIA) assumption, the Logit-based SUE model is incapable to deal with route overlapping problem and cannot account for perception variance with respect to trips. This paper aims to explore the network capacity with Probit-based traffic assignment model and investigate the differences of it is with Logit-based SUE traffic assignment models. The network capacity is formulated as a bi-level programming where the up-level program is to maximize the network capacity through optimizing input parameters (O-D multiplies and signal splits) while the low-level program is the Logit-based or Probit-based SUE problem formulated to model the drivers' route choice. A heuristic algorithm based on sensitivity analysis of SUE problem is detailed presented to solve the proposed bi-level program. Three numerical example networks are used to discuss the differences of network capacity between Logit-based SUE constraint and Probit-based SUE constraint. This study finds that while the network capacity show different results between Probit-based SUE and Logitbased SUE constraints, the variation pattern of network capacity with respect to increased level of travelers' information for general network under the two type of SUE problems is the same, and with certain level of travelers' information, both of them can achieve the same maximum network capacity.	[Lu, Lili; Zheng, Pengjun] Ningbo Univ, Fac Maritime & Transportat, Ningbo, Zhejiang, Peoples R China; [Lu, Lili; Zheng, Pengjun] Ningbo Univ, Subctr, Natl Traff Management Engn & Technol Res Ctr, Ningbo, Zhejiang, Peoples R China; [Lu, Lili; Zheng, Pengjun; Wang, Wei] Jiangsu Prov Collaborat Innovat Ctr Modern Urban, Nanjing, Jiangsu, Peoples R China; [Wang, Jian] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA	Ningbo University; Ningbo University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wang, J (corresponding author), Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA.	wang2084@purdue.edu	Zheng, Pengjun/AAH-9455-2020; Zheng, P/B-4258-2008; Wang, Jian/HII-8685-2022; Zheng, Pengjun/AHA-3631-2022; Wang, Jian/U-3959-2019	Wang, Jian/0000-0002-0385-3645; Zheng, Pengjun/0000-0003-3834-1401; Wang, Jian/0000-0002-0385-3645	Natural Science Foundation of Zhejiang Province [LQ17E080007, LY15E080013]; National Natural Science Foundation of China [71501009]; Ningbo University	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo University	This work was funded by the Natural Science Foundation of Zhejiang Province (LQ17E080007) to LL, the Natural Science Foundation of Zhejiang Province (LY15E080013) to PZ, the National Natural Science Foundation of China 71501009 LL, and the K.C. Wong Magna Fund from the Ningbo University to LL.	Ceylan H, 2004, ITS J, V8, P87, DOI 10.1080/15472450490437780; Chen A, 2002, TRANSPORT RES B-METH, V36, P225, DOI 10.1016/S0191-2615(00)00048-5; Chen A, 2006, TRANSPORT RES REC, P35, DOI 10.3141/1964-05; Chen A, 2011, TRANSPORT RES A-POL, V45, P105, DOI 10.1016/j.tra.2010.11.003; Chiou SW, 2007, APPL MATH COMPUT, V190, P1602, DOI 10.1016/j.amc.2007.02.041; Chootinan P, 1999, J ADV TRANSPORT, V39, P247; Clark SD, 2002, TRANSPORT RES B-METH, V36, P617, DOI 10.1016/S0191-2615(01)00021-2; Clark SD, 2001, TRANSPORT RES REC, V1733, P88; DIAL RB, 1971, TRANSPORT RES, V5, P83, DOI 10.1016/0041-1647(71)90012-8; Du MQ, 2012, TRANSPORT RES REC, P10, DOI 10.3141/2284-02; Fiacco A. V., 1983, INTRO SENSITIVITY ST; FRIESZ TL, 1990, MATH PROGRAM, V48, P265, DOI 10.1007/BF01582259; Gao ZY, 2002, TRANSPORT RES B-METH, V36, P313, DOI 10.1016/S0191-2615(01)00005-4; Ge YE, 2003, J TRANSP ENG-ASCE, V129, P262, DOI 10.1061/(ASCE)0733-947X(2003)129:3(262); Han F, 2016, ENG OPTIMIZ IN PRESS; Kasikitwiwat P., 2005, J E ASIA SOC TRANSP, V6, P1439; Luo ZQ, 1996, MATH PROGRAMS EQUILI; Miyagi T, 1996, P 7 WORLD C TRANSP R, P65; Prashker JN, 2004, TRANSPORT REV, V24, P437, DOI 10.1080/0144164042000181707; Sheffi Y., 1985, URBAN TRANSPORTATION; TOBIN RL, 1988, TRANSPORT SCI, V22, P242, DOI 10.1287/trsc.22.4.242; Wang J, 2015, TRANSPORT IN PRESS; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wang J, 2016, TRANSPORT RES B-METH, V92, P35, DOI 10.1016/j.trb.2015.09.010; Wong SC, 1997, TRANSPORT RES B-METH, V31, P397, DOI 10.1016/S0191-2615(97)00002-7; Yang H, 1997, TRANSPORT RES B-METH, V31, P55, DOI 10.1016/S0191-2615(96)00015-X; YANG H, 1994, TRANSPORT RES B-METH, V28, P463, DOI 10.1016/0191-2615(94)90015-9; Ying JQ, 2001, TRANSPORT SCI, V35, P124, DOI 10.1287/trsc.35.2.124.10137	28	2	2	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171158	10.1371/journal.pone.0171158	http://dx.doi.org/10.1371/journal.pone.0171158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178284	gold, Green Published, Green Submitted			2022-12-27	WOS:000393712500027
J	Taucher, J; Haunost, M; Boxhammer, T; Bach, LT; Alguero-Muniz, M; Riebesell, U				Taucher, Jan; Haunost, Mathias; Boxhammer, Tim; Bach, Lennart T.; Alguero-Muniz, Maria; Riebesell, Ulf			Influence of ocean acidification on plankton community structure during a winter-to-summer succession: An imaging approach indicates that copepods can benefit from elevated CO2 via indirect food web effects	PLOS ONE			English	Article							CENTRAL BALTIC SEA; PSEUDOCALANUS-ACUSPES; PHYTOPLANKTON BLOOM; SIZE DISTRIBUTIONS; SINKING VELOCITY; MU-M; ZOOPLANKTON; PATTERNS; TEMPERATURE; PARTICLES	Plankton communities play a key role in the marine food web and are expected to be highly sensitive to ongoing environmental change. Oceanic uptake of anthropogenic carbon dioxide (CO2) causes pronounced shifts in marine carbonate chemistry and a decrease in seawater pH. These changes-summarized by the term ocean acidification (OA)-can significantly affect the physiology of planktonic organisms. However, studies on the response of entire plankton communities to OA, which also include indirect effects via food-web interactions, are still relatively rare. Thus, it is presently unclear how OA could affect the functioning of entire ecosystems and biogeochemical element cycles. In this study, we report from a long-term in situ mesocosm experiment, where we investigated the response of natural plankton communities in temperate waters (Gullmarfjord, Sweden) to elevated CO2 concentrations and OA as expected for the end of the century (similar to 760 mu atm pCO(2)). Based on a plankton- imaging approach, we examined size structure, community composition and food web characteristics of the whole plankton assemblage, ranging from picoplankton to mesozooplankton, during an entire winter-to-summer succession. The plankton imaging system revealed pronounced temporal changes in the size structure of the copepod community over the course of the plankton bloom. The observed shift towards smaller individuals resulted in an overall decrease of copepod biomass by 25%, despite increasing numerical abundances. Furthermore, we observed distinct effects of elevated CO2 on biomass and size structure of the entire plankton community. Notably, the biomass of copepods, dominated by Pseudocalanus acuspes, displayed a tendency towards elevated biomass by up to 30-40% under simulated ocean acidification. This effect was significant for certain copepod size classes and was most likely driven by CO2-stimulated responses of primary producers and a complex interplay of trophic interactions that allowed this CO2 effect to propagate up the food web. Such OA-induced shifts in plankton community structure could have far-reaching consequences for food-web interactions, biomass transfer to higher trophic levels and biogeochemical cycling of marine ecosystems.	[Taucher, Jan; Haunost, Mathias; Boxhammer, Tim; Bach, Lennart T.; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Alguero-Muniz, Maria] Alfred Wegener Inst Helmholtz Zentrum Polar & Mar, Inst Biol, Helgoland, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Taucher, J (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany.	jtaucher@geomar.de	Algueró-Muñiz, María/AAA-9748-2020; Boxhammer, Tim/GLN-6190-2022; Riebesell, Ulf/AAC-9717-2020; Boxhammer, Tim/AAE-6416-2020; Taucher, Jan/AAA-9195-2019	Algueró-Muñiz, María/0000-0001-8064-6212; Boxhammer, Tim/0000-0002-9632-5947; Boxhammer, Tim/0000-0002-9632-5947; Riebesell, Ulf/0000-0002-9442-452X; Bach, Lennart/0000-0003-0202-3671; Taucher, Jan/0000-0001-9944-0775	German Federal Ministry of Science and Education (BMBF): BIOACID II project [FKZ 03F06550]; Leibniz Award by the German Science Foundation (DFG); Swedish Academy of Sciences	German Federal Ministry of Science and Education (BMBF): BIOACID II project(Federal Ministry of Education & Research (BMBF)); Leibniz Award by the German Science Foundation (DFG)(German Research Foundation (DFG)); Swedish Academy of Sciences	This work was supported by the German Federal Ministry of Science and Education (BMBF): BIOACID II project (FKZ 03F06550) https://www.bmbf.de (all authors); Leibniz Award 2012 by the German Science Foundation (DFG) (UR); Swedish Academy of Sciences (MAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2009, P ROY SOC B-BIOL SCI, V276, P109, DOI 10.1098/rspb.2008.0951; Andersen KH, ANN REV MARINE SCI, V8, P217; [Anonymous], 2011, BIOL REV, V86, P311, DOI [10.1111/j.1469-185X.2010.00148.x, DOI 10.1111/J.1469-185X.2010.00148.X]; Bach LT, 2016, GLOBAL BIOGEOCHEM CY, V30, P1145, DOI 10.1002/2016GB005372; Bach LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159068; Bach LT, 2015, PROG OCEANOGR, V135, P125, DOI 10.1016/j.pocean.2015.04.012; Bach LT, 2012, MAR BIOL, V159, P1853, DOI 10.1007/s00227-012-1945-2; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Basedow SL, 2010, J PLANKTON RES, V32, P1105, DOI 10.1093/plankt/fbp110; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Benfield MC, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.63; Boissonnot L, 2016, J PLANKTON RES; BOUDREAU PR, 1992, CAN J FISH AQUAT SCI, V49, P1528, DOI 10.1139/f92-169; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Corkett CJ, ADV MARINE BIOL, P1; Cotonnec G, 2001, J PLANKTON RES, V23, P693, DOI 10.1093/plankt/23.7.693; Cripps G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151739; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Edenhofer O., 2014, CONTRIBUTION WORKING; FALKOWSKI PG, 1988, CONT SHELF RES, V8, P457, DOI 10.1016/0278-4343(88)90064-7; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Forest A, 2012, BIOGEOSCIENCES, V9, P1301, DOI 10.5194/bg-9-1301-2012; GAEDKE U, 1993, LIMNOL OCEANOGR, V38, P112, DOI 10.4319/lo.1993.38.1.0112; Gamble J.C., 1982, P25; Gao KS, 2014, FUNCT PLANT BIOL, V41, P449, DOI 10.1071/FP13247; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; HEATH MR, 1995, ICES J MAR SCI, V52, P627, DOI 10.1016/1054-3139(95)80077-8; Hildebrandt N, 2015, J CONSEIL; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; Huete-Ortega M, 2010, J PLANKTON RES, V32, P1, DOI 10.1093/plankt/fbp104; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jackson GA, 1997, DEEP-SEA RES PT I, V44, P1739, DOI 10.1016/S0967-0637(97)00029-0; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Litchman E, 2013, J PLANKTON RES, V35, P473, DOI 10.1093/plankt/fbt019; LOCHTE K, 1993, DEEP-SEA RES PT II, V40, P91, DOI 10.1016/0967-0645(93)90008-B; LOGAN BE, 1987, LIMNOL OCEANOGR, V32, P1034, DOI 10.4319/lo.1987.32.5.1034; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; Peters J, 2006, MAR BIOL, V149, P1417, DOI 10.1007/s00227-006-0290-8; Platt T., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V173, P60; Rakotomalala R., 2005, MODULAD, P71; Renz J, 2007, MAR BIOL, V151, P515, DOI 10.1007/s00227-006-0510-2; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Romagnan JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119219; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Sigaud O, 2007, SOFT COMPUT, V11, P1065, DOI 10.1007/s00500-007-0164-0; SILVERT W, 1978, LIMNOL OCEANOGR, V23, P813, DOI 10.4319/lo.1978.23.4.0813; Sommer U, ANN REV ECOLOGY EVOL, V43, P429; Sprules WG, 2016, CAN J FISH AQUAT SCI, V73, P477, DOI 10.1139/cjfas-2015-0115; Stemmann L, 2004, DEEP-SEA RES PT I, V51, P865, DOI 10.1016/j.dsr.2004.03.001; Stemmann L, BIOGEOSCIENCES; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Turner JT, 2015, PROG OCEANOGR, V130, P205, DOI 10.1016/j.pocean.2014.08.005; Vandromme P, 2014, OCEAN SCI, V10, P821, DOI 10.5194/os-10-821-2014; Vandromme P., 2012, METHODS OCEANOGRAPHY, V1, P3, DOI DOI 10.1016/J.MI0.2012.06.001; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Wolf-Gladrow D, 1997, MAR CHEM, V59, P17, DOI 10.1016/S0304-4203(97)00069-8; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Zarauz L, 2009, J PLANKTON RES, V31, P193, DOI 10.1093/plankt/fbn107; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zhou M, 1997, MAR ECOL PROG SER, V159, P61, DOI 10.3354/meps159061; Zhou M, 2006, J PLANKTON RES, V28, P437, DOI 10.1093/plankt/fbi119	86	27	27	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0169737	10.1371/journal.pone.0169737	http://dx.doi.org/10.1371/journal.pone.0169737			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178268	Green Published, Green Accepted, gold			2022-12-27	WOS:000393712500002
J	Causer, J; Smeeton, NJ; Williams, AM				Causer, Joe; Smeeton, Nicholas J.; Williams, A. Mark			Expertise differences in anticipatory judgements during a temporally and spatially occluded task	PLOS ONE			English	Article							VISUAL-SEARCH; SOCCER GOALKEEPERS; BIOLOGICAL MOTION; PERCEPTION; SKILL	There is contradictory evidence surrounding the role of critical cues in the successful anticipation of penalty kicks in soccer. In the current study, skilled and less-skilled soccer goalkeepers were required to anticipate when viewing penalty kicks that were both spatially (full body; hip region) and temporally (-160 ms, -80 ms before, foot-ball contact) occluded. The skilled group outperformed the less-skilled group in all conditions. Participants performed better in the full body condition when compared to hip region condition. Performance in the hip only condition was significantly better than chance for the skilled group across all occlusion conditions. However, the less-skilled group were no better than chance in the hip condition for the early occlusion points when predicting direction and height. Later temporal occlusion conditions were associated with increased performance both in the correct response and correct direction analyses, but not for correct height. These data suggest that postural information solely from the hip region may be used by skilled goalkeepers to make accurate predictions of penalty kick direction, however, information from other sources are needed in order to make predictions of height. Findings demonstrate how the importance of anticipation cues evolve over time, which has implications for the design of training programs to enhance perceptual-cognitive skill.	[Causer, Joe] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Tom Reilly Bldg, Liverpool, Merseyside, England; [Smeeton, Nicholas J.] Univ Brighton, Ctr Sport & Exercise Sci & Med, Welkin Labs, Brighton, E Sussex, England; [Williams, A. Mark] Univ Utah, Dept Hlth Kinesiol & Recreat, Coll Hlth, Salt Lake City, UT USA	Liverpool John Moores University; University of Brighton; Utah System of Higher Education; University of Utah	Causer, J (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Tom Reilly Bldg, Liverpool, Merseyside, England.	j.causer@ljmu.ac.uk	Causer, Joe/M-1502-2019	Causer, Joe/0000-0002-8939-8769; Smeeton, Nicholas/0000-0003-3371-3237				Abernethy B, 2001, PERCEPTION, V30, P233, DOI 10.1068/p2872; Abernethy B, 1984, AUSTR J SCI MED SPOR, V16, P2; Bruland R, 2009, J MOTOR BEHAV, V41, P158; Causer J., 2013, ROUTLEDGE HDB SPORTS, P21; Causer J., 2012, P306; Causer J, 2015, J SPORT EXERCISE PSY, V37, P74, DOI 10.1123/jsep.2014-0200; Causer J, 2014, COGN PROCESS, V15, P385, DOI 10.1007/s10339-014-0598-0; Diaz GJ, 2012, J EXP PSYCHOL HUMAN, V38, P848, DOI 10.1037/a0026962; Farrow D, 2005, MOTOR CONTROL, V9, P332; Hagemann N, 2006, J SPORT EXERCISE PSY, V28, P143, DOI 10.1123/jsep.28.2.143; Hughes M., 2002, INT J PERF ANAL SPOR, V2, P55, DOI DOI 10.1080/24748668.2002.11868261; Huys R, 2008, PERCEPT PSYCHOPHYS, V70, P1217, DOI 10.3758/PP.70.7.1217; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; Kuhn W., 1988, SCI FOOTBALL, P489; Runigo C, 2010, J SPORT SCI, V28, P327, DOI 10.1080/02640410903502782; Lopes JE, 2014, HUM MOVEMENT SCI, V36, P199, DOI 10.1016/j.humov.2014.04.004; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Muller S, 2006, Q J EXP PSYCHOL, V59, P2162, DOI 10.1080/02643290600576595; Piras A, 2011, COGN PROCESS, V12, P245, DOI 10.1007/s10339-011-0406-z; Savelsbergh GJP, 2005, ERGONOMICS, V48, P1686, DOI 10.1080/00140130500101346; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Smeeton NJ, 2012, BRIT J PSYCHOL, V103, P539, DOI 10.1111/j.2044-8295.2011.02092.x; Smeeton NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079811; Ward P, 2002, RES Q EXERCISE SPORT, V73, P107, DOI 10.1080/02701367.2002.10608997; Williams A. M., 1999, VISUAL PERCEPTION AC; Williams AM, 2009, PROG BRAIN RES, V174, P73, DOI 10.1016/S0079-6123(09)01307-7; Williams AM, 2009, HUM MOVEMENT SCI, V28, P362, DOI 10.1016/j.humov.2008.10.006; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; WILLIAMS AM, 1993, SCIENCE AND FOOTBALL II, P239	29	28	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171330	10.1371/journal.pone.0171330	http://dx.doi.org/10.1371/journal.pone.0171330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170412	Green Published, Green Accepted, gold			2022-12-27	WOS:000393705500034
J	Anguiano, M; Castilla, C; Maska, M; Ederra, C; Pelaez, R; Morales, X; Munoz-Arrieta, G; Mujika, M; Kozubek, M; Munoz-Barrutia, A; Rouzaut, A; Arana, S; Garcia-Aznar, JM; Ortiz-de-Solorzano, C				Anguiano, Maria; Castilla, Carlos; Maska, Martin; Ederra, Cristina; Pelaez, Rafael; Morales, Xabier; Munoz-Arrieta, Gorka; Mujika, Maite; Kozubek, Michal; Munoz-Barrutia, Arrate; Rouzaut, Ana; Arana, Sergio; Manuel Garcia-Aznar, Jose; Ortiz-de-Solorzano, Carlos			Characterization of three-dimensional cancer cell migration in mixed collagen-Matrigel scaffolds using microfluidics and image analysis	PLOS ONE			English	Article							NETWORK GEOMETRY; BREAST-CANCER; TUMOR-CELLS; IN-VITRO; INVASION; TRANSITION; ADHESION; CONTRACTILITY; METASTASIS; ALGORITHM	Microfluidic devices are becoming mainstream tools to recapitulate in vitro the behavior of cells and tissues. In this study, we use microfluidic devices filled with hydrogels of mixed collagen-Matrigel composition to study the migration of lung cancer cells under different cancer invasion microenvironments. We present the design of the microfluidic device, characterize the hydrogels morphologically and mechanically and use quantitative image analysis to measure the migration of H1299 lung adenocarcinoma cancer cells in different experimental conditions. Our results show the plasticity of lung cancer cell migration, which turns from mesenchymal in collagen only matrices, to lobopodial in collagen-Matrigel matrices that approximate the interface between a disrupted basement membrane and the underlying connective tissue. Our quantification of migration speed confirms a biphasic role of Matrigel. At low concentration, Matrigel facilitates migration, most probably by providing a supportive and growth factor retaining environment. At high concentration, Matrigel slows down migration, possibly due excessive attachment. Finally, we show that antibody-based integrin blockade promotes a change in migration phenotype from mesenchymal or lobopodial to amoeboid and analyze the effect of this change in migration dynamics, in regards to the structure of the matrix. In summary, we describe and characterize a robust microfluidic platform and a set of software tools that can be used to study lung cancer cell migration under different microenvironments and experimental conditions. This platform could be used in future studies, thus benefitting from the advantages introduced by microfluidic devices: precise control of the environment, excellent optical properties, parallelization for high throughput studies and efficient use of therapeutic drugs.	[Anguiano, Maria; Castilla, Carlos; Ederra, Cristina; Pelaez, Rafael; Morales, Xabier; Ortiz-de-Solorzano, Carlos] Ctr Appl Med Res, Div Solid Tumors & Biomarkers, Lab Preclin Models & Analyt Tools, Navarra, Spain; [Anguiano, Maria; Castilla, Carlos; Ederra, Cristina; Pelaez, Rafael; Morales, Xabier; Ortiz-de-Solorzano, Carlos] CIBERONC, Navarra, Spain; [Maska, Martin; Kozubek, Michal] Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic; [Munoz-Arrieta, Gorka; Mujika, Maite; Arana, Sergio] CEIT, Biodevices & MEMS Grp, Water & Hlth Div, Donostia San Sebastian, Gipuzkoa, Spain; [Munoz-Arrieta, Gorka; Mujika, Maite; Arana, Sergio] Univ Navarra, TECNUN, Donostia San Sebastian, Gipuzkoa, Spain; [Munoz-Barrutia, Arrate] Univ Carlos III Madrid, Bioengn & Aerosp Engn Dept, Madrid, Spain; [Munoz-Barrutia, Arrate] Inst Invest Sanitaria Gregorio Maranon, Biomed Engn Div, Madrid, Spain; [Rouzaut, Ana] Univ Navarra, Fac Sci, Dept Biochem & Genet, Navarra, Spain; [Rouzaut, Ana] CIMA, Dept Immunol & Inmunotherapy, Navarra, Spain; [Manuel Garcia-Aznar, Jose] Univ Zaragoza, Dept Mech Engn, Multiscale Mech & Biol Engn M2BE, Aragon Inst Engn Res I3A, Zaragoza, Spain; [Pelaez, Rafael] Ctr Biomed Res La Rioja CIBIR, Div Oncol, Dept Biomarkers & Mol Signaling, Logrono, La Rioja, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Masaryk University Brno; University of Navarra; University of Navarra; Universidad Carlos III de Madrid; University of Navarra; University of Navarra; University of Zaragoza	Ortiz-de-Solorzano, C (corresponding author), Ctr Appl Med Res, Div Solid Tumors & Biomarkers, Lab Preclin Models & Analyt Tools, Navarra, Spain.; Ortiz-de-Solorzano, C (corresponding author), CIBERONC, Navarra, Spain.	codesolorzano@unav.es	Munoz-Barrutia, Arrate/G-1776-2016; Maška, Martin/J-3302-2013; Arana, Sergio/C-7762-2017; Kozubek, Michal/G-8939-2013; Garcia-Aznar, Jose Manuel/F-8256-2010; Peláez, Rafael/R-9458-2019; Arana, Sergio/I-8913-2019; Rouzaut, Ana/I-2576-2017; Ortiz-de-Solorzano, Carlos/G-3278-2010	Munoz-Barrutia, Arrate/0000-0002-1573-1661; Maška, Martin/0000-0003-3544-6494; Arana, Sergio/0000-0003-0970-7638; Kozubek, Michal/0000-0001-7902-589X; Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Peláez, Rafael/0000-0002-4047-6017; Rouzaut, Ana/0000-0003-3226-9162; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Morales, Xabier/0000-0003-0303-9958	Spanish Ministry of Economy and Competitiveness [DPI2012-38090-C03-02, DPI2015-64221-C2-2-R, TEC2013-48552-C2-1-R, TEC2016-78052-R, TEC2015-73064-EXP]; Torres Quevedo program [PTQ-11-04778]; Spanish Ministry of Health [FIS PI13/02313]; Czech Science Foundation [302/12/G157]; European Research Council (ERC) [ERC-2012-StG 306751]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Torres Quevedo program; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Czech Science Foundation(Grant Agency of the Czech Republic); European Research Council (ERC)(European Research Council (ERC)European Commission)	We would like to acknowledge the support of the Spanish Ministry of Economy and Competitiveness, under grants number DPI2012-38090-C03-02 and DPI2015-64221-C2-2-R (COS), TEC2013-48552-C2-1-R, TEC2016-78052-R, TEC2015-73064-EXP (AMB) and the Torres Quevedo program PTQ-11-04778 (RP); the Spanish Ministry of Health (FIS PI13/02313) (AR); the Czech Science Foundation, under grant number 302/12/G157 (MK, MMaska); and the European Research Council (ERC) through project ERC-2012-StG 306751 (JMGA).; We would like to acknowledge the support of the Spanish Ministry of Economy and Competitiveness, under grants number DPI2012-38090-C03-02 and DPI2015-64221-C2-2-R (COS), TEC2013-48552-C2-1-R, TEC2016-78052-R, TEC2015-73064-EXP (AMB) and the Torres Quevedo program PTQ-11-04778 (RP); the Spanish Ministry of Health (FIS PI13/02313) (AR); the Czech Science Foundation, under grant number 302/12/G157 (MK, MMagka); and the European Research Council (ERC) through project ERC-2012-StG 306751 (JMGA).	Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hotaling NA, 2015, BIOMATERIALS, V61, P327, DOI 10.1016/j.biomaterials.2015.05.015; Jacob M, 2004, IEEE T PATTERN ANAL, V26, P1007, DOI 10.1109/TPAMI.2004.44; Jeon JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056910; Kiss A., 2014, PLOS ONE, V9, P1; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lang NR, 2015, ACTA BIOMATER, V13, P61, DOI 10.1016/j.actbio.2014.11.003; Lautscham LA, 2015, BIOPHYS J, V109, P900, DOI 10.1016/j.bpj.2015.07.025; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mak M, 2013, LAB CHIP, V13, P340, DOI 10.1039/c2lc41117b; Maska M, 2015, IEEE IMAGE PROC, P1791, DOI 10.1109/ICIP.2015.7351109; Maska M, 2013, IEEE T MED IMAGING, V32, P995, DOI 10.1109/TMI.2013.2243463; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Polacheck WJ, 2014, P NATL ACAD SCI USA, V111, P2447, DOI 10.1073/pnas.1316848111; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rasband W., 2006, IMAGEJ; Shaw Leslie M., 2004, V294, P97; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Tsai KKC, 2005, CANCER RES, V65, P6734, DOI 10.1158/0008-5472.CAN-05-0703; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wu PH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.030; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	45	79	81	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171417	10.1371/journal.pone.0171417	http://dx.doi.org/10.1371/journal.pone.0171417			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166248	Green Published, gold			2022-12-27	WOS:000393700100040
J	Van Goor, A; Ashwell, CM; Persia, ME; Rothschild, MF; Schmidt, CJ; Lamont, SJ				Van Goor, Angelica; Ashwell, Chris M.; Persia, Michael E.; Rothschild, Max F.; Schmidt, Carl J.; Lamont, Susan J.			Unique genetic responses revealed in RNA-seq of the spleen of chickens stimulated with lipopolysaccharide and short-term heat	PLOS ONE			English	Article							STRESS IMPAIRS PERFORMANCE; ACUTE-PHASE PROTEINS; ESCHERICHIA-COLI; BROILER-CHICKENS; INFLAMMATORY RESPONSE; IMMUNE-RESPONSES; VITAMIN-E; TEMPERATURE; EXPRESSION; PARAMETERS	Climate change and disease have large negative impacts on poultry production, but little is known about the interactions of responses to these stressors in chickens. Fayoumi (heat and disease resistant) and broiler (heat and disease susceptible) chicken lines were stimulated at 22 days of age, using a 2x2x2 factorial design including: breed (Fayoumi or broiler), inflammatory stimulus (lipopolysaccharide (LPS) or saline), and temperature (35 degrees C or 25 degrees C). Transcriptional changes in spleens were analyzed using RNA-sequencing on the Illumina HiSeq 2500. Thirty-two individual cDNA libraries were sequenced (four per treatment) and an average of 22 million reads were generated per library. Stimulation with LPS induced more differentially expressed genes (DEG, log2 fold change >= 2 and FDR <= 0.05) in the broiler (N = 283) than the Fayoumi (N = 85), whereas heat treatment resulted in fewer DEG in broiler (N = 22) compared to Fayoumi (N = 107). The double stimulus of LPS+ heat induced the largest numbers of changes in gene expression, for which broiler had 567 DEG and Fayoumi had 1471 DEG of which 399 were shared between breeds. Further analysis of DEG revealed pathways impacted by these stressors such as Remodelling of Epithelial Adherens Junctions due to heat stress, Granulocyte Adhesion and Diapedesis due to LPS, and Hepatic Fibrosis/Hepatic Stellate Cell Activation due to LPS+ heat. The genes and pathways identified provide deeper understanding of the response to the applied stressors and may serve as biomarkers for genetic selection for heat and disease tolerant chickens.	[Van Goor, Angelica; Rothschild, Max F.; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Ashwell, Chris M.] North Carolina State Univ, Dept Poultry Sci, Box 7608, Raleigh, NC 27695 USA; [Persia, Michael E.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	Iowa State University; University of North Carolina; North Carolina State University; Virginia Polytechnic Institute & State University; University of Delaware	Lamont, SJ (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sjlamont@iastate.edu	; Ashwell, Christopher/N-1332-2016	Schmidt, Carl/0000-0002-8386-4781; Ashwell, Christopher/0000-0002-8190-1147	U.S. Department of Agriculture [2011-38420-20050]; National Institute of Food and Agriculture [5358, 2011-67003-30228]	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by: U.S. Department of Agriculture (http.//www.usda.gov/), Award Number: 2011-38420-20050, Recipient: Susan J. Lamont; National Institute of Food and Agriculture (http://www.usda.gov/), Award Number: 5358, Recipient: Susan J. Lamont; National Institute of Food and Agriculture (http://www.usda.gov/), Award Number: 2011-67003-30228, Recipient: Carl J Schmidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2009, POULTRY SCI, V88, P744, DOI 10.3382/ps.2008-00419; Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bartlett JR, 2003, POULTRY SCI, V82, P1580, DOI 10.1093/ps/82.10.1580; BIGGS PM, 1982, AVIAN PATHOL, V11, P281, DOI 10.1080/03079458208436101; Casebere KR, 2015, 661 AS AN IND; Chartoumpekis DV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/340731; Cheeseman JH, 2007, DEV COMP IMMUNOL, V31, P52, DOI 10.1016/j.dci.2006.04.001; Cheng HW, 2004, POULTRY SCI, V83, P707, DOI 10.1093/ps/83.5.707; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; De Boever S, 2008, AVIAN PATHOL, V37, P39, DOI 10.1080/03079450701784875; DEATON JW, 1978, POULTRY SCI, V57, P1070, DOI 10.3382/ps.0571070; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Deng W, 2012, POULTRY SCI, V91, P575, DOI 10.3382/ps.2010-01293; DONKER RA, 1990, POULTRY SCI, V69, P599, DOI 10.3382/ps.0690599; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GRABER CD, 1971, J AMER MED ASSOC, V216, P1195, DOI 10.1001/jama.216.7.1195; Haley P, 2005, TOX PATHOL, V33; HELLER ED, 1979, AVIAN PATHOL, V8, P195, DOI 10.1080/03079457908418345; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; JONES CA, 1981, POULTRY SCI, V60, P2189, DOI 10.3382/ps.0602189; JONES CA, 1983, POULTRY SCI, V62, P1553, DOI 10.3382/ps.0621553; Kaiser MG, 2012, POULTRY SCI, V91, P1893, DOI 10.3382/ps.2011-02116; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; KOGUT MH, 1994, MICROB PATHOGENESIS, V16, P141, DOI 10.1006/mpat.1994.1015; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MELTZER A, 1982, BRIT POULTRY SCI, V23, P383, DOI 10.1080/00071688208447972; Meltzer A., 1983, BRIT POULT SCI, V24; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; NAKAMURA K, 1985, VET PATHOL, V22, P592, DOI 10.1177/030098588502200614; Nakamura K, 1998, POULTRY SCI, V77, P908, DOI 10.1093/ps/77.6.908; NATHAN D B, 1976, British Poultry Science, V17, P481, DOI 10.1080/00071667608416303; Niu ZY, 2009, POULTRY SCI, V88, P2101, DOI 10.3382/ps.2009-00220; NRC, 2001, NUTR REQ POULTR, P1262; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Post J, 2003, POULTRY SCI, V82, P1313, DOI 10.1093/ps/82.8.1313; Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315; Quinteiro WM, 2012, J ANIM SCI, V90, P1986, DOI 10.2527/jas.2011-3949; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Redmond SB, 2009, VET IMMUNOL IMMUNOP, V132, P129, DOI 10.1016/j.vetimm.2009.05.010; SIJTSMA SR, 1991, DEV COMP IMMUNOL, V15, P349, DOI 10.1016/0145-305X(91)90027-V; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Star L, 2009, POULTRY SCI, V88, P2253, DOI 10.3382/ps.2008-00373; USDA, 2012, CLIM CHANG SCI WHIT; Van Goor A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2601-x; Van Goor A, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0176-7; VANDERHEL W, 1991, POULTRY SCI, V70, P1882, DOI 10.3382/ps.0701882; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Yao M, 2008, ENDOCRINOLOGY, V149, P2352, DOI 10.1210/en.2007-1551; Zhou WT, 1997, BRIT POULTRY SCI, V38, P107, DOI 10.1080/00071669708417949	61	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171414	10.1371/journal.pone.0171414	http://dx.doi.org/10.1371/journal.pone.0171414			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166270	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100039
J	Meng, ZJ; Duan, AW; Chen, DL; Dassanayake, KB; Wang, X; Liu, ZG; Liu, H; Gao, SG				Meng, Zhaojiang; Duan, Aiwang; Chen, Deli; Dassanayake, Kithsiri Bandara; Wang, Xiaosen; Liu, Zugui; Liu, Hao; Gao, Shengguo			Suitable indicators using stem diameter variation-derived indices to monitor the water status of greenhouse tomato plants	PLOS ONE			English	Article							DAILY TRUNK SHRINKAGE; YOUNG LEMON TREES; DEFICIT IRRIGATION; SAP FLOW; SENSITIVE INDICATOR; THRESHOLD VALUES; OLIVE TREES; FRUIT SIZE; STRESS; GROWTH	It is very important to seek a simple nondestructive method to continuously measure plant water status for irrigation scheduling. Changes in stem diameter in response to plant water status and soil water content (SWC) were experimentally investigated during the growing seasons of 2011/2012 and 2012/2013 in pot-cultivated tomato (Lycopersicon esculentum L.) plants in a plastic greenhouse. This study was conducted to determine suitable SDV (stem diameter variation)-derived indices as indicators of tomato plant water status for irrigation scheduling. The experiment was designed as a two-factor randomized block using the SWC and growth stages as variables. The SWC was controlled at 70-80% (well-watered), 60-70% (slightly deficit watered), 50-60% (moderately deficit watered) of the field capacity (FC), and the prescribed growing stages were vegetative, flowering and fruit-forming, and harvesting stages. Regression analysis showed that the SD6 (the difference between the stem diameter value at 06: 00 am and the initial sensor reading) was closely related to the SWC (p<0.01) during rapid vegetative growth, whereas the MDS (the maximum daily shrinkage) was closely related to the SWC (p<0.01) during slow vegetative growth. Our results suggest that SDV-derived indicators can be used for determining plant water status and for scheduling irrigation at different growth/developmental stages.	[Meng, Zhaojiang; Duan, Aiwang; Wang, Xiaosen; Liu, Zugui; Liu, Hao; Gao, Shengguo] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan, Peoples R China; [Chen, Deli; Dassanayake, Kithsiri Bandara] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic, Australia	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; University of Melbourne	Meng, ZJ (corresponding author), Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan, Peoples R China.	zhaojiang_meng@aliyun.com			earmarked fund for the National High Technology Research and Development Program of China (863 Program of China) [2011AA100509]; key and Open Laboratory of Crop Water Requirements Regulation, Ministry of Agriculture; Chinese farmland ecosystem research station in open country in Shang Qiu	earmarked fund for the National High Technology Research and Development Program of China (863 Program of China)(National High Technology Research and Development Program of China); key and Open Laboratory of Crop Water Requirements Regulation, Ministry of Agriculture; Chinese farmland ecosystem research station in open country in Shang Qiu	The study was financially supported by the earmarked fund for the National High Technology Research and Development Program of China (863 Program of China, grant numbers: 2011AA100509), key and Open Laboratory of Crop Water Requirements Regulation, Ministry of Agriculture, and the funds of Chinese farmland ecosystem research station in open country in Shang Qiu.	Badal E, 2010, AGR WATER MANAGE, V98, P143, DOI 10.1016/j.agwat.2010.08.007; CHEN LH, 1971, CROP SCI, V11, P428, DOI 10.2135/cropsci1971.0011183X001100030036x; Conejero W, 2011, ENVIRON EXP BOT, V71, P409, DOI 10.1016/j.envexpbot.2011.02.014; Cuevas MV, 2010, AGR WATER MANAGE, V97, P1293, DOI 10.1016/j.agwat.2010.03.011; de la Rosa JM, 2013, AGR WATER MANAGE, V126, P133, DOI 10.1016/j.agwat.2013.05.009; De Swaef T, 2009, AGR WATER MANAGE, V96, P541, DOI 10.1016/j.agwat.2008.09.013; De Swaef T, 2010, FUNCT PLANT BIOL, V37, P429, DOI 10.1071/FP09233; Deslauriers A, 2003, TREES-STRUCT FUNCT, V17, P477, DOI 10.1007/s00468-003-0260-4; Domingo R, 1996, IRRIGATION SCI, V16, P115, DOI 10.1007/BF02215619; Downes G, 1999, TREES-STRUCT FUNCT, V14, P102, DOI 10.1007/PL00009752; Fernandez JE, 2011, AGR WATER MANAGE, V98, P1813, DOI 10.1016/j.agwat.2011.06.011; Ferreira MI, 1997, ACTA HORTIC, P379, DOI 10.17660/ActaHortic.1997.449.53; Gallardo M, 2006, J HORTIC SCI BIOTECH, V81, P483, DOI 10.1080/14620316.2006.11512092; Gallardo M, 2014, RESPONSE STEM DIAMET; Garcia-Orellana Y, 2007, AGR WATER MANAGE, V89, P167, DOI 10.1016/j.agwat.2006.12.008; Goldhamer D. A., 2003, California Agriculture, V57, P138, DOI 10.3733/ca.v057n04p138; Goldhamer DA, 2004, IRRIGATION SCI, V23, P11, DOI 10.1007/s00271-003-0088-0; Goldhamer DA, 2001, IRRIGATION SCI, V20, P115, DOI 10.1007/s002710000034; HUCK MG, 1977, AGRON J, V69, P593, DOI 10.2134/agronj1977.00021962006900040017x; Intrigliolo DS, 2004, IRRIGATION SCI, V23, P93, DOI 10.1007/s00271-004-0097-7; Johnson RS, 2000, HORTSCIENCE, V35, P1048, DOI 10.21273/HORTSCI.35.6.1048; KATERJI N, 1988, AGRONOMIE, V8, P425, DOI 10.1051/agro:19880508; Khairi NM, 2012, PROCEDIA ENGINEER, V41, P1421, DOI 10.1016/j.proeng.2012.07.330; Kramer P.J., 1983, WATER RELATIONS PLAN, P489; Lee B.W., 1998, AGR INFO TECH ASIA O, P87; Livellara N, 2011, AGR WATER MANAGE, V98, P684, DOI 10.1016/j.agwat.2010.11.005; MCBURNEY T, 1984, J EXP BOT, V35, P1787, DOI 10.1093/jxb/35.12.1787; MCCUTCHAN H, 1992, J AM SOC HORTIC SCI, V117, P607, DOI 10.21273/JASHS.117.4.607; Moreno F, 2006, AGR WATER MANAGE, V84, P290, DOI 10.1016/j.agwat.2006.03.005; Moriana A, 2013, SCI HORTIC-AMSTERDAM, V164, P102, DOI 10.1016/j.scienta.2013.09.029; Moriana A, 2010, AGR WATER MANAGE, V97, P1822, DOI 10.1016/j.agwat.2010.06.022; Moriana A, 2002, IRRIGATION SCI, V21, P83, DOI 10.1007/s00271-001-0053-8; Naor A, 2008, TREE PHYSIOL, V28, P1255, DOI 10.1093/treephys/28.8.1255; Naor A, 1999, J AM SOC HORTIC SCI, V124, P189, DOI 10.21273/JASHS.124.2.189; Naor A., 2006, Horticultural Reviews, V32, P111; Nortes PA, 2005, AGR WATER MANAGE, V77, P296, DOI 10.1016/j.agwat.2004.09.034; Ortuno MF, 2009, AGR WATER MANAGE, V96, P80, DOI 10.1016/j.agwat.2008.07.001; Ortuno MF, 2006, PLANT SOIL, V279, P229, DOI 10.1007/s11104-005-1302-z; Ortuno MF, 2006, TREES-STRUCT FUNCT, V20, P1, DOI 10.1007/s00468-005-0004-8; Ortuno MF, 2005, ENVIRON EXP BOT, V54, P155, DOI 10.1016/j.envexpbot.2004.06.009; Ortuno MF, 2004, PLANT SOIL, V267, P263, DOI 10.1007/s11104-005-0108-3; Ortuno MF, 2004, PLANT SCI, V167, P275, DOI 10.1016/j.plantsci.2004.03.023; Remorini D, 2003, IRRIGATION SCI, V22, P39, DOI 10.1007/s00271-003-0068-4; SO HB, 1979, AGRON J, V71, P675, DOI 10.2134/agronj1979.00021962007100040037x; Stao N, 1995, ACTA HORTIC, V226, P91; Steduto P, 2007, IRRIGATION SCI, V25, P189, DOI 10.1007/s00271-007-0064-1; Valancogne C, 1997, ACTA HORTIC, P423, DOI 10.17660/ActaHortic.1997.449.59; Velez JE, 2007, AGR WATER MANAGE, V90, P197, DOI 10.1016/j.agwat.2007.03.007; Yatapanage KG, 2001, AGRON J, V93, P1341, DOI 10.2134/agronj2001.1341; Yu KS, 1999, J FRUIT SCI, V2, P86; Yuan XK, 2015, PHOTOSYNTHETICA, V53, P1	51	15	16	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171423	10.1371/journal.pone.0171423	http://dx.doi.org/10.1371/journal.pone.0171423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158246	gold, Green Published			2022-12-27	WOS:000396161700077
J	Miermans, CA; Kusters, RPT; Hoogenraad, CC; Storm, C				Miermans, C. A.; Kusters, R. P. T.; Hoogenraad, C. C.; Storm, C.			Biophysical model of the role of actin remodeling on dendritic spine morphology	PLOS ONE			English	Article							SERIAL ELECTRON-MICROSCOPY; LONG-TERM POTENTIATION; RECYCLING ENDOSOMES; MEMBRANE TENSION; RAT HIPPOCAMPUS; DYNAMICS; PLASTICITY; CYTOSKELETON; PROTRUSION; FILOPODIA	Dendritic spines are small membranous structures that protrude from the neuronal dendrite. Each spine contains a synaptic contact site that may connect its parent dendrite to the axons of neighboring neurons. Dendritic spines are markedly distinct in shape and size, and certain types of stimulation prompt spines to evolve, in fairly predictable fashion, from thin nascent morphologies to the mushroom-like shapes associated with mature spines. It is well established that the remodeling of spines is strongly dependent upon the actin cytoskeleton inside the spine. A general framework that details the precise role of actin in directing the transitions between the various spine shapes is lacking. We address this issue, and present a quantitative, model-based scenario for spine plasticity validated using realistic and physiologically relevant parameters. Our model points to a crucial role for the actin cytoskeleton. In the early stages of spine formation, the interplay between the elastic properties of the spine membrane and the protrusive forces generated in the actin cytoskeleton propels the incipient spine. In the maturation stage, actin remodeling in the form of the combined dynamics of branched and bundled actin is required to form mature, mushroom-like spines. Importantly, our model shows that constricting the spine-neck aids in the stabilization of mature spines, thus pointing to a role in stabilization and maintenance for additional factors such as ring-like F-actin structures. Taken together, our model provides unique insights into the fundamental role of actin remodeling and polymerization forces during spine formation and maturation.	[Miermans, C. A.; Kusters, R. P. T.; Storm, C.] Eindhoven Univ Technol, Dept Appl Phys, Theory Polymers & Soft Matter, Eindhoven, Netherlands; [Hoogenraad, C. C.] Univ Utrecht, Cell Biol, Fac Sci, Utrecht, Netherlands; [Storm, C.] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands; [Miermans, C. A.] Ludwig Maximilians Univ Munchen, Arnold Sommerfeld Ctr Theoret Phys, Theoret Stat & Biol Phys, Munich, Germany	Eindhoven University of Technology; Utrecht University; Eindhoven University of Technology; University of Munich	Miermans, CA (corresponding author), Eindhoven Univ Technol, Dept Appl Phys, Theory Polymers & Soft Matter, Eindhoven, Netherlands.; Miermans, CA (corresponding author), Ludwig Maximilians Univ Munchen, Arnold Sommerfeld Ctr Theoret Phys, Theoret Stat & Biol Phys, Munich, Germany.	c.miermans@lmu.de	Storm, Cornelis/K-1486-2013	Storm, Cornelis/0000-0002-4391-8984; Miermans, Christiaan/0000-0002-3810-4660				Angelov B, 2000, P 1 INT C GEOM INT Q, P27; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bar J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37136; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Chazeau A, 2014, EMBO J, V33, P2745, DOI 10.15252/embj.201488837; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012; Ewers H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113916; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; JULICHER F, 1994, PHYS REV E, V49, P4728, DOI 10.1103/PhysRevE.49.4728; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Powers TR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041901; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; Semrau S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088101; Shao JY, 1999, BIOPHYS J, V77, P587, DOI 10.1016/S0006-3495(99)76915-8; Stone M, 2012, MATH PHYS, DOI [10.1017/CB09780511627040, DOI 10.1017/CB09780511627040]; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	40	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170113	10.1371/journal.pone.0170113	http://dx.doi.org/10.1371/journal.pone.0170113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158194	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700008
J	Park, YJ; Koh, J; Kwon, JT; Park, YS; Yang, LJ; Cha, S				Park, Yun-Jong; Koh, Jin; Kwon, Jin Teak; Park, Yong-Seok; Yang, Lijun; Cha, Seunghee			Uncovering stem cell differentiation factors for salivary gland regeneration by quantitative analysis of differential proteomes	PLOS ONE			English	Article							TCF3 REPRESSION; STROMAL CELLS; BONE-MARROW; NECK-CANCER; EXPRESSION; PTF1A; PLURIPOTENCY; RADIATION; THERAPY; MIST1	Severe xerostomia (dry mouth) compromises the quality of life in patients with Sjogren's syndrome or radiation therapy for head and neck cancer. A clinical management of xerostomia is often unsatisfactory as most interventions are palliative with limited efficacy. Following up our previous study demonstrating that mouse BM-MSCs are capable of differentiating into salivary epithelial cells in a co-culture system, we further explored the molecular basis that governs the MSC reprogramming by utilizing high-throughput iTRAQ-2D-LC-MS/MS-based proteomics. Our data revealed the novel induction of pancreas-specific transcription factor 1a (PTF1 alpha), muscle, intestine and stomach expression-1 (MIST-1), and achaete-scute complex homolog 3 (ASCL3) in 7 day co-cultured MSCs but not in control MSCs. More importantly, a common notion of pancreatic-specific expression of PTF1 alpha was challenged for the first time by our verification of PTF1 alpha expression in the mouse salivary glands. Furthermore, a molecular network simulation of our selected putative MSC reprogramming factors demonstrated evidence for their perspective roles in salivary gland development. In conclusion, quantitative proteomics with extensive data analyses narrowed down a set of MSC reprograming factors potentially contributing to salivary gland regeneration. Identification of their differential/synergistic impact on MSC conversion warrants further investigation.	[Park, Yun-Jong; Kwon, Jin Teak; Cha, Seunghee] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA; [Koh, Jin] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Park, Yong-Seok] Seoul Natl Univ, Dept Oral Anat, Sch Dent, Seoul, South Korea; [Yang, Lijun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Seoul National University (SNU); State University System of Florida; University of Florida	Cha, S (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32611 USA.	scha@dental.ufl.edu			NIH/NIDCR [DE019644, DE025726]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A2074617]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025726] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR grants DE019644 and DE025726 (SC) and The National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A2074617) (YSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afelik S, 2013, WIRES DEV BIOL, V2, P531, DOI 10.1002/wdev.99; Aframian DJ, 2000, TISSUE ENG, V6, P209, DOI 10.1089/10763270050044380; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006; Arany S, 2011, DEV BIOL, V353, P186, DOI 10.1016/j.ydbio.2011.02.025; Atlasi Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003424; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Bell M, 1999, J RHEUMATOL, V26, P2051; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Bullard T, 2008, DEV BIOL, V320, P72, DOI 10.1016/j.ydbio.2008.04.018; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fathi A, 2009, PROTEOMICS, V9, P4859, DOI 10.1002/pmic.200900003; Fiegel HC, 2006, J CELL MOL MED, V10, P577, DOI 10.1111/j.1582-4934.2006.tb00422.x; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Fox RI, 2002, SCAND J RHEUMATOL, V31, P3; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geraerts M, 2007, STEM CELLS, V25, P263, DOI 10.1634/stemcells.2006-0364; GREENSPAN D, 1987, CANCER, V59, P1123, DOI 10.1002/1097-0142(19870315)59:6<1123::AID-CNCR2820590614>3.0.CO;2-X; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Huang L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0061-x; Humphreys-Beher MG, 1999, ARCH ORAL BIOL, V44, pS21, DOI 10.1016/S0003-9969(99)00045-X; Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Kurisaki A, 2005, BIOCHEM BIOPH RES CO, V335, P667, DOI 10.1016/j.bbrc.2005.07.128; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Lombaert IMA, 2010, FRONT ORAL BIOL, V14, P90, DOI 10.1159/000313709; Makarov A, 2006, J AM SOC MASS SPECTR, V17, P977, DOI 10.1016/j.jasms.2006.03.006; Maria OM, 2011, STEM CELLS DEV, V20, P959, DOI 10.1089/scd.2010.0214; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Metzler MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125153; Mikhailova A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14684; Mimeault M, 2006, STEM CELLS, V24, P2319, DOI 10.1634/stemcells.2006-0066; Nair GG, 2014, STEM CELLS, V32, P1195, DOI 10.1002/stem.1616; Nasrabadi D, 2009, J PROTEOME RES, V8, P1527, DOI 10.1021/pr800880v; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112158; Passier R, 2003, CARDIOVASC RES, V58, P324, DOI 10.1016/S0008-6363(02)00770-8; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pringle S, 2011, JOURNAL OF VISUALIZE; Pringle S, 2013, STEM CELLS, V31, P613, DOI 10.1002/stem.1327; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Redman RS, 2008, BIOTECH HISTOCHEM, V83, P103, DOI 10.1080/10520290802374683; Saarilahti K, 2005, RADIOTHER ONCOL, V74, P251, DOI 10.1016/j.radonc.2004.11.004; Santana A, 2006, J CELL MOL MED, V10, P866, DOI 10.2755/jcmm010.004.06; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; van Vliet Patrick, 2007, Expert Rev Cardiovasc Ther, V5, P33, DOI 10.1586/14779072.5.1.33; Vissink A, 2015, ORAL DIS, V21, pE1, DOI 10.1111/odi.12222; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Xu YX, 2008, MED HYPOTHESES, V71, P390, DOI 10.1016/j.mehy.2008.03.046; Yang YH, 2012, STEM CELL TRANSL MED, V1, P843, DOI 10.5966/sctm.2012-0083; Yaniv A, 2010, TISSUE ENG PART C-ME, DOI [10.1016/j.ydbio.2011.02.025, DOI 10.1016/J.YDBIO.2011.02.025]; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016; Zheng CY, 2011, CLIN CANCER RES, V17, P2842, DOI 10.1158/1078-0432.CCR-10-2982; Zuo Q, 2013, INT ORTHOP, V37, P747, DOI 10.1007/s00264-013-1782-z	77	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169677	10.1371/journal.pone.0169677	http://dx.doi.org/10.1371/journal.pone.0169677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158262	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700005
J	Sok, SPM; Arshad, NM; Azmi, MN; Awang, K; Ozpolat, B; Nagoor, NH				Sok, Sophia P. M.; Arshad, Norhafiza M.; Azmi, Mohamad Nurul; Awang, Khalijah; Ozpolat, Bulent; Nagoor, Noor Hasima			The apoptotic effect of 1 ' S-1 '-Acetoxychavicol Acetate (ACA) enhanced by inhibition of noncanonical autophagy in human non-small cell lung cancer cells	PLOS ONE			English	Article							1'-ACETOXYCHAVICOL ACETATE; DEATH; RESVERATROL; EXPRESSION; RESISTANCE; BCL-2; ROS	Autophagy plays a role in deciding the fate of cells by inducing either survival or death. 1'S-1- acetoxychavicol acetate (ACA) is a phenylpropanoid isolated from rhizomes of Alpinia conchigera and has been reported previously on its apoptotic effects on various cancers. However, the effect of ACA on autophagy remains ambiguous. The aims of this study were to investigate the autophagy-inducing ability of ACA in human non-small cell lung cancer (NSCLC), and to determine its role as pro-survival or pro-death mechanism. Cell viability assay was conducted using MTT. The effect of autophagy was assessed by acridine orange staining, GFP-LC3 punctate formation assay, and protein level were analysed using western blot. Annexin V-FITC/PI staining was performed to detect percentage of cells undergoing apoptosis by using flow cytometry. ACA inhibits the cell viability and induced formation of cytoplasmic vacuoles in NSCLC cells. Acidic vesicular organelles and GFP-LC3 punctate formation were increased in response to ACA exposure in A549 and SK-LU-1 cell lines; implying occurrence of autophagy. In western blot, accumulation of LC3-II accompanied by degradation of p62 was observed, which further confirmed the full flux of autophagy induction by ACA. The reduction of Beclin-1 upon ACA treatment indicated the Beclin-1-independent autophagy pathway. An early autophagy inhibitor, 3-methyaldenine (3-MA), failed to suppress the autophagy triggered by ACA; validating the existence of Beclin-1-independent autophagy. Silencing of LC3-II using short interfering RNA (siRNA) abolished the autophagy effects, enhancing the cytotoxicity of ACA through apoptosis. This proposed ACA triggered a pro-survival autophagy in NSCLC cells. Consistently, co-treatment with lysosomal inhibitor, chloroquine (CQ), exerted a synergistic effect resulting in apoptosis. Our findings suggested ACA induced pro-survival autophagy through Beclin-1-independent pathway in NSCLC. Hence, targeting autophagy pathway using autophagy inhibitor such as CQ represented a novel promising approach to potentiate the cytotoxicity of ACA through apoptosis in NSCLC.	[Sok, Sophia P. M.; Arshad, Norhafiza M.; Nagoor, Noor Hasima] Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia; [Arshad, Norhafiza M.; Nagoor, Noor Hasima] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia; [Azmi, Mohamad Nurul; Awang, Khalijah] Univ Malaya, Dept Chem, Ctr Nat Prod Res & Drug Discovery CENAR, Fac Sci, Kuala Lumpur, Malaysia; [Ozpolat, Bulent] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Texas System; UTMD Anderson Cancer Center	Nagoor, NH (corresponding author), Univ Malaya, Inst Biol Sci Genet & Mol Biol, Fac Sci, Kuala Lumpur, Malaysia.; Nagoor, NH (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	hasima@um.edu.my	PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; ARSHAD, NORHAFIZA MOHD/N-7615-2018; AWANG, KHALIJAH/B-8781-2010; Mohamad Taib, Mohamad Nurul Azmi/L-5644-2016; Sok, Sophia P. M./AAA-6067-2021	ARSHAD, NORHAFIZA MOHD/0000-0003-1522-3373; AWANG, KHALIJAH/0000-0001-5971-6570; Mohamad Taib, Mohamad Nurul Azmi/0000-0002-2447-0897; Sok, Sophia P. M./0000-0001-5084-068X; Nagoor, Noor Hasima/0000-0003-3905-3129	Ministry of Science Technology and Innovation and University of Malaya through Science Fund [SF014-2013]; Research University Operation Grant, NHN [RU005C-2014]	Ministry of Science Technology and Innovation and University of Malaya through Science Fund; Research University Operation Grant, NHN	This work was supported by Ministry of Science Technology and Innovation and University of Malaya through Science Fund (SF014-2013) and Research University Operation Grant (RU005C-2014) respectively, NHN. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad NM, 2015, ONCOTARGET, V6, P16151, DOI 10.18632/oncotarget.3951; Awang K, 2010, MOLECULES, V15, P8048, DOI 10.3390/molecules15118048; Chen WL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-015-1988-0; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Dupont N, 2013, CURR PATHOBIOL REP, V1, P263, DOI [10.1007/s40139-013-0030-y, DOI 10.1007/S40139-013-0030-Y]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Goldberg SB, 2012, J THORAC ONCOL, V7, P1602, DOI 10.1097/JTO.0b013e318262de4a; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467; Hsieh MJ, 2014, TOXICOL SCI, V137, P65, DOI 10.1093/toxsci/kft238; In LLA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-179; Ito K, 2004, CLIN CANCER RES, V10, P2120, DOI 10.1158/1078-0432.CCR-1142-03; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kaminskyy VO, 2012, AUTOPHAGY, V8, P1032, DOI 10.4161/auto.20123; Kato R, 2014, CHEM-BIOL INTERACT, V212, P1, DOI 10.1016/j.cbi.2014.01.010; Kim JY, 2012, ARCH ORAL BIOL, V57, P1018, DOI 10.1016/j.archoralbio.2012.04.005; Lee YJ, 2011, KOREAN J PHYSIOL PHA, V15, P1, DOI 10.4196/kjpp.2011.15.1.1; Liu BQ, 2013, AUTOPHAGY, V9, P905, DOI 10.4161/auto.24292; Liu C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-622; Miki H, 2012, INT J ONCOL, V40, P1020, DOI 10.3892/ijo.2012.1325; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Ozpolat B, 2015, CANCER MANAG RES, V7, P291, DOI 10.2147/CMAR.S34859; PAGLIN S, 2001, CANC RES, V61; Phuah NH, 2013, REPROD SCI, V20, P567, DOI 10.1177/1933719112459220; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Tang MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119135; Wang G, 2016, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT: INNOVATION AND PRACTICE IN INDUSTRIAL ENGINEERING AND MANAGEMENT (VOL 2), P3, DOI 10.2991/978-94-6239-177-2_1; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wu M, 2015, PHYTOMEDICINE, V22, P902, DOI 10.1016/j.phymed.2015.06.008; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	35	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171329	10.1371/journal.pone.0171329	http://dx.doi.org/10.1371/journal.pone.0171329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158287	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396161700061
J	Stolarska, MA; Rammohan, AR				Stolarska, Magdalena A.; Rammohan, Aravind R.			Center or periphery? Modeling the effects of focal adhesion placement during cell spreading	PLOS ONE			English	Article							SUBSTRATE RIGIDITY; GROWTH; STIFFNESS; STRESS; CONTRACTION; FORCE; ARCHITECTURE; MECHANICS; MOTILITY; ASSAYS	Focal adhesions are often observed at the cell's periphery. We provide an explanation for this observation using a system-level mathematical model of a cell interacting with a two-dimensional substrate. The model describes the biological cell as a hypoelastic continuum material whose behavior is coupled to a deformable, linear elastic substrate via focal adhesions that are represented by collections of linear elastic attachments between the cell and the substrate. The evolution of the focal adhesions is coupled to local intracellular stresses which arise from mechanical cell-substrate interactions. Using this model we show that the cell has at least three mechanisms through which it can control its intracellular stresses: focal adhesion position, size, and attachment strength. We also propose that one reason why focal adhesions are typically located on the cell periphery instead of its center is because peripheral focal adhesions allow the cell to be more sensitive to changes in the microenvironment. This increased sensitivity is caused by the fact that peripherally located focal adhesions allow the cells to modulate its intracellular properties over a much larger portion of the cell area.	[Stolarska, Magdalena A.] Univ St Thomas, Dept Math, St Paul, MN 55105 USA; [Rammohan, Aravind R.] Corning Inc, Adv Modeling & Anal, Corning, NY 14831 USA	University of St Thomas Minnesota; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Rammohan, AR (corresponding author), Univ St Thomas, Dept Math, St Paul, MN 55105 USA.	mastolarska@stthomas.edu; RammohanA@corning.com			Corning, Inc.; Center for Applied Mathematics at the University of St. Thomas	Corning, Inc.; Center for Applied Mathematics at the University of St. Thomas	The authors received small amounts of funding from Corning, Inc. and the Center for Applied Mathematics at the University of St. Thomas for this work. Funding was not part of a grant received by the authors. Rather, it was used to provide travel funds so that the author could attend conferences and spend time collaborating on this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranson IS, 2016, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-319-24448-8_1; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Buenemann M, 2010, BIOPHYS J, V99, P50, DOI 10.1016/j.bpj.2010.03.057; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013; Fang Y, 2008, COMB CHEM HIGH T SCR, V11, P357, DOI 10.2174/138620708784534789; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; Greiner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077328; Haupt BJ, 2007, LANGMUIR, V23, P9352, DOI 10.1021/la700693f; Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Holzapfel G., 2000, NONLINEAR SOLID MECH; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Leonov AI, 2000, INT J SOLIDS STRUCT, V37, P2565, DOI 10.1016/S0020-7683(99)00009-8; Marinkovic A, 2012, AM J PHYSIOL-LUNG C, V303, pL169, DOI 10.1152/ajplung.00108.2012; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Olberding JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012043; Pathak A, 2008, J R SOC INTERFACE, V5, P507, DOI 10.1098/rsif.2007.1182; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rajagopal KR, 2009, P ROY SOC A-MATH PHY, V465, P493, DOI 10.1098/rspa.2008.0319; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; Skalak R, 1982, P IUTAM S FIN EL, P347; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stephanou A, 2008, J THEOR BIOL, V253, P701, DOI 10.1016/j.jtbi.2008.04.035; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; Vernerey FJ, 2014, J MATH BIOL, V68, P989, DOI 10.1007/s00285-013-0656-8; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Walcott S, 2011, BIOPHYS J, V101, P2919, DOI 10.1016/j.bpj.2011.11.010; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yip AK, 2013, BIOPHYS J, V104, P19, DOI 10.1016/j.bpj.2012.11.3805; Ziebert F, 2014, EUR PHYS J-SPEC TOP, V223, P1265, DOI 10.1140/epjst/e2014-02190-2	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171430	10.1371/journal.pone.0171430	http://dx.doi.org/10.1371/journal.pone.0171430			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158263	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700078
J	Costa, MS; Silva, RJ; Paulino-Neto, HF; Pereira, MJB				Costa, Marilza Silva; Silva, Ricardo Jose; Paulino-Neto, Hipolito Ferreira; Barbosa Pereira, Monica Josene			Beetle pollination and flowering rhythm of Annona coriacea Mart. (Annonaceae) in Brazilian cerrado: Behavioral features of its principal pollinators	PLOS ONE			English	Article							FLORAL SCENT; REPRODUCTIVE-BIOLOGY; BREEDING SYSTEMS; CONSEQUENCES; LANDSCAPE; COMMUNITY; DIVERSE	The conservation and sustainable management of Annona coriacea requires knowledge of its floral and reproductive biology, and of its main pollinators and their life cycles. In this work, we analyzed these aspects in detail. Floral biology was assessed by observing flowers from the beginning of anthesis to senescence. The visiting hours and behavior of floral visitors in the floral chamber were recorded, as were the sites of oviposition. Excavations were undertaken around specimens of A. coriacea to determine the location of immature pollinators. Anthesis was nocturnal, starting at sunset, and lasted for 52-56 h. The flowers were bisexual, protogynous and emitted a strong scent similar to the plant's own ripe fruit. There was pronounced synchrony among all floral events (the period and duration of stigmatic receptivity, release of odor, pollen release and drooping flowers) in different individuals, but no synchrony in the same individuals. All of the flowers monitored were visited by beetle species of the genera Cyclocephala and Arriguttia. Beetles arrived at the flowers with their bodies covered in pollen and these pollen grains were transferred to the stigmata while foraging on nutritious tissues at the base of the petals. With dehiscence of the stamens and retention within the floral chamber, the bodies of the floral visitors were again covered with pollen which they carried to newly opened flowers, thus promoting the cycle of pollination. After leaving the flowers, female beetles often excavated holes in the soil to lay eggs. Larvae were found between the leaf litter and the first layer of soil under specimens of A. coriacea. Cyclocephala beetles were the main pollinators of A. coriacea, but Arriguttia brevissima was also considered a pollinator and is the first species of this genus to be observed in Annonaceae flowers. Annona coriacea was found to be self-compatible with a low reproductive efficiency in the area studied. The results of this investigation provide ecological data that should contribute to the conservation and economic exploitation of A. coriacea.	[Costa, Marilza Silva] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Silva, Ricardo Jose] Univ Estado Mato Grosso UNEMAT, Lab Zool, CPEDA, Tangara Da Serra, MT, Brazil; [Paulino-Neto, Hipolito Ferreira] Univ Sao Paulo, Programa Posgrad Entomol, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Paulino-Neto, Hipolito Ferreira] UEMG, Curso Ciencias Biol, Unidade Passos, MG, Brazil; [Paulino-Neto, Hipolito Ferreira] UEMG, LEPEC, Unidade Passos, MG, Brazil; [Barbosa Pereira, Monica Josene] Univ Estado Mato Grosso UNEMAT, Dept Agron, Lab Entomol, CPEDA, Tangara Da Serra, MT, Brazil	Universidade Federal de Vicosa; Universidade do Estado de Mato Grosso; Universidade de Sao Paulo; Universidade do Estado de Mato Grosso	Costa, MS (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.	marilza.costa@ufv.br	Pereira, Mônica J.B./F-4736-2014; Neto, Hipólito Ferreira Paulino/Q-1662-2019	Neto, Hipólito Ferreira Paulino/0000-0003-4993-1191; Silva, Ricardo/0000-0002-0792-5925	Projeto de Conservacao e Utilizacao Sustentavel da Diversidade Biologica Brasileira (PROBIO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES National Post-Doctoral Program PNPD) [02958/09-0]	Projeto de Conservacao e Utilizacao Sustentavel da Diversidade Biologica Brasileira (PROBIO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES National Post-Doctoral Program PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Projeto de Conservacao e Utilizacao Sustentavel da Diversidade Biologica Brasileira (PROBIO) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), scholarships for graduation. Hipolito Ferreira Paulino-Neto was supported by a post-doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES National Post-Doctoral Program PNPD, grant no. 02958/09-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar JR, 2000, REV CIENC AGRON, V31, P51; Almeida S.P., 1998, CERRADO AMBIENTE FLO, P169; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Barroso MG, 2002, SISTEMATICA ANGIOSPE; Batalha M. A., 2001, Acta Botanica Brasilica, V15, P289, DOI 10.1590/S0102-33062001000300001; BAWA KS, 1974, EVOLUTION, V28, P85, DOI [10.2307/2407241, 10.1111/j.1558-5646.1974.tb00729.x]; BULLOCK SH, 1985, BIOTROPICA, V17, P287, DOI 10.2307/2388591; Buzato S, 1994, RES 45 C NAC BOT, P64; Castro AAJF, 1999, ANN MO BOT GARD, V86, P192, DOI 10.2307/2666220; Maia ACD, 2012, J CHEM ECOL, V38, P1072, DOI 10.1007/s10886-012-0173-z; Nogueira GAD, 2013, BIOTA NEOTROP, V13, P86, DOI 10.1590/S1676-06032013000100009; Eugenio P., 1990, Plant Systematics and Evolution, V172, P35; Franco AM, 2011, REV BRAS ENTOMOL, V55, P381, DOI 10.1590/S0085-56262011000300011; Ghazoul J, 2004, BIOTROPICA, V36, P156, DOI 10.1111/j.1744-7429.2004.tb00308.x; Golin V, 2011, CIENC RURAL, V41, P101, DOI 10.1590/S0103-84782011000100016; Goodrich KR, 2012, BOT J LINN SOC, V169, P262, DOI 10.1111/j.1095-8339.2012.01220.x; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P189, DOI 10.1007/BF00936405; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P165, DOI 10.1007/BF00936404; Gottsberger G., 2006, LIFE CERRADO S AM TR, V1; Gottsberger Gerhard, 1999, Plant Species Biology, V14, P143, DOI 10.1046/j.1442-1984.1999.00018.x; Gottsberger Gerhard, 1996, Progress in Botany, V57, P368; Gottsberger Gerhard, 1994, Revista Brasileira de Biologia, V54, P391; Gottsberger G, 2013, PLANT SYST EVOL, V299, P793, DOI 10.1007/s00606-013-0763-4; Gottsberger G, 2012, BOT J LINN SOC, V169, P245, DOI 10.1111/j.1095-8339.2011.01209.x; Herrera CM, 2000, ECOLOGY, V81, P15, DOI 10.1890/0012-9658(2000)081[0015:FTSCOD]2.0.CO;2; HERRERA CM, 1989, OECOLOGIA, V80, P241, DOI 10.1007/BF00380158; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; Jurgens A, 2000, PHYTOCHEMISTRY, V55, P551, DOI 10.1016/S0031-9422(00)00241-7; Jurgens A, 2004, AM J BOT, V91, P1969, DOI 10.3732/ajb.91.12.1969; Kiill L, BIOL FLORAL SISTEMA; Kuchmeister H, POLINIZAC ESPECIES A; Lopes LE, 2007, OECOLOGIA, V154, P305, DOI 10.1007/s00442-007-0830-z; Machado IC, 2004, ANN BOT-LONDON, V94, P365, DOI 10.1093/aob/mch152; Maues MM, 2012, POLINIZADORES BRASIL, P49; Cavalcante Tadeu Robson Melo, 2009, Bragantia, V68, P13, DOI 10.1590/S0006-87052009000100002; Mendes FN, 2011, BIOTA NEOTROP, V11, P103, DOI 10.1590/S1676-06032011000400011; Mendonca RC, 1998, CERRADO ECOLOGIA FLO, V289-556, DOI DOI 10.1590/S0100-84042008000300005; Montesinos D, 2015, WEB ECOL, V14, P79, DOI 10.5194/we-14-79-2014; Morellato L. P. C., 1992, HIST NATURAL SERRA J, P98; Munin Roberto Lobo, 2008, Braz. J. Bot., V31, P15, DOI 10.1590/S0100-84042008000100003; Oliveira P.E., 2008, CERRADO ECOLOGIA FLO, V2, P274; Oliveira PE, 2000, FLORA, V195, P311; Neto HFP, 2013, BRAZ J BOT, V36, P55, DOI 10.1007/s40415-013-0011-8; Paulino-Neto HF., 2006, CIENCIA HOJE, V38, P59; Paulino-Neto HF, 2014, 11 C LAT BOT SEPT 20, P462; Paulino-Neto HF, 2014, BIOL POLINIZACAO, P297; Paulino-Neto HF, 2014, REV BRAS FRUTIC, V36, P132, DOI 10.1590/S0100-29452014000500016; Paulino-Neto HP, UM SISTEMA EM PERIGO; Ponchel Y, 2006, DYNASTIDAE WORLD BIO; Puker Anderson, 2009, Biota Neotrop., V9, P105; RAMIREZ N, 1992, BOT J LINN SOC, V110, P277, DOI 10.1111/j.1095-8339.1992.tb00294.x; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Rodrigues SR, 2010, NEOTROP ENTOMOL, V39, P15, DOI 10.1590/S1519-566X2010000100003; Ruiz-Zapata T R, 1978, BIOTROPICA, V10, P221; Santos V, 2007, REV AGR, V82, P288; Saraiva A.M., 2012, POLINIZADORES BRASIL, P153; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Silberbauer-Gottsberger I, 1988, REV BRAS BIOL; Silberbauer-Gottsberger I., 2006, LIFE CERRADO S AM TR, V2; Silva CA, 2009, BIOTA CICLO ESTUDOS, V1, P1; Silva Celice Alexandre, 2010, Biotemas, V23, P69; Silva RR, 2013, BIOTA NEOTROP, V13, P297, DOI 10.1590/S1676-06032013000200029; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Tannus, 2006, BIOTA NEOTROP, V6, P1, DOI DOI 10.1590/S1676-06032006000300008; Webber A. C., 1981, Acta Amazonica, V11, P61; Webber A.C., 2000, REV BRAS BOT, V23, P421, DOI 10.1590/S0100-84042000000400008; Westra L.Y.T., 1993, ANNONACEAE NEWSLETTE, V9, P29	69	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171092	10.1371/journal.pone.0171092	http://dx.doi.org/10.1371/journal.pone.0171092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152094	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200088
J	Fatima, F; Fei, Y; Ali, A; Mohammad, M; Erlandsson, MC; Bokarewa, MI; Nawaz, M; Valadi, H; Na, ML; Jin, T				Fatima, Farah; Fei, Ying; Ali, Abukar; Mohammad, Majd; Erlandsson, Malin C.; Bokarewa, Maria I.; Nawaz, Muhammad; Valadi, Hadi; Na, Manli; Jin, Tao			Radiological features of experimental staphylococcal septic arthritis by micro computed tomography scan	PLOS ONE			English	Article							BONE TURNOVER MARKERS; AUREUS; MODEL; METASTASES; INFECTION; SEPSIS; CT	Background Permanent joint dysfunction due to bone destruction occurs in up to 50% of patients with septic arthritis. Recently, imaging technologies such as micro computed tomography (mu CT) scan have been widely used for preclinical models of autoimmune joint disorders. However, the radiological features of septic arthritis in mice are still largely unknown. Methods NMRI mice were intravenously or intra-articularly inoculated with S. aureus Newman or LS1 strain. The radiological and clinical signs of septic arthritis were followed for 10 days using mu CT. We assessed the correlations between joint radiological changes and clinical signs, histological changes, and serum levels of cytokines. Results On days 5-7 after intravenous infection, bone destruction verified by mu CT became evident in most of the infected joints. Radiological signs of bone destruction were dependent on the bacterial dose. The site most commonly affected by septic arthritis was the distal femur in knees. The bone destruction detected by mu CT was positively correlated with histological changes in both local and hematogenous septic arthritis. The serum levels of IL-6 were significantly correlated with the severity of joint destruction. Conclusion mu CT is a sensitive method for monitoring disease progression and determining the severity of bone destruction in a mouse model of septic arthritis. IL-6 may be used as a biomarker for bone destruction in septic arthritis.	[Fatima, Farah; Ali, Abukar; Mohammad, Majd; Erlandsson, Malin C.; Bokarewa, Maria I.; Nawaz, Muhammad; Valadi, Hadi; Na, Manli; Jin, Tao] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Fatima, Farah; Nawaz, Muhammad] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Pathol & Forens Med, Sao Paulo, Brazil; [Fei, Ying] GuiZhou Med Univ, Affiliated Hosp, Dept Microbiol & Immunol, Guiyang, Peoples R China; [Jin, Tao] Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden	University of Gothenburg; Universidade de Sao Paulo; Guizhou Medical University; Sahlgrenska University Hospital	Jin, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.; Jin, T (corresponding author), Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden.	tao.jin@rheuma.gu.se	Na, Manli/AAM-9864-2020; Fatima, Farah/AAB-8297-2019; Nawaz, Muhammad/B-6596-2014; Bokarewa, Maria I/A-8114-2019; Jin, Tao/K-3323-2015; Valadi, Hadi/ABH-9766-2020	Fatima, Farah/0000-0002-0696-8675; Nawaz, Muhammad/0000-0002-0792-8296; Bokarewa, Maria I/0000-0001-9424-5145; Jin, Tao/0000-0001-9039-0628; Valadi, Hadi/0000-0003-3482-2451; Ali, Abukar/0000-0002-1963-3356; Mohammad, Majd/0000-0002-3672-2991; Na, Manli/0000-0002-7306-8941	Swedish Medical Research Council [523-2013-2750]; Swedish Medical Society [SLS-496741, SLS-402871]; Stiftelsen Clas Groschinskys Minnesfond [M1566, M14099, M1626]; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation [SLS-501701]; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning [2015-00056, 2016-075]; Professor Nanna Svartz Fond [2015-00074]; Adlerbertska Forskningsstiftelsen; Coordination for the improvement of higher education personnel, CAPES; National Natural Science Foundation of China [81460334]; State Scholarship Fund of China Scholarship Council [201508525101]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Medical Society; Stiftelsen Clas Groschinskys Minnesfond; Royal Society of Arts and Sciences in Gothenburg; Wilhelm and Martina Lundgren Foundation; Scandinavian Society for Antimicrobial Chemotherapy Foundation; Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning; Professor Nanna Svartz Fond; Adlerbertska Forskningsstiftelsen; Coordination for the improvement of higher education personnel, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This work was supported by the Swedish Medical Research Council (grant 523-2013-2750 to T. Jin), the Swedish Medical Society (SLS-496741 and SLS-402871 to T. Jin), the Stiftelsen Clas Groschinskys Minnesfond (grant M1566, M14099, and M1626 to T. Jin), the Royal Society of Arts and Sciences in Gothenburg (grant to T. Jin and ML. Na), the Wilhelm and Martina Lundgren Foundation (grant to T. Jin, ML. Na, and A. Ali), the Scandinavian Society for Antimicrobial Chemotherapy Foundation (grant SLS-501701 to T. Jin), Rune och Ulla Amlovs Stiftelse for Neurologisk och Reumatologisk Forskning (grant 2015-00056 and 2016-075 to T. Jin), Professor Nanna Svartz Fond (grant 2015-00074 to T. Jin), and Adlerbertska Forskningsstiftelsen (grant to T. Jin and ML. Na), Coordination for the improvement of higher education personnel, CAPES (grant to F. Fatima and M. Nawaz), National Natural Science Foundation of China (grant 81460334 to Y. Fei), and the State Scholarship Fund of China Scholarship Council (grant 201508525101 to Y. Fei). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Ali A, 2015, J INFECT DIS, V212, P1308, DOI 10.1093/infdis/jiv212; Ali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131645; Ali A, 2015, ARTHRITIS RHEUMATOL, V67, P107, DOI 10.1002/art.38902; Andrisano-Ruggieri R, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016629527; Aruga A, 1997, BRIT J CANCER, V76, P760, DOI 10.1038/bjc.1997.458; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Blomqvist C, 1996, BRIT J CANCER, V73, P1074, DOI 10.1038/bjc.1996.207; Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017; BREMELL T, 1990, ARTHRITIS RHEUM, V33, P1739, DOI 10.1002/art.1780331120; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Colavite PM, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-19; EPSTEIN JH, 1986, J RHEUMATOL, V13, P1105; Fei Y, 2011, J INFECT DIS, V204, P348, DOI 10.1093/infdis/jir266; GOLD RH, 1991, AM J ROENTGENOL, V157, P365, DOI 10.2214/ajr.157.2.1853823; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Kaandorp CJE, 1997, ANN RHEUM DIS, V56, P470, DOI 10.1136/ard.56.8.470; Khoury BM, 2015, CONNECT TISSUE RES, V56, P106, DOI 10.3109/03008207.2015.1005211; Koopmans N, 2007, J UROLOGY, V178, P849, DOI 10.1016/j.juro.2007.05.029; Lane NE, 1998, J BONE MINER RES, V13, P229, DOI 10.1359/jbmr.1998.13.2.229; Marenzana M, 2015, BEST PRACT RES CL RH, V29, P715, DOI 10.1016/j.berh.2016.02.001; McQueen FM, 2013, BEST PRACT RES CL RH, V27, P499, DOI 10.1016/j.berh.2013.09.005; Mohan G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3543; Molne L, 2000, J INVEST DERMATOL, V114, P1120, DOI 10.1046/j.1523-1747.2000.00973.x; Na ML, 2016, INFECT IMMUN, V84, P930, DOI 10.1128/IAI.01520-15; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pecoraro V, 2015, CRIT REV ONCOL HEMAT, V96, P54, DOI 10.1016/j.critrevonc.2015.05.001; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Silva MD, 2004, MOL IMAGING, V3, P312, DOI 10.1162/1535350042973562; Tarkowski A, 2001, TRENDS MICROBIOL, V9, P321, DOI 10.1016/S0966-842X(01)02078-9; Vesga O, 1996, J INFECT DIS, V173, P739, DOI 10.1093/infdis/173.3.739	33	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171222	10.1371/journal.pone.0171222	http://dx.doi.org/10.1371/journal.pone.0171222			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152087	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161200107
J	Pianka, F; Probst, P; Keller, AV; Saure, D; Grummich, K; Buchler, MW; Diener, MK				Pianka, Frank; Probst, Pascal; Keller, Anne-Valerie; Saure, Daniel; Grummich, Kathrin; Buechler, Markus W.; Diener, Markus K.			Prophylactic mesh placement for the PREvention of paraSTOmal hernias: The PRESTO systematic review and meta-analysis	PLOS ONE			English	Review							PROSTHETIC MESH; LAPAROSCOPIC REPAIR; SURGICAL-TREATMENT; COLOSTOMY; STOMA; SURGERY; COMPLICATIONS; CHALLENGE; FAILURE; TRIAL	Background Parastomal hernia (PH) is the most common complication after ostomy formation. Prophylactic mesh placement may be effective in reducing the rate of PH at the stoma site. The aims of this systematic review were to summarize the evidence with regard to the safety and effectiveness in comparison with the standard procedure without mesh placement and to identify important risk constellations. Method A systematic literature search was performed in PubMed, EMBASE and the Cochrane library with no language or date restrictions. Randomized (RCTs) and non-randomized controlled trials (nRCTs) were included. The main outcomes of interest were PH (primary outcome) rate and stoma-related complications (secondary outcomes) such as stenosis or fistula. Statistical analysis included meta-analyses of pooled data and subgroup analyses. Results Eleven trials (eight RCTs; three nRCTs) with a total of 755 patients were included. PH rate varied from 0% to 59% in the intervention and from 20% to 94% in the control group. RCTs showed a significant reduction of PH rate in the mesh group (OR 0.24; 95% CI 0.10 to 0.58, p = 0.034), whereas included nRCTs did not. No significant differences were observed in postoperative complication rates. Subgroup analyses showed superiority of non-absorbable meshes and sublay mesh positioning in open surgery. Conclusion Prophylactic mesh placement is safe and reduces PH rate. A recommendation for prophylactic non-absorbable meshes in a sublay position can be made for patients undergoing open colorectal operations with end-ostomies. Further research endeavors should focus on patient-oriented outcomes, not only PH rate, with respect to tailored treatment in specific patient populations.	[Pianka, Frank; Probst, Pascal; Buechler, Markus W.; Diener, Markus K.] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Pianka, Frank; Probst, Pascal; Keller, Anne-Valerie; Grummich, Kathrin; Diener, Markus K.] Univ Heidelberg Heidelberg, Study Ctr German Surg Soc, Heidelberg, Germany; [Saure, Daniel] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Diener, MK (corresponding author), Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.; Diener, MK (corresponding author), Univ Heidelberg Heidelberg, Study Ctr German Surg Soc, Heidelberg, Germany.	markus.diener@med.uni-heidelberg.de	Probst, Pascal/GSD-6170-2022		German Federal Ministry of Education and Research [01KG1219]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Financial support was granted by the German Federal Ministry of Education and Research (www.bmbf.de, project number: 01KG1219). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENMERSH TG, 1988, BRIT J SURG, V75, P416, DOI 10.1002/bjs.1800750507; [Anonymous], 2014, PHYS STAT CLASS SYST; BAYER I, 1986, SURG GYNECOL OBSTET, V163, P579; Berger D, 2009, HERNIA, V13, P167, DOI 10.1007/s10029-008-0435-4; Berger D, 2007, DIS COLON RECTUM, V50, P1668, DOI 10.1007/s10350-007-9028-z; Cheung MT, 2001, DIS COLON RECTUM, V44, P266, DOI 10.1007/BF02234303; CHEUNG MT, 1995, AUST NZ J SURG, V65, P808, DOI 10.1111/j.1445-2197.1995.tb00566.x; Cui Ji, 2009, Zhonghua Wei Chang Wai Ke Za Zhi, V12, P480; de Ruiter P, 2005, DIGEST SURG, V22, P152, DOI 10.1159/000087147; Fleshman JW, 2014, DIS COLON RECTUM, V57, P623, DOI 10.1097/DCR.0000000000000106; Guzman-Valdivia G, 2008, WORLD J SURG, V32, P465, DOI 10.1007/s00268-007-9373-z; Hammond TM, 2008, HERNIA, V12, P475, DOI 10.1007/s10029-008-0383-z; Hansson BME, 2009, SURG ENDOSC, V23, P1456, DOI 10.1007/s00464-008-0253-x; Helgstrand F, 2008, HERNIA, V12, P577, DOI 10.1007/s10029-008-0387-8; Hofstetter WL, 1998, DIS COLON RECTUM, V41, P1054, DOI 10.1007/BF02237400; Hotouras A, 2013, COLORECTAL DIS, V15, pE202, DOI 10.1111/codi.12156; Janes A, 2004, BRIT J SURG, V91, P280, DOI 10.1002/bjs.4417; Jano Z, 2013, EUR SURG, V1, P25; Kroese LF, 2016, DIS COLON RECTUM, V59, P688, DOI 10.1097/DCR.0000000000000605; Lambrecht JR, 2015, COLORECTAL DIS, V17, pO191, DOI 10.1111/codi.13065; LONDONOSCHIMMER EE, 1994, DIS COLON RECTUM, V37, P916, DOI 10.1007/BF02052598; Longman RJ, 2005, COLORECTAL DIS, V7, P292, DOI 10.1111/j.1463-1318.2005.00750.x; Lopez-Cano M, 2012, HERNIA, V16, P661, DOI 10.1007/s10029-012-0952-z; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris-Stiff G, 1998, ANN ROY COLL SURG, V80, P184; Muysoms F, 2007, ACTA CHIR BELG, V107, P476, DOI 10.1080/00015458.2007.11680104; Nikberg M, 2015, INT J COLORECTAL DIS, V30, P1217, DOI 10.1007/s00384-015-2293-8; Pastor DM, 2009, JSLS-J SOC LAPAROEND, V13, P170; PEARL RK, 1989, WORLD J SURG, V13, P569, DOI 10.1007/BF01658872; Riansuwan W, 2010, COLORECTAL DIS, V12, P681, DOI 10.1111/j.1463-1318.2009.01868.x; Rieger N, 2004, Colorectal Dis, V6, P203, DOI 10.1111/j.1463-1318.2004.00587.x; RUBIN MS, 1994, ARCH SURG-CHICAGO, V129, P413; Sajid MS, 2012, MINERVA CHIR, V67, P289; Sakai Y, 2001, ARCH SURG-CHICAGO, V136, P338, DOI 10.1001/archsurg.136.3.338; Serra-Aracil X, 2009, ANN SURG, V249, P583, DOI 10.1097/SLA.0b013e31819ec809; Shabbir J, 2012, COLORECTAL DIS, V14, P931, DOI 10.1111/j.1463-1318.2011.02835.x; Steele SR, 2003, AM J SURG, V185, P436, DOI 10.1016/S0002-9610(03)00040-0; Tam KW, 2010, WORLD J SURG, V34, P2723, DOI 10.1007/s00268-010-0739-2; Tarcoveanu E, 2014, CHIRURGIA-BUCHAREST, V109, P179; van Sprundel TC, 2005, COLORECTAL DIS, V7, P445, DOI 10.1111/j.1463-1318.2005.00820.x; Ventham NT, 2012, ANN ROY COLL SURG, V94, P569, DOI 10.1308/003588412X13373405386493; Vierimaa M, 2015, DIS COLON RECTUM, V58, P943, DOI 10.1097/DCR.0000000000000443; WALLENSTEIN S, 1993, BIOMETRICS, V49, P1077, DOI 10.2307/2532249; Wara P, 2011, SURG ENDOSC, V25, P526, DOI 10.1007/s00464-010-1205-9; Wijeyekoon SP, 2010, J AM COLL SURGEONS, V211, P637, DOI 10.1016/j.jamcollsurg.2010.06.111; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	47	38	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171548	10.1371/journal.pone.0171548	http://dx.doi.org/10.1371/journal.pone.0171548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182642	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800073
J	Skaaby, T; Husemoen, LLN; Thuesen, BH; Fenger, RV; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Fenger, Runa Vavia; Linneberg, Allan			IgE sensitization to inhalant allergens and the risk of airway infection and disease: A population-based study	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; ASTHMA; IMMUNOTHERAPY; ADULTS; HEALTH; TRENDS; ATOPY	Background Immunoglobulin E (IgE) sensitization, which is the propensity to develop IgE antibodies against common environmental allergens, is associated with a lymphocyte T-helper type 2 (Th2) skewed immune response and a high risk of allergic respiratory disease. Little is known about whether IgE sensitization confers an increased risk of respiratory infections in adults. We investigated the association between IgE sensitization and the incidence of acute airway infections, other infections and chronic lower airway disease events as recorded in nationwide registries. Methods We included 14,849 persons from five population-based studies with measurements of serum specific IgE positivity against inhalant allergens. Participants were followed by linkage to Danish national registries (median follow-up time 11.3 years). The study-specific relative risks were estimated by Cox regression analysis, meta-analysed, and expressed as hazard ratios, HRs (95% confidence intervals, CIs). Results The relative risks for IgE sensitized vs. non-sensitized were: for pneumonia (HR = 1.20, 95% CI: 1.01, 1.41), other acute airway infection (HR = 0.86, 95% CI: 0.60, 1.22), infection (HR = 1.06, 95% CI: 0.90, 1.24), asthma (HR = 2.26, 95% CI: 1.79, 2.86), and other chronic lower airway disease (HR = 1.31, 95% CI: 1.08, 1.58). In never smokers, the higher risk of pneumonia (HR = 1.73, 95% CI: 1.23, 2.44) and asthma (HR = 3.17, 95% CI: 2.10, 4.76) among IgE sensitized was more pronounced. Conclusions IgE sensitization was associated with a higher risk of asthma, other chronic lower airway diseases, and pneumonia. However, the association between IgE sensitization and pneumonia may be explained by undiagnosed asthma causing the pneumonia. Further studies are needed for confirmation.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Fenger, Runa Vavia; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Capital Reg Denmark, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk		Thuesen, Betina/0000-0001-9772-4344; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184	Lundbeck Foundation [R165-2013-15410, R108-A10225]; Lundbeck Foundation [R219-2016-471] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	Tea Skaaby was supported by a grant from the Lundbeck Foundation (Grant number R165-2013-15410). Betina Heinsbaek Thuesen was Supported by a grant from the Lundbeck Foundation (Grant number R108-A10225). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Ciprandi G, 2013, J BIOL REG HOMEOS AG, V27, P1053; Ciprandi G, 2006, PEDIAT ALLERG IMM-UK, V17, P389, DOI 10.1111/j.1399-3038.2006.00413.x; Ciprandi G, 2009, ANN ALLERG ASTHMA IM, V102, P262, DOI 10.1016/S1081-1206(10)60095-6; Cirillo I, 2007, ALLERGY, V62, P1087, DOI 10.1111/j.1398-9995.2007.01401.x; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Fattahi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-10; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; James KM, 2012, J ALLERGY CLIN IMMUN, V130, P343, DOI 10.1016/j.jaci.2012.05.056; Juel K, 1999, DAN MED BULL, V46, P354; Jung JA, 2010, J ALLERGY CLIN IMMUN, V125, P217, DOI 10.1016/j.jaci.2009.10.045; Linneberg A, 2007, CLIN EXP ALLERGY, V37, P1137, DOI 10.1111/j.1365-2222.2007.02760.x; Linneberg A, 2006, ALLERGY, V61, P344, DOI 10.1111/j.1398-9995.2006.00968.x; Linneberg A, 2001, RESP MED, V95, P258, DOI 10.1053/rmed.2001.1031; Linneberg A, 2001, ALLERGY, V56, P328, DOI 10.1034/j.1398-9995.2000.00509.x-i1; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen AB, 2004, CLIN BIOCHEM, V37, P882, DOI 10.1016/j.clinbiochem.2004.06.010; Rantala A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068582; Rantala A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027912; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Skaaby T, 2014, CLIN EXP ALLERGY, V44, P1361, DOI 10.1111/cea.12408; Skaaby T, 2014, ENDOCRINE; Skaaby T, 2014, ATOPY DEV CANC POPUL; Skaaby T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137406; Skaaby T, 2015, AUTOIMMUNITY, V48, P282, DOI 10.3109/08916934.2014.1003640	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171525	10.1371/journal.pone.0171525	http://dx.doi.org/10.1371/journal.pone.0171525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182643	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800069
J	van Rensburg, G; Mackedenski, S; Lee, CH				van Rensburg, Gerrit; Mackedenski, Sebastian; Lee, Chow H.			Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor (MITF) mRNA interaction	PLOS ONE			English	Article							C-MYC; CRD-BP; KH DOMAINS; CANCER; EXPRESSION; MELANOMA; GROWTH; STABILIZATION; INHIBITION; CELLS	Coding region determinant-binding protein (CRD-BP) binds to the 3'-UTR of microphthalmia-associated transcription factor (MITF) mRNA to prevent its targeted degradation by miR-340. Here, we aim to further understand the molecular interaction between CRD-BP and MITF RNA. Using point mutation in the GXXG motif of each KH domains, we showed that all four KH domains of CRD-BP are important for their physical association with MITF RNA. We mapped the CRD-BP-binding site in the 3'-UTR of MITF RNA from nts 1330-1740 and showed that the 49-nt fragment 1621-1669 is the minimal size MITF RNA for binding. Upon deletion of nts 1621-1669 within the nts1550-1740 of MITF RNA, there was a 3-fold increase in dissociation constant Kd, which further confirms the critical role sequences within nts 1621-1669 in binding to CRD-BP. Amongst the eight antisense oligonucleotides designed against MITF RNA 1550-1740, we found MHO-1 and MHO-7 as potent inhibitors of the CRD-BP-MITF RNA interaction. Using RNase protection and fluorescence polarization assays, we showed that both MHO-1 and MHO-7 have affinity for the MITF RNA, suggesting that both antisense oligonucleotides inhibited CRD-BP-MITF RNA interaction by directly binding to MITF RNA. The new molecular insights provided in this study have important implications for understanding the oncogenic function of CRD-BP and development of specific inhibitors against CRD-BP-MITF RNA interaction.	[van Rensburg, Gerrit; Mackedenski, Sebastian; Lee, Chow H.] Univ Northern British Columbia, Chem Program, Prince George, BC, Canada	University of Northern British Columbia	Lee, CH (corresponding author), Univ Northern British Columbia, Chem Program, Prince George, BC, Canada.	chow.lee@unbc.ca						Barnes M, 2015, J BIOL CHEM, V290, P625, DOI 10.1074/jbc.M114.614735; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; Goswami S, 2015, J BIOL CHEM, V290, P384, DOI 10.1074/jbc.M114.590158; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; King DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091585; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mehmood K, 2016, MOL PHARMACOL, V89, P695, DOI 10.1124/mol.115.102434; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen FC, 2002, J CELL SCI, V115, P2087; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171196	10.1371/journal.pone.0171196	http://dx.doi.org/10.1371/journal.pone.0171196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182633	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800043
J	Kim, TH; Chang, JS; Park, KS; Park, J; Kim, N; Lee, JI; Kong, ID				Kim, Tae Ho; Chang, Jae Seung; Park, Kyu-Sang; Park, Jeeyeon; Kim, Nahyun; Lee, Jong In; Kong, In Deok			Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; POSTMENOPAUSAL WOMEN; POOR-PROGNOSIS; SUPPRESSOR-CELLS; SERUM DICKKOPF-1; WNT PATHWAY; WEIGHT-LOSS; EXPRESSION; SFRP1; DKK1	Background Wingless and integration site growth factor (Wnt) signaling is a tumorigenesis-related signaling pathway. Dickkpof-1 (DKK1) and secreted frizzled-related protein-1 (SFRP1) are endogenous negative regulators of Wnt/beta-catenin signaling. Accumulating evidence indicates that higher serum levels of DKK1 are correlated with poor prognosis of various types of cancer. Here, we investigated whether exercise training causes changes in the serum levels of DKK1 and SFRP1 in patients with breast cancer. Methods Twenty-four breast cancer survivors, after chemo-or radiotherapy, participated in this single-blind randomized, controlled pilot study. Subjects were randomized to either an exercise program or a control group for 12 weeks and completed pre-and post-training tests for health-related fitness and body composition as well as blood biomarkers. The serum levels of DKK1 and SFRP1 were measured using enzyme-linked immunosorbent assay as the primary outcome. Results Exercise training for 12 weeks remarkably increased muscle strength, endurance, and flexibility and decreased body fat percentage, waist circumference, and visceral fat area (all p < 0.05). Exercise training lowered serum insulin levels and leptin/adiponectin ratios (all p < 0.05). The levels of DKK1 and SFRP1 were also significantly decreased by exercise training in breast cancer survivors (all p < 0.01). Conclusions Our results indicate that DKK1 and SFRP1 may be potentially useful biomarkers for evaluating the beneficial effects of long-term exercise on physical fitness and metabolism as well as the prognosis of patients with cancer.	[Kim, Tae Ho; Chang, Jae Seung; Park, Kyu-Sang; Kong, In Deok] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea; [Kim, Tae Ho; Chang, Jae Seung; Kong, In Deok] Yonsei Inst Sports Sci & Exercise Med, Wonju, South Korea; [Park, Jeeyeon] Kyungsung Univ, Dept Nursing Sci, Busan, South Korea; [Kim, Nahyun] Keimyung Univ, Dept Basic Nursing Sci, Coll Nursing, Daegu, South Korea; [Lee, Jong In] Yonsei Univ, Wonju Coll Med, Dept Hematol Oncol, Wonju, South Korea	Yonsei University; Kyungsung University; Keimyung University; Yonsei University	Kong, ID (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea.; Kong, ID (corresponding author), Yonsei Inst Sports Sci & Exercise Med, Wonju, South Korea.	kong@yonsei.ac.kr						Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bayod S, 2014, BRAIN RES, V1543, P38, DOI 10.1016/j.brainres.2013.10.048; Befort CA, 2012, BREAST CANCER RES TR, V132, P631, DOI 10.1007/s10549-011-1922-3; Bernemann C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-174; Bhandari R, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/189384; Binkley JM, 2012, CANCER-AM CANCER SOC, V118, P2207, DOI 10.1002/cncr.27469; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cao Dinh H, 2016, CALCIF TISSUE INT; Capietto AH, 2013, J EXP MED, V210, P2257, DOI 10.1084/jem.20130281; Chan DNS, 2010, J ADV NURS, V66, P1902, DOI 10.1111/j.1365-2648.2010.05374.x; D'Amico L, 2016, J EXP MED, V213, P827, DOI 10.1084/jem.20150950; DeCensi A, 2011, J CLIN ONCOL, V29, P7, DOI 10.1200/JCO.2010.32.3022; Fairey AS, 2005, BRAIN BEHAV IMMUN, V19, P381, DOI 10.1016/j.bbi.2005.04.001; Gattinoni L, 2010, CLIN CANCER RES, V16, P4695, DOI 10.1158/1078-0432.CCR-10-0356; Giannopoulou I, 2005, METABOLISM, V54, P866, DOI 10.1016/j.metabol.2005.01.033; Gough NR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002806; Han SX, 2015, ONCOTARGET, V6, P19907, DOI 10.18632/oncotarget.4529; Irwin ML, 2012, ACSMS GUIDE EXERCISE; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kerschan-Schindl K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132478; Klopocki E, 2004, INT J ONCOL, V25, P641; Knols R, 2005, J CLIN ONCOL, V23, P3830, DOI 10.1200/JCO.2005.02.148; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Liu YQ, 2014, TUMOR BIOL, V35, P3145, DOI 10.1007/s13277-013-1411-x; Loprinzi PD, 2012, BREAST CANCER-TOKYO, V19, P4, DOI 10.1007/s12282-011-0292-3; Mauro L, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00157; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Polakis P, 2012, COLD SPRING HARB PER, V4; Rachner TD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-649; Rachner TD, 2014, CANCER LETT, V346, P172, DOI 10.1016/j.canlet.2014.01.010; Riesco E, 2012, METABOLISM, V61, P273, DOI 10.1016/j.metabol.2011.06.025; Ryan AS, 2003, INT J OBESITY, V27, P1066, DOI 10.1038/sj.ijo.0802387; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Spillane M, 2015, STEROIDS, V98, P63, DOI 10.1016/j.steroids.2015.02.019; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Voorzanger-Rousselot N, 2009, CALCIFIED TISSUE INT, V84, P348, DOI 10.1007/s00223-009-9225-y; Wang M, 2015, CLIMACTERIC, V18, P852, DOI 10.3109/13697137.2015.1071346; Winters-Stone KM, 2012, J CANCER SURVIV, V6, P189, DOI 10.1007/s11764-011-0210-x; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Zhou F, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-124; Zhou SJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0161-4	54	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171771	10.1371/journal.pone.0171771	http://dx.doi.org/10.1371/journal.pone.0171771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178355	gold, Green Published, Green Submitted			2022-12-27	WOS:000393712500070
J	Nicholas, D; Proctor, EA; Raval, FM; Ip, BC; Habib, C; Ritou, E; Grammatopoulos, TN; Steenkamp, D; Dooms, H; Apovian, CM; Lauffenburger, DA; Nikolajczyk, BS				Nicholas, Dequina; Proctor, Elizabeth A.; Raval, Forum M.; Ip, Blanche C.; Habib, Chloe; Ritou, Eleni; Grammatopoulos, Tom N.; Steenkamp, Devin; Dooms, Hans; Apovian, Caroline M.; Lauffenburger, Douglas A.; Nikolajczyk, Barbara S.			Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis	PLOS ONE			English	Article							REGULATORY T-CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; B-CELLS; ACTIVATED MACROPHAGES; CYTOKINE PRODUCTION; OXYGEN-CONSUMPTION; INFLAMMATION; OBESITY; GLUCOSE	Numerous studies show that mitochondrial energy generation determines the effectiveness of immune responses. Furthermore, changes in mitochondrial function may regulate lymphocyte function in inflammatory diseases like type 2 diabetes. Analysis of lymphocyte mitochondria) function has been facilitated by introduction of 96-well format extracellular flux (XF96) analyzers, but the technology remains imperfect for analysis of human lymphocytes. Limitations in XF technology include the lack of practical protocols for analysis of archived human cells, and inadequate data analysis tools that require manual quality checks. Current analysis tools for XF outcomes are also unable to automatically assess data quality and delete untenable data from the relatively high number of biological replicates needed to power complex human cell studies. The objectives of work presented herein are to test the impact of common cellular manipulations on XF outcomes, and to develop and validate a new automated tool that objectively analyzes a virtually unlimited number of samples to quantitate mitochondrial function in immune cells. We present significant improvements on previous XF analyses of primary human cells that will be absolutely essential to test the prediction that changes in immune cell mitochondrial function and fuel sources support immune dysfunction in chronic inflammatory diseases like type 2 diabetes.	[Nicholas, Dequina; Raval, Forum M.; Ip, Blanche C.; Dooms, Hans; Nikolajczyk, Barbara S.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Proctor, Elizabeth A.; Lauffenburger, Douglas A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Habib, Chloe; Steenkamp, Devin; Apovian, Caroline M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Ritou, Eleni; Grammatopoulos, Tom N.] BioEnerget LLC, Boston, MA USA; [Dooms, Hans] Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; [Nikolajczyk, Barbara S.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Nikolajczyk, Barbara S.] Boston Univ, Sch Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Ip, Blanche C.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Boston University; Massachusetts Institute of Technology (MIT); Boston University; Boston University; Boston University; Boston University; Brown University	Nikolajczyk, BS (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.; Nikolajczyk, BS (corresponding author), Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA.; Nikolajczyk, BS (corresponding author), Boston Univ, Sch Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.	bnikol@bu.edu	Proctor, Elizabeth A./K-2350-2012; Nicholas, Dequina/AAF-1412-2019	Proctor, Elizabeth A./0000-0002-7627-2198; Dooms, Hans/0000-0001-7964-0876; Nicholas, Dequina/0000-0003-4996-2190	National Institutes of Health [R56DK096525, R01DK108056, R24DK090963, P30DK057521]; BU Genome Sciences Institute; NIDDK Diabetic Complications Consortium [DK076169]; Hematology Training Program [HL007501]; Inflammatory Disorders Training Grant [Al1089673]; Metabolism, Endocrinology and Obesity Training Grant [DK007201]; Institute for Collaborative Biotechnologies through grant from the U.S. Army Research Office [W911NF-09-0001]; BioEnergetics LLC; NATIONAL CANCER INSTITUTE [U01CA182898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BU Genome Sciences Institute; NIDDK Diabetic Complications Consortium; Hematology Training Program; Inflammatory Disorders Training Grant; Metabolism, Endocrinology and Obesity Training Grant; Institute for Collaborative Biotechnologies through grant from the U.S. Army Research Office; BioEnergetics LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R56DK096525 (BN), R01DK108056 (BN, CA, DL), R24DK090963 (DL) and P30DK057521 (HD); The BU Genome Sciences Institute (www.bumc.bu.edu/gsi/) (BN); The NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org) DK076169 (DN); the following National Institutes of Health training grants: The Hematology Training Program HL007501 (FR), The Inflammatory Disorders Training Grant Al1089673 (DN), The Metabolism, Endocrinology and Obesity Training Grant DK007201 (DN), and the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office www.icb.uscb. edu (DL). TG and ER are paid employees of BioEnergetics LLC, a commercial entity that provided financial support in the form of salaries, research materials, specialized equipment and technical support for assistance in study design, data collection and analysis. The specific roles of these authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAND K, 1988, EUR J BIOCHEM, V172, P695, DOI 10.1111/j.1432-1033.1988.tb13944.x; Caro-Maldonado A, 2014, J IMMUNOL; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hartman ML, 2014, VASC MED, V19, P67, DOI 10.1177/1358863X14521315; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Keane KN, 2015, CLIN SCI, V128, P723, DOI 10.1042/CS20140725; Kramer PA, 2014, JOVE-J VIS EXP, DOI 10.3791/51301; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Milasta S, 2016, IMMUNITY, V44, P88, DOI 10.1016/j.immuni.2015.12.002; Nikolajczyk BS, 2010, CYTOKINE, V50, P234, DOI 10.1016/j.cyto.2010.02.022; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Perry CGR, 2013, DIABETES, V62, P1041, DOI 10.2337/db12-1219; Procaccini C, 2016, IMMUNITY, V44, P406, DOI 10.1016/j.immuni.2016.01.028; Raval Forum M, 2013, Discoveries (Craiova), V1, pe6; Renner K, 2015, EUR J IMMUNOL, V45, P2504, DOI 10.1002/eji.201545473; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin H, 2009, J LEUKOCYTE BIOL, V85, P648, DOI 10.1189/jlb.0708428; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Vacaflores A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157175; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835	44	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170975	10.1371/journal.pone.0170975	http://dx.doi.org/10.1371/journal.pone.0170975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178278	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500018
J	Nuvolone, M; Schmid, N; Miele, G; Sorce, S; Moos, R; Schori, C; Beerli, RR; Bauer, M; Saudan, P; Dietmeier, K; Lachmann, I; Linnebank, M; Martin, R; Kallweit, U; Kana, V; Rushing, EJ; Budka, H; Aguzzi, A				Nuvolone, Mario; Schmid, Nicolas; Miele, Gino; Sorce, Silvia; Moos, Rita; Schori, Christian; Beerli, Roger R.; Bauer, Monika; Saudan, Philippe; Dietmeier, Klaus; Lachmann, Ingolf; Linnebank, Michael; Martin, Roland; Kallweit, Ulf; Kana, Veronika; Rushing, Elisabeth J.; Budka, Herbert; Aguzzi, Adriano			Cystatin F is a biomarker of prion pathogenesis in mice	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODELS; CYSTEINE PROTEASES; NEURONAL CELLS; CATHEPSIN-B; C GENE; EXPRESSION; SCRAPIE; PROTEIN	Misfolding of the cellular prion protein (PrPc) into the scrapie prion protein (PrPsc) results in progressive, fatal, transmissible neurodegenerative conditions termed prion diseases. Experimental and epidemiological evidence point toward a protracted, clinically silent phase in prion diseases, yet there is no diagnostic test capable of identifying asymptomatic individuals incubating prions. In an effort to identify early biomarkers of prion diseases, we have compared global transcriptional profiles in brains from pre-symptomatic prion-infected mice and controls. We identified Cst7, which encodes cystatin F, as the most strongly upregulated transcript in this model. Early and robust upregulation of Cst7 m RNA levels and of its cognate protein was validated in additional mouse models of prion disease. Surprisingly, we found no significant increase in cystatin F levels in both cerebrospinal fluid or brain parenchyma of patients with Creutzfeldt-Jakob disease compared to Alzheimer's disease or non demented controls. Our results validate cystatin F as a useful biomarker of early pathogenesis in experimental models of prion disease, and point to unexpected species-specific differences in the transcriptional responses to prion infections.	[Nuvolone, Mario; Schmid, Nicolas; Miele, Gino; Sorce, Silvia; Moos, Rita; Kana, Veronika; Rushing, Elisabeth J.; Budka, Herbert; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, Zurich, Switzerland; [Schori, Christian; Beerli, Roger R.; Bauer, Monika; Saudan, Philippe; Dietmeier, Klaus] Cytos Biotechnol AG, Zurich, Switzerland; [Lachmann, Ingolf] AJ Roboscreen GmbH, Leipzig, Germany; [Linnebank, Michael; Martin, Roland; Kallweit, Ulf] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Kallweit, Ulf] Univ Hosp Bern, Dept Neurol, Bern, Switzerland; [Kallweit, Ulf] Univ Bern, Bern, Switzerland; [Beerli, Roger R.] NBE Therapeut AG, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Bern	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Zurich, Switzerland.	adriano.aguzzi@usz.ch	Budka, Herbert/I-3486-2019; Kallweit, Ulf/AAM-3989-2021; Nuvolone, Mario/K-4763-2018	Budka, Herbert/0000-0002-1933-1577; Nuvolone, Mario/0000-0001-8334-1684; Sorce, Silvia/0000-0002-3843-8644; Kana, Veronika/0000-0002-9362-3156	European Research Council (ERC) [250356]; European Union; Swiss National Foundation; Swiss Initiative in Systems Biology; SystemsX.ch; Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs); Cytos Biotechnology; AJ Roboscreen GmbH	European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Initiative in Systems Biology; SystemsX.ch; Novartis Institutes of Biomedical Research; Klinische Forschungsschwerpunkte (KFSPs); Cytos Biotechnology; AJ Roboscreen GmbH	AA is the recipient of an Advanced Grant of the European Research Council (ERC, No. 250356) and is supported by grants from the European Union (DEMTEST, NEURINOX), the Swiss National Foundation, the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX), the Novartis Institutes of Biomedical Research, and the Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases". GM was supported by a grant from the Swiss National Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CS, RRB, MB, PS and KD were employed by Cytos Biotechnology AG and IL by AJ Roboscreen GmbH. Cytos Biotechnology and AJ Roboscreen GmbH provided support in the form of salaries for authors CS, RRB, MB, PS and KD (Cytos Biotechnology AG) and IL (AJ Roboscreen GmbH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Beasley TM, 2005, AM J PHARMACOGENOMIC, V5, P197, DOI 10.2165/00129785-200505030-00006; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Duan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052566; Halfon S, 1998, J BIOL CHEM, V273, P16400, DOI 10.1074/jbc.273.26.16400; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Koller D, 2001, NAT BIOTECHNOL, V19, P851, DOI 10.1038/nbt0901-851; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kovacs GG, 2007, J NEUROPATH EXP NEUR, V66, P628, DOI 10.1097/nen.0b013e318093ecc7; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Llorens F, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00198; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Luhr KM, 2004, J VIROL, V78, P4776, DOI 10.1128/JVI.78.9.4776-4782.2004; Ma JM, 2011, J NEUROSCI RES, V89, P639, DOI 10.1002/jnr.22567; Matthews SP, 2016, IMMUNITY, V44, P795, DOI 10.1016/j.immuni.2016.03.003; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Miele G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003870; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Morita M, 2000, GENOMICS, V67, P87, DOI 10.1006/geno.2000.6237; Ni J, 1998, J BIOL CHEM, V273, P24797, DOI 10.1074/jbc.273.38.24797; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117208; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; PALSDOTTIR A, 1988, LANCET, V2, P603; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Parchi P, 2012, FOLIA NEUROPATHOL, V50, P20; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Schinke-Braun Martina, 2007, Methods Mol Biol, V366, P13; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Smith AM, 2014, TRENDS NEUROSCI, V37, P125, DOI 10.1016/j.tins.2013.12.001; Sorce S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004531; Stilling RM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00373; Stoeck K, 2012, BRAIN, V135, P3051, DOI 10.1093/brain/aws238; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Teunissen CE, 2014, CLIN BIOCHEM, V47, P288, DOI 10.1016/j.clinbiochem.2013.12.024; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal E, 2013, J COMP PATHOL, V148, P22, DOI 10.1016/j.jcpa.2012.05.004; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x; Zanusso G, 2016, NAT REV NEUROL, V12, P325, DOI 10.1038/nrneurol.2016.65; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang YH, 2003, J GEN VIROL, V84, P2279, DOI 10.1099/vir.0.19153-0; Zhu CH, 2016, J EXP MED, V213, P1047, DOI 10.1084/jem.20151000; Zhu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144983	66	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171923	10.1371/journal.pone.0171923	http://dx.doi.org/10.1371/journal.pone.0171923			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178353	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500079
J	Sharma, A; Kirkpatrick, G; Chen, V; Skolnik, K; Hollander, Z; Wilcox, P; Quon, BS				Sharma, Ashutosh; Kirkpatrick, Gordon; Chen, Virginia; Skolnik, Kate; Hollander, Zsuzsanna; Wilcox, Pearce; Quon, Bradley S.			Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PSEUDOMONAS-AERUGINOSA; INFLAMMATORY RESPONSE; HUMAN MONOCYTES; LUNG-DISEASE; INFECTION; FAILURE; MARKERS; EPIDEMIOLOGY; OUTCOMES	Rationale C-reactive protein (CRP) is a systemic marker of inflammation that correlates with disease status in cystic fibrosis (CF). The clinical utility of CRP measurement to guide pulmonary exacerbation (PEx) treatment decisions remains uncertain. Objectives To determine whether monitoring CRP during PEx treatment can be used to predict treatment response. We hypothesized that early changes in CRP can be used to predict treatment response. Methods We reviewed all PEx events requiring hospitalization for intravenous (IV) antibiotics over 2 years at our institution. 83 PEx events met our eligibility criteria. CRP levels from admission to day 5 were evaluated to predict treatment non-response, using a modified version of a prior published composite definition. CRP was also evaluated to predict time until next exacerbation (TUNE). Measurements and main results 53% of 83 PEx events were classified as treatment non-response. Paradoxically, 24% of PEx events were characterized by a >= 50% increase in CRP levels within the first five days of treatment. Absolute change in CRP from admission to day 5 was not associated with treatment non-response (p = 0.58). Adjusted for FEV1% predicted, admission log(10) CRP was associated with treatment non-response (OR: 2.39; 95% CI: 1.14 to 5.91; p = 0.03) and shorter TUNE (HR: 1.60; 95% CI: 1.13 to 2.27; p = 0.008). The area under the receiver operating characteristics (ROC) curve of admission CRP to predict treatment non-response was 0.72 (95% CI 0.61-0.83; p<0.001). 23% of PEx events were characterized by an admission CRP of > 75 mg/L with a specificity of 90% for treatment non-response. Conclusions Admission CRP predicts treatment non -response and time until next exacerbation. Avery elevated admission CRP (>75mg/L) is highly specific for treatment non -response and might be used to target high-risk patients for future interventional studies aimed at improving exacerbation outcomes.	[Sharma, Ashutosh; Wilcox, Pearce; Quon, Bradley S.] Univ British Columbia, Ctr Heart Lung Innovat, Dept Med, Vancouver, BC, Canada; [Sharma, Ashutosh; Wilcox, Pearce; Quon, Bradley S.] St Pauls Hosp, Vancouver, BC, Canada; [Kirkpatrick, Gordon; Wilcox, Pearce; Quon, Bradley S.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada; [Chen, Virginia; Hollander, Zsuzsanna] Prevent Organ Failure PROOF Ctr Excellence, Vancouver, BC, Canada; [Skolnik, Kate] Univ Calgary, Div Resp Med, Dept Med, Calgary, AB, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Calgary	Quon, BS (corresponding author), Univ British Columbia, Ctr Heart Lung Innovat, Dept Med, Vancouver, BC, Canada.; Quon, BS (corresponding author), St Pauls Hosp, Vancouver, BC, Canada.; Quon, BS (corresponding author), Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada.	bradley.quon@hli.ubc.ca			Cystic Fibrosis Canada; British Columbia Lung Association; University of British Columbia Summer Student Research Program; Providence Health Care Research Institute	Cystic Fibrosis Canada; British Columbia Lung Association; University of British Columbia Summer Student Research Program; Providence Health Care Research Institute	This study was supported by Cystic Fibrosis Canada (http://www.cystictihrosis.ca/research/what-we-are-funding), the British Columbia Lung Association (https://bc.lung.ca/recent-grant-recipients-0), the University of British Columbia Summer Student Research Program (http://www.med.ubc.ca/current-learners./summer-student-research- program/), and the Providence Health Care Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Janice, 2003, Paediatr Drugs, V5, P41, DOI 10.2165/00148581-200305010-00004; Bell SC, 2000, EUR J CLIN INVEST, V30, P553; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; DEKIMPE SJ, 1995, P NATL ACAD SCI USA, V92, P10359, DOI 10.1073/pnas.92.22.10359; DOFFERHOFF ASM, 1993, J ANTIMICROB CHEMOTH, V31, P373, DOI 10.1093/jac/31.3.373; Dovey M, 2007, CHEST, V132, P1212, DOI 10.1378/chest.07-0843; Duggan C, 1996, AM J CLIN NUTR, V64, P635, DOI 10.1093/ajcn/64.4.635; ELBORN JS, 1993, RESP MED, V87, P603, DOI 10.1016/S0954-6111(05)80263-X; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Heltshe SL, 2015, THORAX; Hendry J, 1999, EUR RESPIR J, V14, P435, DOI 10.1034/j.1399-3003.1999.14b32.x; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; LEESON MC, 1994, SHOCK, V2, P235, DOI 10.1097/00024382-199410000-00001; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; McCoy KS, 2007, NEW ENGL J MED, V357, P2310, DOI 10.1056/NEJMc071717; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nixon LS, 1998, AM J RESP CRIT CARE, V157, P1764, DOI 10.1164/ajrccm.157.6.9704086; NORMAN D, 1991, THORAX, V46, P91, DOI 10.1136/thx.46.2.91; Ordonez CL, 2003, AM J RESP CRIT CARE, V168, P1471, DOI 10.1164/rccm.200306-731OC; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; PECKHAM D, 1994, THORAX, V49, P803, DOI 10.1136/thx.49.8.803; Roderfeld M, 2009, J CYST FIBROS, V8, P338, DOI 10.1016/j.jcf.2009.06.001; Sagel SD, 2015, ANN AM THORAC SOC, V12, P708, DOI 10.1513/AnnalsATS.201410-493OC; Sanders DB, 2015, J CYST FIBROS, V14, P679, DOI 10.1016/j.jcf.2015.10.002; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sanders DB, 2010, PEDIATR PULM, V45, P127, DOI 10.1002/ppul.21117; Sequeiros IM, 2012, CHRON RESP DIS, V9, P9, DOI 10.1177/1479972311433575; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Waters V, 2015, J CYSTIC FIBROSIS OF; Waters V, 2012, J CYST FIBROS, V11, P8, DOI 10.1016/j.jcf.2011.07.008; Waters VJ, 2015, JOURNAL OF CYSTIC FI; WATKIN SL, 1994, PEDIATR PULM, V17, P6, DOI 10.1002/ppul.1950170103; Wojewodka G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088567	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171229	10.1371/journal.pone.0171229	http://dx.doi.org/10.1371/journal.pone.0171229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178305	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500033
J	Drannik, A; Martin, J; Peterson, R; Ma, XX; Jiang, F; Turnbull, J				Drannik, Anna; Martin, Joan; Peterson, Randy; Ma, Xiaoxing; Jiang, Fan; Turnbull, John			Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FRONTOTEMPORAL LOBAR DEGENERATION; MOTONEURON-LIKE CELLS; G93A SOD1 MICE; SPINAL-CORD; NUCLEOCYTOPLASMIC TRANSPORT; MOTOR-NEURONS; GLI PROTEINS; SIGNALING PATHWAY; REPEAT EXPANSION	Sonic hedgehog (Shh) is a morphogen essential to the developing nervous system that continues to play an important role in adult life by contributing to cell proliferation and differentiation, maintaining blood-brain barrier integrity, and being cytoprotective against oxidative and excitotoxic stress, all features of importance in amyotrophic lateral sclerosis (ALS). ALS is a fatal disease characterized by selective loss of motor neurons due to poorly understood mechanisms. Evidence indicates that Shh might play an important role in ALS, and that Shh signaling might be also adversely affected in ALS. Since little is known about the functional status of Shh pathway in patients with ALS, we therefore sought to determine whether Shh protein levels or biological activity in cerebrospinal fluid (CSF) was less in ALS patients than controls, and whether these measures could be correlated with ALS disease severity and disease progression, and with other CSF analytes of biological interest in ALS. Comparing Shh levels in the CSF of normal controls (n = 13), neurological controls (n = 12), and ALS patients (n = 9) measured by ELISA, we found that CSF Shh levels were not different between controls and ALS patients. However, when assessing Shh biological activity in CSF using in vitro cell-based assays, which measure Shh activity as inducible Gli-driven luminescence, we found that in the presence of exogenous recombinant Shh or the Shh agonist, purmorphamine, the inducible activity of CSF was significantly augmented in the control groups as expected, but not in the ALS group, suggesting the presence of an inhibitor of Shh signaling in ALS CSF samples. Since purmorphamine acts on Smoothened, downstream of Shh and its receptor Patched, the inhibitory action is downstream of Smoothened. Our results also demonstrated that while the inhibitory effect of ALS CSF on Shh signaling did not correlate significantly with ALS disease characteristics, the levels of IL-1 beta and TNF-alpha did. In addition to being significantly elevated in ALS CSF, these cytokines negatively correlated with the disease duration, whereas GDF11 was a favorable predictor of ALS clinical score. We also found that TNF-a significantly inhibited Shh biological activity in vitro, potentially suggesting a novel role of TNF-a in ALS pathogenesis. Collectively, this is the first report demonstrating that Shh signaling in CSF of ALS patients is compromised.	[Drannik, Anna; Martin, Joan; Ma, Xiaoxing; Jiang, Fan; Turnbull, John] McMaster Univ, Div Neurol, Dept Med, Hamilton, ON, Canada; [Peterson, Randy] SGS Life Sci Serv Canada, Life Sci Serv, Mississauga, ON, Canada	McMaster University	Turnbull, J (corresponding author), McMaster Univ, Div Neurol, Dept Med, Hamilton, ON, Canada.	turnbull@mcmaster.ca			ALS research at McMaster University	ALS research at McMaster University	This work was undertaken with the support of Mr David Hunt, whose charity has supported ALS research at McMaster University. Mr Hunt has had no role in the study design, data collection, analysis, or preparation of the manuscript.	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Appel S H, 2011, Acta Myol, V30, P4; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Aronica E, 2015, NEUROBIOL DIS, V74, P359, DOI 10.1016/j.nbd.2014.12.002; Babu GN, 2008, NEUROCHEM RES, V33, P1145, DOI 10.1007/s11064-007-9564-x; Beers DR, 2011, BRAIN BEHAV IMMUN, V25, P1025, DOI 10.1016/j.bbi.2010.12.008; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Cohen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7709; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Drannik AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035866; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Furukawa T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000138; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; Garbuzova-Davis S, 2012, BRAIN RES, V1469, P114, DOI 10.1016/j.brainres.2012.05.056; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Gonzalez-Reyes LE, 2012, NEURON, V75, P306, DOI 10.1016/j.neuron.2012.05.018; Hovden H, 2013, ACTA NEUROL SCAND, V128, P287, DOI 10.1111/ane.12125; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097518; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu FL, 2013, INVEST NEW DRUG, V31, P823, DOI 10.1007/s10637-012-9908-5; Ma XX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-119; Ma XX, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-71; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Mir M, 2009, NEUROSCIENCE, V162, P959, DOI 10.1016/j.neuroscience.2009.05.049; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Murdock BJ, 2015, NEUROBIOL DIS, V77, P1, DOI 10.1016/j.nbd.2015.02.017; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Peterson R, 2012, J MOL NEUROSCI, V47, P31, DOI 10.1007/s12031-011-9660-x; Pitter KL, 2014, GLIA, V62, P1595, DOI 10.1002/glia.22702; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Raducu M, 2016, EMBO J, V35, P1400, DOI 10.15252/embj.201593374; Rentzos M, 2010, ACTA NEUROL SCAND, V122, P425, DOI 10.1111/j.1600-0404.2010.01333.x; Sasaki H NY, DEVELOPMENT, DOI [10.1242/JCS.142828, DOI 10.1242/JCS.142828]; Shi Q, 2014, J CELL SCI, V127, P1092, DOI 10.1242/jcs.142828; Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011; Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Vanbekbergen Nele, 2014, BMC Res Notes, V7, P766, DOI 10.1186/1756-0500-7-766; Wang Y, 2008, ANN NEUROL, V64, P417, DOI 10.1002/ana.21457; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhu SL, 2015, RHEUMATOLOGY, V54, P1093, DOI 10.1093/rheumatology/keu421; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	70	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171668	10.1371/journal.pone.0171668	http://dx.doi.org/10.1371/journal.pone.0171668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170441	gold, Green Published, Green Submitted			2022-12-27	WOS:000393705500051
J	Cantor, M; Pires, MM; Marquitti, FMD; Raimundo, RLG; Sebastian-Gonzalez, E; Coltri, PP; Perez, SI; Barneche, DR; Brandt, DYC; Nunes, K; Daura-Jorge, FG; Floeter, SR; Guimaraes, PR				Cantor, Mauricio; Pires, Mathias M.; Marquitti, Flavia M. D.; Raimundo, Rafael L. G.; Sebastian-Gonzalez, Esther; Coltri, Patricia P.; Perez, S. Ivan; Barneche, Diego R.; Brandt, Debora Y. C.; Nunes, Kelly; Daura-Jorge, Fabio G.; Floeter, Sergio R.; Guimaraes, Paulo R., Jr.			Nestedness across biological scales	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; GENETIC-STRUCTURE; POPULATION-SIZE; ARCHITECTURE; COMMUNITIES; SPECIALIZATION; ORGANIZATION; SPLICEOSOME; INTEGRATION; MODULARITY	Biological networks pervade nature. They describe systems throughout all levels of biological organization, from molecules regulating metabolism to species interactions that shape ecosystem dynamics. The network thinking revealed recurrent organizational patterns in complex biological systems, such as the formation of semi-independent groups of connected elements (modularity) and non-random distributions of interactions among elements. Other structural patterns, such as nestedness, have been primarily assessed in ecological networks formed by two non-overlapping sets of elements; information on its occurrence on other levels of organization is lacking. Nestedness occurs when interactions of less connected elements form proper subsets of the interactions of more connected elements. Only recently these properties began to be appreciated in one-mode networks (where all elements can interact) which describe a much wider variety of biological phenomena. Here, we compute nestedness in a diverse collection of one-mode networked systems from six different levels of biological organization depicting gene and protein interactions, complex phenotypes, animal societies, metapopulations, food webs and vertebrate metacommunities. Our findings suggest that nestedness emerge independently of interaction type or biological scale and reveal that disparate systems can share nested organization features characterized by inclusive subsets of interacting elements with decreasing connectedness. We primarily explore the implications of a nested structure for each of these studied systems, then theorize on how nested networks are assembled. We hypothesize that nestedness emerges across scales due to processes that, although system-dependent, may share a general compromise between two features: specificity (the number of interactions the elements of the system can have) and affinity (how these elements can be connected to each other). Our findings suggesting occurrence of nestedness throughout biological scales can stimulate the debate on how pervasive nestedness may be in nature, while the theoretical emergent principles can aid further research on commonalities of biological networks.	[Cantor, Mauricio] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Pires, Mathias M.; Marquitti, Flavia M. D.; Raimundo, Rafael L. G.; Sebastian-Gonzalez, Esther; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Marquitti, Flavia M. D.] Univ Estadual Campinas, Dept Fis Materia Condensada, Campinas, SP, Brazil; [Sebastian-Gonzalez, Esther] Univ Hawaii, Dept Biol, Trop Conservat Biol & Environm Sci, Hilo, HI 96720 USA; [Coltri, Patricia P.] Univ Sao Paulo, Dept Biol Celular & Desenvolvimento, Sao Paulo, Brazil; [Coltri, Patricia P.] Univ Nacl La Plata, Div Antropol, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina; [Perez, S. Ivan] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Barneche, Diego R.] Monash Univ, Sch Biol Sci, Ctr Geometr Biol, Clayton, Vic, Australia; [Brandt, Debora Y. C.; Nunes, Kelly] Univ Sao Paulo, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Cantor, Mauricio; Daura-Jorge, Fabio G.; Floeter, Sergio R.] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Raimundo, Rafael L. G.] Univ Fed Paraiba, Ctr Ciencias Aplicadas & Educ, Dept Engn & Meio Ambiente, Rio Tinto, Paraiba, Brazil	Dalhousie University; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Hawaii System; University Hawaii Hilo; Universidade de Sao Paulo; National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Monash University; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC); Universidade Federal da Paraiba	Cantor, M (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.; Cantor, M (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil.	m.cantor@ymail.com	, Mauricio/E-6171-2012; Coltri, Patricia P./E-6294-2014; Marquitti, Flavia Maria/B-2697-2013; Guimarães-Junior, Paulo R/M-1298-2016; Raimundo, Rafael L. G./AAU-2695-2021; Raimundo, R./F-5083-2012; Guimaraes, Paulo R./E-1915-2016; Sebastián-González, Esther/J-7883-2012; Floeter, S. R./B-1438-2012; Nunes, Kelly/AAU-6879-2021; Pires, Mathias/I-4489-2012	, Mauricio/0000-0002-0019-5106; Coltri, Patricia P./0000-0001-8447-7516; Marquitti, Flavia Maria/0000-0003-0510-3992; Raimundo, Rafael L. G./0000-0001-8166-3241; Raimundo, R./0000-0001-8166-3241; Guimaraes, Paulo R./0000-0001-9161-8305; Sebastián-González, Esther/0000-0001-7229-1845; Floeter, S. R./0000-0002-3201-6504; Nunes, Kelly/0000-0003-0864-2414; Pires, Mathias/0000-0003-2500-4748; Daura-Jorge, Fabio/0000-0003-2923-1446; Barneche, Diego/0000-0002-4568-2362; Yoshihara Caldeira Brandt, Debora/0000-0002-9565-7835	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [202581/2011-0, 474672/2013-1, 407190/2012-0, 563276/2010-0]; Sao Paulo Research Foundation [2013/22016-6, 2011/11346-0, 2015/11985-3, 2011/13054-6, 2014/21106-4, 2011/17968, 2012/09950-9, 2012/ 22796-9, 2013/02738-7, 2009/54422-8]; Killam Trusts; Evaluation of Graduate Education within the Ministry of Education of Brazil; Fundacao de Amparo a Pesquisa e Inovagao do Estado de Santa Catarina through SISBIOTA-Mar [6308/2011-8, TR2012000295]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Killam Trusts; Evaluation of Graduate Education within the Ministry of Education of Brazil; Fundacao de Amparo a Pesquisa e Inovagao do Estado de Santa Catarina through SISBIOTA-Mar(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	Grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http:// cnpq.bri) supported MC (#202581/2011-0), PC (#474672/2013-1), FGDJ (#407190/2012-0), SRF (#563276/2010-0), and PRGJr; Grants from the Sao Paulo Research Foundation (http://www. fapesp.brien/) supported MMP (#2013/22016-6), FMDM (#2011/11346-0, #2015/11985-3), RLGR (#2011/13054-6, #2014/21106-4), ESG (#2011/17968), KN (#2012/09950-9), DYCB (#2012/ 22796-9), PC (#2013/02738-7) and PRGJr (#2009/54422-8); Grant from Killam Trusts (ht :/hen killamlaureates.ca) supported MC. The Brazilian Federal Agency for Support and Evaluation of Graduate Education within the Ministry of Education of Brazil (http://www.capes.gov.br) supported RLGR; Grants from Fundacao de Amparo a Pesquisa e Inovagao do Estado de Santa Catarina (http://www.fapesc.sc.gov.br) through SISBIOTA-Mar supported SRF (#6308/2011-8) and FGDJ (#TR2012000295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baalsrud HT, 2014, MOL ECOL, V23, P2653, DOI 10.1111/mec.12770; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barneche DR, 2014, ECOL LETT, V17, P1067, DOI 10.1111/ele.12309; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bender MG, 2013, GLOBAL ECOL BIOGEOGR, V22, P1173, DOI 10.1111/geb.12099; Bender MG, 2016, ECOGRAPHY; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Cantor M, 2012, ANIM BEHAV, V84, P641, DOI 10.1016/j.anbehav.2012.06.019; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Coltri PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045678; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Dunne JA, 2006, SFI S SCI C, P27; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Gomez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016143; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Holekamp KE, 2011, SOC DEMOGRAPHY GENET; Howells W. W., 1973, PAPERS PEABODY MUSEU, V67; Perez SI, 2009, EVOL BIOL, V36, P416, DOI 10.1007/s11692-009-9074-7; Jonhson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074025; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kulbicki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081847; Lee DS, 2012, J KOREAN PHYS SOC, V60, P648, DOI 10.3938/jkps.60.648; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Lobato FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102094; Lorenz DM, 2011, PHYS LIFE REV, V8, P129, DOI 10.1016/j.plrev.2011.02.003; Luz JS, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-22; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Neutel AM, 2007, NATURE, V449, P599, DOI 10.1038/nature06154; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Pascual M., 2005, ECOLOGICAL NETWORKS; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Pires MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14865; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rooney N, 2012, TRENDS ECOL EVOL, V27, P40, DOI 10.1016/j.tree.2011.09.001; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; SLATKIN M, 1995, GENETICS, V139, P457; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strona G, 2015, METHODS ECOL EVOL, V6, P907, DOI 10.1111/2041-210X.12395; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Tufto J, 2005, AM NAT, V165, pE13, DOI 10.1086/426698; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Valtonen ET, 2001, PARASITOLOGY, V122, P471, DOI 10.1017/S0031182001007491; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang S, 2013, POPULATION SIZE TIME; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wang SP, 2014, MOL ECOL, V23, P637, DOI 10.1111/mec.12634; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x	79	32	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171691	10.1371/journal.pone.0171691	http://dx.doi.org/10.1371/journal.pone.0171691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166284	gold, Green Published			2022-12-27	WOS:000393700100062
J	Librero, J; Ibanez, B; Martinez-Lizaga, N; Peiro, S; Bernal-Delgado, E				Librero, Julian; Ibanez, Berta; Martinez-Lizaga, Natalia; Peiro, Salvador; Bernal-Delgado, Enrique		Spanish Atlas Med Practice Variati	Applying spatio-temporal models to assess variations across health care areas and regions: Lessons from the decentralized Spanish National Health System	PLOS ONE			English	Article							DISEASE; PERFORMANCE	Objective To illustrate the ability of hierarchical Bayesian spatio-temporal models in capturing different geo-temporal structures in order to explain hospital risk variations using three different conditions: Percutaneous Coronary Intervention (PCI), Colectomy in Colorectal Cancer (CCC) and Chronic Obstructive Pulmonary Disease (COPD). Research design This is an observational population-based spatio-temporal study, from 2002 to 2013, with a two-level geographical structure, Autonomous Communities (AC) and Health Care Areas (HA). Setting The Spanish National Health System, a quasi-federal structure with 17 regional governments (AC) with full responsibility in planning and financing, and 203 HA providing hospital and primary care to a defined population. Methods A poisson-log normal mixed model in the Bayesian framework was fitted using the INLA efficient estimation procedure. Measures The spatio-temporal hospitalization relative risks, the evolution of their variation, and the relative contribution (fraction of variation) of each of the model components (AC, HA, year and interaction AC-year). Results Following PCI-CCC-CODP order, the three conditions show differences in the initial hospitalization rates (from 4 to 21 per 10,000 person-years) and in their trends (upward, inverted V shape, downward). Most of the risk variation is captured by phenomena occurring at the HA level (fraction variance: 51.6, 54.7 and 56.9%). At AC level, the risk of PCI hospitalization follow a heterogeneous ascending dynamic (interaction AC-year: 17.7%), whereas in COPD the AC role is more homogenous and important (37%). Conclusions In a system where the decisions loci are differentiated, the spatio-temporal modeling allows to assess the dynamic relative role of different levels of decision and their influence on health outcomes.	[Librero, Julian; Ibanez, Berta] Navarrabiomed Fdn Miguel Servet, Pamplona, Spain; [Librero, Julian; Ibanez, Berta; Martinez-Lizaga, Natalia; Peiro, Salvador; Bernal-Delgado, Enrique] Red Invest Serv Salud Enfermedades Cron REDISSEC, Bilbao, Spain; [Martinez-Lizaga, Natalia; Bernal-Delgado, Enrique] IIS Aragon, Inst Aragones Ciencias Salud, Zaragoza, Spain; [Peiro, Salvador] Ctr Super Invest Salud Publ CSISP FISABIO, Valencia, Spain	Navarrabiomed	Ibanez, B (corresponding author), Navarrabiomed Fdn Miguel Servet, Pamplona, Spain.; Ibanez, B (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Bilbao, Spain.	berta.ibanez.beroiz@navarra.es	Librero, Julian/F-4947-2017; Peiro, Salvador/H-5778-2017; Lizaga, Natalia Martínez/C-9945-2019; Ibáñez, Berta/A-6924-2017	Librero, Julian/0000-0002-4859-9054; Peiro, Salvador/0000-0002-3902-569X; Lizaga, Natalia Martínez/0000-0002-9586-7955; Ibáñez, Berta/0000-0002-7797-4845; BERNAL-DELGADO, ENRIQUE/0000-0002-0961-3298	Institute de Salud Carlos III [PI08/90255, PI10/00494, PI14/00786]; Spanish thematic network Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC from the Institute de Salud Carlos III, Spanish Ministry of Health) [RD12/0001]; European Regional Development Fund	Institute de Salud Carlos III(Instituto de Salud Carlos III); Spanish thematic network Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC from the Institute de Salud Carlos III, Spanish Ministry of Health); European Regional Development Fund(European Commission)	This study is part of the Atlas of Medical Practice Variation in the Spanish National Health System research project, funded by the Institute de Salud Carlos III (Grants PI08/90255, PI10/00494, PI14/00786), and the Spanish thematic network Red de Investigacion en Servicios de Salud en Enfermedades Cronicas (REDISSEC, grant RD12/0001 from the Institute de Salud Carlos III, Spanish Ministry of Health, co-financed by the European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2016, SPAT SPATIO-TEMPORAL, V16, P11, DOI 10.1016/j.sste.2015.11.005; Bernal-Delgado E, 2015, EUR J PUBLIC HEALTH, V25, P3, DOI 10.1093/eurpub/cku219; Blangiardo M, SPATIAL SPATIOTEMPOR, V7, P39; Garcia-Armesto Sandra, 2010, Health Syst Transit, V12, P1; Gillum RF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-410; Hakkinen U, 2013, HEALTH POLICY, V112, P100, DOI 10.1016/j.healthpol.2013.04.013; Ibanez B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-60; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Lawson AB, 2010, STAT MED, V29, P2012, DOI 10.1002/sim.3917; Martin-Moreno JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1170; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; Mohan AV, 2014, CIRC-CARDIOVASC QUAL, V7, P125, DOI 10.1161/CIRCOUTCOMES.113.000282; OECD, 2014, OECD HLTH POL STUD; Richardson S, 2006, STAT METHODS MED RES, V15, P385, DOI 10.1191/0962280206sm458oa; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Ugarte MD, 2015, CANCER EPIDEMIOL, V39, P480, DOI 10.1016/j.canep.2015.03.013; Ugarte MD, 2009, ENVIRONMETRICS, V20, P647, DOI 10.1002/env.969; Waller LA, 1997, J AM STAT ASSOC, V92, P607, DOI 10.2307/2965708	21	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170480	10.1371/journal.pone.0170480	http://dx.doi.org/10.1371/journal.pone.0170480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166233	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100009
J	Britton, GJ; Mitchell, RE; Burton, BR; Wraith, DC				Britton, Graham J.; Mitchell, Ruth E.; Burton, Bronwen R.; Wraith, David C.			Protein kinase C theta is required for efficient induction of IL-10-secreting T cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIGEN-SPECIFIC IMMUNOTHERAPY; PKC-THETA; TRANSPLANT RECIPIENTS; REGULATORY CELLS; IN-VIVO; IL-10; EXPRESSION; DIFFERENTIATION; SOTRASTAURIN	Secretion of interleukin-10 (IL-10) by CD4(+) T cells is an essential immunoregulatory mechanism. The work presented here assesses the role of the signaling molecule protein kinase C theta (PKC theta) in the induction of IL-10 expression in CD4(+) T cells. Using wildtype and PKC theta-deficient Tg4 T cell receptor transgenic mice, we implemented a well-described protocol of repeated doses of myelin basic protein (MBP) Ac1-9[4Y] antigen to induce Tr1-like IL-10(+) T cells. We find that PKC theta is required for the efficient induction of IL-10 following antigen administration. Both serum concentrations of IL-10 and the proportion of IL-10(+) T cells were reduced in PKC theta-deficient mice relative to wildtype mice following [4Y] treatment. We further characterized the T cells of [4Y] treated PKC theta-deficient Tg4 mice and found reduced expression of the transcription factors cMaf, Nfil3 and FoxP3 and the surface receptors PD-1 and Tim3, all of which have been associated with the differentiation or function of IL-10(+) T cells. Finally, we demonstrated that, unlike [4Y] treated wildtype Tg4 T cells, cells from PKC theta-deficient mice were unable to suppress the priming of naive T cells in vitro and in vivo. In summary, we present data demonstrating a role for PKC theta in the induction of suppressive, IL-10-secreting T cells induced in TCR-transgenic mice following chronic antigen administration. This should be considered when contemplating PKC theta as a suitable drug target for inducing immune suppression and graft tolerance.	[Britton, Graham J.; Mitchell, Ruth E.; Burton, Bronwen R.; Wraith, David C.] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Britton, Graham J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Wraith, David C.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Bristol; Icahn School of Medicine at Mount Sinai; University of Birmingham	Wraith, DC (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.; Wraith, DC (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.	D.Wraith@bham.ac.uk	Britton, Graham/CAI-2177-2022; Britton, Graham/V-1370-2019	Britton, Graham/0000-0003-4630-1223; Wraith, David/0000-0003-2147-5614	Wellcome Trust; Medical Research Council; GB; MRC [MR/K007645/1] Funding Source: UKRI; Medical Research Council [MR/K007645/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GB; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust, Medical Research Council, GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 2014, DRUG DISCOV TODAY, V19, P1217, DOI 10.1016/j.drudis.2014.05.008; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Burkhart C, 1999, INT IMMUNOL, V11, P1625, DOI 10.1093/intimm/11.10.1625; Burton BR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5741; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chand S, 2012, CURR PHARM DESIGN, V18, P4725, DOI 10.2174/138161212802651625; Friman S, 2011, AM J TRANSPLANT, V11, P1444, DOI 10.1111/j.1600-6143.2011.03538.x; Gabrysova L, 2010, EUR J IMMUNOL, V40, P1386, DOI 10.1002/eji.200940151; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Kwon Myung-Ja, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P367; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Morley SC, 2008, J IMMUNOL, V181, P4696, DOI 10.4049/jimmunol.181.7.4696; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Nicolson KS, 2006, J IMMUNOL, V176, P5329, DOI 10.4049/jimmunol.176.9.5329; Pfeifhofer-Obermair C, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0137-y; Sabatos-Peyton CA, 2010, CURR OPIN IMMUNOL, V22, P609, DOI 10.1016/j.coi.2010.08.006; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Tedesco-Silva H, 2013, AM J TRANSPLANT, V13, P1757, DOI 10.1111/ajt.12255; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Yang MX, 2015, J EXP MED, V212, P253, DOI 10.1084/jem.20141703; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171547	10.1371/journal.pone.0171547	http://dx.doi.org/10.1371/journal.pone.0171547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158245	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700097
J	Chew, F; Wu, XW				Chew, Fiona; Wu, Xianwei			Sources of information influencing the state-of-the-science gap in hormone replacement therapy usage	PLOS ONE			English	Article							HEALTH INITIATIVE TRIAL; CORONARY-HEART-DISEASE; OBSTETRICIAN-GYNECOLOGISTS; POSTMENOPAUSAL WOMEN; NEWSPAPER COVERAGE; PRIMARY PREVENTION; TIMING HYPOTHESIS; PRACTICE PATTERNS; PARADIGM SHIFT; ATTITUDES	Objective Medical reviews and research comprise a key information source for news media stories on medical therapies and innovations as well as for physicians in updating their practice. The present study examined medical review journal articles, physician surveys and news media coverage of hormone replacement therapy (HT) to assess the relationship between the three information sources and whether/if they contributed to a state-of-the-science gap (a condition when the evaluation of a medical condition or therapy ascertained by the highest standards of investigation is incongruent with the science-in-practice such as physician recommendations and patient actions). Methods We content-analyzed 177 randomly sampled HT medical reviews between 2002 and 2014, and HT news valence in three major TV networks, newspapers and magazines/internet sites in 2002-2003, 2008-2009 and 2012-14. The focus in both analyses was whether HT benefits outweighed risks, risks outweighed benefits or both risks and benefits were presented. We also qualitatively content-analyzed all 19 surveys of US physicians' HT recommendations from 2002 to 2009, and 2012 to 2014. Results Medical reviews yielded a mixed picture about HT (40.1% benefits, 26.0% risks, and 33.9% both benefits and risks). While a majority of physician surveys were pro-HT 10/19), eight showed varied attitudes and one was negative. Newspaper and television coverage reflected a pro and con balance while magazine stories were more positive in the later reporting period. Conclusion Medical journal review articles, physicians, and media reports all provide varying view points towards hormone therapy use thus leading to limited knowledge about the actual risks and benefits of HT among peri-and menopausal women and a state-of-the-science gap.	[Chew, Fiona] Syracuse Univ, SI Newhouse Sch Publ Commun, Syracuse, NY USA; [Wu, Xianwei] Univ Iowa, Sch Journalism & Mass Commun, Iowa City, IA USA	Syracuse University; University of Iowa	Chew, F (corresponding author), Syracuse Univ, SI Newhouse Sch Publ Commun, Syracuse, NY USA.	cmrfchew@syr.edu						[Anonymous], 2012, MONDAYMORNING   0625; [Anonymous], 2010, NAT AMB MED CAR SURV; Audit Bureau of Circulation, 2010, AV CIRC US NEWSP; Birkhauser MH, 2008, CLIMACTERIC, V11, P192, DOI 10.1080/13697130802060455; Breslau Erica S, 2003, J Am Med Womens Assoc (1972), V58, P33; Brett AS, 2005, J GEN INTERN MED, V20, P416, DOI 10.1111/j.1525-1497.2005.0089.x; Chew F, 2004, FAM MED, V36, P645; Chew F, 1995, PUBLIC UNDERST SCI, V4, P17; Chew F, 2006, SCI COMMUN, V27, P1; Christian AH, 2007, J WOMENS HEALTH, V16, P68, DOI 10.1089/jwh.2006.M072; Coomarasamy A, 2001, Health Info Libr J, V18, P183, DOI 10.1046/j.1365-2532.2001.00349.x; Devi Gayatri, 2013, Menopause Int, V19, P121, DOI 10.1177/1754045313478941; Dutta-Bergman MJ, 2004, HEALTH COMMUN, V16, P273, DOI 10.1207/S15327027HC1603_1; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Food and Drug Administration, 2009, QUEST ANSW ESTR ESTR; Fugh-Berman A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000425; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Gallup, 2002, AM RAT CONF DOCT; Gurney EP, 2014, J STEROID BIOCHEM, V142, P4, DOI 10.1016/j.jsbmb.2013.10.009; Haas JS, 2007, J GEN INTERN MED, V22, P68, DOI 10.1007/s11606-007-0122-7; Haas JS, 2006, J GEN INTERN MED, V21, P304, DOI 10.1111/j.1525-1497.2006.00342.x; Henwood F, 2003, SOCIOL HEALTH ILL, V25, P589, DOI 10.1111/1467-9566.00360; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Hing E, 2006, OBSTET GYNECOL, V108, P33, DOI 10.1097/01.AOG.0000220502.77153.5a; Hodis HN, 2014, J STEROID BIOCHEM, V142, P68, DOI 10.1016/j.jsbmb.2013.06.011; Hodis HN, 2013, J AM GERIATR SOC, V61, P1011, DOI 10.1111/jgs.12281; Hodis HN, 2013, J AM GERIATR SOC, V61, P1005, DOI 10.1111/jgs.12140; Hou NQ, 2013, JNCI-J NATL CANCER I, V105, P1365, DOI 10.1093/jnci/djt207; Huston SA, 2009, WOMEN HEALTH ISS, V19, P144, DOI 10.1016/j.whi.2009.01.004; Jones Teresa H, 2007, BMC Pediatr, V7, P1, DOI 10.1186/1471-2431-7-1; Kahn C, 2001, Mark Health Serv, V21, P12; Kelly JP, 2005, PHARMACOEPIDEM DR S, V14, P837, DOI 10.1002/pds.1103; Kiatpongsan S, 2014, MENOPAUSE, V21, P33, DOI [10.1097/gme.0000000000000129, 10.1097/GME.0000000000000129]; Kim N, 2005, J GEN INTERN MED, V20, P1026, DOI 10.1111/j.1525-1497.2005.0221.x; Kosteniuk JG, 2013, J MED LIBR ASSOC, V101, P32, DOI 10.3163/1536-5050.101.1.006; Langer RD, 2012, CLIMACTERIC, V15, P206, DOI 10.3109/13697137.2012.666916; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; McIntosh J, 2005, AM J HEALTH-SYST PH, V62, P1031, DOI [10.1111/j.1525-1497.2005.0221.x, DOI 10.1111/J.1525-1497.2005.0221.X]; Morgan MA, 2010, OBSTET GYNECOL, V116, P715, DOI 10.1097/AOG.0b013e3181eeb630; MRI+, 2009, AUD SURV REP; Neuendorf K. A, 2002, CONTENT ANAL GUIDEBO; Newton KM, 2010, MENOPAUSE, V17, P734, DOI 10.1097/gme.0b013e3181d2ce57; North American Menopause Society, 2012, OV MEN; Power ML, 2008, MED DECIS MAKING, V28, P411, DOI 10.1177/0272989X07312722; Power ML, 2007, MENOPAUSE, V14, P20, DOI 10.1097/01.gme.0000229571.44505.cb; Power ML, 2006, J REPROD MED, V51, P525; Power ML, 2009, MENOPAUSE, V16, P500, DOI 10.1097/gme.0b013e31818fc36e; Power ML, 2006, MENOPAUSE, V13, P434, DOI 10.1097/01.gme.0000185753.77704.65; Rigby AJ, 2007, MENOPAUSE, V14, P853, DOI 10.1097/gme.0b013e3180333a33; Rolnick SJ, 2005, MENOPAUSE, V12, P399, DOI 10.1097/01.GME.0000148644.55486.36; Rossouw JE, 2013, OBSTET GYNECOL, V121, P172, DOI [10.1097/AOG.0b013e31827a08c8, http://10.1097/AOG.0b013e31827a08c8]; Rossouw JE, 2002, J HYPERTENS, V20, pS62; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schwitzer G, 2005, PLOS MED, V2, P576, DOI 10.1371/journal.pmed.0020215; Seagram B., 2003, GREATEST EXPT EVER P; Singer N., 2009, NY TIMES; Stevenson JC, 2013, MATURITAS, V76, P10, DOI 10.1016/j.maturitas.2013.05.018; Tsai SA, 2011, MENOPAUSE, V18, P385, DOI 10.1097/gme.0b013e3181f43404; TVbythenumbers.com, 2011, WORLD NEWS DIAN SAW; USPSTF, 2012, FIN REC STAT MEN HOR; Verschoor CC, 2012, STRATEGIC FINANC AUG, P11; Viera AJ, 2005, FAM MED, V37, P360; Wathen CN, 2006, J HEALTH COMMUN, V11, P477, DOI 10.1080/10810730600751979; Wilson RA, 1966, FEMININE FOREVER	65	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171189	10.1371/journal.pone.0171189	http://dx.doi.org/10.1371/journal.pone.0171189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158240	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700039
J	Sidova, V; Zoufaly, P; Pokorny, J; Dzubak, P; Hajduch, M; Popa, I; Urban, M				Sidova, Veronika; Zoufaly, Pavel; Pokorny, Jan; Dzubak, Petr; Hajduch, Marian; Popa, Igor; Urban, Milan			Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives	PLOS ONE			English	Article							POTENTIAL ANTICANCER AGENTS; BIOLOGICAL EVALUATION; PENTACYCLIC TRITERPENOIDS; LUPANE TRITERPENOIDS; ANTITUMOR-ACTIVITY; BETULONIC ACID; CANCER-CELLS; DERIVATIVES; SAPONINS; HEDERAGENIN	In this work, we describe synthesis of conjugates of betulinic acid with substituted triazoles prepared via Huisgen 1,3-cycloaddition. All compounds contain free 28-COOH group. Allylic bromination of protected betulinic acid by NBS gave corresponding 30-bromoderivatives, their substitution with sodium azides produced 30-azidoderivatives and these azides were subjected to Cu-I catalysed Huisgen 1,3-cycloaddition to give the final conjugates. Reactions had moderate to high yields. All new compounds were tested for their in vitro cytotoxic activities on eight cancer and two non-cancer cell lines. The most active compounds were conjugates of 3 beta-O-acetylbetulinic acid and among them, conjugate with triazole substituted by benzaldehyde 9b was the best with IC50 of 3.3 mu M and therapeutic index of 9.1. Five compounds in this study had IC50 below 10 mu M and inhibited DNA and RNA synthesis and caused block in G0/G1 cell cycle phase which is highly similar to actinomycin D. It is unusual that here prepared 3 beta-O-acetates were more active than compounds with the free 3-OH group and this suggests that this set may have common mechanism of action that is different from the mechanism of action of previously known 3 beta-O-acetoxybetulinic acid derivatives. Benzaldehyde type conjugate 9b is the best candidate for further drug development.	[Sidova, Veronika; Zoufaly, Pavel; Pokorny, Jan; Popa, Igor; Urban, Milan] Palacky Univ, Fac Sci, Dept Organ Chem, Olomouc, Czech Republic; [Dzubak, Petr; Hajduch, Marian; Popa, Igor; Urban, Milan] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Urban, M (corresponding author), Palacky Univ, Fac Sci, Dept Organ Chem, Olomouc, Czech Republic.; Urban, M (corresponding author), Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.	milan.urban@gmail.com	Hajduch, Marian/J-4015-2014; Urban, Milan/C-9611-2010; Urban, Milan/AAW-4540-2020; Dzubak, Petr/D-2175-2013	Hajduch, Marian/0000-0002-4834-908X; Urban, Milan/0000-0002-8249-028X; Urban, Milan/0000-0002-8249-028X; Pokorny, Jan/0000-0001-9265-8608; Dzubak, Petr/0000-0002-3098-5969	Czech Science Foundation [15-05620S]; Palacky University [IGA_PrF_2016_020, IGA_LF_2016_19]; Technology Agency of the Czech Republic [TE01020028]; National Sustainability Programme [LO1304]	Czech Science Foundation(Grant Agency of the Czech Republic); Palacky University; Technology Agency of the Czech Republic; National Sustainability Programme	All material, chemicals, and small equipment for both chemistry and biology was paid by Czech Science Foundation (15-05620S); stipendia to students were paid by internal grants of Palacky University IGA_PrF_2016_020, IGA_LF_2016_19. Starting terpenes were paid from the Technology Agency of the Czech Republic (TE01020028). The infrastructural part (Institute of Molecular and Translational Medicine) is supported by the National Sustainability Programme (LO1304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antimonova AN, 2013, CHEM NAT COMPD+, V49, P657, DOI 10.1007/s10600-013-0702-1; Borkova L, 2016, EUR J MED CHEM, V121, P120, DOI 10.1016/j.ejmech.2016.05.029; Borkova L, 2015, EUR J MED CHEM, V96, P482, DOI 10.1016/j.ejmech.2015.03.068; Bourderioux A, 2011, J MED CHEM, V54, P5498, DOI 10.1021/jm2005173; Chakraborty B, 2015, EUR J MED CHEM, V102, P93, DOI 10.1016/j.ejmech.2015.07.035; Chianese G, 2010, J NAT PROD, V73, P1448, DOI 10.1021/np100325q; Csuk R, 2012, EUR J MED CHEM, V53, P337, DOI 10.1016/j.ejmech.2012.04.023; Csuk R, 2011, ARCH PHARM, V344, P37, DOI 10.1002/ardp.201000232; Csuk R, 2010, BIOORGAN MED CHEM, V18, P7252, DOI 10.1016/j.bmc.2010.08.023; Dalvie DK, 2002, CHEM RES TOXICOL, V15, P269, DOI 10.1021/tx015574b; Dang Z, 2013, J MED CHEM, V56, P2029, DOI 10.1021/jm3016969; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Flekhter O. B., 2000, RUSS J BIOORG CHEM+, V26, P192, DOI DOI 10.1007/BF02786345; Fu YH, 2014, FEBS J, V281, P2543, DOI 10.1111/febs.12801; Gao J, 2012, BIOORG MED CHEM LETT, V22, P2396, DOI 10.1016/j.bmcl.2012.02.032; Gauthier C, 2009, J NAT PROD, V72, P72, DOI 10.1021/np800579x; Ghosh P, 2011, INDIAN J CHEM B, V50, P1519; Govdi AI, 2011, RUSS CHEM B+, V60, P2401, DOI 10.1007/s11172-011-0369-3; Govdi AI, 2015, MEDCHEMCOMM, V6, P230, DOI 10.1039/c4md00236a; Gruza M, 2014, ACTA POL PHARM, V71, P959; Hill RA, 2015, NAT PROD REP, V32, P273, DOI 10.1039/c4np00101j; Innocente A, 2014, CHEM BIOL DRUG DES, V83, P344, DOI 10.1111/cbdd.12251; Khan I, 2016, EUR J MED CHEM, V108, P104, DOI 10.1016/j.ejmech.2015.11.018; Kim DSHL, 1998, BIOORG MED CHEM LETT, V8, P1707, DOI 10.1016/S0960-894X(98)00295-9; Kim HK, 2005, INT J BIOCHEM CELL B, V37, P1921, DOI 10.1016/j.biocel.2005.04.015; Kommera H, 2010, EUR J MED CHEM, V45, P3346, DOI 10.1016/j.ejmech.2010.04.018; Kvasnica M, 2015, NAT PROD REP, V32, P1303, DOI 10.1039/c5np00015g; Leunis JC, 2013, Betulonic and Betulinic Acid Derivatives, Patent No. 8586569; Majeed R, 2013, EUR J MED CHEM, V63, P782, DOI 10.1016/j.ejmech.2013.03.028; Morikawa T, 2014, PHYTOCHEMISTRY, V102, P169, DOI 10.1016/j.phytochem.2014.03.002; Noskova V, 2002, NEOPLASMA, V49, P418; Parida PK, 2014, BIOORG MED CHEM LETT, V24, P3865, DOI 10.1016/j.bmcl.2014.06.054; Patro JN, 2009, BIOCHEMISTRY-US, V48, P8271, DOI 10.1021/bi900777s; Qian KD, 2011, BIOORG MED CHEM LETT, V21, P5944, DOI 10.1016/j.bmcl.2011.07.072; Rashid S, 2013, EUR J MED CHEM, V66, P238, DOI 10.1016/j.ejmech.2013.05.029; Rodriguez-Hernandez D, 2016, EUR J MED CHEM, V124, P153, DOI 10.1016/j.ejmech.2016.08.030; Rodriguez-Hernandez D, 2016, EUR J MED CHEM, V115, P257, DOI 10.1016/j.ejmech.2016.03.018; Sanchez-Quesada C, 2013, J AGR FOOD CHEM, V61, P12173, DOI 10.1021/jf403154e; Sarek J, 2010, CANCER ETIOL DIAGN T, P159; Shi W, 2015, J ASIAN NAT PROD RES, V17, P159, DOI 10.1080/10286020.2014.979164; Soural M, 2015, BIOCONJUGATE CHEM, V26, P2563, DOI 10.1021/acs.bioconjchem.5b00567; Spivak AY, 2016, TETRAHEDRON, V72, P1249, DOI 10.1016/j.tet.2016.01.024; Srinivasan T, 2002, BIOORG MED CHEM LETT, V12, P2803, DOI 10.1016/S0960-894X(02)00623-6; Ngoc TD, 2014, BIOORGAN MED CHEM, V22, P3292, DOI 10.1016/j.bmc.2014.04.061; Thi TAD, 2014, BIOORG MED CHEM LETT, V24, P5190, DOI 10.1016/j.bmcl.2014.09.079; Urban M, 2005, BIOORGAN MED CHEM, V13, P5527, DOI 10.1016/j.bmc.2005.07.011; Urban M., 2015, TERPENOIDS SQUALENE, P25; Urban M, 2006, SYNTHESIS-STUTTGART, P3979, DOI 10.1055/s-2006-950327; Urban M, 2007, J NAT PROD, V70, P526, DOI 10.1021/np060436d; Urban M, 2012, BIOORGAN MED CHEM, V20, P3666, DOI 10.1016/j.bmc.2012.03.066; Uzenkova NV, 2005, CHEM NAT COMPD+, V41, P692, DOI 10.1007/s10600-006-0014-9; Vasilevsky SF, 2011, BIOORG MED CHEM LETT, V21, P62, DOI 10.1016/j.bmcl.2010.11.072; Vlk M, 2016, J RADIOANAL NUCL CH, V308, P733, DOI 10.1007/s10967-015-4479-5; Pertino MW, 2013, MOLECULES, V18, P7661, DOI 10.3390/molecules18077661; Waring MJ, 2010, EXPERT OPIN DRUG DIS, V5, P235, DOI 10.1517/17460441003605098; Wei GF, 2015, ORG BIOMOL CHEM, V13, P1507, DOI 10.1039/c4ob01605j; Willmann M, 2009, EUR J CLIN INVEST, V39, P384, DOI 10.1111/j.1365-2362.2009.02105.x; Xu J, 2012, J MED CHEM, V55, P3122, DOI 10.1021/jm201540h; YANO S, 1989, CHEM PHARM BULL, V37, P2500, DOI 10.1248/cpb.37.2500; Zhang LY, 2014, CHEM BIOL DRUG DES, V83, P297, DOI 10.1111/cbdd.12241; Zuo WJ, 2011, PLANTA MED, V77, P1835, DOI 10.1055/s-0030-1271164	61	26	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171621	10.1371/journal.pone.0171621	http://dx.doi.org/10.1371/journal.pone.0171621			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158265	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700114
J	Solis-Lopez, A; Kriebs, U; Marx, A; Mannebach, S; Liedtke, WB; Caterina, MJ; Freichel, M; Tsvilovskyy, VV				Solis-Lopez, A.; Kriebs, U.; Marx, A.; Mannebach, S.; Liedtke, W. B.; Caterina, M. J.; Freichel, M.; Tsvilovskyy, V. V.			Analysis of TRPV channel activation by stimulation of FC epsilon RI and MRGPR receptors in mouse peritoneal mast cells	PLOS ONE			English	Article							MICE LACKING; PHYSICAL STIMULI; GENE-EXPRESSION; CATION CHANNELS; HOMEOSTASIS; RESPONSES; RELEASE; CALCIUM; MODEL; PAIN	The activation of mast cells (MC) is part of the innate and adaptive immune responses and depends on Ca2+ entry across the plasma membrane, leading to the release of preformed inflammatory mediators by degranulation or by de novo synthesis. The calcium conducting channels of the TRPV family, known by their thermo and osmotic sensitivity, have been proposed to be involved in the MC activation in murine, rat, and human mast cell models. So far, immortalized mast cell lines and nonspecific TRPV blockers have been employed to characterize the role of TRPV channels in MC. The aim of this work was to elucidate the physiological role of TRPV channels by using primary peritoneal mast cells (PMCs), a model of connective tissue type mast cells. Our RT-PCR and NanoString analysis identified the expression of TRPV1, TRPV2, and TRPV4 channels in PMCs. For determination of the functional role of the expressed TRPV channels we performed measurements of intracellular free Ca2+ concentrations and beta-hexosaminidase release in PMCs obtained from wild type and mice deficient for corresponding TRPV1, TRPV2 and TRPV4 in response to various receptor-mediated and physical stimuli. Furthermore, substances known as activators of corresponding TRPV-channels were also tested using these assays. Our results demonstrate that TRPV1, TRPV2, and TRPV4 do not participate in activation pathways triggered by activation of the high-affinity receptors for IgE (Fc epsilon RI), Mrgprb2 receptor, or Endothelin-1 receptor nor by heat or osmotic stimulation in mouse PMCs.	[Solis-Lopez, A.; Kriebs, U.; Marx, A.; Freichel, M.; Tsvilovskyy, V. V.] Heidelberg Univ, Inst Pharmakol, Heidelberg, Baden Wurttembe, Germany; [Mannebach, S.] Univ Saarland, Expt & Klin Pharmakol & Toxikol, Homburg, Saarland, Germany; [Liedtke, W. B.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Caterina, M. J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosurg, Baltimore, MD USA; [Caterina, M. J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Biol Chem, Baltimore, MD USA; [Caterina, M. J.] Johns Hopkins Sch Med, Neurosurg Pain Res Inst, Dept Neurosci, Baltimore, MD USA	Ruprecht Karls University Heidelberg; Saarland University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Tsvilovskyy, VV (corresponding author), Heidelberg Univ, Inst Pharmakol, Heidelberg, Baden Wurttembe, Germany.	volodymyr.tsvilovskyy@pharma.uni-heidelberg.de	Liedtke, Wolfgang/GNH-1878-2022		German Academic Exchange Service, DAAD; DFG Priority Programme [1394]; Transregional Collaborative Research Centre (TR-SFB) [152]	German Academic Exchange Service, DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); DFG Priority Programme(German Research Foundation (DFG)); Transregional Collaborative Research Centre (TR-SFB)	This work was supported by the German Academic Exchange Service, DAAD (PhD scholarship for AS), by the DFG Priority Programme 1394 (MF) and by the Transregional Collaborative Research Centre (TR-SFB) 152 (MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Bevan S, 2014, HANDB EXP PHARMACOL, V222, P207, DOI 10.1007/978-3-642-54215-2_9; Biro T, 1998, BLOOD, V91, P1332, DOI 10.1182/blood.V91.4.1332; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Bradding P, 2003, J LEUKOCYTE BIOL, V73, P614, DOI 10.1189/jlb.1202602; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chen Y, 2016, J BIOL CHEM, V291, P10252, DOI 10.1074/jbc.M116.716464; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Freichel M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00150; Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kim KS, 2010, KOREAN J PHYSIOL PHA, V14, P419, DOI 10.4196/kjpp.2010.14.6.419; Kojima I, 2014, HANDB EXP PHARMACOL, V222, P247, DOI 10.1007/978-3-642-54215-2_10; Lazzeri M, 2004, EUR UROL, V46, P792, DOI 10.1016/j.eururo.2004.08.007; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malbec O, 2007, J IMMUNOL, V178, P6465, DOI 10.4049/jimmunol.178.10.6465; Mascarenhas NL, J INVEST DERMATOL, DOI 10.1016/j.yjmcc.2011.06.012; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Moore C, 2013, P NATL ACAD SCI USA, V110, pE3225, DOI 10.1073/pnas.1312933110; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nilius F, 2014, MAMMALIAN TRANSIENT; Nishihara E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022246; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Stander S, 2004, EXP DERMATOL, V13, P129, DOI 10.1111/j.0906-6705.2004.0178.x; Stokes AJ, 2004, J EXP MED, V200, P137, DOI 10.1084/jem.20032082; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vukman KV, 2012, INFLAMM RES, V61, P79, DOI 10.1007/s00011-011-0394-6; Yang WZ, 2007, PHOTOCHEM PHOTOBIOL, V83, P979, DOI 10.1111/j.1751-1097.2007.00116.x; Zhang D, 2012, PHYSIOL RES, V61, P113, DOI 10.33549/physiolres.932053	40	20	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171366	10.1371/journal.pone.0171366	http://dx.doi.org/10.1371/journal.pone.0171366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158279	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700066
J	Wichert, S; Juliusson, G; Johansson, A; Sonesson, E; Teige, I; Wickenberg, AT; Frendeus, B; Korsgren, M; Hansson, M				Wichert, Stina; Juliusson, Gunnar; Johansson, Asa; Sonesson, Elisabeth; Teige, Ingrid; Wickenberg, Anna Teige; Frendeus, Bjorn; Korsgren, Magnus; Hansson, Markus			A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INDOLENT MYELOMA; DRUG-RESISTANCE; ZOLEDRONIC ACID; STAGE-I; ICAM-1; THALIDOMIDE; PROGRESSION; DIAGNOSIS; CRITERIA	Background Smoldering multiple myeloma (SMM) is an indolent disease stage, considered to represent the transition phase from the premalignant MGUS (Monoclonal Gammopathy of Undetermined Significance) state towards symptomatic multiple myeloma (MM). Even though this diagnosis provides an opportunity for early intervention, few treatment studies have been done and the current standard of care is observation until progression. BI-505, a monoclonal antibody directed against intercellular adhesion molecule 1 (ICAM-1) with promising antimyeloma activity in preclinical trials, is a possible treatment approach for this patient category with potential to eliminate tumor cells with minimal long-term side effects. BI-505 was well tolerated in an earlier phase 1 trial. Methods and findings In this phase 2 trial the effects of BI-505 in patients with SMM were studied. Four patients were enrolled and three of them completed the first cycle of treatment defined as 5 doses of BI-505, a total of 43 mg/kg BW, over a 7-week period. In the three evaluable patients, BI-505 showed a benign safety profile. None of the patients achieved a response as defined per protocol. EudraCT number: 2012-004884-29. Conclusions The study was conducted to assess the efficacy, safety and pharmacodynamics of BI-505 in patients with SMM. BI-505 showed no clinically relevant efficacy on disease activity in these patients with SMM, even if well tolerated.	[Wichert, Stina; Juliusson, Gunnar; Hansson, Markus] Skane Univ Hosp, Dept Hematol, Lund, Sweden; [Wichert, Stina; Juliusson, Gunnar; Hansson, Markus] Lund Univ, Lund, Sweden; [Johansson, Asa] Univ & Reg Labs Reg Skane, Clin Immunol & Transfus Med, Lund, Sweden; [Sonesson, Elisabeth; Wickenberg, Anna Teige; Korsgren, Magnus] BioInvent Int AB, Clin Dev, Lund, Sweden; [Teige, Ingrid; Frendeus, Bjorn] BioInvent Int AB, Res, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Wichert, S (corresponding author), Skane Univ Hosp, Dept Hematol, Lund, Sweden.; Wichert, S (corresponding author), Lund Univ, Lund, Sweden.	stina.wichert@med.lu.se			BioInvent International AB	BioInvent International AB	This study was funded by BioInvent International AB. ES, IT, ATW, BF, and MK are, or were, full-time employees of BioInvent International AB at the time of this study. IT, ATW and BF are currently employed and own stock (>50,000) in the company. BioInvent International AB provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barlogie B, 2008, BLOOD, V112, P3122, DOI 10.1182/blood-2008-06-164228; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Blade J, 2010, J CLIN ONCOL, V28, P690, DOI 10.1200/JCO.2009.22.2257; Caers J, 2016, ONCOLOGIST, V21, P333, DOI 10.1634/theoncologist.2015-0303; D'Arena G, 2011, LEUKEMIA LYMPHOMA, V52, P771, DOI 10.3109/10428194.2011.553000; Detweiler-Short K, 2010, AM J HEMATOL, V85, P737, DOI 10.1002/ajh.21821; Fransson J, 2006, INT J CANCER, V119, P349, DOI 10.1002/ijc.21829; Guillerey C, 2016, CELLULAR MOL LIFE SC; Hansson M, 2015, CLIN CANCER RES, V21, P2730, DOI 10.1158/1078-0432.CCR-14-3090; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; HJORTH M, 1993, EUR J HAEMATOL, V50, P95; HUANG YW, 1995, CANCER RES, V55, P610; JOHNSON JP, 1988, IMMUNOBIOLOGY, V178, P275, DOI 10.1016/S0171-2985(88)80071-8; KAVANAUGH AF, 1994, ARTHRITIS RHEUM, V37, P992, DOI 10.1002/art.1780370703; Kavanaugh AF, 1996, J RHEUMATOL, V23, P1338; Kavanaugh AF, 1997, ARTHRITIS RHEUM, V40, P849, DOI 10.1002/art.1780400511; Korde N, 2015, JAMA ONCOL, V1, P746, DOI 10.1001/jamaoncol.2015.2010; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; KYLE RA, 1980, NEW ENGL J MED, V302, P1347, DOI 10.1056/NEJM198006123022405; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Leaf RK, 2015, CURR HEMATOL MALIG R, V10, P395, DOI 10.1007/s11899-015-0283-0; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Maciocia N, 2016, HEMATOLOGICAL ONCOLO; Martin A, 2002, BRIT J HAEMATOL, V118, P239, DOI 10.1046/j.1365-2141.2002.03549.x; Mateos MV, 2013, NEW ENGL J MED, V369, P438, DOI 10.1056/NEJMoa1300439; Mileski WJ, 2003, J TRAUMA, V54, P950, DOI 10.1097/01.TA.0000030626.84680.11; Musto P, 2003, J CLIN ONCOL, V21, P3177, DOI 10.1200/JCO.2003.99.248; Musto P, 2008, CANCER-AM CANCER SOC, V113, P1588, DOI 10.1002/cncr.23783; Rajkumar SV, 2015, BLOOD, V125, P3069, DOI 10.1182/blood-2014-09-568899; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Ramos TN, 2014, J IMMUNOL, V192, P4469, DOI 10.4049/jimmunol.1400135; Riccardi A, 2000, BRIT J CANCER, V82, P1254; Almeida MSS, 2009, HISTOL HISTOPATHOL, V24, P991, DOI 10.14670/HH-24.991; Schmidmaier R, 2006, INT J BIOL MARKER, V21, P218, DOI 10.1177/172460080602100404; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Veitonmaki N, 2013, CANCER CELL, V23, P502, DOI 10.1016/j.ccr.2013.02.026; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Vuorte J, 1999, J IMMUNOL, V162, P2353; Witzig TE, 2013, LEUKEMIA, V27, P220, DOI 10.1038/leu.2012.236; Zheng Y, 2013, LEUKEMIA, V27, P702, DOI 10.1038/leu.2012.272	41	31	32	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171205	10.1371/journal.pone.0171205	http://dx.doi.org/10.1371/journal.pone.0171205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158311	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700043
J	Alzaharna, M; Alqouqa, I; Cheung, HY				Alzaharna, Mazen; Alqouqa, Iyad; Cheung, Hon-Yeung			Taxifolin synergizes Andrographolide-induced cell death by attenuation of autophagy and augmentation of caspase dependent and independent cell death in HeLa cells	PLOS ONE			English	Article							MITOCHONDRIAL-MEDIATED APOPTOSIS; BREAST-CANCER CELLS; N-TERMINAL KINASE; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; JNK ACTIVATION; CYCLE ARREST; IN-VITRO; FLAVONOIDS; P53	Andrographolide (Andro) has emerged recently as a potential and effective anticancer agent with induction of apoptosis in some cancer cell lines while induction of G2/M arrest with weak apoptosis in others. Few studies have proved that Andro is also effective in combination therapy. The flavonoid Taxifolin (Taxi) has showed anti-oxidant and antiproliferative effects against different cancer cells. Therefore, the present study investigated the cytotoxic effects of Andro alone or in combination with Taxi on HeLa cells. The combination of Andro with Taxi was synergistic at all tested concentrations and combination ratios. Andro alone induced caspase-dependent apoptosis which was enhanced by the combination with Taxi and attenuated partly by using Z-Vad-Fmk. Andro induced a protective reactive oxygen species (ROS)-dependent autophagy which was attenuated by Taxi. The activation of p53 was involved in Andro-induced autophagy where the use of Taxi or pifithrin-alpha (PFT-alpha) decreased it while the activation of JNK was involved in the cell death of HeLa cells but not in the induction of autophagy. The mitochondrial outer-membrane permeabilization (MOMP) plays an important role in Andro-induced cell death in HeLa cells. Andro alone increased the MOMP which was further increased in the case of combination. This led to the increase in AIF and cytochrome c release from mitochondria which consequently increased caspase-dependent and independent cell death. In conclusion, Andro induced a protective autophagy in HeLa cells which was reduced by Taxi and the cell death was increased by increasing the MOMP and subsequently the caspase-dependent and independent cell death.	[Alzaharna, Mazen; Alqouqa, Iyad; Cheung, Hon-Yeung] City Univ Hong Kong, Dept Biomed Sci, Res Grp Bioact Prod, Hong Kong, Hong Kong, Peoples R China; [Alzaharna, Mazen] Islamic Univ Gaza, Fac Hlth Sci, Dept Med Lab Sci, Alremal, Gaza, Palestine	City University of Hong Kong	Alzaharna, M (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Res Grp Bioact Prod, Hong Kong, Hong Kong, Peoples R China.	mzaharna@iugaza.edu.ps	Alzaharna, Mazen/ABG-8279-2021	Alzaharna, Mazen/0000-0002-1111-958X				Akbar S, 2011, ALTERN MED REV, V16, P66; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Campbell JK, 2006, J FOOD SCI, V71, pS358, DOI 10.1111/j.1750-3841.2006.00013.x; Chen W, 2012, CARCINOGENESIS, V33, P2190, DOI 10.1093/carcin/bgs264; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Chen Z, 2016, CLIN CANCER RES, V22, P187, DOI 10.1158/1078-0432.CCR-15-0987; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Cheung HY, 2005, PLANTA MED, V71, P1106, DOI 10.1055/s-2005-873128; Cheung MTW, 2012, LIFE SCI, V91, P751, DOI 10.1016/j.lfs.2012.04.009; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Galati G, 2004, FREE RADICAL BIO MED, V37, P287, DOI 10.1016/j.freeradbiomed.2004.04.034; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; He W, 2013, ONCOGENE; Hemalswarya S, 2007, ANN TRADITIONAL CHIN, P363; Jada SR, 2008, BRIT J PHARMACOL, V155, P641, DOI 10.1038/bjp.2008.368; Ji L, 2007, PLANTA MED, V73, P1397, DOI 10.1055/s-2007-990230; Jones Russell G, 2009, F1000 Biol Rep, V1, P68, DOI 10.3410/B1-68; Karna P, 2010, J BIOL CHEM, V285, P18737, DOI 10.1074/jbc.M109.091694; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Kerr DJ, 2004, ANN ONCOL, V15, P1727, DOI 10.1093/annonc/mdh480; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Leung EL, 2013, BRIEF BIOINFORM, V14, P491, DOI 10.1093/bib/bbs043; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Li JL, 2007, EUR J PHARMACOL, V568, P31, DOI 10.1016/j.ejphar.2007.04.027; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Middleton E, 2000, PHARMACOL REV, V52, P673; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Notte A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.167; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Oi N, 2012, CANCER PREV RES, V5, P1103, DOI 10.1158/1940-6207.CAPR-11-0397; Raina K, 2007, ACTA PHARMACOL SIN, V28, P1466, DOI 10.1111/j.1745-7254.2007.00691.x; Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Sharma DK, 2006, J SCI IND RES INDIA, V65, P477; Shen Kai-kai, 2009, Yaoxue Xuebao, V44, P973; Shi MD, 2008, CHEM-BIOL INTERACT, V174, P201, DOI 10.1016/j.cbi.2008.06.006; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Siegelin MD, 2008, MOL CANCER THER, V7, P3566, DOI 10.1158/1535-7163.MCT-08-0236; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Tafolla E, 2005, J BIOL CHEM, V280, P19992, DOI 10.1074/jbc.M500331200; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Theriault A, 2000, J LIPID RES, V41, P1969; Tsao R, 2010, FRUIT VEGETABLE PHYT, P131; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; Vasantha S, 2010, DRUG INVENT TODAY, V2, P440; Verschooten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048264; Vladimirov YA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P301, DOI 10.1134/S0006297909030092; Wang JP, 2000, MOL CARCINOGEN, V29, P179, DOI 10.1002/1098-2744(200011)29:3<179::AID-MC7>3.0.CO;2-K; Wang TG, 2004, J PHARMACOL EXP THER, V308, P975, DOI 10.1124/jpet.103.059683; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Woo AYH, 2008, J PHARMACOL EXP THER, V325, P226, DOI 10.1124/jpet.107.133918; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yang L, 2009, CANCER LETT, V276, P180, DOI 10.1016/j.canlet.2008.11.015; Yang S, 2010, CLIN CANCER RES, V16, P4755, DOI 10.1158/1078-0432.CCR-10-0883; Zhang H, 2016, ONCOTARGET, V7, P14350, DOI 10.18632/oncotarget.7320; Zhang XD, 2014, MOL CELL BIOCHEM, V385, P265, DOI 10.1007/s11010-013-1835-z; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhao F, 2008, J ASIAN NAT PROD RES, V10, P473, DOI [10.1080/10286020801948334, 10.1080/10286020801948599]; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071; Zhou J, 2012, AUTOPHAGY, V8, P338, DOI 10.4161/auto.18721	64	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171325	10.1371/journal.pone.0171325	http://dx.doi.org/10.1371/journal.pone.0171325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182713	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800054
J	Chen, YW; Wang, JS; Sheu, WHH; Lin, SY; Lee, IT; Song, YM; Fu, CP; Lee, CL				Chen, Yu-Wei; Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te; Song, Yuh-Min; Fu, Chia-Po; Lee, Chia-Lin			Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes	PLOS ONE			English	Article							BIOLOGICAL VARIATION; IDENTIFIES SUBPOPULATIONS; TREATMENT INTENSIFICATION; INTENSIVE TREATMENT; OXIDATIVE STRESS; RANDOMIZED-TRIAL; GLYCEMIC CONTROL; DOUBLE-BLIND; INFLAMMATION; MONOTHERAPY	Introduction A high hemoglobin glycation index (HGI) and glycated hemoglobin (HbA1c) level are associated with greater inflammatory status, and dipeptidyl peptidase-4 (DPP-4) inhibitors can suppress inflammation. We aimed to evaluate the relationship between HGI and the therapeutic effect of DPP-4 inhibitors. Methods This retrospective cohort study followed 468 patients with type 2 diabetes receiving DPP-4 inhibitor treatment for 1 year. Estimated HbA1c was calculated using a linear regression equation derived from another 2969 randomly extracted patients with type 2 diabetes based on fasting plasma glucose (FPG) level. The subjects were divided into two groups based on HGI (HGI = observed HbA1c -estimated HbA1c). Mixed model repeated measures were used to compare the treatment efficacy after 1 year in patients with a low (HGI<0, n = 199) and high HGI (HGI >= 0, n = 269). Results There were no significant group differences in mean changes of FPG after 1 year (-12.8 and -13.4 mg/dL in the low and high HGI groups, respectively). However, the patients with a high HGI had a significantly greater reduction in HbA1c from baseline compared to those with a low HGI (-1.9 versus -0.3% [-20.8 versus -3.3 mmol/mol]). Improvements in glycemic control were statistically significantly associated with the tested DPP-4 inhibitors in the high HGI group (- 2.4, - 1.4, - 1.2 and - 2.2% [-26.2, - 15.3, - 13.1 and - 24.0 mmol/mol] for vildagliptin, linagliptin, saxagliptin and sitagliptin, respectively) but not in the low HGI group. Conclusions The HGI index derived from FPG and HbA1c may be able to identify who will have a better response to DPP-4 inhibitors.	[Chen, Yu-Wei; Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te; Song, Yuh-Min; Fu, Chia-Po; Lee, Chia-Lin] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Sheu, Wayne H-H] Natl Def Med Ctr, Coll Med, Taipei, Taiwan; [Lin, Shih-Yi] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Taichung, Taiwan; [Fu, Chia-Po] Natl Taiwan Univ, Coll Elect Engn & Comp Sci, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Lee, Chia-Lin] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan; [Lee, Chia-Lin] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Taichung Veterans General Hospital; National Taiwan University; China Medical University Taiwan; Taichung Veterans General Hospital	Lee, CL (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.; Lee, CL (corresponding author), China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan.; Lee, CL (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.	u502107@yahoo.com.tw		Lee, I-Te/0000-0003-2665-3635; Wang, Jun-Sing/0000-0002-0887-6432				Braga F, 2011, CLIN CHIM ACTA, V412, P1412, DOI 10.1016/j.cca.2011.04.014; Derosa G, 2010, METABOLISM, V59, P887, DOI 10.1016/j.metabol.2009.10.007; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Donath MY, 2013, DIABETES OBES METAB, V15, P193, DOI 10.1111/dom.12172; Esposito K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005892; Esposito K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005442; Fang FS, 2012, INTERNAL MED, V51, P3109, DOI 10.2169/internalmedicine.51.8077; Frandsen CSS, 2014, DIABETIC MED, V31, P1293, DOI 10.1111/dme.12561; Hempe JM, 2015, DIABETES CARE, V38, P1067, DOI 10.2337/dc14-1844; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Kawamori R, 2012, DIABETES OBES METAB, V14, P348, DOI 10.1111/j.1463-1326.2011.01545.x; Ketema EB, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0088-6; Liu SQ, 2015, J CLIN ENDOCR METAB, V100, P2364, DOI 10.1210/jc.2014-4454; Matsubara J, 2013, CIRC J, V77, P1337, DOI 10.1253/circj.CJ-12-1168; McCarter RJ, 2004, DIABETES CARE, V27, P1259, DOI 10.2337/diacare.27.6.1259; McCoy RG, 2015, AM J MANAG CARE, V21, pE288; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Pan C, 2008, DIABETIC MED, V25, P435, DOI 10.1111/j.1464-5491.2008.02391.x; Pfutzner A, 2011, DIABETES OBES METAB, V13, P567, DOI 10.1111/j.1463-1326.2011.01385.x; Pupillo Mario, 2008, Diabetes Res Clin Pract, V80, pe1, DOI 10.1016/j.diabres.2008.01.001; Riddle MC, 2015, DIABETES CARE, V38, pE170, DOI 10.2337/dc15-1073; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Rohlfing C, 2002, CLIN CHEM, V48, P1116; Shinjo T, 2015, AM J PHYSIOL-ENDOC M, V309, pE214, DOI 10.1152/ajpendo.00553.2014; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Soros AA, 2010, PEDIATR DIABETES, V11, P455, DOI 10.1111/j.1399-5448.2009.00630.x; Tremblay AJ, 2014, METABOLISM, V63, P1141, DOI 10.1016/j.metabol.2014.06.004; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; Wang JS, 2011, DIABETES-METAB RES, V27, P79, DOI 10.1002/dmrr.1149; Wang JS, 2016, DIABETES RES CLIN PR, V113, P108, DOI 10.1016/j.diabres.2015.12.010; Wilson DM, 2011, DIABETES CARE, V34, P1315, DOI 10.2337/dc10-1661; Wu D, 2014, DIABETES OBES METAB, V16, P30, DOI 10.1111/dom.12174; Xiaoyan C, 2016, CURR MED RES OPIN, P1; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798	35	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171753	10.1371/journal.pone.0171753	http://dx.doi.org/10.1371/journal.pone.0171753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182722	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800099
J	Flamier, A; Singh, S; Rasmussen, TP				Flamier, Anthony; Singh, Supriya; Rasmussen, Theodore P.			A standardized human embryoid body platform for the detection and analysis of teratogens	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; VALPROIC ACID; STEM-CELLS; DEVELOPMENTAL TOXICITY; THALIDOMIDE; CHEMICALS; EXPOSURE; CULTURE	Teratogens are compounds that can induce birth defects upon exposure of the developing fetus. To date, most teratogen studies utilize pregnant rodents to determine compound teratogenicity in vivo. However, this is a low throughput approach that cannot easily meet the need for comprehensive high-volume teratogen assessment, a goal of the US Environmental Protection Agency. In addition, rodent and human development differ substantially, and therefore the use of assays using relevant human cells has utility. For these reasons, interest has recently focused on the use of human embryonic stem cells for teratogen assessment. Here we present a highly standardized and quantitative system for the detection and analysis of teratogens that utilizes well-characterized and purified highly pluripotent stem cells. We have devised strategies to mass-produce thousands of uniformly sized spheroids of human ESCs (hESCs) that can be caused to undergo synchronous differentiation to yield embryoid bodies (EBs) in the presence and absence of suspected teratogens. The system uses all human cells and rigorously controlled and standardized EB culture conditions. Furthermore, the approach has been made quantitative by using high-content imaging approaches. Our system offers distinct advantages over earlier EB systems that rely heavily on the use on mouse ESCs and EB aggregates of stochastic sizes. Together, our results show that thousands of suspected teratogens could be assessed using human EB-based approaches.	[Flamier, Anthony; Rasmussen, Theodore P.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Singh, Supriya; Rasmussen, Theodore P.] Univ Connecticut, Biobehav Sci Grad Degree Program, Storrs, CT 06269 USA; [Rasmussen, Theodore P.] Univ Connecticut, Stem Cell Inst, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Rasmussen, TP (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA.; Rasmussen, TP (corresponding author), Univ Connecticut, Biobehav Sci Grad Degree Program, Storrs, CT 06269 USA.; Rasmussen, TP (corresponding author), Univ Connecticut, Stem Cell Inst, Storrs, CT 06269 USA.	theodore.rasmussen@uconn.edu		Rasmussen, Theodore/0000-0001-9450-3394				Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Colleoni S, 2014, TOXICOL LETT, V231, P38, DOI 10.1016/j.toxlet.2014.08.023; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; Gaffield W, 1999, CELL MOL BIOL, V45, P579; Holmes LB, 2002, AM J MED GENET, V112, P297, DOI 10.1002/ajmg.10781; Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025; Krueger WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067296; Krueger WH, 2013, CELL REPROGRAM, V15, P151, DOI 10.1089/cell.2012.0059; Kuegler PB, 2010, ALTEX-ALTERN ANIM EX, V27, P17; LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319; Ma ZL, 2014, J CELL MOL MED, V18, P1134, DOI 10.1111/jcmm.12260; Ma ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034278; Mai CT, 2015, BIRTH DEFECTS RES A, V103, P972, DOI 10.1002/bdra.23461; Matthews SJ, 2003, CLIN THER, V25, P342, DOI 10.1016/S0149-2918(03)80085-1; Mayshar Y, 2011, J CELL MOL MED, V15, P1393, DOI 10.1111/j.1582-4934.2010.01105.x; Nathanson S, 2000, J AM SOC NEPHROL, V11, P874, DOI 10.1681/ASN.V115874; NAU H, 1994, CIBA F SYMP, V181, P144; NAU H, 1991, PHARMACOL TOXICOL, V69, P310, DOI 10.1111/j.1600-0773.1991.tb01303.x; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Sipes NS, 2011, TOXICOL SCI, V124, P109, DOI 10.1093/toxsci/kfr220; Smith J, 2009, NEONATAL NETW, V28, P363, DOI 10.1891/0730-0832.28.6.363; STEELE CE, 1991, HUM REPROD, V6, P144, DOI 10.1093/oxfordjournals.humrep.a137249; Tanasijevic B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021512; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Van Houtte E, 2014, INT J PEDIATR OTORHI, V78, P2007, DOI 10.1016/j.ijporl.2014.08.030; 2008, MORBIDITY MORTALITY, V57, P1	28	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171101	10.1371/journal.pone.0171101	http://dx.doi.org/10.1371/journal.pone.0171101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182681	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800033
J	Ogden, NH; Arsenault, J; Hatchette, TF; Mechai, S; Lindsay, LR				Ogden, Nicholas H.; Arsenault, Julie; hatchette, Todd F.; Mechai, Samir; Lindsay, L. Robbin			Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada	PLOS ONE			English	Article							LYME-DISEASE; SENSU-STRICTO; SURVEILLANCE; DIAGNOSIS; EMERGENCE; GENOTYPE; TICKS; C6	Lyme disease is emerging in eastern and central Canada, and most cases are diagnosed using the two-tier serological test (Enzyme Immuno Assay [EIA] followed by Western blot [WB]). Simplification of this algorithm would be advantageous unless it impacts test performance. In this study, accuracy of individual proteins of the IgG WB algorithm in predicting the overall test result in samples from Canadians was assessed. Because Borrelia burgdorferi strains vary geographically in Canada, geographic variations in serological responses were also explored. Metrics of relative sensitivity, specificity and the kappa statistic measure of concordance were used to assess the capacity of responses to individual proteins to predict the overall IgG WB result of 2524 EIA (C6)-positive samples from across Canada. Geographic and interannual variations in proportions of samples testing positive were explored by logistic regression. No one protein was highly concordant with the IgG WB result. Significant variations were found amongst years and geographic regions in the prevalence of samples testing positive using the overall IgG WB algorithm, and for individual proteins of the algorithm. In most cases the prevalence of samples testing positive were highest in Nova Scotia, and lower in samples from Manitoba westwards. These findings suggest that the current two tier test may not be simplified and continued use of the current two-tier test method and interpretation is recommended. Geographic and interannual variations in the prevalence of samples testing positive may be consistent with B. burgdorferi strain variation in Canada, and further studies are needed to explore this.	[Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Ogden, Nicholas H.; Arsenault, Julie; Mechai, Samir] GREZOSP, St Hyacinthe, PQ, Canada; [Arsenault, Julie; Mechai, Samir] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [hatchette, Todd F.] Nova Scotia Hlth Author, Dept Pathol & Lab Med, Halifax, NS, Canada; [hatchette, Todd F.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Public Health Agency of Canada; Universite de Montreal; Dalhousie University; Public Health Agency of Canada	Ogden, NH (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada.; Ogden, NH (corresponding author), GREZOSP, St Hyacinthe, PQ, Canada.	nicholas.ogden@phac-aspc.gc.ca	DeHaas, Keith/I-4957-2017; Arsenault, Julie/D-5077-2015	Arsenault, Julie/0000-0001-8382-7326; Mechai, Sam/0000-0001-9979-5525; Hatchette, Todd/0000-0002-5377-2528; Lindsay, Robbin/0000-0001-7236-2930				Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Cameron Daniel, 2004, Expert Rev Anti Infect Ther, V2, pS1; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Dessau RB, 2015, J MED MICROBIOL, V64, P224, DOI 10.1099/jmm.0.000009; Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703; Ferrouillet C, 2015, CAN J INFECT DIS MED, V26, P151, DOI 10.1155/2015/846963; Gabriele-Rivet V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131282; George D, 2003, SPSS WINDOWS STEP ST; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hatchette TF, 2015, EMERG INFECT DIS, V21, P1751, DOI 10.3201/eid2110.141640; Johnson BJB, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, P493; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Magnarelli LA, 2000, J CLIN MICROBIOL, V38, P1735, DOI 10.1128/JCM.38.5.1735-1739.2000; Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14; Molins CR, 2015, CLIN INFECT DIS, V60, P1767, DOI 10.1093/cid/civ185; Molins CR, 2014, J CLIN MICROBIOL, V52, P3755, DOI 10.1128/JCM.01409-14; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden N H, 2015, Can Commun Dis Rep, V41, P132; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Panelius J, 2001, J CLIN MICROBIOL, V39, P4013, DOI 10.1128/JCM.39.11.4013-4019.2001; Patrick DM, 2015, CLIN INFECT DIS, V61, P1084, DOI 10.1093/cid/civ470; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; Tugwell P, 1997, ANN INTERN MED, V127, P1109, DOI 10.7326/0003-4819-127-12-199712150-00011; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; Wormser GP, 2008, CLIN INFECT DIS, V47, P910, DOI 10.1086/591529; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003	30	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171731	10.1371/journal.pone.0171731	http://dx.doi.org/10.1371/journal.pone.0171731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182723	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800097
J	Vellinga, D; Bruijn, S; Briaire, JJ; Kalkman, RK; Frijns, JHM				Vellinga, Dirk; Bruijn, Saskia; Briaire, Jeroen J.; Kalkman, Randy K.; Frijns, Johan H. M.			Reducing interaction in simultaneous paired stimulation with CI	PLOS ONE			English	Article							COCHLEAR IMPLANT RECIPIENTS; COMPUTATIONAL MODEL; SPEECH RECOGNITION; PULSE-RATE; PSYCHOPHYSICS; EXCITATION; INTERFACE; STRATEGY; CHANNELS; MASKING	In this study simultaneous paired stimulation of electrodes in cochlear implants is investigated by psychophysical experiments in 8 post-lingually deaf subjects (and one extra subject who only participated in part of the experiments). Simultaneous and sequential monopolar stimulation modes are used as references and are compared to channel interaction compensation, partial tripolar stimulation and a novel sequential stimulation strategy named phased array compensation. Psychophysical experiments are performed to investigate both the loudness integration during paired stimulation at the main electrodes as well as the interaction with the electrode contact located halfway between the stimulating pair. The study shows that simultaneous monopolar stimulation has more loudness integration on the main electrodes and more interaction in between the electrodes than sequential stimulation. Channel interaction compensation works to reduce the loudness integration at the main electrodes, but does not reduce the interaction in between the electrodes caused by paired stimulation. Partial tripolar stimulation uses much more current to reach the needed loudness, but shows the same interaction in between the electrodes as sequential monopolar stimulation. In phased array compensation we have used the individual impedance matrix of each subject to calculate the current needed on each electrode to exactly match the stimulation voltage along the array to that of sequential stimulation. The results show that the interaction in between the electrodes is the same as monopolar stimulation. The strategy uses less current than partial tripolar stimulation, but more than monopolar stimulation. In conclusion, the paper shows that paired stimulation is possible if the interaction is compensated.	[Vellinga, Dirk; Bruijn, Saskia; Briaire, Jeroen J.; Kalkman, Randy K.; Frijns, Johan H. M.] Leiden Univ, Med Ctr, ENT Dept, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Briaire, JJ (corresponding author), Leiden Univ, Med Ctr, ENT Dept, Leiden, Netherlands.	j.j.briaire@lumc.nl	Kalkman, Randy/AAR-6911-2021; Briaire, Jeroen/A-7972-2008; Frijns, Johan H.M./H-6249-2011	Kalkman, Randy/0000-0002-4060-4138; Briaire, Jeroen/0000-0003-4302-817X; Frijns, Johan H.M./0000-0002-1180-3314				Battmer RD, 2010, INT J AUDIOL, V49, P657, DOI 10.3109/14992021003801471; Bierer JA, 2010, HEARING RES, V270, P134, DOI 10.1016/j.heares.2010.08.006; Bonham BH, 2008, HEARING RES, V242, P141, DOI 10.1016/j.heares.2008.03.006; Bonnet RM, 2012, EAR HEARING, V33, P489, DOI 10.1097/AUD.0b013e31824c761a; Buechner A, 2005, OTOL NEUROTOL, V26, P941, DOI 10.1097/01.mao.0000185069.27705.f0; Cohen LT, 2003, HEARING RES, V179, P72, DOI 10.1016/S0378-5955(03)00096-0; Compernolle Dv, 1985, SPEECH PROCESSING ST; Frijns JHM, 2011, ACTA OTO-LARYNGOL, V131, P362, DOI 10.3109/00016489.2010.541939; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; Kalkman RK, 2015, HEARING RES, V322, P89, DOI 10.1016/j.heares.2014.12.004; Kalkman RK, 2014, HEARING RES, V315, P10, DOI 10.1016/j.heares.2014.06.003; Kiefer J, 2000, ANN OTO RHINOL LARYN, V109, P1009, DOI 10.1177/000348940010901105; Litvak LM, 2007, J ACOUST SOC AM, V122, P967, DOI 10.1121/1.2749414; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; Potts LG, 2007, EAR HEARING, V28, P495, DOI 10.1097/AUD.0b013e31806dc16e; Shefin SG, 2015, J NEURAL ENG, V12, DOI [10.1088/1741-2560/12/6/066005, DOI 10.1088/1741-2560/12/6/066005]; van den Honert C, 2007, J ACOUST SOC AM, V121, P3703, DOI 10.1121/1.2722047; Vanpoucke FJ, 2004, IEEE T BIO-MED ENG, V51, P2174, DOI 10.1109/TBME.2004.836518; Vellinga D, EAR HEARING IN PRESS; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Zeng Fan-Gang, 2004, Trends Amplif, V8, P1, DOI 10.1177/108471380400800102; Zeng FG, 2008, IEEE REV BIOMEDICAL, V1; Zierhofer CM, 2008, IEEE T BIO-MED ENG, V55, P1907, DOI 10.1109/TBME.2008.919839	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171071	10.1371/journal.pone.0171071	http://dx.doi.org/10.1371/journal.pone.0171071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182685	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800031
J	Yan, LL; Su, JQ; Wang, ZP; Yan, XW; Yu, RH; Ma, PZ; Li, YC; Du, JP				Yan, Lulu; Su, Jiaqi; Wang, Zhaoping; Yan, Xiwu; Yu, Ruihai; Ma, Peizhen; Li, Yangchun; Du, Junpeng			Transcriptomic analysis of Crassostrea sikamea x Crassostrea angulata hybrids in response to low salinity stress	PLOS ONE			English	Article							NOD-LIKE RECEPTORS; SHRIMP LITOPENAEUS-VANNAMEI; GLYCOGEN-BINDING SUBUNIT; PACIFIC OYSTER; INNATE IMMUNITY; EXPRESSION ANALYSIS; PROTEIN PHOSPHATASE-1G; OXYGEN-CONSUMPTION; RECIPROCAL CROSSES; SUSPENDED CULTURE	Hybrid oysters often show heterosis in growth rate, weight, survival and adaptability to extremes of salinity. Oysters have also been used as model organisms to study the evolution of host-defense system. To gain comprehensive knowledge about various physiological processes in hybrid oysters under low salinity stress, we performed transcriptomic analysis of gill tissue of Crassostrea sikamea female x Crassostrea angulata male hybrid using the deep-sequencing platform Illumina HiSeq. We exploited the high-throughput technique to delineate differentially expressed genes (DEGs) in oysters maintained in hypotonic conditions. A total of 199,391 high quality unigenes, with average length of 644 bp, were generated. Of these 35 and 31 genes showed up- and down-regulation, respectively. Functional categorization and pathway analysis of these DEGs revealed enrichment for immune mechanism, apoptosis, energy metabolism and osmoregulation under low salinity stress. The expression patterns of 41 DEGs in hybrids and their parental species were further analyzed by quantitative real-time PCR (qRT-PCR). This study will serve as a platform for subsequent gene expression analysis regarding environmental stress. Our findings will also provide valuable information about gene expression to better understand the immune mechanism, apoptosis, energy metabolism and osmoregulation in hybrid oysters under low salinity stress.	[Yan, Lulu; Wang, Zhaoping; Yu, Ruihai; Ma, Peizhen; Li, Yangchun; Du, Junpeng] Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China; [Su, Jiaqi] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Key Lab South China Sea Fishery Resources Exploit, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Yan, Xiwu] Dalian Ocean Univ, Coll Fisheries & Life Sci, Engn Res Ctr Shellfish Culture & Breeding Liaonin, Dalian, Liaoning, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Dalian Ocean University	Wang, ZP (corresponding author), Ocean Univ China, Coll Fisheries, Qingdao, Shandong, Peoples R China.	zpwang@ouc.edu.cn			National Natural Science Foundation of China [31172403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant no.31172403). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset C, 2003, VACCINE, V21, pS12, DOI 10.1016/S0264-410X(03)00195-6; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Berteau O, 2004, BIOCHEMISTRY-US, V43, P7881, DOI 10.1021/bi036066z; Box A, 2009, COMP BIOCHEM PHYS C, V149, P456, DOI 10.1016/j.cbpc.2008.10.107; BROWN JR, 1988, AQUACULTURE, V70, P231, DOI 10.1016/0044-8486(88)90099-3; BROWN JR, 1988, AQUACULTURE, V70, P253, DOI 10.1016/0044-8486(88)90100-7; Butt D, 2006, AQUACULTURE, V251, P159, DOI 10.1016/j.aquaculture.2005.05.045; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Cheng W, 2004, FISH SHELLFISH IMMUN, V17, P235, DOI 10.1016/j.fsi.2004.03.007; Chong-Robles J, 2014, AQUACULTURE, V422, P261, DOI 10.1016/j.aquaculture.2013.11.034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Croke SJ, 2002, ENVIRON TOXICOL CHEM, V21, P1683, DOI [10.1897/1551-5028(2002)021<1683:TFDOIM>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1683:TFDOIM&gt;2.0.CO;2]; Dautremepuits C, 2009, SCI TOTAL ENVIRON, V407, P1055, DOI 10.1016/j.scitotenv.2008.10.004; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; De Zoysa M, 2009, COMP BIOCHEM PHYS B, V154, P387, DOI 10.1016/j.cbpb.2009.08.002; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dunn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003366; Eierman LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-503; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; EV K, 2004, GENOME BIOL, V5, P60; Fiol DF, 2011, BBA-GEN SUBJECTS, V1810, P439, DOI 10.1016/j.bbagen.2010.11.005; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gagnaire B, 2006, FISH SHELLFISH IMMUN, V20, P536, DOI 10.1016/j.fsi.2005.07.003; Gbulubo Awotongha J., 2011, Journal of Fisheries International, V6, P71; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Gjedrem T., 2010, SELECTIVE BREEDING A; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Guo XM, 2015, FISH SHELLFISH IMMUN, V46, P107, DOI 10.1016/j.fsi.2015.05.018; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hosoi M, 2003, FISHERIES SCI, V69, P395, DOI 10.1046/j.1444-2906.2003.00634.x; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; HUBBARD MJ, 1989, EUR J BIOCHEM, V180, P457, DOI 10.1111/j.1432-1033.1989.tb14668.x; Huo ZM, 2014, J WORLD AQUACULT SOC, V45, P226, DOI 10.1111/jwas.12098; HUTCHINSON S, 1992, J MOLLUS STUD, V58, P215, DOI 10.1093/mollus/58.2.215; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Intra J, 2007, GENE, V392, P34, DOI 10.1016/j.gene.2006.11.002; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; KAPLANHARRIS L, 1980, J LIPID RES, V21, P617; Knowles G, 2014, J INVERTEBR PATHOL, V121, P78, DOI 10.1016/j.jip.2014.06.013; Kumar V., 2011, INT J PHARM BIOL SCI, V1, P129; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lockwood BL, 2011, MOL ECOL, V20, P517, DOI 10.1111/j.1365-294X.2010.04973.x; Luna-Acosta A, 2011, COMP BIOCHEM PHYS B, V159, P220, DOI 10.1016/j.cbpb.2011.04.009; Lutz CG, 2010, AQUAC RES, V41, pe770, DOI 10.1111/j.1365-2109.2010.02583.x; MACINNES JR, 1979, ARCH ENVIRON CON TOX, V8, P553, DOI 10.1007/BF01055036; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; Madsen LM, 1996, INFECT IMMUN, V64, P2425, DOI 10.1128/IAI.64.7.2425-2430.1996; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matozzo V, 2007, MAR BIOL, V151, P1051, DOI 10.1007/s00227-006-0543-6; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Meng XF, 2014, MOL NEUROBIOL, V49, P673, DOI 10.1007/s12035-013-8551-2; Moreira A, 2016, ENVIRON POLLUT, V214, P756, DOI 10.1016/j.envpol.2016.04.036; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; PIERCE SK, 1992, MAR BIOL, V113, P107, DOI 10.1007/BF00367644; PIERCE SK, 1982, BIOL BULL-US, V163, P405, DOI 10.2307/1541452; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Richter B W, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.44.pe1; Rosales C, 2011, ISJ-INVERT SURVIV J, V8, P109; Sekino M, 2009, FISHERIES SCI, V75, P819, DOI 10.1007/s12562-009-0100-6; Setiarto A, 2004, AQUAC RES, V35, P669, DOI 10.1111/j.1365-2109.2004.01064.x; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shekhar MS, 2013, FISH SHELLFISH IMMUN, V35, P1957, DOI 10.1016/j.fsi.2013.09.038; SHUMWAY SE, 1982, MAR ECOL PROG SER, V9, P59, DOI 10.3354/meps009059; Silke J, 2001, J CELL SCI, V114, P1821; Sonoda Y, 2014, P CIVIL ENG OCEAN, V70, pI1164; Su J., 2015, THESIS; Tong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134280; Wang CD, 2011, AQUACULTURE, V310, P380, DOI 10.1016/j.aquaculture.2010.11.014; Wang H, 2013, PROCESS IDENTIFICATI; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Xu F, 2014, J MOLLUS STUD, V80, P435, DOI 10.1093/mollus/eyu040; Xu F, 2011, MAR BIOL RES, V7, P796, DOI 10.1080/17451000.2011.569555; Xu F, 2009, J SHELLFISH RES, V28, P453, DOI 10.2983/035.028.0305; Xu Z, 2015, PLOS ONE, V10; Yajima M, 2003, BIOCHEM J, V371, P205, DOI 10.1042/BJ20021603; Yao T, 2015, J OCEAN U CHINA, V14, P710, DOI 10.1007/s11802-015-2546-8; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang D, 2015, GENE; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang H, 2007, AQUACULTURE, V272, pS88, DOI 10.1016/j.aquaculture.2007.08.008; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang Y, 2015, J PROTEOME RES, V14, P304, DOI 10.1021/pr500940s; Zhao Q, 2015, FISH SHELLFISH IMMUN, V42, P400, DOI 10.1016/j.fsi.2014.11.020; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244	95	22	24	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171483	10.1371/journal.pone.0171483	http://dx.doi.org/10.1371/journal.pone.0171483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182701	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800065
J	Jones, DOB; Kaiser, S; Sweetman, AK; Smith, CR; Menot, L; Vink, A; Trueblood, D; Greinert, J; Billett, DSM; Arbizu, PM; Radziejewska, T; Singh, R; Ingole, B; Stratmann, T; Simon-Lledo, E; Durden, JM; Clark, MR				Jones, Daniel O. B.; Kaiser, Stefanie; Sweetman, Andrew K.; Smith, Craig R.; Menot, Lenaick; Vink, Annemiek; Trueblood, Dwight; Greinert, Jens; Billett, David S. M.; Arbizu, Pedro Martinez; Radziejewska, Teresa; Singh, Ravail; Ingole, Baban; Stratmann, Tanja; Simon-Lledo, Erik; Durden, Jennifer M.; Clark, Malcolm R.			Biological responses to disturbance from simulated deep-sea polymetallic nodule mining	PLOS ONE			English	Article							ENVIRONMENTAL-IMPACT; BENTHIC DISTURBANCE; PHYSICAL DISTURBANCE; SPECIES-DIVERSITY; FRACTURE-ZONE; SEDIMENT; COLONIZATION; RECOVERY; PACIFIC; COMMUNITIES	Commercial-scale mining for polymetallic nodules could have a major impact on the deepsea environment, but the effects of these mining activities on deep-sea ecosystems are very poorly known. The first commercial test mining for polymetallic nodules was carried out in 1970. Since then a number of small-scale commercial test mining or scientific disturbance studies have been carried out. Here we evaluate changes in faunal densities and diversity of benthic communities measured in response to these 11 simulated or test nodule mining disturbances using meta-analysis techniques. We find that impacts are often severe immediately after mining, with major negative changes in density and diversity of most groups occurring. However, in some cases, the mobile fauna and small-sized fauna experienced less negative impacts over the longer term. At seven sites in the Pacific, multiple surveys assessed recovery in fauna over periods of up to 26 years. Almost all studies show some recovery in faunal density and diversity for meiofauna and mobile megafauna, often within one year. However, very few faunal groups return to baseline or control conditions after two decades. The effects of polymetallic nodule mining are likely to be long term. Our analyses show considerable negative biological effects of seafloor nodule mining, even at the small scale of test mining experiments, although there is variation in sensitivity amongst organisms of different sizes and functional groups, which have important implications for ecosystem responses. Unfortunately, many past studies have limitations that reduce their effectiveness in determining responses. We provide recommendations to improve future mining impact test studies. Further research to assess the effects of test-mining activities will inform ways to improve mining practices and guide effective environmental management of mining activities.	[Jones, Daniel O. B.; Billett, David S. M.; Simon-Lledo, Erik; Durden, Jennifer M.] Univ Southampton, Natl Oceanog Ctr, Waterfront Campus, Southampton, Hants, England; [Kaiser, Stefanie] German Ctr Marine Biodivers Res DZMB, Senckenberg Meer, Wilhelmshaven, Germany; [Sweetman, Andrew K.] Heriot Watt Univ, Lyell Ctr Earth & Marine Sci & Technol, Edinburgh, Midlothian, Scotland; [Smith, Craig R.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Menot, Lenaick] IFREMER, Ctr Bretagne, Plouzane, France; [Vink, Annemiek] Geozentrum Hannover, Bundesanstalt Geowissensch & Rohstoffe, Fed Inst Geosci & Nat Resources, Hannover, Germany; [Trueblood, Dwight] Univ New Hampshire, NOAA, Off Coastal Management, Durham, NH 03824 USA; [Greinert, Jens] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Greinert, Jens] Christian Albrechts Univ Kiel, Inst Geosci, Kiel, Germany; [Radziejewska, Teresa] Univ Szczecin, Fac Geosci, Palaeoceanol Unit, Szczecin, Poland; [Ingole, Baban] CSIR, Natl Inst Oceanog, Panaji, Goa, India; [Stratmann, Tanja] NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Yerseke, Netherlands; [Stratmann, Tanja] Univ Utrecht, Yerseke, Netherlands; [Simon-Lledo, Erik] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, European Way, Southampton, Hants, England; [Clark, Malcolm R.] Natl Inst Water Atmospher Res, Wellington, New Zealand	NERC National Oceanography Centre; University of Southampton; Senckenberg Gesellschaft fur Naturforschung (SGN); Heriot Watt University; University of Hawaii System; University of Hawaii Manoa; Ifremer; Universite de Bretagne Occidentale; National Oceanic Atmospheric Admin (NOAA) - USA; University System Of New Hampshire; University of New Hampshire; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; University of Szczecin; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; NERC National Oceanography Centre; University of Southampton; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Jones, DOB (corresponding author), Univ Southampton, Natl Oceanog Ctr, Waterfront Campus, Southampton, Hants, England.	dj1@noc.ac.uk	Jones, Daniel/A-3412-2009; Vink, Annemiek/GXG-6435-2022; Radziejewska, Teresa/AAK-8233-2021; MENOT, LENAICK/N-6899-2016; Ingole, Baban Shravan/GLR-9722-2022	Jones, Daniel/0000-0001-5218-1649; Vink, Annemiek/0000-0002-5178-9721; MENOT, LENAICK/0000-0002-8117-1607; Simon-Lledo, Erik/0000-0001-9667-2917; Stratmann, Tanja/0000-0001-7997-1157; Kaiser, Stefanie/0000-0003-2026-4663; Ingole, Baban/0000-0001-6096-6980; Durden, Jennifer/0000-0002-6529-9109; Greinert, Jens/0000-0001-6186-8573	European Union Seventh Framework Programme (FP7)under MIDAS (Managing Impacts of Deep-seA reSource exploitation) [603418]; Polish National Science Centre [2014/13/B/ST10/02996]; UK Natural Environment Research Council through National Capability; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009] Funding Source: researchfish	European Union Seventh Framework Programme (FP7)under MIDAS (Managing Impacts of Deep-seA reSource exploitation); Polish National Science Centre; UK Natural Environment Research Council through National Capability; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS (Managing Impacts of Deep-seA reSource exploitation) project, grant agreement 603418. TR received funding from the Polish National Science Centre grant 2014/13/B/ST10/02996. Funding was also provided from the UK Natural Environment Research Council through National Capability funding to NOC. The funders had no role in the study data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Michelle Bond from the International Seabed Authority library for help in obtaining some of the studies used in this paper. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS (Managing Impacts of Deep-seA reSource exploitation) project, grant agreement 603418. TR acknowledges funding provided by the Polish National Science Centre grant 2014/13/B/ST10/02996. We acknowledge support from the UK Natural Environment Research Council through National Capability funding to NOC. The funders had no role in the study data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert A, 2001, DEEP-SEA RES PT II, V48, P3779, DOI 10.1016/S0967-0645(01)00067-4; AMANN H, 1985, MAR MINING, V5, P103; AMANN H, 1989, MAR MINING, V8, P1; Amann H, 1991, P 23 ANN OFFSH TECHN, P469; Amon DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30492; AMOS AF, 1972, MAR TECHNOL SOC J, V6, P40; AMOS AF, 1977, MAR POLICY, V1, P156, DOI 10.1016/0308-597X(77)90050-1; Amos AF, 1975, LAMONT DOHERTY GEOLO, V1975, P31; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Bluhm H, 2001, DEEP-SEA RES PT II, V48, P3841, DOI 10.1016/S0967-0645(01)00070-4; Boetius A., 2015, RV SONNE FAHRTBERICH; Borenstein M., 2009, INTRO METAANALYSIS; Borowski C, 2001, DEEP-SEA RES PT II, V48, P3809, DOI 10.1016/S0967-0645(01)00069-8; Borowski C, 1998, DEEP-SEA RES PT II, V45, P55, DOI 10.1016/S0967-0645(97)00073-8; BROCKETT T, 1994, SEA TECHNOL, V35, P77; Burns RE, 1978, MESA47 NOAA ERL US D; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Chung JS, 2013, 3 GENERATION COMMERC; Chung JS, 2009, DEEP OC MIN TECHN 3; Chung JS, 2002, OMSEN1 INT SOC OFFSH; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins PC, 2013, MAR POLICY, V42, P198, DOI 10.1016/j.marpol.2013.01.020; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cummins AB, 1992, SME MINING ENG HDB, V1; Desa E, 1997, P INT S ENV STUD DEE, P49; Fukushima T, 2002, INT OFFSHORE POLAR E, P443; Fukushima T, 1995, PROCEEDINGS OF THE FIRST (1995) ISOPE OCEAN MINING SYMPOSIUM, P47; Fukushima T, 1997, P INT S ENV STUD DEE, P331; Fukushima Tomohiko, 2000, Publications of the Seto Marine Biological Laboratory, V39, P17; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Gates AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044114; Glover AG, 2002, MAR ECOL PROG SER, V240, P157, DOI 10.3354/meps240157; GRASSLE JF, 1989, TRENDS ECOL EVOL, V4, P12, DOI 10.1016/0169-5347(89)90007-4; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; GRASSLE JF, 1987, DEEP-SEA RES, V34, P1911, DOI 10.1016/0198-0149(87)90091-4; Grassle JF, 1987, DEEP-SEA RES PT 1, V34, P7; Greinert J., 2015, RV SONNE FAHRTBERICH; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Ingole BS, 2005, MAR GEORESOUR GEOTEC, V23, P267, DOI 10.1080/10641190500446573; Ingole BS, 2001, DEEP-SEA RES PT II, V48, P3401, DOI 10.1016/S0967-0645(01)00048-0; Ingole BS, 2000, MAR GEORESOUR GEOTEC, V18, P263, DOI 10.1080/10641190009353794; International Seabed Authority, 2011, ENV MAN NEEDS EXPL E; International Seabed Authority, 1999, P INT SEAB AUTH WORK; Jankowski JA, 1996, J GEOPHYS RES-OCEANS, V101, P3545, DOI 10.1029/95JC03564; Jankowski JA, 2001, DEEP-SEA RES PT II, V48, P3487, DOI 10.1016/S0967-0645(01)00054-6; Jones DOB, 2012, MAR ECOL PROG SER, V461, P71, DOI 10.3354/meps09827; JUMARS P A, 1981, Marine Mining, V3, P213; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kaneko TS, 1997, INT OFFSHORE POLAR E, P475; Khripounoff A, 2006, LIMNOL OCEANOGR, V51, P2033, DOI 10.4319/lo.2006.51.5.2033; Kitazato H, 1997, P INT S ENV STUD DEE, P317; Kotlinski R, 1998, P 8 INT OFFSH POL EN; LEVIN LA, 1984, DEEP-SEA RES, V31, P1277, DOI 10.1016/0198-0149(84)90001-3; Madureira P, 2016, MAR POLICY, V70, P101, DOI 10.1016/j.marpol.2016.04.051; Mahatma R., 2009, MEIOFAUNA COMMUNITIE; Martinez Arbizu P, 2015, SO239 HELMH ZENTR OZ; Masuda Y, 1971, OFFSH TECHN C 19 21, P1410; Masuda Y, 1997, OFFSH TECHN C 5 MAY; McClain Craig R, 2012, Proc Natl Acad Sci U S A, V109, P15366; Miljutin D, 2015, DEEP-SEA RES PT I, V106, P126, DOI 10.1016/j.dsr.2015.10.009; Miljutin DM, 2011, DEEP-SEA RES PT I, V58, P885, DOI 10.1016/j.dsr.2011.06.003; MORGAN CL, 1993, MAR GEORESOUR GEOTEC, V11, P1, DOI 10.1080/10641199309379903; Nautilus Minerals, 2016, 43101 NI TOML CLAR C; NICHOLS JA, 1978, J SEDIMENT PETROL, V48, P419; Norkko A, 2006, J EXP MAR BIOL ECOL, V330, P195, DOI 10.1016/j.jembe.2005.12.027; Oebius HU, 2001, DEEP-SEA RES PT II, V48, P3453, DOI 10.1016/S0967-0645(01)00052-2; Ozturgut E, 1978, MESA48 NOAA ERL; Ozturgut E, 1978, MESA33 NOAA ERL MAR; Ozturgut E, 1997, P INT S ENV STUD DEE, P23; Radziejewska T, 2001, PROCEEDINGS OF THE FOURTH (2001) ISOPE OCEAN MINING SYMPOSIUM, P63; Radziejewska T, 2014, SPRINGERBR EARTH SYS, P1, DOI 10.1007/978-3-642-41458-9; Radziejewska T, 2001, PROCEEDINGS OF THE FOURTH (2001) ISOPE OCEAN MINING SYMPOSIUM, P38; Radziejewska T, 2002, INT REV HYDROBIOL, V87, P457, DOI 10.1002/1522-2632(200207)87:4<457::AID-IROH457>3.0.CO;2-3; Radziejewska T., 1997, P INT S ENV STUD DEE, P223; Radziejewska Teresa, 2000, Oceanological Studies, V29, P83; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; REYSS JL, 1982, NATURE, V295, P401, DOI 10.1038/295401a0; ROELS OA, 1974, MAR TECHNOL SOC J, V8, P17; Ruhlemann C, 2010, CRUISE REPORT SO 205; Ruhlemann C, 2011, P 9 2011 ISOPE OC MI, P168; Sharma R, 2001, DEEP-SEA RES PT II, V48, P3363, DOI 10.1016/S0967-0645(01)00046-7; Shirayama Y, 1997, INT S ENV STUD DEEP, P187; Smit MGD, 2008, ENVIRON TOXICOL CHEM, V27, P1006, DOI 10.1897/07-339.1; Smith C, 1988, ASSESSMENT BENTHIC F, P14; SMITH CR, 1989, LIMNOL OCEANOGR, V34, P1263, DOI 10.4319/lo.1989.34.7.1263; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; Thiel H, 2001, DEEP-SEA RES PT II, V48, P3433, DOI 10.1016/S0967-0645(01)00051-0; THIEL H, 1990, AMBIO, V19, P245; Thiel H, 2003, ECOSY WORLD, V28, P427; THIEL H, 1986, AMBIO, V15, P34; Thiel H, 2001, DEEP-SEA RES PT II, V48, P3869, DOI 10.1016/S0967-0645(01)00071-6; Thomson CW, 1895, REPORT SCI RESULTS V; Tkatchenko G, INT SEM DEEP SEA BED; Trueblood DD, 1997, INT OFFSHORE POLAR E, P481; Vanreusel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26808; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Welling CG, 1981, OFFSH TECHN C 4 7 MA; Yamazaki T, 2001, INT OFFSHORE POLAR E, P528; Yamazaki T, 1999, PROCEEDINGS OF THE THIRD (1999) ISOPE OCEAN MINING SYMPOSIUM, P55; Yasukawa H, 1999, INT OFFSHORE POLAR E, P100; Young DK, 2001, DEEP SEA ORGANISM SE	103	158	159	14	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171750	10.1371/journal.pone.0171750	http://dx.doi.org/10.1371/journal.pone.0171750			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178346	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000393712500067
J	Birkhauer, J; Gaab, J; Kossowsky, J; Hasler, S; Krummenacher, P; Werner, C; Gerger, H				Birkhauer, Johanna; Gaab, Jens; Kossowsky, Joe; Hasler, Sebastian; Krummenacher, Peter; Werner, Christoph; Gerger, Heike			Trust in the health care professional and health outcome: A meta-analysis	PLOS ONE			English	Article							PHYSICIAN SCALE; BIAS; COMMUNICATION; MEDICINE; DOCTORS; QUALITY; PLACEBO; TRIALS	Objective To examine whether patients' trust in the health care professional is associated with health outcomes. Study selection We searched 4 major electronic databases for studies that reported quantitative data on the association between trust in the health care professional and health outcome. We screened the full-texts of 400 publications and included 47 studies in our meta-analysis. Data extraction and data synthesis We conducted random effects meta-analyses and meta-regressions and calculated correlation coefficients with corresponding 95% confidence intervals. Two interdependent researchers assessed the quality of the included studies using the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Results Overall, we found a small to moderate correlation between trust and health outcomes (r = 0.24, 95% CI: 0.19-0.29). Subgroup analyses revealed a moderate correlation between trust and self-rated subjective health outcomes (r = 0.30, 0.24-0.35). Correlations between trust and objective (r = -0.02, -0.08-0.03) as well as observer-rated outcomes (r = 0.10, -0.16-0.36) were non-significant. Exploratory analyses showed a large correlation between trust and patient satisfaction and somewhat smaller correlations with health behaviours, quality of life and symptom severity. Heterogeneity was small to moderate across the analyses. Conclusions From a clinical perspective, patients reported more beneficial health behaviours, less symptoms and higher quality of life and to be more satisfied with treatment when they had higher trust in their health care professional. There was evidence for upward bias in the summarized results. Prospective studies are required to deepen our understanding of the complex interplay between trust and health outcomes.	[Birkhauer, Johanna; Gaab, Jens; Kossowsky, Joe; Hasler, Sebastian; Werner, Christoph; Gerger, Heike] Univ Basel, Dept Psychol, Clin Psychol & Psychotherapy, Basel, Switzerland; [Kossowsky, Joe] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Kossowsky, Joe] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Program Placebo Studies & Therapeut Encounter, Boston, MA USA; [Krummenacher, Peter] Univ Zurich, Coll Helveticum, Zurich, Switzerland; [Krummenacher, Peter] Swiss Fed Inst Technol, Zurich, Switzerland	University of Basel; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Birkhauer, J (corresponding author), Univ Basel, Dept Psychol, Clin Psychol & Psychotherapy, Basel, Switzerland.	j.birkhaeuer@unibas.ch	Gerger, Heike/Q-6862-2017; Gaab, Jens/AAE-4798-2019; Kossowsky, Joe/AAO-1964-2021	Gerger, Heike/0000-0002-7077-658X; Gaab, Jens/0000-0002-9194-8491; Kossowsky, Joe/0000-0002-6272-6259; Werner, Christoph Patrick/0000-0001-9250-4529	Swiss National Science Foundation [POBSP1_155446]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Johanna Birkhauer's contributions to this study were supported by the Swiss National Science Foundation (http://www.snf.ch), grant project (POBSP1_155446). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373; Boothroyd RA, 2008, EVAL HEALTH PROF, V31, P81, DOI 10.1177/0163278707311882; Borenstein M., 2009, INTRO METAANALYSIS; Borenstein M, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P193; Calnan Michael, 2006, J Health Organ Manag, V20, P349, DOI 10.1108/14777260610701759; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coulter A, 2002, BRIT MED J, V325, P668, DOI 10.1136/bmj.325.7366.668; Croker JE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002762; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Durant RW, 2010, ETHNIC DIS, V20, P282; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Giordano GN, 2016, J EPIDEMIOL COMMUN H, V70, P10, DOI 10.1136/jech-2015-205822; Gopichandran V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007305; Graham JL, 2013, AIDS BEHAV, V17, P266, DOI 10.1007/s10461-011-0114-9; Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Keating NL, 2004, ARCH INTERN MED, V164, P1015, DOI 10.1001/archinte.164.9.1015; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Lee YY, 2011, PATIENT EDUC COUNS, V85, P406, DOI 10.1016/j.pec.2010.12.005; Lee YY, 2008, BRIT J HOSP MED, V69, P42, DOI 10.12968/hmed.2008.69.1.28040; Lewicki RJ, 2006, J MANAGE, V32, P991, DOI 10.1177/0149206306294405; LINDEN M, 1988, FORTSCHR NEUROL PSYC, V56, P35, DOI 10.1055/s-2007-1001215; Mechanic D, 1996, JAMA-J AM MED ASSOC, V275, P1693, DOI 10.1001/jama.275.21.1693; Moustgaard H, 2014, J CLIN EPIDEMIOL, V67, P1327, DOI 10.1016/j.jclinepi.2014.06.020; Nursing & Midwifery Council (NMC), COD NURS MIDW READ C; Ommen O, 2011, INT J PUBLIC HEALTH, V56, P319, DOI 10.1007/s00038-010-0212-x; Pearson SD, 2000, J GEN INTERN MED, V15, P509, DOI 10.1046/j.1525-1497.2000.11002.x; Pfaff H, 2003, KOLNER PATIENTENFRAG; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI [10.1186/1471-2288-8-79, DOI 10.1186/1471-2288-8-79]; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Sakallaris Bonnie R, 2016, Glob Adv Health Med, V5, P51, DOI 10.7453/gahmj.2015.085; Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051; Shortell SM, 1998, JAMA-J AM MED ASSOC, V280, P1102, DOI 10.1001/jama.280.12.1102; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; The British Psychological Society, COD ETH COND GUID PU; Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wampold BE, 2015, GREAT PSYCHOTHERAPY DEBATE: THE EVIDENCE FOR WHAT MAKES PSYCHOTHERAPY WORK, 2ND EDITION, P1; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Weech-Maldonado R, 2012, MED CARE, V50, pS22, DOI 10.1097/MLR.0b013e318263134b; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright EB, 2004, BMJ-BRIT MED J, V328, P864, DOI 10.1136/bmj.38046.771308.7C	54	244	247	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170988	10.1371/journal.pone.0170988	http://dx.doi.org/10.1371/journal.pone.0170988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170443	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500015
J	Dupret, V; Sanchez, S; Goujet, D; Ahlberg, PE				Dupret, Vincent; Sanchez, Sophie; Goujet, Daniel; Ahlberg, Per Erik			The internal cranial anatomy of Romundina stellina Orvig, 1975 (Vertebrata, Placodermi, Acanthothoraci) and the origin of jawed vertebrates-Anatomical atlas of a primitive gnathostome	PLOS ONE			English	Article							ARTHRODIRA; MORPHOLOGY; BRAINCASE; CHINA; GENUS; FISH; ACTINOLEPIDA; EVOLUTION; LAMPREY; EAR	Placoderms are considered as the first jawed vertebrates and constitute a paraphyletic group in the stem-gnathostome grade. The acanthothoracid placoderms are among the phylogenetically most basal and morphologically primitive gnathostomes, but their neurocranial anatomy is poorly understood. Here we present a near-complete three-dimensional skull of Romundina stellina, a small Early Devonian acanthothoracid from the Canadian Arctic Archipelago, scanned with propagation phase contrast microtomography at a 7.46 mu m isotropic voxel size at the European Synchrotron Radiation Facility, Grenoble, France. This is the first model of an early gnathostome skull produced using this technique, and as such represents a major advance in objectivity compared to past descriptions of placoderm neurocrania on the basis of grinding series. Despite some loss of material along an oblique crack, most of the internal structures are remarkably preserved, and most of the missing structures can be reconstructed by symmetry. This virtual approach offers the possibility to connect with certainty all the external foramina to the blood and nerve canals and the central structures, and thus identify accurate homologies without destroying the specimen. The high level of detail enables description of the main arterial, venous and nerve canals of the skull, and other perichondrally ossified endocranial structures such as the palatoquadrate articulations, the endocranial cavity and the inner ear cavities. The braincase morphology appears less extreme than that of Brindabellaspis, and is in some respects more reminiscent of a basal arthrodire such as Kujdanowiaspis.	[Dupret, Vincent; Sanchez, Sophie; Ahlberg, Per Erik] Sci Life Lab, Se Uppsala, Sweden; [Dupret, Vincent; Sanchez, Sophie; Ahlberg, Per Erik] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Se Uppsala, Sweden; [Sanchez, Sophie] European Synchrotron Radiat Facil, Grenoble, France; [Goujet, Daniel] UPMC Paris 6, CNRS, MNHN, CR2P UMR 7207,Sorbonne Univ,Museum Natl Hist Nat, Paris, France; [Dupret, Vincent] Australian Natl Univ, Dept Appl Math, Res Sch Phys & Engn, Canberra, ACT, Australia	Uppsala University; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Australian National University	Dupret, V; Ahlberg, PE (corresponding author), Sci Life Lab, Se Uppsala, Sweden.; Dupret, V; Ahlberg, PE (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Se Uppsala, Sweden.; Dupret, V (corresponding author), Australian Natl Univ, Dept Appl Math, Res Sch Phys & Engn, Canberra, ACT, Australia.	vincent.dupret@anu.edu.au; Per.Ahlberg@ebc.uu.se	Sanchez, Sophie/AAE-1168-2022; Dupret, Vincent/L-2306-2015	Dupret, Vincent/0000-0002-6859-1041; Ahlberg, Per/0000-0001-9054-2900; Sanchez, Sophie/0000-0002-3611-6836	European Research Council Advanced Investigator Grant [233111]; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; ESRF; Museum National d'Histoire Naturelle	European Research Council Advanced Investigator Grant(European Research Council (ERC)); Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; ESRF; Museum National d'Histoire Naturelle	This work was funded by European Research Council Advanced Investigator Grant 233111 (https://erc.europa.eu/)-funding only; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/)-funding only; and ESRF (https://www.esrf.en)-data collection (microtromography). The Museum National d'Histoire Naturelle provided support in the form of salaries for author DG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BROILI FERDINAND, 1929, SITZUNGSBER MATH NATURWISS ABT BAYERISCHEN AKAD WISS MUNCHEN, V1929, P143; CARR RK, 1991, ZOOL J LINN SOC-LOND, V103, P349, DOI 10.1111/j.1096-3642.1991.tb00909.x; Clement AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141277; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; De Iuliis G., 2007, DISSECTION VERTEBRAT; Denison R. H, 1978, PLACODERMI; Dennis-Bryan Kim, 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P127; Dupret V, 2008, GEOL MAG, V145, P257, DOI 10.1017/S0016756807004207; Dupret V, 2010, 1975 COMPTE RENDUS P, V9, P369; Dupret V., 2004, FOSSILS STRATA, V50, P40; Dupret V, 2007, J VERTEBR PALEONTOL, V27, P266, DOI 10.1671/0272-4634(2007)27[266:ANGOPA]2.0.CO;2; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dupret V, 2010, GEODIVERSITAS, V32, P5, DOI 10.5252/g2010n1a1; Dupret V, 2009, ZOOL J LINN SOC-LOND, V157, P70, DOI 10.1111/j.1096-3642.2009.00519.x; Francillon-Vieillot H., 1990, P471; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Giles S, 2015, NATURE; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Goujet D., 1975, C INT CTR NAT RECH S, V218, P81; Goujet D, 1984, POISSONS PLACODERMES; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Gross W., 1959, Palaeontographica, V113A, P1; Gross W., 1958, Jahrbuch der Geologischen Bundesanstalt Wien, V101, P139; Hall B.K., 2015, BONES CARTILAGE DEV; Heintz, 1932, BASHFORD DEAN MEMORI, V4, P115; Hirasawa T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0007-7; Hueter RE, 2004, CRC MAR BIOL SER, P325; Jaekel O., 1919, SITZUNGSERICHTEN GES, V1919, P6; Janvier P., 1981, Palaeovertebrata (Montpellier), V11, P19; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; Janvier P., 1985, CEPHALASPIDES SPITZB; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johnson HG, 2000, ZOOL J LINN SOC-LOND, V129, P241, DOI 10.1006/zjls.1999.0206; King B, 2016, SYSTEMATIC BIOL; Kuratani S, 1999, DEV BIOL, V210, P381, DOI 10.1006/dbio.1999.9266; Kuratani S, 2005, J ANAT, V207, P489, DOI 10.1111/j.1469-7580.2005.00483.x; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lelievre H, 2009, J VERTEBR PALEONTOL, V29, P584, DOI 10.1671/039.029.0233; Liu Yu-hai, 1991, P139; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Luksevics E, 2001, J VERTEBR PALEONTOL, V21, P687, DOI 10.1671/0272-4634(2001)021[0687:TONAOA]2.0.CO;2; Luksevics E., 1999, LATVIJAS GEOLOGIJAS, V7, P12; Lychakov DV, 2000, FISH RES, V46, P27, DOI 10.1016/S0165-7836(00)00130-2; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P807, DOI 10.1671/0272-4634(2001)021[0807:CSRNCF]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey JG, 2001, J MORPHOL, V250, P236, DOI 10.1002/jmor.1068; Maisey JG, 2002, MAJOR EVENTS EARLY V, P263; Marss T., 2007, AGNATHA; McCoy F., 1848, ANN MAGAZINE NATURAL, V2, P1, DOI DOI 10.1080/03745485809496133; MILES RS, 1971, PHILOS T R SOC B, V263, P101, DOI 10.1098/rstb.1971.0111; Miller H., 1841, OLD RED SANDSTONES N; Millot J., 1958, ANATOMIE LATIMERIA C; Novitskaya LI., 1983, MORPHOLOGIJA DREVNIC; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Olive S, 2011, GEODIVERSITAS, V33, P393, DOI 10.5252/g2011n3a1; Orvig T., 1975, PROBLEMES ACTUELS PA, V218, P41; Orvig T., 1962, EXTRAIT C INT CTR NA, V104, P49; Ota KG, 2007, INTEGR COMP BIOL, P1; Pan Z-H, 2015, COMPTES RENDUS PALEV; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Retzius MG., 1881, GEHORORGAN WIERBELTH; Schultze HP, 2009, ACTA ZOOL-STOCKHOLM, V90, P22, DOI 10.1111/j.1463-6395.2008.00354.x; Smith R. E., 1980, GEOLOGICAL SURVEY CA, V308, P1, DOI DOI 10.4095/106238; Sollas WJ, 1904, PHILOS T R SOC LON B, V196, P257; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; Stensio E., 1963, Skr Norske Vidensk-Akad Oslo Mat Nat Kl (NS), V13, P1; STENSIO E, 1971, Annales de Paleontologie Vertebres, V57, P1; Stensio E, 1934, KUNGLICA SVENSKA VET, V3, P1; Stensio E., 1948, PALAEOZOOL GROENL, V2, P5; STENSIO E., 1939, MEDDELELSER GRONLAND, V97, P1; Stensio E., 1963, TAXONOMIC APPENDIX K, V9, P1; Stensio E., 1931, MEDDELELSER GRONLAND, V86, P1; Stensio E., 1942, KUNGLIGA SVENSKA VET, V20, P1; Stensio E., 1950, CAVITE LABYRINTHIQUE, P9; Stensio E., TRAITE ZOOLOGIE; Stensio E. A., 1936, Mudd Gronland, V97, P1; Stensio E. A., 1945, K SVENSKA VETENSKAPSAKAD HANDL, V22, P1; Stensio E. A., 1947, Kungliga Svenska Vetenskapsakademiens Handlingar Stockholm (3), V24, P1; Stensio E. A., 1925, Field Museum Publications Chicago Geological Series, V4, P87; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; STENSIO ERIK, 1959, K SVENSKA VETENSKAPSAKAD HANDL, V8, P1; STENSIO ERIK A, 1934, MEDDELELSER OM GRONLAND, V97, P1; Stensio Erik A., 1944, ARKIV ZOOL [STOCKHOLM], V35A, P1; TESTER AL, 1972, PAC SCI, V26, P264; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Trinajstic K, 2012, J VERTEBR PALEONTOL, V32, P757, DOI 10.1080/02724634.2012.661379; VANDERBRUGGHEN W, 1993, NATURE, V364, P107; WHITE E I, 1972, Bulletin of the British Museum (Natural History) Geology, V22, P379; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Woodward A. S., 1891, CATALOGUE FOSSIL FIS; Yopak KE, 2008, BRAIN BEHAV EVOLUT, V71, P287, DOI 10.1159/000127048; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; Young GC, 2008, BIOL LETTERS, V4, P110, DOI 10.1098/rsbl.2007.0545; Young Gavin C., 1991, P67; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; YOUNG GC, 1984, PALAEONTOLOGY, V27, P635; Young GC, 1980, ZOOLOGICAL J LINNEAN, V66, P309; Zhu M, 1996, J VERTEBR PALEONTOL, V16, P1, DOI 10.1080/02724634.1996.10011278; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; [No title captured]	106	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171241	10.1371/journal.pone.0171241	http://dx.doi.org/10.1371/journal.pone.0171241			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170434	Green Submitted, Green Published, gold			2022-12-27	WOS:000393705500025
J	Ciesielska, A; Samaranch, L; San Sebastian, W; Dickson, DW; Goldman, S; Forsayeth, J; Bankiewicz, KS				Ciesielska, Agnieszka; Samaranch, Lluis; San Sebastian, Waldy; Dickson, Dennis W.; Goldman, Samuel; Forsayeth, John; Bankiewicz, Krystof S.			Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; CONVECTION-ENHANCED DELIVERY; L-DOPA THERAPY; BASAL GANGLIA; AAV-HAADC; MONKEYS; SEROTONIN; STRIATUM; LEVODOPA; NEURONS	In Parkinson's disease (PD), aromatic L-amino acid decarboxylase (AADC) is the rate-limiting enzyme in the conversion of L-DOPA (Sinemet) to dopamine (DA). Previous studies in PD animal models demonstrated that lesion of dopaminergic neurons is associated with profound loss of AADC activity in the striatum, blocking efficient conversion of L-DOPA to DA. Relatively few studies have directly analyzed AADC in PD brains. Thus, the aim of this study was to gain a better understanding of regional changes in AADC activity, DA, serotonin and their monoamine metabolites in the striatum of PD patients and experimentally lesioned animals (rat and MPTP-treated nonhuman primate, NHP). Striatal AADC activity was determined postmortem in neuropathologically confirmed PD subjects, animal models and controls. A regional analysis was performed for striatal AADC activity and monoamine levels in NHP tissue. Interestingly, analysis of putaminal AADC activity revealed that control human striatum contained much less AADC activity than rat and NHP striata. Moreover, a dramatic loss of AADC activity in PD striatum compared to controls was detected. In MPTP-treated NHP, caudate nucleus was almost as greatly affected as putamen, although mean DA turnover was higher in caudate nucleus. Similarly, DA and DA metabolites were dramatically reduced in different regions of PD brains, including caudate nucleus, whereas serotonin was relatively spared. After L-DOPA administration in MPTP-treated NHP, very poor conversion to DA was detected, suggesting that AADC in NHP nigrostriatal fibers is mainly responsible for L-DOPA to DA conversion. These data support further the rationale behind viral gene therapy with AAV2-hAADC to restore AADC levels in putamen and suggest further the advisability of expanding vector delivery to include coverage of anterior putamen and the caudate nucleus.	[Ciesielska, Agnieszka; Samaranch, Lluis; San Sebastian, Waldy; Forsayeth, John; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Dickson, Dennis W.] Mayo Clin, Jacksonville, FL 32224 USA; [Goldman, Samuel] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Mayo Clinic; University of California System; University of California San Francisco	Bankiewicz, KS (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	Krystof.Bankiewicz@ucsf.edu	Samaranch, Lluis/AAU-8464-2021; Goldman, Samuel/A-2225-2014	Samaranch, Lluis/0000-0001-8151-473X; Goldman, Samuel/0000-0002-3039-9927	Kinetics Foundation	Kinetics Foundation	This study was funded by an unrestricted gift from the Kinetics Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Aminoff MJ, 2001, NEUROL CLIN, V19, P119, DOI 10.1016/S0733-8619(05)70008-6; Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5; Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Brooks DJ, 2011, PROG NEUROBIOL, V95, P614, DOI 10.1016/j.pneurobio.2011.08.009; Carta M, 2010, MOVEMENT DISORD, V25, pS174, DOI 10.1002/mds.22792; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Ciesielska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122708; Doroudchi MM, 2005, J NEUROCHEM, V93, P634, DOI 10.1111/j.1471-4159.2005.03048.x; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; GERMAN DC, 1993, J COMP NEUROL, V331, P297, DOI 10.1002/cne.903310302; GIBB JW, 1990, NEUROTOXICOLOGY, V11, P317; GOLDSTEIN DJ, 1988, ARCH NEUROL-CHICAGO, V45, P715, DOI 10.1001/archneur.1988.00520310017009; Huot P, 2013, PHARMACOL REV, V65, P171, DOI 10.1124/pr.111.005678; Ikemoto K, 1997, NEUROSCI LETT, V232, P111, DOI 10.1016/S0304-3940(97)00587-9; Johnston LC, 2008, MOL THER, V16, P1392, DOI 10.1038/mt.2008.113; Kells AP, 2010, J NEUROSCI, V30, P9567, DOI 10.1523/JNEUROSCI.0942-10.2010; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; Lima MMS, 2012, CNS NEUROL DISORD-DR, V11, P439; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; MARICLE RA, 1995, MOVEMENT DISORD, V10, P329, DOI 10.1002/mds.870100316; MARICLE RA, 1995, NEUROLOGY, V45, P1757, DOI 10.1212/WNL.45.9.1757; Melamed E, 1996, ADV NEUROL, V69, P545; Mittermeyer G, 2012, HUM GENE THER, V23, P377, DOI 10.1089/hum.2011.220; Nagatsu T, 2007, J NEURAL TRANSM-SUPP, P113; NAGATSU T, 1979, ANAL BIOCHEM, V100, P160, DOI 10.1016/0003-2697(79)90126-X; NYBERG P, 1985, BRAIN RES, V333, P139, DOI 10.1016/0006-8993(85)90133-7; Oiwa Y, 2003, FRONT BIOSCI, V8, pA155, DOI 10.2741/1104; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Poewe Werner, 2009, Parkinsonism Relat Disord, V15 Suppl 4, pS28, DOI 10.1016/S1353-8020(09)70831-4; Ravina B, 2012, MOVEMENT DISORD, V27, P1392, DOI 10.1002/mds.25157; Rickards H, 2005, J NEUROL NEUROSUR PS, V76, pI48, DOI 10.1136/jnnp.2004.060426; Sanchez-Pernaute R, 2001, MOL THER, V4, P324, DOI 10.1006/mthe.2001.0466; SKIRBOLL S, 1990, EXP NEUROL, V110, P187, DOI 10.1016/0014-4886(90)90029-R; Stoessl A Jon, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS55, DOI 10.1016/S1353-8020(11)70019-0; Stoessl AJ, 2011, LANCET NEUROL, V10, P987, DOI 10.1016/S1474-4422(11)70214-9; Vriend C, 2014, J NEUROL NEUROSUR PS, V85, P159, DOI 10.1136/jnnp-2012-304811; Whone AL, 2003, ANN NEUROL, V53, P206, DOI 10.1002/ana.10427	41	20	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0169965	10.1371/journal.pone.0169965	http://dx.doi.org/10.1371/journal.pone.0169965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166239	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100003
J	Fan, M; Li, H; Wang, SJ; Zheng, B; Zhang, J; Li, LH				Fan, Ming; Li, Hui; Wang, Shijian; Zheng, Bin; Zhang, Juan; Li, Lihua			Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer	PLOS ONE			English	Article							IMAGING FEATURES; NEOADJUVANT CHEMOTHERAPY; RADIOGENOMIC ANALYSIS; HETEROGENEITY; RECURRENCE; BIOMARKERS; DIAGNOSIS; THERAPY; IMAGES; IMMUNOHISTOCHEMISTRY	The purpose of this study was to investigate the role of features derived from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and to incorporated clinical information to predict the molecular subtypes of breast cancer. In particular, 60 breast cancers with the following four molecular subtypes were analyzed: luminal A, luminal B, human epidermal growth factor receptor-2 (HER2)-over-expressing and basal-like. The breast region was segmented and the suspicious tumor was depicted on sequentially scanned MR images from each case. In total, 90 features were obtained, including 88 imaging features related to morphology and texture as well as dynamic features from tumor and background parenchymal enhancement (BPE) and 2 clinical information-based parameters, namely, age and menopausal status. An evolutionary algorithm was used to select an optimal subset of features for classification. Using these features, we trained a multi-class logistic regression classifier that calculated the area under the receiver operating characteristic curve (AUC). The results of a prediction model using 24 selected features showed high overall classification performance, with an AUC value of 0.869. The predictive model discriminated among the luminal A, luminal B, HER2 and basal-like subtypes, with AUC values of 0.867, 0.786, 0.888 and 0.923, respectively. An additional independent dataset with 36 patients was utilized to validate the results. A similar classification analysis of the validation dataset showed an AUC of 0.872 using 15 image features, 10 of which were identical to those from the first cohort. We identified clinical information and 3D imaging features from DCE-MRI as candidate biomarkers for discriminating among four molecular subtypes of breast cancer.	[Fan, Ming; Li, Hui; Wang, Shijian; Zheng, Bin; Li, Lihua] Hangzhou Dianzi Univ, Inst Biomed Engn & Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Zheng, Bin] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA; [Zhang, Juan] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China	Hangzhou Dianzi University; University of Oklahoma System; University of Oklahoma - Norman; Zhejiang Cancer Hospital	Li, LH (corresponding author), Hangzhou Dianzi Univ, Inst Biomed Engn & Instrumentat, Hangzhou, Zhejiang, Peoples R China.; Zhang, J (corresponding author), Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China.	zhangjuan_496@163.com; lilh@hdu.edu.cn			National Natural Science Foundation of China [61401131, 61271063]; National Basic Research Program of China (973 Program) [2013CB329502]; Natural Science Foundation of Zhejiang Province of China [LZ15F010001, LQ14F010011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the financial support of the National Natural Science Foundation of China (61401131 and 61271063), the National Basic Research Program of China (973 Program) (2013CB329502), and the Natural Science Foundation of Zhejiang Province of China (LZ15F010001 and LQ14F010011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by financial support from the National Natural Science Foundation of China (61271063 and 61401131), the National Basic Research Program of China (973 Program) (2013CB329502), and the Natural Science Foundation of Zhejiang Province of China (LZ15F010001 and LQ14F010011).	Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197; Blaschke E, 2015, J MAGN RESON IMAGING, V42, P920, DOI 10.1002/jmri.24884; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; Costantini M, 2012, CLIN BREAST CANCER, V12, P331, DOI 10.1016/j.clbc.2012.07.002; Crabb SJ, 2008, CLIN BREAST CANCER, V8, P249, DOI 10.3816/CBC.2008.n.028; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Engstrom MJ, 2013, BREAST CANCER RES TR, V140, P463, DOI 10.1007/s10549-013-2647-2; Foroutan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082875; Fusco R, 2016, J MED BIOL ENG, V36, P449, DOI 10.1007/s40846-016-0163-7; Fusco R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/237863; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grimm LJ, 2016, J MAGN RESON IMAGING, V43, P1269, DOI 10.1002/jmri.25116; Grimm LJ, 2015, J MAGN RESON IMAGING, V42, P902, DOI 10.1002/jmri.24879; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; King AD, 2013, RADIOLOGY, V266, P531, DOI 10.1148/radiol.12120167; Koo HR, 2012, J MAGN RESON IMAGING, V36, P145, DOI 10.1002/jmri.23635; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Mazurowski MA, 2015, J AM COLL RADIOL, V12, P862, DOI 10.1016/j.jacr.2015.04.019; Mazurowski MA, 2014, RADIOLOGY, V273, P365, DOI 10.1148/radiol.14132641; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Parikh J, 2014, RADIOLOGY, V272, P100, DOI 10.1148/radiol.14130569; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Scutt D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1388; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sung JS, 2013, BREAST J, V19, P643, DOI 10.1111/tbj.12182; Sutton EJ, 2016, J MAGN RESON IMAGING; Sutton EJ, 2015, J MAGN RESON IMAGING, V42, P1398, DOI 10.1002/jmri.24890; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Witten I. H., DATA MINING PRACTICA; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yamaguchi K, 2015, BREAST CANCER-TOKYO, V22, P496, DOI 10.1007/s12282-013-0512-0; Yamamoto S, 2012, AM J ROENTGENOL, V199, P654, DOI 10.2214/AJR.11.7824; Yang Q, 2015, MED PHYS, V42, P103, DOI 10.1118/1.4903280; Yang Q, 2014, EUR J RADIOL, V83, P1086, DOI 10.1016/j.ejrad.2014.03.014; Yang Q, 2014, J DIGIT IMAGING, V27, P152, DOI 10.1007/s10278-013-9617-4; Yoo C, 2012, J BREAST CANCER, V15, P203, DOI 10.4048/jbc.2012.15.2.203; Zhang C, 2014, MED IMAGING 2014 IMA; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655	48	92	103	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171683	10.1371/journal.pone.0171683	http://dx.doi.org/10.1371/journal.pone.0171683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166261	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100061
J	Kwiatkowska, A; Granicka, LH; Grzeczkowicz, A; Stachowiak, R; Kaminski, M; Grubek, Z; Bielecki, J; Strawski, M; Szklarczyk, M				Kwiatkowska, Angelika; Granicka, Ludomira H.; Grzeczkowicz, Anna; Stachowiak, Radoslaw; Kaminski, Michal; Grubek, Zuzanna; Bielecki, Jacek; Strawski, Marcin; Szklarczyk, Marek			Stabilized nanosystem of nanocarriers with an immobilized biological factor for anti-tumor therapy	PLOS ONE			English	Article								Objective The inadequate efficiency of existing therapeutic anti-cancer regiments and the increase in the multidrug resistance of cancer cells underscore the need to investigate novel anticancer strategies. The induction of apoptosis in tumors by cytotoxic agents produced by pathogenic microorganisms is an example of such an approach. Nevertheless, even the most effective drug should be delivered directly to targeted sites to reduce any negative impact on other cells. Accordingly, the stabilized nanosystem (SNS) for active agent delivery to cancer cells was designed for further application in local anti-tumor therapy. A product of genetically modified Escherichia coli, listeriolysin O (LLO), was immobilized within the polyelectrolyte membrane (poly(ethylenimine)lhyaluronic acid) shells of 'LLO nanocarriers' coupled with the stabilizing element of natural origin. Methods and results The impact of LLO was evaluated in human leukemia cell lines in vitro. Correspondingly, the influence of the SNS and its elements was assessed in vitro. The viability of targeted cells was evaluated by flow cytometry. Visualization of the system structure was performed using confocal microscopy. The membrane shell applied to the nanocarriers was analyzed using atomic force microscopy and Fourier transform infrared spectroscopy techniques. Furthermore, the presence of a polyelectrolyte layer on the nanocarrier surface and/or in the cell was confirmed by flow cytometry. Finally, the structural integrity of the SNS and the corresponding release of the fluorescent solute listeriolysin were investigated. Conclusion The construction of a stabilized system offers LLO release with a lethal impact on model eukaryotic cells. The applied platform design may be recommended for local anti-tumor treatment purposes.	[Kwiatkowska, Angelika; Granicka, Ludomira H.; Grzeczkowicz, Anna] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Stachowiak, Radoslaw; Kaminski, Michal; Grubek, Zuzanna; Bielecki, Jacek] Univ Warsaw, Dept Appl Microbiol, Fac Biol, Warsaw, Poland; [Strawski, Marcin; Szklarczyk, Marek] Univ Warsaw, Fac Chem, Lab Electrochem, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; University of Warsaw; University of Warsaw	Granicka, LH (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	l.granicka@ibib.waw.pl	Strawski, Marcin/ABD-2231-2020; Grzeczkowicz, Anna/G-3911-2016	Strawski, Marcin/0000-0002-8253-0878; Grzeczkowicz, Anna/0000-0002-8970-4578; Bielecki, Jacek/0000-0001-6533-2282; Stachowiak, Radoslaw/0000-0002-7207-9753	National Science Centre [DEC-2012/07/D/ST5/02257]	National Science Centre(National Science Centre, Poland)	This part of work was financed by The National Science Centre (the number of decisions: DEC-2012/07/D/ST5/02257).	Bienkowski K, 2011, J ELECTROANAL CHEM, V662, P196, DOI 10.1016/j.jelechem.2011.06.014; Carlini L, 2013, REV NANOSCI NANOTECH, V2; Center M., 2011, GLOBAL CANC FACTS FI; Chari RV, ACC CHEM RES, V41, P1; Craft N, J IMMUNOL, V175; Dejugnat C, 2004, LANGMUIR, V20, P7265, DOI 10.1021/la049706n; EKBLOM P, 1983, INT J CANC, V31; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Granicka L, 2014, MEMBRANES MEMBRANES, P355; Granicka L H, ARTIF CELL BLOOD SUB, V39, P5; Granicka L H, J BIOMED MAT RES A, V102; Granicka LH, 1996, ASAIO J, V42, pM863, DOI 10.1097/00002480-199609000-00114; Han F, 2013, J NANOSCI NANOTECHNO, V13, P6996, DOI 10.1166/jnn.2013.7759; Huang SK, 2013, BIOCHEM ENG J, V74, P20, DOI 10.1016/j.bej.2013.02.015; Itoh Y, 2004, CHEM LETT, V33; Jemal A, CA CANC J CLIN, V61; Jensen E R, J VIROL, V71; Kanavos P, 2006, ANN ONCOLOGY S8; Kurapati R, 2013, J MATER CHEM B, V1, P3175, DOI 10.1039/c3tb20192a; Lokeshwar VB, 2014, ADV CANCER RES, V123, P35, DOI 10.1016/B978-0-12-800092-2.00002-2; Lue SJ, 2013, J NANOSCI NANOTECHNO, V13, P5305, DOI 10.1166/jnn.2013.7532; Mainardes RM, 2012, J NANOSCI NANOTECHNO, V12, P8513, DOI 10.1166/jnn.2012.6638; Minotti G, 2004, PHARM REV, V2; Neu B, 2001, J MICROENCAPSUL, V18, P385; Pandey S, 2013, NANOSCI NANOTECHNOL, V5; Pollakis G, 1983, FEBS LETT, V2; SadAbadi H, 2013, J NANOSCI NANOTECHNO, V13; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Schuerch D W, 2005, P NAT ACAD SCI US, V102; Shen X, PROT ENG DES SEL, V22, P12; Song J, 2013, J NANOSCI NANOTECHNO, V13; Soto ER, 2008, BIOCONJUGATE CHEM, V19, P840, DOI 10.1021/bc700329p; Stachowiak R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/954375; Stachowiak R, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-77; Stewart W., 2014, WORLD CANC REPORT 20; Sun R, HUM VACC IMMUNOTHER, V9, P5; Theerasilp M, 2013, J MICROENCAPSUL, V30, P390, DOI 10.3109/02652048.2012.746746; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wadajkar A S, 2012, REV NANOSCI NANOTECH, V1; Wang N, BR J PHARM, V164, p2b; Wang X., 2013, MATH PROBL ENG, V2013, P13, DOI DOI 10.1109/ICCIS.2013.384; Yoshimura K, CANC RES, V66; Zaboronok A, 2013, NANOSCI NANOTECHNOL, V5; Zhao F, 2013, J NANOSCI NANOTECHNO, V13; Zhao L, 2013, J NANOSCI NANOTECHNO, V13	45	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170925	10.1371/journal.pone.0170925	http://dx.doi.org/10.1371/journal.pone.0170925			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166290	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100016
J	Choi, JW; Moon, S; Jang, EJ; Lee, CH; Park, JS				Choi, Jong Wook; Moon, Shinje; Jang, Eun Jung; Lee, Chang Hwa; Park, Joon-Sung			Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuria	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; CHRONIC KIDNEY-DISEASE; GENERAL-POPULATION; MENDELIAN RANDOMIZATION; GLUCOKINASE MUTATIONS; DIABETES-MELLITUS; RENAL-FAILURE; RISK; PREVALENCE; COMPLICATIONS	Increased glycemic exposure, even below the diagnostic criteria for diabetes mellitus, is crucial in the pathogenesis of diabetic microvascular complications represented by microalbuminuria. Nonetheless, there is limited evidence regarding which single nucleotide polymorphisms (SNPs) are associated with prediabetes and whether genetic predisposition to prediabetes is related to microalbuminuria, especially in the general population. Our objective was to answer these questions. We conducted a genomewide association study (GWAS) separately on two population-based cohorts, Ansung and Ansan, in the Korean Genome and Epidemiology Study (KoGES). The initial GWAS was carried out on the Ansung cohort, followed by a replication study on the Ansan cohort. A total of 5682 native Korean participants without a significant medical illness were classified into either control group (n = 3153) or prediabetic group (n = 2529). In the GWAS, we identified two susceptibility loci associated with prediabetes, one at 17p15.3-p15.1 in the GCK gene and another at 7p15.1 in YKT6. When variations in GCK and YKT6 were used as a model of prediabetes, this genetically determined prediabetes increased microalbuminuria. Multiple logistic regression analyses revealed that fasting glucose concentration in plasma and SNP rs2908289 in GCK were associated with microalbuminuria, and adjustment for age, gender, smoking history, systolic blood pressure, waist circumference, and serum triglyceride levels did not attenuate this association. Our results suggest that prediabetes and the associated SNPs may predispose to microalbuminuria before the diagnosis of diabetes mellitus. Further studies are needed to explore the details of the physiological and molecular mechanisms underlying this genetic association.	[Choi, Jong Wook; Lee, Chang Hwa; Park, Joon-Sung] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Moon, Shinje] Hallym Univ, Coll Med, Div Endocrinol & Metab, Seoul, South Korea; [Jang, Eun Jung] Korea Ctr Dis Control & Prevent, Cheongju, Chungcheongbuk, South Korea	Hanyang University; Hallym University; Korea Centers for Disease Control & Prevention (KCDC)	Lee, CH; Park, JS (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	changhwa@hanyang.ac.kr; sjpjoon@hanyang.ac.kr						[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Brouwers MCGJ, 2015, TRENDS MOL MED, V21, P583, DOI 10.1016/j.molmed.2015.08.004; Calmettes G, 2015, J MOL CELL CARDIOL, V78, P107, DOI 10.1016/j.yjmcc.2014.09.020; de Jong PE, 2003, NEPHROL DIAL TRANSPL, V18, P10, DOI 10.1093/ndt/18.1.10; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Gu Y, 2011, TRANSL RES, V157, P111, DOI 10.1016/j.trsl.2010.11.003; HAFFNER SM, 1993, DIABETOLOGIA, V36, P1002, DOI 10.1007/BF02374491; Hishida A, 2014, J NEPHROL, V27, P143, DOI 10.1007/s40620-013-0025-0; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Kim CH, 2014, DIABETES RES CLIN PR, V106, pE18, DOI 10.1016/j.diabres.2014.09.004; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kim Y, 2016, INT J EPIDEMIOL; Kitada M, 2010, J DIABETES INVEST, V1, P77, DOI 10.1111/j.2040-1124.2010.00018.x; Kivimaki M, 2008, EUR HEART J, V29, P2552, DOI 10.1093/eurheartj/ehn252; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Krolewski AS, 2012, SEMIN NEPHROL, V32, P407, DOI 10.1016/j.semnephrol.2012.07.002; Li H, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-24; Maeda S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000842; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Meigs JB, 2002, DIABETES CARE, V25, P977, DOI 10.2337/diacare.25.6.977; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; Ooe A, 2007, BREAST CANCER RES TR, V101, P305, DOI 10.1007/s10549-006-9293-x; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Packham DK, 2012, AM J KIDNEY DIS, V59, P75, DOI 10.1053/j.ajkd.2011.09.017; Pezzolesi MG, 2009, DIABETES, V58, P2698, DOI 10.2337/db09-0641; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Ruiz-Martinez M., 2016, ONCOTARGET; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Steele AM, 2014, JAMA-J AM MED ASSOC, V311, P279, DOI 10.1001/jama.2013.283980; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Szopa M, 2015, EUR J ENDOCRINOL, V172, P277, DOI 10.1530/EJE-14-0713; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Wasada T, 1997, DIABETES RES CLIN PR, V34, P157, DOI 10.1016/S0168-8227(96)01348-4; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Won JB, 2014, EVID BASED COMP ALTE, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083273; Xu W, 2013, INT J MOL SCI, V14, P6467, DOI 10.3390/ijms14036467	44	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171367	10.1371/journal.pone.0171367	http://dx.doi.org/10.1371/journal.pone.0171367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158221	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700067
J	Hausen, M; Soares, PP; Araujo, MP; Porto, F; Franchini, E; Bridge, CA; Gurgel, J				Hausen, Matheus; Soares, Pedro Paulo; Araujo, Marcus Paulo; Porto, Flavia; Franchini, Emerson; Bridge, Craig Alan; Gurgel, Jonas			Physiological responses and external validity of a new setting for taekwondo combat simulation	PLOS ONE			English	Article							HEART-RATE RESPONSES; PERCEIVED EXERTION; OXYGEN-UPTAKE; COMPETITION; EXERCISE; PERFORMANCE; FITNESS; ISSUES; MATCH; COST	Combat simulations have served as an alternative framework to study the cardiorespiratory demands of the activity in combat sports, but this setting imposes rule-restrictions that may compromise the competitiveness of the bouts. The aim of this study was to assess the cardiorespiratory responses to a full-contact taekwondo combat simulation using a safe and externally valid competitive setting. Twelve male national level taekwondo athletes visited the laboratory on two separate occasions. On the first visit, anthropometric and running cardiopulmonary exercise assessments were performed. In the following two to seven days, participants performed a full-contact combat simulation, using a specifically designed gas analyser protector. Oxygen uptake ((V) over dotO(2)), heart rate (HR) and capillary blood lactate measurements ([La-]) were obtained. Time-motion analysis was performed to compare activity profile. The simulation yielded broadly comparable activity profiles to those performed in competition, a mean (V) over dotO(2) of 36.6 +/- 3.9 ml.kg(-1).min(-1) (73 +/- 6% (V) over dotO(2PEAK)) and mean HR of 177 +/- 10 beats.min(-1) (93 +/- 5% HRPEAK). A peak (V) over dotO(2) of 44.8 +/- 5.0 ml.kg(-1).min(-1) (89 +/- 5% (V) over dotO(2PEAK)), a peak heart rate of 190 +/- 13 beats.min(-1) (98 +/- 3% HRmax) and peak [La-] of 12.3 +/- 2.9 mmol.L-1 was elicited by the bouts. Regarding time-motion analysis, combat simulation presented a similar exchange time, a shorter preparation time and a longer exchange-preparation ratio. Taekwondo combats capturing the full-contact competitive elements of a bout elicit moderate to high cardiorespiratory demands on the competitors. These data are valuable to assist preparatory strategies within the sport.	[Hausen, Matheus; Soares, Pedro Paulo; Araujo, Marcus Paulo; Gurgel, Jonas] Univ Fed Fluminense, Grad Program Cardiovasc Sci, Med Sci Ctr, Niteroi, RJ, Brazil; [Hausen, Matheus; Soares, Pedro Paulo; Araujo, Marcus Paulo; Porto, Flavia; Gurgel, Jonas] Univ Fed Fluminense, Biomech Res Grp, Niteroi, RJ, Brazil; [Porto, Flavia] Univ Estado Rio De Janeiro, Phys Educ & Sports Inst, Rio De Janeiro, Brazil; [Franchini, Emerson] Univ Sao Paulo, Sch Phys Educ & Sport, Mart Arts & Combat Sports Res Grp, Sao Paulo, Brazil; [Bridge, Craig Alan] Edge Hill Univ, Dept Sport & Phys Act, Sport & Exercise Res Grp, Ormskirk, England	Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Edge Hill University	Gurgel, J (corresponding author), Univ Fed Fluminense, Grad Program Cardiovasc Sci, Med Sci Ctr, Niteroi, RJ, Brazil.; Gurgel, J (corresponding author), Univ Fed Fluminense, Biomech Res Grp, Niteroi, RJ, Brazil.	jonasgurgel@terra.com.br	Franchini, Emerson/B-9119-2012; Porto, Flávia/AAO-4142-2021; da Silva Soares, Pedro Paulo/AAM-7383-2021	Franchini, Emerson/0000-0002-0769-8398; Porto, Flávia/0000-0002-3811-3188; da Silva Soares, Pedro Paulo/0000-0001-9589-4294; Hausen, Matheus/0000-0001-5736-0865; Bridge, Craig/0000-0002-9109-5185	FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/190.233/2013]	FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by FAPERJ - Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Grant E-26/190.233/2013) http://www.faperj.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MP, 2015, J STRENGTH COND RES; Atkinson G, 2001, J SPORT SCI, V19, P811, DOI 10.1080/026404101317015447; Beneke R, 2004, EUR J APPL PHYSIOL, V92, P518, DOI 10.1007/s00421-004-1073-x; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bouhlel E, 2006, SCI SPORT, V21, P285, DOI 10.1016/j.scispo.2006.08.003; Bridge CA, 2013, INT J SPORTS MED, V34, P573, DOI 10.1055/s-0032-1327578; Bridge CA, 2007, J STRENGTH COND RES, V21, P718; Bridge CA, 2014, SPORTS MED, V44, P713, DOI 10.1007/s40279-014-0159-9; Bridge CA, 2011, INT J SPORT PHYSIOL, V6, P344, DOI 10.1123/ijspp.6.3.344; Bridge CA, 2009, INT J SPORT PHYSIOL, V4, P485, DOI 10.1123/ijspp.4.4.485; Butios S, 2007, J SPORT MED PHYS FIT, V47, P179; Capranica L, 2012, EUR J APPL PHYSIOL, V112, P647, DOI 10.1007/s00421-011-2023-z; Chiodo S, 2011, J STRENGTH COND RES, V25, P334, DOI 10.1519/JSC.0b013e3182027288; Crisafulli A, 2009, APPL PHYSIOL NUTR ME, V34, P143, DOI 10.1139/H09-002; Cunha FA, 2013, EUR J APPL PHYSIOL, V113, P1441, DOI 10.1007/s00421-012-2571-x; da Cunha FA, 2011, J SCI MED SPORT, V14, P46, DOI 10.1016/j.jsams.2010.07.008; da Silva SC, 2012, PULM MED, V2012, DOI 10.1155/2012/542402; Campos FAD, 2012, EUR J APPL PHYSIOL, V112, P1221, DOI 10.1007/s00421-011-2071-4; Doria C, 2009, EUR J APPL PHYSIOL, V107, P603, DOI 10.1007/s00421-009-1154-y; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Glass S, 2007, MED AC S ACSMS MET C; Haddad M, 2011, J HUM KINET, V29, P59, DOI 10.2478/v10078-011-0040-y; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Matthews CE, 1999, MED SCI SPORT EXER, V31, P486, DOI 10.1097/00005768-199903000-00019; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; Lopes-Silva JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142078; Santos VGF, 2011, J STRENGTH COND RES, V25, P1743, DOI 10.1519/JSC.0b013e3181ddfb0f; Shephard RJ, 1988, J SPORTS MED PHYS FI, V5, P185; Tabben M, 2015, J SPORT SCI, V33, P841, DOI 10.1080/02640414.2014.965192; Tanner RK, 2010, EUR J APPL PHYSIOL, V109, P551, DOI 10.1007/s00421-010-1379-9; Tomczak M., 2014, TRENDS SPORT SCI, V1, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; World Taekwondo Federation, 2015, COMP RUL INT	34	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171553	10.1371/journal.pone.0171553	http://dx.doi.org/10.1371/journal.pone.0171553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158252	Green Published, gold			2022-12-27	WOS:000396161700099
J	Li, Q; Zhong, SF; Sun, SF; Fatima, SA; Zhang, M; Chen, WQ; Huang, QL; Tang, SW; Luo, PG				Li, Qing; Zhong, Shengfu; Sun, Sifan; Fatima, Syeda Akash; Zhang, Min; Chen, Wanquan; Huang, Qianglan; Tang, Shengwen; Luo, Peigao			Differential effect of whole-ear shading after heading on the physiology, biochemistry and yield index of stay-green and non-stay-green wheat genotypes	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; PHOTOSYNTHETIC PRODUCTIVITY; SUPEROXIDE-DISMUTASE; GRAIN-YIELD; RESISTANCE; CHROMOSOME; PEROXIDASE; CULTIVARS; RADIATION; GROWTH	Two winter wheat cultivars (the functional stay-green CN12 and non-stay-green CN19) were used to investigate the effects of ear-shading on grain yield and to elucidate the differential mechanisms of different cultivars. The photosynthetic parameters, chlorophyll fluorescence, antioxidant enzyme activities, and chlorophyll contents were measured 0, 15 and 30 days after heading (DAH) under both shaded and non-shaded conditions. The final grain-yield index was also measured. Shading had a smaller effect on the net photosynthetic rate (Pn), intercellular CO2 concentration (Ci), stomatal conductance (Gs), maximal photochemical efficiency of PSII (Fv/Fm) and coefficient of non-photochemical fluorescence quenching (qN) but a greater effect on both superoxide dismutase (SOD) and catalase (CAT) activities in CN12 than it did in CN19. Shading slightly altered the timeframe of leaf senescence in CN12 and may have accelerated leaf senescence in CN19. Moreover, shading had only a small effect on the weight of grains per spike (WGS) in CN12 compared with CN19, mainly resulting from the number of grains per spike (NGS) rather than the 1000-grain weight (SGW). In conclusion, the flag leaves of functional stay-green wheat could serve as potential "buffers" and/or "compensators" for ear photosynthesis, which is actively regulated by the antioxidant enzyme system and prevents yield loss. Thus, a functional stay-green genotype could be more tolerant to environmental stress than a non-stay-green genotype.	[Li, Qing; Zhong, Shengfu; Sun, Sifan; Fatima, Syeda Akash; Zhang, Min; Huang, Qianglan; Tang, Shengwen; Luo, Peigao] Sichuan Agr Univ, Prov Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China; [Li, Qing] Chongqing Ind & Trade Polytech, Dept Biol & Chem, Chongqing, Peoples R China; [Chen, Wanquan; Luo, Peigao] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China	Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Luo, PG (corresponding author), Sichuan Agr Univ, Prov Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China.; Luo, PG (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China.	lpglab@sicau.edu.cn	Fatima, Akash/ABH-9427-2020	Fatima, Akash/0000-0003-3660-7165	National Natural Science Foundation of China [31271721, 31571661]; Committee of Science and Technology of Fuling of Chongqing [FLKJ-2015ABB1048]; Chongqing Industry and Trade Polytechnic [ZR201507]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology of Fuling of Chongqing; Chongqing Industry and Trade Polytechnic	This work was supported by the National Natural Science Foundation of China (31271721 and 31571661), the Committee of Science and Technology of Fuling of Chongqing (FLKJ-2015ABB1048) and Chongqing Industry and Trade Polytechnic (ZR201507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bestwick CS, 1998, PLANT PHYSIOL, V118, P1067, DOI 10.1104/pp.118.3.1067; Chen JB, 2010, ACTA PHYSIOL PLANT, V32, P875, DOI 10.1007/s11738-010-0475-0; Chuartzman SG, 2008, PLANT CELL, V20, P1029, DOI 10.1105/tpc.107.055830; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; Guo JW, 2015, CEREAL RES COMMUN, V43, P364, DOI 10.1556/0806.43.2015.014; Guo ZJ, 2014, FIELD CROP RES, V166, P102, DOI 10.1016/j.fcr.2014.06.004; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Herrmann B, 1998, PHYSIOL PLANTARUM, V103, P320, DOI 10.1034/j.1399-3054.1998.1030304.x; KEMP DR, 1980, AUST J PLANT PHYSIOL, V7, P501, DOI 10.1071/PP9800501; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Li HW, 2010, J GENET GENOMICS, V37, P399, DOI 10.1016/S1673-8527(09)60058-8; Li HW, 2010, EUR J AGRON, V33, P267, DOI 10.1016/j.eja.2010.07.002; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Luo PG, 2008, CAN J PLANT PATHOL, V30, P254, DOI 10.1080/07060661.2008.10540540; Luo PG, 2013, PLANT CELL ENVIRON, V36, P683, DOI 10.1111/pce.12006; Luo PG, 2008, GENOME, V51, P922, DOI 10.1139/G08-079; Luo PG, 2009, CAN J PLANT SCI, V89, P1, DOI 10.4141/CJPS07072; Luo Pei-Gao, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P330; Luo PG, 2006, CHINESE SCI BULL, V51, P2595, DOI 10.1007/s11434-006-2175-0; Luo PG, 2005, PHYTOPATHOLOGY, V95, P1266, DOI 10.1094/PHYTO-95-1266; Ma LX, 2015, PHYSIOL MOL PLANT P, V90, P39, DOI 10.1016/j.pmpp.2015.02.005; Mahalakshmi V, 2002, CROP SCI, V42, P965, DOI 10.2135/cropsci2002.0965; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Maydup ML, 2012, FIELD CROP RES, V134, P208, DOI 10.1016/j.fcr.2012.06.008; Maydup ML, 2010, FIELD CROP RES, V119, P48, DOI 10.1016/j.fcr.2010.06.014; Mu H, 2010, J AGRON CROP SCI, V196, P38, DOI 10.1111/j.1439-037X.2009.00394.x; Nigro D, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/629379; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Qin XL, 2015, FIELD CROP RES, V177, P117, DOI 10.1016/j.fcr.2015.03.013; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Saxena I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00570; Shao HB, 2005, COLLOID SURFACE B, V45, P7, DOI 10.1016/j.colsurfb.2005.06.016; Spano G, 2003, J EXP BOT, V54, P1415, DOI 10.1093/jxb/erg150; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Tang ZX, 2008, GENOME, V51, P399, DOI 10.1139/G08-027; Tang ZongXiang, 2006, Agricultural Sciences in China, V5, P417, DOI 10.1016/S1671-2927(06)60070-9; Thomas H, 2000, J EXP BOT, V51, P329, DOI 10.1093/jexbot/51.suppl_1.329; Wang FBA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161203; Wang Z, 2003, J AGRON CROP SCI, V189, P280, DOI 10.1046/j.1439-037X.2003.00041.x; Xu CL, 2016, J INTEGR AGR, V15, P63, DOI 10.1016/S2095-3119(15)61047-4; Xu D.Q., 1997, PLANT PHYSL COMMUN, V33, P241, DOI [10.13592/j.cnki.ppj.1997.04.001, DOI 10.13592/J.CNKI.PPJ.1997.04.001]; Yang SM, 2016, PLANT DIS, V100, P847, DOI 10.1094/PDIS-04-14-0398-RE; Zhang LF, 2014, SHANGHAI TEXTILE SCI, V42, P42; 任正隆, 2003, [麦类作物学报, Journal of triticeae crops], V23, P97; 任正隆, 2004, [麦类作物学报, Journal of triticeae crops], V24, P159	47	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171589	10.1371/journal.pone.0171589	http://dx.doi.org/10.1371/journal.pone.0171589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158297	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700104
J	Steineck, G; Skokic, V; Sjoberg, F; Bull, C; Alevronta, E; Dunberger, G; Bergmark, K; Wilderang, U; Oh, JH; Deasy, JO; Jornsten, R				Steineck, Gunnar; Skokic, Viktor; Sjoberg, Fei; Bull, Cecilia; Alevronta, Eleftheria; Dunberger, Gail; Bergmark, Karin; Wilderang, Ulrica; Oh, Jung Hun; Deasy, Joseph O.; Jornsten, Rebecka			Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; FECAL INCONTINENCE; BOOTSTRAP; DISEASE	Background During radiotherapy unwanted radiation to normal tissue surrounding the tumor triggers survivorship diseases; we lack a nosology for radiation-induced survivorship diseases that decrease bowel health and we do not know which symptoms are related to which diseases. Methods Gynecological-cancer survivors were followed-up two to 15 years after having undergone radiotherapy; they reported in a postal questionnaire the frequency of 28 different symptoms related to bowel health. Population-based controls gave the same information. With a modified factor analysis, we determined the optimal number of factors, factor loadings for each symptom, factor-specific factor-loading cutoffs and factor scores. Results Altogether data from 623 survivors and 344 population-based controls were analyzed. Six factors best explain the correlation structure of the symptoms; for five of these a statistically significant difference (P< 0.001, Mann-Whitney U test) was found between survivors and controls concerning factor score quantiles. Taken together these five factors explain 42 percent of the variance of the symptoms. We interpreted these five factors as radiation-induced syndromes that may reflect distinct survivorship diseases. We obtained the following frequencies, defined as survivors having a factor loading above the 95 percent percentile of the controls, urgency syndrome (190 of 623, 30 percent), leakage syndrome (164 of 623, 26 percent), excessive gas discharge (93 of 623, 15 percent), excessive mucus discharge (102 of 623, 16 percent) and blood discharge (63 of 623, 10 percent). Conclusion Late effects of radiotherapy include five syndromes affecting bowel health; studying them and identifying the underlying survivorship diseases, instead of the approximately 30 long- term symptoms they produce, will simplify the search for prevention, alleviation and elimination.	[Steineck, Gunnar; Skokic, Viktor; Sjoberg, Fei; Bull, Cecilia; Alevronta, Eleftheria; Bergmark, Karin; Wilderang, Ulrica] Univ Gothenburg, Inst Clin Sci, Div Clin Canc Epidemiol, Dept Oncol,Sahlgrenska Acad, Gothenburg, Sweden; [Steineck, Gunnar] Karolinska Inst, Div Clin Canc Epidemiol, Dept Pathol & Oncol, Stockholm, Sweden; [Dunberger, Gail] Ersta Skondal Univ Coll, Inst Caring Sci, Stockholm, Sweden; [Oh, Jung Hun; Deasy, Joseph O.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Jornsten, Rebecka] Chalmers, Gothenburg, Sweden	University of Gothenburg; Karolinska Institutet; Memorial Sloan Kettering Cancer Center; Chalmers University of Technology	Steineck, G (corresponding author), Univ Gothenburg, Inst Clin Sci, Div Clin Canc Epidemiol, Dept Oncol,Sahlgrenska Acad, Gothenburg, Sweden.; Steineck, G (corresponding author), Karolinska Inst, Div Clin Canc Epidemiol, Dept Pathol & Oncol, Stockholm, Sweden.	Gunnar.Steineck@gu.se	Steineck, Gunnar/W-1515-2019	Steineck, Gunnar/0000-0002-0787-3969; Oh, Jung Hun/0000-0001-8791-2755; Deasy, Joseph/0000-0002-9437-266X; Sjoberg, Fei/0000-0002-8305-7648	Swedish Cancer Society; King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden; Swedish state under the ALF agreement in Gbteborg and Stockholm; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden; Swedish state under the ALF agreement in Gbteborg and Stockholm; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Swedish Cancer Society, the King Gustav V Jubilee Clinic Cancer Foundation in Goteborg, Sweden, the Swedish state under the ALF agreement in Gbteborg and Stockholm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyev HJN, 2015, COLORECTAL DIS, V17, P2, DOI 10.1111/codi.12812; Andreyev HJN, 2015, FRONTLINE GASTROENTE, V6, P53, DOI 10.1136/flgastro-2014-100468; Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Choi J, 2010, STAT INTERFACE, V3, P429; Dunberger G, 2011, ACTA ONCOL, V50, P233, DOI 10.3109/0284186X.2010.535013; Dunberger G, 2010, INT J GYNECOL CANCER, V20, P449, DOI 10.1111/IGC.0b013e3181d373bf; Dunberger G, 2010, EUR J CANCER, V46, P606, DOI 10.1016/j.ejca.2009.10.023; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GILMAN A, 1963, AM J SURG, V105, P574, DOI 10.1016/0002-9610(63)90232-0; GOODMAN LS, 1946, JAMA-J AM MED ASSOC, V132, P126, DOI 10.1001/jama.1946.02870380008004; Jackson A, 2010, INT J RADIAT ONCOL, V76, pS155, DOI 10.1016/j.ijrobp.2009.08.074; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Mansson A, 2004, EUR UROL, V46, P195, DOI 10.1016/j.eururo.2004.04.010; Michalski JM, 2010, INT J RADIAT ONCOL, V76, pS123, DOI 10.1016/j.ijrobp.2009.03.078; Oh JH, 2016, METHODS INF MED, V55; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Steineck G, 2016, SEMIN RADIAT ONCOL, V26, P236, DOI 10.1016/j.semradonc.2016.03.002; Teo MTW, 2015, CLIN ONCOL-UK, V27, P656, DOI 10.1016/j.clon.2015.06.010; Yamauchi FI, 2015, MAGN RESON IMAGING, V33, P525, DOI 10.1016/j.mri.2015.02.006; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163	24	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171461	10.1371/journal.pone.0171461	http://dx.doi.org/10.1371/journal.pone.0171461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158314	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700081
J	Baslam, M; Baroja-Fernandez, E; Ricarte-Bermejo, A; Sanchez-Lopez, AM; Aranjuelo, I; Bahaji, A; Munoz, FJ; Almagro, G; Pujol, P; Galarza, R; Teixidor, P; Pozueta-Romero, J				Baslam, Marouane; Baroja-Fernandez, Edurne; Ricarte-Bermejo, Adriana; Maria Sanchez-Lopez, Angela; Aranjuelo, Iker; Bahaji, Abdellatif; Jose Munoz, Francisco; Almagro, Goizeder; Pujol, Pablo; Galarza, Regina; Teixidor, Pilar; Pozueta-Romero, Javier			Genetic and isotope ratio mass spectrometric evidence for the occurrence of starch degradation and cycling in illuminated Arabidopsis leaves	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; NUCLEAR-MAGNETIC-RESONANCE; SUGAR-BEET LEAVES; MAIZE ROOT-TIPS; TRANSITORY STARCH; BETA-AMYLASE; FUTILE CYCLES; CARBOHYDRATE-METABOLISM; CIRCADIAN REGULATION; SUSPENSION-CULTURES	Although there is a great wealth of data supporting the occurrence of simultaneous synthesis and breakdown of storage carbohydrate in many organisms, previous (CO2)-C-13 pulse-chase based studies indicated that starch degradation does not operate in illuminated Arabidopsis leaves. Here we show that leaves of gwd, sex4, bam4, barn1/bam3 and amy3/isa3/Ida starch breakdown mutants accumulate higher levels of starch than wild type (WT) leaves when cultured under continuous light (CL) conditions. We also show that leaves of CL grown dpel plants impaired in the plastidic disproportionating enzyme accumulate higher levels of maltotriose than WT leaves, the overall data providing evidence for the occurrence of extensive starch degradation in illuminated leaves. Moreover, we show that leaves of CL grown mexl/ pglct plants impaired in the chloroplastic maltose and glucose transporters display a severe dwarf phenotype and accumulate high levels of maltose, strongly indicating that the MEX1 and pGIcT transporters are involved in the export of starch breakdown products to the cytosol to support growth during illumination. To investigate whether starch breakdown products can be recycled back to starch during illumination through a mechanism involving ADP-glucose pyrophosphorylase (AGP) we conducted kinetic analyses of the stable isotope carbon composition (delta C-13) in starch of leaves of (CO2)-C-13 pulsed-chased WT and AGP lacking aps1 plants. Notably, the rate of increase of delta C-13 in starch of aps1 leaves during the pulse was exceedingly higher than that of WT leaves. Furthermore, delta C-13 decline in starch of aps1 leaves during the chase was much faster than that of WT leaves, which provides strong evidence for the occurrence of AGP-mediated cycling of starch breakdown products in illuminated Arabidopsis leaves.	[Baslam, Marouane; Baroja-Fernandez, Edurne; Ricarte-Bermejo, Adriana; Maria Sanchez-Lopez, Angela; Aranjuelo, Iker; Bahaji, Abdellatif; Jose Munoz, Francisco; Almagro, Goizeder; Pozueta-Romero, Javier] UPNA, CSIC, Gobierno Navarra, Inst Agrobiotecnol, Irunako Etorbidea 123, Mutiloabeti, Nafarroa, Spain; [Pujol, Pablo; Galarza, Regina] Univ Publ Navarra, Serv Apoyo Invest, Campus Arrosadia, Iruna, Nafarroa, Spain; [Teixidor, Pilar] Univ Barcelona, Ctr Cient & Tecnol, C Lluis Sole & Sabaris 1-3, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Universidad Publica de Navarra; University of Barcelona	Pozueta-Romero, J (corresponding author), UPNA, CSIC, Gobierno Navarra, Inst Agrobiotecnol, Irunako Etorbidea 123, Mutiloabeti, Nafarroa, Spain.	javier.pozueta@unavarra.es	Bahaji, Abdellatif/C-4105-2015; Pozueta-Romero, Javier/AAP-9341-2021; Sánchez-López, Ángela María/Y-9884-2019; Edurne, Baroja-Fernandez/I-4037-2012; Pozueta-Romero, Javier/G-3766-2011; Muñoz, Francisco/I-3547-2012; Almagro, Goizeder/Y-9900-2019; Aranjuelo, Iker/N-5635-2019; BASLAM, Marouane/K-9312-2014	Bahaji, Abdellatif/0000-0002-5270-497X; Pozueta-Romero, Javier/0000-0002-0335-9663; Sánchez-López, Ángela María/0000-0001-9620-0258; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Pozueta-Romero, Javier/0000-0002-0335-9663; Muñoz, Francisco/0000-0002-0426-2118; Almagro, Goizeder/0000-0001-7035-9965; Aranjuelo, Iker/0000-0002-8231-5043; Ricarte-Bermejo, Adriana/0000-0003-3051-876X; BASLAM, Marouane/0000-0003-3598-7565	Comision Interministerial de Ciencia y Tecnologia; Fondo Europeo de Desarrollo Regional (Spain) [BIO2010-18239, BIO2013-49125-C2-1-P]	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission)	Comision Interministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain) Grant numbers: BIO2010-18239 and BIO2013-49125-C2-1-P, http://www.mineco.gob.es/portal/site/mineco/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; Alonso AP, 2007, PHYTOCHEMISTRY, V68, P2222, DOI 10.1016/j.phytochem.2007.04.022; Alonso AP, 2005, PLANT PHYSIOL, V138, P2220, DOI 10.1104/pp.105.062083; Bago B, 1999, PLANT PHYSIOL, V121, P263, DOI 10.1104/pp.121.1.263; Bahaji A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119641; Bahaji A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104997; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P1162, DOI 10.1093/pcp/pcr067; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; BARANYAI JM, 1989, BIOCHEM J, V258, P121, DOI 10.1042/bj2580121; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; Boschker HTS, 2008, RAPID COMMUN MASS SP, V22, P3902, DOI 10.1002/rcm.3804; Bruggeman Q, 2015, PLANT CELL, V27, P1801, DOI 10.1105/tpc.15.00068; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; DAVID M, 1990, J CLIN INVEST, V86, P612, DOI 10.1172/JCI114752; DIEUAIDENOUBHANI M, 1995, J BIOL CHEM, V270, P13147, DOI 10.1074/jbc.270.22.13147; FONDY BR, 1985, PLANT PHYSIOL, V78, P753, DOI 10.1104/pp.78.4.753; Gamez-Arjona FM, 2011, PLANT BIOTECHNOL J, V9, P1049, DOI 10.1111/j.1467-7652.2011.00626.x; GAUDET G, 1992, EUR J BIOCHEM, V207, P155, DOI 10.1111/j.1432-1033.1992.tb17032.x; GEIGENBERGER P, 1991, PLANTA, V185, P81, DOI 10.1007/BF00194518; Guedon E, 2000, J BACTERIOL, V182, P2010, DOI 10.1128/JB.182.7.2010-2017.2000; Hausler RE, 1998, PLANTA, V204, P366, DOI 10.1007/s004250050268; HILL SA, 1994, PLANTA, V192, P52, DOI 10.1007/BF00198692; Jones ME, 2002, J THEOR BIOL, V217, P509, DOI 10.1006/jtbi.2002.3042; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kleczkowski LA, 2000, BBA-PROTEIN STRUCT M, V1476, P103, DOI 10.1016/S0167-4838(99)00229-0; Kleczkowski LA, 1999, FEBS LETT, V448, P153, DOI 10.1016/S0014-5793(99)00346-4; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; LEHMANN M, 1976, ARCH MICROBIOL, V111, P93, DOI 10.1007/BF00446554; LI B, 1992, PLANT PHYSIOL, V99, P1393, DOI 10.1104/pp.99.4.1393; Li J, 2012, PLANT CELL PHYSIOL, V53, P433, DOI 10.1093/pcp/pcr193; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; Lozovaya VV, 1996, PLANT PHYSIOL, V111, P921, DOI 10.1104/pp.111.3.921; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Sanchez-Lopez AM, 2016, PLANT PHYSIOL, V172, P1989, DOI 10.1104/pp.16.00945; MASSILLON D, 1995, J BIOL CHEM, V270, P19351, DOI 10.1074/jbc.270.33.19351; Matheron C, 1998, APPL ENVIRON MICROB, V64, P74; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Moerdijk-Poortvliet TCW, 2015, RAPID COMMUN MASS SP, V29, P1205, DOI 10.1002/rcm.7217; Montero M, 2011, BIOCHEM J, V433, P107, DOI 10.1042/BJ20101186; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; NAVAS MA, 1993, P NATL ACAD SCI USA, V90, P1290, DOI 10.1073/pnas.90.4.1290; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; Nguyen-Quoc B, 2001, J EXP BOT, V52, P881, DOI 10.1093/jexbot/52.358.881; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; Portais JC, 2002, MICROBIOLOGY REV, V26, P375; Ragel P, 2013, PLANT PHYSIOL, V163, P75, DOI 10.1104/pp.113.223420; RAO IM, 1995, PLANT PHYSIOL, V107, P1313, DOI 10.1104/pp.107.4.1313; Richter A, 2009, RAPID COMMUN MASS SP, V23, P2476, DOI 10.1002/rcm.4088; Sanchez-Lopez A M, 2016, PLANT CELL ENV; Santelia D, 2015, CURR OPIN PLANT BIOL, V25, P1, DOI 10.1016/j.pbi.2015.04.003; Schneider A, 2002, PLANT J, V32, P685, DOI 10.1046/j.1365-313X.2002.01460.x; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; STITT M, 1981, BIOCHIM BIOPHYS ACTA, V638, P1, DOI 10.1016/0005-2728(81)90179-1; Streb Sebastian, 2012, Arabidopsis Book, V10, pe0160, DOI 10.1199/tab.0160; Sun JD, 1999, PLANT PHYSIOL, V119, P267, DOI 10.1104/pp.119.1.267; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; WENDLER R, 1991, PLANTA, V183, P31, DOI 10.1007/BF00197564; Zanella M, 2016, J EXP BOT, V67, P1819, DOI 10.1093/jxb/erv572; Zeeman SC, 2002, PLANT PHYSIOL, V129, P516, DOI 10.1104/pp.003756; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319	76	15	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171245	10.1371/journal.pone.0171245	http://dx.doi.org/10.1371/journal.pone.0171245			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152100	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200114
J	Yasui, K; Sakai, K; Kano, T; Owaki, D; Ishiguro, A				Yasui, Kotaro; Sakai, Kazuhiko; Kano, Takeshi; Owaki, Dai; Ishiguro, Akio			Decentralized control scheme for myriapod robot inspired by adaptive and resilient centipede locomotion	PLOS ONE			English	Article							UNEVEN TERRAIN	Recently, myriapods have attracted the attention of engineers because mobile robots that mimic them potentially have the capability of producing highly stable, adaptive, and resilient behaviors. The major challenge here is to develop a control scheme that can coordinate their numerous legs in real time, and an autonomous decentralized control could be the key to solve this problem. Therefore, we focus on real centipedes and aim to design a decentralized control scheme for myriapod robots by drawing inspiration from behavioral experiments on centipede locomotion under unusual conditions. In the behavioral experiments, we observed the response to the removal of a part of the terrain and to amputation of several legs. Further, we determined that the ground reaction force is significant for generating rhythmic leg movements; the motion of each leg is likely affected by a sensory input from its neighboring legs. Thus, we constructed a two-dimensional model wherein a simple local reflexive mechanism was implemented in each leg. We performed simulations by using this model and demonstrated that the myriapod robot could move adaptively to changes in the environment and body properties. Our findings will shed new light on designing adaptive and resilient myriapod robots that can function under various circumstances.	[Yasui, Kotaro; Sakai, Kazuhiko; Kano, Takeshi; Owaki, Dai; Ishiguro, Akio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Ishiguro, Akio] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Yasui, K (corresponding author), Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan.	k.yasui@riec.tohoku.ac.jp	Yasui, Kotaro/AEV-3178-2022	Owaki, Dai/0000-0003-1217-3892	Japan Science and Technology Agency, CREST	Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Science and Technology Agency, CREST http://www.jst.go.jp/kisoken/crest/en/index.html) to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/11/110001; Braga RR, 2008, BIOSIGNALS 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, VOL II, P58; Daun-Gruhn S, 2011, BIOL CYBERN, V105, P71, DOI 10.1007/s00422-011-0446-6; Dubey S., 2015, INT J APPL ENG RES, V10, P7357; Hoffman KL, 2011, IEEE INT C INT ROBOT, P1479, DOI 10.1109/IROS.2011.6048268; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Inagaki S, 2010, IEEE INT C INT ROBOT, P5341, DOI 10.1109/IROS.2010.5651324; Koh D, 2010, P IEEE RAS-EMBS INT, P877, DOI 10.1109/BIOROB.2010.5627776; Kuroda S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0205; Manton, 1977, ARTHROPODA HABITS FU; Matthey L, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P1860, DOI 10.1109/IROS.2008.4650999; Maus HM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1073; Onat A, 2001, P 1 INT C INF TECHN, P191; Owaki D, 2010, IEEE INT CONF ROBOT, P5237, DOI 10.1109/ROBOT.2010.5509166; Pfeifer R., 2006, BODY SHAPES WAY WE T; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Umedachi T, 2010, BIOL CYBERN, V102, P261, DOI 10.1007/s00422-010-0367-9	17	11	11	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171421	10.1371/journal.pone.0171421	http://dx.doi.org/10.1371/journal.pone.0171421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152103	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200144
J	Li, X; Yang, J; Nie, XL; Zhang, Y; Li, XY; Li, LH; Wang, DX; Ma, DQ				Li, Xue; Yang, Jing; Nie, Xiao-Lu; Zhang, Yan; Li, Xue-Ying; Li, Li-Huan; Wang, Dong-Xin; Ma, Daqing			Impact of dexmedetomidine on the incidence of delirium in elderly patients after cardiac surgery: A randomized controlled trial	PLOS ONE			English	Article							CARE-UNIT PATIENTS; BYPASS GRAFT-SURGERY; CONFUSION ASSESSMENT METHOD; CRITICALLY-ILL PATIENTS; POSTOPERATIVE DELIRIUM; RISK-FACTORS; SEDATION; METAANALYSIS; SLEEP; RELIABILITY	Background Delirium is a frequent complication after cardiac surgery and its occurrence is associated with poor outcomes. The purpose of this study was to investigate the impact of perioperative dexmedetomidine administration on the incidence of delirium in elderly patients after cardiac surgery. Methods This randomized, double-blinded, and placebo-controlled trial was conducted in two tertiary hospitals in Beijing between December 1, 2014 and July 19, 2015. Eligible patients were randomized into two groups. Dexmedetomidine (DEX) was administered during anesthesia and early postoperative period for patients in the DEX group, whereas normal saline was administered in the same rate for the same duration for patients in the control (CTRL) group. The primary endpoint was the incidence of delirium during the first five days after surgery. Secondary endpoints included the cognitive function assessed on postoperative days 6 and 30, the overall incidence of non-delirium complications within 30 days after surgery, and the all-cause 30-day mortality. Results Two hundred eighty-five patients were enrolled and randomized. Dexmedetomidine did not decrease the incidence of delirium (4.9% [7/142] in the DEX group vs 7.7% [11/143] in the CTRL group; OR 0.62, 95% CI 0.23 to 1.65, p = 0.341). Secondary endpoints were similar between the two groups; however, the incidence of pulmonary complications was slightly decreased (OR 0.51, 95% CI 0.26 to 1.00, p = 0.050) and the percentage of early extubation was significantly increased (OR 3.32, 95% CI 1.36 to 8.08, p = 0.008) in the DEX group. Dexmedetomidine decreased the required treatment for intraoperative tachycardia (21.1% [30/142] in the DEX group vs 33.6% [48/143] in the CTRL group, p = 0.019), but increased the required treatment for postoperative hypotension (84.5% [120/142] in the DEX group vs 69.9% [100/143] in the CTRL group, p = 0.003). Conclusions Dexmedetomidine administered during anesthesia and early postoperative period did not decrease the incidence of postoperative delirium in elderly patients undergoing elective cardiac surgery. However, considering the low delirium incidence, the trial might have been underpowered.	[Li, Xue; Zhang, Yan; Wang, Dong-Xin] Peking Univ, Hosp 1, Dept Anesthesiol & Crit Care Med, Beijing, Peoples R China; [Yang, Jing; Li, Li-Huan] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Yang, Jing; Li, Li-Huan] Peking Union Med Coll, Beijing, Peoples R China; [Nie, Xiao-Lu] Capital Med Univ, Beijing Childrens Hosp, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China; [Li, Xue-Ying] Peking Univ, Hosp 1, Dept Biostat, Beijing, Peoples R China; [Ma, Daqing] Chelsea & Westminster Hosp, Imperial Coll London, Dept Surg & Canc, Sect Anaesthet Pain Management & Intens Care, London, England	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Peking University; Imperial College London	Wang, DX (corresponding author), Peking Univ, Hosp 1, Dept Anesthesiol & Crit Care Med, Beijing, Peoples R China.	wangdongxin@hotmail.com	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; Nie, Xiaolu/0000-0001-8026-7845				Abdel-Meguid Mohamed Essam, 2013, Saudi J Anaesth, V7, P6, DOI 10.4103/1658-354X.109557; Alexopoulou C, 2014, ANESTHESIOLOGY, V121, P801, DOI 10.1097/ALN.0000000000000361; Bucerius J, 2004, J THORAC CARDIOV SUR, V127, P57, DOI 10.1016/S0022-5223(03)01281-9; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; Chi XJ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0554-5; Chrysostomou C, 2008, EXPERT OPIN DRUG MET, V4, P619, DOI [10.1517/17425255.4.5.619, 10.1517/17425255.4.5.619 ]; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fraser GL, 2013, CRIT CARE MED, V41, pS30, DOI 10.1097/CCM.0b013e3182a16898; Gao SQ, 2015, INT J CLIN EXP PATHO, V8, P3144; Gerresheim G, 2013, ANAESTHESIST, V62, P661, DOI 10.1007/s00101-013-2206-6; Groen JA, 2012, J CARDIAC SURG, V27, P589, DOI 10.1111/j.1540-8191.2012.01508.x; Guenther U, 2016, CURR OPIN ANAESTHESI; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; Huupponen E, 2008, ACTA ANAESTH SCAND, V52, P289, DOI 10.1111/j.1399-6576.2007.01537.x; Inouye SK, 2003, ARCH INTERN MED, V163, P958, DOI 10.1001/archinte.163.8.958; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Khalil MA, 2013, SEMIN CARDIOTHORAC V, V17, P66, DOI 10.1177/1089253212463969; Koster S, 2009, ANN THORAC SURG, V87, P1469, DOI 10.1016/j.athoracsur.2009.02.080; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966, DOI 10.1345/aph.1H241; Leung JM, 2006, NEUROLOGY, V67, P1251, DOI 10.1212/01.wnl.0000233831.87781.a9; Leung JM, 2013, AM J GERIAT PSYCHIAT, V21, P946, DOI 10.1016/j.jagp.2013.01.069; Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320; Lin YY, 2012, CRIT CARE, V16, DOI 10.1186/cc11646; Maldonado JR, 2009, PSYCHOSOMATICS, V50, P206, DOI 10.1176/appi.psy.50.3.206; Mariscalco G, 2012, ANN THORAC SURG, V93, P1439, DOI 10.1016/j.athoracsur.2012.02.012; Mo Y, 2013, ANN PHARMACOTHER, V47, P869, DOI 10.1345/aph.1AR708; Mu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077637; Mu Dong-liang, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P242; Mu DL, 2010, CRIT CARE, V14, DOI 10.1186/cc9393; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Priye S, 2015, SAUDI J ANAESTH, V9, P353, DOI 10.4103/1658-354X.154715; Radtke FM, 2013, BRIT J ANAESTH, V110, P98, DOI 10.1093/bja/aet055; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rudolph JL, 2005, J AM GERIATR SOC, V53, P462, DOI 10.1111/j.1532-5415.2005.53165.x; Santos FS, 2004, INT PSYCHOGERIATR, V16, P175, DOI 10.1017/S1041610204000365; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783; Su X, 2016, LANCET, V388, P1893, DOI 10.1016/S0140-6736(16)30580-3; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013	43	72	82	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170757	10.1371/journal.pone.0170757	http://dx.doi.org/10.1371/journal.pone.0170757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182690	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800017
J	Malinova, V; Psychogios, MN; Tsogkas, I; Koennecke, B; Bleuel, K; Iliev, B; Rohde, V; Mielke, D				Malinova, Vesna; Psychogios, Marios N.; Tsogkas, Ioannis; Koennecke, Birte; Bleuel, Kim; Iliev, Bogdan; Rohde, Veit; Mielke, Dorothee			MR-angiography allows defining severity grades of cerebral vasospasm in an experimental double blood injection subarachnoid hemorrhage model in rats	PLOS ONE			English	Article							ARTERY OCCLUSION; ISCHEMIA; METAANALYSIS	Objective Magnetic resonance (MR) imaging has been used for the detection of cerebral vasospasm (VSP) related infarction in experimental subarachnoid hemorrhage (eSAH) in rats. Conventional angiography is generally used to visualize VSP, which is an invasive technique with a possible increase in morbidity and mortality. In this study we evaluated the validity of MR-angiography (MRA) in detecting VSP and its feasibility to define VSP severity grades after eSAH in rats. Methods SAH was induced using the double-hemorrhage model in 12 rats. In two rats, saline solution was injected instead of blood (sham group). MR was performed on day 1, 2 and on day 5. T1-, T2-, T2*- weighted and time-of-flight MR sequences were applied, which were analyzed by two blinded neuroradiologists. Vessel narrowing of 25-50% was defined as mild, 50-75% as moderate and >75% as severe VSP. Results We performed a total of 34 MRAs in 14 rats. In 14 rats, MRA was performed on day 2 and day 5. In six rats MRA was additionally performed on day1 before the blood injection. A good visualization of cerebral vessels was possible in all cases. No VSP was seen in the sham group neither on day 2 nor on day 5. We found vasospasm on day 2 in 7 of the 14 rats (50%) whereas all 7 rats had mild and one rat had additionally moderate and severe vasospasm in one vessel, respectively. On day 5 we found vasospasm in 8 of the 14 rats (60%) whereas 4 rats had severe vasospasm, 1 rat had moderate vasospasm and 3 rats demonstrated mild vasospasm. In 4 of the 14 rats (30%) an ischemic lesion was detected on day 5. Three of these rats had severe vasospasm and one rat had mild vasospasm. Severe vasospasm on day 5 was statistically significant correlated with the occurrence of ischemic lesions (Fisher's Exact test, OR 19.5, p = 0.03). Conclusions MRA is a noninvasive diagnostic tool, which allows a good visualization of the cerebral vasculature and provides reproducible results concerning the detection of VSP and the differentiation into three severity grades in rats. Future studies are needed to directly compare MRA with conventional angiography.	[Malinova, Vesna; Bleuel, Kim; Iliev, Bogdan; Rohde, Veit; Mielke, Dorothee] Georg August Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Psychogios, Marios N.; Tsogkas, Ioannis] Georg August Univ Gottingen, Dept Neuroradiol, Gottingen, Germany; [Koennecke, Birte] Georg August Univ Gottingen, Dept Neurol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Malinova, V (corresponding author), Georg August Univ Gottingen, Dept Neurosurg, Gottingen, Germany.	vesna.malinova@gmail.com	Mielke, Dorothee/AAU-6776-2021					Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Gerriets T, 2004, STROKE, V35, P2372, DOI 10.1161/01.STR.0000142134.37512.a7; Grandin CB, 2000, AM J NEURORADIOL, V21, P1611; Guresir E, 2012, ACTA NEUROCHIR, V154, P11, DOI 10.1007/s00701-011-1191-2; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Koktekir E, 2010, ACTA NEUROCHIR, V152, P463, DOI 10.1007/s00701-009-0540-x; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sehba FA, 2014, TRANSL STROKE RES, V5, P660, DOI 10.1007/s12975-014-0368-4; van den Bergh WM, 2005, ACTA NEUROCHIR, V147, P977, DOI 10.1007/s00701-005-0539-x; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66	14	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171121	10.1371/journal.pone.0171121	http://dx.doi.org/10.1371/journal.pone.0171121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182715	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800034
J	Jo, K; Bajgur, SS; Kim, H; Choi, HA; Huh, PW; Lee, K				Jo, KwangWook; Bajgur, Suhas S.; Kim, Hoon; Choi, Huimahn A.; Huh, Pil-Woo; Lee, Kiwon			A simple prediction score system for malignant brain edema progression in large hemispheric infarction	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; CT ANGIOGRAPHY; DECOMPRESSIVE HEMICRANIECTOMY; RANDOMIZED-TRIAL; ALBERTA STROKE; OCCLUSION; THROMBECTOMY; MULTICENTER; CRANIECTOMY	Malignant brain edema (MBE) due to hemispheric infarction can result in brain herniation, poor outcomes, and death; outcome may be improved if certain interventions, such as decompressive craniectomy, are performed early. We sought to generate a prediction score to easily identify those patients at high risk for MBE. 121 patients with large hemispheric infarction (LHI) (2011 to 2014) were included. Patients were divided into two groups: those who developed MBE and those who did not. Independent predictors of MBE were identified by logistic regression and a score was developed. Four factors were independently associated with MBE: baseline National Institutes of Health Stroke Scale (NIHSS) score (p = 0.048), Alberta Stroke Program Early Computed Tomography Score (ASPECTS) (p = 0.007), collateral score (CS) (p<0.001) and revascularization failure (p = 0.013). Points were assigned for each factor as follows: NIHSS <= 8 (= 0), 9-17 (= 1), >= 18 (= 2); ASPECTS <= 7 (= 1), >8 (= 0); CS<2 (= 1), >= 2 (= 0); revascularization failure (= 1), success (= 0). The MBE Score (MBES) represents the sum of these individual points. Of 26 patients with a MBES of 0 to 1, none developed MBE. All patients with a MBES of 6 developed MBE. Both MBE development and functional outcomes were strongly associated with the MBES (p = 0.007 and 0.002, respectively). The MBE score is a simple reliable tool for the prediction of MBE.	[Jo, KwangWook; Kim, Hoon] Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea; [Bajgur, Suhas S.; Choi, Huimahn A.; Lee, Kiwon] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX USA; [Huh, Pil-Woo] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea	Catholic University of Korea; University of Texas System; University of Texas Health Science Center Houston; Catholic University of Korea	Huh, PW (corresponding author), Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Neurosurg, Seoul, South Korea.	jkw945453@gmail.com		Whang, Kum/0000-0002-3701-847X				Arnaout OM, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1160; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burghaus L, 2008, NEUROCRIT CARE, V9, P13, DOI 10.1007/s12028-007-9025-z; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2013, J CEREBR BLOOD F MET, V33, P1168, DOI 10.1038/jcbfm.2013.77; Chen R, 2015, J STROKE CEREBROVASC, V24, P958, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.016; Daou B, 2015, NEUROSURGERY, V77, P355, DOI 10.1227/NEU.0000000000000830; Efron B, 1994, INTRO BOOTSTRAPED; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2015, STROKE, V46, P2695, DOI 10.1161/STROKEAHA.115.010078; Jeon SB, 2014, J STROKE, V16, P146, DOI 10.5853/jos.2014.16.3.146; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim H, 2015, J CLIN NEUROSCI, V22, P554, DOI 10.1016/j.jocn.2014.08.021; Kurland DB, 2015, NEUROCRIT CARE; Lemeshow S., 2004, APPLIED LOGISTIC REG; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Lu XC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07070; Maas MB, 2009, STROKE, V40, P2988, DOI 10.1161/STROKEAHA.109.555664; MacCallum C, 2014, CEREBROVASC DIS, V38, P39, DOI 10.1159/000363619; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; MOULIN DE, 1985, STROKE, V16, P282, DOI 10.1161/01.STR.16.2.282; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Sillanpaa N, 2012, NEURORADIOLOGY, V54, P663, DOI 10.1007/s00234-011-0954-z; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; Thomalla GJ, 2003, STROKE, V34, P1892, DOI 10.1161/01.STR.0000081985.44625.B6; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; ZWECKBERGER K, 2014, REV CEREBROVASC DIS, V38, P313, DOI DOI 10.1159/000365864	39	27	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171425	10.1371/journal.pone.0171425	http://dx.doi.org/10.1371/journal.pone.0171425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178299	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500041
J	Paul, M; Bhadra, A				Paul, Manabi; Bhadra, Anindita			Selfish Pups: Weaning Conflict and Milk Theft in Free-Ranging Dogs	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; EVOLUTION; BEHAVIOR; GROWTH; CARE	Parent-offspring conflict theory predicts the emergence of weaning conflict between a mother and her offspring arising from skewed relatedness benefits. Empirical observations of weaning conflict have not been carried out in canids. In a field-based study on free-ranging dogs we observed that nursing/suckling bout durations decrease, proportion of mother-initiated nursing bouts decrease and mother-initiated nursing/suckling terminations increase with pup age. We identified the 7th -13th week period of pup age as the zone of conflict between the mother and her pups, beyond which suckling solicitations cease, and before which suckling refusals are few. We also report for the first time milk theft by pups who take advantage of the presence of multiple lactating females, due to the promiscuous mating system of the dogs. This behaviour, though apparently disadvantageous for the mothers, is perhaps adaptive for the dogs in the face of high mortality and competition for resources.	[Paul, Manabi; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Behav & Ecol Lab, Dept Biol Sci, Mohanpur, W Bengal, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Bhadra, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Behav & Ecol Lab, Dept Biol Sci, Mohanpur, W Bengal, India.	abhadra@iiserkol.ac.in	Bhadra, Anindita/H-6899-2019	Bhadra, Anindita/0000-0002-3717-9732	CSIR, India [37(1399)/10/EMR-II]; SERB, India [SB/WEA-005/2013, SBNS/LS-38/2013]; IISER Kolkata	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); SERB, India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); IISER Kolkata	This project was funded by grants from CSIR, India (http://csirhrdg.res.in/), grant no. 37(1399)/10/EMR-II, and SERB, India (http://serbonline.in/SERB), grant nos. SB/WEA-005/2013 and SBNS/LS-38/2013. The work was supported by IISER Kolkata.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beaver B.V., 2009, CANINE BEHAV INSIGHT, Vsecond; Bhadra A, 2016, ETHOL ECOL EVOL, V28, P427, DOI 10.1080/03949370.2015.1076526; BOWEN WD, 1985, CAN J ZOOL, V63, P2841, DOI 10.1139/z85-424; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; GADAGKAR R, 1990, PHILOS T ROY SOC B, V329, P17, DOI 10.1098/rstb.1990.0146; GODFRAY HCJ, 1992, ANIM BEHAV, V43, P473, DOI 10.1016/S0003-3472(05)80106-X; Kleiman D., 1968, International Zoo Yearbook, V8, P3, DOI 10.1111/j.1748-1090.1968.tb00419.x; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; MacLeod KJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0378; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Malm K, 1996, APPL ANIM BEHAV SCI, V49, P223, DOI 10.1016/0168-1591(96)01044-1; MARTIN P, 1984, ANIM BEHAV, V32, P1257, DOI 10.1016/S0003-3472(84)80245-6; Mech LD, 1999, CAN J ZOOL, V77, P1192, DOI 10.1139/cjz-77-8-1192; Oftedal O.T., 1985, BIOENERGETICS WILD H, V10, P215; Paul M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150580; Paul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19641; Paul M, 2014, J ETHOL, V32, P75, DOI 10.1007/s10164-014-0396-2; Paul M, 2014, BEHAV PROCESS, V103, P17, DOI 10.1016/j.beproc.2013.10.006; PICKFORD M, 1960, J PHYSIOL-LONDON, V152, P515, DOI 10.1113/jphysiol.1960.sp006506; Pluhacek J, 2010, APPL ANIM BEHAV SCI, V122, P127, DOI 10.1016/j.applanim.2009.11.009; R Core Team, 2015, R LANG ENV STAT COMP; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROBINSON WB, 1952, J MAMMAL, V33, P470, DOI 10.2307/1376020; Sen Majumder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143501; Spotte S, 2012, SOCIETIES OF WOLVES AND FREE-RANGING DOGS, P1, DOI 10.1017/CBO9781139057769; TRIVERS RL, 1974, AM ZOOL, V14, P249; UVNASMOBERG K, 1985, ACTA PHYSIOL SCAND, V124, P391, DOI 10.1111/j.1748-1716.1985.tb07674.x; van den Berg P, 2013, EVOL HUM BEHAV, V34, P405, DOI 10.1016/j.evolhumbehav.2013.07.004; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Vasquez CG, 2004, NEW ZEAL J AGR RES, V47, P1, DOI 10.1080/00288233.2004.9513565	33	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170590	10.1371/journal.pone.0170590	http://dx.doi.org/10.1371/journal.pone.0170590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178276	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500010
J	Quero, C; Monteys, VSI; Rosell, G; Puigmarti, M; Guerrero, A				Quero, Carmen; Sarto i Monteys, Victor; Rosell, Gloria; Puigmarti, Marc; Guerrero, Angel			Sexual communication in castniid moths: Males mark their territories and appear to bear all chemical burden	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; BUTTERFLIES LEPIDOPTERA; NYMPHALIDAE; BIOLOGY	Castniid moths (Lepidoptera: Castniidae) display a butterfly-like reproductive behavior, i.e., they use visual stimuli for mate location and females have apparently lost their pheromone glands in an evolutionary context. In this paper we report for the first time the identification of three new compounds, namely n-octadecyl acetate, (Z)-9-octadecenyl acetate and (E,Z)-2,13-octadecadienyl acetate, in males of the Castniid Palm Borer, Paysandisia archon, which could be involved in its short-range courtship behavior, and also shed light on recent controversies on the sexual behavior of the species. The compounds are produced in a ring shaped gland of the male terminalia and have occasionally been detected in very minor amounts (ng) in ovipositor extracts of females, but only while mating or just after copulation. We also report that males use the already known (E,Z)-2,13-octadecadienol to mark their territory by rubbing their midlegs against the upper side of nearby leaves, especially palm leaves. This compound, produced in large amounts, is mostly concentrated in the midleg basitarsi and its maximum production is detected on the sexually mature 1-day-old specimens. In addition, analysis of male wings extracts confirms the presence of Z,E and E,E-farnesals, which are mostly produced in the median band of hindwings of 48-53 h-old insects. The biological significance of farnesals in this species is unknown. Our results point out that the chemical communication of P. archon relies mostly on males, which appear to bear all chemical burden in this respect.	[Quero, Carmen; Puigmarti, Marc; Guerrero, Angel] CSIC, IQAC, Dept Biol Chem & Mol Modelling, Barcelona, Spain; [Sarto i Monteys, Victor] Autonomous Univ Barcelona, Inst Environm Sci & Technol ICTA, Entomol Plants & Hlth, ICTA ICP Bldg, Bellaterra, Barcelona, Spain; [Sarto i Monteys, Victor] Catalonian Govt, Serv Plant Hlth, Dept Agr Livestock Fisheries & Food DARP, Barcelona, Spain; [Rosell, Gloria] Univ Barcelona, Dept Pharmacol & Therapeut Chem, CSIC, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Quero, C; Guerrero, A (corresponding author), CSIC, IQAC, Dept Biol Chem & Mol Modelling, Barcelona, Spain.	cqlqob@cid.csic.es; agpqob@cid.csic.es	Guerrero, Angel/AAW-3731-2020; MONTEYS, VICTOR SARTO I/ABE-7326-2020; Guerrero, Angel/G-8495-2015	Quero, Carmen/0000-0003-3599-2778; Guerrero, Angel/0000-0003-2323-2691	MINECO [AGL2012-39869-C02-01, AGL2015-66469-R]; European Regional Development Fund; CSIC	MINECO(Spanish Government); European Regional Development Fund(European Commission); CSIC	The research was partially supported by MINECO (grants AGL2012-39869-C02-01, AGL2015-66469-R, and a FPI contract to MP) with assistance from the European Regional Development Fund, and CSIC for a postdoctoral contract to CQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin P, 2009, INSECT BIOCHEM MOLEC, V39, P11, DOI 10.1016/j.ibmb.2008.09.007; BERNARDI R, 1967, TETRAHEDRON LETT, P3893; BOPPRE M, 1983, OECOLOGIA, V59, P414, DOI 10.1007/BF00378873; BROWER LINCOLN PIERSON, 1965, ZOOLOGICA [NEW YORK], V50, P1; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Delle-Vedove R, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.52; Delle-Vedove R, 2012, EUR J ENTOMOL, V109, P289, DOI 10.14411/eje.2012.037; Edwards E.D., 1998, LEPIDOPTERA MOTHS BU, VIV, P181; EI-Sayed AM, PHEROBASE DATABASE I; Eisner T., 1987, P251; Frerot B, 2013, CHEMOECOLOGY, V23, P137, DOI 10.1007/s00049-013-0128-z; Hallberg E., 2003, LEPIDOPTERA MOTHS BU, V2, P361; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; Jordan K., 1923, Novitates Zoologicae, V30, P159; Knudsen JT, 2002, AM J BOT, V89, P1772, DOI 10.3732/ajb.89.11.1772; Larsdotter-Mellstrom H, 2016, FRONT PHYSIOL, V7, P1; Le Cerf F., 1936, Bulletin de la Societe Entomologique de France Paris, V41, P191; Miller J. Y., 1986, Dissertation Abstracts International, B (Sciences and Engineering), V47, P2289; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; NATION JL, 1990, J CHEM ECOL, V16, P553, DOI 10.1007/BF01021786; Percy-Cunningham J.E., 1987, P27; Pliske TE, 1947, ANN ENTOMOL SOC AM, V68, P143; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Riolo P, 2014, J ECON ENTOMOL, V107, P1009, DOI 10.1603/EC13298; Ruschioni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124607; Monteys VSI, 2016, B ENTOMOL RES, V106, P421, DOI 10.1017/S0007485316000158; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; Sarto i Monteys Victor, 2005, Nachrichten des Entomologischen Vereins Apollo, V26, P61; Schultz S., 1993, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, V342, P161, DOI 10.1098/rstb.1993.0144; Schulz S, 2004, BIOCHEM SYST ECOL, V32, P699, DOI 10.1016/j.bse.2003.12.004; Tanahashi I., 2007, Aroma Research, V8, P390; TRIGO JR, 1994, J CHEM ECOL, V20, P2883, DOI 10.1007/BF02098396; Vassiliou V, 2014, 10 EUR C ENT 2014 3; Widemo F, 2006, P ROY SOC B-BIOL SCI, V273, P713, DOI 10.1098/rspb.2005.3379; Wiklund Christer, 2003, P67; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Yang CY, 2009, J CHEM ECOL, V35, P1197, DOI 10.1007/s10886-009-9694-5; ZAGATTI P, 1987, J CHEM ECOL, V13, P1561, DOI 10.1007/BF00980200; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	40	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171166	10.1371/journal.pone.0171166	http://dx.doi.org/10.1371/journal.pone.0171166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178286	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500029
J	Rahm, T; Heise, E; Schuldt, M				Rahm, Tobias; Heise, Elke; Schuldt, Mirijam			Measuring the frequency of emotions-validation of the Scale of Positive and Negative Experience (SPANE) in Germany	PLOS ONE			English	Article							SUBJECTIVE HAPPINESS; FLOURISHING SCALE; LIFE SCALE; VALIDITY; SATISFACTION; RELIABILITY; VERSION; PANAS	The Scale of Positive and Negative Experience (SPANE) measures the frequency of positive and negative affect. It consists of two subscales, one for positive and one for negative affect with six adjectives each and assesses a broad range of emotions. In this study, the psychometric properties of the German version of the scale were explored with reliability and confirmatory factorial analysis by using a German sample of N= 498. To examine the convergent validity of the SPANE we correlated its subscales with other well-being and happiness measures. Retest-reliabilities were tested after four weeks, taking into account the occurrence of emotionally significant life events. The scale was also applied to evaluate a training of subjective well-being and in a study on text comprehensibility. The results confirmed the postulated two-factor structure of the SPANE and showed good psychometric properties and convergent validity. In conclusion, the German version of the scale behaves in accordance with the original scale and may be used in future studies of well-being.	[Rahm, Tobias; Heise, Elke; Schuldt, Mirijam] Tech Univ Carolo Wilhelmina Braunschweig, Inst Padagog Psychol, Braunschweig, Germany	Braunschweig University of Technology	Rahm, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Padagog Psychol, Braunschweig, Germany.	t.rahm@tu-braunschweig.de	Rahm, Tobias/I-2199-2019	Rahm, Tobias/0000-0002-0870-7022				[Anonymous], 2015, PERSONALITY INDIVIDU, V86, P487; Blickhan D, 2015, 8 SELF BIENN INT C A; Conclusion Diener E., 2009, SOCIAL INDICATORS RE, V37, P267; Dalbert C., 2003, DIAGNOSTIC PROCEDURE, P170; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2010, J PERS SOC PSYCHOL, V97, P143, DOI DOI 10.1007/S11205-009-9493-Y; Friedrich MCG, 2015, THESIS; Glaesmer H, 2011, EUR J PSYCHOL ASSESS, V27, P127, DOI 10.1027/1015-5759/a000058; Kemeny ME, 2012, EMOTION, V12, P338, DOI 10.1037/a0026118; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061137; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; OECD, 2013, OECD GUID MEAS SUBJ; Pavot W., 2013, OXFORD HDB HAPPINESS, P134; Rahm T, 2015, 8 SELF BIENN INT C A; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shin L. J., 2016, HDB POSITIVE CLIN PS, P349, DOI [10.1002/9781118468197.ch23, DOI 10.1002/9781118468197.CH23]; Silva AJ, 2013, SOC INDIC RES, V110, P469, DOI 10.1007/s11205-011-9938-y; Sumi K, 2014, SOC INDIC RES, V118, P601, DOI 10.1007/s11205-013-0432-6; Swami V, 2009, SOC INDIC RES, V93, P393, DOI 10.1007/s11205-008-9331-7; Telef B, 2015, EUROPEAN SCI J, V11, P49, DOI DOI 10.13140/RG.2.1.3987.3124; Watson D, 1996, J PERS SOC PSYCHOL, V70, P567, DOI 10.1037/0022-3514.70.3.567; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	26	36	36	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171288	10.1371/journal.pone.0171288	http://dx.doi.org/10.1371/journal.pone.0171288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178328	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500036
J	Xu, X; Hu, JZ; Lu, HB				Xu, Xiang; Hu, Jianzhong; Lu, Hongbin			Histological observation of a gelatin sponge transplant loaded with bone marrow-derived mesenchymal stem cells combined with platelet-rich plasma in repairing an annulus defect	PLOS ONE			English	Article							INTERVERTEBRAL DISC; IN-VITRO; DIFFERENTIATION	Objective To research the histological characteristics of a gelatin sponge transplant loaded with goat BMSCs (bone marrow-derived mesenchymal stem cells) combined with PRP (platelet-rich plasma) in repairing an annulus defect. Method BMSCs were separated from the iliac crest of goats, sub-cultured and identified after the third generation. Then, PRP was obtained using blood from the jugular vein of goats via two degrees of centrifugation. In the animal experiments, the goats were divided into the following three groups: a sham group, an injury group and a therapeutic group. In the sham group, we decompressed the lamina and exposed the annulus fibrosus. In the injury group, we exposed the annulus fibrosus after decompression of the lamina and created a 1 x 1 cm defect in the annulus using surgical instruments. In the therapeutic group, after decompression of the lamina, we exposed the annulus, created a 1 x 1 cm defect using surgical instruments, and placed a gelatin sponge combined with BMSCs and PRP into the defect for a combined method of repair. Three, six and twelve weeks after the surgery, the previously damaged or undamaged annulus tissue was removed from the three groups. Then, the above tissue was assayed using HE (hematoxylin-eosin) staining, Masson trichrome staining, AB-PAS (Alcian blue-periodic acid Schiff) staining, and type II collagen staining and observed by microscopy. Results From the HE staining, we observed that the number of repair cells gradually increased. Compared to the injury group, the cell density and gross morphology of cells in the therapeutic group were closer to those of the sham group. As observed by Masson trichrome gelatin staining, many of the fibroblast cells or tissues were under repair, and as time progressed, the number of fibroblast cells and amount of tissue gradually increased. The results of the AB-PAS staining suggest that chondrocytes participated in the repair of the annulus. The level of type II collagen gradually increased, as determined by immunohistochemical staining. Conclusion Our results demonstrate that a gelatin sponge transplant loaded with BMSCs and PRP can effectively repair annulus defects.	[Xu, Xiang; Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China; [Hu, Jianzhong; Lu, Hongbin] Key Lab Organ Injury Aging & Regenerat Med Hunan, Changsha, Hunan, Peoples R China; [Lu, Hongbin] Cent S Univ, Xiangya Hosp 10, Dept Sports Med, Res Ctr Sports Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Hu, JZ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China.; Hu, JZ; Lu, HB (corresponding author), Key Lab Organ Injury Aging & Regenerat Med Hunan, Changsha, Hunan, Peoples R China.; Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp 10, Dept Sports Med, Res Ctr Sports Med, Changsha, Hunan, Peoples R China.	jianzhonghu@hotmail.com; hongbinlu@hotmail.com						Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004; Cavallo C, 2014, J BONE JOINT SURG AM, V96A, P423, DOI 10.2106/JBJS.M.00726; Chen GX, 2011, CHIN J CLIN ELECTRON, V5, P1547; Forte A, 2012, CARDIOVASC DRUG THER, V26, P9, DOI 10.1007/s10557-011-6359-8; Kim TH, 2014, ARCH ORAL BIOL, V59, P550, DOI 10.1016/j.archoralbio.2014.02.004; Kozanoglu I, 2009, CYTOTHERAPY, V11, P527, DOI 10.1080/14653240902923153; Kushida S, 2014, J ARTIF ORGANS, V17, P186, DOI 10.1007/s10047-014-0761-5; Li ZH, 2015, J CLIN NEUROSCI, V22, P331, DOI 10.1016/j.jocn.2014.06.098; Liu Chen, 2014, Zhonghua Shao Shang Za Zhi, V30, P433; Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031; Pan Bing, 2014, Zhongguo Gu Shang, V27, P712; Quah C, 2014, ANN ROY COLL SURG, V96, P140, DOI 10.1308/003588414X13814021676873; Saeed H, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0116-4; Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038; Tian Rong, 2014, Zhonghua Wai Ke Za Zhi, V52, P258; [王海燕 Wang Haiyan], 2009, [眼科研究, Ophthalmic Research], V27, P743; Wang ZC, 2014, EXP THER MED, V8, P1528, DOI 10.3892/etm.2014.1950; Wen J LD, 2014, MED RECAPITULATE, V20, P3473; Wu G, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-97; Xiao C, 2014, J CLIN MED LIT ELECT, V2, P132; Xu QC, 2014, INT J CLIN EXP PATHO, V7, P1580; Yao Gong-he, 2009, Zhongguo Gu Shang, V22, P247; [张巍 Zhang Wei], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P7047; Zhao Lin, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P145; Zhao QG, 2015, P NATL ACAD SCI USA, V112, P530, DOI 10.1073/pnas.1423008112	25	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171500	10.1371/journal.pone.0171500	http://dx.doi.org/10.1371/journal.pone.0171500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178294	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500048
J	Zhao, X; Yang, G				Zhao, Xia; Yang, Guang			Winter to winter recurrence of atmospheric circulation anomalies over East Asia and its impact on winter surface air temperature anomalies	PLOS ONE			English	Article							ARCTIC-OSCILLATION; SST ANOMALIES; TEMPORAL COHERENCE; MONSOON; REANALYSIS; VARIABILITY; NORTHERN; MODES	The persistence of atmospheric circulation anomalies over East Asia shows a winter to winter recurrence (WTWR) phenomenon. Seasonal variations in sea level pressure anomalies and surface wind anomalies display significantly different characteristics between WTWR and non-WTWR years. The WTWR years are characterized by the recurrence of both a strong (weak) anomalous Siberian High and an East Asian winter monsoon over two successive winters without persistence through the intervening summer. However, anomalies during the non-WTWR years have the opposite sign between the current and ensuing winters. The WTWR of circulation anomalies contributes to that of surface air temperature anomalies (SATAs), which is useful information for improving seasonal and interannual climate predictions over East Asia and China. In the positive (negative) WTWR years, SATAs are cooler (warmer) over East Asia in two successive winters, but the signs of the SATAs are opposite in the preceding and subsequent winters during the non-WTWR years.	[Zhao, Xia] Chinese Acad Sci, Key Lab Ocean Circulat & Waves, Qingdao, Peoples R China; [Zhao, Xia] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Zhao, Xia] Qingdao Natl Lab Marine Sci & Technol, Lab Ocean & Climate Dynam, Qingdao, Peoples R China; [Yang, Guang] State Ocean Adm, Inst Oceanog 1, Ctr Ocean & Climate Res, Qingdao, Peoples R China; [Yang, Guang] Qingdao Natl Lab Marine Sci & Technol, Lab Reg Oceanog & Numer Modeling, Qingdao, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology	Zhao, X (corresponding author), Chinese Acad Sci, Key Lab Ocean Circulat & Waves, Qingdao, Peoples R China.; Zhao, X (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.; Zhao, X (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Ocean & Climate Dynam, Qingdao, Peoples R China.	zhaoxia@qdio.ac.cn			NSFC [41375094, 41406028]; Basic Scientific Research Fund for National Public Institutes of China [GY2015PO4]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA11010102]; NSFC-Shandong Joint Fund for Marine Science Research Centers [U1406401]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [41421005]; Open Fund of the Key Laboratory of Ocean Circulation and Waves, Chinese Academy of Sciences [KLOCAW1501]	NSFC(National Natural Science Foundation of China (NSFC)); Basic Scientific Research Fund for National Public Institutes of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Shandong Joint Fund for Marine Science Research Centers; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of the Key Laboratory of Ocean Circulation and Waves, Chinese Academy of Sciences(Ministry of Education, ChinaChinese Academy of Sciences)	This work was supported by NSFC grant (Grant No. 41375094, 41406028), the Basic Scientific Research Fund for National Public Institutes of China (GY2015PO4), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA11010102), NSFC-Shandong Joint Fund for Marine Science Research Centers (Grant No. U1406401), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 41421005), Open Fund of the Key Laboratory of Ocean Circulation and Waves, Chinese Academy of Sciences (KLOCAW1501).	ALEXANDER MA, 1995, J PHYS OCEANOGR, V25, P122, DOI 10.1175/1520-0485(1995)025<0122:AMFTRO>2.0.CO;2; Alexander MA, 1999, J CLIMATE, V12, P2419, DOI 10.1175/1520-0442(1999)012<2419:TROSAI>2.0.CO;2; Cassou C, 2007, J CLIMATE, V20, P3510, DOI 10.1175/JCLI4202.1; Chen W, 2000, ADV ATMOS SCI, V17, P48; Chen Z, 2014, J CLIMATE, V27, P5433, DOI 10.1175/JCLI-D-13-00731.1; Chen Z, 2014, J CLIMATE, V27, P835, DOI 10.1175/JCLI-D-13-00314.1; Deser C, 2003, J CLIMATE, V16, P57, DOI 10.1175/1520-0442(2003)016<0057:UTPOSS>2.0.CO;2; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Huang R.-H., 1999, CHIN J ATMOS SCI, V23, P226; Huang R H, 2006, WINTER MONEX QUARTER, P126; Jhun JG, 2004, J CLIMATE, V17, P711, DOI 10.1175/1520-0442(2004)017&lt;0711:ANEAWM&gt;2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; [康丽华 KANG LiHua], 2006, [气候与环境研究, Climatic and environmental research], V11, P330; [康丽华 KANG Lihua], 2009, [气候与环境研究, Climatic and Environmental Research], V14, P45; 纪立人, 1997, Advances in Atmospheric Sciences, V14, P1; Kushnir Y, 2002, J CLIMATE, V15, P2233, DOI 10.1175/1520-0442(2002)015<2233:AGRTES>2.0.CO;2; Liu G, 2012, ATMOS OCEAN SCI LETT, V5, P195, DOI 10.1080/16742834.2012.11446985; NAMIAS J, 1970, J GEOPHYS RES, V75, P5952, DOI 10.1029/JC075i030p05952; NAMIAS J, 1974, J GEOPHYS RES, V79, P797, DOI 10.1029/JC079i006p00797; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wang L, 2010, ADV ATMOS SCI, V27, P855, DOI 10.1007/s00376-009-9094-3; Wang L, 2009, J CLIMATE, V22, P4860, DOI 10.1175/2009JCLI2973.1; [王遵娅 Wang Zunya], 2006, [大气科学, Chinese Journal of Atmospheric Sciences], V30, P1068; Wu BY, 2006, MON WEATHER REV, V134, P2165, DOI 10.1175/MWR3150.1; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Wu BY, 2002, ADV ATMOS SCI, V19, P297; Wu RG, 2005, J CLIMATE, V18, P3048, DOI 10.1175/JCLI3465.1; Wu ZW, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011501; Xue X, 2015, THEOR APPL CLIMATOL, V120, P673, DOI 10.1007/s00704-014-1200-5; Zhao X, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008248; Zhao X, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007845; Zhao X, 2010, J CLIMATE, V23, P3835, DOI 10.1175/2009JCLI2583.1	32	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171641	10.1371/journal.pone.0171641	http://dx.doi.org/10.1371/journal.pone.0171641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178351	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500056
J	Hangoma, P; Aakvik, A; Robberstad, B				Hangoma, Peter; Aakvik, Arild; Robberstad, Bjarne			Explaining changes in child health inequality in the run up to the 2015 Millennium Development Goals (MDGs): The case of Zambia	PLOS ONE			English	Article							BIRTH-ORDER; FAMILY-SIZE; CONCENTRATION INDEX; GIRLS BORN; FOLLOW-UP; GROWTH; FEVER; INFANTS; MALNUTRITION; NUTRITION	Background Child health interventions were drastically scaled up in the period leading up to 2015 as countries aimed at meeting the 2015 target of the Millennium Development Goals (MDGs). MDGs were defined in terms of achieving improvements in average health. Significant improvements in average child health are documented, but evidence also points to rising inequality. It is important to investigate factors that drive the increasing disparities in order to inform the post-2015 development agenda of reducing inequality, as captured in the Sustainable Development Goals (SDGs). We investigated changes in socioeconomic inequality in stunting and fever in Zambia in 2007 and 2014. Unlike the huge literature that seeks to quantify the contribution of different determinants on the observed inequality at any given time, we quantify determinants of changes in inequality. Methods Data from the 2007 and 2014 waves of the Zambia Demographic and Health Survey (DHS) were utilized. Our sample consisted of children aged 0-5 years (n = 5,616 in 2007 and n = 12,714 in 2014). We employed multilevel models to assess the determinants of stunting and fever, which are two important child health indicators. The concentration index (CI) was used to measure the magnitude of inequality. Changes in inequality of stunting and fever were investigated using Oaxaca-type decomposition of the CI. In this approach, the change in the CI for stunting/fever is decomposed into changes in CI for each determinant and changes in the effect-measured as an elasticity-of each determinant on stunting/fever. Results While average rates of stunting reduced in 2014 socioeconomic inequality in stunting increased significantly. Inequality in fever incidence also increased significantly, but average rates of fever did not reduce. The increase in the inequality (CI) of determinants accounted for the largest part (42.5%) of the increase in inequality of stunting, while the increase in the effect of determinants explained 35% of the increase. The determinants with the greatest total contribution (change in CI plus change in effect) to the increase in inequality of stunting were mother's height and weight, wealth, birth order, facility delivery, duration of breastfeeding, and maternal education. For fever, almost all (86%) the increase in inequality was accounted for by the increase in the effect of determinants of fever, while the distribution of determinants mattered less. The determinants with the greatest total contribution to the increase in inequality of fever were wealth, maternal education, birth order and breastfeeding duration. In the multilevel model, we found that the likelihood of a child being stunted or experiencing fever depends on the community in which they live. Conclusions To curb the increase in inequality of stunting and fever, policy may focus on improving levels of, and reducing inequality in, access to facility deliveries, maternal nutrition (which may be related to maternal weight and height), complementary feeding (for breastfed children), wealth, maternal education, and child care (related to birth order effects). Improving overall levels of these determinants contribute to the persistence of inequality if these determinants are unequally concentrated on the well off to begin with.	[Hangoma, Peter; Robberstad, Bjarne] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Hangoma, Peter] Univ Zambia, Sch Publ Hlth, Unit Hlth Econ, Lusaka, Zambia; [Aakvik, Arild] Univ Bergen, Dept Econ, Bergen, Norway; [Robberstad, Bjarne] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway	University of Bergen; University of Zambia; University of Bergen; University of Bergen	Hangoma, P (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Hangoma, P (corresponding author), Univ Zambia, Sch Publ Hlth, Unit Hlth Econ, Lusaka, Zambia.	peterhangoma555@gmail.com	Robberstad, Bjarne/AAG-9322-2020	Robberstad, Bjarne/0000-0002-0708-2016	Fogarty International Center of the National Institutes of Health [5R24TW008873]; PEPFAR [D43TWO01035]; University of Bergen; University of Zambia; Office of the US Global AIDS Coordinator (OGAC); Office of AIDS Research (OAR)	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); PEPFAR; University of Bergen; University of Zambia; Office of the US Global AIDS Coordinator (OGAC); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Fogarty International Center of the National Institutes of Health and PEPFAR under Award Number D43TWO01035, the University of Bergen, the University of Zambia, and Grant Number5R24TW008873 administered by the Fogarty International Center of the National Institutes of Health and funded by the Office of the US Global AIDS Coordinator (OGAC) and Office of AIDS Research (OAR). PH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165; Banerjee A, 2010, REV ECON STAT, V92, P714, DOI 10.1162/REST_a_00024; Beaglehole R., 2003, WORLD HLTH REPORT 20; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black SE, 2005, Q J ECON, V120, P669, DOI 10.1162/0033553053970179; Bredenkamp C, 2014, INT J EPIDEMIOL, V43, P1328, DOI 10.1093/ije/dyu075; Brennan L, 2004, ECON HUM BIOL, V2, P139, DOI 10.1016/j.ehb.2003.09.003; Colson KE, 2015, BMC MED, V13, P1; Spyrides MHC, 2008, J PEDIAT-BRAZIL, V84, P237, DOI [10.2223/JPED.1797, 10.1590/S0021-75572008000300009]; Currie J, 2015, J POLICY ANAL MANAG, V34, P208, DOI 10.1002/pam.21805; De Haan M, 2014, J HUM RESOUR, V49, P359, DOI 10.3368/jhr.49.2.359; De Neve JW, 2015, LANCET GLOB HEALTH, V3, pE470, DOI 10.1016/S2214-109X(15)00087-X; Duggleby SL, 2001, CLIN SCI, V101, P65, DOI 10.1042/CS20000330; ELLIOTT BA, 1992, SOC SCI MED, V35, P443, DOI 10.1016/0277-9536(92)90337-P; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Friedman J, 2013, HEALTH ECON, V22, P611, DOI 10.1002/hec.2818; Green R, 2013, SAMJ S AFR MED J, V103, P948, DOI [10.7196/samj.7207, 10.7196/SAMJ.7207]; Griffen AS, 2016, ECON HUM BIOL, V20, P55, DOI 10.1016/j.ehb.2015.10.004; Grimm M, 2011, OXFORD EC PAPERS; Harkonen J, 2014, EUR SOCIOL REV, V30, P166, DOI 10.1093/esr/jct027; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS60, DOI 10.1097/00005176-200007001-00006; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Ickes SB, 2015, J NUTR; Kabeer N., 2010, CAN MDGS PROVIDE PAT; Kandala NB, 2006, SOC SCI MED, V62, P1138, DOI 10.1016/j.socscimed.2005.07.028; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kattula D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005404; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Kien VD, 2016, GLOBAL HLTH ACTION, P9; Kipp AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007675; Kjellsson G, 2013, J HEALTH ECON, V32, P659, DOI 10.1016/j.jhealeco.2012.10.012; Krebs NF, 2012, AM J CLIN NUTR, V96, P840, DOI 10.3945/ajcn.112.041962; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Kroger H, 2016, PUBLIC HEALTH, V133, P67, DOI 10.1016/j.puhe.2015.10.022; KWIATKOWSKI D, 1990, IMMUNOL LETT, V25, P213, DOI 10.1016/0165-2478(90)90117-9; Lee G, 2012, INT J EPIDEMIOL, V41, P531, DOI 10.1093/ije/dyr190; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; Leroy J.L., 2011, ZSCORE06 STATA COMMA; Luszczak T, 2001, AM FAM PHYSICIAN, V64, P1219; Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6; Mogstad M, 2016, QUANT ECON, V7, P157, DOI 10.3982/QE322; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myrskyla M, 2013, J EPIDEMIOLOGY COMMU; Ng M, 2016, AM J TROPICAL MED HY; Ngianga-Bakwin K., 2004, AFRICAN POPUL STUD S, V19, P199; Nielsen GA, 1998, ACTA PAEDIATR, V87, P911, DOI 10.1080/080352598750031536; O'Donnell O, 2009, J DEV ECON, V88, P45, DOI 10.1016/j.jdeveco.2008.01.004; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Plaza JJG, 2016, INTRACTABLE RARE DIS, V5, P97, DOI 10.5582/irdr.2016.01009; Quentin W, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-95; Rahman M, 2016, CAD SAUDE PUBLICA, V32, DOI [10.1590/0102-311x00011215, 10.1590/0102-311X00011215]; Rodgers JL, 2000, AM PSYCHOL, V55, P599, DOI 10.1037//0003-066X.55.6.599; Rutstein S.O, 2014, DHS METHODOLOGICAL R; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Tenikue M, 2010, J AFR ECON, V19, P459, DOI 10.1093/jae/ejq013; The World Bank, 2012, HLTH EQ FIN PROT DAT; UN, 2009, IMPL MILL DEV GOALS; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Woodward A, 2000, J EPIDEMIOL COMMUN H, V54, P923, DOI 10.1136/jech.54.12.923; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2	72	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170995	10.1371/journal.pone.0170995	http://dx.doi.org/10.1371/journal.pone.0170995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170442	Green Submitted, gold, Green Published			2022-12-27	WOS:000393705500017
J	Paul, R; Choudhury, A; Kumar, S; Giri, A; Sandhir, R; Borah, A				Paul, Rajib; Choudhury, Amarendranath; Kumar, Sanjeev; Giri, Anirudha; Sandhir, Rajat; Borah, Anupom			Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; BODY-MASS INDEX; ALPHA-SYNUCLEIN; ROTENONE MODEL; BRAIN; PATHOLOGY; IMPAIRMENT; PROTECTS; MICE; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	Hypercholesterolemia is a known contributor to the pathogenesis of Alzheimer's disease while its role in the occurrence of Parkinson's disease (PD) is only conjecture and far from conclusive. Altered antioxidant homeostasis and mitochondrial functions are the key mechanisms in loss of dopaminergic neurons in the substantia nigra (SN) region of the midbrain in PD. Hypercholesterolemia is reported to cause oxidative stress and mitochondrial dysfunctions in the cortex and hippocampus regions of the brain in rodents. However, the impact of hypercholesterolemia on the midbrain dopaminergic neurons in animal models of PD remains elusive. We tested the hypothesis that hypercholesterolemia in MPTP model of PD would potentiate dopaminergic neuron loss in SN by disrupting mitochondrial functions and antioxidant homeostasis. It is evident from the present study that hypercholesterolemia in naive animals caused dopamine neuronal loss in SN with subsequent reduction in striatal dopamine levels producing motor impairment. Moreover, in the MPTP model of PD, hypercholesterolemia exacerbated MPTP-induced reduction of striatal dopamine as well as dopaminergic neurons in SN with motor behavioral depreciation. Activity of mitochondrial complexes, mainly complex-I and III, was impaired severely in the nigrostriatal pathway of hypercholesterolemic animals treated with MPTP. Hypercholesterolemia caused oxidative stress in the nigrostriatal pathway with increased generation of hydroxyl radicals and enhanced activity of antioxidant enzymes, which were further aggravated in the hypercholesterolemic mice with Parkinsonism. In conclusion, our findings provide evidence of increased vulnerability of the midbrain dopaminergic neurons in PD with hypercholesterolemia.	[Paul, Rajib; Choudhury, Amarendranath; Borah, Anupom] Assam Univ, Dept Life Sci & Bioinformat, Cellular & Mol Neurobiol Lab, Silchar, Assam, India; [Kumar, Sanjeev] Assam Univ, Dept Life Sci & Bioinformat, Microbial & Mol Immunol Lab, Silchar, Assam, India; [Giri, Anirudha] Assam Univ, Dept Life Sci & Bioinformat, Environm Toxicol Lab, Silchar, India; [Sandhir, Rajat] Panjab Univ, Dept Biochem, Chandigarh, India	Assam University; Assam University; Assam University; Panjab University	Borah, A (corresponding author), Assam Univ, Dept Life Sci & Bioinformat, Cellular & Mol Neurobiol Lab, Silchar, Assam, India.	anupomborahh@gmail.com	Choudhury, Amarendranath/A-1581-2018; Borah, Anupom/I-2967-2019	Choudhury, Amarendranath/0000-0002-7042-8139; Paul, Rajib/0000-0002-2433-9266; Borah, Anupom/0000-0002-6283-5367; Kumar, Sanjeev/0000-0002-4454-9914	Department of Biotechnology, Government of India [BT/230/NE/TBP/2011]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We sincerely acknowledge the funding and support provided by Department of Biotechnology, Government of India (Sanction Order No. BT/230/NE/TBP/2011, dated April 23, 2012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely acknowledge the support provided by the Department of Biotechnology, Government of India (Sanction Order No. BT/230/NE/TBP/2011, dated April 23, 2012).	Aebi H, 1984, Methods Enzymol, V105, P121; ALLAIN CC, 1974, CLIN CHEM, V20, P470; AMBANI LM, 1975, ARCH NEUROL-CHICAGO, V32, P114, DOI 10.1001/archneur.1975.00490440064010; Aytan N, 2008, BIOFACTORS, V33, P225, DOI 10.1002/biof.5520330308; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Bhattacharjee Nivedita, 2016, Biochem Biophys Rep, V6, P47, DOI 10.1016/j.bbrep.2016.02.013; Bhattacharjee N, 2016, NEUROSCI LETT, V628, P225, DOI 10.1016/j.neulet.2016.06.011; Borah A, 2007, CELL MOL NEUROBIOL, V27, P985, DOI 10.1007/s10571-007-9213-6; Borah A, 2010, NEUROCHEM INT, V56, P357, DOI 10.1016/j.neuint.2009.11.008; Bousquet M, 2012, NEUROBIOL DIS, V45, P529, DOI 10.1016/j.nbd.2011.09.009; Choi JY, 2005, FREE RADICAL BIO MED, V38, P806, DOI 10.1016/j.freeradbiomed.2004.12.008; de Oliveira J, 2011, NEUROSCIENCE, V197, P99, DOI 10.1016/j.neuroscience.2011.09.009; de Oliveira J, 2013, NEUROCHEM RES, V38, P2028, DOI 10.1007/s11064-013-1110-4; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Doria M, 2016, FREE RADICAL BIO MED, V101, P393, DOI 10.1016/j.freeradbiomed.2016.10.008; Govindaiah, 2000, DEV BRAIN RES, V124, P117; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Hu G, 2008, NEUROLOGY, V70, P1972, DOI 10.1212/01.wnl.0000312511.62699.a8; Hu G, 2006, NEUROLOGY, V67, P1955, DOI 10.1212/01.wnl.0000247052.18422.e5; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Karuppagounder SS, 2013, NEUROSCIENCE, V236, P136, DOI 10.1016/j.neuroscience.2013.01.032; Knight EM, 2014, NEUROBIOL AGING, V35, P1821, DOI 10.1016/j.neurobiolaging.2014.02.010; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Marwarha G, 2011, J NEUROCHEM, V119, P1119, DOI 10.1111/j.1471-4159.2011.07497.x; Mazumder MK, 2013, CNS NEUROSCI THER, V19, P596, DOI 10.1111/cns.12113; Mazumder MK, 2016, LIFE SCI, V161, P27, DOI 10.1016/j.lfs.2016.07.020; Mazzoni P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009282; Medeiros MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146129; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Meredith GE, 2011, J PARKINSON DIS, V1, P19, DOI 10.3233/JPD-2011-11023; Naskar A, 2015, J PINEAL RES, V58, P262, DOI 10.1111/jpi.12212; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Pandey M, 2008, J NEUROCHEM, V104, P420, DOI 10.1111/j.1471-4159.2007.04996.x; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Paul R, 2016, BBA-GEN SUBJECTS, V1860, P1989, DOI 10.1016/j.bbagen.2016.06.018; Paul R, 2015, NEUROCHEM INT, V90, P125, DOI 10.1016/j.neuint.2015.07.025; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; Prasanthi JRP, 2010, FREE RADICAL BIO MED, V49, P1212, DOI 10.1016/j.freeradbiomed.2010.07.007; Przedborski S, 1998, MOVEMENT DISORD, V13, P35; Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484; Rao WW, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050516; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sindhu KM, 2006, PHARMACOL BIOCHEM BE, V84, P321, DOI 10.1016/j.pbb.2006.05.017; Tapias V, 2010, J NEUROSCI RES, V88, P420, DOI 10.1002/jnr.22201; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Thomas B, 2004, J PINEAL RES, V36, P25, DOI 10.1046/j.1600-079X.2003.00096.x; Toyama K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10844; Tripathy D, 2014, CNS NEUROSCI THER, V20, P717, DOI 10.1111/cns.12295; Ullrich C, 2010, MOL CELL NEUROSCI, V45, P408, DOI 10.1016/j.mcn.2010.08.001; WEBER AF, 1956, J HISTOCHEM CYTOCHEM, V4, P308, DOI 10.1177/4.4.308; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Zhu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144983	59	54	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171285	10.1371/journal.pone.0171285	http://dx.doi.org/10.1371/journal.pone.0171285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170429	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500029
J	Al-Gobari, M; Le, HH; Fall, M; Gueyffier, F; Burnand, B				Al-Gobari, Muaamar; Le, Hai-Ha; Fall, Mor; Gueyffier, Francois; Burnand, Bernard			No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							ENDOTHELIAL FUNCTION; DOUBLE-BLIND; NONISCHEMIC CARDIOMYOPATHY; ATORVASTATIN THERAPY; INFLAMMATORY MARKERS; CLINICAL-OUTCOMES; TOTAL CHOLESTEROL; RATE-VARIABILITY; SERUM MARKERS; TASK-FORCE	Background and objectives Statins showed mixed results in heart failure (HF) patients. The benefits in major HF outcomes, including all-cause mortality and sudden cardiac death (SCD), have always been discordant across systematic reviews and meta-analyses. We intended to systematically identify and appraise the available evidence that evaluated the effectiveness of statins in clinical outcomes for HF patients. Design Systematic review and meta-analysis Data sources We searched, until April 28, 2016: Medline, Embase, ISI Web of Science and EBM reviews (Cochrane DSR, ACP journal club, DARE, CCTR, CMR, HTA, and NHSEED), checked clinicaltrials.gov for ongoing trials and manually searched references of included studies. Eligibility criteria for selecting studies We identified 24 randomized clinical trials that evaluated the efficacy of statins for HF patients. All randomized clinical trials were assessed for risk of bias and pooled together in a meta-analysis. Pre-specified outcomes were sudden cardiac death, all-cause mortality, and hospitalization for worsening heart failure. Results Statins did not reduce sudden cardiac death (SCD) events in HF patients [relative risk (RR) 0.92, 95% confidence interval (CI) 0.70 to 1.21], all-cause mortality [RR 0.88, 95% CI 0.75 to 1.02] but significantly reduced hospitalization for worsening heart failure (HWHF) although modestly [RR 0.79, 95% CI 0.66 to 0.94]. Nevertheless, estimated predictive intervals were insignificant in SCD, all-cause mortality and HWHF [RR, 0.54 to 1.63, 0.64 to 1.19, and 0.54 to 1.15], respectively. An important finding was the possible presence of publication bias, small-study effects and heterogeneity of the trials conducted in HF patients. Conclusions Statins do not reduce sudden cardiac death, all-cause mortality, but may slightly decrease hospitalization for worsening heart failure in HF patients. The evaluation of the risk of biases suggested moderate quality of the published results. Until new evidence is available, this study supports the 2013 ACCF/AHA guidelines to not systematically prescribe statins in "only" HF patients, which should help avoid unnecessary polypharmacy.	[Al-Gobari, Muaamar; Burnand, Bernard] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Al-Gobari, Muaamar; Burnand, Bernard] Lausanne Univ Hosp CHUV, Cochrane Switzerland, Lausanne, Switzerland; [Le, Hai-Ha; Fall, Mor; Gueyffier, Francois] Univ Claude Bernard Lyon1, EMET, Lab Biol & Biometrie Evolut, Serv Pharmacol Clin,UMR, Lyon, France; [Fall, Mor] Univ Cheikh Anta Diop, Lab Pharmacol & Pharmacodynamie, Dakar, Senegal	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University Cheikh Anta Diop Dakar	Al-Gobari, M (corresponding author), Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.; Al-Gobari, M (corresponding author), Lausanne Univ Hosp CHUV, Cochrane Switzerland, Lausanne, Switzerland.	muaamar.algobari@gmail.com	Al-Gobari, Muaamar/D-7382-2016	Al-Gobari, Muaamar/0000-0003-1522-9812	Federal Department of Economic Affairs, Education and Research (EAER), Switzerland [2014.0193]; University Claude Bernard Lyon (scholarship of French Ministry of Higher Education Research) [10/2014-09/2017, UMR 5558 CNRS]	Federal Department of Economic Affairs, Education and Research (EAER), Switzerland; University Claude Bernard Lyon (scholarship of French Ministry of Higher Education Research)	MA, the corresponding author, received a financial grant (2014.0193) from The Federal Department of Economic Affairs, Education and Research (EAER), Switzerland. HHL received a financial grant from University Claude Bernard Lyon 1 (scholarship of French Ministry of Higher Education & Research) for a three-year PhD contract (10/2014-09/2017) at the UMR 5558 CNRS. All funding is independent from the study design, data interpretation, writing or the decision to submit the article for publication.	Abulhul E, 2012, CLIN THER, V34, P91, DOI 10.1016/j.clinthera.2011.11.002; Afsarmanesh N, 2006, AM HEART J, V152, P1077, DOI 10.1016/j.ahj.2006.06.015; Al-Gobari M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-52; [Anonymous], 2014, DAT ABSTR REV EFF DA; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Beri A, 2010, AM J CARDIOVASC DRUG, V10, P155, DOI 10.2165/11536690-000000000-00000; Bielecka-Dabrowa A, 2009, MED SCI MONITOR, V15, pMS12; Bleske BE, 2006, J AM COLL CARDIOL, V47, P338, DOI 10.1016/j.jacc.2005.06.087; Bonsu KO, 2015, EUR HEART J, V36, P546; Bonsu KO, 2016, CARDIOVASC DRUGS THE; Chaimani A, 2014, EVID-BASED MENT HEAL, V17, P111, DOI 10.1136/eb-2014-101967; Chow S-C, 2008, SAMPLE SIZE CALCULAT; Deo SV, 2014, HEART LUNG CIRC, V23, P985, DOI 10.1016/j.hlc.2014.04.007; DuBroff R, 2016, PREV MED, V85, P32, DOI 10.1016/j.ypmed.2016.01.004; Erbs S, 2011, INT J CARDIOL, V146, P56, DOI 10.1016/j.ijcard.2010.02.019; Granger Christopher B, 2010, Ann Intern Med, V152, pJC4, DOI 10.7326/0003-4819-152-8-201004200-02006; Hamaad A, 2005, CARDIOVASC DRUG THER, V19, P183, DOI 10.1007/s10557-005-2219-8; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hong YJ, 2005, AM J CARDIOL, V95, P619, DOI 10.1016/j.amjcard.2004.10.039; Hopper I, 2014, J CARD FAIL, V20, P522, DOI 10.1016/j.cardfail.2014.04.013; Horwich TB, 2011, J CARD FAIL, V17, P879, DOI 10.1016/j.cardfail.2011.07.008; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Krum H, 2007, J CARD FAIL, V13, P1, DOI 10.1016/j.cardfail.2006.09.008; Laufs U, 2004, Z KARDIOL, V93, P103, DOI 10.1007/s00392-004-1005-0; Le HH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145958; Lee E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-51; Levantesi G, 2007, AM J CARDIOL, V100, P1644, DOI 10.1016/j.amjcard.2007.07.015; Lipinski MJ, 2009, AM J CARDIOL, V104, P1708, DOI 10.1016/j.amjcard.2009.07.055; Liu G, 2014, HEART LUNG CIRC, V23, P970, DOI 10.1016/j.hlc.2014.05.005; Liu G, 2014, AM J CARDIOL, V113, P1198, DOI 10.1016/j.amjcard.2013.12.023; Liu M, 2009, CARDIOVASC DRUG THER, V23, P369, DOI 10.1007/s10557-009-6186-3; Lopez-Sendon J, 2004, EUR HEART J, V25, P1454, DOI 10.1016/j.ehj.2004.06.003; Mozaffarian D, 2005, AM J CARDIOL, V96, P1699, DOI 10.1016/j.amjcard.2005.07.092; Node K, 2003, CIRCULATION, V108, P839, DOI 10.1161/01.CIR.0000084539.58092.DE; Preiss D, 2015, EUR HEART J, V36, P1536, DOI 10.1093/eurheartj/ehv072; Rahimi K, 2012, EUR HEART J, V33, P1571, DOI 10.1093/eurheartj/ehs005; Rain C, 2015, MEDWAVE, V15, DOI 10.5867/medwave.2015.04.6140; Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016; Ross SD, 1999, ARCH INTERN MED, V159, P1793, DOI 10.1001/archinte.159.15.1793; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Strey CH, 2006, HEART, V92, P1603, DOI 10.1136/hrt.2005.082560; Takagi H, 2012, INT J CARDIOL, V155, P296, DOI 10.1016/j.ijcard.2011.11.079; Takagi H, 2012, INT J CARDIOL, V154, P78, DOI 10.1016/j.ijcard.2011.09.065; Takano H, 2013, CIRC J, V77, P917, DOI 10.1253/circj.CJ-12-1062; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Tousoulis D, 2005, EUR J HEART FAIL, V7, P1126, DOI 10.1016/j.ejheart.2005.03.007; Tousoulis D, 2005, ATHEROSCLEROSIS, V178, P359, DOI 10.1016/j.atherosclerosis.2004.08.037; van der Harst P, 2006, PLOS MED, V3, P1403, DOI 10.1371/journal.pmed.0030333; Vrtovec B, 2005, J CARD FAIL, V11, P684, DOI 10.1016/j.cardfail.2005.06.439; Vrtovec B, 2008, J CARD FAIL, V14, P140, DOI 10.1016/j.cardfail.2007.10.013; Wang JQ, 2014, HEART LUNG CIRC, V23, P105, DOI 10.1016/j.hlc.2013.07.012; Westman PC, 2015, J THORAC DIS, V7, P1687, DOI 10.3978/j.issn.2072-1439.2015.10.47; White J, 2014, HEART LUNG CIRC, V23, P989, DOI 10.1016/j.hlc.2014.04.133; Wilczynski NL, 2007, J CLIN EPIDEMIOL, V60, P29, DOI 10.1016/j.jclinepi.2006.04.001; Wojnicz R, 2006, AM J CARDIOL, V97, P899, DOI 10.1016/j.amjcard.2005.09.142; Xie RQ, 2010, INT J CARDIOL, V140, P255, DOI 10.1016/j.ijcard.2008.11.030; Xu MW, 2010, ARCH MED SCI, V6, P866, DOI 10.5114/aoms.2010.19293; Yamada T, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.03.027; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhang L, 2011, CLIN CARDIOL, V34, P117, DOI 10.1002/clc.20821; Zhang L, 2010, ARCH MED RES, V41, P464, DOI 10.1016/j.arcmed.2010.08.009; Zhang SN, 2011, EUR J INTERN MED, V22, P478, DOI 10.1016/j.ejim.2011.06.003; Zhang YC, 2015, MED SCI MONITOR, V21, P1792, DOI 10.12659/MSM.893681; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	66	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171168	10.1371/journal.pone.0171168	http://dx.doi.org/10.1371/journal.pone.0171168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166237	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100027
J	Huang, WC; Tsai, HC; Tao, CW; Chen, JS; Shih, YJ; Kao, PM; Huang, TY; Hsu, BM				Huang, Wen-Chien; Tsai, Hsin-Chi; Tao, Chi-Wei; Chen, Jung-Sheng; Shih, Yi-Jia; Kao, Po-Min; Huang, Tung-Yi; Hsu, Bing-Mu			Approach to determine the diversity of Legionella species by nested PCR-DGGE in aquatic environments	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; DNA-EXTRACTION; COMMUNITIES; GENES; SOIL; PNEUMOPHILA; BACTERIA; PRIMERS	In this study, we describe a nested PCR-DGGE strategy to detect Legionella communities from river water samples. The nearly full-length 16S rRNA gene was amplified using bacterial primer in the first step. After, the amplicons were employed as DNA templates in the second PCR using Legionella specific primer. The third round of gene amplification was conducted to gain PCR fragments apposite for DGGE analysis. Then the total numbers of amplified genes were observed in DGGE bands of products gained with primers specific for the diversity of Legionella species. The DGGE patterns are thus potential for a high-throughput preliminary determination of aquatic environmental Legionella species before sequencing. Comparative DNA sequence analysis of excised DGGE unique band patterns showed the identity of the Legionella community members, including a reference profile with two pathogenic species of Legionella strains. In addition, only members of Legionella pneumophila and uncultured Legionella sp. were detected. Development of three step nested PCR-DGGE tactic is seen as a useful method for studying the diversity of Legionella community. The method is rapid and provided sequence information for phylogenetic analysis.	[Huang, Wen-Chien] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Huang, Wen-Chien] Mackay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan; [Huang, Wen-Chien] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Tsai, Hsin-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tsai, Hsin-Chi] Tzu Chi Gen Hosp, Dept Psychiat, Hualien, Taiwan; [Tao, Chi-Wei] Cheng Hsin Gen Hosp, Sect Resp Therapy, Taipei, Taiwan; [Chen, Jung-Sheng] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shih, Yi-Jia; Kao, Po-Min; Huang, Tung-Yi; Hsu, Bing-Mu] Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Cheng Hsin General Hospital; National Defense Medical Center; National Chung Cheng University	Hsu, BM (corresponding author), Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi, Taiwan.	bmhsu@ccu.edu.tw	Hsu, Bing-Mu/AAN-5768-2021; Chen, Jung-Sheng/GWR-2603-2022	Hsu, Bing-Mu/0000-0002-2988-8408; Shih, YiJia/0000-0001-9571-2171; Chen, Jung-Sheng/0000-0003-3187-9479	Mackay Medicine College and Hospital [105DMH0100139]; Ministry of Science and Technology of Republic of China (Taiwan) [MOST 104-2116-M-194-011]	Mackay Medicine College and Hospital; Ministry of Science and Technology of Republic of China (Taiwan)	This research was supported by grants from the Mackay Medicine College and Hospital (105DMH0100139), entitle by WCH and Ministry of Science and Technology of Republic of China (Taiwan) (MOST 104-2116-M-194-011), entitle by BMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleke AA, 2001, INT J SYST EVOL MICR, V51, P1151, DOI 10.1099/00207713-51-3-1151; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Dar SA, 2005, APPL ENVIRON MICROB, V71, P2325, DOI 10.1128/AEM.71.5.2325-2330.2005; DROZANSKI W., 1956, ACTA MICROBIOL POLONICA, V5, P315; DROZANSKI WJ, 1991, INT J SYST BACTERIOL, V41, P82, DOI 10.1099/00207713-41-1-82; ElFantroussi S, 1997, APPL ENVIRON MICROB, V63, P806, DOI 10.1128/AEM.63.2.806-811.1997; ERB RW, 1993, APPL ENVIRON MICROB, V59, P4065, DOI 10.1128/AEM.59.12.4065-4073.1993; Fritsche TR, 1998, FEMS MICROBIOL LETT, V166, P231, DOI 10.1111/j.1574-6968.1998.tb13895.x; Heuer H., 1997, Modern soil microbiology., P353; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Levesque MJ, 1997, APPL MICROBIOL BIOT, V47, P719, DOI 10.1007/s002530051001; Liu YC, 1985, J FORMOS MED ASSOC, P1180; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Phillips CJ, 2000, APPL ENVIRON MICROB, V66, P5410, DOI 10.1128/AEM.66.12.5410-5418.2000; Pulawska J, 2005, J APPL MICROBIOL, V98, P710, DOI 10.1111/j.1365-2672.2004.02503.x; Regeard C, 2004, J MICROBIOL METH, V56, P107, DOI 10.1016/j.mimet.2003.09.019; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; ROWBOTHAM TJ, 1986, ISRAEL J MED SCI, V22, P678; Shen SM, 2015, PATHOG GLOB HEALTH, V109, P236, DOI 10.1179/2047773215Y.0000000023; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P6380, DOI 10.1128/AEM.69.11.6380-6385.2003; World Health Organization, 2007, LEGIONELLA PREVENTIO	23	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170992	10.1371/journal.pone.0170992	http://dx.doi.org/10.1371/journal.pone.0170992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166249	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100017
J	Reynaud, Y; Zheng, C; Wu, GH; Sun, Q; Rastogi, N				Reynaud, Yann; Zheng, Chao; Wu, Guihui; Sun, Qun; Rastogi, Nalin			Bayesian population structure analysis reveals presence of phylogeographically specific sublineages within previously ill-defined T group of Mycobacterium tuberculosis	PLOS ONE			English	Article							GENETIC DIVERSITY; DRUG SUSCEPTIBILITY; COMPUTER-PROGRAM; DATABASE; IDENTIFICATION; ETHIOPIA; NUMBER	Mycobacterium tuberculosis genetic structure, and evolutionary history have been studied for years by several genotyping approaches, but delineation of a few sublineages remains controversial and needs better characterization. This is particularly the case of T group within lineage 4 (L4) which was first described using spoligotyping to pool together a number of strains with ill-defined signatures. Although T strains were not traditionally considered as a real phylogenetic group, they did contain a few phylogenetically meaningful sublineages as shown using SNPs. We therefore decided to investigate if this observation could be corroborated using other robust genetic markers. We consequently made a first assessment of genetic structure using 24-loci MIRU-VNTRs data extracted from the SITVIT2 database (n = 607 clinical isolates collected in Russia, Albania, Turkey, Iraq, Brazil and China). Combining Minimum Spanning Trees and Bayesian population structure analyses (using STRUCTURE and TESS softwares), we distinctly identified eight tentative phylogenetic groups (T1-T8) with a remarkable correlation with geographical origin. We further compared the present structure observed with other L4 sublineages (n = 416 clinical isolates belonging to LAM, Haarlem, X, S sublineages), and showed that 5 out of 8 T groups seemed phylogeographically well-defined as opposed to the remaining 3 groups that partially mixed with other L4 isolates. These results provide with novel evidence about phylogeographically specificity of a proportion of ill-defined T group of M. tuberculosis. The genetic structure observed will now be further validated on an enlarged worldwide dataset using Whole Genome Sequencing (WGS).	[Reynaud, Yann; Zheng, Chao; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Morne Joliviere Abymes, Guadeloupe, France; [Zheng, Chao; Sun, Qun] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Wu, Guihui] Chengdu Publ Hlth Clin Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University	Reynaud, Y; Rastogi, N (corresponding author), Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Morne Joliviere Abymes, Guadeloupe, France.	yreynaud@pasteur-guadeloupe.fr; nrastogi@pasteur-guadeloupe.fr	RASTOGI, NALIN/AAP-1958-2020; Reynaud, Yann/ABD-7936-2021	RASTOGI, NALIN/0000-0002-7199-7747; Reynaud, Yann/0000-0002-1966-7249	European Regional Development Fund and European Social Fund (ERDF-ESF); Institut Pasteur International Network; China Scholarship Council (CSC) [201506240129]	European Regional Development Fund and European Social Fund (ERDF-ESF); Institut Pasteur International Network; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the European Regional Development Fund and European Social Fund (ERDF-ESF) under the scheme "Programme Operationnel FEDER-FSE Guadeloupe Conseil Regional 2014-2020" (Grant number pending). Yann Reynaud was awarded a Calmette and Yersin postdoctoral fellowship by the Institut Pasteur International Network. Chao Zheng was financially supported by China Scholarship Council (CSC, File NO.201506240129) under a co-training program for the fulfillment of his PhD research program between College of Life Sciences, Sichuan University, Chengdu, China, and Tuberculosis and Mycobacteria Unit, Institut Pasteur de la Guadeloupe.	Afanas'ev MV, 2011, EUR J CLIN MICROBIOL, V30, P181, DOI 10.1007/s10096-010-1067-z; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Amante C, NGDC24 NOAA NESDIS; Bouza E, 2005, ANAL MYCOBACTERIUM T, V43, P1797, DOI [10.1128/JCM.43.4.1797-1806.2005, DOI 10.1128/JCM.43.4.1797-1806.2005]; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chen L, 2012, J CLIN MICROBIOL, V50, P1043, DOI 10.1128/JCM.06095-11; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dong H, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/901842; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; HERMANS PWM, 1995, J INFECT DIS, V171, P1504, DOI 10.1093/infdis/171.6.1504; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lari N, 2005, J CLIN MICROBIOL, V43, P1617, DOI 10.1128/JCM.43.4.1617-1624.2005; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mustafa Ali R, 2014, BIOMED RES INT, V2014, P1806, DOI [10.1093/bioinformatics/btm233, DOI 10.1093/BIOINFORMATICS/BTM233]; Ohata Ritsuko, 2004, Kekkaku, V79, P47; Olsen LR, 2013, J IMMUNOL METHODS, V400, P37, DOI 10.1016/j.jim.2013.08.014; Ozkara S, 2015, MIKROBIYOL BUL, V49, P143; Perdigao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-991; Pritchard JK, 2000, GENETICS, V155, P945; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Valcheva V, 2015, INT J MYCOBACT, V4, P191, DOI 10.1016/j.ijmyco.2015.04.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Zhang D, 2013, INFECT GENET EVOL, V13, P310, DOI 10.1016/j.meegid.2012.10.008; Zheng C, 2015, J CLIN MICROBIOL, V53, P2138, DOI 10.1128/JCM.03507-14	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171584	10.1371/journal.pone.0171584	http://dx.doi.org/10.1371/journal.pone.0171584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166309	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100055
J	Bilotta, GS; Burnside, NG; Turley, MD; Gray, JC; Orr, HG				Bilotta, Gary S.; Burnside, Niall G.; Turley, Matthew D.; Gray, Jeremy C.; Orr, Harriet G.			The effects of run-of-river hydroelectric power schemes on invertebrate community composition in temperate streams and rivers	PLOS ONE			English	Article							MACROINVERTEBRATES; HYDROPOWER; DAMS; IMPACTS; PASSAGE; WORLD	Run-of-river (ROR) hydroelectric power (HEP) schemes are often presumed to be less ecologically damaging than large-scale storage HEP schemes. However, there is currently limited scientific evidence on their ecological impact. The aim of this article is to investigate the effects of ROR HEP schemes on communities of invertebrates in temperate streams and rivers, using a multi-site Before-After, Control-Impact (BACI) study design. The study makes use of routine environmental surveillance data collected as part of long-term national and international monitoring programmes at 22 systematically-selected ROR HEP schemes and 22 systematically-selected paired control sites. Five widely-used family-level invertebrate metrics (richness, evenness, LIFE, E-PSI, WHPT) were analysed using a linear mixed effects model. The analyses showed that there was a statistically significant effect (p<0.05) of ROR HEP construction and operation on the evenness of the invertebrate community. However, no statistically significant effects were detected on the four other metrics of community composition. The implications of these findings are discussed in this article and recommendations are made for best-practice study design for future invertebrate community impact studies.	[Bilotta, Gary S.; Burnside, Niall G.; Turley, Matthew D.] Univ Brighton, Aquat Res Ctr, Sch Environm & Technol, Brighton, E Sussex, England; [Gray, Jeremy C.] Precima Inc, Toronto, ON, Canada; [Orr, Harriet G.] Environm Agcy, Bristol, Avon, England	University of Brighton	Bilotta, GS (corresponding author), Univ Brighton, Aquat Res Ctr, Sch Environm & Technol, Brighton, E Sussex, England.	G.S.Bilotta@brighton.ac.uk	Orr, Harriet/AAP-2665-2020	Burnside, Niall/0000-0002-0416-1608; Orr, Harriet/0000-0001-5021-1074; Bilotta, Gary/0000-0003-1935-9040	Natural Environment Research Council; Environment Agency [NE/M019810/1]; NERC [NE/M019810/1] Funding Source: UKRI; Natural Environment Research Council [NE/M019810/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Environment Agency; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was co-funded by the Natural Environment Research Council (http://www.nerc.ac.uk,/) and the Environment Agency (https://www.gov.uk/government/organisations/environment-agency) under grant reference NE/M019810/1. Only GSB received the funding for this work. The Environment Agency had a role in the original collection of the routine surveillance monitoring data used in this study, though it was not collected specifically for the purposes of this study. The study was designed by GSB and it was his decision to publish the work. HGO (an employee of the Environment Agency funding body) did contribute towards the preparation of the manuscript. JCG is employed by Precima Incorporated. The funder provided support in the form of salaries for authors [JCG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbasi T, 2011, RENEW SUST ENERG REV, V15, P2134, DOI 10.1016/j.rser.2010.11.050; Anderson D, 2015, WATER ENVIRON J, V29, P268, DOI 10.1111/wej.12101; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Bilotta GS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154271; Bilotta GS, 2015, ENVIRON SCI EUR, V27, DOI 10.1186/s12302-015-0041-x; British Hydropower Association, 2005, GUID UK MIN DEV; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; COOK SEK, 1976, ENVIRON POLLUT, V11, P269, DOI 10.1016/0013-9327(76)90067-7; Coutant CC, 2000, T AM FISH SOC, V129, P351, DOI 10.1577/1548-8659(2000)129<0351:FBIRTP>2.0.CO;2; Environment Agency, 2013, TECHNICAL REPORT; Environment Agency, RIV OBSTR DAT ENGL W; Environment Agency, 2009, FRESHW MACR INV SAMP; Extence CA, 2013, RIVER RES APPL, V29, P17, DOI 10.1002/rra.1569; Extence CA, 1999, REGUL RIVER, V15, P543, DOI 10.1002/(SICI)1099-1646(199911/12)15:6&lt;545::AID-RRR561&gt;3.0.CO;2-W; Feld CK, 2014, FRESHWATER BIOL, V59, P233, DOI 10.1111/fwb.12260; Fidler F, 2006, CONSERV BIOL, V20, P1539, DOI 10.1111/j.1523-1739.2006.00525.x; Fthenakis V, 2010, RENEW SUST ENERG REV, V14, P2039, DOI 10.1016/j.rser.2010.03.008; Hutchinson TH, 1998, CHEMOSPHERE, V36, P129, DOI 10.1016/S0045-6535(97)10025-X; International Energy Agency, 2012, WORLD EN OUTL 2012; Kumar A., 2011, IPCC SPECIAL REPORT; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Mekonnen MM, 2015, ENVIRON SCI-WAT RES, V1, P285, DOI [10.1039/c5ew00026b, 10.1039/C5EW00026B]; Moomaw W., 2011, IPCC SPECIAL REPORT; Paish O, 2002, P I MECH ENG A-J POW, V216, P31, DOI 10.1243/095765002760024827; Paisley MF, 2014, RIVER RES APPL, V30, P887, DOI 10.1002/rra.2686; PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001; Pielou E., 1977, MATH ECOLOGY; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; PRATT JM, 1976, WATER RES, V10, P1019, DOI 10.1016/0043-1354(76)90083-X; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; Robson AL, 2013, THESIS; Schilt CR, 2007, APPL ANIM BEHAV SCI, V104, P295, DOI 10.1016/j.applanim.2006.09.004; Stroup WW., 1997, P BIOPH SECT AM STAT, P15; Turley MD, 2016, ECOL INDIC, V70, P151, DOI 10.1016/j.ecolind.2016.05.040; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	38	15	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171634	10.1371/journal.pone.0171634	http://dx.doi.org/10.1371/journal.pone.0171634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158282	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700117
J	Caminha, C; Furtado, V; Pequeno, THC; Ponte, C; Melo, HPM; Oliveira, EA; Andrade, JS				Caminha, Carlos; Furtado, Vasco; Pequeno, Tarcisio H. C.; Ponte, Caio; Melo, Hygor P. M.; Oliveira, Erneson A.; Andrade, Jose S., Jr.			Human mobility in large cities as a proxy for crime	PLOS ONE			English	Article							GROWTH; POPULATION; LAWS	We investigate at the subscale of the neighborhoods of a highly populated city the incidence of property crimes in terms of both the resident and the floating population. Our results show that a relevant allometric relation could only be observed between property crimes and floating population. More precisely, the evidence of a superlinear behavior indicates that a disproportional number of property crimes occurs in regions where an increased flow of people takes place in the city. For comparison, we also found that the number of crimes of peace disturbance only correlates well, and in a superlinear fashion too, with the resident population. Our study raises the interesting possibility that the super-linearity observed in previous studies [Bettencourt et al., Proc. Natl. Acad. Sci. USA 104, 7301 (2007) and Melo et al., Sci. Rep. 4, 6239 (2014)] for homicides versus population at the city scale could have its origin in the fact that the floating population, and not the resident one, should be taken as the relevant variable determining the intrinsic microdynamical behavior of the system.	[Caminha, Carlos; Furtado, Vasco; Pequeno, Tarcisio H. C.; Ponte, Caio; Oliveira, Erneson A.] Univ Fortaleza, Programa Pos Grad Informat Aplicada, Fortaleza, Ceara, Brazil; [Melo, Hygor P. M.] Inst Fed Educ Ciencia & Tecnol Ceara, Dept Ensino, Crateus, Ceara, Brazil; [Melo, Hygor P. M.; Oliveira, Erneson A.; Andrade, Jose S., Jr.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Instituto Federal do Ceara (IFCE); Universidade Federal do Ceara	Caminha, C (corresponding author), Univ Fortaleza, Programa Pos Grad Informat Aplicada, Fortaleza, Ceara, Brazil.	caminha@unifor.br	Furtado, Vasco/AAB-8318-2019; Melo, Hygor Piaget Monteiro/AAY-1792-2020; Andrade, José S/C-5451-2013; Furtado, Vasco/C-3748-2013	Furtado, Vasco/0000-0001-8721-4308; Melo, Hygor Piaget Monteiro/0000-0002-2507-4511; Andrade, José S/0000-0002-5571-7610; Furtado, Vasco/0000-0001-8721-4308	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico; National Institute of Science and Technology for Complex Systems	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); National Institute of Science and Technology for Complex Systems	JSA, CC, VF, THCP, CP, EAO and HPMM have been funded by the Brazilian Agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) and Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (www.funcap.ce.gov.br). JSA has also been funded by the National Institute of Science and Technology for Complex Systems (www.cbpf.br/inct-sc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/18002; Alves LGA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134862; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Arcaute E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150691; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Brantingham P.L., 1981, ENV CRIMINOLOGY, P27; Caminha C., 2012, P 21 INT WORLD WID W; Clarke RV, 1993, ADV CRIMINOLOGICAL T; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Cottineau C, 2016, ARXIV160105664; D'Orsogna MR, 2015, PHYS LIFE REV, V12, P1, DOI 10.1016/j.plrev.2014.11.001; Duranton G., 2013, GROWTH CITIES; Duranton G, 2015, ADV JPN BUS ECON, V4, P107, DOI 10.1007/978-4-431-55390-8_6; Eeckhout J, 2004, AM ECON REV, V94, P1429, DOI 10.1257/0002828043052303; Felson M., 2019, CRIME EVERYDAY LIFE, V6th; Furtado V, 2012, IEEE INTELL SYST, V27, P63, DOI 10.1109/MIS.2012.80; Gallos LK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00454; Giesen K, 2010, J URBAN ECON, V68, P129, DOI 10.1016/j.jue.2010.03.007; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Guedes R, 2014, INT SEC INF C JISIC, P288; Hanley QS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149546; Ignazzi C.A., 2014, ESPACE GEOGRAPHIQUE, V43, P324, DOI [DOI 10.3917/EG.434.0324, 10.3917/eg.434.0324]; Kiani R., 2015, ANALYSIS, V4; Kinney J. B., 2008, BUILD ENVIRON, V34, P62, DOI [10.2148/benv.34.1.62, DOI 10.2148/BENV.34.1.62]; Kleiber M, 1932, ENE-REV ENFERM, V1, pE9; Leitao JC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150649; Makse HA, 1998, PHYS REV E, V58, P7054, DOI 10.1103/PhysRevE.58.7054; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Michael J, 1933, INT LIB PSYCHOL PHIL; Montgomery D.C., 2015, INTRO LINEAR REGRESS; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Rapoport A., 1963, GEN SYSTEMS; Rawlings JO., 2001, APPL REGRESSION ANAL; Roman C., 2005, GEOGRAPHIC INFORM SY, P293, DOI [10.4018/978-1-59140-453-8.ch017, DOI 10.4018/978-1-59140-453-8.CH017]; Rozenfeld HD, 2011, AM ECON REV, V101, P2205, DOI 10.1257/aer.101.5.2205; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Short MB, 2010, P NATL ACAD SCI USA, V107, P3961, DOI 10.1073/pnas.0910921107; Taylor R. B., 1996, PHYS ENV CRIME; Wang T., 2013, LEARNING DETECT PATT, P515; Watson G.S, 1964, SANKHYA A, P359, DOI DOI 10.2307/25049340	47	35	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171609	10.1371/journal.pone.0171609	http://dx.doi.org/10.1371/journal.pone.0171609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158268	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700111
J	Conner, TS; Brookie, KL; Carr, AC; Mainvil, LA; Vissers, MCM				Conner, Tamlin S.; Brookie, Kate L.; Carr, Anitra C.; Mainvil, Louise A.; Vissers, Margreet C. M.			Let them eat fruit! The effect of fruit and vegetable consumption on psychological well-being in young adults: A randomized controlled trial	PLOS ONE			English	Article							SELF-RATED HEALTH; DEPRESSIVE SYMPTOMS; MENTAL-HEALTH; DIET QUALITY; RISK-FACTORS; VITAMIN-C; LIFE; ASSOCIATION; MOOD; FOOD	This study tested the psychological benefits of a 14-day preregistered clinical intervention to increase fruit and vegetable (FV) consumption in 171 low-FV-consuming young adults (67% female, aged 18-25). Participants were randomly assigned into a diet-as-usual control condition, an ecological momentary intervention (EMI) condition involving text message reminders to increase their FV consumption plus a voucher to purchase FV, or a fruit and vegetable intervention (FVI) condition in which participants were given two additional daily servings of fresh FV to consume on top of their normal diet. Self-report outcome measures were depressive symptoms and anxiety measured pre-and post-intervention, and daily negative and positive mood, vitality, flourishing, and flourishing behaviors (curiosity, creativity, motivation) assessed nightly using a smartphone survey. Vitamin C and carotenoids were measured from blood samples pre-and post-intervention, and psychological expectancies about the benefits of FV were measured post-intervention to test as mediators of psychological change. Only participants in the FVI condition showed improvements to their psychological well-being with increases in vitality, flourishing, and motivation across the 14-days relative to the other groups. No changes were found for depressive symptoms, anxiety, or mood. Intervention benefits were not mediated by vitamin C, carotenoids, or psychological expectancies. We conclude that providing young adults with high-quality FV, rather than reminding them to eat more FV (with a voucher to purchase FV), resulted in significant short-term improvements to their psychological well-being. These results provide initial proof-of-concept that giving young adults fresh fruit and vegetables to eat can have psychological benefits even over a brief period of time.	[Conner, Tamlin S.; Brookie, Kate L.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Carr, Anitra C.; Vissers, Margreet C. M.] Univ Otago, Dept Pathol, Ctr Free Rad Res, Christchurch, New Zealand; [Mainvil, Louise A.] Univ Otago, Dept Human Nutr, Dunedin, Otago, New Zealand	University of Otago; University of Otago; University of Otago	Conner, TS (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	tconner@psy.otago.ac.nz	Vissers, Margreet C M/T-4159-2017	, Anitra/0000-0002-5890-2977; Conner, Tamlin S./0000-0003-1520-5407	University of Otago Research Grant [H15/010]	University of Otago Research Grant	This work was supported by a non-commercial University of Otago Research Grant to TS Conner (H15/010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TB, 2008, J AM COLL HEALTH, V56, P455, DOI 10.3200/JACH.56.44.455-464; Akbaraly TN, 2013, AM J CLIN NUTR, V97, P419, DOI 10.3945/ajcn.112.041582; Allgower A, 2001, HEALTH PSYCHOL, V20, P223, DOI 10.1037//0278-6133.20.3.223; Appleton KM, 2007, J AFFECT DISORDERS, V104, P217, DOI 10.1016/j.jad.2007.03.012; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Baldrick FR, 2011, CRIT REV FOOD SCI, V51, P795, DOI 10.1080/10408398.2010.482217; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bellavia A, 2013, AM J CLIN NUTR, V98, P454, DOI 10.3945/ajcn.112.056119; Blanchflower DG, 2013, SOC INDIC RES, V114, P785, DOI 10.1007/s11205-012-0173-y; Boehm JK, 2013, PSYCHOSOM MED, V75, P2, DOI 10.1097/PSY.0b013e31827c08a9; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; Brookie KL, 2017, APPETITE, V108, P32, DOI 10.1016/j.appet.2016.09.015; Carr AC, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.12; Carty SA, 2016, NUTR DIETETICS; Conner TS, 2015, BRIT J HEALTH PSYCH, V20, P413, DOI 10.1111/bjhp.12113; Conner TS, 2012, PSYCHOSOM MED, V74, P327, DOI 10.1097/PSY.0b013e3182546f18; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dash S, 2015, CURR OPIN PSYCHIATR, V28, P1, DOI 10.1097/YCO.0000000000000117; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Dodd LJ, 2010, PREV MED, V51, P73, DOI 10.1016/j.ypmed.2010.04.005; El Ansari W, 2015, INT J PUBLIC HEALTH, V60, P707, DOI 10.1007/s00038-015-0717-4; Epton T, 2014, HEALTH PROMOT INT; Ghosh D, 2009, MOL NUTR FOOD RES, V53, P322, DOI 10.1002/mnfr.200800182; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hennessey BA, 2010, ANNU REV PSYCHOL, V61, P569, DOI 10.1146/annurev.psych.093008.100416; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Kashdan TB, 2009, J RES PERS, V43, P987, DOI 10.1016/j.jrp.2009.04.011; Kasser T., 2001, LIFE GOALS WELL BEIN, V1, P116, DOI DOI 10.1093/HER/CYG041; Keyes CLM, 2007, AM PSYCHOL, V62, P95, DOI 10.1037/0003-066X.62.2.95; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Kulkarni AA, 2015, EUR J CLIN NUTR, V69, P79, DOI 10.1038/ejcn.2014.130; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Lengyel Christina O., 2009, Journal of Nutrition for the Elderly, V28, P158, DOI 10.1080/01639360902950182; Lohman TJ, 1992, MED SCI SPORTS EXERC, V24, P952, DOI [10.1249/00005768-199208000-00020, DOI 10.1249/00005768-199208000-00020]; May JM, 2012, BIOCHEM BIOPH RES CO, V426, P148, DOI 10.1016/j.bbrc.2012.08.054; McMartin SE, 2013, PREV MED, V56, P225, DOI 10.1016/j.ypmed.2012.12.016; McNair D., 2005, PROFILE MOOD STATES; Mujcic R, 2016, AM J PUBLIC HEALTH, V106, P1504, DOI 10.2105/AJPH.2016.303260; New Zealand Government, 2020, ED TRAIN ACT 2020; Nezlek JB, 2012, HDB RES METHODS STUD, P257; Oyebode O, 2014, J EPIDEMIOLOGY COMMU; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raudenbush SW, 2009, HLM 6 08 HIERARCHICA; Raudenbush SW, 2002, HIERARCHICAL LINEAR, V1; Rienks J, 2013, EUR J CLIN NUTR, V67, P75, DOI 10.1038/ejcn.2012.193; Rooney C, 2013, P NUTR SOC, V72, P420, DOI 10.1017/S0029665113003388; Rucklidge JJ, 2013, EXPERT REV NEUROTHER, V13, P49, DOI [10.1586/ern.12.143, 10.1586/ERN.12.143]; Rucklidge JJ, 2013, BRIT J PSYCHIAT, V203, P154, DOI 10.1192/bjp.203.2.154; Ryan RM, 2008, SOC PERSONAL PSYCHOL, V2, P702, DOI 10.1111/j.1751-9004.2008.00098.x; Skarupski KA, 2013, J NUTR HEALTH AGING, V17, P441, DOI 10.1007/s12603-012-0437-x; Smith Andrew Paul, 2014, Front Nutr, V1, P10, DOI 10.3389/fnut.2014.00010; Smith C, 1997, PUBLIC HEALTH NUTR, V2015, P1; Steptoe A, 2004, BRIT J NUTR, V92, P177, DOI 10.1079/BJN20041177; Toure-Tillery M, 2014, SOC PERSONAL PSYCHOL, V8, P328, DOI 10.1111/spc3.12110; Tsai AC, 2012, PUBLIC HEALTH NUTR, V15, P1087, DOI 10.1017/S1368980011002977; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wei W, 2001, AM J PUBLIC HEALTH, V91, P258, DOI 10.2105/AJPH.91.2.258; White BA, 2013, BRIT J HEALTH PSYCH, V18, P782, DOI 10.1111/bjhp.12021; WHO, 2021, WHO GUID HLTH WORKF; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	73	74	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171206	10.1371/journal.pone.0171206	http://dx.doi.org/10.1371/journal.pone.0171206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158239	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700044
J	Holder, MK; Blaustein, JD				Holder, Mary K.; Blaustein, Jeffrey D.			Developmental time course and effects of immunostressors that alter hormone-responsive behavior on microglia in the peripubertal and adult female mouse brain	PLOS ONE			English	Article							CONDITIONED AVOIDANCE RESPONSES; ESTROGEN-RECEPTOR-ALPHA; VENTROMEDIAL NUCLEUS; ADOLESCENT PSYCHOPATHOLOGY; ESTRADIOL REPLACEMENT; OVARIECTOMIZED RATS; GENDER DIFFERENCES; OVARIAN HORMONES; IMMUNE CHALLENGE; LORDOSIS REFLEX	In female mice, the experience of being shipped from the breeder facility or a single injection of the bacterial endotoxin, lipopolysaccharide (LPS), during pubertal development alters the behavioral response to estradiol in adulthood as demonstrated by perturbations of estradiol's effects on sexual behavior, cognitive function, as well as its anxiolytic and anti-depressive properties. Microglia, the primary type of immunocompetent cell within the brain, contribute to brain development and respond to stressors with marked and long-lasting morphological and functional changes. Here, we describe the morphology of microglia and their response to shipping and LPS in peripubertal and adult female mice. Peripubertal mice have more microglia with long, thick processes in the hippocampus, amygdala and hypothalamus as compared with adult mice in the absence of an immune challenge. An immune challenge also increases immunoreactivity (IR) of ionized calcium binding adaptor molecule 1 (Iba1), which is constitutively expressed in microglia. In the hippocampus, the age of animal was without effect on the increase in Iba1-IR following shipping from the breeder facility or LPS exposure. In the amygdala, we observed more Iba1-IR following shipping or LPS treatment in peripubertal mice, compared to adult mice. In the hypothalamus, there was a disassociation of the effects of shipping and LPS treatment as LPS treatment, but not shipping, induced an increase in Iba1-IR. Taken together these data indicate that microglial morphologies differ between pubertal and adult mice; moreover, the microglial response to complex stressors is greater in pubertal mice as compared to adult mice.	[Holder, Mary K.; Blaustein, Jeffrey D.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA; [Holder, Mary K.; Blaustein, Jeffrey D.] Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA; [Holder, Mary K.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University System of Georgia; Georgia State University	Holder, MK (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA.; Holder, MK (corresponding author), Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA.; Holder, MK (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.	mconklin@gsu.edu		Holder, Mary/0000-0003-3585-1094	National Institutes of Mental Health [R21 MH093854]; National Science Foundation [IOS 1050179]; Division Of Integrative Organismal Systems [1050179] Funding Source: National Science Foundation	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Institutes of Mental Health (http://www.nimh.nih.gov/index.shtml) grant R21 MH093854 and National Science Foundation (http://www.nsf.gov/) IOS 1050179 awarded to Jeffrey D. Blaustein. The funding agencies played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Angold A, 2006, CHILD ADOL PSYCH CL, V15, P919, DOI 10.1016/j.chc.2006.05.013; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; CARPENTER AF, 1993, J NEUROPATH EXP NEUR, V52, P601, DOI 10.1097/00005072-199311000-00007; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Dalla C, 2004, EUR J NEUROSCI, V20, P217, DOI 10.1111/j.1460-9568.2004.03443.x; DAVIS PG, 1979, ENDOCRINOLOGY, V104, P898, DOI 10.1210/endo-104-4-898; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dewing P, 2008, ENDOCRINOLOGY, V149, P5934, DOI 10.1210/en.2008-0847; DIAZVELIZ G, 1989, PHYSIOL BEHAV, V46, P397, DOI 10.1016/0031-9384(89)90010-3; DIAZVELIZ G, 1991, PHYSIOL BEHAV, V50, P61, DOI 10.1016/0031-9384(91)90498-D; DiazVeliz G, 1997, PHARMACOL BIOCHEM BE, V58, P637, DOI 10.1016/S0091-3057(97)90004-6; Doorn KJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00084; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Galeeva A, 2001, BEHAV BRAIN RES, V119, P41, DOI 10.1016/S0166-4328(00)00341-7; Gandhi R, 2007, BRAIN BEHAV IMMUN, V21, P477, DOI 10.1016/j.bbi.2006.12.005; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Gibb J, 2008, BRAIN BEHAV IMMUN, V22, P573, DOI 10.1016/j.bbi.2007.12.001; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Grant KE, 2004, J CLIN CHILD ADOLESC, V33, P412, DOI 10.1207/s15374424jccp3302_23; Grant KE, 2003, PSYCHOL BULL, V129, P447, DOI 10.1037/0033-2909.129.3.447; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; Holder MK, 2014, FRONT NEUROENDOCRIN, V35, P89, DOI 10.1016/j.yfrne.2013.10.004; Ismail N., 2012, NEUROSCIENCE; Ismail N, 2013, PSYCHONEUROENDOCRINO, V38, P1170, DOI 10.1016/j.psyneuen.2012.11.003; Ismail N, 2011, HORM BEHAV, V59, P565, DOI 10.1016/j.yhbeh.2011.02.010; Korzhevskii D.E., 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [DOI 10.1007/S11055-016-0231-Z, 10.1007/s11055-016-0231-z]; Laroche J, 2009, ENDOCRINOLOGY, V150, P3717, DOI 10.1210/en.2009-0099; Laroche J, 2009, ENDOCRINOLOGY, V150, P2351, DOI 10.1210/en.2008-1595; Likhtik E, 2015, TRENDS NEUROSCI, V38, P158, DOI 10.1016/j.tins.2014.12.007; Mohr MA, 2013, P NATL ACAD SCI USA, V110, P4792, DOI 10.1073/pnas.1219443110; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Okada M, 1997, JPN J PHARMACOL, V73, P93, DOI 10.1254/jjp.73.93; Olesen KM, 2011, HORM BEHAV, V60, P318, DOI 10.1016/j.yhbeh.2011.06.005; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Patton GC, 1996, J EPIDEMIOL COMMUN H, V50, P661, DOI 10.1136/jech.50.6.661; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Rachman IM, 1998, P NATL ACAD SCI USA, V95, P13941, DOI 10.1073/pnas.95.23.13941; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Schafer D.P., 2012, GLIA; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Soucy G, 2005, J IMMUNOL, V174, P6391, DOI 10.4049/jimmunol.174.10.6391; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Turner RJ, 2004, ARCH GEN PSYCHIAT, V61, P481, DOI 10.1001/archpsyc.61.5.481; Verney C, 2010, J ANAT, V217, P436, DOI 10.1111/j.1469-7580.2010.01245.x; WONG AKC, 1989, IEEE T SYST MAN CYB, V19, P866, DOI 10.1109/21.35351	59	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171381	10.1371/journal.pone.0171381	http://dx.doi.org/10.1371/journal.pone.0171381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158270	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700071
J	McDermott-Roe, C; Leleu, M; Rowe, GC; Palygin, O; Bukowy, JD; Kuo, J; Rech, M; Hermans-Beijnsberger, S; Schaefer, S; Adami, E; Creemers, EE; Heinig, M; Schroen, B; Arany, Z; Petretto, E; Geurts, AM				McDermott-Roe, Chris; Leleu, Marion; Rowe, Glenn C.; Palygin, Oleg; Bukowy, John D.; Kuo, Judy; Rech, Monika; Hermans-Beijnsberger, Steffie; Schaefer, Sebastian; Adami, Eleonora; Creemers, Esther E.; Heinig, Matthias; Schroen, Blanche; Arany, Zoltan; Petretto, Enrico; Geurts, Aron M.			Transcriptome-wide co-expression analysis identifies LRRC2 as a novel mediator of mitochondrial and cardiac function	PLOS ONE			English	Article							HEART-FAILURE; PGC-1 COACTIVATORS; GENE-EXPRESSION; HUMAN-DISEASE; PROTEIN; DYSFUNCTION; BIOGENESIS; NETWORK; MUSCLE; CELLS	Mitochondrial dysfunction contributes to myriad monogenic and complex pathologies. To understand the underlying mechanisms, it is essential to define the full complement of proteins that modulate mitochondrial function. To identify such proteins, we performed a metaanalysis of publicly available gene expression data. Gene co-expression analysis of a large and heterogeneous compendium of microarray data nominated a sub-population of transcripts that whilst highly correlated with known mitochondrial protein-encoding transcripts (MPETs), are not themselves recognized as generating proteins either localized to the mitochondrion or pertinent to functions therein. To focus the analysis on a medically-important condition with a strong yet incompletely understood mitochondrial component, candidates were cross-referenced with an MPET-enriched module independently generated via genome-wide co-expression network analysis of a human heart failure gene expression dataset. The strongest uncharacterized candidate in the analysis was Leucine Rich Repeat Containing 2 (LRRC2). LRRC2 was found to be localized to the mitochondria in human cells and transcriptionally- regulated by the mitochondrial master regulator Pgc-1 alpha. We report that Lrrc2 transcript abundance correlates with that of beta-MHC, a canonical marker of cardiac hypertrophy in humans and experimentally demonstrated an elevation in Lrrc2 transcript in in vitro and in vivo rodent models of cardiac hypertrophy as well as in patients with dilated cardiomyopathy. RNAi-mediated Lrrc2 knockdown in a rat-derived cardiomyocyte cell line resulted in enhanced expression of canonical hypertrophic biomarkers as well as increased mitochondrial mass in the context of increased Pgc-1 alpha expression. In conclusion, our meta-analysis represents a simple yet powerful springboard for the nomination of putative mitochondrially-pertinent proteins relevant to cardiac function and enabled the identification of LRRC2 as a novel mitochondrially- relevant protein and regulator of the hypertrophic response.	[McDermott-Roe, Chris; Palygin, Oleg; Bukowy, John D.; Kuo, Judy; Geurts, Aron M.] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Leleu, Marion] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Rowe, Glenn C.] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Rech, Monika; Hermans-Beijnsberger, Steffie; Schroen, Blanche] Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Cardiol, Ctr Heart Failure Res, Maastricht, Netherlands; [Schaefer, Sebastian] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Adami, Eleonora] Max Delbruck Ctr Mol Med, Cardiovasc & Metab Sci, Berlin, Germany; [Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Expt Cardiol, Amsterdam, Netherlands; [Heinig, Matthias] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Arany, Zoltan] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Petretto, Enrico] Imperial Coll London, MRC Clin Sci Ctr, London, England; [Petretto, Enrico] Duke NUS Grad Med Sch, Singapore, Singapore	Medical College of Wisconsin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Alabama System; University of Alabama Birmingham; Maastricht University; National Heart Centre Singapore; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Pennsylvania Medicine; Imperial College London; National University of Singapore	McDermott-Roe, C (corresponding author), Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA.	mcdec@mail.med.upenn.edu	Rowe, Glenn/N-5314-2019; Palygin, Oleg/AAT-3047-2020	Palygin, Oleg/0000-0002-3680-5527; Creemers, Esther/0000-0002-9001-3854; Heinig, Matthias/0000-0002-5612-1720; Adami, Eleonora/0000-0002-1813-6681; Petretto, Enrico/0000-0003-2163-5921; Rowe, Glenn/0000-0002-8195-9605; Schafer, Sebastian/0000-0002-6909-8275	NIH New Innovator Award [OD008396]; Medical Research Council [MC_U120097112] Funding Source: researchfish; MRC [MC_U120097112] Funding Source: UKRI	NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH New Innovator Award OD008396 (AMG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Boland ML, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00292; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Clemente P, 2015, NUCLEIC ACIDS RES, V43, P7398, DOI 10.1093/nar/gkv692; Creemers EE, 2016, CIRC RES, V118, P433, DOI 10.1161/CIRCRESAHA.115.307082; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fahrenbach JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090408; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016; Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197; Gradman AH, 2006, PROG CARDIOVASC DIS, V48, P326, DOI 10.1016/j.pcad.2006.02.001; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Rosello-Lleti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112971; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170458	10.1371/journal.pone.0170458	http://dx.doi.org/10.1371/journal.pone.0170458			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158196	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000396161700013
J	Wang, JH; Haapalainen, M; Schott, T; Thompson, SM; Smith, GR; Nissinen, AI; Pirhonen, M				Wang, Jinhui; Haapalainen, Minna; Schott, Thomas; Thompson, Sarah M.; Smith, Grant R.; Nissinen, Anne I.; Pirhonen, Minna			Genomic sequence of 'Candidatus Liberibacter solanacearum' haplotype C and its comparison with haplotype A and B genomes	PLOS ONE			English	Article							PSYLLID-AFFECTED CARROTS; ZEBRA CHIP DISEASE; APICALIS HEMIPTERA TRIOZIDAE; 16S RIBOSOMAL-RNA; 1ST REPORT; SP-NOV; OCEANOSPIRILLUM-JANNASCHII; PSEUDOMONAS-STANIERI; SOLANUM-TUBEROSUM; ESCHERICHIA-COLI	Haplotypes A and B of 'Candidatus Liberibacter solanacearum' (CLso) are associated with diseases of solanaceous plants, especially Zebra chip disease of potato, and haplotypes C, D and E are associated with symptoms on apiaceous plants. To date, one complete genome of haplotype B and two high quality draft genomes of haplotype A have been obtained for these unculturable bacteria using metagenomics from the psyllid vector Bactericera cockerelli. Here, we present the first genomic sequences obtained for the carrot-associated CLso. These two genomic sequences of haplotype C, FIN114 (1.24 Mbp) and FIN111 (1.20 Mbp), were obtained from carrot psyllids (Trioza apicalis) harboring CLso. Genomic comparisons between the haplotypes A, B and C revealed that the genome organization differs between these haplotypes, due to large inversions and other recombinations. Comparison of protein-coding genes indicated that the core genome of CLso consists of 885 ortholog groups, with the pan-genome consisting of 1327 ortholog groups. Twenty-seven ortholog groups are unique to CLso haplotype C, whilst 11 ortholog groups shared by the haplotypes A and B, are not found in the haplotype C. Some of these ortholog groups that are not part of the core genome may encode functions related to interactions with the different host plant and psyllid species.	[Wang, Jinhui; Haapalainen, Minna; Pirhonen, Minna] Univ Helsinki, Dept Agr Sci, FI-00014 Helsinki, Finland; [Thompson, Sarah M.; Smith, Grant R.] New Zealand Inst Plant & Food Res Ltd, Lincoln, New Zealand; [Thompson, Sarah M.; Smith, Grant R.] Plant Biosecur Cooperat Res Ctr, Canberra, ACT, Australia; [Smith, Grant R.] Better Border Biosecur, Lincoln, New Zealand; [Nissinen, Anne I.] Nat Resources Inst Finland Luke, Management & Prod Renewable Resources, Jokioinen, Finland	University of Helsinki; New Zealand Institute for Plant & Food Research Ltd; Natural Resources Institute Finland (Luke)	Wang, JH (corresponding author), Univ Helsinki, Dept Agr Sci, FI-00014 Helsinki, Finland.	jinhui.wang@helsinki.fi	Wang, Jinhui/K-2490-2012; Smith, Grant R/F-8902-2010	Wang, Jinhui/0000-0002-4328-984X; Smith, Grant R/0000-0002-7983-9743; Pirhonen, Minna/0000-0001-5249-563X	Ministry of Agriculture and Forestry of Finland [1651/311/2011, 2052/312/2011, 1842/312/2013]; Marjatta & Eino Kolli Foundation; China Scholarship Council; New Zealand Institute for Plant & Food Research Limited; Better Border Biosecurity; Australian Government via the Plant Biosecurity Cooperative Research Centre	Ministry of Agriculture and Forestry of Finland; Marjatta & Eino Kolli Foundation; China Scholarship Council(China Scholarship Council); New Zealand Institute for Plant & Food Research Limited; Better Border Biosecurity; Australian Government via the Plant Biosecurity Cooperative Research Centre(Australian Government)	Funding for this project was provided by the Ministry of Agriculture and Forestry of Finland (project numbers 1651/311/2011, 2052/312/2011 and 1842/312/2013), Marjatta & Eino Kolli Foundation, China Scholarship Council, the New Zealand Institute for Plant & Food Research Limited, Better Border Biosecurity and the Australian Government via the Plant Biosecurity Cooperative Research Centre. The authors declare that one co-author (TS) provides bioinformatics services as a commercial freelancer under the name Herne Genomik, Neustadt, Germany. The funders provided support in the form of salaries and grants for authors [AN, MH, JW, ST, GS, TS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abad JA, 2009, PLANT DIS, V93, P108, DOI 10.1094/PDIS-93-1-0108C; Albar L, 2006, PLANT J, V47, P417, DOI 10.1111/j.1365-313X.2006.02792.x; Alfaro-Fernandez A, 2012, PLANT DIS, V96, P582, DOI 10.1094/PDIS-11-11-0918-PDN; Alfaro-Fernandez A, 2012, PLANT DIS, V96, P581, DOI 10.1094/PDIS-10-11-0878-PDN; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BAUMANN P, 1983, INT J SYST BACTERIOL, V33, P857, DOI 10.1099/00207713-33-4-857; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bertolini E, 2015, PLANT PATHOL, V64, P276, DOI 10.1111/ppa.12245; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; BOWDITCH RD, 1984, CURR MICROBIOL, V10, P221, DOI 10.1007/BF01627259; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Choi YU, 2012, J BACTERIOL, V194, P1260, DOI 10.1128/JB.06703-11; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fagen JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084469; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Haapalainen M, 2016, PLANT PATHOL; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Hao GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0211-9; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jain M, 2015, MOL PLANT MICROBE IN, V28, P1330, DOI 10.1094/MPMI-07-15-0145-R; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P126, DOI 10.1017/CBO9780511790461.007; Kim H, 2007, INT J SYST EVOL MICR, V57, P1659, DOI 10.1099/ijs.0.64892-0; Kobayashi I, 1999, CURR OPIN GENET DEV, V9, P649, DOI 10.1016/S0959-437X(99)00026-X; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kuykendall LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034673; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, INT J SYST EVOL MICR, V59, P2274, DOI 10.1099/ijs.0.007377-0; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Lin H, 2009, J PLANT PATHOL, V91, P215; Lin H, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00733-15; Lin H, 2013, PHYTOPATHOLOGY, V103, P524, DOI 10.1094/PHYTO-09-12-0238-RVW; Lin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Loiseau M, 2014, PLANT DIS, V98, P839, DOI 10.1094/PDIS-08-13-0900-PDN; Munyaneza JE, 2015, PLANT DIS, V99, P1269, DOI 10.1094/PDIS-02-15-0206-PDN; Munyaneza JE, 2012, PLANT DIS, V96, P453, DOI 10.1094/PDIS-10-11-0871; Munyaneza JE, 2012, PLANT DIS, V96, P454, DOI 10.1094/PDIS-10-11-0870; Munyaneza JE, 2011, J PLANT PATHOL, V93, P697; Munyaneza JE, 2010, PLANT DIS, V94, P639, DOI 10.1094/PDIS-94-5-0639A; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Nelson WR, 2013, EUR J PLANT PATHOL, V135, P633, DOI 10.1007/s10658-012-0121-3; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Nissinen AI, 2014, PLANT PATHOL, V63, P812, DOI 10.1111/ppa.12144; Niu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034585; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pasternak Z, 2013, ISME J, V7, P756, DOI 10.1038/ismej.2012.149; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Satomi M, 2002, INT J SYST EVOL MICR, V52, P739, DOI [10.1099/ijs.0.01427-0, 10.1099/00207713-52-3-739]; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tahzima R, 2014, PLANT DIS, V98, P1426, DOI 10.1094/PDIS-05-14-0509-PDN; Teresani GR, 2014, PHYTOPATHOLOGY, V104, P804, DOI 10.1094/PHYTO-07-13-0182-R; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; THOMAS L, 1982, BIOCHEMISTRY-US, V21, P1162, DOI 10.1021/bi00535a009; Thompson SM, 2015, PHYTOPATHOLOGY, V105, P863, DOI 10.1094/PHYTO-12-14-0363-FI; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; Willems A., 2014, PROKARYOTES ALPHAPRO, P355; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wu F, 2015, GENOME ANNOUNC, V3; Wulff NA, 2014, MOL PLANT MICROBE IN, V27, P163, DOI 10.1094/MPMI-09-13-0292-R; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Yao JX, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00062; Yoshii M, 2004, J VIROL, V78, P6102, DOI 10.1128/JVI.78.12.6102-6111.2004; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; Zheng Z, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01353-14; Zhou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082248; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	82	24	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171531	10.1371/journal.pone.0171531	http://dx.doi.org/10.1371/journal.pone.0171531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158295	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700093
J	Gueguen, J; Piot, MA; Orri, M; Gutierre, A; Le Moan, J; Berthoz, S; Falissard, B; Godart, N				Gueguen, Juliette; Piot, Marie-Aude; Orri, Massimiliano; Gutierre, Andrea; Le Moan, Jocelyne; Berthoz, Sylvie; Falissard, Bruno; Godart, Nathalie			Group Qigong for Adolescent Inpatients with Anorexia Nervosa: Incentives and Barriers	PLOS ONE			English	Article							EATING-DISORDERS; PHYSICAL-ACTIVITY; BODY; PSYCHOTHERAPY; PERCEPTION; MOTIVATION; ALLIANCE; EXERCISE; ANXIETY; ADULTS	Background Qigong is a mind-body intervention focusing on interoceptive awareness that appears to be a promising approach in anorexia nervosa (AN). In 2008, as part of our multidimensional treatment program for adolescent inpatients with AN, we began a weekly qigong workshop that turned out to be popular among our adolescent patients. Moreover psychiatrists perceived clinical benefits that deserved further exploration. Methods and findings A qualitative study therefore sought to obtain a deeper understanding of how young patients with severe AN experience qigong and to determine the incentives and barriers to adherence to qigong, to understanding its meaning, and to applying it in other contexts. Data were collected through 16 individual semi-structured face-to-face interviews and analyzed with the interpretative phenomenological analysis method. Eleven themes emerged from the analysis, categorized in 3 superordinate themes describing the incentives and barriers related to the patients themselves (individual dimension), to others (relational dimension), and to the setting (organizational dimension). Individual dimensions associated with AN (such as excessive exercise and mind-body cleavage) may curb adherence, whereas relational and organizational dimensions appear to provide incentives to join the activity in the first place but may also limit its post-discharge continuation. Once barriers are overcome, patients reported positive effects: satisfaction associated with relaxation and with the experience of mind-body integration. Conclusions Qigong appears to be an interesting therapeutic tool that may potentiate psychotherapy and contribute to the recovery process of patients with AN. Further analysis of the best time window for initiating qigong and of its place in overall management might help to overcome some of the barriers, limit the risks, and maximize its benefits.	[Gueguen, Juliette; Orri, Massimiliano; Berthoz, Sylvie; Falissard, Bruno; Godart, Nathalie] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Paris, France; [Gueguen, Juliette; Piot, Marie-Aude; Orri, Massimiliano; Falissard, Bruno] Univ Paris 05, Paris, France; [Piot, Marie-Aude; Gutierre, Andrea; Le Moan, Jocelyne; Berthoz, Sylvie; Godart, Nathalie] Inst Mutualiste Montsouris, Psychiat Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite	Gueguen, J (corresponding author), Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Paris, France.; Gueguen, J (corresponding author), Univ Paris 05, Paris, France.	juliette.gueguen@inserm.fr	Berthoz Landron, Sylvie/M-4517-2018; Zamora, Cristina Cuesta/E-2864-2016; PIOT, Marie-Aude/AAO-9051-2021; Orri, Massimiliano/S-9220-2019	Zamora, Cristina Cuesta/0000-0003-1121-9561; Piot, Marie-Aude/0000-0001-6776-1611; Orri, Massimiliano/0000-0003-1389-2610; Berthoz, Sylvie/0000-0002-6862-2362				Ainley V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055568; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andres-Perpina S, 2011, EUR CHILD ADOLES PSY, V20, P541, DOI 10.1007/s00787-011-0216-y; [Anonymous], 1960, CARTESIAN MEDITATION; Arlington Va., 2011, DEV EVIDENCE BASED C; Atkinson MJ, 2015, INT J EAT DISORDER, V48, P1024, DOI 10.1002/eat.22416; Boudette Robin, 2006, Eat Disord, V14, P167, DOI 10.1080/10640260500536334; Carei TR, 2010, J ADOLESCENT HEALTH, V46, P346, DOI 10.1016/j.jadohealth.2009.08.007; Coulon N, 2009, ENCEPHALE, V35, P531, DOI 10.1016/j.encep.2008.09.005; Courty A, 2015, COMPR PSYCHIAT, V56, P217, DOI 10.1016/j.comppsych.2014.09.011; Eklund M, 2016, SCAND J OCCUP THER, V23, P304, DOI 10.3109/11038128.2016.1143529; Ellis DA, 2012, J PEDIATR PSYCHOL, V37, P75, DOI 10.1093/jpepsy/jsr072; Eshkevari E, 2014, EUR EAT DISORD REV, V22, P383, DOI 10.1002/erv.2305; Espindola CR, 2009, ANN CLIN PSYCHIATRY, V21, P38; Farb N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00763; Fuchs T, 2009, CURR OPIN PSYCHIATR, V22, P570, DOI 10.1097/YCO.0b013e3283318e5c; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Godart N, 2004, Eat Weight Disord, V9, P224; Godart N, 2005, ARCH PEDIATRIE, V12, P1544, DOI 10.1016/j.arcped.2005.02.030; Godart N.T., 2013, OPEN J EPIDEMIOL, V03, P53, DOI [10.4236/ojepi.2013.32009, DOI 10.4236/0JEPI.2013.32009, DOI 10.4236/OJEPI.2013.32009]; Godart N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028249; Griffiths R, 1998, INT J EAT DISORDER, V23, P443; Halmi KA, 2012, INT J EAT DISORDER, V45, P800, DOI 10.1002/eat.22019; Harrison A, 2009, CLIN PSYCHOL PSYCHOT, V16, P348, DOI 10.1002/cpp.628; Hartmann AS, 2015, BODY IMAGE, V14, P77, DOI 10.1016/j.bodyim.2015.03.013; HAS, 2010, AN MENT PRIS CHARG; Herbert BM, 2012, TOP COGN SCI, V4, P692, DOI 10.1111/j.1756-8765.2012.01189.x; Hillen S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0516-8; Horndasch S, 2015, EUR ARCH PSY CLIN N, V265, P677, DOI 10.1007/s00406-015-0603-3; Hyland ME, 2005, CLIN MED, V5, P361, DOI 10.7861/clinmedicine.5-4-361; Jeammet P, 1984, PSYCHOL FR, V29, P137; Keski-Rahkonen A, 2014, INT J EAT DISORDER, V47, P117, DOI 10.1002/eat.22168; Keyes A, 2015, INT J EAT DISORDER, V48, P46, DOI 10.1002/eat.22354; Kohl M, 2004, ENCEPHALE, V30, P492; Kolnes LJ, 2012, J BODYW MOV THER, V16, P281, DOI 10.1016/j.jbmt.2011.12.005; Lang K, 2015, PSYCHIAT RES, V225, P387, DOI 10.1016/j.psychres.2014.12.008; Laumer U, 1997, PSYCHOTHER PSYCH MED, V47, P170; Lerner MD, 2011, BEHAV THER, V42, P449, DOI 10.1016/j.beth.2010.11.006; Lloyd S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111697; Mason M, 2010, FORUM QUAL SOZIALFOR, V11, pe8; McIver S, 2009, QUAL HEALTH RES, V19, P1234, DOI 10.1177/1049732309343954; Mehta Neeta, 2011, Mens Sana Monogr, V9, P202, DOI 10.4103/0973-1229.77436; National Collaborating Centre for Mental Health (UK), 2004, EAT DIS COR INT TREA; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Patton M. Q., 2001, QUALITATIVE RES EVAL; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00484; Pollatos O, 2016, PSYCHIAT RES, V240, P328, DOI 10.1016/j.psychres.2016.04.072; Posadzki P, 2010, COMPLEMENT THER MED, V18, P87, DOI 10.1016/j.ctim.2009.12.002; Sansone Randy A, 2005, Psychiatry (Edgmont), V2, P40; Schmidt U, 2006, BRIT J CLIN PSYCHOL, V45, P343, DOI 10.1348/014466505X53902; Shapiro JR, 2008, INT J EAT DISORDER, V41, P728, DOI 10.1002/eat.20552; Shelef K, 2005, J CONSULT CLIN PSYCH, V73, P689, DOI 10.1037/0022-006X.73.4.689; Smink FRE, 2014, INT J EAT DISORDER, V47, P610, DOI 10.1002/eat.22316; Smith J., 2008, DOING SOCIAL PSYCHOL, P229; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Steinglass JE, 2006, J INT NEUROPSYCH SOC, V12, P431, DOI 10.1017/S1355617706060528; Steinhausen HC, 2002, AM J PSYCHIAT, V159, P1284, DOI 10.1176/appi.ajp.159.8.1284; Suri H, 2011, QUAL RES J, V11, P63, DOI 10.3316/QRJ1102063; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Tan JOA, 2010, INT J LAW PSYCHIAT, V33, P13, DOI 10.1016/j.ijlp.2009.10.003; Tsang H, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/706892; Vancampfort D, 2014, DISABIL REHABIL, V36, P628, DOI 10.3109/09638288.2013.808271; Vansteelandt K, 2007, BEHAV RES THER, V45, P1717, DOI 10.1016/j.brat.2006.12.005; Vansteenkiste M, 2005, INT J EAT DISORDER, V37, P207, DOI 10.1002/eat.20099; Vocks S, 2007, J PSYCHOSOM RES, V62, P231, DOI 10.1016/j.jpsychores.2006.08.007; Wang CW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-8; Yang Y., 2011, J AGING RES, V2011, DOI [10.4061/2011/650210, DOI 10.4061/2011/650210, 10. 4061/2011/650210]; Yuan CS, 2011, TRADITIONAL CHINESE MEDICINE, P1, DOI 10.3109/9781841848433	71	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170885	10.1371/journal.pone.0170885	http://dx.doi.org/10.1371/journal.pone.0170885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152083	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200055
J	Tang, Y; Shen, PH; Liang, W; Jin, JL; Jiang, XF				Tang, Yu; Shen, Pinghua; Liang, Wei; Jin, Jialin; Jiang, Xiaofei			A putative multi-replicon plasmid co-harboring beta-lactamase genes bla(KPC-2), bla(CTX-M-14) and bla(TEM-1) and trimethoprim resistance gene dfrA25 from a Klebsiella pneumoniae sequence type (ST) 11 strain in China	PLOS ONE			English	Article							ESCHERICHIA-COLI; HIGH PREVALENCE; INFECTIONS; VIRULENCE	The global emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae poses a major public health threat requiring immediate and aggressive action. Some older generation antibiotics, such as trimethoprim, serve as alternatives for treatment of infections. Here, we determined the complete nucleotide sequence of plasmid pHS091147, which co-harbored the carbapenemase (bla(KPC-2)) and trimethoprim resistance genes (dfrA25) from a Klebsiella pneumoniae sequence type (ST) 11 clone recovered in Shanghai, China. pHS091147 had three replication genes, several plasmid-stability genes and an intact type IV secretion system gene cluster. Besides bla(KPC-2) and dfrA25, pHS091147 carried several other resistance genes, including beta-lactamase genes bla(TEM-1) and bla(CTX-M-14), sulphonamide resistance gene sul1, a quinolone resistance gene remnant (Delta qnrB2), and virulence associated gene iroN. Notably, the multidrug-resistance region was a chimeric structure composed of three subregions, which shared strong sequence homology with several plasmids previously assigned in Genbank. To our knowledge, this is the first report of the co-localization of bla(KPC-2) and dfrA25 on a novel putative multi-replicon plasmid in a Klebsiella pneumoniae ST11 clone.	[Tang, Yu; Liang, Wei; Jiang, Xiaofei] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai, Peoples R China; [Shen, Pinghua] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Lab Med, Sch Med, Shanghai, Peoples R China; [Jin, Jialin] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, XF (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai, Peoples R China.; Jin, JL (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China.	jinjialin2002@126.com; jiangxi2154@aliyun.com			National Natural Science Foundation of China [81071396, 81572031]; Shanghai Natural Science Fund [14ZR1404500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund	Support was provided by the National Natural Science Foundation of China (Grants 81071396 and 81572031), Shanghai Natural Science Fund (No. 14ZR1404500).	Agerso Y, 2006, J ANTIMICROB CHEMOTH, V58, P1044, DOI 10.1093/jac/dkl366; Alvarado A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040438; [Anonymous], 2014, M100S24 CLIN LAB STA, P34; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Bi DX, 2015, J ANTIMICROB CHEMOTH, V70, P2770, DOI 10.1093/jac/dkv204; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chen L, 2013, ANTIMICROB AGENTS CH, V57, P1542, DOI 10.1128/AAC.02332-12; Chen YT, 2014, J ANTIMICROB CHEMOTH, V69, P628, DOI 10.1093/jac/dkt409; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Falagas ME, 2015, INT J ANTIMICROB AG, V46, P231, DOI 10.1016/j.ijantimicag.2015.04.002; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; He DD, 2015, ANTIMICROB AGENTS CH, V59, P5976, DOI 10.1128/AAC.04920-14; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; Jiang Y, 2010, ANTIMICROB AGENTS CH, V54, P3967, DOI 10.1128/AAC.00137-10; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Peirano G, 2006, J ANTIMICROB CHEMOTH, V58, P305, DOI 10.1093/jac/dkl248; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Quan JJ, 2017, J ANTIMICROB CHEMOTH, V72, P273, DOI 10.1093/jac/dkw372; Sbrana F, 2013, CLIN INFECT DIS, V56, P697, DOI 10.1093/cid/cis969; Shen PH, 2016, BRAZ J INFECT DIS, V20, P384, DOI 10.1016/j.bjid.2016.04.003; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Sorsa LJ, 2003, INFECT IMMUN, V71, P3285, DOI 10.1128/IAI.71.6.3285-3293.2003; Wilkowski P, 2016, TRANSPL P, V48, P1576, DOI 10.1016/j.transproceed.2016.01.060; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Xiang DR, 2016, ANTIMICROB AGENTS CH, V60, P1343, DOI 10.1128/AAC.01488-15; Yano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064359; Zhang HN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00239; Zhang T, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00005, 10.3389/fmicb.2016.01830, 10.3389/fmicb.2016.00227]; Zhong YM, 2015, J ANTIMICROB CHEMOTH, V70, P2223, DOI 10.1093/jac/dkv114; Zong Z, 2015, PLASMID, V80, P118, DOI 10.1016/j.plasmid.2015.04.007	33	6	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171339	10.1371/journal.pone.0171339	http://dx.doi.org/10.1371/journal.pone.0171339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152085	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200128
J	Crowley, EJ; King, JM; Wilkinson, T; Worgan, HJ; Huson, KM; Rose, MT; McEwan, NR				Crowley, Edward J.; King, Jonathan M.; Wilkinson, Toby; Worgan, Hilary J.; Huson, Kathryn M.; Rose, Michael T.; McEwan, Neil R.			Comparison of the microbial population in rabbits and guinea pigs by next generation sequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; BACTERIAL DIVERSITY; CECUM; DIET; IDENTIFICATION; COMMUNITIES; PROTEIN	This study aimed to determine the microbial composition of faeces from two groups of caecotrophagic animals; rabbits and guinea pigs. In addition the study aimed to determine the community present in the different organs in the rabbit. DNA was extracted from seven of the organs in wild rabbits (n = 5) and from faecal samples from domesticated rabbits (n = 6) and guinea pigs (n = 6). Partial regions of the small ribosomal sub-unit were amplified by PCR and then the sequences present in each sample were determined by next generation sequencing. Differences were detected between samples from rabbit and guinea pig faeces, suggesting that there is not a microbial community common to caecotrophagic animals. Differences were also detected in the different regions of the rabbits' digestive tracts. As with previous work, many of the organisms detected were Firmicutes or unclassified species and there was a lack of Fibrobacteres, but for the first time we observed a high number of Bacteroidetes in rabbit samples. This work re-iterates high levels of Firmicutes and unclassified species are present in the rabbit gut, together with low number of Fibrobacteres. This suggests that in the rabbit gut, organisms other than the Fibrobacteres must be responsible for fibre digestion. However observation of high numbers of Bacteroidetes suggests that this phylum may indeed have a role to play in digestion in the rabbit gut.	[Crowley, Edward J.; Wilkinson, Toby; Worgan, Hilary J.; Huson, Kathryn M.; Rose, Michael T.; McEwan, Neil R.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Penglais Campus, Aberystwyth SY23 3FG, Dyfed, Wales; [King, Jonathan M.] Ystwyth Vet Grp, Aberystwyth, Dyfed, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	McEwan, NR (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Penglais Campus, Aberystwyth SY23 3FG, Dyfed, Wales.	nrm@aber.ac.uk	Rose, Michael/AAI-6335-2021	Crowley, Edward/0000-0003-1733-7606; Rose, Michael/0000-0001-6058-1319; McEwan, Neil/0000-0003-3839-9072				Abecia L, 2005, FEMS MICROBIOL LETT, V244, P111, DOI 10.1016/j.femsle.2005.01.028; Abecia L, 2012, ANAEROBE, V18, P344, DOI 10.1016/j.anaerobe.2012.04.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Combes S, 2014, J ANIM SCI, V92, P652, DOI 10.2527/jas.2013-6394; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Huybens N, 2013, VET J, V196, P109, DOI 10.1016/j.tvjl.2012.08.014; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Lebas F., 1997, FAO ANIMAL PRODUCTIO, V21, P19; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Monteils V, 2008, FEMS MICROBIOL ECOL, V66, P620, DOI 10.1111/j.1574-6941.2008.00611.x; Moon-van der Staay SY, 2014, EUR J PROTISTOL, V50, P166, DOI 10.1016/j.ejop.2014.01.004; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; UDEN P, 1982, BRIT J NUTR, V48, P329, DOI 10.1079/BJN19820117; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitford MF, 1998, ANAEROBE, V4, P153, DOI 10.1006/anae.1998.0155	27	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0165779	10.1371/journal.pone.0165779	http://dx.doi.org/10.1371/journal.pone.0165779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182658	Green Published, gold, Green Accepted			2022-12-27	WOS:000394231800001
J	Gao, K; Tankovic, A; Zhang, YJ; Kusumoto, H; Zhang, J; Chen, WJ; XiangWei, WS; Shaulsky, GH; Hu, C; Traynelis, SF; Yuan, HJ; Jiang, YW				Gao, Kai; Tankovic, Anel; Zhang, Yujia; Kusumoto, Hirofumi; Zhang, Jin; Chen, Wenjuan; XiangWei, Wenshu; Shaulsky, Gil H.; Hu, Chun; Traynelis, Stephen F.; Yuan, Hongjie; Jiang, Yuwu			A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; GLUTAMATE BINDING-SITE; NMDA RECEPTOR; ZINC INHIBITION; INTELLECTUAL DISABILITY; MOLECULAR DETERMINANTS; SUBUNIT ARRANGEMENT; CHANNEL BLOCK; NR1 SUBUNIT; ION CHANNEL	Objective N-methyl-D-aspartate receptors (NMDAR) subunit GRIN2A/GluN2A mutations have been identified in patients with various neurological diseases, such as epilepsy and intellectual disability / developmental delay (ID/DD). In this study, we investigated the phenotype and underlying molecular mechanism of a GRIN2A missense mutation identified by next generation sequencing on idiopathic focal epilepsy using in vitro electrophysiology. Methods Genomic DNA of patients with epilepsy and ID/DD were sequenced by targeted next-generation sequencing within 300 genes related to epilepsy and ID/DD. The effects of one missense GRIN2A mutation on NMDAR function were evaluated by two-electrode voltage clamp current recordings and whole cell voltage clamp current recordings. Results We identified one de novo missense GRIN2A mutation (Asp731Asn, GluN2A(D731N)) in a child with unexplained epilepsy and DD. The D731N mutation is located in a portion of the agonist-binding domain (ABD) in the GluN2A subunit, which is the binding pocket for agonist glutamate. This residue in the ABD is conserved among vertebrate species and all other NMDAR subunits, suggesting an important role in receptor function. The proband shows developmental delay as well as EEG-confirmed seizure activity. Functional analyses reveal that the GluN2A(D731N) mutation decreases glutamate potency by over 3,000-fold, reduces amplitude of current response, shortens synaptic-like response time course, and decreases channel open probability, while enhancing sensitivity to negative allosteric modulators, including extracellular proton and zinc inhibition. The combined effects reduce NMDAR function. Significance We identified a de novo missense mutation in the GRIN2A gene in a patient with childhood focal epilepsy and acquired epileptic aphasia. The mutant decreases NMDAR activation suggesting NMDAR hypofunction may contribute to the epilepsy pathogenesis.	[Gao, Kai; Zhang, Yujia; XiangWei, Wenshu; Jiang, Yuwu] Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China; [Gao, Kai; Zhang, Yujia; XiangWei, Wenshu; Jiang, Yuwu] Peking Univ, Hosp 1, Pediat Epilepsy Ctr, Beijing, Peoples R China; [Tankovic, Anel; Kusumoto, Hirofumi; Zhang, Jin; Chen, Wenjuan; Shaulsky, Gil H.; Hu, Chun; Traynelis, Stephen F.; Yuan, Hongjie] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Chen, Wenjuan] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Traynelis, Stephen F.; Yuan, Hongjie] Emory Univ, Sch Med, CFERV, Atlanta, GA USA; [Jiang, Yuwu] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China; [Zhang, Jin] Shanxi Med Univ, Hosp 1, Dept Neurol, Taiyuan, Peoples R China	Peking University; Peking University; Emory University; Central South University; Emory University; Shanxi Medical University	Jiang, YW (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing, Peoples R China.; Jiang, YW (corresponding author), Peking Univ, Hosp 1, Pediat Epilepsy Ctr, Beijing, Peoples R China.; Yuan, HJ (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.; Jiang, YW (corresponding author), Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing, Peoples R China.	hyuan@emory.edu; jiangyuwu@bjmu.edu.cn	jiang, yu/HGU-0029-2022; Hu, Chun/AAZ-7920-2021	Hu, Chun/0000-0002-0949-9878; Yuan, Hongjie/0000-0002-8127-7145; Shaulsky, Gil/0000-0001-9723-4812	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD082373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS092989] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD082373] Funding Source: Medline; NINDS NIH HHS [R24 NS092989] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Arning L, 2005, NEUROGENETICS, V6, P25, DOI 10.1007/s10048-004-0198-8; Bagasrawala I, 2016, CEREB CORTEX; Blanpied TA, 1997, J NEUROPHYSIOL, V77, P309, DOI 10.1152/jn.1997.77.1.309; Burnashev N, 2015, CURR OPIN PHARMACOL, V20, P73, DOI 10.1016/j.coph.2014.11.008; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeVries SP, 2013, PEDIATR NEUROL, V49, P482, DOI 10.1016/j.pediatrneurol.2013.08.023; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Dyment DA, 2015, CLIN GENET, V88, P34, DOI 10.1111/cge.12464; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Nicita F, 2012, SEIZURE-EUR J EPILEP, V21, P3, DOI 10.1016/j.seizure.2011.08.007; Ogden KK, 2017, PLOS GENETICS IN PRE; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; John A, 2013, AUTISM RES, V6, P69, DOI 10.1002/aur.1264; Swanger SA, 2016, AM J HUM GENET, V99, P1261, DOI 10.1016/j.ajhg.2016.10.002; Tassinari CA, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2009.02209.x; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Venkateswaran S, 2014, EPILEPSIA, V55, pE75, DOI 10.1111/epi.12663; Williams K, 1996, MOL PHARMACOL, V50, P701; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Xi D, 2009, J NEUROSCI METH, V176, P172, DOI 10.1016/j.jneumeth.2008.09.013; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Yuan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4251; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028	52	37	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170818	10.1371/journal.pone.0170818	http://dx.doi.org/10.1371/journal.pone.0170818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182669	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800018
J	Marana, MH; Jorgensen, LV; Skov, J; Chettri, JK; Mattsson, AH; Dalsgaard, I; Kania, PW; Buchmann, K				Marana, Moonika Haahr; Jorgensen, Louise von Gersdorff; Skov, Jakob; Chettri, Jiwan Kumar; Mattsson, Andreas Holm; Dalsgaard, Inger; Kania, Per Walter; Buchmann, Kurt			Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss	PLOS ONE			English	Article							SALMO-SALAR L; OUTER-MEMBRANE PROTEINS; III SECRETION SYSTEM; A-LAYER PROTEIN; ATLANTIC SALMON; SUBSP SALMONICIDA; ESCHERICHIA-COLI; IN-VIVO; SIDEROPHORE RECEPTOR; VIRULENCE	Aeromonas salmonicida subsp. salmonicida is the etiological agent of furunculosis and a major fish health problem in salmonid aquaculture worldwide. Injection vaccination with commercial mineral oil-adjuvanted bacterin vaccines has been partly successful in preventing the disease but in Danish rainbow trout (Oncorhynchus mykiss, Walbaum) aquaculture furunculosis outbreaks still occur. In this study we tested the efficacy of experimental subunit vaccines against A. salmonicida infection in rainbow trout. We utilized in silico screening of the proteome of A. salmonicida subsp. salmonicida strain A449 and identified potential protective protein antigens that were tested by in vivo challenge trial. A total of 14 proteins were recombinantly expressed in Escherichia coli and prepared in 3 different subunit vaccine combinations to immunize 3 groups of rainbow trout by intraperitoneal (i.p.) injection. The fish were exposed to virulent A. salmonicida 7 weeks after immunization. To assess the efficacy of the subunit vaccines we evaluated the immune response in fish after immunization and challenge infection by measuring the antibody levels and monitoring the survival of fish in different groups. The survival of fish at 3 weeks after challenge infection showed that all 3 groups of fish immunized with 3 different protein combinations exhibited significantly lower mortalities (17-30%) compared to the control groups (48% and 56%). The ELISA results revealed significantly elevated antibody levels in fish against several protein antigens, which in some cases were positively correlated to the survival.	[Marana, Moonika Haahr; Jorgensen, Louise von Gersdorff; Skov, Jakob; Kania, Per Walter; Buchmann, Kurt] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1168 Copenhagen, Denmark; [Chettri, Jiwan Kumar; Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark; [Mattsson, Andreas Holm] Evax Biotech, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark	Marana, MH (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1168 Copenhagen, Denmark.	mmarana@hotmail.com	; Chettri, Jiwan Kumar/A-5243-2015	Dalsgaard, Inger/0000-0003-2066-1060; Buchmann, Kurt/0000-0002-2747-237X; Jorgensen, Louise von Gersdorff/0000-0002-6005-3249; Marana, Moonika/0000-0003-3535-6341; Chettri, Jiwan Kumar/0000-0001-8127-8773	Danish Council for Strategic Research under the PROFISH project [DSF: 11-116252]; European Commission FP7 project Targetfish [311993]	Danish Council for Strategic Research under the PROFISH project; European Commission FP7 project Targetfish	This study was funded by from the Danish Council for Strategic Research under the PROFISH project (Grant No. DSF: 11-116252) and the European Commission FP7 project Targetfish (Grant No. 311993). The funder provided support in the form of salaries for authors [MHM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section. The commercial affiliation (Evaxion Biotech) did not provide financial support in this study. The commercial affiliation (Evaxion Biotech) provided the protein sequences tested in this study but played no role in data collection, analysis or decision to publish.	Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; Andreoni F, 2016, METHODS MOL BIOL, V1404, P181, DOI 10.1007/978-1-4939-3389-1_12; Andreoni F, 2013, VACCINE, V31, P820, DOI 10.1016/j.vaccine.2012.11.064; [Anonymous], F1000 BIOL REP; ARNESEN JA, 1993, J FISH DIS, V16, P409, DOI 10.1111/j.1365-2761.1993.tb00875.x; Bagnoli F, 2015, P NATL ACAD SCI USA, V112, P3680, DOI 10.1073/pnas.1424924112; Beaz-Hidalgo R, 2013, J FISH DIS, V36, P371, DOI 10.1111/jfd.12025; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bernoth Eva-Maria, 1997, P1, DOI 10.1016/B978-012093040-1/50003-8; BJORNSDOTTIR R, 1992, J FISH DIS, V15, P105, DOI 10.1111/j.1365-2761.1992.tb00645.x; Boyd JM, 2008, INFECT IMMUN, V76, P1445, DOI 10.1128/IAI.01019-07; Bricknell IR, 1997, FISH SHELLFISH IMMUN, V7, P1, DOI 10.1006/fsim.1996.0059; Burr SE, 2005, MICROBIOL-SGM, V151, P2111, DOI 10.1099/mic.0.27926-0; Burr SE, 2003, DIS AQUAT ORGAN, V57, P167, DOI 10.3354/dao057167; Burr SE, 2002, J BACTERIOL, V184, P5966, DOI 10.1128/JB.184.21.5966-5970.2002; Chettri JK, 2015, FISH SHELLFISH IMMUN, V44, P485, DOI 10.1016/j.fsi.2015.03.003; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; CIPRIANO RC, 1982, CAN J FISH AQUAT SCI, V39, P218, DOI 10.1139/f82-028; CIPRIANO RC, 1982, CAN J FISH AQUAT SCI, V39, P1512, DOI 10.1139/f82-203; Dacanay A, 2006, MICROBIOL-SGM, V152, P1847, DOI 10.1099/mic.0.28768-0; Dalsgaard I, 2000, J FISH DIS, V23, P199, DOI 10.1046/j.1365-2761.2000.00242.x; Ebanks RO, 2004, PROTEOMICS, V4, P1074, DOI 10.1002/pmic.200300664; ELLIS AE, 1981, J FISH DIS, V4, P41, DOI 10.1111/j.1365-2761.1981.tb01108.x; ELLIS AE, 1991, J FISH DIS, V14, P265, DOI 10.1111/j.1365-2761.1991.tb00824.x; Emmerich R., 1894, ARCH HYG BAKTERIOL, V21, P1; Garduno R, 2000, CAN J MICROBIOL, V46, P660, DOI 10.1139/cjm-46-7-660; Gourlay LJ, 2009, HUM VACCINES, V5, P872, DOI 10.4161/hv.9778; HIRST ID, 1994, FISH SHELLFISH IMMUN, V4, P29, DOI 10.1006/fsim.1994.1004; KAY WW, 1981, J BACTERIOL, V147, P1077, DOI 10.1128/JB.147.3.1077-1084.1981; Koppang EO, 2008, J IMMUNOL, V181, P4807, DOI 10.4049/jimmunol.181.7.4807; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEE KK, 1990, J BACTERIOL, V172, P5382, DOI 10.1128/jb.172.9.5382-5393.1990; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; LILLEHAUG A, 1992, J FISH DIS, V15, P485, DOI 10.1111/j.1365-2761.1992.tb00680.x; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Lund V, 2003, FISH SHELLFISH IMMUN, V15, P367, DOI 10.1016/S1050-4648(02)00180-8; Mahendran R, 2016, DRUG DES DEV THER, V10, P1703, DOI 10.2147/DDDT.S95691; Marana MH, 2016, J FISH DIS; Menanteau-Ledouble S, 2016, J FISH DIS, V39, P1015, DOI 10.1111/jfd.12430; Menanteau-Ledouble S, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-29; Midtlying PJ, 1996, FISH SHELLFISH IMMUN, V6, P335, DOI 10.1006/fsim.1996.0034; Midtlyng PJ, 1996, FISH SHELLFISH IMMUN, V6, P599, DOI 10.1006/fsim.1996.0055; Morgan JK, 2014, MICROB PATHOGENESIS, V77, P42, DOI 10.1016/j.micpath.2014.10.010; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Mulder N., 2007, COMP GENOMICS, P59; Najimi M, 2008, ARCH MICROBIOL, V190, P439, DOI 10.1007/s00203-008-0391-5; NEELAM B, 1993, MICROBIOS, V74, P59; Pedersen K, 2008, J FISH DIS, V31, P659, DOI 10.1111/j.1365-2761.2008.00941.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Romstad AB, 2013, VACCINE, V31, P791, DOI 10.1016/j.vaccine.2012.11.069; Russo TA, 2003, INFECT IMMUN, V71, P7164, DOI 10.1128/IAI.71.12.7164-7169.2003; SAKAI DK, 1985, INFECT IMMUN, V48, P146, DOI 10.1128/IAI.48.1.146-152.1985; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Semmler ABT, 2000, MICROBIOL-UK, V146, P1321, DOI 10.1099/00221287-146-6-1321; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; SHIEH HS, 1975, INT J BIOCHEM, V6, P653, DOI 10.1016/0020-711X(75)90016-6; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Suyama M, 2003, BIOINFORMATICS, V19, P673, DOI 10.1093/bioinformatics/btg031; TATNER MF, 1991, J FISH DIS, V14, P395, DOI 10.1111/j.1365-2761.1991.tb00838.x; Thomson DU, 2009, FOODBORNE PATHOG DIS, V6, P871, DOI 10.1089/fpd.2009.0290; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-44; Vanden Bergh P, 2013, VACCINE, V31, P5256, DOI 10.1016/j.vaccine.2013.08.057; Vanden Bergh P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-42; Villumsen KR, 2015, FISH SHELLFISH IMMUN, V42, P193, DOI 10.1016/j.fsi.2014.09.024; Villumsen KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046733; Wehbi H, 2011, J BACTERIOL, V193, P540, DOI 10.1128/JB.01048-10; Xueqin J, 2012, J FISH DIS, V35, P127, DOI 10.1111/j.1365-2761.2011.01329.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	71	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171944	10.1371/journal.pone.0171944	http://dx.doi.org/10.1371/journal.pone.0171944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182704	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800136
J	Montane, E; Barriocanal, AM; Arellano, AL; Valderrama, A; Sanz, Y; Perez-Alvarez, N; Cardona, P; Vilaplana, C; Cardona, PJ				Montane, Eva; Maria Barriocanal, Ana; Lucia Arellano, Ana; Valderrama, Angelica; Sanz, Yolanda; Perez-Alvarez, Nuria; Cardona, Paula; Vilaplana, Cristina; Cardona, Pere-Joan			Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae (R) in adults with or without latent TB infection: Safety and immunogenicity	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; NONTUBERCULOUS MYCOBACTERIA; ACTIVE TUBERCULOSIS; DRINKING-WATER; CELLS; IMMUNITY; IDENTIFICATION; RESPONSES; TREG; VACCINATION	Background Nyaditum resae (R) (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in a murine experimental model that develop human-like lesions. Methods Double-blind, randomized, placebo-controlled Clinical Trial (51 volunteers included). Two different doses of NR and a placebo were tested, the randomization was stratified by Latent Tuberculosis Infection (LTBI)-positive (n = 21) and LTBI-negative subjects (n = 30). Each subject received 14 drinkable daily doses for 2 weeks. Results All patients completed the study. The 46.3% of the overall reported adverse events (AE) were considered related to the investigational treatment. None of them were severe (94% were mild and 6% moderate). No statistical differences were found when comparing the median number of AE between the placebo group and both treatment groups. The most common AE reported were gastrointestinal events, most frequently mild abdominal pain and increase in stool frequency. Regarding the immunogenic response, both LTBI-negative and LTBI-positive volunteers treated with NR experienced a global increase on the Treg response, showed both in the population of CD25+CD39-, mainly effector Treg cells, or CD25+CD39+ memory PPD-specific Treg cells. Conclusion This clinical trial demonstrates an excellent tolerability profile of NR linked to a significant increase in the population of specific effector and memory Tregs in the groups treated with NR in both LTBI-positive and negative subjects. NR shows a promising profile to be used to reduce the risk of active TB.	[Montane, Eva; Lucia Arellano, Ana; Valderrama, Angelica; Sanz, Yolanda] Hosp Badalona Germans Trias & Pujol, Dept Clin Pharmacol, Badalona, Catalonia, Spain; [Montane, Eva; Maria Barriocanal, Ana; Lucia Arellano, Ana] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Barcelona, Catalonia, Spain; [Maria Barriocanal, Ana] Fdn Inst Germans Trias & Pujol, Badalona, Catalonia, Spain; [Perez-Alvarez, Nuria] Lluita Contra Sida Fdn, Badalona, Catalonia, Spain; [Perez-Alvarez, Nuria] Univ Politecn Cataluna, BarcelonaTech, Stat & Operat Res Dept, Barcelona, Catalonia, Spain; [Cardona, Paula; Vilaplana, Cristina; Cardona, Pere-Joan] Univ Autonoma Barcelona, CIBERES, Fdn Inst Germans Trias & Pujol, Unitat TB Expt, Badalona, Catalonia, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Universitat Politecnica de Catalunya; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cardona, PJ (corresponding author), Univ Autonoma Barcelona, CIBERES, Fdn Inst Germans Trias & Pujol, Unitat TB Expt, Badalona, Catalonia, Spain.	pjcardona@igtp.cat	Arellano, Ana Lucía/H-9422-2017; Cardona, Paula/H-5034-2017; Arellano, Ana Lucía/AAE-7248-2022; Eva, Montané/O-5164-2019; Perez-Alvarez, Nuria/O-9244-2014; Vilaplana, Cristina/K-7216-2012; Cardona, Pere-Joan/A-5258-2011; Sanz, Yolanda/H-5498-2012	Arellano, Ana Lucía/0000-0001-8601-3504; Cardona, Paula/0000-0002-8613-9390; Arellano, Ana Lucía/0000-0001-8601-3504; Eva, Montané/0000-0002-1691-7652; Perez-Alvarez, Nuria/0000-0001-6582-1553; Vilaplana, Cristina/0000-0002-2808-7270; Cardona, Pere-Joan/0000-0001-5623-7873; Sanz, Yolanda/0000-0002-1615-1976				Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Cardona P, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01482; Casabona NM, 2000, MED CLIN-BARCELONA, V115, P663; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Chen CY, 2012, J IMMUNOL, V188, P4278, DOI 10.4049/jimmunol.1101291; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Chiacchio T, 2009, CLIN EXP IMMUNOL, V156, P463, DOI 10.1111/j.1365-2249.2009.03908.x; COLDITZ GA, 1995, PEDIATRICS, V96, P29; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Fernandez-Rendon E, 2012, J HOSP INFECT, V80, P74, DOI 10.1016/j.jhin.2011.10.003; Feruglio SL, 2015, CLIN EXP IMMUNOL, V179, P454, DOI 10.1111/cei.12468; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Imwidthaya P, 1989, J Med Assoc Thai, V72, P317; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; KARCH FE, 1977, CLIN PHARMACOL THER, V21, P247; Kubalek I, 1996, EUR J EPIDEMIOL, V12, P471, DOI 10.1007/BF00143998; Lahtinen Sampo J., 2012, Microbial Ecology in Health and Disease, V23, P10, DOI 10.3402/mehd.v23i0.18567; Li L, 2007, TUBERCULOSIS, V87, P526, DOI 10.1016/j.tube.2007.07.004; Marzo E, 2014, TUBERCULOSIS, V94, P55, DOI 10.1016/j.tube.2013.09.004; May YL, 2009, INFECT IMMUN AM SOC, V77, P5071; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Meyboom R., 1992, PHARMACOEPIDEM DR S, V1, P87; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moghim S, 2012, IRAN J BASIC MED SCI, V15, P1076; Murray C. J., 2013, LANCET, V384, P1005, DOI DOI 10.1016/S0140-6736(14)60844-8; Nasr-Esfahani B, 2012, IRAN J PUBLIC HEALTH, V41, P108; Norquist JM, 2012, HUM VACC IMMUNOTHER, V8, P1208, DOI 10.4161/hv.21408; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ocejo-Vinyals JG, 2013, CYTOKINE; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Rech G, 2015, GENOME ANNOUNC, V3; Rief W, 2001, PSYCHOSOM MED, V63, P595, DOI 10.1097/00006842-200107000-00012; ROSENZWEIG P, 1993, CLIN PHARMACOL THER, V54, P578, DOI 10.1038/clpt.1993.190; SCARLATA G, 1985, B I SIEROTER MILAN, V64, P479; Serafini M, 2012, INT J FOOD SCI NUTR, V63, P7, DOI 10.3109/09637486.2011.637488; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Shinkai S, 2013, BRIT J NUTR, V109, P1856, DOI 10.1017/S0007114512003753; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Sun Q, 2012, RESPIROLOGY, V17, P876, DOI 10.1111/j.1440-1843.2012.02184.x; Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x; Tortoli E, 2001, J CLIN MICROBIOL, V39, P1079, DOI 10.1128/JCM.39.3.1079-1084.2001; Vilaplana C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100830; Vilaplana C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00055; West NP, 2009, EXERCISE IMMUNOLOGY, P107; Zhang B, 2012, INT J MOL MED, V30, P248, DOI 10.3892/ijmm.2012.1010; Zheng SG, 2013, AM J CLIN EXP IMMUNO, V2, P94; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	54	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171294	10.1371/journal.pone.0171294	http://dx.doi.org/10.1371/journal.pone.0171294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182700	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800052
J	Pikovski, A				Pikovski, Alexander			Note on a differentiation formula, with application to the two-dimensional Schrodinger equation	PLOS ONE			English	Article								A method for obtaining discretization formulas for the derivatives of a function is presented, which relies on a generalization of divided differences. These modified divided differences essentially correspond to a change of the dependent variable. This method is applied to the numerical solution of the eigenvalue problem for the two-dimensional Schrodinger equation, where standard methods converge very slowly while the approach proposed here gives accurate results. The presented approach has the merit of being conceptually simple and might prove useful in other instances.	[Pikovski, Alexander] Univ Colorado, NIST, JILA, Boulder, CO 80309 USA; [Pikovski, Alexander] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Pikovski, A (corresponding author), Univ Colorado, NIST, JILA, Boulder, CO 80309 USA.; Pikovski, A (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	alexander.pikovski@colorado.edu	Pikovski, Alexander/AAU-7813-2021	Pikovski, Alexander/0000-0003-3452-194X	Army Research Office	Army Research Office	This work was supported by the Army Research Office.	Castro Neto AH, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/082501; Grossmann C., 2007, NUMERICAL TREATMENT; Hildebrand F. B, 1987, INTRO NUMERICAL ANAL; Kantorovich L. V., 1964, APPROXIMATE METHODS; Leggett AJ, 2006, NAT PHYS, V2, P134, DOI 10.1038/nphys254; MANTEUFFEL TA, 1986, MATH COMPUT, V47, P511, DOI 10.1090/S0025-5718-1986-0856700-3; Reimann SM, 2002, REV MOD PHYS, V74, P1283, DOI 10.1103/RevModPhys.74.1283; Roy AK, 2008, INT J QUANTUM CHEM, V108, P827, DOI 10.1002/qua.21571; Smith CG, 1996, REP PROG PHYS, V59, P235, DOI 10.1088/0034-4885/59/2/003; Zadorin AI, 2009, NUMERICAL ANAL ITS A	10	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171444	10.1371/journal.pone.0171444	http://dx.doi.org/10.1371/journal.pone.0171444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178300	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500043
J	Houri, H; Pormohammad, A; Riahi, SM; Nasiri, MJ; Fallah, F; Dabiri, H; Pouriran, R				Houri, Hamidreza; Pormohammad, Ali; Riahi, Seyed Mohammad; Nasiri, Mohammad Javad; Fallah, Fatemeh; Dabiri, Hossein; Pouriran, Ramin			Acute bacterial meningitis in Iran: Systematic review and meta-analysis	PLOS ONE			English	Review							INFLUENZAE TYPE-B; CHILDREN; DISEASE; DIAGNOSIS; VACCINE; AFRICA; RISK; TOOL	Introduction Bacterial meningitis persists in being a substantial cause of high mortality and severe neurological morbidity, despite the advances in antimicrobial therapy. Accurate data has not been available regarding the epidemiology of bacterial meningitis particularly in developing countries, yet. Indeed, the present systematic review provides a comprehensive data analysis on the prevalence and epidemiology of bacterial meningitis in Iran. Methods We systematically reviewed articles from 1994 to 2015. The reports which contained the prevalence and etiology of acute bacterial meningitis by valid clinical and laboratory diagnosis were comprised in the present study. Results Our analysis indicated that Streptococcus pneumoniae (30% [I2 = 56% p < 0.01]), Haemophilus influenza type b (15% [I2 = 82.75% p < 0.001]), coagulase negative staphylococci (CoNS) (14% [I2 = 60.5% p < 0.06]), and Neisseria meningitidis (13% [I2 = 74.16% p < 0.001]) were the most common cause of acute bacterial meningitis among meningitis cases in Iran. Notably, high frequency rates of nosocomial meningitis pathogens were detected in the present analysis. Conclusions It was magnificently attained that the majority of cases for bacterial meningitis in Iran could be avertable by public immunization schemes and by preventive care to inhibit the broadening of hospital acquired pathogens.	[Houri, Hamidreza; Pormohammad, Ali; Nasiri, Mohammad Javad; Fallah, Fatemeh; Dabiri, Hossein] Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran; [Riahi, Seyed Mohammad] Birjand Univ Med Sci, Dept Epidemiol, Birjand, Iran; [Riahi, Seyed Mohammad] Shahid Beheshti Univ Med Sci, Fac Hlth, Dept Epidemiol, Tehran, Iran; [Pouriran, Ramin] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Pormohammad, A (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran.	pormohammadali@yahoo.com	amiri, omolbanin/G-4425-2017; Riahi, Seyed Mohammad/Y-1531-2018; Houri, Hamidreza/AAP-9232-2021	amiri, omolbanin/0000-0002-3815-5716; Riahi, Seyed Mohammad/0000-0002-3184-2126; Nasiri, Mohammad Javad/0000-0002-3279-0671; Houri, Hamidreza/0000-0002-6813-0229; Fallah, Fatemeh/0000-0002-3380-9549				Abdinia B, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.17616; Alavi S, 2010, JUNDISHAPUR SCI MED, V9, P222; Aletayeb MH, 2010, PEDIATR INT, V52, P463, DOI 10.1111/j.1442-200X.2010.03107.x; Ataee RA, 2011, J RES MED SCI, V16, P207; Attarpour-yazdi MM, 2014, IRAN J MICROBIOL, V6, P211; Bagheri-Nesami M, 2015, J CLIN DIAGN RES, V9, pIC1, DOI 10.7860/JCDR/2015/11991.5936; Bahador M., 2009, Iranian Journal of Pathology, V4, P75; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Ceyhan M, 2012, INT J INFECT DIS, V16, pE574, DOI 10.1016/j.ijid.2012.03.011; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Ehsanipour F, 2005, RAZI J MED SCI, V11, P907; Feikin DR, 2004, EMERG INFECT DIS, V10, P1270, DOI 10.3201/eid1007.030737; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Ghotaslou Reza, 2012, Acta Med Iran, V50, P192; Haghiashteiani MT, 2008, IRAN J PUBLIC HEALTH, V37, P52; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Heckenberg Sebastiaan G B, 2014, Handb Clin Neurol, V121, P1361, DOI 10.1016/B978-0-7020-4088-7.00093-6; Heydarian F, 2014, NEUROSCIENCES, V19, P297; Hoffman Olaf, 2009, Ther Adv Neurol Disord, V2, P1, DOI 10.1177/1756285609337975; Kessler AT, 2007, INFECTION, V35, P271, DOI 10.1007/s15010-007-6211-z; Khalessi Nasrin, 2014, Iran J Child Neurol, V8, P46; Kim BN, 2009, LANCET INFECT DIS, V9, P245, DOI 10.1016/S1473-3099(09)70055-6; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kumar A, 2015, INDIAN J PEDIATR, V82, P311, DOI 10.1007/s12098-014-1357-z; LINNAN MJ, 1988, NEW ENGL J MED, V319, P823, DOI 10.1056/NEJM198809293191303; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mahmoudi S, 2013, JPN J INFECT DIS, V66, P503, DOI 10.7883/yoken.66.503; Martin M, 2004, PEDIATR INFECT DIS J, V23, P842, DOI 10.1097/01.inf.0000137575.82874.0c; Mashouf R. Y., 2006, Pakistan Journal of Biological Sciences, V9, P1293, DOI 10.3923/pjbs.2006.1293.1298; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moradi-Lakeh M, 2012, INT J PREVENTIVE MED, V3, P332; MORENO MT, 1994, PEDIATR INFECT DIS J, V13, P516, DOI 10.1097/00006454-199406000-00010; Motamedifar M, 2015, ARCH CLIN INFECT DIS, V10; Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Portnoy A, 2015, VACCINE, V33, pA240, DOI 10.1016/j.vaccine.2014.11.061; Qurbanalizadegan M, 2010, IRAN J PUBLIC HEALTH, V39, P45; Rezaei M, 2013, BRIT J BIOMED SCI, V70, P101, DOI 10.1080/09674845.2013.11669943; Roine I, 2008, CLIN INFECT DIS, V46, P1248, DOI 10.1086/533448; Saez-Llorens X, 1999, INFECT DIS CLIN N AM, V13, P619, DOI 10.1016/S0891-5520(05)70097-0; Teleb N, 2013, J PEDIATR-US, V163, pS25, DOI 10.1016/j.jpeds.2013.03.027; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; VanDemark M, 2013, CRIT CARE NURS CLIN, V25, P351, DOI 10.1016/j.ccell.2013.04.004; Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858; ZAMANI A, 2005, MED J ISLAMIC REPUBL, V19, P241	46	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0169617	10.1371/journal.pone.0169617	http://dx.doi.org/10.1371/journal.pone.0169617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170400	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500002
J	Komatsu, T; Sasaki, S; Manabe, Y; Hirata, T; Sugawara, T				Komatsu, Toshiyuki; Sasaki, Suguru; Manabe, Yuki; Hirata, Takashi; Sugawara, Tatsuya			Preventive effect of dietary astaxanthin on UVA-induced skin photoaging in hairless mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ULTRAVIOLET-RADIATION; CHOLESTEROL SULFATE; HUMAN HEALTH; EXTRACTION; EXPRESSION; TARGET; MODELS; ALPHA	Astaxanthin, a carotenoid found mainly in seafood, has potential clinical applications due to its antioxidant activity. In this study, we evaluated the effect of dietary astaxanthin derived from Haematococcus pluvialis on skin photoaging in UVA-irradiated hairless mice by assessing various parameters of photoaging. After chronic ultraviolet A (UVA) exposure, a significant increase in transepidermal water loss (TEWL) and wrinkle formation in the dorsal skin caused by UVA was observed, and dietary astaxanthin significantly suppressed these photoaging features. We found that the mRNA expression of lympho-epithelial Kazal-type-related inhibitor, steroid sulfatase, and aquaporin 3 in the epidermis was significantly increased by UVA irradiation for 70 days, and dietary astaxanthin significantly suppressed these increases in mRNA expression to be comparable to control levels. In the dermis, the mRNA expression of matrix metalloprotease 13 was increased by UVA irradiation and significantly suppressed by dietary astaxanthin. In addition, HPLC-PDA analysis confirmed that dietary astaxanthin reached not only the dermis but also the epidermis. Our results indicate that dietary astaxanthin accumulates in the skin and appears to prevent the effects of UVA irradiation on filaggrin metabolism and desquamation in the epidermis and the extracellular matrix in the dermis.	[Komatsu, Toshiyuki; Sasaki, Suguru; Manabe, Yuki; Hirata, Takashi; Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Hirata, Takashi] Shijonawate Gakuen Univ, Osaka, Japan	Kyoto University	Sugawara, T (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	sugawara@kais.kyoto-u.ac.jp	Manabe, Yuki/AAJ-2599-2020	Manabe, Yuki/0000-0002-5663-0074; Sugawara, Tatsuya/0000-0002-1203-5521	FUJIFILM Corporation	FUJIFILM Corporation	FUJIFILM Corporation funded this study and provided support for the author TS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Bennett K, 2010, J PROTEOME RES, V9, P4289, DOI 10.1021/pr1003467; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bohm M, 2004, J BIOL CHEM, V279, P6959, DOI 10.1074/jbc.M312549200; Breithaupt DE, 2003, BRIT J NUTR, V90, P795, DOI 10.1079/BJN2003962; Chew BP, 1999, ANTICANCER RES, V19, P1849; Coral-Hinostroza GN, 2004, COMP BIOCHEM PHYS C, V139, P99, DOI 10.1016/j.cca.2004.09.011; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; de Veer SJ, 2014, TRENDS MOL MED, V20, P166, DOI 10.1016/j.molmed.2013.11.005; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P353, DOI 10.1016/j.bbalip.2013.11.009; EPSTEIN EH, 1984, J AM ACAD DERMATOL, V10, P866, DOI 10.1016/S0190-9622(84)80144-9; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; GILCHREST BA, 1992, BRIT J DERMATOL, V127, P25, DOI 10.1111/j.1365-2133.1992.tb16984.x; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Hussein G, 2006, J NAT PROD, V69, P443, DOI 10.1021/np050354+; JYONOUCHI H, 1995, J NUTR, V125, P2483; Kidd P, 2011, ALTERN MED REV, V16, P355; Kishimoto Y, 2016, MAR DRUGS, V14, DOI 10.3390/md14020035; Kobayashi M, 2000, APPL MICROBIOL BIOT, V54, P550, DOI 10.1007/s002530000416; Kuttner V, 2014, J INVEST DERMATOL, V134, P2381, DOI 10.1038/jid.2014.185; Lamore SD, 2012, PHOTOCH PHOTOBIO SCI, V11, P163, DOI 10.1039/c1pp05131h; Lee CM, 1999, J NUTR, V129, P2271, DOI 10.1093/jn/129.12.2271; Lennikov Anton, 2012, Mol Vis, V18, P455; Lyons NM, 2002, J DERMATOL SCI, V30, P73, DOI 10.1016/S0923-1811(02)00063-4; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; Mariani TJ, 1998, MOL BIOL CELL, V9, P1411, DOI 10.1091/mbc.9.6.1411; Martin HD, 1999, PURE APPL CHEM, V71, P2253, DOI 10.1351/pac199971122253; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Miyazawa T, 2011, BIOSCI BIOTECH BIOCH, V75, P1856, DOI 10.1271/bbb.110368; Nakahigashi K, 2011, J INVEST DERMATOL, V131, P865, DOI 10.1038/jid.2010.395; Natarajan VT, 2014, NAT CHEM BIOL, V10, P542, DOI [10.1038/NCHEMBIO.1548, 10.1038/nchembio.1548]; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Parisi AV, 2000, J PHOTOCH PHOTOBIO B, V54, P126, DOI 10.1016/S1011-1344(00)00006-3; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Petri D, 2007, COMP BIOCHEM PHYS C, V145, P202, DOI 10.1016/j.cbpc.2006.12.008; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Sakabe J, 2013, J BIOL CHEM, V288, P17179, DOI 10.1074/jbc.M113.476820; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Shimada E, 2011, J OLEO SCI, V60, P321, DOI 10.5650/jos.60.321; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C., 2016, PHOTOCHEM PHOTOBIOL; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2015, PHOTODERMATOL PHOTO, V31, P121, DOI 10.1111/phpp.12165; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sugawara T, 2001, J NUTR, V131, P2921, DOI 10.1093/jn/131.11.2921; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; Tyrrell RM, 1996, BIOESSAYS, V18, P139, DOI 10.1002/bies.950180210; Urbach F, 1997, J PHOTOCH PHOTOBIO B, V40, P3, DOI 10.1016/S1011-1344(97)00029-8; Urikura I, 2011, BIOSCI BIOTECH BIOCH, V75, P757, DOI 10.1271/bbb.110040; Yamamoto M, 2012, J BIOL CHEM, V287, P32825, DOI 10.1074/jbc.M112.357467; Yoshihisa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152288	59	57	60	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171178	10.1371/journal.pone.0171178	http://dx.doi.org/10.1371/journal.pone.0171178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170435	Green Published, gold			2022-12-27	WOS:000393705500022
J	Yang, MX; Chen, XZ; Bo, LN; Lao, LX; Chen, J; Yu, SY; Yu, Z; Tang, HZ; Yi, L; Wu, X; Yang, J; Liang, FR				Yang, Mingxiao; Chen, Xiangzhu; Bo, Linna; Lao, Lixing; Chen, Jiao; Yu, Siyi; Yu, Zheng; Tang, Hongzhi; Yi, Ling; Wu, Xi; Yang, Jie; Liang, Fanrong			Moxibustion for pain relief in patients with primary dysmenorrhea: A randomized controlled trial	PLOS ONE			English	Article							MENSTRUAL PAIN; UNIVERSITY-STUDENTS; CLINICAL-TRIALS; ACUPUNCTURE; PREVALENCE; HEAT; ENDOMETRIOSIS; ADOLESCENTS; PREVENTION; MANAGEMENT	Background Though moxibustion is frequently used to treat primary dysmenorrhea in China, relevant evidence supporting its effectiveness is still scanty. Methods This study was a pragmatic randomized, conventional drug controlled, open-labeled clinical trial. After initial screen, 152 eligible participants were averagely randomized to receive two different treatment strategies: Moxibustion and conventional drugs. Participants and practitioners were not blinded in this study. The duration of each treatment was 3 months. The primary outcome was pain relief measured by the Visual Analogue Scale. The menstrual pain severity was recorded in a menstrual pain diary. Results 152 eligible patients were included but only 133 of them eventually completed the whole treatment course. The results showed that the menstrual pain intensity in experimental group and control group was reduced from 6.38 +/- 1.28 and 6.41 +/- 1.29, respectively, at baseline, to 2.54 +/- 1.41 and 2.47 +/- 1.29 after treatment. The pain reduction was not significantly different between these two groups (P = 0.76), however; the pain intensity was significantly reduced relative to baseline for each group (P<0.01). Three months after treatment, the effectiveness of moxibustion sustained and started to be superior to the drug's effect (-0.87, 95% CI -1.32 to -0.42, P<0.01). Secondary outcome analyses showed that moxibustion was as effective as drugs in alleviating menstrual pain-related symptoms. The serum levels of pain mediators, such as PGF(2 alpha), OT, vWF, beta-EP, PGE(2), were significantly improved after treatment in both groups (P<0.05). No adverse events were reported in this trial. Conclusions Both moxibustion and conventional drug showed desirable merits in managing menstrual pain, given their treatment effects and economic costs. This study as a pragmatic trial only demonstrates the effectiveness, not the efficacy, of moxibustion for menstrual pain. It can't rule out the effect of psychological factors during treatment process, because no blind procedure or sham control was used due to availability. In clinical practice, moxibustion should be used at the discretion of patients and their physicians.	[Yang, Mingxiao; Chen, Jiao; Yu, Siyi; Tang, Hongzhi; Wu, Xi; Yang, Jie; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Moxibust, Chengdu, Sichuan, Peoples R China; [Chen, Xiangzhu; Yu, Zheng] Pixian Hosp Tradit Chinese Med, Chengdu, Sichuan, Peoples R China; [Bo, Linna] Rentong Clin Tradit Chinese Med, Chengdu, Sichuan, Peoples R China; [Lao, Lixing] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Yi, Ling] Med Ctr & Hosp Qionglai, Chengdu, Sichuan, Peoples R China	Chengdu University of Traditional Chinese Medicine; University of Hong Kong	Yang, J; Liang, FR (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Moxibust, Chengdu, Sichuan, Peoples R China.	jenny_yang_jie@126.com; acuresearch@126.com	chen, JJ/HGB-6029-2022; Yang, Mingxiao/ABF-6416-2021; Yang, Mingxiao/ABF-7200-2021; Lao, Lixing/P-9107-2019; CHEN, JIAO/GZA-5784-2022	Yang, Mingxiao/0000-0002-6514-3366; Lao, Lixing/0000-0003-0198-9714; Liang, Fanrong/0000-0003-2210-2027	National Basic Research Program, China 973 program [2012CB518501]; National Natural Science Foundation of China [81590950, 81574089, 81303060]; Chinese Scholarship Council	National Basic Research Program, China 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council)	This study was financially supported by the National Basic Research Program, China 973 program, No. 2012CB518501 and the "2011 Innovation Center" Program from the Education Department of Sichuan province, grants from the National Natural Science Foundation of China (No. 81590950, 81574089, 81303060) and the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin MD, 2001, OBSTET GYNECOL, V97, P343, DOI 10.1016/S0029-7844(00)01163-7; Arulkumaran S., 2012, ROLES PROSTANOID EP; Ayan M, 2012, ARCH GYNECOL OBSTET, V286, P403, DOI 10.1007/s00404-012-2316-4; [卜彦青 Bu Yanqing], 2010, [中医杂志, Journal of Traditional Chinese Medicine], V51, P811; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Chang XR, 2007, WORLD J GASTROENTERO, V13, P4355, DOI 10.3748/wjg.v13.i32.4355; Chiu J-H., 2013, EVIDENCE BASED COMPL, V2013; Cho SH, 2010, BJOG-INT J OBSTET GY, V117, P509, DOI 10.1111/j.1471-0528.2010.02489.x; Chung YC, 2012, COMPLEMENT THER MED, V20, P353, DOI 10.1016/j.ctim.2012.02.008; Dawood MY, 2006, OBSTET GYNECOL, V108, P428, DOI 10.1097/01.AOG.0000230214.26638.0c; Dawood MY, 2007, AM J OBSTET GYNECOL, V196, P35, DOI 10.1016/j.ajog.2006.06.091; DAWOOD MY, 1985, J REPROD MED, V30, P154; Deadman P., 1998, J CHINESE MED PUBLIC; Farquhar C., 2015, NONSTEROIDAL ANTIINF; French L, 2005, AM FAM PHYSICIAN, V71, P285; Gao J, 2015, COMPLEMENT THER MED, V23, P773, DOI 10.1016/j.ctim.2015.08.005; Glickman-Simon R, 2015, EXPLORE-NY, V11, P489, DOI 10.1016/j.explore.2015.08.013; Grandi Giovanni, 2012, J Pain Res, V5, P169, DOI 10.2147/JPR.S30602; Harel Z, 2008, ANN NY ACAD SCI, V1135, P185, DOI 10.1196/annals.1429.007; Harel Z, 2012, EXPERT OPIN PHARMACO, V13, P2157, DOI 10.1517/14656566.2012.725045; Helms PJ, 2002, PEDIAT ALLERG IMM-UK, V13, P4, DOI 10.1034/j.1399-3038.2002.00194.x; Ju H, 2014, EPIDEMIOL REV, V36, P104, DOI 10.1093/epirev/mxt009; Kawakita K, 2006, J PHARMACOL SCI, V100, P443, DOI 10.1254/jphs.CRJ06004X; Kennedy S, 1997, LANCET, V349, P1116, DOI 10.1016/S0140-6736(05)63018-8; Kim JI, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-33; Kim Jung Wan, 2015, Journal of Acupuncture Research, V32, P123; KOBAYASHI K, 1995, AM J CHINESE MED, V23, P327, DOI 10.1142/S0192415X95000390; Koga K, 2015, FERTIL STERIL, V104, P793, DOI 10.1016/j.fertnstert.2015.08.026; Langevin HM, 2015, J ALTERN COMPLEM MED, V21, P113, DOI 10.1089/acm.2014.0186; Lee IS, 2015, PHYSIOL BEHAV, V140, P148, DOI 10.1016/j.physbeh.2014.12.030; Lee IS, 2004, J KOREAN PUBLIC HLTH, V18, P39; Lefebvre G, 2005, J OBSTET GYNAECOL CA, V27, P1117; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Ma Y-x, 2015, EVID-BASED COMPL ALT, V501; Ma YX, 2010, PAIN MED, V11, P1564, DOI 10.1111/j.1526-4637.2010.00949.x; Modaress Nejad V, 2006, COMP EFFECTIVENESS F; Okada K, 2009, EVID-BASED COMPL ALT, V6, P11, DOI 10.1093/ecam/nem090; Ortiz MI, 2010, EUR J OBSTET GYN R B, V152, P73, DOI 10.1016/j.ejogrb.2010.04.015; Proctor M, 2001, HERBAL DIETARY THERA; READING AE, 1982, PAIN, V13, P185, DOI 10.1016/0304-3959(82)90028-8; Rigi SN, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-25; Shi GX, 2011, CLIN J PAIN, V27, P258, DOI 10.1097/AJP.0b013e3181fb27ae; Smith CA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep239; Steen M, 1998, BRIT J MIDWIFERY, V6, P572; Sun Li-hong, 2009, Zhen Ci Yan Jiu, V34, P398; Tian X, 2014, ALTERN THER HEALTH M, V20, P33; Tu CH, 2010, PAIN, V150, P462, DOI 10.1016/j.pain.2010.05.026; Tu CH, 2009, NEUROIMAGE, V47, P28, DOI 10.1016/j.neuroimage.2009.03.080; Unsal A, 2010, UPSALA J MED SCI, V115, P138, DOI 10.3109/03009730903457218; Wang MC, 2009, J ALTERN COMPLEM MED, V15, P235, DOI 10.1089/acm.2008.0164; Wei SY, 2016, PAIN, V157, P92, DOI 10.1097/j.pain.0000000000000340; Xue Zhe, 2014, Zhongguo Zhen Jiu, V34, P209; Yang J, 2014, EVIDENCE BASED COMPL, V2014; Yang J, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0552-1; Yu S, 2015, EVIDENCE BASED COMPL, V2015; Zahradnik HP, 2010, CONTRACEPTION, V81, P185, DOI 10.1016/j.contraception.2009.09.014; Zhu Ying, 2010, Zhongguo Zhen Jiu, V30, P453; Zorbas KA, 2015, ARCH GYNECOL OBSTET, V292, P37, DOI 10.1007/s00404-015-3641-1	58	42	46	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170952	10.1371/journal.pone.0170952	http://dx.doi.org/10.1371/journal.pone.0170952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170396	Green Submitted, gold, Green Published			2022-12-27	WOS:000393705500014
J	Konstantakou, EG; Velentzas, AD; Anagnostopoulos, AK; Litou, ZI; Konstandi, OA; Giannopoulou, AF; Anastasiadou, E; Voutsinas, GE; Tsangaris, GT; Stravopodis, DJ				Konstantakou, Eumorphia G.; Velentzas, Athanassios D.; Anagnostopoulos, Athanasios K.; Litou, Zoi I.; Konstandi, Ourania A.; Giannopoulou, Aikaterini F.; Anastasiadou, Ema; Voutsinas, Gerassimos E.; Tsangaris, George Th.; Stravopodis, Dimitrios J.			Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; L-TYROSINE; THERAPEUTIC TARGETS; TUMOR-SUPPRESSOR; 14-3-3 PROTEINS; RAF INHIBITOR; GENE-FUNCTION; RESISTANCE; GROWTH	Cutaneous melanoma is a malignant tumor of skin melanocytes that are pigment-producing cells located in the basal layer (stratum basale) of epidermis. Accumulation of genetic mutations within their oncogenes or tumor-suppressor genes compels melanocytes to aberrant proliferation and spread to distant organs of the body, thereby resulting in severe and/or lethal malignancy. Metastatic melanoma's heavy mutational load, molecular heterogeneity and resistance to therapy necessitate the development of novel biomarkers and drug-based protocols that target key proteins involved in perpetuation of the disease. To this direction, we have herein employed a nano liquid chromatography-tandem mass spectrometry (nLCMS/MS) proteomics technology to profile the deep-proteome landscape of WM-266-4 human metastatic melanoma cells. Our advanced melanoma-specific catalogue proved to contain 6,681 unique proteins, which likely constitute the hitherto largest single cell-linederived proteomic collection of the disease. Through engagement of UNIPROT, DAVID, KEGG, PANTHER, INTACT, CYTOSCAPE, dbEMT and GAD bioinformatics resources, WM-266-4 melanoma proteins were categorized according to their sub-cellular compartmentalization, function and tumorigenicity, and successfully reassembled in molecular networks and interactomes. The obtained data dictate the presence of plastically inter-converted sub-populations of non-cancer and cancer stem cells, and also indicate the oncoproteomic resemblance of melanoma to glioma and lung cancer. Intriguingly, WM-266-4 cells seem to be subjected to both epithelial-to-mesenchymal (EMT) and mesenchymal-to-epithelial (MET) programs, with 1433G and ADT3 proteins being identified in the EMT/MET molecular interface. Oncogenic addiction of WM-266-4 cells to autocrine/paracrine signaling of IL17-, DLL3-, FGF(2/13)-and OSTP-dependent sub-routines suggests their critical contribution to the metastatic melanoma chemotherapeutic refractoriness. Interestingly, the 1433G family member that is shared between the BRAF-and EMT/MET-specific interactomes likely emerges as a novel and promising druggable target for the malignancy. Derailed proliferation and metastatic capacity of WM-266-4 cells could also derive from their metabolic addiction to pathways associated with glutamate/ammonia, propanoate and sulfur homeostasis, whose successful targeting may prove beneficial for advanced melanomaaffected patients.	[Konstantakou, Eumorphia G.; Velentzas, Athanassios D.; Litou, Zoi I.; Konstandi, Ourania A.; Giannopoulou, Aikaterini F.; Stravopodis, Dimitrios J.] Natl & Kapodistrian Univ Athens, Sch Sci, Sect Cell Biol & Biophys, Dept Biol, Athens, Greece; [Anagnostopoulos, Athanasios K.; Tsangaris, George Th.] Acad Athens, Prote Core Facil, Syst Biol Ctr, Biomed Res Fdn, Athens, Greece; [Anastasiadou, Ema] Acad Athens, Basic Res Ctr, Biomed Res Fdn, Athens, Greece; [Voutsinas, Gerassimos E.] Natl Ctr Sci Res Demokritos, Lab Environm Mutagenesis & Carcinogenesis, Inst Biosci & Applicat, Athens, Greece; [Konstantakou, Eumorphia G.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA	National & Kapodistrian University of Athens; Academy of Athens; Academy of Athens; National Centre of Scientific Research "Demokritos"; Harvard University; Massachusetts General Hospital	Stravopodis, DJ (corresponding author), Acad Athens, Prote Core Facil, Syst Biol Ctr, Biomed Res Fdn, Athens, Greece.	gthtsangaris@bioacademy.gr; dstravop@biol.uoa.gr	Tsangaris, George/Q-6139-2019; Konstantakou, Eumorphia/AAZ-7294-2020; Velentzas, Athanassios D/C-1261-2011; Anagnostopoulos, Athanasios/AAF-5809-2021	Konstantakou, Eumorphia/0000-0002-5160-4045; Velentzas, Athanassios D/0000-0002-9755-395X; Anagnostopoulos, Athanasios/0000-0001-5161-7850; Stravopodis, Dimitrios/0000-0002-9535-2134	European Social Fund UoA ((European Union) [MIS 375784]; Bodossaki Foundation	European Social Fund UoA ((European Union); Bodossaki Foundation	Financial support of the present work was kindly and generously provided by the (a) "European Social Fund UoA - MIS 375784" (European Union and Greek National Funds 2012 - 2015 / "THALIS" Program) and (b) "Bodossaki Foundation Donation Program" 2013 - 2014, Athens, Greece, to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Al-Ghoul M, 2008, J PROTEOME RES, V7, P4107, DOI 10.1021/pr800174k; Amaral AU, 2016, J NEUROCHEM, V137, P62, DOI 10.1111/jnc.13544; Anagnostopoulos AK, 2016, J CHROMATOGR B ANALY; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; [Anonymous], [No title captured]; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Ashkenazi S, 2016, ONCOTARGET, V7, P30166, DOI 10.18632/oncotarget.7379; Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Balter V, 2015, P NATL ACAD SCI USA, V112, P982, DOI 10.1073/pnas.1415151112; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blackwell C, 2016, ONCOTARGET, V7, P39861, DOI 10.18632/oncotarget.9515; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeBerardinis RJ, 2016, CELL METAB, V23, P957, DOI 10.1016/j.cmet.2016.05.008; Donoghue PCJ, 2008, BIOESSAYS, V30, P530, DOI 10.1002/bies.20767; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Fu BB, 2007, MOL CANCER THER, V6, P220, DOI 10.1158/1535-7163.MCT-06-0526; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Ghosh Papia, 2009, Expert Rev Dermatol, V4, P131, DOI 10.1586/edm.09.2; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guo JY, 2013, AUTOPHAGY, V9, P1636, DOI 10.4161/auto.26123; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Halaban R, 2001, J BIOL CHEM, V276, P11933, DOI 10.1074/jbc.M008703200; Harder LM, 2014, AUTOPHAGY, V10, P339, DOI 10.4161/auto.26863; Hata S, 2008, INT J ONCOL, V33, P1065, DOI 10.3892/ijo_00000095; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hoyne GF, 2011, IMMUNOL CELL BIOL, V89, P696, DOI 10.1038/icb.2010.154; Hu ZY, 2015, BBA-MOL BASIS DIS, V1852, P1876, DOI 10.1016/j.bbadis.2015.06.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Q, 2016, AM J CANCER RES, V6, P440; Martinez AI, 2010, MOL GENET METAB, V101, P311, DOI 10.1016/j.ymgme.2010.08.002; Kale S, 2014, ONCOGENE, V33, P2295, DOI 10.1038/onc.2013.184; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kawai T, 2015, CLIN CANCER RES, V21, P3081, DOI 10.1158/1078-0432.CCR-14-1936; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kircher DA, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1128516; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kothari AN, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040039; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Lee S, 2014, NAT CHEM BIOL, V10, P1055, DOI 10.1038/nchembio.1669; Lefevre G, 2009, INVEST OPHTH VIS SCI, V50, P1047, DOI 10.1167/iovs.08-2378; Li W, 2009, ANAL BIOCHEM, V386, P282, DOI 10.1016/j.ab.2008.12.017; Phan L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8530; Lin X, 2016, CANCER SCI, V107, P1079, DOI 10.1111/cas.12978; Liu R, 2013, CANCER RES, V73, P5926, DOI 10.1158/0008-5472.CAN-12-4718; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Ma JL, 2016, J SURG ONCOL, V114, P520, DOI 10.1002/jso.24348; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Markou A, 2011, CLIN CHEM, V57, P421, DOI 10.1373/clinchem.2010.154328; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Merlino G, 2003, TRENDS MOL MED, V9, P102, DOI 10.1016/S1471-4914(03)00006-6; Messaritou G, 2010, J BIOL CHEM, V285, P1692, DOI 10.1074/jbc.M109.045989; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mori Mattia, 2013, Drug Discov Today Technol, V10, pe541, DOI 10.1016/j.ddtec.2012.10.001; Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567; Mukhopadhyay A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26580; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okada T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02899; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Parajuli P, 2016, ONCOTARGET, V7, P6121, DOI 10.18632/oncotarget.6847; Park D, 2016, BIOMATERIALS, V98, P131, DOI 10.1016/j.biomaterials.2016.05.007; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Peng C, 2015, ONCOTARGET, V6, P20177, DOI 10.18632/oncotarget.3896; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Rad EB, 2016, CANCER RES, V76, P1690, DOI 10.1158/0008-5472.CAN-15-1722; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Raychaudhuri K, 2016, J BIOL CHEM, V291, P16068, DOI 10.1074/jbc.M116.723767; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Saunders LR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9459; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1989, LIFE SCI, V45, P1799, DOI 10.1016/0024-3205(89)90520-1; SLOMINSKI A, 1983, BIOSCIENCE REP, V3, P189, DOI 10.1007/BF01121951; SLOMINSKI A, 1988, J CELL SCI, V89, P287; SLOMINSKI A, 1985, J CANCER RES CLIN, V109, P29, DOI 10.1007/BF01884251; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Spagnolo F, 2012, ARCH DERMATOL RES, V304, P177, DOI 10.1007/s00403-012-1223-7; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Tollenaere MAX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10075; VanderVen BC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004679; Verdoodt B, 2006, CELL CYCLE, V5, P2920, DOI 10.4161/cc.5.24.3571; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Waisbren SE, 2016, J INHERIT METAB DIS, V39, P573, DOI 10.1007/s10545-016-9942-0; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25722; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Wierer M, 2016, HUM MOL GENET, V25, pR106, DOI 10.1093/hmg/ddw208; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhang Q, 2016, ONCOGENE; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhao LQ, 2016, ONCOTARGET, V7, P31572, DOI 10.18632/oncotarget.7765; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	148	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171512	10.1371/journal.pone.0171512	http://dx.doi.org/10.1371/journal.pone.0171512			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158294	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700089
J	Kumar, U; Quick, WP; Barrios, M; Cruz, PCS; Dingkuhn, M				Kumar, Uttam; Quick, William Paul; Barrios, Marilou; Cruz, Pompe C. Sta; Dingkuhn, Michael			Atmospheric CO2 concentration effects on rice water use and biomass production	PLOS ONE			English	Article							CARBON-DIOXIDE; ELEVATED CO2; STOMATAL CONDUCTANCE; YIELD ENHANCEMENT; ENRICHMENT FACE; TROPICAL RICE; TEMPERATURE; GROWTH; WHEAT; NITROGEN	Numerous studies have addressed effects of rising atmospheric CO2 concentration on rice biomass production and yield but effects on crop water use are less well understood. Irrigated rice evapotranspiration (ET) is composed of floodwater evaporation and canopy transpiration. Crop coefficient Kc (ET over potential ET, or ETo) is crop specific according to FAO, but may decrease as CO2 concentration rises. A sunlit growth chamber experiment was conducted in the Philippines, exposing 1.44-m(2) canopies of IR72 rice to four constant CO2 levels (195, 390, 780 and 1560 ppmv). Crop geometry and management emulated field conditions. In two wet (WS) and two dry (DS) seasons, final aboveground dry weight (agdw) was measured. At 390 ppmv [CO2] (current ambient level), agdw averaged 1744 g m(-2), similar to field although solar radiation was only 61% of ambient. Reduction to 195 ppmv [CO2] reduced agdw to 56 +/- 5% (SE), increase to 780 ppmv increased agdw to 128 +/- 8%, and 1560 ppmv increased agdw to 142 +/- 5%. In 2013WS, crop ET was measured by weighing the water extracted daily from the chambers by the air conditioners controlling air humidity. Chamber ETo was calculated according to FAO and empirically corrected via observed pan evaporation in chamber vs. field. For 390 ppmv [CO2], Kc was about 1 during crop establishment but increased to about 3 at flowering. 195 ppmv CO2 reduced Kc, 780 ppmv increased it, but at 1560 ppmv it declined. Whole-season crop water use was 564 mm (195 ppmv), 719 mm (390 ppmv), 928 mm (780 ppmv) and 803 mm (1560 ppmv). With increasing [CO2], crop water use efficiency (WUE) gradually increased from 1.59 g kg(-1) (195 ppmv) to 2.88 g kg(-1) (1560 ppmv). Transpiration efficiency (TE) measured on flag leaves responded more strongly to [CO2] than WUE. Responses of some morphological traits are also reported. In conclusion, increased CO2 promotes biomass more than water use of irrigated rice, causing increased WUE, but it does not help saving water. Comparability with field conditions is discussed. The results will be used to train crop models.	[Kumar, Uttam; Quick, William Paul; Barrios, Marilou; Dingkuhn, Michael] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines; [Kumar, Uttam; Cruz, Pompe C. Sta] Univ Philippines Los Banos, Crop Sci Cluster, College Los Banos, Laguna, Philippines; [Dingkuhn, Michael] Ctr Cooperat Int Rech Agron Dev Cirad, Montpellier, France	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; CIRAD	Dingkuhn, M (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines.; Dingkuhn, M (corresponding author), Ctr Cooperat Int Rech Agron Dev Cirad, Montpellier, France.	michael.dingkuhn@cirad.fr	Kumar, Uttam/GVT-4765-2022	Kumar, Uttam/0000-0003-3875-541X	Climate Change, Agriculture and Food Security program of the CGIAR (CCAFS); Bill and Melinda Gates Foundation through the C4-Rice project	Climate Change, Agriculture and Food Security program of the CGIAR (CCAFS)(CGIAR); Bill and Melinda Gates Foundation through the C4-Rice project(CGIAR)	This research was supported by the Climate Change, Agriculture and Food Security program of the CGIAR (CCAFS) and the Bill and Melinda Gates Foundation through the C4-Rice project.	Alberto MCR, 2011, AGR WATER MANAGE, V98, P1417, DOI 10.1016/j.agwat.2011.04.011; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baker J. T., 1993, J AGR METEOROL, V48, P575, DOI DOI 10.2480/AGRMET.48.575; BAKER JT, 1993, VEGETATIO, V104, P239, DOI 10.1007/BF00048156; BAKER JT, 1990, AGRON J, V82, P834, DOI 10.2134/agronj1990.00021962008200040034x; Bunce JA, 2000, GLOBAL CHANGE BIOL, V6, P371, DOI 10.1046/j.1365-2486.2000.00314.x; Choudhury BU, 2013, AGR WATER MANAGE, V123, P20, DOI 10.1016/j.agwat.2013.03.006; Dingkuhn M, 2015, FIELD CROP RES, V182, P43, DOI 10.1016/j.fcr.2015.05.025; Doorenbos J., 1977, FAO Irrigation and Drainage Paper; GIFFORD RM, 1979, AUST J PLANT PHYSIOL, V6, P367, DOI 10.1071/PP9790367; Grant RF, 2001, AGRON J, V93, P638, DOI 10.2134/agronj2001.933638x; GRiSP (Global Rice Science Partnership). (, 2013, RICE ALMANAC, V4th edition; Hasegawa T, 2013, FUNCT PLANT BIOL, V40, P148, DOI 10.1071/FP12357; Homma K, 1999, JPN J CROP SCI, V68, P137, DOI 10.1626/jcs.68.137; JONES P, 1985, AGRON J, V77, P242, DOI 10.2134/agronj1985.00021962007700020016x; Julia C, 2013, EUR J AGRON, V49, P50, DOI 10.1016/j.eja.2013.03.006; Mamta Kumari, 2013, International Journal of Geomatics and Geosciences, V4, P61; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; Oue H, 2005, PHYTON-ANN REI BOT A, V45, P117; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Sharma P. K., 1986, Advances in Soil Science, V5, P139; Shih SF, 1982, AM SOC AGR ENG, V25, P701; Shimono H, 2009, ANN BOT-LONDON, V103, P87, DOI 10.1093/aob/mcn209; Shimono H, 2013, GLOBAL CHANGE BIOL, V19, P2444, DOI 10.1111/gcb.12214; Shimono H, 2009, J EXP BOT, V60, P523, DOI 10.1093/jxb/ern288; SIONIT N, 1981, J AGR SCI, V97, P335, DOI 10.1017/S0021859600040764; SIONIT N, 1981, AGRON J, V73, P1023, DOI 10.2134/agronj1981.00021962007300060027x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Wang JY, 2015, CLIMATIC CHANGE, V130, P529, DOI 10.1007/s10584-015-1374-6; Weerakoon WMW, 2000, PLANT SOIL, V220, P99, DOI 10.1023/A:1004786414113; WIGLEY TML, 1983, CLIMATIC CHANGE, V5, P315, DOI 10.1007/BF00140798; Wilson KB, 1999, GLOB CHANGE BIOL, V5, P903, DOI 10.1046/j.1365-2486.1999.00280.x; Yang LX, 2006, FIELD CROP RES, V98, P141, DOI 10.1016/j.fcr.2005.12.014; YOSHIDA S, 1979, SOIL SCI PLANT NUTR, V25, P81, DOI 10.1080/00380768.1979.10433148; Yoshimoto M, 2005, AGR FOREST METEOROL, V133, P226, DOI 10.1016/j.agrformet.2005.09.010; Zhu CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12719; Ziska LH, 1997, AGRON J, V89, P45, DOI 10.2134/agronj1997.00021962008900010007x	37	8	8	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169706	10.1371/journal.pone.0169706	http://dx.doi.org/10.1371/journal.pone.0169706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158204	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700006
J	Winckers, K; Thomassen, S; ten Cate, H; Hackeng, TM				Winckers, Kristien; Thomassen, Stella; ten Cate, Hugo; Hackeng, Tilman M.			Platelet full length TFPI-alpha in healthy volunteers is not affected by sex or hormonal use	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY; RECURRENT VENOUS THROMBOEMBOLISM; PROTEIN-S; COAGULATION INHIBITOR; ORAL-CONTRACEPTIVES; THROMBIN GENERATION; FACTOR-XA; PLASMA; RISK	Background Only 10% of plasma TFPI alpha (TFPI) exists in the full length form, the rest circulates as a C-terminally truncated form. However, blood platelets exclusively contain full length TFPI, which is released at the site of injury upon platelet activation, and which could play an important local regulatory role in thrombin generation and prevention of thrombosis. Methods The anticoagulant activities of full length and truncated TFPI were investigated using thrombin generation assays. Blood samples were obtained from 30 healthy volunteers (10 male subjects, 10 female subjects, and 10 females using oral contraceptives). Platelet TFPI was released in platelet rich plasma and in platelet isolates using convulxin or thrombin, and measured by free TFPI ELISA and thrombin generation assays. Results Full length TFPI and platelet TFPI were much more potent inhibitors of thrombin generation than truncated TFPI, which was virtually inactive. Although mean plasma TFPI antigen levels decreased from men (0.30 nM) to women (0.20 nM) to women using oral contraceptives (0.11 nM), no relevant differences were found in platelet TFPI among those subgroups. Conclusions Platelets release similar amounts of TFPI regardless of plasma TFPI concentrations and is unaffected by sex or oral contraceptive use. We speculate that platelet TFPI is important to prevent systemic coagulation and thrombosis and restrict thrombus formation to the site of the growing platelet plug. The stable contribution of platelet TFPI to the anticoagulant potential in plasma is likely to become particularly relevant under conditions of low plasma TFPI levels in combination of oral contraceptives use.	[Winckers, Kristien; Thomassen, Stella; ten Cate, Hugo; Hackeng, Tilman M.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands; [Winckers, Kristien; ten Cate, Hugo] Maastricht Univ, Med Ctr, CARIM, Dept Internal Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Hackeng, TM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands.	t.hackeng@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021	Hackeng, Tilman/0000-0003-0142-0843; Thomassen, Stella/0000-0002-9686-6364; ten Cate, Hugo/0000-0001-7796-4463	Netherlands Heart Foundation, the Netherlands [2007.B138]	Netherlands Heart Foundation, the Netherlands(Netherlands Heart FoundationNetherlands Government)	This study was supported by grants from the Netherlands Heart Foundation, the Netherlands, (grant 2007.B138 to KW).	Ariens RAS, 1999, THROMB HAEMOSTASIS, V81, P203; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1047; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; BROZE GJ, 1994, BLOOD COAGUL FIBRIN, V5, P551; BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90; Castoldi E, 2010, HAEMATOLOGICA; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; Dahm A, 2003, BLOOD, V101, P4387, DOI 10.1182/blood-2002-10-3188; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Harris GM, 1999, AM J HEMATOL, V60, P175, DOI 10.1002/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.3.CO;2-O; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Helmerhorst FM, 1997, THROMB HAEMOSTASIS, V78, P327; Hoke M, 2005, THROMB HAEMOSTASIS, V94, P787, DOI 10.1160/TH05-06-0412; Huang ZF, 1997, BLOOD, V90, P944, DOI 10.1182/blood.V90.3.944.944_944_951; LINDAHL AK, 1991, BLOOD COAGUL FIBRIN, V2, P713, DOI 10.1097/00001721-199112000-00004; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Maroney SA, 2008, TRANSFUS APHER SCI, V38, P9, DOI 10.1016/j.transci.2007.12.001; Maroney SA, 2012, P NATL ACAD SCI USA, V109, P3927, DOI 10.1073/pnas.1119858109; Maurissen LFA, 2010, J THROMB HAEMOST, V8, P750, DOI 10.1111/j.1538-7836.2010.03743.x; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; NOVOTNY WF, 1991, BLOOD, V78, P394; NOVOTNY WF, 1988, BLOOD, V72, P2020; NOVOTNY WF, 1991, BLOOD, V78, P387; Peraramelli S, 2012, THROMB HAEMOSTASIS, V108, P266, DOI 10.1160/TH11-12-0902; Raps M, 2013, THROMB HAEMOSTASIS, V109, P606, DOI 10.1160/TH12-10-0771; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Thomassen MCLGD, 2003, HAEMATOLOGICA, V88, P1150; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; Winckers K, 2012, J THROMB HAEMOST, V10, P2208, DOI 10.1111/j.1538-7836.2012.04884.x; Wood JP, 2014, ARTERIOSCL THROM VAS, V34, P169, DOI 10.1161/ATVBAHA.113.302655; Zakai NA, 2010, THROMB HAEMOSTASIS, V104, P207, DOI 10.1160/TH09-10-0693	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0168273	10.1371/journal.pone.0168273	http://dx.doi.org/10.1371/journal.pone.0168273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158181	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700003
J	Anstice, NS; Jacobs, RJ; Simkin, SK; Thomson, M; Thompson, B; Collins, AV				Anstice, Nicola S.; Jacobs, Robert J.; Simkin, Samantha K.; Thomson, Melissa; Thompson, Benjamin; Collins, Andrew V.			Do picture- based charts overestimate visual acuity? Comparison of Kay Pictures, Lea Symbols, HOTV and Keeler logMAR charts with Sloan letters in adults and children	PLOS ONE			English	Article							AMBLYOPIA TREATMENT; DIABETIC-RETINOPATHY; COMPUTERIZED METHOD; PRESCHOOL-CHILDREN; TESTS; ADAPTATION; OPTOTYPES; DESIGN; BLUR	Purpose Children may be tested with a variety of visual acuity (VA) charts during their ophthalmic care and differences between charts can complicate the interpretation of VA measurements. This study compared VA measurements across four pediatric charts with Sloan letters and identified chart design features that contributed to inter-chart differences in VA. Methods VA was determined for right eyes of 25 adults and 17 children (4-9 years of age) using Crowded Kay Pictures, Crowded linear Lea Symbols, Crowded Keeler logMAR, Crowded HOTV and Early Treatment of Diabetic Retinopathy Study (ETDRS) charts in focused and defocused (+1.00 DS optical blur) conditions. In a separate group of 25 adults, we compared the VA from individual Kay Picture optotypes with uncrowded Landolt C VA measurements. Results Crowded Kay Pictures generated significantly better VA measurements than all other charts in both adults and children (p < 0.001; 0.15 to 0.30 logMAR). No significant differences were found between other charts in adult participants; children achieved significantly poorer VA measurements on the ETDRS chart compared with pediatric acuity tests. All Kay Pictures optotypes produced better VA (p < 0.001), varying from -0.38 +/- 0.13 logMAR (apple) to -0.57 +/- 0.10 logMAR ( duck), than the reference Landolt C task (mean VA -0.19 +/- 0.08 logMAR). Conclusion Kay Pictures over-estimated VA in all participants. Variability between Kay Pictures optotypes suggests that shape cues aid in optotype determination. Other pediatric charts offer	[Anstice, Nicola S.; Jacobs, Robert J.; Simkin, Samantha K.; Thomson, Melissa; Thompson, Benjamin; Collins, Andrew V.] Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand; [Thompson, Benjamin] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Simkin, Samantha K.] Univ Auckland, Dept Ophthalmol, Auckland, New Zealand; [Thomson, Melissa] OPSM Thames, Thames, Waikato, New Zealand	University of Auckland; University of Waterloo; University of Auckland	Anstice, NS (corresponding author), Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand.	n.anstice@auckland.ac.nz	Anstice, Nicola/AAM-8072-2021; Collins, Andrew V/AIA-7677-2022	Collins, Andrew V/0000-0001-7554-6006; Thompson, Benjamin/0000-0002-3902-2712; Anstice, Nicola/0000-0003-1999-5274	University of Auckland Faculty Research Development Fund [3704420]; New Zealand Association of Optometrists, Paul Dunlop Memorial Scholarship	University of Auckland Faculty Research Development Fund; New Zealand Association of Optometrists, Paul Dunlop Memorial Scholarship	This study was supported by the University of Auckland Faculty Research Development Fund, grant number 3704420, https://www.staff.auckland.ac.nz/en/research/funding-and-ethics/applying-for-research-funding/applying-for-internal-fuuding/faculty-research-development-fund-frdf/html, and the New Zealand Association of Optometrists, Paul Dunlop Memorial Scholarship, http://www.nzao.co.nz/sites/default/files/students/Paul_Dunlop_regs_plus_NERF_Application_Form_Research_2014.pdf.	Alexander KR, 1997, VISION RES, V37, P813, DOI 10.1016/S0042-6989(96)00190-3; [Anonymous], 1980, Adv Ophthalmol, V41, P103; Anstice NS, 2014, CLIN EXP OPTOM, V97, P3, DOI 10.1111/cxo.12086; ARDITI A, 1993, INVEST OPHTH VIS SCI, V34, P120; Avery RA, 2012, J NEURO-ONCOL, V110, P1, DOI 10.1007/s11060-012-0944-y; Beck RW, 2003, AM J OPHTHALMOL, V135, P194, DOI 10.1016/S0002-9394(02)01825-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Candy TR, 2011, INVEST OPHTH VIS SCI, V52, P4307, DOI 10.1167/iovs.10-6391; Carkeet A, 2001, OPTOMETRY VISION SCI, V78, P529, DOI 10.1097/00006324-200107000-00017; Chakraborty A, 2015, SCI REPORTS, P5; Chen SI, 2006, INVEST OPHTH VIS SCI, V47, P614, DOI 10.1167/iovs.05-0610; Ciner EB, 1999, SURV OPHTHALMOL, V43, P445, DOI 10.1016/S0039-6257(99)00021-1; Cross M, 2015, BRIT IRISH ORTHOPTIC, V7, P66; Cyert L, 2004, OPTOMETRY VISION SCI, V81, P678, DOI 10.1097/01.opx.0000144746.80718.67; Dobson V, 2003, OPTOMETRY VISION SCI, V80, P698, DOI 10.1097/00006324-200310000-00011; Dobson V, 2009, J AAPOS, V13, P253, DOI 10.1016/j.jaapos.2009.01.007; Dobson V, 2009, OPHTHALMOLOGY, V116, P1397, DOI 10.1016/j.ophtha.2009.01.019; Drover JR, 2008, J AAPOS, V12, P145, DOI 10.1016/j.jaapos.2007.08.014; Formankiewicz MA, 2013, INVEST OPHTH VIS SCI, V54, P6934, DOI 10.1167/iovs.13-12543; Hered RW, 1997, J PEDIAT OPHTH STRAB, V34, P24; Holmes JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1345; Hopkins S, 2013, CLIN EXP OPTOM, V96, P443, DOI 10.1111/cxo.12029; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P507; Jones D, 2003, OPHTHAL PHYSL OPT, V23, P541, DOI 10.1046/j.1475-1313.2003.00150.x; Lai YH, 2013, OPHTHALMOLOGY, V120, P271, DOI 10.1016/j.ophtha.2012.08.009; Lalor SJH, 2016, VISION RES, V121, P31, DOI 10.1016/j.visres.2016.01.007; Langeslag-Smith MA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009207; Leone JF, 2012, EYE, V26, P925, DOI 10.1038/eye.2012.60; Leone JF, 2014, ACTA OPHTHALMOL, V92, pe521, DOI 10.1111/aos.12366; Little JA, 2012, OPHTHAL PHYSL OPT, V32, P492, DOI 10.1111/j.1475-1313.2012.00939.x; Mathur A, 2015, OPTOMETRY VISION SCI, V92, P267, DOI 10.1097/OPX.0000000000000459; MCGRAW PV, 1993, OPHTHAL PHYSL OPT, V13, P400, DOI 10.1111/j.1475-1313.1993.tb00499.x; McKinlay CJD, 2015, NEW ENGL J MED, V373, P1507, DOI 10.1056/NEJMoa1504909; Mercer ME, 2013, OPTOMETRY VISION SCI, V90, P236, DOI 10.1097/OPX.0b013e3182825eb7; Moganeswari D, 2015, J CLIN DIAGN RES, V9, pNC01, DOI 10.7860/JCDR/2015/14407.6747; Moke PS, 2001, AM J OPHTHALMOL, V132, P903, DOI 10.1016/S0002-9394(01)01256-9; Noordzij M, 2010, NEPHROL DIAL TRANSPL; Norgett Y, 2014, J VISION, V14, DOI 10.1167/14.12.23; Norgett Y, 2011, OPTOMETRY VISION SCI, V88, P920, DOI 10.1097/OPX.0b013e31821bd2d3; Rice ML, 2004, AM J OPHTHALMOL, V137, P278, DOI 10.1016/j.ajo.2003.08.016; Rosenfield M, 2009, OPTOMETRY SCI TECHNI; Saul T, 2015, BRIT IRISH ORTHOPTIC, V9, P36; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Shah N, 2011, EYE LOND, DOI [10.1167/iovs.10-6391PMID: 21436270, DOI 10.1167/IOVS.10-6391]; Song S, 2014, J VISION, V14, DOI 10.1167/14.5.3; STRONG G, 1985, ARCH OPHTHALMOL-CHIC, V103, P44; Tsirlin I, 2015, INVEST OPHTH VIS SCI, V56, P4061, DOI 10.1167/iovs.15-16583; VandenBosch ME, 1997, EYE, V11, P411, DOI 10.1038/eye.1997.87; Yu TY, 2013, INVEST OPHTH VIS SCI, V54, P8408, DOI 10.1167/iovs.13-13051	49	11	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170839	10.1371/journal.pone.0170839	http://dx.doi.org/10.1371/journal.pone.0170839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152076	gold, Green Published			2022-12-27	WOS:000396161200047
J	Levy, I; Olmer, L; Livnat, Y; Yanko, A; Shinar, E				Levy, Itzchak; Olmer, Liraz; Livnat, Yuval; Yanko, Adir; Shinar, Eilat			Attitudes, perceptions and knowledge among men who have sex with men towards the blood donation deferral policy in Israel	PLOS ONE			English	Article							HAD SEX; RISK BEHAVIORS; BENEFITS	Background Men who have sex with men (MSM) are permanently deferred from donating blood in Israel. Pressure to change this policy exists, despite data showing higher prevalence and incidence of HIV in MSM. A survey was conducted to evaluate current knowledge, attitudes, perceptions and compliance if deferral was changed. Study design and methods Anonymous survey was published in a gay-oriented website, collecting demographic information, history of blood donation, attitudes, knowledge and compliance with permanent versus temporary deferral. Responses were analyzed given 1 point for every "yes" response (0-7 points). Student's t-test was applied to compare differences between continuous variables. Correlations were described with the Pearson correlation coefficient. Results Responses from 492 MSM were analyzed. Average age was 31 +/- 9 years. 76% donated blood at least once, mostly for social solidarity (score of 3.2 on 1-5 scale). Tests seeking or protest scores were 1.7 and 1.6, respectively. 66% were unaware of the higher risk of HIV transmission by MSM, or the potential to infect 3 recipients. Knowledge regarding HIV transmission by blood positively correlated with knowledge regarding other routes of HIV transmission (r = 0.11; p = 0.03), age (r = 0.10; p = 0.04), and higher rate of non-compliance with the current deferral policy (OR = 1.9; p = 0.02). Activism for LGBT rights was associated with lower risk for non-adherence (OR = 0.5; p = 0.03). If temporary deferral is introduced 66% will comply with the new policy, but 23% will continue to donate as long as MSM deferral policy is in place. Conclusion A high proportion of MSM do not comply with the current lifetime deferral. This may partially change if temporary deferral is introduced.	[Levy, Itzchak] Sheba Med Ctr, Infect Dis Unit, HIV Unit, Ramat Gan, Israel; [Olmer, Liraz] Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Livnat, Yuval; Yanko, Adir] Israeli AIDS Task Force, Tel Aviv, Israel; [Shinar, Eilat] Magen David Adom Natl Blood Serv, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center	Levy, I (corresponding author), Sheba Med Ctr, Infect Dis Unit, HIV Unit, Ramat Gan, Israel.	itsik.levi@sheba.health.gov.il		Levy, Itzchak/0000-0003-4716-1293	ministry of health	ministry of health	This work was funded in part by the ministry of health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2009, TRANSFUSION, V49, P1102, DOI 10.1111/j.1537-2995.2009.02124.x; [Anonymous], PER REP HIV AIDS CAS; [Anonymous], 2008, GENDER DISTRIBUTION; Bani M, 2010, BLOOD TRANSFUS-ITALY, V8, P278, DOI [10.2450/2010.0156-09, 10.2450/2010.0156.09]; Benjamin RJ, 2011, VOX SANG, V101, P339, DOI 10.1111/j.1423-0410.2011.01489.x; Custer B, 2015, TRANSFUSION, V55, P2826, DOI 10.1111/trf.13247; Davison KL, 2013, VOX SANG, V105, P85, DOI 10.1111/vox.12024; Dodd RY, 2016, TRANSFUSION, V56, P2781, DOI 10.1111/trf.13759; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Grenfell P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5604; Lee SS, 2014, BLOOD TRANSFUS-ITALY, V12, P166, DOI 10.2450/2013.0103-13; Lucky TTA, 2014, TRANSFUSION, V54, P1739, DOI 10.1111/trf.12554; O'Brien SF, 2007, TRANSFUS MED REV, V21, P205, DOI 10.1016/j.tmrv.2007.03.002; Pillonel J, 2012, VOX SANG, V102, P13, DOI 10.1111/j.1423-0410.2011.01509.x; Seed CR, 2014, VOX SANG, V106, P14, DOI 10.1111/vox.12093; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; UK Department of Health, 2011, DON SEL CRIT REV; Vamvakas EC, 2009, TRANSFUSION, V49, P1037, DOI 10.1111/j.1537-2995.2009.02175.x; Weinberg I, 2009, VOX SANG, V96, P128, DOI 10.1111/j.1423-0410.2008.01137.x; Wong HTH, 2015, TRANSFUSION, V55, P2175, DOI 10.1111/trf.13106; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	21	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170364	10.1371/journal.pone.0170364	http://dx.doi.org/10.1371/journal.pone.0170364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152072	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200022
J	Barnett, LM; Hughes, TE; Drobizhev, M				Barnett, Lauren M.; Hughes, Thomas E.; Drobizhev, Mikhail			Deciphering the molecular mechanism responsible for GCaMP6m's Ca2+-dependent change in fluorescence	PLOS ONE			English	Article							2-PHOTON ABSORPTION PROPERTIES; IMAGING NEURAL ACTIVITY; CALCIUM INDICATOR; STRUCTURAL BASIS; PROTEIN; STATE; PROBE; PH; CHROMOPHORE; ACTIVATION	The goal of this work is to determine how GCaMP6m's fluorescence is altered in response to Ca2+-binding. Our detailed spectroscopic study reveals the simplest explanation for how GCaMP6m changes fluorescence in response to Ca2+ is with a four-state model, in which a Ca2+-dependent change of the chromophore protonation state, due to a shift in pK(a), is the predominant factor. The pKa shift is quantitatively explained by a change in electrostatic potential around the chromophore due to the conformational changes that occur in the protein when calmodulin binds Ca2+ and interacts with the M13 peptide. The absolute pKa values for the Ca2+-free and Ca2+-saturated states of GCaMP6m are critical to its high signal-to-noise ratio. This mechanism has important implications for further improvements to GCaMP6m and potentially for other similarly designed biosensors.	[Barnett, Lauren M.; Hughes, Thomas E.; Drobizhev, Mikhail] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Drobizhev, M (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	mikhail.drobijev@montana.edu		Drobizhev, Mikhail/0000-0001-9072-1300; Hughes, Thomas/0000-0002-8430-070X	NINDS NIH HHS [U01 NS094246] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS094246] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ast C, 2015, ELIFE, V4, DOI 10.7554/eLife.07113; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Bhargava Y, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00026; Boyd AM, 2015, CELL REP, V10, P1032, DOI 10.1016/j.celrep.2015.01.047; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YX, 2013, PROTEIN CELL, V4, P299, DOI 10.1007/s13238-013-2103-4; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; De Michele R, 2013, ELIFE, V2, DOI 10.7554/eLife.00800; Ding JJ, 2014, SCI CHINA LIFE SCI, V57, P269, DOI 10.1007/s11427-013-4599-5; Drobizhev M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13223; Drobizhev M, 2012, J PHYS CHEM B, V116, P1736, DOI 10.1021/jp211020k; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Grover D, 2016, NAT METHODS, V13, P569, DOI [10.1038/NMETH.3866, 10.1038/nmeth.3866]; Han Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113873; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Heckscher ES, 2015, NEURON, V88, P314, DOI 10.1016/j.neuron.2015.09.009; Hinckley CA, 2015, NEURON, V87, P1008, DOI 10.1016/j.neuron.2015.08.005; Inoue M, 2015, NATURE; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jung G, 2005, BIOPHYS J, V88, P1932, DOI 10.1529/biophysj.104.044412; Kang BE, 2016, SCI REP-UK, V6, DOI 10.1038/srep23865; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lossau H, 1996, CHEM PHYS, V213, P1, DOI 10.1016/S0301-0104(96)00340-0; Makarov NS, 2008, INTEGRATED OPTOELECT; Martin ME, 2004, J AM CHEM SOC, V126, P5452, DOI 10.1021/ja037278m; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Marvin JS, 2011, PROTEINS, V79, P3025, DOI 10.1002/prot.23118; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100252; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sarkisyan KS, 2015, BIOPHYS J, V109, P380, DOI 10.1016/j.bpj.2015.06.018; Scott JN, 2013, J PHYS CHEM B, V117, P9598, DOI 10.1021/jp4041716; Shen Y, 2014, J CELL BIOL, V207, P419, DOI 10.1083/jcb.201404107; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stoltzfus CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11968; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Theis L, 2016, NEURON, V90, P471, DOI 10.1016/j.neuron.2016.04.014; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Treger JS, 2015, ELIFE, V4, DOI [10.7554/eLife.10482.001, 10.7554/eLife.10482]; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Warp E, 2012, CURR BIOL, V22, P93, DOI 10.1016/j.cub.2011.12.002; WARSHEL A, 1981, BIOCHEMISTRY-US, V20, P3167, DOI 10.1021/bi00514a028; Wu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6262; Xie DQ, 2005, J COMPUT CHEM, V26, P1487, DOI 10.1002/jcc.20273; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang MY, 2013, ORG BIOMOL CHEM, V11, P1414, DOI 10.1039/c2ob26914g; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	69	54	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170934	10.1371/journal.pone.0170934	http://dx.doi.org/10.1371/journal.pone.0170934			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182677	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800024
J	Burgdorf, KS; Simonsen, J; Sundby, A; Rostgaard, K; Pedersen, OB; Sorensen, E; Nielsen, KR; Bruun, MT; Frisch, M; Edgren, G; Erikstrup, C; Hjalgrim, H; Ullum, H				Burgdorf, Kristoffer Solvsten; Simonsen, Jacob; Sundby, Anna; Rostgaard, Klaus; Pedersen, Ole Birger; Sorensen, Erik; Nielsen, Kaspar Rene; Bruun, Mie Topholm; Frisch, Morten; Edgren, Gustaf; Erikstrup, Christian; Hjalgrim, Henrik; Ullum, Henrik			Socio-demographic characteristics of Danish blood donors	PLOS ONE			English	Article							DONATION FREQUENCY; DEMOGRAPHIC CHARACTERISTICS; WHOLE-BLOOD; POPULATION; PATTERNS	Background Blood transfusion is an essential component of a modern healthcare system. Because knowledge about blood donor demography may inform the design of strategies for donor recruitment and retention, we used nationwide registers to characterize the entire population of blood donors in Denmark in 2010. Methods The study population comprised all Danes in the age range eligible for blood donation (N = 3,236,753) at the end of 2010. From the Scandinavian Donations and Transfusions (SCANDAT) register, we identified 174,523 persons who donated blood in Danish blood banks at least once in 2010. The association between sociodemographic characteristics and blood donor prevalence was examined using regression models. Results The overall prevalence of blood donation was 5.4% among both women and men. The age-specific prevalence of blood donation peaked at 25 years of age (6.8%) for women and 30 years of age (5.7%) for men. Children of any age were associated with lower prevalence of blood donation among women, while the opposite was seen for men. Middle to high income groups, but not the highest income group, had fourfold higher donor prevalence than the lowest income group (6.7% compared to 1.7%). The prevalence of blood donation was considerably lower among men living with their parents (2.9%) or alone (3.9%) than among men cohabitating with a woman (6.2%). Summary Social marginalization, as indicated by low income and being a male living without a woman, was associated with lower prevalence of blood donation. However, individuals with very high incomes and women with children were underrepresented in the Danish blood donor population.	[Burgdorf, Kristoffer Solvsten; Sorensen, Erik; Ullum, Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Simonsen, Jacob; Rostgaard, Klaus; Frisch, Morten; Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Sundby, Anna] Univ Aarhus, Dept Clin Med, Aarhus, Denmark; [Sundby, Anna] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Pedersen, Ole Birger] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Nielsen, Kaspar Rene] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark; [Bruun, Mie Topholm] Odense Univ Hosp, Dept Clin Immunol, Odense, Denmark; [Frisch, Morten] Aalborg Univ, Ctr Sexol Res, Denmark & Dept Clin Med, Aalborg, Denmark; [Edgren, Gustaf] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Edgren, Gustaf] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Hjalgrim, Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Naestved Hospital; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Aalborg University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Aarhus University; Rigshospitalet; University of Copenhagen	Burgdorf, KS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark.	kristoffer.soelvsten.burgdorf@regionh.dk	Frisch, Morten/E-9206-2016; Hjalgrim, Henrik/AAG-4973-2021; Edgren, Gustaf/F-4013-2014; Pedersen, Ole Birger/W-8679-2019	Frisch, Morten/0000-0002-3864-8860; Edgren, Gustaf/0000-0002-2198-4745; Pedersen, Ole Birger/0000-0003-2312-5976; Rostgaard, Klaus/0000-0001-6220-9414; Sundby, Anna/0000-0003-0421-9854; Erikstrup, Christian/0000-0001-6551-6647; Ullum, Henrik/0000-0001-7306-9058; Simonsen, Jacob/0000-0002-8700-4826; Burgdorf, Kristoffer/0000-0001-5814-6844	Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Atherley AE, 2016, TRANSFUS MED; Atsma F, 2011, TRANSFUSION, V51, P412, DOI 10.1111/j.1537-2995.2010.02867.x; Boulware LE, 2002, TRANSFUSION, V42, P669, DOI 10.1046/j.1537-2995.2002.00120.x; Burgdorf KS, 2015, ISBT SCI SER, V10, P225, DOI 10.1111/voxs.12119; Burgdorf KS, 2016, COMPUT METH PROG BIO, V135, P101, DOI 10.1016/j.cmpb.2016.07.023; Carneiro-Proietti AB, 2010, TRANSFUSION, V50, P918, DOI 10.1111/j.1537-2995.2009.02529.x; Cimaroli K, 2012, HEALTH PLACE, V18, P424, DOI 10.1016/j.healthplace.2011.12.005; CLEVELAND WS, 1988, J ECONOMETRICS, V37, P87, DOI 10.1016/0304-4076(88)90077-2; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; Edgren G, 2015, TRANSFUSION; Johannsdottir V, 2016, TRANSFUSION, V56, P1654, DOI 10.1111/trf.13522; Lattimore S, 2015, TRANSFUSION, V55, P91, DOI 10.1111/trf.12835; Muller-Steinhardt M, 2012, VOX SANG, V102, P134, DOI 10.1111/j.1423-0410.2011.01531.x; Murphy EL, 2009, TRANSFUSION, V49, P2221, DOI 10.1111/j.1537-2995.2009.02271.x; Notari EP, 2009, TRANSFUSION, V49, P2229, DOI 10.1111/j.1537-2995.2009.02288.x; Ou Y, 2015, TRANSFUSION MED, V25, P366, DOI 10.1111/tme.12267; Ritter S, 2008, BUNDESGESUNDHEITSBLA, V51, P915, DOI 10.1007/s00103-008-0613-7; Ritter S, 2012, BUNDESGESUNDHEITSBLA, V55, P914, DOI 10.1007/s00103-012-1515-2; Sachdev Suchet, 2016, Asian J Transfus Sci, V10, P59, DOI 10.4103/0973-6247.164274; Schreiber GB, 2006, TRANSFUSION, V46, P545, DOI 10.1111/j.1537-2995.2006.00757.x; Shaz BH, 2010, TRANSFUSION, V50, P881, DOI 10.1111/j.1537-2995.2009.02501.x; Shaz BH, 2011, J NATL MED ASSOC, V103, P351, DOI 10.1016/S0027-9684(15)30316-3; Srzentic SJ, 2015, VOJNOSANIT PREGL, V72, P489, DOI 10.2298/VSP1506489J; Veldhuizen IJT, 2009, VOX SANG, V97, P129, DOI 10.1111/j.1423-0410.2009.01201.x; Yang BC, 2015, TRANSFUSION, V55, P1108, DOI 10.1111/trf.12964; Zou SM, 2008, TRANSFUSION, V48, P251, DOI [10.1111/j.1537-2995.2008.01903.x, 10.1111/j.1537-2995.2007.01517.x]	26	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0169112	10.1371/journal.pone.0169112	http://dx.doi.org/10.1371/journal.pone.0169112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182624	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800005
J	Deng, L; Li, W; Zhong, ZJ; Gong, C; Cao, XF; Song, Y; Wang, WY; Huang, XM; Liu, XH; Hu, YC; Fu, HL; He, M; Wang, Y; Zhang, Y; Wu, KJ; Peng, GN				Deng, Lei; Li, Wei; Zhong, Zhijun; Gong, Chao; Cao, Xuefeng; Song, Yuan; Wang, Wuyou; Huang, Xiangming; Liu, Xuehan; Hu, Yanchun; Fu, Hualin; He, Min; Wang, Ya; Zhang, Yue; Wu, Kongju; Peng, Guangneng			Multi-locus genotypes of Enterocytozoon bieneusi in captive Asiatic black bears in southwestern China: High genetic diversity, broad host range, and zoonotic potential	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CRYPTOSPORIDIUM SPP.; MICROSPORIDIOSIS; SEQUENCE; IDENTIFICATION; SPECIFICITY; HOMINIS	Enterocytozoon bieneusi is an obligate eukaryotic intracellular parasite that infects a wide variety of vertebrate and invertebrate hosts. Although considerable research has been conducted on this organism, relatively little information is available on the occurrence of E. bieneusi in captive Asiatic black bears. The present study was performed to determine the prevalence, genetic diversity, and zoonotic potential of E. bieneusi in captive Asiatic black bears in zoos in southwestern China. Fecal specimens from Asiatic black bears in four zoos, located in four different cities, were collected and analyzed for the prevalence of E. bieneusi. The average prevalence of E. bieneusi was 27.4% (29/106), with the highest prevalence in Guiyang Zoo (36.4%, 16/44). Altogether, five genotypes of E. bieneusi were identified among the 29 E. bieneusi-positive samples, including three known genotypes (CHB1, SC02, and horse2) and two novel genotypes named ABB1 and ABB2. Multi-locus sequence typing using three microsatellites (MS1, MS3, and MS7) and one minisatellite (MS4) revealed V, III, V, and IV genotypes at these four loci, respectively. Phylogenetic analysis showed that the genotypes SC02 and ABB2 were clustered into group 1 of zoonotic potential, the genotypes CHB1 and ABB1 were clustered into a new group, and the genotype horse2 was clustered into group 6 of unclear zoonotic potential. In conclusion, this study identified two novel E. bieneusi genotypes in captive Asiatic black bears, and used microsatellite and minisatellite markers to reveal E. bieneusi genetic diversity. Moreover, our findings show that genotypes SC02 (identified in humans) and ABB2 belong to group 1 with zoonotic potential, suggesting the risk of transmission of E. bieneusi from Asiatic black bears to humans and other animals.	[Deng, Lei; Li, Wei; Zhong, Zhijun; Gong, Chao; Cao, Xuefeng; Song, Yuan; Wang, Wuyou; Liu, Xuehan; Hu, Yanchun; Fu, Hualin; He, Min; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan Provinc, Peoples R China; [Huang, Xiangming; Wang, Ya; Zhang, Yue; Wu, Kongju] Chengdu Giant Panda Breeding Res Base, Chengdu, Sichuan Provinc, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan Provinc, Peoples R China.; Wu, KJ (corresponding author), Chengdu Giant Panda Breeding Res Base, Chengdu, Sichuan Provinc, Peoples R China.	646401864@qq.com; pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	Chengdu giant panda breeding research foundation [CPF2014-14, CPF2015-4]	Chengdu giant panda breeding research foundation	The study was financially supported by the Chengdu giant panda breeding research foundation(CPF2014-14; CPF2015-4).	Akinbo FO, 2013, AM J TROP MED HYG, V89, P157, DOI 10.4269/ajtmh.12-0635; Deng L, 2016, PARASITES VECTORS, V9; Deng LT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159458, 10.137]; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Duncan RB, 1999, J WILDLIFE DIS, V35, P381, DOI 10.7589/0090-3558-35.2.381; Feng YY, 2011, APPL ENVIRON MICROB, V77, P4822, DOI 10.1128/AEM.02803-10; Fuchang Y, 2014, PARASITOL RES, V113, P1; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Karim MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117991; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Li W, 2014, PARASITOL RES, V113, P1147, DOI 10.1007/s00436-014-3752-9; Li W, 2013, INFECT GENET EVOL, V14, P111, DOI 10.1016/j.meegid.2012.11.021; Li W, 2012, INT J PARASITOL, V42, P287, DOI 10.1016/j.ijpara.2012.01.003; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Ma JB, 2015, VET PARASITOL, V207, P220, DOI 10.1016/j.vetpar.2014.10.011; Majid P, 2013, INFECT GENET EVOL; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Qi M, 2016, J EUKARYOT MICROBIOL; Sak B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109751; Sak B, 2011, VET PARASITOL, V178, P246, DOI 10.1016/j.vetpar.2010.12.044; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Wagnerova P, 2015, PARASITOL RES, V114, P1619, DOI 10.1007/s00436-015-4353-y; Wang L, 2013, J CLIN MICROBIOL, V51, P557, DOI 10.1128/JCM.02758-12; Wang XT, 2016, PARASITOL RES, V115, P1355, DOI 10.1007/s00436-016-4908-6; Wei JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1795-8; Xiao LH, 2000, J PARASITOL, V86, P1166, DOI 10.1645/0022-3395(2000)086[1166:MCOACI]2.0.CO;2; Zhao GH, 2015, INFECT GENET EVOL, V34, P394, DOI 10.1016/j.meegid.2015.07.016; Zhao W, 2016, INFECT GENET EVOL, V40, P151, DOI 10.1016/j.meegid.2016.02.037; Zhao W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142611; Zhao W, 2014, PARASITOL RES, V113, P4243, DOI 10.1007/s00436-014-4100-9	36	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171772	10.1371/journal.pone.0171772	http://dx.doi.org/10.1371/journal.pone.0171772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182656	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800105
J	Palombella, S; Pirrone, C; Cherubino, M; Valdatta, L; Bernardini, G; Gornati, R				Palombella, Silvia; Pirrone, Cristina; Cherubino, Mario; Valdatta, Luigi; Bernardini, Giovanni; Gornati, Rosalba			Identification of reference genes for qPCR analysis during hASC long culture maintenance	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; POLYMERASE-CHAIN-REACTION; STEM-CELLS DIFFERENTIATE; REAL-TIME; IN-VITRO; QUANTITATIVE PCR; STROMAL CELLS; RT-PCR; EXPRESSION; QUANTIFICATION	Up to now quantitative PCR based assay is the most common method for characterizing or confirming gene expression patterns and comparing mRNA levels in different sample populations. Since this technique is relative easy and low cost compared to other methods of characterization, e.g. flow cytometry, we used it to typify human adipose-derived stem cells (hASCs). hASCs possess several characteristics that make them attractive for scientific research and clinical applications. Accurate normalization of gene expression relies on good selection of reference genes and the best way to choose them appropriately is to follow the common rule of the "Best3", at least three reference genes, three different validation software and three sample replicates. Analysis was performed on hASCs cultivated until the eleventh cell confluence using twelve candidate reference genes, initially selected from literature, whose stability was evaluated by the algorithms NormFinder, BestKeeper, RefFinder and IdealRef, a home-made version of GeNorm. The best gene panel (RPL13A, RPS18, GAPDH, B2M, PPIA and ACTB), determined in one patient by IdealRef calculation, was then investigated in other four donors. Although patients demonstrated a certain gene expression variability, we can assert that ACTB is the most unreliable gene whereas ribosomal proteins (RPL13A and RPS18) show minor inconstancy in their mRNA expression. This work underlines the importance of validating reference genes before conducting each experiment and proposes a free software as alternative to those existing.	[Palombella, Silvia; Pirrone, Cristina; Cherubino, Mario; Valdatta, Luigi; Bernardini, Giovanni; Gornati, Rosalba] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Bernardini, Giovanni; Gornati, Rosalba] CNR Milano, Politecn Milan, ICRM, Prot Factory Res Ctr, Milan, Italy; [Bernardini, Giovanni; Gornati, Rosalba] Univ Insubria, Milan, Italy	University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Polytechnic University of Milan; University of Insubria	Gornati, R (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.; Gornati, R (corresponding author), CNR Milano, Politecn Milan, ICRM, Prot Factory Res Ctr, Milan, Italy.; Gornati, R (corresponding author), Univ Insubria, Milan, Italy.	rosalba.gornati@uninsubria.it	Bernardini, Giovanni/GRJ-0070-2022; Cherubino, Mario/N-1780-2019; Palombella, Silvia/AAU-2251-2020; Palombella, Silvia/K-5448-2018	Cherubino, Mario/0000-0003-1196-3075; Gornati, Rosalba/0000-0002-1544-2122; Palombella, Silvia/0000-0002-7628-5677; Valdatta, Luigi/0000-0003-1568-2262				Amable PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073792; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bonora-Centelles A, 2009, CELL TRANSPLANT, V18, P1319, DOI 10.3727/096368909X12483162197321; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chapman JR, 2015, PLOS ONE, V10; Cheng WC, 2011, PLOS ONE, V6; Cherubino M, 2016, REGEN MED, V11, P261, DOI 10.2217/rme-2015-0010; Dijkstra JR, 2014, MOL ONCOL, V8, P813, DOI 10.1016/j.molonc.2013.12.016; Du YQ, 2010, MOL VIS, V16, P2680; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Gronthos S, 2011, METHODS MOL BIOL, V702, P109, DOI 10.1007/978-1-61737-960-4_9; Holmgren G, 2015, PHYSIOL GENOMICS, V47, P232, DOI 10.1152/physiolgenomics.00130.2014; Jang S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-25; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Lemma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149481; Li X, 2015, TRANSPL P, V47, P2017, DOI 10.1016/j.transproceed.2015.06.017; Li XY, 2015, MOL MED REP, V11, P1304, DOI 10.3892/mmr.2014.2841; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rauh J, 2015, TISSUE ENG PART C-ME, V21, P192, DOI [10.1089/ten.TEC.2014.0230, 10.1089/ten.tec.2014.0230]; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmitz HD, 2002, CELL BIOL INT, V26, P155, DOI 10.1006/cbir.2001.0819; Studer D, 2012, TISSUE ENG PART C-ME, V18, P761, DOI 10.1089/ten.tec.2012.0081; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Xie F., 2012, PLANT MOL BIOL; Yang LQ, 2011, NEUROREPORT, V22, P370, DOI 10.1097/WNR.0b013e3283469615; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170918	10.1371/journal.pone.0170918	http://dx.doi.org/10.1371/journal.pone.0170918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182697	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800023
J	Reich, HG; Robertson, DL; Goodbody-Gringley, G				Reich, Hannah G.; Robertson, Deborah L.; Goodbody-Gringley, Gretchen			Do the shuffle: Changes in Symbiodinium consortia throughout juvenile coral development	PLOS ONE			English	Article							MUSTARD HILL CORAL; GREAT-BARRIER-REEF; AMINO-ACIDS MAAS; PORITES-ASTREOIDES; MONTASTRAEA-CAVERNOSA; SCLERACTINIAN CORALS; DIVERSITY; GROWTH; SPECIFICITY; POPULATIONS	Previous studies of symbiotic associations between scleractinians corals and Symbiodinium have demonstrated that the consortium of symbionts can change in response to environmental conditions. However, less is known about symbiont shuffling during early coral development, particularly in brooding species. This study examined whether Symbiodinium consortia (1) varied in Porites astreoides on shallow (10m) and upper mesophotic (30m) reefs, (2) changed during coral development, and (3) influenced growth of juveniles in different environments. Symbiodinium ITS2 sequences were amplified using universal primers and analyzed using phylotype-specific primers designed for phylotypes A, B, and C. Adults from both depths were found to host only phylotype A, phylotypes A and B, or phylotypes A, B, and C and the frequency of the phylotype composition did not vary with depth. However, phylotype A was the dominant symbiont that was vertically transmitted to the planulae. The presence of phylotypes B and C was detected in the majority of juveniles when transplanted onto the shallow and upper mesophotic reefs whereas only phylotype A was detected in the majority of juveniles reared in outdoor aquaria. In addition, growth of juvenile P. astreoides harboring different combinations of Symbiodinium phylotypes did not vary when transplanted to different reef zones. However, juveniles reared in in situ reef environments grew faster than those reared in ex situ outdoor aquaria. These results show that Symbiodinium consortia change during development of P. astreoides and are influenced by environmental conditions.	[Reich, Hannah G.; Robertson, Deborah L.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Goodbody-Gringley, Gretchen] Bermuda Inst Ocean Sci, 17 Biol Lane, St George, Bermuda	Clark University; Bermuda Institute of Ocean Sciences	Reich, HG (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	hgreich16@gmail.com	Robertson, Deborah/AAF-2512-2020		PADI Foundation [14837]; Bermuda Institute of Ocean Sciences Education Department; Albert, Normaand Howard Geller '77 Endowed Research Award	PADI Foundation; Bermuda Institute of Ocean Sciences Education Department; Albert, Normaand Howard Geller '77 Endowed Research Award	This study was funded by PADI Foundation grant #14837 (www.padifoundation. org), a Bermuda Institute of Ocean Sciences Grant-I n-Aid (www.bios.edu), funding from the Bermuda Institute of Ocean Sciences Education Department (www.bios.edu), an Albert, Normaand Howard Geller '77 Endowed Research Award (ClarkUniversity George Perkins Marsh Institute; www2. clarku.edu/departments/marsh/index.cfm), and a Phycological Society of America Grant-In-Aid of Research award (www.psaalgae.org/grants-in-aido f-research-program). Allaward swere to HGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050311; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, R LANG ENV STAT COMP; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; ARONSON RB, 1995, J EXP MAR BIOL ECOL, V192, P1, DOI 10.1016/0022-0981(95)00052-S; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Banaszak AT, 2006, J EXP MAR BIOL ECOL, V337, P131, DOI 10.1016/j.jembe.2006.06.014; Banaszak AT, 2000, J EXP MAR BIOL ECOL, V249, P219; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140297; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Boulotte NM, 2016, ISME J, V10, P2693, DOI 10.1038/ismej.2016.54; Byler KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059596; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Cunning R, 2015, CORAL REEFS, V34, P155, DOI 10.1007/s00338-014-1216-4; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DODGE RE, 1982, B MAR SCI, V32, P745; Edmunds PJ, 2008, MAR BIOL, V154, P153, DOI 10.1007/s00227-008-0910-6; Edmunds PJ, 2004, MAR ECOL PROG SER, V278, P115, DOI 10.3354/meps278115; Edmunds PJ, 2004, BIOL BULL-US, V206, P61, DOI 10.2307/1543536; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Goodbody-Gringley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142427; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; Goodbody-Gringley G, 2012, MAR ECOL-EVOL PERSP, V33, P32, DOI 10.1111/j.1439-0485.2011.00452.x; Goodbody-Gringley G, 2010, MAR BIOL, V157, P2591, DOI 10.1007/s00227-010-1521-6; Goodbody-Gringley G, 2010, J EXP MAR BIOL ECOL, V389, P70, DOI 10.1016/j.jembe.2010.03.016; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Holstein DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146068; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; JOHANNES RE, 1970, LIMNOL OCEANOGR, V15, P822, DOI 10.4319/lo.1970.15.5.0822; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kenkel CD, 2015, HEREDITY, V115, P509, DOI 10.1038/hdy.2015.52; Kenkel CD, 2013, MOL ECOL, V22, P4335, DOI 10.1111/mec.12391; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Kopp C, 2016, SCI ADV, V29, P255; Lee MJ, 2016, MICROB ECOL, V71, P771, DOI 10.1007/s00248-015-0724-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Marlow HQ, 2007, EVOL DEV, V9, P355, DOI 10.1111/j.1525-142X.2007.00173.x; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; Mitchell A, 2016, FUNCT ECOL, V30, P733, DOI 10.1111/1365-2435.12535; Nitschke MR, 2016, CORAL REEFS, V35, P335, DOI 10.1007/s00338-015-1349-0; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; Padilla-Gamino JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038440; Pochon X, 2001, MAR BIOL, V139, P1069; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Sambrook J., 2001, MOL CLONING LAB MANU; Savage AM, 2002, MAR ECOL PROG SER, V244, P17, DOI 10.3354/meps244017; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Serrano XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21619; SIEGEL DA, 1995, J GEOPHYS RES-OCEANS, V100, P8695, DOI 10.1029/95JC00447; Silverstein RN, 2015, GLOBAL CHANGE BIOL, V21, P236, DOI 10.1111/gcb.12706; Stambler N, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P87, DOI 10.1007/978-94-007-0114-4_7; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Venn AA, 2006, PLANT CELL ENVIRON, V29, P2133, DOI 10.1111/j.1365-3040.2006.001587.x; Vermeij Mark J.A., 2011, Diversity, V3, P296, DOI 10.3390/d3030296; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097003; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Zar JH, 1999, BIOSTATISTICAL ANAL	71	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171768	10.1371/journal.pone.0171768	http://dx.doi.org/10.1371/journal.pone.0171768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182684	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800104
J	Ryu, Y; Ogata, T; Nagao, M; Kitamura, T; Morioka, K; Ichihara, Y; Doi, T; Sawada, Y; Akai, M; Nishimura, R; Fujita, N				Ryu, Youngjae; Ogata, Toru; Nagao, Motoshi; Kitamura, Taku; Morioka, Kazuhito; Ichihara, Yoshinori; Doi, Toru; Sawada, Yasuhiro; Akai, Masami; Nishimura, Ryohei; Fujita, Naoki			The swimming test is effective for evaluating spasticity after contusive spinal cord injury	PLOS ONE			English	Article							LONG-LASTING REFLEXES; PERSISTENT SODIUM; MUSCLE SPASMS; H-REFLEX; RAT; RECOVERY; MOTONEURON; RECEPTOR; EXCITABILITY; MODULATION	Spasticity is a frequent chronic complication in individuals with spinal cord injury (SCI). However, the severity of spasticity varies in patients with SCI. Therefore, an evaluation method is needed to determine the severity of spasticity. We used a contusive SCI model that is suitable for clinical translation. In this study, we examined the feasibility of the swimming test and an EMG for evaluating spasticity in a contusive SCI rat model. Sprague-Dawley rats received an injury at the 8th thoracic vertebra. Swimming tests were performed 3 to 6 weeks after SCI induction. We placed the SCI rats into spasticity-strong or spasticity-weak groups based on the frequency of spastic behavior during the swimming test. Subsequently, we recorded the Hoffman reflex (H-reflex) and examined the immunoreactivity of serotonin (5HT) and its receptor (5-HT2A) in the spinal tissues of the SCI rats. The spasticity-strong group had significantly decreased rate-dependent depression of the H-reflex compared to the spasticity-weak group. The area of 5-HT2A receptor immunoreactivity was significantly increased in the spasticity-strong group. Thus, both electrophysiological and histological evaluations indicate that the spasticity-strong group presented with a more severe upper motor neuron syndrome. We also observed the groups in their cages for 20 hours. Our results suggest that the swimming test provides an accurate evaluation of spasticity in this contusive SCI model. We believe that the swimming test is an effective method for evaluating spastic behaviors and developing treatments targeting spasticity after SCI.	[Ryu, Youngjae; Nishimura, Ryohei; Fujita, Naoki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Surg, Tokyo, Japan; [Ryu, Youngjae; Ogata, Toru; Nagao, Motoshi; Kitamura, Taku; Morioka, Kazuhito; Ichihara, Yoshinori; Doi, Toru; Sawada, Yasuhiro; Akai, Masami] Natl Rehabil Ctr, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan; [Morioka, Kazuhito] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurosurg, San Francisco, CA 94143 USA; [Akai, Masami] Int Univ Hlth & Welf, Grad Sch, Tokyo, Japan	University of Tokyo; University of California System; University of California San Francisco; International University of Health & Welfare	Ogata, T (corresponding author), Natl Rehabil Ctr, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan.	toogata-tky@umin.ac.jp	Sawada, Yasuhiro/H-8044-2012; Ogata, Toru/ADC-3560-2022; Ryu, Youngjae/ABE-9618-2020; Morioka, Kazuhito/AAH-7835-2020; Doi, Toru/AAC-3441-2020	Sawada, Yasuhiro/0000-0003-0625-3335; Ogata, Toru/0000-0001-9011-8640; Ryu, Youngjae/0000-0002-7921-7856; Morioka, Kazuhito/0000-0001-5407-8178; Doi, Toru/0000-0001-8833-2437; Ichihara, Yoshinori/0000-0002-6746-5617	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [24300197, 15H03048]	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by KAKENHI (24300197, 15H03048) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Bennett DJ, 2004, J NEUROPHYSIOL, V91, P2247, DOI 10.1152/jn.00946.2003; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Corleto JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144642; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; D'Amico JM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00036; Doly S, 2004, J COMP NEUROL, V472, P496, DOI 10.1002/cne.20082; Elbasiouny SM, 2010, NEUROREHAB NEURAL RE, V24, P23, DOI 10.1177/1545968309343213; Gonzenbach RR, 2010, ANN NEUROL, V68, P48, DOI 10.1002/ana.22009; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Kapitza S, 2012, EXP NEUROL, V236, P179, DOI 10.1016/j.expneurol.2012.04.023; Kitzman P, 2005, EXP NEUROL, V192, P100, DOI 10.1016/j.expneurol.2004.10.021; Kong XY, 2011, NEUROSCIENCE, V177, P114, DOI 10.1016/j.neuroscience.2010.12.062; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lee JK, 2007, EXP NEUROL, V203, P502, DOI 10.1016/j.expneurol.2006.09.003; Lee JK, 2005, EXP NEUROL, V196, P430, DOI 10.1016/j.expneurol.2005.08.018; Li Y, 2004, J NEUROPHYSIOL, V91, P2236, DOI 10.1152/jn.01010.2003; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; LITTLE JW, 1989, AM J PHYS MED REHAB, V68, P32, DOI 10.1097/00002060-198902000-00009; Magnuson DSK, 2009, NEUROREHAB NEURAL RE, V23, P535, DOI 10.1177/1545968308331147; Murray KC, 2011, J NEUROPHYSIOL, V105, P731, DOI 10.1152/jn.00774.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navarrett S, 2012, NEUROSCI LETT, V506, P74, DOI 10.1016/j.neulet.2011.10.052; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Reese NB, 2006, SPINAL CORD, V44, P28, DOI 10.1038/sj.sc.3101810; Roy RR, 2012, EXP NEUROL, V235, P116, DOI 10.1016/j.expneurol.2012.01.017; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0; Singh A, 2011, J NEUROTRAUM, V28, P2405, DOI 10.1089/neu.2010.1660; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Skold C, 2000, ARCH PHYS MED REHAB, V81, P144, DOI 10.1016/S0003-9993(00)90132-1; Smith RR, 2006, J NEUROTRAUM, V23, P1654, DOI 10.1089/neu.2006.23.1654; Snoek GJ, 2015, FUNCTIONAL HINDRANCE; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; Thompson FJ, 2001, J CHILD NEUROL, V16, P2, DOI 10.1177/088307380101600102; Trompetto C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/354906	37	19	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171937	10.1371/journal.pone.0171937	http://dx.doi.org/10.1371/journal.pone.0171937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182676	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800134
J	Sheu, JJ; Chu, KT; Li, NF; Lee, CC				Sheu, Jyh-Jian; Chu, Ko-Tsung; Li, Nien-Feng; Lee, Cheng-Chi			An efficient incremental learning mechanism for tracking concept drift in spam filtering	PLOS ONE			English	Article								This research manages in-depth analysis on the knowledge about spams and expects to propose an efficient spam filtering method with the ability of adapting to the dynamic environment. We focus on the analysis of email's header and apply decision tree data mining technique to look for the association rules about spams. Then, we propose an efficient systematic filtering method based on these association rules. Our systematic method has the following major advantages: (1) Checking only the header sections of emails, which is different from those spam filtering methods at present that have to analyze fully the email's content. Meanwhile, the email filtering accuracy is expected to be enhanced. (2) Regarding the solution to the problem of concept drift, we propose a window-based technique to estimate for the condition of concept drift for each unknown email, which will help our filtering method in recognizing the occurrence of spam. (3) We propose an incremental learning mechanism for our filtering method to strengthen the ability of adapting to the dynamic environment.	[Sheu, Jyh-Jian] Natl Chengchi Univ, Coll Commun, Taipei, Taiwan; [Chu, Ko-Tsung] Minghsin Univ Sci & Technol, Dept Finance, Hsinchu, Taiwan; [Li, Nien-Feng] Yilan Cty Govt Police Bur, Yilan, Taiwan; [Lee, Cheng-Chi] Fu Jen Catholic Univ, Dept Lib & Informat Sci, Taipei, Taiwan; [Lee, Cheng-Chi] Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan	National Chengchi University; Fu Jen Catholic University; Asia University Taiwan	Chu, KT (corresponding author), Minghsin Univ Sci & Technol, Dept Finance, Hsinchu, Taiwan.; Lee, CC (corresponding author), Fu Jen Catholic Univ, Dept Lib & Informat Sci, Taipei, Taiwan.; Lee, CC (corresponding author), Asia Univ, Dept Photon & Commun Engn, Taichung, Taiwan.	ktc1009@must.edu.tw; cclee@mail.fju.edu.tw	Lee, Cheng-Chi/AGH-0724-2022; Lee, Cheng-Chi/J-4185-2016	Lee, Cheng-Chi/0000-0002-8918-1703; Lee, Cheng-Chi/0000-0002-8918-1703	Ministry of Science and Technology, Taiwan, R.O.C. [MOST 105-2410-H-004-097-MY2]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was partially supported by the Ministry of Science and Technology, Taiwan, R.O.C., under contract no.: MOST 105-2410-H-004-097-MY2. All funders and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bansal RP, 2014, U. S. Patent, Patent No. [8,676,903, 8676903]; Carpinter J, 2006, COMPUT SECUR, V25, P566, DOI 10.1016/j.cose.2006.06.001; Carreras X., 2001, P RANLP, P58; Chiou PR, 2013, INT CONF ADV COMMUN, P184; Cohen W. W., 1996, AAAI SPRING S MACH L, V18, P25; DeBarr D, 2012, PATTERN RECOGN LETT, V33, P1237, DOI 10.1016/j.patrec.2012.03.012; Delany SJ, 2005, KNOWL-BASED SYST, V18, P187, DOI 10.1016/j.knosys.2004.10.002; Delany SJ, 2005, TCDCS200519 COMP SCI; Derhab A., 2014, P 21 IEEE INT C TEL; Drucker H, 1999, IEEE T NEURAL NETWOR, V10, P1048, DOI 10.1109/72.788645; Du L, 2014, INTELL DATA ANAL, V18, P337, DOI 10.3233/IDA-140645; Fdez-Riverola F, 2007, EXPERT SYST APPL, V33, P36, DOI 10.1016/j.eswa.2006.04.011; Fdez-Riverola F, 2007, DECIS SUPPORT SYST, V43, P722, DOI 10.1016/j.dss.2006.11.012; Hayat M. Zi, 2010, 2010 5th International Symposium on Telecommunications (IST), P531, DOI 10.1109/ISTEL.2010.5734082; He J., 2007, P 4 C EM ANT CEAS; Hsiao WF, 2008, EXPERT SYST APPL, V34, P1599, DOI 10.1016/j.eswa.2007.01.018; Jayanthi S.K., 2014, COMPUT SCI TELECOMMU, V41, P3; Khan WZ, 2015, IEEE COMMUN SURV TUT, V17, P2271, DOI 10.1109/COMST.2015.2459015; Klinkenberg R., 2004, Intelligent Data Analysis, V8, P281; Koychev I., 2005, P 25 SGAI INT C INN, P46; Lai CC, 2007, KNOWL-BASED SYST, V20, P249, DOI 10.1016/j.knosys.2006.05.016; Lazarescu M. M., 2004, Intelligent Data Analysis, V8, P29; Liu YN, 2014, ADV MATER RES-SWITZ, V846-847, P1672, DOI 10.4028/www.scientific.net/AMR.846-847.1672; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Prasse P, 2015, J MACH LEARN RES, V16, P3687; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Rafique M.Z., 2011, P 16 GEN EV COMP C D; Sanpakdee U, 2006, ADV COMM TECHN ICACT, V1, P441; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Sheu JJ, 2009, INT J INNOV COMPUT I, V5, P3717; Stanley K.O, 2003, UTAITR03302 U TEX AU; Tretyakov K., 2004, TECHNICAL REPORT; Wang CC, 2007, COMPUT SECUR, V26, P381, DOI 10.1016/j.cose.2006.12.012; Widmer G, 1996, MACH LEARN, V23, P69, DOI 10.1007/BF00116900; Zhou B, 2014, J INTELL INF SYST, V42, P19, DOI 10.1007/s10844-013-0254-7	37	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171518	10.1371/journal.pone.0171518	http://dx.doi.org/10.1371/journal.pone.0171518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182691	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800068
J	Zhang, QR; Yu, H; Qi, J; Tang, DS; Chen, XJ; Wan, JB; Li, P; Hu, H; Wang, YT; Hu, YJ				Zhang, Qianru; Yu, Hua; Qi, Jin; Tang, Daisheng; Chen, Xiaojia; Wan, Jian-bo; Li, Peng; Hu, Hao; Wang, Yi-tao; Hu, Yuanjia			Natural formulas and the nature of formulas: Exploring potential therapeutic targets based on traditional Chinese herbal formulas	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; XUEFU-ZHUYU DECOCTION; NITRIC-OXIDE; NETWORK PHARMACOLOGY; HYDROXYSAFFLOR YELLOW; ISCHEMIA-REPERFUSION; HEART-DISEASE; MEDICINE; MACROSTEMONOSIDE; HYPERLIPIDEMIA	By comparing the target proteins (TPs) of classic traditional Chinese medicine (TCM) herbal formulas and modern drugs used for treating coronary artery disease (CAD), this study aimed to identify potential therapeutic TPs for treating CAD. Based on the theory of TCM, the Xuefu-Zhuyu decoction (XZD) and Gualou-Xiebai-Banxia decoction (GXBD), both of which are classic herbal formulas, were selected for treating CAD. Data on the chemical ingredients and corresponding TPs of the herbs in these two formulas and data on modern drugs approved for treating CAD and related TPs were retrieved from professional TCM and bioinformatics databases. Based on the associations between the drugs or ingredients and their TPs, the TP networks of XZD, GXBD, and modern drugs approved for treating CAD were constructed separately and then integrated to create a complex master network in which the vertices represent the TPs and the edges, the ingredients or drugs that are linked to the TPs. The reliability of this master network was validated through statistical tests. The common TPs of the two herbal formulas have a higher possibility of being targeted by modern drugs in comparison with the formula-specific TPs. A total of 114 common XZD and GXBD TPs that are not yet the target of modern drugs used for treating CAD should be experimentally investigated as potential therapeutic targets for treating CAD. Among these TPs, the top 10 are NOS3, PTPN1, GABRA1, PRKACA, CDK2, MAOB, ESR1, ADH1C, ADH1B, and AKR1B1. The results of this study provide a valuable reference for further experimental investigations of therapeutic targets for CAD. The established method shows promise for searching for potential therapeutic TPs based on herbal formulas. It is crucial for this work to select beneficial therapeutic targets of TCM, typical TCM syndromes, and corresponding classic formulas.	[Zhang, Qianru; Yu, Hua; Chen, Xiaojia; Wan, Jian-bo; Li, Peng; Hu, Hao; Wang, Yi-tao; Hu, Yuanjia] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhang, Qianru] Zunyi Med Coll, Sch Pharm, Zunyi, Guizhou, Peoples R China; [Qi, Jin] China Pharmaceut Univ, Dept Complex Prescript Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Tang, Daisheng] Beijing Jiaotong Univ, Beijing, Peoples R China	University of Macau; Zunyi Medical University; China Pharmaceutical University; Beijing Jiaotong University	Hu, YJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	yuanjiahu@umac.mo	Chen, Xiao-Jia/E-4425-2017; HU, Hao/H-7813-2018; Wang, Yitao/O-5184-2016; Hu, Yuanjia/AAW-7721-2021; Yu, Hua/B-8854-2012; Wan, Jian-Bo/D-8368-2014	Chen, Xiao-Jia/0000-0001-5872-5790; HU, Hao/0000-0001-9441-106X; Yu, Hua/0000-0003-0737-9925; yuanjia, Hu/0000-0001-5244-8577; Wan, Jian-Bo/0000-0002-6750-2617	University of Macau [MYRG2015-00172-ICMS-QRCM]	University of Macau	The University of Macau provides financial support for this research by the project MYRG2015-00172-ICMS-QRCM.	Anusree SS, 2015, MOL CELL ENDOCRINOL, V413, P120, DOI 10.1016/j.mce.2015.06.018; ARAUJO RP, 2004, DRUG DISCOV TODAY TH, V1, P425, DOI DOI 10.1016/j.ddstr.2004.11.004; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bi YF, 2013, WORLD SCI TECHNOL MO, V15, P804; Borges FRM, 2014, J ETHNOPHARMACOL, V151, P144, DOI 10.1016/j.jep.2013.10.009; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Chan K, 2005, J ETHNOPHARMACOL, V96, P1, DOI 10.1016/j.jep.2004.09.019; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Coyle M, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/380678; de Chantemele EJB, 2009, CIRCULATION, V120, P753, DOI 10.1161/CIRCULATIONAHA.109.853077; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Ding F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116441; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fliri AF, 2010, TRENDS PHARMACOL SCI, V31, P547, DOI 10.1016/j.tips.2010.07.005; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; Gao ZY, 2012, J ETHNOPHARMACOL, V141, P578, DOI 10.1016/j.jep.2011.08.071; Giovanni Maciocia, 1994, PRACTICE CHINESE MED; Guo Hao, 2012, Zhongguo Zhong Yao Za Zhi, V37, P120; Guo SW, 1997, CHIN J INTEGR MED, V17, P23; Hao DC, 2014, DRUG DEVELOP RES, V75, P299, DOI 10.1002/ddr.21214; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077247; Huang Q, 2007, BIOORG MED CHEM LETT, V17, P1779, DOI 10.1016/j.bmcl.2006.12.078; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kaludercic N, 2014, J MOL CELL CARDIOL, V73, P34, DOI 10.1016/j.yjmcc.2013.12.032; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keith RJ, 2009, CHEM-BIOL INTERACT, V178, P242, DOI 10.1016/j.cbi.2008.10.055; Lange M, 2014, CELL CYCLE, V13, P315, DOI 10.4161/cc.27056; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Levinson AD, 2010, SCIENCE, V328, P137, DOI 10.1126/science.1189749; Li HY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/495840; Li R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01543; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; [李响 LI Xiang], 2009, [系统工程理论与实践, Systems Engineering-Theory & Practice], V29, P19, DOI 10.1016/S1874-8651(10)60060-9; Lin JR, 2009, SOCIAL NETWORK ANAL, V1; Lozano F, 2014, BASIC THEORIES TRADI, P13, DOI [DOI 10.1007/978-1-4614-5275-12, 10.1007/978-1-4614-5275-12]; Manimaran P, 2009, MOL BIOSYST, V5, P1936, DOI [10.1039/b905264j, 10.1039/B905264j]; [毛静远 MAO Jingyuan], 2011, [中医杂志, Journal of Traditional Chinese Medicine], V52, P958; Newman Mark E. J., 2004, WHO IS BEST CONNECTE; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Nie PH, 2012, J ETHNOPHARMACOL, V139, P746, DOI 10.1016/j.jep.2011.11.054; Ott R. L., 2015, CENGAGE LEARNING; PAN SY, 2011, EVID-BASED COMPL ALT, DOI DOI 10.1093/ECAM/NEQ056; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Qi FH, 2013, DRUG DISCOV THER, V7, P212, DOI 10.5582/ddt.2013.v7.6.212; Rader DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008535; Ren Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/714517; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Song J, 2012, CHIN J INTEGR MED, V18, P502, DOI 10.1007/s11655-012-1143-6; Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014; Sun X, 2010, BIOORG MED CHEM LETT, V20, P4120, DOI 10.1016/j.bmcl.2010.05.076; Takahashi T, 2004, CANCER SCI, V95, P448, DOI 10.1111/j.1349-7006.2004.tb03230.x; Tsutsumi S, 2008, J ENDOCRINOL, V199, P267, DOI 10.1677/JOE-07-0292; Wang YY, 2014, COMPLEMENT THER MED, V22, P826, DOI 10.1016/j.ctim.2014.06.004; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie WD, 2008, EUR J PHARMACOL, V599, P159, DOI 10.1016/j.ejphar.2008.09.042; [徐砚通 Xu Yantong], 2015, [中草药, Chinese Traditional and Herbal Drugs], V46, P465; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yang JY, 2012, CHIN HERB MED, V4, P26, DOI 10.3969/j.issn.1674-6384.2012.01.005; Yang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/731969; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/456747; Zhang GB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/621423; Zhang HM, 2011, J TRADIT CHIN MED, V31, P338, DOI 10.1016/S0254-6272(12)60015-6; Zhou H, 2007, BIOL PHARM BULL, V30, P279, DOI 10.1248/bpb.30.279; Zhou W, 2014, J ETHNOPHARMACOL, V151, P66, DOI 10.1016/j.jep.2013.11.007; Zhuang Y., 2014, J SD U TCM, V38, P316; Zimmermann K, 2002, P NATL ACAD SCI USA, V99, P17167, DOI 10.1073/pnas.252345399	77	21	21	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171628	10.1371/journal.pone.0171628	http://dx.doi.org/10.1371/journal.pone.0171628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182702	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800082
J	Backman, TWH; Evans, DS; Girke, T				Backman, Tyler William H.; Evans, Daniel S.; Girke, Thomas			Large-scale bioactivity analysis of the small molecule assayed proteome	PLOS ONE			English	Article							DRUG; DATABASE; RESOURCE	This study presents an analysis of the small molecule bioactivity profiles across large quantities of diverse protein families represented in PubChem BioAssay. We compared the bioactivity profiles of FDA approved drugs to non-FDA approved compounds, and report several distinct patterns characteristic of the approved drugs. We found that a large fraction of the previously reported higher target promiscuity among FDA approved compounds, compared to non-FDA approved bioactives, was frequently due to cross-reactivity within rather than across protein families. We identified 804 potentially novel protein target candidates for FDA approved drugs, as well as 901 potentially novel target candidates with active non-FDA approved compounds, but no FDA approved drugs with activity against these targets. We also identified 486348 potentially novel compounds active against the same targets as FDA approved drugs, as well as 153402 potentially novel compounds active against targets without active FDA approved drugs. By quantifying the agreement among replicated screens, we estimated that more than half of these novel outcomes are reproducible. Using biclustering, we identified many dense clusters of FDA approved drugs with enriched activity against a common set of protein targets. We also report the distribution of compound promiscuity using a Bayesian statistical model, and report the sensitivity and specificity of two common methods for identifying promiscuous compounds. Aggregator assays exhibited greater accuracy in identifying highly promiscuous compounds, while PAINS substructures were able to identify a much larger set of "middle range" promiscuous compounds. Additionally, we report a large number of promiscuous compounds not identified as aggregators or PAINS. In summary, the results of this study represent a rich reference for selecting novel drug and target protein candidates, as well as for eliminating candidate compounds with unselective activities.	[Backman, Tyler William H.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Backman, Tyler William H.; Girke, Thomas] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Evans, Daniel S.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; California Pacific Medical Center; California Pacific Medical Center Research Institute	Girke, T (corresponding author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	thomas.girke@ucr.edu		Backman, Tyler/0000-0002-6056-353X	National Science Foundation [ABI-0957099, MRI-1429826]; National Institutes of Health [U24AG051129, 1S10OD016290-01A1]; NATIONAL INSTITUTE ON AGING [U24AG051129] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Science Foundation: ABI-0957099 and MRI-1429826 to TG; and the National Institutes of Health: U24AG051129 to DE, and 1S10OD016290-01A1 to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman TWH, 2016, J CHEM INF MODEL; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bastian M., 2009, 3 INT AAAI C WEBL SO; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cheng TJ, 2010, BIOINFORMATICS, V26, P2881, DOI 10.1093/bioinformatics/btq550; Consortium TU, 2011, NUCLEIC ACIDS RES, V40; Csardi G, 2006, INTERJOURNAL; Dancik V, 2014, J BIOMOL SCREEN, V19, P771, DOI 10.1177/1087057113520226; Dandapani S, 2010, NAT CHEM BIOL, V6, P861, DOI 10.1038/nchembio.479; Eddy Sean R, 2009, Genome Inform, V23, P205; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Han LY, 2009, BIOINFORMATICS, V25, P2251, DOI 10.1093/bioinformatics/btp380; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Howe EA, 2015, NUCLEIC ACIDS RES, V43, pD1163, DOI 10.1093/nar/gku1244; Hu Y, 2013, F1000RES; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Jasial S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153873; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kumar R., 2013, ISRN CHEM ENG, V2013, P10, DOI DOI 10.1371/JOURNAL.PONE.0078174; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Lee Shun J., 2009, Journal of Biology (London), V8, P30, DOI 10.1186/jbiol134; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moya-Garcia AA, 2013, BIOINFORMATICS, V29, P1934, DOI 10.1093/bioinformatics/btt321; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Saubern S, 2011, MOL INFORM, V30, P847, DOI 10.1002/minf.201100076; Schmidt U, 2009, NUCLEIC ACIDS RES, V37, pD295, DOI 10.1093/nar/gkn850; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; van Uitert M, 2008, J COMPUT BIOL, V15, P1329, DOI 10.1089/cmb.2008.0066; Visser U, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-257; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wassermann AM, 2010, CHEMMEDCHEM, V5, P847, DOI 10.1002/cmdc.201000064; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yan SF, 2006, J CHEM INF MODEL, V46, P2381, DOI 10.1021/ci060102u; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zhang JI, 2011, ANAL CHEM, V83, P4738, DOI 10.1021/ac1030946	57	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171413	10.1371/journal.pone.0171413	http://dx.doi.org/10.1371/journal.pone.0171413			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178331	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500040
J	Tanito, M; Nitta, K; Katai, M; Kitaoka, Y; Yokoyama, Y; Omodaka, K; Nakazawa, T				Tanito, Masaki; Nitta, Koji; Katai, Maki; Kitaoka, Yasushi; Yokoyama, Yu; Omodaka, Kazuko; Nakazawa, Toru			Differentiation of glaucomatous optic discs with different appearances using optic disc topography parameters: The Glaucoma Stereo Analysis Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DAMAGE LIKELIHOOD SCALE; VISUAL-FIELD; COHERENCE TOMOGRAPHY; POPULATION; OPHTHALMOSCOPY; PROGRESSION; PREVALENCE; AGREEMENT; BLINDNESS	The Glaucoma Stereo Analysis Study (GSAS) is a multicenter collaborative study of the characteristics of glaucomatous optic disc morphology using a stereo fundus camera. Using GSAS dataset, the formulas for predicting different glaucomatous optic disc appearances were established. The GSAS dataset containing three-dimensionally-analyzed optic disc topographic parameters from 187 eyes with primary open-angle glaucoma was assessed with discrimination analyses to obtain formulas predictive of glaucomatous optic disc appearances: focal ischemic (FI); generalized enlargement (GE), myopic glaucomatous (MY), and senile sclerotic (SS). Using 38 optic disc parameters-substituted discrimination analyses with a stepwise forward-selection method, six parameters (temporal and nasal rim-disc ratios, mean cup depth, height variation contour, disc tilt angle, and rim decentering absolute) were selected into the formulas. The area under the receiver operating characteristic curves for predicting the four disc types with established formulas were 0.88, 0.91, 0.93, and 0.86 for FI, MY, SS, and GE, respectively. Age, visual acuity, refractive error, glaucoma (normal or high-tension glaucoma), and baseline intraocular pressure differed significantly among the four optic disc types, suggesting the appearances represent different clinical glaucoma phenotypes. Using six optic disc topographic parameters obtained by stereo fundus camera, the GSAS classification formulas predicted and quantified each component of different optic disc appearances in each eye and provided a novel parameter to describe glaucomatous optic disc characteristics.	[Tanito, Masaki] Matsue Red Cross Hosp, Div Ophthalmol, 200 Horo Machi, Matsue, Shimane, Japan; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, 89-1 Enya, Izumo, Shimane, Japan; [Nitta, Koji] Fukui Ken Saiseikai Hosp, Dept Ophthalmol, Fukui, Japan; [Katai, Maki] Nippon Telegraph & Tel East Corp, Dept Ophthalmol, Sapporo Med Ctr, Sapporo, Hokkaido, Japan; [Kitaoka, Yasushi] St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan; [Yokoyama, Yu; Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan	Shimane University; Saint Marianna University; Tohoku University	Tanito, M (corresponding author), Matsue Red Cross Hosp, Div Ophthalmol, 200 Horo Machi, Matsue, Shimane, Japan.; Tanito, M (corresponding author), Shimane Univ, Fac Med, Dept Ophthalmol, 89-1 Enya, Izumo, Shimane, Japan.	tanito-oph@umin.ac.jp			Kowa Company, Ltd.	Kowa Company, Ltd.	Drs. Maki Katai, Yasushi Kitaoka, Yu Yokoyama, Kazuko, Omodaka, and Toru Nakazawa were provided a stereo fundus camera from Kowa Company, Ltd. for conducting the study. Kowa Company had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Asakawa K, 2013, J GLAUCOMA, V22, P698, DOI 10.1097/IJG.0b013e318264be18; Bayer A, 2002, AM J OPHTHALMOL, V133, P758, DOI 10.1016/S0002-9394(02)01422-8; Broadway DC, 1998, AM J OPHTHALMOL, V125, P593, DOI 10.1016/S0002-9394(98)00002-6; Broadway DC, 1999, SURV OPHTHALMOL, V43, pS223, DOI 10.1016/S0039-6257(99)00007-7; Broadway DC, 1998, BRIT J OPHTHALMOL, V82, P862, DOI 10.1136/bjo.82.8.862; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; GLOSTER J, 1974, BRIT J OPHTHALMOL, V58, P850, DOI 10.1136/bjo.58.10.850; Henderer JD, 2003, AM J OPHTHALMOL, V135, P44, DOI 10.1016/S0002-9394(02)01833-0; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Kitaoka Y, 2016, GRAEF ARCH CLIN EXP, V254, P523, DOI 10.1007/s00417-015-3239-0; Nakazawa T, 2012, J GLAUCOMA, V21, P426, DOI 10.1097/IJG.0b013e3182182897; Nakazawa T, 2010, JPN J OPHTHALMOL, V54, P291, DOI 10.1007/s10384-010-0816-y; Nicolela MT, 2003, OPHTHALMOLOGY, V110, P2178, DOI 10.1016/S0161-6420(03)00801-7; Nicolela MT, 2001, AM J OPHTHALMOL, V132, P836, DOI 10.1016/S0002-9394(01)01254-5; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P629; Roberts KF, 2012, ARCH OPHTHALMOL-CHIC, V130, P980, DOI 10.1001/archophthalmol.2012.371; Sawada Y, 2015, INVEST OPHTH VIS SCI, V56, P5777, DOI 10.1167/iovs.14-15942; Shin HY, 2014, OPHTHALMOLOGY, V121, P1990, DOI 10.1016/j.ophtha.2014.04.030; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tanito M, 2014, JPN J OPHTHALMOL, V58, P56, DOI 10.1007/s10384-013-0280-6; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wolfs RCW, 1999, OPHTHALMOLOGY, V106, P1597, DOI 10.1016/S0161-6420(99)90458-X; Yamamoto S, 2014, OPHTHALMOLOGY, V121, P1558, DOI 10.1016/j.ophtha.2014.03.003; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0169858	10.1371/journal.pone.0169858	http://dx.doi.org/10.1371/journal.pone.0169858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178303	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500003
J	Tripathi, VS; Brandt, AR				Tripathi, Vinay S.; Brandt, Adam R.			Estimating decades-long trends in petroleum field energy return on investment (EROI) with an engineering-based model	PLOS ONE			English	Article							OIL PRODUCTION; GHG EMISSIONS; GAS; EFFICIENCY	This paper estimates changes in the energy return on investment (EROI) for five large petroleum fields over time using the Oil Production Greenhouse Gas Emissions Estimator (OPGEE). The modeled fields include Cantarell (Mexico), Forties (U.K.), Midway-Sunset (U.S.), Prudhoe Bay (U.S.), and Wilmington (U.S.). Data on field properties and production/ processing parameters were obtained from a combination of government and technical literature sources. Key areas of uncertainty include details of the oil and gas surface processing schemes. We aim to explore how long-term trends in depletion at major petroleum fields change the effective energetic productivity of petroleum extraction. Four EROI ratios are estimated for each field as follows: The net energy ratio (NER) and external energy ratio (EER) are calculated, each using two measures of energy outputs, (1) oil-only and (2) all energy outputs. In all cases, engineering estimates of inputs are used rather than expenditure -based estimates (including off-site indirect energy use and embodied energy). All fields display significant declines in NER over the modeling period driven by a combination of (1) reduced petroleum production and (2) increased energy expenditures on recovery methods such as the injection of water, steam, or gas. The fields studied had NER reductions ranging from 46% to 88% over the modeling periods (accounting for all energy outputs). The reasons for declines in EROI differ by field. Midway-Sunset experienced a 5-fold increase in steam injected per barrel of oil produced. In contrast, Prudhoe Bay has experienced nearly a 30-fold increase in amount of gas processed and reinjected per unit of oil produced. In contrast, EER estimates are subject to greater variability and uncertainty due to the relatively small magnitude of external energy investments in most cases.	[Tripathi, Vinay S.; Brandt, Adam R.] Stanford Univ, Dept Energy Resources Engn, Stanford, CA 94305 USA	Stanford University	Brandt, AR (corresponding author), Stanford Univ, Dept Energy Resources Engn, Stanford, CA 94305 USA.	abrandt@stanford.edu			Stanford University	Stanford University(Stanford University)	VST was supported by Stanford University faculty support funds to ARB during the writing of this paper.	Alford WO, 1983, DOEET120595; [Anonymous], ANN REP STAT OIL GAS; [Anonymous], ALASKA OIL GAS CONSE; [Anonymous], INJ HIST PRUDH BAY P; AOGCC Pool Statistics Prudhoe Bay Unit, PRUDH OIL POOL; Bartosh EJ, 1938, AAPG BULL, V22, P1048; Beal C, 1945, DRILLING PRODUCTION; Berman B, 1987, GEOLOGIC FIELD GUIDE, P99; Brand PJ, 1996, J PETROL TECHNOL, V48, P280, DOI 10.2118/30440-JPT; Brandt AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144141; Brandt AR, 2015, ENVIRON SCI TECHNOL, V49, P13059, DOI 10.1021/acs.est.5b03540; Brandt AR, 2013, ENERGY, V55, P693, DOI 10.1016/j.energy.2013.03.080; Brandt AR, 2011, SUSTAINABILITY-BASEL, V3, P1833, DOI 10.3390/su3101833; Bujanos J.L. Sanchez, 2005, SPE LAT AM CAR PETR; Carpenter DE, 1992, SPE DOE ENH OIL REC; Chesterman A, 2009, 124605 SPE, V124605; Department for Business, ENT REG REF WELL INJ; Department for Business, ENT REG REF WELL PRO; El-Houjeiri HM, 2013, ENVIRON SCI TECHNOL, V47, P5998, DOI 10.1021/es304570m; El-Houjeiri HM, 2016, USER GUIDE TECHNICAL; El-Houjeiri HM, 2016, MODEL OIL PRODUCTION; Frame RG, 1957, ANN REPORT CALFORNIA, V43, P59; Hall CAS, 1981, ENERGY ECOLOGICAL MO, V1, P715; Hanson ES, 1985, SPE CAL REG M; Hook M, 2009, ENERG POLICY, V37, P2262, DOI 10.1016/j.enpol.2009.02.020; Hu Y, 2011, SUSTAINABILITY-BASEL, V3, P2323, DOI 10.3390/su3122323; Huey WF, 1964, ANN REPORT CALFORNIA, V50, P5; Kettles R, 2001, OFFSH TECHN C; Littlewood R, 2013, AP CORP 36 GAS LIFT; Lozada M, 2014, SPE INT S EXH FORM D; Murphy DJ, 2011, SUSTAINABILITY-BASEL, V3, P1888, DOI 10.3390/su3101888; Nogovitsyn R, 2014, SUSTAINABILITY-BASEL, V6, P6751, DOI 10.3390/su6106751; Odum HT, 2013, ENV POWER SOC 21 CEN; Parshall J, 2015, J PETROLEUM TECHNOLO; Poisson A, 2013, ENERGIES, V6, P5940, DOI 10.3390/en6115940; Rohatgi A., 2015, WEBPLOTDIGITIZER VER; Smith MI, 1997, OFFSH EUR C; Sun Y, 2015, OPERATING DATA CEIP; Thomas M, 2015, FORTIES AT 40 E P; Tripathi V. S., 2016, THESIS; UK Monthly Oil Production, UK MONTHL OIL PROD; Vafi K, 2014, ENVIRON SCI TECHNOL, V48, P10511, DOI 10.1021/es502107s; Webb MG, 1978, J CANADIAN PETROLEUM, V17; White B, 2015, PRUDHOE GAS SALES 20	44	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171083	10.1371/journal.pone.0171083	http://dx.doi.org/10.1371/journal.pone.0171083			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178318	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500021
J	Shadab, M; Jha, B; Asad, M; Deepthi, M; Kamran, M; Ali, N				Shadab, Md.; Jha, Baijayanti; Asad, Mohammad; Deepthi, Makaraju; Kamran, Mohd.; Ali, Nahid			Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; MITOCHONDRIAL DYSFUNCTION; MEDIATED APOPTOSIS; LIPID FORMULATIONS; OXIDATIVE STRESS; IMMUNE-RESPONSE; PLASMA-MEMBRANE; PHOSPHATIDYLSERINE; MECHANISMS; INHIBITION	Objective The present study aimed to elucidate the cell death mechanism in Leishmania donovani upon treatment with KalsomeTM10, a new liposomal amphotericin B. Methodology/Principal findings We studied morphological alterations in promastigotes through phase contrast and scanning electron microscopy. Phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential and disruption of mitochondrial integrity was determined by flow cytometry using annexinV-FITC, JC-1 and mitotraker, respectively. For analysing oxidative stress, generation of H2O2 (bioluminescence kit) and mitochondrial superoxide O-2(-) (mitosox) were measured. DNA fragmentation was evaluated using terminal deoxyribonucleotidyl transferase mediated dUTP nick-end labelling (TUNEL) and DNA laddering assay. We found that KalsomeTM10 is more effective then Ambisome against the promastigote as well as intracellular amastigote forms. The mechanistic study showed that KalsomeTM10 induced several morphological alterations in promastigotes typical of apoptosis. KalsomeTM10 treatment showed a dose-and time-dependent exposure of PS in promastigotes. Further, study on mitochondrial pathway revealed loss of mitochondrial membrane potential as well as disruption in mitochondrial integrity with depletion of intracellular pool of ATP. KalsomeTM10 treated promastigotes showed increased ROS production, diminished GSH levels and increased caspase-like activity. DNA fragmentation and cell cycle arrest was observed in KalsomeTM10 treated promastigotes. Apoptotic DNA fragmentation was also observed in KalsomeTM10 treated intracellular amastigotes. KalsomeTM10 induced generation of ROS and nitric oxide leads to the killing of the intracellular parasites. Moreover, endocytosis is indispensable for KalsomeTM10 mediated anti-leishmanial effect in host macrophage. Conclusions KalsomeTM10 induces apoptotic-like cell death in L. donovani parasites to exhibit its antileishmanial function.	[Shadab, Md.; Jha, Baijayanti; Asad, Mohammad; Deepthi, Makaraju; Kamran, Mohd.; Ali, Nahid] Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ali, N (corresponding author), Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, W Bengal, India.	nali@iicb.res.in	KAMRAN, MOHD/ABF-8235-2021; Asad, Mohammad/AAE-4367-2020	KAMRAN, MOHD/0000-0001-9007-6735; Asad, Mohammad/0000-0003-3078-200X; Shadab, Mohammad/0000-0003-4148-0365	Council of Scientific and Industrial Research (CSIR), Government of India; CSIR-Senior Research Fellow [31/002(0831)/2010/EMR-I]; Indian Council of Medical Research (ICMR)	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Senior Research Fellow; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was supported through grants from Council of Scientific and Industrial Research (CSIR), Government of India to MS, a CSIR-Senior Research Fellow (No. 31/002(0831)/2010/EMR-I) and Indian Council of Medical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Asad M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0928-6; Awasthi BP, 2016, APOPTOSIS, V21, P941, DOI 10.1007/s10495-016-1259-9; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Banerjee A, 2008, J ANTIMICROB CHEMOTH, V61, P103, DOI 10.1093/jac/dkm396; Berman J, 2003, CURR OPIN INFECT DIS, V16, P397, DOI 10.1097/00001432-200310000-00005; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Boswell GW, 1998, J CLIN PHARMACOL, V38, P583, DOI 10.1002/j.1552-4604.1998.tb04464.x; Brajtburg J, 1996, CLIN MICROBIOL REV, V9, P512, DOI 10.1128/CMR.9.4.512; Chowdhury S, 2012, EMBO MOL MED, V4, P1126, DOI 10.1002/emmm.201201316; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cohen-Sfady M, 2009, J IMMUNOL, V183, P890, DOI 10.4049/jimmunol.0804238; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; Di Giorgio C, 1999, J ANTIMICROB CHEMOTH, V44, P71, DOI 10.1093/jac/44.1.71; Dupont B, 2002, J ANTIMICROB CHEMOTH, V49, P31, DOI 10.1093/jac/49.suppl_1.31; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Gannavaram S, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00095; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hiemenz JW, 1996, CLIN INFECT DIS, V22, pS133, DOI 10.1093/clinids/22.Supplement_2.S133; Holzmuller P, 2002, INFECT IMMUN, V70, P3727, DOI 10.1128/IAI.70.7.3727-3735.2002; Imbert L, 2012, ANAL BIOANAL CHEM, V402, P1169, DOI 10.1007/s00216-011-5520-3; Islamuddin M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00626; Kathuria M, 2014, ANTIMICROB AGENTS CH, V58, P5916, DOI 10.1128/AAC.02459-14; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LANG T, 1994, J CELL SCI, V107, P2137; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Legrand P, 1996, J ANTIMICROB CHEMOTH, V37, P519, DOI 10.1093/jac/37.3.519; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Mishra J, 2013, INDIAN J MED RES, V137, P767; Mojic M, 2012, MOL PHARMACOL, V82, P700, DOI 10.1124/mol.112.077842; Mondal S, 2010, EXPERT REV ANTI-INFE, V8, P919, DOI 10.1586/ERI.10.78; Mourdjeva M, 2005, APOPTOSIS, V10, P209, DOI 10.1007/s10495-005-6076-5; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nagao G, 2010, ANTICANCER RES, V30, P3167; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Persaud-Sawin DA, 2009, GLIA, V57, P320, DOI 10.1002/glia.20759; Ribeiro GA, 2013, J ANTIMICROB CHEMOTH, V68, P789, DOI 10.1093/jac/dks498; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Russo R, 1996, J INFECTION, V32, P133, DOI 10.1016/S0163-4453(96)91343-2; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; Salih NA, 2014, TROP MED INT HEALTH, V19, P146, DOI 10.1111/tmi.12238; Sardar AH, 2013, EXP PARASITOL, V135, P715, DOI 10.1016/j.exppara.2013.10.011; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Shibuya-Fujiwara N, 2001, LIFE SCI, V70, P291, DOI 10.1016/S0024-3205(01)01392-3; SHIMASAKI H, 1994, METHOD ENZYMOL, V233, P338; Sinha R, 2015, ANTIMICROB AGENTS CH, V59, P344, DOI 10.1128/AAC.03305-14; Sundar S, 2010, J GLOB INFECT DIS, V2, P159, DOI 10.4103/0974-777X.62886; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vishwakarma P, 2016, J MOL MED, V94, P695, DOI 10.1007/s00109-016-1384-5; Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071	73	40	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171306	10.1371/journal.pone.0171306	http://dx.doi.org/10.1371/journal.pone.0171306			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170432	gold, Green Submitted, Green Published			2022-12-27	WOS:000393705500031
J	Qu, F; Weschler, LB; Sun, YX; Sundell, J				Qu, Fang; Weschler, Louise B.; Sun, Yuexia; Sundell, Jan			High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; POPULATION-BASED SURVEILLANCE; INDOOR AIR-POLLUTION; CHILDHOOD PNEUMONIA; YOUNG-CHILDREN; RESPIRATORY-INFECTIONS; PRESCHOOL-CHILDREN; GLOBAL BURDEN; DISEASE	Objectives To compare the proportion of Beijing children who have ever had pneumonia (%Pneumonia) to those in other locations, and to estimate by how much national vaccine coverage with Pneumococcal Conjugate Vaccine (PCV) and Haemophilus lnfluenzae Type b (Hib) could reduce Beijing %Pneumonia. Methods %Pneumonia was obtained for each age group from 1 to 8 years inclusive from 5,876 responses to a cross-sectional questionnaire. Literature searches were conducted for world-wide reports of %Pneumonia. Previous vaccine trials conducted worldwide were used to estimate the pneumococcal (S. pneumoniae) and Hib (H. influenzae) burdens and % Pneumonia as well as the potential for PCV and Hib vaccines to reduce Beijing children's % Pneumonia. Findings The majority of pneumonia cases occurred by the age of three. The cumulative %Pneumonia for 3-8 year-old Beijing children, 26.9%, was only slightly higher than the 25.4% for the discrete 3 year-old age group, similar to trends for Tianjin (China) and Texas (USA). Beijing's %Pneumonia is disproportionally high relative to its Gross National Income (GNI) per capita, and markedly higher than %Pneumonia in the US and other high GNI per capita countries. Chinese diagnostic guidelines recommend chest X-ray confirmation while most other countries discourage it in favor of clinical diagnosis. Literature review shows that chest X-ray confirmation returns far fewer pneumonia diagnoses than clinical diagnosis. Accordingly, Beijing's %Pneumonia is likely higher than indicated by raw numbers. Vaccine trials suggest that national PCV and Hib vaccination could reduce Beijing's %Pneumonia from 26.9% to 19.7% and 24.9% respectively. Conclusion National PCV and Hib vaccination programs would substantially reduce Beijing children's pneumonia incidence.	[Qu, Fang] China Meteorol Adm, China Meteorol Adm Training Ctr, Beijing, Peoples R China; [Qu, Fang; Sundell, Jan] Tsinghua Univ, Dept Bldg Sci, Beijing, Peoples R China; [Sun, Yuexia] Tianjin Univ, Sch Environm Sci & Engn, Tianjin, Peoples R China	China Meteorological Administration; Tsinghua University; Tianjin University		lulu.weschler1@gmail.com		Weschler, Louise/0000-0002-5778-6134				Benavides JA, 2012, VACCINE, V30, P5886, DOI 10.1016/j.vaccine.2012.03.054; Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; Arguedas A, 2012, VACCINE, V30, P2342, DOI 10.1016/j.vaccine.2012.01.047; Ayalon I, 2013, PEDIATR EMERG CARE, V29, P893, DOI 10.1097/PEC.0b013e31829e7d6a; Ben Shimol S, 2012, EUR J PEDIATR, V171, P369, DOI 10.1007/s00431-011-1543-1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Castro-Rodriguez JA, 1999, AM J RESP CRIT CARE, V159, P1891, DOI 10.1164/ajrccm.159.6.9811035; Centers for Disease Control and Prevention, MMWR MORB MORTAL WKL; Che DT, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-56; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chiu SS, 2016, J MICROBIOL IMMUNOL, V49, P225, DOI 10.1016/j.jmii.2014.05.007; Clark JE, 2007, ARCH DIS CHILD, V92, P394, DOI 10.1136/adc.2006.097402; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Garces-Sanchez M D, 2005, An Pediatr (Barc), V63, P125; Gessner BD, 2014, VACCINE, V32, P3133, DOI 10.1016/j.vaccine.2014.04.019; GROSSMAN LK, 1988, ANN EMERG MED, V17, P43, DOI 10.1016/S0196-0644(88)80502-X; Guan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011721; Gupta D, 1996, J TROP PEDIATRICS, V42, P196, DOI 10.1093/tropej/42.4.196; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hazir T, 2006, BMJ-BRIT MED J, V333, P629, DOI 10.1136/bmj.38915.673322.80; Ho PL, 2007, VACCINE, V25, P6837, DOI 10.1016/j.vaccine.2007.07.039; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; International Vaccine Access Center (IVAC), 2016, VACC INF MAN SYST VI; Kuti BP, 2014, WORLD J MED MED SCI, V2, P1; Leonardi GS, 2002, EUR RESPIR J, V20, P890, DOI 10.1183/09031936.02.00260802; Li AG, 2014, CHINESE SCI BULL, V59, P2024, DOI 10.1007/s11434-014-0241-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Liu W, 2014, INDOOR BUILT ENVIRON, V23, P270, DOI 10.1177/1420326X13516970; Lu C, 2014, INDOOR BUILT ENVIRON, V23, P259, DOI 10.1177/1420326X13504423; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Lucero MG, 2005, LANCET, V365, P1113, DOI 10.1016/S0140-6736(05)71853-5; Lynch T, 2004, PEDIATRICS, V113, pE186, DOI 10.1542/peds.113.3.e186; Lynch Tim, 2010, PLoS One, V5, pe11989, DOI 10.1371/journal.pone.0011989; MacIntyre CR, 2003, EPIDEMIOL INFECT, V131, P1091, DOI 10.1017/S0950268803001365; Madhi SA, 2013, PEDIATR INFECT DIS J, V32, pE119, DOI 10.1097/INF.0b013e3182784b26; Medicine CSoR, 2006, CHIN J TUBERCUL RESP, V29, P651; Mulholland EK, 2004, J HEALTH POPUL NUTR, V22, P257; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Neuman MI, 2010, PEDIATR EMERG CARE, V26, P817, DOI 10.1097/PEC.0b013e3181fb0d95; Njeze N. R., 2011, Advances in Bio Research, V2, P18; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Grady KAF, 2014, PNEUMONIA, V5, P38, DOI 10.15172/pneu.2014.5/482; Pilishvili T, 2013, J PEDIATR-US, V163, pS12, DOI 10.1016/j.jpeds.2013.03.025; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Qu F, 2013, CHINESE SCI BULL, V58, P4190, DOI 10.1007/s11434-013-5790-6; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; Rothrock SG, 2001, PEDIATR EMERG CARE, V17, P240, DOI 10.1097/00006565-200108000-00003; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Saadatian-Elahi M, 2016, VACCINE, V34, P1139, DOI 10.1016/j.vaccine.2016.01.021; Schnabel E, 2009, EUR J PEDIATR, V168, P1251, DOI 10.1007/s00431-008-0921-9; Shah S, 2010, PEDIATR INFECT DIS J, V29, P406, DOI 10.1097/INF.0b013e3181cb45a7; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Sun YX, 2011, J ASTHMA, V48, P790, DOI 10.3109/02770903.2011.604884; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Turner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054026; Wagner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097800; Weigl JAI, 2003, EUR J PEDIATR, V162, P309, DOI 10.1007/s00431-002-1140-4; Wikipedia, 2016, LIST CHIN ADM DIV GD; World Bank, 2016, SCROLL EC GROWTH GDP; World Bank, 2016, SCROLL EC GROWTH GNI; Yan Shujuan, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P484; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983	71	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171438	10.1371/journal.pone.0171438	http://dx.doi.org/10.1371/journal.pone.0171438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166256	Green Submitted, gold, Green Published			2022-12-27	WOS:000393700100043
J	Steenholt, JV; Nielsen, C; Baudewijn, L; Staal, A; Rasmussen, KS; Sabir, HJ; Barington, T; Husby, S; Toft-Hansen, H				Steenholt, Janni V.; Nielsen, Christian; Baudewijn, Leen; Staal, Anne; Rasmussen, Karina S.; Sabir, Hardee J.; Barington, Torben; Husby, Steffen; Toft-Hansen, Henrik			The composition of T cell subtypes in duodenal biopsies are altered in coeliac disease patients	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; SMALL-INTESTINE; PREVALENCE; CHILDREN; GLUTEN; EXPRESSION; PEPTIDES; TRIGGERS; COMPLEX; CD4(+)	One of the hallmarks of Celiac disease (CD) is intraepithelial lymphocytosis in the small intestine. Until now, investigations to characterize the T cell subpopulations within the epithelial layer have not discriminated between the heterodimeric co -receptor molecule, CD8 alpha beta, and the possibly immunoregulatory CD8 alpha alpha homodimer molecule. Besides TCR alpha beta+ CD4+ cells, no other phenotypes have been shown to be gluten -reactive. Using flow cytometry on lymphocytes from duodenal biopsies, we determined that the number of B cells (CD3-CD19 +) and the number of CD3+ CD4-CD8-double -negative (DN) T cells were elevated 6-7 fold in children with CD. We next isolated and quantified intraepithelial lymphocytes (IELs) from biopsies obtained from patients (both children and adults) with CD, potential CD and non -CD controls. Flow cytometric analysis of the duodenal T cell subpopulations was performed including the markers TCR alpha beta, TCR gamma delta, CD4, CD8a and CD8 beta. Proportions of gamma delta T cells and CD8 alpha beta+ cells among IELs were increased in CD patients, whereas proportions of CD4+ CD8 alpha alpha+ and CD4+ single -positive T cells were decreased. Additionally, two gluten -reactive T cell lines (TCLs) derived from CD biopsies were analyzed for changes in proportions of T cell subsets before and after gluten stimulation. In a proliferation assay, dividing cells were tracked with carboxyfluorescein succinimidyl ester (CFSE), and both alpha beta and gamma delta T cells proliferated in response to gluten. Changes in duodenal T cell subpopulations in potential CD patients followed the same pattern as for CD patients, but with less pronounced effect.	[Steenholt, Janni V.; Staal, Anne; Rasmussen, Karina S.; Husby, Steffen; Toft-Hansen, Henrik] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark; [Steenholt, Janni V.; Nielsen, Christian; Baudewijn, Leen; Staal, Anne; Rasmussen, Karina S.; Sabir, Hardee J.; Barington, Torben; Toft-Hansen, Henrik] Odense Univ Hosp, Dept Clin Immunol, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Husby, S (corresponding author), Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark.	steffen.husby@rsyd.dk	Barington, Torben/R-6841-2019; Barington, Torben/C-3922-2009	Barington, Torben/0000-0001-6968-148X; Husby, Steffen/0000-0002-6286-2496; Nielsen, Christian/0000-0002-5711-6595	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare [0603-00199B]; Odense University Hospital Research Council; Novo Nordisk Fonden [NNF14OC0012869] Funding Source: researchfish; The Danish Cancer Society [R71-A4807] Funding Source: researchfish	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare; Odense University Hospital Research Council; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This project was funded by The Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare (contract no. 0603-00199B), and by a grant from Odense University Hospital Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Calleja S, 2011, DIGEST DIS SCI, V56, P2042, DOI 10.1007/s10620-010-1534-5; Carton J, 2004, EUR J GASTROEN HEPAT, V16, P961, DOI 10.1097/00042737-200410000-00003; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; du Pre MF, 2015, BEST PRACT RES CL GA, V29, P413, DOI 10.1016/j.bpg.2015.04.001; Dydensborg S, 2012, ACTA PAEDIATR, V101, P179, DOI 10.1111/j.1651-2227.2011.02392.x; FERGUSON A, 1971, GUT, V12, P988, DOI 10.1136/gut.12.12.988; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jarvinen TT, 2003, AM J GASTROENTEROL, V98, P1332, DOI 10.1016/S0002-9270(03)00230-2; JENKINS D, 1986, GUT, V27, P1330, DOI 10.1136/gut.27.11.1330; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kupfer Sonia S, 2012, Gastrointest Endosc Clin N Am, V22, P639, DOI 10.1016/j.giec.2012.07.003; Lonardi S, 2013, VIRCHOWS ARCH, V463, P409, DOI 10.1007/s00428-013-1448-7; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Meresse B, 2012, IMMUNITY, V36, P907, DOI 10.1016/j.immuni.2012.06.006; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; SELBY WS, 1983, CLIN EXP IMMUNOL, V52, P219; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Silvester JA, 2016, CLIN PRACTICE J AM G; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sperandeo MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021281; TERRY LA, 1990, TISSUE ANTIGENS, V35, P82, DOI 10.1111/j.1399-0039.1990.tb01761.x; Toft-Hansen H, 2014, CLIN IMMUNOL, V153, P323, DOI 10.1016/j.clim.2014.05.009; Tosco A, 2011, CLIN GASTROENTEROL H, V9, P320, DOI 10.1016/j.cgh.2010.09.006; VERKASALO MA, 1990, GUT, V31, P422, DOI 10.1136/gut.31.4.422; Volta U, 2015, CLIN PRACTICE J AM G; Witherden DA, 2013, J LEUKOCYTE BIOL, V94, P69, DOI 10.1189/jlb.0213101	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170270	10.1371/journal.pone.0170270	http://dx.doi.org/10.1371/journal.pone.0170270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166225	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100008
J	Antoni, G; Marini, E; Curreli, N; Tuveri, V; Comandini, O; Cabras, S; Gabba, S; Madeddu, C; Crisafulli, A; Rinaldi, AC				Antoni, Giorgia; Marini, Elisabetta; Curreli, Nicoletta; Tuveri, Valerio; Comandini, Ornella; Cabras, Stefano; Gabba, Silvia; Madeddu, Clelia; Crisafulli, Antonio; Rinaldi, Andrea C.			Energy expenditure in caving	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE VECTOR; EXERCISE; HEAT; CHALLENGES; STRATEGIES; CAVE	The aim of this study was to determine the energy expenditure of a group of cavers of both genders and different ages and experience during a 10 hour subterranean exploration, using portable metabolimeters. The impact of caving activity on body composition and hydration were also assessed through bioelectrical impedance, and nutritional habits of cavers surveyed. During cave activity, measured total energy expenditure (TEE) was in the range 225-287 kcal/h for women-men (MET = 4.1), respectively; subjects had an energy intake from food in the range 1000-1200 kcal, thus inadequate to restore lost calories. Bayesian statistical analysis estimated the effect of predictive variables on TEE, revealing that experienced subjects had a 5% lower TEE than the less skilled ones and that women required a comparatively larger energy expenditure than men to perform the same task. BIVA (bioelectrical impedance vector analysis) showed that subjects were within the range of normal hydration before and after cave activity, but bioelectrical changes indicated a reduction of extracellular water in men, which might result in hypo-osmolal dehydration in the case of prolonged underground exercise. All these facts should be considered when planning cave explorations, preparing training programs for subjects practising caving, and optimizing a diet for cavers. Further, information gathered through this study could be of value to reduce accidents in caves related to increase in fatigue.	[Antoni, Giorgia; Rinaldi, Andrea C.] Grp Speleo Archeol Giovanni Spano, Cagliari, Italy; [Antoni, Giorgia; Curreli, Nicoletta; Rinaldi, Andrea C.] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Marini, Elisabetta; Comandini, Ornella] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Tuveri, Valerio] Corpo Nazl Soccorso Alpino & Speleol, Sardinia, Italy; [Cabras, Stefano] Univ Cagliari, Dept Math & Informat, Cagliari, Italy; [Cabras, Stefano] Univ Carlos III Madrid, Dept Stat, Getafe, Spain; [Gabba, Silvia; Madeddu, Clelia; Crisafulli, Antonio] Univ Cagliari, Dept Med Sci, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari; Universidad Carlos III de Madrid; University of Cagliari	Rinaldi, AC (corresponding author), Grp Speleo Archeol Giovanni Spano, Cagliari, Italy.; Rinaldi, AC (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	rinaldi@unica.it	Cabras, Stefano/AAA-2477-2019; Rinaldi, Andrea/N-1007-2019	Cabras, Stefano/0000-0001-6690-8378; Rinaldi, Andrea/0000-0002-9352-1037; Madeddu, Clelia/0000-0001-8940-6987; Marini, Elisabetta/0000-0001-8779-8745				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 1996, AM J CLIN NUTR, V64, P524, DOI DOI 10.1093/ajcn/64.3.524S; Arrica S, 2014, SPELEOLOGIA, V70, P44; Badino G, 2009, P 15 INT C SPEL KERR; Berntsen S, 2010, BRIT J SPORT MED, V44, P657, DOI 10.1136/bjsm.2008.048868; Bessone L., 2013, P 16 INT C SPEL BRNO, P321; Bregani ER, 2005, MED SPORT, V58, P233; Buffa R, 2014, EUR J CLIN NUTR, V68, P1234, DOI 10.1038/ejcn.2014.170; Buffa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058533; Buzzacott P, 2014, DIVING HYPERB MED, V44, P74; Cheeptham N., 2013, CAVE MICROBIOMES NOV; Cowart David W, 2014, Hawaii J Med Public Health, V73, P10; Czeisler CA, 2007, COLD SPRING HARB SYM, V72, P579, DOI 10.1101/sqb.2007.72.064; DE FELICE F, 1952, Boll Soc Ital Biol Sper, V28, P1138; De Waele JVL., 2004, ACTA CARSOLOGICA, V33, P37, DOI [10.3986/ac.v33i2.290, DOI 10.3986/AC.V33I2.290]; Elliott LR, 2015, SOC SCI MED, V139, P53, DOI 10.1016/j.socscimed.2015.06.038; Espana-Romero V, 2012, EUR J APPL PHYSIOL, V112, P821, DOI 10.1007/s00421-011-2022-0; Hamill J, 2014, BIOMECHANICAL BASIS; Hempel JC, 2001, CALL COMPLETE REFERE; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Hollowell RP, 2009, MED SCI SPORT EXER, V41, P1640, DOI 10.1249/MSS.0b013e31819c71a4; Hue O, 2012, W INDIAN MED J, V61, P94; Ibanez ME, 2015, AM J HUM BIOL, V27, P871, DOI 10.1002/ajhb.22728; International Olympic Committee, 2016, 3 NEW SPORTS JOIN BU; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Kent M., 1997, FOOD FITNESS DICT DI; Kreider RB, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-7; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P117, DOI 10.1111/j.1600-0838.2010.01221.x; MIT Caving Club, 1999, INTR CAV NOV CAV; Mouret C., 2004, ENCY CAVES KARST SCI, P483; PICCOLI A, 1995, AM J CLIN NUTR, V61, P269, DOI 10.1093/ajcn/61.2.269; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Piccoli A., 2002, BIVA SOFTWARE; Plowman SA, 2014, EXERCISE PHYSL HLTH; Praz C, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0108-5; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sawka MN, 2015, SPORTS MED, V45, pS51, DOI 10.1007/s40279-015-0395-7; Schneider TM, 2016, INJURY, V47, P280, DOI 10.1016/j.injury.2015.09.005; SportAccord, 2016, DEF SPORT; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Stella-Watts AC, 2012, WILD ENVIRON MED, V23, P215, DOI 10.1016/j.wem.2012.03.004; Stenner E, 2006, BRIT J SPORT MED, V40, P235, DOI 10.1136/bjsm.2005.021402; Tyler CJ, 2016, SPORTS MED, V46, P1699, DOI 10.1007/s40279-016-0538-5; Walker EJ, 2016, J SCI MED SPORT, V19, P177, DOI 10.1016/j.jsams.2015.01.013; Wendt D, 2007, SPORTS MED, V37, P669, DOI 10.2165/00007256-200737080-00002; White W. B., 2012, ENCY CAVES; Zubieta-Calleja G, 2004, TXB MED PHYSL PATHOP	49	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170853	10.1371/journal.pone.0170853	http://dx.doi.org/10.1371/journal.pone.0170853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158208	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700018
J	Derbel, O; Heudel, PE; Cropet, C; Meeus, P; Vaz, G; Biron, P; Cassier, P; Decouvelaere, AV; Ranchere-Vince, D; Collard, O; De Laroche, E; Thiesse, P; Farsi, F; Cellier, D; Gilly, FN; Blay, JY; Ray-Coquard, I				Derbel, Olfa; Heudel, Pierre Etienne; Cropet, Claire; Meeus, Pierre; Vaz, Gualter; Biron, Pierre; Cassier, Philippe; Decouvelaere, Anne-Valerie; Ranchere-Vince, Dominique; Collard, Olivier; De Laroche, Eric; Thiesse, Philippe; Farsi, Fadila; Cellier, Dominic; Gilly, Francois-Noel; Blay, Jean-Yves; Ray-Coquard, Isabelle			Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)	PLOS ONE			English	Article							CANCER STATISTICS; RECOMMENDATIONS; MANAGEMENT; DIAGNOSIS	Purpose The outcome of sarcoma has been suggested in retrospective and non-exhaustive studies to be better through management by a multidisciplinary team of experts and adherence to clinical practice guidelines (CPGs). The aim of this prospective and exhaustive population based study was to confirm the impact of adherence to CPGs on survival in patients with localized sarcoma. Experimental design Between 2005 and 2007, all evaluable adult patients with a newly diagnosis of localized sarcoma located in Rhone Alpes region (n = 634), including 472 cases of soft-tissue sarcoma (STS), were enrolled. The prognostic impact of adherence to CPGs on progression-free survival (PFS) and overall survival (OS) was assessed by multivariate Cox model in this cohort. Results The median age was 61 years (range 16-92). The most common subtypes were liposarcoma (n = 133, 28%), unclassified sarcoma (n = 98, 20.7%) and leiomyosarcoma (n = 69, 14.6%). In the initial management phase, from diagnosis to adjuvant treatment, the adherence to CPGs for patients with localized STS was 36% overall, corresponding to 56%, 85%, 96% and 84% for initial surgery, radiation therapy, chemotherapy and follow-up, respectively. Adherence to CPGs for surgery was the strongest independent prognostic factor PFS, along with age, gender, grade, and tumor size. For OS, multivariate analysis adherence to CPGs for surgery was a strong independent prognostic factor, with an important interaction with a management in the regional expert centers. Conclusions This study demonstrates impact of CPGs and treatment within an expert center on survival for STS patients in a whole population-based cohort.	[Derbel, Olfa; Heudel, Pierre Etienne; Biron, Pierre; Cassier, Philippe; Cellier, Dominic; Blay, Jean-Yves; Ray-Coquard, Isabelle] Ctr Leon Berard, Dept Med Oncol, Lyon, France; [Cropet, Claire] Ctr Leon Berard, Dept Biostat, Lyon, France; [Meeus, Pierre; Vaz, Gualter] Ctr Leon Berard, Dept Surg, Lyon, France; [Meeus, Pierre; Vaz, Gualter; Ranchere-Vince, Dominique; Collard, Olivier; Blay, Jean-Yves; Ray-Coquard, Isabelle] GSF GETO, Lyon, France; [Vaz, Gualter] Clin IRIS, Dept Orthoped Surg, Lyon, France; [Decouvelaere, Anne-Valerie; Ranchere-Vince, Dominique] Ctr Leon Berard, Dept Pathol, Lyon, France; [Collard, Olivier; De Laroche, Eric] Inst Cancerol Lucien Neuwirth, St Priest En Jarez, France; [Thiesse, Philippe] Ctr Leon Berard, Dept Radiol, Lyon, France; [Farsi, Fadila; Blay, Jean-Yves; Ray-Coquard, Isabelle] Reseau Espace Sante Canc, Rhone Alpes, France; [Gilly, Francois-Noel; Blay, Jean-Yves; Ray-Coquard, Isabelle] Univ Claude Bernard, Lyon, France; [Blay, Jean-Yves; Ray-Coquard, Isabelle] Univ Lyon 1, Lab HESPER EA 7425, Lyon, France	UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Institut de Cancerologie de la Loire; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Derbel, O (corresponding author), Ctr Leon Berard, Dept Med Oncol, Lyon, France.	Olfa.derbel@lyon.unicancer.fr	Blay, Jean-Yves/N-3966-2016	Blay, Jean-Yves/0000-0001-7190-120X; HEUDEL, Pierre/0000-0002-2155-549X				Bauer HCF, 2001, ACTA ORTHOP SCAND, V72, P150, DOI 10.1080/000164701317323408; Bhangu A. A., 2004, Sarcoma, V8, P1, DOI 10.1080/13577140410001679185; Blay JY, 2012, ANN ONCOL, V23, P92, DOI 10.1093/annonc/mds253; Casali PG, 2009, ANN ONCOL, V20, P132, DOI 10.1093/annonc/mdp153; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.x; Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hebert-Croteau N, 2004, J CLIN ONCOL, V22, P3685, DOI 10.1200/JCO.2004.07.018; Heudel PE, 2013, INT J CLIN ONCOL; Hussein R, 2005, ANN ROY COLL SURG, V87, P171, DOI 10.1308/1478708051658; Jansen-Landheer MLEA, 2009, EJSO-EUR J SURG ONC, V35, P1326, DOI 10.1016/j.ejso.2009.05.002; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lurkin A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-150; Mankin Henry J, 2005, Cancer Control, V12, P5; Misra A, 2009, J PLAST RECONSTR AES, V62, P161, DOI 10.1016/j.bjps.2008.08.018; Paszat Lawrence, 2002, Sarcoma, V6, P19, DOI 10.1080/13577140220127521; Paulson EC, 2008, ANN SURG, V248, P675, DOI 10.1097/SLA.0b013e318187a757; Ray-Coquard I, 2004, ANN ONCOL, V15, P307, DOI 10.1093/annonc/mdh058; Rossi CR, 2013, ANN ONCOL, V24, P1685, DOI 10.1093/annonc/mdt031; Rydholm A, 1997, ACTA ORTHOP SCAND, V68, P4, DOI 10.1080/17453674.1997.11744695; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stojadinovic A, 2002, ANN SURG, V235, P424, DOI 10.1097/00000658-200203000-00015; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Woll PJ, 2012, LANCET ONCOL, V13, P1045, DOI 10.1016/S1470-2045(12)70346-7	27	49	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0158406	10.1371/journal.pone.0158406	http://dx.doi.org/10.1371/journal.pone.0158406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158190	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700001
J	Mayekar, HV; Kodandaramaiah, U				Mayekar, Harshad Vijay; Kodandaramaiah, Ullasa			Pupal colour plasticity in a tropical butterfly, Mycalesis mineus (Nymphalidae: Satyrinae)	PLOS ONE			English	Article							PAPILIO-MACHAON L; BATTUS-PHILENOR L; SWALLOWTAIL BUTTERFLIES; PIERIS-BRASSICAE; PHENOTYPIC PLASTICITY; INFORMATION CRITERION; ENVIRONMENTAL-CONTROL; BICYCLUS BUTTERFLIES; MODEL SELECTION; LEPIDOPTERA	Lepidopteran insects have provided excellent study systems for understanding adaptive phenotypic plasticity. Although there are a few well-studied examples of adult plasticity among tropical butterflies, our understanding of plasticity of larval and pupal stages is largely restricted to temperate butterflies. The environmental parameters inducing phenotypic plasticity and the selective pressures acting on phenotypes are likely to differ across tropical and temperate climate regimes. We tested the influence of relative humidity (RH), a prominent yet under-appreciated tropical climatic component, along with pupation substrate, larval development time, pupal sex and weight in determining pupal colour in the tropical satyrine butterfly Mycalesis mineus. Pupae of this butterfly are either brown or green or very rarely intermediate. Larvae were reared at high (85%) and low (60%) RH at a constant temperature. Proportions of green and brown pupae were expected to vary across low and high RH and pupation substrates in order to enhance crypsis. Brown pupae were more common at low RH than at high RH, as predicted, and developed faster than green pupae. Pupal colour was correlated with pupation substrate. Choice of pupation substrate differed across RH treatments. It is unclear whether pupal colour influences substrate selection or whether substrate influences pupal colour. Our study underscores the need for further work to understand the basis of pupal plasticity in tropical butterflies.	[Mayekar, Harshad Vijay; Kodandaramaiah, Ullasa] Indian Inst Sci Educ & Res Thiruvananthapuram, ICREEE, Maruthamala PO Vithura, Thiruvananthapuram, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Mayekar, HV (corresponding author), Indian Inst Sci Educ & Res Thiruvananthapuram, ICREEE, Maruthamala PO Vithura, Thiruvananthapuram, Kerala, India.	mayekarharshad@iisertvm.ac.in	Mayekar, Harshad Vijay/AAE-3791-2022	Mayekar, Harshad/0000-0003-4053-5918; Kodandaramaiah, Ullasa/0000-0002-1564-1738	Indian Institute of Science Education and Research Thiruvananthapuram, Kerala; Department of Science and Technology (INSPIRE Faculty Award) [DST/INSPIRE/04/2013/000476]	Indian Institute of Science Education and Research Thiruvananthapuram, Kerala; Department of Science and Technology (INSPIRE Faculty Award)(Department of Science & Technology (India))	This work was supported by the Indian Institute of Science Education and Research Thiruvananthapuram, Kerala; http://www.iisertvm.ac.in, and the Department of Science and Technology (INSPIRE Faculty Award to UK: DST/INSPIRE/04/2013/000476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Agresti A., 2011, CATEGORICAL DATA ANA; Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Andersson S, 1996, P ROY SOC B-BIOL SCI, V263, P843, DOI 10.1098/rspb.1996.0124; ANGERSBACH D, 1975, J INSECT PHYSIOL, V21, P1691, DOI 10.1016/0022-1910(75)90181-X; ANGERSBACH D, 1971, NATURWISSENSCHAFTEN, V58, P571, DOI 10.1007/BF00598731; BAKER RR, 1970, J ZOOL, V162, P43; Bowden S.R., 1979, Entomologist's Gazette, V30, P112; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brakefield P. M., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P337; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1984, BIOL J LINN SOC, V22, P1, DOI 10.1111/j.1095-8312.1984.tb00795.x; Brecher L, 1921, ARCH ENTWICKLUNG ORG, V48, P1, DOI 10.1007/BF02554478; Brisson JA, 2005, EVOLUTION, V59, P1046; Burnham K P, 2003, MODEL SELECT MULTIMO; CLARKE CA, 1972, J ENTOMOL SER A-GEN, V46, P123; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Danks H. V., 1987, BIOL SURVEY CANADA M, V1, P1; Edmunds M., 1974, DEFENCE ANIMALS; Evans WH, 1927, IDENTIFICATION INDIA; Fox J., 2014, R COMPANION APPL REG; Fox J., 2016, PACKAGE CAR; GARDINER BO, 1974, ROUX ARCH DEV BIOL, V176, P13, DOI 10.1007/BF00577829; Harrison JWH, 1928, P R SOC LOND B-CONTA, V102, P347, DOI 10.1098/rspb.1928.0010; HAZEL W, 1987, HEREDITY, V59, P449, DOI 10.1038/hdy.1987.155; Hazel W, 1998, ECOL ENTOMOL, V23, P41, DOI 10.1046/j.1365-2311.1998.00092.x; HAZEL WN, 1979, ECOL ENTOMOL, V4, P393, DOI 10.1111/j.1365-2311.1979.tb00599.x; HAZEL WN, 1983, ECOL ENTOMOL, V8, P37, DOI 10.1111/j.1365-2311.1983.tb00480.x; Hidaka T., 1959, JAP J EXP MORPH, V13, P1; Hidaka T., 1959, DOBUTSUGAKU ZASSHI, V68, P222; Hiraga S, 2005, J INSECT PHYSIOL, V51, P1033, DOI 10.1016/j.jinsphys.2005.04.018; Hiraga S, 2006, J INSECT PHYSIOL, V52, P826, DOI 10.1016/j.jinsphys.2006.05.002; HONDA K, 1981, APPL ENTOMOL ZOOL, V16, P467, DOI 10.1303/aez.16.467; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Ishizaki H., 1956, Memoirs of the College of Science University of Kyoto (B), V23, P11; KAYSER H, 1974, J INSECT PHYSIOL, V20, P2277, DOI 10.1016/0022-1910(74)90050-X; KINGSOLVER JG, 1991, AM NAT, V137, P816, DOI 10.1086/285195; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Majerus M, 1998, MELANISM EVOLUTION A; Mazerolle M.J., 2011, R PACKAGE VERSION, V1; McCullagh P, 1989, GEN LINEAR MODELS; Merrifield F, 1899, T ROY ENT SOC LONDON, V47, P369; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; NYLIN S, 1989, BIOL J LINN SOC, V38, P155, DOI 10.1111/j.1095-8312.1989.tb01571.x; Ohnishi E., 1956, Zoological Magazine Tokyo, V65, P185; Oltmer A., 1968, STEUERUNG MELANINEIN, V160, P401; Parkash R, 2008, J INSECT PHYSIOL, V54, P1050, DOI 10.1016/j.jinsphys.2008.04.008; Parkash R, 2010, EVOL ECOL, V24, P207, DOI 10.1007/s10682-009-9301-9; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Poulton E. B., 1887, Philosophical Transactions, Vvol. 178, P311, DOI 10.1098/rstb.1887.0014; R Core Team, 2013, R LANG ENV STAT COMP; R Studio Team, 2016, RSTUDIO INT DEV ENV; RAI SN, 1986, J ECOL, V74, P455, DOI 10.2307/2260267; Rajpurohit S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163414; ROFF D, 1983, DIAPAUSE LIFE CYCLE, P253; ROTHSCHILD M, 1975, NATURE, V254, P592, DOI 10.1038/254592a0; Saji K, 2017, BUTTERFLIES INDIA, V2.24; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; Sheppard PM, 1958, NAT SEL HERED; SIMS SR, 1983, HEREDITY, V50, P159, DOI 10.1038/hdy.1983.17; SIMS SR, 1983, ECOL ENTOMOL, V8, P95, DOI 10.1111/j.1365-2311.1983.tb00486.x; SINGER MC, 1982, AM NAT, V119, P440, DOI 10.1086/283924; SMITH AG, 1978, PROC R SOC SER B-BIO, V200, P295, DOI 10.1098/rspb.1978.0021; SMITH AG, 1980, PROC R SOC SER B-BIO, V207, P163, DOI 10.1098/rspb.1980.0019; SMITH DAS, 1988, BIOL J LINN SOC, V33, P17, DOI 10.1111/j.1095-8312.1988.tb00444.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WEST DA, 1972, J NEW YORK ENTOMOL S, V80, P205; WEST DA, 1985, PHYSIOL ENTOMOL, V10, P113, DOI 10.1111/j.1365-3032.1985.tb00025.x; West-Eberhard Mary Jane, 2003, pi; Whitman D.W., 2009, PHENOTYPIC PLASTICIT, V1st; WIKLUND C, 1991, OIKOS, V60, P241, DOI 10.2307/3544871; WIKLUND C, 1972, NATURWISSENSCHAFTEN, V59, P219, DOI 10.1007/BF00595518; WIKLUND C, 1975, T ROY ENT SOC LONDON, V127, P73; Windig JJ, 1999, HEREDITY, V82, P57, DOI 10.1038/sj.hdy.6884510; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Wood TW., 1867, P ROYAL ENTOMOLOGICA, P98; Wynter Blyth MA, 1957, BUTTERFLIES INDIAN R; Yamamoto K, 2011, J INSECT PHYSIOL, V57, P930, DOI 10.1016/j.jinsphys.2011.04.002	82	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171482	10.1371/journal.pone.0171482	http://dx.doi.org/10.1371/journal.pone.0171482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158254	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700083
J	Ovsyannikova, IG; Schaid, DJ; Larrabee, BR; Haralambieva, IH; Kennedy, RB; Poland, GA				Ovsyannikova, Inna G.; Schaid, Daniel J.; Larrabee, Beth R.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.			A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CLASS-I SUPERTYPES; IMMUNE-RESPONSES; CYTOKINE RESPONSES; SMALLPOX VACCINE; GENETIC-CONTROL; VIRUS; POLYMORPHISMS; ALLELES; CELL	Human antibody response to measles vaccine is highly variable in the population. Host genes contribute to inter-individual antibody response variation. The killer cell immunoglobulin- like receptors (KIR) are recognized to interact with HLA molecules and possibly influence humoral immune response to viral antigens. To expand on and improve our previous work with HLA genes, and to explore the genetic contribution of KIR genes to the inter-individual variability in measles vaccine-induced antibody responses, we performed a large population-based study in 2,506 healthy immunized subjects (ages 11 to 41 years) to identify HLA and KIR associations with measles vaccine-induced neutralizing antibodies. After correcting for the large number of statistical tests of allele effects on measles-specific neutralizing antibody titers, no statistically significant associations were found for either HLA or KIR loci. However, suggestive associations worthy of follow-up in other cohorts include B*57: 01, DQB1*06: 02, and DRB1*15: 05 alleles. Specifically, the B*57: 01 allele (1,040 mIU/mL; p = 0.0002) was suggestive of an association with lower measles antibody titer. In contrast, the DQB1*06: 02 (1,349 mIU/mL; p = 0.0004) and DRB1*15: 05 (2,547 mIU/mL; p = 0.0004) alleles were suggestive of an association with higher measles antibodies. Notably, the associations with KIR genotypes were strongly nonsignificant, suggesting that KIR loci in terms of copy number and haplotypes are not likely to play a major role in antibody response to measles vaccination. These findings refine our knowledge of the role of HLA and KIR alleles in measles vaccine-induced immunity.	[Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN 55905 USA; [Schaid, Daniel J.; Larrabee, Beth R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967; Larrabee, Beth/0000-0001-9100-563X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI033144, R37AI048793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048793, R37AI048793, R01AI127365] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI033144 and R37AI048793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Aranda-Romo S, 2012, IMMUNOGENETICS, V64, P653, DOI 10.1007/s00251-012-0623-3; Clifford HD, 2012, VACCINE, V30, P6180, DOI 10.1016/j.vaccine.2012.07.063; Clifford HD, 2012, CLIN VACCINE IMMUNOL, V19, P704, DOI 10.1128/CVI.05652-11; Clifford HD, 2012, IMMUNOGENETICS, V64, P219, DOI 10.1007/s00251-011-0574-0; de Wit J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00286; EMBL-EBI, 2016, IPD IMGT HLA DAT; FORTHAL DN, 1993, J INFECT DIS, V168, P1020, DOI 10.1093/infdis/168.4.1020; Gardiner CM, 2008, INT J IMMUNOGENET, V35, P1, DOI 10.1111/j.1744-313X.2007.00739.x; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Haralambieva IH, 2008, CLIN VACCINE IMMUNOL, V15, P1054, DOI 10.1128/CVI.00008-08; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Jamil KM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/298348; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Johnson KL, 2005, J PROTEOME RES, V4, P2243, DOI 10.1021/pr0501416; Kennedy RB, 2012, HUM GENET, V131, P1403, DOI 10.1007/s00439-012-1174-2; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin WHW, 2014, MBIO, V5, DOI 10.1128/mBio.01047-14; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ovsyannikova IG, 2006, J INFECT DIS, V193, P655, DOI 10.1086/500144; Ovsyannikova IG, 2005, IMMUNOGENETICS, V57, P828, DOI 10.1007/s00251-005-0061-6; Ovsyannikova IG, 2005, IMMUNOGENETICS, V56, P798, DOI 10.1007/s00251-004-0756-0; Ovsyannikova IG, 2004, VACCINE, V22, P1914, DOI 10.1016/j.vaccine.2003.11.016; Ovsyannikova IG, 2004, J VIROL, V78, P42, DOI 10.1128/JVI.78.1.42-51.2004; Ovsyannikova IG, 2007, VACCINE, V25, P3090, DOI 10.1016/j.vaccine.2007.01.020; Ovsyannikova IG, 2006, CYTOKINE, V36, P173, DOI 10.1016/j.cyto.2006.12.001; Ovsyannikova IG, 2014, HUM GENET, V133, P1083, DOI 10.1007/s00439-014-1449-x; Ovsyannikova IG, 2013, HUM IMMUNOL, V74, P768, DOI 10.1016/j.humimm.2013.01.031; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Ovsyannikova IG, 2012, PHARMACOGENET GENOM, V22, P20, DOI 10.1097/FPC.0b013e32834df186; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Ovsyannikova I, 2011, HUM GENET, V130, P547, DOI 10.1007/s00439-011-0977-x; Ovsyannikova IG, 2011, J INFECT DIS, V203, P1546, DOI 10.1093/infdis/jir167; Ovsyannikova IG, 2012, VACCINE, V30, P2146, DOI 10.1016/j.vaccine.2012.01.038; Parham P, 2003, TISSUE ANTIGENS, V62, P194, DOI 10.1034/j.1399-0039.2003.00126.x; Poland GA, 2001, VACCINE, V20, P430, DOI 10.1016/S0264-410X(01)00346-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SenGupta D, 2004, J IMMUNOL, V173, P1987, DOI 10.4049/jimmunol.173.3.1987; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Vukcevic D, 2015, AM J HUM GENET, V97, P593, DOI 10.1016/j.ajhg.2015.09.005; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Ward BJ, 1999, DIAGN MICR INFEC DIS, V33, P147, DOI 10.1016/S0732-8893(98)00069-8	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171261	10.1371/journal.pone.0171261	http://dx.doi.org/10.1371/journal.pone.0171261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158231	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700047
J	Song, YR; Sullivan, T; Klarmann, K; Gilbert, D; O'Sullivan, TN; Lu, L; Wang, S; Haines, DC; Van Dyke, T; Keller, JR				Song, Yurong; Sullivan, Teresa; Klarmann, Kimberly; Gilbert, Debra; O'Sullivan, T. Norene; Lu, Lucy; Wang, Sophie; Haines, Diana C.; Van Dyke, Terry; Keller, Jonathan R.			RB inactivation in keratin 18 positive thymic epithelial cells promotes non-cell autonomous T cell hyperproliferation in genetically engineered mice	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DELTA-LIKE-1 IN-VITRO; DELTA-LIKE 4; LINEAGE COMMITMENT; CYCLIN D1; EXPRESSION; PRB; MICROENVIRONMENT; PROLIFERATION; HYPERPLASIA	Thymic epithelial cells (TEC), as part of thymic stroma, provide essential growth factors/cytokines and self-antigens to support T cell development and selection. Deletion of Rb family proteins in adult thymic stroma leads to T cell hyperplasia in vivo. To determine whether deletion of Rb specifically in keratin (K) 18 positive TEC was sufficient for thymocyte hyperplasia, we conditionally inactivated Rb and its family members p107 and p130 in K18+ TEC in genetically engineered mice (TgK18GT(121); K18 mice). We found that thymocyte hyperproliferation was induced in mice with Rb inactivation in K18+ TEC, while normal T cell development was maintained; suggesting that inactivation of Rb specifically in K18+ TEC was sufficient and responsible for the phenotype. Transplantation of wild type bone marrow cells into mice with Rb inactivation in K18+ TEC resulted in donor T lymphocyte hyperplasia confirming the non-cell autonomous requirement for Rb proteins in K18+ TEC in regulating T cell proliferation. Our data suggests that thymic epithelial cells play an important role in regulating lymphoid proliferation and thymus size.	[Song, Yurong; Sullivan, Teresa; Klarmann, Kimberly; Gilbert, Debra; O'Sullivan, T. Norene; Lu, Lucy; Wang, Sophie; Van Dyke, Terry; Keller, Jonathan R.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA; [Klarmann, Kimberly; Keller, Jonathan R.] Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Haines, Diana C.] Leidos Biomed Res Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Keller, JR (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA.; Keller, JR (corresponding author), Leidos Biomed Res Inc, Basic Sci Program, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.	kellerjo@mail.nih.gov	Keller, Jonathan R./O-6677-2018; Song, Yurong/GRX-9328-2022		Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; National Cancer Institute (NCI) [NCI CA084314, CA046283]; DOD [PC040619, PC050306]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [ZIABC010001] Funding Source: NIH RePORTER	Frederick National Laboratory for Cancer Research, NIH; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part with Federal funds from the Frederick National Laboratory for Cancer Research, NIH, under Contract HHSN261200800001E (https://frederick.cancer.gov/), and in part with research funding from National Cancer Institute (NCI, https://www.cancer.gov/), and NCI CA084314 and CA046283 (https://www.cancer.gov/), DOD PC040619 (http://www.defense.gov/), Prostate Cancer Foundation to TVD (http://www.pcf.org/), and DOD PC050306 to YS (http://www.defense.gov/). The funders including Frederick National Laboratory operated by Leidos Biomedical Research, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsements by the US Government.	Alexandropoulos K, 2012, IMMUNOL RES, V54, P177, DOI 10.1007/s12026-012-8301-y; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Awong G, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-22; Badea TC, 2003, J NEUROSCI, V23, P2314; Billiard F, 2011, EUR J IMMUNOL, V41, P2207, DOI 10.1002/eji.201041343; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Carraresi L, 2001, ONCOGENE, V20, P8148, DOI 10.1038/sj.onc.1205007; CHANTRY D, 1989, EUR J IMMUNOL, V19, P783, DOI 10.1002/eji.1830190433; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Danzl NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086129; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Garfin PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149430; Garfin PM, 2013, J EXP MED, V210, P1087, DOI 10.1084/jem.20121716; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; Holmes R, 2009, COLD SPRING HARB PRO; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2000, J IMMUNOL, V164, P1881, DOI 10.4049/jimmunol.164.4.1881; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Magri M, 2009, EUR J IMMUNOL, V39, P1231, DOI 10.1002/eji.200838765; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mulligan GJ, 1998, MOL CELL BIOL, V18, P206, DOI 10.1128/MCB.18.1.206; Nitta T, 2016, CELL MOL LIFE SCI, V73, P1021, DOI 10.1007/s00018-015-2107-8; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robles AI, 1996, P NATL ACAD SCI USA, V93, P7634, DOI 10.1073/pnas.93.15.7634; Rodriguez-Puebla ML, 2000, AM J PATHOL, V157, P1039, DOI 10.1016/S0002-9440(10)64616-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Song YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080459; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Szabova L, 2012, CANCER RES, V72, P13; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Zhao YB, 2007, CANCER RES, V67, P2425, DOI 10.1158/0008-5472.CAN-06-3977	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171510	10.1371/journal.pone.0171510	http://dx.doi.org/10.1371/journal.pone.0171510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158249	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700088
J	Zou, J; Semagn, K; Iqbal, M; Chen, H; Asif, M; N'Diaye, A; Navabi, A; Perez-Lara, E; Pozniak, C; Yang, RC; Randhawa, H; Spaner, D				Zou, Jun; Semagn, Kassa; Iqbal, Muhammad; Chen, Hua; Asif, Mohammad; N'Diaye, Amidou; Navabi, Alireza; Perez-Lara, Enid; Pozniak, Curtis; Yang, Rong-Cai; Randhawa, Harpinder; Spaner, Dean			QTLs associated with agronomic traits in the Attila x CDC Go spring wheat population evaluated under conventional management	PLOS ONE			English	Article							WEED-COMPETITIVE ABILITY; MOLECULAR CHARACTERIZATION; CHROMOSOMAL LOCATIONS; GENETIC-ANALYSIS; DWARFING GENES; QUALITY TRAITS; GRAIN-YIELD; VERNALIZATION; EARLINESS; MARKERS	Recently, we investigated the effect of the wheat 90K single nucleotide polymorphic (SNP) array and three gene-specific (Ppd-D1, Vrn-A1 and Rht-B1) markers on quantitative trait loci (QTL) detection in a recombinant inbred lines (RILs) population derived from a cross between two spring wheat (Triticum aestivum L.) cultivars, 'Attila' and 'CDC Go', and evaluated for eight agronomic traits at three environments under organic management. The objectives of the present study were to investigate the effect of conventional management on QTL detection in the same mapping population using the same set of markers as the organic management and compare the results with organic management. Here, we evaluated 167 RILs for number of tillers (tillering), flowering time, maturity, plant height, test weight (grain volume weight), 1000 kernel weight, grain yield, and grain protein content at seven conventionally managed environments from 2008 to 2014. Using inclusive composite interval mapping (ICIM) on phenotypic data averaged across seven environments and a subset of 1203 informative markers (1200 SNPs and 3 gene specific markers), we identified a total of 14 QTLs associated with flowering time (1), maturity (2), plant height (1), grain yield (1), test weight (2), kernel weight (4), tillering (1) and grain protein content (2). Each QTL individually explained from 6.1 to 18.4% of the phenotypic variance. Overall, the QTLs associated with each trait explained from 9.7 to 35.4% of the phenotypic and from 22.1 to 90.8% of the genetic variance. Three chromosomal regions on chromosomes 2D (61-66 cM), 4B (80-82 cM) and 5A (296-297 cM) harbored clusters of QTLs associated with two to three traits. The coincidental region on chromosome 5A harbored QTL clusters for both flowering and maturity time, and mapped about 2 cM proximal to the Vrn-A1 gene, which was in high linkage disequilibrium (0.70 <= r(2) <= 0.75) with SNP markers that mapped within the QTL confidence interval. Six of the 14 QTLs (one for flowering time and plant height each, and two for maturity and kernel weight each) were common between the conventional and organic management systems, which suggests issues in directly utilizing gene discovery results based on conventional management to make in detail selection (decision) for organic management.	[Zou, Jun; Semagn, Kassa; Iqbal, Muhammad; Chen, Hua; Perez-Lara, Enid; Yang, Rong-Cai; Spaner, Dean] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Iqbal, Muhammad] Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Islamabad, Pakistan; [Asif, Mohammad] Kansas State Univ, Throckmorton Plant Sci Ctr 2004, Dept Agron, Manhattan, KS 66506 USA; [Asif, Mohammad] Kansas Wheat Innovat Ctr, Heartland Plant Innovat, Manhattan, KS USA; [N'Diaye, Amidou; Pozniak, Curtis] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada; [N'Diaye, Amidou; Pozniak, Curtis] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Navabi, Alireza] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [Yang, Rong-Cai] Alberta Agr & Forestry, St Edmonton, AB, Canada; [Randhawa, Harpinder] Agr & Agri Food Canada, Lethbridge, AB, Canada	University of Alberta; National Agricultural Research Council - Pakistan; Kansas State University; University of Saskatchewan; University of Saskatchewan; University of Guelph; Agriculture & Agri Food Canada	Spaner, D (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	dspaner@ualberta.ca	Randhawa, Harpinder/AAQ-7207-2021; Semagn, Kassa/S-8858-2017	Semagn, Kassa/0000-0001-6486-5685; N'Diaye, Amidou/0000-0001-7769-7801; Iqbal, Muhammad/0000-0002-7519-6023; Zou, Jun/0000-0003-3271-895X; Spaner, Dean/0000-0002-2088-5104; Perez-Lara, Enid/0000-0002-9672-0226	Alberta Crop Industry Development Fund; Alberta Wheat Commission; Organic Agriculture Cluster grant from Agriculture and Agri-Food Canada; Western Grains Research Foundation; NSERC; Saskatchewan Ministry of Agriculture; Agriculture and Agri-Food Canada; Genome Canada; Genome Prairie; Genome Alberta; Alberta Innovates; Chinese Government; Pakistani Government	Alberta Crop Industry Development Fund; Alberta Wheat Commission; Organic Agriculture Cluster grant from Agriculture and Agri-Food Canada; Western Grains Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Ministry of Agriculture; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Genome Canada(Genome Canada); Genome Prairie; Genome Alberta; Alberta Innovates; Chinese Government; Pakistani Government	The present study was financed by grants to the University of Alberta wheat breeding program from the Alberta Crop Industry Development Fund, the Alberta Wheat Commission, an Organic Agriculture Cluster grant from Agriculture and Agri-Food Canada, Western Grains Research Foundation Endowment and check-off Funds, and an NSERC Discovery Grant to D. Spaner. This work was conducted in part within the project "Canadian Triticum Advancement Through Genomics (CTAG)". We would like to acknowledge CTAG funding provided by the Saskatchewan Ministry of Agriculture, Western Grains Research Foundation, Agriculture and Agri-Food Canada, Genome Canada, Genome Prairie, Genome Alberta and Alberta Innovates. The study was also partly supported by Chinese Government Scholarships to both Jun Zou and Hua Chen, and Pakistani Government Fellowships to Mohammad Asif and Muhammad Iqbal.	Asif M, 2015, CROP SCI, V55, P1129, DOI 10.2135/cropsci2014.01.0080; Babiker EM, 2015, THEOR APPL GENET, V128, P605, DOI 10.1007/s00122-015-2456-6; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Chen F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-199; Chen H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0373-7; CUDNEY DW, 1991, WEED SCI, V39, P175, DOI 10.1017/S0043174500071435; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Elouafi I, 2004, THEOR APPL GENET, V108, P401, DOI 10.1007/s00122-003-1440-8; Entz MH, 2001, CAN J PLANT SCI, V81, P351, DOI 10.4141/P00-089; Evans L., 1998, FEEDING 10 BILLION P; GALIBA G, 1995, THEOR APPL GENET, V90, P1174, DOI 10.1007/BF00222940; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Iqbal M, 2007, EUPHYTICA, V154, P207, DOI 10.1007/s10681-006-9289-y; Kamran A, 2013, THEOR APPL GENET, V126, P1965, DOI 10.1007/s00122-013-2110-0; Kaut AHEE, 2008, AGRON SUSTAIN DEV, V28, P363, DOI 10.1051/agro:2008017; Kaut AHEE, 2009, J AGR SCI-CAMBRIDGE, V147, P141, DOI 10.1017/S0021859608008319; Letourneau DK, 2008, COMP ORGANIC CONVENT, P430; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li WL, 2002, EUPHYTICA, V125, P357, DOI 10.1023/A:1016069809977; Liu SY, 2016, CROP SCI, V56, P364, DOI 10.2135/cropsci2015.03.0194; Mason H, 2007, RENEW AGR FOOD SYST, V22, P157, DOI 10.1017/S1742170507001688; Mason H, 2007, AGRON J, V99, P1199, DOI 10.2134/agronj2006.0262; Mason HE, 2007, CROP SCI, V47, P1167, DOI 10.2135/cropsci2006.09.0566; McCallum BD, 2008, CAN J PLANT SCI, V88, P649, DOI 10.4141/CJPS07159; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Pearson D, 2011, RENEW AGR FOOD SYST, V26, P171, DOI 10.1017/S1742170510000499; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Perez-Lara E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160623; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Randhawa HS, 2013, PLANT BREEDING, V132, P458, DOI 10.1111/pbr.12057; Reid TA, 2011, EUPHYTICA, V177, P253, DOI 10.1007/s10681-010-0257-1; Reid TA, 2009, CAN J PLANT SCI, V89, P591, DOI 10.4141/CJPS08105; Reid TA, 2009, EUPHYTICA, V169, P239, DOI 10.1007/s10681-009-9949-9; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Suprayogi Y, 2009, THEOR APPL GENET, V119, P437, DOI 10.1007/s00122-009-1050-1; Tadesse W, 2010, CROP SCI, V50, P2240, DOI 10.2135/cropsci2010.02.0102; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Zerner MC, 2008, AGRON J, V100, P1729, DOI 10.2134/agronj2008.0068; Zou J, 2016, CROP SCI	49	24	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171528	10.1371/journal.pone.0171528	http://dx.doi.org/10.1371/journal.pone.0171528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158253	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700092
J	Kassahun, CW; Mekonen, AG				Kassahun, Chanyalew Worku; Mekonen, Alemayehu Gonie			Knowledge, attitude, practices and their associated factors towards diabetes mellitus among non diabetes community members of Bale Zone administrative towns, South East Ethiopia. A cross-sectional study	PLOS ONE			English	Article							AWARENESS	Background Diabetes kills more than 4.9 million adults per year. It becomes rapidly increasing, non-communicable disease-a major threat to global public health particularly in Sub-Saharan Africa. Though previous studies among diabetic patients were focused in health institution, limited knowledge, attitude and practice were seen. There is no study conducted about diabetes related to knowledge, attitudes, practice and associated factors in the community level. Objective of the study The study assessed knowledge, attitude, practices, and its associated factors towards diabetes mellitus among non diabetic community members of Bale Zone, Ethiopia. Methods Community based cross-sectional study was conducted from November 15 to December 15, 2015 among 605 non diabetic community members of Bale Zone administrative towns. Data was collected using pretested structured face-to-face interview after taking informed written consent. Respondents were selected by systematic random sampling. The data was entered into EPI data version 3.1 and analyzed using Statistical package for social sciences version 20. Odds ratio and 95% confidence interval were calculated and P<0.05 was considered statistically significant. Finally, multivariable logistic regression analysis was performed to indicate the independent predictors of knowledge, attitude and practice. Result Response rate of the study was 98.2%. About 52.5% of participants were knowledgeable, 55.9% and 56.6% had good attitude and practice respectively. Earning average monthly family income of <= 500 Ethiopian birr (AOR = 0.4, CI = 0.2, 0.6) and 501-1000 (AOR = 0.4, CI = 0.2, 0.7), heard about diabetes (AOR = 4.4, CI = 1.9, 10.2), had diabetes health education exposure (AOR = 5, CI = 2.5, 9.7) resulted to have good diabetes knowledge. Student, (AOR = 5.1, CI = 2.1,12), government/private employee (AOR = 3, CI = 1.4,6.7), merchant (AOR = 2, CI = 1.1,3.6) and Knowledgeable (AOR = 3, CI = 2.1, 4.7) subjects had positive attitude towards diabetes. Having college and above educational level (AOR = 0.33, CI = 0.16, 0.7), having good attitude towards diabetes (AOR = 2, CI = 1.3, 3) had good practiced. Conclusion Considerable limited knowledge, attitude and practices were seen. A great emphasis on health education regarding symptoms and risk factors modification for diabetes are necessary.	[Kassahun, Chanyalew Worku; Mekonen, Alemayehu Gonie] Madda Walabu Univ, Dept Nursing, Coll Med & Hlth Sci, Bale Goba, Ethiopia	University of Gondar	Kassahun, CW (corresponding author), Madda Walabu Univ, Dept Nursing, Coll Med & Hlth Sci, Bale Goba, Ethiopia.	chanyalewworku@gmail.com	Kassahun, Chanyalew Worku/HHN-6462-2022	Kassahun, Chanyalew Worku/0000-0001-9326-8329				Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; Aguiree F., 2013, IDF DIABETES ATLAS, Vsixth, P1; Al-Sarayra L., 2012, Pakistan Journal of Nutrition, V11, P1023; Al-Shafaee MA, 2008, BMC PUBLIC HEALTH, V8, P1; Ambigapathy R, 2003, NCD MALAYSIA, V2, P6, DOI DOI 10.18203/2394-6040.IJC-MPH20183824]; [Anonymous], 2009, INT J PHARM SCI, V1, P96; [Anonymous], 2014, BAL ZON HLTH OFF REP; Asmamaw A, 2015, SCI J PUBLIC HLTH, V3, P199, DOI DOI 10.11648/J.SJPH.20150302.17; Ayesha Motala and Kaushik Ramaiya, 2010, DIABETES HIDDEN SUB; Balla SA, 2014, AM J HLTH RES, V2, P356, DOI DOI 10.11648/j.ajhr.20140206.16; Bani IA, 2015, J DIABETES MELLITUS, V5, P115, DOI [10.4236/jdm.2015.52014, DOI 10.4236/JDM.2015.52014]; Berhane, 2013, PMC, V6, P36; Demaio AR, 2013, BMC PUBLIC HEALTH, V236, P2; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; IDF, 2013, INT DIAB FED DIAB AT, V6th; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Kiawi E, 2006, ETHN DIS, V16; Longo Dan L., 2012, HARRISONS PRINCIPLES; Maina WK, 2011, AFR J DIABETES MED, V19, P15; Masood I, 2016, PRIM CARE DIABETES, V10, P3, DOI 10.1016/j.pcd.2015.06.004; Minhat H. S., 2014, World Journal of Medical Sciences, V11, P217; Mohamad S, 2006, PAK J MED SCI, V22, P2; Moira A, 2015, NITTE U J HEAL SCI, V5, P4; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Mufunda E, 2012, PAN AFRICA MED J, V13, P1; Mumu SJ, 2014, BMC, P2; Pongmesa T, 2007, COMP DIABETES KNOWLE, V95; Rani PK, 2008, INT ELECT J RURAL RE, P1; Rathod GB., 2014, INT J CURR RES REV, V6, P63; Smeltzer S.C., 2012, BRUNNER SUDDARTHS TX; Sristi S, 2015, INT J DIABETES DEV C, V35, P33, DOI 10.1007/s13410-014-0219-6; Thungathurthi S, 2012, INT J LIFE SCI PHARM, V2, pP16; Ulvi Osman Saleem, 2009, JPMA Journal of the Pakistan Medical Association, V59, P798; Williams K.D., 2010, AFR J PRIM HEALTH CA, V7, P1; World Health Organization, 2005, PREV BLINDN DIAB MEL; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zuhaid Muhammad, 2012, J Ayub Med Coll Abbottabad, V24, P105	37	41	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170040	10.1371/journal.pone.0170040	http://dx.doi.org/10.1371/journal.pone.0170040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152066	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161200013
J	Lafarge, T; Bueno, C; Frouin, J; Jacquin, L; Courtois, B; Ahmadi, N				Lafarge, Tanguy; Bueno, Crisanta; Frouin, Julien; Jacquin, Laval; Courtois, Brigitte; Ahmadi, Nourollah			Genome-wide association analysis for heat tolerance at flowering detected a large set of genes involved in adaptation to thermal and other stresses	PLOS ONE			English	Article							TEMPERATURE-INDUCED STERILITY; WALL-ASSOCIATED KINASES; SPIKELET STERILITY; CLIMATE-CHANGE; AIR-TEMPERATURE; RICE PRODUCTION; COMPLEX TRAITS; JAPONICA-RICE; EXPRESSION; ANTHESIS	Fertilization sensitivity to heat in rice is a major issue within climate change scenarios in the tropics. A panel of 167 indica landraces and improved varieties was phenotyped for spikelet sterility (SPKST) under 38 C during anthesis and for several secondary traits potentially affecting panicle micro-climate and thus the fertilization process. The panel was genotyped with an average density of one marker per 29 kb using genotyping by sequencing. Genome-wide association analyses (GWAS) were conducted using three methods based on single marker regression, haplotype regression and simultaneous fitting of all markers, respectively. Fourteen loci significantly associated with SPKST under at least two GWAS methods were detected. A large number of associations was also detected for the secondary traits. Analysis of co-localization of SPKST associated loci with QTLs detected in progenies of bi-parental crosses reported in the literature allowed to narrow-down the position of eight of those QTLs, including the most documented one, qHTSF4.1. Gene families underlying loci associated with SPKST corresponded to functions ranging from sensing abiotic stresses and regulating plant response, such as wall associated kinases and heat shock proteins, to cell division and gametophyte development. Analysis of diversity at the vicinity of loci associated with SPKST within the rice three thousand genomes, revealed widespread distribution of the favourable alleles across 0. sativa genetic groups. However, few accessions assembled the favourable alleles at all loci. Effective donors included the heat tolerant variety N22 and some Indian and Taiwanese varieties. These results provide a basis for breeding for heat tolerance during anthesis and for functional validation of major loci governing this trait.	[Lafarge, Tanguy; Frouin, Julien; Jacquin, Laval; Courtois, Brigitte; Ahmadi, Nourollah] CIRAD, UMR AGAP, Montpellier, France; [Bueno, Crisanta] Int Rice Res Inst, Los Banos, Philippines	CIRAD; Universite de Montpellier; CGIAR; International Rice Research Institute (IRRI)	Ahmadi, N (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	ahmadi@cirad.fr	COURTOIS, Brigitte/A-4004-2009	COURTOIS, Brigitte/0000-0003-2118-7102; AHMADI, Nourollah/0000-0003-0072-6285	CIRAD; IRRI	CIRAD; IRRI	The authors received no specific funding for this work. The work was supported by the core budget of CIRAD and IRRI.	Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Chandel G, 2013, J PLANT BIOCHEM BIOT, V22, P277, DOI 10.1007/s13562-012-0156-8; Charmet G, 1999, THEOR APPL GENET, V99, P1143, DOI 10.1007/s001220051318; Cheng LR, 2012, J INTEGR AGR, V11, P359, DOI 10.1016/S2095-3119(12)60020-3; Chotamonsak C, 2011, ATMOS SCI LETT, V12, P213, DOI 10.1002/asl.313; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Das S, 2014, ENVIRON EXP BOT, V101, P36, DOI 10.1016/j.envexpbot.2014.01.004; Delteil A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0711-x; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Gammulla C, 2014, PROTEOMICS, V10, P3001; Grenier C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136594; Hasegawa Toshihiro, 2011, Journal of Agricultural Meteorology, V67, P225, DOI 10.2480/agrmet.67.4.3; Hayes Ben, 2013, Methods Mol Biol, V1019, P149, DOI 10.1007/978-1-62703-447-0_6; Hu Y, 2010, PLANT PHYSIOL BIOCH, V70, P33; Jacquin L, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-45; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jagadish SVK, 2010, CROP SCI, V50, P1633, DOI 10.2135/cropsci2009.09.0516; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Julia C, 2013, EUR J AGRON, V49, P50, DOI 10.1016/j.eja.2013.03.006; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Kanneganti Vydehi, 2008, Physiology and Molecular Biology of Plants, V14, P109, DOI 10.1007/s12298-008-0010-6; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Krishnan P, 2007, AGR ECOSYST ENVIRON, V122, P233, DOI 10.1016/j.agee.2007.01.019; Matsui T, 1997, JPN J CROP SCI, V66, P449, DOI 10.1626/jcs.66.449; Matsui T, 2001, PLANT PROD SCI, V4, P90, DOI 10.1626/pps.4.90; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; Matsui T, 2007, PLANT PROD SCI, V10, P57, DOI 10.1626/pps.10.57; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Meuwissen THE, 2001, GENETICS, V157, P1819; Nakagawa H., 2002, RICE SCI INNOVATIONS, P635; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Park JB, 2006, INT J INNOVATIONS EN, V1, P1, DOI DOI 10.1038/NATURE04788; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perrier X., 2006, DARWIN SOFTWARE; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Pritchard JK, 2000, GENETICS, V155, P945; Radanielina T, 2013, GENET RESOUR CROP EV, V60, P311, DOI 10.1007/s10722-012-9837-3; Rebolledo MC, 2015, J EXP BOT, V66, P5555, DOI 10.1093/jxb/erv258; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P321, DOI 10.1007/s12192-012-0384-9; SATAKE T, 1978, JPN J CROP SCI, V47, P6, DOI 10.1626/jcs.47.6; Sathishraj R, 2016, FIELD CROP RES, V190, P10, DOI 10.1016/j.fcr.2015.10.012; Shah F, 2011, J AGR SCI; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Tanamachi K, 2016, PLANT PROD SCI, V19, P300, DOI 10.1080/1343943X.2016.1140007; Tian XH, 2010, PLANT PROD SCI, V13, P243, DOI 10.1626/pps.13.243; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Wassmann R, 2009, ADV AGRON, V102, P91, DOI 10.1016/S0065-2113(09)01003-7; Xia M. Y., 2004, HUBEI AGR SCI, V2, P21; Xiao YH, 2011, RICE SCI, V18, P204, DOI 10.1016/S1672-6308(11)60028-0; Xiong DL, 2015, FUNCT PLANT BIOL, V42, P347, DOI 10.1071/FP14166; Ye CR, 2012, PLANT BREEDING, V131, P33, DOI 10.1111/j.1439-0523.2011.01924.x; Ye G, 2005, BMC GENET, V16, P41; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zagorchev L, 2014, SCI WORLD J, DOI 10.1155/2014/764089; Zhang GL, 2009, AGR SCI CHINA, V8, P482, DOI 10.1016/S1671-2927(08)60235-7; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhi-guo E, 2014, SCI WORLD J; Zou J, 2008, EXPRESSION ANAL 9 HE; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	75	25	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171254	10.1371/journal.pone.0171254	http://dx.doi.org/10.1371/journal.pone.0171254			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152098	Green Published, gold			2022-12-27	WOS:000396161200116
J	Gebremariam, MK; Chinapaw, MJ; Bringolf-Isler, B; Bere, E; Kovacs, E; Verloigne, M; Stok, FM; Manios, Y; Brug, J; Lien, N				Gebremariam, Mekdes K.; Chinapaw, Mai J.; Bringolf-Isler, Bettina; Bere, Elling; Kovacs, Eva; Verloigne, Maite; Stok, F. Marijn; Manios, Yannis; Brug, Johannes; Lien, Nanna			Screen-based sedentary time: Association with soft drink consumption and the moderating effect of parental education in European children: The ENERGY study	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; HEALTH INDICATORS; DIETARY-INTAKE; BEHAVIOR; TELEVISION; FOOD; OBESITY; YOUTH; PROJECT; SUGAR	Aim The aim of the present study was to explore if children who spend more time on screen-based sedentary behaviors (i.e. TV viewing and computer use) drink more sugar-sweetened soft drinks. The study also assessed whether these associations were independent of individual and home environmental correlates of soft drink consumption and whether they were moderated by parental education. Methods Data were collected from 7886 children participating in the EuropeaN Energy balance Research to prevent excessive weight Gain among Youth (ENERGY) survey conducted in eight European countries. Self-report questionnaires were used. Multilevel linear regression analyses with soft drink consumption as dependent variable, TV viewing and computer use as independent variables and age, gender, parental education, attitude towards soft drinks, self-efficacy, parental modelling, parental rules and home availability of soft drinks as covariates were conducted. Further interactions were tested to explore if these associations were moderated by parental education. Country-specific analyses were conducted. Results In six of the eight included countries, a significant positive association was observed between TV viewing (min/day) and soft drink consumption (ml/day), independent of individual and home environmental correlates of soft drink consumption (B = 0.46 (0.26-0.66) in Greece, B = 0.77 (0.36-1.17) in Norway, B = 0.82 (0.12-1.51) in Hungary, B = 1.06 (0.67-1.46) in Spain, B = 1.21 (0.67-1.74) in Belgium and B = 1.49 (0.72-2.27) in Switzerland). There was no significant association between computer use and soft drink consumption in six of the eight included countries in the final models. Moderation effects of parental education in the association between TV viewing and soft drink consumption were found in Norway and Hungary, the association being stronger among those with low parental education. Conclusions TV viewing appears to be independently associated with soft drink consumption and this association was moderated by parental education in two countries only. Reducing TV time might therefore favorably impact soft drink consumption.	[Gebremariam, Mekdes K.; Brug, Johannes; Lien, Nanna] Univ Oslo, Fac Med, Dept Nutr, Oslo, Norway; [Chinapaw, Mai J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Bringolf-Isler, Bettina] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Bringolf-Isler, Bettina] Univ Basel, Basel, Switzerland; [Bere, Elling] Univ Agder, Dept Publ Hlth Sport & Nutr, Kristiansand, Norway; [Kovacs, Eva] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Kovacs, Eva] Ludwig Maximilians Univ Munchen, German Ctr Vertigo & Balance Disorders, Inst Med Informat Proc Biometr & Epidemiol, Munich, Germany; [Verloigne, Maite] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Stok, F. Marijn] Univ Konstanz, Dept Psychol Assessment & Hlth Psychol, Constance, Germany; [Manios, Yannis] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Brug, Johannes] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands	University of Oslo; Vrije Universiteit Amsterdam; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Agder; University of Pecs; University of Munich; Ghent University; University of Konstanz; Harokopio University Athens; University of Amsterdam	Gebremariam, MK (corresponding author), Univ Oslo, Fac Med, Dept Nutr, Oslo, Norway.	mekdes.gebremariam@medisin.uio.no	Paw, Mai Chin A/N-1665-2019; Manios, Yannis/AAM-8953-2021; Brug, Johannes/A-8242-2018	Paw, Mai Chin A/0000-0001-6259-2441; Manios, Yannis/0000-0001-6486-114X; Brug, Johannes/0000-0002-1904-7349	DEterminants of DIet and Physical ACtivity (DEDIPAC) Knowledge Hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; The Research Council of Norway, Division for Society and Health; Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-B) [223254]	DEterminants of DIet and Physical ACtivity (DEDIPAC) Knowledge Hub; Joint Programming Initiative 'Healthy Diet for a Healthy Life'; The Research Council of Norway, Division for Society and Health(Research Council of Norway); Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-B)	The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) Knowledge Hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agency supporting this work in Norway is The Research Council of Norway, Division for Society and Health. The ENERGY project was funded by the Seventh Framework Programme (CORDIS FP7) of the European Commision, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The preparation of this paper was supported by the DEterminants of DIet and Physical ACtivity (DEDIPAC) knowledge hub. This work is supported by the Joint Programming Initiative 'Healthy Diet for a Healthy Life'. The funding agency supporting this work in Norway is the Research Council of Norway, Division for Society and Health. The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B).	Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Barnekow V., 2008, INEQUALITIES YOUNG P; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Boyland EJ, 2011, PEDIATRICS, V128, pE93, DOI 10.1542/peds.2010-1859; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Buijzen M, 2008, APPETITE, V50, P231, DOI 10.1016/j.appet.2007.07.006; Caraher M, 2006, PUBLIC HEALTH NUTR, V9, P596, DOI 10.1079/PHN2005879; de Bruijn GJ, 2009, APPETITE, V53, P66, DOI 10.1016/j.appet.2009.05.008; DeMattia L, 2007, OBES REV, V8, P69, DOI 10.1111/j.1467-789X.2006.00259.x; Epstein LH, 2009, PSYCHOL REV, V116, P384, DOI 10.1037/a0015074; Gebremariam MK, 2015, OBES REV, V16, P988, DOI 10.1111/obr.12314; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hastings G, 2003, REV RES EFFECTS FOOD, P1; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Kremers SPJ, 2007, APPETITE, V48, P345, DOI 10.1016/j.appet.2006.10.002; Leung MM, 2012, J OBES, V2012, DOI 10.1155/2012/685430; Lissner L, 2012, EUR J EPIDEMIOL, V27, P705, DOI 10.1007/s10654-012-9718-2; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Matthews AE, 2008, EUR J PUBLIC HEALTH, V18, P7, DOI 10.1093/eurpub/ckm015; Olafsdottir S, 2014, INT J PUBLIC HEALTH, V59, P67, DOI 10.1007/s00038-013-0473-2; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Sleddens EFC, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0164-x; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; van Ekris E, 2016, OBES REV, V17, P833, DOI 10.1111/obr.12426; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Zarnowiecki DM, 2014, OBES REV, V15, P375, DOI 10.1111/obr.12139	31	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171537	10.1371/journal.pone.0171537	http://dx.doi.org/10.1371/journal.pone.0171537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182671	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800072
J	Schwarz, C; Brandt, C; Antweiler, E; Krannich, A; Staab, D; Schmitt-Grohe, S; Fischer, R; Hartl, D; Thronicke, A; Tintelnot, K				Schwarz, Carsten; Brandt, Claudia; Antweiler, Elisabeth; Krannich, Alexander; Staab, Doris; Schmitt-Grohe, Sabina; Fischer, Rainald; Hartl, Dominik; Thronicke, Anja; Tintelnot, Kathrin			Prospective multicenter German study on pulmonary colonization with Scedosporium/Lomentospora species in cystic fibrosis: Epidemiology and new association factors	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ORGAN TRANSPLANT RECIPIENTS; OF-THE-ART; PSEUDALLESCHERIA-BOYDII; APIOSPERMUM COMPLEX; CLINICAL-SIGNIFICANCE; YOUNG-CHILDREN; SERUM MARKERS; PROLIFICANS; INFECTIONS	Background An increasing rate of respiratory colonization and infection in cystic fibrosis (CF) is caused by fungi of the Scedosporium apiospermum species complex or Lomentospora prolificans (Sac-Lp). These fungi rank second among the filamentous fungi colonizing the CF airways, after Aspergillus fumigatus. However, the epidemiology, clinical relevance and risk of pulmonary colonization with Sac-Lp are rarely understood in CF. The objective of the present prospective multicenter study was to study pathogen distribution and determine association factors of pulmonary Sac-Lp colonization in patients with CF. Material and methods Clinical, microbiological and laboratory data of 161 patients aged 6-59 years with CF in Germany were analyzed for Sac-Lp distribution and association factors. The free statistical software R was utilized to investigate adjusted logistic regression models for association factors. Results Of the 161 patients included in the study, 74 (56%) were male. The median age of the study cohort was 23 years (interquartile range 13-32 years). 58 patients of the total cohort (36%) were < 18 years old. Adjusted multivariate regression analysis revealed that Sac-Lp colonization was associated with younger age (OR 0.8684, 95% CI: 0.7955-0.9480, p<0.005) and less colonization with H. influenzae (OR 0.0118, 95% CI: 0.0009-0.1585, p<0.001). In addition, Sac-Lp-colonized patients had more often allergic bronchopulmonary aspergillosis (ABPA) (OR 14.6663, 95% CI: 2.1873-98.3403, p<0.01) and have been colonized more often with the mucoid phenotype of Pseudomonas aeruginosa (OR 9.8941, 95% CI: 1.0518- 93.0705, p<0.05). Conclusion Newly found association of ABPA and Pseudomonas revealed new probable risk factors for Sac-Lp colonization. Allergy might play a role in inducing immunologic host reactions which lead to a less effective response to species of Sac-Lp.	[Schwarz, Carsten; Brandt, Claudia; Staab, Doris; Thronicke, Anja] Charite, Cyst Fibrosis Ctr Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany; [Antweiler, Elisabeth; Tintelnot, Kathrin] Robert Koch Inst, Reference Lab Cryptococcosis Scedosporiosis & Imp, FG 16, Berlin, Germany; [Krannich, Alexander] Charite, Berlin Inst Hlth, Biostat Unit, Berlin, Germany; [Schmitt-Grohe, Sabina] Univ Klinikum Bonn, Dept Gen Pediat, Bonn, Germany; [Fischer, Rainald] Privat Praxis West Munchen, Munich, Germany; [Hartl, Dominik] Univ Klinikum Kinder & Jugendmed Tubingen, Dept Gen Pediat Pediat Hematol & Oncol, Tubingen, Germany; [Thronicke, Anja] Res Inst Havelhohe gGmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn	Schwarz, C (corresponding author), Charite, Cyst Fibrosis Ctr Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany.	carsten.schwarz@charite.de	Schwarz, Carsten/AAE-9576-2022; Thronicke, Anja/AAZ-3508-2020; Schwarz, Carsten/AFE-4586-2022; Krannich, Alexander/AAR-1285-2021; Thronicke, Anja/AAR-2482-2021	Krannich, Alexander/0000-0002-4025-6495; Schmitt-Grohe, Sabina/0000-0002-8280-5309; Thronicke, Anja/0000-0002-6421-8290				Bernhardt A, 2014, MYCOSES, V57, P35; Bernhardt A, 2013, J CYST FIBROS, V12, P592, DOI 10.1016/j.jcf.2013.05.007; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; Blyth CC, 2010, MED MYCOL, V48, pS37, DOI 10.3109/13693786.2010.500627; Cardines R, 2012, INT J MED MICROBIOL, V302, P45, DOI 10.1016/j.ijmm.2011.08.003; Castiglioni B, 2002, MEDICINE, V81, P333, DOI 10.1097/00005792-200209000-00001; Chotirmall SH, 2014, INT J BIOCHEM CELL B, V52, P161, DOI 10.1016/j.biocel.2014.03.001; Cimon B, 2000, EUR J CLIN MICROBIOL, V19, P53, DOI 10.1007/s100960050011; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; De Soyza A, 2017, MED MYCOL, V55, P69, DOI 10.1093/mmy/myw109; Delhaes L, 2010, MED MYCOL, V48, pS77, DOI 10.3109/13693786.2010.514301; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; HAASE G, 1991, MYCOSES, V34, P373, DOI 10.1111/j.1439-0507.1991.tb00797.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harun A, 2010, MED MYCOL, V48, pS70, DOI 10.3109/13693786.2010.515254; Hector A, 2016, J CYST FIBROS, V15, P340, DOI 10.1016/j.jcf.2016.01.004; Horre R, 2009, MED MYCOL, V47, P415, DOI 10.1080/13693780902801259; Husain S, 2005, CLIN INFECT DIS, V40, P89, DOI 10.1086/426445; Husain S, 2003, CLIN INFECT DIS, V37, P221, DOI 10.1086/375822; Kaltseis J, 2009, MED MYCOL, V47, P398, DOI 10.1080/13693780802585317; Kaur J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00866; Lackner M, 2014, FUNGAL DIVERS, V67, P1, DOI 10.1007/s13225-014-0295-4; LAKE FR, 1990, THORAX, V45, P489, DOI 10.1136/thx.45.6.489; Latzin P, 2008, EUR RESPIR J, V31, P36, DOI 10.1183/09031936.00078107; Littlewood J.M., 2009, ANTIBIOTIC TREATMENT, P1; Rodriguez-Tudela JL, 2009, MED MYCOL, V47, P359, DOI 10.1080/13693780802524506; MILLER MA, 1993, AM REV RESPIR DIS, V148, P810, DOI 10.1164/ajrccm/148.3.810; Parize P, 2014, J CYST FIBROS, V13, P667, DOI 10.1016/j.jcf.2014.01.011; Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Rainer J, 2008, ANTON LEEUW INT J G, V93, P315, DOI 10.1007/s10482-007-9206-y; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; Sahi H, 2007, J HEART LUNG TRANSPL, V26, P350, DOI 10.1016/j.healun.2007.01.011; Sedlacek L, 2015, J CYST FIBROS, V14, P237, DOI 10.1016/j.jcf.2014.12.014; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010; Tintelnot K, 2009, MED MYCOL, V47, P351, DOI 10.1080/13693780802627440; Zouhair R, 2013, MED MYCOL, V51, P603, DOI 10.3109/13693786.2013.770606	39	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171485	10.1371/journal.pone.0171485	http://dx.doi.org/10.1371/journal.pone.0171485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178337	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500047
J	Cassim, N; Schnippel, K; Coetzee, LM; Glencross, DK				Cassim, Naseem; Schnippel, Kathryn; Coetzee, Lindi Marie; Glencross, Deborah Kim			Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV plus patients with CD4 counts less than 100 cells/mu l using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa	PLOS ONE			English	Article							PROGRAM; CARE	Introduction Cryptococcal meningitis is a major cause of mortality and morbidity in countries with high HIV prevalence, primarily affecting patients whose CD4 are < = 100 cells/mu l. Routine Cryptococcal Antigen (CrAg) screening is thus recommended in the South African HIV treatment guidelines for all patients with CD4 counts < = 100 cells/mu l, followed by pre-emptive anti-fungal therapy where CrAg results are positive. A laboratory-based reflexed CrAg screening approach, using a Lateral Flow Assay (LFA) on remnant EDTA CD4 blood samples, was piloted at three CD4 laboratories. Objectives This study aimed to assess the cost-per-result of laboratory-based reflexed CrAg screening at one pilot CD4 referral laboratory. Methods CD4 test volumes from 2014 were extracted to estimate percentage of CD4 < = 100 cells/mu l. Daily average volumes were derived, assuming 12 months per/year and 21.73 working days per/month. Costing analyses were undertaken using Microsoft Excel and Stata with a provider prospective. The cost-per-result was estimated using a bottom-up method, inclusive of test kits and consumables (reagents), laboratory equipment and technical effort costs. The ZAR/$ exchange of 14.696/$1 was used, where applicable. One-way sensitivity analyses on the cost-per-result were conducted for possible error rates (3%-8%, reductions or increases in reagent costs as well as test volumes (ranging from -60% to +60%). Results The pilot CD4 laboratory performed 267000 CD4 tests in 2014; similar to 9.3% (27500) reported CD4< = 100 cells/mu l, equivalent to 106 CrAg tests performed daily. A batch of 30-tests could be performed in 1.6 hours, including preparation and analysis time. A cost-per-result of $4.28 was reported, with reagents contributing $3.11 (72.8%), while technical effort and laboratory equipment overheads contributed $1.17 (27.2%) and $0.03 (<1%) respectively. One-way sensitivity analyses including increasing or decreasing test volumes by 60% revealed a cost-per-result range of $3.84 to $6.03. Conclusion A cost-per-result of $4.28 was established in a typical CD4 service laboratory to enable local budgetary cost projections and programmatic cost-effectiveness modelling. Varying reagent costs linked to currency exchange and varying test volumes in different levels of service can lead to varying cost-per-test and technical effort to manage workload, with an inverse relationship of higher costs expected at lower volumes of tests.	[Cassim, Naseem; Coetzee, Lindi Marie; Glencross, Deborah Kim] NHLS, Natl Prior Programmes, Johannesburg, South Africa; [Cassim, Naseem; Coetzee, Lindi Marie; Glencross, Deborah Kim] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa; [Schnippel, Kathryn] Right Care, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand	Glencross, DK (corresponding author), NHLS, Natl Prior Programmes, Johannesburg, South Africa.; Glencross, DK (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa.	debbie.glencross@nhls.ac.za	Cassim, Naseem/GLR-4911-2022; Cassim, Naseem/AFU-5522-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X; Schnippel, Kathryn/0000-0003-0757-4325				Binnicker MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1988, DOI 10.1128/CVI.00446-12; Cassim N, 2016, ESTIMATING COST RESU; Cassim N, 2015, 8 INT WORKSH HIV TRE; Coetzee LM, 2014, 7 SA AIDS C DURB S A; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Govender NP, 2012, SAMJ S AFR MED J, V102, P914, DOI [10.7196/samj.6228, 10.7196/SAMJ.6228]; Govender N. P. M G, 2013, GUIDELINE PREVENTION; Husereau Don, 2013, J Med Econ, V16, P713, DOI 10.3111/13696998.2013.784591; Jarvis JN, 2011, SAMJ S AFR MED J, V101, P232, DOI 10.7196/SAMJ.4752; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kozel Thomas R, 2012, Expert Opin Med Diagn, V6, P245, DOI 10.1517/17530059.2012.681300; Larson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158986; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; National Department of Health (NDOH), 2013, 2012 NAT ANT SENT HI; [National Health Laboratory Service (NHLS) (CDW) CDW], 2015, CORP DAT WAR CCMT RE; NDoH, 2015, NAT CONS GUID PREV M; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Standard Bank of South Africa (SBSA), 2015, FOR CLOS IND RAT 23; Standard Bank of South Africa (SBSA), 2016, FOR CLOS IND RAT 04; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171675	10.1371/journal.pone.0171675	http://dx.doi.org/10.1371/journal.pone.0171675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166254	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100060
J	Chang, JY; Jung, S; Park, H; Han, MK				Chang, Jun Young; Jung, Seunguk; Park, Hyun; Han, Moon-Ku			Major vessel occlusion may predict subtherapeutic anticoagulation intensity and feasibility of administration of intravenous thrombolytics	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ORAL ANTICOAGULATION; CARDIOEMBOLIC STROKE; WARFARIN; FREQUENCY; THERAPY; SUBTYPE	Objective We investigated the association between the presence of major vessel occlusion (MVO) and the intensity of the International Normalized Ratio (INR) in cardioembolic high-risk patients taking warfarin. We also evaluated whether the presence of MVO could predict the subtherapeutic range of INR <= 1.7 ensuring safe administration of intravenous thrombolytics. Methods The medical records of 177 cardioembolic stroke patients who were taking warfarin between April, 2008 and March, 2015 were retrospectively analyzed. Logistic regression analysis was performed to calculate the odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association between vessel occlusion and intensity of INR. To predict INR <= 1.7, decision tree analysis was performed. Results INR was inversely associated with MVO in an unadjusted model (OR, 0.36; 95% CI, 0.17- 0.76), and in a model adjusted for initial NIHSS score and time from symptom onset to arrival (OR, 0.28; 95% CI, 0.11-0.73). Fifty-two of 58 (89.7%) patients with MVO had an INR <= 1.7, compared with 83 of 119 (69.7%) patients without MVO. Indication for anticoagulation agent use was dichotomized into NVAF and others, and applied to the subgroup of patients with MVO. All patients with NVAF (31/31, 100%) had INR <= 1.7, while 21 of 27 of the other patients (77.8%) had INR <= 1.7. Conclusions Low INR at presentation in cardioembolic stroke patients during anticoagulation treatment was associated with occurrence of major vessel occlusive stroke. Presence of MVO and indications for anticoagulation may be utilized to ensure the feasibility of administration of intravenous thrombolytics.	[Chang, Jun Young; Jung, Seunguk] Gyeongsang Natl Univ, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Park, Hyun] Gyeongsang Natl Univ, Changwon Hosp, Dept Neurosurg, Chang Won, South Korea; [Han, Moon-Ku] Seoul Natl Univ, Bun Dang Hosp, Dept Neurol, Seongnam, South Korea	Gyeongsang National University; Gyeongsang National University; Seoul National University (SNU)	Han, MK (corresponding author), Seoul Natl Univ, Bun Dang Hosp, Dept Neurol, Seongnam, South Korea.	mkhan@snu.ac.kr		Chang, Jun Young/0000-0003-4880-9258				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arboix A, 2012, CURR CARDIOL REV, V8, P54, DOI 10.2174/157340312801215791; Arboix A, 2010, CURR CARDIOL REV, V6, P150, DOI 10.2174/157340310791658730; Bruch TP, 2014, ARQ NEURO-PSIQUIAT, V72, P487, DOI 10.1590/0004-282X20140075; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Ko Y, 2014, J STROKE, V16, P161, DOI 10.5853/jos.2014.16.3.161; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Nakamura A, 2013, STROKE, V44, P3239, DOI 10.1161/STROKEAHA.113.002523; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Rombouts EK, 2009, THROMB HAEMOSTASIS, V101, P552, DOI 10.1160/TH08-09-0626; Rose AJ, 2009, CIRC-CARDIOVASC QUAL, V2, P591, DOI 10.1161/CIRCOUTCOMES.109.862763; Shroff GR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000756; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Xian Y, 2012, JAMA-J AM MED ASSOC, V307, P2600, DOI 10.1001/jama.2012.6756	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170978	10.1371/journal.pone.0170978	http://dx.doi.org/10.1371/journal.pone.0170978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158211	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700022
J	Endesfelder, S; Makki, H; von Haefen, C; Spies, CD; Buhrer, C; Sifringer, M				Endesfelder, Stefanie; Makki, Hanan; von Haefen, Clarissa; Spies, Claudia D.; Buehrer, Christoph; Sifringer, Marco			Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; PRETERM INFANTS; DEVELOPMENTAL-DISABILITY; INDUCED NEUROAPOPTOSIS; HIPPOCAMPAL-NEURONS; ADULT NEUROGENESIS; ANALYSIS REVEALS; SELF-RENEWAL	Dexmedetomidine (DEX) is a highly selective agonist of alpha 2-receptors with sedative, anxiolytic, and analgesic properties. Neuroprotective effects of dexmedetomidine have been reported in various brain injury models. In the present study, we investigated the effects of dexmedetomidine on hippocampal neurogenesis, specifically the proliferation capacity and maturation of neurons and neuronal plasticity following the induction of hyperoxia in neonatal rats. Six-day old sex-matched Wistar rats were exposed to 80% oxygen or room air for 24 h and treated with 1, 5 or 10 mu g/kg of dexmedetomidine or normal saline. A single pretreatment with DEX attenuated the hyperoxia-induced injury in terms of neurogenesis and plasticity. In detail, both the proliferation capacity (PCNA+cells) as well as the expression of neuronal markers (Nestin+, PSA-NCAM+, NeuN+ ells) and transcription factors (SOX2, Tbr1/2, Prox1) were significantly reduced under hyperoxia compared to control. Furthermore, regulators of neuronal plasticity (Nrp1, Nrg1, Syp, and Sema3a/f) were also drastically decreased. A single administration of dexmedetomidine prior to oxygen exposure resulted in a significant up-regulation of expression-profiles compared to hyperoxia. Our results suggest that dexmedetomidine may have neuroprotective effects in an acute hyperoxic model of the neonatal rat.	[Endesfelder, Stefanie; Makki, Hanan; Buehrer, Christoph] Charite, Dept Neonatol, Berlin, Germany; [von Haefen, Clarissa; Spies, Claudia D.; Sifringer, Marco] Charite, Dept Anesthesiol & Intens Care Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Endesfelder, S (corresponding author), Charite, Dept Neonatol, Berlin, Germany.	stefanie.endesfelder@charite.de	Endesfelder, Stefanie/AAA-5534-2022	Endesfelder, Stefanie/0000-0002-4030-7969; Spies, Claudia/0000-0002-1062-0495				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Agarwal A, 2014, CELL REP, V8, P1130, DOI 10.1016/j.celrep.2014.07.026; Ahmed S, 2013, CRIT CARE, V17, DOI 10.1186/cc12707; Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Bendix I, 2012, INT J MOL SCI, V13, P12939, DOI 10.3390/ijms131012939; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buchman AS, 2016, NEUROLOGY, V86, P735, DOI 10.1212/WNL.0000000000002387; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Chrysostomou C, 2014, J PEDIATR-US, V164, P276, DOI 10.1016/j.jpeds.2013.10.002; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Deguchi K, 2015, INT J DEV NEUROSCI, V47, P58, DOI 10.1016/j.ijdevneu.2015.04.164; Deulofeut R, 2007, ACTA PAEDIATR, V96, P990, DOI 10.1111/j.1651-2227.2007.00365.x; Duan X, 2014, ACTA ANAESTH SCAND, V58, P1121, DOI 10.1111/aas.12356; Duerden EG, 2016, ANN NEUROL, V79, P548, DOI 10.1002/ana.24601; Endesfelder S, 2014, FREE RADICAL BIO MED, V67, P221, DOI 10.1016/j.freeradbiomed.2013.09.026; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GALAND P, 1989, CELL TISSUE KINET, V22, P383, DOI 10.1111/j.1365-2184.1989.tb00223.x; Gavazzi I, 2001, CELL TISSUE RES, V305, P275, DOI 10.1007/s004410100365; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Harrison PJ, 2001, HIPPOCAMPUS, V11, P508, DOI 10.1002/hipo.1067.abs; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Jessberger S, 2009, TRENDS PHARMACOL SCI, V30, P61, DOI 10.1016/j.tips.2008.11.003; Kaindl AM, 2006, CELL DEATH DIFFER, V13, P1097, DOI 10.1038/sj.cdd.4401796; Kato RI, 2014, J ANESTH, V28, P828, DOI 10.1007/s00540-014-1853-3; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Knickmeyer RC, 2006, EARLY HUM DEV, V82, P755, DOI 10.1016/j.earlhumdev.2006.09.014; Koropouli E, 2014, CURR OPIN NEUROBIOL, V27, P1, DOI 10.1016/j.conb.2014.02.005; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuban KCK, 2016, J PEDIATR-US, V173, P69, DOI 10.1016/j.jpeds.2016.02.048; Lado FA, 2002, EPILEPTIC DISORD, V4, P83; Laudenbach V, 2002, ANESTHESIOLOGY, V96, P134, DOI 10.1097/00000542-200201000-00026; Lee Yuan-Shun, 2005, Chang Gung Med J, V28, P846; Li YG, 2007, BRAIN RES, V1184, P277, DOI 10.1016/j.brainres.2007.09.037; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093639; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Loi M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00013; Mantz J, 2011, EUR J ANAESTH, V28, P3, DOI 10.1097/EJA.0b013e32833e266d; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McPherson Christopher, 2012, J Pediatr Pharmacol Ther, V17, P351, DOI 10.5863/1551-6776-17.4.351; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Namiki J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/430138; Neu J, 2014, WORLD REV NUTR DIET, V110, P253, DOI 10.1159/000358474; O'Mara Keliana, 2012, J Pediatr Pharmacol Ther, V17, P252, DOI 10.5863/1551-6776-17.3.252; O'Mara K, 2009, ANN PHARMACOTHER, V43, P1707, DOI 10.1345/aph.1M245; Ozsurekci Y, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2768365; Pan W, 2015, CELL MOL NEUROBIOL; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Patel KN, 2009, PEDIATR EMERG CARE, V25, P133, DOI 10.1097/PEC.0b013e31819a7f75; Perrone S, 2014, CURR PEDIATR REV, V10, P202, DOI 10.2174/1573396309666140101235126; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P110, DOI 10.3109/14767058.2012.664344; Petroz GC, 2006, ANESTHESIOLOGY, V105, P1098, DOI 10.1097/00000542-200612000-00009; Pickard A, 2014, BRIT J ANAESTH, V112, P982, DOI 10.1093/bja/aeu093; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; Potts AL, 2009, PEDIATR ANESTH, V19, P1119, DOI 10.1111/j.1460-9592.2009.03133.x; Qian XL, 2015, EUR J PHARMACOL, V746, P206, DOI 10.1016/j.ejphar.2014.11.017; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Revishchin AV, 2008, INT REV CYTOL, V265, P55, DOI 10.1016/S0074-7696(07)65002-5; Role LW, 2007, NATURE, V448, P263, DOI 10.1038/448263a; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Rubenstein J. L. R., 2013, CELLULAR MIGRATION F; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Schwarz Q, 2010, CELL ADHES MIGR, V4, P61, DOI 10.4161/cam.4.1.10207; Siddappa R, 2011, PEDIATR ANESTH, V21, P153, DOI 10.1111/j.1460-9592.2010.03502.x; Sifringer M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/530371; Sifringer M, 2013, DEV NEUROSCI-BASEL, V35, P255, DOI 10.1159/000346723; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Stone WL, 2016, FRONT BIOSCI-LANDMRK, V21, P165, DOI 10.2741/4382; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; SZELE FG, 1994, NEUROSCIENCE, V60, P133, DOI 10.1016/0306-4522(94)90209-7; Tachibana K, 2012, PEDIATR ANESTH, V22, P713, DOI 10.1111/j.1460-9592.2012.03810.x; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tobias JD, 2007, PEDIATR CRIT CARE ME, V8, P115, DOI 10.1097/01.PCC.0000257100.31779.41; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wang XN, 2015, INT J CLIN EXP MED, V8, P17281; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Wu YQ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/562154	106	49	53	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171498	10.1371/journal.pone.0171498	http://dx.doi.org/10.1371/journal.pone.0171498			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158247	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700086
J	Kloss, TG; Gonzaga, MO; de Oliveira, LL; Sperber, CF				Kloss, Thiago Gechel; Gonzaga, Marcelo Oliveira; de Oliveira, Leandro Licursi; Sperber, Carlos Frankl			Proximate mechanism of behavioral manipulation of an orb-weaver spider host by a parasitoid wasp	PLOS ONE			English	Article							BUILDING BEHAVIOR; LIFE-HISTORIES; HYMENOPTERA; ARANEAE; ICHNEUMONIDAE; PIMPLINAE; TETRAGNATHIDAE; ARANEIDAE; WEBS	Some ichneumonid wasps induce modifications in the web building behavior of their spider hosts to produce resistant "cocoon" webs. These structures hold and protect the wasp's cocoon during pupa development. The mechanism responsible for host manipulation probably involves the inoculation of psychotropic chemicals by the parasitoid larva during a specific developmental period. Recent studies indicate that some spiders build cocoon webs similar to those normally built immediately before ecdysis, suggesting that this substance might be a molting hormone or a precursor chemical of this hormone. Here, we report that Cyclosa spider species exhibiting modified behavior presented higher 20-OH-ecdysone levels than parasitized spiders acting normally or unparasitized individuals. We suggest that the lack of control that spiders have when constructing modified webs can be triggered by anachronic activation of ecdysis.	[Kloss, Thiago Gechel] Univ Fed Vicosa, Programa Posgrad Entomol, Vicosa, MG, Brazil; [Kloss, Thiago Gechel] Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil; [Gonzaga, Marcelo Oliveira] Univ Fed Uberlandia, Inst Biol, Uberlandia, MG, Brazil; [de Oliveira, Leandro Licursi; Sperber, Carlos Frankl] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal do Espirito Santo; Universidade Federal de Uberlandia; Universidade Federal de Vicosa	Kloss, TG (corresponding author), Univ Fed Vicosa, Programa Posgrad Entomol, Vicosa, MG, Brazil.; Kloss, TG (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, ES, Brazil.	thiagokloss@yahoo.com.br	Kloss, Thiago Gechel/AAT-8207-2020; Sperber, Carlos Frankl/F-9298-2012; de Oliveira, Leandro Licursi/D-3616-2009; Sperber, Carlos Frankl/AAH-4443-2021; Gonzaga, Marcelo O/A-4805-2013	Kloss, Thiago Gechel/0000-0003-0958-1748; Sperber, Carlos Frankl/0000-0002-0334-7216; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Gonzaga, Marcelo O/0000-0003-0093-1801	MOG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-02104-14, CRA-30058/12]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; TGK; MOG; CFS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [140508/2012-0, 300295/2016-2, 309787/2012-2, 306157/2014-4, 403733/2012-0, 445832/2014-2, 573802/2008-4]; Financiadora de Estudos e Projetos; Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da Clenda, Tecnologia e Informacao	MOG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); TGK; MOG; CFS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da Clenda, Tecnologia e Informacao	This work was supported by MOG-Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Grant number APQ-02104-14, CRA-30058/12) (http://www.fapemig.br/pt-br/); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/); TGK, MOG, CFS: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant numbers 140508/2012-0, 300295/2016-2,309787/2012-2,306157/2014-4, 403733/2012-0; 445832/2014-2, 573802/2008-4) (http://www.chpq.br/); Financiadora de Estudos e Projetos (www.finep.gov.br); and Sistema Nacional de Laboratorios em Nanotecnologias (SisNANO)/Ministerio da Clenda, Tecnologia e Informacao (www.mcti.gov.br/sisnano). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funders offer research grants or money for laboratory equipment maintenance.	Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; Biron DG, 2006, INSECT MOL BIOL, V15, P731, DOI 10.1111/j.1365-2583.2006.00671.x; Bonaric J.C., 1987, P111; CADY A, 1993, CAN ENTOMOL, V125, P931, DOI 10.4039/Ent125931-5; Crawley MJ, 2013, R BOOK, P557; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Eberhard WG, 2001, J ARACHNOL, V29, P354, DOI 10.1636/0161-8202(2001)029[0354:UTIWAB]2.0.CO;2; Eberhard WG., 2010, PSYCHE; Eberhard WG, 2013, ANN ENTOMOL SOC AM, V106, P652, DOI 10.1603/AN12147; Eberhard WG, 2010, ANIM BEHAV, V79, P375, DOI 10.1016/j.anbehav.2009.10.033; Gauld I.D., 1991, MEMOIRS AM ENTOMOLOG, V47, P1; Gauld ID, 2006, SYST ENTOMOL, V31, P529, DOI 10.1111/j.1365-3113.2006.00334.x; Gonzaga MO, 2010, ETHOL ECOL EVOL, V22, P151, DOI 10.1080/03949371003707836; Gonzaga MO, 2007, NATURWISSENSCHAFTEN, V94, P223, DOI 10.1007/s00114-006-0177-z; Gonzaga MO, 2015, ACTA OECOL, V69, P113, DOI 10.1016/j.actao.2015.10.001; Gonzaga MO, 2011, ENTOMOL SCI, V14, P220, DOI 10.1111/j.1479-8298.2010.00436.x; Gonzaga MO, 2015, BEHAVIOUR, V152, P181, DOI 10.1163/1568539X-00003238; Haspel G, 2003, J NEUROBIOL, V54, P28; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Kloss TG, 2016, J INSECT BEHAV, V29, P315, DOI 10.1007/s10905-016-9560-6; Kloss TG, 2016, ANIM BEHAV, V111, P289, DOI 10.1016/j.anbehav.2015.11.001; Korenko S, 2014, ECOL ENTOMOL, V39, P30, DOI 10.1111/een.12067; Korenko S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024628; Levi Herbert W., 1999, Bulletin of the Museum of Comparative Zoology, V155, P299; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Matsumoto R, 2007, ENTOMOL SCI, V10, P267, DOI 10.1111/j.1479-8298.2007.00223.x; Matsumoto R, 2009, J INSECT BEHAV, V22, P39, DOI 10.1007/s10905-008-9152-1; Nielsen E., 1923, Entomologiske Meddelelser, V14, P137; Poulin R, 2015, TRENDS PARASITOL, V31, P563, DOI 10.1016/j.pt.2015.07.002; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Schlinger EI, 1987, BIOL ACROCERIDAE DIP, P319; Sobczak JF, 2009, J NAT HIST, V43, P2691, DOI 10.1080/00222930903244010; Takasuka K, 2015, J EXP BIOL, V218, P2326, DOI 10.1242/jeb.122739; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; TRABALON M, 1992, GEN COMP ENDOCR, V88, P128, DOI 10.1016/0016-6480(92)90201-T; Weng JL, 2007, J HYMENOPT RES, V16, P326; Yu DS, 2012, TAXAPAD HOME ICHNEUM; Zhou JH, 2011, J CHROMATOGR B, V879, P2533, DOI 10.1016/j.jchromb.2011.07.006	38	21	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171336	10.1371/journal.pone.0171336	http://dx.doi.org/10.1371/journal.pone.0171336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158280	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700062
J	Lansade, L; Marchand, AR; Coutureau, E; Balle, C; Polli, F; Calandreau, L				Lansade, Lea; Marchand, Alain R.; Coutureau, Etienne; Balle, Cyrielle; Polli, Floriane; Calandreau, Ludovic			Personality and predisposition to form habit behaviours during instrumental conditioning in horses (Equus caballus)	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; TEMPERAMENT TRAIT; EXPLORATORY-BEHAVIOR; LEARNING-ABILITIES; STRESS; TIME; PERFORMANCE; MEMORY; CONTINGENCY; FEARFULNESS	The relationship between personality and learning abilities has become a growing field of interest. Studies have mainly focused on the relationship with performance, such as the speed of acquisition. In this study, we hypothesised that personality could in part also be related to a certain predisposition of an individual to switch more easily from a goal-directed process to a habit process during learning. To identify these processes, we conducted a contingency degradation protocol. This study investigated 1/ whether in general horses are able to adjust their response according to the contingency between their action and the reward, 2/ whether there are any relationships between certain personality profiles and a predisposition to switch more rapidly to habitual processes, and 3/ whether emotional states experienced during the learning procedure play a role in this switching. Personality tests were conducted on 29 horses, followed by a degradation contingency protocol. Overall, results show that horses were sensitive to contingency degradation between their action and the reward. Nevertheless, there was inter-individual variability: the horses presenting high fearfulness, and to a lesser extent low sensory sensitivity and low gregariousness were less sensitive to the degradation, demonstrating that they were more likely to switch to a habitual process. Contrary to our expectations, the emotional state experienced during the procedure did not seem to explain this switching. We conclude that personality is not only related to learning performance, but also in part to the process involved during learning, independently of the emotion experienced during the process. This study provides new theoretical knowledge on cognitive skills in ungulates.	[Lansade, Lea; Balle, Cyrielle; Polli, Floriane; Calandreau, Ludovic] Univ Tours, IFCE, CNRS, PRC,INRA, Nouzilly, France; [Marchand, Alain R.; Coutureau, Etienne] Univ Bordeaux, INCIA, Talence, France; [Marchand, Alain R.; Coutureau, Etienne] CNRS, INCIA, UMR 5287, Talence, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Lansade, L (corresponding author), Univ Tours, IFCE, CNRS, PRC,INRA, Nouzilly, France.	lea.lansade@inra.fr		Coutureau, Etienne/0000-0001-6695-020X; Marchand, Alain/0000-0002-0231-5562	IFCE (Institut Francais du Cheval et de l'Equitation)	IFCE (Institut Francais du Cheval et de l'Equitation)	This experiment was funded by IFCE (Institut Francais du Cheval et de l'Equitation; grant: temperament-apprentissage; URL: http://www.ifce.fr/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2007, J COGNITIVE NEUROSCI, V19, P468, DOI 10.1162/jocn.2007.19.3.468; Amy M, 2012, ANIM COGN, V15, P763, DOI 10.1007/s10071-012-0500-3; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; BERRIDGE CW, 1989, J NEUROSCI, V9, P3513; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; Christensen JW, 2012, APPL ANIM BEHAV SCI, V140, P44, DOI 10.1016/j.applanim.2012.05.003; Dezfouli A, 2012, EUR J NEUROSCI, V35, P1036, DOI 10.1111/j.1460-9568.2012.08050.x; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griffin AS, 2015, TRENDS ECOL EVOL, V30, P207, DOI 10.1016/j.tree.2015.01.012; Guillette LM, 2015, ANIM COGN, V18, P165, DOI 10.1007/s10071-014-0787-3; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Ijichi CL, 2013, ANIM BEHAV, V85, P1145, DOI 10.1016/j.anbehav.2013.03.033; Jiao XL, 2011, BEHAV BRAIN RES, V221, P98, DOI 10.1016/j.bbr.2011.02.029; Konig v. Borstel U., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138006; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2016, APPL ANIM BEHAV SCI, V176, P43, DOI 10.1016/j.applanim.2016.01.005; Lansade L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064853; Lansade L, 2010, APPL ANIM BEHAV SCI, V125, P30, DOI 10.1016/j.applanim.2010.02.010; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lisman J, 2013, J COGNITIVE NEUROSCI, V25, P273, DOI 10.1162/jocn_a_00319; Martinez-Valbuena I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00614; Parker M, 2009, BEHAV BRAIN RES, V200, P100, DOI 10.1016/j.bbr.2008.12.033; Range F, 2006, BEHAV PROCESS, V73, P100, DOI 10.1016/j.beproc.2006.04.002; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Schwabe L, STRESS MULTIPLE MEMO; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2011, PSYCHONEUROENDOCRINO, V36, P1287, DOI 10.1016/j.psyneuen.2011.02.002; Schwabe L, 2010, NEUROSCI BIOBEHAV R, V34, P584, DOI 10.1016/j.neubiorev.2009.11.015; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Stamps JA, 2016, BIOL REV, V91, P534, DOI 10.1111/brv.12186; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Valenchon M, 2013, ANIM BEHAV, V86, P1233, DOI 10.1016/j.anbehav.2013.09.026; Valenchon M, 2013, ANIM COGN, V16, P1001, DOI 10.1007/s10071-013-0648-5; Valenchon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062324; Visser EK, 2008, J APPL ANIM WELF SCI, V11, P267, DOI 10.1080/10888700802101254	42	9	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171010	10.1371/journal.pone.0171010	http://dx.doi.org/10.1371/journal.pone.0171010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158199	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700023
J	Nunes, D; Boa-Sorte, N; Grassi, MFR; Taylor, GP; Teixeira, MG; Barreto, ML; Dourado, I; Galvao-Castro, B				Nunes, David; Boa-Sorte, Ney; Rios Grassi, Maria Fernanda; Taylor, Graham P.; Teixeira, Maria Gloria; Barreto, Mauricio L.; Dourado, Ines; Galvao-Castro, Bernardo			HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil	PLOS ONE			English	Article							LYMPHOTROPIC VIRUS TYPE-1; T-CELL LEUKEMIA; SPASTIC PARAPARESIS HAM/TSP; GENERAL-POPULATION; PREGNANT-WOMEN; RISK-FACTORS; INFECTIVE DERMATITIS; NORTHEASTERN BRAZIL; I INFECTION; BAHIA STATE	Background Salvador is the city with the highest number of HTLV-1 infected individuals in Brazil, yet the main route of HTLV-1 transmission is unknown. Objective To investigate the association of syphilis infection as a proxy for sexual transmission of HTLV-1 infection in the general population of this city. Methods A cross sectional population-based study was conducted with 3,451 serum samples obtained by a representative simple random sampling. Data on gender, age, income, and years of education were collected by questionnaire and the presence of HTLV, HIV and Treponema pallidum infection was determined by serology. Logistic regression analysis was used to evaluate the independent effect of the potential explanatory variables to HTLV1 infection and Odds Ratios (OR) and 95% CI were calculated. Results The majority of studied individuals were female (56.4%), had less than 7 years of education (55.3%) and earned two or less minimum wages (52.0%). The overall prevalence of HTLV-1 was 1.48% (51/3,451; 95% CI: 1.10% 1.94%), which increased with age. Only three persons younger than 17 (3/958; 0.31%; CI 95% 0.06-0.91) years were infected by HTLV-1. Among the 45 syphilis positives, 12 (26.7%) were HTLV positive, while among 21 HIV positives, only one (4.8%) was HTLV positive. HTLV-1 infection was found to be associated with syphilis infection (ORADJusTED 36.77; 95% CI 14.96-90.41). Conclusion The data presented herein indicate that horizontal transmission between adults is the main route of HTLV-1 infection in the general population of Salvador and that this is likely to occur through sexual contact.	[Nunes, David; Boa-Sorte, Ney; Rios Grassi, Maria Fernanda; Galvao-Castro, Bernardo] Escola Bahiana Med & Saude Publ, Ctr Integrat & Interdisciplinar HTLV, Salvador, BA, Brazil; [Rios Grassi, Maria Fernanda; Barreto, Mauricio L.; Galvao-Castro, Bernardo] Fundacao Oswaldo Cruz Bahia, Inst Goncalo Moniz, Salvador, BA, Brazil; [Taylor, Graham P.; Dourado, Ines] Imperial Coll Healthcare NHS Trust, Natl Ctr Human Retrovirol, St Marys Hosp, London, England; [Teixeira, Maria Gloria; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil	Escola Bahiana de Medicina e Saude Publica; Imperial College London; Universidade Federal da Bahia	Galvao-Castro, B (corresponding author), Escola Bahiana Med & Saude Publ, Ctr Integrat & Interdisciplinar HTLV, Salvador, BA, Brazil.; Galvao-Castro, B (corresponding author), Fundacao Oswaldo Cruz Bahia, Inst Goncalo Moniz, Salvador, BA, Brazil.	bgalvao@bahiana.edu.br	Dourado, Ines/Q-6535-2016; Grassi, Fernanda/X-7360-2019; Boa-Sorte, Ney A/Q-9902-2018; Boa-Sorte, Ney/AAG-8718-2020; Barreto, Mauricio L/B-1752-2008; Teixeira, Maria Gloria L C/G-4808-2012	Dourado, Ines/0000-0003-1675-2146; Grassi, Fernanda/0000-0002-7356-5569; Boa-Sorte, Ney/0000-0001-7068-3319; Barreto, Mauricio L/0000-0002-0215-4930; Teixeira, Maria Gloria L C/0000-0003-3318-3408	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a pesquisa do Estado da Bahia (FAPESB)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and by Fundacao de Amparo a pesquisa do Estado da Bahia (FAPESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Maria da Conceição Chagas de, 2003, Rev. Saúde Pública, V37, P566; Barbosa HS, 1999, J ACQ IMMUN DEF SYND, V21, P65, DOI 10.1097/00126334-199905010-00009; Bittencourt A L, 1998, Rev Inst Med Trop Sao Paulo, V40, P245, DOI 10.1590/S0036-46651998000400008; Bittencourt A, 2009, ACTA ONCOL, V48, P598, DOI 10.1080/02841860802657235; Bittencourt AL, 2001, J ACQ IMMUN DEF SYND, V26, P490, DOI 10.1097/00126334-200104150-00016; Brignol S, 2015, CAD SAUDE PUBLICA, V31, P1035, DOI 10.1590/0102-311X00178313; Casseb J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000487; Cooper Joshua M., 2016, Rev. paul. pediatr., V34, P251, DOI 10.1016/j.rppede.2016.06.004; Damacena GN, 2011, JAIDS-J ACQ IMM DEF, V57, pS144, DOI 10.1097/QAI.0b013e31821e9bf6; Demontis MA, 2015, J MED VIROL, V87, P2130, DOI 10.1002/jmv.24264; Dourado I, 1998, J ACQ IMMUN DEF SYND, V19, P426, DOI 10.1097/00042560-199812010-00016; Dourado I, 2007, CAD SAUDE PUBLICA, V23, P25, DOI 10.1590/S0102-311X2007000100004; Dourado I, 2003, JAIDS-J ACQ IMM DEF, V34, P527, DOI 10.1097/00126334-200312150-00013; Einsiedel L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu023; European Centre for Disease Prevention and Control, 2012, RISK ASS HTLV 1 2 TR; GalvaoCastro B, 1997, TRANSFUSION, V37, P242, DOI 10.1046/j.1537-2995.1997.37297203532.x; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Mello MAG, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-28; Hanchard B, 2005, CLIN INFECT DIS, V41, P542, DOI 10.1086/432066; Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152; Hlela C, 2009, AIDS REV, V11, P205; Honarbakhsh S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1002-0; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; KRAMER A, 1995, AM J EPIDEMIOL, V142, P1212; LAGRENADE L, 1990, LANCET, V336, P1345; Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812; Magalhaes T, 2008, J MED VIROL, V80, P2040, DOI 10.1002/jmv.21278; Matsumoto Y, 2011, J OBSTET GYNAECOL RE, V37, P887, DOI 10.1111/j.1447-0756.2010.01461.x; MOCHIZUKI M, 1992, AM J OPHTHALMOL, V114, P123, DOI 10.1016/S0002-9394(14)73974-1; Mota Augusto, 2006, Rev. Bras. Hematol. Hemoter., V28, P120, DOI 10.1590/S1516-84842006000200011; Murphy EL, 1996, INT J EPIDEMIOL, V25, P1083, DOI 10.1093/ije/25.5.1083; MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; OSAME M, 1986, LANCET, V1, P1031; Paiva A, 2014, REV SOC BRAS MED TRO, V47, P265, DOI 10.1590/0037-8682-0232-2013; Rafatpanah H, 2011, J CLIN VIROL, V52, P172, DOI 10.1016/j.jcv.2011.07.004; RIEDEL DA, 1989, J INFECT DIS, V159, P603, DOI 10.1093/infdis/159.4.603; de Oliveira MDSP, 2012, CLIN INFECT DIS, V54, P1714, DOI 10.1093/cid/cis273; Snelling D, 2007, J BIOSOC SCI, V39, P421, DOI 10.1017/S0021932006001465; STUVER SO, 1993, J INFECT DIS, V167, P57, DOI 10.1093/infdis/167.1.57; Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011; Torii Y, 2013, PEDIATR INFECT DIS J, V32, P699, DOI 10.1097/INF.0b013e3182897c36; TSUJI Y, 1990, PEDIATRICS, V86, P11; UN, 2013, WORLD POP PROSP 2012, P2; Vargens CCL, 2011, J CLIN VIROL, V52, P177, DOI 10.1016/j.jcv.2011.07.016; Venancio SI, 2010, J PEDIAT-BRAZIL, V86, P317, DOI 10.2223/JPED.2016; Venancio SI, 2013, REV SAUDE PUBL, V47, P1205, DOI 10.1590/S0034-8910.2013047004676; Walcott MM, 2014, SEX HEALTH, V11, P42, DOI 10.1071/SH13099; Yamada T, 2014, MICROBIOL IMMUNOL, V58, P427, DOI 10.1111/1348-0421.12165; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	53	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171303	10.1371/journal.pone.0171303	http://dx.doi.org/10.1371/journal.pone.0171303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158226	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700056
J	Nyffenegger, C; Nordvang, RT; Jers, C; Meyer, AS; Mikkelsen, JD				Nyffenegger, Christian; Nordvang, Rune Thorbjorn; Jers, Carsten; Meyer, Anne S.; Mikkelsen, Jorn Dalgaard			Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase activity	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; BIOCATALYTIC PRODUCTION; 3'-SIALYLLACTOSE; MECHANISM	A sialidase (EC 3.2.1.18) from the non-pathogenic Trypanosoma rangeli, TrSA, has been shown to exert trans-sialidase activity after mutation of five specific amino acids in the active site (M96V, A98P, S120Y, G249Y, Q284P) to form the so-called TrSA(5mut) enzyme. By computational and hypothesis driven approaches additional mutations enhancing the transsialidase activity have been suggested. In the present work, we made a systematic combination of these mutations leading to seven new variants of the T. rangeli sialidase, having 6-16 targeted amino acid mutations. The resulting enzyme variants were analyzed via kinetics for their ability to carry out trans-sialidase reaction using CGMP and D-lactose as substrates. The sialidase variants with 15 and 16 mutations, respectively, exhibited significantly improved trans-sialidase activity for D-lactose sialylation. Our results corroborate, that computational studies of trans-glycosylation can be a valuable input in the design of novel trans-glycosidases, but also highlight the importance of experimental validation in order to assess the performance. In conclusion, two of the seven mutants displayed a dramatic switch in specificity from hydrolysis towards trans-sialylation and constitute the most potent trans-sialidase mutants of TrSA described in literature to date.	[Nyffenegger, Christian; Nordvang, Rune Thorbjorn; Jers, Carsten; Meyer, Anne S.; Mikkelsen, Jorn Dalgaard] Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark	Technical University of Denmark	Jers, C (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Ctr BioProc Engn, Lyngby, Denmark.	cjer@dtu.dk	Meyer, Anne S/AAN-2157-2020	Meyer, Anne S/0000-0001-8910-9931	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	Danish Dairy Research Foundation (Mejeribrugets Forskningsfond)	This work was supported by the funding from Danish Dairy Research Foundation (Mejeribrugets Forskningsfond; www.ddrf.dk) (grant to JDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MF, 2003, J MOL BIOL, V325, P773, DOI 10.1016/S0022-2836(02)01306-2; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Bissaro B, 2015, BIOCHEM J, V467, P17, DOI 10.1042/BJ20141412; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Castillo-Courtade L, 2015, ALLERGY, V70, P1091, DOI 10.1111/all.12650; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Holck J, 2014, NEW BIOTECHNOL, V31, P156, DOI 10.1016/j.nbt.2013.11.006; Jers C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083902; Lin AE, 2014, J INFECT DIS, V209, P389, DOI 10.1093/infdis/jit464; Luo JQ, 2014, BIORESOURCE TECHNOL, V166, P9, DOI 10.1016/j.biortech.2014.05.003; Michalak M, 2014, PROCESS BIOCHEM, V49, P265, DOI 10.1016/j.procbio.2013.10.023; Nordvang RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158434; Paris G, 2005, J MOL BIOL, V345, P923, DOI 10.1016/j.jmb.2004.09.031; Pereira MEA, 1996, INFECT IMMUN, V64, P3884, DOI 10.1128/IAI.64.9.3884-3892.1996; Pierdominici-Sottile G, 2014, PROTEINS, V82, P424, DOI 10.1002/prot.24408; SAITO T, 1992, J DAIRY SCI, V75, P1768, DOI 10.3168/jds.S0022-0302(92)77936-3; Vera C, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2159-4; Zeuner B, 2014, ENZYME MICROB TECH, V55, P85, DOI 10.1016/j.enzmictec.2013.12.009	21	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171585	10.1371/journal.pone.0171585	http://dx.doi.org/10.1371/journal.pone.0171585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158299	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700103
J	Lee, MY; Park, C; Ha, SE; Park, PJ; Berent, RM; Jorgensen, BG; Corrigan, RD; Grainger, N; Blair, PJ; Slivano, OJ; Miano, JM; Ward, SM; Smith, TK; Sanders, KM; Ro, S				Lee, Moon Young; Park, Chanjae; Ha, Se Eun; Park, Paul J.; Berent, Robyn M.; Jorgensen, Brian G.; Corrigan, Robert D.; Grainger, Nathan; Blair, Peter J.; Slivano, Orazio J.; Miano, Joseph M.; Ward, Sean M.; Smith, Terence K.; Sanders, Kenton M.; Ro, Seungil			Serum response factor regulates smooth muscle contractility via myotonic dystrophy protein kinases and L-type calcium channels	PLOS ONE			English	Article							INTERSTITIAL-CELLS; IN-VIVO; ICC-MY; WAVES; EXPRESSION; CA(V)1.2; CAJAL; MICE; SRF	Serum response factor (SRF) transcriptionally regulates expression of contractile genes in smooth muscle cells (SMC). Lack or decrease of SRF is directly linked to a phenotypic change of SMC, leading to hypomotility of smooth muscle in the gastrointestinal (GI) tract. However, the molecular mechanism behind SRF-induced hypomotility in GI smooth muscle is largely unknown. We describe here how SRF plays a functional role in the regulation of the SMC contractility via myotonic dystrophy protein kinase (DMPK) and L-type calcium channel CACNA1C. GI SMC expressed Dmpk and Cacnalc genes into multiple alternative transcriptional isoforms. Deficiency of SRF in SMC of Srf knockout (KO) mice led to reduction of SRF-dependent DMPK, which down-regulated the expression of CACNA1C. Reduction of CACNA1C in KO SMC not only decreased intracellular Ca2+ spikes but also disrupted their coupling between cells resulting in decreased contractility. The role of SRF in the regulation of SMC phenotype and function provides new insight into how SMC lose their contractility leading to hypomotility in pathophysiological conditions within the GI tract.	[Lee, Moon Young; Park, Chanjae; Ha, Se Eun; Park, Paul J.; Berent, Robyn M.; Jorgensen, Brian G.; Corrigan, Robert D.; Grainger, Nathan; Blair, Peter J.; Ward, Sean M.; Smith, Terence K.; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Lee, Moon Young] Wonkwang Univ, Dept Physiol, Wonkwang Digest Dis Res Inst, Sch Med, Iksan, Chonbuk, South Korea; [Lee, Moon Young] Wonkwang Univ, Inst Wonkwang Med Sci, Sch Med, Iksan, Chonbuk, South Korea; [Slivano, Orazio J.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wonkwang University; Wonkwang University; University of Rochester	Ro, S (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.	sro@medicine.nevada.edu	Miano, Joseph/L-5634-2018	Miano, Joseph/0000-0001-7522-3207; Grainger, Nathan/0000-0002-3954-7041; Grainger, Nathan/0000-0002-9956-9592; Ro, Seungil/0000-0003-0861-8334	National Institute of Diabetes and Digestive and Kidney Diseases [DK094886, DK103055]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103055, P01DK041315, R01DK094886, R01DK091336] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases grants, DK094886 and DK103055, to SR.	Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P4453, DOI 10.1113/jphysiol.2010.196824; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; DROOGMANS G, 1986, PFLUG ARCH EUR J PHY, V406, P259, DOI 10.1007/BF00640911; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Hennig GW, 2002, J PHYSIOL-LONDON, V543, P233, DOI 10.1113/jphysiol.2002.018986; Hirst GDS, 2002, J PHYSIOL-LONDON, V540, P1003, DOI 10.1113/jphysiol.2001.013672; Huizinga JD, 2002, GASTROENTEROLOGY, V123, P1627, DOI 10.1053/gast.2002.36549; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Kaliman P, 2008, CELL SIGNAL, V20, P1935, DOI 10.1016/j.cellsig.2008.05.005; Lee MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133751; Mack CP, 1999, CIRC RES, V84, P852; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Park C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.353; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Ro S, 2006, AM J PHYSIOL-GASTR L, V290, pG710, DOI 10.1152/ajpgi.00420.2005; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Timchenko L, 2013, INT J BIOCHEM CELL B, V45, P2280, DOI 10.1016/j.biocel.2013.06.010; Ueda H, 2000, PROG HISTOCHEM CYTO, V35, P187, DOI 10.1016/S0079-6336(00)80002-9; van Helden DF, 2003, J PHYSIOL-LONDON, V548, P271, DOI 10.1113/jphysiol.2002.033720; Vogalis F, 1991, AM J PHYS 1, V260, P34, DOI [10.1093/emboj/cdg583, DOI 10.1093/EMBOJ/CDG583]; Ward SM, 2000, J NEUROSCI, V20, P1393; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666	33	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171262	10.1371/journal.pone.0171262	http://dx.doi.org/10.1371/journal.pone.0171262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152551	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161200119
J	Li, Y; Zhao, L; Gu, BY; Cai, JJ; Lv, YY; Yu, LK				Li, Yan; Zhao, Li; Gu, Boya; Cai, Jiajia; Lv, Yuanyuan; Yu, Laikang			Aerobic exercise regulates Rho/cofilin pathways to rescue synaptic loss in aged rats	PLOS ONE			English	Article							SPATIAL-LEARNING DEFICITS; MONKEY PREFRONTAL-CORTEX; ENVIRONMENTAL ENRICHMENT; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MODERATE EXERCISE; FORCED EXERCISE; PYRAMIDAL CELLS; NEURON NUMBER; PLASTICITY	Purpose The role of exercise to prevent or reverse aging-induced cognitive decline has been widely reported. This neuroprotection is associated with changes in the synaptic structure plasticity. However, the mechanisms of exercise-induced synaptic plasticity in the aging brain are still unclear. Thus, the aim of the present study is to investigate the aging-related alterations of Rho-GTPase and the modulatory influences of exercise training. Methods Young and old rats were used in this study. Old rats were subjected to different schedules of aerobic exercise (12 m/min, 60 min/d, 3d/w or 5d/w) or kept sedentary for 12 w. After 12 w of aerobic exercise, the synapse density in the cortex and hippocampus was detected with immunofluorescent staining using synaptophysin as a marker. The total protein levels of RhoA, Rac1, Cdc42 and cofilin in the cortex and hippocampus were detected with Western Blot. The activities of RhoA, Rac1 and Cdc42 were determined using a pull down assay. Results We found that synapse loss occurred in aging rats. However, the change of expression and activity of RhoA, Rac1 and Cdc42 was different in the cortex and hippocampus. In the cortex, the expression and activity of Rac1 and Cdc42 was greatly increased with aging, whereas there were no changes in the expression and activity of RhoA. In the hippocampus, the expression and activity of Rac1 and Cdc42 was greatly decreased and there were no changes in the expression and activity of RhoA. As a major downstream substrate of the Rho GTPase family, the increased expression of cofilin was only observed in the cortex. High frequency exercise ameliorated all aging-related changes in the cortex and hippocampus. Conclusions These data suggest that aerobic exercise reverses synapse loss in the cortex and hippocampus in aging rats, which might be related to the regulation of Rho GTPases.	[Li, Yan; Zhao, Li; Cai, Jiajia; Yu, Laikang] Beijing Sport Univ, Dept Exercise Physiol, Beijing, Peoples R China; [Gu, Boya; Lv, Yuanyuan] Beijing Sport Univ, Key Lab Phys Fitness & Exercise, Minist Educ, Beijing, Peoples R China	Beijing Sport University; Beijing Sport University	Zhao, L (corresponding author), Beijing Sport Univ, Dept Exercise Physiol, Beijing, Peoples R China.	zhaolispring@126.com		Yu, Laikang/0000-0001-7649-5095	National Natural Science Foundation of China [31271278, 31571229]; Chinese Universities Scientific Fund [2015ZX002, 2015ZD009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This work was supported by National Natural Science Foundation of China www.nsfc.gov.cn (31271278, 31571229), and the Chinese Universities Scientific Fund www.bsu.edu.cn (2015ZX002, 2015ZD009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang ET, 2006, BRAIN RES, V1113, P186, DOI 10.1016/j.brainres.2006.07.023; [Anonymous], 2010, TRENDS COGN SCI, V14, P365, DOI [10.1016/j.tics.2010.05.003, DOI 10.1016/J.TICS.2010.05.003]; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chang YM, 2005, CEREB CORTEX, V15, P409, DOI 10.1093/cercor/bhh144; Chen C, 2012, INT J BIOCHEM CELL B, V44, P447, DOI 10.1016/j.biocel.2011.11.022; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Ferreira AFB, 2010, BRAIN RES, V1361, P31, DOI 10.1016/j.brainres.2010.09.045; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Huesa G, 2010, J ALZHEIMERS DIS, V19, P37, DOI 10.3233/JAD-2010-1203; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Lambert TJ, 2005, NEUROBIOL LEARN MEM, V83, P206, DOI 10.1016/j.nlm.2004.12.001; Larson MJ, 2013, SUBST ABUS, V34, P179, DOI 10.1080/08897077.2012.746255; Li Yan, 2013, J BEIJING SPORT U, V36, P44; Luebke JI, 2007, NEUROSCIENCE, V150, P556, DOI 10.1016/j.neuroscience.2007.09.042; Luebke J, 2010, BRAIN RES REV, V62, P212, DOI 10.1016/j.brainresrev.2009.12.002; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MacIntosh BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085163; Maloney MT, 2008, ADF COFILIN ACTIN DY; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Miller MB, 2013, NEUROSCIENTIST, V19, P255, DOI 10.1177/1073858413475486; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Niederost B, 2002, J NEUROSCI, V22, P10368; Peters A, 2008, NEUROSCIENCE, V152, P970, DOI 10.1016/j.neuroscience.2007.07.014; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Rapp PR, 2002, CEREB CORTEX, V12, P1171, DOI 10.1093/cercor/12.11.1171; Real CC, 2010, BRAIN RES, V1363, P63, DOI 10.1016/j.brainres.2010.09.060; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shamy JL, 2011, CEREB CORTEX, V21, P1559, DOI 10.1093/cercor/bhq210; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234; [赵丽 Zhao Li], 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P5357; 赵丽, 2011, [中国老年学杂志, Chinese Journal of Gerontology], V31, P2134	49	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171491	10.1371/journal.pone.0171491	http://dx.doi.org/10.1371/journal.pone.0171491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152068	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200148
J	Chang, HY; Chen, JH; Chang, JH; Lin, HC; Lin, CY; Peng, CC				Chang, Hung-Yang; Chen, Jin-Hua; Chang, Jui-Hsing; Lin, Hung-Chih; Lin, Chien-Yu; Peng, Chun-Chih			Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; LATE-ONSET SEPSIS; LACTIS BB12 SUPPLEMENTATION; PRETERM INFANTS; DOUBLE-BLIND; BIFIDOBACTERIUM-BREVE; ORAL SUPPLEMENTATION; PROPHYLACTIC PROBIOTICS; INTESTINAL MICROBIOTA; LACTOBACILLUS-REUTERI	Background Some oral probiotics have been shown to prevent necrotizing enterocolitis (NEC) and decrease mortality effectively in preterm very low birth weight (PVLBW) infants. However, it is unclear whether a single probiotic or a mixture of probiotics is most effective for the prevention of NEC. Objective A meta-analysis was conducted by reviewing the most up to date literature to investigate whether multiple strains probiotics are more effective than a single strain in reducing NEC and death in PVLBW infants. Data sources Relevant studies were identified by searches of the MEDLINE, EMBASE, and Cochrane CENTRAL databases, from 2001 to 2016. Data extraction and synthesis The inclusion criteria were randomized controlled trials of any enteral probiotic supplementation that was initiated within the first 7 days and continued for at least 14 days in preterm infants (<= 34 weeks' gestation) and/or those of a birth weight <= 1500 g. Results A total of 25 trials (n = 7345 infants) were eligible for inclusion in the meta-analysis using a fixed-effects model. Multiple strains probiotics were associated with a marked reduction in the incidence of NEC, with a pooled OR of 0.36 (95% CI, 0.24-0.53; P < .00001). Single strain probiotic using Lactobacillus species had a borderline effect in reducing NEC (OR of 0.60; 95% CI 0.36-1.0; P = .05), but not mortality. Multiple strains probiotics had a greater effectiveness in reducing mortality and were associated with a pooled OR of 0.58 (95% CI, 0.43-0.79; P = .0006). Trials using single strain of Bifidobacterium species and Saccharomyces boulardii did not reveal any beneficial effects in terms of reducing NEC or mortality. Conclusion This updated report found that multiple strains probiotics appear to be the most feasible and effective strategy for the prevention of NEC and reduction of mortality in PVLBW neonates. Further clinical trials should focus on which probiotic combinations are most effective.	[Chang, Hung-Yang; Chang, Jui-Hsing; Peng, Chun-Chih] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan; [Chang, Hung-Yang; Peng, Chun-Chih] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Chang, Hung-Yang] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Chen, Jin-Hua] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Chen, Jin-Hua] Taipei Med Univ, Ctr Biostat, Taipei, Taiwan; [Lin, Hung-Chih] China Med Univ, Childrens Hosp, Dept Pediat, Taichung, Taiwan; [Lin, Hung-Chih] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lin, Chien-Yu] Hsinchu MacKay Mem Hosp, Dept Pediat, Hsinchu, Taiwan	Mackay Medical College; Taipei Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; Mackay Memorial Hospital	Lin, HC (corresponding author), China Med Univ, Childrens Hosp, Dept Pediat, Taichung, Taiwan.; Lin, HC (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.	d0373@mail.cmuh.org.tw						Aceti A, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0199-2; Agarwal R, 2003, J PEDIATR GASTR NUTR, V36, P397, DOI 10.1097/00005176-200303000-00019; Al-Hosni M, 2012, J PERINATOL, V32, P253, DOI 10.1038/jp.2011.51; Fernandez-Carrocera LA, 2013, ARCH DIS CHILD-FETAL, V98, pF5, DOI 10.1136/archdischild-2011-300435; AlFaleh K., 2014, EVID BASED CHILD HLT, V9, P584, DOI [10.1002/14651858.CD005496.pub4, DOI 10.1002/EBCH.1976]; AlFaleh K, 2010, NEONATOLOGY, V97, P93, DOI 10.1159/000235684; [Anonymous], J PEDIAT PHARM; Athalye-Jape G, 2016, JPEN-PARENTER ENTER, V40, P783, DOI 10.1177/0148607115588113; Barclay AR, 2007, J PEDIATR GASTR NUTR, V45, P569, DOI 10.1097/MPG.0b013e3181344694; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Braga TD, 2011, AM J CLIN NUTR, V93, P81, DOI 10.3945/ajcn.2010.29799; Cassir N, 2016, FUTURE MICROBIOL, V11, P273, DOI 10.2217/fmb.15.136; Chapman CMC, 2011, EUR J NUTR, V50, P1, DOI 10.1007/s00394-010-0166-z; Chen AC, 2014, J PEDIATR GASTR NUTR, V58, P7, DOI 10.1097/MPG.0b013e3182a7dc74; Costalos C, 2003, EARLY HUM DEV, V74, P89, DOI 10.1016/S0378-3782(03)00090-2; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; Demirel G, 2013, ACTA PAEDIATR, V102, pE560, DOI 10.1111/apa.12416; Deshpande G, 2007, LANCET, V369, P1614, DOI 10.1016/S0140-6736(07)60748-X; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Di M, 2010, ZHONG GUO SHE QU YI, V231, P69; Dilli D, 2015, J PEDIATR-US, V166, P545, DOI 10.1016/j.jpeds.2014.12.004; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Garland SM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-210; Hikaru U., 2010, International Journal of Probiotics and Prebiotics, V5, P33; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Huang B, 2009, J GUANGDONG MED COLL, V27, P37; Indrio F, 2008, J PEDIATR-US, V152, P801, DOI 10.1016/j.jpeds.2007.11.005; Jacobs SE, 2013, PEDIATRICS, V132, P1055, DOI 10.1542/peds.2013-1339; Ke D, 2008, CHIN PEDIAT EMERG ME, V15, P69; Kitajima H, 1997, ARCH DIS CHILD-FETAL, V76, pF101, DOI 10.1136/fn.76.2.F101; Lau CSM, 2015, J PEDIATR SURG, V50, P1405, DOI 10.1016/j.jpedsurg.2015.05.008; Li YD, 2004, PEDIATR INT, V46, P509, DOI 10.1111/j.1442-200x.2004.01953.x; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Luig M, 2005, J PAEDIATR CHILD H, V41, P169, DOI 10.1111/j.1440-1754.2005.00582.x; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Mihatsch WA, 2010, NEONATOLOGY, V98, P156, DOI 10.1159/000280291; MILLAR MR, 1993, ARCH DIS CHILD-FETAL, V69, P483, DOI 10.1136/adc.69.5_Spec_No.483; Mohan R, 2008, PEDIATR RES, V64, P418, DOI 10.1203/PDR.0b013e318181b7fa; Mohan R, 2006, J CLIN MICROBIOL, V44, P4025, DOI 10.1128/JCM.00767-06; Oncel MY, 2014, ARCH DIS CHILD-FETAL, V99, pF110, DOI 10.1136/archdischild-2013-304745; Patole S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089511; REUMAN PD, 1986, PEDIATR INFECT DIS J, V5, P663, DOI 10.1097/00006454-198611000-00013; Rojas MA, 2012, PEDIATRICS, V130, pE1113, DOI 10.1542/peds.2011-3584; Romeo MG, 2011, J PERINATOL, V31, P63, DOI 10.1038/jp.2010.57; Rouge C, 2009, AM J CLIN NUTR, V89, P1828, DOI 10.3945/ajcn.2008.26919; Roy A, 2014, N AM J MED SCI, V6, P50, DOI 10.4103/1947-2714.125870; Saengtawesin Varaporn, 2014, Journal of the Medical Association of Thailand, V97, pS20; Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091; Sari FN, 2011, EUR J CLIN NUTR, V65, P434, DOI 10.1038/ejcn.2010.278; Schulzke SM, 2007, ARCH PEDIAT ADOL MED, V161, P583, DOI 10.1001/archpedi.161.6.583; Serce O, 2013, EARLY HUM DEV, V89, P1033, DOI 10.1016/j.earlhumdev.2013.08.013; Shiou SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065108; Stratiki Z, 2007, EARLY HUM DEV, V83, P575, DOI 10.1016/j.earlhumdev.2006.12.002; Tewari VV, 2015, J TROP PEDIATRICS, V61, P377, DOI 10.1093/tropej/fmv050; Thymann T, 2009, AM J PHYSIOL-GASTR L, V297, pG1115, DOI 10.1152/ajpgi.00261.2009; Totsu S, 2014, PEDIATR INT, V56, P714, DOI 10.1111/ped.12330; Underwood MA, 2009, J PEDIATR GASTR NUTR, V48, P216, DOI 10.1097/MPG.0b013e31818de195; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; Wu SF, 2013, J PEDIATR GASTR NUTR, V57, P23, DOI 10.1097/MPG.0b013e3182929210	66	79	83	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171579	10.1371/journal.pone.0171579	http://dx.doi.org/10.1371/journal.pone.0171579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182644	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800076
J	Bravo, SP; Cueto, VR; Gorosito, CA				Patricia Bravo, Susana; Rodolfo Cueto, Victor; Andres Gorosito, Cristian			Migratory timing, rate, routes and wintering areas of White-crested Elaenia (Elaenia albiceps chilensis), a key seed disperser for Patagonian forest regeneration	PLOS ONE			English	Article							BIRD MIGRATION; NORTHERN PATAGONIA; ANNUAL CYCLE; RAIN-FOREST; TRACKING; ABUNDANCE; SONGBIRD; HEMISPHERE; DIVERSITY; DYNAMICS	Migratory animals often play key ecological roles within the communities they visit throughout their annual journeys. As a consequence of the links between biomes mediated by migrants, changes in one biome could affect remote areas in unpredictable ways. Migratory routes and timing of most Neotropical austral migrants, which breed at south temperate latitudes of South America and overwinter closer to or within tropical latitudes of South America, have yet to be described in detail. As a result, our understanding about how these birds provide links between South American biomes is almost non-existent. White-crested Elaenia (Elaenia albiceps chilensis) is a long-distance austral migrant that breeds in the Patagonian Forest biome and overwinters in tropical South America. Because this small flycatcher plays a key role in the regeneration of this ecosystem, our objective was to describe the annual cycle of White-crested elaenias to evaluate the degree of migratory connectivity between breeding and wintering areas and therefore to determine if there are specific biomes of northern South America linked by elaenias to Patagonian forests. Fifteen individuals were successfully tracked throughout a complete migration cycle using miniature light-level geolocators. All individuals resided and moved through the same general regions. During fall (March-April-May), elaenias were located in the Caatinga and the Atlantic Forest biomes, from Rio de Janeiro to the region near Salvador da Bahia, Brazil. During winter (June-July-Aug.), birds were located further inland, within the Cerrado biome. Birds used three different routes during fall migration. Our results indicate that some individuals use a direct route, flying between 500-600 km/day, crossing desert and grasslands, while others took a detour, flying 100-200 km/day through forested areas with refueling opportunities. All birds used the Yunga forest during spring migration, with ten out of 15 individuals showing a clear counterclockwise loop trajectories throughout their annual cycle. None of the elaenias passed through Amazonia, traveled to western South America or crossed the Equator. Eleanias exhibited a high migratory connectivity between breeding area in Patagonian Forests and winter areas, Atlantic Forest and Cerrado. Our results suggest that Patagonian Forests could be strongly impacted by changes in those biomes or in the Yungas.	[Patricia Bravo, Susana; Rodolfo Cueto, Victor; Andres Gorosito, Cristian] UNPSJB, CONICET, CIEMEP, Esquel, Chubut, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bravo, SP (corresponding author), UNPSJB, CONICET, CIEMEP, Esquel, Chubut, Argentina.	sbravo@conicet.gov.ar	Gorosito, Cristian/GXZ-4845-2022	Cueto, Victor/0000-0001-9594-0086; Bravo, Susana/0000-0002-9745-6279; Gorosito, Cristian/0000-0002-9277-7903				Aizen MA, 2002, REV CHIL HIST NAT, V75, P79, DOI 10.4067/S0716-078X2002000100008; Aizen Marcelo A., 1998, Ecologia Austral, V8, P217; Akesson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041195; Amico Guillermo C, 2005, Ecol. austral, V15, P89; [Anonymous], TERR EC; ARMESTO JJ, 1987, REV CHIL HIST NAT, V60, P321; Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Batalha MA, 2004, AUST J BOT, V52, P149, DOI 10.1071/BT03098; Batalha MA, FLORIDA ENTOMOLOGIST, V98, P170; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Beason JP, 2012, WILSON J ORNITHOL, V124, P1; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Bravo SP, 2015, PLANT ECOL, V216, P383, DOI 10.1007/s11258-014-0443-7; Camilotti D. C., 2011, Iheringia, Serie Botanica, V66, P31; Campo de Ferreras A, 2004, CLIMA SO BONAERENSE; Cavallero L, 2013, BIOL CONSERV, V158, P342, DOI 10.1016/j.biocon.2012.10.004; Chesser R. Terry, 1994, Bird Conservation International, V4, P91; Cueto VR, 2016, EMU, V116, P301, DOI 10.1071/MU15078; Cueto VR, 2015, REV BRAS ORNITOL, V23, P18; Cueto Víctor R., 2008, Hornero, V23, P1; de Faria R.A.P.G., 2012, PHENOLOGY SPECIES CE; Delmore KE, 2012, P R SOC B, V279; Develey PF, 2000, J TROP ECOL, V16, P33, DOI 10.1017/S0266467400001255; Dingle H, 2008, EMU, V108, P341, DOI 10.1071/MU08010; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Fair J., 2010, ORNITHOLOGICAL COUNC; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Fox JW., 2012, INTIGEO SERIES GEOLO; Fox JW., 2013, USER REFERENCE MANUA; Gill RE, 2014, ANIM BEHAV, V90, P117, DOI 10.1016/j.anbehav.2014.01.020; GRIGERA D, 1994, REV CHIL HIST NAT, V67, P273; Heckscher CM, 2011, AUK, V128, P531, DOI 10.1525/auk.2011.10280; Hobson KA, 2015, AUK, V132, P540, DOI 10.1642/AUK-14-260.1; Ippi S, 2009, ORNITOL NEOTROP, V20, P231; Jahn AE, 2004, AUK, V121, P1005, DOI 10.1642/0004-8038(2004)121[1005:RAHASA]2.0.CO;2; Jahn AE, 2009, P 4 INT PARTN FLIGHT, P557; Jahn AE, 2013, AUK, V130, P223, DOI 10.1525/auk.2013.12077; Jahn AE, 2013, AUK, V130, P247, DOI 10.1525/auk.2013.13010; Jimenez JE, 2016, WILSON J ORNITHOL, V128, P419, DOI 10.1676/1559-4491-128.2.419; Jimenez JE, 2000, J FIELD ORNITHOL, V71, P66, DOI 10.1648/0273-8570-71.1.66; Kitzberger T, 1997, J BIOGEOGR, V24, P35, DOI 10.1111/j.1365-2699.1997.tb00048.x; KITZBERGER T, 1995, CAN J FOREST RES, V25, P1684, DOI 10.1139/x95-182; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; La Sorte FA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2588; La Sorte FA, 2014, J BIOGEOGR, V41, P1685, DOI 10.1111/jbi.12328; La Sorte FA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0984; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lisovski S, 2012, METHODS ECOL EVOL, V3, P1055, DOI 10.1111/j.2041-210X.2012.00248.x; Lisovski S, 2012, METHODS ECOL EVOL, V3, P603, DOI 10.1111/j.2041-210X.2012.00185.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MARINI M A, 1990, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V6, P59; Nazareno AG, 2016, NATURE, V531, P580, DOI 10.1038/531580e; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Olrog C. C., 1963, Opera Lilloana, VNo. 9, P1; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Prohaska F., 1976, CLIMATE CENTRAL S AM, P57; Purificacao KN, 2014, BIOTA NEOTROP, V14, DOI 10.1590/1676-06032014006814; Pyle P., 2015, MANUAL AGEING SEXING; QGIS Development Team, 1991, QGIS GEOGR INF SYST; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Rodriguez-Ruiz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115615; Schiavini I, 2014, BRAZ J BOT; Schmaljohann H, 2012, BEHAV ECOL SOCIOBIOL, V66, P915, DOI 10.1007/s00265-012-1340-5; Schmidt M.H., 2015, REV GEOPANTANAL, V18, P121; Sergio F, 2014, NATURE, V515, P410, DOI 10.1038/nature13696; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Silva FWS, 2015, FLA ENTOMOL, V98, P170, DOI 10.1653/024.098.0129; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Traylor MA, 1958, FIELDIANA ZOOL, V35, P87; VEBLEN TT, 1992, J VEG SCI, V3, P507, DOI 10.2307/3235807; Wolfe JD, 2015, J FIELD ORNITHOL, V86, P238, DOI 10.1111/jofo.12107	73	20	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170188	10.1371/journal.pone.0170188	http://dx.doi.org/10.1371/journal.pone.0170188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182628	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800007
J	Zhao, HL; Li, X; Zhao, TT; Zhang, HJ; Yan, MH; Dong, X; Chen, PM; Ma, L; Li, P				Zhao, Hailing; Li, Xin; Zhao, Tingting; Zhang, Haojun; Yan, Meihua; Dong, Xi; Chen, Pengmin; Ma, Liang; Li, Ping			Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression	PLOS ONE			English	Article							GROWTH; MECHANISMS	The Chinese herbal granule Tangshen Formula (TSF) has been proven to decrease proteinuria and improve estimated glomerular filtration rate (eGFR) in diabetic kidney disease (DKD) patients. However, the underlying mechanism of TSF on treatment of diabetic nephropathy (DN) remains unclear. The present study aimed to identify the therapeutic target of TSF in diabetic renal injuries through microarray-based gene expression profiling and establish its underlying mechanism. TSF treatment significantly attenuated diabetic renal injuries by inhibiting urinary excretion of albumin and renal histological injuries in diabetic (db/db) mice. We found that PLZF might be the molecular target of TSF in DN. In vivo, the db/db mice showed a significant increase in renal protein expression of PLZF and collagen III, and decrease in renal autophagy levels (downregulated LC3 II and upregulated p62/SQSTM1) compared to db/m mice. The application of TSF resulted in the downregulation of PLZF and collagen III and upregulation of autophagy level in the kidneys of db/db mice. In vitro, TSF reduced high glucose (HG)-induced cell proliferation for NRK52E cells. Further studies indicated that the exposure of NRK52E cells to high levels of glucose resulted in the downregulation of cellular autophagy and upregulation of collagen III protein, which was reversed by TSF treatment by decreasing PLZF expression. In conclusion, TSF might have induced cellular autophagy by inhibiting PLZF expression, which in turn resulted in an increase in autophagic degradation of collagen III that attenuated diabetic renal injuries.	[Zhao, Hailing; Li, Xin; Zhao, Tingting; Zhang, Haojun; Yan, Meihua; Dong, Xi; Chen, Pengmin; Ma, Liang; Li, Ping] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China; [Ma, Liang] China Japan Friendship Hosp, Clin Lab, Beijing, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital	Li, P (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China.	lp8675@163.com; lp8675@163.com			International Cooperation and Exchange of the National Natural Science Foundation of China [81620108031]; International Collaboration in Science and Technology Grant, China [2011DFA31860]; National Natural Science Foundation of China [81503418, 81473526]	International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Collaboration in Science and Technology Grant, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from a Project of International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 81620108031 to PL), http://www.nsfc.gov.cn/; a Project of International Collaboration in Science and Technology Grant, China (Grant No. 2011DFA31860 to PL), http://www.istcp.org.cn/; and the National Natural Science Foundation of China (Grant No. 81503418 to HLZ, No. 81473526 to TTZ), http://www.nsfc.gov.cn/.	Currie G, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0798-3; Gao JR, 2016, J ETHNOPHARMACOL; Hu C, 2015, CURR MED CHEM, V22, P2858, DOI 10.2174/0929867322666150625095407; Jia X, 2016, J DIABETES; Jones C, 2013, INT J CANCER, V133, P58, DOI 10.1002/ijc.28008; Kong Q, 2016, INT J MOL MED, V38, P1715, DOI 10.3892/ijmm.2016.2799; Li P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1802036; Li P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126027; Liu N, 2016, KIDNEY DIS-BASEL, V2, P37, DOI 10.1159/000444841; Liu SL, 2016, ARCH BIOCHEM BIOPHYS, V590, P37, DOI 10.1016/j.abb.2015.11.001; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117400; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Peng KY, 2011, METABOLISM, V60, P888, DOI 10.1016/j.metabol.2010.08.009; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Pushpakumar SB, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.63; Sun GD, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5749857; Suzuki H, 2017, CURR OPIN STRUC BIOL, V43, P10, DOI 10.1016/j.sbi.2016.09.010; Vallon V, 2013, AM J PHYSIOL-RENAL, V304, pF156, DOI 10.1152/ajprenal.00409.2012; Wang LL, 2015, MOL BIOSYST, V11, P3033, DOI 10.1039/c5mb00379b; Wang XT, 2013, FASEB J, V27, P4194, DOI 10.1096/fj.13-229070; Xiang L, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/1064924; Xu Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1888; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734; Zhao TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147693	24	13	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171475	10.1371/journal.pone.0171475	http://dx.doi.org/10.1371/journal.pone.0171475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182710	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800063
J	Chan, HL; Sinjab, K; Chung, MP; Chiang, YC; Wang, HL; Giannobile, WV; Kripfgans, OD				Chan, Hsun-Liang; Sinjab, Khaled; Chung, Ming-Pang; Chiang, Yi-Chen; Wang, Hom-Lay; Giannobile, William V.; Kripfgans, Oliver D.			Non-invasive evaluation of facial crestal bone with ultrasonography	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; GINGIVAL THICKNESS; PERIODONTAL BIOTYPE; TISSUE BIOTYPE; AESTHETIC ZONE; DIMENSIONS; SWELLINGS; DIAGNOSIS; IMPLANTS; EFFICACY	Purpose Facial crestal bone level and dimension determine function and esthetics of dentition and dental implants. We have previously demonstrated that ultrasound can identify bony and soft tissue structures in the oral cavity. The aim of this study is to evaluate the accuracy of using ultrasound to measure facial crestal bone level and thickness. Materials and methods A commercially available medical ultrasound scanner, paired with a 14 MHz imaging probe was used to scan dental and periodontal tissues at the mid-facial site of each tooth on 6 fresh cadavers. The alveolar crest level in relation to the cemento-enamel junction and its thickness on ultrasound images were measured and compared to those on cone-beam computed tomography (CBCT) scans and/or direct measurements on a total of 144 teeth. Results The mean crestal bone level measured by means of ultrasound, CBCT and direct measures was 2.66 +/- 0.86 mm, 2.51 +/- 0.82 mm, and 2.71 +/- 1.04 mm, respectively. The mean crestal bone thickness was 0.71 +/- 0.44 mm and 0.74 +/- 0.34 mm, measured by means of ultrasound and CBCT, respectively. The correlations of the ultrasound readings to the other two methods were between 0.78 and 0.88. The mean absolute differences in crestal bone height and thickness between ultrasound and CBCT were 0.09 mm (-1.20 to 1.00 mm, p = 0.06) and 0.03 mm (-0.48 to 0.54 mm, p = 0.03), respectively. Conclusion Ultrasound was as accurate in determining alveolar bone level and its thickness as CBCT and direct measurements. Clinical trials will be required to further validate this non -ionizing and non-invasive method for determining facial crestal bone position and dimension.	[Chan, Hsun-Liang; Sinjab, Khaled; Chung, Ming-Pang; Chiang, Yi-Chen; Wang, Hom-Lay; Giannobile, William V.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Giannobile, William V.; Kripfgans, Oliver D.] Coll Engn, Dept Biomed Engn, Ann Arbor, MI USA; [Kripfgans, Oliver D.] Univ Michigan, Dept Radiol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chan, HL (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	hlchan@umich.edu	Kripfgans, Oliver/AAN-4919-2020	Kripfgans, Oliver/0000-0003-2905-1496; Giannobile, William/0000-0002-7102-9746	Michigan Institute for Clinical and Health Research (MICHR) [UL1TR000433]; University of Michigan Periodontal Graduate Student Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER	Michigan Institute for Clinical and Health Research (MICHR); University of Michigan Periodontal Graduate Student Research Fund(University of Michigan System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported by a pilot grant (UL1TR000433) from the Michigan Institute for Clinical and Health Research (MICHR) and the University of Michigan Periodontal Graduate Student Research Fund.	Braut V, 2011, INT J PERIODONT REST, V31, P125; Chan HL, 2016, CLIN ORAL IMPLANTS R; Chan Hsun-Liang, 2015, Dent Clin North Am, V59, P981, DOI 10.1016/j.cden.2015.06.010; Chandak R, 2011, DENTOMAXILLOFAC RAD, V40, P213, DOI 10.1259/dmfr/68658286; Chao Yi-Chi, 2015, Int J Periodontics Restorative Dent, V35, pe75, DOI 10.11607/prd.2097; CLAFFEY N, 1986, J CLIN PERIODONTOL, V13, P654, DOI 10.1111/j.1600-051X.1986.tb00861.x; De Bruyckere T, 2015, J CLIN PERIODONTOL, V42, P876, DOI 10.1111/jcpe.12448; De Rouck T, 2009, J CLIN PERIODONTOL, V36, P428, DOI 10.1111/j.1600-051X.2009.01398.x; Eghbali A, 2014, CLIN IMPLANT DENT RE; Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x; Friedrich RE, 2010, ANTICANCER RES, V30, P1787; Frost NA, 2015, J PERIODONTOL, V86, P1141, DOI 10.1902/jop.2015.140394; Fu JH, 2011, INT J ORAL MAX IMPL, V26, P499; Fu JH, 2010, J PERIODONTOL, V81, P569, DOI 10.1902/jop.2009.090591; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Kan JYK, 2010, INT J PERIODONT REST, V30, P237; Lin GH, 2014, J PERIODONTOL, V85, P92, DOI 10.1902/jop.2013.130064; Muller HP, 2007, CLIN ORAL INVEST, V11, P439, DOI 10.1007/s00784-007-0125-0; Muller HP, 2005, J PERIODONTAL RES, V40, P239, DOI 10.1111/j.1600-0765.2005.00798.x; OLSSON M, 1991, J CLIN PERIODONTOL, V18, P78, DOI 10.1111/j.1600-051X.1991.tb01124.x; Pallagatti S, 2012, EUR J RADIOL, V81, P1821, DOI 10.1016/j.ejrad.2011.04.065; Timock AM, 2011, AM J ORTHOD DENTOFAC, V140, P734, DOI 10.1016/j.ajodo.2011.06.021; Vera C, 2012, INT J ORAL MAX IMPL, V27, P1514; Wakasugi-Sato N, 2010, INT J DENT, V2010, DOI 10.1155/2010/639382; Wang HM, 2014, INT J ORAL MAX IMPL, V29, P1123, DOI 10.11607/jomi.3348; Noriaki Y, 2011, ORAL ONCOL, V47, P163, DOI 10.1016/j.oraloncology.2010.10.015; Zweers J, 2014, J CLIN PERIODONTOL, V41, P958, DOI 10.1111/jcpe.12275	27	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171237	10.1371/journal.pone.0171237	http://dx.doi.org/10.1371/journal.pone.0171237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178323	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500034
J	Lian, Y; Zhu, Y; Tang, F; Yang, B; Duan, RS				Lian, Ying; Zhu, Yun; Tang, Fang; Yang, Bing; Duan, Ruisheng			Herpes zoster and the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis	PLOS ONE			English	Article							COST-EFFECTIVENESS; VIRUS VASCULOPATHIES; VACCINE; INFECTION; EVENTS; COHORT; ADULTS	Background Herpes zoster infection and stroke are highly prevalent in the general population; however, reports have presented inconsistent findings regarding the relationship between herpes zoster infection and stroke. In this meta-analysis, we aimed to clarify this association. Material and methods The PubMed and Embase databases were searched for studies published from their inception to January 2016. Two investigators independently extracted the data. The pooled relative risk (RR) was calculated using a random effects model. Results A total of 8 studies met the inclusion criteria. During the first 1 month after herpes zoster infection, the pooled RRs for ischemic stroke and hemorrhagic stroke were 1.55 (95% CI, 1.46-1.65) and 1.70 (95% CI, 0.73-3.96), respectively, and within 3 months after infection, the corresponding RRs were 1.17 (95% CI, 1.12-1.23) and 2.05 (95% CI, 1.17-3.60), respectively. At 1 year and more than 1 year after herpes zoster infection, a significant relationship was not observed between herpes zoster infection and the incidence of ischemic and hemorrhagic stroke. Publication bias was not observed. Conclusion The accumulated evidence generated from this systematic review indicates that an increased risk for ischemic stroke occurred in the short term after herpes zoster infection, whereas a significant relationship was not observed in the long term after infection. With respect to hemorrhagic stroke, the association was not significant. With respect to hemorrhagic stroke, the association between was not significant except within 3 months after a herpes zoster infection.	[Lian, Ying] Shandong Univ, Qianfoshan Hosp Affiliated, Dept Case Adm, Jinan, Peoples R China; [Zhu, Yun] Shanghai Jiao Tong Univ, Sch Med, Dept Oromaxillofacial Head & Neck Oncol, Peoples Hosp 9,Coll Stomatol, Shanghai, Peoples R China; [Tang, Fang] Shandong Univ, Qianfoshan Hosp, Hlth Management Ctr, Jinan, Peoples R China; [Yang, Bing; Duan, Ruisheng] Shandong Univ, Qianfoshan Hosp, Dept Neurol, Jinan, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Duan, RS (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Neurol, Jinan, Peoples R China.	ruisheng_duan@yahoo.cm	duan, rui/AAK-8037-2020		Shandong provincial Natural Science Foundation [ZR2015HL102]	Shandong provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was supported by Shandong provincial Natural Science Foundation (nos. ZR2015HL102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuer J, 2014, NEUROLOGY, V83, pE27, DOI 10.1212/WNL.0000000000000584; Bricout H, 2014, EUROPEAN GERIATRIC M, V5, pS53; Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; de Boer PT, 2014, HUM VACC IMMUNOTHER, V10, P2048, DOI 10.4161/hv.28670; Don Gilden, 2013, CURR NEUROL NEUROSCI; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; GILBERT GJ, 1974, JAMA-J AM MED ASSOC, V229, P302, DOI 10.1001/jama.229.3.302; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Guignard AP, 2014, INFECTION, V42, P729, DOI 10.1007/s15010-014-0645-x; Hayman M, 2001, PEDIATR NEUROL, V24, P387, DOI 10.1016/S0887-8994(01)00272-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hornberger J, 2006, ANN INTERN MED, V145, P317, DOI 10.7326/0003-4819-145-5-200609050-00004; Johnson Robert W, 2015, Ther Adv Vaccines, V3, P109, DOI 10.1177/2051013615599151; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Langan SM, 2014, CLIN INFECT DIS, V58, P1497, DOI 10.1093/cid/ciu098; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Minassian C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001919; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nagel MA, 2008, NEUROLOGY, V70, P853, DOI 10.1212/01.wnl.0000304747.38502.e8; Nagel M, 2014, CLIN INFECT DIS, V58, P1504, DOI 10.1093/cid/ciu099; Nagel MA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0534-4; Nencini P, 2003, CEREBROVASC DIS, V15, P215, DOI 10.1159/000068831; Le P, 2015, ANN INTERN MED, V163, P489, DOI 10.7326/M15-0093; Powell 2nd D. R., 2014, AM J MED SCI; Sreenivasan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069156; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sundstrom K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1170-y; Vila N, 2000, J INTERF CYTOK RES, V20, P325, DOI 10.1089/107999000312478; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wise Jacqui, 2015, BMJ, V351, ph6757, DOI 10.1136/bmj.h6757; Wu PY, 2014, J MED VIROL, V86, P772, DOI 10.1002/jmv.23892; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2016, MAYO CLIN PROC, V91, P33, DOI 10.1016/j.mayocp.2015.09.015	40	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171182	10.1371/journal.pone.0171182	http://dx.doi.org/10.1371/journal.pone.0171182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178287	gold, Green Published, Green Submitted			2022-12-27	WOS:000393712500030
J	Liu, WX; Golovatch, S; Wesener, T; Tian, MY				Liu, Weixin; Golovatch, Sergei; Wesener, Thomas; Tian, Mingyi			Convergent Evolution of Unique Morphological Adaptations to a Subterranean Environment in Cave Millipedes (Diplopoda)	PLOS ONE			English	Article							GENUS GLYPHIULUS GERVAIS; NEW-SPECIES DIPLOPODA; EUTRICHODESMUS SILVESTRI; DESMOXYTES CHAMBERLIN; DWELLING MILLIPEDE; SOUTHEAST-ASIA; CHINA; SPIROSTREPTIDA; POLYDESMIDA; CHORDEUMATIDA	Animal life in caves has fascinated researchers and the public alike because of the unusual and sometimes bizarre morphological adaptations observed in numerous troglobitic species. Despite their worldwide diversity, the adaptations of cave millipedes (Diplopoda) to a troglobitic lifestyle have rarely been examined. In this study, morphological characters were analyzed in species belonging to four different orders (Glomerida, Polydesmida, Chordeumatida, and Spirostreptida) and six different families (Glomeridae, Paradoxosomatidae, Polydesmidae, Haplodesmidae, Megalotylidae, and Cambalopsidae) that represent the taxonomic diversity of class Diplopoda. We focused on the recently discovered millipede fauna of caves in southern China. Thirty different characters were used to compare cave troglobites and epigean species within the same genera. A character matrix was created to analyze convergent evolution of cave adaptations. Males and females were analyzed independently to examine sex differences in cave adaptations. While 10 characters only occurred in a few phylogenetic groups, 20 characters were scored for in all families. Of these, four characters were discovered to have evolved convergently in all troglobitic millipedes. The characters that represented potential morphological cave adaptations in troglobitic species were: (1) a longer body; (2) a lighter body color; (3) elongation of the femora; and (4) elongation of the tarsi of walking legs. Surprisingly, female, but not male, antennae were more elongated in troglobites than in epigean species. Our study clearly shows that morphological adaptations have evolved convergently in different, unrelated millipede orders and families, most likely as a direct adaptation to cave life.	[Liu, Weixin; Tian, Mingyi] South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Liu, Weixin; Wesener, Thomas] Leibniz Inst Terr Biodivers, Zool Res Museum A Koenig, Bonn, Germany; [Golovatch, Sergei] Russian Acad Sci, Inst Problems Ecol & Evolut, Moscow, Russia	South China Agricultural University; Russian Academy of Sciences	Tian, MY (corresponding author), South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China.; Wesener, T (corresponding author), Leibniz Inst Terr Biodivers, Zool Res Museum A Koenig, Bonn, Germany.	t.wesener@zfmk.de; mytian@scau.edu.cn	Liu, Weixin/AAL-6371-2020		China Scholarship Council [201508440257]	China Scholarship Council(China Scholarship Council)	Weixin Liu was financially supported by the China Scholarship Council (No.201508440257, www.csc.ed men) for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135243; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; [Anonymous], 2015, MATH PROBL ENG, DOI DOI 10.1007/S00382-015-2782-Z; Ashe JS, 2000, ZOOL J LINN SOC-LOND, V130, P471, DOI 10.1111/j.1096-3642.2000.tb02197.x; BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Barr TC, 1968, EVOLUTIONARY BIOL, P33; Barr TC, 1960, AM MIDL NAT, P45; Beron Petar, 2015, Historia Naturalis Bulgarica, V21, P169; Beron Petar, 2011, P583; Blanke A, 2014, ARTHROPOD STRUCT DEV, V43, P63, DOI 10.1016/j.asd.2013.10.003; Buzila R, 2000, EVOLUTION ADAPTATION, V6, P117; Causey N.B., 1971, Bulletin Ass mex Cave Stud, VNo. 4,1971, P23; CHRISTIANSEN K, 1961, EVOLUTION, V15, P288, DOI 10.2307/2406229; Christiansen K., 2012, ENCY CAVES, P517, DOI 10.1016/B978-0-12-383832-2.00075-X; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2015, ACTA CARSOLOGICA, V44, P415; Culver DC, 2010, J CRUSTACEAN BIOL, V30, P68, DOI 10.1651/09-3156.1; Culver DC, 2006, ECOGRAPHY, V29, P120; Culver DC, 2014, Shallow Subterranean Habitats: Ecology, Evolution, and Conservation, P1, DOI 10.1093/acprof:oso/9780199646173.001.0001; CULVER DC, 1986, STYGOLOGIA, V2, P208; Culver DC, 2012, ENCY CAVES, P538; Darda DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127248; David J.-F., 2015, TREATISE ZOOLOGY ANA, V2, P303, DOI DOI 10.1163/9789004188273_013; De Azara LN, 2013, ZOOTAXA, V3709, P432; Deharveng L, 2000, ECOSY WORLD, V30, P603; Deharveng L., 2012, ENCY CAVES, P238, DOI [10.1016/B978-0-12-383832-2.00032-3, DOI 10.1016/B978-0-12-383832-2.00032-3]; Deharvening Louis, 2005, P166; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Enghoff H., 1985, BIJDRAGEN DIERKUNDE, V55, P66; Enghoff H, 1985, LAVORI SOC VENEZIANA, V10, P69; Enghoff H., 2015, TREATISE ZOOLOGY ANA, V2, P363, DOI 10.1163/9789004188273_017; Enghoff H, 2013, ZOOTAXA, V 3736, P175, DOI 10.11646/zootaxa.3736.2.5; Enghoff H, 2013, J NAT HIST, V47, P1613, DOI 10.1080/00222933.2012.759289; Enghoff H, 2013, ZOOTAXA, V3652, P485, DOI 10.11646/zootaxa.3652.4.6; Enghoff Henrik, 2012, European Journal of Taxonomy, V15, P1; Fudge Douglas S., 2009, Aquatic Mammals, V35, P226, DOI 10.1578/AM.35.2.2009.226; Geoffroy J.-J., 2004, Arthropoda Selecta, V13, P19; Giachino P. M., 2010, WBA HDB, V3; Golovatch SI, 2014, ZOOTAXA, V3760, P275, DOI 10.11646/zootaxa.3760.2.7; Golovatch S. I., 2012, Russian Entomological Journal, V21, P133; Golovatch S. I., 2011, Arthropoda Selecta, V20, P167; Golovatch S. I., 2011, Arthropoda Selecta, V20, P149; Golovatch S. I., 2011, Arthropoda Selecta, V20, P65; Golovatch S. I., 2010, Arthropoda Selecta, V19, P63; Golovatch S. I., 2010, Arthropoda Selecta, V19, P57; Golovatch SI, 2007, ZOOSYSTEMA, V29, P417; Golovatch SI, 2007, ZOOSYSTEMA, V29, P7; Golovatch Sergei I., 2003, Vieraea, V31, P9; Golovatch SI, 2006, ZOOTAXA, P363; Golovatch SI, 2015, ZOOKEYS, P79, DOI 10.3897/zookeys.510.8640; Golovatch SI, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.505.9862; Golovatch SI, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.185.3082; Golovatch SI, 2012, ZOOTAXA, P1; Golovatch Sergei I., 2014, Russian Entomological Journal, V23, P91; Golovatch Sergei I., 2013, Fragmenta Faunistica (Warsaw), V56, P157, DOI 10.3161/00159301FF2013.56.2.157; Golovatch SI, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.12.167; Golovatch Sergei I., 2006, Arthropoda Selecta, V15, P81; Golovatch SI, 2006, ZOOSYSTEMA, V28, P75; Harvey MS, 2000, ECOSY WORLD, V30, P79; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; Hoffman Richard L., 1994, Myriapodologica, V3, P19; Hoffman RL, 1956, ALABAMA GEOLOGICAL S, V35, P5; Hopkin P.S., 1992, BIOL MILLIPEDES; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; Howes C., 1994, P U BRISTOL SPELAEOL, V20, P15; Huppop K., 2012, ENCY CAVES, V2nd ed., P1, DOI 10.1016/B978-0-12-383832-2.00001-3; Ishii K, 1996, MEMOIR MUS NATL HIST, V169, P101; Jeannel R., 1949, FOSSILES VIVANTS CAV; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Juberthie C, 1980, MEMOIRES BIOSPEOLO, V7, P719; JUBERTHIE C, 1995, UNDERGROUND HABITATS; KOHLER HR, 1990, ZOOL SCR, V19, P195, DOI 10.1111/j.1463-6409.1990.tb00255.x; Lamprecht G, 1979, REGRESSIVE EVOLUTION, V18, P69; Lewis JJ, 2005, ZOOTAXA, P17, DOI 10.11646/zootaxa.1080.1.2; Liu WX, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.577.7825; Liu WX, 2015, ZOOKEYS, P123, DOI 10.3897/zookeys.517.9949; Liu WX, 2014, ZOOKEYS, P9, DOI 10.3897/zookeys.448.8081; Liu WX, 2013, ZOOTAXA, V3734, P281, DOI 10.11646/zootaxa.3734.2.11; Loria Stephanie F., 2011, International Journal of Myriapodology, V5, P35, DOI 10.3897/ijm.5.1891; Manton SM, 1954, J LINN SOC LOND, P299, DOI DOI 10.1111/J.1096-3642.1954.TB02211.X; Mauries J.-P., 2004, ENCYCLOPAEDIA CAVE K, P534; Mauries Jean-Paul, 2005, Arthropoda Selecta, V14, P241; Miller JA, 2005, ZOOL SCR, V34, P565, DOI 10.1111/j.1463-6409.2005.00206.x; Moldovan O. T, 2012, ENCY CAVES, P54, DOI DOI 10.1016/B978-0-12-383832-2.00008-6; Moldovan Oana Teodora, 2004, Natura Croatica, V13, P1; Iniesta LFM, 2012, ZOOTAXA, P26; Muller C.H.G., 2015, TREATISE ZOOLOGY ANA, V2, P181; Pipan T, 2012, BIOL J LINN SOC, V107, P1, DOI 10.1111/j.1095-8312.2012.01964.x; POULSON THOMAS L., 1963, AMER MIDLAND NAT, V70, P257, DOI 10.2307/2423056; POULSON TL, 1969, SCIENCE, V165, P971; Pricop Emilian, 2009, ELBA Bioflux, V1, P41; Racovita E.G., 2006, EG RACOVITZA ESSAY B, P127; Reboleira ASPS, 2015, EUR J TAXON, V161, P1, DOI 10.5852/ejt.2015.161; Reboleira ASPS, 2014, J CAVE KARST STUD, V76, P20, DOI 10.4311/2013LSC0113; ROUCH R, 1987, STYGOLOGIA, V3, P345; Schonhofer AL, 2012, ORG DIVERS EVOL, V12, P409, DOI 10.1007/s13127-012-0073-7; Shear WA, 1977, QUADERNO ACCAD NAZ L, V171, P235; Shear WA, 2015, BIOCHEM SYST ECOL, V61, P78, DOI 10.1016/j.bse.2015.04.033; Shear William A., 2002, Proceedings of the California Academy of Sciences, V53, P63; Shear WA, 2009, ZOOTAXA, P47; Sket B., 1985, Bulletin of the National Speleological Society, V47, P78; Stahl BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140484; Stoev P, 2005, J NAT HIST, V39, P1875, DOI 10.1080/00222930400025896; Stoev P, 2004, ZOOTAXA, P1; Stoev Pavel, 2004, Acta Arachnologica, V53, P93, DOI 10.2476/asjaa.53.93; Tabacaru I., 1963, LUCRARILE I SPEOLOGI, V1-2, P341; Tabacura I, 2003, TRAVAUX I SPEOLOGIE, P121; Taylor SJ, 2008, ENCY ENTOMOLOGY, P803; Tian MY, 2016, ZOOKEYS, P121, DOI 10.3897/zookeys.564.6819; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; TUTTLE MD, 1977, AM MIDL NAT, V97, P235, DOI 10.2307/2424704; Vandel A., 1965, BIOSPELEOLGY BIOL CA; Veni, 1994, CAVES KARST TEXAS, P31; Wesener T, 2009, CLADISTICS, V25, P545, DOI 10.1111/j.1096-0031.2009.00267.x; Wesener T, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.19.221; Whitten T, 2009, J APPL ECOL, V46, P520, DOI 10.1111/j.1365-2664.2009.01630.x; Zapparoli M, 1997, INT J SPELEOL, V25, P59	119	35	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170717	10.1371/journal.pone.0170717	http://dx.doi.org/10.1371/journal.pone.0170717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178274	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500014
J	Vestberg, T; Reinebo, G; Maurex, L; Ingvar, M; Petrovic, P				Vestberg, Torbjorn; Reinebo, Gustaf; Maurex, Liselotte; Ingvar, Martin; Petrovic, Predrag			Core executive functions are associated with success in young elite soccer players	PLOS ONE			English	Article							LATENT VARIABLE ANALYSIS; WORKING-MEMORY; PROGRESSIVE MATRICES; COGNITIVE CONTROL; FUNCTION SYSTEM; LATE CHILDHOOD; SKILLS; ANTICIPATION; INFORMATION; ACQUISITION	Physical capacity and coordination cannot alone predict success in team sports such as soccer. Instead, more focus has been directed towards the importance of cognitive abilities, and it has been suggested that executive functions (EF) are fundamentally important for success in soccer. However, executive functions are going through a steep development from adolescence to adulthood. Moreover, more complex EF involving manipulation of information (higher level EF) develop later than simple executive functions such as those linked to simple working memory capacity (Core EF). The link between EF and success in young soccer players is therefore not obvious. In the present study we investigated whether EF are associated with success in soccer in young elite soccer players. We performed tests measuring core EF (a demanding working memory task involving a variable n-back task; dWM) and higher level EF (Design Fluency test; DF). Color-Word Interference Test and Trail Making Test were performed on an exploratory level as they contain a linguistic element. The lower level EF test (dWM) was taken from CogStateSport computerized concussion testing and the higher level EF test (DF) was from Delis-Kaplan Executive Function System test battery (D-KEFS). In a group of young elite soccer players (n = 30; aged 12-19 years) we show that they perform better than the norm in both the dWM (+0.49 SD) and DF (+0.86 SD). Moreover, we could show that both dWM and DF correlate with the number of goals the players perform during the season. The effect was more prominent for dWM (r=0.437) than for DF (r=0.349), but strongest for a combined measurement (r= 0.550). The effect was still present when we controlled for intelligence, length and age in a partial correlation analysis. Thus, our study suggests that both core and higher level EF may predict success in soccer also in young players.	[Vestberg, Torbjorn; Reinebo, Gustaf; Maurex, Liselotte; Ingvar, Martin; Petrovic, Predrag] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Vestberg, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	Torbjorn.vestberg@ki.se	Petrovic, Predrag/AAS-6736-2020	Petrovic, Predrag/0000-0002-5536-945X; Ingvar, Martin/0000-0002-9041-5714; Vestberg, Torbjorn/0000-0003-0523-6621; Reinebo, Gustaf/0000-0001-8444-8686	PRIMA Barnoch Vuxenpsykiatri AB; Karolinska Institutet	PRIMA Barnoch Vuxenpsykiatri AB; Karolinska Institutet(Karolinska Institutet)	TV received funding from PRIMA Barnoch Vuxenpsykiatri AB [http://primapsykiatn.sen page td=237]. PP received funding from the Karolinska Institutet [http://ki.seistart]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1989, CAN J SPORT SCI, V14, P27; Abernethy B, 2001, PERCEPTION, V30, P233, DOI 10.1068/p2872; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Barkley R.A., 2012, EXECUTIVE FUNCTIONS; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cieslik EC, 2015, NEUROSCI BIOBEHAV R, V48, P22, DOI 10.1016/j.neubiorev.2014.11.003; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Constantinidis C, 2016, NAT REV NEUROSCI, V17, P438, DOI 10.1038/nrn.2016.43; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Delis DC, 2001, DELIS KAPLAN EXECUTI; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Farrow D, 2002, J SPORT SCI, V20, P471, DOI 10.1080/02640410252925143; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstein S., 2014, EXECUTIVE FUNCTIONIN; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Hopwood MJ, 2011, INT J SPORTS SCI COA, V6, P523, DOI 10.1260/1747-9541.6.4.523; Huijgen BCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144580; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Karbach J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00390; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Luciana M, 2005, CHILD DEV, V76, P697, DOI 10.1111/j.1467-8624.2005.00872.x; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Lundgren T, 2016, J CLIN SPOR IN PRESS; Mackintosh NJ, 2005, INTELLIGENCE, V33, P663, DOI 10.1016/j.intell.2005.03.004; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Murgia M, 2014, PSYCHOL SPORT EXERC, V15, P642, DOI 10.1016/j.psychsport.2014.07.009; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Petrovic P, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00070; Pind J, 2003, PERS INDIV DIFFER, V34, P375, DOI 10.1016/S0191-8869(02)00058-2; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J.C., 1998, ADV PROGR MATRICES; Ryu D, 2013, RES Q EXERCISE SPORT, V84, P252, DOI 10.1080/02701367.2013.784843; Savelsbergh GJP, 2010, INT J SPORT PSYCHOL, V41, P24; Shim J, 2005, J MOTOR BEHAV, V37, P164, DOI 10.3200/JMBR.37.2.164-175; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shunk A. W., 2006, APPL NEUROPSYCHOL, V13, P275, DOI [10.1207/s15324826an1304_9, DOI 10.1207/S15324826AN1304_9]; Stratton G., 2004, YOUTH SOCCER SCI PER; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Strauss E, 2006, COMPENDIUM NEUROPSYC; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Swanson J, 2005, CAN J SCH PSYCHOL, V20, P117, DOI 10.1177/0829573506295469; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Williams AM, 2005, J SPORT SCI, V23, P637, DOI 10.1080/02640410400021328	53	99	99	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170845	10.1371/journal.pone.0170845	http://dx.doi.org/10.1371/journal.pone.0170845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178738	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500016
J	Cox, MJ; Turek, EM; Hennessy, C; Mirza, GK; James, PL; Coleman, M; Jones, A; Wilson, R; Bilton, D; Cookson, WOC; Moffatt, MF; Loebinger, MR				Cox, Michael J.; Turek, Elena M.; Hennessy, Catherine; Mirza, Ghazala K.; James, Phillip L.; Coleman, Meg; Jones, Andrew; Wilson, Robert; Bilton, Diana; Cookson, William O. C.; Moffatt, Miriam F.; Loebinger, Michael R.			Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients	PLOS ONE			English	Article							AIRWAY MICROBIOTA; PULMONARY	Background Bronchiectasis is accompanied by chronic bronchial infection that may drive disease progression. However, the evidence base for antibiotic therapy is limited. DNA based methods offer better identification and quantification of microbial constituents of sputum than standard clinical culture and may help inform patient management strategies. Our study objective was to determine the longitudinal variability of the non-cystic fibrosis (CF) bronchiectasis microbiome in sputum with respect to clinical variables. Eighty-five patients with non-CF bronchiectasis and daily sputum production were recruited from outpatient clinics and followed for six months. Monthly sputum samples and clinical measurements were taken, together with additional samples during exacerbations. 16S rRNA gene sequencing of the sputum microbiota was successful for 381 samples from 76 patients and analysed in conjunction with clinical data. Results Microbial communities were highly individual in composition and stability, usually with limited diversity and often containing multiple pathogens. When compared to DNA sequencing, microbial culture had restricted sensitivity in identifying common pathogens such as Pseudomonas aeruginosa, Haemophilus influenzae, Moraxella catarrhalis. With some exceptions, community characteristics showed poor correlations with clinical features including underlying disease, antibiotic use and exacerbations, with the subject showing the strongest association with community structure. When present, the pathogens mucoid Pseudomonas aeruginosa and Haemophilus influenzae may also shape the structure of the rest of the microbial community. Conclusions The use of microbial community analysis of sputum added to information from microbial culture. A simple model of exacerbations driven by bacterial overgrowth was not supported, suggesting a need for revision of principles for antibiotic therapy. In individual patients, the management of chronic bronchial infection may be improved by therapy specific to their microbiome, taking into account pathogen load, community stability, and acute and chronic community responses to antibiotics.	[Cox, Michael J.; Turek, Elena M.; Mirza, Ghazala K.; James, Phillip L.; Bilton, Diana; Cookson, William O. C.; Moffatt, Miriam F.; Loebinger, Michael R.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Hennessy, Catherine; James, Phillip L.; Coleman, Meg; Jones, Andrew; Wilson, Robert; Bilton, Diana; Cookson, William O. C.; Loebinger, Michael R.] Royal Brompton & Harefield NHS Fdn Trust, London, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust	Moffatt, MF; Loebinger, MR (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Loebinger, MR (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, London, England.	m.moffatt@imperial.ac.uk; m.loebinger@imperial.ac.uk	Bilton, Diana/D-2972-2012; Cookson, William/HHC-1790-2022	Cox, Michael/0000-0002-4002-1506; Bilton, Diana/0000-0002-1913-9171	Wellcome Trust [WT077959, WT096964]; NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London; Novartis UK; Wellcome Trust Joint Senior Investigator's Award; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10126] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre, MRC-AsthmaUKCentre] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust; Imperial College London(General Electric); Novartis UK(Novartis); Wellcome Trust Joint Senior Investigator's Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The study was funded by the Wellcome Trust under WT077959 and WT096964. This project was funded and supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, The National Institute for Health Research or the Department of Health. Funding for sequencing was provided by a grant to DB from Novartis UK. WOCC and MFM are supported by a Wellcome Trust Joint Senior Investigator's Award, which also supports MJC and EMT and WOCC is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cox MJ, 2016, BIORXIV; Cox MJ, 2015, ATS J; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fierer N, 2008, P NATL ACAD SCI USA, P105; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Haworth CS, 2014, AM J RESP CRIT CARE, V189, P975, DOI 10.1164/rccm.201312-2208OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Molyneaux PL, 2013, AM J RESP CRITICAL C; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rogers Geraint B, 2009, BMC Pulm Med, V9, P14, DOI 10.1186/1471-2466-9-14; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Team RC, 2014, R A LANGUAGE AND ENV; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Zhao J, 2012, P NATL ACAD SCI	28	71	72	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170622	10.1371/journal.pone.0170622	http://dx.doi.org/10.1371/journal.pone.0170622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170403	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500007
J	Nesterenko, AM; Kuznetsov, MB; Korotkova, DD; Zaraisky, AG				Nesterenko, Alexey M.; Kuznetsov, Maxim B.; Korotkova, Daria D.; Zaraisky, Andrey G.			Morphogene adsorption as a Turing instability regulator: Theoretical analysis and possible applications in multicellular embryonic systems	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BIOLOGICAL PATTERN-FORMATION; REACTION-DIFFUSION SYSTEM; TRANSCRIPTIONAL RESPONSE; SPEMANNS ORGANIZER; XENOPUS-EMBRYOS; PROTEIN; SIZE; WNT; MECHANISM	The Turing instability in the reaction-diffusion system is a widely recognized mechanism of the morphogen gradient self-organization during the embryonic development. One of the essential conditions for such self-organization is sharp difference in the diffusion rates of the reacting substances (morphogens). In classical models this condition is satisfied only for significantly different values of diffusion coefficients which cannot hold for morphogens of similar molecular size. One of the most realistic explanations of the difference in diffusion rate is the difference between adsorption of morphogens to the extracellular matrix (ECM). Basing on this assumption we develop a novel mathematical model and demonstrate its effectiveness in describing several well-known examples of biological patterning. Our model consisting of three reaction-diffusion equations has the Turing-type instability and includes two elements with equal diffusivity and immobile binding sites as the third reaction substance. The model is an extension of the classical Gierer-Meinhardt two-components model and can be reduced to it under certain conditions. Incorporation of ECM in the model system allows us to validate the model for available experimental parameters. According to our model introduction of binding sites gradient, which is frequently observed in embryonic tissues, allows one to generate more types of different spatial patterns than can be obtained with two-components models. Thus, besides providing an essential condition for the Turing instability for the system of morphogen with close values of the diffusion coefficients, the morphogen adsorption on ECM may be important as a factor that increases the variability of self-organizing structures.	[Nesterenko, Alexey M.; Korotkova, Daria D.; Zaraisky, Andrey G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Nesterenko, Alexey M.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Kuznetsov, Maxim B.] Russian Acad Sci, Lebedev Physcal Inst, Moscow, Russia; [Korotkova, Daria D.] Lomonosov Moscow State Univ, Dept Embryol, Fac Biol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Lomonosov Moscow State University	Nesterenko, AM; Zaraisky, AG (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Nesterenko, AM (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia.	comconadin@gmail.com; azaraisky@gmail.com	Zaraisky, Andrey G/Q-2323-2016; , Alexey Nesterenko/C-8646-2012; Kuznetsov, Maxim B/M-3539-2015	Zaraisky, Andrey G/0000-0003-4681-8169; , Alexey Nesterenko/0000-0003-1592-257X; Kuznetsov, Maxim B/0000-0002-0004-9002; Korotkova, Daria/0000-0001-7098-0962	Russian Science Foundation [14-14-00557]; Russian Foundation for Basic Research [14-01-00196]; RSCF [14-14-00557]; RFBR [14-01-00196]; Russian Science Foundation [17-14-00022] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RSCF(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (Grant: 14-14-00557, www.rscf.ru) to AGZ. Particularly, the work on computational scheme was supported the Russian Foundation for Basic Research (Grant: 14-01-00196, www.rfbr.ru) to MBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by RSCF grant 14-14-00557 (AGZ). Computational experiments were performed at computers of Sector of Mathematical Biophysics of Complex Systems (Faculty of Biology, Lomonosov Moscow State University). Computational scheme development and coding was supported by RFBR 14-01-00196 (MBK). Authors thank Tatyana Galochkina for fruitful discussion.	Asai R, 1999, MECH DEVELOP, V89, P87, DOI 10.1016/S0925-4773(99)00211-7; BAKER BI, 1994, TRENDS ENDOCRIN MET, V5, P120, DOI 10.1016/1043-2760(94)90093-0; Belintsev B. N., 1983, Soviet Physics - Uspekhi, V26, P775, DOI 10.1070/PU1983v026n09ABEH004492; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Crank J., 1975, MATH DIFFUSION; Dawes JHP, 2010, PHILOS T R SOC A, V368, P3519, DOI 10.1098/rsta.2010.0057; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Eames BF, 2005, DEVELOPMENT, V132, P1499, DOI 10.1242/dev.01719; Eom DS, 2015, ELIFE, V4, DOI 10.7554/eLife.12401; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Eroshkin FM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23049; Fedorenko R. P., 1994, INTRO COMPUTATIONAL; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gonpot P., 2008, TRENDS APPL SCI RES, V3, P115, DOI [10.3923/tasr.2008.115.128, DOI 10.3923/TASR.2008.115.128]; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Inomata H, 2013, CELL, V153, P1296, DOI 10.1016/j.cell.2013.05.004; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kiryanov D, 2007, COMPUTATIONAL SCI IN; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Levin M, 2012, BIOSYSTEMS, V109, P243, DOI 10.1016/j.biosystems.2012.04.005; Maini PK, 2012, INTERFACE FOCUS, V2, P487, DOI 10.1098/rsfs.2011.0113; McClure M, 2003, EVOLUTION, V57, P1863, DOI 10.1111/j.0014-3820.2003.tb00594.x; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; Meinhardt H, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001362; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Moos M, 1995, DEVELOPMENT, V121, P4293; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; MURRAY JD, 1991, J THEOR BIOL, V149, P339, DOI 10.1016/S0022-5193(05)80310-8; Nesterenko AM, 2015, BIOCHEM BIOPH RES CO, V468, P331, DOI 10.1016/j.bbrc.2015.10.100; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Petrov I.B., 2006, LECT COMPUTATIONAL M; Plouhinec JL, 2013, P NATL ACAD SCI USA, V110, P20372, DOI 10.1073/pnas.1319745110; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Satnoianu RA, 2000, J MATH BIOL, V41, P493, DOI 10.1007/s002850000056; Sen S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046212; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yang LF, 2002, J CHEM PHYS, V117, P7259, DOI 10.1063/1.1507110; Zaraiskii A, 1990, ONTOGENEZ, V22, P365; ZHABOTINSKY AM, 1995, J CHEM PHYS, V103, P10306, DOI 10.1063/1.469932	52	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171212	10.1371/journal.pone.0171212	http://dx.doi.org/10.1371/journal.pone.0171212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170437	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500023
J	Florence, JM; Krupa, A; Booshehri, LM; Allen, TC; Kurdowska, AK				Florence, Jon M.; Krupa, Agnieszka; Booshehri, Laela M.; Allen, Timothy C.; Kurdowska, Anna K.			Metalloproteinase-9 contributes to endothelial dysfunction in atherosclerosis via protease activated receptor-1	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; CARDIOVASCULAR-DISEASE; VASCULAR-DISEASE; MOUSE MODELS; MATRIX-METALLOPROTEINASE-9; INFLAMMATION; MICE; ASSOCIATION; NEUTROPHILS; MARKERS	The atherosclerotic process begins when vascular endothelial cells undergo pro-inflammatory changes such as aberrant activation to dysfunctional phenotypes and apoptosis, leading to loss of vascular integrity. Our laboratory has demonstrated that exposure of mice to second hand smoke triggers an increase in expression of metalloproteinase-9. Further, metalloproteinase-9 released by second hand smoke activated leukocytes may propagate pro-atherogenic alterations in endothelial cells. We have shown that levels of metalloproteinase-9 were increased in the plasma from apolipoprotein E deficient (ApoE(-/-)) mice exposed to second hand smoke relative to non-exposed controls. Moreover, we have collected data from two different, but complementary, treatments of second hand smoke exposed atherosclerotic mice. Animals received either cell specific metalloproteinase-9 directed siRNA to minimize metalloproteinase-9 expression in neutrophils and endothelial cells, or a pharmacological inhibitor of Bruton's tyrosine kinase which indirectly limits metalloproteinase-9 production in neutrophils. These treatments reduced atherosclerotic changes in mice and improved overall vascular health. We also demonstrated that metalloproteinase-9 could activate endothelial cells and induce their apoptosis via cleavage of protease activated receptor-1. In summary, better understanding of metalloproteinase-9's pathogenic capabilities as well as novel signaling pathways involved may lead to development of treatments which may provide additional benefits to atherosclerosis patients with a history of second hand smoke exposure.	[Florence, Jon M.; Krupa, Agnieszka; Booshehri, Laela M.; Kurdowska, Anna K.] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Krupa, Agnieszka] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Allen, Timothy C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Texas System; University of Texas Medical Branch Galveston	Kurdowska, AK (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA.	Anna.Kurdowska@uthct.edu		Krupa, Agnieszka/0000-0003-1303-4608	Flight Attendant Medical Research Institute (FAMRI) [113016_CIA]	Flight Attendant Medical Research Institute (FAMRI)	This work was supported by Flight Attendant Medical Research Institute (FAMRI ID# 113016_CIA) to AKK (http://famri.org/researchers/awards_history.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes JA, 2004, MOL CELL BIOCHEM, V263, P227, DOI 10.1023/B:MCBI.0000041864.14092.5b; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Corrado E, 2005, ACTA CHIR BELG, V105, P567, DOI 10.1080/00015458.2005.11679782; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Gottipati KR, 2008, EXP DERMATOL, V17, P780, DOI 10.1111/j.1600-0625.2007.00685.x; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Krupa A, 2014, AM J PHYSIOL-LUNG C, V307, pL435, DOI 10.1152/ajplung.00234.2013; Krupa A, 2013, AM J RESP CELL MOL, V48, P240, DOI 10.1165/rcmb.2012-0039OC; Krupa A, 2009, AM J RESP CELL MOL, V41, P155, DOI 10.1165/rcmb.2008-0183OC; Kuldo Joanna M., 2005, Current Vascular Pharmacology, V3, P11, DOI 10.2174/1570161052773898; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Maganto-Garcia E, 2012, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1524s96; Meuwese MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014262; Monier F, 2000, CLIN CHIM ACTA, V299, P11, DOI 10.1016/S0009-8981(00)00271-0; Olson FJ, 2008, J INTERN MED, V263, P626, DOI 10.1111/j.1365-2796.2008.01927.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rauch I, 2008, EUR J CLIN INVEST, V38, P24, DOI 10.1111/j.1365-2362.2007.01902.x; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Steinberg SF, 2005, MOL PHARMACOL, V67, P2, DOI 10.1124/mol.104.003103; Szmitko PE, 2003, CIRCULATION, V108, P2041, DOI 10.1161/01.CIR.0000089093.75585.98; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhao HJ, 2006, CIRC J, V70, P615, DOI 10.1253/circj.70.615	33	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171427	10.1371/journal.pone.0171427	http://dx.doi.org/10.1371/journal.pone.0171427			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166283	Green Submitted, gold, Green Published			2022-12-27	WOS:000393700100041
J	Forstner, AJ; Hecker, J; Hofmann, A; Maaser, A; Reinbold, CS; Muhleisen, TW; Leber, M; Strohmaier, J; Degenhardt, F; Treutlein, J; Mattheisen, M; Schumacher, J; Streit, F; Meier, S; Herms, S; Hoffmann, P; Lacour, A; Witt, SH; Reif, A; Muller-Myhsok, B; Lucae, S; Maier, W; Schwarz, M; Vedder, H; Kammerer-Ciernioch, J; Pfennig, A; Bauer, M; Hautzinger, M; Moebus, S; Schenk, LM; Fischer, SB; Sivalingam, S; Czerski, PM; Hauser, J; Lissowska, J; Szeszenia-Dabrowska, N; Brennan, P; McKay, JD; Wright, A; Mitchell, PB; Fullerton, JM; Schofield, PR; Montgomery, GW; Medland, SE; Gordon, SD; Martin, NG; Krasnov, V; Chuchalin, A; Babadjanova, G; Pantelejeva, G; Abramova, LI; Tiganov, AS; Polonikov, A; Khusnutdinova, E; Alda, M; Cruceanu, C; Rouleau, GA; Turecki, G; Laprise, C; Rivas, F; Mayoral, F; Kogevinas, M; Grigoroiu-Serbanescu, M; Becker, T; Schulze, TG; Rietschel, M; Cichon, S; Fier, H; Nothen, MM				Forstner, Andreas J.; Hecker, Julian; Hofmann, Andrea; Maaser, Anna; Reinbold, Celine S.; Muehleisen, Thomas W.; Leber, Markus; Strohmaier, Jana; Degenhardt, Franziska; Treutlein, Jens; Mattheisen, Manuel; Schumacher, Johannes; Streit, Fabian; Meier, Sandra; Herms, Stefan; Hoffmann, Per; Lacour, Andre; Witt, Stephanie H.; Reif, Andreas; Mueller-Myhsok, Bertram; Lucae, Susanne; Maier, Wolfgang; Schwarz, Markus; Vedder, Helmut; Kammerer-Ciernioch, Jutta; Pfennig, Andrea; Bauer, Michael; Hautzinger, Martin; Moebus, Susanne; Schenk, Lorena M.; Fischer, Sascha B.; Sivalingam, Sugirthan; Czerski, Piotr M.; Hauser, Joanna; Lissowska, Jolanta; Szeszenia-Dabrowska, Neonila; Brennan, Paul; McKay, James D.; Wright, Adam; Mitchell, Philip B.; Fullerton, Janice M.; Schofield, Peter R.; Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.; Krasnov, Valery; Chuchalin, Alexander; Babadjanova, Gulja; Pantelejeva, Galina; Abramova, Lilia I.; Tiganov, Alexander S.; Polonikov, Alexey; Khusnutdinova, Elza; Alda, Martin; Cruceanu, Cristiana; Rouleau, Guy A.; Turecki, Gustavo; Laprise, Catherine; Rivas, Fabio; Mayoral, Fermin; Kogevinas, Manolis; Grigoroiu-Serbanescu, Maria; Becker, Tim; Schulze, Thomas G.; Rietschel, Marcella; Cichon, Sven; Fier, Heide; Noethen, Markus M.			Identification of shared risk loci and pathways for bipolar disorder and schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DORSOLATERAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; PSYCHIATRIC-DISORDERS; GENE-EXPRESSION; ENRICHMENT; COMMON; METAANALYSIS; POPULATIONS; GLUTAMATE	Bipolar disorder (BD) is a highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. BD shows substantial clinical and genetic overlap with other psychiatric disorders, in particular schizophrenia (SCZ). The genes underlying this etiological overlap remain largely unknown. A recent SCZ genome wide association study (GWAS) by the Psychiatric Genomics Consortium identified 128 independent genome-wide significant single nucleotide polymorphisms (SNPs). The present study investigated whether these SCZ-associated SNPs also contribute to BD development through the performance of association testing in a large BD GWAS dataset (9747 patients, 14278 controls). After re-imputation and correction for sample overlap, 22 of 107 investigated SCZ SNPs showed nominal association with BD. The number of shared SCZ-BD SNPs was significantly higher than expected (p = 1.46x10(-8)). This provides further evidence that SCZ-associated loci contribute to the development of BD. Two SNPs remained significant after Bonferroni correction. The most strongly associated SNP was located near TRANK1, which is a reported genome-wide significant risk gene for BD. Pathway analyses for all shared SCZ-BD SNPs revealed 25 nominally enriched gene-sets, which showed partial overlap in terms of the underlying genes. The enriched gene-sets included calcium-and glutamate signaling, neuropathic pain signaling in dorsal horn neurons, and calmodulin binding. The present data provide further insights into shared risk loci and disease-associated pathways for BD and SCZ. This may suggest new research directions for the treatment and prevention of these two major psychiatric disorders.	[Forstner, Andreas J.; Hofmann, Andrea; Maaser, Anna; Muehleisen, Thomas W.; Degenhardt, Franziska; Mattheisen, Manuel; Schumacher, Johannes; Herms, Stefan; Hoffmann, Per; Schenk, Lorena M.; Sivalingam, Sugirthan; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Forstner, Andreas J.; Hofmann, Andrea; Maaser, Anna; Muehleisen, Thomas W.; Degenhardt, Franziska; Schumacher, Johannes; Herms, Stefan; Hoffmann, Per; Schenk, Lorena M.; Sivalingam, Sugirthan; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Gen Life & Brain Ctr, Bonn, Germany; [Forstner, Andreas J.] Univ Basel, Dept Psychiat, Basel, Switzerland; [Forstner, Andreas J.; Reinbold, Celine S.; Muehleisen, Thomas W.; Herms, Stefan; Hoffmann, Per; Fischer, Sascha B.; Cichon, Sven] Univ Basel, Dept Biomed, Human Genom Res Grp, Basel, Switzerland; [Forstner, Andreas J.; Reinbold, Celine S.; Muehleisen, Thomas W.; Herms, Stefan; Hoffmann, Per; Fischer, Sascha B.; Cichon, Sven] Univ Basel Hosp, Inst Med Genet & Pathol, Basel, Switzerland; [Hecker, Julian; Fier, Heide] Univ Bonn, Inst Genom Math, Bonn, Germany; [Hofmann, Andrea] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Muehleisen, Thomas W.; Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Leber, Markus] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Strohmaier, Jana; Treutlein, Jens; Streit, Fabian; Meier, Sandra; Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Mattheisen, Manuel] Aarhus Univ, iSEQ, Dept Biomed, Aarhus, Denmark; [Mattheisen, Manuel] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, Aarhus, Denmark; [Mattheisen, Manuel; Meier, Sandra] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Mattheisen, Manuel; Meier, Sandra] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Meier, Sandra] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Lacour, Andre; Becker, Tim] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Reif, Andreas] Univ Hosp Frankfurt Am Main, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Mueller-Myhsok, Bertram; Lucae, Susanne] Max Planck Inst Psychiat, Munich, Germany; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Schwarz, Markus; Vedder, Helmut] Psychiat Ctr Nordbaden, Wiesloch, Germany; [Kammerer-Ciernioch, Jutta] Ctr Psychiat Weinsberg, Weinsberg, Germany; [Pfennig, Andrea; Bauer, Michael] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Psychiat & Psychotherapy, Dresden, Germany; [Hautzinger, Martin] Univ Tubingen, Dept Psychol Clin Psychol & Psychotherapy, Tubingen, Germany; [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Czerski, Piotr M.; Hauser, Joanna] Poznan Univ Med Sci, Dept Psychiat, Lab Psychiat Genet, Poznan, Poland; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol Warsaw, Warsaw, Poland; [Szeszenia-Dabrowska, Neonila] Nofer Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, Lyon, France; [McKay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil Grp, Lyon, France; [Wright, Adam; Mitchell, Philip B.] Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia; [Wright, Adam; Mitchell, Philip B.] Prince Wales Hosp, Black Dog Inst, Randwick, NSW, Australia; [Fullerton, Janice M.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Fullerton, Janice M.; Schofield, Peter R.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Montgomery, Grant W.; Medland, Sarah E.; Gordon, Scott D.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld, Australia; [Krasnov, Valery] Moscow Res Inst Psychiat, Moscow, Russia; [Chuchalin, Alexander; Babadjanova, Gulja] Russian State Med Univ, Inst Pulmonol, Moscow, Russia; [Pantelejeva, Galina; Abramova, Lilia I.; Tiganov, Alexander S.] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow, Russia; [Polonikov, Alexey] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk, Russia; [Polonikov, Alexey] Kursk State Med Univ, Res Inst Genet & Mol Epidemiol, Kursk, Russia; [Khusnutdinova, Elza] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa, Russia; [Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Alda, Martin] NIMH, Klecany, Czech Republic; [Cruceanu, Cristiana; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Cruceanu, Cristiana; Turecki, Gustavo] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Cruceanu, Cristiana; Turecki, Gustavo] McGill Grp Suicide Studies, Montreal, PQ, Canada; [Cruceanu, Cristiana; Turecki, Gustavo] Douglas Res Inst, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi UQAC, Dept Sci Fondamentales, Saguenay, PQ, Canada; [Rivas, Fabio; Mayoral, Fermin] Hosp Reg Univ, Biomed Inst Malaga, Dept Psychiat, Malaga, Spain; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Clin Psychiat Hosp, Biometr Psychiat Genet Res Unit, Bucharest, Romania; [Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Schulze, Thomas G.] Univ Munich, Inst Psychiat Phen & Genom, Munich, Germany	University of Bonn; University of Bonn; University of Basel; University of Basel; University of Basel; University of Bonn; University of Bonn; Helmholtz Association; Research Center Julich; University of Cologne; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; University of Munich; University of Liverpool; University of Bonn; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; University of Duisburg Essen; Poznan University of Medical Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); University of New South Wales Sydney; Black Dog Institute; Neuroscience Research Australia; University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; Pirogov Russian National Research Medical University; Russian Academy of Medical Sciences; Kursk State Medical University; Kursk State Medical University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Dalhousie University; National Institute of Mental Health - Czech Republic; McGill University; McGill University; McGill University; McGill University; University of Quebec; University of Quebec Chicoutimi; Pompeu Fabra University; University of Bonn; University of Munich	Nothen, MM (corresponding author), Univ Bonn, Inst Human Genet, Bonn, Germany.; Nothen, MM (corresponding author), Univ Bonn, Dept Gen Life & Brain Ctr, Bonn, Germany.	markus.noethen@uni-bonn.de	Krasnov, Valery N/A-5117-2013; Hoffmann, Per/A-5149-2010; Mattheisen, Manuel/B-4949-2012; Mattheisen, Manuel/S-3725-2019; Khusnutdinova, Elza Kamilevna/A-4810-2013; Lissowska, Jolanta/AAH-3252-2020; Fullerton, Janice/F-8485-2013; Meier, Sandra/AAB-1242-2021; Degenhardt, Franziska/H-4169-2017; Serbanescu, Maria/D-4306-2011; Panteleeva, G/K-4636-2013; Polonikov, Alexey/R-7537-2016; Herms, Stefan/J-1949-2014; Montgomery, Grant W/B-7148-2008; Abramova, Liliya/K-4665-2013; Alda, Martin/F-5812-2010; Tiganov, Alexander S/B-6768-2016; Medland, Sarah E/C-7630-2013; Kogevinas, Manolis/C-3918-2017; Medland, Sarah/AAT-7595-2020; Cruceanu, Cristiana/AAK-2885-2021; Grigoroiu-Serbanescu, Maria/R-3689-2019; Schofield, Peter/C-9669-2011; Cucalin, Aleksandr/P-5678-2018; Cichon, Sven/B-9618-2014	Hoffmann, Per/0000-0002-6573-983X; Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Lissowska, Jolanta/0000-0003-2695-5799; Fullerton, Janice/0000-0003-4014-4490; Serbanescu, Maria/0000-0002-1304-6687; Panteleeva, G/0000-0002-5001-3198; Polonikov, Alexey/0000-0001-6280-247X; Herms, Stefan/0000-0002-2786-8200; Montgomery, Grant W/0000-0002-4140-8139; Abramova, Liliya/0000-0003-4397-924X; Alda, Martin/0000-0001-9544-3944; Tiganov, Alexander S/0000-0003-0148-7538; Medland, Sarah E/0000-0003-1382-380X; Kogevinas, Manolis/0000-0002-9605-0461; Medland, Sarah/0000-0003-1382-380X; Cruceanu, Cristiana/0000-0002-7799-5531; Grigoroiu-Serbanescu, Maria/0000-0002-1304-6687; Reinbold, Celine S/0000-0002-3394-3158; Laprise, Catherine/0000-0001-5526-9945; Maaser-Hecker, Anna/0000-0002-9440-0712; Schofield, Peter/0000-0003-2967-9662; Czerski, Piotr M./0000-0003-0745-5916; Cucalin, Aleksandr/0000-0002-6808-5528; Streit, Fabian/0000-0003-1080-4339; Cichon, Sven/0000-0002-9475-086X; Turecki, Gustavo/0000-0003-4075-2736; Krasnov, Valery/0000-0002-5249-3316; Moebus, Susanne/0000-0002-0072-5410; Mayoral-Cleries, Fermin/0000-0002-9710-9672; Lacour, Andre/0000-0003-2692-2583	German Federal Ministry of Education and Research (BMBF) [01ZX1314A, 01ZX1314G]; DFG [RI 908/7-1]; German Research Foundation (DFG) [FOR2107, RI908/11-1, N0246/10-1]; Swiss National Science Foundation (SNSF) [156791]; UEFISCDI, Romania [89/2012]; Heinz Nixdorf Foundation; Australian NHMRC program [1037196]; Canadian Institutes of Health Research [64410, MOP-13506]; European Commission, GABRIEL [018996, LSH-2004-1.2.5-1]; Wellcome Trust [084703]; Canada Research Chair Environment; Quebec Respiratory Network of the Fonds de rechercheen Sante du Quebec (FRQS); Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); UEFISCDI, Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Heinz Nixdorf Foundation; Australian NHMRC program(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Commission, GABRIEL(European Commission); Wellcome Trust(Wellcome Trust); Canada Research Chair Environment; Quebec Respiratory Network of the Fonds de rechercheen Sante du Quebec (FRQS); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders), under the auspices of the e:Med Programme (grant 01ZX1314A to M.M.N. and S.C., grant 01ZX1314G to M.R.). M.M.N. is a member of the DFG-funded Excellence-Cluster ImmunoSensation. M.M.N. also received support from the Alfried Krupp von Bohlen and Halbach-Stiftung. The study was supported by the German Research Foundation (DFG; grant FOR2107; RI908/11-1 to M.R.; N0246/10-1 to M.M.N.). The study was also supported by the Swiss National Science Foundation (SNSF, grant 156791 to S.C.). M.G.S. received grant no. 89/2012 from UEFISCDI, Romania. Canadian patients were genotyped within the ConLiGen project (www.ConLiGen.org), with the support of a grant from the DFG to M.R., M.B., and T.G.S. (RI 908/7-1). Controls for Germany II were drawn from the Heinz Nixdorf Recall Study (HNR) cohort, which was established with the support of the Heinz Nixdorf Foundation. Recruitment of the Australian sample was supported by an Australian NHMRC program grant (number 1037196). The recruitment of the Canadian patients was supported by a grant from the Canadian Institutes of Health Research #64410 to M.A. The study also used data generated by the GABRIEL consortium (controls for the sample Russia). Funding for the generation of these data was provided by the European Commission as part of GABRIEL contract number 018996 under the Integrated Program LSH-2004-1.2.5-1. Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control and the Wellcome Trust under award 084703. Canadian controls were drawn from the French Canadian study (SLSJ), which was supported in part by the Canada Research Chair Environment and genetics of respiratory diseases and allergy, the Canadian Institutes of Health Research (Operating grant No. MOP-13506), and the Quebec Respiratory Network of the Fonds de rechercheen Sante du Quebec (FRQS). Polish controls were recruited by the International Agency for Research on Cancer (IARC)/Centre National de Genotypage (CNG) GWAS Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Green EK, 2013, MOL PSYCHIATR, V18, P614, DOI 10.1038/mp.2012.48; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Harrison PJ, 2016, CURR OPIN NEUROBIOL, V36, P1, DOI 10.1016/j.conb.2015.07.002; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Miro X, 2012, AM J PSYCHIAT, V169, P982, DOI 10.1176/appi.ajp.2012.11101585; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Muhleisen TW, 2012, SCHIZOPHR RES, V138, P69, DOI 10.1016/j.schres.2012.03.007; Nothen Markus M, 2010, Dialogues Clin Neurosci, V12, P85; Nurnberger JI, 2014, JAMA PSYCHIAT, V71, P657, DOI 10.1001/jamapsychiatry.2014.176; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Ohi K, 2016, PSYCHIAT GENET, V26, P142, DOI 10.1097/YPG.0000000000000127; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Salavati B, 2015, SCHIZOPHRENIA BULL, V41, P44, DOI 10.1093/schbul/sbu132; Shim SS, 2012, NEUROSCI LETT, V524, P5, DOI 10.1016/j.neulet.2012.06.047; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winham SJ, 2014, J AFFECT DISORDERS, V165, P151, DOI 10.1016/j.jad.2014.04.026; Xu W, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-2	46	55	58	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171595	10.1371/journal.pone.0171595	http://dx.doi.org/10.1371/journal.pone.0171595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166306	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000393700100056
J	Hershaw, JN; Barry, DM; Ettenhofer, ML				Hershaw, Jamie N.; Barry, David M.; Ettenhofer, Mark L.			Increased risk for age-related impairment in visual attention associated with mild traumatic brain injury: Evidence from saccadic response times	PLOS ONE			English	Article							COGNITIVE DECLINE; TASK; COMPENSATION; MAINTENANCE; DYSFUNCTION; CONCUSSION; EFFICIENCY; COMPLAINTS; DEFICITS; HISTORY	It was hypothesized that risk for age-related impairment in attention would be greater among those with remote history of mild TBI than individuals without history of head injury. Twenty-seven adults with remote history of mild TBI and a well-matched comparison group of 54 uninjured controls completed a computerized test of visual attention while saccadic and manual response times were recorded. Within the mild TBI group only, older age was associated with slower saccadic responses and poorer saccadic inhibition. Saccadic slowing was mitigated in situations where the timing and location of attention targets was fully predictable. Mild TBI was not associated with age-related increases in risk for neuropsychological impairment or neurobehavioral symptoms. These results provide preliminary evidence that risk for age-related impairment in visual attention may be higher among those with a history of mild TBI. Saccadic measures may provide enhanced sensitivity to this subtle form of cognitive impairment.	[Hershaw, Jamie N.; Ettenhofer, Mark L.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Barry, David M.] Madigan Army Med Ctr, Dept Behav Hlth, Tacoma, WA 98431 USA	Uniformed Services University of the Health Sciences - USA; Madigan Army Medical Center	Hershaw, JN (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA.	jamie.hershaw.ctr@usuhs.edu	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	Uniformed Services University of Health Sciences (USUHS) Research [R072LP]; USUHS	Uniformed Services University of Health Sciences (USUHS) Research; USUHS	This study was supported by Uniformed Services University of Health Sciences (USUHS) Research Award #R072LP to MLE and institutional support from USUHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MP, 1995, NEUROLOGY; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Bigler ED, 2007, TRAUMATIC BRAIN INJU; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chen NK, 2009, BRAIN STRUCT FUNCT, V213, P571, DOI 10.1007/s00429-009-0218-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conners C.K., 2000, CONNERSCONTINUOUS PE; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; FOLK CL, 1992, PSYCHOL AGING, V7, P453, DOI 10.1037/0882-7974.7.3.453; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Holdnack J, 2001, WECHSLER TEST ADULT; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jennings JM, 2007, AGING NEUROPSYCHOL C, V14, P353, DOI 10.1080/13825580600788837; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Li L, 2013, NEUROBIOL AGING, V34, P477, DOI 10.1016/j.neurobiolaging.2012.02.025; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Mahoney JR, 2010, J INT NEUROPSYCH SOC, V16, P877, DOI 10.1017/S1355617710000767; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Ozen LJ, 2015, AGING NEUROPSYCHOL C, V22, P517, DOI 10.1080/13825585.2014.993584; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stuss D., 1994, NEUROPSYCHOLOGY, V8, P316, DOI [DOI 10.1037/0894-4105.8.3.316, DOI 10.1037//0894-4105.8.3.316]; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D., 2008, ADV CLIN SOLUTIONS W; Wechsler D., 2012, WAIS 4 KASIKIRJA; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	58	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171752	10.1371/journal.pone.0171752	http://dx.doi.org/10.1371/journal.pone.0171752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166259	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100070
J	Lee, W; Lim, S; Kim, Y				Lee, Wanho; Lim, Sookkyung; Kim, Yangjin			The role of myosin II in glioma invasion: A mathematical model	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL-MIGRATION; MATRIX METALLOPROTEINASES; GLIOBLASTOMA CELLS; MALIGNANT GLIOMA; HYBRID MODEL; TUMOR; PROLIFERATION; MOTILITY; BLEBBISTATIN	Gliomas are malignant tumors that are commonly observed in primary brain cancer. Glioma cells migrate through a dense network of normal cells in microenvironment and spread long distances within brain. In this paper we present a two-dimensional multiscale model in which a glioma cell is surrounded by normal cells and its migration is controlled by cell-mechanical components in the microenvironment via the regulation of myosin II in response to chemoattractants. Our simulation results show that the myosin II plays a key role in the deformation of the cell nucleus as the glioma cell passes through the narrow intercellular space smaller than its nuclear diameter. We also demonstrate that the coordination of biochemical and mechanical components within the cell enables a glioma cell to take the mode of amoeboid migration. This study sheds lights on the understanding of glioma infiltration through the narrow intercellular spaces and may provide a potential approach for the development of antiinvasion strategies via the injection of chemoattractants for localization.	[Lee, Wanho] Natl Inst Math Sci, Daejeon 34047, South Korea; [Lim, Sookkyung] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA; [Kim, Yangjin] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Kim, Yangjin] Konkuk Univ, Dept Math, Seoul 05029, South Korea	National Institute for Mathematical Sciences (NIMS), Republic of Korea; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; Konkuk University	Kim, Y (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.; Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul 05029, South Korea.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014	Kim, Yangjin/0000-0002-8905-8481	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01058702]; faculty research fund of Konkuk University; National Institute for Mathematical Sciences (NIMS) - Korea government [A21300000]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; faculty research fund of Konkuk University; National Institute for Mathematical Sciences (NIMS) - Korea government	This research (Y. Kim) was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01058702) and the faculty research fund of Konkuk University in 2014. Lee's work was supported by the National Institute for Mathematical Sciences (NIMS) grant funded by Korea government (A21300000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022; Amberger VR, 1998, CANCER RES, V58, P149; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Cancer Genome Atlas Research Network, 2010, NATURE, V455, P1061; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Choe GY, 2002, CLIN CANCER RES, V8, P2894; Coghill PA, 2013, BIOMED MICRODEVICES, V15, P183, DOI 10.1007/s10544-012-9715-y; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; de Groot JF, 2007, CURR OPIN NEUROL, V20, P712, DOI 10.1097/WCO.0b013e3282f15650; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; de los Reyes AA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1392; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; El-Obeid A, 1997, CANCER RES, V57, P5598; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Giese A, 1996, NEUROSURGERY, V38, P755, DOI 10.1227/00006123-199604000-00026; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gillespie GY, 1999, CANCER RES, V59, P2076; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; Gordon K, 2006, THESIS; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Ivkovic S, 2012, MOL BIOL CELL, V23, P533, DOI 10.1091/mbc.E11-01-0039; Jaalinoja J, 2000, J NEURO-ONCOL, V46, P81, DOI 10.1023/A:1006421112839; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Kim Y, 2017, IEEE T BIO-MED ENG, V64, P519, DOI 10.1109/TBME.2016.2637828; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114370; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Koo S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-143; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Laurent VM, 2005, BIOPHYS J, V89, P667, DOI 10.1529/biophysj.104.052316; Lee HG, 2015, JPN J IND APPL MATH, V32, P771, DOI 10.1007/s13160-015-0188-2; Lim FY, 2013, COMPUT METHOD BIOMEC, V16, P1085, DOI 10.1080/10255842.2012.757598; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Mertsch S, 2013, MOL NEUROBIOL, V48, P169, DOI 10.1007/s12035-013-8429-3; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; MOHANAM S, 1994, J NEURO-ONCOL, V22, P153, DOI 10.1007/BF01052890; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nagane M, 1996, CANCER RES, V27, P25639; Newell-Litwa KA, 2015, DIS MODEL MECH, V8, P1495, DOI 10.1242/dmm.022103; O'Brien ER, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00040; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Pozrikidis C., 2003, MODELING SIMULATION, DOI [10.1201/9780203503959, DOI 10.1201/9780203503959]; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Rejniak K.A., 2007, COMPUT MATH METHOD M, V8, P51, DOI DOI 10.1080/17486700701303143; Rejniak KA, 2007, J THEOR BIOL, V247, P186, DOI 10.1016/j.jtbi.2007.02.019; Rejniak KA, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00111; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Sakamoto Y, 2014, J MATH BIOL, V68, P267, DOI 10.1007/s00285-012-0634-6; Sakamoto Y, 2011, ANN BIOMED ENG, V39, P2735, DOI 10.1007/s10439-011-0360-z; Salhia B, 2008, CELL MOTIL CYTOSKEL, V65, P12, DOI 10.1002/cm.20240; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schattler H, 2013, IEEE DECIS CONTR P, P1810, DOI 10.1109/CDC.2013.6760145; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Swift LM, 2012, PFLUG ARCH EUR J PHY, V464, P503, DOI 10.1007/s00424-012-1147-2; Taft JR, 2005, INT J NEUROSCI, V115, P1333, DOI 10.1080/00207450590934570; Thiam HR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10997; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Westphal M, 2003, LOCAL THERAPIES GLIO, DOI [10.1007/978-3-7091-6090-9, DOI 10.1007/978-3-7091-6090-9]; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; WULLICH B, 1994, ANTICANCER RES, V14, P577; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Zhong J, 2010, J ONCOL, V2010, DOI 10.1155/2010/430142; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200	106	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e171312	10.1371/journal.pone.0171312	http://dx.doi.org/10.1371/journal.pone.0171312			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166231	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100033
J	Boerner, B; Tini, GM; Fachinger, P; Graber, SM; Irani, S				Boerner, Bettina; Tini, Gabrielo M.; Fachinger, Patrick; Graber, Sereina M.; Irani, Sarosh			Significant improvement of olfactory performance in sleep apnea patients after three months of nasal CPAP therapy - Observational study and randomized trial	PLOS ONE			English	Article							ODOR DISCRIMINATION; IDENTIFICATION; CONSEQUENCES; DISORDERS	Objectives The olfactory function highly impacts quality of life (QoL). Continuous positive airway pressure is an effective treatment for obstructive sleep apnea (OSA) and is often applied by nasal masks (nCPAP). The influence of nCPAP on the olfactory performance of OSA patients is unknown. The aim of this study was to assess the sense of smell before initiation of nCPAP and after three months treatment, in moderate and severe OSA patients. Methods The sense of smell was assessed in 35 patients suffering from daytime sleepiness and moderate to severe OSA (apnea/hypopnea index >= 15/h), with the aid of a validated test battery (Sniffin' Sticks) before initiation of nCPAP therapy and after three months of treatment. Additionally, adherent subjects were included in a double-blind randomized three weeks CPAP-withdrawal trial (sub-therapeutic CPAP pressure). Results Twenty five of the 35 patients used the nCPAP therapy for more than four hours per night, and for more than 70% of nights (adherent group). The olfactory performance of these patients improved significantly (p = 0.007) after three months of nCPAP therapy. When considering the entire group of patients, olfaction also improved significantly (p = 0.001). In the randomized phase the sense of smell of six patients deteriorated under sub-therapeutic CPAP pressure (p = 0.046) whereas five patients in the maintenance CPAP group showed no significant difference (p = 0.501). Conclusions Olfactory performance improved significantly after three months of nCPAP therapy in patients suffering from moderate and severe OSA. It seems that this effect of nCPAP is reversible under sub-therapeutic CPAP pressure.	[Boerner, Bettina; Tini, Gabrielo M.; Fachinger, Patrick; Irani, Sarosh] Cantonal Hosp Aarau, Clin Pulm & Sleep Med, Aarau, Switzerland; [Graber, Sereina M.] Univ Zurich Irchel, Anthropol Inst & Museum, Zurich, Switzerland	Kantonsspital Aarau AG (KSA); University of Zurich	Irani, S (corresponding author), Cantonal Hosp Aarau, Clin Pulm & Sleep Med, Aarau, Switzerland.	siran@gmx.ch	Irani, Sarosh/AAO-6911-2020	Irani, Sarosh/0000-0002-7667-9748	Research Council of the Cantonal Hospital Aarau, Switzerland	Research Council of the Cantonal Hospital Aarau, Switzerland	The Research Funding from the Research Council of the Cantonal Hospital Aarau, Switzerland provided financial support in the form of funding of the salary of the study nurse (60'000 Euro).	Almendros I, 2008, SLEEP, V31, P127, DOI 10.1093/sleep/31.1.127; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Blomqvist EH, 2004, RHINOLOGY, V42, P189; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Fu D, 2015, EUR ARCH OTO-RHINO-L, V272, P357, DOI 10.1007/s00405-014-3096-1; Geissler K, 2014, EUR ARCH OTO-RHINO-L, V271, P1557, DOI 10.1007/s00405-013-2747-y; Gelardi M, 2012, SLEEP MED, V13, P859, DOI 10.1016/j.sleep.2012.04.004; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Irani S, 2010, J HEART LUNG TRANSPL, V29, P265, DOI 10.1016/j.healun.2009.07.016; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; Randhawa PS, 2016, CLIN OTOLARYNGOL, V41, P15, DOI 10.1111/coa.12463; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Salihoglu M, 2014, LARYNGOSCOPE, V124, P2190, DOI 10.1002/lary.24565; Shadan FF, 2008, RHINOLOGY, V46, P347; Verstraeten E, 2007, CURR NEUROL NEUROSCI, V7, P161, DOI 10.1007/s11910-007-0012-8; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Wolfensberger M, 2000, ACTA OTO-LARYNGOL, V120, P303, DOI 10.1080/000164800750001134	23	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171087	10.1371/journal.pone.0171087	http://dx.doi.org/10.1371/journal.pone.0171087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158212	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161700028
J	Endo, F; Tabata, T; Sadato, D; Kawamura, M; Ando, N; Oboki, K; Ukaji, M; Kobayashi, K; Kobayashi, Y; Ikeda, T; Shibasaki, F				Endo, Fumiko; Tabata, Tsutomu; Sadato, Daichi; Kawamura, Machiko; Ando, Noriyuki; Oboki, Keisuke; Ukaji, Masako; Kobayashi, Kaoru; Kobayashi, Yukuharu; Ikeda, Tomoaki; Shibasaki, Futoshi			Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; HPV-16/18 AS04-ADJUVANTED VACCINE; LONG-TERM; CERVICAL-CANCER; YOUNG-WOMEN; HPV VACCINE; FOLLOW-UP; IMMUNOGENICITY; RESPONSES; EFFICACY	lmmunochromatography (IC) is widely used to detect target molecules in biological fluids. Since this method can be performed without a special technique or device, IC is a convenient way to assess the existence of antibodies or pathogens such as viruses and bacteria, simply and quickly. In this study, we established an IC method to detect serum antibodies against oncogenic human papillomavirus (HPV)-16 and HPV-18 L1 proteins using recombinant L1 proteins produced by silkworms as antigens. Infection of oncogenic HPVs is a major risk factor of cervical cancer, which is one of the most common cancers in women worldwide. We first measured blood sera of two groups by magnetic beads enzyme -linked immunosorbent assay (MB-ELISA). For the first group, sera were collected prospectively from young women who planned to receive HPV vaccination. The second group consisted of children under 20 years of age, non -vaccinated healthy women, vaccinated healthy women, dysplasia, cervical intraepithelial neoplasia III, and cervical cancer patients. We confirmed that standard vaccination doses significantly increased serum HPV antibody concentrations, and the level was sustained at least more than 30 months after vaccination. In contrast, an increase in antibody concentration was not observed in patients with precancerous cervical changes and cervical cancer. We next measured the samples in both groups using the IC method we originally developed, and found that the measurement values of IC highly correlated with those of MB-ELISA. The simple and quick IC method would be a useful tool for rapid monitoring of L1 specific antibody levels in a non-laboratory environment. With less than one drop of serum, our IC can easily detect serum HPV-16/-18 antibodies within 15 minutes, without the need for electronic devices or techniques.	[Endo, Fumiko; Sadato, Daichi; Oboki, Keisuke; Ukaji, Masako; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kami Kitazawa, Tokyo, Japan; [Tabata, Tsutomu; Ikeda, Tomoaki] Mie Univ, Dept Obstet & Gynecol, Fac Med, 2-174 Edobashi, Tsu, Mie, Japan; [Sadato, Daichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba, Japan; [Kawamura, Machiko] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Pediat, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo, Japan; [Ando, Noriyuki] Josei Kokoro Clin, Arakawa Ku, 1-1-9 Machiya, Tokyo, Japan; [Kobayashi, Kaoru; Kobayashi, Yukuharu] ADTEC Co LTD, 1693-6 Yokkaichi, Usa City, Oita, Japan; [Kawamura, Machiko] Saitama Canc Ctr, Dept Hematol, 780 Komuro, Ina, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; Mie University; Tokyo University of Science; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital	Oboki, K; Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kami Kitazawa, Tokyo, Japan.	ooboki-ks@igakuken.or.jp; shibasaki-ft@igakuken.or.jp	Oboki, Keisuke/AAR-1813-2020	Oboki, Keisuke/0000-0001-7011-6234; Sadato, Daichi/0000-0002-3873-8268; Kawamura, Machiko/0000-0002-6138-1690	Japan Society for the Promotion of Science KAKENHI [JP23659314, JP23650620, JP26640096]; Tokyo Metropolitan Government	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo Metropolitan Government(Tokyo Metropolitan Government)	This work was supported by grants from the Japan Society for the Promotion of Science KAKENHI, grant numbers JP23659314 (FS), JP23650620 and JP26640096 (FE) and by some part of the special grant from Tokyo Metropolitan Government (FS). The funder provided support in the form of salaries for authors (FE, KO, MU), but did not have any additional role in the study design,	Angioli R, 2016, CRIT REV ONCOL HEMAT, V102, P65, DOI 10.1016/j.critrevonc.2016.03.020; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Bierl C, 2005, GYNECOL ONCOL, V99, pS262, DOI 10.1016/j.ygyno.2005.07.100; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2011, HUM VACCINES, V7, P230, DOI 10.4161/hv.7.2.13948; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Einstein MH, 2014, HUM VACC IMMUNOTHER, V10, P3455, DOI 10.4161/hv.36117; Ferris D, 2014, PEDIATRICS, V134, pE657, DOI 10.1542/peds.2013-4144; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Handisurya A, 2016, BRIT J CANCER, V114, P409, DOI 10.1038/bjc.2015.462; Herrero R, 2015, LANCET ONCOL, V16, pE206, DOI 10.1016/S1470-2045(14)70481-4; Hestbech MS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007921; Kemp TJ, 2008, VACCINE, V26, P3608, DOI 10.1016/j.vaccine.2008.04.074; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kollmann TR, 2016, TRENDS IMMUNOL, V37, P523, DOI 10.1016/j.it.2016.05.005; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Maeda S., 1989, INVERTEBRATE CELL SY, P167; Marais DJ, 2001, J MED VIROL, V65, P149, DOI 10.1002/jmv.2014; Marin AC, 2015, WORLD J GASTROENTERO, V21, P11273, DOI 10.3748/wjg.v21.i40.11273; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Nakano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128351; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Naud PS, 2014, HUM VACC IMMUNOTHER, V10, P2147, DOI 10.4161/hv.29532; Nygard M, 2015, CLIN VACCINE IMMUNOL, V22, P943, DOI 10.1128/CVI.00133-15; Pagliusi SR, 2007, DIS MARKERS, V23, P283, DOI 10.1155/2007/591826; Peirson L, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-35; Pellegrino P, 2015, VACCINE, V33, P3444, DOI 10.1016/j.vaccine.2015.05.041; Pollock KGJ, 2014, BRIT J CANCER, V111, P1824, DOI 10.1038/bjc.2014.479; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Ruiz Wanda, 2005, J Immune Based Ther Vaccines, V3, P2, DOI 10.1186/1476-8518-3-2; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Suzuki T, 1997, J GEN VIROL, V78, P3073, DOI 10.1099/0022-1317-78-12-3073; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinberg A, 2012, J INFECT DIS, V206, P1309, DOI 10.1093/infdis/jis489; Wentzensen N, 2011, J INFECT DIS, V204, P94, DOI 10.1093/infdis/jir209; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171314	10.1371/journal.pone.0171314	http://dx.doi.org/10.1371/journal.pone.0171314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158224	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700059
J	Gauthier, L; Bonnin, RA; Dortet, L; Naas, T				Gauthier, Lauraine; Bonnin, Remy A.; Dortet, Laurent; Naas, Thierry			Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae	PLOS ONE			English	Article							NP TEST; PSEUDOMONAS-AERUGINOSA; RAPID DETECTION; OXA-48; ASSAY; TIME; IDENTIFICATION; SPREAD; KPC	Background There is an urgent need for accurate and rapid diagnostic tests to identify carbapenemase producing enterobacteria (CPE). Here, we have evaluated the Carbapenem Inactivation Method (CIM) test to detect CPEs from cultured colonies. Methods A total of 256 enterobacterial isolates were used to evaluate the performance of the CIM in comparison to Carba NP test and molecular detection used a reference method. Ninety three well-characterized isolates (including 29 non-CPE and 63 CPEs of worldwide origin) with decreased susceptibility to at least one carbapenem were used to (i) evaluate the efficacy of CIM test and (ii) to compare it to the Carba NP test. We also tested different carbapenems to determine the best substrate for this test. Finally, the CIM test was then evaluated prospectively against 164 isolates referred to the French National Reference Center (NRC) for Antimicrobial Resistance from may 2016 to july 2016. Results Based on the results of this retrospective study, sensitivity and specificity of the CIM and the Carba NP test were 92.1% and 100%, respectively. We demonstrated that the meropenem was the best substrate to perform the CIM test since sensitivity and specificity were 81.1% and 100% using ertapenem disk, and 100% and 65.6% using imipenem disk, and respectively. Taking in account the results of retrospective and prospective studies, CIM and Carba NP tests have similar sensitivity, specificity, positive predictive value and negative predictive values being 96.3%, 98.9%, 99.0% and 98.4% for the CIM test versus 96.9%, 100%, 100% and 100% for the Carba NP test. Conclusions Our results confirm that the CIM test may be a useful tool for the reliable confirmation of carbapenemase- activity in enterobacterial isolates, especially in clinical microbiological laboratories with limited resources, no trained personnel, and no specialized equipment.	[Gauthier, Lauraine; Bonnin, Remy A.; Dortet, Laurent; Naas, Thierry] Univ Paris Sud, French Natl Reference Ctr Antibiot Resistance Car, Bicetre Hosp,LabEx Lermit,Fac Med, AP HP,Bacteriol Hyg Unit,Struct Dynam Funct & Exp, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Naas, T (corresponding author), Univ Paris Sud, French Natl Reference Ctr Antibiot Resistance Car, Bicetre Hosp,LabEx Lermit,Fac Med, AP HP,Bacteriol Hyg Unit,Struct Dynam Funct & Exp, Le Kremlin Bicetre, France.	thierry.naas@aphp.fr	Naas, Thierry/O-3999-2018; DORTET, Laurent/D-5159-2014	Naas, Thierry/0000-0001-9937-9572; DORTET, Laurent/0000-0001-6596-7384; Bonnin, Remy A./0000-0002-2307-3232	Ministere de l'Education Nationale et de la Recherche, Universite Paris Sud [EA7361]; ANR "Agence National pour la Recherche" [ANR-10-LABX-33]	Ministere de l'Education Nationale et de la Recherche, Universite Paris Sud; ANR "Agence National pour la Recherche"(French National Research Agency (ANR))	This work was funded by a grant from the Ministere de l'Education Nationale et de la Recherche (EA7361), Universite Paris Sud. LG, RAB, LD and TN are members of the Laboratory of Excellence LERMIT supported by a grant from ANR "Agence National pour la Recherche" (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayramoglu G, 2016, MIKROBIYOL BUL, V50, P505, DOI 10.5578/mb.26497; Bogaerts P, 2016, J CLIN MICROBIOL, V54, P349, DOI 10.1128/JCM.02404-15; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cuzon G, 2013, DIAGN MICR INFEC DIS, V76, P502, DOI 10.1016/j.diagmicrobio.2013.05.004; Dortet L, 2016, J ANTIMICROB CHEMOTH, V71, P1834, DOI 10.1093/jac/dkw058; Dortet L, 2016, ANTIMICROB AGENTS CH, V60, P3832, DOI 10.1128/AAC.00517-16; Dortet L, 2016, J ANTIMICROB CHEMOTH, V71, P135, DOI 10.1093/jac/dkv308; Dortet L, 2015, J ANTIMICROB CHEMOTH, V70, P3014, DOI 10.1093/jac/dkv213; Dortet L, 2015, ANTIMICROB AGENTS CH, V59, P7100, DOI 10.1128/AAC.01512-15; Dortet L, 2012, ANTIMICROB AGENTS CH, V56, P6437, DOI 10.1128/AAC.01395-12; Glasner C., 2013, EURP SURVEILL, P18, DOI DOI 10.2807/1560-7917.ES2013.18.28.20525; Glupczynski Y, 2016, J ANTIMICROB CHEMOTH, V71, P1217, DOI 10.1093/jac/dkv472; Hemarajata P, 2015, ANTIMICROB AGENTS CH, V59, P5574, DOI 10.1128/AAC.00425-15; Hrabak J, 2014, CLIN MICROBIOL INFEC, V20, P839, DOI 10.1111/1469-0691.12678; Kabir MH, 2016, J ANTIMICROB CHEMOTH, V71, P1213, DOI 10.1093/jac/dkv468; Lasserre C, 2015, J CLIN MICROBIOL, V53, P2163, DOI 10.1128/JCM.03467-14; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Osterblad M, 2014, ANTIMICROB AGENTS CH, V58, P7553, DOI 10.1128/AAC.02761-13; Tijet N, 2016, J ANTIMICROB CHEMOTH, V71, P274, DOI 10.1093/jac/dkv283; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; Tsakris A, 2015, J CLIN MICROBIOL, V53, P1245, DOI 10.1128/JCM.03318-14; van der Zwaluw K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123690; Yamada K, 2016, J MICROBIOL METH, V128, P48, DOI 10.1016/j.mimet.2016.06.019	23	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170769	10.1371/journal.pone.0170769	http://dx.doi.org/10.1371/journal.pone.0170769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158310	Green Published, gold			2022-12-27	WOS:000396161700017
J	Meli, P; Holl, KD; Benayas, JMR; Jones, HP; Jones, PC; Montoya, D; Mateos, DM				Meli, Paula; Holl, Karen D.; Rey Benayas, Jose Maria; Jones, Holly P.; Jones, Peter C.; Montoya, Daniel; Mateos, David Moreno			A global review of past land use, climate, and active vs. passive restoration effects on forest recovery	PLOS ONE			English	Article							ABOVEGROUND BIOMASS ACCUMULATION; ECOSYSTEM SERVICES; ECOLOGICAL RESTORATION; NATURAL REGENERATION; SPECIES COMPOSITION; TROPICAL FOREST; CARBON STORAGE; RAPID RECOVERY; TRADE-OFF; BIODIVERSITY	Global forest restoration targets have been set, yet policy makers and land managers lack guiding principles on how to invest limited resources to achieve them. We conducted a meta-analysis of 166 studies in naturally regenerating and actively restored forests worldwide to answer: (1) To what extent do floral and faunal abundance and diversity and biogeochemical functions recover? (2) Does recovery vary as a function of past land use, time since restoration, forest region, or precipitation? (3) Does active restoration result in more complete or faster recovery than passive restoration? Overall, forests showed a high level of recovery, but the time to recovery depended on the metric type measured, past land use, and region. Abundance recovered quickly and completely, whereas diversity recovered slower in tropical than in temperate forests. Biogeochemical functions recovered more slowly after agriculture than after logging or mining. Formerly logged sites were mostly passively restored and generally recovered quickly. Mined sites were nearly always actively restored using a combination of planting and either soil amendments or recontouring topography, which resulted in rapid recovery of the metrics evaluated. Actively restoring former agricultural land, primarily by planting trees, did not result in consistently faster or more complete recovery than passively restored sites. Our results suggest that simply ending the land use is sufficient for forests to recover in many cases, but more studies are needed that directly compare the value added of active versus passive restoration strategies in the same system. Investments in active restoration should be evaluated relative to the past land use, the natural resilience of the system, and the specific objectives of each project.	[Meli, Paula] Nat & Ecosistemas Mexicanos AC, Mexico City, DF, Mexico; [Meli, Paula; Rey Benayas, Jose Maria; Mateos, David Moreno] Fdn Int Restaurac Ecosistemas, Madrid, Spain; [Holl, Karen D.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Rey Benayas, Jose Maria] Univ Alcala, Dept Ciencias Vida, Alcala De Henares, Spain; [Jones, Holly P.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA; [Jones, Holly P.] Northern Illinois Univ, Inst Study Environm Sustainabil & Energy, De Kalb, IL USA; [Jones, Peter C.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA; [Montoya, Daniel] CNRS, Stn Ecol Expt, Ctr Biodivers Theory & Modeling, Moulis, France; [Montoya, Daniel] Ctr INRA Dijon, Dijon, France; [Montoya, Daniel] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Mateos, David Moreno] Basque Ctr Climate Change, Bilbao, Spain; [Mateos, David Moreno] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Meli, Paula] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil	University of California System; University of California Santa Cruz; Universidad de Alcala; Northern Illinois University; Northern Illinois University; Northern Illinois University; Centre National de la Recherche Scientifique (CNRS); INRAE; University of Bristol; Basque Centre for Climate Change (BC3); Basque Foundation for Science; Universidade de Sao Paulo	Meli, P (corresponding author), Nat & Ecosistemas Mexicanos AC, Mexico City, DF, Mexico.; Meli, P (corresponding author), Fdn Int Restaurac Ecosistemas, Madrid, Spain.; Meli, P (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil.	paula@naturamexicana.org.mx	Montoya, Daniel/L-2266-2019; , 0000-0001-5390-7552/G-1872-2018	Montoya, Daniel/0000-0002-5521-5282; , 0000-0001-5390-7552/0000-0001-5390-7552; Jones, Holly/0000-0002-5512-9958	National Socio-Environmental Synthesis Center (SESYNC) from the National Science Foundation [DBI-1052875]; German Helmholtz Centre for Environmental Research - UFZ, Leipzig (Research Program 'Terrestrial Environments'); sDiv; Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (German Research Foundation DFG) [FZT 118]; 'Improving the way knowledge on forests is understood and used internationally (KNOW-FOR)' program from the International Union for Conservation of Nature; Department for International Development (DFID); Div Of Biological Infrastructure [1639145, 1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) from the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); German Helmholtz Centre for Environmental Research - UFZ, Leipzig (Research Program 'Terrestrial Environments'); sDiv; Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (German Research Foundation DFG)(German Research Foundation (DFG)); 'Improving the way knowledge on forests is understood and used internationally (KNOW-FOR)' program from the International Union for Conservation of Nature; Department for International Development (DFID); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) with funding received from the National Science Foundation DBI-1052875; by the German Helmholtz Centre for Environmental Research - UFZ, Leipzig (Research Program 'Terrestrial Environments'); by sDiv, the Synthesis Centre of the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig (German Research Foundation DFG FZT 118); and by a grant to the Fundacion Internacional para la Restauracion de Ecosistemas from 'Improving the way knowledge on forests is understood and used internationally (KNOW-FOR)' program from the International Union for Conservation of Nature. The KNOW-FOR program is funded by the Department for International Development (DFID).	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alexander S, 2011, RESTOR ECOL, V19, P683, DOI 10.1111/j.1526-100X.2011.00822.x; [Anonymous], 2012, RESTOR ECOL; Barto K, 2013, MUMIN MULTIMODEL INF; Belote RT, 2012, ECOL APPL, V22, P502, DOI 10.1890/11-0925.1; Birch JC, 2010, P NATL ACAD SCI USA, V107, P21925, DOI 10.1073/pnas.1003369107; Bonner MTL, 2013, FOREST ECOL MANAG, V291, P73, DOI 10.1016/j.foreco.2012.11.024; Brancalion PHS, 2016, BIOTROPICA, V48, P856, DOI 10.1111/btp.12383; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burton JI, 2013, ECOL APPL, V23, P1297, DOI 10.1890/12-1472.1; Chazdon R.L., 2014, 2 GROWTH PROMISE TRO, DOI DOI 10.1017/CBO9781107415324.004; Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381; Cole LES, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4906; Convention on Biological Diversity, 2016, STRAT PLAN BIOD 2011; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; Curran M, 2014, ECOL APPL, V24, P617, DOI 10.1890/13-0243.1; Dodson EK, 2012, CAN J FOREST RES, V42, P345, DOI [10.1139/x11-188, 10.1139/X11-188]; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Gibb H, 2013, J APPL ECOL, V50, P449, DOI 10.1111/1365-2664.12054; Graham SA, 2005, WETLANDS, V25, P594, DOI 10.1672/0277-5212(2005)025[0594:FAAOSP]2.0.CO;2; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 2014, FOREST ECOL MANAG, V319, P36, DOI 10.1016/j.foreco.2014.01.024; Holl KD, 2013, OECOLOGIA, V173, P569, DOI 10.1007/s00442-013-2632-9; Holl KD, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P411; Holl KD, 2002, J APPL ECOL, V39, P960, DOI 10.1046/j.1365-2664.2002.00767.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Knoke T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6612; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lajeunesse MJ, 2003, ECOL LETT, V6, P448, DOI 10.1046/j.1461-0248.2003.00448.x; Le HD, 2012, J RURAL STUD, V28, P5, DOI 10.1016/j.jrurstud.2011.07.006; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Lu N, 2014, LANDSCAPE ECOL, V29, P1697, DOI 10.1007/s10980-014-0101-4; Marin-Spiotta Erika, 2008, P22, DOI 10.1007/978-0-387-33642-8_2; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; Meli P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093507; Minnemayer S, 2011, WORLD OPPORTUNITY; Montoya D, 2012, TRENDS ECOL EVOL, V27, P666, DOI 10.1016/j.tree.2012.07.004; Moreno-Mateos D, 2015, J APPL ECOL, V52, P1528, DOI 10.1111/1365-2664.12518; Moreno-Mateos D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001247; Mundry R, 2011, BEHAV ECOL SOCIOBIOL, V65, P57, DOI 10.1007/s00265-010-1040-y; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; NAKAGOSHI N, 1990, VEGETATIO, V87, P73, DOI 10.1007/BF00045657; Norden N, 2015, P NATL ACAD SCI USA, V112, P8013, DOI 10.1073/pnas.1500403112; Barral MP, 2015, AGR ECOSYST ENVIRON, V202, P223, DOI 10.1016/j.agee.2015.01.009; Pinheiro J, R PACKAGE VERSION; Plieninger T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098355; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Sampaio AB, 2007, RESTOR ECOL, V15, P462, DOI 10.1111/j.1526-100X.2007.00242.x; Schwenk WS, 2012, ECOL APPL, V22, P1612, DOI 10.1890/11-0864.1; Shoo LP, 2013, RESTOR ECOL, V21, P670, DOI 10.1111/rec.12048; Society for Ecology Restoration Science & Policy Working Group, 2009, SER PRIM EC REST 200; Stanturf JA, 2014, FOREST ECOL MANAG, V331, P292, DOI 10.1016/j.foreco.2014.07.029; Suganuma MS, 2014, COMMUNITY ECOL, V15, P27, DOI [10.1556/COMEC.15.2014.1.3, 10.1556/ComEc.15.2014.1.3]; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang MC, 1998, PSYCHOL METHODS, V3, P46, DOI 10.1037/1082-989X.3.1.46; Whisenant S.G., 1999, REPAIRING DAMAGED WI, DOI [10.1017/CBO9780511612565, DOI 10.1017/CBO9780511612565]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zuur Alain F., 2009, P1	64	190	193	19	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171368	10.1371/journal.pone.0171368	http://dx.doi.org/10.1371/journal.pone.0171368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158256	Green Published, gold			2022-12-27	WOS:000396161700068
J	Sakaki, M; Ebihara, Y; Okamura, K; Nakabayashi, K; Igarashi, A; Matsumoto, K; Hata, K; Kobayashi, Y; Maehara, K				Sakaki, Mizuho; Ebihara, Yukiko; Okamura, Kohji; Nakabayashi, Kazuhiko; Igarashi, Arisa; Matsumoto, Kenji; Hata, Kenichiro; Kobayashi, Yoshiro; Maehara, Kayoko			Potential roles of DNA methylation in the initiation and establishment of replicative senescence revealed by array-based methylome and transcriptome analyses	PLOS ONE			English	Article							CELLULAR SENESCENCE; HETEROCHROMATIN FORMATION; HUMAN FIBROBLASTS; GENE-EXPRESSION; CELLS; DEMETHYLATION; P53; CANCER; PROTEINS; PATHWAY	Cellular senescence is classified into two groups: replicative and premature senescence. Gene expression and epigenetic changes are reported to differ between these two groups and cell types. Normal human diploid fibroblast TIG-3 cells have often been used in cellular senescence research; however, their epigenetic profiles are still not fully understood. To elucidate how cellular senescence is epigenetically regulated in TIG-3 cells, we analyzed the gene expression and DNA methylation profiles of three types of senescent cells, namely, replicatively senescent, ras-induced senescent (RIS), and non-permissive temperatureinduced senescent SVts8 cells, using gene expression and DNA methylation microarrays. The expression of genes involved in the cell cycle and immune response was commonly either down-or up-regulated in the three types of senescent cells, respectively. The altered DNA methylation patterns were observed in replicatively senescent cells, but not in prematurely senescent cells. Interestingly, hypomethylated CpG sites detected on non-CpG island regions ("open sea") were enriched in immune response-related genes that had non-CpG island promoters. The integrated analysis of gene expression and methylation in replicatively senescent cells demonstrated that differentially expressed 867 genes, including cell cycle-and immune response-related genes, were associated with DNA methylation changes in CpG sites close to the transcription start sites (TSSs). Furthermore, several miRNAs regulated in part through DNA methylation were found to affect the expression of their targeted genes. Taken together, these results indicate that the epigenetic changes of DNA methylation regulate the expression of a certain portion of genes and partly contribute to the introduction and establishment of replicative senescence.	[Sakaki, Mizuho; Ebihara, Yukiko; Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan; [Sakaki, Mizuho; Kobayashi, Yoshiro] Toho Univ, Grad Sch Sci, Dept Biomol Sci, Funabashi, Chiba, Japan; [Okamura, Kohji] Natl Res Inst Child Hlth & Dev, Dept Syst BioMed, Setagaya Ku, Tokyo, Japan; [Igarashi, Arisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya Ku, Tokyo, Japan; [Maehara, Kayoko] Kio Univ, Grad Sch Hlth Sci, Dept Nutr, Nara, Japan	National Center for Child Health & Development - Japan; Toho University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Maehara, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Setagaya Ku, Tokyo, Japan.	sakaki-m@ncchd.go.jp; yoshiro@biomol.sci.toho-u.ac.jp; k.maehara@kio.ac.jp		Igarashi, Arisa/0000-0001-7206-3105	Takeda Science Foundation; Kio University; National Research Institute for Child Health and Development [24-3]; JSPS [15K19439]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kio University; National Research Institute for Child Health and Development; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Takeda Science Foundation (http://www.takeda-sci.or.jp/) to KMae, a grant from Kio University (http://www.kio.ac.jp/) to KMae, grant 24-3 from the National Research Institute for Child Health and Development to KN and KMat, and Grant-in-Aid for Young Scientists (B 15K19439) from JSPS KAKENHI to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/17142; Asuthkar S, 2012, ONCOTARGET, V3, P1439; Ayala-Ortega E, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2273-6; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; BAUMANN H, 1991, J BIOL CHEM, V266, P20424; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Disayabutr S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158367; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Kaneda A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002359; Koch CM, 2013, METHODS MOL BIOL, V1048, P309, DOI 10.1007/978-1-62703-556-9_20; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Li CW, 2016, ONCOTARGET, V7, P8556, DOI 10.18632/oncotarget.7388; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Oliveira NFP, 2009, J CLIN PERIODONTOL, V36, P719, DOI 10.1111/j.1600-051X.2009.01446.x; Overhoff MG, 2014, NUCLEIC ACIDS RES, V42, P1606, DOI 10.1093/nar/gkt1096; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Price ME, 2013, EPIGENETICS CHROMATI, V6, P4; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rusiecki JA, 2013, FRONT PSYCHIATRY, V4, P1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Taguchi YH, 2012, AGING DIS, V3, P301; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Truong TP, 2015, J CLIN EXP HEMATOP, V55, P1, DOI 10.3960/jslrt.55.1; TSUYAMA N, 1991, CELL STRUCT FUNCT, V16, P55, DOI 10.1247/csf.16.55; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806; Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu Z, 2015, J IMMUNOL RES, V2015, DOI [10.1155/2015/471342, 10.1155/2015/412515]; Yin HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep18824; Zhang WJ, 2014, FREE RADICAL RES, V48, P550, DOI 10.3109/10715762.2014.893580; Zhang ZH, 2016, IEEE PHOTONICS J, V8, DOI 10.1109/JPHOT.2016.2628205	69	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171431	10.1371/journal.pone.0171431	http://dx.doi.org/10.1371/journal.pone.0171431			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158250	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700079
J	Broring, T; Oostrom, KJ; Lafeber, HN; Jansma, EP; Oosterlaan, J				Broering, Tinka; Oostrom, Kim J.; Lafeber, Harrie N.; Jansma, Elise P.; Oosterlaan, Jaap			Sensory modulation in preterm children: Theoretical perspective and systematic review	PLOS ONE			English	Review							NEONATAL INTENSIVE-CARE; BIRTH-WEIGHT CHILDREN; BRAIN-DEVELOPMENT; PROCESSING DISORDER; BEHAVIORAL OUTCOMES; DEVELOPMENTAL CARE; EVERYDAY LIFE; INFANTS; BORN; AGE	Background Neurodevelopmental sequelae in preterm born children are generally considered to result from cerebral white matter damage and noxious effects of environmental factors in the neonatal intensive care unit (NICU). Cerebral white matter damage is associated with sensory processing problems in terms of registration, integration and modulation. However, research into sensory processing problems and, in particular, sensory modulation problems, is scarce in preterm children. Aim This review aims to integrate available evidence on sensory modulation problems in preterm infants and children (<37 weeks of gestation) and their association with neurocognitive and behavioral problems. Method Relevant studies were extracted from PubMed, EMBASE.com and PsycINFO following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Selection criteria included assessment of sensory modulation in preterm born children (<37 weeks of gestation) or with prematurity as a risk factor. Results Eighteen studies were included. Results of this review support the presence of sensory modulation problems in preterm children. Although prematurity may distort various aspects of sensory modulation, the nature and severity of sensory modulation problems differ widely between studies. Conclusions Sensory modulation problems may play a key role in understanding neurocognitive and behavioral sequelae in preterm children. Some support is found for a dose-response relationship between both white matter brain injury and length of NICU stay and sensory modulation problems.	[Broering, Tinka; Oostrom, Kim J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Lafeber, Harrie N.] Vrije Univ Amsterdam, Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Ctr, Med Lib, Amsterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Broring, T (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.	t.broring@vumc.nl	Jansma, Elise/AAG-7983-2020; Jansma, Elise P/E-8358-2016	Jansma, Elise P/0000-0002-1516-2171				Aarnoudse-Moens CSH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055994; Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Adams JN, 2015, EARLY HUM DEV, V91, P227, DOI 10.1016/j.earlhumdev.2015.01.013; Als H, 1997, SEMIN PERINATOL, V21, P178, DOI 10.1016/S0146-0005(97)80062-6; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; ALS H, 1994, JAMA-J AM MED ASSOC, V272, P853, DOI 10.1001/jama.272.11.853; ALS H, 1986, PEDIATRICS, V78, P1123; Als H., 1986, PHYS OCCUP THER PEDI, V6, P3, DOI DOI 10.1080/J006V06N03_02; Anand KJS, 2000, BIOL NEONATE, V77, P69, DOI 10.1159/000014197; Anderson PJ, 2014, SEMIN FETAL NEONAT M, V19, P90, DOI 10.1016/j.siny.2013.11.012; Aucott S, 2002, MENT RETARD DEV D R, V8, P298, DOI 10.1002/mrdd.10040; Bart O, 2011, RES DEV DISABIL, V32, P2732, DOI 10.1016/j.ridd.2011.05.037; Bayley N, 1993, BAYLEY SCALES INFANT; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Bhutta AT, 2002, CLIN PERINATOL, V29, P357, DOI 10.1016/S0095-5108(02)00011-8; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bisiacchi PS, 2009, BIOL PSYCHOL; Cabral TI, 2016, EARLY HUM DEV; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Case-Smith J, 1998, AM J OCCUP THER, V52, P547, DOI 10.5014/ajot.52.7.547; Chorna O, 2014, ARCH DIS CHILD-FETAL, V99, pF475, DOI 10.1136/archdischild-2014-306486; Christou Helen, 2005, J Intensive Care Med, V20, P76, DOI 10.1177/0885066604273494; Crepeau-Hobson MF, 2009, J DEV PHYS DISABIL, V21, P315, DOI 10.1007/s10882-009-9144-x; Crozier SC, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.018747; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; DeGangi GA., 1989, TEST SENSORY FUNCTIO; Dubois J, 2008, BRAIN; Dubois J, 2008, CEREB CORTEX; Dudova I, 2014, NEUROPSYCH DIS TREAT, V10, P277, DOI 10.2147/NDT.S57057; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 2002, J EARLY INTERVENTION, V25, P27, DOI 10.1177/105381510202500104; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Dunn W, 1999, SENSORY PROFILE USER; Dunn W., 2002, INFANT TODDLER SENSO; Dunn W, 2007, INFANT YOUNG CHILD, V20, P84, DOI 10.1097/01.IYC.0000264477.05076.5d; Ecevit A, 2012, TURKISH J PEDIATR, V54, P509; Eeles AL, 2013, EARLY HUM DEV, V89, P1075, DOI 10.1016/j.earlhumdev.2013.07.027; Eeles AL, 2013, EARLY HUM DEV, V89, P727, DOI 10.1016/j.earlhumdev.2013.05.005; Eeles AL, 2013, DEV MED CHILD NEUROL, V55, P314, DOI 10.1111/j.1469-8749.2012.04434.x; Geldof CJA, 2012, RES DEV DISABIL, V33, P726, DOI 10.1016/j.ridd.2011.08.025; Geldof CJA, 2014, DEV MED CHILD NEUROL, V56, P862, DOI 10.1111/dmcn.12404; Gioia GA, 2003, BRIEF P BEHAV RATING; Goldsmith HH, 1996, CHILD DEV, V67, P218, DOI 10.1111/j.1467-8624.1996.tb01730.x; Gomot M, 2007, INT J PSYCHOPHYSIOL, V64, P123, DOI 10.1016/j.ijpsycho.2007.01.003; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Janssens A, 2009, ACTA PAEDIATR, V98, P1988, DOI 10.1111/j.1651-2227.2009.01488.x; Jiang ZD, 2013, EUR J PEDIATR, V172, P1033, DOI 10.1007/s00431-013-1989-4; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Kaindl AN, 2009, J CHILD NEUROL, V24, P1112, DOI 10.1177/0883073809337920; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Koziol LF, 2011, CEREBELLUM, V10, P770, DOI 10.1007/s12311-011-0288-8; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lickliter R, 2011, CLIN PERINATOL, V38, P591, DOI 10.1016/j.clp.2011.08.007; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Mangeot SD, 2001, DEV MED CHILD NEUROL, V43, P399, DOI 10.1017/S0012162201000743; Maroney Dianne I, 2003, J Perinatol, V23, P679, DOI 10.1038/sj.jp.7211010; May-Benson TA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.031.2009; McIntosh D. N., 1999, OVERVIEW SHORT SENSO; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Mento G, 2012, NEUROSCIENCE BIOBEHA; Mento G, 2010, EUR J NEUROSCI; Milgrom J, 2010, PEDIAT RES; Miller LJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.022.2009; Miller LJ, 2007, AM J OCCUP THER, V61, P135, DOI 10.5014/ajot.61.2.135; Miller LJ, 2012, RES DEV DISABIL, V33, P804, DOI 10.1016/j.ridd.2011.12.005; Mitchell A, 2015, AM J OCCUP THER, V1-11; Mitha A, 2013, PEDIATRICS, V132, pE372, DOI 10.1542/peds.2012-3979; National Center for Infants Toddlers and Families, 1994, ZER TOT 3 DIAGN CLAS; Nevalainen P, 2008, INT J PSYCHOPHYSIOL, V68, P85, DOI 10.1016/j.ijpsycho.2007.10.014; Ortibus EL, 2011, PEDIATR NEUROL, V45, P1, DOI 10.1016/j.pediatrneurol.2011.02.008; Owen JP, 2013, NEUROIMAGE-CLIN, V2, P844, DOI 10.1016/j.nicl.2013.06.009; Pekcetin S, 2016, PERCEPT MOTOR SKILL, V123, P411, DOI 10.1177/0031512516662895; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Provost B, 1994, SENSORY RATING SCALE, V13, P15; Rahkonen P, 2015, ACTA PAEDIATR, V104, P522, DOI 10.1111/apa.12911; Roofthooft DWE, 2014, NEONATOLOGY, V105, P218, DOI 10.1159/000357207; Schendel D, 2008, PEDIATRICS, V121, P1155, DOI 10.1542/peds.2007-1049; Scher MS, 2009, CLIN NEUROPHYSIOL; Scherder EJA, 2008, EUR J PAEDIATR NEURO, V12, P461, DOI 10.1016/j.ejpn.2007.11.004; Shea B., 2011, NEW CASTLE OTTAWA SC; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Smith GC, 2011, ANN NEUROL, V70, P541, DOI 10.1002/ana.22545; Symington A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001814.pub2; Treyvaud K, 2013, J CHILD PSYCHOL PSYC, V54, P772, DOI 10.1111/jcpp.12040; Van Hulle C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129968; van Noort-van der Spek IL, 2012, PEDIATRICS, V129, P745, DOI 10.1542/peds.2011-1728; Verkerk G, 2011, J PEDIATR-US, V159, P933, DOI 10.1016/j.jpeds.2011.05.035; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Walker SM, 2009, PAIN, V141, P79, DOI 10.1016/j.pain.2008.10.012; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Wickremasinghe AC, 2013, J PERINATOL, V33, P631, DOI 10.1038/jp.2013.12; Wiener Andrea Santman, 1996, Physical and Occupational Therapy in Pediatrics, V16, P1, DOI 10.1300/J006v16n04_01; World Health Organization, 1992, INT CLASS DIS REL HL	99	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170828	10.1371/journal.pone.0170828	http://dx.doi.org/10.1371/journal.pone.0170828			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK9GJ	28182680	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800020
J	Callebaut, C; Liu, Y; Babusis, D; Ray, A; Miller, M; Kitrinos, K				Callebaut, Christian; Liu, Yang; Babusis, Darius; Ray, Adrian; Miller, Michael; Kitrinos, Kathryn			Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; ACTIVATION; DISEASE; EMTRICITABINE; INHIBITORS; TURNOVER; PRODRUGS; ADULTS	Tenofovir alafenamide (TAF) is a phosphonoamidate prodrug of the nucleotide HIV reverse transcriptase inhibitor tenofovir (TFV). TAF is approved for the treatment of HIV-1 infection as part of the single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and TAF. When dosed once-daily, TAF results in approximately 90% lower levels of plasma TFV and a 4-fold increase in intracellular TFV-diphosphate (TFV-DP) in PBMCs compared with the TFV prodrug tenofovir disoproxil fumarate (TDF). Several antiretrovirals, including TDF, have been associated with bone mineral density decreases in patients; the effect of clinically relevant TAF concentrations on primary osteoblast viability was therefore assessed in vitro. Studies in PBMCs determined that a 2-hour TAF exposure at concentrations similar to human plasma C-max achieved intracellular TFV-DP levels comparable to those observed after the maximum recommended human dose of 25 mg TAF. Comparable intracellular TFV-DP levels were achieved in primary osteoblasts with 2-hour TAF exposure daily for 3 days at concentrations similar to those used for PBMCs (100-400 nM). No change in cell viability was observed in either primary osteoblasts or PBMCs. The mean TAF CC50 in primary osteoblasts after 3 days of daily 2-hour pulses was >500 mu M, which is >1033 times higher than the TAF maximum recommended human dose plasma Cmax. In summary, primary osteoblasts were not preferentially loaded by TAF compared with PBMCs, with comparable TFV-DP levels achieved in both cell types. Furthermore, there was no impact on osteoblast cell viability at clinically relevant TAF concentrations.	[Callebaut, Christian; Liu, Yang; Miller, Michael; Kitrinos, Kathryn] Gilead Sci, Dept Clin Virol, Foster City, CA 94404 USA; [Babusis, Darius; Ray, Adrian] Gilead Sci, Dept Drug Metab, Foster City, CA USA	Gilead Sciences; Gilead Sciences	Callebaut, C (corresponding author), Gilead Sci, Dept Clin Virol, Foster City, CA 94404 USA.	christian.callebaut@gilead.com		Ray, Adrian/0000-0002-3508-3008				Abbott, KALETRA LOPINAVIR RI; Agouron Pharmaceuticals Inc, 2013, VIRACEPT NELF TABL O; Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Arimilli MN, 1997, ANTIVIR CHEM CHEMOTH, V8, P557, DOI 10.1177/095632029700800610; Bedimo R, 2012, AIDS; Birkus G, 2008, MOL PHARMACOL, V74, P92, DOI 10.1124/mol.108.045526; Callebaut C, 2015, ANTIMICROB AGENTS CH; Callebaut C, 2011, ANTIMICROB AGENTS CH, V55, P1366, DOI 10.1128/AAC.01183-10; Durand-Gasselin L, 2009, MOL PHARMACEUT, V6, P1145, DOI 10.1021/mp900036s; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Foisy MM, 2013, AM J HEALTH-SYST PH, V70, P1272, DOI 10.2146/ajhp120030; Gilead Sciences Inc, VIREAD TEN DIS FUM T; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V394, P48, DOI 10.1016/j.bbrc.2010.02.080; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Lee WA, 2005, ANTIMICROB AGENTS CH, V49, P1898, DOI 10.1128/AAC.49.5.1898-1906.2005; Lee WA, 2006, ANTIVIR RES, V71, P254, DOI 10.1016/j.antiviral.2006.05.020; Lenzi L, 2013, INT J CLIN PHARM TH, V51, P141, DOI 10.5414/CP201818; Malizia AP, 2007, ANTIVIR RES, V74, P72, DOI 10.1016/j.antiviral.2006.12.003; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Mooser V, 2003, AIDS, V17, pS65, DOI 10.1097/00002030-200304001-00009; Naesens L, 1998, ANTIMICROB AGENTS CH, V42, P1568, DOI 10.1128/AAC.42.7.1568; Pozniak A, 2015, J ACQUIR IMMUNE DEFI; Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009; ROBBINS BL, 1995, ANTIMICROB AGENTS CH, V39, P2304, DOI 10.1128/AAC.39.10.2304; Rowe PS, 2015, CURR OPIN PHARMACOL, V22, P64, DOI 10.1016/j.coph.2015.03.006; Ruane P, 2012, 19 C RETR OPP INF CR; Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45; Sax P, 2013, 53 ICAAC; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Schafer JJ, 2013, PHARMACOTHERAPY, V33, P665, DOI 10.1002/phar.1257; Seminari E, 2005, HIV MED, V6, P145, DOI 10.1111/j.1468-1293.2005.00278.x; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Tozser J, 2001, ANN NY ACAD SCI, V946, P145, DOI 10.1111/j.1749-6632.2001.tb03909.x; Vigouroux C, 1999, DIABETES METAB, V25, P383; Yin MT, 2012, AIDS, V26, P2175, DOI 10.1097/QAD.0b013e328359a8ca; Zolopa A, 2013, 20 C RETR OPP INF 20	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0169948	10.1371/journal.pone.0169948	http://dx.doi.org/10.1371/journal.pone.0169948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182625	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800006
J	Kinar, Y; Akiva, P; Choman, E; Kariv, R; Shalev, V; Levin, B; Narod, SA; Goshen, R				Kinar, Yaron; Akiva, Pinchas; Choman, Eran; Kariv, Revital; Shalev, Varda; Levin, Bernard; Narod, Steven A.; Goshen, Ran			Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer	PLOS ONE			English	Article								Individuals with colorectal cancer (CRC) have a tendency to intestinal bleeding which may result in mild to severe iron deficiency anemia, but for many colon cancer patients hematological abnormalities are subtle. The fecal occult blood test (FOBT) is used as a pre-screening test whereby those with a positive FOBT are referred to colonscopy. We sought to determine if information contained in the complete blood count (CBC) report coud be processed automatically and used to predict the presence of occult colorectal cancer (CRC) in the setting of a large health services plan. Using the health records of the Maccabi Health Services (MHS) we reviewed CBC reports for 112,584 study subjects of whom 133 were diagnosed with CRC in 2008 and analysed these with the MeScore tool. The odds ratio for being diagnosed with CRC in 2008 was calculated with regards to the MeScore, using cutoff levels of 97% and 99% percentiles. For individuals in the highest one percentile, the odds ratio for CRC was 21.8 (95% CI 13.8 to 34.2). For the majority of the individuals with cancer, CRC was not suspected at the time of the blood draw. Frequent use of anticoagulants, the presence of other gastrointestinal pathologies and non-GI malignancies were assocaitged with false positive MeScores. The MeScore can help identify individuals in the population who would benefit most from CRC screening, including those with no clinical signs or symptoms of CRC.	[Kinar, Yaron; Akiva, Pinchas] Medial Res, Kfar Malal, Israel; [Choman, Eran; Levin, Bernard; Goshen, Ran] Medial EarlySign, Kfar Malal, Israel; [Kariv, Revital] Souraski Med Ctr, Dept Gastroenterol, Tel Aviv, Israel; [Kariv, Revital] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Shalev, Varda] Maccabi Healthcare Serv, Inst Hlth Res & Innovat, Tel Aviv, Israel; [Narod, Steven A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Narod, Steven A.] Womens Coll, Res Inst, Toronto, ON, Canada	Tel Aviv University; University of Toronto; University of Toronto; Women's College Research Institute	Goshen, R (corresponding author), Medial EarlySign, Kfar Malal, Israel.	ran@earlysign.com	Narod, Steven A/AAA-6112-2022		Medial Research	Medial Research	The study was funded by Medial Research. Thefunder (Medial) provided support in the form of salaries for authors RG, YK, BL, PA and EC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Guillem-Llobat P, 2014, SEMIN ONCOL, V41, P385, DOI 10.1053/j.seminoncol.2014.04.008; Kershenbaum A, 2013, EUR J CANCER, V49, P923, DOI 10.1016/j.ejca.2012.09.020; Kinar Y, 2016, J AM MED INFORM ASSN, V23, P879, DOI 10.1093/jamia/ocv195; ROCKEY DC, 1993, NEW ENGL J MED, V329, P1691, DOI 10.1056/NEJM199312023292303; Rossi PG, 2015, AM J GASTROENTEROL, V110, P1359, DOI 10.1038/ajg.2015.240; Seretis C, 2015, PLATELETS, V26, P114, DOI 10.3109/09537104.2014.894969	9	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171759	10.1371/journal.pone.0171759	http://dx.doi.org/10.1371/journal.pone.0171759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182647	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800103
J	Kim, SS; Shin, N; Bae, SS; Lee, MY; Rhee, H; Kim, IY; Seong, EY; Lee, DW; Lee, SB; Kwak, IS; Lovett, DH; Song, SH				Kim, Sang Soo; Shin, Nari; Bae, Sun Sik; Lee, Min Young; Rhee, Harin; Kim, Il Young; Seong, Eun Young; Lee, Dong Won; Lee, Soo Bong; Kwak, Ihm Soo; Lovett, David H.; Song, Sang Heon			Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; OXIDATIVE STRESS; INHIBITION	Background We recently reported on the enhanced expression of two isoforms of matrix metalloproteinase-2 (MMP-2) in human renal transplantation delayed graft function. These consist of the conventional secreted, full length MMP-2 isoform (FL-MMP-2) and a novel intracellular N Terminal Truncated isoform (NTT-MMP-2) generated by oxidative stress-mediated activation of an alternate promoter in the MMP-2 first intron. Here we evaluated the effect of hyperglycemia and diabetes mellitus on the in vitro and in vivo expression of the two MMP-2 isoforms. Methods We quantified the abundance of the FL-MMP-2 and NTT-MMP-2 transcripts by qPCR in HK2 cells cultured in high glucose or 4-hydroxy-2-hexenal (HHE) and tested the effects of the NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC). The streptozotocin (STZ) murine model of Type I diabetes mellitus and renal biopsies of human diabetic nephropathy were used in this study. Results Both isoforms of MMP-2 in HK2 cells were upregulated by culture in high glucose or with HHE. PDTC treatment did not suppress high glucose -mediated FL-MMP-2 expression but potently inhibited NTT-MMP-2 expression. With STZ-treated mice, renal cortical expression of both isoforms was increased (FL-MMP-2, 1.8-fold; NTT-MMP-2, greater than 7-fold). Isoform-specific immunohistochemical staining revealed low, but detectable levels of the FL-MMP-2 isoform in controls, while NTT-MMP-2 was not detected. While there was a modest increase in tubular epithelial cell staining for FL-MMP-2 in STZ-treated mice, NTT-MMP-2 was intensely expressed in a basolateral pattern. FL-MMP-2 and NTT-MMP-2 isoform expression as quantified by qPCR were both significantly elevated in renal biopsies of human diabetic nephropathy (12 -fold and 3 -fold, respectively). Conclusions The expression of both isoforms of MMP-2 was enhanced in an experimental model of diabetic nephropathy and in human diabetic nephropathy. Selective MMP-2 isoform inhibition could offer a novel approach for the treatment of diabetic renal disease.	[Kim, Sang Soo; Lee, Min Young; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Sang Soo; Lee, Min Young; Rhee, Harin; Seong, Eun Young; Kwak, Ihm Soo; Song, Sang Heon] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea; [Shin, Nari] Pusan Natl Univ, Dept Pathol, Yangsan Hosp, Yangsan, Gyeongnam, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, MRC Ischem Tissue Regenerat, Med Res Inst, Yangsan, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, Dept Phamacol, Yangsan, South Korea; [Kim, Il Young; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, Gyeongnam, South Korea; [Kim, Il Young; Lee, Dong Won; Lee, Soo Bong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, Gyeongnam, South Korea; [Lovett, David H.] Univ Calif San Francisco, San Francisco Dept Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94143 USA	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; University of California System; University of California San Francisco	Song, SH (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.; Song, SH (corresponding author), Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.	shsong0209@gmail.com	Kim, Il Young/ABG-2156-2021; Kim, Il Young/ABG-2153-2021	Kim, Il Young/0000-0002-1731-6357; Kim, Sang Soo/0000-0002-9687-8357	Biomedical Research Institute Grant [2015-3]; Pusan National University Hospital; Department of Veterans Affairs Merit Review [I-1BX000593]; National Institutes of Diabetes, Digestive and Kidney Disease [R01DK39776]	Biomedical Research Institute Grant; Pusan National University Hospital(Pusan National University); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); National Institutes of Diabetes, Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Biomedical Research Institute Grant (2015-3), Pusan National University Hospital (www.pnuh.co.kr). The bio-specimens and data used for this study were provided by the Biobank of Pusan National University Hospital, a member of the Korean Biobank Network. DHL was supported by Department of Veterans Affairs Merit Review Award I-1BX000593 and National Institutes of Diabetes, Digestive and Kidney Disease grant R01DK39776. DHL's contributions are the result of work supported with the resources and the use of facilities at the San Francisco VA Medical Center.	Alfonso-Jaume MA, 2006, AM J PHYSIOL-HEART C, V291, pH1838, DOI 10.1152/ajpheart.00026.2006; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chang CM, 2012, ACTA DIABETOL, V49, pS171, DOI 10.1007/s00592-012-0398-x; Cheng SF, 2003, AM J PATHOL, V162, P1937, DOI 10.1016/S0002-9440(10)64327-1; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Lovett DH, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00363; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Novak KB, 2010, PEDIATR RES, V67, P257, DOI 10.1203/PDR.0b013e3181ca0aa2; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Wanga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136276; Xu X, 2014, CURR MED CHEM, V21, P3244, DOI 10.2174/0929867321666140716092052	19	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171625	10.1371/journal.pone.0171625	http://dx.doi.org/10.1371/journal.pone.0171625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178341	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500054
J	Luz, LL; Currie, SP; Daw, MI				Luz, Liliana L.; Currie, Stephen P.; Daw, Michael I.			Alterations in the properties of neonatal thalamocortical synapses with time in in vitro slices	PLOS ONE			English	Article							NASCENT DENDRITIC SPINES; BARREL CORTEX; DEPENDENT PLASTICITY; NEUROTROPHIC FACTOR; KAINATE RECEPTOR; VIVO; INHIBITION; MATURATION; NEOCORTEX; STABILIZATION	New synapses are constantly being generated and lost in the living brain with only a subset of these being stabilized to form an enduring component of neuronal circuitry. The properties of synaptic transmission have primarily been established in a variety of in vitro neuronal preparations. It is not clear, however, if newly-formed and persistent synapses contribute to the results of these studies consistently throughout the lifespan of these preparations. In neonatal somatosensory, barrel, cortex we have previously hypothesized that a population of thalamocortical synapses displaying unusually slow kinetics represent newly-formed, default-transient synapses. This clear phenotype would provide an ideal tool to investigate if such newly formed synapses consistently contribute to synaptic transmission throughout a normal experimental protocol. We show that the proportion of synapses recorded in vitro displaying slow kinetics decreases with time after brain slice preparation. However, slow synapses persist in vitro in the presence of either minocycline, an inhibitor of microglia-mediated synapse elimination, or the TrkB agonist 7,8-dihydroxyflavone a promoter of synapse formation. These findings show that the observed properties of synaptic transmission may systematically change with time in vitro in a standard brain slice preparation.	[Luz, Liliana L.; Currie, Stephen P.; Daw, Michael I.] Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh, Midlothian, Scotland; [Luz, Liliana L.] Univ Porto, Inst Mol & Cell Biol IBMC, Inst Res & Innovat Hlth I3S, Oporto, Portugal	University of Edinburgh; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Daw, MI (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, George Sq, Edinburgh, Midlothian, Scotland.	michael.daw@ed.ac.uk	Luz, Liliana L/A-4208-2019	Luz, Liliana L/0000-0001-8109-3891; Daw, Michael/0000-0002-8374-5977; Currie, Stephen/0000-0002-6994-1568	UK Medical Research Council [G0900461/1]; MRC [G0900461] Funding Source: UKRI; Medical Research Council [G0900461] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in full by the UK Medical Research Council (grant no G0900461/1 (http://www.mrc.ac.uk/?nav=main)). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ashby MC, 2011, NEURON, V70, P510, DOI 10.1016/j.neuron.2011.02.057; Bannister NJ, 2005, J NEUROSCI, V25, P5259, DOI 10.1523/JNEUROSCI.0827-05.2005; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bruno RM, 2002, J NEUROSCI, V22, P10966; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Crocker-Buque A, 2015, CEREB CORTEX, V25, P2255, DOI 10.1093/cercor/bhu031; Daw MI, 2006, J NEUROSCI, V26, P4178, DOI 10.1523/JNEUROSCI.0150-06.2006; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Dziembowska M, 2013, AM J MED GENET A, V161, P1897, DOI 10.1002/ajmg.a.36023; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Hill TC, 2013, J NEUROSCI, V33, P678, DOI 10.1523/JNEUROSCI.1404-12.2013; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kirov SA, 1999, J NEUROSCI, V19, P2876; Koyama R, 2015, NEUROSCI RES, V100, P1, DOI 10.1016/j.neures.2015.06.005; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maximo JO, 2014, NEUROPSYCHOL REV, V24, P16, DOI 10.1007/s11065-014-9250-0; Nicolescu AC, 2009, BIOCHEM BIOPH RES CO, V387, P646, DOI 10.1016/j.bbrc.2009.07.080; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Sajikumar S, 2005, CURR OPIN NEUROBIOL, V15, P607, DOI 10.1016/j.conb.2005.08.009; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SCHURR A, 1984, BRAIN RES, V297, P357, DOI 10.1016/0006-8993(84)90576-6; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171897	10.1371/journal.pone.0171897	http://dx.doi.org/10.1371/journal.pone.0171897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178342	Green Submitted, gold, Green Published			2022-12-27	WOS:000393712500077
J	Schrapers, P; Ilina, J; Gregg, CM; Mebs, S; Jeoung, JH; Dau, H; Dobbek, H; Haumann, M				Schrapers, Peer; Ilina, Julia; Gregg, Christina M.; Mebs, Stefan; Jeoung, Jae-Hun; Dau, Holger; Dobbek, Holger; Haumann, Michael			Ligand binding at the A-cluster in full-length or truncated acetyl-CoA synthase studied by X-ray absorption spectroscopy	PLOS ONE			English	Article							CARBON-MONOXIDE DEHYDROGENASES; COENZYME-A; METHANOSARCINA-THERMOPHILA; DECARBONYLASE/SYNTHASE COMPLEX; CRYSTAL-STRUCTURE; SITE STRUCTURE; METAL CENTERS; SUBUNIT-BETA; IRON-SULFUR; MECHANISM	Bacteria integrate CO2 reduction and acetyl coenzyme-A (CoA) synthesis in the WoodLjungdal pathway. The acetyl-CoA synthase (ACS) active site is a [4Fe4S]-[NiNi] complex (A-cluster). The dinickel site structure (with proximal, p, and distal, d, ions) was studied by X-ray absorption spectroscopy in ACS variants comprising all three protein domains or only the C-terminal domain with the A-cluster. Both variants showed two square-planar Ni(II) sites and an OH- bound at Ni(II)(p) in oxidized enzyme and a H2O at Ni(l)(p) in reduced enzyme; a Ni (l)p-CO species was induced by CO incubation and a Ni(II)-CH3- species with an additional water ligand by a methyl group donor. These findings render a direct effect of the N-terminal and middle domains on the A-cluster structure unlikely.	[Schrapers, Peer; Mebs, Stefan; Dau, Holger; Haumann, Michael] Free Univ Berlin, Dept Phys, Berlin, Germany; [Ilina, Julia; Gregg, Christina M.; Jeoung, Jae-Hun; Dobbek, Holger] Humboldt Univ, Inst Biol Struct Biol Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, Dept Phys, Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013	Gregg, Christina/0000-0003-4440-4624	Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis"; Bundesministerium fur Bildung and Forschung, PT-DESY [05K14KE1]	Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis"; Bundesministerium fur Bildung and Forschung, PT-DESY	This work was supported by Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis", hftps:// www.unicat.tu-berlin.de; and Bundesministerium fur Bildung and Forschung, PT-DESY, 05K14KE1, https//pt.desy.de.	Amara P, 2005, J AM CHEM SOC, V127, P2776, DOI 10.1021/ja0439221; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Bachmeier A, 2015, CURR OPIN CHEM BIOL, V25, P141, DOI 10.1016/j.cbpa.2015.01.001; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Bender G, 2010, BIOCHEMISTRY-US, V49, P7516, DOI 10.1021/bi1010128; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; Evans DJ, 2005, COORDIN CHEM REV, V249, P1582, DOI 10.1016/j.ccr.2004.09.012; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Funk T, 2004, J AM CHEM SOC, V126, P88, DOI 10.1021/ja0366033; Gencic S, 2010, J BIOL CHEM, V285, P15450, DOI 10.1074/jbc.M109.080994; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; Goetzl S, 2014, THESIS; Greco C, 2015, CHEM COMMUN, V51, P8551, DOI 10.1039/c5cc01575h; Gu WW, 2015, J SYNCHROTRON RADIAT, V22, P124, DOI 10.1107/S1600577514025041; Gu WW, 2003, J AM CHEM SOC, V125, P15343, DOI 10.1021/ja036602a; Gu WW, 2003, J INORG BIOCHEM, V93, P41, DOI 10.1016/S0162-0134(02)00494-4; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hegg EL, 2004, ACCOUNTS CHEM RES, V37, P775, DOI 10.1021/ar040002e; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, METAL IONS LIFE SCI, V14, P37, DOI 10.1007/978-94-017-9269-1_3; Jeoung JH, 2014, BIOL CHEM, V395, P545, DOI 10.1515/hsz-2013-0290; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Koningsberger D.C., 1988, XRAY ABSORPTION PRIN; Kung Y, 2011, CURR OPIN CHEM BIOL, V15, P276, DOI 10.1016/j.cbpa.2010.11.005; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Lindahl PA, 2004, J BIOL INORG CHEM, V9, P516, DOI 10.1007/s00775-004-0564-x; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; Ottenwaelder X, 2005, DALTON T, P2516, DOI 10.1039/b502478a; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Ragsdale SW, 2012, BIOCHEM SOC T, V40, P501, DOI 10.1042/BST20120083; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rehr JJ, 2010, PHYS CHEM CHEM PHYS, V12, P5503, DOI 10.1039/b926434e; Russell WK, 1998, J AM CHEM SOC, V120, P7502, DOI 10.1021/ja981165z; Schrapers P, 2016, J PHYS CONF SER, V712, DOI 10.1088/1742-6596/712/1/012029; Schrapers P, 2016, PLOSONE; Schuth N, 2016, J PHYS CONF SER, V712, DOI 10.1088/1742-6596/712/1/012134; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; Sigfridsson KGV, 2015, BBA-BIOENERGETICS, V1847, P162, DOI 10.1016/j.bbabio.2014.06.011; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Tan X, 2008, J AM CHEM SOC, V130, P6712, DOI 10.1021/ja801981h; Tan XS, 2004, J AM CHEM SOC, V126, P5954, DOI 10.1021/ja039600z; Volbeda A, 2009, BIOCHEMISTRY-US, V48, P7916, DOI 10.1021/bi9003952; Wang VCC, 2014, METAL IONS LIFE SCI, V14, P71, DOI 10.1007/978-94-017-9269-1_4	49	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171039	10.1371/journal.pone.0171039	http://dx.doi.org/10.1371/journal.pone.0171039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178309	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500020
J	Sabe, VT; Basson, AR; Jordaan, E; Mazinu, M				Sabe, Victor Tinashe; Basson, Abigail Raffner; Jordaan, Esme; Mazinu, Mikateko			The association between environmental exposures during childhood and the subsequent development of Crohn's disease: A score analysis approach	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; HYGIENE HYPOTHESIS; ULCERATIVE-COLITIS; PATHOGENESIS; POPULATION; MICROBIOME; PREVALENCE; MECHANISMS; MUTATIONS	Background Environmental factors during childhood are thought to play a role in the aetiology of Crohn's Disease (CD). In South Africa, recently published work based on an investigation of 14 childhood environmental exposures during 3 age intervals (0-5, 6-10 and 11-18 years) has provided insight into the role of timing of exposure in the future development of CD. The `overlapping' contribution of the investigated variables however, remains unclear. The aim of this study was to perform a post hoc analysis using this data and investigate the extent to which each variable contributes to the subsequent development of CD relative to each aforementioned age interval, based on a score analysis approach. Methods Three methods were used for the score analysis. Two methods employed the subgrouping of one or more (similar) variables (methods A and B), with each subgroup assigned a score value weighting equal to one. For comparison, the third approach (method 0) involved no grouping of the 14 variables. Thus, each variable held a score value of one. Results Results of the score analysis (Method 0) for the environmental exposures during 3 age intervals (0-5, 6-10 and 11-18 years) revealed no significant difference between the case and control groups. By contrast, results from Method A and Method B revealed a significant difference during all 3 age intervals between the case and control groups, with cases having significantly lower exposure scores (approximately 30% and 40% lower, respectively). Conclusion Results from the score analysis provide insight into the `compound' effects from multiple environmental exposures in the aetiology of CD.	[Sabe, Victor Tinashe; Basson, Abigail Raffner] Univ Western Cape, Med BioSci Dept, Bellville, Western Cape, South Africa; [Basson, Abigail Raffner] Case Western Reserve Univ, Sch Med, Div Gastroenterol & Liver Dis, Cominelli Lab, Cleveland, OH USA; [Jordaan, Esme; Mazinu, Mikateko] Med Res Council South Africa, Biostat Unit, Parow, Western Cape, South Africa; [Mazinu, Mikateko] Univ Western Cape, Populat Studies Dept, Bellville, Western Cape, South Africa	University of the Western Cape; Case Western Reserve University; University of the Western Cape	Sabe, VT (corresponding author), Univ Western Cape, Med BioSci Dept, Bellville, Western Cape, South Africa.	vt.sabe@gmail.com		Basson, Abigail/0000-0002-8369-919X	Scholarship in Gastroenterology; AstraZeneca/South African Gastroenterology Society (SAGES); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948, T32DK083251] Funding Source: NIH RePORTER	Scholarship in Gastroenterology; AstraZeneca/South African Gastroenterology Society (SAGES); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the 2011 Scholarship in Gastroenterology; a grant from the AstraZeneca/South African Gastroenterology Society (SAGES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2014, AM J GASTROENTEROL, V109, P395, DOI 10.1038/ajg.2013.464; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115492; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104859; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Biswas A, 2012, J MOL MED, V90, P15, DOI 10.1007/s00109-011-0802-y; Castiglione F, 2012, J CROHNS COLITIS, V6, P324, DOI 10.1016/j.crohns.2011.09.003; Chamberlin WM, 2006, MED SCI MONITOR, V12, pRA27; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Danese S, 2004, AUTOIMMUN REV, V3, P394, DOI 10.1016/j.autrev.2004.03.002; De Hertogh G, 2008, WORLD J GASTROENTERO, V14, P845, DOI 10.3748/wjg.14.845; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; Foster A, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00034; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Guo AY, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0216-8; Hampe J, 2003, INT J COLORECTAL DIS, V18, P413, DOI 10.1007/s00384-003-0484-1; Han DY, 2010, MUTAT RES-FUND MOL M, V690, P116, DOI 10.1016/j.mrfmmm.2009.09.002; Hansen TS, 2011, J CROHNS COLITIS, V5, P577, DOI 10.1016/j.crohns.2011.05.010; Hildebrand H, 2008, SCAND J GASTROENTERO, V43, P961, DOI 10.1080/00365520801971736; Hlavaty T, 2013, UNITED EUR GASTROENT, V1, P109, DOI 10.1177/2050640613478011; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Karatzas PS, 2014, ANN GASTROENTEROL, V27, P125; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Loftus Edward V Jr, 2004, Curr Gastroenterol Rep, V6, P506, DOI 10.1007/s11894-004-0073-7; Lopez-Serrano P, 2010, SCAND J GASTROENTERO, V45, P1464, DOI 10.3109/00365521.2010.510575; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Rogler G, 2015, INFLAMM BOWEL DIS, V21, P400, DOI 10.1097/MIB.0000000000000229; Rosenfeld G, 2010, CAN J GASTROENTEROL, V24, P619, DOI 10.1155/2010/698362; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Strisciuglio C, 2016, J PAEDIATR GASTROENT; Strisciuglio C, 2014, DIGEST LIVER DIS, V46, P512, DOI 10.1016/j.dld.2014.02.016; Strober W, 2008, MUCOSAL IMMUNOL, V1, pS5, DOI 10.1038/mi.2008.42	40	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171742	10.1371/journal.pone.0171742	http://dx.doi.org/10.1371/journal.pone.0171742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170439	gold, Green Published, Green Submitted			2022-12-27	WOS:000393705500053
J	Fan, Q; Xie, ZX; Xie, ZQ; Deng, XW; Xie, LJ; Huang, L; Luo, SS; Huang, JL; Zhang, YF; Zeng, TT; Wang, S; Liu, JB; Pang, YS				Fan, Qing; Xie, Zhixun; Xie, Zhiqin; Deng, Xianwen; Xie, Liji; Huang, Li; Luo, Sisi; Huang, Jiaoling; Zhang, Yanfang; Zeng, Tingting; Wang, Sheng; Liu, Jiabo; Pang, Yaoshan			Development of a GeXP-multiplex PCR assay for the simultaneous detection and differentiation of six cattle viruses	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; MOUTH-DISEASE; VESICULAR-STOMATITIS; ANALYZER; FOOT; SWINE; DIAGNOSIS; ANTIBODIES; DESIGN; HERDS	Foot-and-mouth disease virus ( FMDV), Bluetongue virus (BTV), Vesicular stomatitis Virus (VSV), Bovine viral diarrheal (BVDV), Bovine rotavirus (BRV), and Bovine herpesvirus 1 (IBRV) are common cattle infectious viruses that cause a great economic loss every year in many parts of the world. A rapid and high-throughput GenomeLab Gene Expression Profiler (GeXP) analyzer-based multiplex PCR assay was developed for the simultaneous detection and differentiation of these six cattle viruses. Six pairs of chimeric primers consisting of both the gene-specific primer and a universal primer were designed and used for amplification. Then capillary electrophoresis was used to separate the fluorescent labeled PCR products according to the amplicons size. The specificity of GeXP-multiplex PCR assay was examined with samples of the single template and mixed template of six viruses. The sensitivity was evaluated using the GeXP-multiplex PCR assay on serial 10-fold dilutions of ssRNAs obtained via in vitro transcription. To further evaluate the reliability, 305 clinical samples were tested by the GeXP-multiplex PCR assay. The results showed that the corresponding virus specific fragments of genes were amplified. The detection limit of the GeXP-multiplex PCR assay was 100 copies/mu L in a mixed sample of ssRNAs containing target genes of six different cattle viruses, whereas the detection limit for the Gexp-mono PCR assay for a single target gene was 10 copies/mu L. In detection of viruses in 305 clinical samples, the results of GeXP were consistent with simplex real-time PCR. Analysis of positive samples by sequencing demonstrated that the GeXP-multiplex PCR assay had no false positive samples of nonspecific amplification. In conclusion, this GeXP-multiplex PCR assay is a high throughput, specific, sensitive, rapid and simple method for the detection and differentiation of six cattle viruses. It is an effective tool that can be applied for the rapid differential diagnosis of clinical samples and for epidemiological investigation.	[Fan, Qing; Xie, Zhixun; Xie, Zhiqin; Deng, Xianwen; Xie, Liji; Huang, Li; Luo, Sisi; Huang, Jiaoling; Zhang, Yanfang; Zeng, Tingting; Wang, Sheng; Liu, Jiabo; Pang, Yaoshan] Guangxi Vet Res Inst, Guangxi Key Lab Vet Biotechnol, Nanning, Guangxi Provinc, Peoples R China	Guangxi Veterinary Research Institute	Xie, ZX (corresponding author), Guangxi Vet Res Inst, Guangxi Key Lab Vet Biotechnol, Nanning, Guangxi Provinc, Peoples R China.	xiezhixun@126.com			Guangxi Key Technologies Research and Development Program [0992033-5]; Guangxi Government Senior Scientist Foundation (Guangxi, China) [20116020]	Guangxi Key Technologies Research and Development Program; Guangxi Government Senior Scientist Foundation (Guangxi, China)	This work was supported by the Guangxi Key Technologies Research and Development Program (0992033-5) and by the Guangxi Government Senior Scientist Foundation (20116020) (Guangxi, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brito BP, 2015, TRANSBOUND EMERG DIS; Cernicchiaro N, 2013, AM J VET RES, V74, P300, DOI 10.2460/ajvr.74.2.300; Drew JE, 2011, J MOL DIAGN, V13, P233, DOI 10.1016/j.jmoldx.2010.10.001; Fernandez J, 2008, J VIROL METHODS, V147, P301, DOI 10.1016/j.jviromet.2007.09.010; Hashish EA, 2013, CLIN VACCINE IMMUNOL, V20, P1076, DOI 10.1128/CVI.00249-13; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hofmann M, 2008, SCHWEIZ ARCH TIERH, V150, P49, DOI 10.1024/0036-7281.150.2.49; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; Karreman Hubert J., 2009, Animal Health Research Reviews, V10, P121, DOI 10.1017/S1466252309990156; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; Li M, 2016, INFLUENZA OTHER RESP, V10, P141, DOI 10.1111/irv.12370; Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005; Otte PH, 2015, VET MICROBIOL, V179, P168, DOI 10.1016/j.vetmic.2015.07.021; Park JY, 2011, J CLIN MICROBIOL, V49, P1389, DOI [10.1128/JCM.00710-10, DOI 10.1128/JCM.00710-10]; Qin M, 2010, J VIROL METHODS, V168, P255, DOI 10.1016/j.jviromet.2010.04.031; Rai AJ, 2009, ANAL BIOANAL CHEM, V393, P1505, DOI 10.1007/s00216-008-2436-7; Santman-Berends IMGA, 2015, J DAIRY SCI, V98, P7699, DOI 10.3168/jds.2014-9255; Shaw AE, 2007, J VIROL METHODS, V143, P81, DOI 10.1016/j.jviromet.2007.02.009; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Smith PF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-183; Tomas JD, 2009, REBHUNS DIS DAIRY CA; Waldner CL, 2008, AM J VET RES, V69, P916, DOI 10.2460/ajvr.69.7.916; Wang JN, 2008, VET MICROBIOL, V126, P11, DOI 10.1016/j.vetmic.2007.06.005; Wen W, 2016, CHINA ANIMAL HUSBAND, V32, P45; Wernery U, 2012, REV SCI TECH OIE, V31, P907; Wilson WC, 2009, J VET DIAGN INVEST, V21, P179, DOI 10.1177/104063870902100201; Word organization for animal health (OIE), 2016, OIE LIST NOT TERR AQ; Xie Jin-xin, 2010, Chinese Journal of Virology, V26, P407; Xie ZX, 2014, J VIROL METHODS, V207, P188, DOI 10.1016/j.jviromet.2014.07.007; Yang MJ, 2012, J MED VIROL, V84, P957, DOI 10.1002/jmv.23275; Zeng TT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0455-5; Zeng ZY, 2014, J VIROL METHODS, V208, P102, DOI 10.1016/j.jviromet.2014.08.001; Zhang MX, 2015, J VIROL METHODS, V224, P9, DOI 10.1016/j.jviromet.2015.08.001; Zhang YF, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0590-6	34	6	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171287	10.1371/journal.pone.0171287	http://dx.doi.org/10.1371/journal.pone.0171287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166243	Green Published, gold			2022-12-27	WOS:000393700100031
J	Montiel-Luque, A; Nunez-Montenegro, AJ; Martin-Aurioles, E; Canca-Sanchez, JC; Toro-Toro, MC; Gonzalez-Correa, JA				Montiel-Luque, Alonso; Jesuas Nunez-Montenegro, Antonio; Martin-Aurioles, Esther; Carlos Canca-Sanchez, Jose; Carmen Toro-Toro, Maria; Antonio Gonzalez-Correa, Jose		Polipresact Res Grp	Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy	PLOS ONE			English	Article							GENERAL-POPULATION; UNITED-KINGDOM; ADHERENCE; RISK; INTERVENTIONS; MANAGEMENT; MEDICINES; EUROQOL; EQ-5D; HOME	In the current public health framework, the importance of medication as a determinant of citizens' health has emerged as a factor warranting special attention. Most studies investigating the relationship between medication and quality of life do so from the perspective of adherence. However, other medication-related factors identified at home visits may be associated with health-related quality of life. Methods and design Objective: To describe the relationship between medication-related factors and the healthrelated quality of life in patients older than 65 years who use multiple medications (polypharmacy). Design: Cross-sectional descriptive study. Setting: Primary care. Participants: Patients older than 65 years who use multiple medications (n = 375). Measurements: The main outcome measure was health-related quality of life according to the EuroQol-5D instrument. Sociodemographic, clinical and medication-related variables were recorded during home interviews. Results Mean age was 74.72 +/- 5.59 years, and 65.5% of our participants were women. The global level of health-related quality of life according to the EQ-5D visual analog scale was 59.25 +/- 20.92. Of the five EuroQol dimensions, anxiety/depression and pain were the most frequently reported, while mobility and self-care were the dimensions with the greatest impact on selfreported quality of life. Multivariate analysis indicated that functional independence was the factor most strongly associated (beta = 14.27 p < 0.001) with better health-related quality of life, while illiteracy (beta = -13.58 p < 0.001), depression (beta = -10.13 p < 0.001), social risk (beta = -7.23 p = 0.004) and using more than 10 medicines (beta = -4.85 p = 0.009) were strongly associated with a poorer health-related quality of life. Conclusions Factors inherent within the patient such as functional incapacity, cognitive impairment and social and emotional problems were the main constraints to quality of life in our study population. The number of medicines taken was negatively related with quality of life.	[Montiel-Luque, Alonso] Andalusian Hlth Serv, San Miguel Hlth Ctr, Costa Sol Primary Healthcare Dist, Malaga, Spain; [Jesuas Nunez-Montenegro, Antonio] Andalusian Hlth Serv, North Malaga Hlth Area, Malaga, Spain; [Martin-Aurioles, Esther] Andalusian Hlth Serv, La Roca Hlth Ctr, Malaga Guadalhorce Primary Healthcare Dist, Malaga, Spain; [Carlos Canca-Sanchez, Jose] Andalusian Hlth Serv, Costa Sol Hlth Agcy, Marbella, Malaga, Spain; [Carmen Toro-Toro, Maria] Andalusian Hlth Serv, North Malaga Hlth Area, Campillo Hlth Ctr, Malaga, Spain; [Antonio Gonzalez-Correa, Jose] Univ Malaga, Biomed Res Inst Malaga, Dept Pharmacol, Malaga, Spain	Universidad de Malaga	Montiel-Luque, A (corresponding author), Andalusian Hlth Serv, San Miguel Hlth Ctr, Costa Sol Primary Healthcare Dist, Malaga, Spain.	alonsomontiel@uma.es	Montiel-Luque, Alonso/K-7258-2018; Canca-Sanchez, Jose Carlos/AAA-7838-2019; Gonzalez-Correa, Jose Antonio/L-4433-2014	Montiel-Luque, Alonso/0000-0003-4576-8112; Gonzalez-Correa, Jose Antonio/0000-0001-8862-3760; Canca Sanchez, Jose Carlos/0000-0002-1906-3568	Andalusian Health Service [111222 SAS]	Andalusian Health Service	This study was funded by The Andalusian Health Service, file number: 111222 SAS, according to Resolution of April 15, 2011, published in BOJA No. 92 of 12 May 2011. (http://www.juntadeandalucia.es/boja/2011/92/32 to AML, AJNM, EMA, MCTT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, STUD QUAL LIF PAT AF; Azpiazu Garrido M, 2003, Aten Primaria, V31, P285; Azpiazu Garrido Mercedes, 2002, Rev. Esp. Salud Publica, V76, P683; Badia X, 2001, MED DECIS MAKING, V21, P7, DOI 10.1177/0272989X0102100102; Badia X, 1998, QUAL LIFE RES, V7, P311, DOI 10.1023/A:1024933913698; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Badia X, 1999, MEASUREMENT SCALES G; Baernholdt M, 2012, QUAL LIFE RES, V21, P527, DOI 10.1007/s11136-011-9954-z; Casado J, 2001, Aten Primaria, V28, P167; Chang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128356; Chew BH, 2015, QUAL LIFE RES; Chico-Barba G, 2011, REV METAB OSEO MIN, V9, P145; De la Fuente Sanz M Milagros, 2011, Rev Esp Geriatr Gerontol, V46, P111, DOI 10.1016/j.regg.2010.09.007; de Lyra Divaldo Pereira, 2007, Ther Clin Risk Manag, V3, P989; de Rivas B, 2008, QUAL LIFE RES, V17, P1229, DOI 10.1007/s11136-008-9397-3; Fernandez Lison L C, 2006, Farm Hosp, V30, P280; Ferrer A, 2010, MED CLIN-BARCELONA, V134, P303, DOI 10.1016/j.medcli.2009.06.070; Fundacion General CSIC, 2010, REP ON AG; Garrido-Garrido EM, 2011, REV CALID ASSIST, V26, P90, DOI 10.1016/j.cali.2010.10.002; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Gonzalez-Bueno J, 2015, ATEN PRIMARIA; Herdman M, 2001, Aten Primaria, V28, P425; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Holt EW, 2010, AGE AGEING, V39, P481, DOI 10.1093/ageing/afq040; Jia HM, 2009, PUBLIC HEALTH REP, V124, P692, DOI 10.1177/003335490912400511; Zamora-Sanchez JJ, 2012, ENFERM CLIN, V22, P239, DOI 10.1016/j.enfcli.2012.04.009; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Konig HH, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-143; Krska J, 2013, INT J CLIN PHARM-NET, V35, P1161, DOI 10.1007/s11096-013-9841-5; Lizan L, 2009, ATEN PRIM, V41, P411, DOI [10.1016/j.aprim.2008.10.019, DOI 10.1016/J.APRIM.2008.10.019]; Ludt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029334; Mira JJ, 2015, EXPERT OPIN DRUG SAF, V14, P815, DOI 10.1517/14740338.2015.1026326; Lopez TM, 2012, ATEN PRIM, V44, P453, DOI 10.1016/j.aprim.2011.09.015; National Institute for Educational Development (NIED), 2020, MATH SYLL ADV SUBS; Niquille A, 2010, PHARM WORLD SCI, V32, P512, DOI 10.1007/s11096-010-9401-1; Riker Gretchen I, 2012, Home Healthc Nurse, V30, P474, DOI 10.1097/NHH.0b013e31826502dd; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; Rosenberg J, 2014, J AM GERIATR SOC, V62, P580, DOI 10.1111/jgs.12714; Ruiz A, 2009, ANALES PATOLOGIA VAS, V3, P233; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Sanjuas C., 2011, FMC, V18, P452; Savoia E, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-47; Schumaker SA, 1995, QUALITY LIFE THEORY; Shafie Asrul Akmal, 2013, Value Health Reg Issues, V2, P107, DOI 10.1016/j.vhri.2013.02.005; Sorensen L, 2005, AGE AGEING, V34, P626, DOI 10.1093/ageing/afi202; United Nations, 2009, WORLD POP AG 2009; Van Camp YP, 2013, EUR J CLIN PHARMACOL, V69, P761, DOI 10.1007/s00228-012-1419-y; Van der Weele G. M., 2008, INT J GERIATR PSYCH, V21, P2162; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Wanden-Berghe C, 2008, MED CLIN-BARCELONA, V131, P281, DOI 10.1016/S0025-7753(08)72258-9	50	54	54	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171320	10.1371/journal.pone.0171320	http://dx.doi.org/10.1371/journal.pone.0171320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166266	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100034
J	Grondin, JM; Duan, D; Kirlin, AC; Abe, KT; Chitayat, S; Spencer, HL; Spencer, C; Campigotto, A; Houliston, S; Arrowsmith, CH; Allingham, JS; Boraston, AB; Smith, SP				Grondin, Julie M.; Duan, Da; Kirlin, Alyssa C.; Abe, Kento T.; Chitayat, Seth; Spencer, Holly L.; Spencer, Craig; Campigotto, Alisha; Houliston, Scott; Arrowsmith, Cheryl H.; Allingham, John S.; Boraston, Alisdair B.; Smith, Steven P.			Diverse modes of galacto-specific carbohydrate recognition by a family 31 glycoside hydrolase from Clostridium perfringens	PLOS ONE			English	Article							BINDING MODULE; STRUCTURAL-ANALYSIS; N-ACETYLGLUCOSAMINIDASE; MOLECULAR-BASIS; BACTERIA; SEQUENCE; INSIGHTS; DYNAMICS; QUALITY; SYSTEM	Clostridium perfringens is a commensal member of the human gut microbiome and an opportunistic pathogen whose genome encodes a suite of putative large, multi-modular carbohydrate-active enzymes that appears to play a role in the interaction of the bacterium with mucin-based carbohydrates. Among the most complex of these is an enzyme that contains a presumed catalytic module belonging to glycoside hydrolase family 31 (GH31). This large enzyme, which based on its possession of a GH31 module is a predicted a-glucosidase, contains a variety of non-catalytic ancillary modules, including three CBM32 modules that to date have not been characterized. NMR-based experiments demonstrated a preference of each module for galacto-configured sugars, including the ability of all three CBM32s to recognize the common mucin monosaccharide GalNAc. X-ray crystal structures of the CpGH31 CBM32s, both in apo form and bound to GalNAc, revealed the finely-tuned molecular strategies employed by these sequentially variable CBM32s in coordinating a common ligand. The data highlight that sequence similarities to previously characterized CBMs alone are insufficient for identifying the molecular mechanism of ligand binding by individual CBMs. Furthermore, the overlapping ligand binding profiles of the three CBMs provide a fail-safe mechanism for the recognition of GalNAc among the dense eukaryotic carbohydrate networks of the colonic mucosa. These findings expand our understanding of ligand targeting by large, multi-modular carbohydrate-active enzymes, and offer unique insights into of the expanding ligand-binding preferences and binding site topologies observed in CBM32s.	[Grondin, Julie M.; Duan, Da; Kirlin, Alyssa C.; Chitayat, Seth; Spencer, Holly L.; Spencer, Craig; Campigotto, Alisha; Allingham, John S.; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Grondin, Julie M.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Abe, Kento T.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Houliston, Scott; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Houliston, Scott; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Queens University - Canada; Agriculture & Agri Food Canada; University of Victoria; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Smith, SP (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	steven.smith@queensu.ca	Allingham, John/AAW-9262-2020	Arrowsmith, Cheryl/0000-0002-4971-3250; Smith, Steven/0000-0003-2710-4400; Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research [MOP-68913]; Natural Science and Engineering Council of Canada (NSERC) [RGPIN-2015-06667]; NSERC PGS-D fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PGS-D fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Canadian Institutes of Health Research operating grant (MOP-68913) awarded to ABB and SPS and a Natural Science and Engineering Council of Canada (NSERC) Discovery grant (RGPIN-2015-06667) to SPS. JMG was a recipient of a NSERC PGS-D fellowship. JAA is a Tier 2 Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Adams JJ, 2008, P NATL ACAD SCI USA, V103, P305; Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deplancke B, 2002, AM J CLIN NUTR, V76, P1117, DOI 10.1093/ajcn/76.5.1117; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etzold S, 2014, CURR OPIN STRUC BIOL, V28, P23, DOI 10.1016/j.sbi.2014.07.002; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Ficko-Blean E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033524; Ficko-Blean E, 2012, GLYCOBIOLOGY, V22, P590, DOI 10.1093/glycob/cwr165; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Ficko-Blean E, 2009, J BIOL CHEM, V284, P9876, DOI 10.1074/jbc.M808954200; Ghosh A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P672, DOI 10.1134/S0006297914070098; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Grondin JM, 2014, J MOL BIOL, V426, P869, DOI 10.1016/j.jmb.2013.11.029; Grondin JM, 2012, BIOMOL NMR ASSIGN, V6, P139, DOI 10.1007/s12104-011-9342-1; Higgins MA, 2011, J MOL BIOL, V411, P1017, DOI 10.1016/j.jmb.2011.06.035; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Scharpf M, 2002, BIOCHEMISTRY-US, V41, P4255, DOI 10.1021/bi015866b; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Stevens DL, 2012, ANAEROBE, V18, P254, DOI 10.1016/j.anaerobe.2011.11.001; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Viegas A, 2013, BIOCHEM J, V451, P289, DOI 10.1042/BJ20120627; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171606	10.1371/journal.pone.0171606	http://dx.doi.org/10.1371/journal.pone.0171606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158290	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700108
J	Li, J; Xu, HZ; Pan, W; Wu, B				Li, Juan; Xu, Hanzhang; Pan, Wei; Wu, Bei			Association between tooth loss and cognitive decline: A 13-year longitudinal study of Chinese older adults	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; REPORTED ORAL-HEALTH; TERM PERIODONTAL MAINTENANCE; ALZHEIMERS-DISEASE; DENTITION STATUS; DENTAL-HEALTH; DEMENTIA; IMPAIRMENT; COMMUNITY; LIFE	Objectives To examine the association between the number of teeth remaining and cognitive decline among Chinese older adults over a 13-year period. Design A large national longitudinal survey of Chinese older adults Setting The Chinese Longitudinal Healthy Longevity Survey (CLHLS) (1998-2011). Participants A total of 8,153 eligible participants aged 60+ interviewed in up to six waves. Measurements Cognitive function and teeth number were measured at each interview. Cognitive function was measured by the Mini-Mental Status Examination (MMSE). Number of natural teeth was self-reported. Individuals with severe cognitive impairment were excluded. Covariates included demographic characteristics, adult socioeconomic status characteristics, childhood socioeconomic status, health conditions, and health behaviors. Linear mixed models were applied in the analysis. Results The mean teeth number at baseline was 17.5(SD = 0.1), and the mean of baseline cognitive function was 27.3(SD = 0.0). Cognitive function declined over time (beta = -0.19, P <.001) after controlling covariates. But, regardless of time, more teeth were associated with better cognitive function (beta = 0.01, P <.001). The interaction of teeth number and time was significant (beta = 0.01, P <.001), suggesting that the participants who had more teeth showed a slower pace of cognitive decline over time than those with fewer teeth after controlling for other covariates. Conclusion This study showed that tooth loss was associated with cognitive decline among Chinese older adults. Further studies are needed to examine the linkages between cognitive decline and oral health status using clinical examination data.	[Li, Juan] Second Mil Med Univ, Sch Nursing, Shanghai, Peoples R China; [Li, Juan; Xu, Hanzhang; Pan, Wei] Duke Univ, Sch Nursing, Durham, NC 27706 USA; [Xu, Hanzhang] Duke Global Hlth Inst, Durham, NC USA; [Wu, Bei] NYU, Rory Meyers Coll Nursing, New York, NY 10010 USA	Naval Medical University; Duke University; Duke University; New York University	Wu, B (corresponding author), NYU, Rory Meyers Coll Nursing, New York, NY 10010 USA.	bei.wu@nyu.edu	Wu, Bei/X-2404-2019	Wu, Bei/0000-0002-6891-244X				Al-Shammari KF, 2005, J PERIODONTOL, V76, P1910, DOI 10.1902/jop.2005.76.11.1910; [Anonymous], 2001, MISSING DATA; Arrive E, 2012, COMMUNITY DENT ORAL, V40, P230, DOI 10.1111/j.1600-0528.2011.00650.x; Batty GD, 2013, EUR PSYCHIAT, V28, P49, DOI 10.1016/j.eurpsy.2011.07.005; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Carrillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0100476; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P675, DOI 10.1111/j.1600-051X.2010.01587.x; Chen HY, 2015, INT J MED SCI, V12, P502, DOI 10.7150/ijms.11911; De Cicco V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148715; Ding D, 2015, ALZHEIMERS DEMENT, V11, P300, DOI 10.1016/j.jalz.2013.11.002; DOUGLASS CW, 1991, J PUBLIC HEALTH DENT, V51, P220, DOI 10.1111/j.1752-7325.1991.tb02218.x; [高宝迪 Gao Baodi], 2011, [实用口腔医学杂志, Journal of Practical Stomatology], V27, P279; Gao SJ, 2014, AM J GERIAT PSYCHIAT, V22, P670, DOI 10.1016/j.jagp.2013.02.015; Gatz Margaret, 2006, Alzheimers Dement, V2, P110, DOI 10.1016/j.jalz.2006.01.002; Gu D.-N., 2008, J FUNCTIONAL MAT, V1, P1; Han WJ, 2015, ARCH GERONTOL GERIAT, V60, P168, DOI 10.1016/j.archger.2014.09.001; Jia JP, 2014, ALZHEIMERS DEMENT, V10, P439, DOI 10.1016/j.jalz.2013.09.008; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kaye EK, 2010, J AM GERIATR SOC, V58, P713, DOI 10.1111/j.1532-5415.2010.02788.x; Kim JM, 2007, INT J GERIATR PSYCH, V22, P850, DOI 10.1002/gps.1750; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; Krall E, 1998, J AM DENT ASSOC, V129, P1261, DOI 10.14219/jada.archive.1998.0423; Langa KM, 2014, JAMA-J AM MED ASSOC, V312, P2551, DOI 10.1001/jama.2014.13806; Luo Y, 2005, J GERONTOL B-PSYCHOL, V60, pS93, DOI 10.1093/geronb/60.2.S93; Martinez-Canut P, 2015, J CLIN PERIODONTOL, V42, P1115, DOI 10.1111/jcpe.12475; Meng Q, 2010, UNIVERSAL COVERAGE H; Miyake S, 2012, ARCH ORAL BIOL, V57, P1491, DOI 10.1016/j.archoralbio.2012.06.008; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Ono Y, 2010, J ORAL REHABIL, V37, P624, DOI 10.1111/j.1365-2842.2010.02079.x; Paganini-Hill A, 2012, J AM GERIATR SOC, V60, P1556, DOI 10.1111/j.1532-5415.2012.04064.x; Pink C, 2015, J CLIN PERIODONTOL; Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x; Prevention CC for DC and, 2007, CHIN 3 OR EP SURV OU; Qi XQ, 2008, 3 NATL ORAL HLTH SUR; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Shimazaki Y, 2001, J DENT RES, V80, P340, DOI 10.1177/00220345010800010801; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spencer RJ, 2013, EXP AGING RES, V39, P382, DOI 10.1080/0361073X.2013.808109; Starr JM, 2010, CURR OPIN CLIN NUTR, V13, P19, DOI 10.1097/MCO.0b013e328333aa37; Stein PS, 2010, J DENT RES, V89, P473, DOI 10.1177/0022034509357881; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Stewart R, 2015, ASS ORAL HLTH RISK D, P100; Stewart R, 2008, PSYCHOSOM MED, V70, P936, DOI 10.1097/PSY.0b013e3181870aec; Stewart R, 2015, J AM GERIATR SOC, V63, P100, DOI 10.1111/jgs.13194; Stewart R, 2013, J AM GERIATR SOC, V61, P177, DOI 10.1111/jgs.12094; Thomson WM, 2004, COMMUNITY DENT ORAL, V32, P345, DOI 10.1111/j.1600-0528.2004.00173.x; Thorstensson H, 2010, GERODONTOLOGY, V27, P19, DOI 10.1111/j.1741-2358.2009.00297.x; Trzepacz PT, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0103-3; Tsakos G, 2004, J AM GERIATR SOC, V324; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Watts Amber, 2008, Neuropsychiatr Dis Treat, V4, P865; Wen M, 2011, DEMOGRAPHY, V48, P153, DOI 10.1007/s13524-010-0003-2; Wu B, 2007, AM J PUBLIC HEALTH, V97, P2216, DOI 10.2105/AJPH.2007.109934; Wu B, 2011, J AGING HEALTH, V23, P267, DOI 10.1177/0898264310382135; Yi Z, 2008, RELIABILITY AGE REPO, P61; Yin ZX, 2012, AGE AGEING, V41, P600, DOI 10.1093/ageing/afs033; Zhang ZM, 2010, SOC SCI MED, V71, P941, DOI 10.1016/j.socscimed.2010.05.013; Zimmer Z, 2010, DEMOGRAPHY, V47, P537	61	42	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171404	10.1371/journal.pone.0171404	http://dx.doi.org/10.1371/journal.pone.0171404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158261	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700074
J	Liu, XY; Behrman, JR; Stein, AD; Adair, LS; Bhargava, SK; Borja, JB; da Silveira, MF; Horta, BL; Martorell, R; Norris, SA; Richter, LM; Sachdev, HS				Liu, Xiaoying; Behrman, Jere R.; Stein, Aryeh D.; Adair, Linda S.; Bhargava, Santosh K.; Borja, Judith B.; da Silveira, Mariangela Freitas; Horta, Bernardo L.; Martorell, Reynaldo; Norris, Shane A.; Richter, Linda M.; Sachdev, Harshpal S.			Prenatal care and child growth and schooling in four low- and medium-income countries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; BIRTH-WEIGHT; COHORT PROFILE; ANTENATAL CARE; NUTRITION; OUTCOMES; HEALTH; PATTERNS; IMPACT; MORTALITY	Background The effectiveness of prenatal care for improving birth and subsequent child outcomes in low-income countries remains controversial, with much of the evidence to date coming from high-income countries and focused on early-life outcomes. We examined associations between prenatal care visits and birth weight, height-for-age at 24 months and attained schooling in four low- and middle-income countries. Methods We pooled data from prospective birth-cohort studies from Brazil, Guatemala, Philippines and South Africa. We created a prenatal care utilization index based on the number and timing of prenatal visits. Associations were examined between this index and birth weight, height-for-age at 24 months, and highest attained schooling grade until adulthood. Results Among 7203 individuals in the analysis, 68.9% (Philippines) to 96.7% (South Africa) had at least one prenatal care visit, with most having at least four visits. Over 40% of Brazilians and Guatemalans had their first prenatal visit in the first trimester, but fewer Filipinos (13.9%) and South Africans (19.8%) did so. Prenatal care utilization was not significantly associated with birth weight (p>0.05 in pooled data). Each unit increase in the prenatal care utilization index was associated with 0.09 (95% CI 0.04 to 0.15) higher height-for-age z-score at 24 months and with 0.26 (95% CI 0.17 to 0.35) higher schooling grades attained. Although there was some heterogeneity and greater imprecision across sites, the results were qualitatively similar among the four different populations. Conclusions While not related to birth weight, prenatal care utilization was associated with important outcomes later in life, specifically higher height-for-age at 24 months and higher attained school grades. These results suggest the relevance of prenatal care visits for human capital outcomes important over the lifecycle.	[Liu, Xiaoying; Behrman, Jere R.] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Stein, Aryeh D.; Martorell, Reynaldo] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Stein, Aryeh D.; Norris, Shane A.; Richter, Linda M.] Univ Witwatersrand, Med Res Council Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Adair, Linda S.] Univ North Carolina Chapel Hill, Dept Nutr, Chapel Hill, NC USA; [Bhargava, Santosh K.] SL Jain Hosp, Dept Pediat, Delhi, India; [Borja, Judith B.] Univ San Carlos, USC Off Populat Studies Fdn Inc, Cebu, Philippines; [Borja, Judith B.] Univ San Carlos, Dept Nutr & Dietet, Cebu, Philippines; [da Silveira, Mariangela Freitas; Horta, Bernardo L.] Univ Fed Pelotas, Fac Med, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Richter, Linda M.] Univ Witwatersrand, DST NRF Ctr Excellence Human Dev, Johannesburg, South Africa; [Sachdev, Harshpal S.] Sitaram Bhartia Inst Sci & Res, Dept Pediat & Clin Epidemiol, New Delhi, India	University of Pennsylvania; Emory University; Rollins School Public Health; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of San Carlos; University of San Carlos; Universidade Federal de Pelotas; University of Witwatersrand; Sitaram Bhartia Institute of Science & Research	Liu, XY (corresponding author), Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA.	xiaoyliu@sas.upenn.edu	Stein, Aryeh D/J-9831-2012; Silveira, Mariangela F/L-6868-2013; Horta, Bernardo/A-7604-2008; Norris, Shane/C-4664-2014; Martorell, Reynaldo/I-2539-2012; Behrman, Jere R/A-9734-2009	Silveira, Mariangela F/0000-0002-3551-9713; Horta, Bernardo/0000-0001-9843-412X; Norris, Shane/0000-0001-7124-3788; Liu, Xiaoying/0000-0001-9897-1291; Sachdev, Harshpal Singh/0000-0002-4956-9391; Stein, Aryeh/0000-0003-1138-6458	Grand Challenges Canada Grant [0072-03]; Bill & Melinda Gates Foundation Global Health Grant [OPP1032713]; Eunice Shriver Kennedy National Institute of Child Health and Development [R01 HD070993, HD070993]; Wellcome Trust (UK); Bill & Melinda Gates Foundation [OPP1032713]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD070993] Funding Source: NIH RePORTER	Grand Challenges Canada Grant; Bill & Melinda Gates Foundation Global Health Grant; Eunice Shriver Kennedy National Institute of Child Health and Development; Wellcome Trust (UK)(Wellcome Trust); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Grand Challenges Canada Grant 0072-03 (http://www.grandchallenges ca/), Bill & Melinda Gates Foundation Global Health Grant OPP1032713 (http://www.gatesfoundaton org/) and Eunice Shriver Kennedy National Institute of Child Health and Development Grant R01 HD070993 (https://www.nichd.nih.gov/Pages/index.aspx). COHORTS has received support from the Wellcome Trust (UK), the Bill & Melinda Gates Foundation. Funding for the individual cohorts was as follows: Guatemala (US National Institutes of Health; US National Science Foundation); Pelotas (Wellcome Trust); Birth To Twenty (Wellcome Trust, Human Sciences Research Council, South African Medical Research Council, Mellon Foundation, Anglo American Chairman's Fund, University of the Witwatersrand); Cebu (US National Institutes of Health). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Grant sponsors: Grand Challenges Canada Grant 0072-03, Bill & Melinda Gates Foundation Global Health Grant OPP1032713 and Eunice Shriver Kennedy National Institute of Child Health and Development Grant R01 HD070993. COHORTS has received supports from the Wellcome Trust (UK), the Bill & Melinda Gates Foundation. Funding for the individual cohorts was as follows: Guatemala (US National Institutes of Health; US National Science Foundation); Pelotas (Wellcome Trust); Birth To Twenty (Wellcome Trust, Human Sciences Research Council, South African Medical Research Council, Mellon Foundation, Anglo American Chairman's Fund, University of the Witwatersrand); Cebu (US National Institutes of Health).	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Adair LS, 2011, INT J EPIDEMIOL, V40, P619, DOI 10.1093/ije/dyq085; Alderman H, 2006, WORLD BANK RES OBSER, V21, P25, DOI 10.1093/wbro/lkj001; Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; [Anonymous], 1988, HDB DEV EC, DOI DOI 10.1016/S1573-4471(88)01016-2; Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Becker G. S., 2009, TREATISE FAMILY; Behrman JR, 2010, HBK ECON, V5, P4883, DOI 10.1016/B978-0-444-52944-2.00011-2; Behrman JR, 2009, AM J CLIN NUTR, V90, P1372, DOI 10.3945/ajcn.2009.27524; Behrman JR, 2004, REV ECON STAT, V86, P586, DOI 10.1162/003465304323031139; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Chamberlain C, 2013, COCHRANE DB SYST REV, P10; Christian P, 2012, J NUTR, V142, p173S, DOI 10.3945/jn.111.149898; Conley D, 2001, J HEALTH SOC BEHAV, V42, P450, DOI 10.2307/3090189; Conley D, 2006, ECON HUM BIOL, V4, P151, DOI 10.1016/j.ehb.2005.12.001; Conway KS, 2005, J HEALTH ECON, V24, P489, DOI 10.1016/j.jhealeco.2004.09.012; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Gajate-Garrido G, 2013, ECON DEV CULT CHANGE, V62, P95, DOI 10.1086/671716; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Glewwe Paul, 2006, HDB EC ED, V2, P945, DOI [10.1016/S1574-0692(06)02016-2, DOI 10.1016/S1574-0692(06)02016-2]; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; GROSSMAN M, 1990, J POLIT ECON, V98, P983, DOI 10.1086/261716; GUILKEY DK, 1989, J DEV EC, V30; Haas JD, 1996, NUTR REV, V54, pS41, DOI 10.1111/j.1753-4887.1996.tb03869.x; Habibov NN, 2011, ECON HUM BIOL, V9, P56, DOI 10.1016/j.ehb.2010.08.003; Haider BA, 2013, BMJ-BRIT MED J, P346; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Hoddinott J, 2013, AM J CLIN NUTR; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Hollowell J, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-13; HUNTINGTON J, 1994, NEW ENGL J MED, V331, P1303, DOI 10.1056/NEJM199411103311910; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Kirkham C, 2005, AM FAM PHYSICIAN, V71, P1307; Krueger Paul M., 2000, Journal of the American Osteopathic Association, V100, P485; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Lu M C, 2003, J Matern Fetal Neonatal Med, V13, P362, DOI 10.1080/713605924; Maluccio JA, 2009, ECON J, V119, P734, DOI 10.1111/j.1468-0297.2009.02220.x; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Noonan K, 2013, MATERN CHILD HLTH J, V17, P189, DOI 10.1007/s10995-012-0966-2; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Ramakrishna T, 1999, PHYSIOL RES, V48, P175; Ramakrishnan U, 2014, MATERNAL NUTR INTERV; REYNES JF, 1985, J SOUTHE ASIAN STUD, V16, P292, DOI 10.1017/S0022463400008468; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; ROSENZWEIG MR, 1983, J POLIT ECON, V91, P723, DOI 10.1086/261179; SCHULTZ TW, 1961, AM ECON REV, V51, P1; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; SHWARTZ S, 1962, AM J OBSTET GYNECOL, V83, P591, DOI 10.1016/S0002-9378(16)35888-4; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Stein AD, 2008, INT J EPIDEMIOL, V37, P716, DOI 10.1093/ije/dyn028; Stein AD, 2013, J PEDIATR-US, V163, P1740, DOI 10.1016/j.jpeds.2013.08.012; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; United Nations Department of Economic, 2008, MILL DEV GOALS REP 2; VanderWeele TJ, 2012, SOC SCI MED, V74, P196, DOI 10.1016/j.socscimed.2011.10.031; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 2010, PEDIATRICS; von Hippel PT, 2009, SOCIOL METHODOL, V39, P265, DOI 10.1111/j.1467-9531.2009.01215.x; Wehby GL, 2009, ECON HUM BIOL, V7, P84, DOI 10.1016/j.ehb.2008.10.001; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WONG EL, 1987, SOC SCI MED, V24, P927, DOI 10.1016/0277-9536(87)90286-3; Woodhouse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091292	69	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171299	10.1371/journal.pone.0171299	http://dx.doi.org/10.1371/journal.pone.0171299			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158229	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700055
J	Scheuerle, RL; Bruggraber, SFA; Gerrard, SE; Kendall, RA; Tuleu, C; Slater, NKH				Scheuerle, Rebekah L.; Bruggraber, Sylvaine F. A.; Gerrard, Stephen E.; Kendall, Richard A.; Tuleu, Catherine; Slater, Nigel K. H.			Characterisation of zinc delivery from a nipple shield delivery system using a breastfeeding simulation apparatus	PLOS ONE			English	Article							MILK; SUPPLEMENTATION; CHILDREN; HIV	Zinc delivery from a nipple shield delivery system (NSDS), a novel platform for administering medicines to infants during breastfeeding, was characterised using a breastfeeding simulation apparatus. In this study, human milk at flow rates and pressures physiologically representative of breastfeeding passed through the NSDS loaded with zinc-containing rapidly disintegrating tablets, resulting in release of zinc into the milk. Inductively coupled plasma optical emission spectrometry was used to detect the zinc released, using a method that does not require prior digestion of the samples and that could be applied in other zinc analysis studies in breast milk. Four different types of zinc-containing tablets with equal zinc load but varying excipient compositions were tested in the NSDS in vitro. Zinc release measured over 20 minutes ranged from 32-51% of the loaded dose. Total zinc release for sets tablets of the same composition but differing hardness were not significantly different from one another with P = 0.3598 and P = 0.1270 for two tested pairs using unpaired t tests with Welch's correction. By the same test total zinc release from two sets of tablets having similar hardness but differing composition were also not significantly significant with P = 0.2634. Future zinc tablet composition and formulation optimisation could lead to zinc supplements and therapeutics with faster drug release, which could be administered with the NSDS during breastfeeding. The use of the NSDS to deliver zinc could then lead to treatment and prevention of some of the leading causes of child mortality, including diarrheal disease and pneumonia.	[Scheuerle, Rebekah L.; Gerrard, Stephen E.; Slater, Nigel K. H.] Univ Cambridge, Dept Chem Engn & Biotechnol, BioSci Engn Res Grp, New Museums Site,Pembroke St, Cambridge, England; [Bruggraber, Sylvaine F. A.] Elsie Widdowson Lab, Biomineral Res Grp, Med Res Council Human Nutr Res, Cambridge, England; [Tuleu, Catherine] UCL, Sch Pharm, Dept Pharmaceut, London, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of London; University College London; University of London School of Pharmacy	Scheuerle, RL (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, BioSci Engn Res Grp, New Museums Site,Pembroke St, Cambridge, England.	rs765@cam.ac.uk	tuleu, catherine/AAL-5039-2020	Scheuerle, Rebekah/0000-0001-6396-5043	United States Agency for International Development (USAID); Government of Norway; Bill & Melinda Gates Foundation; Grand Challenges Canada; UK Department for International Development (DFID) [0454-03]; Medical Research Council [MC_US_A090_0008, U1059]; MRC [MC_U105960399] Funding Source: UKRI; Medical Research Council [MC_U105960399] Funding Source: researchfish	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of Norway; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Grand Challenges Canada(CGIAR); UK Department for International Development (DFID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was made possible for all authors through the support of the Saving Lives at Birth partners: the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada and the UK Department for International Development (DFID) through the Saving Lives at Birth Award Scheme, grant number 0454-03. The website for the award scheme is https://savinglivesatbirth.net/. We also thank the Medical Research Council (grant number MC_US_A090_0008/Unit Programme number U1059) for their support of Sylvaine Bruggraber (S. F.A.B.). The website for this grant is http://www.mrc-ewl.cam.ac.uk/. The Gates Cambridge Trust is also thanked for their funding of Rebekah Scheuerle (R.L.S) through an academic scholarship. Their website is https://www.gatescambridge.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 1998, AM J CLIN NUTR, V68, p495S, DOI 10.1093/ajcn/68.2.495S; [Anonymous], 2013, BRADFORD ASSAY SIGMA; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 2003, J NUTR, P1485; Brown KH, 2013, FOOD NUTR BULL, V34, P199, DOI 10.1177/156482651303400209; Charoo NA, 2012, INT J PHARMACEUT, V423, P167, DOI 10.1016/j.ijpharm.2011.12.024; Costa P, 2001, INT J PHARM, V220, P77, DOI 10.1016/S0378-5173(01)00651-2; Geddes DT, 2008, EARLY HUM DEV, V84, P471, DOI 10.1016/j.earlhumdev.2007.12.008; Gerrard SE, 2013, J PHARM SCI-US, V102, P3773, DOI 10.1002/jps.23688; Gerrard SE, 2013, BIOTECHNOL BIOENG, V110, P2058, DOI 10.1002/bit.24867; Hart CW, 2015, J HUM LACT, V31, P68, DOI 10.1177/0890334414559980; Hassan A, 2012, ZINC SUPPLEMENTATION; Kasper SC, 1999, J CHROMATOGR B, V726, P203, DOI 10.1016/S0378-4347(99)00017-1; Kent JC, 2006, PEDIATRICS, V117, pE387, DOI 10.1542/peds.2005-1417; Larson CP, 2008, J HEALTH POPUL NUTR, V26, P356; LUCAS A, 1978, BRIT MED J, V1, P1018, DOI 10.1136/bmj.1.6119.1018; Ninonuevo MR, 2009, NUTR REV S2, V67; Ramsay DT, 2004, PEDIATRICS, V113, P361, DOI 10.1542/peds.113.2.361; Sazawal S, 2013, J HUM NUTR FOOD SCI, V1, P1; Scheuerle RL, 2015, INT J PHARMACEUT, V486, P136, DOI 10.1016/j.ijpharm.2015.03.023; Sokal DC, 2013, United States Patent, P0, Patent No. 2013212012; Wang C D, 1999, J Perinatol, V19, P343, DOI 10.1038/sj.jp.7200204; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization, 2014, REV WHO CLASS TREATM; World Health Organization, 2004, WORLD HEAL J, V1, P11, DOI DOI 10.1089/ACM.2009.0657; World Health Organization, 2015, ZINC SUPPL MAN DIARR; Zoppou C, 1997, B MATH BIOL, V59, P953, DOI 10.1007/BF02460001; Zoppou C, 1997, J Hum Lact, V13, P195, DOI 10.1177/089033449701300307	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171624	10.1371/journal.pone.0171624	http://dx.doi.org/10.1371/journal.pone.0171624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158283	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700115
J	Siland, JE; Geelhoed, B; van Gelder, IC; van der Harst, P; Rienstra, M				Siland, Joylene E.; Geelhoed, Bastiaan; van Gelder, Isabelle C.; van der Harst, Pim; Rienstra, Michiel			Telomere length and incident atrial fibrillation - data of the PREVEND cohort	PLOS ONE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; RISK; PREVALENCE; MORTALITY; STROKE; POPULATION; LEUKOCYTES; PREDICTOR; FIBROSIS	Background The incidence of atrial fibrillation (AF) increases with age. Telomere length is considered a marker of biological ageing. We investigated the association between leukocyte telomere length and incident AF in the Dutch Prevention of Renal and Vascular End-stage Disease (PREVEND) study. Methods We included 7775 individuals without prevalent AF, and with leukocyte telomere length measured. Mean telomere length was determined by a monochrome multiplex quantitative polymerase chain reaction-based assay. Results Mean age of our cohort was 49 +/- 13 years, and 50% were men. During a mean follow-up of 11.4 +/- 2.9 years incident AF was detected in 367 (4.7%) individuals. Telomere length was shorter in individuals developing incident AF compared to those without AF (p = 0.013). Incident AF was inversely related to the telomere length. In the quartile with the longest telomere length 68 (3.5%) individuals developed AF, in the shortest telomere length quartile 100 (5.1%) individuals (p = 0.032). Telomere length was associated with incident AF in the second shortest telomere length quartile using the longest telomere length quartile as reference (hazard ratio 1.64; 95% CI 1.02-2.66; p = 0.043). After including age or AF risk factors, the relation between telomere length and incident AF was no longer significant. We found a significant interaction of age, male sex, systolic blood pressure, BMI, heart failure, and myocardial infarction with telomere length for the association with incident AF. Conclusions We found that shorter leukocyte telomere length is not independently associated with incident AF in a community-based cohort.	[Siland, Joylene E.; Geelhoed, Bastiaan; van Gelder, Isabelle C.; van der Harst, Pim; Rienstra, Michiel] Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	University of Groningen	Rienstra, M (corresponding author), Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	m.rienstra@umcg.nl		Siland, Joylene/0000-0003-4404-1245; Rienstra, Michiel/0000-0002-2581-070X	Dutch Kidney Foundation [E0.13]; National Institutes of Health [2R01LM010098]; Netherlands organization for health research and development (NWO-Groot grant) [175.010.2007.006]; ZonMw [90.700.441]; Dutch Inter University Cardiology Institute Netherlands (ICIN); Netherlands Heart Foundation [NHS20108280]; Netherlands Organization for Scientific Research [016.136.055]	Dutch Kidney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands organization for health research and development (NWO-Groot grant); ZonMw(Netherlands Organization for Health Research and Development); Dutch Inter University Cardiology Institute Netherlands (ICIN); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The PREVEND study is supported by the Dutch Kidney Foundation (grant E0.13), the National Institutes of Health (grant 2R01LM010098), The Netherlands organization for health research and development (NWO-Groot grant 175.010.2007.006, ZonMw grant 90.700.441), and the Dutch Inter University Cardiology Institute Netherlands (ICIN), and the Netherlands Heart Foundation (grant NHS20108280). Dr. M. Rienstra is supported by a grant from the Netherlands Organization for Scientific Research (Veni grant 016.136.055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ANDERSON KR, 1979, J PATHOL, V128, P79, DOI 10.1002/path.1711280205; Angel N, 2015, J CARDIOVASC ELECTR, V26, P1352, DOI 10.1111/jce.12773; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Carlquist JF, 2016, HEART RHYTHM, V13, P21, DOI 10.1016/j.hrthm.2015.07.032; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Dewland TA, 2013, ANN INTERN MED, V159, P721, DOI 10.7326/0003-4819-159-11-201312030-00004; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; FLEGEL KM, 1987, LANCET, V1, P526; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gates PE, 2003, EUR HEART J, V24, P2213, DOI 10.1016/j.ehj.2003.09.026; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Huzen J, 2014, J INTERN MED, V275, P155, DOI 10.1111/joim.12149; Jones SA, 2007, CIRCULATION, V115, P1183, DOI 10.1161/CIRCULATIONAHA.106.663070; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Lin CY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002192; Linssen GCM, 2010, EUR HEART J, V31, P120, DOI 10.1093/eurheartj/ehp420; Lubitz SA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000126; Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; Roberts JD, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1026, DOI 10.1161/CIRCEP.114.001781; Samani NJ, 2008, HEART, V94, P537, DOI 10.1136/hrt.2007.136010; Stuveling EM, 2004, ATHEROSCLEROSIS, V172, P107, DOI 10.1016/S0021-9150(03)00252-1; Thong T, 2004, IEEE T BIO-MED ENG, V51, P561, DOI 10.1109/TBME.2003.821030; Van de Veire NR, 2006, INT J CARDIOVAS IMAG, V22, P633, DOI 10.1007/s10554-006-9082-y; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895; Vermond RA, 2015, J AM COLL CARDIOL, V66, P1000, DOI 10.1016/j.jacc.2015.06.1314; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171545	10.1371/journal.pone.0171545	http://dx.doi.org/10.1371/journal.pone.0171545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158257	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700096
J	Song, H; Wang, PF; Li, CS; Han, SY; Zhao, CZ; Xia, H; Bi, YP; Guo, BZ; Zhang, XY; Wang, XJ				Song, Hui; Wang, Pengfei; Li, Changsheng; Han, Suoyi; Zhao, Chuanzhi; Xia, Han; Bi, Yuping; Guo, Baozhu; Zhang, Xinyou; Wang, Xingjun			Comparative analysis of NBS-LRR genes and their response to Aspergillus flavus in Arachis	PLOS ONE			English	Article							DISEASE RESISTANCE GENES; GENOME-WIDE IDENTIFICATION; ARABIDOPSIS-THALIANA; MEDICAGO-TRUNCATULA; CULTIVATED PEANUT; EVOLUTION; BLAST; EXPRESSION; HYPOGAEA; DURANENSIS	Studies have demonstrated that nucleotide-binding site-leucine-rich repeat (NBS-LRR) genes respond to pathogen attack in plants. Characterization of NBS-LRR genes in peanut is not well documented. The newly released whole genome sequences of Arachis duranensis and Arachis ipaensis have allowed a global analysis of this important gene family in peanut to be conducted. In this study, we identified 393 (AdNBS) and 437 (AiNBS) NBS-LRR genes from A. duranensis and A. ipaensis, respectively, using bioinformatics approaches. Full-length sequences of 278 AdNBS and 303 AiNBS were identified. Fifty-one orthologous, four AdNBS paralogous, and six AiNBS paralogous gene pairs were predicted. All paralogous gene pairs were located in the same chromosomes, indicating that tandem duplication was the most likely mechanism forming these paralogs. The paralogs mainly underwent purifying selection, but most LRR 8 domains underwent positive selection. More gene clusters were found in A. ipaensis than in A. duranensis, possibly owing to tandem duplication events occurring more frequently in A. ipaensis. The expression profile of NBS-LRR genes was different between A. duranensis and A. hypogaea after Aspergillus flavus infection. The up-regulated expression of NBS-LRR in A. duranensis was continuous, while these genes responded to the pathogen temporally in A. hypogaea.	[Song, Hui; Wang, Pengfei; Li, Changsheng; Zhao, Chuanzhi; Xia, Han; Bi, Yuping; Wang, Xingjun] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China; [Song, Hui; Wang, Pengfei; Li, Changsheng; Zhao, Chuanzhi; Xia, Han; Bi, Yuping; Wang, Xingjun] Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Li, Changsheng; Wang, Xingjun] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Han, Suoyi; Zhang, Xinyou] Henan Acad Agr Sci, Zhengzhou, Peoples R China; [Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA	Shandong Academy of Agricultural Sciences; Shandong Normal University; Henan Academy of Agricultural Sciences; United States Department of Agriculture (USDA)	Wang, XJ (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China.; Wang, XJ (corresponding author), Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China.; Wang, XJ (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China.; Zhang, XY (corresponding author), Henan Acad Agr Sci, Zhengzhou, Peoples R China.	haasz@sohu.com; xingjunw@hotmail.com	Zhao, Chuanzhi/AAC-9232-2022		National High Tech Project [2013AA102602]; NSFC [31500217]; Genetically Modified Organisms Breeding Major Project [2013ZX08010-004]; Shandong Provincial Natural Science Foundation [ZR2015YL061]; Young Talents Training Program of Shandong Academy of Agricultural Sciences; Shandong Province Germplasm Innovation and Utilization Project	National High Tech Project(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Project; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Young Talents Training Program of Shandong Academy of Agricultural Sciences; Shandong Province Germplasm Innovation and Utilization Project	This study was supported by grants from National High Tech Project (2013AA102602), NSFC (31500217), Genetically Modified Organisms Breeding Major Project (2013ZX08010-004), Shandong Provincial Natural Science Foundation (ZR2015YL061), Young Talents Training Program of Shandong Academy of Agricultural Sciences and Shandong Province Germplasm Innovation and Utilization Project.	Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Ashfield T, 2012, PLANT PHYSIOL, V159, P336, DOI 10.1104/pp.112.195040; Ben C, 2013, NEW PHYTOL, V199, P758, DOI 10.1111/nph.12299; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bertioli DJ, 2003, MOL GENET GENOMICS, V270, P34, DOI 10.1007/s00438-003-0893-4; Borhan MH, 2010, MOL PLANT PATHOL, V11, P283, DOI 10.1111/j.1364-3703.2009.00599.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0305-6; Chen NWG, 2010, NEW PHYTOL, V187, P941, DOI 10.1111/j.1469-8137.2010.03337.x; Cheng SP, 2015, FORESTS, V6, P839, DOI 10.3390/f6030839; Christie N, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01238; David P, 2009, PLANT PHYSIOL, V151, P1048, DOI 10.1104/pp.109.142109; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Feng S, 2012, COMP FUNCT GENOM, V7, P1; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Fukuoka S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04550; Gu LJ, 2015, MOL GENET GENOMICS, V290, P727, DOI 10.1007/s00438-014-0948-8; HERBERT T T, 1981, Peanut Science, V8, P45, DOI 10.3146/i0095-3679-8-1-12; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KEEN NT, 1991, THEOR APPL GENET, V81, P133, DOI 10.1007/BF00226123; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li CJ, 2013, PHYSIOL MOL PLANT P, V84, P70, DOI 10.1016/j.pmpp.2013.07.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Michelotto MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128811; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Ramos ML, 2006, MOL GENET GENOMICS, V275, P578, DOI 10.1007/s00438-006-0114-z; Ratnaparkhe MB, 2011, NEW PHYTOL, V192, P164, DOI 10.1111/j.1469-8137.2011.03800.x; Samoluk SS, 2014, GENETIC RESOURCES CR, V61, P1; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Shao ZQ, 2016, PLANT PHYSIOL; Simpson C. E., 2001, Peanut Science, V28, P114, DOI 10.3146/i0095-3679-28-2-12; Song H, 2015, GENET MOL RES, V14, P16024, DOI 10.4238/2015.December.7.16; Song H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35245; Song H, 2014, CHINESE SCI BULL, V59, P1129, DOI 10.1007/s11434-014-0155-3; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Xia H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-517; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yang SM, 2008, P NATL ACAD SCI USA, V105, P12164, DOI 10.1073/pnas.0802518105; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Yuksel B, 2005, MOL GENET GENOMICS, V274, P248, DOI 10.1007/s00438-005-0022-7; Zhang HL, 2015, J PHYTOPATHOL, V163, P212, DOI 10.1111/jph.12311; Zhang XH, 2015, PLANT J, V84, P20, DOI 10.1111/tpj.12955; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	63	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171181	10.1371/journal.pone.0171181	http://dx.doi.org/10.1371/journal.pone.0171181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158222	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700036
J	Tan, SY; Chowdhury, S; Polak, N; Gorrell, MD; Weninger, W				Tan, Sioh-Yang; Chowdhury, Sumaiya; Polak, Natasa; Gorrell, Mark D.; Weninger, Wolfgang			Fibroblast activation protein is dispensable in the anti-influenza immune response in mice	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; TUMOR-ASSOCIATED FIBROBLASTS; INTEGRAL MEMBRANE PROTEASE; MALIGNANT MELANOMA-CELLS; T-CELLS; STROMAL CELLS; DENDRITIC CELLS; VIRUS-INFECTION; ALPHA; EXPRESSION	Fibroblast activation protein alpha (FAP) is a unique dual peptidase of the S9B serine protease family, being capable of both dipeptidyl peptidase and endopeptidase activities. FAP is expressed at low level in healthy adult organs including the pancreas, cervix, uterus, submaxillary gland and the skin, and highly upregulated in embryogenesis, chronic inflammation and tissue remodelling. It is also expressed by cancer-associated stromal fibroblasts in more than 90% of epithelial tumours. FAP has enzymatic and non-enzymatic functions in the growth, immunosuppression, invasion and cell signalling of tumour cells. FAP deficient mice are fertile and viable with no gross abnormality, but little data exist on the role of FAP in the immune system. FAP is upregulated in association with microbial stimulation and chronic inflammation, but its function in infection remains unknown. We showed that major populations of immune cells including CD4(+) and CD8(+) T cells, B cells, dendritic cells and neutrophils are generated and maintained normally in FAP knockout mice. Upon intranasal challenge with influenza virus, FAP mRNA was increased in the lungs and lung-draining lymph nodes. Nonetheless, FAP deficient mice showed similar pathologic kinetics to wildtype controls, and were capable of supporting normal anti-influenza T and B cell responses. There was no evidence of compensatory upregulation of other DPP4 family members in influenza-infected FAP-deficient mice. FAP appears to be dispensable in anti-influenza adaptive immunity.	[Tan, Sioh-Yang; Weninger, Wolfgang] Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, NSW, Australia; [Tan, Sioh-Yang; Chowdhury, Sumaiya; Polak, Natasa; Gorrell, Mark D.; Weninger, Wolfgang] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Chowdhury, Sumaiya; Polak, Natasa; Gorrell, Mark D.] Centenary Inst Canc Med & Cell Biol, Mol Hepatol Lab, Newtown, NSW, Australia; [Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Tan, SY (corresponding author), Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, NSW, Australia.; Tan, SY (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	tansiohy@gmail.com	Gorrell, Mark/AAX-6394-2021; Gorrell, Mark Douglas/H-7231-2019	Gorrell, Mark Douglas/0000-0002-0528-2604	Australian National Health and Medical Research Council [APP1030145, APP512282]; National Institutes of Health [BAA-NIAID-DAIT-HHSN272201100018C]; Rebecca L. Cooper Medical Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rebecca L. Cooper Medical Research Foundation	This work was supported by project grants from the Australian National Health and Medical Research Council (https://www.nhmrc.gov.au) (APP1030145 to W.W., APP512282 to MDG), a contract from the National Institutes of Health (https://www.niaid.nih.gov/Pages/default.aspx) (BAA-NIAID-DAIT-HHSN272201100018C to W.W.), and the Rebecca L. Cooper Medical Research Foundation (http://www.cooperfoundation.org.au) (MDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya PS, 2006, HUM PATHOL, V37, P352, DOI 10.1016/j.humpath.2005.11.020; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; AOYAMA A, 1990, P NATL ACAD SCI USA, V87, P8296, DOI 10.1073/pnas.87.21.8296; Arnold JN, 2014, CANCER IMMUNOL RES, V2, P121, DOI 10.1158/2326-6066.CIR-13-0150; Baird SK, 2015, APOPTOSIS, V20, P1483, DOI 10.1007/s10495-015-1166-5; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Brokopp CE, 2011, EUR HEART J, V32, P2713, DOI 10.1093/eurheartj/ehq519; Chowdhury S, 2013, WORLD J GASTROENTERO, V19, P2883, DOI 10.3748/wjg.v19.i19.2883; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Cooksley CD, 2005, CANCER-AM CANCER SOC, V104, P618, DOI 10.1002/cncr.21203; Coppage AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151269; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Denton AE, 2014, P NATL ACAD SCI USA, V111, P12139, DOI 10.1073/pnas.1412910111; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dunshee DR, 2016, J BIOL CHEM, V291, P5986, DOI 10.1074/jbc.M115.710582; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Fan MH, 2016, J BIOL CHEM, V291, P8070, DOI 10.1074/jbc.M115.701433; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Ghersi G, 2002, J BIOL CHEM, V277, P29231, DOI 10.1074/jbc.M202770200; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Guo J, 2015, INT J CLIN EXP PATHO, V8, P10014; Hamson EJ, 2014, PROTEOM CLIN APPL, V8, P454, DOI 10.1002/prca.201300095; Huang SC, 2011, J DRUG TARGET, V19, P487, DOI 10.3109/1061186X.2010.511225; Jacob M, 2012, CURR MOL MED, V12, P1220, DOI 10.2174/156652412803833607; Jenkins MR, 2006, J IMMUNOL, V177, P2917, DOI 10.4049/jimmunol.177.5.2917; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Keane FM, 2014, FEBS OPEN BIO, V4, P43, DOI 10.1016/j.fob.2013.12.001; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kelly T, 2012, INT REV CEL MOL BIO, V297, P83, DOI 10.1016/B978-0-12-394308-8.00003-0; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Koczorowska MM, 2016, MOL ONCOL, V10, P40, DOI 10.1016/j.molonc.2015.08.001; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; LeBeau AM, 2009, MOL CANCER THER, V8, P1378, DOI 10.1158/1535-7163.MCT-08-1170; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Levy MT, 2002, LIVER, V22, P93, DOI 10.1034/j.1600-0676.2002.01503.x; Lo A, 2015, CANCER RES, V75, P2800, DOI 10.1158/0008-5472.CAN-14-3041; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1877; MONSKY WL, 1994, CANCER RES, V54, P5702; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Osborne B, 2014, BBA-PROTEINS PROTEOM, V1844, P1248, DOI 10.1016/j.bbapap.2014.03.015; Ospelt C, 2010, ARTHRITIS RHEUM-US, V62, P1224, DOI 10.1002/art.27395; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Ramirez-Montagut T, 2004, ONCOGENE, V23, P5435, DOI 10.1038/sj.onc.1207730; RETTIG WJ, 1993, CANCER RES, V53, P3327; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; Roberts EW, 2013, J EXP MED, V210, P1137, DOI 10.1084/jem.20122344; Rovedatti L, 2011, INFLAMM BOWEL DIS, V17, P1251, DOI 10.1002/ibd.21446; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Schreiber H, 2010, SCIENCE, V330, P761, DOI 10.1126/science.1198345; Schuberth PC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-187; Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x; Sun SX, 2002, PROTEIN EXPRES PURIF, V24, P274, DOI 10.1006/prep.2001.1572; Tan SY, 2012, IMMUNOL CELL BIOL, V90, P722, DOI 10.1038/icb.2011.104; Teichgraber V, 2015, ADV MED SCI-POLAND, V60, P264, DOI 10.1016/j.advms.2015.04.006; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Waumans Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00387; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871; Yan SL, 2012, EUR J IMMUNOL, V42, P533, DOI 10.1002/eji.201041038; Yan SL, 2003, EUR J IMMUNOL, V33, P1519, DOI 10.1002/eji.200323469; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhang YD, 2016, ONCOTARGET; Zhen EY, 2016, BIOCHEM J, V473, P605, DOI 10.1042/BJ20151085	75	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171194	10.1371/journal.pone.0171194	http://dx.doi.org/10.1371/journal.pone.0171194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158223	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700041
J	Villalobos, C; Maldonado, PE; Valdes, JL				Villalobos, Claudio; Maldonado, Pedro E.; Valdes, Jose L.			Asynchronous ripple oscillations between left and right hippocampi during slow-wave sleep	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; SPATIAL MEMORY; EPISODIC MEMORY; TAXI DRIVERS; NETWORK; RAT; ACTIVATION; ALLOCATION; ASYMMETRY; PATTERNS	Spatial memory, among many other brain processes, shows hemispheric lateralization. Most of the published evidence suggests that the right hippocampus plays a leading role in the manipulation of spatial information. Concurrently in the hippocampus, memory consolidation during sleep periods is one of the key steps in the formation of newly acquired spatial memory traces. One of the most characteristic oscillatory patterns in the hippocampus are sharp-wave ripple (SWR) complexes. Within this complex, fast -field oscillations or ripples have been demonstrated to be instrumental in the memory consolidation process. Since these ripples are relevant for the consolidation of memory traces associated with spatial navigation, and this process appears to be lateralized, we hypothesize that ripple events between both hippocampi would exhibit different temporal dynamics. We tested this idea by using a modified "split-hyperdrive" that allows us to record simultaneous LFPs from both right and left hippocampi of Sprague-Dawley rats during sleep. We detected individual events and found that during sleep periods these ripples exhibited a different occurrence patterns between hemispheres. Most ripple events were synchronous between intra- rather than inter -hemispherical recordings, suggesting that ripples in the hippocampus are independently generated and locally propagated within a specific hemisphere. In this study, we propose the ripples' lack of synchrony between left and right hippocampi as the putative physiological mechanism underlying lateralization of spatial memory.	[Villalobos, Claudio; Maldonado, Pedro E.; Valdes, Jose L.] Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Santiago, Chile; [Villalobos, Claudio; Maldonado, Pedro E.; Valdes, Jose L.] Univ Chile, Biomed Neurosci Inst, Santiago, Chile; [Villalobos, Claudio] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA USA; [Villalobos, Claudio] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Biobehav Sci, Los Angeles, CA USA	Universidad de Chile; Universidad de Chile; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Maldonado, PE; Valdes, JL (corresponding author), Univ Chile, Fac Med, ICBM, Programa Disciplinario Fisiol & Biofis, Santiago, Chile.; Maldonado, PE; Valdes, JL (corresponding author), Univ Chile, Biomed Neurosci Inst, Santiago, Chile.	pedro@neuro.med.uchile.cl; jlvaldes@med.uchile.cl	Maldonado, Pedro/AAH-7670-2019	Valdes, Jose L/0000-0002-9178-2743; VILLALOBOS, CLAUDIO/0000-0002-7943-5888	Iniciativa Cientifica Milenio, Center for Neuroscience of Memory [P10-001-F]; Iniciativa Cientifica Milenio, Biomedical Neuroscience Institute [ICM P09-015-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [3140473]; Anillo Conicyt [ACT-66]; Puelma Foundation	Iniciativa Cientifica Milenio, Center for Neuroscience of Memory; Iniciativa Cientifica Milenio, Biomedical Neuroscience Institute; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Puelma Foundation	This work was supported by Iniciativa Cientifica Milenio, Center for Neuroscience of Memory, #P10-001-F and Iniciativa Cientifica Milenio, Biomedical Neuroscience Institute, ICM P09-015-F (JLV, PEM) http:/www.iniciativamilenio.cl, Fondo Nacional de Desarrollo Cientifico y Tecnologico #3140473 (CV) Anillo Conicyt ACT-66 (PEM, JLV) http://www.conicyt.cl/ fondecyt, Puelma Foundation (PEM, JLV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Bohbot VD, 2002, PHYSIOL RES, V51, pS49; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Herve PY, 2013, TRENDS COGN SCI, V17, P69, DOI 10.1016/j.tics.2012.12.004; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Motley SE, 2012, J NEUROSCI, V32, P13076, DOI 10.1523/JNEUROSCI.5920-11.2012; Oliva A, 2016, NEURON, V91, P1342, DOI 10.1016/j.neuron.2016.08.008; Patel J, 2013, J NEUROSCI, V 33, P17029, DOI 10.1523/JNEUROSCI.2036-13.2013; Rogers LJ, 2014, GENESIS, V52, P555, DOI 10.1002/dvg.22741; Roumis DK, 2015, CURR OPIN NEUROBIOL, V35, P6, DOI 10.1016/j.conb.2015.05.001; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; Yun SH, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0003.2002	31	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171304	10.1371/journal.pone.0171304	http://dx.doi.org/10.1371/journal.pone.0171304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158285	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700057
J	Wang, X; Li, YS; Zhang, J; Zhang, QW; Liu, XX; Li, Z				Wang, Xiu; Li, Yisong; Zhang, Jing; Zhang, Qingwen; Liu, Xiaoxia; Li, Zhen			De novo characterization of microRNAs in oriental fruit moth Grapholita molesta and selection of reference genes for normalization of microRNA expression	PLOS ONE			English	Article							REAL-TIME; SMALL RNA; HELICOVERPA-ARMIGERA; RT-PCR; LEPIDOPTERA-TORTRICIDAE; PHOTOPERIODIC DIAPAUSE; FUNCTIONAL-ANALYSIS; ECDYSONE RECEPTOR; FAT-BODY; QRT-PCR	MicroRNAs (miRNAs) are a group of endogenous non-coding small RNAs that have critical regulatory functions in almost all known biological processes at the post-transcriptional level in a variety of organisms. The oriental fruit moth Grapholita molesta is one of the most serious pests in orchards worldwide and threatens the production of Rosacea fruits. In this study, a de novo small RNA library constructed from mixed stages of G. molesta was sequenced through Illumina sequencing platform and a total of 536 mature miRNAs consisting of 291 conserved and 245 novel miRNAs were identified. Most of the conserved and novel miRNAs were detected with moderate abundance. The miRNAs in the same cluster normally showed correlated expressional profiles. A comparative analysis of the 79 conserved miRNA families within 31 arthropod species indicated that these miRNA families were more conserved among insects and within orders of closer phylogenetic relationships. The KEGG pathway analysis and network prediction of target genes indicated that the complex composed of miRNAs, clock genes and developmental regulation genes may play vital roles to regulate the developmental circadian rhythm of G. molesta. Furthermore, based on the sRNA library of G. molesta, suitable reference genes were selected and validated for study of miRNA transcriptional profile in G. molesta under two biotic and six abiotic experimental conditions. This study systematically documented the miRNA profile in G. molesta, which could lay a foundation for further understanding of the regulatory roles of miRNAs in the development and metabolism in this pest and might also suggest clues to the development of genetic-based techniques for agricultural pest control.	[Wang, Xiu; Li, Yisong; Zhang, Jing; Zhang, Qingwen; Liu, Xiaoxia; Li, Zhen] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Li, Yisong] Shihezi Univ, Dept Plant Protect, Shihezi, Peoples R China	China Agricultural University; Shihezi University	Liu, XX; Li, Z (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	liuxiaoxia611@cau.edu.cn; lizhencau@cau.edu.cn			Chinese Universities Scientific Fund [2014XJ018]; Modern Agro-industry Technology Research System Grants [CARS-29-08]	Chinese Universities Scientific Fund; Modern Agro-industry Technology Research System Grants	This study was supported by Chinese Universities Scientific Fund (No. 2014XJ018) and Modern Agro-industry Technology Research System Grants (No. CARS-29-08). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Andrews SV, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0107-z; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Biryukova I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-557; Blenkiron C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122203; Boisen MK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2030-2; Cao JJ, 2015, COMP BIOCHEM PHYS B, V190, P54, DOI 10.1016/j.cbpb.2015.08.008; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Chang ZX, 2016, INSECT SCI, V23, P452, DOI 10.1111/1744-7917.12343; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Choi IK, 2012, DEV COMP IMMUNOL, V37, P50, DOI 10.1016/j.dci.2011.12.008; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Gharbi S, 2015, CELL J, V17, P494; Greenberg JK, 2012, GENES BRAIN BEHAV, V11, P660, DOI 10.1111/j.1601-183X.2012.00782.x; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; He J, 2016, P NATL ACAD SCI USA, V113, P584, DOI 10.1073/pnas.1521098113; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Hussain M, 2010, J VIROL, V84, P612, DOI 10.1128/JVI.01794-09; Ikeno T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-116; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jayachandran B, 2013, J INVERTEBR PATHOL, V114, P151, DOI 10.1016/j.jip.2013.07.004; Jiang JH, 2013, INSECT BIOCHEM MOLEC, V43, P692, DOI 10.1016/j.ibmb.2013.05.002; Jin H, 2012, GENE DEV, V26, P1427, DOI 10.1101/gad.192872.112; Kagias K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-222; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanga LHB, 2003, PEST MANAG SCI, V59, P921, DOI 10.1002/ps.702; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kim K, 2014, CELL REP, V7, P2066, DOI 10.1016/j.celrep.2014.05.025; Kirk H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-12; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Li GW, 2016, ARCH INSECT BIOCHEM, V91, P67, DOI 10.1002/arch.21309; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Liang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078787; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Liu F, 2012, INSECT MOL BIOL, V21, P297, DOI 10.1111/j.1365-2583.2012.01135.x; Liu SP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-88; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-85; Long QX, 2017, METHODS MOL BIOL, V1540, P211, DOI 10.1007/978-1-4939-6700-1_17; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Macedo LMF, 2016, INSECT MOL BIOL, V25, P216, DOI 10.1111/imb.12214; Mahdipour M, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0075-8; Marco A, 2010, GENOME BIOL EVOL, V2, P686, DOI 10.1093/gbe/evq053; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meuti ME, 2013, INTEGR COMP BIOL, V53, P131, DOI 10.1093/icb/ict023; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Nelson C, 2014, MOL CELL, V56, P376, DOI 10.1016/j.molcel.2014.09.011; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ninova M, 2014, GENOME BIOL EVOL, V6, P2459, DOI 10.1093/gbe/evu183; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ragupathy R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39373; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rothschild G. H. L., 1991, TORTRICID PESTS THEI, V5, P389; Rubio M, 2013, J INSECT PHYSIOL, V59, P1089, DOI 10.1016/j.jinsphys.2013.09.003; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Sun KL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002515; Surridge AK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-62; Tollerup KE, 2012, J ECON ENTOMOL, V105, P1712, DOI 10.1603/EC11419; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168166; Yang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098164; Yang YT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00086; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhang XF, 2015, INSECT BIOCHEM MOLEC, V62, P11, DOI 10.1016/j.ibmb.2014.08.006; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006; Zhang YL, 2015, GENE, V557, P215, DOI 10.1016/j.gene.2014.12.038; Zhou GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103041; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4; Zhu X, 2015, INT J MOL SCI, V16, P8310, DOI 10.3390/ijms16048310	98	12	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171120	10.1371/journal.pone.0171120	http://dx.doi.org/10.1371/journal.pone.0171120			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158242	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700030
J	Yang, CR; Shang, XY; Cheng, L; Yang, L; Liu, XF; Bai, CL; Wei, ZY; Hua, JL; Li, GP				Yang, Chunrong; Shang, Xueying; Cheng, Lei; Yang, Lei; Liu, Xuefei; Bai, Chunling; Wei, Zhuying; Hua, Jinlian; Li, Guangpeng			DNMT 1 maintains hypermethylation of CAG promoter specific region and prevents expression of exogenous gene in fat-1 transgenic sheep	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DNA METHYLATION; STEM-CELLS; MICE; GENOME; MUSCLE; CATTLE; MODEL; PIGS	Methylation is an important issue in gene expression regulation and also in the fields of genetics and reproduction. In this study, we created fat-1 transgenic sheep, investigated the fine-mapping and the modulatory mechanisms of promoter methylation. Sheep fetal fibroblasts were transfected by pCAG-fat1-IRES-EGFP. Monoclonal cell line was screened as nuclear donor and carried out nuclear transfer (441 transgenic cloned embryos, 52 synchronism recipient sheep). Six offsprings were obtained. Expressions of exogenous genes fat-1 and EGFP were detectable in 10 examined tissues and upregulated omega-3 fatty acid content. Interestingly, more or less EGFP negative cells were detectable in the positive transgenic fetal skin cells. EGFP negative and positive cells were sorted by flow cytometry, and their methylation status in the whole promoter region (1701 nt) were investigated by bisulphate sequencing. The fine-mapping of methylation in CAG promoter were proposed. The results suggested that exogenous gene expression was determined by the methylation status from 721-1346 nt and modulated by methylation levels at 101, 108 and 115 nt sites in CAG promoter. To clarify the regulatory mechanism of methylation, examination of four DNA methyltransferases (DNMTs) demonstrated that hypermethylation of CAG promoter is mainly maintained by DNMT 1 in EGFP negative cells. Furthermore, investigation of the cell surface antigen CD34, CD45 and CD166 indicated that EGFP positive and negative cells belong to different types. The present study systematically clarified methylation status of CAG promoter in transgenic sheep and regulatory mechanism, which will provide research strategies for gene expression regulation in transgenic animals.	[Yang, Chunrong; Cheng, Lei; Yang, Lei; Liu, Xuefei; Bai, Chunling; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, Res Ctr Lab Anim Sci, Hohhot, Peoples R China; [Yang, Chunrong] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China; [Shang, Xueying] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Hua, Jinlian] Northwest A&F Univ, Coll Vet Med, Yangling, Peoples R China	Inner Mongolia University; Huazhong Agricultural University; Northwest A&F University - China; Northwest A&F University - China	Li, GP (corresponding author), Inner Mongolia Univ, Res Ctr Lab Anim Sci, Hohhot, Peoples R China.	gpengli@imu.edu.cn		Yang, Lei/0000-0002-9767-9026	National Natural Science Foundation of China [31372289]; Key basic research project of Inner Mongolia Autonomous Region [20130902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key basic research project of Inner Mongolia Autonomous Region	This work was supported by National Natural Science Foundation of China (grant No. 31372289) and Key basic research project of Inner Mongolia Autonomous Region (grant No. 20130902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15465; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Gao MM, 2014, CELL RES, V24, P380, DOI 10.1038/cr.2014.2; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Guo T, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-244; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Han YM, 2016, INT J CANCER, V138, P2247, DOI 10.1002/ijc.29956; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep08292; Li ZG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0685-2; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liu X, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0895-2; McKinney-Freeman S, 2002, EXP HEMATOL, V30, P47; Miao XY, 2013, CELL MOL LIFE SCI, V70, P815, DOI 10.1007/s00018-012-1081-7; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Poh WJ, 2016, THERANOSTICS, V6, P369, DOI 10.7150/thno.13438; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Richards MP, 2011, FOOD BIOTECHNOL, V25, P103, DOI 10.1080/08905436.2011.576552; Samiec M, 2005, MED WETER, V61, P24; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Venkatesh MN, 2008, RES J BIOTECHNOL, V3, P53; Wang W, 2012, J ANIM VET ADV, V11, P1041; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yang C, 2012, J FISH BIOL, V80, P2605, DOI 10.1111/j.1095-8649.2012.03316.x; Zeyland J, 2013, J APPL GENET, V54, P293, DOI 10.1007/s13353-013-0156-y; Zhang P, 2012, CELL REPROGRAM, V14, P258, DOI 10.1089/cell.2011.0073; Zhou L, 2014, MOL HUM REPROD, V20, P271, DOI 10.1093/molehr/gat081; Zhou Y, 2014, MOL BIOL REP, V41, P5177, DOI 10.1007/s11033-014-3385-1	39	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171442	10.1371/journal.pone.0171442	http://dx.doi.org/10.1371/journal.pone.0171442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158319	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700080
J	Della Ventura, B; Iannaccone, M; Funari, R; Ciamarra, MP; Altucci, C; Capparelli, R; Roperto, S; Velotta, R				Della Ventura, Bartolomeo; Iannaccone, Marco; Funari, Riccardo; Ciamarra, Massimo Pica; Altucci, Carlo; Capparelli, Rosanna; Roperto, Sante; Velotta, Raffaele			Effective antibodies immobilization and functionalized nanoparticles in a quartz-crystal microbalance-based immunosensor for the detection of parathion	PLOS ONE			English	Article							GOLD NANOPARTICLES; SENSITIVE DETECTION; QCM IMMUNOSENSOR; PIEZOELECTRIC IMMUNOSENSOR; SMALL MOLECULES; BIOSENSORS; AMPLIFICATION; ORIENTATION	Background Biosensor-based detection provides a rapid and low-cost alternative to conventional analytical methods for revealing the presence of the contaminants in water as well as solid matrices. Although important to be detected, small analytes (few hundreds of Daltons) are an issue in biosensing since the signal they induce in the transducer, and specifically in a Quartz-Crystal Microbalance, is undetectable. A pesticide like parathion (M = 292 Da) is a typical example of contaminant for which a signal amplification procedure is desirable. Methods/Findings The ballasting of the analyte by gold nanoparticles has been already applied to heavy target as proteins or bacteria to improve the limit of detection. In this paper, we extend the application of such a method to small analytes by showing that once the working surface of a QuartzCrystal Microbalance (QCM) has been properly functionalized, a limit of detection lower than 1 ppb is reached for parathion. The effective surface functionalization is achieved by immobilizing antibodies upright oriented on the QCM gold surface by a simple photochemical technique (Photonic Immobilization Technique, PIT) based on the UV irradiation of the antibodies, whereas a simple protocol provided by the manufacturer is applied to functionalize the gold nanoparticles. Thus, in a non-competitive approach, the small analyte is made detectable by weighing it down through a "sandwich protocol" with a second antibody tethered to heavy gold nanoparticles. The immunosensor has been proved to be effective against the parathion while showing no cross reaction when a mixture of compounds very similar to parathion is analyzed. Conclusion/Significance The immunosensor described in this paper can be easily applied to any small molecule for which polyclonal antibodies are available since both the functionalization procedure of the QCM probe surface and gold nanoparticle can be applied to any IgG, thereby making our device of general application in terms of target analyte.	[Della Ventura, Bartolomeo; Funari, Riccardo; Altucci, Carlo; Velotta, Raffaele] Univ Naples Federico II, Dept Phys Ettore Pancini, Naples, Italy; [Iannaccone, Marco; Capparelli, Rosanna; Roperto, Sante] Univ Naples Federico II, Dept Agr, Portici, Italy; [Ciamarra, Massimo Pica] Nanyang Technol Univ, Sch Math Sci, Div Phys & Appl Phys, Singapore, Singapore; [Ciamarra, Massimo Pica] Univ Naples Federico II, CNR, SPIN, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II	Velotta, R (corresponding author), Univ Naples Federico II, Dept Phys Ettore Pancini, Naples, Italy.	rvelotta@unina.it	DELLA VENTURA, BARTOLOMEO/AAC-7761-2022; Ciamarra, Massimo Pica/F-2865-2011; Velotta, Raffaele/I-5298-2012; Iannaccone, Marco/K-7559-2016; Pica Ciamarra, Massimo/GRR-4883-2022; Capparelli, Rosanna/Q-3144-2017; Altucci, Carlo/AAK-1271-2020; Funari, Riccardo/N-3541-2017	DELLA VENTURA, BARTOLOMEO/0000-0003-2920-6187; Ciamarra, Massimo Pica/0000-0001-8931-9058; Velotta, Raffaele/0000-0003-1077-8353; Iannaccone, Marco/0000-0002-2283-6613; Capparelli, Rosanna/0000-0001-8614-6251; Altucci, Carlo/0000-0003-2270-9128; Funari, Riccardo/0000-0003-1786-3833; roperto, sante/0000-0001-6210-5519	Fondazione con ilSud [2011-PDR-18]; Italian Ministry for Reaserch (MIUR) [PON_0101517]	Fondazione con ilSud; Italian Ministry for Reaserch (MIUR)(Ministry of Education, Universities and Research (MIUR))	We acknowledge the financial support of the "Fondazione con ilSud" (project Nr. 2011-PDR-18, "Biosensoripiezoelettrici a risposta in tempo reale per applicazioniambientali e agro-alimentari" and the Italian Ministry for Reaserch (MIUR) under the Grant No. PON_0101517.	Aitken A., 2002, PROTEIN PROTOCOLS HD; Akter R, 2015, BIOSENS BIOELECTRON, V66, P539, DOI 10.1016/j.bios.2014.12.007; Chauhan R, 2016, SENSOR ACTUAT B-CHEM, V222, P804, DOI 10.1016/j.snb.2015.08.117; Cheng SY, 2012, ANAL CHEM, V84, P2129, DOI 10.1021/ac3001463; Chu X, 2006, SENSOR ACTUAT B-CHEM, V114, P696, DOI 10.1016/j.snb.2005.06.014; Della Ventura B, 2015, APPL PHYS B-LASERS O, V119, P497, DOI 10.1007/s00340-015-6091-3; Della Ventura B, 2011, BIOMED OPT EXPRESS, V2, P3223, DOI 10.1364/BOE.2.003223; Ding PF, 2013, SENSOR ACTUAT B-CHEM, V188, P1277, DOI 10.1016/j.snb.2013.07.099; Fonseca RAS, 2011, SENSORS-BASEL, V11, P10785, DOI 10.3390/s111110785; Funari R, 2016, LANGMUIR; Funari R, 2015, BIOSENS BIOELECTRON, V67, P224, DOI 10.1016/j.bios.2014.08.020; Funari R, 2013, ANAL CHEM, V85, P6392, DOI 10.1021/ac400852c; Geschwindner S, 2012, SENSORS-BASEL, V12, P4311, DOI 10.3390/s120404311; Hao RZ, 2011, BIOSENS BIOELECTRON, V26, P3398, DOI 10.1016/j.bios.2011.01.010; Ioerger TR, 1999, MOL IMMUNOL, V36, P373, DOI 10.1016/S0161-5890(99)00032-2; Jiang XS, 2011, BIOSENS BIOELECTRON, V29, P23, DOI 10.1016/j.bios.2011.07.059; Jin XF, 2009, ANAL CHIM ACTA, V645, P92, DOI 10.1016/j.aca.2009.04.041; Jones AM, 2013, CURR OPIN PLANT BIOL, V16, P389, DOI 10.1016/j.pbi.2013.02.010; Jung Y, 2008, ANALYST, V133, P697, DOI 10.1039/b800014j; Justino CIL, 2016, TRAC TRENDS ANAL CHE; Leng CA, 2010, ANAL CHIM ACTA, V666, P97, DOI 10.1016/j.aca.2010.03.060; Li DJ, 2011, BIOSENS BIOELECTRON, V26, P4146, DOI 10.1016/j.bios.2011.04.010; Li YY, 2010, GOLD BULL, V43, P29, DOI 10.1007/BF03214964; Masson J-F, 2015, NANOBIOSENSORS NANOB, P305; MILLES HL, 1950, BRIT MED J, V2, P444, DOI 10.1136/bmj.2.4676.444; Mitchell JS, 2010, BIOSENSORS, P151; Neves-Petersen M. T., 2012, MOL PHOTOCHEMISTRY V; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Nicu L, 2008, J APPL PHYS, V104, DOI 10.1063/1.2973147; Salam F, 2013, TALANTA, V115, P761, DOI 10.1016/j.talanta.2013.06.034; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Schultz NM, 1997, HDB CAPILLARY ELECTR, P611; Sharma V, 2009, MAT SCI ENG R, V65, P1, DOI 10.1016/j.mser.2009.02.002; Springer T, 2014, ANAL CHEM, V86, P10350, DOI 10.1021/ac502637u; Trilling AK, 2013, ANALYST, V138, P1619, DOI 10.1039/c2an36787d; Trilling AK, 2013, BIOSENS BIOELECTRON, V40, P219, DOI 10.1016/j.bios.2012.07.027; Vashist SK, 2011, J SENSORS, V2011, DOI 10.1155/2011/571405; VIOT P, 1992, J CHEM PHYS, V97, P5212, DOI 10.1063/1.463820; Wang JL, 2008, ANAL CHEM, V80, P7174, DOI 10.1021/ac801281c; Wang XH, 2008, SENSORS-BASEL, V8, P6045, DOI 10.3390/s8096045; Xia F, 2010, P NATL ACAD SCI USA, V107, P10837, DOI 10.1073/pnas.1005632107; Zheng B, 2013, ANAL BIOCHEM, V438, P144, DOI 10.1016/j.ab.2013.03.030	42	25	25	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171754	10.1371/journal.pone.0171754	http://dx.doi.org/10.1371/journal.pone.0171754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182720	Green Published, gold			2022-12-27	WOS:000394231800100
J	Salih, RHM; Majesky, L; Schwarzacher, T; Gornall, R; Heslop-Harrison, P				Salih, Rubar Hussein M.; Majesky, Lubos; Schwarzacher, Trude; Gornall, Richard; Heslop-Harrison, Pat			Complete chloroplast genomes from apomictic Taraxacum (Asteraceae): Identity and variation between three microspecies	PLOS ONE			English	Article							GENETIC-STRUCTURE; PLASTID GENOMES; DNA; SEQUENCE; EVOLUTION; ORGANIZATION; INHERITANCE; IDENTIFICATION; ANGIOSPERMS; COMPOSITAE	Chloroplast DNA sequences show substantial variation between higher plant species, and less variation within species, so are typically excellent markers to investigate evolutionary, population and genetic relationships and phylogenies. We sequenced the plastomes of Taraxacum obtusifrons Markl. (O978); T. stridulum Travnicek ined. (S3); and T. amplum Markl. (A978), three apomictic triploid (2n = 3x = 24) dandelions from the T. officinale agg. We aimed to characterize the variation in plastomes, define relationships and correlations with the apomictic microspecies status, and refine placement of the microspecies in the evolutionary or phylogenetic context of the Asteraceae. The chloroplast genomes of accessions O978 and S3 were identical and 151,322 bp long (where the nuclear genes are known to show variation), while A978 was 151,349 bp long. All three genomes contained 135 unique genes, with an additional copy of the trnF-GGA gene in the LSC region and 20 duplicated genes in the IR region, along with short repeats, the typical major Inverted Repeats (IR1 and IR2, 24,431bp long), and Large and Small Single Copy regions (LSC 83,889bp and SSC 18,571bp in O978). Between the two Taraxacum plastomes types, we identified 28 SNPs. The distribution of polymorphisms suggests some parts of the Taraxacum plastome are evolving at a slower rate. There was a hemi-nested inversion in the LSC region that is common to Asteraceae, and an SSC inversion from ndhF to rps15 found only in some Asteraceae lineages. A comparative repeat analysis showed variation between Taraxacum and the phylogenetically close genus Lactuca, with many more direct repeats of 40bp or more in Lactuca (1% larger plastome than Taraxacum). When individual genes and non-coding regions were for Asteraceae phylogeny reconstruction, not all showed the same evolutionary scenario suggesting care is needed for interpretation of relationships if a limited number of markers are used. Studying genotypic diversity in plastomes is important to characterize the nature of evolutionary processes in nuclear and cytoplasmic genomes with the different selection pressures, population structures and breeding systems.	[Salih, Rubar Hussein M.; Schwarzacher, Trude; Gornall, Richard; Heslop-Harrison, Pat] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Salih, Rubar Hussein M.] Univ Sulaimani, Fac Agr Sci, Field Crops Dept, Sulaimani, Kurdistan Regio, Iraq; [Majesky, Lubos] Palacky Univ Olomouc, Fac Sci, Dept Bot, Olomouc, Olomouc Holice, Czech Republic	University of Leicester; University of Sulimanyah; Palacky University Olomouc	Salih, RHM; Heslop-Harrison, P (corresponding author), Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England.; Salih, RHM (corresponding author), Univ Sulaimani, Fac Agr Sci, Field Crops Dept, Sulaimani, Kurdistan Regio, Iraq.	river202002@yahoo.com; phh4@le.ac.uk	Heslop-Harrison, J.S./M-9826-2019	Heslop-Harrison, J.S./0000-0002-3105-2167; Schwarzacher, Trude/0000-0001-8310-5489; Majesky, Lubos/0000-0002-8860-5703				Ahmed I, 2012, GENOME BIOL EVOL, V4, P1316, DOI 10.1093/gbe/evs110; Asker S. E., 1992, APOMIXIS PLANTS; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Doorduin L, 2011, DNA RES, V28; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellis JR, 2008, HEREDITY, V100, P574, DOI 10.1038/hdy.2008.11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FORD H, 1985, BIOL J LINN SOC, V25, P169, DOI 10.1111/j.1095-8312.1985.tb00390.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Heslop-Harrison JS, 1997, GENETICA, V100, P197, DOI 10.1023/A:1018337831039; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kanamoto H, 2004, PLANT CELL PHYSIOL, V45, pS39; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kilian N., 2009, SYSTEMATICS, P343; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; KING LM, 1990, P NATL ACAD SCI USA, V87, P998, DOI 10.1073/pnas.87.3.998; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; Kirschner J, 2016, PRESLIA, V88, P1; Kirschner J, 2015, PLANT SYST EVOL, V301, P1135, DOI 10.1007/s00606-014-1139-0; Kumar S, 2009, BMC PLANT BIOL, V17, P1; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048970; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu C, 2015, MITOCHONDR DNA, P1; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Majesky L, 2015, PLANT SYST EVOL, V301, P2105, DOI 10.1007/s00606-015-1218-x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; McCauley DE, 2007, AM J BOT, V94, P1333, DOI 10.3732/ajb.94.8.1333; MENDEL G, 1951, J HERED, V42, P3; Mes THM, 2002, MOL ECOL, V11, P253, DOI 10.1046/j.1365-294X.2002.01427.x; Mes THM, 2000, GENOME, V43, P634, DOI 10.1139/gen-43-4-634; MOGIE M, 1988, BIOL J LINN SOC, V35, P155, DOI 10.1111/j.1095-8312.1988.tb00463.x; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Nogler G. A, 1984, GAMETOPHYTIC APOMIXI; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; RAUBESON LA, 1992, BIOCHEM SYST ECOL, V20, P17, DOI 10.1016/0305-1978(92)90067-N; Richards A. J., 1986, PLANT BREEDING SYSTE; RICHARDS AJ, 1973, BOT J LINN SOC, V66, P189, DOI 10.1111/j.1095-8339.1973.tb02169.x; RICHARDS AJ, 1989, PLANT SYST EVOL, V163, P177, DOI 10.1007/BF00936513; Saeidi H, 2006, GENET RESOUR CROP EV, V53, P1477, DOI 10.1007/s10722-005-7110-8; Sarkinen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082266; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Sterk AA, 1987, PAARDE BLOEMEN PLANT, P184; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; Turner KG, 2014, CENTAUREA DIFFUSA, V1; van der Hulst RGM, 2000, MOL ECOL, V9, P1, DOI 10.1046/j.1365-294x.2000.00704.x; Van der Hulst RGM, 2003, HEREDITY, V90, P326, DOI 10.1038/sj.hdy.6800248; Walker JF, 2014, AM J BOT, V101, P722, DOI 10.3732/ajb.1400049; Wang MX, 2015, PLANT MOL BIOL REP, V33, P1526, DOI 10.1007/s11105-015-0853-2; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082692; Wittzell H, 1999, MOL ECOL, V8, P2023, DOI 10.1046/j.1365-294x.1999.00807.x; Wojciechowski MF, 2006, IRLC; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zehdi-Azouzi S, 2015, ANN BOT-LONDON, V116, P101, DOI 10.1093/aob/mcv068; Zhang Y, 2014, GENE, V549, P58, DOI 10.1016/j.gene.2014.07.041	76	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0168008	10.1371/journal.pone.0168008	http://dx.doi.org/10.1371/journal.pone.0168008			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182646	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800003
J	Wang, Q; Guo, JC; Hu, HL; Lu, YC; Zhang, JQ; Qin, BL; Wang, YF; Zhang, ZB; Wang, SG				Wang, Qing; Guo, Jiachao; Hu, Henglong; Lu, Yuchao; Zhang, Jiaqiao; Qin, Baolong; Wang, Yufeng; Zhang, Zongbiao; Wang, Shaogang			Rigid ureteroscopic lithotripsy versus percutaneous nephrolithotomy for large proximal ureteral stones: A meta-analysis	PLOS ONE			English	Article							ANTEGRADE URETEROLITHOTRIPSY; LASER LITHOTRIPSY; MANAGEMENT; COMPLICATIONS; RETROGRADE; HOLMIUM; CALCULI; EFFICACY; REMOVAL; MINI	Object To compare the safety and efficacy of rigid ureteroscopic lithotripsy (rigid URSL) and percutaneous nephrolithotomy (PCNL) in treating large proximal ureteral stones. Methods A systematic search of PubMed, EMBASE, Cochrane Library, and Web of Science databases was performed to find out relevant studies. After literature screening according to the predetermined inclusion and exclusion criteria, data of eligible studies was extracted and then a meta-analysis was conducted via RevMan 5.3 software. Results Five randomized controlled trials (RCTs), one prospective and four retrospective cohort studies involving 837 patients were included. Patients underwent rigid URSL were associated with shorter operation time (WMD, -23.66min; 95% CI, - 45.00 to -2.32; p = 0.03), shorter hospital stay (WMD, -2.76d; 95% CI, -3.51 to -2.02; p < 0.00001), lower 3rd-day (RR, 0.73; 95% CI, 0.66 to 0.82; p < 0.00001) and 1st-month (RR, 0.82; 95% CI, 0.77 to 0.87; p < 0.00001) stone-free rate, higher risk of conversion to other surgical procedures (RR, 4.28; 95% CI, 1.93 to 9.46; p = 0.0003), higher incidence of migration (RR, 28.49; 95% CI, 9.12 to 89.00; p < 0.00001) and ureteral perforation (RR, 6.06; 95% CI, 1.80 to 20.44; p = 0.004), lower risk of fever (RR, 0.64; 95% CI, 0.42 to 0.97; p = 0.04), transfusion (RR, 0.19; 95% CI, 0.04 to 0.85; p = 0.03) and hematuria (RR, 0.38; 95% CI, 0.25 to 0.57; p < 0.0001). No significant difference was observed in terms of incidence of embolization, pain and ureterostenosis. When cohort studies or studies in which flexible ureteroscopy was used as an intraoperative auxiliary procedure were excluded, we both found that most of the results kept stable. Conclusions Both PCNL and rigid URSL are safe for patients with large proximal ureteral stones while PCNL is more effective in stone clearance.	[Wang, Qing; Hu, Henglong; Lu, Yuchao; Zhang, Jiaqiao; Qin, Baolong; Wang, Yufeng; Zhang, Zongbiao; Wang, Shaogang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan, Hubei, Peoples R China; [Guo, Jiachao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, SG (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan, Hubei, Peoples R China.	sgwangtjm@163.com	Wang, Shaogang/AGO-4944-2022; Zhang, Jiaqiao/GMX-0790-2022	Wang, Shaogang/0000-0002-3206-1495; Wang, Qing/0000-0001-6540-1858; Hu, Henglong/0000-0002-3618-7036				Basiri A, 2008, J ENDOUROL, V22, P2677, DOI 10.1089/end.2008.0095; Bozkurt IH, 2015, CUAJ-CAN UROL ASSOC, V9, pE122, DOI 10.5489/cuaj.2280; Chen DY, 2010, UROL SCI, V21, P81, DOI 10.1016/S1879-5226(10)60017-6; Chow GK, 2003, J UROLOGY, V170, P99, DOI 10.1097/01.ju.0000070883.44091.24; Dean A, SURG MANAGEMENT STON; Goel R, 2005, J ENDOUROL, V19, P54, DOI 10.1089/end.2005.19.54; Gu XJ, 2013, WORLD J UROL, V31, P1605, DOI 10.1007/s00345-013-1026-2; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hussain Manzoor, 1997, JPMA (Journal of the Pakistan Medical Association), V47, P159; Istanbulluoglu MO, 2011, UROL RES, V39, P389, DOI 10.1007/s00240-010-0351-9; Juan YS, 2008, KAOHSIUNG J MED SCI, V24, P204, DOI 10.1016/S1607-551X(08)70118-9; Juan YS, 2007, KAOHSIUNG J MED SCI, V23, P412, DOI 10.1016/S0257-5655(07)70005-6; Kallidonis P, 2016, CURR OPIN UROL, V26, P88, DOI 10.1097/MOU.0000000000000232; Kyriazis I, 2015, WORLD J UROL, V33, P1069, DOI 10.1007/s00345-014-1400-8; Lam JS, 2002, J UROLOGY, V167, P1972, DOI 10.1016/S0022-5347(05)65065-3; Leijte JAP, 2008, J ENDOUROL, V22, P257, DOI 10.1089/end.2007.0299; Li H, 2013, J ENDOUROL, V27, P1120, DOI 10.1089/end.2012.0535; Liu YH, 2013, PAK J MED SCI, V29, P1358; Long QL, 2013, UROL INT, V90, P384, DOI 10.1159/000343668; Maheshwari PN, 1999, J ENDOUROL, V13, P441, DOI 10.1089/end.1999.13.441; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Phillips BB BC, 2011, OXFORD CTR EVIDENCE; Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Qi SY, 2014, J ENDOUROL, V28, P1064, DOI 10.1089/end.2014.0167; Roberts WW, 1998, J UROLOGY, V159, P723, DOI 10.1016/S0022-5347(01)63711-X; Salem HK, 2009, UROLOGY, V74, P1216, DOI 10.1016/j.urology.2009.06.076; Seitz C, 2007, EUR UROL, V52, P1751, DOI 10.1016/j.eururo.2007.04.029; Seitz C, 2012, EUR UROL, V61, P146, DOI 10.1016/j.eururo.2011.09.016; Sun XW, 2008, J ENDOUROL, V22, P913, DOI 10.1089/end.2007.0230; Turk C, 2016, GUIDELINES UROLITHIA; Wells G.A., NEWCASTLE OTTAWA SCA; Wright A, 2016, THER ADV UROL, V8, P142, DOI 10.1177/1756287215617674; Wright Anna E, 2014, World J Nephrol, V3, P243, DOI 10.5527/wjn.v3.i4.243; Wu CF, 2004, J UROLOGY, V172, P1899, DOI 10.1097/01.ju.0000142848.43880.b3; Zhu HJ, 2014, J ENDOUROL, V28, P100, DOI 10.1089/end.2013.0391	36	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171478	10.1371/journal.pone.0171478	http://dx.doi.org/10.1371/journal.pone.0171478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182718	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800064
J	Gluchowska, M; Trudnowska, E; Goszczko, I; Kubiszyn, AM; Blachowiak-Samolyk, K; Walczowski, W; Kwasniewski, S				Gluchowska, Marta; Trudnowska, Emilia; Goszczko, Ilona; Kubiszyn, Anna Maria; Blachowiak-Samolyk, Katarzyna; Walczowski, Waldemar; Kwasniewski, Slawomir			Variations in the structural and functional diversity of zooplankton over vertical and horizontal environmental gradients en route to the Arctic Ocean through the Fram Strait	PLOS ONE			English	Article							WEST SPITSBERGEN CURRENT; MARGINAL ICE-ZONE; CALANUS-FINMARCHICUS; COMMUNITY STRUCTURE; NORTH-ATLANTIC; GREENLAND SEA; BARENTS-SEA; NORDIC SEAS; CANADA BASIN; SPRING BLOOM	A multi-scale approach was used to evaluate which spatial gradient of environmental variability is the most important in structuring zooplankton diversity in the West Spitsbergen Current (WSC). The WSC is the main conveyor of warm and biologically rich Atlantic water to the Arctic Ocean through the Fram Strait. The data set included 85 stratified vertical zooplankton samples (obtained from depths up to 1000 metres) covering two latitudinal sections (76 degrees 30' N and 79 degrees N) located across the multi-path WSC system. The results indicate that the most important environmental variables shaping the zooplankton structural and functional diversity and standing stock variability are those associated with depth, whereas variables acting in the horizontal dimension are of lesser importance. Multivariate analysis of the zooplankton assemblages, together with different univariate descriptors of zooplankton diversity, clearly illustrated the segregation of zooplankton taxa in the vertical plane. The epipelagic zone (upper 200 m) hosted plentiful, Oithona similis-dominated assemblages with a high proportion of filter-feeding zooplankton. Although total zooplankton abundance declined in the mesopelagic zone (200 - 1000 m), zooplankton assemblages in that zone were more diverse and more evenly distributed, with high contributions from both herbivorous and carnivorous taxa. The vertical distribution of integrated biomass (mg DW m (-2)) indicated that the total zooplankton biomass in the epipelagic and mesopelagic zones was comparable. Environmental gradients acting in the horizontal plane, such as the ones associated with different ice cover and timing of the spring bloom, were reflected in the latitudinal variability in protist community structure and probably caused differences in succession in the zooplankton community. High abundances of Calanus finmarchicus in the WSC core branch suggest the existence of mechanisms advantageous for higher productivity or/and responsible for physical concentration of zooplankton. Our results indicate that regional hydrography plays a primary role in shaping zooplankton variability in the WSC on the way to the Arctic Ocean, with additional effects caused by biological factors related to seasonality in pelagic ecosystem development, resulting in regional differences in food availability or biological production between the continental slope and the deep ocean regions.	[Gluchowska, Marta; Trudnowska, Emilia; Goszczko, Ilona; Kubiszyn, Anna Maria; Blachowiak-Samolyk, Katarzyna; Walczowski, Waldemar; Kwasniewski, Slawomir] Inst Oceanol Polish Acad Sci, Powstancow Warszawy Sopo, Poland	Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Gluchowska, M (corresponding author), Inst Oceanol Polish Acad Sci, Powstancow Warszawy Sopo, Poland.	mgluchowska@iopan.gda.pl	; Trudnowska, Emilia/K-9293-2016	Blachowiak-Samolyk, Katarzyna/0000-0001-8076-2168; Gluchowska, Marta/0000-0002-3032-4925; Walczowski, Waldemar/0000-0002-0243-3307; Trudnowska, Emilia/0000-0003-3471-6632; Kwasniewski, Slawomir/0000-0003-3104-0761; Goszczko, Ilona/0000-0002-5719-5860	Polish Scientific Council project KongHau_ZOOM [2375/Svalbard/2012/2]; Polish-Norwegian grant PAVE (Atlantic Water Pathways to the Arctic: Variability and Effects on Climate and Ecosystems) [POL-NOR/202006/10/2013]; Research Council of Norway project CarbonBridge (Bridging productivity regimes in the Arctic Ocean) [226415/E10]; Leading National Research Centre (KNOW); Institute of Oceanology, Polish Academy of Sciences (10 PAN)	Polish Scientific Council project KongHau_ZOOM; Polish-Norwegian grant PAVE (Atlantic Water Pathways to the Arctic: Variability and Effects on Climate and Ecosystems); Research Council of Norway project CarbonBridge (Bridging productivity regimes in the Arctic Ocean); Leading National Research Centre (KNOW); Institute of Oceanology, Polish Academy of Sciences (10 PAN)	The research leading to the presented results has received main financing from the Polish Scientific Council project KongHau_ZOOM (2375/Svalbard/2012/2). Additionally, it was also a contribution of the Polish-Norwegian grant PAVE (Atlantic Water Pathways to the Arctic: Variability and Effects on Climate and Ecosystems, No. POL-NOR/202006/10/2013); the Research Council of Norway project CarbonBridge (Bridging productivity regimes in the Arctic Ocean, No. 226415/E10); the funds of the Leading National Research Centre (KNOW) received by the Centre for Polar Studies for the period 2014-2018, and, last but not least, from the budget of the statutory activity of the Institute of Oceanology, Polish Academy of Sciences (10 PAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD K, 1987, J GEOPHYS RES-OCEANS, V92, P3778, DOI 10.1029/JC092iC04p03778; Aarbakke ONS, 2017, POLAR BIOL, V40, P51, DOI 10.1007/s00300-016-1923-0; aeter T., 1994, PHYS BIOL FACTORS IN; Anderson M., 2005, PERMANOVA PERMUTATIO; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Auel H, 2003, J EXP MAR BIOL ECOL, V296, P183, DOI 10.1016/S0022-0981(03)00321-6; Auel H, 2002, MAR BIOL, V140, P1013, DOI 10.1007/s00227-001-0775-4; BAMSTEDT U, 1991, POLAR RES, V10, P339, DOI 10.1111/j.1751-8369.1991.tb00658.x; Bamstedt U, 1986, CHEM COMPOSITION ENE, P1; BANSE K., 1964, PROGR OCEANOGR, V2, P53, DOI 10.1016/0079-6611(64)90003-5; Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2002, MAR ECOL PROG SER, V232, P179, DOI 10.3354/meps232179; BERESTOVSKII EG, 1989, RELATIONSHIPS SIZE B; Beszczynska-Moller A, 2012, ICES J MAR SCI, V69, P852, DOI 10.1093/icesjms/fss056; Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Blachowiak-Samolyk K, 2006, MAR ECOL PROG SER, V308, P101, DOI 10.3354/meps308101; Blachowiak-Samolyk K, 2008, DEEP-SEA RES PT II, V55, P2210, DOI 10.1016/j.dsr2.2008.05.018; Blachowiak-Samolyk K, 2007, DEEP-SEA RES PT II, V54, P2716, DOI 10.1016/j.dsr2.2007.08.004; BOURKE RH, 1988, J GEOPHYS RES-OCEANS, V93, P14065, DOI 10.1029/JC093iC11p14065; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Carstensen J, 2012, J PLANKTON RES, V34, P951, DOI 10.1093/plankt/fbs059; Cherkasheva A, 2014, J MARINE SYST, V132, P196, DOI 10.1016/j.jmarsys.2013.11.008; Clarke K., 2001, PRIMER V5 USER MANUA; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Daase M, 2008, MAR BIOL RES, V4, P193, DOI 10.1080/17451000801907948; DEIBEL D, 1986, MAR BIOL, V93, P429, DOI 10.1007/BF00401110; Edler L., RECOMMENDATIONS METH; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; EILERTSEN HC, 1989, POLAR BIOL, V9, P253, DOI 10.1007/BF00263773; Estrada R, 2012, PROG OCEANOGR, V101, P121, DOI 10.1016/j.pocean.2012.02.003; Evans C, 1983, MANUAL MEASUREMENT C; Falk-Petersen S, 2000, J MARINE SYST, V27, P131, DOI 10.1016/S0924-7963(00)00064-6; FENAUX R, 1976, MAR BIOL, V34, P229, DOI 10.1007/BF00388800; Folt CL, 1999, TRENDS ECOL EVOL, V14, P300, DOI 10.1016/S0169-5347(99)01616-X; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Gallienne CP, 2001, J PLANKTON RES, V23, P1421, DOI 10.1093/plankt/23.12.1421; Garcon VC, 2001, DEEP-SEA RES PT II, V48, P2199, DOI 10.1016/S0967-0645(00)00183-1; Gislason A., 2003, LIFE CYCLE STRATEGIE; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; GRADINGER RR, 1991, MAR BIOL, V111, P311, DOI 10.1007/BF01319714; Hansen BW, 1999, AQUAT MICROB ECOL, V16, P233, DOI 10.3354/ame016233; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Harris R., 2000, ICES ZOOPLANKTON MET; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; HAY SJ, 1991, CONT SHELF RES, V11, P1453, DOI 10.1016/0278-4343(91)90021-W; Head EJH, 2003, PROG OCEANOGR, V59, P1, DOI 10.1016/S0079-6611(03)00111-3; Heip C, 1985, MARINE BIOL; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hirche H.-J., 1991, Journal of Marine Systems, V2, P477, DOI 10.1016/0924-7963(91)90048-Y; Hirche HJ, 2007, DEEP-SEA RES PT II, V54, P2729, DOI 10.1016/j.dsr2.2007.08.006; Hirche HJ, 1996, OPHELIA, V44, P129, DOI 10.1080/00785326.1995.10429843; Hop H, 2006, PROG OCEANOGR, V71, P182, DOI 10.1016/j.pocean.2006.09.007; Hopcroft RR, 1998, MAR BIOL, V132, P67, DOI 10.1007/s002270050372; Hopcroft RR, 2005, POLAR BIOL, V28, P198, DOI 10.1007/s00300-004-0680-7; Hopcroft RR, 2010, DEEP-SEA RES PT II, V57, P27, DOI 10.1016/j.dsr2.2009.08.003; Hygum BH, 2000, MAR BIOL, V136, P1075, DOI 10.1007/s002270000313; Hygum BH, 2000, ICES J MAR SCI, V57, P1740, DOI 10.1006/jmsc.2000.0956; Ikeda T, 1999, J PLANKTON RES, V21, P299, DOI 10.1093/plankt/21.2.299; Ingels J, 2013, BIOGEOSCIENCES, V10, P4547, DOI 10.5194/bg-10-4547-2013; Kosobokova K, 2000, DEEP-SEA RES PT I, V47, P2029, DOI 10.1016/S0967-0637(00)00015-7; Kosobokova K, 2009, PROG OCEANOGR, V82, P265, DOI 10.1016/j.pocean.2009.07.006; Kosobokova KN, 2010, DEEP-SEA RES PT II, V57, P96, DOI 10.1016/j.dsr2.2009.08.009; Kubiszyn A, 2014, J PLANKTON RES; Kwasniewski S, 2003, J PLANKTON RES, V25, P1, DOI 10.1093/plankt/25.1.1; Kwasniewski S, 2010, PROG OCEANOGR, V87, P72, DOI 10.1016/j.pocean.2010.06.004; Labat JP, 2009, DEEP-SEA RES PT I, V56, P1742, DOI 10.1016/j.dsr.2009.05.013; Lane PVZ, 2008, J MARINE SYST, V70, P97, DOI 10.1016/j.jmarsys.2007.04.001; Loeng H, 2007, DEEP-SEA RES PT II, V54, P2478, DOI 10.1016/j.dsr2.2007.08.013; MACKAS DL, 1982, J MAR RES, V40, P1173; MATTHEWS JBL, 1977, SARSIA, V63, P57, DOI 10.1080/00364827.1977.10411322; Mayzaud P, 2013, MAR BIOL, V160, P383, DOI 10.1007/s00227-012-2095-2; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Miles MW, 2014, GEOPHYS RES LETT, V41, P463, DOI 10.1002/2013GL058084; Morison J, 2000, ARCTIC, V53, P359; Mumm N., 1991, SUMMERLY DISTRIBUTIO, P92; Nilsen F, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002991; Nothig EM, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.23349; Nost OA, 2003, J MAR RES, V61, P175, DOI 10.1357/002224003322005069; Oliver KIC, 2008, J PHYS OCEANOGR, V38, P2755, DOI 10.1175/2008JPO3844.1; Paganelli D, 2012, ESTUAR COAST SHELF S, V96, P245, DOI 10.1016/j.ecss.2011.11.014; PEDERSEN G, 1995, ICES J MAR SCI, V52, P523, DOI 10.1016/1054-3139(95)80066-2; PERKIN RG, 1984, J PHYS OCEANOGR, V14, P1315, DOI 10.1175/1520-0485(1984)014<1315:MITWSC>2.0.CO;2; Piwosz K, 2009, POLAR BIOL, V32, P549, DOI 10.1007/s00300-008-0549-2; Poltermann M., 1997, BIOL ECOLOGY CRYOPEL, P225; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Pomerleau C, 2015, J PLANKTON RES, V37, P712, DOI 10.1093/plankt/fbv045; QUADFASEL D, 1987, J GEOPHYS RES-OCEANS, V92, P6719, DOI 10.1029/JC092iC07p06719; Reigstad M, 2011, PROG OCEANOGR, V90, P33, DOI 10.1016/j.pocean.2011.02.005; Richter C., 1994, BER POLARFORSCH, V154, P1, DOI 10.2312/BzP_0154_1994; Saiz E, 2013, DEEP-SEA RES PT I, V72, P17, DOI 10.1016/j.dsr.2012.10.003; SAMEOTO DD, 1984, POLAR BIOL, V2, P213, DOI 10.1007/BF00263627; Schauer U, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001823; Schittko C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099065; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Seuthe L, 2011, POLAR BIOL, V34, P751, DOI 10.1007/s00300-010-0930-9; SMITH SL, 1988, J MAR RES, V46, P145, DOI 10.1357/002224088785113720; Soreide JE, 2008, DEEP-SEA RES PT II, V55, P2225, DOI 10.1016/j.dsr2.2008.05.024; Speirs DC, 2006, MARINE ECOLOGY PROGR, V313; SPIES A, 1987, POLAR BIOL, V7, P195, DOI 10.1007/BF00287416; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Svensen C, 2011, PROG OCEANOGR, V91, P534, DOI 10.1016/j.pocean.2011.08.001; Teigen SH, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005996; Thor P, 2005, J PLANKTON RES, V27, P341, DOI 10.1093/plankt/fbi010; Trudnowska E, 2016, MAR ECOL PROG SER, V560, P1, DOI 10.3354/meps11925; Turner JT, 2001, MAR ECOL PROG SER, V221, P209, DOI 10.3354/meps221209; Turner JT, 2004, ZOOL STUD, V43, P255; Utermohl H., 1958, VERVOLLKOMMNUNG QUAN; Walczowski W, 2005, DEEP-SEA RES PT I, V52, P1374, DOI 10.1016/j.dsr.2005.03.009; Walczowski W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029974; Walczowski W, 2011, INT J CLIMATOL, V31, P1088, DOI 10.1002/joc.2338; Weydmann A, 2014, MAR ECOL PROG SER, V501, P41, DOI 10.3354/meps10694; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189; Yamaguchi A, 2000, MAR BIOL, V137, P99; Yebra L, 2009, DEEP-SEA RES PT I, V56, P703, DOI 10.1016/j.dsr.2008.11.008	116	21	24	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171715	10.1371/journal.pone.0171715	http://dx.doi.org/10.1371/journal.pone.0171715			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178320	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500062
J	Hendrikx, T; Sundqvist, M; Sandstrom, H; Sahlin, C; Rohani, M; Al-Khalili, F; Hornsten, R; Blomberg, A; Wester, P; Rosenqvist, M; Franklin, KA				Hendrikx, Tijn; Sundqvist, Martin; Sandstrom, Herbert; Sahlin, Carin; Rohani, Morteza; Al-Khalili, Faris; Hornsten, Rolf; Blomberg, Anders; Wester, Per; Rosenqvist, Marten; Franklin, Karl A.			Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea	PLOS ONE			English	Article							DAYTIME SLEEPINESS; RISK-FACTOR; ASSOCIATION; STROKE; GUIDELINES; MANAGEMENT; RECURRENCE	Study objectives Obstructive sleep apnea is common among patients with atrial fibrillation, but the prevalence and risk factors for atrial fibrillation among patients who are being investigated on suspicion of sleep apnea are not well known. The aim of the study was to estimate the prevalence of atrial fibrillation among patients investigated for suspected obstructive sleep apnea and to identify risk factors for atrial fibrillation among them. Methods The prevalence of atrial fibrillation was investigated among 201 patients referred for suspected obstructive sleep apnea. Patients without known atrial fibrillation were investigated with a standard 12 -lead ECG at hospital and short intermittent handheld ECG recordings at home, during 14 days. Results Atrial fibrillation occurred in 13 of 201 subjects (6.5%), and in 12 of 61 men aged 60 years and older (20%). The prevalence of atrial fibrillation increased with sleep apnea severity (p = 0.038). All patients with atrial fibrillation were men and all had sleep apnea. Age 60 or older, the occurrence of central sleep apnea and diabetes mellitus were independent risk factors for atrial fibrillation after adjustments for body mass index, gender, sleep apnea and cardiovascular disease. Conclusions Atrial fibrillation is common among subjects referred for sleep apnea investigation and the prevalence of atrial fibrillation increases with sleep apnea severity. Independent risk factors for atrial fibrillation among patients investigated for suspected obstructive sleep apnea include the occurrence of coexisting central sleep apnea, age 60 years or older and diabetes mellitus.	[Hendrikx, Tijn; Sandstrom, Herbert] Umea Univ, Publ Hlth & Clin Med, Family Med, Umea, Sweden; [Sundqvist, Martin] Soder Sjukhuset, Karolinska Inst, Clin Sci & Educ, Stockholm, Sweden; [Sahlin, Carin; Blomberg, Anders; Wester, Per] Umea Univ, Publ Hlth & Clin Med, Med, Umea, Sweden; [Rohani, Morteza; Al-Khalili, Faris] Danderyd Hosp, Karolinska Inst, Clin Sci, Stockholm, Sweden; [Rohani, Morteza] Nord Heart Ctr, Stockholm, Sweden; [Al-Khalili, Faris] Stockholm Heart Ctr, Stockholm, Sweden; [Hornsten, Rolf] Umea Univ, Clin Physiol, Surg & Perioperat Sci, Umea, Sweden; [Rosenqvist, Marten] Danderyd Hosp, Karolinska Inst, Clin Sci, Stockholm, Sweden; [Franklin, Karl A.] Umea Univ, Surg & Perioperat Sci, Surg, Umea, Sweden	Umea University; Karolinska Institutet; Sodersjukhuset Hospital; Umea University; Danderyds Hospital; Karolinska Institutet; Umea University; Danderyds Hospital; Karolinska Institutet; Umea University	Hendrikx, T (corresponding author), Umea Univ, Publ Hlth & Clin Med, Family Med, Umea, Sweden.	tijn.hendrikx@fammed.umu.se		Blomberg, Anders/0000-0002-2452-7347; Franklin, Karl/0000-0002-5306-1697	Vinnvard Foundation; Swedish Heart and Lung Foundation; Umea University	Vinnvard Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Umea University	This study was supported by grants from the Vinnvard Foundation, the Swedish Heart and Lung Foundation and Umea University. Zenicor Medical Systems AB, Stockholm, provided handheld ECG devices (Zenicor-EKG (R)) at a reduced price. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albuquerque FN, 2012, CHEST, V141, P967, DOI 10.1378/chest.11-0975; Asirvatham SJ, 2009, J AM COLL CARDIOL, V54, P2084, DOI 10.1016/j.jacc.2009.09.017; BALFORS EM, 1994, AM J RESP CRIT CARE, V150, P1587, DOI 10.1164/ajrccm.150.6.7952619; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Braga B, 2009, SLEEP MED, V10, P212, DOI 10.1016/j.sleep.2007.12.007; Cadby G, 2015, CHEST, V148, P945, DOI 10.1378/chest.15-0229; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Doliwa PS, 2009, SCAND CARDIOVASC J, V43, P163, DOI 10.1080/14017430802593435; Falk RH, 2001, NEW ENGL J MED, V344, P1067, DOI 10.1056/NEJM200104053441407; Fein AS, 2013, J AM COLL CARDIOL, V62, P300, DOI 10.1016/j.jacc.2013.03.052; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Franklin KA AS, 2007, REPORT OF A JOINT NO; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Ghias M, 2009, J AM COLL CARDIOL, V54, P2075, DOI 10.1016/j.jacc.2009.09.014; HEDNER J, 1988, J HYPERTENS, V6, pS529, DOI 10.1097/00004872-198812040-00166; Javaheri S, 1999, NEW ENGL J MED, V341, P949, DOI 10.1056/NEJM199909233411304; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanagala R, 2003, CIRCULATION, V107, P2589, DOI 10.1161/01.CIR.0000068337.25994.21; KANNEL WB, 1998, AM J CARDIOL, V0082; Leung RST, 2005, SLEEP, V28, P1543, DOI 10.1093/sleep/28.12.1543; Marin JM, 2014, J INTERN MED, V276, P648, DOI 10.1111/joim.12300; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Neilan TG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000421; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Sahlin C, 2008, ARCH INTERN MED, V168, P297, DOI 10.1001/archinternmed.2007.70; Shukla Ashish, 2015, JACC Clin Electrophysiol, V1, P41, DOI 10.1016/j.jacep.2015.02.014; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Valham F, 2008, CIRCULATION, V118, P955, DOI 10.1161/CIRCULATIONAHA.108.783290; Wilson D, 2014, INT J CARDIOL, V172, P297, DOI 10.1016/j.ijcard.2014.01.007; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171575	10.1371/journal.pone.0171575	http://dx.doi.org/10.1371/journal.pone.0171575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178304	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500051
J	Levy, TS; Mendez-Gomez-Humaran, I; Ruan, MDM; Tapia, BM; Hernandez, SV; Avila, MH				Shamah Levy, Teresa; Mendez-Gomez-Humaran, Ignacio; Morales Ruan, Maria del Carmen; Martinez Tapia, Brenda; Villalpando Hernandez, Salvador; Hernandez Avila, Mauricio			Validation of Masimo Pronto 7 and HemoCue 201 for hemoglobin determination in children from 1 to 5 years of age	PLOS ONE			English	Article							CAPILLARY; ACCURACY; DEVICE; ANEMIA; SYSTEM; BLOOD	Objective To evaluate the accuracy and precision of HemoCue 201 (HemoCue) and Masimo Pronto 7 (Masimo) devices for measuring hemoglobin (Hb) in epidemiological studies, having venous blood samples as a gold standard. Material and methods We measured Hb concentrations in a field sample of 148 children from one to five years of age. Masimo and HemoCue were used for capillary blood samples and an automatic analyzer for venous blood samples. Regression models with no intercept were constructed to measure precision and predictability, concordance correlations to measure accuracy and precision, and Bland-Altman limits of agreement as well as hierarchical linear models to estimate variance. Results Both HemoCue and Masimo underestimated Hb concentrations compared to the gold standard. They respectively yielded the following results: regression coefficients of 0.887 and 0.876 with 98.7% and 98.6% predictability; concordance correlation coefficients of 0.183 (p<0.001) and 0.166 (p<0.001); and Bland-Altman variances of -1.51 and -1.62. With regard to Masimo specifically, the three-level Hierarchical Linear Model showed that 57.9% of total variance stemmed from random errors in repeated measures from the same subject. Conclusions HemoCue and Masimo measure lower Hb concentrations than the gold standard. Their accuracy and precision levels are comparable. It is essential to ensure proper use of devices through enhanced training of field workers.	[Shamah Levy, Teresa; Morales Ruan, Maria del Carmen; Martinez Tapia, Brenda; Villalpando Hernandez, Salvador; Hernandez Avila, Mauricio] Natl Publ Hlth Inst INSP, Cuernavaca, Morelos, Mexico; [Mendez-Gomez-Humaran, Ignacio] Ctr Res Math, Aguascalientes, Aguascalientes, Mexico		Mendez-Gomez-Humaran, I (corresponding author), Ctr Res Math, Aguascalientes, Aguascalientes, Mexico.	imendez@cimat.mx	HUMARAN, IGNACIO MENDEZ GOMEZ/S-7593-2018	HUMARAN, IGNACIO MENDEZ GOMEZ/0000-0002-3908-0867; Morales Ruan, Carmen/0000-0002-6754-4630	Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico	Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico	The funds for this study were supported by the Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico. The grant was 10,000 USD. The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Amano I, 2013, PEDIATR INT, V55, P803, DOI 10.1111/ped.12236; [Anonymous], 2010, OPERATORS MANUAL; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bridges N, 1987, AM CLIN PROD REV, V6, P22; Bruells CS, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-159; CHEN PP, 1992, ANAESTH INTENS CARE, V20, P497, DOI 10.1177/0310057X9202000419; COHEN AR, 1988, AM J CLIN PATHOL, V90, P302, DOI 10.1093/ajcp/90.3.302; Morales-Ruan MD, 2013, SALUD PUBLICA MEXICO, V55, pS199; Giraud B, 2013, BRIT J ANAESTH, V111, P946, DOI 10.1093/bja/aet252; Gutierrez JP, 2012, ENCUESTA NACL SALUDY; Hiscock R, 2015, ANAESTH INTENS CARE, V43, P341, DOI 10.1177/0310057X1504300310; International committee for standardization in haematology, 1967, BRIT J HAEMATOL, V13, P71; Lamhaut L, 2011, ANESTHESIOLOGY, V115, P548, DOI 10.1097/ALN.0b013e3182270c22; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Neufeld L, 2002, SALUD PUBLICA MEXICO, V44, P219, DOI 10.1590/S0036-36342002000300005; NEVILLE RG, 1987, BRIT MED J, V294, P1263, DOI 10.1136/bmj.294.6582.1263; Patel AJ, 2013, VOX SANG, V104, P317, DOI 10.1111/vox.12006; Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0; VONSCHENCK H, 1986, CLIN CHEM, V32, P526; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]; World Health Organization, 2011, SER FERR CONC ASS IR	22	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170990	10.1371/journal.pone.0170990	http://dx.doi.org/10.1371/journal.pone.0170990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170445	Green Submitted, Green Published, gold			2022-12-27	WOS:000393705500016
J	Agusto, FB; ELmojtaba, IM				Agusto, Folashade B.; ELmojtaba, Ibrahim M.			Optimal control and cost-effective analysis of malaria/visceral leishmaniasis co-infection	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; SENSITIVITY ANALYSIS; SELF-MEDICATION; RISK-FACTORS; KALA-AZAR; MALARIA; IDENTIFICATION; TRANSMISSION; PREVALENCE; RESERVOIRS	In this paper, a deterministic model involving the transmission dynamics of malaria/visceral leishmaniasis co-infection is presented and studied. Optimal control theory is then applied to investigate the optimal strategies for curtailing the spread of the diseases using the use of personal protection, indoor residual spraying and culling of infected reservoirs as the system control variables. Various combination strategies were examined so as to investigate the impact of the controls on the spread of the disease. And we investigated the most cost-effective strategy of all the control strategies using three approaches, the infection averted ratio (IAR), the average cost-effectiveness ratio (ACER) and incremental cost-effectiveness ratio (ICER). Our results show that the implementation of the strategy combining all the time dependent control variables is the most cost-effective control strategy. This result is further emphasized by using the results obtained from the cost objective functional, the ACER, and the ICER.	[Agusto, Folashade B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [ELmojtaba, Ibrahim M.] Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, POB 36, Al Khoud, Oman	University of Kansas; Sultan Qaboos University	Agusto, FB (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	fbagusto@gmail.com	Elmojtaba, Ibrahim/AAH-4270-2020	ELmojtaba, Ibrahim/0000-0001-6018-4671; Agusto, Folashade/0000-0001-6137-6480	Sultan Qaboos University [IG\DOMS\16\16]	Sultan Qaboos University	ELmojtaba was supported by grant No: IG\DOMS\16\16, from Sultan Qaboos University.; The research of I. M. Elmojtaba is supported by grant No: IG\DOMS\16\16, from Sultan Qaboos University.	Agusto FB, 2013, BIOSYSTEMS, V113, P155, DOI 10.1016/j.biosystems.2013.06.004; Agusto F, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013400020; Agusto FB, 2012, ELECTRON J DIFFER EQ; [Anonymous], 2013, AFR J PHARM THER; Arriola LM, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.27; Awad A, 2005, J PHARM PHARM SCI, V8, P326; Bashaye S, 2009, AM J TROP MED HYG, V81, P34, DOI 10.4269/ajtmh.2009.81.34; Chipwaza B, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-252; Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; Coutinho FAB, 2005, MATH COMPUT SIMULAT, V70, P149, DOI 10.1016/j.matcom.2005.06.003; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Dereure J, 2000, T ROY SOC TROP MED H, V94, P154, DOI 10.1016/S0035-9203(00)90253-0; Dereure J, 2003, MICROBES INFECT, V5, P1103, DOI 10.1016/j.micinf.2003.07.003; Diniz SA, 2008, J INFECT DEV COUNTR, V2, P24; ELmojtaba IM, 2016, MATH METHOD APPL SCI, V39, P4334, DOI 10.1002/mma.3864; FIALHO RF, 1995, J ANIM ECOL, V64, P553, DOI 10.2307/5799; Fleming WH, 2012, DETERMINISTIC STOCHA, V1; Gasim S, 2000, CLIN EXP IMMUNOL, V119, P523, DOI 10.1046/j.1365-2249.2000.01163.x; Gemperli A, 2006, AM J EPIDEMIOL, V163, P289, DOI 10.1093/aje/kwj026; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hassan MM, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-26; HELTON JC, 1985, ECOL MODEL, V28, P243, DOI 10.1016/0304-3800(85)90077-8; Joshi HR, 2002, OPTIM CONTR APPL MET, V23, P199, DOI 10.1002/oca.710; Jung E, 2002, DISCRETE CONT DYN-B, V2, P473; Kasap OE, 2006, J VECTOR ECOL, V31, P378, DOI 10.3376/1081-1710(2006)31[378:CDOTSF]2.0.CO;2; Kern Daniel L, 2007, J Biol Dyn, V1, P413, DOI 10.1080/17513750701605556; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; LAINSON R, 1987, Memorias do Instituto Oswaldo Cruz, V82, P421, DOI 10.1590/S0074-02761987000300015; Laxminarayan R, 2004, AM J TROP MED HYG, V71, P187, DOI 10.4269/ajtmh.2004.71.187; Lenhart S., 2007, OPTIMAL CONTROL APPL; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maroli M., 2004, Parassitologia (Rome), V46, P211; MUTINGA MJ, 1980, ANN TROP MED PARASIT, V74, P139, DOI 10.1080/00034983.1980.11687323; Osemene KP, 2012, TROP J PHARM RES, V11, P683, DOI 10.4314/tjpr.v11i4.21; Pang LY, 2016, CHAOS SOLITON FRACT, V87, P293, DOI 10.1016/j.chaos.2016.03.032; Pontryagin LS, 1987, MATH THEORY OPTIMAL; Stager S, 2010, IMMUNOL RES, V47, P14, DOI 10.1007/s12026-009-8135-4; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; van den Bogaart E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-332; van den Bogaart E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001617; WHO, 2012, POST KAL AZ DERM LEI; Yan X, 2008, MATH COMPUT MODEL, V47, P235, DOI 10.1016/j.mcm.2007.04.003; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6; Zijlstra EE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1721-0	45	38	38	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171102	10.1371/journal.pone.0171102	http://dx.doi.org/10.1371/journal.pone.0171102			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166308	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100022
J	Cho, S; Lee, TS; Song, IH; Kim, AR; Lee, YJ; Kim, H; Hwang, H; Jeong, MS; Kang, SG; Hong, HJ				Cho, Seulki; Lee, Tae Sup; Song, In Ho; Kim, A-Ram; Lee, Yoon-Jin; Kim, Haejung; Hwang, Haein; Jeong, Mun Sik; Kang, Seung Goo; Hong, Hyo Jeong			Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma	PLOS ONE			English	Article							BILIARY-TRACT CANCER; FACTOR RECEPTOR ACTIVATION; GALLBLADDER CARCINOMA; OPEN-LABEL; PHASE-II; N-CAM; L1; MULTICENTER; L1CAM; OXALIPLATIN	Cholangiocarcinoma has a poor prognosis and is refractory to conventional chemotherapy and radiation therapy. Improving survival of patients with advanced cholangiocarcinoma urgently requires the development of new effective targeted therapies in combination with chemotherapy. We previously developed a human monoclonal antibody (mAb) Ab417 that binds to both the human and mouse L1 cell adhesion molecule (L1CAM) with high affinities. In the present study, we observed that Ab417 exhibited tumor targeting ability in biodistribution studies and dose-dependent tumor growth inhibition in an intrahepatic cholangiocarcinoma (Choi-CK) xenograft mouse model. Regarding the mechanism of action, Ab417 was internalized into the tumor cells and thereby down-regulated membrane L1CAM, and inhibited tumor growth by reducing tumor cell proliferation in vivo. Gemcitabine inhibited the tumor growth in a dose-dependent manner in the Choi-CK xenograft model. However, cisplatin inhibited the tumor growth moderately and not in a dose-dependent way, suggesting that the tumors may have developed resistance to apoptosis induced by cisplatin. Combined treatment with Ab417 and gemcitabine or cisplatin exerted enhanced tumor growth inhibition compared to treatment with antibody or drug alone. The results suggest that Ab417 in combination with chemotherapy may have potential as a new therapeutic regimen for cholangiocarcinoma. Our study is the first to show an enhanced therapeutic effect of a therapeutic antibody targeting L1CAM in combination with chemotherapy in cholangiocarcinoma models.	[Cho, Seulki] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea; [Cho, Seulki; Hong, Hyo Jeong] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon, South Korea; [Lee, Tae Sup; Song, In Ho] Korea Inst Radiol & Med Sci, Div RI Convergence Res, Seoul, South Korea; [Kim, A-Ram; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Basic Radiat Biosci, Seoul, South Korea; [Kim, Haejung] Kangwon Natl Univ, Dept Biol, Chunchon, South Korea; [Hwang, Haein; Jeong, Mun Sik; Kang, Seung Goo; Hong, Hyo Jeong] Kangwon Natl Univ, Dept Syst Immunol, Chunchon, South Korea	University of Science & Technology (UST); Kangwon National University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Kangwon National University; Kangwon National University	Hong, HJ (corresponding author), Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon, South Korea.; Hong, HJ (corresponding author), Kangwon Natl Univ, Dept Syst Immunol, Chunchon, South Korea.	hjhong@kangwon.ac.kr	LEE, TAE SUP/K-9638-2019	Kang, Seung Goo/0000-0003-3981-1399; Lee, Tae Sup/0000-0002-8266-7380	Korea Drug Development Fund (KDDF) - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health Welfare [KDDF-201212-12]; Kangwon National University [520160427]; Leaders INdustry-university Cooperation Project - Ministry of Education, Science & Technology (MEST) [C1012957-01-01]	Korea Drug Development Fund (KDDF) - Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health Welfare; Kangwon National University; Leaders INdustry-university Cooperation Project - Ministry of Education, Science & Technology (MEST)	This research was supported by a grant (KDDF-201212-12) from the Korea Drug Development Fund (KDDF) funded by Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy and Ministry of Health & Welfare, 2016 Research Grant from Kangwon National University (No. 520160427), and the Leaders INdustry-university Cooperation Project supported by the Ministry of Education, Science & Technology (MEST) (No. C1012957-01-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altevogt P, 2016, INT J CANCER, V138, P1565, DOI 10.1002/ijc.29658; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Cho S, 2016, MABS-AUSTIN, V8, P414, DOI 10.1080/19420862.2015.1125067; Choi SY, 2011, HUM PATHOL, V42, P1476, DOI 10.1016/j.humpath.2011.01.003; Colombo F, 2015, TRENDS PHARMACOL SCI, V36, P769, DOI 10.1016/j.tips.2015.08.004; Debiec H, 1998, J CELL BIOL, V143, P2067, DOI 10.1083/jcb.143.7.2067; Ebeling O, 1996, EUR J IMMUNOL, V26, P2508, DOI 10.1002/eji.1830261035; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jung J, 2011, ONCOL REP, V25, P945, DOI 10.3892/or.2011.1181; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Kim DG, 2001, GENE CHROMOSOME CANC, V30, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1053>3.0.CO;2-P; Lee CS, 1995, PATHOL RES PRACT, V191, P1087, DOI 10.1016/S0344-0338(11)80652-7; Lee J, 2012, LANCET ONCOL, V13, P181, DOI 10.1016/S1470-2045(11)70301-1; Li S, 2009, CLIN CANCER RES, V15, P7345, DOI 10.1158/1078-0432.CCR-09-0959; Malka D, 2014, LANCET ONCOL, V15, P819, DOI 10.1016/S1470-2045(14)70212-8; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Okusaka T, 2006, CANCER CHEMOTH PHARM, V57, P647, DOI 10.1007/s00280-005-0095-3; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Pancook JD, 1997, J IMMUNOL, V158, P4413; Press OW, 1996, CANCER RES, V56, P2123; Ramirez-Merino N, 2013, WORLD J GASTRO ONCOL, V5, P171, DOI 10.4251/wjgo.v5.i7.171; RATHJEN FG, 1984, EMBO J, V3, P1; Rizvi S, 2014, SEMIN LIVER DIS, V34, P456, DOI 10.1055/s-0034-1394144; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Song IH, 2016, J NUCL MED, V57, P1105, DOI 10.2967/jnumed.115.167155; THOR G, 1987, EMBO J, V6, P2581, DOI 10.1002/j.1460-2075.1987.tb02548.x; Valle JW, 2009, BRIT J CANCER, V101, P621, DOI 10.1038/sj.bjc.6605211; Yoon H, 2012, CANCER LETT, V316, P70, DOI 10.1016/j.canlet.2011.10.024; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170078	10.1371/journal.pone.0170078	http://dx.doi.org/10.1371/journal.pone.0170078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166242	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100004
J	Hermans, F; Sartas, M; Van Schagen, B; van Asten, P; Schut, M				Hermans, Frans; Sartas, Murat; Van Schagen, Boudy; van Asten, Piet; Schut, Marc			Social network analysis of multi-stakeholder platforms in agricultural research for development: Opportunities and constraints for innovation and scaling	PLOS ONE			English	Article							STATISTICAL-MODELS; SYSTEMS; FRAMEWORK; PARTICIPATION; GOVERNANCE; TRANSITION; CHALLENGES; MANAGEMENT; POLICY; UNFOLD	Multi-stakeholder platforms (MSPs) are seen as a promising vehicle to achieve agricultural development impacts. By increasing collaboration, exchange of knowledge and influence mediation among farmers, researchers and other stakeholders, MSPs supposedly enhance their 'capacity to innovate' and contribute to the 'scaling of innovations'. The objective of this paper is to explore the capacity to innovate and scaling potential of three MSPs in Burundi, Rwanda and the South Kivu province located in the eastern part of Democratic Republic of Congo (DRC). In order to do this, we apply Social Network Analysis and Exponential Random Graph Modelling (ERGM) to investigate the structural properties of the collaborative, knowledge exchange and influence networks of these MSPs and compared them against value propositions derived from the innovation network literature. Results demonstrate a number of mismatches between collaboration, knowledge exchange and influence networks for effective innovation and scaling processes in all three countries: NGOs and private sector are respectively over- and under-represented in the MSP networks. Linkages between local and higher levels are weak, and influential organisations (e.g., high-level government actors) are often not part of the MSP or are not actively linked to by other organisations. Organisations with a central position in the knowledge network are more sought out for collaboration. The scaling of innovations is primarily between the same type of organisations across different administrative levels, but not between different types of organisations. The results illustrate the potential of Social Network Analysis and ERGMs to identify the strengths and limitations of MSPs in terms of achieving development impacts.	[Hermans, Frans] Leibniz Inst Agr Dev Transit Econ IAMO, Theodor Lieser Str 2, Halle, Saale, Germany; [Sartas, Murat; Schut, Marc] Wageningen Univ, Knowledge Technol & Innovat Grp, Ew Wageningen, Netherlands; [Sartas, Murat; Schut, Marc] Int Inst Trop Agr, Kacyiru, Kigali, Rwanda; [Sartas, Murat] Swedish Univ Agr Sci SLU, Dept Urban & Rural Dev, Ulls Vag Uppsala, Sweden; [Van Schagen, Boudy] Biovers Int Quartier Kabondo, Rohero 1,Ave 18 Septembre 10, Bujumbura, Burundi; [van Asten, Piet] Int Inst Trop Agr, Kampala, Uganda	Leibniz Institut fur Agrarentwicklung in Transformationsokonomien (IAMO); Wageningen University & Research; Swedish University of Agricultural Sciences	Schut, M (corresponding author), Wageningen Univ, Knowledge Technol & Innovat Grp, Ew Wageningen, Netherlands.; Schut, M (corresponding author), Int Inst Trop Agr, Kacyiru, Kigali, Rwanda.	m.schut@cgiar.org	, IAMO/G-2328-2012; Sartas, Murat/AHE-3077-2022; Sartas, Murat/ABB-8093-2020; Hermans, Frans/G-6161-2018; Change, Structural/W-8306-2019; Schut, Marc/F-5488-2012	, IAMO/0000-0001-7922-9665; Sartas, Murat/0000-0001-7331-4201; Hermans, Frans/0000-0003-3394-9012; Change, Structural/0000-0002-2459-4646; van Asten, Piet/0000-0003-0584-3552; Schut, Marc/0000-0002-3361-4581	Consortium for Improving Agricultural Livelihoods in Central Africa (CIALCA); Belgian Directorate General for Development Cooperation and Humanitarian Aid (DGD); Humidtropics; RTB; CGIAR	Consortium for Improving Agricultural Livelihoods in Central Africa (CIALCA); Belgian Directorate General for Development Cooperation and Humanitarian Aid (DGD); Humidtropics; RTB; CGIAR(CGIAR)	This work was funded under the framework of the Consortium for Improving Agricultural Livelihoods in Central Africa (CIALCA), which is funded by the Belgian Directorate General for Development Cooperation and Humanitarian Aid (DGD). CIALCA forms part of the CGIAR Research Program on Integrated Systems for the Humid Tropics (Humidtropics), and the CGIAR Research Program on Roots, Tubers and Bananas (RTB). We would like to acknowledge Humidtropics, RTB, and the CGIAR Fund Donors (http://www.cgiar.org/about-us/governing-2010-june-2016/cgiar.fund/fund-donors-2/) for their provision of core funding without which this research could not have been possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avelino F, 2009, EUR J SOC THEORY, V12, P543, DOI 10.1177/1368431009349830; Beers PJ, 2014, NJAS-WAGEN J LIFE SC, V69, P5, DOI 10.1016/j.njas.2013.10.001; Beers PJ, 2013, J AGRIC EDUC EXT, V20, P1; Boloquy M., 2014, CITIZENS PERCEPTIONS; Cash DW, 2006, ECOL SOC, V11; De Nooy W., 2005, EXPLORATORY SOCIAL N; Dhand A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145916; Ekboir J, 2008, AGR SYST, V98, P1, DOI 10.1016/j.agsy.2008.03.004; Esparcia J, 2014, J RURAL STUD, V34, P1, DOI 10.1016/j.jrurstud.2013.12.004; Faysse N, 2006, NAT RESOUR FORUM, V30, P219, DOI 10.1111/j.1477-8947.2006.00112.x; Fujisaka S., 2004, CIAT PUBLICATION, V340; Goodreau SM, 2007, SOC NETWORKS, V29, P231, DOI 10.1016/j.socnet.2006.08.001; Hall A, 2003, AGR SYST, V78, P213, DOI 10.1016/S0308-521X(03)00127-6; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Harris J.K., 2014, INTRO EXPONENTIAL RA; Harris JK, 2012, J PUBLIC HEALTH RES, V1, P67, DOI 10.4081/jphr.2012.e12; Hekkert MP, 2007, TECHNOL FORECAST SOC, V74, P413, DOI 10.1016/j.techfore.2006.03.002; Hermans F, 2016, ECOL ECON, V130, P285, DOI 10.1016/j.ecolecon.2016.07.011; Hermans F, 2015, J AGRIC EDUC EXT, V21, P35, DOI 10.1080/1389224X.2014.991113; Hermans F, 2013, AGR SYST, V115, P117, DOI 10.1016/j.agsy.2012.09.006; Hermans FLP, 2011, REG ENVIRON CHANGE, V11, P805, DOI 10.1007/s10113-011-0216-y; Hunter DR, 2008, J AM STAT ASSOC, V103, P248, DOI 10.1198/016214507000000446; IITA, 2014, STRAT CENTR AFR HUB; Isaac ME, 2012, AGR SYST, V109, P9, DOI 10.1016/j.agsy.2012.01.011; Kemp R, 1998, TECHNOL ANAL STRATEG, V10, P175, DOI 10.1080/09537329808524310; Kilelu CW, 2013, AGR SYST, V118, P65, DOI 10.1016/j.agsy.2013.03.003; Koskinen J., 2013, EXPONENTIAL RANDOM G; Krivitsky PN, 2011, STAT METHODOL, V8, P319, DOI 10.1016/j.stamet.2011.01.005; Krivitsky PN, 2016, ERGM EGO FIT SIMULAT; Krivitsky PN, 2015, 0515 U WOLL NAT I AP; Lambrecht I, 2014, WORLD DEV, V59, P132, DOI 10.1016/j.worlddev.2014.01.024; Lamprinopoulou C, 2014, AGR SYST, V129, P40, DOI 10.1016/j.agsy.2014.05.001; Leeuwis C, 2000, DEV CHANGE, V31, P931, DOI 10.1111/1467-7660.00184; Leeuwis C, 2014, CAPACITY INNOVATE SY; Leeuwis C., 2002, WHEELBARROWS FULL FR; Leeuwis C., 2013, ECOLOGY SOC, V18, P16; Lemarchand R, 2007, AFR AFFAIRS, V106, P1, DOI 10.1093/afraf/adl041; Lubell M, 2014, SOC NATUR RESOUR, V27, P1089, DOI 10.1080/08941920.2014.933496; Lubell M, 2012, POLICY STUD J, V40, P351, DOI 10.1111/j.1541-0072.2012.00457.x; Messely L, 2013, J RURAL STUD, V32, P400, DOI 10.1016/j.jrurstud.2013.09.002; Moore ML, 2011, ECOL SOC, V16; Muchunguzi P, 2016, INNOVATION PLATFORMS, P42; Neef A, 2011, AGR HUM VALUES, V28, P179, DOI 10.1007/s10460-010-9272-z; Nooteboom B, 2007, RES POLICY, V36, P1016, DOI 10.1016/j.respol.2007.04.003; OECD/Eurostat, 2005, OSL MAN GUID COLL IN; Prell C, 2009, SOC NATUR RESOUR, V22, P501, DOI 10.1080/08941920802199202; Rivera W.M., 2005, ENHANCING COORDINATI; Rivera WM, 2009, OUTLOOK AGR, V38, P267, DOI 10.5367/000000009789396810; Rodriguez M, 2015, AGR SYST, V135, P122; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Roling NG, 1998, SOCIAL LEARNING SUST; Schot J, 2008, TECHNOL ANAL STRATEG, V20, P537, DOI 10.1080/09537320802292651; Schut M, EXPT AGR; Schut M., 2016, EXPT AGR; Schut M, 2016, AGR SYST, V145, P165, DOI 10.1016/j.agsy.2016.03.005; Schut M, 2015, AGR SYST, V132, P1, DOI 10.1016/j.agsy.2014.08.009; Schut M, 2014, SCI PUBL POLICY, V41, P207, DOI 10.1093/scipol/sct048; Schut M, 2014, ENERG POLICY, V65, P631, DOI 10.1016/j.enpol.2013.09.007; Smink M, 2015, TECHNOL FORECAST SOC, V100, P225, DOI 10.1016/j.techfore.2015.07.004; Smith A, 2014, J CLEAN PROD, V63, P114, DOI 10.1016/j.jclepro.2012.12.025; Smits R, 2002, TECHNOL FORECAST SOC, V69, P861, DOI 10.1016/S0040-1625(01)00181-0; Snijders TAB, 2011, ANNU REV SOCIOL, V37, P131, DOI 10.1146/annurev.soc.012809.102709; Spielman D, 2010, AGR HUM VALUES, P1; Spielman DJ, 2011, AGR HUM VALUES, V28, P195, DOI 10.1007/s10460-010-9273-y; Sumberg J, 2013, OUTLOOK AGR, V42, P233, DOI 10.5367/oa.2013.0144; Suurs R.A.A, 2009, THESIS; Thornton P.H., 2012, I LOGICS PERSPECTIVE, DOI 10.1093/acprof:oso/9780199601936.001.0001; Uvin P, 2000, WORLD DEV, V28, P1409, DOI 10.1016/S0305-750X(00)00037-1; Van Damme J., 2013, ANAL SYSTEMIQUE PROC; van Mierlo B, 2014, OUTLOOK AGR, V43, P157, DOI 10.5367/oa.2014.0179; van Paassen A, 2014, OUTLOOK AGR, V43, P193, DOI 10.5367/oa.2014.0178; Vanlauwe B, 2013, AGRO ECOLOGICAL INTE; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wellbrock W, 2013, J RURAL STUD, V32, P420, DOI 10.1016/j.jrurstud.2013.10.002; Wigboldus S, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0380-z; Wood BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105203; Woolthuis RK, 2005, TECHNOVATION, V25, P609, DOI 10.1016/j.technovation.2003.11.002	77	63	64	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0169634	10.1371/journal.pone.0169634	http://dx.doi.org/10.1371/journal.pone.0169634			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166226	Green Published, gold			2022-12-27	WOS:000393700100002
J	Huang, N; Wang, WW; Yao, YL; Zhu, FX; Wang, WP; Chang, XJ				Huang, Nan; Wang, Weiwei; Yao, Yanlai; Zhu, Fengxiang; Wang, Weiping; Chang, Xiaojuan			The influence of different concentrations of bio-organic fertilizer on cucumber Fusarium wilt and soil microflora alterations	PLOS ONE			English	Article							SUBTILIS SQR 9; MICROBIAL COMMUNITY; RHIZOSPHERE SOIL; IDENTIFICATION; BIOFERTILIZER; COLONIZATION; DISCRIMINATE; SUPPRESSION; BIOCONTROL; DISEASE	Fusarium wilt is one of the main diseases of cucumber, and bio-organic fertilizer has been used to control Fusarium wilt. In this study, a pot experiment was conducted to evaluate the effects of bio-organic fertilizer applied at four levels on the suppression of Fusarium wilt disease in cucumber, the soil physico-chemical properties and the microbial communities. In comparison with the control (CK), low concentrations of bio-organic fertilizer (BIO2.5 and BIO5) did not effectively reduce the disease incidence and had little effect on soil microorganisms. High concentrations of bio-organic fertilizer (BIO10 and BIO20) significantly reduced the disease incidence by 33.3%-66.7% and the production was significantly improved by 83.8%-100.3%. The soil population of F. oxysporum f. sp. cucumerinum was significantly lower in bio-organic fertilizer treatments, especially in BIO10 and BIO20. The microorganism activity increased with the bio-organic fertilizer concentration. High-throughput sequencing demonstrated that, at the order level, Sphingomonadales, Bacillales, Solibacterales and Xylariales were significantly abundant in BIO10 and BIO20 soils. At the genus level, the abundance and composition of bacterial and fungal communities in BIO10 and BIO20 were similar, illustrating that high concentrations of bio-organic fertilizer activated diverse groups of microorganisms. Redundancy analysis (RDA) showed that Xanthomonadales, Sphingomonadales, Bacillales, Orbiliales, Sordariales, and Mucorales occurred predominantly in the BIO10 and BIO20. These microorganisms were related to the organic matter, available potassium and available phosphorus contents. In conclusion, a high concentration of bio-organic fertilizer application suppressed the Fusarium wilt disease and increased cucumber production after continuous cropping might through improving soil chemical condition and manipulating the composition of soil microbial community.	[Huang, Nan; Wang, Weiwei; Chang, Xiaojuan] Northwest Univ Xian, Coll Life Sci, Xian, Shaanxi, Peoples R China; [Wang, Weiwei] Northwest Univ Xian, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China; [Yao, Yanlai; Zhu, Fengxiang; Wang, Weiping] Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Zhejiang Academy of Agricultural Sciences	Wang, WW (corresponding author), Northwest Univ Xian, Coll Life Sci, Xian, Shaanxi, Peoples R China.; Wang, WW (corresponding author), Northwest Univ Xian, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Minist Educ, Xian, Shaanxi, Peoples R China.; Yao, YL (corresponding author), Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China.	wwwang@nwu.edu.cn; yaoyl0679@hotmail.com		Yao, Yanlai/0000-0003-4086-2556	National Natural Science Foundation [41571243]; Special Fund for Agro-scientific Research in the Public Interest [201503110, 201103004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation, grant # No. 41571243 to WWW and the Special Fund for Agro-scientific Research in the Public Interest, grant # No. 201503110 and No. 201103004 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atiyeh RM, 2001, BIORESOURCE TECHNOL, V78, P11, DOI 10.1016/S0960-8524(00)00172-3; Avis TJ, 2008, SOIL BIOL BIOCHEM, V40, P1733, DOI 10.1016/j.soilbio.2008.02.013; Bergkemper F, 2016, ENV MICROBIOL, V18; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Campbell CD, 1997, J MICROBIOL METH, V30, P33, DOI 10.1016/S0167-7012(97)00041-9; Cao Y, 2012, SCI HORTIC-AMSTERDAM, V135, P32, DOI 10.1016/j.scienta.2011.12.002; Cao Y, 2011, BIOL FERT SOILS, V47, P495, DOI 10.1007/s00374-011-0556-2; Chauvin C, 2015, APPL SOIL ECOL, V96, P131, DOI 10.1016/j.apsoil.2015.07.013; Chellemi DO, 2016, PHYTOPATHOLOGY, V106, P216, DOI 10.1094/PHYTO-09-15-0204-RVW; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; Giuliano B, 2010, SOIL BIOL BIOCHEM, V42, P136; Huang XQ, 2012, MICROBIOL RES, V167, P135, DOI 10.1016/j.micres.2011.06.002; Klaubauf S, 2010, FUNGAL DIVERS, V44, P65, DOI 10.1007/s13225-010-0053-1; Lam MK, 2012, APPL ENERG, V94, P303, DOI 10.1016/j.apenergy.2012.01.075; Leps J., 2005, AUSTRAL ECOL, V86, P6, DOI [10.1890/0012-9623(2005)86[6a:MAOEDU]2.0.CO;2, DOI 10.1111/J.1442-9993.2005.01433.X]; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Lievens B, 2007, ENVIRON MICROBIOL, V9, P2145, DOI 10.1111/j.1462-2920.2007.01329.x; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes AR, 2014, FEMS MICROBIOL ECOL, V87, P650, DOI 10.1111/1574-6941.12253; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pegg K. G., 2002, P299, DOI 10.1079/9780851993577.0299; Phitsuwan P, 2013, FOLIA MICROBIOL, V58, P163, DOI 10.1007/s12223-012-0184-8; Qiu MH, 2014, BIOL FERT SOILS, V50, P217, DOI 10.1007/s00374-013-0835-1; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raza W, 2009, EUR J PLANT PATHOL, V125, P471, DOI 10.1007/s10658-009-9496-1; Schutter ME, 2001, SOIL BIOL BIOCHEM, V33, P1947, DOI 10.1016/S0038-0717(01)00123-7; Senechkin IV, 2014, APPL SOIL ECOL, V73, P148, DOI 10.1016/j.apsoil.2013.09.003; Shen ZZ, 2015, BIOL FERT SOILS, V51, P553, DOI 10.1007/s00374-015-1002-7; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; Wang X, 2015, BIOESSAYS, V37, P1045, DOI 10.1002/bies.201500071; Weng J, 2013, APPL MICROBIOL BIOT, V97, P8823, DOI 10.1007/s00253-012-4572-4; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Xu JB, 2013, BIOL FERT SOILS, V49, P839, DOI 10.1007/s00374-013-0777-7; Yao H, 2000, MICROB ECOL, V40, P223; Zhang N, 2014, PLANT SOIL, V374, P689, DOI 10.1007/s11104-013-1915-6	41	35	39	12	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171490	10.1371/journal.pone.0171490	http://dx.doi.org/10.1371/journal.pone.0171490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166302	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100047
J	Mujtaba, G; Shuib, L; Raj, RG; Rajandram, R; Shaikh, K; Al-Garadi, MA				Mujtaba, Ghulam; Shuib, Liyana; Raj, Ram Gopal; Rajandram, Retnagowri; Shaikh, Khairunisa; Al-Garadi, Mohammed Ali			Automatic ICD-10 multi-class classification of cause of death from plaintext autopsy reports through expert-driven feature selection	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; TEXT; EXTRACTION	Objectives Widespread implementation of electronic databases has improved the accessibility of plain text clinical information for supplementary use. Numerous machine learning techniques, such as supervised machine learning approaches or ontology-based approaches, have been employed to obtain useful information from plaintext clinical data. This study proposes an automatic multi-class classification system to predict accident-related causes of death from plaintext autopsy reports through expert-driven feature selection with supervised automatic text classification decision models. Methods Accident-related autopsy reports were obtained from one of the largest hospital in Kuala Lumpur. These reports belong to nine different accident-related causes of death. Master feature vector was prepared by extracting features from the collected autopsy reports by using unigram with lexical categorization. This master feature vector was used to detect cause of death [according to internal classification of disease version 10 (ICD-10) classification system] through five automated feature selection schemes, proposed expert-driven approach, five subset sizes of features, and five machine learning classifiers. Model performance was evaluated using precision(M), recall(M), F-measure(M), accuracy, and area under ROC curve. Four baselines were used to compare the results with the proposed system. Results Random forest and J48 decision models parameterized using expert-driven feature selection yielded the highest evaluation measure approaching (85% to 90%) for most metrics by using a feature subset size of 30. The proposed system also showed approximately 14% to 16% improvement in the overall accuracy compared with the existing techniques and four baselines. Conclusion The proposed system is feasible and practical to use for automatic classification of ICD-10-related cause of death from autopsy reports. The proposed system assists pathologists to accurately and rapidly determine underlying cause of death based on autopsy findings. Furthermore, the proposed expert-driven feature selection approach and the findings are generally applicable to other kinds of plaintext clinical reports.	[Mujtaba, Ghulam; Shuib, Liyana; Al-Garadi, Mohammed Ali] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur, Malaysia; [Mujtaba, Ghulam] Sukkur Inst Business Adm, Dept Comp Sci, Sukkur, Pakistan; [Raj, Ram Gopal] Univ Malaya, Dept Artificial Intelligence, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Rajandram, Retnagowri] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Shaikh, Khairunisa] Shaheed Mohtarma Benazir Bhutto Med Univ, Dept Community Med, Larkana, Pakistan	Universiti Malaya; Universiti Malaya; Universiti Malaya	Mujtaba, G (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur, Malaysia.; Mujtaba, G (corresponding author), Sukkur Inst Business Adm, Dept Comp Sci, Sukkur, Pakistan.; Raj, RG (corresponding author), Univ Malaya, Dept Artificial Intelligence, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia.	mujtaba@siswa.um.edu.my; ramdr@um.edu.my	Rajandram, Retnagowri/O-6135-2019; Rajandram, Retnagowri/E-4709-2010; Raj, Ram Gopal/B-3399-2010; Shuib, Liyana/ABH-6159-2020; Rajandram, Retnagowri/E-1245-2012; Ali Al-Garadi, Mohammed/GXM-3256-2022; Mujtaba, Ghulam/AAW-4254-2021; Shuib, Nor Liyana Mohd/M-8698-2013	Rajandram, Retnagowri/0000-0001-5247-2817; Rajandram, Retnagowri/0000-0001-5247-2817; Raj, Ram Gopal/0000-0002-8627-1113; Shuib, Liyana/0000-0002-7907-0671; Rajandram, Retnagowri/0000-0001-5247-2817; Shuib, Nor Liyana Mohd/0000-0002-7907-0671	University Malaya Research Grant [RP026-14AET]	University Malaya Research Grant	This research was fully funded by the University Malaya Research Grant (Grant No: RP026-14AET), Grant Number: RP026-14AET [https://umresearch.um.edu.my/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal C. C., 2012, MINING TEXT DATA SPR; Al-Garadi MA, 2016, J BIOMED INFORM, V62, P1, DOI 10.1016/j.jbi.2016.05.005; Al-garadr MA, 2016, COMPUT HUM BEHAV, V63, P433, DOI 10.1016/j.chb.2016.05.051; Bao YG, 2004, LECT NOTES COMPUT SC, V3177, P634; Ben Abacha A, 2015, J BIOMED INFORM, V58, P122, DOI 10.1016/j.jbi.2015.09.015; Bird S., 2009, NATURAL LANGUAGE PRO; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cheng QA, 2011, IEEE T PATTERN ANAL, V33, P1217, DOI 10.1109/TPAMI.2010.195; Chomutare T, 2014, L N INST COMP SCI SO, V100, P125, DOI 10.1007/978-3-319-11564-1_13; Costache Mariana, 2014, Maedica (Bucur), V9, P261; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dahiya Shashi, 2016, International Journal of Advanced Research in Artificial Intelligence, V5, P1; Danso S, 2014, ARXIV14024380; Danso S, 2013, LECT NOTES ARTIF INT, V8105, P47, DOI 10.1007/978-3-642-40722-2_5; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; de la Iglesia D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110331; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Fukunaga K., 2013, INTRO STAT PATTERN R; Gerbis N, 2010, LIVE SCI; Gurm HS, 2014, PLOS ONE, V9, P9; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall M.A., 1998, PRACTICAL FEATURE SU; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hoelz BW, 2009, ARTIF INTELL, P883; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Jouhet V, 2012, METHOD INFORM MED, V51, P242, DOI 10.3414/ME11-01-0005; Kang N, 2012, J BIOMED INFORM, V45, P423, DOI 10.1016/j.jbi.2011.12.009; Kasthurirathne SN, 2016, J BIOMED INFORM, V60, P145, DOI 10.1016/j.jbi.2016.01.008; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Koopman B, 2015, INT J MED INFORM, V84, P956, DOI 10.1016/j.ijmedinf.2015.08.004; Koopman B, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0174-2; Krauthammer M, 2004, J BIOMED INFORM, V37, P512, DOI 10.1016/j.jbi.2004.08.004; Lewis D. D., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P4, DOI 10.1007/BFb0026666; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Mahmood T, 2014, INF SYST E-BUS MANAG, V12, P213, DOI 10.1007/s10257-013-0222-3; Mahmood T, 2013, EXPERT SYST APPL, V40, P1152, DOI 10.1016/j.eswa.2012.08.022; Manavalan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106542; Marafino B, 2014, J AM MED INFORM ASSN, V21, P871, DOI 10.1136/amiajnl-2014-002694; Miasnikof P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0521-2; Mujtaba G, 2011, ADAPTIVE AUTOMATED 1, P1; Ong MS, 2010, QUAL SAF HEALTH CARE, V19, P7; Organization WH, 1979, MED CERTIFICATION CA; Osanaiye O, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0623-3; Prati RC, 2012, COMBINING FEATURE RA, P1; Provost F., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P445; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Refaeilzadeh P., 2009, ENCYCL DATABASE SYST, P532, DOI [10.1007/978-0-387-39940-9, DOI 10.1007/978-0-387-39940-9_565]; Romero R, 2014, BIOCLASS TOOL BIOMED, P243; Sarker A, 2015, J BIOMED INFORM, V53, P196, DOI 10.1016/j.jbi.2014.11.002; Schuemie MJ, 2012, PHARMACOEPIDEM DR S, V21, P651, DOI 10.1002/pds.3205; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Siddiqui MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135875; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Spasic I, 2014, INT J MED INFORM, V83, P605, DOI 10.1016/j.ijmedinf.2014.06.009; Steven B., 2006, P COLING ACL 2006 IN, DOI 10.3115/1225403.1225421; Uysal AK, 2016, EXPERT SYST APPL, V43, P82, DOI 10.1016/j.eswa.2015.08.050; van den Tweel JG, 2016, VIRCHOWS ARCH, V468, P75, DOI 10.1007/s00428-015-1833-5; Witten I. H., 2005, DATA MINING PRACTICA; Wolpert D.H., 1995, SFITR9502010; Yeow WL, 2014, EXPERT SYST APPL, V41, P3497, DOI 10.1016/j.eswa.2013.10.054; You ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125811; Zang H., 2004, AA, V1, P3; Zhang YD, 2015, J MED IMAG HEALTH IN, V5, P1395, DOI 10.1166/jmihi.2015.1542; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015; Zhang YD, 2012, SENSORS-BASEL, V12, P12489, DOI 10.3390/s120912489; Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020	73	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170242	10.1371/journal.pone.0170242	http://dx.doi.org/10.1371/journal.pone.0170242			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166263	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100006
J	Stone, DU; Fife, D; Brown, M; Earley, KE; Radfar, L; Kaufman, CE; Lewis, DM; Rhodus, NL; Segal, BM; Wallace, DJ; Weisman, MH; Venuturupalli, S; Brennan, MT; Lessard, CJ; Montgomery, CG; Scofield, RH; Sivils, KL; Rasmussen, A				Stone, Donald U.; Fife, Dustin; Brown, Michael; Earley, Keith E.; Radfar, Lida; Kaufman, C. Erick; Lewis, David M.; Rhodus, Nelson L.; Segal, Barbara M.; Wallace, Daniel J.; Weisman, Michael H.; Venuturupalli, Swamy; Brennan, Michael T.; Lessard, Christopher J.; Montgomery, Courtney G.; Scofield, R. Hal; Sivils, Kathy L.; Rasmussen, Astrid			Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjogren's Syndrome	PLOS ONE			English	Article							CIGARETTE-SMOKING; RISK-FACTORS; CLASSIFICATION CRITERIA; AUTOANTIBODY PRODUCTION; RHEUMATOID-ARTHRITIS; T-CELL; ASSOCIATION; DISEASE; SICCA; ANTIBODIES	Objectives To assess the association of smoking habits with the clinical, serological, and histopathological manifestations of Sjogren's syndrome (SS) and non-Sjogren's sicca (non-SS sicca). Methods Cross-sectional case-control study of 1288 patients with sicca symptoms (587 SS and 701 non-SS sicca) evaluated in a multi-disciplinary research clinic. Smoking patterns were obtained from questionnaire data and disease-related clinical and laboratory data were compared between current, past, ever, and never smokers. Results Current smoking rates were 4.6% for SS patients compared to 14.1% in non-SS sicca (p = 5.17x10E-09), 18% in a local lupus cohort (p = 1.13x10E-14) and 16.8% in the community (p = 4.12x10E-15). Current smoking was protective against SS classification (OR 0.35, 95%Cl 0.22-0.56, FDR q = 1.9E10-05), focal lymphocytic sialadenitis (OR 0.26, 95`)/X10.15-0.44, FDR q = 1.52x10E-06), focus score >= 1 (OR 0.22, 95%Cl 0.13-0.39, FDR q = 1.43x10E-07), and anti-Ro/SSA(+) (OR 0.36, 95%Cl 0.2-0.64, FDR q = 0.0009); ever smoking was protective against the same features and against anti-La/SSB(+) (OR 0.52, 95%Cl 0.39-0.70, FDR q = 5.82x10E-05). Duration of smoking was inversely correlated with SS even after controlling for socioeconomic status, BMI, alcohol and caffeine consumption. Conclusions Current tobacco smoking is negatively and independently associated with SS, protecting against disease-associated humoral and cellular autoimmunity. The overall smoking rate amongst SS patients is significantly lower than in matched populations and the effects of smoking are proportional to exposure duration. In spite of the protective effects of tobacco on SS manifestations, it is associated with other serious comorbidities such as lung disease, cardiovascular risk and malignancy, and should thus be strongly discouraged in patients with sicca.	[Stone, Donald U.] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD USA; [Stone, Donald U.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Fife, Dustin; Brown, Michael; Lessard, Christopher J.; Montgomery, Courtney G.; Scofield, R. Hal; Sivils, Kathy L.; Rasmussen, Astrid] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Earley, Keith E.] Joint Base San Antonio Lackland Air Force Base, US Air Force 59th Med Wing, San Antonio, TX USA; [Radfar, Lida] Univ Oklahoma, Dept Oral Diag & Radiol, Coll Dent, Oklahoma City, OK USA; [Kaufman, C. Erick] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Lewis, David M.] Univ Oklahoma, Coll Dent, Dept Oral Pathol, Oklahoma City, OK USA; [Rhodus, Nelson L.] Univ Minnesota, Sch Dent, Dept Oral Surg, Minneapolis, MN 55455 USA; [Segal, Barbara M.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Wallace, Daniel J.; Weisman, Michael H.; Venuturupalli, Swamy] Cedars Sinai Med Ctr, Div Rheumatol, Los Angeles, CA 90048 USA; [Brennan, Michael T.] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA; [Scofield, R. Hal] Dept Vet Affairs Med Ctr, Oklahoma City, OK USA	Johns Hopkins University; King Khaled Eye Specialist Hospital; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; Cedars Sinai Medical Center; Carolinas Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rasmussen, A (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Astrid-Rasmussen@omrf.org	Brennan, Michael/AAZ-2891-2020; Scofield, Robert Hal/AEJ-8314-2022	Montgomery, Courtney/0000-0002-9606-3772; Scofield, Robert Hal/0000-0003-1015-5850; Lessard, Christopher J./0000-0003-2440-3843	National Institutes of Health [AR053483, AR050782, DE018209, DE015223, AI082714, GM104938, AR060804, AI118787-01A1, AI012717, GM103510, AR065953, RR020143]; Oklahoma Medical Research Foundation; Phileona Foundation; Sjogren's Syndrome Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Medical Research Foundation; Phileona Foundation; Sjogren's Syndrome Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health [grant numbers AR053483, AR050782, DE018209, DE015223, AI082714, GM104938, AR060804 to KLS; AI118787-01A1, AI012717, GM103510 to AR; and AR065953, RR020143 to CJL], the Oklahoma Medical Research Foundation, the Phileona Foundation, and the Sjogren's Syndrome Foundation to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinors DD, 2006, AM J OPHTHALMOL, V141, P1016, DOI 10.1016/j.ajo.2005.12.047; Alunno A, 2014, J AUTOIMMUN, V51, P38, DOI 10.1016/j.jaut.2014.01.030; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Bartoloni E, 2015, J INTERN MED, V278, P185, DOI 10.1111/joim.12346; BASCOM R, 1991, ENVIRON HEALTH PERSP, V95, P39, DOI 10.2307/3431104; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Caramori G, 2015, ANN NY ACAD SCI, V1340, P55, DOI 10.1111/nyas.12619; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Csordas A, 2013, NAT REV CARDIOL, V10, P219, DOI 10.1038/nrcardio.2013.8; Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Freemer MM, 2006, ANN RHEUM DIS, V65, P581, DOI 10.1136/ard.2005.039438; Fujinami Y, 2009, ORAL DIS, V15, P466, DOI 10.1111/j.1601-0825.2009.01572.x; Galor A, 2011, CURR OPIN OPHTHALMOL, V22, P477, DOI 10.1097/ICU.0b013e32834bbe7a; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Goransson LG, 2011, SCAND J RHEUMATOL, V40, P221, DOI 10.3109/03009742.2010.536164; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Karabulut G, 2011, MOD RHEUMATOL, V21, P602, DOI 10.1007/s10165-011-0446-3; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee YH, 2014, INT J RHEUM DIS, V17, P528, DOI 10.1111/1756-185X.12307; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Lin X, 2014, ANN RHEUM DIS, V73, DOI [10.1136/annrheumdis-2014-205521, 10.1136/annrheumdis-2013-204584]; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; MAIER H, 1988, KLIN WOCHENSCHR, V66, P140; Manthorpe R, 2000, ANN RHEUM DIS, V59, P54, DOI 10.1136/ard.59.1.54; Masdottir B, 2000, RHEUMATOLOGY, V39, P1202, DOI 10.1093/rheumatology/39.11.1202; MATHEWS JD, 1973, LANCET, V2, P754; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Nilsson AM, 2015, J RHEUMATOL, V42, P464, DOI 10.3899/jrheum.140370; Ozaki Y, 2001, ARTHRITIS RHEUM-US, V44, P419, DOI 10.1002/1529-0131(200102)44:2<419::AID-ANR61>3.0.CO;2-U; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Perez-De-Lis M, 2010, LUPUS, V19, P941, DOI 10.1177/0961203310367504; Rad Maryam, 2010, J Dent Res Dent Clin Dent Prospects, V4, P110, DOI 10.5681/joddd.2010.028; Rasmussen A, 2014, ANN RHEUM DIS, V73, P31, DOI 10.1136/annrheumdis-2013-203845; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Rodriguez JW, 1999, IMMUNOPHARM IMMUNOT, V21, P379, DOI 10.3109/08923979909052769; Saha SP, 2007, INT J ANGIOL, V16, P77; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Singh N, 2012, J AUTOIMMUN, V39, P229, DOI 10.1016/j.jaut.2012.05.019; Smith CJ, 2001, ATHEROSCLEROSIS, V158, P257, DOI 10.1016/S0021-9150(01)00570-6; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sorensen LT, 2012, ANN SURG, V255, P1069, DOI 10.1097/SLA.0b013e31824f632d; Soy M, 2000, CLIN RHEUMATOL, V19, P508, DOI 10.1007/s100670070020; Sparks JA, 2016, ARTHRITIS RHEUMATOLO; Sparks JA, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0563-2; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; TOLLERUD DJ, 1991, AM REV RESPIR DIS, V144, P612, DOI 10.1164/ajrccm/144.3_Pt_1.612; Tzioufas AG, 2008, NEUROIMMUNOMODULAT, V15, P37, DOI 10.1159/000135622; van der Mei IAF, 2016, MULT SCLER J, V22, P461, DOI 10.1177/1352458515594040; VANBIJSTERVELD OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P189; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Young KA, 2014, LUPUS, V23, P360, DOI 10.1177/0961203314520838; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337; Zuo L, 2014, AM J PHYSIOL-LUNG C, V307, pL205, DOI 10.1152/ajplung.00330.2013	61	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0170249	10.1371/journal.pone.0170249	http://dx.doi.org/10.1371/journal.pone.0170249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166540	gold, Green Published, Green Submitted			2022-12-27	WOS:000393700100007
J	Roeleveld, DM; Marijnissen, RJ; Walgreen, B; Helsen, MM; van den Bersselaar, L; de Loo, FAV; van Lent, PL; van der Kraan, PM; van den Berg, WB; Koenders, MI				Roeleveld, Debbie M.; Marijnissen, Renoud J.; Walgreen, Birgitte; Helsen, Monique M.; van den Bersselaar, Liduine; de Loo, Fons A. van; van Lent, Peter L.; van der Kraan, Peter M.; van den Berg, Wim B.; Koenders, Marije I.			Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis	PLOS ONE			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; NECROSIS-FACTOR; DOUBLE-BLIND; INADEQUATE RESPONSE; PROMOTES OSTEOCLASTOGENESIS; CARTILAGE DESTRUCTION; TH17 DIFFERENTIATION; INCOMPLETE RESPONSE	Th17 cells and their cytokines are linked to the pathogenesis of rheumatoid arthritis, a chronic autoimmune disease characterized by joint inflammation. Th17 development is initiated by combined signaling of TGF-beta and IL-6 or IL-21, and can be reduced in the absence of either IL-6 or IL-21. The aim of this study was to assess whether combinatorial IL-6/IL-21 blockade would more potently inhibit Th17 development, and be more efficacious in treating arthritis than targeting either cytokine. We assessed in vitro Th17 differentiation efficacy in the absence of IL-6 and/or IL-21. To investigate in vivo effects of IL-6/IL-21 blockade on Th17 and arthritis development, antigen-induced arthritis (AIA) was induced in IL-6(-/-) x IL-21R(-/-) mice. The therapeutic potential of this combined blocking strategy was assessed by treating mice with collagen-induced arthritis (CIA) with anti-IL-6R antibodies and soluble (s) IL-21R.Fc. We demonstrated that combined IL-6/IL-21 blocking synergistically reduced in vitro Th17 differentiation. In mice with AIA, absence of IL-6 and IL-21 signaling more strongly reduced Th17 levels and resulted in stronger suppression of arthritis than the absence of either cytokine. Additionally, anti-IL-6/anti-IL-21 treatment of CIA mice during the arthritis induction phase reduced disease development more potent than IL-6 or IL-21 inhibition alone, as effective as anti-TNF treatment. Collectively, these results suggest dual IL-6/IL-21 inhibition may be a more efficacious therapeutic strategy compared to single cytokine blockade to suppress arthritis development.	[Roeleveld, Debbie M.; Marijnissen, Renoud J.; Walgreen, Birgitte; Helsen, Monique M.; van den Bersselaar, Liduine; de Loo, Fons A. van; van Lent, Peter L.; van der Kraan, Peter M.; van den Berg, Wim B.; Koenders, Marije I.] Radboud Univ Nijmegen, Med Ctr, Dept Expt Rheumatol, Nijmegen, Netherlands	Radboud University Nijmegen	Roeleveld, DM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Expt Rheumatol, Nijmegen, Netherlands.	Debbie.Roeleveld@radboudumc.nl	van der Kraan, Peter M/D-9115-2011; van de Loo, Fons AJ/A-3425-2014; van Lent, Peter/A-4047-2014; Koenders, Marije I/A-1341-2012; Marijnissen, Renoud/M-5541-2013; Roeleveld, Debbie/P-8730-2015	van de Loo, Fons AJ/0000-0002-5851-099X; Koenders, Marije I/0000-0001-5845-8362; Marijnissen, Renoud/0000-0002-6836-675X; Roeleveld, Debbie/0000-0002-5414-3299	Innovative Medicines Initiative Joint Undertaking [115142-2]	Innovative Medicines Initiative Joint Undertaking	DR received funding from the Innovative Medicines Initiative Joint Undertaking funded project BTCure [http://btcure.eu/ grant number: 115142-2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts NE, 2010, RHEUMATOLOGY, V49, P2264, DOI 10.1093/rheumatology/keq224; Alzabin S, 2012, ANN RHEUM DIS, V71, P1741, DOI 10.1136/annrheumdis-2011-201024; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Block KE, 2013, J IMMUNOL, V191, P2948, DOI 10.4049/jimmunol.1301173; Burmester GR, 2016, RHEUMATOLOGY, V55, P49, DOI 10.1093/rheumatology/kev258; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; de Hooge ASK, 2000, AM J PATHOL, V157, P2081, DOI 10.1016/S0002-9440(10)64846-8; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Genovese MC, 2014, ARTHRITIS RHEUMATOL, V66, P1693, DOI 10.1002/art.38617; Genovese MC, 2014, J RHEUMATOL, V41, P414, DOI 10.3899/jrheum.130637; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Kim KW, 2012, ARTHRITIS RHEUM-US, V64, P1015, DOI 10.1002/art.33446; Koenders MI, 2015, TRENDS PHARMACOL SCI, V36, P189, DOI 10.1016/j.tips.2015.02.001; Koenders MI, 2011, ARTHRITIS RHEUM-US, V63, P2329, DOI 10.1002/art.30418; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Kwok SK, 2012, ARTHRITIS RHEUM-US, V64, P740, DOI 10.1002/art.33390; Leipe J, 2011, ANN RHEUM DIS, V70, P1453, DOI 10.1136/ard.2011.152074; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Marijnissen RJ, 2014, ARTHRITIS RHEUMATOL, V66, P886, DOI 10.1002/art.38312; Martin DA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4347; McInnes IB, 2015, LANCET, V386, P1137, DOI 10.1016/S0140-6736(15)61134-5; Mease PJ, 2015, NEW ENGL J MED, V373, P1329, DOI 10.1056/NEJMoa1412679; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pavelka K, 2015, J RHEUMATOL, V42, P912, DOI 10.3899/jrheum.141271; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Roeleveld DM, 2015, CYTOKINE, V74, P101, DOI 10.1016/j.cyto.2014.10.006; Rosu A, 2012, ROM J MORPHOL EMBRYO, V53, P73; Sakuraba K, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1086-y; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Song SNJ, 2015, EXPERT OPIN DRUG MET, V11, P307, DOI 10.1517/17425255.2015.992779; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yoshida H, 2011, RHEUMATOL INT, V31, P127, DOI 10.1007/s00296-010-1552-9; Zhao L, 2013, INT J RHEUM DIS, V16, P518, DOI 10.1111/1756-185X.12099; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	54	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171757	10.1371/journal.pone.0171757	http://dx.doi.org/10.1371/journal.pone.0171757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158305	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700122
J	Cha, S; Chae, HM; Lee, SH; Shim, JK				Cha, Sangsub; Chae, Hee-Myung; Lee, Sang-Hoon; Shim, Jae-Kuk			Effect of elevated atmospheric CO2 concentration on growth and leaf litter decomposition of Quercus acutissima and Fraxinus rhynchophylla	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; MICROBIAL BIOMASS; SOIL CARBON; TEMPERATURE SENSITIVITY; NITROGEN LIMITATION; LIGNIN CONTROL; PLANT-GROWTH; ROOT-GROWTH; ENRICHMENT; DYNAMICS	The atmospheric carbon dioxide (CO2) level is expected to increase substantially, which may change the global climate and carbon dynamics in ecosystems. We examined the effects of an elevated atmospheric CO2 level on the growth of Quercus acutissima and Fraxinus rhynchophylla seedlings. We investigated changes in the chemical composition of leaf litter, as well as litter decomposition. Q. acutissima and F. rhynchophylla did not show differences in dry weight between ambient CO2 and enriched CO2 treatments, but they exhibited different patterns of carbon allocation, namely, lower shoot/root ratio (S/R) and decreased specific leaf area (SLA) under CO2-enriched conditions. The elevated CO2 concentration significantly reduced the nitrogen concentration in leaf litter while increasing lignin concentrations and carbon/nitrogen (C/N) and lignin/N ratios. The microbial biomass associated with decomposing Q. acutissima leaf litter was suppressed in CO2 enrichment chambers, while that of F. rhynchophylla was not. The leaf litter of Q. acutissima from the CO2-enriched chambers, in contrast with F. rhynchophylla, contained much lower nutrient concentrations than that of the litter in the ambient air chambers. Consequently, poorer litter quality suppressed decomposition.	[Cha, Sangsub; Chae, Hee-Myung; Lee, Sang-Hoon; Shim, Jae-Kuk] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chung Ang University	Shim, JK (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul, South Korea.	shimjk@cau.ac.kr						Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Allen S.E., 1974, CHEM ANAL ECOLOGICAL; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Andresen LC, 2010, PLANT SOIL, V328, P381, DOI 10.1007/s11104-009-0118-7; [Anonymous], 2014, CLIMATE CHANGE 2013; [Anonymous], 2015, WMO GREENH GAS B; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; BEARE MH, 1991, AGR ECOSYST ENVIRON, V34, P65, DOI 10.1016/0167-8809(91)90094-E; Berg B., 2008, PLANT LITTER; Bloom AJ, 2014, NAT CLIM CHANGE, V4, P477, DOI [10.1038/NCLIMATE2183, 10.1038/nclimate2183]; Brandstatter C, 2013, PLANT SOIL, V371, P139, DOI 10.1007/s11104-013-1671-7; Brandt LA, 2007, GLOBAL CHANGE BIOL, V13, P2193, DOI 10.1111/j.1365-2486.2007.01428.x; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Ceulemans R, 1999, ANN BOT-LONDON, V84, P577, DOI 10.1006/anbo.1999.0945; CEULEMANS R, 1994, NEW PHYTOL, V127, P425, DOI 10.1111/j.1469-8137.1994.tb03961.x; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cotrufo M. Francesca, 1998, Environmental Reviews, V6, P1, DOI 10.1139/a97-013; Cotrufo MF, 1996, OECOLOGIA, V106, P525, DOI 10.1007/BF00329711; COTRUFO MF, 1994, PLANT SOIL, V163, P121, DOI 10.1007/BF00033948; Cotrufo MF, 1998, SOIL BIOL BIOCHEM, V30, P1565, DOI 10.1016/S0038-0717(98)00032-7; COUTEAUX MM, 1991, OIKOS, V61, P54, DOI 10.2307/3545406; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; De Angelis P, 2000, PLANT SOIL, V224, P31, DOI 10.1023/A:1004790328560; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; de la Mata L, 2012, J PLANT PHYSIOL, V169, P1392, DOI 10.1016/j.jplph.2012.05.024; de Oliveira ED, 2013, FUNCT PLANT BIOL, V40, P160, DOI 10.1071/FP12206; Eamus D, 2004, ADV ECOL RES, V34; Entry JA, 1998, ROOT DEMOGRAPHICS TH; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Faria T, 1996, J EXP BOT, V47, P1755, DOI 10.1093/jxb/47.11.1755; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Gavazov KS, 2010, PLANT SOIL, V337, P19, DOI 10.1007/s11104-010-0477-0; Gebauer RLE, 1998, OECOLOGIA, V113, P29, DOI 10.1007/s004420050350; Heagle AS, 2002, ENVIRON ENTOMOL, V31, P594, DOI 10.1603/0046-225X-31.4.594; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Helrich K, 1990, OFF METH AN AOAC, V1; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hunt R., 1990, BASIC PLANT GROWTH A, DOI 10.1007/978-94-010-9117-6; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jarvis PG, 1998, EUROPEAN FORESTS GLO; Jastrow JD, 2005, GLOBAL CHANGE BIOL, V11, P2057, DOI 10.1111/j.1365-2486.2005.01077.x; Jiang S, 2016, ENTOMOL EXP ET APPL; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1023, DOI 10.1016/0038-0717(90)90027-W; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Kasurinen A, 2006, PLANT SOIL, V282, P261, DOI 10.1007/s11104-005-6026-6; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Keiser AD, 2013, PLANT SOIL, V372, P167, DOI 10.1007/s11104-013-1730-0; Khalsa SDS, 2016, SOIL SCI PLANT NUTR, V62, P271, DOI 10.1080/00380768.2016.1188413; Kohen AE, 1992, ANN SCI FORESTIERES; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Lee T. B., 2003, COLOURED FLORA KOREA, V1; Lee TB, 2003, COLOURED FLORA KOREA, V2; Lee TD, 2003, OECOLOGIA, V137, P22, DOI 10.1007/s00442-003-1309-1; Li TQ, 2012, PLANT SOIL, V354, P325, DOI 10.1007/s11104-011-1068-4; Lindroth RL, 2010, J CHEM ECOL, V36, P2, DOI 10.1007/s10886-009-9731-4; Lopes A, 2015, HYDROBIOLOGIA, P1; Loudermilk EL, 2013, GLOBAL CHANGE BIOL, V19, P3502, DOI 10.1111/gcb.12310; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Lynch JP, 2004, FIELD CROP RES, V90, P101, DOI 10.1016/j.fcr.2004.07.008; Madhu M, 2013, AGRON J, V105, P657, DOI 10.2134/agronj2013.0018; Martin PH, 2001, ANNU REV ENERG ENV, V26, P435, DOI 10.1146/annurev.energy.26.1.435; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Melillo J., 1983, WILL INCREASES ATMOS, P10; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Murray TJ, 2013, GLOBAL CHANGE BIOL, V19, P1407, DOI 10.1111/gcb.12142; Nakamoto T, 2004, PLANT PROD SCI, V7, P70, DOI 10.1626/pps.7.70; Neha Sharma, 2014, Climate Change and Environmental Sustainability, V2, P69, DOI 10.5958/2320-642X.2014.00001.5; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Norby RJ, 1999, PLANT CELL ENVIRON, V22, P683, DOI 10.1046/j.1365-3040.1999.00391.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pardos M, 2006, TREES-STRUCT FUNCT, V20, P713, DOI 10.1007/s00468-006-0086-y; PARMELEE RW, 1989, SOIL BIOL BIOCHEM, V21, P97, DOI 10.1016/0038-0717(89)90017-5; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Reich PB, 2014, NAT GEOSCI, V7, P920, DOI [10.1038/NGEO2284, 10.1038/ngeo2284]; Reverchon F, 2012, J SOIL SEDIMENT, V12, P150, DOI 10.1007/s11368-011-0445-1; Richet N, 2012, J EXP BOT, V63, P4291, DOI 10.1093/jxb/ers118; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Rutledge S, 2010, GLOBAL CHANGE BIOL, V16, P3065, DOI 10.1111/j.1365-2486.2009.02149.x; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Smith AR, 2013, GLOBAL CHANGE BIOL, V19, P217, DOI 10.1111/gcb.12039; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Sulman BN, 2014, NAT CLIM CHANGE, V4, P1099, DOI [10.1038/nclimate2436, 10.1038/NCLIMATE2436]; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Tissue DT, 1997, PLANT CELL ENVIRON, V20, P1123, DOI 10.1046/j.1365-3040.1997.d01-140.x; Tyrrell ML, 2012, MANAGING EST CARB; van Groenigen KJ, 2014, SCIENCE, V344, P508, DOI 10.1126/science.1249534; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Varga B, 2016, J AGRONOMY CROP SCI; Wamelink GWW, 2009, FOREST ECOL MANAG, V258, P1794, DOI 10.1016/j.foreco.2009.05.018; Ward SE, 2015, ECOLOGY, V96, P113, DOI 10.1890/14-0292.1; Wymore AS, 2016, MICROB ECOL, V71, P825, DOI 10.1007/s00248-016-0735-7; Xu CY, 2012, J EXP BOT, V63, P5829, DOI 10.1093/jxb/ers231; Yuan ZY, 2015, NAT CLIM CHANGE, V5, P465, DOI [10.1038/nclimate2549, 10.1038/NCLIMATE2549]; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Ziska LH, 2005, GLOBAL CHANGE BIOL, V11, P1325, DOI 10.1111/j.1365-2486.2005.00992.x	109	21	22	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171197	10.1371/journal.pone.0171197	http://dx.doi.org/10.1371/journal.pone.0171197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182638	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800044
J	Huang, P; Li, WS; Yang, ZF; Zhang, N; Xu, YX; Bao, JY; Jiang, DK; Dong, XP				Huang, Peng; Li, Wenshu; Yang, Zhifang; Zhang, Ning; Xu, Yixin; Bao, Jianying; Jiang, Deke; Dong, Xianping			LYZL6, an acidic, bacteriolytic, human sperm-related protein, plays a role in fertilization	PLOS ONE			English	Article							LYSOZYME-LIKE PROTEIN; PICHIA-PASTORIS; EGG FUSION; BINDING; SLLP1; SPERMATOZOA; EXPRESSION; PLASMA	Lysozyme-like proteins (LYZLs) belong to the c-type lysozyme/alpha-lactalbumin family and are selectively expressed in the mammalian male reproductive tract. Two members, human sperm lysozyme-like protein (SLLP) -1 and mouse LYZL4, have been reported to contribute to fertilization but show no bacteriolytic activity. Here, we focused on the possible contribution of LYZL6 to immunity and fertilization. In humans, LYZL6 was selectively expressed by the testis and epididymis and became concentrated on spermatozoa. Native LYZL6 isolated from sperm extracts exhibited bacteriolytic activity against Micrococcus lysodeikticus. Recombinant LYZL6 (rLYZL6) reached its peak activity at pH 5.6 and 15 mM of Na+, and could inhibit the growth of Gram-positive, but not Gram-negative bacteria. Nevertheless, the bacteriolytic activity of rLYZL6 proved to be much lower than that of human lysozyme under physiological conditions. Immunodetection with a specific antiserum localized the LYZL6 protein on the postacrosomal membrane of mature spermatozoa. Immunoneutralization of LYZL6 significantly decreased the numbers of human spermatozoa fused with zona-free hamster eggs in a dose-dependent manner in vitro. Thus, we report here for the first time that LYZL6, an acidic, bacteriolytic and human sperm-related protein, is likely important for fertilization but not for the innate immunity of the male reproductive tract.	[Huang, Peng; Yang, Zhifang; Zhang, Ning; Bao, Jianying] Shanghai Univ Med & Hlth Sci, Coll Basic Med, Shanghai, Peoples R China; [Li, Wenshu] New York Univ, Coll Arts & Sci, Shanghai, Peoples R China; [Xu, Yixin] Shanghai Univ Med & Hlth Sci, Coll Pharm, Shanghai, Peoples R China; [Jiang, Deke] Southern Med Univ, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Dong, Xianping] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada	Shanghai University of Medicine & Health Sciences; Shanghai University of Medicine & Health Sciences; Southern Medical University - China; Dalhousie University	Huang, P (corresponding author), Shanghai Univ Med & Hlth Sci, Coll Basic Med, Shanghai, Peoples R China.; Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	huangp_15@sumhs.edu.cn; xpdong@dal.ca		Dong, Xianping/0000-0002-4496-7104	Science and Technology Commission of Shanghai Municipality [15ZR1421800]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Science and Technology Commission of Shanghai Municipality (no. 15ZR1421800). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doussau M, 2008, FERTIL STERIL, V90, P853, DOI 10.1016/j.fertnstert.2007.07.1329; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Huang P, 2011, MOL IMMUNOL, V48, P524, DOI 10.1016/j.molimm.2010.10.008; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; MASON DY, 1975, J CLIN PATHOL, V28, P124, DOI 10.1136/jcp.28.2.124; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Prager E.M., 1996, Experientia Supplementum (Basel), V75, P323; Prager E.M., 1996, Experientia Supplementum (Basel), V75, P9; Rubinstein E, 2006, SEMIN CELL DEV BIOL, V17, P254, DOI 10.1016/j.semcdb.2006.02.012; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; SAMUEL T, 1987, CLIN EXP IMMUNOL, V67, P454; Sava G, 1996, EXS, V75, P433; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Stein KK, 2004, J CELL SCI, V117, P6269, DOI 10.1242/jcs.01598; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Wei J, 2013, ASIAN J ANDROL, V15, P824, DOI 10.1038/aja.2013.93; Yanagimachi R., 1994, P189; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yudin AI, 2005, BIOL REPROD, V73, P1243, DOI 10.1095/biolreprod.105.042432; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zhou XY, 2014, J BIOSCI BIOENG, V118, P420, DOI 10.1016/j.jbiosc.2014.03.009	25	8	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171452	10.1371/journal.pone.0171452	http://dx.doi.org/10.1371/journal.pone.0171452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182716	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800060
J	Wu, CH; Chang, CS; Yang, YK; Shen, LH; Yao, WJ				Wu, Chih-Hsing; Chang, Chin-Sung; Yang, Yen Kuang; Shen, Lie-Hang; Yao, Wei-Jen			Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder	PLOS ONE			English	Article							BODY-MASS INDEX; HEALTHY-VOLUNTEERS; I-123 ADAM; AVAILABILITY; SPECT; DOPAMINE; BINDING; ASSOCIATION; WEIGHT; DRUGS	Cerebral serotonin metabolism has an important but controversial role in obesity. However, it is not given enough attention in morbidly obese young adults. We used single photon emission computed tomography (SPECT) with [I-123]-labeled 2-((2-((dimethylamino) methyl) phenyl) thio)-5- iodophenylamine (ADAM) to investigate changes in serotonin transporter (SERT) availability in 10 morbidly obese young adults without an eating disorder (M/F =5/5, body mass index (BMI): 40.3 +/- 4.1 kg/m(2), percentage of body fat (BF%): 46.0 +/- 3.9%) and 10 age- and sex-matched non-obese controls (BMI: 20.3 +/- 1.2 kg/m(2), BF%: 20.6 +/- 8.9%). All participants underwent SPECT at 10 min and 6 h after an injection of 200 MBq of [I-123]-ADAM. The SERT binding site (midbrain) was drawn with cerebellum normalization. The BF% and fat distribution were measured using dual-energy X-ray absorptiometry. The midbrain/cerebellum SERT binding ratios (2.49 +/- 0.46 vs. 2.47 +/- 0.47; p = 0.912) at 6 h were not significantly different between groups, nor was the distribution of the summed images at 10 min (1.36 +/- 0.14 vs. 1.35 +/- 0.11; p = 0.853). There were no significant correlations between midbrain/cerebellum SERT binding ratio and age, BMI, BF%, or fat distribution. No significant difference in SERT availability in the midbrain between morbidly obese and non-obese young adults without an eating disorder indicates an unmet need for investigating the role of cerebral serotonin in obesity.	[Wu, Chih-Hsing; Chang, Chin-Sung] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Family Med, Tainan, Taiwan; [Wu, Chih-Hsing; Yang, Yen Kuang] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan, Taiwan; [Wu, Chih-Hsing] Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan; [Chang, Chin-Sung] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Yang, Yen Kuang] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Psychiat, Tainan, Taiwan; [Shen, Lie-Hang] Inst Nucl Energy Res, Taoyuan, Taiwan; [Yao, Wei-Jen] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Nucl Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Institute of Nuclear Energy Research - Taiwan; National Cheng Kung University	Yao, WJ (corresponding author), Natl Cheng Kung Univ, Coll Med & Hosp, Dept Nucl Med, Tainan, Taiwan.	wjyao@mail.ncku.edu.tw						Acton PD, 2001, J NUCL MED, V42, P1556; Adan RAH, 2013, TRENDS NEUROSCI, V36, P133, DOI 10.1016/j.tins.2012.12.001; Allison DB, 2008, OBESITY, V16, P1161, DOI 10.1038/oby.2008.231; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Bello NT, 2011, DRUG DES DEV THER, V5, P95, DOI 10.2147/DDDT.S11859; Berlie HD, 2013, EXPERT OPIN DRUG MET, V9, P1053, DOI 10.1517/17425255.2013.798643; Borgers AJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00106; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chang WH, 2015, PSYCHIAT RES-NEUROIM, V231, P320, DOI 10.1016/j.pscychresns.2015.01.015; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Cheng YS, 2011, PSYCHIAT RES-NEUROIM, V194, P396, DOI 10.1016/j.pscychresns.2011.04.005; Chou MH, 2012, PSYCHOPHARMACOLOGY, V219, P1011, DOI 10.1007/s00213-011-2431-0; Chou YH, 2009, PSYCHIAT RES-NEUROIM, V172, P38, DOI 10.1016/j.pscychresns.2008.12.006; Colman E, 2012, NEW ENGL J MED, V367, P1577, DOI 10.1056/NEJMp1211277; Darby A, 2007, INT J OBESITY, V31, P876, DOI 10.1038/sj.ijo.0803501; Darby A, 2009, INT J EAT DISORDER, V42, P104, DOI 10.1002/eat.20601; Erlandsson K, 2005, EUR J NUCL MED MOL I, V32, P1329, DOI 10.1007/s00259-005-1912-y; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Giannaccini G, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-128; Gibson CD, 2010, J NEUROENDOCRINOL, V22, P833, DOI 10.1111/j.1365-2826.2010.02025.x; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Hesse S, 2014, EUR NEUROPSYCHOPHARM, V24, P1240, DOI 10.1016/j.euroneuro.2014.05.005; Hsu JW, 2011, PSYCHIAT RES-NEUROIM, V194, P224, DOI 10.1016/j.pscychresns.2011.04.011; Huang CI, 2010, NUCL MED COMMUN, V31, P734, DOI 10.1097/MNM.0b013e32833b7534; Huang HY, 2013, J PSYCHOSOM RES, V75, P577, DOI 10.1016/j.jpsychores.2013.09.006; Koebnick C, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-15; Koopman KE, 2013, MOL METAB, V2, P417, DOI 10.1016/j.molmet.2013.07.006; Koskela AK, 2008, PHYSIOL BEHAV, V93, P724, DOI 10.1016/j.physbeh.2007.11.043; Koskela AK, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-19; Kuikka JT, 2001, PSYCHOPHARMACOLOGY, V155, P310, DOI 10.1007/s002130100716; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lin KJ, 2006, NUCL MED BIOL, V33, P193, DOI 10.1016/j.nucmedbio.2005.10.006; Marston OJ, 2011, EUR J PHARMACOL, V660, P70, DOI 10.1016/j.ejphar.2010.12.024; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Mond JM, 2007, OBESITY, V15, P2769, DOI 10.1038/oby.2007.329; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Nigro SC, 2013, CURR MED RES OPIN, V29, P839, DOI 10.1185/03007995.2013.794776; Organization WH, 1998, WELLB MEAS PRIM HLTH; Oya S, 2000, NUCL MED BIOL, V27, P249, DOI 10.1016/S0969-8051(00)00084-6; Pedersen Sue D, 2012, Endocrinol Nutr, V59, P521, DOI 10.1016/j.endonu.2012.07.001; Sargent BJ, 2011, CURR OPIN PHARMACOL, V11, P52, DOI 10.1016/j.coph.2011.01.005; SILVERSTONE T, 1986, APPETITE, V7, P85, DOI 10.1016/S0195-6663(86)80054-X; Thomsen G, 2013, OBESITY, V21, P1803, DOI 10.1002/oby.20225; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wolfe BE, 2000, NEUROPSYCHOPHARMACOL, V22, P257, DOI 10.1016/S0893-133X(99)00117-7; Wu CH, 1998, ATHEROSCLEROSIS, V137, P157, DOI 10.1016/S0021-9150(97)00270-0; Wu CH, 2009, ASIA PAC J CLIN NUTR, V18, P423; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	50	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170886	10.1371/journal.pone.0170886	http://dx.doi.org/10.1371/journal.pone.0170886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182708	Green Submitted, gold, Green Published			2022-12-27	WOS:000394231800021
J	Alta, RYP; Vitorino, HA; Goswami, D; Liria, CW; Wisnovsky, SP; Kelley, SO; Machini, MT; Esposito, BP				Alta, Roxana Y. P.; Vitorino, Hector A.; Goswami, Dibakar; Liria, Cleber W.; Wisnovsky, Simon P.; Kelley, Shana O.; Machini, M. Teresa; Esposito, Breno P.			Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron	PLOS ONE			English	Article							FRIEDREICHS-ATAXIA; OVERLOAD DISEASE; CELL-DEATH; DOXORUBICIN; DELIVERY; DNA	Desferrioxamine (DFO) is a bacterial siderophore with a high affinity for iron, but low cell penetration. As part of our ongoing project focused on DFO-conjugates, we synthesized, purified, characterized and studied new mtDFOs (DFO conjugated to the Mitochondria Penetrating Peptides TAT(49-57), 1A, SS02 and SS20) using a succinic linker. These new conjugates retained their strong iron binding ability and antioxidant capacity. They were relatively non toxic to A2780 cells (IC50 40-100 mu M) and had good mitochondrial localization (Rr +0.45-+0.68) as observed when labeled with carboxy-tetramethylrhodamine (TAMRA) In general, mtDFO caused only modest levels of mitochondrial DNA (mtDNA) damage. DFO-SS02 retained the antioxidant ability of the parent peptide, shown by the inhibition of mitochondrial superoxide formation. None of the compounds displayed cell cycle arrest or enhanced apoptosis. Taken together, these results indicate that mtDFO could be promising compounds for amelioration of the disease symptoms of iron overload in mitochondria.	[Alta, Roxana Y. P.; Vitorino, Hector A.; Esposito, Breno P.] Univ Sao Paulo, Inst Chem, Dept Fundamental Chem, Sao Paulo, Brazil; [Alta, Roxana Y. P.; Liria, Cleber W.; Machini, M. Teresa] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Goswami, Dibakar] Bhabha Atom Res Ctr, Bombay, Maharashtra, India; [Wisnovsky, Simon P.; Kelley, Shana O.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Kelley, Shana O.] Univ Toronto, Fac Pharm, Toronto, ON, Canada	Universidade de Sao Paulo; Universidade de Sao Paulo; Bhabha Atomic Research Center (BARC); University of Toronto; University of Toronto	Esposito, BP (corresponding author), Univ Sao Paulo, Inst Chem, Dept Fundamental Chem, Sao Paulo, Brazil.; Machini, MT (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	breno@iq.usp.br; mtmachini@iq.usp.br	goswami, dibakar/AAE-2672-2019; Kelley, Shana/H-5856-2015; PASTRANA ALTA, ROXANA YESENIA/K-2351-2017; Esposito, Breno/B-7136-2008; Vitorino, Hector Aguilar/T-5780-2019; Machini, M. Teresa/D-2009-2012; Vitorino, Hector Aguilar/J-2749-2015; Kelley, Shana/ABA-7403-2021	Kelley, Shana/0000-0003-3360-5359; PASTRANA ALTA, ROXANA YESENIA/0000-0002-8671-4578; Esposito, Breno/0000-0002-1447-435X; Vitorino, Hector Aguilar/0000-0002-6891-0524; Machini, M. Teresa/0000-0001-5772-004X; Vitorino, Hector Aguilar/0000-0002-6891-0524; PASTRANA ALTA, ROXANA YESENIA/0000-0003-4316-6572	FAPESP (Brazilian agency) [2011/50318-1, 2016/03709-9, 2012/09068-4]; CNPq (Brazilian agency); CAPES (Brazilian agency)	FAPESP (Brazilian agency)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazilian agency)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazilian agency)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We declare financial support from FAPESP (grants 2011/50318-1 and 2016/03709-9 for BPE and 2012/09068-4 for MTM), CNPq and CAPES (Brazilian agencies).	Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Cabantchik ZI, 2013, THALASS REP, V3, P7, DOI 10.4081/thal.2013.s1.e3; Chamberlain GR, 2013, ACS CHEM BIOL, V8, P1389, DOI 10.1021/cb400095v; Cowan J.A., 1997, INORGANIC BIOCH INTR; Del Gaizo V, 2003, MOL GENET METAB, V80, P170, DOI 10.1016/j.ymgme.2003.08.017; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Dusek P, 2016, J TRACE ELEM MED BIO, V38, P81, DOI 10.1016/j.jtemb.2016.03.010; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Farkas E, 1997, J INORG BIOCHEM, V65, P281, DOI 10.1016/S0162-0134(96)00144-4; Fonseca SB, 2011, CHEM BIOL, V18, P445, DOI 10.1016/j.chembiol.2011.02.010; Goswami D, 2015, BIOMETALS, V28, P869, DOI 10.1007/s10534-015-9873-5; Goswami D, 2014, BIOCONJUGATE CHEM, V25, P2067, DOI 10.1021/bc5004197; Grubman A, 2014, BRIT J PHARMACOL, V171, P2159, DOI 10.1111/bph.12513; Halliwell B., 2007, FREE RADICALS BIOL M; Hider RC, 1999, BIOCHEM PHARMACOL, V57, P1031, DOI 10.1016/S0006-2952(99)00014-3; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Jean SR, 2015, ACS CHEM BIOL, V10, P2007, DOI 10.1021/acschembio.5b00268; Kalinowski DS, 2008, J MED CHEM, V51, P331, DOI 10.1021/jm7012562; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kwiatkowski JL, 2011, HEMATOL-AM SOC HEMAT, P451, DOI 10.1182/asheducation-2011.1.451; Loffredo C, 2009, J PEPT SCI, V15, P808, DOI 10.1002/psc.1178; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Mourtada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060253; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Rapoport M, 2011, J MOL MED, V89, P161, DOI 10.1007/s00109-010-0693-3; Richardson DR, 2001, BBA-MOL BASIS DIS, V1536, P133, DOI 10.1016/S0925-4439(01)00041-2; Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Sooriyaarachchi M, 2010, DALTON T, V39, P7466, DOI 10.1039/c0dt00229a; Srinivasan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017732; Velasco-Sanchez D, 2011, CEREBELLUM, V10, P1, DOI 10.1007/s12311-010-0212-7; VOEST EE, 1993, CELL PROLIFERAT, V26, P77, DOI 10.1111/j.1365-2184.1993.tb00008.x; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; Wilson RB, 2012, J CHILD NEUROL, V27, P1212, DOI 10.1177/0883073812449691; Wisnovsky SP, 2013, CHEM BIOL, V20, P1323, DOI 10.1016/j.chembiol.2013.08.010; Yamada Y, 2008, ADV DRUG DELIVER REV, V60, P1439, DOI 10.1016/j.addr.2008.04.016; Yousif LF, 2009, CHEMBIOCHEM, V10, P2081, DOI 10.1002/cbic.200900017; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	42	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171729	10.1371/journal.pone.0171729	http://dx.doi.org/10.1371/journal.pone.0171729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178347	Green Submitted, gold, Green Published			2022-12-27	WOS:000393712500064
J	Hellinger, J; Jagers, P; Donner, M; Sutt, F; Mark, MD; Senen, B; Tollrian, R; Herlitze, S				Hellinger, Jens; Jaegers, Peter; Donner, Marcel; Sutt, Franziska; Mark, Melanie D.; Senen, Budiono; Tollrian, Ralph; Herlitze, Stefan			The Flashlight Fish Anomalops katoptron Uses Bioluminescent Light to Detect Prey in the Dark	PLOS ONE			English	Article							CORAL-REEF FISH; SIPHAMIA-VERSICOLOR; LEIOGNATHID FISH; SOUTH-PACIFIC; ORGAN; BERYCIFORMES; LUMINESCENCE; SEA; PHOTOPHORES; COMPETITION	Bioluminescence is a fascinating phenomenon occurring in numerous animal taxa in the ocean. The reef dwelling splitfin flashlight fish (Anomalops katoptron) can be found in large schools during moonless nights in the shallow water of coral reefs and in the open surrounding water. Anomalops katoptron produce striking blink patterns with symbiotic bacteria in their sub-ocular light organs. We examined the blink frequency in A. katoptron under various laboratory conditions. During the night A. katoptron swims in schools roughly parallel to their conspecifics and display high blink frequencies of approximately 90 blinks/minute with equal on and off times. However, when planktonic prey was detected in the experimental tank, the open time increased compared to open times in the absence of prey and the frequency decreased to 20% compared to blink frequency at night in the absence of planktonic prey. During the day when the school is in a cave in the reef tank the blink frequency decreases to approximately 9 blinks/minute with increasing off-times of the light organ. Surprisingly the non-luminescent A. katoptron with non-functional light organs displayed the same blink frequencies and light organ open/closed times during the night and day as their luminescent conspecifics. In the presence of plankton non-luminescent specimens showed no change in the blink frequency and open/closed times compared to luminescent A. katoptron. Our experiments performed in a coral reef tank show that A. katoptron use bioluminescent illumination to detect planktonic prey and that the blink frequency of A. katoptron light organs follow an exogenous control by the ambient light.	[Hellinger, Jens; Jaegers, Peter; Donner, Marcel; Sutt, Franziska; Mark, Melanie D.; Herlitze, Stefan] Ruhr Univ, Fac Biol & Biotechnol, Dept Zool & Neurobiol, Bochum, Germany; [Senen, Budiono] Fisheries Coll Hatta Syahrir, Banda Naira, Malukuh Tengah, Indonesia; [Tollrian, Ralph] Ruhr Univ, Fac Biol & Biotechnol, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Herlitze, S (corresponding author), Ruhr Univ, Fac Biol & Biotechnol, Dept Zool & Neurobiol, Bochum, Germany.	sxh106@gmail.com	Mark, Melanie/ABF-9102-2020; Senen, Budiono/AAF-6631-2021	Mark, Melanie/0000-0002-2788-6003; 	Ruhr-University Bochum, Germany	Ruhr-University Bochum, Germany	The work was supported by funds from the Ruhr-University Bochum, Germany.	Baldwin CC, 1997, P BIOL SOC WASH, V110, P373; Bassot J.-M., 1968, B SOC ZOOLOGIQUE FRA, V9, P569; Boddaert P., 1781, NEUE NORDISCHE BEITR, V2, P55, DOI DOI 10.5962/BHL.TITLE.48400; Bonin MC, 2015, ANNU REV ECOL EVOL S, V46, P169, DOI 10.1146/annurev-ecolsys-112414-054413; Calado R, 2004, J PLANKTON RES, V26, P737, DOI 10.1093/plankt/fbh072; Claes JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04328; Claes JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01308; Claes JM, 2012, J EXP BIOL, V215, P1691, DOI 10.1242/jeb.066704; Dahlgren U, 1928, SCIENCE, V68, P65, DOI 10.1126/science.68.1751.65; Davis MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155154; Dunlap PV, 2012, J FISH BIOL, V81, P1340, DOI 10.1111/j.1095-8649.2012.03415.x; Dunlap PV, 2011, J MORPHOL, V272, P897, DOI 10.1002/jmor.10956; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HAGER MC, 1991, BEHAV ECOL SOCIOBIOL, V29, P271, DOI 10.1007/BF00163984; HANEDA Y, 1971, SCIENCE, V173, P143, DOI 10.1126/science.173.3992.143; Harvey EN, 1921, SCIENCE, V53, P314, DOI 10.1126/science.53.1370.314; HAYGOOD MG, 1993, CRIT REV MICROBIOL, V19, P191, DOI 10.3109/10408419309113529; HAYGOOD MG, 1993, NATURE, V363, P154, DOI 10.1038/363154a0; Hendry TA, 2014, ENVIRON MICROBIOL, V16, P2611, DOI 10.1111/1462-2920.12302; Herring P. J., 1987, BIOLUMINESCENCE ACTI, P273; Herring PJ, 2005, MAR BIOL, V148, P383, DOI 10.1007/s00227-005-0085-3; Ho HC, 2012, ZOOTAXA, P77; Ikejima K, 2008, MAR BIOL, V153, P1009, DOI 10.1007/s00227-007-0869-8; JOHNSON GD, 1988, ZOOL J LINN SOC-LOND, V94, P65, DOI 10.1111/j.1096-3642.1988.tb00882.x; Johnson GD, 2001, P BIOL SOC WASH, V114, P497; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; MCCOSKER JE, 1977, SCI AM, V236, P106, DOI 10.1038/scientificamerican0377-106; MCCOSKER JE, 1987, JPN J ICHTHYOL, V34, P157, DOI 10.1007/BF02912410; MCFALLNGAI MJ, 1983, MAR BIOL, V73, P227, DOI 10.1007/BF00392247; MENSINGER AF, 1990, J EXP MAR BIOL ECOL, V144, P1, DOI 10.1016/0022-0981(90)90015-5; MEYERROCHOW VB, 1976, EXPERIENTIA, V32, P1175, DOI 10.1007/BF01927610; MORIN JG, 1975, SCIENCE, V190, P74, DOI 10.1126/science.190.4209.74; Munday PL, 2001, ECOLOGY, V82, P2177, DOI 10.1890/0012-9658(2001)082[2177:ICACIA]2.0.CO;2; Munk O, 1999, ACTA ZOOL-STOCKHOLM, V80, P265, DOI 10.1046/j.1463-6395.1999.00023.x; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; ROSENBLATT RH, 1991, P BIOL SOC WASH, V104, P328; ROSENBLATT RH, 1976, COPEIA, P510; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Siebeck UE, 2008, J EXP BIOL, V211, P354, DOI 10.1242/jeb.012880; SILVESTER CHARLES F., 1926, PROC ACAD NAT SCI PHILADELPHIA, V78, P245; Steche Otto, 1909, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V93; THETMEYER H, 1995, MAR ECOL PROG SER, V126, P1, DOI 10.3354/meps126001; WATSON M, 1978, PROC R SOC SER B-BIO, V202, P339, DOI 10.1098/rspb.1978.0071; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269	44	16	16	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170489	10.1371/journal.pone.0170489	http://dx.doi.org/10.1371/journal.pone.0170489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178297	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500007
J	Lozano-Garcia, M; Fiz, JA; Martinez-Rivera, C; Torrents, A; Ruiz-Manzano, J; Jane, R				Lozano-Garcia, Manuel; Antonio Fiz, Jose; Martinez-Rivera, Carlos; Torrents, Aurora; Ruiz-Manzano, Juan; Jane, Raimon			Novel approach to continuous adventitious respiratory sound analysis for the assessment of bronchodilator response	PLOS ONE			English	Article							FORCED EXHALATION; LUNG SOUNDS; WHEEZE; ASTHMA; CHILDREN	Background A thorough analysis of continuous adventitious sounds (CAS) can provide distinct and complementary information about bronchodilator response (BDR), beyond that provided by spirometry. Nevertheless, previous approaches to CAS analysis were limited by certain methodology issues. The aim of this study is to propose a new integrated approach to CAS analysis that contributes to improving the assessment of BDR in clinical practice for asthma patients. Methods Respiratory sounds and flow were recorded in 25 subjects, including 7 asthma patients with positive BDR (BDR+), assessed by spirometry, 13 asthma patients with negative BDR (BDR-), and 5 controls. A total of 5149 acoustic components were characterized using the Hilbert spectrum, and used to train and validate a support vector machine classifier, which distinguished acoustic components corresponding to CAS from those corresponding to other sounds. Once the method was validated, BDR was assessed in all participants by CAS analysis, and compared to BDR assessed by spirometry. Results BDR+ patients had a homogenous high change in the number of CAS after bronchodilation, which agreed with the positive BDR by spirometry, indicating high reversibility of airway obstruction. Nevertheless, we also found an appreciable change in the number of CAS in many BDR-patients, revealing alterations in airway obstruction that were not detected by spirometry. We propose a categorization for the change in the number of CAS, which allowed us to stratify BDR-patients into three consistent groups. From the 13 BDR-patients, 6 had a high response, similar to BDR+ patients, 4 had a noteworthy medium response, and 1 had a low response. Conclusions In this study, a new non-invasive and integrated approach to CAS analysis is proposed as a high-sensitive tool for assessing BDR in terms of acoustic parameters which, together with spirometry parameters, contribute to improving the stratification of BDR levels in patients with obstructive pulmonary diseases.	[Lozano-Garcia, Manuel; Antonio Fiz, Jose; Jane, Raimon] Inst Bioengn Catalonia IBEC, Biomed Signal Proc & Interpretat Grp, Barcelona, Spain; [Lozano-Garcia, Manuel; Antonio Fiz, Jose; Jane, Raimon] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Antonio Fiz, Jose; Martinez-Rivera, Carlos; Torrents, Aurora; Ruiz-Manzano, Juan] Germans Trias & Pujol Univ Hosp, Pulmonol Serv, Badalona, Spain; [Jane, Raimon] Univ Politecn Cataluna, Barcelona Tech, Dept Automat Control ESAII, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya	Lozano-Garcia, M (corresponding author), Inst Bioengn Catalonia IBEC, Biomed Signal Proc & Interpretat Grp, Barcelona, Spain.; Lozano-Garcia, M (corresponding author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain.	mlozanogar@gmail.com	García, Manuel Lozano/S-2482-2018	García, Manuel Lozano/0000-0002-4146-9839; Jane, Raimon/0000-0002-6541-8729	Secretary of Universities and Research of the Department of Economy and Knowledge of the Government of Catalonia [GRC 2014 SGR 1569]; CERCA Programme / Generalitat de Catalunya; Spanish Ministry of Economy and Competitiveness; European Regional Development Fund [DPI2015-68820-R]	Secretary of Universities and Research of the Department of Economy and Knowledge of the Government of Catalonia; CERCA Programme / Generalitat de Catalunya; Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission)	This work was supported by Secretary of Universities and Research of the Department of Economy and Knowledge of the Government of Catalonia (http://universitatsirecerca.gencat. cat/ca/inici/) (Consolidated research group GRC 2014 SGR 1569), RJ; CERCA Programme / Generalitat de Catalunya (http://cerca.cat/en/), RJ; The Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/menuitem. 19368ee62a6eae4c2adf03a0026041a0/? vgnextoid=f2e9154527515310VgnVCM 1000001d04140aRCRD&lang_choosen=en) and the European Regional Development Fund (http://ec.europa.eu/regional_policy/en/funding/erdf/) (DPI2015-68820-R), RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUGHMAN RP, 1984, CHEST, V86, P718, DOI 10.1378/chest.86.5.718; Bentur L, 2003, EUR RESPIR J, V21, P621, DOI 10.1183/09031936.03.00036302; BOHADANA AB, 1995, THORAX, V50, P955, DOI 10.1136/thx.50.9.955; Bohadana A, 2014, NEW ENGL J MED, V370, P744, DOI 10.1056/NEJMra1302901; BRAND PLP, 1992, THORAX, V47, P429, DOI 10.1136/thx.47.6.429; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Charbonneau G., 2000, EUR RESPIR REV, V10, P625; Fiz JA, 2006, RESPIRATION, V73, P55, DOI 10.1159/000087690; Fiz JA, 2002, CHEST, V122, P186, DOI 10.1378/chest.122.1.186; Fiz JA, 1999, CHEST, V116, P633, DOI 10.1378/chest.116.3.633; Fiz JA, 2014, PLOS ONE; GAVRIELY N, 1994, EUR RESPIR J, V7, P35, DOI 10.1183/09031936.94.07010035; Gjevre John A, 2006, Can Respir J, V13, P433; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Gong H, 1990, CLIN METHODS HIST PH; Guntupalli KK, 2008, J ASTHMA, V45, P923, DOI 10.1080/02770900802395496; Hegewald MJ, 2012, RESP CARE, V57, P1564, DOI 10.4187/respcare.01537; Homs-Corbera A, 2004, IEEE T BIO-MED ENG, V51, P182, DOI 10.1109/TBME.2003.820359; Hsu C, 2016, PRACTICAL GUIDE SUPP; Jin F, 2011, IEEE T BIO-MED ENG, V58, P3078, DOI 10.1109/TBME.2011.2160721; KERSTJENS HAM, 1994, THORAX, V49, P1109, DOI 10.1136/thx.49.11.1109; Lehmann S, 2007, RESP MED, V101, P1183, DOI 10.1016/j.rmed.2006.11.007; Lin BS, 2006, BIOMED ENG-APP BAS C, V18, P128, DOI 10.4015/S1016237206000221; Loudon RG, 1997, THE LUNG, P1383; Lozano M, 2016, IEEE J BIOMED HEALTH, V20, P486, DOI 10.1109/JBHI.2015.2396636; Lozano M, 2016, SIGNAL PROCESS, V120, P99, DOI 10.1016/j.sigpro.2015.09.005; MARINI JJ, 1979, AM REV RESPIR DIS, V120, P1069; Melbye H, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000136; MESLIER N, 1995, EUR RESPIR J, V8, P1942, DOI 10.1183/09031936.95.08111942; Nagasaka Y, 2012, ALLERGOL INT, V61, P353, DOI 10.2332/allergolint.12-RAI-0449; Olson D.L., 2008, TECHNIQUES, DOI [10.1007/978-3-540-76917-0, DOI 10.1007/978-3-540-76917-0]; Ouksel H, 2003, RESPIRATION, V70, P54, DOI 10.1159/000068419; Pasterkamp H, 2016, EUR RESPIR J, V47, P724, DOI 10.1183/13993003.01132-2015; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Richter Daphne C, 2008, Int J Chron Obstruct Pulmon Dis, V3, P693; RIETVELD S, 1995, THORAX, V50, P143, DOI 10.1136/thx.50.2.143; Rossi M, 2000, EUR RESPIR REV, V10, P611; Sanchez I, 2005, RESPIROLOGY, V10, P603, DOI 10.1111/j.1440-1843.2005.00756.x; Sarkar M, 2015, ANN THORAC MED, V10, P158, DOI 10.4103/1817-1737.160831; Schreur HJW, 1996, AM J RESP CRIT CARE, V153, P1474, DOI 10.1164/ajrccm.153.5.8630589; SCHREUR HJW, 1994, CHEST, V106, P91, DOI 10.1378/chest.106.1.91; SHIM CS, 1983, ARCH INTERN MED, V143, P890, DOI 10.1001/archinte.143.5.890; Sovijû±rvi ARA., 2000, EUR RESPIR REV, V10, P591; Tan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058932; Taplidou SA, 2004, P ANN INT IEEE EMBS, V26, P3832; Taplidou SA, 2007, COMPUT BIOL MED, V37, P1073, DOI 10.1016/j.compbiomed.2006.09.007; Taplidou SA, 2010, IEEE T BIO-MED ENG, V57, P1596, DOI 10.1109/TBME.2010.2041777; Tse SM, 2013, J ALLERGY CLIN IMMUN, V132, P554, DOI 10.1016/j.jaci.2013.03.031	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171455	10.1371/journal.pone.0171455	http://dx.doi.org/10.1371/journal.pone.0171455			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178317	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500044
J	Lu, XL; Kang, XJ; Liu, YJ; Cui, Z; Guo, W; Zhao, CY; Li, Y; Chen, SL; Li, JY; Zhang, YQ; Zhao, HR				Lu, Xinli; Kang, Xianjiang; Liu, Yongjian; Cui, Ze; Guo, Wei; Zhao, Cuiying; Li, Yan; Chen, Suliang; Li, Jingyun; Zhang, Yuqi; Zhao, Hongru			HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China	PLOS ONE			English	Article							WESTERN YUNNAN; EVOLUTIONARY HISTORY; GENETIC DIVERSITY; GENOME SEQUENCE; IDENTIFICATION; CRF01-AE; AREA; MEN; SEX	New human immunodeficiency virus type 1 (HIV-1) diagnoses are increasing rapidly in Hebei. The aim of this study presents the most extensive HIV-1 molecular epidemiology investigation in Hebei province in China thus far. We have carried out the most extensive systematic cross-sectional study based on newly diagnosed HIV-1 positive individuals in 2013, and characterized the molecular epidemiology of HIV-1 based on full length gag-partial pol gene sequences in the whole of Hebei. Nine HIV-1 genotypes based on full length gag-partial pol gene sequence were identified among 610 newly diagnosed naive individuals. The four main genotypes were circulating recombinant form (CRF) 01_AE (53.4%), CRF07_BC (23.4%), subtype B (15.9%), and unique recombinant forms URFs (4.9%). Within 1 year, three new genotypes (subtype A1, CRF55_01B, CRF65_cpx), unknown before in Hebei, were first found among men who have sex with men (MSM). All nine genotypes were identified in the sexually contracted HIV-1 population. Among 30 URFs, six recombinant patterns were revealed, including CRF01_AE/BC (40.0%), CRF01_AE/B (23.3%), B/C (16.7%), CRF01_AE/C (13.3%), CRF01_AE/B/A2 (3.3%) and CRF01_AE/BC/A2 (3.3%), plus two potential CRFs. This study elucidated the complicated characteristics of HIV-1 molecular epidemiology in a low HIV-1 prevalence northern province of China and revealed the high level of HIV-1 genetic diversity. All nine HIV-1 genotypes circulating in Hebei have spread out of their initial risk groups into the general population through sexual contact, especially through MSM. This highlights the urgency of HIV prevention and control in China.	[Lu, Xinli; Kang, Xianjiang] Hebei Univ, Coll Life Sci, Baoding, Hebei, Peoples R China; [Lu, Xinli; Cui, Ze; Zhao, Cuiying; Li, Yan; Chen, Suliang; Zhang, Yuqi; Zhao, Hongru] Hebei Prov Ctr Dis Control & Prevent, Shjiazhuang, Hebei, Peoples R China; [Liu, Yongjian; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Guo, Wei] 201 Hosp Peoples Liberat Army China, Liaoyang, Liaoning, Peoples R China	Hebei University; Beijing Institute of Microbiology & Epidemiology	Kang, XJ (corresponding author), Hebei Univ, Coll Life Sci, Baoding, Hebei, Peoples R China.; Chen, SL (corresponding author), Hebei Prov Ctr Dis Control & Prevent, Shjiazhuang, Hebei, Peoples R China.	xjkang@hbu.edu.cn; hebeicdc2013@sina.com	Liu, Yong/GWQ-6163-2022		Natural Science Fund of Hebei Province [H2016303006]	Natural Science Fund of Hebei Province	This study was implemented with the support of the Natural Science Fund of Hebei Province (H2016303006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Chen M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-382; China M. o.H.o.t.P.s.R.o., 2012, EST HIV AIDS EP CHIN; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Duan S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-180; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19279; Feng Y, 2014, AIDS RES HUM RETROV, V30, P598, DOI [10.1089/aid.2013.0233, 10.1089/AID.2013.0233]; Han XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep18147; Han XX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00050-12; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Li Lan, 2010, Laboratory Animal Research, V26, P1; Li L, 2011, J VISION, V11, DOI 10.1167/11.1.22; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046777; Li LN, 2014, AIDS RES HUM RETROV, V30, P160, DOI [10.1089/aid.2013.0144, 10.1089/AID.2013.0144]; Li X, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/563517; Li Xi, 2014, Trust and Trustworthy Computing. 7th International Conference, TRUST 2014. Proceedings: LNCS 8564, P1, DOI 10.1007/978-3-319-08593-7_1; Li XL, 2013, IEEE CONF IMAGING SY, P1, DOI 10.1109/IST.2013.6729651; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Liu Hui-xin, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P892; Lu XL, 2016, AIDS RES HUM RETROV, V32, P475, DOI [10.1089/aid.2016.0005, 10.1089/AID.2016.0005]; Lu XL, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-015-0087-2; Lu XL, 2015, AIDS RES HUM RETROV, V31, P1038, DOI [10.1089/aid.2015.0160, 10.1089/AID.2015.0160]; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Wang HQ, 2010, J NANOTECHNOL, V2010, DOI [10.1155/2010/479172, 10.1155/2010/345701]; Wang Ning, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P541; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059050; Yang Chaojun, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P70; Yang L, 2015, MOD PREV MED, V42, P156; Yang Li, 2015, Modern Preventive Medicine, V42, P137; ZENG Y, 1986, AIDS RES, V2, pS147; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693; [赵翠英 ZHAO Cuiying], 2005, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V25, P533; Zhao CY, 2010, CHIN J HLTH LAB TECH, V20, P3136; Zheng Y Y, 1988, Zhonghua Yi Xue Za Zhi, V68, P5	42	22	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171481	10.1371/journal.pone.0171481	http://dx.doi.org/10.1371/journal.pone.0171481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178737	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500046
J	Rasool, M; Ashraf, MAB; Malik, A; Waquar, S; Khan, SA; Qazi, MH; Ahmad, W; Asif, M; Khan, SU; Zaheer, A; Qaisrani, MM; Khan, AR; Iqbal, A; Raza, A; Iram, S; Kamran, K; Iqbal, A; Mustafa, MZ; Choudhry, H; Zamzami, MA; Abdulaal, WH; Jamal, MS				Rasool, Mahmood; Ashraf, Muhammad Abdul Basit; Malik, Arif; Waquar, Sulayman; Khan, Shahida Aziz; Qazi, Mahmood Husain; Ahmad, Waseem; Asif, Muhammad; Khan, Sami Ullah; Zaheer, Ahmad; Qaisrani, Muther Mansoor; Khan, Abdul Rehman; Iqbal, Aamir; Raza, Amir; Iram, Saima; Kamran, Kashif; Iqbal, Asim; Mustafa, Mohammad Zahid; Choudhry, Hani; Zamzami, Mazin A.; Abdulaal, Wesam H.; Jamal, Mohammad Sarwar			Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; NITRIC-OXIDE; VITAMIN-E; PROTEIN PRODUCTS; RENAL-FAILURE; STRESS; SUPEROXIDE; GLUTATHIONE; INFLAMMATION; ASCORBATE	Background Chronic kidney disease (CKD) is a group of heterogeneous abnormalities affecting the function and structure of the kidney and mostly further proceeds to cardiovascular damage prior to end stage renal disease (ESRD). The oxidative insult and inflammatory mediators have some undefined role in CKD and cardiovascular complications. It is therefore, aimed at to pin point the predictive factors in the development of cardiovascular disorder in patients with chronic kidney disease. Methods Fifty patients of CKD experiencing cardiovascular distress and twenty normal individuals having same age and sex acted as control during these observations. Blood samples (Each 5 ml) were drawn and subjected to centrifugation for 10-15 minutes to separate the serum at 4000-5000rpm. The levels of MDA, GSH, SOD, CAT, VIT C, VIT E, IL-1, TNF-alpha, nitric oxide (NO) and advanced oxidation protein products (AOPPs) were estimated and analyzed. Results The nitric oxide levels in the CKD patients decreased significantly (13.26 +/- 1.25 ng/ml) compared to controls (42.15 +/- 5.26 ng/ml). The serum vitamin E and C levels in these patients recorded 2.15 +/- 0.25 mu g/ml and 0.97 +/- 0.09 mu g/ml respectively as against their assigned controls which read 6.35 +/- 1.22 mu g/ml and 3.29 +/- 0.25 mu g/ml. Furthermore, a significantly higher level of Malondialdehyde (MDA) as1.25 +/- 0.07 nmol/ml was observed in CKD patients viz-a-viz relevant control. However, the serum SOD, catalase (CAT) and GSH levels in the same patients registered a significant decline as evident from respective figures 0.07 +/- 0.002 mu g/dl, 1.22 +/- 0.012 mu mol/mol, and 3.25 +/- 1.05 mu g/dl. The control for these was observed as 0.99 +/- 0.06 mu g/dl, 3.19 +/- 0.05 mu mol/mol, and 8.64 +/- 0.03 mu g/dL. On the other hand, the IL-1 levels in the CKD patients found quite higher (402.5 +/- 18.26 pg/ml). This clearly points to substantial increase in oxidative insult and reduced NO levels leading to the renal and cardiovascular damage. Conclusion Observations support the fact that the decrease in anti-oxidative capacity accompanied by higher inflammatory mediators in CKD is indicative of oxidative stress, consequently leading to CKD progression, in all probability to cardiovascular insult. The outcome reiterates that strategies be designed afresh to contain CKD progression to cardiovascular complications and ESRD. One way could be to focus on early detection of stress related to the disease. It requires analyzing the factors related to stress, such as the one reported here. Linking these factors with the symptoms could be a crucial step forward. And further, the disease could be monitored in a more disciplined manner.	[Rasool, Mahmood; Ahmad, Waseem] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia; [Ashraf, Muhammad Abdul Basit; Malik, Arif; Waquar, Sulayman] Univ Lahore, IMBB, Lahore, Pakistan; [Khan, Shahida Aziz; Jamal, Mohammad Sarwar] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Qazi, Mahmood Husain] Univ Lahore, Ctr Res Mol Med CRiMM, Lahore, Pakistan; [Asif, Muhammad] BUITEMS, Dept Biotechnol & Informat, Quetta, Pakistan; [Khan, Sami Ullah] Women Univ Azad Jammu & Kashmir, Dept Bot, Bagh, Pakistan; [Zaheer, Ahmad; Iqbal, Aamir; Raza, Amir] NIBGE, Faisalabad, Pakistan; [Qaisrani, Muther Mansoor] Ghazi Univ, Dept Bot, Dera Ghazi Khan, Pakistan; [Khan, Abdul Rehman] Univ Azad Jammu & Kashmir, Dept Chem, Obes & Diabet Res Lab, Muzaffarabad, Pakistan; [Iram, Saima] Bolan Med Hosp, Quetta, Pakistan; [Kamran, Kashif; Iqbal, Asim] Univ Balochistan, Fac Life Sci, Quetta, Pakistan; [Mustafa, Mohammad Zahid] Univ Balochistan, CASVAB, Quetta, Pakistan; [Choudhry, Hani] King Abdulaziz Univ, Dept Biochem, King Fahd Ctr Med Res,Canc Metab & Epigenet Unit, Fac Sci,Ctr Innovat Personalized Med,Canc & Mutag, Jeddah, Saudi Arabia; [Zamzami, Mazin A.; Abdulaal, Wesam H.] King Abdulaziz Univ, Canc & Mutagenesis Unit, King Fahd Ctr Med Res, Dept Biochem,Canc Metab & Epigenet Unit,Fac Sci, Jeddah, Saudi Arabia	King Abdulaziz University; University of Lahore; King Abdulaziz University; University of Lahore; Balochistan University of Information Technology, Engineering & Management Sciences BUITEMS; Pakistan Institute of Engineering & Applied Science; University of Azad Jammu & Kashmir; University of Balochistan; University of Balochistan; King Abdulaziz University; King Abdulaziz University	Jamal, MS (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.	sarwar4u@gmail.com	Khan, Shahida A/H-9636-2012; Qaisrani, Muther Mansoor/AAP-3143-2021; Jamal, Mohammad Sarwar/K-3842-2013; Asif, Muhammad/AAF-3615-2020; Rasool, Mahmood/H-9475-2012; Waquar, Sulayman/G-8809-2017; Waquar, Sulayman/K-8437-2019; Abdulaal, Wesam/AAT-9475-2021; Zaheer, Ahmad/H-4182-2013; Malik, Arif/A-5218-2016	Asif, Muhammad/0000-0003-4761-837X; Rasool, Mahmood/0000-0003-2997-5891; Waquar, Sulayman/0000-0003-0557-0064; Waquar, Sulayman/0000-0003-0557-0064; Abdulaal, Wesam/0000-0002-2510-1946; Zaheer, Ahmad/0000-0001-5131-3240; Malik, Arif/0000-0002-1894-6772; Choudhry, Hani/0000-0003-0401-6619	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to all participants of this study. This article was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah. The authors, therefore, acknowledge with thanks DSR technical and financial support.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Amann K, 2001, J AM SOC NEPHROL, V12, P2040, DOI 10.1681/ASN.V12102040; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Atamer A, 2008, J NEPHROL, V21, P924; Azzi A, 2002, FEBS LETT, V519, P8, DOI 10.1016/S0014-5793(02)02706-0; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bergmeijer H, 1983, METHODS ENZYMATIC AN; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Capeillere-Blandin C, 2004, BBA-MOL BASIS DIS, V1689, P91, DOI 10.1016/j.bbadis.2004.02.008; CHINOY NJ, 1986, INT J FERTIL, V31, P232; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Devaraj S, 1998, CURR OPIN LIPIDOL, V9, P11, DOI 10.1097/00041433-199802000-00004; Feelisch M., 1996, METHODS NITRIC OXIDE; Fortuno A, 2005, KIDNEY INT, V68, P71; Fujisawa S, 2006, IN VIVO, V20, P445; Fumeron C, 2005, NEPHROL DIAL TRANSPL, V20, P1874, DOI 10.1093/ndt/gfh928; Gajjala PR, 2015, NEPHROL DIAL TRANSPL, V30, P1814, DOI 10.1093/ndt/gfv048; Gongora MC, 2008, AM J PATHOL, V173, P915, DOI 10.2353/ajpath.2008.080119; Graf J, 2009, OVERVIEW CHRONIC KID; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Guo Q, 2000, FREE RADICAL BIO MED, V29, P368, DOI 10.1016/S0891-5849(00)00309-9; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; HORII Y, 1993, KIDNEY INT, V43, pS71; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kaneda H, 2002, ATHEROSCLEROSIS, V162, P221, DOI 10.1016/S0021-9150(01)00706-7; Karamouzis I, 2008, AM J NEPHROL, V28, P397, DOI 10.1159/000112413; Kobayashi M, 2005, KIDNEY INT, V68, P1018, DOI 10.1111/j.1523-1755.2005.00494.x; Korish AA, 2010, RENAL FAILURE, V32, P203, DOI 10.3109/08860221003592820; Kuchta A, 2011, KIDNEY BLOOD PRESS R, V34, P12, DOI 10.1159/000321508; Landmesser U, 2000, CIRCULATION, V101, P2264, DOI 10.1161/01.CIR.101.19.2264; Lash LH, 2002, J PHARMACOL EXP THER, V303, P476, DOI 10.1124/jpet.102.040220; May JM, 1996, FREE RADICAL BIO MED, V20, P543, DOI 10.1016/0891-5849(95)02130-2; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MYERS SI, 1995, AM J SURG, V169, P604, DOI 10.1016/S0002-9610(99)80230-X; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pinkus R, 1996, J BIOL CHEM, V271, P13422, DOI 10.1074/jbc.271.23.13422; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; Rosenberg HR., 1992, CHEM PHYSL VITAMINS, P452; Saran R, 2003, NEPHROL DIAL TRANSPL, V18, P2415, DOI 10.1093/ndt/gfg406; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Small DM, 2013, OXIDATIVE STRESS CHR, P233, DOI DOI 10.5772/51923; Sung C-C, 2013, OXIDATIVE MED CELLUL; Tain YL, 2007, AM J PHYSIOL-RENAL, V292, pF1404, DOI 10.1152/ajprenal.00260.2006; Tesch GH, 2010, NEPHROLOGY, V15, P609, DOI 10.1111/j.1440-1797.2010.01361.x; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Yan LJ, 1996, ARCH BIOCHEM BIOPHYS, V327, P330, DOI 10.1006/abbi.1996.0130; Yilmaz MI, 2006, AM J KIDNEY DIS, V47, P42, DOI 10.1053/j.ajkd.2005.09.029; Zalba G, 2005, ARTERIOSCL THROM VAS, V25, P1452, DOI 10.1161/01.ATV.0000168411.72483.08; Zalba G, 2006, NEPHROL DIAL TRANSPL, V21, P2686, DOI 10.1093/ndt/gfl398; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	54	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171561	10.1371/journal.pone.0171561	http://dx.doi.org/10.1371/journal.pone.0171561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178330	gold, Green Submitted, Green Published			2022-12-27	WOS:000393712500050
J	Narimani, Z; Beigy, H; Ahmad, A; Masoudi-Nejad, A; Frohlich, H				Narimani, Zahra; Beigy, Hamid; Ahmad, Ashar; Masoudi-Nejad, Ali; Froehlich, Holger			Expectation propagation for large scale Bayesian inference of non-linear molecular networks from perturbation data	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; NESTED EFFECTS MODELS; SIGNALING NETWORKS; SYSTEMS; RECONSTRUCTION; ALGORITHM	Inferring the structure of molecular networks from time series protein or gene expression data provides valuable information about the complex biological processes of the cell. Causal network structure inference has been approached using different methods in the past. Most causal network inference techniques, such as Dynamic Bayesian Networks and ordinary differential equations, are limited by their computational complexity and thus make large scale inference infeasible. This is specifically true if a Bayesian framework is applied in order to deal with the unavoidable uncertainty about the correct model. We devise a novel Bayesian network reverse engineering approach using ordinary differential equations with the ability to include non-linearity. Besides modeling arbitrary, possibly combinatorial and time dependent perturbations with unknown targets, one of our main contributions is the use of Expectation Propagation, an algorithm for approximate Bayesian inference over large scale network structures in short computation time. We further explore the possibility of integrating prior knowledge into network inference. We evaluate the proposed model on DREAM4 and DREAM8 data and find it competitive against several state-of-the-art existing network inference methods.	[Narimani, Zahra; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Beigy, Hamid] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Ahmad, Ashar; Froehlich, Holger] Univ Bonn, Bonn Aachen Int Ctr IT, Algorithm Bioinformat, Bonn, Germany; [Froehlich, Holger] UCB Biosci GmbH, Monheim, Germany	University of Tehran; Sharif University of Technology; University of Bonn	Masoudi-Nejad, A (corresponding author), Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran.; Frohlich, H (corresponding author), Univ Bonn, Bonn Aachen Int Ctr IT, Algorithm Bioinformat, Bonn, Germany.; Frohlich, H (corresponding author), UCB Biosci GmbH, Monheim, Germany.	amasoudin@ut.ac.ir; frohlich@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017; Masoudi-Nejad, Ali/ABH-2078-2021; Beigy, Hamid/ABF-7542-2020; AHMAD, ASHAR/ABH-9603-2020	Fröhlich, Holger/0000-0002-5328-1243; Beigy, Hamid/0000-0003-1679-2092; AHMAD, ASHAR/0000-0001-6417-4454; Narimani, Zahra/0000-0003-2534-9201	Deutscher Akademischer Austauschdienst (DAAD); University of Tehran	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Tehran(University of Tehran)	ZN would like to acknowledge the Deutscher Akademischer Austauschdienst (DAAD) and University of Tehran for partially supporting her visiting stay in Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. UCB Biosciences GmbH partially provided support in the form of salaries for author HF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Chambers JM., 1992, STAT MODELS S; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Eaton D, 2007, P MACHINE LEARNING R, V2, P107; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forsythe G. E., 1977, COMPUTER METHODS MAT; Fraley C, 2012, NETWORKBMA REGRESSIO; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Frohlich H, 2015, BIOINFORMATICS, V31, P3290, DOI 10.1093/bioinformatics/btv379; Frohlich H, 2009, BIOMETRICAL J, V51, P304, DOI 10.1002/bimj.200800185; Gat-Viks I, 2006, J COMPUT BIOL, V13, P165, DOI 10.1089/cmb.2006.13.165; George EI, 1997, STAT SINICA, V7, P339; Hill S., 2015, NAT BIOTECH; Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/NMETH.3773, 10.1038/nmeth.3773]; Klamt S, 2010, BIOINFORMATICS, V26, P2160, DOI 10.1093/bioinformatics/btq342; LAURITZEN SL, 1992, J AM STAT ASSOC, V87, P1098, DOI 10.2307/2290647; Lo K, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-101; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Mazloomian A, 2013, INTELL DATA ANAL, V17, P295, DOI 10.3233/IDA-130579; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Minka T., 2012, INFER NET 2 5; Minka T. P., 2001, P 17 C UNC ART INT, P362; Molinelli EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003290; Morrissey ER, 2011, BIOSTATISTICS, V12, P682, DOI 10.1093/biostatistics/kxr009; Nelander S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.53; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pe'er D., 2005, SCI STKE, V2005, P14, DOI DOI 10.1126/STKE.2812005PL4; Praveen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067410; Rau A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1513; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tresch A, 2007, J COMPUT BIOL, V14, P1217, DOI 10.1089/cmb.2007.0085; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Yavari F., 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P297, DOI 10.1109/ICBBE.2008.76; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121; Young WC, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-47; Zacher B, 2012, BIOINFORMATICS, V28, P1714, DOI 10.1093/bioinformatics/bts257	45	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171240	10.1371/journal.pone.0171240	http://dx.doi.org/10.1371/journal.pone.0171240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166542	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100029
J	Baipluthong, B; Anekthananon, T; Munsakul, W; Jirajariyavej, S; Asavapiriyanont, S; Hancharoenkit, U; Roongpisuthipong, A; Pattanasin, S; Martin, M; Guntamala, L; Lolekha, R				Baipluthong, Benjamas; Anekthananon, Thanomsak; Munsakul, Warangkana; Jirajariyavej, Supunnee; Asavapiriyanont, Suvanna; Hancharoenkit, Ubonsri; Roongpisuthipong, Anuvat; Pattanasin, Sarika; Martin, Michael; Guntamala, Lisa; Lolekha, Rangsima			Implementation and assessment of a prevention with positives intervention among people living with HIV at five hospitals in Thailand	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; SEXUAL-BEHAVIOR; VIRAL LOAD; CARE; WOMEN; RISK; POPULATION; INDICATORS; PHYSICIAN	Background We implemented a hospital-based prevention with positives (PwP) intervention among people living with HIV (PLHIV) that included HIV transmission risk screening, short HIV prevention messages, family planning, HIV disclosure counseling, and partner HIV testing at five hospitals in Thailand. We assessed changes in sexual risk behaviors among PLHIV who received the PwP services at the hospitals. Methods From January 2008-March 2009, we systematically selected a subset of PLHIV receiving care at the five hospitals to offer participation in the PwP intervention. We collected demographic, risk behavior, and laboratory data using a standardized questionnaire. We analyzed data from PLHIV who completed at least four visits, using generalized estimating equations to identify baseline participant characteristics that were associated with adopting sexual practices less likely to be associated with HIV transmission during follow-up. Results A total of 830 PLHIV were interviewed and 756 (91.1%) completed four visits. The median age of these 756 participants was 37 years, 400 (52.9%) were women, and 475 (62.8%) had a steady partner. At baseline, 353 (74.3%) of the steady partners had been tested for HIV and 132 (37.4%) had tested negative. Among the 756 PLHIV, 427 (56.5%) reported having sex in the 3 months before enrollment and 413 (54.6%) in the 3 months before the fourth visit. The proportion reporting having vaginal or anal sex without a condom decreased from 20.8% at baseline to 5.1% at the fourth visit (p<0.001). Factors associated (p<0.05) with abstinence or 100% condom use at follow-up visits included: completing >= two visits, being diagnosed with HIV for longer than 3 months, and receiving HIV prevention messages from a doctor (versus a nurse or counselor). Conclusion Safe sex behaviors increased among PLHIV receiving PwP services, suggesting that expansion of hospital-based PwP services may reduce the number of new HIV infections in Thailand.	[Baipluthong, Benjamas; Pattanasin, Sarika; Martin, Michael; Lolekha, Rangsima] US Ctr Dis Control & Prevent, Div Global HIV & TB, Nonthaburi, Thailand; [Anekthananon, Thanomsak; Roongpisuthipong, Anuvat] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand; [Munsakul, Warangkana] Navamindharadhiraj Univ, Vajira Hosp, Fac Med, Bangkok, Thailand; [Jirajariyavej, Supunnee] Taksin Hosp, HIV Clin, Bangkok, Thailand; [Asavapiriyanont, Suvanna] Rajavithi Hosp, Obstet & Gynecol Unit, Bangkok, Thailand; [Hancharoenkit, Ubonsri] Wiang Pa Pao Hosp, HIV Clin, Chiang Rai, Thailand; [Guntamala, Lisa] Thailand Minist Publ Hlth, Dept Dis Control, Bur AIDS TB & STIs, Nonthaburi, Thailand	Mahidol University; Rajavithi Hospital; Ministry of Public Health - Thailand	Lolekha, R (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Nonthaburi, Thailand.	hpu8@cdc.gov			President's Emergency Plan for AIDS Relief (PEPFAR) through CDC [3U19GH000004-03]	President's Emergency Plan for AIDS Relief (PEPFAR) through CDC	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through CDC under the terms of 3U19GH000004-03.	Alemayehu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-746; Asavapiriyanont S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-373; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baipluthong B, 2011, 10 INT C AIDS AS PAC; Bajunirwe F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-430; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fitzgerald DW, 2004, AIDS PATIENT CARE ST, V18, P658, DOI 10.1089/apc.2004.18.658; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Gilliam PP, 2009, J ASSOC NURSE AIDS C, V20, P92, DOI 10.1016/j.jana.2008.11.001; Guntamala L, 2011, 10 INT C AIDS AS PAC; Jones DL, 2006, AIDS CARE, V18, P629, DOI 10.1080/09540120500415371; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kidder DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057215; King-Spooner S, 1999, INT J STD AIDS, V10, P141, DOI 10.1258/0956462991913763; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KONINGS E, 1995, AIDS, V9, P375, DOI 10.1097/00002030-199509040-00009; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Kuzoe-Liengme Bayi, 2010, Rev Med Suisse, V6, P714; Llabre MM, 2006, AIDS PATIENT CARE ST, V20, P701, DOI 10.1089/apc.2006.20.701; Lolekha R, 2008, GUIDELINES SETTING P; MacNeil JM, 1999, AIDS CARE, V11, P537, DOI 10.1080/09540129947695; Mark KE, 2007, J WOMENS HEALTH, V16, P1200, DOI 10.1089/jwh.2006.0238; Medley A, 2015, JAIDS-J ACQ IMM DEF, V68, pS286, DOI 10.1097/QAI.0000000000000520; MoH, 2014, NATL GUIDELINES MANA, V1st, P8; Munsakul W, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0123-2; Ngure K, 2009, AIDS, V23, pS89, DOI 10.1097/01.aids.0000363781.50580.03; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/00002030-200405210-00011; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Tunthanathip P, 2009, SEX TRANSM INFECT, V85, P36, DOI 10.1136/sti.2008.032532; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson IB, 2000, J ACQ IMMUN DEF SYND, V25, P417, DOI 10.1097/00126334-200012150-00006; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107652	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170558	10.1371/journal.pone.0170558	http://dx.doi.org/10.1371/journal.pone.0170558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158210	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700014
J	Patel, HN; Carroll, I; Lopez, R; Sankararaman, S; Etienne, C; Kodigala, SR; Paul, MR; Postma, HWC				Patel, Hirai N.; Carroll, Ian; Lopez, Rodolfo, Jr.; Sankararaman, Sandeep; Etienne, Charles; Kodigala, Subba Ramaiah; Paul, Mark R.; Postma, Henk W. Ch.			DNA-graphene interactions during translocation through nanogaps	PLOS ONE			English	Article							SOLID-STATE NANOPORES	We study how double-stranded DNA translocates through graphene nanogaps. Nanogaps are fabricated with a novel capillary-force induced graphene nanogap formation technique. DNA translocation signatures for nanogaps are qualitatively different from those obtained with circular nanopores, owing to the distinct shape of the gaps discussed here. Translocation time and conductance values vary by similar to 100%, which we suggest are caused by local gap width variations. We also observe exponentially relaxing current traces. We suggest that slow relaxation of the graphene membrane following DNA translocation may be responsible. We conclude that DNA-graphene interactions are important, and need to be considered for graphene-nanogap based devices. This work further opens up new avenues for direct read of single molecule activitities, and possibly sequencing.	[Patel, Hirai N.; Carroll, Ian; Lopez, Rodolfo, Jr.; Sankararaman, Sandeep; Etienne, Charles; Kodigala, Subba Ramaiah; Postma, Henk W. Ch.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Paul, Mark R.] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA	California State University System; California State University Northridge; Virginia Polytechnic Institute & State University	Postma, HWC (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	postma@csun.edu	Postma, Henk W.Ch./A-8770-2014; Paul, Mark/E-3567-2014; Patel, Hiral/AAC-8251-2021	Paul, Mark/0000-0002-0701-1955; Postma, Henk/0000-0003-4349-9406	National Science Foundation, USA [DMR-1034937]; National Science Foundation [DMR-1034937]	National Science Foundation, USA(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	H.W.Ch.P. gratefully acknowledges support from the National Science Foundation, USA, under award number DMR-1034937.; We acknowledge support from the National Science Foundation under award DMR-1034937. We thank Richard Kaner and Jaime Torres for discussions. We thank Cees Dekker and Greg Schneider for useful discussions and their hospitality while helping us learn their wedge-transfer technique.	Amorim RG, 2016, J PHYS CHEM C, V120, P19384, DOI 10.1021/acs.jpcc.6b04683; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836; Bundschuh R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208104; Fennouri A, 2012, ACS NANO, V6, P9672, DOI 10.1021/nn3031047; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; He H, 2008, J PHYS CHEM C, V112, P3456, DOI 10.1021/jp7115142; He YH, 2011, ADV FUNCT MATER, V21, P2674, DOI 10.1002/adfm.201002530; Heerema SJ, 2016, NAT NANOTECHNOL, V11, P127, DOI [10.1038/NNANO.2015.307, 10.1038/nnano.2015.307]; Held R, 1998, PHYSICA E, V2, P748, DOI 10.1016/S1386-9477(98)00153-2; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Koenig SP, 2011, NAT NANOTECHNOL, V6, P543, DOI [10.1038/nnano.2011.123, 10.1038/NNANO.2011.123]; Kuan AT, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921620; Kwok H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092880; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Muthukumar M, 2015, PHYS TODAY, V68, P40, DOI 10.1063/PT.3.2881; Paul MR, 2006, NANOTECHNOLOGY, V17, P4502, DOI 10.1088/0957-4484/17/17/037; Paul MR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.235501; Plesa C, 2016, NAT NANOTECHNOL, V11, P1093, DOI [10.1038/nnano.2016.153, 10.1038/NNANO.2016.153]; Postma HWC, 2010, NANO LETT, V10, P420, DOI 10.1021/nl9029237; Postma HWC, 2012, DAQ DATA ACQUISITION; Prasongkit J, 2011, NANO LETT, V11, P1941, DOI 10.1021/nl200147x; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Schneider GF, 2010, NANO LETT, V10, P1912, DOI 10.1021/nl1008037; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Wang HM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291110; Wanunu M, 2008, BIOPHYS J, V95, P4716, DOI 10.1529/biophysj.108.140475; Wei XD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205407; Yanagi I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05000; Zacharia R, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155406; Zhao Q, 2007, NANO LETT, V7, P1680, DOI 10.1021/nl070668c	34	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171505	10.1371/journal.pone.0171505	http://dx.doi.org/10.1371/journal.pone.0171505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158244	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700087
J	Shou, LH; Cao, DA; Dong, XH; Fang, Q; Wu, Y; Zhang, Y; Fei, JP; Xu, BL				Shou, Li-Hong; Cao, Dan; Dong, Xiao-Hui; Fang, Qiu; Wu, Ying; Zhang, Yan; Fei, Ju-Ping; Xu, Bao-Lian			Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis	PLOS ONE			English	Article							ASXL1 MUTATIONS; TRANSFORMATION; I(17)(Q10)	Objectives This meta- analysis investigates the prognostic effect of SET binding protein 1 (SETBP1) mutations in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or chronic neutrophilic leukemia (CNL). Methods Eligible studies from Pubmed, Embase, and Web of Science were searched from database inception through April 2016. Hazard ratios (HRs) and 95% confidence interval (CI) of overall survival (OS) were pooled to calculate the prognostic significance of SETBP1 mutation in patients. Results A total of 12 studies with 2321 patients were included in this meta- analysis; 4 studies for MDS, 5 studies for CMML, and 3 studies for CNL. Pooled results suggested that MDS and CMML patients with SETBP1 mutations had a significantly poorer prognosis when compared with patients with wild- type SETBP1 (MDS: HR = 1.808, 95% CI (1.218-2.685), P = 0.001; CMML: HR = 2.223, 95% CI (1.493-3.308), P<0.001). SETBP1 mutations in CNL patients however, showed no significant effect on the overall survival (HR = 1.773, 95% CI (0.877-3.582), P = 0.111). The Begg's and Egger's tests did not show significant publication bias in any groups. Conclusions Current evidence shows that SETBP1 mutation is associated with a poor prognosis in patients with MDS and CMML, but not in patients with CNL.	[Shou, Li-Hong; Cao, Dan; Dong, Xiao-Hui; Fang, Qiu; Wu, Ying; Zhang, Yan; Fei, Ju-Ping; Xu, Bao-Lian] Huzhou Cent Hosp, Dept Hematol, Huzhou, Zhejiang, Peoples R China	Huzhou University	Shou, LH (corresponding author), Huzhou Cent Hosp, Dept Hematol, Huzhou, Zhejiang, Peoples R China.	hzzxslh@126.com						Adema V, 2015, BRIT J HAEMATOL, V171, P137, DOI 10.1111/bjh.13355; Cristobal I, 2010, BLOOD, V115, P615, DOI 10.1182/blood-2009-06-227363; Cui Yajuan, 2014, Zhonghua Xue Ye Xue Za Zhi, V35, P1069, DOI 10.3760/cma.j.issn.0253-2727.2014.12.005; Damm F, 2013, LEUKEMIA, V27, P1401, DOI 10.1038/leu.2013.35; Elliott MA, 2015, AM J HEMATOL, V90, P653, DOI 10.1002/ajh.24031; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hou HA, 2014, AM J HEMATOL, V89, P181, DOI 10.1002/ajh.23611; Inoue D, 2015, LEUKEMIA, V29, P847, DOI 10.1038/leu.2014.301; Itzykson R, 2013, J CLIN ONCOL, V31, P2428, DOI 10.1200/JCO.2012.47.3314; Laborde RR, 2013, LEUKEMIA, V27, P2100, DOI 10.1038/leu.2013.97; Lin Y, 2016, HEMATOLOGY, V21, P454, DOI 10.1080/10245332.2015.1106815; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Mason CC, 2016, LEUKEMIA, V30, P906, DOI 10.1038/leu.2015.337; Meggendorfer M, 2013, LEUKEMIA, V27, P1852, DOI 10.1038/leu.2013.133; Merlevede J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10767; Pardanani A, 2013, LEUKEMIA, V27, P1870, DOI 10.1038/leu.2013.122; Patnaik MM, 2014, LEUKEMIA, V28, P2206, DOI 10.1038/leu.2014.125; Patnaik MM, 2015, AM J HEMATOL, V90, P411, DOI 10.1002/ajh.23962; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Thol F, 2013, LEUKEMIA, V27, P2072, DOI 10.1038/leu.2013.145	21	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171608	10.1371/journal.pone.0171608	http://dx.doi.org/10.1371/journal.pone.0171608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158286	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700110
J	Zhou, C; Wu, FR; Lu, LH; Wei, LP; Pai, E; Yao, Y; Song, YC				Zhou, Chao; Wu, Fangrui; Lu, Lianghao; Wei, Liping; Pai, Eric; Yao, Yuan; Song, Yongcheng			Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1	PLOS ONE			English	Article							LSD1; CANCER; LEUKEMIA; POTENT; METHYLATION	Post-translational modifications of histone play important roles in gene transcription. Aberrant methylation of histone lysine sidechains have been often found in cancer. Lysine specific demethylase 1 (LSD1), which can demethylate histone H3 lysine 4 (H3K4) and other proteins, has recently been found to be a drug target for acute myeloid leukemia. To understand structure activity/selectivity relationships of LSD1 inhibitors, several series of cyclopropylamine and related compounds were synthesized and tested for their activities against LSD1 and related monoamine oxidase (MAO) A and B. Several cyclopropylamine containing compounds were found to be highly potent and selective inhibitors of LSD1. A novel series cyclopropylimine compounds also exhibited strong inhibitory activity against LSD1. Structure activity relationships (SAR) of these compounds are discussed. Docking studies were performed to provide possible binding models of a representative compound in LSD1 and MAO-A. Moreover, these modeling studies can rationalize the observed SARs and selectivity.	[Zhou, Chao; Wu, Fangrui; Lu, Lianghao; Wei, Liping; Pai, Eric; Yao, Yuan; Song, Yongcheng] Baylor Coll Med, Dept Pharmacol, 1 Baylor Pl, Houston, TX 77030 USA	Baylor College of Medicine	Song, YC (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Pl, Houston, TX 77030 USA.	ysong@bcm.edu	黎, 伟/GXM-4040-2022; wei, li/GSD-3630-2022		Cancer Prevention and Research Institute of Texas (CPRIT) [RP150129, RP140469]; National Institute of Neurological Disorders and Stroke (NINDS/NIH) [R01NS080963]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080963] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); National Institute of Neurological Disorders and Stroke (NINDS/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants RP150129 and RP140469 from Cancer Prevention and Research Institute of Texas (CPRIT) and a grant (R01NS080963) from National Institute of Neurological Disorders and Stroke (NINDS/NIH) to Y.S.	Binda C, 2010, J AM CHEM SOC, V132, P6827, DOI 10.1021/ja101557k; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Feng ZZ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0252-7; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hitchin JR, 2013, MEDCHEMCOMM, V4, P1513, DOI 10.1039/c3md00226h; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kutz CJ, 2014, MEDCHEMCOMM, V5, P1863, DOI 10.1039/c4md00283k; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Mould DP, 2015, MED RES REV, V35, P586, DOI 10.1002/med.21334; Neelamegam R, 2012, ACS CHEM NEUROSCI, V3, P120, DOI 10.1021/cn200104y; Prusevich P, 2014, ACS CHEM BIOL, V9, P1284, DOI 10.1021/cb500018s; Schrodinger LLC, 2016, SCHROD SUIT VERS 201; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Song YC, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0279-9; Sorna V, 2013, J MED CHEM, V56, P9496, DOI 10.1021/jm400870h; Suzuki T, 2011, J MED CHEM, V54, P8236, DOI 10.1021/jm201048w; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wu FR, 2016, J MED CHEM, V59, P253, DOI 10.1021/acs.jmedchem.5b01361; Zheng YC, 2013, J MED CHEM, V56, P8543, DOI 10.1021/jm401002r	28	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170301	10.1371/journal.pone.0170301	http://dx.doi.org/10.1371/journal.pone.0170301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158205	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700010
J	Gao, XL; Wu, JS; Cao, MX; Gao, SY; Cen, X; Jiang, YP; Wang, SS; Tang, YJ; Chen, QM; Liang, XH; Tang, YL				Gao, Xiao-lei; Wu, Jia-shun; Cao, Min-xin; Gao, Shi-yu; Cen, Xiao; Jiang, Ya-ping; Wang, Sha-sha; Tang, Ya-jie; Chen, Qian-ming; Liang, Xin-hua; Tang, Yaling			Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma	PLOS ONE			English	Article							CANCER-CELL INVASION; GLAND TUMORS; MIGRATION; METASTASIS; EXPRESSION; LUNG; DISSEMINATION; TRANSITIONS; PROGRESSION; EPITHELIUM	Collective invasion of cells plays a fundamental role in tissue growth, wound healing, immune response and cancer metastasis. This paper aimed to investigate cytokeratin-14 (CK14) expression and analyze its association with collective invasion in the invasive front of salivary adenoid cystic carcinoma (SACC) to uncover the role of collective invasion in SACC. Here, in the clinical data of 121 patients with SACC, the positive expression of CK14 was observed in 35/121(28.93%) of the invasive front of SACC. CK14 expression in the invasive front, local regional recurrence and distant metastasis were independent and significant prognostic factors in SACC patients. Then, we found that in an ex vivo 3D culture assay, CK14 siRNA receded the collective invasion, and in 2D monolayer culture, CK14 overexpression induced a collective SACC cell migration. These data indicated that the presence of characterized CK14+ cells in the invasive front of SACC promoted collective cell invasion of SACC and may be a biomarker of SACC with a worse prognosis.	[Gao, Xiao-lei; Wu, Jia-shun; Cao, Min-xin; Gao, Shi-yu; Cen, Xiao; Jiang, Ya-ping; Wang, Sha-sha; Chen, Qian-ming; Liang, Xin-hua; Tang, Yaling] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Peoples R China; [Tang, Ya-jie] Hubei Univ Technol, Key Lab Fermentat Engn, Minist Educ, Wuhan, Peoples R China; [Liang, Xin-hua] Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu, Peoples R China; [Tang, Yaling] Sichuan Univ, West China Hosp Stomatol, Dept Oral Pathol, Chengdu, Peoples R China	Sichuan University; Hubei University of Technology; Sichuan University; Sichuan University	Liang, XH; Tang, YL (corresponding author), Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Peoples R China.; Liang, XH (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral & Maxillofacial Surg, Chengdu, Peoples R China.; Tang, YL (corresponding author), Sichuan Univ, West China Hosp Stomatol, Dept Oral Pathol, Chengdu, Peoples R China.	lxh88866@scu.edu.cn; tangyaling@scu.edu.cn		Cen, Xiao/0000-0002-3959-1608	National Natural Science Foundation of China [81572650, 81372891, 81672672, 81361120399, 81621062]; Fundamental Research Funds of the Central Universities of China; State Key Laboratory of Oral Diseases Special Funded Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of the Central Universities of China; State Key Laboratory of Oral Diseases Special Funded Projects	This study was supported by the National Natural Science Foundation of China (nos. 81572650, 81372891, 81672672, 81361120399, and 81621062); Fundamental Research Funds of the Central Universities of China (2015); State Key Laboratory of Oral Diseases Special Funded Projects 2016.	Bleaken BM, 2016, MOL BIOL CELL, V27, P451, DOI 10.1091/mbc.E15-09-0615; Chapnick DA, 2014, MOL BIOL CELL, V25, P1586, DOI 10.1091/mbc.E14-01-0697; Cheung KJ, 2016, SCIENCE, V352, P167, DOI 10.1126/science.aaf6546; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2014, CURR OPIN CELL BIOL, V30, P99, DOI 10.1016/j.ceb.2014.07.003; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GOLDBLATT LI, 1987, CANCER-AM CANCER SOC, V60, P74, DOI 10.1002/1097-0142(19870701)60:1<74::AID-CNCR2820600113>3.0.CO;2-B; Graves ML, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0670-4; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hart IR, 2009, J PATHOL, V219, P275, DOI 10.1002/path.2616; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Perez DED, 2006, ORAL ONCOL, V42, P139, DOI 10.1016/j.oraloncology.2005.06.024; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI [10.1146/annurev.cellbio.042308.113231, DOI 10.1146/ANNUREV.CELLBIO.042308.113231]; SCHAAFSMA HE, 1990, AM J PATHOL, V136, P329; SEIFERT G, 1992, CANCER-AM CANCER SOC, V70, P379, DOI 10.1002/1097-0142(19920715)70:2<379::AID-CNCR2820700202>3.0.CO;2-C; Senft E, 2015, INT J ORAL SCI, V7, P18, DOI 10.1038/ijos.2014.28; SEQUEIROS SG, 2005, ACTA OTORRINOLARINGO, V56, P361; Southgate J, 1999, HISTOL HISTOPATHOL, V14, P657, DOI 10.14670/HH-14.657; Tang YL, 2015, ONCOTARGET, V6, P9031, DOI 10.18632/oncotarget.3320; Tang YL, 2014, ONCOTARGET, V5, P1491, DOI 10.18632/oncotarget.1606; Theveneau E, 2013, CELL MOL LIFE SCI, V70, P3481, DOI 10.1007/s00018-012-1251-7; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsubokawa F, 2002, PATHOL INT, V52, P286, DOI 10.1046/j.1440-1827.2002.01353.x; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wu JS, 2017, FUTURE ONCOL; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	33	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171341	10.1371/journal.pone.0171341	http://dx.doi.org/10.1371/journal.pone.0171341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152077	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200129
J	Rogers, NT; Marshall, A; Roberts, CH; Demakakos, P; Steptoe, A; Scholes, S				Rogers, Nina T.; Marshall, Alan; Roberts, Chrissy H.; Demakakos, Panayotes; Steptoe, Andrew; Scholes, Shaun			Physical activity and trajectories of frailty among older adults: Evidence from the English Longitudinal Study of Ageing	PLOS ONE			English	Article							BODY-COMPOSITION; ELDERLY-PEOPLE; DISABILITY; EXERCISE; AGE; METAANALYSIS; AMERICANS; LIFE; HOME; US	Background Frail older adults are heavy users of health and social care. In order to reduce the costs associated with frailty in older age groups, safe and cost-effective strategies are required that will reduce the incidence and severity of frailty. Objective We investigated whether self-reported intensity of physical activity (sedentary, mild, moderate or vigorous) performed at least once a week can significantly reduce trajectories of frailty in older adults who are classified as non-frail at baseline (Rockwood's Frailty Index [FI] <= 0.25). Methods Multi-level growth curve modelling was used to assess trajectories of frailty in 8649 non-frail adults aged 50 and over and according to baseline self-reported intensity of physical activity. Frailty was measured in five-year age cohorts based on age at baseline (50-54; 55-59; 60-64; 65-69; 70-74; 75-79; 80+) on up to 6 occasions, providing an average of 10 years of follow-up. All models were adjusted for baseline sex, education, wealth, cohabitation, smoking, and alcohol consumption. Results Compared with the sedentary reference group, mild physical activity was insufficient to significantly slow the progression of frailty, moderate physical activity reduced the progression of frailty in some age groups (particularly ages 65 and above) and vigorous activity significantly reduced the trajectory of frailty progression in all older adults. Conclusion Healthy non-frail older adults require higher intensities of physical activity for continued improvement in frailty trajectories.	[Rogers, Nina T.; Demakakos, Panayotes; Steptoe, Andrew; Scholes, Shaun] UCL, Dept Epidemiol & Publ Hlth, London, England; [Marshall, Alan] Univ St Andrews, Dept Geog & Sustainable Dev, Irvine Bldg, St Andrews, Fife, Scotland; [Roberts, Chrissy H.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London, England	University of London; University College London; University of St Andrews; University of London; London School of Hygiene & Tropical Medicine	Rogers, NT (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	n.rogers@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019	Marshall, Alan/0000-0003-0971-829X; Roberts, Chrissy h./0000-0003-1064-5980; Rogers, Nina/0000-0003-1857-2122; Demakakos, Panayotes/0000-0002-7663-2122; Scholes, Shaun/0000-0002-7865-5264	National Institute on Aging in the United States [2R01AG7644-01A1, 2R01AG017644, 2R01AG764401A1]; UK government departments; ESRC [ES/K007394/1] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK government departments; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the National Institute on Aging in the United States (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. The data were made available through the UK Data Archive. The English Longitudinal Study of Ageing (ELSA) was developed by a team of researchers based at University College London, the Institute of Fiscal Studies and the National Centre for Social Research.The work was supported by the National Institute on Aging in the United States (grants 2RO1AG764401A1 and 2RO1AG017644) and a consortium of UK government departments. The funders had no role in the study design; in the collection, analysis and interpretation of data; in writing of the report; or in the decision to submit the paper for publication. The developers and funders of ELSA and the Archive do not bear any responsibility for the analyses or interpretations presented here.	Binder EF, 2005, J GERONTOL A-BIOL, V60, P1425, DOI 10.1093/gerona/60.11.1425; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cooper C, 2016, AGE AGEING, V45, P148, DOI [10.1093/ageing/afu148, 10.1093/ageing/afv154]; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; de Vries NM, 2012, AGEING RES REV, V11, P136, DOI 10.1016/j.arr.2011.11.002; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Department of Health, 2011, START ACT STAY ACT R; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Henry KD, 1999, PHYS THER, V79, P270, DOI 10.1093/ptj/79.3.270; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS; Marshall A, 2015, J EPIDEMIOL COMMUN H, V69, P316, DOI 10.1136/jech-2014-204655; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Peterson MJ, 2009, J GERONTOL A-BIOL, V64, P61, DOI 10.1093/gerona/gln001; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Samper-Ternent R, 2012, J AGING HEALTH, V24, P641, DOI 10.1177/0898264311428490; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; Smith L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007423; Soong J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008456; Sourial N, 2012, J GERONTOL A-BIOL, V67, P1197, DOI 10.1093/gerona/gls084; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P647, DOI 10.1016/j.jclinepi.2009.08.007; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Tak E, 2013, AGEING RES REV, V12, P329, DOI 10.1016/j.arr.2012.10.001; Theou Olga, 2011, J Aging Res, V2011, P569194, DOI 10.4061/2011/569194; Tribess S, REV ASS MED BRAS, V58, P341; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102	32	72	72	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0170878	10.1371/journal.pone.0170878	http://dx.doi.org/10.1371/journal.pone.0170878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DB	28152084	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000396161200054
J	Bartel, F; Vrenken, H; Bijma, F; Barkhof, F; van Herk, M; de Munck, JC				Bartel, Fabian; Vrenken, Hugo; Bijma, Fetsje; Barkhof, Frederik; van Herk, Marcel; de Munck, Jan C.			Regional analysis of volumes and reproducibilities of automatic and manual hippocampal segmentations	PLOS ONE			English	Article							ADNI HARMONIZED PROTOCOL; WHOLE-BRAIN RADIOTHERAPY; TEMPORAL-LOBE EPILEPSY; ALZHEIMERS-DISEASE; MAGNETIC-RESONANCE; MEMORY PERFORMANCE; METHODS FREESURFER; COGNITIVE DECLINE; ATROPHY RATES; MRI	Purpose Precise and reproducible hippocampus outlining is important to quantify hippocampal atrophy caused by neurodegenerative diseases and to spare the hippocampus in whole brain radiation therapy when performing prophylactic cranial irradiation or treating brain metastases. This study aimed to quantify systematic differences between methods by comparing regional volume and outline reproducibility of manual, FSL-FIRST and FreeSurfer hippocampus segmentations. Materials and methods This study used a dataset from ADNI (Alzheimer's Disease Neuroimaging Initiative), including 20 healthy controls, 40 patients with mild cognitive impairment (MCI), and 20 patients with Alzheimer's disease (AD). For each subject back-to-back (BTB) T1-weighted 3D MPRAGE images were acquired at time-point baseline (BL) and 12 months later (M12). Hippocampi segmentations of all methods were converted into triangulated meshes, regional volumes were extracted and regional Jaccard indices were computed between the hippocampi meshes of paired BTB scans to evaluate reproducibility. Regional volumes and Jaccard indices were modelled as a function of group (G), method (M), hemisphere (H), timepoint (T), region (R) and interactions. Results For the volume data the model selection procedure yielded the following significant main effects G, M, H, T and R and interaction effects G-R and M-R. The same model was found for the BTB scans. For all methods volumes reduces with the severity of disease. Significant fixed effects for the regional Jaccard index data were M, R and the interaction M-R. For all methods the middle region was most reproducible, independent of diagnostic group. FSL-FIRST was most and FreeSurfer least reproducible. Discussion/Conclusion A novel method to perform detailed analysis of subtle differences in hippocampus segmentation is proposed. The method showed that hippocampal segmentation reproducibility was best for FSL-FIRST and worst for Freesurfer. We also found systematic regional differences in hippocampal segmentation between different methods reinforcing the need of adopting harmonized protocols.	[Bartel, Fabian; Vrenken, Hugo; de Munck, Jan C.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [Vrenken, Hugo; Barkhof, Frederik] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Bijma, Fetsje] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Barkhof, Frederik] Vrije Univ Amsterdam, Med Ctr, Image Anal Ctr, Amsterdam, Netherlands; [van Herk, Marcel] Univ Manchester, Dept Radiotherapy Phys, Manchester M13 9PL, Lancs, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Manchester	Bartel, F (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands.	f.bartel@vumc.nl	van Herk, Marcel B/P-6307-2015; Barkhof, Frederik/AAJ-6226-2020	van Herk, Marcel B/0000-0001-6448-898X; Barkhof, Frederik/0000-0003-3543-3706; Vrenken, Hugo/0000-0001-9106-1172; De Munck, Jan/0000-0002-5206-0086				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aoyama H, 2007, INT J RADIAT ONCOL, V68, P1388, DOI 10.1016/j.ijrobp.2007.03.048; Apostolova LG, 2015, ALZHEIMERS DEMENT, V11, P139, DOI 10.1016/j.jalz.2015.01.001; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Basso M, 2006, PSYCHIAT RES-NEUROIM, V146, P251, DOI 10.1016/j.pscychresns.2006.01.007; Boccardi M, 2011, ADV ALZH DIS, V2, P111, DOI 10.3233/978-1-60750-793-2-111; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; De Flores R, 2015, NEUROSCIENCE, V309, P29, DOI 10.1016/j.neuroscience.2015.08.033; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Frisoni GB, 2008, BRAIN, V131, P3266, DOI 10.1093/brain/awn280; Germeyan SC, 2014, EPILEPSIA, V55, P1374, DOI 10.1111/epi.12694; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Gordon BA, 2013, J ALZHEIMERS DIS, V37, P41, DOI 10.3233/JAD-130011; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Hackert VH, 2002, NEUROIMAGE, V17, P1365, DOI 10.1006/nimg.2002.1248; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Honeycutt N A, 1995, J Neuroimaging, V5, P95; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; JACK CR, 1994, EPILEPSIA, V35, pS21, DOI 10.1111/j.1528-1157.1994.tb05986.x; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Kim H, 2012, NEUROIMAGE, V59, P3178, DOI 10.1016/j.neuroimage.2011.11.040; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; Oskan F, 2014, STRAHLENTHER ONKOL, V190, P337, DOI 10.1007/s00066-013-0518-8; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Patenaude B, 2007, DEP CLIN NEUROL, P247; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sanchez-Benavides G, 2010, PSYCHIAT RES-NEUROIM, V181, P219, DOI 10.1016/j.pscychresns.2009.10.011; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96; van Herk M, 1998, MED PHYS, V25, P2054, DOI 10.1118/1.598393; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0166785	10.1371/journal.pone.0166785	http://dx.doi.org/10.1371/journal.pone.0166785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182655	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800002
J	Li, QS; Wang, Y; Ma, T; Lv, Y; Wu, RQ				Li, Qingshan; Wang, Yue; Ma, Tao; Lv, Yi; Wu, Rongqian			Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis	PLOS ONE			English	Review							LONG-TERM PROGNOSIS; HEPATOCELLULAR-CARCINOMA; PERIOPERATIVE MORTALITY; RISK-FACTOR; RESECTION; IMPACT; BIAS; RECURRENCE; THERAPY; WORSENS	Background Clinical data regarding the influence of diabetes mellitus (DM) on the outcomes of patients undergoing hepatectomy are conflicting. To determine the impact of DM on the clinical outcomes of patients undergoing hepatectomy, we systematically reviewed published studies and carried out a meta-analysis. Methods A systematic literature search of Pubmed, Sciencedirect, Web of Science, and Chinese Biomedical Database was conducted from their inception through February 2, 2016. The combined relative risk (RR) or hazard ratio (HR) with 95% confidence intervals (95% CI) was calculated. Results A total of 16 observational studies with 15710 subjects were eligible for meta-analysis. The pooled results showed that DM significantly increased the risk of overall postoperative complications (RR 1.34; 95% CI 1.19-1.51; P<0.001), DM-associated complications (RR 1.8; 95% CI 1.29-2.53; P<0.001), liver failure (RR 2.21; 95% CI 1.3-3.76; P = 0.028) and postoperative infections (RR 1.59; 95% CI 1.01-2.5; P = 0.045). In addition, DM was also found to be significantly associated with unfavorable overall survival and disease free survival after liver resection. The pooled HR was 1.63 (95% CI 1.33-1.99; P<0.001) for overall survival and 1.55 (95% CI 1.07-2.25; P = 0.019) for disease free survival. Conclusion DM is associated with poor outcomes in patients undergoing hepatectomy. DM should be taken into account cautiously in the management of patients undergoing hepatectomy. Further prospective studies are warranted to explore effective interventions to improve the poor outcomes of diabetic patients undergoing hepatectomy.	[Li, Qingshan; Wang, Yue; Ma, Tao; Lv, Yi; Wu, Rongqian] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1,Shaanxi Ctr Regenerat Med & Sur, Dept Hepatobiliary Surg,Inst Adv Surg Technol & E, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	Lv, Y; Wu, RQ (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1,Shaanxi Ctr Regenerat Med & Sur, Dept Hepatobiliary Surg,Inst Adv Surg Technol & E, Xian, Shaanxi Provinc, Peoples R China.	Luyi169@126.com; rwu001@mail.xjtu.edu.cn	Wu, Rongqian/I-3614-2012	Wu, Rongqian/0000-0003-0993-4531				Amptoulach S, 2015, J SURG RES, V199, P378, DOI 10.1016/j.jss.2015.05.059; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bucerius J, 2005, Z KARDIOL, V94, P575, DOI 10.1007/s00392-005-0273-7; Donadon V, 2010, LIVER INT, V30, P750, DOI 10.1111/j.1478-3231.2010.02223.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Facciorusso A, 2013, CURR DIABETES REV, V9, P382, DOI 10.2174/15733998113099990068; Guckelberger O, 2006, EXP CLIN ENDOCR DIAB, V114, P257, DOI 10.1055/s-2006-924234; Huo TI, 2004, AM J GASTROENTEROL, V99, P1479, DOI 10.1111/j.1572-0241.2004.30024.x; Huo TI, 2003, AM J GASTROENTEROL, V98, P2293, DOI 10.1016/S0002-9270(03)00694-4; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Kuroda S, 2011, WORLD J SURG, V35, P834, DOI 10.1007/s00268-010-0929-y; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Little SA, 2002, J GASTROINTEST SURG, V6, P88, DOI 10.1016/S1091-255X(01)00019-1; Mik Michal, 2016, Pol Przegl Chir, V88, P26, DOI 10.1515/pjs-2016-0023; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Neal CP, 2012, J GASTROINTEST SURG, V16, P2064, DOI 10.1007/s11605-012-2008-1; Newhook TE, 2016, AM J SURG, V211, P102, DOI 10.1016/j.amjsurg.2015.06.010; Ou DP, 2007, ZHONG HUA GAN DAN WA, V13, P317; Pang PYK, 2016, ANN ACAD MED SINGAP, V45, P83; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Song FJ, 1998, BRIT MED J, V316, P471; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ting CT, 2012, TOHOKU J EXP MED, V227, P73, DOI 10.1620/tjem.227.73; Tsai MS, 2014, ANN SURG ONCOL, V21, P3810, DOI 10.1245/s10434-014-3777-4; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095485; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; YANAGA K, 1993, ARCH SURG-CHICAGO, V128, P445; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770	34	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171129	10.1371/journal.pone.0171129	http://dx.doi.org/10.1371/journal.pone.0171129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182632	Green Submitted, Green Published, gold			2022-12-27	WOS:000394231800037
J	Liu, TE; Krysiak, K; Shirai, CL; Kim, S; Shao, J; Ndonwi, M; Walter, MJ				Liu, Tuoen; Krysiak, Kilannin; Shirai, Cara Lunn; Kim, Sanghyun; Shao, Jin; Ndonwi, Matthew; Walter, Matthew J.			Knockdown of HSPA9 induces TP53dependent apoptosis in human hematopoietic progenitor cells	PLOS ONE			English	Article							COMMONLY DELETED REGION; MYELODYSPLASTIC SYNDROMES; DEL(5Q); HAPLOINSUFFICIENCY; MUTATIONS; HSP70; GENE; P53; MORTALIN; IDENTIFICATION	Myelodysplastic syndromes (MDS) are the most common adult myeloid blood cancers in the US. Patients have increased apoptosis in their bone marrow cells leading to low peripheral blood counts. The full complement of gene mutations that contribute to increased apoptosis in MDS remains unknown. Up to 25% of MDS patients harbor and acquired interstitial deletion on the long arm of chromosome 5 [del(5q)], creating haploinsufficiency for a large set of genes including HSPA9. Knockdown of HSPA9 in primary human CD34+ hematopoietic progenitor cells significantly inhibits growth and increases apoptosis. We show here that HSPA9 knockdown is associated with increased TP53 expression and activity, resulting in increased expression of target genes BAX and p21. HSPA9 protein interacts with TP53 in CD34+ cells and knockdown of HSPA9 increases nuclear TP53 levels, providing a possible mechanism for regulation of TP53 by HSPA9 haploinsufficiency in hematopoietic cells. Concurrent knockdown of TP53 and HSPA9 rescued the increased apoptosis observed in CD34 + cells following knockdown of HSPA9. Reduction of HSPA9 below 50% results in severe inhibition of cell growth, suggesting that del(5q) cells may be preferentially sensitive to further reductions of HSPA9 below 50%, thus providing a genetic vulnerability to del(5q) cells. Treatment of bone marrow cells with MKT-077, an HSPA9 inhibitor, induced apoptosis in a higher percentage of cells from MDS patients with del(5q) compared to non-del(5q) MDS patients and normal donor cells. Collectively, these findings indicate that reduced levels of HSPA9 may contribute to TP53 activation and increased apoptosis observed in del(5q)associated MDS.	[Liu, Tuoen; Krysiak, Kilannin; Shirai, Cara Lunn; Kim, Sanghyun; Shao, Jin; Ndonwi, Matthew; Walter, Matthew J.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Walter, Matthew J.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Walter, MJ (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.; Walter, MJ (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63130 USA.	mjwalter@wustl.edu	Walter, Matthew J/S-7758-2018	Kim, Sanghyun/0000-0001-9519-1994; Krysiak, Kilannin/0000-0002-6299-9230	National Cancer Institute of the National Institutes of Health [F31CA165702]; Siteman Cancer Biology Pathway Fellowship; National Heart Lung Blood Institute of the National Institutes of Health [R01HL109336]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; Leukemia and Lymphoma Society Scholar Award; NCI Cancer Center Support Grant [P30 CA91842]; Neuroscience Blueprint Interdisciplinary Center Core Award [P30NS057105]; NIH [DK106829]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109336] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siteman Cancer Biology Pathway Fellowship; National Heart Lung Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Neuroscience Blueprint Interdisciplinary Center Core Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Cancer Institute of the National Institutes of Health (F31CA165702) and Siteman Cancer Biology Pathway Fellowship (KK) as well as the National Heart Lung Blood Institute of the National Institutes of Health (R01HL109336), a Howard Hughes Medical Institute Physician-Scientist Early Career Award, and a Leukemia and Lymphoma Society Scholar Award (MJW). The Siteman Flow Cytometry Core is supported in part by an NCI Cancer Center Support Grant (#P30 CA91842). Additional technical assistance was provided by the Hope Center Viral Vectors Core, which is supported by a Neuroscience Blueprint Interdisciplinary Center Core Award (P30NS057105). The Fred Hutchinson Cancer Research Center that supplied CD34+ cells is supported by a Cooperative Centers of Excellence in Hematology grant from NIH (DK106829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Chen THP, 2011, BLOOD, V117, P1530, DOI 10.1182/blood-2010-06-293167; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Frisan E, 2012, BLOOD, V119, P1532, DOI 10.1182/blood-2011-03-343475; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; Gestl EE, 2012, BIOCHEM BIOPH RES CO, V423, P411, DOI 10.1016/j.bbrc.2012.05.139; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Jadersten M, 2011, J CLIN ONCOL, V29, P1971, DOI 10.1200/JCO.2010.31.8576; Jerez A, 2012, J CLIN ONCOL, V30, P1343, DOI 10.1200/JCO.2011.36.1824; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3; Koya K, 1996, CANCER RES, V56, P538; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Krysiak K, 2015, EXP HEMATOL, V43, P319, DOI 10.1016/j.exphem.2014.12.005; Lane SW, 2010, BLOOD, V115, P3489, DOI 10.1182/blood-2009-11-251728; Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pellagatti A, 2010, BLOOD, V115, P2721, DOI 10.1182/blood-2009-12-259705; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854; Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stoddart A, 2014, BLOOD, V123, P1069, DOI 10.1182/blood-2013-07-517953; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai-Nagara I, 2014, BLOOD, V123, P41, DOI 10.1182/blood-2013-06-508333; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varney ME, 2015, J EXP MED, V212, P1967, DOI 10.1084/jem.20141898; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Wang JH, 2010, BLOOD, V115, P3481, DOI 10.1182/blood-2009-11-251835; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Young DJ, 2014, HAEMATOLOGICA, V99, P1032, DOI 10.3324/haematol.2013.098657; Zaika A, 2001, J BIOL CHEM, V276, P11310, DOI 10.1074/jbc.M005737200; Zhao ND, 1997, P NATL ACAD SCI USA, V94, P6948, DOI 10.1073/pnas.94.13.6948	48	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0170470	10.1371/journal.pone.0170470	http://dx.doi.org/10.1371/journal.pone.0170470			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178280	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500006
J	Yahiaoui, A; Meadows, SA; Sorensen, RA; Cui, ZH; Keegan, KS; Brockett, R; Chen, G; Queva, C; Li, L; Tannheimer, SL				Yahiaoui, Anella; Meadows, Sarah A.; Sorensen, Rick A.; Cui, Zhi-Hua; Keegan, Kathleen S.; Brockett, Robert; Chen, Guang; Queva, Christophe; Li, Li; Tannheimer, Stacey L.			PI3K delta inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3K delta and BTK inhibitors	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BRUTONS TYROSINE KINASE; NON-HODGKIN-LYMPHOMA; I PI3 KINASE; CLINICAL-TRIAL; RECEPTOR; CANCER; IBRUTINIB; CLL; ACTIVATION	Activated B-cell-like diffuse large B-cell lymphoma relies on B-cell receptor signaling to drive proliferation and survival. Downstream of the B-cell receptor, the key signaling kinases Bruton's tyrosine kinase and phosphoinositide 3-kinase delta offer opportunities for therapeutic intervention by agents such as ibrutinib, ONO/GS-4059, and idelalisib. Combination therapy with such targeted agents could provide enhanced efficacy due to complimentary mechanisms of action. In this study, we describe both the additive interaction of and resistance mechanisms to idelalisib and ONO/GS-4059 in a model of activated B-cell-like diffuse large B-cell lymphoma. Significant tumor regression was observed with a combination of PI3K delta and Bruton's tyrosine kinase inhibitors in the mouse TMD8 xenograft. Acquired resistance to idelalisib in the TMD8 cell line occurred by loss of phosphatase and tensin homolog and phosphoinositide 3-kinase pathway upregulation, but not by mutation of PIK3CD. Sensitivity to idelalisib could be restored by combining idelalisib and ONO/GS-4059. Further evaluation of targeted inhibitors revealed that the combination of idelalisib and the phosphoinositidedependent kinase-1 inhibitor GSK2334470 or the AKT inhibitor MK-2206 could partially overcome resistance. Characterization of acquired Bruton's tyrosine kinase inhibitor resistance revealed a novel tumor necrosis factor alpha induced protein 3 mutation (TNFAIP3 0143*), which led to a loss of A20 protein, and increased p-I kappa B alpha. The combination of idelalisib and ONO/GS-4059 partially restored sensitivity in this resistant line. Additionally, a mutation in Bruton's tyrosine kinase at C481F was identified as a mechanism of resistance. The combination activity observed with idelalisib and ONO/GS-4059, taken together with the ability to overcome resistance, could lead to a new therapeutic option in activated B -cell-like diffuse large B -cell lymphoma. A clinical trial is currently underway to evaluate the combination of idelalisib and ONO/GS-4059 (NCT02457598).	[Yahiaoui, Anella; Meadows, Sarah A.; Sorensen, Rick A.; Cui, Zhi-Hua; Keegan, Kathleen S.; Brockett, Robert; Chen, Guang; Queva, Christophe; Li, Li; Tannheimer, Stacey L.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Queva, Christophe] iTeos Therapeut, Gosselies, Belgium	Gilead Sciences	Tannheimer, SL (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Stacey.Tannheimer@gilead.com			Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	This study was funded by Gilead Sciences, Inc. Since all authors were employees of the study sponsor at the time the study was conducted, the sponsor was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Anthony Mato C N, 2015, BLOOD, V126, P719; Bojarczuk K, 2016, BLOOD, V127, P3192, DOI 10.1182/blood-2015-10-675009; Brown JR, 2016, SEMIN ONCOL, V43, P260, DOI 10.1053/j.seminoncol.2016.02.004; Burger MT, 2011, ACS MED CHEM LETT, V2, P774, DOI 10.1021/ml200156t; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elkabets M, 2015, CANCER CELL, V27, P533, DOI 10.1016/j.ccell.2015.03.010; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Graf SA, 2016, EXPERT OPIN PHARMACO, V17, P265, DOI 10.1517/14656566.2016.1135130; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Hamasy A, 2016, SUBSTITUTION SCANNIN; Huw LY, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.46; Jones JA, 2014, BLOOD, V123, P1455, DOI 10.1182/blood-2013-09-453092; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kim Y, 2014, HUM PATHOL, V45, P556, DOI 10.1016/j.humpath.2013.10.023; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuo HP, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.505.505; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Liu YJ, 2015, CANC RES S, V75; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nakanishi Y, 2016, CANCER RES, V76, P1193, DOI 10.1158/0008-5472.CAN-15-2201; Niemann CU, 2013, SEMIN CANCER BIOL, V23, P410, DOI 10.1016/j.semcancer.2013.09.001; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Nylander S, 2012, J THROMB HAEMOST, V10, P2127, DOI 10.1111/j.1538-7836.2012.04898.x; Patel L, 2016, J MED CHEM; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Somoza JR, 2015, J BIOL CHEM, V290, P8439, DOI 10.1074/jbc.M114.634683; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Trabucco SE, 2015, CLIN CANCER RES, V21, P113, DOI 10.1158/1078-0432.CCR-13-3346; Vanhaesebroeck B, 2016, J MOL MED, V94, P5, DOI 10.1007/s00109-015-1352-5; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Walter HS, 2016, BLOOD, V127, P411, DOI 10.1182/blood-2015-08-664086; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Yang QS, 2015, CLIN CANCER RES, V21, P1537, DOI 10.1158/1078-0432.CCR-14-2034; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Yeomans A, 2016, BLOOD, V127, P449, DOI 10.1182/blood-2015-07-660969; Zhang SQ, 2015, BRIT J HAEMATOL, V170, P445, DOI 10.1111/bjh.13427	47	37	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171221	10.1371/journal.pone.0171221	http://dx.doi.org/10.1371/journal.pone.0171221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178345	gold, Green Published, Green Submitted			2022-12-27	WOS:000393712500032
J	Yu, XQ; Luo, QW; Smith, DP; Clements, MS; Patel, MI; O'Connell, DL				Yu, Xue Qin; Luo, Qingwei; Smith, David P.; Clements, Mark S.; Patel, Manish I.; O'Connell, Dianne L.			Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; ELDERLY-MEN; NEEDS; HEALTH; DIAGNOSIS; FUTURE; COHORT; RISK; PROJECTIONS; MANAGEMENT	Objective To develop a method for estimating the future numbers of prostate cancer survivors requiring different levels of care. Design, setting and participants Analysis of population-based cancer registry data for prostate cancer cases (aged 18-84 years) diagnosed in 1996-2007, and a linked dataset with hospital admission data for men with prostate cancer diagnosed during 2005-2007 in New South Wales (NSW), Australia. Methods Cancer registry data (1996-2007) were used to project complete prostate cancer prevalence in NSW, Australia for 2008-2017, and treatment information from hospital records (2005-2007) was used to estimate the inpatient care needs during the first year after diagnosis. The projected complete prevalence was divided into care needs-based groups. We first divided the cohort into two groups based on patient's age (<75 and 75-84 years). The younger cohort was further divided into initial care and monitoring phases. Cause of death data were used as a proxy for patients requiring last year of life prostate cancer care. Finally, episode data were used to estimate the future number of cases with metastatic progression. Results Of the estimated total of 60,910 men with a previous diagnosis of prostate cancer in 2017, the largest groups will be older patients (52.0%) and younger men who require monitoring (42.5%). If current treatment patterns continue, in the first year post-diagnosis 41% (1380) of patients (<75 years) will have a radical prostatectomy, and 52.6% (1752) will be likely to have either active surveillance, external beam radiotherapy or androgen deprivation therapy. About 3% will require care for subsequent metastases, and 1288 men with prostate cancer are likely to die from the disease in 2017. Conclusions This method extends the application of routinely collected population-based data, and can contribute much to the knowledge of the number of men with prostate cancer and their health care requirements. This could be of significant use in planning future cancer care services and facilities in Australia.	[Yu, Xue Qin; Luo, Qingwei; Smith, David P.; O'Connell, Dianne L.] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Yu, Xue Qin; Luo, Qingwei; O'Connell, Dianne L.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Clements, Mark S.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Clements, Mark S.] Nord Informat Act eSci Ctr, Stockholm, Sweden; [Clements, Mark S.] KTH, Dept Mech, Swedish E Sci Res Ctr, Stockholm, Sweden; [Patel, Manish I.] Univ Sydney, Discipline Surg, Sydney, NSW, Australia; [Patel, Manish I.] Westmead Hosp, Dept Urol, Sydney, NSW, Australia; [O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia	Cancer Council New South Wales; University of Sydney; Griffith University; Menzies Health Institute Queensland; Karolinska Institutet; Royal Institute of Technology; University of Sydney; University of Sydney; University of Newcastle	Yu, XQ (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.; Yu, XQ (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.	xueqiny@nswcc.org.au	Clements, Mark/W-5906-2018; Luo, Qingwei/I-4143-2016; Yu, Xue Qin/E-7405-2013	Clements, Mark/0000-0003-4518-5670; Luo, Qingwei/0000-0002-8902-6869; Yu, Xue Qin/0000-0001-8638-7979; Smith, David/0000-0002-1474-3214	Prostate Cancer Foundation of Australia [PCFA-Y10410]; Australian NHM RC Early Career Fellowship [App1016598]	Prostate Cancer Foundation of Australia; Australian NHM RC Early Career Fellowship	This study was funded by the Prostate Cancer Foundation of Australia (PCFA-Y10410) (to Xue Qin Yu). David Smith was supported by an Australian NHM RC Early Career Fellowship (App1016598). However, the funders played no role in study design, data analysis and interpretation, the content of this paper or the decision where to submit the article for publication.	Australian Institute of Health and Welfare, 2007, OLD AUSTR GLANC; Autstralian Institute of Health and Welfare, 2013, CANC SER, V79; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Bian SX, 2013, SEMIN RADIAT ONCOL, V23, P198, DOI 10.1016/j.semradonc.2013.01.007; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; CHeReL, 2014, DAT DICT NSW ADM PAT; Cockle-Hearne J, 2013, BRIT J CANCER, V109, P2121, DOI 10.1038/bjc.2013.568; Dion P, 2015, CAN STUD POPUL, V42, P102, DOI 10.25336/P69K6X; Evans SM, 2013, MED J AUSTRALIA, V198, P540, DOI 10.5694/mja12.11241; Fritz A, 2000, INT CLASSIFICATION D; Ganz PA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-14; Goldsbury DE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-253; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Keating NL, 2012, J NATL CANCER I, V104, P1518, DOI 10.1093/jnci/djs376; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Konety BR, 2008, J UROLOGY, V179, P1797, DOI 10.1016/j.juro.2008.01.044; Konety BR, 2008, J UROLOGY, V179, P1803, DOI [10.1016/j.juro.2008.01.044, DOI 10.1016/J.JURO.2008.01.044]; Lintz K, 2003, PSYCHO-ONCOLOGY, V12, P769, DOI 10.1002/pon.702; Loeb S, 2013, J UROLOGY, V190, P1742, DOI 10.1016/j.juro.2013.05.054; Luo QW, 2015, CANCER EPIDEMIOL, V39, P617, DOI 10.1016/j.canep.2015.04.013; Maher EJ, 2007, CLIN ONCOL-UK, V19, P743, DOI 10.1016/j.clon.2007.08.007; Maher J, 2011, BRIT J CANCER, V105, pS5, DOI 10.1038/bjc.2011.417; Mariotto AB, 2006, CANCER CAUSE CONTROL, V17, P1215, DOI 10.1007/s10552-006-0072-0; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Ream E, 2008, BRIT J CANCER, V98, P1903, DOI 10.1038/sj.bjc.6604406; Ruseckaite R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2655-9; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Thompson JC, 2007, BRIT MED BULL, V83, P341, DOI 10.1093/bmb/ldm018; Weerakoon M, 2015, BJU INT, V115, P50, DOI 10.1111/bju.13049; World Health Organization, 1996, CANC PAIN REL; Yip K, 2015, BRIT J CANCER, V112, P1594, DOI 10.1038/bjc.2014.650; Yu XQ, 2006, INT J CANCER, V119, P894, DOI 10.1002/ijc.21909; Yu XQ, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000104; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P29, DOI 10.1016/j.canep.2014.11.009; Yu XQ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-936; Yu XQ, 2013, J CANCER SURVIV, V7, P641, DOI 10.1007/s11764-013-0303-9	37	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171013	10.1371/journal.pone.0171013	http://dx.doi.org/10.1371/journal.pone.0171013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178275	Green Published, gold, Green Submitted			2022-12-27	WOS:000393712500019
J	Cortes-Castell, E; Palazon-Bru, A; Pla, C; Goicoechea, M; Rizo-Baeza, MM; Juste, M; Gil-Guillen, VF				Cortes-Castell, Ernesto; Palazon-Bru, Antonio; Pla, Carolina; Goicoechea, Mercedes; Mercedes Rizo-Baeza, Maria; Juste, Mercedes; Francisco Gil-Guillen, Vicente			Impact of prematurity and immigration on neonatal screening for sickle cell disease	PLOS ONE			English	Article							THALASSEMIA; POPULATION	Background Others have described a relationship between hemoglobin A levels and gestational age, gender and ethnicity. However, studies are needed to determine normal cut-off points considering these factors. To address this issue we designed a study to determine the percentiles of normality of neonatal hemoglobin A levels taking these factors into account. Methods This cross-sectional study involved 16,025 samples for sickle cell disease screening in the province of Alicante, Spain, which has a high immigration rate. The primary variable was hemoglobin A, and the secondary variables were gender, gestational age (preterm and full term) and maternal origin (Spain, the rest of Europe, North Africa, Sub-Saharan Africa, Latin America and Asia). Percentiles of normality (1 and 99) were obtained by origin, gender and gestational age using quantile regression models and bootstrap samples. The association between these percentiles of normality and altered levels (>= 1%) of hemoglobin E was analyzed. We obtained the percentiles of normality (1 and 99) for each maternal origin, gender and gestational age. Results Of a total of 88 possible E carriers, 65 had above-normal hemoglobin A levels (74%). The levels of normality for hemoglobin A varied greatly according to the maternal origin and gestational age. Conclusion With the levels of normality that we established it is possible to discard samples with unrecorded blood transfusions. Our methodology could be applied to other diseases in the neonatal screening.	[Cortes-Castell, Ernesto; Juste, Mercedes] Miguel Hernandez Univ, Dept Pharmacol Pediat & Organ Chem, Alicante, Spain; [Palazon-Bru, Antonio; Francisco Gil-Guillen, Vicente] Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain; [Pla, Carolina] Hosp Gen Univ Alicante, Dept Clin Anal, Alicante, Spain; [Goicoechea, Mercedes] Generalitat Valenciana, Ctr Adv Res Publ Hlth, Valencia, Spain; [Mercedes Rizo-Baeza, Maria] Univ Alicante, Dept Nursing, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; General University Hospital of Alicante; Universitat d'Alacant	Palazon-Bru, A (corresponding author), Miguel Hernandez Univ, Dept Clin Med, Alicante, Spain.	antonio.pb23@gmail.com	Cortés-Castell, Ernesto/H-8528-2019; Rizo-Baeza, Mercedes/J-3974-2017; Guillén, Vicente Francisco Gil/AAE-8201-2019	Rizo-Baeza, Mercedes/0000-0002-6754-6505; Palazon-Bru, Antonio/0000-0002-5959-9631; CORTES CASTELL, ERNESTO/0000-0002-8079-1695; Gil-Guillen, Vicente F/0000-0003-3793-9786				COLOMBO B, 1976, BRIT J HAEMATOL, V32, P79, DOI 10.1111/j.1365-2141.1976.tb01877.x; Cooleys Anemia Foundation, 2007, AB THAL; Cortes E, 2014, MANUAL MED PERINATAL, P259; Espada M, 2001, QUIMICA CLIN, V20, P81; FALLETTA JM, 1995, J PEDIATR-US, V127, P685, DOI 10.1016/S0022-3476(95)70154-0; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; GARLICK RL, 1984, BIOCHIM BIOPHYS ACTA, V799, P29, DOI 10.1016/0304-4165(84)90323-4; Gonzalez FA, 2002, HAEMATOLOGICA S1, V87, P368; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hernandez JA, 2002, HAEMATOLOGICA, V87, P373; Hirst C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003427.pub2; King L, 2007, J MED SCREEN, V14, P117, DOI 10.1258/096914107782066185; Lerner NB, 2009, J PEDIATR-US, V154, P121, DOI 10.1016/j.jpeds.2008.06.039; Miguel-Morales Maydelín, 2012, Rev Cubana Hematol Inmunol Hemoter, V28, P423; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Pereira MM, 2009, J CLIN PATHOL, V62, P22, DOI 10.1136/jcp.2008.058834; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Purohit Prasanta, 2014, ISRN Hematol, V2014, P745245, DOI 10.1155/2014/745245; Qiu QW, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-63; Rellan S, 2008, RECIEN NACIDO PREMAT; Sanchaisuriya K, 2005, AM J CLIN PATHOL, V123, P113, DOI 10.1309/FUF9EVGQ24V1PKTP; Villegas A, 2001, HEMOGLOBIN, V25, P273, DOI 10.1081/HEM-100105220	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171604	10.1371/journal.pone.0171604	http://dx.doi.org/10.1371/journal.pone.0171604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170418	gold, Green Published, Green Submitted			2022-12-27	WOS:000393705500045
J	Hussein, M; Pillai, VV; Goddard, JM; Park, HG; Kothapalli, KS; Ross, DA; Ketterings, QM; Brenna, JT; Milstein, MB; Marquis, H; Johnson, PA; Nyrop, JP; Selvaraj, V				Hussein, Mahmoud; Pillai, Viju V.; Goddard, Joshua M.; Park, Hui G.; Kothapalli, Kumar S.; Ross, Deborah A.; Ketterings, Quirine M.; Brenna, J. Thomas; Milstein, Mark B.; Marquis, Helene; Johnson, Patricia A.; Nyrop, Jan P.; Selvaraj, Vimal			Sustainable production of housefly (Musca domestica) larvae as a protein-rich feed ingredient by utilizing cattle manure	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; FATTY-ACID COMPOSITION; SOLDIER FLY LARVAE; RAINBOW-TROUT; POULTRY MANURE; FISH-MEAL; ATLANTIC SALMON; SOYBEAN-MEAL; STABLE FLY; DIPTERA	The common housefly, Musca domestica, is a considerable component of nutrient recycling in the environment. Use of housefly larvae to biodegrade manure presents an opportunity to reduce waste disposal while the rapidly assimilated insect biomass can also be used as a protein rich animal feed. In this study, we examine the biodegradation of dairy cattle manure using housefly larvae, and the nutritional value of the resulting larva meal as a feed ingredient. Our results demonstrated that dairy cattle manure presents a balanced substrate for larval growth, and the spent manure showed reductions in concentration of total nitrogen (24.9%) and phosphorus (6.2%) with an overall reduction in mass. Larva yield at an optimum density was approximately 2% of manure weight. Nutritional analysis of M. domestica larva meal showed values comparable to most high protein feed ingredients. Larva meal was 60% protein with a well-balanced amino acid profile, and 20% fat with 57% monounsaturated fatty acids, and 39% saturated fatty acids. Larva meal lacked any significant amount of omega-3 fatty acids. Evaluation of micronutrients in larva meal suggested that it is a good source of calcium and phosphorus (0.5% and 1.1% respectively). The nutritional value of larva meal closely matches that of fishmeal, making it a potentially attractive alternative for use as a protein-rich feed ingredient for livestock and aquaculture operations.	[Hussein, Mahmoud; Pillai, Viju V.; Goddard, Joshua M.; Ross, Deborah A.; Ketterings, Quirine M.; Johnson, Patricia A.; Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Park, Hui G.; Kothapalli, Kumar S.; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Milstein, Mark B.] Cornell Univ, Johnson Grad Sch Management, Ithaca, NY 14853 USA; [Marquis, Helene] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Nyrop, Jan P.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA.	vs88@cornell.edu	Selvaraj, Vimal/AAC-2853-2022; Pillai, Viju/L-7557-2019	Pillai, Viju/0000-0002-2696-0451; Johnson, Patricia/0000-0001-9432-8039; Brenna, James Thomas/0000-0001-9494-4245	Atkinson Center for a Sustainable Future at Cornell University; GALS Charitable Trust Undergraduate Research Grant from Cornell University	Atkinson Center for a Sustainable Future at Cornell University; GALS Charitable Trust Undergraduate Research Grant from Cornell University	This work was funded by the Atkinson Center for a Sustainable Future at Cornell University to VS, and a GALS Charitable Trust Undergraduate Research Grant from Cornell University to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2004, APPL ENVIRON MICROB, V70, P7578, DOI 10.1128/AEM.70.12.7578-7580.2004; Aniebo A. O., 2008, Livestock Research for Rural Development, V20, P205; [Anonymous], [No title captured]; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; BERGMANN ED, 1954, NATURE, V173, P211, DOI 10.1038/173211a0; BHATTACHARYA AN, 1975, J ANIM SCI, V41, P1438, DOI 10.2527/jas1975.4151438x; Bodenheimer F. S., 1951; BONDARI K, 1981, AQUACULTURE, V24, P103, DOI 10.1016/0044-8486(81)90047-8; BONDARI K, 1987, Aquaculture and Fisheries Management, V18, P209, DOI 10.1111/j.1365-2109.1987.tb00141.x; Bovera F, 2015, BRIT POULTRY SCI, V56, P569, DOI 10.1080/00071668.2015.1080815; Broce AB, 1999, J KANSAS ENTOMOL SOC, V72, P60; BROOKES VICTOR JACK, 1958, PHYSIOL ZOOL, V31, P208; BUCHAN PB, 1981, EXP GERONTOL, V16, P223, DOI 10.1016/0531-5565(81)90017-6; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; CALVERT CC, 1970, POULTRY SCI, V49, P588, DOI 10.3382/ps.0490588; Carter CG, 2000, AQUACULTURE, V185, P299, DOI 10.1016/S0044-8486(99)00353-1; Chouinard PY, 1999, J DAIRY SCI, V82, P2737, DOI 10.3168/jds.S0022-0302(99)75530-X; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Cickova H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032798; Cotanch K, 2007, J ANIM SCI; ELBOUSHY AR, 1991, BIORESOURCE TECHNOL, V38, P45, DOI 10.1016/0960-8524(91)90220-E; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Food and Agriculture Organization [FAO], 2009, GLOBAL AGR 2050; Gaylord TG, 2006, J WORLD AQUACULT SOC, V37, P509, DOI 10.1111/j.1749-7345.2006.00064.x; Gollehon N., 2000, Agricultural Outlook, P12; GOMES EF, 1995, AQUACULTURE, V130, P177, DOI 10.1016/0044-8486(94)00211-6; Graczyk TK, 1999, AM J TROP MED HYG, V61, P500, DOI 10.4269/ajtmh.1999.61.500; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hard DL., 2002, INNOVATIVE DEV PRODU; Harel M, 2002, AQUACULTURE, V213, P347, DOI 10.1016/S0044-8486(02)00047-9; Hartel H., 1968, GEFLUGELKUNDE, V32, P13; HOUSE HL, 1961, ANNU REV ENTOMOL, V6, P13, DOI 10.1146/annurev.en.06.010161.000305; Ido A, 2015, APPL ENTOMOL ZOOL, V50, P213, DOI 10.1007/s13355-015-0325-z; Iwasa M, 1999, J MED ENTOMOL, V36, P108, DOI 10.1093/jmedent/36.1.108; Kaplan JD, 2004, AM J AGR ECON, V86, P688, DOI 10.1111/j.0002-9092.2004.00611.x; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; LAZARUS WF, 1989, J ECON ENTOMOL, V82, P1145, DOI 10.1093/jee/82.4.1145; LEVINSON ZH, 1960, NATURE, V188, P427, DOI 10.1038/188427a0; Lock E R, 2015, AQUACULTURE NUTR, DOI 10.1111-anu.12343; LUSSENHOP J, 1986, OIKOS, V47, P233, DOI 10.2307/3566050; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Mallin MA, 2003, POPUL ENVIRON, V24, P369, DOI 10.1023/A:1023690824045; MILLER BF, 1974, BRIT POULTRY SCI, V15, P231, DOI 10.1080/00071667408416100; MILLER D, 1974, POULTRY SCI, V53, P226, DOI 10.3382/ps.0530226; Moon RD, 2001, J ECON ENTOMOL, V94, P1308, DOI 10.1603/0022-0493-94.5.1308; Muller Z. O., 1980, FEED ANIMAL WASTES S; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Park HG, 2015, FASEB J, V29, P3911, DOI 10.1096/fj.15-271783; Park WJ, 2012, J LIPID RES, V53, P1502, DOI 10.1194/jlr.M025312; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Schou MF, 2013, FLY, V7, DOI 10.4161/fly.22758; SILVERMAN PH, 1954, BIOCHEM J, V58, P291, DOI 10.1042/bj0580291; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; [Subcommittee on Poultry Nutrition NRC NRC], 1994, SUBC POULTR NUTR, P176; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tomberlin JK, 2015, J INSECTS FOOD FEED, V1, P307, DOI 10.3920/JIFF2015.0098; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; UNICEF, SOME FOOD LOSS IS UN; USDA-ARS, 2005, FY 2006 ANN REP MAN; Van Pelt CK, 1999, ANAL CHEM, V71, P1981, DOI 10.1021/ac981387f; van Zanten HHE, 2015, J CLEAN PROD, V102, P362, DOI 10.1016/j.jclepro.2015.04.106; WIESMANN D, 1988, AQUACULTURE, V69, P263, DOI 10.1016/0044-8486(88)90334-1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	68	52	56	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171708	10.1371/journal.pone.0171708	http://dx.doi.org/10.1371/journal.pone.0171708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170420	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500052
J	Link, J; Ramanujam, R; Auer, M; Ryner, M; Hassler, S; Bachelet, D; Mbogning, C; Warnke, C; Buck, D; Jensen, PEH; Sievers, C; Ingenhoven, K; Fissolo, N; Lindberg, R; Grummel, V; Donnellan, N; Comabella, M; Montalban, X; Kieseier, B; Sorensen, PS; Hartung, HP; Derfuss, T; Lawton, A; Sikkema, D; Pallardy, M; Hemmer, B; Deisenhammer, F; Broet, P; Donnes, P; Davidson, J; Fogdell-Hahn, A				Link, Jenny; Ramanujam, Ryan; Auer, Michael; Ryner, Malin; Hassler, Signe; Bachelet, Delphine; Mbogning, Cyprien; Warnke, Clemens; Buck, Dorothea; Jensen, Poul Erik Hyldgaard; Sievers, Claudia; Ingenhoven, Kathleen; Fissolo, Nicolas; Lindberg, Raija; Grummel, Verena; Donnellan, Naoimh; Comabella, Manuel; Montalban, Xavier; Kieseier, Bernd; Sorensen, Per Soelberg; Hartung, Hans-Peter; Derfuss, Tobias; Lawton, Andy; Sikkema, Dan; Pallardy, Marc; Hemmer, Bernhard; Deisenhammer, Florian; Broet, Philippe; Donnes, Pierre; Davidson, Julie; Fogdell-Hahn, Anna		ABIRISK Consortium	Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; REPORTER-GENE; IFN-BETA; DISEASE PROGRESSION; MS-PATIENTS; THERAPY; MULTICENTER; PREVALENCE; VALIDATION; ADALIMUMAB	Antibodies against biopharmaceuticals (anti-drug antibodies, ADA) have been a well-integrated part of the clinical care of multiple sclerosis (MS) in several European countries. ADA data generated in Europe during the more than 10 years of ADA monitoring in MS patients treated with interferon beta (IFN beta) and natalizumab have been pooled and characterized through collaboration within a European consortium. The aim of this study was to report on the clinical practice of ADA testing in Europe, considering the number of ADA tests performed and type of ADA assays used, and to determine the frequency of ADA testing against the different drug preparations in different countries. A common database platform (tranSMART) for querying, analyzing and storing retrospective data of MS cohorts was set up to harmonize the data and compare results of ADA tests between different countries. Retrospective data from six countries (Sweden, Austria, Spain, Switzerland, Germany and Denmark) on 20,695 patients and on 42,555 samples were loaded into tranSMART including data points of age, gender, treatment, samples, and ADA results. The previously observed immunogenic difference among the four IFN beta preparations was confirmed in this large dataset. Decreased usage of the more immunogenic preparations IFN beta-1a subcutaneous (s.c.) and IFN beta-1b s.c. in favor of the least immunogenic preparation IFN beta-1a intramuscular (i.m.) was observed. The median time from treatment start to first ADA test correlated with time to first positive test. Shorter times were observed for IFN beta-1b-Extavia s. c. (0.99 and 0.94 years) and natalizumab (0.25 and 0.23 years), which were introduced on the market when ADA testing was already available, as compared to IFN beta-1a i. m. (1.41 and 2.27 years), IFN beta-1b-Betaferon s. c. (2.51 and 1.96 years) and IFN beta-1a s. c. (2.11 and 2.09 years) which were available years before routine testing began. A higher rate of anti-IFN beta ADA was observed in test samples taken from older patients. Testing for ADA varies between different European countries and is highly dependent on the policy within each country. For drugs where routine monitoring of ADA is not in place, there is a risk that some patients remain on treatment for several years despite ADA positivity. For drugs where a strategy of ADA testing is introduced with the release of the drug, there is a reduced risk of having ADA positive patients and thus of less efficient treatment. This indicates that potential savings in health cost might be achieved by routine analysis of ADA.	[Link, Jenny; Ramanujam, Ryan; Ryner, Malin; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ramanujam, Ryan] KTH Royal Inst Technol, Stockholm, Sweden; [Auer, Michael; Deisenhammer, Florian] Med Univ Innsbruck, Innsbruck, Austria; [Hassler, Signe; Bachelet, Delphine; Mbogning, Cyprien; Broet, Philippe] Univ Paris Saclay, Univ Paris Sud, CESP, UVSQ,INSERM, Villejuif, France; [Warnke, Clemens; Ingenhoven, Kathleen; Kieseier, Bernd; Hartung, Hans-Peter] Univ Dusseldorf, Fac Med, Dept Neurol, Dusseldorf, Germany; [Buck, Dorothea; Grummel, Verena; Hemmer, Bernhard] Tech Univ Munich, Dept Neurol, Munich, Germany; [Jensen, Poul Erik Hyldgaard; Sorensen, Per Soelberg] Univ Copenhagen, Rigshosp, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Sievers, Claudia; Lindberg, Raija; Derfuss, Tobias] Univ Basel Hosp, Basel, Switzerland; [Fissolo, Nicolas; Comabella, Manuel; Montalban, Xavier] Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain; [Donnellan, Naoimh] Ipsen Biopharm Ltd, Slough, Berks, England; [Lawton, Andy; Sikkema, Dan; Davidson, Julie] GlaxoSmithKline R&D, Uxbridge, Middx, England; [Pallardy, Marc] Univ Paris Saclay, Univ Paris Sud, INSERM, Fac Pharm,UMR 996, Chatenay Malabry, France; [Broet, Philippe] Hop Paul Brousse, AP HP, Villejuif, France; [Donnes, Pierre] SciCross AB, Skovde, Sweden	Karolinska Institutet; Royal Institute of Technology; Medical University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Heinrich Heine University Dusseldorf; Technical University of Munich; Rigshospitalet; University of Copenhagen; University of Basel; Hospital Universitari Vall d'Hebron; Ipsen; GlaxoSmithKline; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Fogdell-Hahn, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	pierre@scicross.com; Anna.Fogdell-Hahn@ki.se	Mbogning, Cyprien/AAI-1788-2020; Montalban, Xavier/J-5938-2016; Ramanujam, Ryan/ABE-2426-2020; Hemmer, Bernhard/AAT-8388-2021; Fissolo, Nicolas/J-3067-2012; Bachelet, Delphine/AAD-8385-2022; Hemmer, Bernhard/GPX-8451-2022	Mbogning, Cyprien/0000-0002-6619-3883; Montalban, Xavier/0000-0002-0098-9918; Fissolo, Nicolas/0000-0002-7701-9346; Hemmer, Bernhard/0000-0001-5985-6784; Fogdell-Hahn, Anna/0000-0002-0311-9184; Derfuss, Tobias/0000-0001-8656-4250; Comabella Lopez, Manuel/0000-0002-2373-6657; Ramanujam, Ryan/0000-0001-7360-1497; Donnes, Pierre/0000-0002-4613-2952; /0000-0003-2185-151X; Link, Jenny/0000-0002-6134-9404; BROET, PHILIPPE/0000-0001-9122-2810	Innovative Medicines Initiative Joint Undertaking ABIRISK project [115303]; European Union's Seventh Framework Programme; EFPIA companies; research grants from NEURO Sweden; Stockholm County Council (ALF project); eTRIKS consortium	Innovative Medicines Initiative Joint Undertaking ABIRISK project; European Union's Seventh Framework Programme; EFPIA companies; research grants from NEURO Sweden; Stockholm County Council (ALF project)(Stockholm County Council); eTRIKS consortium	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking ABIRISK project under grant agreement no. 115303, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies. This study was also supported by research grants from NEURO Sweden (www.neuroforbundet.se) and grants provided by the Stockholm County Council (ALF project). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Jan Hillert for support and for building the infrastructure that has enabled the collection of data of patients and samples from Sweden. We thank the eTRIKS consortium (www.etriks.org) for their support in the construction of the TranSMART database.	Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Castrop F, 2013, NEUROPSYCH DIS TREAT, V9, P1339, DOI 10.2147/NDT.S33949; Deisenhammer F, 2009, CNS DRUGS, V23, P379, DOI 10.2165/00023210-200923050-00003; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Farrell R, 2008, MULT SCLER, V14, P212, DOI 10.1177/1352458507082066; Francis G, 2001, NEUROLOGY, V56, P1628; Gneiss C, 2004, MULT SCLER J, V10, P507, DOI 10.1191/1352458504ms1074oa; Hegen H, 2014, MULT SCLER J, V20, P577, DOI 10.1177/1352458513503597; Hermanrud C, 2016, J IMMUNOL METHODS, V430, P1, DOI 10.1016/j.jim.2016.01.004; Hermanrud C, 2014, J INTERF CYTOK RES, V34, P498, DOI 10.1089/jir.2013.0097; Hesse D, 2007, EUR J NEUROL, V14, P850, DOI 10.1111/j.1468-1331.2007.01769.x; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hoffmann S, 2008, AM J HUM GENET, V83, P219, DOI 10.1016/j.ajhg.2008.07.006; Hoxha A, 2016, JOINT BONE SPINE, V83, P167, DOI 10.1016/j.jbspin.2015.04.020; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jensen PEH, 2012, MULT SCLER J, V18, P1493, DOI 10.1177/1352458512441688; Jungedal R, 2012, MULT SCLER J, V18, P1775, DOI 10.1177/1352458512446036; Kappos L, 2004, MULT SCLER J, V10, pS46, DOI 10.1191/1352458504ms1030oa; KAWADE Y, 1986, METHOD ENZYMOL, V119, P558; Koch-Henriksen N, 2006, NEUROLOGY, V66, P1056, DOI 10.1212/01.wnl.0000204018.52311.ec; Lallemand C, 2008, J INTERF CYTOK RES, V28, P393, DOI 10.1089/jir.2007.0142; Lam R, 2008, J IMMUNOL METHODS, V336, P113, DOI 10.1016/j.jim.2008.03.014; Link J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090479; Lundkvist M, 2013, MULT SCLER J, V19, P757, DOI 10.1177/1352458512462920; Massart C, 2007, CLIN CHIM ACTA, V377, P185, DOI 10.1016/j.cca.2006.09.021; Newton Ashley N, 2011, Int J MS Care, V13, P128, DOI 10.7224/1537-2073-13.3.128; Pachner AR, 2003, NEUROLOGY, V61, P1444, DOI 10.1212/01.WNL.0000094198.37489.11; Panitch H, 2005, J NEUROL SCI, V239, P67, DOI 10.1016/j.jns.2005.08.003; Polman CH, 2010, LANCET NEUROL, V9, P740, DOI 10.1016/S1474-4422(10)70103-4; R Core Team, 2013, R LANG ENV STAT COMP; R Development Core Team, 2014, R LANG ENV STAT COMP, P409; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sominanda A, 2008, J NEUROL NEUROSURG P; Sorensen PS, 2011, MULT SCLER J, V17, P1074, DOI 10.1177/1352458511404271; Sorensen PS, 2011, NEUROLOGY, V76, P759, DOI 10.1212/WNL.0b013e31820d62a4; Sorensen PS, 2005, EUR J NEUROL, V12, P817, DOI 10.1111/j.1468-1331.2005.01386.x; Sorensen PS, 2005, NEUROLOGY, V65, P33, DOI 10.1212/01.WNL.0000166049.51502.6A; Szalma S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-68; Walter E, 2014, MULT SCLER RELAT DIS, V3, P670, DOI 10.1016/j.msard.2014.09.003	42	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170395	10.1371/journal.pone.0170395	http://dx.doi.org/10.1371/journal.pone.0170395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170401	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500005
J	Stastny, P; Golas, A; Blazek, D; Maszczyk, A; Wilk, M; Pietraszewski, P; Petr, M; Uhlir, P; Zajac, A				Stastny, Petr; Golas, Artur; Blazek, Dusan; Maszczyk, Adam; Wilk, Michal; Pietraszewski, Przemyslaw; Petr, Miroslav; Uhlir, Petr; Zajac, Adam			A systematic review of surface electromyography analyses of the bench press movement task	PLOS ONE			English	Review							MIND-MUSCLE CONNECTION; CHEST-PRESS; STICKING REGION; SHOULDER MUSCLES; RESISTANCE; STRENGTH; EXERCISE; ACTIVATION; SEGMENTS; JOINT	Background The bench press exercise (BP) plays an important role in recreational and professional training, in which muscle activity is an important multifactorial phenomenon. The objective of this paper is to systematically review electromyography (EMG) studies performed on the barbell BP exercise to answer the following research questions: Which muscles show the greatest activity during the flat BP? Which changes in muscle activity are related to specific conditions under which the BP movement is performed? Strategy PubMed, Scopus, Web of Science and Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library were searched through June 10, 2016. A combination of the following search terms was used: bench press, chest press, board press, test, measure, assessment, dynamometer, kinematics and biomechanics. Only original, full-text articles were considered. Results The search process resulted in 14 relevant studies that were included in the discussion. The triceps brachii (TB) and pectoralis major (PM) muscles were found to have similar activity during the BP, which was significantly higher than the activity of the anterior deltoid. During the BP movement, muscle activity changes with exercise intensity, velocity of movement, fatigue, mental focus, movement phase and stability conditions, such as bar vibration or unstable surfaces. Under these circumstances, TB is the most common object of activity change. Conclusions PM and TB EMG activity is more dominant and shows greater EMG amplitude than anterior deltoid during the BP. There are six factors that can influence muscle activity during the BP; however, the most important factor is exercise intensity, which interacts with all other factors. The research on muscle activity in the BP has several unresolved areas, such as clearly and strongly defined guidelines to perform EMG measurements (e.g., how to elaborate with surface EMG limits) or guidelines for the use of exact muscle models.	[Stastny, Petr; Blazek, Dusan; Petr, Miroslav] Charles Univ Prague, Fac Phys Educ & Sport, Dept Sport Games, Prague, Czech Republic; [Golas, Artur; Maszczyk, Adam; Wilk, Michal; Pietraszewski, Przemyslaw; Zajac, Adam] Jerzy Kukuczka Acad Phys Educ, Dept Sports Theory, Katowice, Poland; [Uhlir, Petr] Palacky Univ, Fac Phys Culture, Olomouc, Czech Republic	Charles University Prague; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; Palacky University Olomouc	Stastny, P (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Dept Sport Games, Prague, Czech Republic.	stastny@ftvs.cuni.cz	Maszczyk, Adam/W-6759-2018; Adam, Zajac/W-9336-2018; Golas, Artur/W-5787-2018; Uhlíř, Petr/K-3694-2017; Petr, Miroslav/C-3648-2015; Wilk, Michal/B-7638-2018; Blažek, Dušan/R-9461-2017; Pietraszewski, Przemysław/X-1825-2018; Wilk, Michal/W-1928-2019; Stastny, Petr/S-3467-2016	Maszczyk, Adam/0000-0001-9139-9747; Adam, Zajac/0000-0002-4374-4822; Golas, Artur/0000-0002-6656-6993; Uhlíř, Petr/0000-0003-0131-3087; Petr, Miroslav/0000-0001-8735-1935; Wilk, Michal/0000-0001-5799-6337; Blažek, Dušan/0000-0002-0397-3006; Pietraszewski, Przemysław/0000-0003-3371-9663; Wilk, Michal/0000-0001-5799-6337; Stastny, Petr/0000-0003-2841-374X	Ministry of Science and Higher Education of Poland [NRSA3 03953, NRSA4 040 54]; PROGRES Q41; Czech Science Foundation Agency [16-13750S]	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); PROGRES Q41; Czech Science Foundation Agency	The author's research is funded by grants of Ministry of Science and Higher Education of Poland (NRSA3 03953 and NRSA4 040 54), PROGRES Q41 and Czech Science Foundation Agency (16-13750S).	Barnett C., 1995, J STRENGTH COND RES, V9, P222, DOI [https://doi.org/10.1519/00124278-199511000-00003, DOI 10.1519/00124278-199511000-00003, 10.1519/00124278-199511000-00003]; Brennecke A, 2009, J STRENGTH COND RES, V23, P1933, DOI 10.1519/JSC.0b013e3181b73b8f; Brown JMM, 2007, J ELECTROMYOGR KINES, V17, P57, DOI 10.1016/j.jelekin.2005.10.007; Cacchio A, 2008, J ELECTROMYOGR KINES, V18, P618, DOI 10.1016/j.jelekin.2006.12.007; Calatayud J, 2016, EUR J APPL PHYSIOL, V116, P527, DOI 10.1007/s00421-015-3305-7; Calatayud J, 2015, J STRENGTH COND RES, V29, P246, DOI 10.1519/JSC.0000000000000589; Campos Yuri de Almeida Costa, 2014, Motriz: rev. educ. fis., V20, P200, DOI 10.1590/S1980-65742014000200010; Castillo F, 2012, REV ANDAL MED DEPORT, V5, P18, DOI DOI 10.1016/S1888-7546(12)70005-9; Chulvi MI, 2008, REV INT MED CIENC AC, V8, P338; Clark RA, 2011, J STRENGTH COND RES, V25, P704, DOI 10.1519/JSC.0b013e3181c6a0ff; Coelho AC, 2015, J APPL PHYSIOL, V118, P646, DOI 10.1152/japplphysiol.00948.2014; de Seze MP, 2004, SURG RADIOL ANAT, V26, P459, DOI 10.1007/s00276-004-0253-z; ELLIOTT BC, 1989, MED SCI SPORT EXER, V21, P450; Enoka RM, 2015, J APPL PHYSIOL, V119, P1516, DOI 10.1152/japplphysiol.00280.2015; Flanagan SD, 2014, J STRENGTH COND RES, V28, P2437, DOI 10.1519/JSC.0000000000000337; Frost DM, 2008, EUR J APPL PHYSIOL, V104, P937, DOI 10.1007/s00421-008-0821-8; Glass SC, 1997, J STRENGTH COND RES, V11, P163; Goodman CA, 2008, J STRENGTH COND RES, V22, P88, DOI 10.1519/JSC.0b013e31815ef6b3; Halperin I, 2016, EUR J APPL PHYSIOL, V116, P863, DOI 10.1007/s00421-016-3341-y; Keogh JWL, 1999, J STRENGTH COND RES, V13, P247; Kristiansen M, 2015, SCAND J MED SCI SPOR, V25, P89, DOI 10.1111/sms.12167; Maeo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079486; Maia MD, 2015, APUNTS-MED ESPORT, V50, P103, DOI 10.1016/j.apunts.2015.01.001; Martin S, 2006, J ELECTROMYOGR KINES, V16, P144, DOI 10.1016/j.jelekin.2005.06.010; Martorelli SS, J STRENGTH CONDIT RE; Moras G, 2010, J STRENGTH COND RES, V24, P2132, DOI 10.1519/JSC.0b013e3181aa3684; Norwood JT, 2007, J STRENGTH COND RES, V21, P343, DOI 10.1519/R-17435.1; Ojasto T, 2009, J STRENGTH COND RES, V23, P946, DOI 10.1519/JSC.0b013e3181a2b22f; Patterson JM, 2015, PEER J, V2015, DOI 10.1080/02640414.2010.543916; Rocha Jr V. D. A., 2007, REVISTA BRASILEIRA D, V13, p43e; Saeterbakken AH, 2013, J STRENGTH COND RES, V27, P1101, DOI 10.1519/JSC.0b013e3182606d3d; Saeterbakken AH, 2011, J SPORT SCI, V29, P533, DOI 10.1080/02640414.2010.543916; Sakamoto A, 2012, EUR J APPL PHYSIOL, V112, P1015, DOI 10.1007/s00421-011-2059-0; Sakoma Y, 2011, J ANAT, V218, P185, DOI 10.1111/j.1469-7580.2010.01325.x; Santana JC, 2007, J STRENGTH COND RES, V21, P1271; Schick EE, 2010, J STRENGTH COND RES, V24, P779, DOI 10.1519/JSC.0b013e3181cc2237; Scholtz B., 2016, INT C INF RES MAN, P1; Snyder BJ, 2012, J STRENGTH COND RES, V26, P2394, DOI 10.1519/JSC.0b013e31823f8d11; Trebs AA, 2010, J STRENGTH COND RES, V24, P1925, DOI 10.1519/JSC.0b013e3181ddfae7; van den Tillaar R, 2014, J HUM KINET, V42, P63, DOI 10.2478/hukin-2014-0061; Van den Tillaar R, 2012, J STRENGTH COND RES, V26, P2962, DOI 10.1519/JSC.0b013e3182443430; van den Tillaar R, 2012, J SPORT SCI, V30, P591, DOI 10.1080/02640414.2012.658844; van den Tillaar R, 2009, MED SCI SPORT EXER, V41, P2056, DOI 10.1249/MSS.0b013e3181a8c360; Vigotsky AD, 2015, J APPL PHYSIOL, P1; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wattanaprakornkul D, 2011, J ELECTROMYOGR KINES, V21, P1041, DOI 10.1016/j.jelekin.2011.09.002	47	72	73	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171632	10.1371/journal.pone.0171632	http://dx.doi.org/10.1371/journal.pone.0171632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170449	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500048
J	Duncan, MC; Herrera, NG; Johnson, KS; Engel, JN; Auerbuch, V				Duncan, Miles C.; Herrera, Natalia G.; Johnson, Kevin S.; Engel, Joanne N.; Auerbuch, Victoria			Bacterial internalization is required to trigger NIK-dependent NF-kappa B activation in response to the bacterial type three secretion system	PLOS ONE			English	Article							YERSINIA-PSEUDOTUBERCULOSIS; INFLAMMASOME; PATHWAY; TUMORIGENESIS; RECOGNITION; EXPRESSION; MATURATION; RELEASE; KINASES; PROTEIN	Infection of human cells with Yersinia pseudotuberculosis expressing a functional type III secretion system (T3SS) leads to activation of host NF-kappa B. We show that the Yersinia T3SS activates distinct NF-kappa B pathways dependent upon bacterial subcellular localization. We found that wildtype Yersinia able to remain extracellular triggered NF-kappa B activation independently of the non-canonical NF-kappa B. kinase NIK in HEK293T cells. In contrast, Yersinia lacking the actin-targeting effectors YopEHO, which become internalized into host cells, induce a NIK-dependent response and nuclear entry of the non-canonical NF-kappa B subunit p52. Blocking actin polymerization and uptake of effector mutant bacteria using cytochalasin D shifted the host NF-kappa B response from NIK-independent to primarily NIK-dependent. We observed similar results using Pseudomonas aeruginosa, which expresses a related T3SS and the actin-targeting effector ExoT. As the NF-kappa B response of HEK293T cells to effectorless Yersinia has been used both as a screening tool for chemical inhibitors of the T3SS and for bacterial forward genetic screens, a better understanding of this response is important for tool optimization and interpretation.	[Duncan, Miles C.; Herrera, Natalia G.; Johnson, Kevin S.; Auerbuch, Victoria] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Engel, Joanne N.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Engel, Joanne N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Duncan, Miles C.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Herrera, Natalia G.] Albert Einstein Coll Med, Program Biomed Sci, Bronx, NY USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tufts University; Yeshiva University; Albert Einstein College of Medicine	Auerbuch, V (corresponding author), Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA.	vastone@ucsc.edu		Johnson, Kevin/0000-0002-1875-7007; Auerbuch, Victoria/0000-0002-9475-4756; Herrera, Natalia/0000-0003-1409-3554	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01A1106930]; Faculty Research Grant from the UC Santa Cruz Committee on Research; University of California Cancer Research Coordinating Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007910, R25GM058903] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Faculty Research Grant from the UC Santa Cruz Committee on Research; University of California Cancer Research Coordinating Committee(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01A1106930, a Faculty Research Grant from the UC Santa Cruz Committee on Research, and a grant from the University of California Cancer Research Coordinating Committee (to VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Hanh Lam for critical review of the manuscript. We thank Benjamin Abrams in the UCSC Life Sciences Microscopy Center for technical support, Ralph Isberg for the anti-Yersinia antibody, and Molly Bergman for the Delta yop6+YopJ strain. Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI106930, a Faculty Research Grant from the UC Santa Cruz Committee on Research, and a grant from the University of California Cancer Research Coordinating Committee (to VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Bliska JB, 2006, ACS CHEM BIOL, V1, P349, DOI 10.1021/cb600261k; Burstein D, 2015, MBIO, V6, DOI 10.1128/mBio.00161-15; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Duncan MC, 2014, ANTIMICROB AGENTS CH, V58, P1118, DOI 10.1128/AAC.02025-13; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Miller HK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004194; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Sheahan KL, 2015, MBIO, V6, DOI 10.1128/mBio.02023-14; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Solomon R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120471; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Thu YM, 2012, ONCOGENE, V31, P2580, DOI 10.1038/onc.2011.427; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293; Zwack EE, 2015, MBIO, V6, DOI 10.1128/mBio.02095-14	30	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171406	10.1371/journal.pone.0171406	http://dx.doi.org/10.1371/journal.pone.0171406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166267	Green Published, gold			2022-12-27	WOS:000393700100038
J	Varallo, FR; Planeta, CS; Herdeiro, MT; Mastroianni, PD				Varallo, Fabiana Rossi; Planeta, Cleopatra S.; Herdeiro, Maria Teresa; Mastroianni, Patricia de Carvalho			Imputation of adverse drug reactions: Causality assessment in hospitals	PLOS ONE			English	Article							PUBLISHED DECISIONAL ALGORITHMS; EXPERT PANEL; PHARMACOVIGILANCE; AGREEMENT; CRITERIA	Background & objectives Different algorithms have been developed to standardize the causality assessment of adverse drug reactions (ADR). Although most share common characteristics, the results of the causality assessment are variable depending on the algorithm used. Therefore, using 10 different algorithms, the study aimed to compare inter-rater and multi-rater agreement for ADR causality assessment and identify the most consistent to hospitals. Methods Using ten causality algorithms, four judges independently assessed the first 44 cases of ADRs reported during the first year of implementation of a risk management service in a medium complexity hospital in the state of Sao Paulo (Brazil). Owing to variations in the terminology used for causality, the equivalent imputation terms were grouped into four categories: definite, probable, possible and unlikely. Inter-rater and multi-rater agreement analysis was performed by calculating the Cohen's and Light's kappa coefficients, respectively. Results None of the algorithms showed 100% reproducibility in the causal imputation. Fair inter rater and multi-rater agreement was found. Emanuele (1984) and WHO-UMC (2010) algorithms showed a fair rate of agreement between the judges (k = 0.36). Interpretation & conclusions Although the ADR causality assessment algorithms were poorly reproducible, our data suggest that WHO-UMC algorithm is the most consistent for imputation in hospitals, since it allows evaluating the quality of the report. However, to improve the ability of assessing the causality using algorithms, it is necessary to include criteria for the evaluation of drug-related problems, which may be related to confounding variables that underestimate the causal association.	[Varallo, Fabiana Rossi; Planeta, Cleopatra S.; Mastroianni, Patricia de Carvalho] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP, Brazil; [Varallo, Fabiana Rossi] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Herdeiro, Maria Teresa] Univ Aveiro, Dept Cincias Med, Aveiro, Portugal	Universidade Estadual Paulista; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade de Aveiro	Mastroianni, PD (corresponding author), Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP, Brazil.	patriciamastroianni@yahoo.com.br	de Carvalho Mastroianni, Patricia/G-8191-2016; Planeta, Cleopatra/Z-5255-2019; Scavone, Cristoforo/C-1580-2012; Herdeiro, Maria/H-8195-2013; Mastroianni, Patricia/Y-7107-2019; Mastroianni, Patricia/Q-2265-2019; Varallo, Fabiana Rossi/G-9070-2016	de Carvalho Mastroianni, Patricia/0000-0001-8467-7278; Planeta, Cleopatra/0000-0002-1378-6327; Scavone, Cristoforo/0000-0002-1206-0882; Herdeiro, Maria/0000-0002-0500-4049; Mastroianni, Patricia/0000-0001-8467-7278; Varallo, Fabiana Rossi/0000-0003-4016-1442	Coordination of Improvement of Higher Education Personnel (CAPES) [014301/2013-00]; Sao Paulo Research Foundation (FAPESP) [2014/12681-2, 2013/10381-1]; Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas da UNESP-PADC	Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas da UNESP-PADC	This work was supported by the Coordination of Improvement of Higher Education Personnel (CAPES) for the scholarship (PDSE) provided [grant number 014301/2013-00]; grant 2013/10381-1, Sao Paulo Research Foundation (FAPESP) for partial presentation; grant 2014/12681-2, Sao Paulo Research Foundation (FAPESP), for a regular project and the Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias Farmaceuticas da UNESP-PADC.	Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Angamo MT, 2016, DRUG SAFETY, V39, P847, DOI 10.1007/s40264-016-0444-7; Arimone Y, 2005, EUR J CLIN PHARMACOL, V61, P169, DOI 10.1007/s00228-004-0869-2; Belhekar MN, 2014, INDIAN J PHARMACOL, V46, P117, DOI 10.4103/0253-7613.125192; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Coloma PM, 2013, DRUG SAFETY, V36, P13, DOI 10.1007/s40264-012-0002-x; DAVIES EC, 2011, PHARM MED, V25, P17; de Vries ST, 2014, J PSYCHOSOM RES, V76, P134, DOI 10.1016/j.jpsychores.2013.11.003; Doherty MJ., 2009, RESP MED CME 2, V2, P63, DOI [10.1016/j.rmedc.2009.01.004, DOI 10.1016/J.RMEDC.2009.01.004]; Edwards IR, 2012, BRIT J CLIN PHARMACO, V73, P979, DOI 10.1111/j.1365-2125.2012.04249.x; Farcas A, 2009, J GASTROINTEST LIVER, V18, P353; Kamarulzaman A, 2015, CURR OPIN INFECT DIS, V28, P10, DOI 10.1097/QCO.0000000000000125; Kane-Gill SL, 2006, ANN PHARMACOTHER, V40, P1267, DOI 10.1345/aph.1H088; Kane-Gill SL, 2012, DRUG SAFETY, V35, P645, DOI 10.2165/11599730-000000000-00000; Khan LM, 2016, SAUDI PHARM J, V24, P485, DOI 10.1016/j.jsps.2015.01.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Macedo AF, 2005, PHARMACOEPIDEM DR S, V14, P885, DOI 10.1002/pds.1138; Macedo AF, 2003, J CLIN PHARM THER, V28, P137, DOI 10.1046/j.1365-2710.2003.00475.x; Meyboom RHB, 1999, DRUG SAFETY, V21, P429, DOI 10.2165/00002018-199921060-00001; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Mugosa S, 2015, VOJNOSANIT PREGL, V72, P975, DOI 10.2298/VSP140710104M; OPS, 5 OPS PARF; Pal SN, 2013, DRUG SAFETY, V36, P75, DOI 10.1007/s40264-012-0014-6; Seeger JD, 2015, DRUG SAFETY, V38, P847, DOI 10.1007/s40264-015-0342-4; Shakir SAW, 2002, DRUG SAFETY, V25, P467, DOI 10.2165/00002018-200225060-00012; Theophile H, 2013, DRUG SAFETY, V36, P1033, DOI 10.1007/s40264-013-0083-1; Theophile H, 2012, J CLIN EPIDEMIOL, V65, P1069, DOI 10.1016/j.jclinepi.2012.04.015; World Health Organization, 1972, WHO TECHN REP SER; World Health Organization, 2002, IMP PHARM; World Health Organization (WHO) UMC, 2010, US WHO UMC SYST STAN	31	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171470	10.1371/journal.pone.0171470	http://dx.doi.org/10.1371/journal.pone.0171470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166274	Green Published, gold, Green Submitted			2022-12-27	WOS:000393700100046
J	Tai, CS; Lin, YR; Teng, TH; Lin, PY; Tu, SJ; Chou, CH; Huang, YR; Huang, WC; Weng, SL; Huang, HD; Chen, YL; Chen, WL				Tai, Chun-San; Lin, Yan-Ren; Teng, Tsung-Han; Lin, Ping-Yi; Tu, Siang-Jyun; Chou, Chih-Hung; Huang, Ya-Rong; Huang, Wei-Chih; Weng, Shun-Long; Huang, Hsien-Da; Chen, Yao-Li; Chen, Wen Liang			Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; SERUM HAPTOGLOBIN; FUCOSYLATED HAPTOGLOBIN; PANCREATIC-CANCER; BIOMARKER; PROTEIN; MARKER	Elevated serum haptoglobin (Hp) is identified as a prognostic marker in multiple types of solid tumors, which is correlated with poor prognosis. HCC is one of the major causes of cancer deaths in worldwide, which remains poor prognosis and is clinically urgent for discovering early diagnostic markers. However, except for serum Hp, the correlation of tumor Hp expression with hepatocellular carcinoma (HCC) progression is still unclear. In this study, we evaluated and identified the tissue Hp expression as a prognostic marker to predict the survival rate of HCC patients. To evaluate the prognostic value of Hp expression for HCC, two cohorts were enrolled in our study, including total 130 matched pair tissue sections (both adjacent non-tumorous and tumor tissue derived from same patient) of HCC patients from Changhua Christian Hospital (CCH) and total 316 RNA-seq data with clinical information of HCC patients from The Cancer Genome Atlas (TCGA) database. In contrast to other types of cancers, HCC tumor tissues have lower Hp protein expression in CCH cohort and have lower Hp mRNA expression in TCGA cohort as compared with adjacent non-tumorous tissues (p < 0.001). Moreover, lower Hp expression is significantly correlated with different stages of HCC cancer differentiation in CCH cohort (one-way ANOVA, p < 0.001). Most importantly, lower Hp expression is highly correlated with poor five-year overall survival rate in TCGA cohort (p < 0.01). Based on our data, we conclude that tissue Hp expression positively correlates with better HCC tumor differentiation and increased five-year overall survival rate of HCC patients. The results indicated that tissue Hp is potentially a prognostic marker for HCC patients. Our findings may further provide a new insight of effective treatments along with biopsy diagnosis of HCC patients.	[Tai, Chun-San; Huang, Hsien-Da; Chen, Wen Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Tai, Chun-San; Teng, Tsung-Han] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan; [Tai, Chun-San] Natl Chiao Tung Univ, Program Interdisciplinary Neurosci, Hsinchu, Taiwan; [Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Lin, Yan-Ren; Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Lin, Ping-Yi] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Tu, Siang-Jyun; Chou, Chih-Hung; Huang, Ya-Rong; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Weng, Shun-Long] Hsinchu MacKay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Weng, Shun-Long] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Kaohsiung Medical University; Chung Shan Medical University; Changhua Christian Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Changhua Christian Hospital	Huang, HD; Chen, WL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Chen, YL (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Huang, HD (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.; Chen, YL (corresponding author), Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan.	bryan@mail.nctu.edu.tw; ylchen.cch@gmail.com; wenurea@yahoo.com.tw	Huang, Hsien-Da/AAA-7376-2019; Chou, Chih-Hung/K-9077-2015; Lin, Yan-Ren/AAU-4136-2020	Chou, Chih-Hung/0000-0001-5714-1718; Lin, Yan-Ren/0000-0002-9015-2678	National Chiao Tung University; Changhua Christian Hospital; National Science Council [MOST 104-2314-B-371-010]; Hsinchu Mackay Memorial Hospital [MMH-HB-10506]	National Chiao Tung University; Changhua Christian Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Hsinchu Mackay Memorial Hospital	This study was supported by National Chiao Tung University, Changhua Christian Hospital, National Science Council (MOST 104-2314-B-371-010) Hsinchu Mackay Memorial Hospital (MMH-HB-10506). Both fundings sponsored this study in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bicho MC, 2013, ACUTE PHASE PROTEINS; Brunt Elizabeth M, 2012, Clin Liver Dis (Hoboken), V1, P194, DOI 10.1002/cld.98; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Chiba T, 2016, HEPATOL RES, V46, P50, DOI 10.1111/hepr.12548; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Dong PP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030320; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galicia G, 2011, HAPTOGLOBIN FUNCTION; Garibay-Cerdenares OL, 2015, CELL ADHES MIGR, V9, P394, DOI 10.1080/19336918.2015.1035504; Giannelli G, 2016, J HEPATOL; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Haas M, 2015, TUMOR BIOL, V36, P2631, DOI 10.1007/s13277-014-2885-x; Han K, 2016, WORLD J GASTROENTERO, V22, P407, DOI 10.3748/wjg.v22.i1.407; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Hoagland LFM, 2007, CANCER-AM CANCER SOC, V110, P2260, DOI 10.1002/cncr.23049; Lee CC, 2013, CLIN CHEM LAB MED, V51, P429, DOI 10.1515/cclm-2012-0197; Lu J, 2016, ONCOTARGET; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Schlageter M, 2014, WORLD J GASTROENTERO, V20, P15955, DOI 10.3748/wjg.v20.i43.15955; Shu H, 2010, ONCOL REP, V24, P1271, DOI 10.3892/or_00000982; Sun LC, 2016, INT J CANCER, V138, P2724, DOI 10.1002/ijc.29993; Tabassum U, 2012, ASIAN PAC J CANCER P, V13, P4541, DOI 10.7314/APJCP.2012.13.9.4541; Takeda Y, 2012, CANCER-AM CANCER SOC, V118, P3036, DOI 10.1002/cncr.26490; Team RC, 2015, R LANG ENV STAT COMP; Wang RH, 2016, ONCOTARGET, V7, P5754, DOI 10.18632/oncotarget.6805; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yu GR, 2007, EXP MOL MED, V39, P641, DOI 10.1038/emm.2007.70; Zhao CQ, 2007, NEOPLASIA, V9, P1, DOI 10.1593/neo.06619	33	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171269	10.1371/journal.pone.0171269	http://dx.doi.org/10.1371/journal.pone.0171269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158312	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700049
J	Xia, J; Cui, JQ; He, X; Liu, YY; Yao, KC; Cao, SJ; Han, XF; Huang, Y				Xia, Jing; Cui, Jia-Qi; He, Xiao; Liu, Yue-Yue; Yao, Ke-Chang; Cao, San-Jie; Han, Xin-Feng; Huang, Yong			Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013-2016	PLOS ONE			English	Article							HEMAGGLUTININ GENE; RECEPTOR-BINDING; VACCINE STRAIN; ACID; IDENTIFICATION; SELECTION; CLONING; FLOCKS	H9N2 avian influenza virus (AIV) has caused significant losses in chicken flocks throughout china in recent years. There is a limited understanding of the genetic and antigenic characteristics of the H9N2 virus isolated in chickens in southwestern China. In this study a total of 12 field strains were isolated from tissue samples from diseased chickens between 2013 and 2016. Phylogenetic analysis of the Hemagglutinin (HA) and Neuraminidase (NA) nucleotide sequences from the 12 field isolates and other reference strains showed that most of the isolates in the past four years could be clustered into a major branch (HA-branch A and NA-branch I) in the Clade h9.4.2 lineages. These sequences are accompanied by nine and seven new amino acids mutations in the HA and NA proteins, respectively, when compared with those previous to 2013. In addition, four new isolates were grouped into a minor branch (HA-branch B) in the Clade h9.4.2 lineages and two potential N-glycosylation sites were observed due to amino acid mutations in the HA protein. Three antigenic groups (1-3), which had low antigenic relatedness with two commonly used vaccines in China, were identified among the 12 isolates by antigenMap analysis. Immunoprotection testing showed that those two vaccines could efficiently prevent the shedding of branch A viruses but not branch B viruses. In conclusion, these results indicate the genotype of branch B may become epidemic in the next few years and that a new vaccine should be developed for the prevention of H9N2 AIV.	[Xia, Jing; Cui, Jia-Qi; He, Xiao; Liu, Yue-Yue; Yao, Ke-Chang; Cao, San-Jie; Han, Xin-Feng; Huang, Yong] Sichuan Agr Univ, Coll Vet Med, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Huang, Y (corresponding author), Sichuan Agr Univ, Coll Vet Med, Chengdu, Sichuan, Peoples R China.	hyong601@163.com						Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Chen F, 2012, VIRUS GENES, V45, P69, DOI 10.1007/s11262-012-0742-9; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Ge FF, 2016, ARCH VIROL, V161, P1437, DOI 10.1007/s00705-016-2767-1; Goto H, 2016, J VIROLOGY; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hassan KE, 2016, POULTRY SCI, V95, P1271, DOI 10.3382/ps/pew068; He J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P708, DOI 10.3760/cma.j.issn.0254-6450.2016.05.025; Huang YY, 2010, VIRUS RES, V151, P26, DOI 10.1016/j.virusres.2010.03.010; Huang YW, 2015, J MED VIROL, V87, P1641, DOI 10.1002/jmv.24231; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Lee CW, 2009, COMP IMMUNOL MICROB, V32, P301, DOI 10.1016/j.cimid.2008.01.007; Lee DH, 2013, CLIN EXP VACCINE RES, V2, P26, DOI 10.7774/cevr.2013.2.1.26; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li Qiuchun, 2010, Weishengwu Xuebao, V50, P1545; Liu Lin-Yu, 2014, Bing Du Xue Bao, V30, P109; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Marinova-Petkova A, 2016, AVIAN DIS, V60, P108, DOI 10.1637/11136-050815-Reg; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Okamatsu M, 2008, ARCH VIROL, V153, P2189, DOI 10.1007/s00705-008-0243-2; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Qi XF, 2016, VET RES, V47, DOI 10.1186/s13567-016-0322-4; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Shanmuganatham K, 2013, EMERGING INFECT DIS, V19; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Su S, 2015, J VIROL, V89, P8671, DOI 10.1128/JVI.01034-15; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Sun YP, 2015, PROTEIN CELL, V6, P18, DOI 10.1007/s13238-014-0111-7; Sun YP, 2012, VET MICROBIOL, V156, P193, DOI 10.1016/j.vetmic.2011.10.003; Sun YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015537; Wan ZM, 2014, J VIROL, V88, P3898, DOI 10.1128/JVI.03440-13; Wei YD, 2016, VET MICROBIOL, V182, P1, DOI 10.1016/j.vetmic.2015.10.031; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Wu ZQ, 2010, POULTRY SCI, V89, P1136, DOI 10.3382/ps.2010-00695; Xia J, 2016, INFECTION GENETICS E; Xu T, 2015, J GEN VIROL, V96, P2939, DOI 10.1099/jgv.0.000238; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020; Zhu YB, 2015, VET MICROBIOL, V178, P144, DOI 10.1016/j.vetmic.2015.04.012; Zou NL, 2010, VIRUS GENES, V41, P202, DOI 10.1007/s11262-010-0500-9	42	20	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171564	10.1371/journal.pone.0171564	http://dx.doi.org/10.1371/journal.pone.0171564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158271	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700100
J	Zuo, LH; Shang, AQ; Zhang, S; Yu, XY; Ren, YC; Yang, MS; Wang, JM				Zuo, Li-Hui; Shang, Ai-Qin; Zhang, Shuang; Yu, Xiao-Yue; Ren, Ya-Chao; Yang, Min-Sheng; Wang, Jin-Mao			The first complete chloroplast genome sequences of Ulmus species by de novo sequencing: Genome comparative and taxonomic position analysis	PLOS ONE			English	Article							DNA; PLANT; MITOCHONDRIAL; GENES; RATES	L Elm (Ulmus) has a long history of use as a high-quality heavy hardwood famous for its resistance to drought, cold, and salt. It grows in temperate, warm temperate, and subtropical regions. This is the first report of Ulmaceae chloroplast genomes by de novo sequencing. The Ulmus chloroplast genomes exhibited a typical quadripartite structure with two single-copy regions (long single copy [LSC] and short single copy [SSC] sections) separated by a pair of inverted repeats (IRs). The lengths of the chloroplast genomes from five Ulmus ranged from 158,953 to 159,453 bp, with the largest observed in Ulmus davidiana and the smallest in Ulmus laciniata. The genomes contained 137-145 protein-coding genes, of which Ulmus davidiana var. japonica and U. davidiana had the most and U. pumila had the fewest. The five Ulmus species exhibited different evolutionary routes, as some genes had been lost. In total, 18 genes contained introns, 13 of which (trnL-TAA(+), trnL-TAA(-), rpoC1(-), rpl2(-), ndhA(-), ycf1, rps12(-), rps12(+), trnA-TGC(+), trnA-TGC(-), trnV-TAC(-), trnl-GAT(+), and trnlGAT) were shared among all five species. The intron of ycf1 was the longest (5,675bp) while that of trnF-AAA was the smallest (53bp). All Ulmus species except U. davidiana exhibited the same degree of amplification in the IR region. To determine the phylogenetic positions of the Ulmus species, we performed phylogenetic analyses using common protein-coding genes in chloroplast sequences of 42 other species published in NCBI. The cluster results showed the closest plants to Ulmaceae were Moraceae and Cannabaceae, followed by Rosaceae. Ulmaceae and Moraceae both belonged to Urticales, and the chloroplast genome clustering results were consistent with their traditional taxonomy. The results strongly supported the position of Ulmaceae as a member of the order Urticales. In addition, we found a potential error in the traditional taxonomies of U. davidiana and U. davidiana var. japonica, which should be confirmed with a further analysis of their nuclear genomes. This study is the first report on Ulmus chloroplast genomes, which has significance for understanding photosynthesis, evolution, and chloroplast transgenic engineering.	[Zuo, Li-Hui; Zhang, Shuang; Yu, Xiao-Yue; Ren, Ya-Chao; Yang, Min-Sheng; Wang, Jin-Mao] Agr Univ Hebei, Inst Forest Biotechnol, Coll Forestry, Baoding, Peoples R China; [Zuo, Li-Hui; Zhang, Shuang; Yu, Xiao-Yue; Ren, Ya-Chao; Yang, Min-Sheng; Wang, Jin-Mao] Hebei Key Lab Tree Genet Resources & Forest Prote, Baoding, Peoples R China; [Shang, Ai-Qin] Agr Univ Hebei, Hort Coll, Baoding, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Yang, MS; Wang, JM (corresponding author), Agr Univ Hebei, Inst Forest Biotechnol, Coll Forestry, Baoding, Peoples R China.; Yang, MS; Wang, JM (corresponding author), Hebei Key Lab Tree Genet Resources & Forest Prote, Baoding, Peoples R China.	yangms100@126.com; swjs224@aliyun.com		Zuo, lihui/0000-0002-3633-2088				BEDBROOK JR, 1976, P NATL ACAD SCI USA, V73, P4309, DOI 10.1073/pnas.73.12.4309; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Conde P, 2008, PLANT CELL TISS ORG, V92, P113, DOI 10.1007/s11240-007-9310-8; Dias MC, 2013, ACTA PHYSIOL PLANT, V35, P1281, DOI 10.1007/s11738-012-1167-8; Goremykin VV, 2012, PLANT J, V71, P615, DOI 10.1111/j.1365-313X.2012.05014.x; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Ni LH, 2016, GENE, V577, P281, DOI 10.1016/j.gene.2015.12.005; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Revanna KV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-316; RIS H, 1962, J CELL BIOL, V13, P383, DOI 10.1083/jcb.13.3.383; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tian Xin, 2002, Acta Botanica Yunnanica, V24, P170; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00280; Wiegrefe SJ, 1998, PLANT SYST EVOL, V210, P249, DOI 10.1007/BF00985671; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zhang XW, 2010, PLOS ONE, V5; [赵静静 Zhao Jingjing], 2010, [食品与生物技术学报, Journal of Food Science and Biotechnology], V29, P755	35	53	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							E0171264	10.1371/journal.pone.0171264	http://dx.doi.org/10.1371/journal.pone.0171264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158318	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700048
J	Pavkov-Keller, T; Steiner, K; Faber, M; Tengg, M; Schwab, H; Gruber-Khadjawi, M; Gruber, K				Pavkov-Keller, Tea; Steiner, Kerstin; Faber, Mario; Tengg, Martin; Schwab, Helmut; Gruber-Khadjawi, Mandana; Gruber, Karl			Crystal Structure and Catalytic Mechanism of CouO, a Versatile C-Methyltransferase from Streptomyces rishiriensis	PLOS ONE			English	Article							PROTEIN; METHYLATION; DISCOVERY; FEATURES	Friedel-Crafts alkylation of aromatic systems is a classic reaction in organic chemistry, for which regiospecific mono-alkylation, however, is generally difficult to achieve. In nature, methyltransferases catalyze the addition of methyl groups to a wide range of biomolecules thereby modulating the physico-chemical properties of these compounds. Specifically, S-adenosyl- L-methionine dependent C-methyltransferases possess a high potential to serve as biocatalysts in environmentally benign organic syntheses. Here, we report on the high resolution crystal structure of CouO, a C-methyltransferase from Streptomyces rishiriensis involved in the biosynthesis of the antibiotic coumermycin A1. Through molecular docking calculations, site-directed mutagenesis and the comparison with homologous enzymes we identified His120 and Arg121 as key functional residues for the enzymatic activity of this group of C-methyltransferases. The elucidation of the atomic structure and the insight into the catalytic mechanism provide the basis for the (semi)-rational engineering of the enzyme in order to increase the substrate scope as well as to facilitate the acceptance of SAM-analogues as alternative cofactors.	[Pavkov-Keller, Tea; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [Pavkov-Keller, Tea; Steiner, Kerstin; Tengg, Martin; Schwab, Helmut; Gruber-Khadjawi, Mandana; Gruber, Karl] Austrian Ctr Ind Biotechnol GmbH, ACIB, Graz, Austria; [Faber, Mario; Tengg, Martin; Schwab, Helmut] Graz Univ Technol, Inst Mol Biotechnol, Graz, Austria; [Faber, Mario; Gruber-Khadjawi, Mandana] Graz Univ Technol, Inst Organ Chem, Graz, Austria	University of Graz; Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology	Gruber, K (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.; Gruber, K (corresponding author), Austrian Ctr Ind Biotechnol GmbH, ACIB, Graz, Austria.	karl.gruber@uni-graz.at	Gruber, Karl/GPP-6706-2022; Pavkov-Keller, Tea/K-9234-2015	Gruber, Karl/0000-0002-3485-9740; Pavkov-Keller, Tea/0000-0001-7871-6680	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET Funding Program; Austrian Science Fund (FWF) [P24135]; Austrian Science Fund (FWF) [P 24135] Funding Source: researchfish	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; Government of Lower Austria; Business Agency Vienna through the COMET Funding Program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been supported by the Federal Ministry of Science, Research and Economy (BMWFW, http://www.bmwfw.gv.at/), the Federal Ministry of Traffic, Innovation and Technology (bmvit, https://www.bmvit.gv.at/), the Styrian Business Promotion Agency (SFG, https://www.sfg.at/), the Standortagentur Tirol (https://www.standort-tirol.at), the Government of Lower Austria (http://www.noe.gv.at/) and Business Agency Vienna (https://wirtschattsagentur.at/) through the COMET Funding Program managed by the Austrian Research Promotion Agency (FFG, https://www.ffg.at/). MGK. and KG. acknowledge financial support from the Austrian Science Fund (FWF, https://www.fwf.ac.at/) through project P24135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai YN, 2014, ACTA CRYSTALLOGR D, V70, P2085, DOI 10.1107/S1399004714011559; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kim J, 2013, NATURE, V498, P123, DOI 10.1038/nature12180; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laurino P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002396; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Liscombe DK, 2012, NAT PROD REP, V29, P1238, DOI 10.1039/c2np20029e; Lyskowski A, 2012, ACTA CRYSTALLOGR F, V68, P698, DOI 10.1107/S1744309112017137; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pacholec M, 2005, BIOCHEMISTRY-US, V44, P14969, DOI 10.1021/bi051599o; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Siegrist J, 2015, CHEMBIOCHEM, V16, P2576, DOI 10.1002/cbic.201500410; Stecher H, 2009, ANGEW CHEM INT EDIT, V48, P9546, DOI 10.1002/anie.200905095; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; Tengg M, 2016, CHEMCATCHEM, V8, P1354, DOI 10.1002/cctc.201501306; Tengg M, 2012, J MOL CATAL B-ENZYM, V84, P2, DOI 10.1016/j.molcatb.2012.03.016; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wessjohann L, 2014, CASCADE BIOCATALYSIS: INTEGRATING STEREOSELECTIVE AND ENVIRONMENTALLY FRIENDLY REACTIONS, P393; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	37	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171056	10.1371/journal.pone.0171056	http://dx.doi.org/10.1371/journal.pone.0171056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152088	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200080
J	Kudo, M; Kobayashi-Nakamura, K; Tsuji-Naito, K				Kudo, Michiko; Kobayashi-Nakamura, Kumiko; Tsuji-Naito, Kentaro			Bifunctional effects of O-methylated flavones from Scutellaria baicalensis Georgi on melanocytes: Inhibition of melanin production and intracellular melanosome transport	PLOS ONE			English	Article							PROTEIN; SKIN; ANTIOXIDANT; RADIX; MITF; SLAC2-A/MELANOPHILIN; MELANOGENESIS; PIGMENTATION; DEGRADATION; TYROSINASE	The growing interest in skin lightening has recently renewed attention on the esthetic applications of Chinese herbal medicine. Although Scutellaria baicalensis Georgi is used for antipyretic and antiinflammatory purposes, its whitening effect remains unclear. This study reports three major findings: (1) S. baicalensis has a potent inhibitory effect on melanogenesis; (2) wogonin and its glycoside are the active components of S. baicalensis; and (3) O-methylated flavones from S. baicalensis, such as wogonin, inhibit intracellular melanosome transport. Using a melanin quantification assay, we showed that S. baicalensis potently inhibits melanogenesis in B16F10 cells. Componential analyses revealed that the main components of S. baicalensis are baicalin, wogonoside, baicalein, wogonin, and oroxylin A. Among these five flavones, wogonin and wogonoside consistently inhibited melanogenesis in both B16F10 melanoma cells and primary melanocytes. Wogonin exhibited the strongest inhibition of melanin production and markedly lightened the color of skin equivalents. We identified microphthalmia-associated transcription factor and tyrosinase-related proteins as potential targets of wogonin- and wogonoside-induced melanogenesis suppression. In culture, we found that the melanosomes in wogonin-treated B16F10 cells were localized to the perinuclear region. Immunoblotting analyses revealed that wogonin significantly reduced in melanophilin protein, which is required for actin-based melanosome transport. Other actin-based melanosome transport-related molecules, i.e., Rab27A and myosin Va, were not affected by wogonin. Cotreatment with MG132 blocked the wogonin-induced decrease in melanophilin, suggesting that wogonin promotes the proteolytic degradation of melanophilin via the calpain/proteasomal pathway. We determined that the structural specificities of the mono-O-methyl group in the flavone A-ring and the aglycone form were responsible for reducing melanosome transport. Furthermore, wogonin and two wogonin analogs, mono-O-methyl flavones, strongly suppressed melanosome transport. Our findings suggest the applicability of S. baicalensis in the esthetic field. Thus, we propose a novel pharmacologic approach for the treatment of hyperpigmentation.	[Kudo, Michiko; Kobayashi-Nakamura, Kumiko; Tsuji-Naito, Kentaro] DHC Corp, Fundamental Res Dept, Fundamental Res Lab, Chiba, Japan		Tsuji-Naito, K (corresponding author), DHC Corp, Fundamental Res Dept, Fundamental Res Lab, Chiba, Japan.	knaito@dhc.co.jp		Naito, Kentaro/0000-0001-5247-7159; Kobayashi-Nakamura, Kumiko/0000-0001-5579-3464	research grant from DHC Corporation	research grant from DHC Corporation	This work was supported by a research grant from DHC Corporation (http://top.dhc.co.jp/company/en/index.html). MK, KKN, and KTN are employed by DHC Corporation. The funder provided support in the form of salaries for authors MK, KKN, and KTN, but did not haveany additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; BENNETT DC, 1990, DEVELOPMENT, V110, P471; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Chang H, 2012, PIGM CELL MELANOMA R, V25, P765, DOI 10.1111/pcmr.12002; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Chiaverini C, 2008, J BIOL CHEM, V283, P12635, DOI 10.1074/jbc.M800130200; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Gao ZH, 1999, BBA-GEN SUBJECTS, V1472, P643, DOI 10.1016/S0304-4165(99)00152-X; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hata Y, 2009, Japan Patent Kokai, Patent No. [2009-294615, 2009294615]; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Itakura K, 2014, Japanese Patent, Patent No. 5507866; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Kang YG, 2011, EXP DERMATOL, V20, P445, DOI 10.1111/j.1600-0625.2010.01236.x; Kondo Taisuke, 2011, Expert Rev Dermatol, V6, P97, DOI 10.1586/edm.10.70; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; LIU XF, 1990, MOL PHARMACOL, V37, P911; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Palmisano I, 2008, HUM MOL GENET, V17, P3487, DOI 10.1093/hmg/ddn241; Pan L, 2015, CELL PROLIFERAT, V48, P631, DOI 10.1111/cpr.12227; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Tsuji-Naito K, 2007, BIOORGAN MED CHEM, V15, P1967, DOI 10.1016/j.bmc.2006.12.042; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu X, 2016, ONCOTARGETS THER, V9, P2935, DOI 10.2147/OTT.S105586; Xiao JR, 2014, J OCUL PHARMACOL TH, V30, P605, DOI 10.1089/jop.2014.0074; Yajima I, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/730170; Zhao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106458	44	21	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171513	10.1371/journal.pone.0171513	http://dx.doi.org/10.1371/journal.pone.0171513			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182699	gold, Green Submitted, Green Published			2022-12-27	WOS:000394231800067
J	Zhang, SW; Liu, Y; Wang, F; Qiang, J; Liu, P; Zhang, J; Xu, JW				Zhang, Shuang-Wei; Liu, Yu; Wang, Fang; Qiang, Jiao; Liu, Pan; Zhang, Jun; Xu, Jin-Wen			Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway	PLOS ONE			English	Article							TRITERPENE SAPONINS; PROTECTS; ROOTS; CARDIOPROTECTION; MECHANISMS; FRACTION; HEART	The protective effects of ilexsaponin A on ischemia-reperfusion-induced myocardial injury were investigated. Myocardial ischemia/reperfusion model was established in male Sprague-Dawley rats. Myocardial injury was evaluated by TTC staining and myocardial marker enzyme leakage. The in vitro protective potential of Ilexsaponin A was assessed on hypoxia/reoxygenation cellular model in neonatal rat cardiomyocytes. Cellular viability and apoptosis were evaluated by MTT and TUNEL assay. Caspase-3, cleaved caspase-3, bax, bcl2, p-Akt and Akt protein expression levels were detected by western-blot. Ilexsaponin A treatment was able to attenuate the myocardial injury in ischemia/reperfusion model by reducing myocardial infarct size and lower the serum levels of LDH, AST and CK-MB. The in vitro study also showed that ilexsaponin A treatment could increase cellular viability and inhibit apoptosis in hypoxia/reoxygenation cardiomyocytes. Proapoptotic proteins including caspase-3, cleaved caspase-3 and bax were significantly reduced and anti-apoptotic protein bcl-2 was significantly increased by ilexsaponin A treatment in hypoxia/reoxygenation cardiomyocytes. Moreover, Ilexsaponin A treatment was able to increase the expression levels of p-Akt in hypoxia/reoxygenation cellular model and myocardial ischemia/reperfusion animal model. Coupled results from both in vivo and in vitro experiments indicate that Ilexsaponin A attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.	[Zhang, Shuang-Wei] Guangzhou Med Univ, Affiliated Hosp 2, Changgang East Rd, Guangzhou, Guangdong, Peoples R China; [Liu, Yu; Wang, Fang; Qiang, Jiao; Liu, Pan; Zhang, Jun; Xu, Jin-Wen] Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Jin-Wen] Guangzhou Univ Chinese Med, Basic Med Coll, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Zhang, J; Xu, JW (corresponding author), Guangzhou Univ Chinese Med, Sch Chinese Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.; Xu, JW (corresponding author), Guangzhou Univ Chinese Med, Basic Med Coll, Guangzhou, Guangdong, Peoples R China.	zhangjun@gzucm.edu.cn; xujinwen@gzucm.edu.cn						Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bassino E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119790; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Dou MY, 2016, EUR J PHARMACOL, V789, P395, DOI 10.1016/j.ejphar.2016.08.002; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Duerr GD, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0425-x; Farrow SN, 1996, CURR OPIN GENET DEV, V6, P45, DOI 10.1016/S0959-437X(96)90009-X; Gao C, 2015, AM J PHYSIOL-HEART C, V308, pH1583, DOI 10.1152/ajpheart.00346.2014; Hai-Mei L, 2013, J CARDIOVASC PHARM, V62, P154, DOI 10.1097/FJC.0b013e31829497ea; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Jennings RB, 2013, CIRC RES, V113, P428, DOI 10.1161/CIRCRESAHA.113.300987; Jiang ZH, 2005, J NAT PROD, V68, P397, DOI 10.1021/np049735y; Li Q, 2016, BIOMED PHARMACOTHER, V84, P106, DOI 10.1016/j.biopha.2016.09.014; Liu CW, 2016, CARDIOVASC THER; Oikawa M, 2013, J MOL CELL CARDIOL, V64, P11, DOI 10.1016/j.yjmcc.2013.08.003; Rafiq K, 2014, CIRCULATION, V129, P2031, DOI 10.1161/CIRCULATIONAHA.113.007004; Singh SS, 2011, CURR PHARM DESIGN, V17, P1783; Vander Heide RS, 2013, CIRC RES, V113, P464, DOI 10.1161/CIRCRESAHA.113.300765; Wang JR, 2008, BIOL PHARM BULL, V31, P643, DOI 10.1248/bpb.31.643; Wang JR, 2008, CHEM BIODIVERS, V5, P1369, DOI 10.1002/cbdv.200890125; Wetzker R, 2004, CURR PHARM DESIGN, V10, P1915, DOI 10.2174/1381612043384402; Wu T, 2012, NAT PROD RES, V26, P1408, DOI 10.1080/14786419.2011.598155; Yang X, 2006, J ASIAN NAT PROD RES, V8, P505, DOI 10.1080/10286020500176344; Yang Y, 2013, CELL SIGNAL, V25, P615, DOI 10.1016/j.cellsig.2012.11.025; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu LM, 2015, APOPTOSIS, V20, P796, DOI 10.1007/s10495-015-1122-4; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014; Zhao WM, 1996, PHYTOCHEMISTRY, V42, P1131, DOI 10.1016/0031-9422(96)00086-6; Zhou YB, 2008, CHINESE CHEM LETT, V19, P550, DOI 10.1016/j.cclet.2008.03.017; Zhou Y, 2014, FITOTERAPIA, V97, P98, DOI 10.1016/j.fitote.2014.05.020; Zhou Y, 2013, PLANTA MED, V79, P70, DOI 10.1055/s-0032-1327927	32	21	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170984	10.1371/journal.pone.0170984	http://dx.doi.org/10.1371/journal.pone.0170984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182689	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800026
J	Zuo, XR; Chan, LS; Gao, JF				Zuo, Xuran; Chan, Lung Sang; Gao, Jian-Feng			Compression-extension transition of continental crust in a subduction zone: A parametric numerical modeling study with implications on Mesozoic-Cenozoic tectonic evolution of the Cathaysia Block	PLOS ONE			English	Article							SOUTH CHINA; SPATIAL-DISTRIBUTION; MARGIN TECTONICS; RHEOLOGY; INSIGHTS; INITIATION; BASIN; LITHOSPHERE; DEFORMATION; DYNAMICS	The Cathaysia Block is located in southeastern part of South China, which situates in the west Pacific subduction zone. It is thought to have undergone a compression-extension transition of the continental crust during Mesozoic-Cenozoic during the subduction of Pacific Plate beneath Eurasia-Pacific Plate, resulting in extensive magmatism, extensional basins and reactivation of fault systems. Although some mechanisms such as the trench roll-back have been generally proposed for the compression-extension transition, the timing and progress of the transition under a convergence setting remain ambiguous due to lack of suitable geological records and overprinting by later tectonic events. In this study, a numerical thermo-dynamical program was employed to evaluate how variable slab angles, thermal gradients of the lithospheres and convergence velocities would give rise to the change of crustal stress in a convergent subduction zone. Model results show that higher slab dip angle, lower convergence velocity and higher lithospheric thermal gradient facilitate the subduction process. The modeling results reveal the continental crust stress is dominated by horizontal compression during the early stage of the subduction, which could revert to a horizontal extension in the back-arc region, combing with the roll-back of the subducting slab and development of mantle upwelling. The parameters facilitating the subduction process also favor the compression-extension transition in the upper plate of the subduction zone. Such results corroborate the geology of the Cathaysia Block: the initiation of the extensional regime in the Cathaysia Block occurring was probably triggered by roll-back of the slowly subducting slab.	[Zuo, Xuran; Chan, Lung Sang] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Gao, Jian-Feng] Chinese Acad Sci, Inst Geochem, State Key Lab Ore Deposit Geochem, Guiyang, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS	Zuo, XR (corresponding author), Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China.	xuran.zuo@gmail.com	Gao, Jianfeng/L-7385-2019	Gao, Jianfeng/0000-0002-0553-025X; Zuo, Xuran/0000-0003-0549-7039	University of Hong Kong; Total Oil and Gas Company; Hundred Talent Program of Chinese Academy of Sciences	University of Hong Kong(University of Hong Kong); Total Oil and Gas Company; Hundred Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	Xuran Zuo was supported by The University of Hong Kong and a grant from Total Oil and Gas Company while working on the project. Jian-Feng Gao was supported by the Hundred Talent Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; XZ wants to thank Prof. Evgeni Burov for providing the modeling code and modeling training during her master's study. We want to express our condolences to his decease months ago, which is a great loss to geodynamic modeling research. XZ also wants to express her gratitude to the University of Hong Kong for providing a 4-year-long PhD scholarship that made this study possible.	Angiboust S, 2012, EARTH PLANET SC LETT, V357, P238, DOI 10.1016/j.epsl.2012.09.012; Atwater T., 1970, GEOL SOC AM BULL, V81, P3513, DOI [DOI 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2, 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2]; Avouac JP, 1996, J GEOPHYS RES-SOL EA, V101, P17747, DOI 10.1029/96JB01344; Baitsch-Ghirardello B, 2014, GONDWANA RES, V25, P546, DOI 10.1016/j.gr.2012.11.003; BARAZANGI M, 1976, GEOLOGY, V4, P686, DOI 10.1130/0091-7613(1976)4<686:SDOEAS>2.0.CO;2; Beaumont C, 1999, J GEOPHYS RES-SOL EA, V104, P17573, DOI 10.1029/1999JB900136; Becker TW, 1999, J GEOPHYS RES-SOL EA, V104, P15207, DOI 10.1029/1999JB900140; Bercovici D, 2001, J GEOPHYS RES-SOL EA, V106, P8925, DOI 10.1029/2000JB900432; Burov E, 1997, EARTH PLANET SC LETT, V150, P7, DOI 10.1016/S0012-821X(97)00069-1; Burov EB, 2011, MAR PETROL GEOL, V28, P1402, DOI 10.1016/j.marpetgeo.2011.05.008; Burov E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041535; Burov E, 2009, GEOPHYS J INT, V178, P1691, DOI 10.1111/j.1365-246X.2009.04238.x; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Capitanio FA, 2014, TECTONICS; Chen CH, 2008, LITHOS, V106, P83, DOI 10.1016/j.lithos.2008.06.009; CLOETINGH SAPL, 1982, NATURE, V297, P139, DOI 10.1038/297139a0; CLOETINGH SAPL, 1984, TECTONOPHYSICS, V109, P147, DOI 10.1016/0040-1951(84)90175-6; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; CUNDALL PA, 1989, ING ARCH, V59, P148, DOI 10.1007/BF00538368; ERICKSON SG, 1993, GEOLOGY, V21, P125, DOI 10.1130/0091-7613(1993)021<0125:SLLFAS>2.3.CO;2; Faccenda M, 2008, LITHOS, V103, P257, DOI 10.1016/j.lithos.2007.09.009; Faccenna C, 1999, J GEOPHYS RES-SOL EA, V104, P2749, DOI 10.1029/1998JB900072; Feldstein SN, 1999, J PETROL, V40, P1301, DOI 10.1093/petrology/40.8.1301; Francois T, 2012, TECTONOPHYSICS; Gerbault M, 1998, J STRUCT GEOL, V20, P301, DOI 10.1016/S0191-8141(97)00089-8; Gerya TV, 2011, J METAMORPH GEOL, V29, P7, DOI 10.1111/j.1525-1314.2010.00904.x; GILDER SA, 1991, TECTONOPHYSICS, V197, P225, DOI 10.1016/0040-1951(91)90043-R; GOETZE C, 1979, GEOPHYS J ROY ASTR S, V59, P463, DOI 10.1111/j.1365-246X.1979.tb02567.x; HAGER BH, 1978, TECTONOPHYSICS, V50, P111, DOI 10.1016/0040-1951(78)90130-0; Handy MR, 1996, GEOL RUNDSCH, V85, P832, DOI 10.1007/s005310050115; Heuret A, 2005, PHYS EARTH PLANET IN, V149, P31, DOI 10.1016/j.pepi.2004.08.022; Heuret A., 2005, DYNAMIQUE ZONES SUBD; Hole M.J., 1994, GEOLOGICAL SOC LONDO, V81, P265, DOI DOI 10.1144/GSL.SP.1994.081.01.15; Huet B, 2011, GEOPHYS J INT, V184, P611, DOI 10.1111/j.1365-246X.2010.04849.x; Huismans RS, 2001, J GEOPHYS RES-SOL EA, V106, P11271, DOI 10.1029/2000JB900424; Jabaloy A, 2003, TECTONOPHYSICS, V366, P55, DOI 10.1016/S0040-1951(03)00060-X; JARRARD RD, 1986, REV GEOPHYS, V24, P217, DOI 10.1029/RG024i002p00217; JORDAN TE, 1983, GEOL SOC AM BULL, V94, P341, DOI 10.1130/0016-7606(1983)94<341:ATRTGO>2.0.CO;2; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Lallemand S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000917; Lallemand S., 2009, SUBDUCTION ZONE GEOD; LARSON RL, 1972, GEOL SOC AM BULL, V83, P3645, DOI 10.1130/0016-7606(1972)83[3645:WCOMMA]2.0.CO;2; Li JH, 2014, EARTH-SCI REV, V134, P98, DOI 10.1016/j.earscirev.2014.03.008; Li ZX, 2012, TECTONOPHYSICS, V532, P271, DOI 10.1016/j.tecto.2012.02.011; Ludmann T, 1999, TECTONOPHYSICS, V311, P113, DOI 10.1016/S0040-1951(99)00155-9; MA XY, 1987, TECTONOPHYSICS, V133, P243, DOI 10.1016/0040-1951(87)90268-X; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; MCCAFFREY R, 1995, SCIENCE, V267, P856, DOI 10.1126/science.267.5199.856; NORTHRUP CJ, 1995, GEOLOGY, V23, P719, DOI 10.1130/0091-7613(1995)023<0719:MOTPPR>2.3.CO;2; PEARCE JA, 1995, ANNU REV EARTH PL SC, V23, P251, DOI 10.1146/annurev.ea.23.050195.001343; Pfiffner OA, 2000, TECTONICS, V19, P1065, DOI 10.1029/2000TC900019; RANALLI G, 1987, TECTONOPHYSICS, V132, P281, DOI 10.1016/0040-1951(87)90348-9; Ranalli G., 1995, RHEOLOGY EARTH; Ren JY, 2002, TECTONOPHYSICS, V344, P175, DOI 10.1016/S0040-1951(01)00271-2; RUFF L, 1980, PHYS EARTH PLANET IN, V23, P240, DOI 10.1016/0031-9201(80)90117-X; Shao JA, 2001, ACTA GEOL SIN-ENGL, V75, P1; SHEA WT, 1992, J GEOPHYS RES-SOL EA, V97, P15201, DOI 10.1029/92JB00620; Shu LS, 2009, J ASIAN EARTH SCI, V34, P376, DOI 10.1016/j.jseaes.2008.06.004; Shu LS, 2007, ACTA GEOL SIN-ENGL, V81, P573; SIMPSON EL, 1989, GEOL SOC AM BULL, V101, P42, DOI 10.1130/0016-7606(1989)101<0042:SOTUFI>2.3.CO;2; Solomatov VS, 2000, J GEOPHYS RES-SOL EA, V105, P21795, DOI 10.1029/2000JB900197; STOCKMAL GS, 1986, AAPG BULL, V70, P181; Tamura Y, 2002, EARTH PLANET SC LETT, V197, P105, DOI 10.1016/S0012-821X(02)00465-X; Thielmann M, 2012, EARTH PLANET SC LETT, V359, P1, DOI 10.1016/j.epsl.2012.10.002; TIAN ZY, 1992, TECTONOPHYSICS, V208, P341, DOI 10.1016/0040-1951(92)90354-9; Tirel C, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2005JB003694; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Wang YJ, 2013, GONDWANA RES, V23, P1273, DOI 10.1016/j.gr.2012.02.019; WILKS KR, 1990, TECTONOPHYSICS, V182, P57, DOI 10.1016/0040-1951(90)90342-6; WOODS MT, 1982, EARTH PLANET SC LETT, V58, P161, DOI 10.1016/0012-821X(82)90191-1; XU JW, 1987, TECTONOPHYSICS, V134, P273, DOI 10.1016/0040-1951(87)90342-8; Yamato P, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004441; Yamato P, 2008, EARTH PLANET SC LETT, V271, P63, DOI 10.1016/j.epsl.2008.03.049; Yamato P, 2006, CONTRAINTES ZONES CO; YU HS, 1990, TECTONOPHYSICS, V183, P177, DOI 10.1016/0040-1951(90)90415-5; Zhou XM, 2006, EPISODES, V29, P26, DOI 10.18814/epiiugs/2006/v29i1/004; Zhou XM, 2000, TECTONOPHYSICS, V326, P269, DOI 10.1016/S0040-1951(00)00120-7; Zhu G, 2005, J STRUCT GEOL, V27, P1379, DOI 10.1016/j.jsg.2005.04.007; Zuo X., 2015, ACTIVE PASSIVE MARGI	80	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171536	10.1371/journal.pone.0171536	http://dx.doi.org/10.1371/journal.pone.0171536			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182640	gold, Green Published, Green Submitted			2022-12-27	WOS:000394231800071
J	Awadasseid, A; Hou, J; Gamallat, Y; Shang, XQ; Eugene, KD; Hago, AM; Bamba, D; Meyiah, A; Gift, C; Xin, Y				Awadasseid, Annoor; Hou, Jie; Gamallat, Yaser; Shang Xueqi; Eugene, Kuugbee D.; Hago, Ahmed Musa; Bamba, Djibril; Meyiah, Abdo; Gift, Chiwala; Xin, Yi			Purification, characterization, and antitumor activity of a novel glucan from the fruiting bodies of Coriolus Versicolor	PLOS ONE			English	Article							PSK INDUCES APOPTOSIS; BETA-GLUCANS; STRUCTURAL ELUCIDATION; POLYSACCHARIDES; CANCER; MUSHROOM; EXTRACTION; ANTIOXIDANT; CELLS	Cancer is one of the most common causes of deaths worldwide. Herein, we report an efficient natural anticancer glucan (CVG) extracted from Coriolus Versicolar (CV). CVG was extracted by the hot water extraction method followed by ethanol precipitation and purified using gas exclusion chromatography. Structural analysis revealed that CVG has a linear aglucan chain composed of only (1 -> 6)-alpha-D-Glcp. The antitumor activity of CVG on Sarcoma -180 cells was investigated in vitro and in vivo. Mice were treated with three doses of CVG (40, 100, 200 mg/kg body weight) for 9 days. Tumor weight, relative spleen, thymus weight, and lymphocyte proliferation were studied. A significant increase (P< 0.01) in relative spleen and thymus weight and a decrease (P< 0.01) in tumor weight at the doses of 100 and 200 mg/kg were observed. The results obtained demonstrate CVG has antitumor activity towards Sarcoma -180 cells by its immunomodulation activity.	[Awadasseid, Annoor; Hou, Jie; Gamallat, Yaser; Shang Xueqi; Eugene, Kuugbee D.; Bamba, Djibril; Meyiah, Abdo; Gift, Chiwala; Xin, Yi] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China; [Awadasseid, Annoor] Northeast Normal Univ, Dept Biochem & Mol Biol, Changchun, Peoples R China; [Awadasseid, Annoor] Univ Kordofan, Dept Biochem & Food Sci, Al Ubayyid, Sudan; [Hago, Ahmed Musa] Dalian Med Univ, Dept Pathol & Pathophysiol, Dalian, Peoples R China	Dalian Medical University; Northeast Normal University - China; Dalian Medical University	Xin, Y (corresponding author), Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China.	jimxin@hotmail.com	Gamallat, Yaser/C-4157-2016; Bakheet, Ahmed/GMW-6033-2022; AWADASSEID, ANNOOR/ABB-6146-2020	Gamallat, Yaser/0000-0001-9980-2107; Bakheet, Ahmed/0000-0002-1016-2594; 	Science and Technology Department Program of Liaoning Province of China [2,011,225,013]	Science and Technology Department Program of Liaoning Province of China	This work was supported by the Science and Technology Department Program of Liaoning Province of China (2,011,225,013).	Aguirre MJ, 2009, CARBOHYD RES, V344, P1095, DOI 10.1016/j.carres.2009.03.024; Al-Fatimi Mohamed, 2016, Medicines (Basel), V3, DOI 10.3390/medicines3020010; Apaya MK, 2016, PHARMACOL THERAPEUT, V162, P58, DOI 10.1016/j.pharmthera.2016.03.001; Baeg IH, 2013, J GINSENG RES, V37, P1, DOI 10.5142/jgr.2013.37.1; Bi H, 2011, COMPLEMENTARY ALTERN, V2011; Casey SC, 2014, IMMUNOL RES, V58, P282, DOI 10.1007/s12026-014-8503-6; Castro P, 2016, WORLD SUSTAIN SER, P13, DOI 10.1007/978-3-319-32318-3_2; Choi Deok-Gyun, 2016, Journal of Ecology and Environment, V39, P81, DOI 10.5141/ecoenv.2016.009; Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004; Cui T, 2003, BIOTECHNOL ADV, V21, P109, DOI 10.1016/S0734-9750(03)00002-8; Ferreira SS, 2015, CARBOHYD POLYM, V132, P378, DOI 10.1016/j.carbpol.2015.05.079; Hirahara N, 2012, ANTICANCER RES, V32, P2631; Hirahara N, 2011, ANTICANCER RES, V31, P2733; Huang F, 2014, MOLECULES, V19, P3909, DOI 10.3390/molecules19043909; Ito G, 2012, EXP THER MED, V3, P925, DOI 10.3892/etm.2012.537; Jang SA, 2011, BIOMOL THER, V19, P438, DOI 10.4062/biomolther.2011.19.4.438; Jeff IB, 2016, CENT EUR J IMMUNOL, V41, P47, DOI 10.5114/ceji.2015.56962; Jia XJ, 2015, MOLECULES, V20, P20901, DOI 10.3390/molecules201119734; Kaviyarasan V., 2014, Proceedings of 8th International Conference on Mushroom Biology and Mushroom Products (ICMBMP8), New Delhi, India, 19-22 November 2014. Volume I & II, P385; Kodama Noriko, 2003, Journal of Medicinal Food, V6, P371, DOI 10.1089/109662003772519949; Kowalczewska M, 2016, IMMUNOL LETT, V174, P37, DOI 10.1016/j.imlet.2016.04.010; Li F, 2009, CARBOHYD POLYM, V78, P80, DOI 10.1016/j.carbpol.2009.04.005; Lili Z, 2013, AFRICAN J PHARM PHAR, V7, P721; Lim BO, 2011, PHYTOTHER RES, V25, P1257, DOI 10.1002/ptr.3378; Lu MK, 2010, FOOD CHEM, V118, P349, DOI 10.1016/j.foodchem.2009.04.126; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Luo KW, 2014, PHYTOMEDICINE, V21, P1078, DOI 10.1016/j.phymed.2014.04.020; Luo X, 2008, FOOD CHEM, V111, P357, DOI 10.1016/j.foodchem.2008.03.076; Mondal S, 2004, CARBOHYD RES, V339, P1135, DOI 10.1016/j.carres.2004.02.019; Moradali MF, 2007, INT IMMUNOPHARMACOL, V7, P701, DOI 10.1016/j.intimp.2007.01.008; Ni WH, 2009, CARBOHYD RES, V344, P2512, DOI 10.1016/j.carres.2009.08.042; Novak M, 2008, J IMMUNOTOXICOL, V5, P47, DOI 10.1080/15476910802019045; Ren DY, 2015, CHEM-BIOL INTERACT, V237, P166, DOI 10.1016/j.cbi.2015.06.017; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Ringo E, 2016, AQUACULT NUTR, V22, P4, DOI 10.1111/anu.12349; Ruthes AC, 2016, CARBOHYD POLYM, V136, P358, DOI 10.1016/j.carbpol.2015.08.061; Ruthes AC, 2015, CARBOHYD POLYM, V117, P753, DOI 10.1016/j.carbpol.2014.10.051; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Sekhon BK, 2013, FOOD CHEM, V138, P2201, DOI 10.1016/j.foodchem.2012.11.009; Semedo MC, 2015, J MICROBIOL METH, V109, P140, DOI 10.1016/j.mimet.2014.12.020; Shrestha B, 2012, MYCOL PROG, V11, P599, DOI 10.1007/s11557-012-0825-y; Stadler M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00127; Stamets P., 2000, GROWING GOURMET MED, V3; Thongbai B, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1105-4; Velusamy B, 2016, INT J PHARM SCI RES, V7, P2065, DOI 10.13040/IJPSR.0975-8232.7(5).2065-73; Vetvicka V, 2009, J IMMUNOTOXICOL, V6, P30, DOI 10.1080/15476910802604317; Wan JMF, 2010, CHINESE MED, V5, P1; Wang Dao-feng, 2012, Cancer Biology Medicine, V9, P164, DOI 10.7497/j.issn.2095-3941.2012.03.002; Wang FF, 2014, LECT NOTES ELECTR EN, V249, P393, DOI 10.1007/978-3-642-37916-1_40; Wang JH, 2010, CARBOHYD RES, V345, P1023, DOI 10.1016/j.carres.2010.03.005; Wang ZX, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0100-5; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Yang SF, 2015, MOL IMMUNOL, V64, P144, DOI 10.1016/j.molimm.2014.11.007; Yi Y, 2011, MOLECULES, V16, P6148, DOI 10.3390/molecules16076148; Yu RM, 2009, CARBOHYD POLYM, V75, P166, DOI 10.1016/j.carbpol.2008.07.023; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zheng YF, 2016, CARBOHYD POLYM, V144, P438, DOI 10.1016/j.carbpol.2016.02.073	57	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171270	10.1371/journal.pone.0171270	http://dx.doi.org/10.1371/journal.pone.0171270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178285	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500035
J	Guiot, J; Henket, M; Corhay, JL; Moermans, C; Louis, R				Guiot, J.; Henket, M.; Corhay, J. L.; Moermans, C.; Louis, R.			Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL LUNG-DISEASES; BRONCHOALVEOLAR LAVAGE; YKL-40 LEVELS; SERUM-LEVEL; KL-6; INTERLEUKIN-8; INFLAMMATION; SARCOIDOSIS	Background Idiopathic pulmonary fibrosis (IPF) is a rare lung disease of unknown origin leading rapidly to death. This paper addresses the issue of whether sputum induction is a suitable tool to study respiratory tract inflammation and potential biomarkers in IPF compared to COPD, a fibrosing airway wall disease. Methods In a cross-sectional analysis, 15 IPF patients, 32 COPD and 30 healthy subjects underwent sputum induction. Total sputum cell counts and the amount of TGF-gamma, IGF-1, IGF-2, IGFBP-1, IGFBP-2, IGFBP-3, IL-8, IL-13, MMP-7, MMP-9, YKL-40, TNF-alpha and KL-6 in sputum supernatant were analysed. We also profiled gene expression of cells in the induced sputum for TGF-beta, MMP-7, YKL-40, IGFBP-2, IL-6, IL-8 and TNF-alpha. Results IPF patients, like COPD, had increased sputum absolute number of neutrophils, eosinophils, macrophages and epithelial cells compared to HS. IPF sputum supernatants had increased concentrations of IGFBP-2, IL-8, TGF-beta, MMP-7, MMP-9 and KL-6 (p<0.05, p<0.0001, p<0.05, p<0.05, p<0.0001, p<0.05 respectively) when compared to healthy subjects where COPD had higher IL-6 and TNF-alpha levels than IPF (p<0.05 and p<0.05 respectively) and HS (p<0.0001 and p<0.001 respectively) and higher IL-8 and MMP-9 than HS (p<0.0001 and p<0.001 respectively). Conversely to IL -6 and TNF-alpha, MMP-7 was increased in IPF compared to COPD (p<0.05). The KL-6 and MMP-7 protein levels in sputum were inversely correlated with total lung capacity (TLC, % of predicted) in IPF patients (r = -0.73 and r = -0.53 respectively). Sputum gene expression analysis identified a significant increase for IGFBP-2, IL -6, IL-8 and MMP-7 in IPF compared to HS (p<0.05, p<0.01, p<0.05 and p<0.0001 respectively) and for IGFBP-2, YKL-40, IL-6, IL-8 and MMP-7 compared to COPD (p<0.01, p<0.01, p<0.05, p<0.01 and p<0.0001 respectively). Furthermore, gene expression of TGF-beta was increased in IPF compared to COPD (p<0.001) but not to HS. Conclusion Our data show clear increase in expression and production of IGFBP-2, IL-8 and MMP-7 in sputum from patients with IPF that may contribute to the disease.	[Guiot, J.; Henket, M.; Corhay, J. L.; Moermans, C.; Louis, R.] CHU Liege, Dept Pneumol, Dept Pneumol, Domaine Univ Sart Tilman, Liege, Belgium	University of Liege	Guiot, J (corresponding author), CHU Liege, Dept Pneumol, Dept Pneumol, Domaine Univ Sart Tilman, Liege, Belgium.	J.Guiot@chu.ulg.ac.be		Guiot, Julien/0000-0001-7800-1730				Antoniou KM, 2005, SARCOIDOSIS VASC DIF, V22, P204; Antoniou KM, 2005, RESPIRATION, V72, P32, DOI 10.1159/000083398; Balestro E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154516; Beeh KM, 2003, SARCOIDOSIS VASC DIF, V20, P138; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Chadelat K, 1998, EUR RESPIR J, V11, P1329, DOI 10.1183/09031936.98.11061329; da Silva J, 2016, CLIN EXPT ALLERGY J; Delvaux M, 2004, THORAX, V59, P111, DOI 10.1136/thorax.2003.011130; Domagaa-Kulawik J, 2012, INFLAMMATION, V35, P803, DOI 10.1007/s10753-011-9378-5; Doubkova M, 2016, SARCOIDOSIS VASC DIF, V33, P224; Fireman E, 1999, RESP MED, V93, P827, DOI 10.1016/S0954-6111(99)90269-X; Fireman E, 2006, CURR OPIN PULM MED, V12, P318, DOI 10.1097/01.mcp.0000239547.62949.82; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Guiot J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0249-6; Huh JW, 2008, CHEST, V133, P1101, DOI 10.1378/chest.07-2116; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; Korthagen NM, 2014, LUNG, V192, P975, DOI 10.1007/s00408-014-9647-9; Korthagen NM, 2011, RESP MED, V105, P106, DOI 10.1016/j.rmed.2010.09.012; Ley B, 2014, AM J PHYSIOL-LUNG C, V307, pL681, DOI 10.1152/ajplung.00014.2014; Meloni F, 2004, SARCOIDOSIS VASC DIF, V21, P111; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moermans C, 2011, CYTOKINE, V56, P298, DOI 10.1016/j.cyto.2011.07.010; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Ohshimo S, 2014, RESP MED, V108, P1031, DOI 10.1016/j.rmed.2014.04.009; Pardo A, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0343-6; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Samukawa T, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-55; Schnyder B, 1999, LAB INVEST, V79, P1403; Tajiri M, 2015, RESPIR INVESTIG, V53, P73, DOI 10.1016/j.resinv.2014.12.003; Ten Klooster L, 2015, CLIN EXPT IMMUNOLOGY; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vuga LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083120; Ziegenhagen MW, 1998, AM J RESP CRIT CARE, V157, P762, DOI 10.1164/ajrccm.157.3.9705014; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	36	55	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171344	10.1371/journal.pone.0171344	http://dx.doi.org/10.1371/journal.pone.0171344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178340	gold, Green Submitted, Green Published			2022-12-27	WOS:000393712500037
J	Lee, SW; Kim, HC; Lee, YH; Song, BM; Choi, H; Park, JH; Rhee, Y; Kim, CO				Lee, Seung Won; Kim, Hyeon Chang; Lee, Yong-ho; Song, Bo Mi; Choi, Hansol; Park, Ji Hye; Rhee, Yumie; Kim, Chang Oh			Association between HbA1c and carotid atherosclerosis among elderly Koreans with normal fasting glucose	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; PLASMA-GLUCOSE; GLYCOSYLATED HEMOGLOBIN; MYOCARDIAL-INFARCTION; GLYCATED HEMOGLOBIN; ARTERIAL STIFFNESS; INSULIN-RESISTANCE; METABOLIC SYNDROME	Aim We examined whether glycated haemoglobin (HbA1c) is associated to carotid atherosclerosis in an elderly Korean population with normal fasting glucose. Methods Using data from the Korean Urban Rural Elderly study, we conducted a cross-sectional analysis of 1,133 participants (335 men and 798 women) with a mean age of 71.8 years. All participants had fasting blood glucose less than 100mg/dL (5.6 mmol/L) and HbA1c level below 6.5% (48 mmol/mol). They were also free from a history of cardiovascular disease, known type 2 diabetes mellitus or use of anti-diabetes medications. Carotid atherosclerosis was assessed by intima-media thickness (IMT) using ultrasonography. The association between HbA1c and carotid IMT was investigated using multivariable linear regression analysis. Results HbA1c levels were independently and positively associated with carotid IMT (beta = 0.020, p = 0.045) after adjusting for sex, age, body mass index, systolic blood pressure, diastolic blood pressure, triglyceride, LDL cholesterol, smoking and alcohol intake. However, fasting insulin and glucose levels were not associated with carotid IMT. Conclusion HbA1c levels were positively associated with carotid atherosclerosis, as assessed by carotid IMT, in an elderly population with normoglycemia. Our study suggested that higher HbA1c level is an effective and informative marker of carotid atherosclerosis in an elderly population.	[Lee, Seung Won; Song, Bo Mi; Choi, Hansol; Park, Ji Hye] Yonsei Univ, Dept Publ Hlth, Grad Sch, Seoul, South Korea; [Lee, Seung Won; Kim, Hyeon Chang; Song, Bo Mi] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, Yong-ho; Rhee, Yumie; Kim, Chang Oh] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea.; Kim, HC (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Kim, CO (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	hckim@yuhs.ac; cokim@yuhs.ac	Lee, Yong-ho/AAT-4106-2020; Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Lee, Yong-ho/0000-0002-6219-4942; Rhee, Yumie/0000-0003-4227-5638; Kim, Hyeon Chang/0000-0001-7867-1240; Kim, Chang Oh/0000-0002-0773-5443	Korea Centers for Disease Control and Prevention [2012-E63001-001, 2013-E63007-00]; Korean Health Technology R&D Project, Ministry of Health Welfare, Korea [H113C0715]	Korea Centers for Disease Control and Prevention; Korean Health Technology R&D Project, Ministry of Health Welfare, Korea	This work was supported by the Korea Centers for Disease Control and Prevention (2012-E63001-001, 2013-E63007-00); and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Korea (H113C0715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-1; BLANKENHORN DH, 1993, CIRCULATION, V88, P20, DOI 10.1161/01.CIR.88.1.20; Bobbert T, 2010, DIABETES CARE, V33, P203, DOI 10.2337/dc09-1009; Bonora E, 1999, DIABETES CARE, V22, P1339, DOI 10.2337/diacare.22.8.1339; BOTS ML, 1994, J CLIN EPIDEMIOL, V47, P921, DOI 10.1016/0895-4356(94)90196-1; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; BOWIE A, 1993, ATHEROSCLEROSIS, V102, P63, DOI 10.1016/0021-9150(93)90084-8; Chen LY, 2015, ATHEROSCLEROSIS, V240, P345, DOI 10.1016/j.atherosclerosis.2015.03.031; Chistiakov DA, 2015, J CELLULAR MOL MED; Choi H, 2016, ARCH GERONTOL GERIAT, V64, P51, DOI 10.1016/j.archger.2016.01.005; Choi SW, 2011, J DIABETES COMPLICAT, V25, P7, DOI 10.1016/j.jdiacomp.2009.12.001; de Groot E, 2008, NAT CLIN PRACT CARD, V5, P280, DOI 10.1038/ncpcardio1163; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Hirai FE, 2008, DIABETES CARE, V31, P493, DOI 10.2337/dc07-1161; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Hung CS, 2011, CLIN ENDOCRINOL, V75, P780, DOI 10.1111/j.1365-2265.2011.04129.x; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; 이정현, 2016, [Journal of Health Informatics and Statistics, 보건정보통계학회지], V41, P49, DOI 10.210332/jhis.2016.41.1.49; Lee EY, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-33; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lee YH, 2016, ATHEROSCLEROSIS, V247, P1, DOI 10.1016/j.atherosclerosis.2016.01.032; Marshall SM, 2000, DIABETIC MED, V17, P5, DOI 10.1046/j.1464-5491.2000.00228.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McNeely MJ, 2009, DIABETES CARE, V32, P1727, DOI 10.2337/dc09-0074; Mohan V, 2000, DIABETOLOGIA, V43, P494, DOI 10.1007/s001250051334; Monnier Louis, 2006, Endocr Pract, V12 Suppl 1, P42; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PERSSON J, 1992, ARTERIOSCLER THROMB, V12, P261, DOI 10.1161/01.ATV.12.2.261; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Simsek E, 2010, TURKISH J PEDIATR, V52, P602; SINGER DE, 1992, DIABETES, V41, P202, DOI 10.2337/diabetes.41.2.202; Song BM, 2016, J AFFECT DISORDERS, V189, P357, DOI 10.1016/j.jad.2015.09.043; Song BM, 2014, NUTRIENTS, V6, P5806, DOI 10.3390/nu6125806; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Venkataraman V, 2012, J DIABETES COMPLICAT, V26, P526, DOI 10.1016/j.jdiacomp.2012.06.002; Vitelli LL, 1997, DIABETES CARE, V20, P1454, DOI 10.2337/diacare.20.9.1454	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171761	10.1371/journal.pone.0171761	http://dx.doi.org/10.1371/journal.pone.0171761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178313	gold, Green Submitted, Green Published			2022-12-27	WOS:000393712500068
J	Luthy, C; Gerstel, PF; Pugliesi, A; Piguet, V; Allaz, AF; Cedraschi, C				Luthy, Christophe; Gerstel, Patricia Francis; Pugliesi, Angela; Piguet, Valerie; Allaz, Anne-Francoise; Cedraschi, Christine			Bedside or not bedside: Evaluation of patient satisfaction in intensive medical rehabilitation wards	PLOS ONE			English	Article							CASE PRESENTATIONS; EXAMINATION ROOM; WORK-ROUNDS; CARE; PERSPECTIVES; PERCEPTIONS; VALIDATION; IMPACT; TRIAL	Background Concerns that bedside presentation (BsP) rounds could make patients uncomfortable led many residency programs to move daily rounds outside the patients' room (OsPR). We performed a prospective quasi-experimental controlled study measuring the effect of these two approaches on patient satisfaction. Methods Patient satisfaction was measured using the Picker questionnaire (PiQ). Results are expressed in problematic percentage scores scaled from 0 = best-100 = worst. During three months, 3 wards of a 6 ward medical rehabilitation division implemented BsP and 3 control wards kept their usual organization of rounds. In total, 90 patients of each group were included in the study and completed the PiQ. Results Socio-clinical characteristics were similar in both groups: mean age = 67 years (SD = 13), mean Charlson comorbidity index = 8.6 (2.4); mean length of stay = 22 days (12). During their stay, patients in the BsP units had a mean of 14.3 (8) BsP rounds and 0.5 (0.8) OsPR; control patients had a mean of 0.9 (0.7) BsP and 14.8 (7.3) OsPR (p< 0.0001). Patients in BsP units reported lower problematic scores regarding coordination of care (39% vs 45%, p = 0.029), involvement of family/friends (29 vs 41%, p = 0.006) and continuity/transition (44% vs 54%, p = 0.020); two questions of the PiQ had worse scores in the BsP: trust in nurses (46.7% vs 30 %, p = 0.021) and recommendation of the institution (61.1% vs 44.4%. p = 0.025). No worsening in dimensions such as respect for patient preferences was seen. Conclusions BsP rounds influenced the patient-healthcare professionals' encounter. These rounds were associated with improved patient satisfaction with care, particularly regarding interprofessional collaboration and discharge planning.	[Luthy, Christophe; Allaz, Anne-Francoise; Cedraschi, Christine] Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland; [Luthy, Christophe; Piguet, Valerie; Allaz, Anne-Francoise; Cedraschi, Christine] Univ Geneva, Geneva, Switzerland; [Gerstel, Patricia Francis] Univ Hosp Geneva, Div Qual Care, Geneva, Switzerland; [Pugliesi, Angela] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland; [Piguet, Valerie] Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Gerstel, Patricia Francis] Clin Colline, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Luthy, C (corresponding author), Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland.; Luthy, C (corresponding author), Univ Geneva, Geneva, Switzerland.	Christophe.luthy@hcuge.ch						Anderson RJ, 2002, AM J MED, V113, P657, DOI 10.1016/S0002-9343(02)01320-7; ASHTON CM, 1994, J GEN INTERN MED, V9, P208, DOI 10.1007/BF02600126; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chauke HL, 2006, SAMJ S AFR MED J, V96, P398; Conroy KM, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0060-1; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Gonzalo JD, 2014, J GEN INTERN MED, V29, P1040, DOI 10.1007/s11606-014-2817-x; Gonzalo JD, 2014, ACAD MED, V89, P326, DOI 10.1097/ACM.0000000000000100; Gonzalo JD, 2010, J GEN INTERN MED, V25, P792, DOI 10.1007/s11606-010-1344-7; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Kianmehr N, 2010, SAUDI MED J, V31, P565; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Kirthi V, 2012, OYAL COLL PHYS ROYAL, DOI [10.1136/bmiqs-2013-002436, DOI 10.1136/BMIQS-2013-002436]; KROENKE K, 1990, J GEN INTERN MED, V5, P229, DOI 10.1007/BF02600540; Kutney-Lee A, 2009, HEALTH AFFAIR, V28, pW669, DOI 10.1377/hlthaff.28.4.w669; Landry MA, 2007, PEDIATRICS, V120, P275, DOI 10.1542/peds.2007-0107; Lehmann LS, 1997, NEW ENGL J MED, V336, P1150, DOI 10.1056/NEJM199704173361606; LEWIS C, 1988, J PEDIATR-US, V112, P378, DOI 10.1016/S0022-3476(88)80316-0; LINFORS EW, 1980, NEW ENGL J MED, V303, P1230, DOI 10.1056/NEJM198011203032110; Luthy C, 2005, SWISS MED WKLY, V135, P82; Muller-Juge V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057570; New PW, 2008, J REHABIL MED, V40, P678, DOI 10.2340/16501977-0224; Norgaard K, 2004, MED EDUC, V38, P700, DOI 10.1111/j.1365-2929.2004.01840.x; Paice E, 2002, BMJ-BRIT MED J, V325, P707, DOI 10.1136/bmj.325.7366.707; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Papastavrou E, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-26; Perneger TV, 2003, MED CARE, V41, P1343, DOI 10.1097/01.MLR.0000100580.94559.AD; Ramani S, 2003, ACAD MED, V78, P384, DOI 10.1097/00001888-200304000-00014; Rogers HD, 2003, ACAD MED, V78, P945, DOI 10.1097/00001888-200309000-00023; Seo M, 2000, MED EDUC, V34, P409, DOI 10.1046/j.1365-2923.2000.00516.x; Sox HC, 2016, JAMA-J AM MED ASSOC, V316, P1205, DOI 10.1001/jama.2016.11409; Tariq M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-53; Taylor SP, 2014, BMJ QUAL SAF, V23, P584, DOI 10.1136/bmjqs-2013-002436; WANGCHENG RM, 1989, J GEN INTERN MED, V4, P284, DOI 10.1007/BF02597397; Ward DR, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-37; WRAY NP, 1986, J MED EDUC, V61, P893; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	39	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0170474	10.1371/journal.pone.0170474	http://dx.doi.org/10.1371/journal.pone.0170474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170431	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500006
J	Soler, M; Ruiz-Raya, F; Roncalli, G; Ibanez-Alamo, JD				Soler, Manuel; Ruiz-Raya, Francisco; Roncalli, Gianluca; Diego Ibanez-Alamo, Juan			Relationships between egg-recognition and egg-ejection in a grasp-ejector species	PLOS ONE			English	Article							BILL-SIZE CONSTRAINTS; CUCULUS-CANORUS; PARASITIC EGGS; COWBIRD EGGS; REJECTION BEHAVIOR; BROOD PARASITISM; REED WARBLERS; TURDUS-MERULA; MODEL SYSTEM; CUCKOO	Brood parasitism frequently leads to a total loss of host fitness, which selects for the evolution of defensive traits in host species. Experimental studies have demonstrated that recognition and rejection of the parasite egg is the most common and efficient defence used by host species. Egg-recognition experiments have advanced our knowledge of the evolutionary and coevolutionary implications of egg recognition and rejection. However, our understanding of the proximate mechanisms underlying both processes remains poor. Egg rejection is a complex behavioural process consisting of three stages: egg recognition, the decision whether or not to reject the putative parasitic egg and the act of ejection itself. We have used the blackbird (Turdus merula) as a model species to explore the relationship between egg recognition and the act of egg ejection. We have manipulated the two main characteristics of parasitic eggs affecting egg ejection in this grasp-ejector species: the degree of colour mimicry (mimetic and non-mimetic, which mainly affects the egg-recognition stage of the egg-rejection process) and egg size (small, medium and large, which affects the decision to eject), while maintaining a control group of non-parasitized nests. The behaviour of the female when confronted with an experimental egg was filmed using a video camera. Our results show that egg touching is an indication of egg recognition and demonstrate that blackbirds recognized (i.e., touched) non-mimetic experimental eggs significantly more than mimetic eggs. However, twenty per cent of the experimental eggs were touched but not subsequently ejected, which confirms that egg recognition does not necessarily mean egg ejection and that accepting parasitic eggs, at least sometimes, is the consequence of acceptance decisions. Regarding proximate mechanisms, our results show that the delay in egg ejection is not only due to recognition problems as usually suggested, given that experimental eggs are not touched significantly more often. Thus, the delay in egg ejection is mainly the consequence of a delay in the decision to eject, probably triggered by mechanical constraints imposed by eggs that are harder to eject (i.e. larger). Our results offer important information on the relationships between recognition and ejection and contribute to a better understanding of host defences against brood parasites.	[Soler, Manuel; Ruiz-Raya, Francisco; Roncalli, Gianluca] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Diego Ibanez-Alamo, Juan] Univ Groningen, Behav & Physiol Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Diego Ibanez-Alamo, Juan] CSIC, Dept Wetland Ecol, Estn Biol Donana, Avda Sevilla, Seville, Spain	University of Granada; University of Groningen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Soler, M (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	msoler@ugr.es	Roncalli, Gianluca/AFX-9281-2022; Ruiz-Raya, Francisco/L-8639-2019; Ibáñez-Álamo, Juan Diego/H-7624-2019	Roncalli, Gianluca/0000-0002-0593-115X; Ruiz-Raya, Francisco/0000-0002-4646-1975; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Junta de Andalucia [CVI-6653]; "Andalucia Talent Hub" program [TAHUB-104]; European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND); regional Government of Andalucia	Junta de Andalucia(Junta de Andalucia); "Andalucia Talent Hub" program; European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND); regional Government of Andalucia(Junta de Andalucia)	Financial support was provided by the Junta de Andalucia (research project CVI-6653). JDI is funded by a postdoctoral contract (TAHUB-104) from the "Andalucia Talent Hub" program (co-funded by the European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND) and the regional Government of Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by the Junta de Andalucia (research project CVI-6653). JDI is funded by a postdoctoral contract from the "Andalucia Talent Hub" program (co-funded by the European's Union Seventh Framework Program Marie Sklodowska-Curie actions (COFUND) and the regional Government of Andalucia). No additional funding was received for this study. We thank two anonymous reviewers for their constructive and helpful comments, which have considerably improved and clarified our manuscript. We are especially indebted to Reviewer 1 for his/her constructive, exhaustive and detailed review, which went far beyond what reviewing requires. He/she contributed numerous suggestions that considerably improved this paper.	ALVAREZ F, 1976, ANIM BEHAV, V24, P907, DOI 10.1016/S0003-3472(76)80021-8; Antonov A, 2008, BEHAV ECOL, V19, P100, DOI 10.1093/beheco/arm102; Antonov A, 2006, AUK, V123, P419, DOI 10.1642/0004-8038(2006)123[419:ERIMWA]2.0.CO;2; Antonov A, 2009, BIOL LETTERS, V5, P169, DOI 10.1098/rsbl.2008.0645; Antonov A, 2008, ANIM BEHAV, V76, P1893, DOI 10.1016/j.anbehav.2008.08.016; BROOKE MD, 1988, NATURE, V335, P630; CRUZ A, 1989, EVOLUTION, V43, P55, DOI 10.1111/j.1558-5646.1989.tb04206.x; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; De Rosario-Martinez H., 2015, PHIA POSTHOC INTERAC; Ibanez-Alamo JD, 2010, BIOL J LINN SOC, V101, P759, DOI 10.1111/j.1095-8312.2010.01543.x; Fox J., 2019, R COMPANION APPL REG, V.; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Guigueno MF, 2012, AUK, V129, P17, DOI 10.1525/auk.2011.11138; Hale K, 2007, J AVIAN BIOL, V38, P198, DOI 10.1111/j.0908-8857.2007.03734.x; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; HIGUCHI H, 1989, IBIS, V131, P94, DOI 10.1111/j.1474-919X.1989.tb02748.x; Honza M, 2005, J AVIAN BIOL, V36, P517, DOI 10.1111/j.0908-8857.2005.03358.x; Honza M, 2004, J ETHOL, V22, P175, DOI 10.1007/s10164-004-0119-1; Honza M, 2008, J ETHOL, V26, P389, DOI 10.1007/s10164-008-0093-0; Honza M, 2007, J AVIAN BIOL, V38, P385, DOI 10.1111/j.2007.0908-8857.03901.x; Honza M, 2007, ETHOLOGY, V113, P344, DOI 10.1111/j.1439-0310.2007.01340.x; Hoskatt E, 1993, ORNIS SCAND, V24, P28; Ibanez-Alamo JD, 2012, BEHAV ECOL SOCIOBIOL, V66, P1067, DOI 10.1007/s00265-012-1357-9; Jackman SD, 2015, PSCL CLASSES METHODS; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; MARCHETTI K, 1992, P ROY SOC B-BIOL SCI, V248, P41, DOI 10.1098/rspb.1992.0040; Martin-Vivaldi M, 2002, J AVIAN BIOL, V33, P295, DOI 10.1034/j.1600-048X.2002.330311.x; Martin-Vivaldi M, 2013, IBIS, V155, P140, DOI 10.1111/ibi.12000; MOKSNES A, 1989, BEHAV ECOL SOCIOBIOL, V24, P25, DOI 10.1007/BF00300114; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; Moskat C, 2010, J EXP BIOL, V213, P1976, DOI 10.1242/jeb.040394; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; Pozgayova M, 2011, BEHAV ECOL, V22, P46, DOI 10.1093/beheco/arq163; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez-Girones MA, 1999, AM NAT, V153, P633, DOI 10.1086/303198; Rohwer S, 1988, EVOL ECOL, V2, P27, DOI 10.1007/BF02071586; ROTHSTEIN SI, 1976, AUK, V93, P675; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Ruiz-Raya F, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0148-y; Ruiz-Raya F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135624; Samas P, 2011, ETHOLOGY, V117, P606, DOI 10.1111/j.1439-0310.2011.01917.x; SEALY SG, 1995, CONDOR, V97, P369, DOI 10.2307/1369023; SEALY SG, 1992, CONDOR, V94, P40, DOI 10.2307/1368794; Sealy Spencer G., 2012, Chinese Birds, V3, P274; Skaug H., 2016, GEN LINEAR MIXED MOD; Soler JJ, 2001, ECOL LETT, V4, P470, DOI 10.1046/j.1461-0248.2001.00247.x; Soler JJ, 2000, OECOLOGIA, V125, P309, DOI 10.1007/s004420000487; Soler M, 2012, ANIM BEHAV, V84, P421, DOI 10.1016/j.anbehav.2012.05.016; Soler M, 2002, ETHOLOGY, V108, P1093, DOI 10.1046/j.1439-0310.2002.00841.x; SOLER M, 1990, ORNIS SCAND, V21, P212, DOI 10.2307/3676781; Soler M, 2015, J AVIAN BIOL, V46, P369, DOI 10.1111/jav.00571; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler M, 2012, ETHOLOGY, V118, P662, DOI 10.1111/j.1439-0310.2012.02058.x; Spottiswoode CN, 2010, J EVOLUTION BIOL, V23, P1792, DOI 10.1111/j.1420-9101.2010.02010.x; Underwood TJ, 2006, ANIM BEHAV, V71, P409, DOI 10.1016/j.anbehav.2005.06.004; Underwood TJ, 2002, OX ORN SER, V13, P280; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zuur Alain F., 2009, P1	62	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0166283	10.1371/journal.pone.0166283	http://dx.doi.org/10.1371/journal.pone.0166283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170402	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500001
J	Morimoto, S; Takao, M; Hatsuta, H; Nishina, Y; Komiya, T; Sengoku, R; Nakano, Y; Uchino, A; Sumikura, H; Saito, Y; Kanemaru, K; Murayama, S				Morimoto, Satoru; Takao, Masaki; Hatsuta, Hiroyuki; Nishina, Yasushi; Komiya, Tadashi; Sengoku, Renpei; Nakano, Yuta; Uchino, Akiko; Sumikura, Hiroyuki; Saito, Yuko; Kanemaru, Kazutomi; Murayama, Shigeo			Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; BODY VARIANT; DES MENSCHEN; HUMAN BRAIN; L-DOPA; CSF; DIAGNOSIS; TAU	Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are the two most common causes of dementia. Both pathologies often coexist, and AD patients with concomitant neocortical LB pathology (referred to as the Lewy body variant of AD) generally show faster cognitive decline and accelerated mortality relative to patients with pure AD. Thus, discriminating among patients with DLB, AD, and coincident DLB and AD is important in clinical practice. We examined levels of homovanillic acid (HVA), 5-hydroxyindole acetic acid (5-HIAA), tau, phosphorylated tau (p-tau), and beta-amyloid (A beta) 1-42 in cerebrospinal fluid (CSF) to evaluate their viability as biomarkers to discriminate among different forms of dementia. We obtained a total of 3498 CSF samples from patients admitted to our hospital during the period from 1996 to 2015. Of these patients, we were able to carry out a brain autopsy in 94 cases. Finally, 78 neuropathologically diagnosed cases (10 AD, six DLB, five DLB with AD, five controls without neurological diseases, and 52 cases with other neurological diseases) were studied. CSF levels of HVA and 5-HIAA were consistently decreased in pathologically advanced Lewy body disorder (LBD; Braak LB stages >3) compared with pathologically incipient LBD (Braak LB stages <2). These results suggest that if an individual has LB pathology in the central nervous system, CSF levels of HVA and 5-HIAA may decrease after the onset of clinical symptoms. In addition, CSF levels of HVA and 5-HIAA decreased with LB pathology, and were especially low in cases of DLB and DLB with AD. Furthermore, the combination of HVA, 5-HIAA, and brain specific proteins t-tau, p-tau, and A beta 1-42 in CSF were useful for discriminating among DLB, DLB with AD, and AD with high diagnostic accuracy.	[Morimoto, Satoru; Takao, Masaki; Hatsuta, Hiroyuki; Nakano, Yuta; Uchino, Akiko; Sumikura, Hiroyuki; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo, Japan; [Morimoto, Satoru; Hatsuta, Hiroyuki; Nishina, Yasushi; Sengoku, Renpei; Nakano, Yuta; Uchino, Akiko; Sumikura, Hiroyuki; Kanemaru, Kazutomi; Murayama, Shigeo] Inst Gerontol, Tokyo, Japan; [Morimoto, Satoru; Nishina, Yasushi; Sengoku, Renpei; Kanemaru, Kazutomi; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo, Japan; [Takao, Masaki] Saitama Med Univ, Int Med Ctr, Dept Neurol & Stroke, Saitama, Japan; [Komiya, Tadashi] Natl Hosp Org, Tokyo Natl Hosp, Dept Neurol, Tokyo, Japan; [Saito, Yuko] Natl Ctr Neurol & Psychiat, Dept Lab Med, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Saitama Medical University; National Center for Neurology & Psychiatry - Japan	Murayama, S (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo, Japan.; Murayama, S (corresponding author), Inst Gerontol, Tokyo, Japan.; Murayama, S (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo, Japan.	smurayam@gmail.com	Nishina, Yuta/AHB-6194-2022; Morimoto, Satoru/L-1223-2013; Nishina, Yuta/B-2427-2011	Nishina, Yuta/0000-0002-4958-1753; Morimoto, Satoru/0000-0003-0022-9529; 	Ministry of Education, Science, Sports and Culture, Japan [221S0003, 24300133]; Ministry of Health, Labor and Welfare of Japan; National Center of Geriatric and Gerontology, Japan; Grants-in-Aid for Scientific Research [16H06277, 16K09736] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center of Geriatric and Gerontology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, the Ministry of Education, Science, Sports and Culture, Japan (to SM: Comprehensive Brain Science Network, 221S0003), a Grant-in-Aid for Study on propagation of Lem body-associated synucleinopathy, Scientific Research B, the Ministry of Education, Science, Sports and Culture, Japan (to SM: 24300133); a Grant-in-Aid for intractable diseases (neurodegenerative disorders) the Ministry of Health, Labor and Welfare of Japan (to SM); and a Grant-in-Aid for establishment of high quality brain bank, Geriatric Research from the National Center of Geriatric and Gerontology, Japan (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts MB, 2011, J ALZHEIMERS DIS, V27, P377, DOI 10.3233/JAD-2011-110482; Benito-Leon J., 2008, TRATADO TRASTORNOS M, V1, P133; Bernheimer H, 1966, Wien Klin Wochenschr, V78, P417; BERNHEIMER H, 1961, KLIN WOCHENSCHR, V39, P1056, DOI 10.1007/BF01487648; BERNHEIMER H, 1964, NATURE, V204, P587, DOI 10.1038/204587b0; BETHLEM J, 1960, J NEUROL NEUROSUR PS, V23, P74, DOI 10.1136/jnnp.23.1.74; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; DAVIDSON DLW, 1977, J NEUROL NEUROSUR PS, V40, P1136, DOI 10.1136/jnnp.40.12.1136; Ehringer H, 1998, Parkinsonism Relat Disord, V4, P53, DOI 10.1016/S1353-8020(98)00012-1; ELDRUP E, 1995, ACTA NEUROL SCAND, V92, P116; Engelborghs S, 2003, NEUROCHEM RES, V28, P1145, DOI 10.1023/A:1024255208563; Funabe S, 2013, NEUROPATHOLOGY, V33, P47, DOI 10.1111/j.1440-1789.2012.01329.x; GULDBERG HC, 1967, CONFIN NEUROL, V29, P73; GUMPERT J, 1973, J NEUROL SCI, V19, P1, DOI 10.1016/0022-510X(73)90050-6; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; HANSEN L, 1990, NEUROLOGY, V40, P1; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; HORNYKIEWICZ O, 1962, DEUT MED WOCHENSCHR, V87, P1807, DOI 10.1055/s-0028-1114024; hrfelt O A, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI [10.1001/archneurol.2012.1654, DOI 10.1001/ARCHNEUROL.2012]; Johansson B, 1967, Life Sci, V6, P1449, DOI 10.1016/0024-3205(67)90193-2; Kanemaru K, 2000, NEUROLOGY, V54, P1875, DOI 10.1212/WNL.54.9.1875; Kanemaru K, 1998, NEUROSCI LETT, V245, P121, DOI 10.1016/S0304-3940(98)00181-5; Kanemaru K, 2002, J NEUROL, V249, P1125, DOI 10.1007/s00415-002-0753-x; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; Koopman K, 2009, NEUROCHEM INT, V55, P214, DOI 10.1016/j.neuint.2009.02.017; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Luo XN, 2013, J NEUROCHEM, V127, P681, DOI 10.1111/jnc.12331; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mori E, 2012, ANN NEUROL, V72, P41, DOI 10.1002/ana.23557; Murayama S, 2004, NEUROPATHOLOGY, V24, P254, DOI 10.1111/j.1440-1789.2004.00571.x; OHAMA E, 1976, ACTA NEUROPATHOL, V34, P311, DOI 10.1007/BF00696560; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; PULLAR IA, 1970, J NEUROL NEUROSUR PS, V33, P851, DOI 10.1136/jnnp.33.6.851; Raftopoulos C, 1996, MOVEMENT DISORD, V11, P59, DOI 10.1002/mds.870110111; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Samuel W, 1997, J NEUROPATH EXP NEUR, V56, P499, DOI 10.1097/00005072-199705000-00006; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; TOHGI H, 1993, NEUROSCI LETT, V150, P71, DOI 10.1016/0304-3940(93)90111-W; TOHGI H, 1993, J NEURAL TRANSM-PARK, V5, P17, DOI 10.1007/BF02260911; TOHGI H, 1993, NEUROSCI LETT, V159, P135, DOI 10.1016/0304-3940(93)90817-5; Tohgi H, 1997, J NEURAL TRANSM, V104, P441, DOI 10.1007/BF01277662; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Toledo JB, 2012, ACTA NEUROPATHOL, V124, P23, DOI 10.1007/s00401-012-0983-7; Weiner MF, 1996, AM J PSYCHIAT, V153, P1269; Wood Heather, 2014, Nat Rev Neurol, V10, P426, DOI 10.1038/nrneurol.2014.119	53	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171524	10.1371/journal.pone.0171524	http://dx.doi.org/10.1371/journal.pone.0171524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166276	Green Submitted, Green Published, gold			2022-12-27	WOS:000393700100051
J	Zou, Z; Liu, JT; Yang, LF; Xie, GS				Zou, Zhi; Liu, Jianting; Yang, Lifu; Xie, Guishui			Survey of the rubber tree genome reveals a high number of cysteine protease-encoding genes homologous to Arabidopsis SAG12	PLOS ONE			English	Article							TAPPING PANEL DRYNESS; HEVEA-BRASILIENSIS MUELL.; SENESCENCE-ASSOCIATED VACUOLES; MYB TRANSCRIPTION FACTOR; LEAF SENESCENCE; SUBSTRATE-SPECIFICITY; EXPRESSION PATTERNS; JASMONIC ACID; DRAFT GENOME; CELL-DEATH	Arabidopsis thaliana SAG12, a senescence-specific gene encoding a cysteine protease, is widely used as a molecular marker for the study of leaf senescence. To date, its potential orthologues have been isolated from several plant species such as Brassica napus and Nicotiana tabacum. However, little information is available in rubber tree (Hevea brasiliensis), a rubber-producing plant of the Euphorbiaceae family. This study presents the identification of SAG12-like genes from the rubber tree genome. Results showed that an unexpected high number of 17 rubber orthologues with a single intron were found, contrasting the single copy with two introns in Arabidopsis. The gene expansion was also observed in another two Euphorbiaceae plants, castor bean (Ricinus communis) and physic nut (Jatropha curcas), both of which contain 8 orthologues. In accordance with no occurrence of recent whole-genome duplication (WGD) events, most duplicates in castor and physic nut were resulted from tandem duplications. In contrast, the duplicated HbSAG12H genes were derived from tandem duplications as well as the recent WGD. Expression analysis showed that most HbSAG12H genes were lowly expressed in examined tissues except for root and male flower. Furthermore, HbSAG12H1 exhibits a strictly senescence-associated expression pattern in rubber tree leaves, and thus can be used as a marker gene for the study of senescence mechanism in Hevea.	[Zou, Zhi; Liu, Jianting; Yang, Lifu; Xie, Guishui] Chinese Acad Trop Agr Sci, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China; [Liu, Jianting] Fujian Acad Agr Sci, Crops Res Inst, Fuzhou, Fujian, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Fujian Academy of Agricultural Sciences	Zou, Z (corresponding author), Chinese Acad Trop Agr Sci, Danzhou Invest & Expt Stn Trop Crops, Minist Agr, Rubber Res Inst, Danzhou, Hainan, Peoples R China.	zouzhi2008@126.com	Zou, Zhi/F-1266-2018	Zou, Zhi/0000-0003-2881-1932	National Natural Science Foundation of China [31371556]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-34-GW5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System	This work was supported by the National Natural Science Foundation of China (31371556) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-34-GW5).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Avila-Ospina L, 2014, J EXP BOT, V65, P3799, DOI 10.1093/jxb/eru039; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carrion CA, 2013, J EXP BOT, V64, P4967, DOI 10.1093/jxb/ert285; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Chen SC, 2003, PLANT MOL BIOL, V51, P51, DOI 10.1023/A:1020719420867; Chow Keng-See, 2014, BMC Res Notes, V7, P69, DOI 10.1186/1756-0500-7-69; Chow KS, 2012, J EXP BOT, V63, P1863, DOI 10.1093/jxb/err363; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo YF, 2014, J EXP BOT, V65, P3901, DOI 10.1093/jxb/eru248; Guo YF, 2012, PLANT CELL ENVIRON, V35, P644, DOI 10.1111/j.1365-3040.2011.02442.x; Hao BZ, 2000, ANN BOT-LONDON, V85, P37, DOI 10.1006/anbo.1999.0995; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; Hua YW, 2010, PLANT BREEDING, V129, P202, DOI 10.1111/j.1439-0523.2009.01663.x; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jibran R, 2013, PLANT MOL BIOL, V82, P547, DOI 10.1007/s11103-013-0043-2; Kim J, 2016, MOL PLANT, V9, P813, DOI 10.1016/j.molp.2016.04.017; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leitch AR, 1998, GENOME, V41, P464, DOI 10.1139/gen-41-3-464; Li DJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23540; Li DJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-140; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1562-9; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noh YS, 1999, PLANT MOL BIOL, V41, P195, DOI 10.1023/A:1006389803990; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Otegui MS, 2005, PLANT J, V41, P831, DOI 10.1111/j.1365-313X.2005.02346.x; Ougham H, 2008, PLANT BIOLOGY, V10, P4, DOI 10.1111/j.1438-8677.2008.00081.x; Peng SQ, 2011, PLANT PHYSIOL BIOCH, V49, P1429, DOI 10.1016/j.plaphy.2011.09.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Putranto RA, 2015, INT J MOL SCI, V16, P17885, DOI 10.3390/ijms160817885; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Schippers JHM, 2015, CURR OPIN PLANT BIOL, V27, P77, DOI 10.1016/j.pbi.2015.06.018; Shen FF, 2004, CHINESE SCI BULL, V49, P2601, DOI 10.1360/982004-401; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.73, 10.1038/nplants.2016.73]; Tang CR, 2010, PLANT CELL ENVIRON, V33, P1708, DOI 10.1111/j.1365-3040.2010.02175.x; Thakurta PG, 2004, BIOCHEMISTRY-US, V43, P1532, DOI 10.1021/bi0357659; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Venkatachalam P, 2007, PLANTA, V226, P499, DOI 10.1007/s00425-007-0500-8; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Yeang H. Y., 2005, Journal of Rubber Research, V8, P160; Zhu JH, 2009, PLANT SIGNAL BEHAV, V4, P1072, DOI 10.4161/psb.4.11.9738; Zou Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00395; Zou Z, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2152-6; [邹智 Zou Zhi], 2012, [生物技术通报, Biotechnology Bulletin], P8; [邹智 ZOU Zhi], 2009, [植物生理学通讯, Plant Physiology Communications], V45, P1231; Zou Zhi, 2010, China Biotechnology, V30, P85	70	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171725	10.1371/journal.pone.0171725	http://dx.doi.org/10.1371/journal.pone.0171725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1QH	28166280	Green Published, Green Submitted, gold			2022-12-27	WOS:000393700100065
J	Huang, KS; Wang, SH; Chuah, SK; Rau, KM; Lin, YH; Hsieh, MC; Shih, LH; Chen, YH				Huang, Kun-Siang; Wang, Shih-Ho; Chuah, Seng-Kee; Rau, Kun-Ming; Lin, Yu-Hung; Hsieh, Meng-Che; Shih, Li-Hsueh; Chen, Yen-Hao			The effects of hospice-shared care for gastric cancer patients	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; PALLIATIVE CARE; LIFE; END; TAIWAN; IMPACT; EXPENDITURE; OUTCOMES; JAPAN	Background Hospice care has been proved to result in changes to the medical behaviors of terminally ill patients. The aim of this study was to evaluate the effects and medical behavior changes of hospice-shared care intervention among terminally ill gastric cancer patients. Methods A total of 174 patients who died of gastric cancer between 2012 and 2014 were identified. These patients were divided into two groups: a hospice-shared care group (n = 93) and a control group (n = 81). Results Among the 174 patients, 84% had advanced stage (stage III or stage IV) cancer. The females and the patients cared by medical oncologists had a higher percentage of hospice-shared care than the males (71% vs 44%, p = 0.001) and those cared by other physicians (63% vs 41%, p = 0.004). Compared to the control group, the hospice-shared care group underwent lower incidence of life sustaining or aggressive medical treatments, including intensive care unit admission (2% vs 26%, p<0.001), intubation (1% vs 27%, p<0.001), cardiopulmonary- cerebral resuscitation (0% vs 11%, p = 0.001), ventilator use (1% vs 27%, p< 0.001), inotropic agent use (8% vs 46%, p< 0.001), total or partial parenteral nutrition use (38% vs. 58%, p = 0.029), and blood transfusion (45% vs 74%, p< 0.001). Besides, the hospice- shared care group had a higher percentage of palliative treatments than the control group, including signed Do-Not-Resuscitate (DNR) orders (95% vs 37%, p< 0.001), receiving home hospice care (16% vs 1%, p< 0.001), and indicating home as the realistically preferred place of death (41% vs 19%, p = 0.001). The hospice ward admission rate in the hospice-shared care group increased from 30% to 53% from 2012 to 2014. Conclusion The use of hospice-shared care for gastric cancer patients could increase the rate of signed DNR orders, decrease the use of life sustaining and aggressive/palliative treatments, and improve quality of life.	[Huang, Kun-Siang] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Kun-Siang; Wang, Shih-Ho; Chuah, Seng-Kee; Rau, Kun-Ming; Lin, Yu-Hung; Hsieh, Meng-Che; Chen, Yen-Hao] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Shih-Ho; Lin, Yu-Hung] Kaohsiung Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Kaohsiung, Taiwan; [Wang, Shih-Ho; Chuah, Seng-Kee; Rau, Kun-Ming; Lin, Yu-Hung; Hsieh, Meng-Che; Shih, Li-Hsueh; Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Gastr Canc Team, Kaohsiung, Taiwan; [Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Rau, Kun-Ming; Hsieh, Meng-Che; Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Shih, Li-Hsueh] Kaohsiung Chang Gung Mem Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Yen-Hao] Kaohsiung Chang Gung Mem Hosp, Hosp Care Team, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Gastr Canc Team, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan.; Chen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Hosp Care Team, Kaohsiung, Taiwan.	alex8701125@gmail.com						Bai Yana, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P306, DOI 10.3760/cma.j.issn.0254-6450.2016.03.002; Chuang R-B, 2005, TAIWAN J HOSPICE PAL, V10, P5; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Everett SM, 1997, GUT, V41, P142, DOI 10.1136/gut.41.2.142; Gwilliam B, 2001, Int J Palliat Nurs, V7, P474; Hong JH, 2013, CANCER RES TREAT, V45, P270, DOI 10.4143/crt.2013.45.4.270; Izadi Azar, 2016, Asian Pac J Cancer Prev, V17, P3007; Kang SC, 2012, J CHIN MED ASSOC, V75, P221, DOI 10.1016/j.jcma.2012.04.005; Lai YL, 1997, SUPPORT CARE CANCER, V5, P348, DOI 10.1007/s005200050090; Lin WY, 2014, SUPPORT CARE CANCER, V22, P1907, DOI 10.1007/s00520-014-2168-5; Liu CN, 2002, J FORMOS MED ASSOC, V101, P552; Loke SS, 2011, J PALLIAT MED, V14, P683, DOI 10.1089/jpm.2010.0331; Loke SS, 2011, CANCER NURS, V34, pE21, DOI 10.1097/NCC.0b013e3181ff78b6; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; MAEHARA Y, 1992, BRIT J SURG, V79, P245, DOI 10.1002/bjs.1800790320; Masuda Y, 2006, J PALLIAT MED, V9, P152, DOI 10.1089/jpm.2006.9.152; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Obermeyer Z, 2015, HEALTH AFFAIR, V34, P993, DOI 10.1377/hlthaff.2014.1055; Okada K, 2012, ENDOSCOPY, V44, P122, DOI 10.1055/s-0031-1291486; Rosania R, 2015, GASTROINTEST TUMORS, V2, P178, DOI 10.1159/000445188; Sato K, 2008, SUPPORT CARE CANCER, V16, P113, DOI 10.1007/s00520-007-0332-x; Torelli GF, 1999, NUTRITION, V15, P665, DOI 10.1016/S0899-9007(99)00118-5; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tse DMW, 2007, PALLIATIVE MED, V21, P425, DOI 10.1177/0269216307079825; Wang HM, 2011, J PAIN SYMPTOM MANAG, V42, P400, DOI 10.1016/j.jpainsymman.2010.12.011; Wu LF, 2016, SUPPORT CARE CANCER, V24, P53, DOI 10.1007/s00520-015-2741-6; Yasuda K, 1999, CANCER, V85, P2119, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M	28	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171365	10.1371/journal.pone.0171365	http://dx.doi.org/10.1371/journal.pone.0171365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158232	Green Submitted, Green Published, gold			2022-12-27	WOS:000396161700065
J	Landry, J; Martinov, T; Mengistu, H; Dhanwada, J; Benck, CJ; Kline, J; Boo, B; Swanson, L; Tonc, E; Daughters, R; Fife, BT; Chatterjea, D				Landry, Jasmine; Martinov, Tijana; Mengistu, Hanna; Dhanwada, Jyothi; Benck, Charles J.; Kline, Jaclyn; Boo, Beebie; Swanson, Linnea; Tonc, Elena; Daughters, Randy; Fife, Brian T.; Chatterjea, Devavani			Repeated hapten exposure induces persistent tactile sensitivity in mice modeling localized provoked vulvodynia	PLOS ONE			English	Article							MAST-CELL PROGENITORS; TUMOR-NECROSIS-FACTOR; VULVAR VESTIBULITIS; MOUSE MODEL; IGE; HYPERSENSITIVITY; HYPERINNERVATION; RECRUITMENT; EXPRESSION; ETIOLOGY	Background Vulvodynia is a remarkably prevalent chronic pain condition of unknown etiology. Epidemiologic studies associate the risk of vulvodynia with a history of atopic disease. We used an established model of hapten-driven contact hypersensitivity to investigate the underlying mechanisms of allergy-provoked prolonged sensitivity to pressure. Methods We sensitized female ND4 Swiss mice to the hapten oxazolone on their flanks, and subsequently challenged them four days later with oxazolone or vehicle for ten consecutive days on the labia. We evaluated labiar sensitivity to touch, local mast cell accumulation, and hyperinnervation after ten challenges. Results Oxazolone-challenged mice developed significant tactile sensitivity that persisted for over three weeks after labiar allergen exposures ceased. Allergic sites were characterized by mast cell accumulation, sensory hyper-innervation and infiltration of regulatory CD4(+)CD25(+)FoxP3(+)T cells as well as localized early increases in transcripts encoding Nerve Growth Factor and nerve-mast cell synapse marker Cell Adhesion Molecule 1. Local depletion of mast cells by intra-labiar administration of secretagogue compound 48/80 led to a reduction in both nerve density and tactile sensitivity. Conclusions Mast cells regulate allergy-provoked persistent sensitivity to touch. Mast cell-targeted therapeutic strategies may provide novel means to manage and limit chronic pain conditions associated with atopic disease.	[Landry, Jasmine; Mengistu, Hanna; Dhanwada, Jyothi; Benck, Charles J.; Kline, Jaclyn; Boo, Beebie; Swanson, Linnea; Tonc, Elena; Daughters, Randy; Chatterjea, Devavani] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Martinov, Tijana; Fife, Brian T.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	Macalester College; University of Minnesota System; University of Minnesota Twin Cities	Chatterjea, D (corresponding author), Macalester Coll, Dept Biol, St Paul, MN 55105 USA.	chatterjead@macalester.edu	Martinov, Tijana/AFU-5047-2022; Landry, Jasmine/AAI-8246-2021; Fife, Brian/D-2042-2013	Landry, Jasmine/0000-0002-3242-9878; Kline, Jaclyn/0000-0002-6897-5520; Fife, Brian/0000-0001-9826-5637; Martinov, Tijana/0000-0002-6027-3380	National Institutes of Health [NIH R15 NS067536-01A1, NIH R15 AI113620-01A1]; National Vulvodynia Association; Macalester College; Arnold and Mabel Beckman Foundation; Howard Hughes Medical Research Institute; National Institute of Health [R01AI106791]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI113620, T35AI118620, R01AI106791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Vulvodynia Association; Macalester College; Arnold and Mabel Beckman Foundation; Howard Hughes Medical Research Institute(Howard Hughes Medical Institute); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding support includes National Institutes of Health grants NIH R15 NS067536-01A1 and NIH R15 AI113620-01A1 (awarded to DC; https://www.nih.gov), a National Vulvodynia Association research grant (awarded to DC; http://www.nva.org), and internal awards from Macalester College. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CJB and JD received stipends from intra-mural programs supported by science education grants to Macalester College from the Arnold and Mabel Beckman Foundation (CJB) and the Howard Hughes Medical Research Institute (HM, JD). TM and BTF are supported by National Institute of Health grant R01AI106791.	Akopians AL, 2015, SEMIN REPROD MED, V33, P239, DOI 10.1055/s-0035-1554919; Almarestani L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-56; Babula O, 2004, AM J OBSTET GYNECOL, V190, P663, DOI 10.1016/j.ajog.2003.09.031; Bax HJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00229; Benck CJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53638; Bomstein J, 2008, INT J GYNECOL PATHOL, V27, P136, DOI 10.1097/pgp.0b013e318140021b; Bornstein J, 2004, GYNECOL OBSTET INVES, V58, P171, DOI 10.1159/000079663; Chakrabarty A, 2011, NEUROSCI LETT, V495, P67, DOI 10.1016/j.neulet.2011.03.043; Chatterjea D, 2015, MOL IMMUNOL, V63, P38, DOI 10.1016/j.molimm.2014.03.001; Chatterjea D, 2012, BIOCHEM BIOPH RES CO, V425, P237, DOI 10.1016/j.bbrc.2012.07.074; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Falsetta ML, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.002; Farage MA, 2011, CURR PROBL DERMATOL, V40, P9, DOI 10.1159/000321042; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Forsythe P, 2012, CHEM IMMUNOL ALLERGY, V98, P196, DOI 10.1159/000336523; Foster DC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.038; Foster DC, 1997, OBSTET GYNECOL, V89, P291, DOI 10.1016/S0029-7844(96)00447-4; Giesecke J, 2004, OBSTET GYNECOL, V104, P126, DOI 10.1097/01.AOG.0000129238.49397.4e; Gimenez-Rivera V, 2016, J IMMUNOL; Goetsch MF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.028; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Hagiyama M, 2013, BRIT J DERMATOL, V168, P771, DOI 10.1111/bjd.12108; Harlow BL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.033; Harlow BL, 2009, ANN EPIDEMIOL, V19, P771, DOI 10.1016/j.annepidem.2009.06.006; Harlow BL, 2005, AM J EPIDEMIOL, V161, P871, DOI 10.1093/aje/kwi108; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Jones TG, 2010, J IMMUNOL, V185, P1804, DOI 10.4049/jimmunol.1001146; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewendorf AI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00140; Martinov T, 2013, JOVE-J VIS EXP, DOI 10.3791/51212; Martinov T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078673; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Nguyen RHN, 2009, J REPROD MED, V54, P385; Nyirjesy P, 2001, SEX TRANSM INFECT, V77, P53, DOI 10.1136/sti.77.1.53; Piovezan AP, 2004, BRIT J PHARMACOL, V141, P755, DOI 10.1038/sj.bjp.0705663; Pukall CF, 2016, J SEX MED, V13, P291, DOI 10.1016/j.jsxm.2015.12.021; Reed BD, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.012; Regauer S, 2015, APMIS, V123, P452, DOI 10.1111/apm.12372; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Sadownik LA, 2014, INT J WOMENS HEALTH, V6, P437, DOI 10.2147/IJWH.S37660; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Tommola P, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.1098; Wesselmann U, 2014, PAIN, V155, P1696, DOI 10.1016/j.pain.2014.05.010; Xiang Z, 2000, CLIN EXP ALLERGY, V30, P1379, DOI 10.1046/j.1365-2222.2000.00906.x; Yoneshige A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00075; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	52	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0169672	10.1371/journal.pone.0169672	http://dx.doi.org/10.1371/journal.pone.0169672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158195	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700004
J	Lima, VD; Wang, L; Brumme, C; Wu, L; Montaner, JSG; Harrigan, PR				Lima, Viviane D.; Wang, Lu; Brumme, Chanson; Wu, Lang; Montaner, Julio S. G.; Harrigan, P. Richard			Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CELL COUNTS; RECOMMENDATIONS; INFECTION; FAILURE; VIREMIA; SAMPLES	Background Plasma HIV-1 RNA levels (pVLs), routinely used for clinical management, are influenced by measurement error (ME) due to physiologic and assay variation. Objective To assess the ME of the COBAS HIV-1 Ampliprep AMPLICOR MONITOR ultrasensitive assay version 1.5 and the COBAS Ampliprep Taqman HIV-1 assay versions 1.0 and 2.0 close to their lower limit of detection. Secondly to examine whether there was any evidence that pVL measurements closest to the lower limit of quantification, where clinical decisions are made, were susceptible to a higher degree of random noise than the remaining range. Methods We analysed longitudinal pVL of treatment-naive patients from British Columbia, Canada, during their first six months on treatment, for time periods when each assay was uniquely available: Period 1 (Amplicor): 08/03/2000-01/02/2008; Period 2 (Taqman v1.0): 07/01/2010-07/03/2012; Period 3 (Taqman v2.0):08/03/2012-30/06/2014. ME was estimated via generalized additive mixed effects models, adjusting for several clinical and demographic variables and follow-up time. Results The ME associated with each assay was approximately 0.5 log(10) copies/mL. The number of pVL measurements, at a given pVL value, was not randomly distributed; values <= 250 copies/mL were strongly systematically overrepresented in all assays, with the prevalence decreasing monotonically as the pVL increased. Model residuals for pVL <= 250 copies/mL were approximately three times higher than that for the higher range, and pVL measurements in this range could not be modelled effectively due to considerable random noise of the data. Conclusions Although the ME was stable across assays, there is substantial increase in random noise in measuring pVL close to the lower level of detection. These findings have important clinical significance, especially in the range where key clinical decisions are made. Thus, pVL values <= 250 copies/mL should not be taken as the "truth" and repeat pVL measurement is encouraged to confirm viral suppression.	[Lima, Viviane D.; Wang, Lu; Montaner, Julio S. G.; Harrigan, P. Richard] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane D.; Montaner, Julio S. G.; Harrigan, P. Richard] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada; [Wu, Lang] Univ British Columbia, Dept Stat, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca		Brumme, Chanson/0000-0003-2722-5288	Canadian Institutes of Heath Research (CIHR) [MOP-125948, PJT-148595]; Scholar Award from the Michael Smith Foundation for Health Research [5199]; New Investigator award from CIHR [288880]; British Columbia Ministry of Health; US National Institutes of Health [R01 DA036307]; CIHR/GlaxoSmithKline Research Chair in Clinical Virology; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307] Funding Source: NIH RePORTER	Canadian Institutes of Heath Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Scholar Award from the Michael Smith Foundation for Health Research; New Investigator award from CIHR(Canadian Institutes of Health Research (CIHR)); British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/GlaxoSmithKline Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	VDL is supported by two grants from the Canadian Institutes of Heath Research (CIHR; MOP-125948; PJT-148595), by a Scholar Award from the Michael Smith Foundation for Health Research (#5199) and a New Investigator award from CIHR (#288880). JSGM is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01 DA036307). PRH is supported by CIHR/GlaxoSmithKline Research Chair in Clinical Virology. The funding sources had no role in the choice of methods, the contents or form of this work, or the decision to submit the results for publication.	Alaeus A, 1997, AIDS, V11, P859, DOI 10.1097/00002030-199707000-00004; British Columbia Centre for Excellence in HIV/AIDS, 2013, THER GUIDL ANT ARV T; Brumme CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043882; Buonaccorsi JP, 2010, INTERD STAT, P1, DOI 10.1201/9781420066586; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Cloherty G, 2014, J VIROL METHODS, V204, P91, DOI 10.1016/j.jviromet.2014.01.025; Cobb BR, 2011, J CLIN VIROL, V52, pS77, DOI 10.1016/j.jcv.2011.09.015; Gallant JE, 2007, J INFECT DIS, V196, P1729, DOI 10.1086/523705; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Kraft CS, 2013, J CLIN VIROL, V57, P77, DOI 10.1016/j.jcv.2012.12.015; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Lima VD, 2015, AIDS, V29, P1871, DOI 10.1097/QAD.0000000000000790; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Luft LM, 2011, INT J INFECT DIS, V15, pE661, DOI 10.1016/j.ijid.2011.05.013; Mine M, 2013, J VIROL METHODS, V194, P217, DOI 10.1016/j.jviromet.2013.08.031; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Palmer S, 2013, CURR OPIN HIV AIDS, V8, P87, DOI 10.1097/COH.0b013e32835d80af; Parekh B, 1999, AIDS RES HUM RETROV, V15, P133, DOI 10.1089/088922299311556; Raboud JM, 1996, J INFECT DIS, V174, P191, DOI 10.1093/infdis/174.1.191; Rebeiro PF, 2008, CLIN INFECT DIS, V47, P1354, DOI 10.1086/592693; Schomaker M, 2015, EPIDEMIOLOGY, V26, P628, DOI 10.1097/EDE.0000000000000334; The Joint United Nations Programme on HIV/AIDS, 2015, LANDM HIV DIAGN ACC; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization, 2015, CONS GUID US ANT DRU; Wu L., 2010, MIXED EFFECTS MODELS	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171155	10.1371/journal.pone.0171155	http://dx.doi.org/10.1371/journal.pone.0171155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152073	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200095
J	Ptaszek, A; Ptaszek, P; Dziubinski, M; Grzesik, NM; Liszka-Skoczylas, M				Ptaszek, Anna; Ptaszek, Pawel; Dziubinski, Marek; Grzesik, N. Miroslaw; Liszka-Skoczylas, Marta			The effect of structural properties on rheological behaviour of starches in binary dimethyl sulfoxide-water solutions	PLOS ONE			English	Article							SHEAR-THICKENING BEHAVIOR; WAXY MAIZE STARCHES; LIGHT-SCATTERING; AQUEOUS-SOLUTION; COMPLEX FLUIDS; DMSO; AMYLOSE; AMYLOPECTIN; VISCOSITY; DYNAMICS	This research study analysed the rheological properties of potato amylose and potato amylopectin in binary solutions of the following water and dimethyl sulfoxide concentrations: 90% DMSO (1), 80% DMSO (2) and 50% DMSO (3), with preparation methodology involving the dissolution at the temperature of 98 degrees C. The studies of dynamic light scattering on the biopolymer coils and the determination of main relaxation times of the solutions were carried out. For the amylose solutions, the fast relaxation phenomena are predominant. The results of the quality tests of the hysteresis loop showed, that the amylose solutions in the solvents (1) and (2) are rheologically stable and shear-thickened. The amylose solutions in solvents (3) reveal oscillatory alterations of viscosity in the time. Amylopectin solutions are characterized by 80% share of slow relaxation phenomena, very low diffusion coefficients and hydrodynamic radii in the range of 2000 nm. The amylopectin solutions are rheologically unstable.	[Ptaszek, Anna; Ptaszek, Pawel; Liszka-Skoczylas, Marta] Agr Univ Krakow, Fac Food Technol, Dept Engn & Machinery Food Ind, Ul Balicka 122, Krakow, Poland; [Dziubinski, Marek] Tech Univ Lodz, Fac Proc & Environm Engn, Dept Chem Engn, Ul Wolczanska 175, Lodz, Poland; [Grzesik, N. Miroslaw] Polish Acad Sci, Inst Chem Engn, Ul Baltycka 5, Gliwice, Poland	Agricultural University Krakow; Lodz University of Technology; Polish Academy of Sciences; Institute of Chemical Engineering of the Polish Academy of Sciences	Ptaszek, A (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Engn & Machinery Food Ind, Ul Balicka 122, Krakow, Poland.	a.ptaszek@ur.krakow.pl	Dziubinski, Marek/P-4524-2019; Ptaszek, Anna/AAF-6615-2019; Ptaszek, Anna/E-4082-2016; Ptaszek, Anna/AAH-1094-2020; Ptaszek, Pawel/K-8177-2017	Dziubinski, Marek/0000-0002-7765-1106; Ptaszek, Anna/0000-0002-2252-7650; Ptaszek, Anna/0000-0002-2252-7650; Ptaszek, Pawel/0000-0003-3190-3547; Grzesik, Miroslaw/0000-0002-9289-2581; Liszka-Skoczylas, Marta/0000-0001-7281-3711	NCN [N N312 171339]	NCN	This work was supported by NCN grant no. N N312 171339.	ABERLE T, 1994, STARCH-STARKE, V46, P329, DOI 10.1002/star.19940460903; Aberle T, 1997, STARCH-STARKE, V49, P215, DOI 10.1002/star.19970490602; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Bello-Perez LA, 1998, J CEREAL SCI, V27, P267, DOI 10.1006/jcrs.1998.0186; Chakraborty S, 2005, CARBOHYD POLYM, V60, P475, DOI 10.1016/j.carbpol.2005.03.011; Chamberlain EK, 1999, CARBOHYD POLYM, V40, P251, DOI 10.1016/S0144-8617(99)00060-0; Cheetham NWH, 1998, CARBOHYD POLYM, V35, P287, DOI 10.1016/S0144-8617(97)00151-3; Das DK, 2016, BIOPHYS CHEM, V216, P31, DOI 10.1016/j.bpc.2016.06.002; de Vasconcelos CL, 2000, CARBOHYD POLYM, V41, P181, DOI 10.1016/S0144-8617(99)00078-8; DEKEE D, 1980, CHEM ENG COMMUN, V6, P273, DOI 10.1080/00986448008912535; Dintzis FR, 1996, CEREAL CHEM, V73, P638; DINTZIS FR, 1995, J RHEOL, V39, P1399, DOI 10.1122/1.550643; Divers T, 2007, CARBOHYD POLYM, V68, P136, DOI 10.1016/j.carbpol.2006.07.026; Eliasson A. -C., 2004, STARCH FOOD STRUCTUR; Ghosh A, 2001, CHEM ENG SCI, V56, P5635, DOI 10.1016/S0009-2509(01)00159-2; Ghosh R, 2011, J PHYS CHEM B, V115, P7612, DOI 10.1021/jp110549h; Ghosh S, 2014, RSC ADV, V4, P14378, DOI 10.1039/c4ra00719k; Han JA, 2004, CARBOHYD POLYM, V55, P265, DOI 10.1016/j.carbpol.2003.09.007; Heineck ME, 2008, POLYMER, V49, P4386, DOI 10.1016/j.polymer.2008.07.062; Honerkamp J, 1990, CONTINUUM MECHANICS, V2, P17, DOI [10.1007/BF01170953, DOI 10.1007/BF01170953]; JORDAN RC, 1980, MACROMOLECULES, V13, P491, DOI 10.1021/ma60075a006; Kapoor B, 2000, CARBOHYD POLYM, V42, P323, DOI 10.1016/S0144-8617(99)00188-5; Kapoor B, 2001, CARBOHYD POLYM, V44, P217, DOI 10.1016/S0144-8617(00)00218-6; Lee JH, 2014, FOOD HYDROCOLLOID, V35, P115, DOI 10.1016/j.foodhyd.2013.05.003; Macosko CW, 1994, VISCOUS LIQUID RHEOL; Mewis J, 2009, ADV COLLOID INTERFAC, V147-48, P214, DOI 10.1016/j.cis.2008.09.005; Millard MM, 1997, CEREAL CHEM, V74, P687, DOI 10.1094/CCHEM.1997.74.5.687; Ptaszek A, 2014, STARCH-STARKE, V66, P326, DOI 10.1002/star.201300113; Ptaszek A, 2012, J FOOD ENG, V111, P272, DOI 10.1016/j.jfoodeng.2012.02.022; Ptaszek P, 2011, STARCH-STARKE, V63, P181, DOI 10.1002/star.201000100; Quemada D, 1998, EUR PHYS J-APPL PHYS, V3, P309, DOI 10.1051/epjap:1998234; Quemada D, 1999, EUR PHYS J-APPL PHYS, V5, P191, DOI 10.1051/epjap:1999128; Quemada D, 1998, EUR PHYS J-APPL PHYS, V2, P175, DOI 10.1051/epjap:1998170; Radosta S, 2001, BIOMACROMOLECULES, V2, P970, DOI 10.1021/bm0100662; Roy S, 2011, J PHYS CHEM B, V115, P685, DOI 10.1021/jp109622h; Schuster HG, 2005, DETERMINISTIC CHAOS: AN INTRODUCTION, 4TH EDITION, P1, DOI 10.1002/3527604804; Teraoka Iwao, 2002, POLYM SOLUTIONS INTR; Yang C, 2006, CARBOHYD POLYM, V64, P190, DOI 10.1016/j.carbpol.2005.11.017; Yang Ch, 2006, CARBOHYD POLYM, V64, P227, DOI [10.1016/j.cis.2008.09.005, DOI 10.1016/J.CIS.2008.09.005]; Yu SF, 2014, CZECH J FOOD SCI, V32, P514, DOI 10.17221/394/2013-CJFS	40	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171109	10.1371/journal.pone.0171109	http://dx.doi.org/10.1371/journal.pone.0171109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152071	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161200091
J	Abdollahi, M; Ng, TSY; Rezaeizadeh, A; Aamidor, S; Twigg, SM; Min, DQ; McLennan, SV				Abdollahi, Maryam; Ng, Taria Shin Yi; Rezaeizadeh, Alireza; Aamidor, Sarah; Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.			Insulin treatment prevents wounding associated changes in tissue and circulating neutrophil MMP-9 and NGAL in diabetic rats	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MATRIX METALLOPROTEINASES; ACTIVATION; ANGIOGENESIS; INFLAMMATION; ULCERS; MODEL	Neutrophils are important for wound repair, but their persistence can impair the healing process. Neutrophils express matrix metalloproteinases including MMP-9 and its regulator neutrophil gelatinase associated lipocalin (NGAL). Whether wounding affects neutrophil MMP-9 and NGAL in diabetic animals is not known. Skin wound tissue MMP-9 and NGAL was examined by qRT-PCR and immunohistochemistry in control, diabetic and insulin treated diabetic rats. The temporal expression of MMP-9 and NGAL mRNA, MMP-9 activity and the NGAL/MMP-9 complex was also investigated in an implant model and their circulating neutrophils. The cellular localisation of MMP-9 and NGAL was confirmed by immunofluorescence and the ability of glucose to regulate these factors was examined in isolated neutrophils. In skin wound tissue compared with control, diabetes increased neutrophil infiltration, NGAL mRNA and MMP-9 protein (P<0.05). Diabetes significantly increased implant neutrophil NGAL and MMP-9 protein as well as NGAL mRNA, wound fluid NGAL/MMP-9 complex and MMP-9 activity (all <0.05). Circulating neutrophil MMP-9 and NGAL was also increased in these diabetic animals (P<0.05). These changes were prevented by insulin treatment. Ex vivo, high glucose (25mM) increased neutrophil NGAL and MMP-9 (both by 2 fold, P<0.05). NGAL and MMP-9 are increased in wound and circulating neutrophils in diabetic rodents. These changes and the association between higher NGAL and increased wound fluid MMP-9 activity suggest that increased neutrophil NGAL may contribute to increased MMP-9 in poorly healing diabetic wounds. Whether targeting neutrophil NGAL or MMP-9 can improve diabetic wound healing remains to be investigated.	[Abdollahi, Maryam; Ng, Taria Shin Yi; Rezaeizadeh, Alireza; Aamidor, Sarah; Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.] Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Greg Brown Diabet & Endocrinol Labs, Sydney, NSW, Australia; [Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia; [Twigg, Stephen M.; Min, Danqing; McLennan, Susan V.] Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW, Australia; [McLennan, Susan V.] Royal Prince Alfred Hosp, NSW Hlth Pathol, Chem Pathol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	McLennan, SV (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney Med Sch, Greg Brown Diabet & Endocrinol Labs, Sydney, NSW, Australia.; McLennan, SV (corresponding author), Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia.; McLennan, SV (corresponding author), Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW, Australia.; McLennan, SV (corresponding author), Royal Prince Alfred Hosp, NSW Hlth Pathol, Chem Pathol, Sydney, NSW, Australia.	sue.mclennan@sydney.edu.au		Min, Danqing/0000-0002-2576-4344; Aamidor, Sarah/0000-0002-5266-1340				Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Balasoiu D, 1997, DIABETES CARE, V20, P392, DOI 10.2337/diacare.20.3.392; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Dasu MR, 2014, WORLD J DIABETES, V5, P219, DOI 10.4239/wjd.v5.i2.219; Dasu MR, 2012, CLIN SCI, V122, P203, DOI 10.1042/CS20110357; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Feng G, 2014, FEBS J, V281, P5054, DOI 10.1111/febs.13043; Hobizal KB, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.18409; Houreld NN, 2014, SCI WORLD J, DOI 10.1155/2014/398412; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]; Mack JA, 2010, J INVEST DERMATOL, V130, P856, DOI 10.1038/jid.2009.305; Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z; McKittrick IB, 2011, AM J PHYSIOL-RENAL, V301, pF1326, DOI 10.1152/ajprenal.00267.2011; McLennan SV, 2008, WOUND REPAIR REGEN, V16, P706, DOI 10.1111/j.1524-475X.2008.00421.x; Min DQ, 2009, AM J PHYSIOL-RENAL, V297, pF1229, DOI 10.1152/ajprenal.00074.2009; Min DQ, 2006, ELECTROPHORESIS, V27, P357, DOI 10.1002/elps.200500484; Muller M, 2008, DIABETIC MED, V25, P419, DOI 10.1111/j.1464-5491.2008.02414.x; Nishio N, 2008, AGE, V30, P11, DOI 10.1007/s11357-007-9043-y; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Osar Z, 2004, EXP DIABESITY RES, V5, P155, DOI 10.1080/15438600490424244; Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x; Serra R, 2013, WOUND REPAIR REGEN, V21, P395, DOI 10.1111/wrr.12035; Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Wong SL, 2015, NATURE MED; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200	31	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0170951	10.1371/journal.pone.0170951	http://dx.doi.org/10.1371/journal.pone.0170951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182694	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800025
J	Hisa, K; Yanagimachi, MD; Naruto, T; Miyamae, T; Kikuchi, M; Hara, R; Imagawa, T; Yokota, S; Mori, M				Hisa, Kaori; Yanagimachi, Masakatsu D.; Naruto, Takuya; Miyamae, Takako; Kikuchi, Masako; Hara, Rhoki; Imagawa, Tomoyuki; Yokota, Shumpei; Mori, Masaaki			PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PEPTIDYLARGININE DEIMINASE-4; FUNCTIONAL HAPLOTYPE; ASSOCIATION; HLA; SUSCEPTIBILITY; POLYMORPHISMS; ALLELES; GENE; LOCALIZATION	Objective Both genetic and environmental factors are associated with susceptibility to juvenile idiopathic arthritis (JIA). Many studies have reported that both a ` shared epitope' (SE) encoded by several HLA-DRB1 alleles and the peptidyl arginine deiminase type 4 (PADI4) gene polymorphisms are associated with susceptibility to rheumatoid arthritis (RA). However, it is uncertain whether JIA and RA share the latter genetic risk factor. Therefore, here we investigated relationships between HLA-SE and PADI4 polymorphisms with clinical subtypes of JIA. Methods JIA patients (39 oligoarthritis, 48 RF-positive polyarthritis, 19 RF-negative polyarthritis and 82 systemic) and 188 healthy controls were genotyped for HLA-DRB1 by PCR-sequencespecific oligonucleotide probe methodology. Three PADI4 gene single nucleotide polymorphisms (SNPs), rs2240340, rs2240337 and rs1748033, were genotyped using TaqMan SNP Genotyping Assays. Results Frequencies of the HLA-SE were higher in RF-positive polyarticular JIA than in healthy controls. RF-positive polyarticular JIA was associated with HLA-SE (OR = 5.3, 95% CI = 2.5-11.9, pc < 0.001). No associations were found between clinical subtypes of JIA and PADI4 allele frequency. Nonetheless, rs2240337 in the PADI4 gene was significantly associated with anti-cyclic citrullinated peptide antibody (ACPA)-positivity in JIA. The A allele at rs2240337 was a significant risk factor for ACPA positivity in JIA (OR = 5.6, 95% CI = 1.71-23.7 pc = 0.03). Conclusion PADI4 gene polymorphism is associated with ACPA-positivity in JIA. The association of HLA-SE with RF-positive polyarticular JIA as well as RA is confirmed in Japanese. Thus, HLA-SE and PADI4 status both influence JIA clinical manifestations.	[Hisa, Kaori; Yanagimachi, Masakatsu D.; Naruto, Takuya; Miyamae, Takako; Kikuchi, Masako; Hara, Rhoki; Imagawa, Tomoyuki; Yokota, Shumpei; Mori, Masaaki] Yokohama City Grad Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan; [Hisa, Kaori; Imagawa, Tomoyuki] Kanagawa Childrens Med Ctr, Dept Infect Dis & Immunol, Yokohama, Kanagawa, Japan; [Yanagimachi, Masakatsu D.] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Mori, Masaaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Lifetime Clin Immunol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yanagimachi, MD (corresponding author), Yokohama City Grad Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan.; Yanagimachi, MD (corresponding author), Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan.	myanagimachi.ped@tmd.ac.jp			Japan Society for the Promotion of Science [16790583]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from Grand-in-Aid for Scientific Research from Japan Society for the Promotion of Science (No. 16790583). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeles-Han Sheila, 2010, Curr Rheumatol Rep, V12, P87, DOI 10.1007/s11926-010-0087-0; BARRON KS, 1992, J RHEUMATOL, V19, P1611; Cha S, 2007, ARTHRITIS RHEUM-US, V56, P1454, DOI 10.1002/art.22570; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Cheng JL, 2012, J RHEUMATOL, V39, P1159, DOI 10.3899/jrheum.120007; CLEMENS LE, 1983, ANN RHEUM DIS, V42, P431, DOI 10.1136/ard.42.4.431; FORRE O, 1983, ARTHRITIS RHEUM, V26, P35, DOI 10.1002/art.1780260106; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gandjbakhch F, 2009, J RHEUMATOL, V36, P881, DOI 10.3899/jrheum.080398; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Ikari K, 2006, RHEUMATOLOGY, V45, P1345, DOI 10.1093/rheumatology/kel169; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Kochi Y, 2010, NAT REV RHEUMATOL, V6, P290, DOI 10.1038/nrrheum.2010.23; Lee YH, 2016, CLIN RHEUMATOL, V35, P961, DOI 10.1007/s10067-015-3098-4; Lin YT, 2011, AUTOIMMUN REV, V10, P482, DOI 10.1016/j.autrev.2011.02.001; Lipinska J, 2012, J RHEUMATOL, V39, P1078, DOI 10.3899/jrheum.110879; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; NEPOM BS, 1984, J CLIN INVEST, V74, P287, DOI 10.1172/JCI111413; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Petty RE, 2004, J RHEUMATOL, V31, P390; Plenge Robert M, 2009, Curr Rheumatol Rep, V11, P351, DOI 10.1007/s11926-009-0050-0; Prahalad S, 2012, ARTHRITIS RHEUM-US, V64, P925, DOI 10.1002/art.33376; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rossi-Semerano L, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/480373; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Syed Reema H, 2008, Curr Rheumatol Rep, V10, P156, DOI 10.1007/s11926-008-0027-4; Thomson W, 2002, RHEUMATOLOGY, V41, P1183, DOI 10.1093/rheumatology/41.10.1183; VEHE RK, 1990, J RHEUMATOL, V17, P11; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Yanagimachi M, 2011, J HUM GENET, V56, P196, DOI 10.1038/jhg.2010.159	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171961	10.1371/journal.pone.0171961	http://dx.doi.org/10.1371/journal.pone.0171961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182665	Green Published, gold, Green Submitted			2022-12-27	WOS:000394231800138
J	Nazareno, AL; Hernandez, BS				Nazareno, Allen Lamarca; Hernandez, Bryan Sapon			A mathematical model of the interaction of abscisic acid, ethylene and methyl jasmonate on stomatal closure in plants	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; GUARD-CELLS; HYDROGEN-PEROXIDE; NITRIC-OXIDE; SIGNAL-TRANSDUCTION; ARABIDOPSIS; ABA; NETWORKS; STRESS; GENERATION	Stomatal closure is affected by various stimuli such as light, atmospheric carbon dioxide concentration, humidity and phytohormones. Our research focuses on phytohormones, specifically: abscisic acid (ABA), ethylene (ET) and methyl jasmonate (MeJA) that are responsible for the regulation of several plant processes, especially in guard cell signalling. While several studies show that these three phytohormones cause stomatal closure in plants, only two studies are notable for establishing a mathematical model of guard cell signalling involving phytohormones. Those two studies employed Boolean modelling and mechanistic ordinary differential equations modelling. In this study, we propose a new mathematical model of guard cell transduction network for stomatal closure using continuous logical modelling framework. Results showed how the different components of the network function. Furthermore, the model verified the role of antioxidants in the closure mechanism, and the diminished closure level of stomata with combined ABA-ET stimulus. The analysis was extended to ABA-ET-MeJA crosstalk.	[Nazareno, Allen Lamarca; Hernandez, Bryan Sapon] Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines; [Hernandez, Bryan Sapon] Malayan Coll Laguna, Coll Arts & Sci, Laguna, Philippines	University of the Philippines System; University of the Philippines Los Banos; Malayan Colleges Laguna	Nazareno, AL (corresponding author), Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines.	allennazareno@gmail.com	Hernandez, Bryan S./AAG-1811-2021	Hernandez, Bryan S./0000-0002-5632-216X; Nazareno, Allen/0000-0002-8969-6774				Beguerisse-Diaz M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-146; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Daszkowska-Golec A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00138; Desikan R, 2004, J EXP BOT, V55, P205, DOI 10.1093/jxb/erh033; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Garcia-Mata C, 2002, PLANT PHYSIOL, V128, P790, DOI 10.1104/pp.011020; Harrison Marcia A, 2012, PHYTOHORMONES ABIOTI, P49, DOI [10.1007/978-981-10-7479-0_12, DOI 10.1007/978-981-10-7479-0_12]; Hayashi M, 2011, PLANT SIGNAL BEHAV, V6, P1662, DOI 10.4161/psb.6.11.17800; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Kwak J. M., 2008, ARABIDOPSIS BOOK, V6, P1; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Macey R, 2001, BERKELEY MADONNA VER; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Munemasa S, 2011, PLANT SIGNAL BEHAV, V6, P939, DOI 10.4161/psb.6.7.15439; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; PALLAS JE, 1982, PLANT PHYSIOL, V70, P598, DOI 10.1104/pp.70.2.598; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Reece J, 2010, CAMBELL BIOL; Saito N, 2008, PLANT CELL PHYSIOL, V49, P1396, DOI 10.1093/pcp/pcn106; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Sankar M, 2011, BIOINFORMATICS, V27, P1404, DOI 10.1093/bioinformatics/btr158; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Suhita D, 2004, PLANT PHYSIOL, V134, P1536, DOI 10.1104/pp.103.032250; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Zhang X, 2001, CELL RES, V11, P195, DOI 10.1038/sj.cr.7290086	29	16	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2017	12	2							e0171065	10.1371/journal.pone.0171065	http://dx.doi.org/10.1371/journal.pone.0171065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9GJ	28182683	Green Published, Green Submitted, gold			2022-12-27	WOS:000394231800030
J	Moon, Y; McGinnis, RS; Seagers, K; Motl, RW; Sheth, N; Wright, JA; Ghaffari, R; Sosnoff, JJ				Moon, Yaejin; McGinnis, Ryan S.; Seagers, Kirsten; Motl, Robert W.; Sheth, Nirav; Wright, John A., Jr.; Ghaffari, Roozbeh; Sosnoff, Jacob J.			Monitoring gait in multiple sclerosis with novel wearable motion sensors	PLOS ONE			English	Article							STEP COUNT ACCURACY; AMBULATORY SYSTEM; OLDER-ADULTS; GO TEST; WALKING; PERFORMANCE; ACCELEROMETERS; INDIVIDUALS; PARAMETERS; ALGORITHM	Background Mobility impairment is common in people with multiple sclerosis (PwMS) and there is a need to assess mobility in remote settings. Here, we apply a novel wireless, skin-mounted, and conformal inertial sensor (BioStampRC, MC10 Inc.) to examine gait characteristics of PwMS under controlled conditions. We determine the accuracy and precision of BioStampRC in measuring gait kinematics by comparing to contemporary research-grade measurement devices. Methods A total of 45 PwMS, who presented with diverse walking impairment (Mild MS = 15, Moderate MS = 15, Severe MS = 15), and 15 healthy control subjects participated in the study. Participants completed a series of clinical walking tests. During the tests participants were instrumented with BioStampRC and MTx (Xsens, Inc.) sensors on their shanks, as well as pan activity monitor GT3X (Actigraph, Inc.) on their non-dominant hip. Shank angular velocity was simultaneously measured with the inertial sensors. Step number and temporal gait parameters were calculated from the data recorded by each sensor. Visual inspection and the MTx served as the reference standards for computing the step number and temporal parameters, respectively. Accuracy (error) and precision (variance of error) was assessed based on absolute and relative metrics. Temporal parameters were compared across groups using ANOVA. Results Mean accuracy precision for the BioStampRC was 2 2 steps error for step number, 6 +/- 9ms error for stride time and 6 +/- 7ms error for step time (0.6-2.6% relative error). Swing time had the least accuracy precision (25 +/- 19ms error, 5 4% relative error) among the parameters. GT3X had the least accuracy precision (8 +/- 14% relative error) in step number estimate among the devices. Both MTx and BioStampRC detected significantly distinct gait characteristics between PwMS with different disability levels (p<0.01). Conclusion BioStampRC sensors accurately and precisely measure gait parameters in PwMS across diverse walking impairment levels and detected differences in gait characteristics by disability level in PwMS. This technology has the potential to provide granular monitoring of gait both inside and outside the clinic.	[Moon, Yaejin; Sosnoff, Jacob J.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [McGinnis, Ryan S.] Univ Vermont, Dept Elect & Biomed Engn, Burlington, VT USA; [Seagers, Kirsten; Sheth, Nirav; Wright, John A., Jr.; Ghaffari, Roozbeh] MC10 Inc, Lexington, MA USA; [Motl, Robert W.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Vermont; University of Alabama System; University of Alabama Birmingham	Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu	Sosnoff, Jacob/P-3397-2019; Ghaffari, Roozbeh/ABD-6718-2021	Sosnoff, Jacob/0000-0002-0286-9207; Seagers, Kirsten/0000-0003-1632-5611; Moon, Yaejin/0000-0002-1187-6847; McGinnis, Ryan/0000-0001-8396-6967	MC10 Inc.	MC10 Inc.	JJS received funding from MC10 Inc. for this research. The funder provided support in the form of salaries for authors RSM, KS, NS, JAW, and RG, but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript.	[Actigraph Actigraph I], 2016, US GUID ACTIGRAPH WG; Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Aminian K, 1999, MED BIOL ENG COMPUT, V37, P686, DOI 10.1007/BF02513368; Balto JM, 2016, MULTIPLE SCLEROSIS J, V2; Bassett Jr DR, 2013, PHYS THERAPY REV; Bethoux Francois, 2011, Int J MS Care, V13, P4, DOI 10.7224/1537-2073-13.1.4; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Cameron MH, 2011, CURR NEUROL NEUROSCI, V11, P507, DOI 10.1007/s11910-011-0214-y; Comber L, 2016, GAIT POSTURE; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Faber MJ, 2006, PHYS THER, V86, P944, DOI 10.1093/ptj/86.7.944; Givon U, 2009, GAIT POSTURE, V29, P138, DOI 10.1016/j.gaitpost.2008.07.011; Goldman MD, 2007, MULTIPLE SCLEROSIS; Greene BR, 2010, MED BIOL ENG COMPUT, V48, P1251, DOI 10.1007/s11517-010-0692-0; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Jasiewicz JM, 2006, GAIT POSTURE, V24, P502, DOI 10.1016/j.gaitpost.2005.12.017; Kaufman M, 2000, MULT SCLER, V6, P286, DOI 10.1177/135245850000600411; Kavanagh JJ, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-9; Kim A., 2004, IEEE; Klaren RE, 2013, ARCH PHYS MED REHAB, V94, P2342, DOI 10.1016/j.apmr.2013.07.011; Korpan SM, 2015, J AGING PHYS ACTIV, V23, P377, DOI 10.1123/japa.2014-0033; Lee JK, 2011, MED BIOL ENG COMPUT, V49, P707, DOI 10.1007/s11517-011-0736-0; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Moon Y, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/964790; Motl RW, 2013, ACTA NEUROL SCAND, V127, P384, DOI 10.1111/ane.12036; Motl RW, 2013, PHYS MED REH CLIN N, V24, P325, DOI 10.1016/j.pmr.2012.11.004; Motl RW, 2012, EXPERT REV NEUROTHER, V12, P1079, DOI [10.1586/ern.12.74, 10.1586/ERN.12.74]; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; National Multiple Sclerosis Society, 2006, MULT SCLER INF SOURC; Nilsagard Y, 2007, PHYSIOTHER RES INT, V12, P105, DOI 10.1002/pri.358; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Pilutti LA, 2013, J NEUROL SCI, V334, P72, DOI 10.1016/j.jns.2013.07.2511; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Preiningerova JL, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0001-0; Ratzker PK, 1997, J NEUROL REHABIL, V11, P207; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Sabatini AM, 2005, IEEE T BIO-MED ENG, V52, P486, DOI 10.1109/TBME.2004.840727; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Sandroff BM, 2013, DISABIL REHABIL, V35, P725, DOI 10.3109/09638288.2012.707745; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Socie MJ, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/645197; Sosnoff JJ, 2012, J REHABIL RES DEV, V49, P1405, DOI 10.1682/JRRD.2011.11.0218; Sosnoff JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028021; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Thoumie P, 2005, MULT SCLER J, V11, P485, DOI 10.1191/1352458505ms1176oa; Webber SC, 2016, J AGING PHYS ACTIV, V24, P451, DOI 10.1123/japa.2015-0234; Zhang JT, 2013, PHYSIOL MEAS, V34, pN63, DOI 10.1088/0967-3334/34/8/N63	51	76	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171346	10.1371/journal.pone.0171346	http://dx.doi.org/10.1371/journal.pone.0171346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1UY	28178288	Green Submitted, Green Published, gold			2022-12-27	WOS:000393712500038
J	Smeets, CCJ; Codd, V; Denniff, M; Samani, NJ; Hokken-Koelega, ACS				Smeets, Carolina C. J.; Codd, Veryan; Denniff, Matthew; Samani, Nilesh J.; Hokken-Koelega, Anita C. S.			Effects of size at birth, childhood growth patterns and growth hormone treatment on leukocyte telomere length	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; BODY-COMPOSITION; GH TREATMENT; LONG-TERM; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; EARLY ORIGINS; RISK-FACTORS; WEIGHT-GAIN	Background Small size at birth and rapid growth in early life are associated with increased risk of cardiovascular disease in later life. Short children born small for gestational age (SGA) are treated with growth hormone (GH), inducing catch-up in length. Leukocyte telomere length (LTL) is a marker of biological age and shorter LTL is associated with increased risk of cardiovascular disease. Objectives To investigate whether LTL is influenced by birth size, childhood growth and long-term GH treatment. Methods We analyzed LTL in 545 young adults with differences in birth size and childhood growth patterns. Previously GH-treated young adults born SGA (SGA-GH) were compared to untreated short SGA (SGA-S), SGA with spontaneous catch-up to a normal body size (SGA-CU), and appropriate for gestational age with a normal body size (AGA-NS). LTL was measured using a quantitative PCR assay. Results We found a positive association between birth length and LTL (p = 0.04), and a trend towards a positive association between birth weight and LTL (p = 0.08), after adjustments for gender, age, gestational age and adult body size. Weight gain during infancy and childhood and fat mass percentage were not associated with LTL. Female gender and gestational age were positively associated with LTL, and smoking negatively. After adjustments for gender, age and gestational age, SGA-GH had a similar LTL as SGA-S (p = 0.11), SGACU (p = 0.80), and AGA-NS (p = 0.30). Conclusions Larger size at birth is positively associated with LTL in young adulthood. Growth patterns during infancy and childhood are not associated with LTL. Previously GH-treated young adults born SGA have similar LTL as untreated short SGA, SGA with spontaneous catch-up and AGA born controls, indicating no adverse effects of GH-induced catch-up in height on LTL.	[Smeets, Carolina C. J.; Hokken-Koelega, Anita C. S.] Erasmus Univ, Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands; [Codd, Veryan; Denniff, Matthew; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Codd, Veryan; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Hokken-Koelega, Anita C. S.] Dutch Growth Res Fdn, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Smeets, CCJ (corresponding author), Erasmus Univ, Med Ctr, Dept Pediat, Subdiv Endocrinol, Rotterdam, Netherlands.	l.smeets@erasmusmc.nl		Codd, Veryan/0000-0002-9430-8254	British Heart Foundation; MRC [MR/M012816/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	VC, MD and NJS are funded by the British Heart Foundation and NJS is a UK National Institute for Health Research (NIHR) Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boot AM, 1997, AM J CLIN NUTR, V66, P232, DOI 10.1093/ajcn/66.2.232; Breukhoven PE, 2011, J CLIN ENDOCR METAB, V96, P3710, DOI 10.1210/jc.2011-1658; Brouilette S, 2003, EUR HEART J, V24, P121, DOI 10.1016/S0195-668X(03)94107-8; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; [CentraalBureauStatistiek Statistiek CBvd], 2006, DUTCH STAND CLASS ED; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; de Zegher F, 2016, PEDIAT OBES; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Guo Y, 2004, OBES RES, V12, P1925, DOI 10.1038/oby.2004.241; Guzzardi MA, 2016, INT J OBESITY, V40, P1063, DOI 10.1038/ijo.2016.58; He QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094385; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Kajantie E, 2012, INT J EPIDEMIOL, V41, P1400, DOI 10.1093/ije/dys127; Kerkhof GF, 2012, J CLIN ENDOCR METAB, V97, P2637, DOI 10.1210/jc.2012-1426; Kerkhof GF, 2009, J CLIN ENDOCR METAB, V94, P4243, DOI 10.1210/jc.2009-1036; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Latifovic L, 2016, CANCER EPIDEM BIOMAR, V25, P374, DOI 10.1158/1055-9965.EPI-14-1364; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Samaras Thomas T., 2012, Nutrition and Health (Bicester), V21, P247, DOI 10.1177/0260106013510996; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Smeets CCJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143951; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; van Dijk M, 2006, J CLIN ENDOCR METAB, V91, P1390, DOI 10.1210/jc.2005-1663; van Dijk M, 2007, J CLIN ENDOCR METAB, V92, P160, DOI 10.1210/jc.2006-1073; van Pareren Y, 2003, J CLIN ENDOCR METAB, V88, P3584, DOI 10.1210/jc.2002-021172; van Pareren Y, 2003, J CLIN ENDOCR METAB, V88, P347, DOI 10.1210/jc.2002-020458; Willemsen RH, 2008, J CLIN ENDOCR METAB, V93, P3449, DOI 10.1210/jc.2008-0623	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2017	12	2							e0171825	10.1371/journal.pone.0171825	http://dx.doi.org/10.1371/journal.pone.0171825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1UY	28178350	Green Published, Green Submitted, gold			2022-12-27	WOS:000393712500073
J	Methy, N; Meyer, L; Bajos, N; Velter, A				Methy, Nicolas; Meyer, Laurence; Bajos, Nathalie; Velter, Annie			Generational analysis of trends in unprotected sex in France among men who have sex with men: The major role of context-driven evolving patterns	PLOS ONE			English	Article							RISK BEHAVIOR; ANTIRETROVIRAL THERAPY; INTERNET SURVEY; HIV TREATMENT; GAY; INTERCOURSE; IMPACT; SURVEILLANCE; COUNTRIES; MSM	Objective Using a generational approach, this study analyses how unprotected anal intercourse has evolved since 1991 in France across different generations of men who have sex with men (MSM) whose sexual lives began at different periods in the history of the HIV epidemic. Design Data were collected from 18-59 year-old respondents to the French Gay Press surveys Enquetes Presse Gay, conducted repeatedly between 1991 and 2011 (N = 32,196) using self-administered questionnaires distributed in gay magazines and over the internet. Methods Trends in unprotected anal intercourse (i.e. condomless anal sex) with casual partners of unknown or different HIV serostatus (hereafter "UAId" in this manuscript) were studied. Responses were analysed according to year and then reorganised for age-cohort analyses by generation, based on the year respondents turned 18. Results UAId rates fell from 1991 to 1997, and then rose from 13.4% in 1997 to 25.5% in 2011 among seronegative respondents, and from 24.8% to 63.3%, respectively, among seropositive respondents. Both in seropositive and seronegative respondents, UAId increased over time for all generations, indicative of a strong period effect. Conclusion Analyses of data from several generations of MSM who started their sexual lives at different time points in the HIV epidemic, revealed very similar trends in UAId between generations, among both seropositive and seronegative respondents. This strong period effect suggests that sexual behaviours in MSM are influenced more by contextual than generational factors. The fact that prevention practices are simultaneously observed in different generations and that there are most likely underlying prevention norms among MSM, suggests that PrEP could become widely accepted by all generations of MSM exposed to the risk of HIV.	[Methy, Nicolas; Meyer, Laurence; Bajos, Nathalie; Velter, Annie] Univ Paris Saclay, INSERM, UVSQ, CESP,Univ Paris Sud, Villejuif, France; [Velter, Annie] Sante Publ France, St Maurice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute of Public Health Surveillance	Velter, A (corresponding author), Univ Paris Saclay, INSERM, UVSQ, CESP,Univ Paris Sud, Villejuif, France.; Velter, A (corresponding author), Sante Publ France, St Maurice, France.	annie.velter@santepubliquefrance.fr	Bajos, Nathalie/M-4170-2018	Bajos, Nathalie/0000-0001-8073-9056	French National Agency for Research on AIDS; Viral Hepatitis (ANRS); French National Institute for Public Health Surveillance (InVS)	French National Agency for Research on AIDS(ANRS); Viral Hepatitis (ANRS)(ANRS); French National Institute for Public Health Surveillance (InVS)	The Gay Press surveys were funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and the French National Institute for Public Health Surveillance (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Gay Press surveys were funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) and the French National Institute for Public Health Surveillance (InVS).	Adam P, 2011, RESULTATS PRELIMINAI; Bajos N., 2012, SEXUALITY FRANCE PRA; Balaji AB, 2013, AIDS LOND ENGL, V27; Beltzer N, 2013, AIDS, V27, P1011, DOI 10.1097/QAD.0b013e32835e1583; Berg RC, 2013, SOC SCI MED, V78, P61, DOI 10.1016/j.socscimed.2012.11.033; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bolding G, 2005, AIDS, V19, P961, DOI 10.1097/01.aids.0000171411.84231.f6; Bozon M., 2012, SEXUALITY FRANCE PRA; Broqua C., 2003, HOMOSEXUALITES AU TE; Cazein F., 2015, B EPIDEMIOL HEBD, V9, P152; Chauvin S., 2013, SOCIOLOGIE HOMOSEXUA; Chen YH, 2016, AIDS BEHAV; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Elford J, 2009, EUROSURVEILLANCE, V14, P47; Girard G, 2016, CULT HEALTH SEX, V18, P15, DOI 10.1080/13691058.2015.1063813; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Hart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1; Hull P, 2016, SEX TRANSM INFECT; Janiec J, 2013, EUROSURVEILLANCE, V18, P20644; Kaye DK, 2013, J INFECT DEV COUNTR, V7, P436, DOI 10.3855/jidc.2644; Kellogg TA, 2013, SEX TRANSM DIS, V40, P689, DOI 10.1097/01.olq.0000431354.96087.50; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lot F, 2015, B EPIDEMIOL HEBD, V40-41, P744; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-826; McDaid LM, 2012, SEX TRANSM DIS, V39, P735, DOI 10.1097/OLQ.0b013e31825a3a3c; Methy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123151; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nguyen VK, 2011, AIDS, V25, P291, DOI 10.1097/QAD.0b013e3283402c3e; Paquette D, 2010, AIDS BEHAV, V14, P1252, DOI 10.1007/s10461-010-9743-7; Paz-Bailey G, 2016, AIDS LOND ENGL; Pharris A, 2015, EURO SURVEILL B EUR, V20; Philip SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012662; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Seng R, 2011, AIDS, V25, P977, DOI 10.1097/QAD.0b013e328345ef12; Shoveller J, 2016, CRIT PUBLIC HEALTH, V26, P487, DOI 10.1080/09581596.2015.1117577; Stromdahl S, 2015, EURO SURVEILL B EUR, V20; Sullivan PS, 2014, CURR OPIN HIV AIDS, V9, P199, DOI 10.1097/COH.0000000000000039; Vallabhaneni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045718; van den Boom W, 2014, JAIDS-J ACQ IMM DEF, V65, P375, DOI 10.1097/QAI.0000000000000051; Velter A, 2015, EURO SURVEILL B EUR, V20; Velter A, 2009, EURO SURVEILL B EUR, V14; Velter A, 2007, RAPPORT PRESSE GAY 2; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171493	10.1371/journal.pone.0171493	http://dx.doi.org/10.1371/journal.pone.0171493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1SG	28170424	Green Published, gold, Green Submitted			2022-12-27	WOS:000393705500040
J	Zhang, JT; Wang, ZM; Liang, SB; Zhang, YH; Zhou, SL; Lu, LQ; Wang, RZ				Zhang, Jing-Ting; Wang, Zhi-Min; Liang, Shuang-Bo; Zhang, Ying-Hua; Zhou, Shun-Li; Lu, Lai-Qing; Wang, Run-Zheng			Quantitative study on the fate of residual soil nitrate in winter wheat based on a N-15-labeling method	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; DOUBLE CROPPING SYSTEM; FERTILIZER-NITROGEN; MAIZE ROTATION; CHINA; MANAGEMENT; CORN; AGRICULTURE; GROUNDWATER; IRRIGATION	A considerable amount of surplus nitrogen (N), which primarily takes the form of nitrate, accumulates in the soil profile after harvesting crops from an intensive production system in the North China Plain. The residual soil nitrate (RSN) is a key factor that is included in the N recommendation algorithm. Quantifying the utilization and losses of RSN is a fundamental necessity for optimizing crop N management, improving N use efficiency, and reducing the impact derived from farmland N losses on the environment. In this study, a N-15-labeling method was introduced to study the fate of the RSN quantitatively during the winter wheat growing season by N-15 tracer technique combined with a soil column study. A soil column with a 2 m height was vertically divided into 10 20-cm layers, and the RSN in each layer was individually labeled with a 15 N tracer before the wheat was sown. The results indicated that approximately 17.68% of the crop N derived from RSN was located in the 0-2 m soil profile prior to wheat sowing. The wheat recovery proportions of RSN at various layers ranged from 0.21% to 33.46%. The percentages that still remained in the soil profile after the wheat harvest ranged from 47.08% to 75.44%, and 19.46-32.64% of the RSN was unaccounted for. Upward and downward movements in the RSN were observed, and the maximum upward and downward distances were 40 cm and 100 cm, respectively. In general, the N-15-labeling method contributes to a deeper understanding of the fates of the RSN. Considering the low crop recovery of the RSN from deep soil layers, water and N saving practices should be adopted during crop production.	[Zhang, Jing-Ting; Wang, Zhi-Min; Zhang, Ying-Hua; Zhou, Shun-Li] China Agr Univ, Key Lab Farming Syst, Minist Agr, Coll Agron & Biotechnol, Beijing, Peoples R China; [Zhang, Jing-Ting; Liang, Shuang-Bo] Hebei Acad Agr & Forestry Sci, Inst Cereal & Oil Crops, Shijiazhuang, Hebei, Peoples R China; [Lu, Lai-Qing; Wang, Run-Zheng] China Agr Univ, Wuqiao Expt Stn, Beijing, Hebei, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Hebei Academy of Agricultural & Forestry Sciences; China Agricultural University	Zhou, SL (corresponding author), China Agr Univ, Key Lab Farming Syst, Minist Agr, Coll Agron & Biotechnol, Beijing, Peoples R China.	zhoushl@cau.edu.cn			National Natural Science Foundation of China [31071367]; New Century Excellent Talents in University [NCET-10-0790]; Special Fund for Agro-scientific Research in the Public Interest [201203031, 201303133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the National Natural Science Foundation of China (31071367), the Program for New Century Excellent Talents in University (NCET-10-0790), and the Special Fund for Agro-scientific Research in the Public Interest (201203031, 201303133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINFORD GD, 1992, AGRON J, V84, P53, DOI 10.2134/agronj1992.00021962008400010012x; Chen X. P., 2003, THESIS; COLBOURN P, 1984, PLANT SOIL, V76, P213, DOI 10.1007/BF02205581; Cui ZL, 2008, AGRON J, V100, P1527, DOI 10.2134/agronj2008.0005; DAVIES DB, 1995, J SCI FOOD AGR, V68, P399, DOI 10.1002/jsfa.2740680402; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Ferguson RB, 2002, SOIL SCI SOC AM J, V66, P544, DOI 10.2136/sssaj2002.0544; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033982; Hansen B, 2011, ENVIRON SCI TECHNOL, V45, P228, DOI 10.1021/es102334u; Hu XK, 2013, ENVIRON POLLUT, V176, P198, DOI 10.1016/j.envpol.2013.01.040; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Ju XiaoTang, 2003, Acta Pedologica Sinica, V40, P538; Kristensen HL, 2004, PLANT SOIL, V265, P93, DOI 10.1007/s11104-005-0696-y; Leip A, 2011, ENVIRON POLLUT, V159, P3243, DOI 10.1016/j.envpol.2011.01.040; LeMonte JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146761; [李虎 Li Hu], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P141; Liu T, 2013, ENVIRON SCI TECHNOL, V47, P13412, DOI 10.1021/es403357m; Liu X.H., 1993, FARMING SYSTEMS CHIN; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; NEWBOULD P, 1989, PLANT SOIL, V115, P297, DOI 10.1007/BF02202596; ONKEN AB, 1985, SOIL SCI SOC AM J, V49, P134, DOI 10.2136/sssaj1985.03615995004900010027x; PETERSON GA, 1979, AGRON J, V71, P371, DOI 10.2134/agronj1979.00021962007100020036x; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Ren CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141458; Richter J, 2000, NUTR CYCL AGROECOSYS, V57, P33, DOI 10.1023/A:1009802225307; ROTH GW, 1990, J ENVIRON QUAL, V19, P243, DOI 10.2134/jeq1990.00472425001900020008x; SMEETS J, 1981, WATER AIR SOIL POLL, V15, P483, DOI 10.1007/BF00279429; Sogbedji JM, 2000, J ENVIRON QUAL, V29, P1813, DOI 10.2134/jeq2000.00472425002900060011x; Steinheimer TR, 1998, ENVIRON SCI TECHNOL, V32, P1039, DOI 10.1021/es970598j; TIMMONS DR, 1981, J ENVIRON QUAL, V10, P421, DOI 10.2134/jeq1981.00472425001000030036x; Wang Z.M., 2006, REV CHINA AGR SCI TE, V8, P38; Wu YC, 2009, AGRON J, V101, P925, DOI 10.2134/agronj2008.0171; Xu ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092850; Yadav SN, 1997, J ENVIRON QUAL, V26, P808, DOI 10.2134/jeq1997.00472425002600030031x; Zhang LiJuan, 2004, Plant Nutrition and Fertilizer Science, V10, P455; Zhang WL, 1996, AGR ECOSYST ENVIRON, V59, P223, DOI 10.1016/0167-8809(96)01052-3; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157; [赵荣芳 Zhao Rongfang], 2009, [土壤学报, Acta Pedologica Sinica], V46, P684; Zhou MH, 2013, PLANT SOIL, V362, P149, DOI 10.1007/s11104-012-1269-5; [周顺利 Zhou Shunli], 2002, [生态学报, Acta Ecologica Sinica], V22, P48; Zhou SL, 2008, ENVIRON POLLUT, V152, P677; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067; Zhu ZL, 1998, PRESENT SITUATION NI	44	5	6	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2017	12	2							e0171014	10.1371/journal.pone.0171014	http://dx.doi.org/10.1371/journal.pone.0171014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK1SG	28170440	Green Published, Green Submitted, gold			2022-12-27	WOS:000393705500019
J	Smiljanic, J; Dankulov, MM				Smiljanic, Jelena; Dankulov, Marija Mitrovic			Associative nature of event participation dynamics: A network theory approach	PLOS ONE			English	Article							MEMBERS; SIZE	The affiliation with various social groups can be a critical factor when it comes to quality of life of each individual, making such groups an essential element of every society. The group dynamics, longevity and effectiveness strongly depend on group's ability to attract new members and keep them engaged in group activities. It was shown that high heterogeneity of scientist's engagement in conference activities of the specific scientific community depends on the balance between the numbers of previous attendances and non-attendances and is directly related to scientist's association with that community. Here we show that the same holds for leisure groups of the Meetup website and further quantify individual members' association with the group. We examine how structure of personal social networks is evolving with the event attendance. Our results show that member's increasing engagement in the group activities is primarily associated with the strengthening of already existing ties and increase in the bonding social capital. We also show that Meetup social networks mostly grow trough big events, while small events contribute to the groups cohesiveness.	[Smiljanic, Jelena; Dankulov, Marija Mitrovic] Univ Belgrade, Inst Phys Belgrade, Ctr Study Complex Syst, Comp Sci Lab, Pregrevica 118, Belgrade 11080, Serbia; [Smiljanic, Jelena] Univ Belgrade, Sch Elect Engn, POB 35-54, Belgrade 11120, Serbia	University of Belgrade; University of Belgrade	Smiljanic, J (corresponding author), Univ Belgrade, Inst Phys Belgrade, Ctr Study Complex Syst, Comp Sci Lab, Pregrevica 118, Belgrade 11080, Serbia.; Smiljanic, J (corresponding author), Univ Belgrade, Sch Elect Engn, POB 35-54, Belgrade 11120, Serbia.	jelenas@ipb.ac.rs	Dankulov, Marija Mitrovic/I-3007-2012; Smiljanic, Jelena/AIC-4573-2022	Dankulov, Marija Mitrovic/0000-0002-8484-3501; Smiljanic, Jelena/0000-0003-0124-1909	Ministry of Education, Science, and Technological Development of the Republic of Serbia [ON171017]; European Commission [675121]	Ministry of Education, Science, and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by ON171017, The Ministry of Education, Science, and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs/: J.S. and M.M.D.); and 675121, The European Commission (http://ec. europaeu/index_en.htm: M.M.D.).	Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Backstrom L., 2006, P SIGKDD, P44, DOI DOI 10.1145/1150402.1150412; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cellai D, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032302; Cho WKT, 2012, Q J POLIT SCI, V7, P105, DOI 10.1561/100.00011051; Cosgrave P, 2014, ENG SERENDIPITY STOR; Dankulov MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12197; Davison KP, 2000, AM PSYCHOL, V55, P205, DOI 10.1037/0003-066X.55.2.205; Dianati N, 2016, ARXIV E PRINTS; Dianati N, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012304; Dunbar R, 2008, P BR ACAD, V154, P403, DOI DOI 10.1098/RSTB.2006.2001; Dunbar RIM, 2011, J I ECON, V7, P345, DOI 10.1017/S1744137410000366; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; Gonzalez-Bailon S, 2013, AM BEHAV SCI, V57, P943, DOI 10.1177/0002764213479371; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hristova D, 2013, P AAAI INT C WEBL SO, P234; Jiang J., 2016, P 10 INT C WEB SOC M, P599; Liebig J, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/28003; Lin Y.R., 2008, P 17 INT C WORLD WID, P685, DOI [10.1145/1367497.1367590, DOI 10.1145/1367497.1367590]; Liu X, 2012, P 18 ACM SIGKDD INT, P1032, DOI DOI 10.1145/2339530.2339693; Macedo A.Q., 2015, RECSYS 2015, P123, DOI DOI 10.1145/2792838.2800187; McCully W., 2011, P 7 INT S WIK OP COL, P39, DOI DOI 10.1145/2038558.2038566; Mitrovic M, 2010, EUR PHYS J B, V73, P293, DOI 10.1140/epjb/e2009-00431-9; Mitrovic M, 2010, EUR PHYS J B, V77, P597, DOI 10.1140/epjb/e2010-00279-x; Mitrovic M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02005; Montazeri A, 2001, PATIENT EDUC COUNS, V45, P195, DOI 10.1016/S0738-3991(01)00121-5; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Qiao Z, 2014, AAAI CONF ARTIF INTE, P3130; Saracco F, 2016, ARXIV E PRINTS; Saracco F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10595; Sessions LF, 2010, INFORM COMMUN SOC, V13, P375, DOI 10.1080/13691180903468954; Smiljanic J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148528; Torok J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.088701; Pham TAN, 2015, PROC INT CONF DATA, P567, DOI 10.1109/ICDE.2015.7113315; van Dijk J, 2006, PAP REG SCI, V85, P483, DOI 10.1111/j.1435-5957.2006.00102.x; Weinberg B. D., 2006, DIRECT DATA DIGITAL, V8, P46, DOI DOI 10.1057/palgrave.dddmp.4340552; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]; Zhang W, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P910	45	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2017	12	2							e0171565	10.1371/journal.pone.0171565	http://dx.doi.org/10.1371/journal.pone.0171565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EK1QH	28166305	gold, Green Submitted, Green Published			2022-12-27	WOS:000393700100053
J	Deng, WP; Zhang, K; Busov, V; Wei, HR				Deng, Wenping; Zhang, Kui; Busov, Victor; Wei, Hairong			Recursive random forest algorithm for constructing multilayered hierarchical gene regulatory networks that govern biological pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; WALL BIOSYNTHESIS; ESCHERICHIA-COLI; SND1	Background Present knowledge indicates a multilayered hierarchical gene regulatory network (ML-hGRN) often operates above a biological pathway. Although the ML-hGRN is very important for understanding how a pathway is regulated, there is almost no computational algorithm for directly constructing ML-hGRNs. Results A backward elimination random forest (BWERF) algorithm was developed for constructing the ML-hGRN operating above a biological pathway. For each pathway gene, the BWERF used a random forest model to calculate the importance values of all transcription factors (TFs) to this pathway gene recursively with a portion (e.g. 1/10) of least important TFs being excluded in each round of modeling, during which, the importance values of all TFs to the pathway gene were updated and ranked until only one TF was remained in the list. The above procedure, termed BWERF. After that, the importance values of a TF to all pathway genes were aggregated and fitted to a Gaussian mixture model to determine the TF retention for the regulatory layer immediately above the pathway layer. The acquired TFs at the secondary layer were then set to be the new bottom layer to infer the next upper layer, and this process was repeated until a ML-hGRN with the expected layers was obtained. Conclusions BWERF improved the accuracy for constructing ML-hGRNs because it used backward elimination to exclude the noise genes, and aggregated the individual importance values for determining the TFs retention. We validated the BWERF by using it for constructing ML-hGRNs operating above mouse pluripotency maintenance pathway and Arabidopsis lignocellulosic pathway. Compared to GENIE3, BWERF showed an improvement in recognizing authentic TFs regulating a pathway. Compared to the bottom-up Gaussian graphical model algorithm we developed for constructing ML-hGRNs, the BWERF can construct ML-hGRNs with significantly reduced edges that enable biologists to choose the implicit edges for experimental validation.	[Deng, Wenping; Busov, Victor; Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Zhang, Kui] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Wei, Hairong] Michigan Technol Univ, Life Sci & Technol Inst, Houghton, MI 49931 USA	Michigan Technological University; Michigan Technological University; Michigan Technological University	Wei, HR (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	hairong@mtu.edu	wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998; Deng, Wenping/0000-0003-3303-8083	National Science Foundation [DBI-1458130]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Advances in Biological Informatics [DBI-1458130], https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014; Blum A, 2011, FUNCT PLANT BIOL, V38, P753, DOI 10.1071/FP11101; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butte AJ, 2000, PAC S BIOCOMPUT; Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jin YC, 2012, IEEE T SYST MAN CY B, V42, P805, DOI 10.1109/TSMCB.2011.2178021; Kumari S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0981-1; Lin YC, 2013, PLANT CELL, V25, P4324, DOI 10.1105/tpc.113.117697; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martinez-Antonio A., 2011, NETWORK BIOL, V1, P1, DOI 10.1073/pnas.0500365102; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Tuszynski J., 2012, CATOOLS TOOLS MOVING; Wei HR, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.27211; Wei HR, 2013, NEW PHYTOL, V200, P483, DOI 10.1111/nph.12375; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	26	13	13	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171532	10.1371/journal.pone.0171532	http://dx.doi.org/10.1371/journal.pone.0171532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158291	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700094
J	Lee, J; Roberts, SC; Reimer, B; Mehler, B				Lee, Joonbum; Roberts, Shannon C.; Reimer, Bryan; Mehler, Bruce			Does order matter? Investigating the effect of sequence on glance duration during on-road driving	PLOS ONE			English	Article							PATTERNS	Previous literature has shown that vehicle crash risks increases as drivers' off-road glance duration increases. Many factors influence drivers' glance duration such as individual differences, driving environment, or task characteristics. Theories and past studies suggest that glance duration increases as the task progresses, but the exact relationship between glance sequence and glance durations is not fully understood. The purpose of this study was to examine the effect of glance sequence on glance duration among drivers completing a visual-manual radio tuning task and an auditory-vocal based multi-modal navigation entry task. Eighty participants drove a vehicle on urban highways while completing radio tuning and navigation entry tasks. Forty participants drove under an experimental protocol that required three button presses followed by rotation of a tuning knob to complete the radio tuning task while the other forty participants completed the task with one less button press. Multiple statistical analyses were conducted to measure the effect of glance sequence on glance duration. Results showed that across both tasks and a variety of statistical tests, glance sequence had inconsistent effects on glance duration-the effects varied according to the number of glances, task type, and data set that was being evaluated. Results suggest that other aspects of the task as well as interface design effect glance duration and should be considered in the context of examining driver attention or lack thereof. All in all, interface design and task characteristics have a more influential impact on glance duration than glance sequence, suggesting that classical design considerations impacting driver attention, such as the size and location of buttons, remain fundamental in designing in-vehicle interfaces.	[Lee, Joonbum; Reimer, Bryan; Mehler, Bruce] MIT AgeLab, Cambridge, MA 02142 USA; [Lee, Joonbum; Reimer, Bryan; Mehler, Bruce] New England Univ Transportat Ctr, Cambridge, MA 02139 USA; [Roberts, Shannon C.] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Lee, J (corresponding author), MIT AgeLab, Cambridge, MA 02142 USA.; Lee, J (corresponding author), New England Univ Transportat Ctr, Cambridge, MA 02139 USA.	joonbum@mit.edu	Lee, Joonbum/ABC-9757-2020; Mehler, Bruce/E-4538-2017	Mehler, Bruce/0000-0001-5929-4179; /0000-0002-4790-0108; Roberts, Shannon/0000-0002-0052-7801	US DOT's Region I New England University Transportation Center at MIT; Toyota Class Action Settlement Safety Research and Education Program; Santos Family Foundation; Toyota's Collaborative Safety Research Center	US DOT's Region I New England University Transportation Center at MIT; Toyota Class Action Settlement Safety Research and Education Program; Santos Family Foundation; Toyota's Collaborative Safety Research Center	Support for this work was provided in part by the US DOT's Region I New England University Transportation Center at MIT and the Toyota Class Action Settlement Safety Research and Education Program. Acknowledgement is also extended to The Santos Family Foundation and Toyota's Collaborative Safety Research Center for providing funding for the studies [13,14] from which the data for this analysis was drawn. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom C, 2012, IEEE T INTELL TRANSP, V13, P553, DOI 10.1109/TITS.2011.2174786; Altmann EM, 2002, COGNITIVE SCI, V26, P39, DOI 10.1207/s15516709cog2601_2; Angell L., 2006, 810635 DOT HS NAT HI; Lee JD, 2012, HUM FACTORS, V54, P250, DOI 10.1177/0018720811429562; Liang YL, 2012, HUM FACTORS, V54, P1104, DOI 10.1177/0018720812446965; Mehler B., 2014, FURTHER EVALUATION E; Munoz M, 2016, TRANSPORT RES F-TRAF, V43, P90, DOI 10.1016/j.trf.2016.09.015; NHTSA, 2013, NHTSA20100053; R Core Team, 2018, R LANG ENV STAT COMP; Reimer Bryan, 2013, EFFECTS PRODUCTION L; Smith D, 2006, TRANSPORT RES REC, V1937, P61; Sudweeks J.D, 2006, 810594 DOT HS NAT HI; Victor T, 2015, SWS08ARW1 NAT HIGHW; Victor TW, 2005, TRANSPORT RES F-TRAF, V8, P167, DOI 10.1016/j.trf.2005.04.014; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]; Wickens CD, 2008, HUM FACTORS, V50, P449, DOI 10.1518/001872008X288394; Yamani Y, 2014, HUMAN FACTORS J HUMA	17	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171730	10.1371/journal.pone.0171730	http://dx.doi.org/10.1371/journal.pone.0171730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158301	Green Published, gold, Green Submitted			2022-12-27	WOS:000396161700121
J	Moynihan, R; Sims, R; Hersch, J; Thomas, R; Glasziou, P; McCaffery, K				Moynihan, Ray; Sims, Rebecca; Hersch, Jolyn; Thomas, Rae; Glasziou, Paul; McCaffery, Kirsten			Communicating about overdiagnosis: Learning from community focus groups on osteoporosis	PLOS ONE			English	Article							OVERTREATMENT	Background Overdiagnosis is considered a risk associated with the diagnosis of osteoporosis-as many people diagnosed won't experience harm from the condition. As yet there's little evidence on community understanding of overdiagnosis outside cancer-where it is an established risk of some screening programs-or effective ways to communicate about it. We examined community understanding around overdiagnosis of osteoporosis, to optimise communication strategies about this problem. Methods and findings Using a qualitative design we recruited a community sample of women, 50-80 years, from the Gold Coast community around Bond University, Australia, using random digit dialing, and conducted 5 focus groups with 41 women. A discussion guide and 4-part presentation were developed and piloted, with independent review from a consumer and clinical experts. Initial discussion had 4 segments: osteoporosis; bone density vs. other risk factors; medication; and overdiagnosis. The second half included the 4 short presentations and discussions on each. Analysis used Framework Analysis method. Initially participants described osteoporosis as bone degeneration causing some fear, demonstrated imprecise understanding of overdiagnosis, had a view osteoporosis couldn't be overdiagnosed as bone scans provided "clear cut" results, expressed belief in early diagnosis, and interest in prevention strategies enabling control. Following presentations, participants expressed some understanding of overdiagnosis, preference for describing osteoporosis as a "risk factor" not "disease", concern about a poor risk-benefit ratio for medications, and surprise and unease the definition of osteoporosis decided bone density of young women was "normal", without age adjustment. Limitations include English-speaking backgrounds of the sample and complex materials. Conclusions Our findings suggest a gap between community expectations and how experts sometimes arbitrarily set low diagnostic thresholds which label those at risk as "diseased". Optimal communication about overdiagnosis could build on community scepticism about treatments, encouraging weighing up benefits and harms of tests and diagnoses, and framing this information as positively adding to knowledge.	[Moynihan, Ray; Sims, Rebecca; Thomas, Rae; Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia; [Hersch, Jolyn; McCaffery, Kirsten] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia	Bond University; University of Sydney	Moynihan, R (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia.	raymoynihan@bond.edu.au	, beccie/AAM-3770-2021; Moynihan, Ray/ABC-3010-2020; Glasziou, Paul/A-7832-2008; McCaffery, Kirsten/K-7945-2019; Hersch, Jolyn/H-7153-2013	, beccie/0000-0002-3885-1199; Glasziou, Paul/0000-0001-7564-073X; McCaffery, Kirsten/0000-0003-2696-5006; Hersch, Jolyn/0000-0001-5225-6639; Sims, Rebecca/0000-0002-1604-8354	Bond University; National Health and Medical Research Council [1112509, 1029241]; National Health and Medical Research Council Screening and Test Evaluation Program grant [633033]	Bond University; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Screening and Test Evaluation Program grant	The focus groups research was funded by an un-numbered grant from the Bond University, Vice-Chancellor's Research Grants scheme. JH is supported by a National Health and Medical Research Council Early Career Fellowship (#1112509). RT and RM were supported by a National Health and Medical Research Council Screening and Test Evaluation Program grant (#633033). KM was supported by a National Health and Medical Research Council fellowship (#1029241). Bond University's website is www.bond.edu.au. The National Health and Medical Research Council website is: https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MJA OPEN S1, V2; Australian Institute of Health and Welfare, 2014, EST PREV OST; Caro J, 2015, EBHC C 2015; Carter SM, 2016, J MED ETHICS, P1; Fenton JJ, 2016, JAMA INTERN MED, V176, P391, DOI 10.1001/jamainternmed.2015.6020; Herndon MB, 2007, HEALTH AFFAIR, V26, P1702, DOI 10.1377/hlthaff.26.6.1702; Hersch J, 2015, LANCET, V385, P1642, DOI 10.1016/S0140-6736(15)60123-4; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Jarvinen TLN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2088; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McClung MR, 2015, J BONE MINER RES, V30, P1754, DOI 10.1002/jbmr.2686; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125165; Moynihan R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001655; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; Rader T., SHOULD I TAKE ALENDR; Reid IR, 2011, SKELETAL RADIOL, V40, P1191, DOI 10.1007/s00256-011-1164-9; Reventlow SD, 2006, SOC SCI MED, V62, P2720, DOI 10.1016/j.socscimed.2005.11.009; RUBIN SM, 1992, ANN INTERN MED, V116, P990, DOI 10.7326/0003-4819-116-12-990; Schleifer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052552; Simmonds R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010337; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703; Welch GH, 2011, OVER DIAGNOSED MAKIN; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; WHO Study Group, 1994, ASS FRACT RISK ITS A	29	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0170142	10.1371/journal.pone.0170142	http://dx.doi.org/10.1371/journal.pone.0170142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN7DG	28158214	Green Published, Green Submitted, gold			2022-12-27	WOS:000396161700009
J	Tian, HL; Ge, XL; Nie, YZ; Yang, LF; Ding, C; McFarland, LV; Zhang, XY; Chen, QY; Gong, JF; Li, N				Tian, Hongliang; Ge, Xiaolong; Nie, Yongzhan; Yang, Linfeng; Ding, Chao; McFarland, Lynne V.; Zhang, Xueying; Chen, Qiyi; Gong, Jianfeng; Li, Ning			Fecal microbiota transplantation in patients with slow-transit constipation: A randomized, clinical trial	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE INFECTION; COLONIC TRANSIT; METAANALYSIS; CHILDHOOD; SYMPTOMS; ADULTS	Fecal microbiota transplantation has been proposed as a therapeutic approach for chronic constipation. This randomized, controlled trial aimed to compare the effects of conventional treatment alone (control) with additional treatment with FMT (intervention) in patients with slow -transit constipation (STC). Adults with STC were randomized to receive intervention or control treatment. The control group received education, behavioral strategies, and oral laxatives. The intervention group was additionally provided 6 days of FMT. The primary endpoint was the clinical cure rate (proportion of patients achieving a mean of > three complete spontaneous bowel movements [CSBMs] per week]. Secondary outcomes and safety parameters were assessed throughout the study. Sixty patients were randomized to either conventional treatment alone (n = 30) or FMT (n = 30) through a nasointestinal tube. There were significant differences between the intervention group and control group in the clinical improvement rate (intention -to -treat [ITT]: 53.3% vs. 20.0%, P= 0.009), clinical cure rate (ITT: 36.7% vs. 13.3%, P= 0.04), mean number of CSBMs per week (ITT: 3.2 1.4 vs. 2.1 1.2, P = 0.001), and the Wexner constipation score (ITT: 8.6 1.5 vs. 12.7 2.5, P< 0.00001). Compared with the control group, the intervention group showed better results in the stool consistency score (ITT: 3.9 vs. 2.4, P< 0.00001) and colonic transit time (ITT: 58.5 vs. 73.6 h, P< 0.00001). The intervention group had more treatment-related adverse events than did the control group (50 vs. 4 cases). FMT was significantly more effective (30% higher cure rate) for treatment of STC than conventional treatment. No serious adverse events were observed.	[Tian, Hongliang; Ge, Xiaolong; Ding, Chao; Zhang, Xueying; Chen, Qiyi; Gong, Jianfeng; Li, Ning] Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Nie, Yongzhan] Fourth Mil Med Univ, Xi Jing Hosp, Inst Digest Dis, Xian, Peoples R China; [Yang, Linfeng] BGI Shenzhen, Shenzhen, Peoples R China; [McFarland, Lynne V.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Li, Ning] Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai, Peoples R China	Nanjing University; Air Force Military Medical University; Beijing Genomics Institute (BGI); University of Washington; University of Washington Seattle; Tongji University	Gong, JF; Li, N (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.; Li, N (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai, Peoples R China.	gongjianfeng@aliyun.com; liningrigsnju@163.com	Yang, Linfeng/AAZ-8792-2020		National Nature Science Foundation of China [81670493]; National Gastroenterology Research Project [2015BAI131307]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Gastroenterology Research Project	This study was supported by the National Nature Science Foundation of China (no. 81670493) (http://www.nsfc.gov.cn/publish/portal1/) and by the National Gastroenterology Research Project (2015BAI131307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agachan F, 1996, DIS COLON RECTUM, V39, P681, DOI 10.1007/BF02056950; ANDREWS P, 1995, GASTROENTEROLOGY, V108, pA563; Benninga MA, 2004, J PEDIATR GASTR NUTR, V39, P448, DOI 10.1097/00005176-200411000-00002; Bharucha Adil E., 2001, Curr Treat Options Gastroenterol, V4, P309, DOI 10.1007/s11938-001-0056-9; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Crouzet L, 2013, NEUROGASTROENT MOTIL, V25, pe272, DOI 10.1111/nmo.12103; Emmanuel A, 2014, AM J GASTROENTEROL, V109, P887, DOI 10.1038/ajg.2014.74; Kang DW, 2015, ANAEROBE, V33, P33, DOI 10.1016/j.anaerobe.2015.01.005; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008; Khalif IL, 2005, DIGEST LIVER DIS, V37, P838, DOI 10.1016/j.dld.2005.06.008; McFarland LV, 2016, WORLD J GASTROENTERO, V22, P3078, DOI 10.3748/wjg.v22.i11.3078; Metcalf AM, 1987, GASTROENTEROLOGY, V92, P40, DOI 10.1016/0016-5085(87)90837-7; Mugie SM, 2011, NAT REV GASTRO HEPAT, V8, P502, DOI 10.1038/nrgastro.2011.130; Parthasarathy G, 2016, GASTROENTEROLOGY, V150, P367, DOI 10.1053/j.gastro.2015.10.005; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Southwell BR, 2009, PEDIATR SURG INT, V25, P559, DOI 10.1007/s00383-009-2387-x; Tian HL, 2016, J CLIN GASTROENTEROL, V50, P865, DOI 10.1097/MCG.0000000000000472; Tian HL, 2015, J CLIN GASTROENTEROL, V49, P537, DOI 10.1097/MCG.0000000000000330; Turan I, 2014, TURK J GASTROENTEROL, V25, P650, DOI 10.5152/tjg.2014.6990; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Voderholzer WA, 1997, AM J GASTROENTEROL, V92, P95; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zhu LX, 2014, PHYSIOL GENOMICS, V46, P679, DOI 10.1152/physiolgenomics.00082.2014; Zoppi G, 1998, ACTA PAEDIATR, V87, P836, DOI 10.1080/080352598750013590	25	74	80	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2017	12	2							e0171308	10.1371/journal.pone.0171308	http://dx.doi.org/10.1371/journal.pone.0171308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DG	28158276	gold, Green Published, Green Submitted			2022-12-27	WOS:000396161700058
J	Frietze, KM; Pascale, JM; Moreno, B; Chackerian, B; Peabody, DS				Frietze, Kathryn M.; Pascale, Juan M.; Moreno, Brechla; Chackerian, Bryce; Peabody, David S.			Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses	PLOS ONE			English	Article							DENGUE VIRUS-INFECTIONS; ENVELOPE GLYCOPROTEIN; IDENTIFICATION; PROTEIN; EPITOPE; PARTICLES; SELECTION; FUSION	Identifying the targets of antibody responses during infection is important for designing vaccines, developing diagnostic and prognostic tools, and understanding pathogenesis. We developed a novel deep sequence-coupled biopanning approach capable of identifying the protein epitopes of antibodies present in human polyclonal serum. Here, we report the adaptation of this approach for the identification of pathogen-specific epitopes recognized by antibodies elicited during acute infection. As a proof-of-principle, we applied this approach to assessing antibodies to Dengue virus (DENV). Using a panel of sera from patients with acute secondary DENV infection, we panned a DENV antigen fragment library displayed on the surface of bacteriophage MS2 virus-like particles and characterized the population of affinity-selected peptide epitopes by deep sequence analysis. Although there was considerable variation in the responses of individuals, we found several epitopes within the Envelope glycoprotein and Non-Structural Protein 1 that were commonly enriched. This report establishes a novel approach for characterizing pathogen-specific antibody responses in human sera, and has future utility in identifying novel diagnostic and vaccine targets.	[Frietze, Kathryn M.; Chackerian, Bryce; Peabody, David S.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, MSC08 4660,1 Univ New Mexico, Albuquerque, NM 87131 USA; [Pascale, Juan M.; Moreno, Brechla] Gorgas Mem Inst Hlth Studies, Ave Justo Arosemena & Calle 35, Panama City, Panama	University of New Mexico; Instituto Conmemorativo Gorgas de Estudios de la Salud	Frietze, KM (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, MSC08 4660,1 Univ New Mexico, Albuquerque, NM 87131 USA.	kfrietze@salud.unm.edu		Frietze, Kathryn/0000-0002-1428-8899	National Institutes of Health [R01 AI 083305]; National Research System from the Panamanian National Council of Science and Technology (SENACYT); NIH [UL1TR00449]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research System from the Panamanian National Council of Science and Technology (SENACYT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (R01 AI 083305) to BC. Dr. Pascale is supported by the National Research System from the Panamanian National Council of Science and Technology (SENACYT). This work was partially supported by a Pilot Project Grant from the NIH-funded University of New Mexico Clinical and Translational Science Center Grant Number: UL1TR00449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Crossey E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132560; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; Frietze KM, 2016, CANCER IMMUNOL RES, V4, P157, DOI 10.1158/2326-6066.CIR-15-0165; Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x; INNIS BL, 1989, AM J TROP MED HYG, V40, P676, DOI 10.4269/ajtmh.1989.40.676; Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Larman HB, 2013, J AUTOIMMUN, V43, P1, DOI 10.1016/j.jaut.2013.01.013; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357; O'Rourke JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111198; Omokoko MD, 2014, AM J TROP MED HYG, V91, P146, DOI 10.4269/ajtmh.13-0624; Ord RL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-326; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; da Silva ANMR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007425; Ryvkin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041469; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463	25	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2017	12	2							e0171511	10.1371/journal.pone.0171511	http://dx.doi.org/10.1371/journal.pone.0171511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN7DB	28152075	gold, Green Submitted, Green Published			2022-12-27	WOS:000396161200152
